Citrus Sinensis ID: 006620

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------64
Protein Sequence
MDQNFKFGQLIISKFSPLTSFCMFILYLLLARTVSGKIDPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSGDDTVLGMFEDDSDLDSASKQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAKVALIIDNSVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDFSSILVRQTESSMATC
Secondary Structure (PSIPRED)
cccccccHHHHHccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccEEEEccccccEEEEcccccEEEEEEEEccEEEEEEEcccccccccccccccccccccccccccccccccccEEEEccccccccccccccccccccccccEEEEEEccccccccccccccccEEEEEEEccccccccccccHHHHHHccEEEEEccccccccccccccccccccccEEEEEcccccccccEEEcccccHHHHHHHHHHHHHHHHEEEEccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHcccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEccccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEcccccccccccccccccccccccccccccccEEEEccccccccccccHHccccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHccccccccccccccccccccccccccEEEEcccccccc
Secondary Structure Prediction (SSPRO)
ccccccHHHHHHccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEcccccccccccccEEEEEcccccEEEEEccccEEEEEEEEccccEEEEEcccccccccccccccccccccccccccEcccccccEEEEEEcccccccccccccccccccccccEEEEEEcccccHHHccccccEEEEEEccccccccccccHHHHHHHHHcccEEEEcccccHHHcccccEEccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHcccccccEEcHHHHHHHHHHHHHHcccccccEEEEcEcccccEEEEEEEccccccHHHHHHHHHHHHHHccHEEEEEEEEccccccEEEEEEEcccccHHHHEcccccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEcccccHHHEEEcccccccHcHccHHHcccccccEEEcccccccccEEcHHHHHcccccEccccHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHcccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mdqnfkfgQLIIskfspltsFCMFILYLLLARtvsgkidpqYLACVAKtcgdgqsisfpfyienqqeaycgypgfnlscndkgnpvlklssdtnYIVEKILYDnhsvlvsnaafsetnsdpactfpriknvslpadfqlapdqkQAVLLyncnssspekLLRHKLlagncsgddtvlgmfeddsdldsaskqckesavapvavdmngegigdhiGIEEMVRKGFLLKwkasdcrackesggscgfdadtfhfqcycpdrrhakfctasgdgkLKLKAKVALIIDNSVIFWKKKTYNYRNIEAFLRNYgslapkryrYADIKKMTNSFKnklgqggyggvykgklldgQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSngslekfihekhpletnqklKWEVLYKIAVGIARGLEYLHRGcntrilhfdikphnilldedfcpkisdfglakicegresivsmtgargtigyiapevfcrnfgevsyksdvySYGMMVFEMTgeknnanvavdrsseiyfphwvYKRLELEedlglqgieneeDKEYARKMILVSLWCiqtnpsdrpsmNRVVEMLEGsldslqipprpfllssgsqpdfsSILVRQtessmatc
Flexible Loop (DISEMBL)
MDQNFKFGQLIISKFSPLTSFCMFILYLLLARTVSGKIDPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSGDDTVLGMFEDDSDLDSASKQCKESavapvavdmngEGIGDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAKVALIidnsvifwkkktynyRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEkhpletnqklkWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFllssgsqpdfSSILVRQtessmatc
Low Complexity Region (SEG)
MDQNFKFGQLIISKFSPLTSFCMFILYLLLARTVSGKIDPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSGDDTVLGMFEDDSDLDSASKQCKESAVAPVAVDMNgegigdhigieeMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGklklkakvalIIDNSVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNklgqggyggvykgklldgQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDFSSILVRQTESSMATC
Disordered region (IsUnstruct)
****FKFGQLIISKFSPLTSFCMFILYLLLARTVSGKIDPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNS****KLLRHKLLAGNCSGDDTVLGM******************VAPVAVDMNGEGIGDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAKVALIIDNSVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQT******************************************************
Disordered Region (DISOPRED)
*********LIISKFSPLTSFCMFILYLLLARTVSGKIDPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSGDDTVLGMFEDDSDLDSASKQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAKVALIIDNSVIFWKKKTY************GSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNET*G*GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNA*****RSS*IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPR***************************
Disordered Region (DISEMBL)
MDQNFKFGQLIISKFSPLTSFCMFILYLLLARTVSGKIDPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSGDDTVLGMFEDDS**************APVAVDMNGEGIGDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAKVALIIDNSVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDFSSILV**********
Disordered Region (DISPRO)
**QNFKFGQLIISKFSPLTSFCMFILYLLLARTVSGKIDPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSGDDTVLGMFEDDSDLDSASKQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAKVALIIDNSVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS**********************
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDQNFKFGQLIISKFSPLTSFCMFILYLLLARTVSGKIDPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSGDDTVLGMFEDDSDLDSASKQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAKVALIIDNSVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDFSSILVRQTESSMATC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	638	2.2.26 [Sep-21-2011]
Q3ECH2	892	Probable receptor-like pr	no	no	0.847	0.606	0.425	1e-115
Q9FID6	813	Probable receptor-like pr	no	no	0.468	0.367	0.595	1e-106
Q9FID5	806	Probable receptor-like pr	no	no	0.457	0.362	0.613	1e-104
P0C5E2	654	Probable serine/threonine	no	no	0.882	0.860	0.306	9e-69
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.459	0.336	0.431	4e-65
Q9XID3	829	G-type lectin S-receptor-	no	no	0.457	0.352	0.417	9e-63
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.470	0.365	0.429	3e-62
O64477	828	G-type lectin S-receptor-	no	no	0.452	0.349	0.4	4e-57
Q9SYS7	659	Putative cysteine-rich re	no	no	0.474	0.459	0.400	1e-56
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.507	0.313	0.378	9e-56

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  416 bits (1070), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 264/621 (42%), Positives = 366/621 (58%), Gaps = 80/621 (12%)

Query: 49  TCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVL 108
           +CG  + +++P +   ++E  CG+P F L+C+  G   + ++S     V+  + D++  L
Sbjct: 259 SCGSQRDLNYPLWKPGREE--CGHPNFKLNCSG-GFAEINIAS-----VKFRILDSYRSL 310

Query: 109 VSNAAFSETNSD--PA--CTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSPEKLLRHK 164
           +   A S+   D  PA   T P I+   LP   +L  + +   L Y C  +S +  +   
Sbjct: 311 I-RLARSDYIGDLCPANPLTAPFIEKF-LPV-LELTGETELLTLYYGCRFNSSD--IPAN 365

Query: 165 LLAGNCSGDD--------TVLGMFEDDSD--LDSASKQCKES----AVAPVAVDMNGEGI 210
           +  G    D+         +     D S   L++  + CK +    A  P   D+     
Sbjct: 366 IYVGELGCDEGRSYYVTRNLSSPLLDSSRGVLNNLREMCKRNVSVPASGPALFDLQTRPN 425

Query: 211 GDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPD------------ 258
            D++ +   + +GF +    SDC  C+ SGG+CG++  +  F CYC D            
Sbjct: 426 QDNLKM--ALDQGFRM-LITSDCERCRGSGGACGYNQTSSGFGCYCKDGKCGYEYDDGFF 482

Query: 259 RRHAKF-CTASGDGKLKLKAKVALIIDNSV---------IFWKKKTYNYRNIEAFLRNYG 308
           RRH +F  T      + L A   ++I   V         IF K+KT +    E  L+   
Sbjct: 483 RRHRRFIATLVRYTFIALGALTGVVIVFLVLLCPCFRVQIFRKRKTSD----EVRLQKLK 538

Query: 309 SLAP-KRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG-NGEDFI 366
           +L P K Y YA++KKMT SF   +G+GG+G VY G L D   VA+KVL ++KG +GEDFI
Sbjct: 539 ALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFI 598

Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
           NEVAS+S+TSHVNIV+LLGFC EG RRA+IYEF+ NGSL+KFI +K    ++  L  + L
Sbjct: 599 NEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDK----SSVNLDLKTL 654

Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
           Y IA+G+ARGLEYLH GC TRI+HFDIKP N+LLD++ CPK+SDFGLAK+CE +ESI+S+
Sbjct: 655 YGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSL 714

Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG----EKNNANVAVDRSSEIY 542
              RGTIGYIAPE+  R +G VS+KSDVYSYGM+V EM G    E+ + N   D SS IY
Sbjct: 715 LDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSS-IY 773

Query: 543 FPHWVYKRLELEEDLGLQGIEN---------EEDKEYARKMILVSLWCIQTNPSDRPSMN 593
           FP W+YK LE      ++  EN          E++E ARKM LV LWCIQ++PSDRP MN
Sbjct: 774 FPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMN 833

Query: 594 RVVEMLEGSLDSLQIPPRPFL 614
           +VVEM+EGSLD+L++PPRP L
Sbjct: 834 KVVEMMEGSLDALEVPPRPVL 854

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  384 bits (987), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 181/304 (59%), Positives = 232/304 (76%), Gaps = 5/304 (1%)

Query: 310 LAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEV 369
           L  K+Y YA++KK+T SF + +G+GG+G VY+G L +G+ VA+KVL + KGNG+DFINEV
Sbjct: 481 LLLKQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEV 540

Query: 370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
            S+S+TSHVNIV+LLGFC+EG +RA+I EF+ +GSL++FI     L  N       LY I
Sbjct: 541 TSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVT----TLYGI 596

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A+GIARGLEYLH GC TRI+HFDIKP NILLD++FCPK++DFGLAK+CE RESI+S+   
Sbjct: 597 ALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDT 656

Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK 549
           RGTIGYIAPEV  R +G +S+KSDVYSYGM+V +M G +N         S  YFP W+YK
Sbjct: 657 RGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYK 716

Query: 550 RLELEEDLGLQGIE-NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI 608
            LE  +   + G E NEED +  +KMILVSLWCI+  PSDRP MN+VVEM+EGSLD+L++
Sbjct: 717 DLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALEL 776

Query: 609 PPRP 612
           PP+P
Sbjct: 777 PPKP 780

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  378 bits (971), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 186/303 (61%), Positives = 235/303 (77%), Gaps = 11/303 (3%)

Query: 315 YRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISR 374
           Y YA++KK+T SF   +G+GG+G VY G L +G+ VA+KVL + KG+ EDFINEVAS+S+
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547

Query: 375 TSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV--LYKIAVG 432
           TSHVNIV+LLGFCFEG +RA++YEF+ NGSL++F      +  N+ L  +V  LY IA+G
Sbjct: 548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQF------MSRNKSLTQDVTTLYGIALG 601

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
           IARGLEYLH GC TRI+HFDIKP NILLD + CPK+SDFGLAK+CE RES++S+   RGT
Sbjct: 602 IARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGT 661

Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANV-AVDR-SSEIYFPHWVYKR 550
           IGYIAPEVF R +G VS+KSDVYS+GM+V +M G ++   V  VD  +S  YFP W+YK 
Sbjct: 662 IGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKD 721

Query: 551 LELEEDLGLQGIE-NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIP 609
           LE  E   + G E  +E+KE A+KMI+V LWCIQ  PSDRPSMNRVVEM+EGSLD+L+IP
Sbjct: 722 LEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIP 781

Query: 610 PRP 612
           P+P
Sbjct: 782 PKP 784

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|P0C5E2|Y1839_ARATH Probable serine/threonine-protein kinase At1g18390 OS=Arabidopsis thaliana GN=At1g18390 PE=1 SV=2

 Score =  261 bits (668), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 194/633 (30%), Positives = 312/633 (49%), Gaps = 70/633 (11%)

Query: 16  SPLTSFCMFILYLLLARTVSGKIDPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGF 75
           +P   +     Y  +  T +  +DP++ AC  K+CG G  IS+PFY+  +QE++CGYP F
Sbjct: 5   TPSLLYTSIFFYFTIIATQTLSLDPKFKACEPKSCGKGPQISYPFYLSGKQESFCGYPSF 64

Query: 76  NLSCNDKGN-PVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSL- 133
            L+C+D+   PVL +S +  Y+++ I Y   S  V N   S+ + DP C  P + N++L 
Sbjct: 65  ELTCDDEEKLPVLGISGE-EYVIKNISYLTQSFQVVN---SKASHDP-CPRP-LNNLTLH 118

Query: 134 PADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSGDDTVLGMFEDD---SDLDSAS 190
              F + P      +LYNC+    E    + L     +      G+F+      +   AS
Sbjct: 119 RTPFFVNPSHINFTILYNCSDHLLEDFRTYPLTCARNTSLLRSFGVFDRKKLGKEKQIAS 178

Query: 191 KQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTF 250
             C++    PV      + +G  +   E++++GF+L W A+ C  C  SGG CG D    
Sbjct: 179 MSCQKLVDVPVLASNESDVMG--MTYVEILKRGFVLNWTANSCFRCITSGGRCGTDQQ-- 234

Query: 251 HFQCYCPD--RRHAKFCTASGDGKLKLKAKVALIIDN----------SVIFW----KKKT 294
            F C CPD  + H        D + ++  K+   I            + IFW    ++KT
Sbjct: 235 EFVCLCPDGPKLHDTCTNGKNDKRRRVIVKITKSISGASAAVVGLIAASIFWYVYHRRKT 294

Query: 295 YNYRNIEAFL-RNYGSLAPKR----------------YRYADIKKMTNSF--KNKLGQGG 335
            +YRN  A L RN  S    +                + Y ++++ TN+F    +LG GG
Sbjct: 295 KSYRNSSALLPRNISSDPSAKSFDIEKAEELLVGVHIFSYEELEEATNNFDPSKELGDGG 354

Query: 336 YGGVYKGKLLDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR- 393
           +G VY GKL DG++VA+K L +      E F NEV  ++   H N+V L G C     R 
Sbjct: 355 FGTVYYGKLKDGRSVAVKRLYDNNFKRAEQFRNEVEILTGLRHPNLVALFG-CSSKQSRD 413

Query: 394 -ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFD 452
             L+YE+V+NG+L   +H   P      L W +  KIAV  A  L+YLH    ++I+H D
Sbjct: 414 LLLVYEYVANGTLADHLH--GPQANPSSLPWSIRLKIAVETASALKYLHA---SKIIHRD 468

Query: 453 IKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV-FCRNFGEVSYK 511
           +K +NILLD++F  K++DFGL+++    ++ VS T  +GT GY+ P+   C    ++S K
Sbjct: 469 VKSNNILLDQNFNVKVADFGLSRLFPMDKTHVS-TAPQGTPGYVDPDYHLCY---QLSNK 524

Query: 512 SDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE--DLGLQGIENEEDKE 569
           SDVYS+ +++ E+       ++   R  EI   +    +++  E  D+    +  + D  
Sbjct: 525 SDVYSFAVVLMELISSLPAVDITRPR-QEINLSNMAVVKIQNHELRDMVDPSLGFDTDTR 583

Query: 570 YARKMILV---SLWCIQTNPSDRPSMNRVVEML 599
             + +I V   +  C+Q++   RP M+ V + L
Sbjct: 584 VRQTVIAVAELAFQCLQSDKDLRPCMSHVQDTL 616

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  249 bits (637), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 133/308 (43%), Positives = 187/308 (60%), Gaps = 15/308 (4%)

Query: 311 APKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGE-DFINEV 369
           +P  + Y D++  TN+F   LG GG+G VYKG +     VA+K L+    +GE +FI EV
Sbjct: 516 SPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEV 575

Query: 370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
            +I    H+N+V L G+C E   R L+YE++ NGSL+K+I      +T   L W   ++I
Sbjct: 576 NTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSE--QTANLLDWRTRFEI 633

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           AV  A+G+ Y H  C  RI+H DIKP NILLD++FCPK+SDFGLAK+  GRE    +T  
Sbjct: 634 AVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMM-GREHSHVVTMI 692

Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK 549
           RGT GY+APE        ++ K+DVYSYGM++ E+ G + N +++ D + + ++P W YK
Sbjct: 693 RGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSYD-AEDFFYPGWAYK 749

Query: 550 RLELEEDLG-----LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD 604
            L     L      LQG+  EE+   A K   V+ WCIQ   S RPSM  VV++LEG+ D
Sbjct: 750 ELTNGTSLKAVDKRLQGVAEEEEVVKALK---VAFWCIQDEVSMRPSMGEVVKLLEGTSD 806

Query: 605 SLQIPPRP 612
            + +PP P
Sbjct: 807 EINLPPMP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  241 bits (616), Expect = 9e-63,   Method: Compositional matrix adjust.
 Identities = 126/302 (41%), Positives = 186/302 (61%), Gaps = 10/302 (3%)

Query: 304 LRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGE 363
           L  Y S AP ++ Y ++++ T SFK KLG GG+G VY+G L +   VA+K L   +   +
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEK 522

Query: 364 DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKW 423
            F  EVA+IS T H+N+V L+GFC +G  R L+YEF+ NGSL+ F+      ++ + L W
Sbjct: 523 QFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTT---DSAKFLTW 579

Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI 483
           E  + IA+G A+G+ YLH  C   I+H DIKP NIL+D++F  K+SDFGLAK+   +++ 
Sbjct: 580 EYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNR 639

Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF 543
            +M+  RGT GY+APE +  N   ++ KSDVYSYGM++ E+   K N +V+ ++++   F
Sbjct: 640 YNMSSVRGTRGYLAPE-WLANL-PITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNHKKF 696

Query: 544 PHWVYKRLELEEDLGLQGIENEEDK----EYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
             W Y+  E      +      ED+    E   +M+  S WCIQ  P  RP+M +VV+ML
Sbjct: 697 SIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQML 756

Query: 600 EG 601
           EG
Sbjct: 757 EG 758

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  240 bits (612), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 133/310 (42%), Positives = 195/310 (62%), Gaps = 10/310 (3%)

Query: 303 FLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNG 362
           FL N   + P R+ Y D++  TN+F  KLGQGG+G VY+G L DG  +A+K L       
Sbjct: 472 FLENLSGM-PIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGK 530

Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++F  EV+ I    H+++V L GFC EG  R L YEF+S GSLE++I  K   + +  L 
Sbjct: 531 KEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKK--DGDVLLD 588

Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
           W+  + IA+G A+GL YLH  C+ RI+H DIKP NILLD++F  K+SDFGLAK+    +S
Sbjct: 589 WDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQS 648

Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY 542
            V  T  RGT GY+APE +  N+  +S KSDVYSYGM++ E+ G + N + + + S + +
Sbjct: 649 HV-FTTMRGTRGYLAPE-WITNYA-ISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEKCH 704

Query: 543 FPHWVYKRLELEE--DLGLQGIEN-EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
           FP + +K++E  +  D+    ++N +   E  ++ +  +LWCIQ +   RPSM++VV+ML
Sbjct: 705 FPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQML 764

Query: 600 EGSLDSLQIP 609
           EG    +Q P
Sbjct: 765 EGVFPVVQPP 774

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  223 bits (568), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 122/305 (40%), Positives = 179/305 (58%), Gaps = 16/305 (5%)

Query: 315 YRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISR 374
           + Y +++  T +F +KLG GG+G V+KG L D  ++A+K L       + F  EV +I  
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542

Query: 375 TSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIA 434
             HVN+V L GFC EG ++ L+Y+++ NGSL+  +     +E    L W++ ++IA+G A
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQ-VEEKIVLGWKLRFQIALGTA 601

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
           RGL YLH  C   I+H DIKP NILLD  FCPK++DFGLAK+  GR+    +T  RGT G
Sbjct: 602 RGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLV-GRDFSRVLTTMRGTRG 660

Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE 554
           Y+APE        ++ K+DVYSYGMM+FE+   + N   + +     +FP W    L  +
Sbjct: 661 YLAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTEQSENEKVR-FFPSWAATILTKD 717

Query: 555 EDL------GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI 608
            D+       L+G  +  D E   +   V+ WCIQ   S RP+M++VV++LEG    L++
Sbjct: 718 GDIRSLVDPRLEG--DAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEG---VLEV 772

Query: 609 PPRPF 613
            P PF
Sbjct: 773 NPPPF 777

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYS7|CRK39_ARATH Putative cysteine-rich receptor-like protein kinase 39 OS=Arabidopsis thaliana GN=CRK39 PE=2 SV=1

 Score =  221 bits (563), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 127/317 (40%), Positives = 186/317 (58%), Gaps = 14/317 (4%)

Query: 314 RYRYADIKKMTNSF--KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGE-DFINEVA 370
           R+    +   T+ F  +N LGQGG+G VYKG LL+GQ VA+K L +  G G+ +F NEV+
Sbjct: 340 RFDLGMVLAATDEFSSENTLGQGGFGTVYKGTLLNGQEVAVKRLTKGSGQGDIEFKNEVS 399

Query: 371 SISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIA 430
            ++R  H N+V LLGFC EG  + L+YEFV N SL+ FI +    E    L WE+ Y+I 
Sbjct: 400 LLTRLQHRNLVKLLGFCNEGDEQILVYEFVPNSSLDHFIFDD---EKRSLLTWEMRYRII 456

Query: 431 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR 490
            GIARGL YLH     +I+H D+K  NILLD +  PK++DFG A++ +  E+        
Sbjct: 457 EGIARGLLYLHEDSQLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKRIA 516

Query: 491 GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYK 549
           GT GY+APE    N G++S KSDVYS+G+M+ EM +GE+NN+    +  +   +  WV  
Sbjct: 517 GTRGYMAPEYL--NHGQISAKSDVYSFGVMLLEMISGERNNS-FEGEGLAAFAWKRWVEG 573

Query: 550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIP 609
           + E+  D  L     E+ +    K+I + L C+Q NP+ RP+M+ V+  L    + + +P
Sbjct: 574 KPEIIIDPFLI----EKPRNEIIKLIQIGLLCVQENPTKRPTMSSVIIWLGSETNIIPLP 629

Query: 610 PRPFLLSSGSQPDFSSI 626
             P    S SQ +  ++
Sbjct: 630 KAPAFTGSRSQSEIGAM 646

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  218 bits (556), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 129/341 (37%), Positives = 200/341 (58%), Gaps = 17/341 (4%)

Query: 282 IIDNSVIFW-KKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSF--KNKLGQGGYGG 338
           II   VIF  +K+   Y + E  L     + P  + Y+++K  T  F   NKLG+GG+G 
Sbjct: 649 IISGVVIFIIRKRRKRYTDDEEILSM--DVKPYTFTYSELKSATQDFDPSNKLGEGGFGP 706

Query: 339 VYKGKLLDGQNVAIKVLN--ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI 396
           VYKGKL DG+ VA+K+L+    +G G+ F+ E+ +IS   H N+V L G C+EG  R L+
Sbjct: 707 VYKGKLNDGREVAVKLLSVGSRQGKGQ-FVAEIVAISAVQHRNLVKLYGCCYEGEHRLLV 765

Query: 397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           YE++ NGSL++ +  +  L     L W   Y+I +G+ARGL YLH     RI+H D+K  
Sbjct: 766 YEYLPNGSLDQALFGEKTLH----LDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKAS 821

Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYS 516
           NILLD    PK+SDFGLAK+ + +++ +S T   GTIGY+APE   R  G ++ K+DVY+
Sbjct: 822 NILLDSKLVPKVSDFGLAKLYDDKKTHIS-TRVAGTIGYLAPEYAMR--GHLTEKTDVYA 878

Query: 517 YGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE-NEEDKEYARKMI 575
           +G++  E+   + N++  ++     Y   W +   E   ++ L   +  E + E  ++MI
Sbjct: 879 FGVVALELVSGRPNSDENLEDEKR-YLLEWAWNLHEKGREVELIDHQLTEFNMEEGKRMI 937

Query: 576 LVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
            ++L C QT+ + RP M+RVV ML G ++   +  +P  L+
Sbjct: 938 GIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGYLT 978

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	638
297737783	621	unnamed protein product [Vitis vinifera]	0.910	0.935	0.555	0.0
357444689	602	Receptor-like protein kinase [Medicago t	0.877	0.930	0.509	1e-169
359472676	459	PREDICTED: probable receptor-like protei	0.680	0.945	0.628	1e-158
224127698	580	predicted protein [Populus trichocarpa]	0.879	0.967	0.492	1e-149
147769927	1001	hypothetical protein VITISV_010117 [Viti	0.586	0.373	0.637	1e-148
145839451	627	receptor-like protein kinase [Capsicum a	0.868	0.883	0.496	1e-148
359472674	637	PREDICTED: probable receptor-like protei	0.586	0.587	0.642	1e-147
147795963	624	hypothetical protein VITISV_039936 [Viti	0.586	0.599	0.642	1e-147
297734241	667	unnamed protein product [Vitis vinifera]	0.932	0.892	0.476	1e-146
359491461	1963	PREDICTED: uncharacterized protein LOC10	0.932	0.303	0.476	1e-145

>gi|297737783|emb|CBI26984.3| unnamed protein product [Vitis vinifera]

 Score =  644 bits (1660), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/618 (55%), Positives = 436/618 (70%), Gaps = 37/618 (5%)

Query: 17  PLTSFCMFILYLLLARTVSGKIDPQYLAC-VAKTCGDGQSISFPFYIENQQEAYCGYPGF 75
           P     +F L L++ +++   +DP +  C +++TCG G +I FPFYIE  Q+  CGY GF
Sbjct: 9   PFIISTIFALLLVIEKSLC--VDPYFKTCSLSRTCG-GLNIGFPFYIEGLQDPLCGYLGF 65

Query: 76  NLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLP- 134
           N+SC    N  +   S+  YI+ +I Y N ++ VSNA  +       C  P  +++ LP 
Sbjct: 66  NVSCLH--NTTILTISENPYIIHQIFYQNQTLRVSNALGN------GC-LPLGRDLLLPN 116

Query: 135 ADFQLA-PDQKQAVL-LYNCNSSSPEKLLRHKLLAGNCSGDD---TVLGMFEDDSDLDSA 189
            +F+L+ PD       L NC++  P+ L+R+K+   NCSGDD    VL M + DS+   A
Sbjct: 117 EEFELSHPDGTDFFFFLSNCSAPLPDNLVRYKI---NCSGDDGASPVLAMSKGDSNWVLA 173

Query: 190 SKQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLLKWKASDCRACKESGGSCGFDADT 249
           S++C     AP   +   +   + IG EE+VR+GF+LKW+ASDC  C+ESGG CGF+   
Sbjct: 174 SEKCGREVKAPF--EEKADDGSNEIG-EELVRRGFMLKWRASDCSKCEESGGKCGFNITD 230

Query: 250 FHFQCYCPDRRHAKFCTASGDGKLKLKAK------VALIIDNSVIFWK-----KKTYNYR 298
           +HF+C+C DR HAK+C +  D  +KL+        V L +     FW+     K+T N  
Sbjct: 231 YHFKCFCRDRAHAKYCVSRNDKGMKLRVAPAVGIGVLLAVVFFFCFWRNCKSIKRTKNQP 290

Query: 299 NIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNET 358
           NIEAFLRN+GSLA KRYR++D+KKMTNSFK+K+G+GGYG VYKGKLLDGQ VA+KVLNET
Sbjct: 291 NIEAFLRNHGSLALKRYRHSDVKKMTNSFKDKIGEGGYGDVYKGKLLDGQMVAVKVLNET 350

Query: 359 KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN 418
           KGNGE+FINEVASI+RTSH+NIV+L GFCFEG +RALIYEF+ NGSLEK+I   H  +TN
Sbjct: 351 KGNGEEFINEVASITRTSHINIVSLRGFCFEGPKRALIYEFMPNGSLEKYICNGHHSKTN 410

Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
            +L WE LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL EDFCPKISDFGLAK+C 
Sbjct: 411 CQLGWETLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLSEDFCPKISDFGLAKLCT 470

Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS 538
            ++SI+SM G RGT GYIAPEVF R FG VS+KSDVYSYGMMV +M G + + +     +
Sbjct: 471 RKDSIISMLGTRGTPGYIAPEVFSRAFGGVSHKSDVYSYGMMVLDMVGGRKDVDGGSSHT 530

Query: 539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
           SEIYFP  +YK +E +EDLGL  I N E +E  RKMI+VSLWCIQT PSDRP M +V++M
Sbjct: 531 SEIYFPDSIYKCIEEDEDLGLPEIMNGE-RECTRKMIIVSLWCIQTRPSDRPPMCQVLDM 589

Query: 599 LEGSLDSLQIPPRPFLLS 616
           L GSL SLQIPP+P+L S
Sbjct: 590 LGGSLQSLQIPPKPYLFS 607

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357444689|ref|XP_003592622.1| Receptor-like protein kinase [Medicago truncatula] gi|355481670|gb|AES62873.1| Receptor-like protein kinase [Medicago truncatula]

 Score =  602 bits (1551), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 314/616 (50%), Positives = 409/616 (66%), Gaps = 56/616 (9%)

Query: 39  DPQYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDK-GNPVLKLSSDTNYIV 97
           + +++ C AKTCG+ QSIS+PFYI   Q +YCGYPGF ++CN+  G P+L LS +T YI+
Sbjct: 11  EQKFVDCEAKTCGN-QSISYPFYIIGLQHSYCGYPGFGITCNNTIGFPILNLS-NTEYII 68

Query: 98  EKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPAD-FQLAPDQKQAVLLYNCNSSS 156
           E+I Y NHS  VSN  FS +N++  C  P  +N++ P + F LAP+Q +  L + C+S+ 
Sbjct: 69  EEIFYQNHSFRVSNVVFSRSNTNKGCLSP-TQNLTFPHNMFYLAPNQSEVKLFFGCDSTK 127

Query: 157 -PEKLLRHKLLAGNCSGDDTVLGMFEDDSDLDSASKQCKESAV-APVAVDMNGEGIGDHI 214
            P +L R+ +     +   +V+ ++ DD +    SK C++  V A V   + G       
Sbjct: 128 LPRELQRNTIGCSEENKTSSVVALYGDDKNASLVSKNCRDEVVYAMVENVVKG------- 180

Query: 215 GIEEMVRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLK 274
           GIEE +R G  L W ASDC  C  +GG CGFD D + F+CYC DR H+  C      +  
Sbjct: 181 GIEESLRNGVRLNWIASDCNECNSTGGRCGFDKDVYSFRCYCTDRVHSAKCDTVAVRRKF 240

Query: 275 LKAKVALIIDN-----------------------SVIFWKKKTYNYRNIEAFLRNYGSLA 311
            + ++ +I+ +                       + + + K+   ++ IE FL+ +G L 
Sbjct: 241 QRVRIVIIVGSEAGVAFGLLMILVCWFRTKIFPPTFLLFGKENPTHQIIENFLKEHGPLL 300

Query: 312 PKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVAS 371
             RY Y+D+KK+TNSFK+KLGQGGYG VYKGKL D   VA+KVLNE+KG+ EDFINEVAS
Sbjct: 301 AARYNYSDVKKITNSFKSKLGQGGYGSVYKGKLHDENTVAVKVLNESKGDSEDFINEVAS 360

Query: 372 ISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIH-EKHPLETNQKLKWEVLYKIA 430
           ISRTSHVN+V LLGFC +G ++ALIYEF+ NGSLEK I+ EK+PL  + +L  + LY IA
Sbjct: 361 ISRTSHVNVVRLLGFCLDGSKKALIYEFMPNGSLEKLIYEEKNPLTDDHQLDCKTLYDIA 420

Query: 431 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR 490
           VG+ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK+C  +E         
Sbjct: 421 VGVARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKVCPRKE--------- 471

Query: 491 GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR 550
                   ++F RNF  VS+KSDVYSYGMMV EM G + N  V VD SSE+YFPHW+YKR
Sbjct: 472 --------KLFSRNFDGVSHKSDVYSYGMMVLEMVGRRKNIKVEVDCSSELYFPHWIYKR 523

Query: 551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
           LEL +DL L+ I+NE D+E  RKM +VSLWCI+T+PS RP M++VVEMLEGSL  L+IPP
Sbjct: 524 LELNQDLELRCIKNEIDEEMVRKMTVVSLWCIRTDPSHRPGMHKVVEMLEGSLQVLEIPP 583

Query: 611 RPFLLS-SGSQPDFSS 625
           +PFL S S S    SS
Sbjct: 584 KPFLSSPSTSSAHLSS 599

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359472676|ref|XP_002279634.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  564 bits (1453), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 282/449 (62%), Positives = 342/449 (76%), Gaps = 15/449 (3%)

Query: 179 MFEDDSDLDSASKQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLLKWKASDCRACKE 238
           M + DS+   AS++C     AP   +   +   + IG EE+VR+GF+LKW+ASDC  C+E
Sbjct: 1   MSKGDSNWVLASEKCGREVKAPF--EEKADDGSNEIG-EELVRRGFMLKWRASDCSKCEE 57

Query: 239 SGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAK------VALIIDNSVIFWK- 291
           SGG CGF+   +HF+C+C DR HAK+C +  D  +KL+        V L +     FW+ 
Sbjct: 58  SGGKCGFNITDYHFKCFCRDRAHAKYCVSRNDKGMKLRVAPAVGIGVLLAVVFFFCFWRN 117

Query: 292 ----KKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDG 347
               K+T N  NIEAFLRN+GSLA KRYR++D+KKMTNSFK+K+G+GGYG VYKGKLLDG
Sbjct: 118 CKSIKRTKNQPNIEAFLRNHGSLALKRYRHSDVKKMTNSFKDKIGEGGYGDVYKGKLLDG 177

Query: 348 QNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           Q VA+KVLNETKGNGE+FINEVASI+RTSH+NIV+L GFCFEG +RALIYEF+ NGSLEK
Sbjct: 178 QMVAVKVLNETKGNGEEFINEVASITRTSHINIVSLRGFCFEGPKRALIYEFMPNGSLEK 237

Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           +I   H  +TN +L WE LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL EDFCPK
Sbjct: 238 YICNGHHSKTNCQLGWETLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLSEDFCPK 297

Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE 527
           ISDFGLAK+C  ++SI+SM G RGT GYIAPEVF R FG VS+KSDVYSYGMMV +M G 
Sbjct: 298 ISDFGLAKLCTRKDSIISMLGTRGTPGYIAPEVFSRAFGGVSHKSDVYSYGMMVLDMVGG 357

Query: 528 KNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPS 587
           + + +     +SEIYFP  +YK +E +EDLGL  I N E +E  RKMI+VSLWCIQT PS
Sbjct: 358 RKDVDGGSSHTSEIYFPDSIYKCIEEDEDLGLPEIMNGE-RECTRKMIIVSLWCIQTRPS 416

Query: 588 DRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
           DRP M +V++ML GSL SLQIPP+P+L S
Sbjct: 417 DRPPMCQVLDMLGGSLQSLQIPPKPYLFS 445

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127698|ref|XP_002329342.1| predicted protein [Populus trichocarpa] gi|222870796|gb|EEF07927.1| predicted protein [Populus trichocarpa]

 Score =  534 bits (1375), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 293/595 (49%), Positives = 377/595 (63%), Gaps = 34/595 (5%)

Query: 39  DPQYLACVAK-TCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIV 97
           D +YL+C     CG+ Q+I++PF+  N+ + YCGYPGF+L C+    PV+K+S +  Y V
Sbjct: 1   DERYLSCSKSFECGNIQNITYPFWGVNRPQ-YCGYPGFHLDCSGDA-PVIKIS-EVAYQV 57

Query: 98  EKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSP 157
            +I   +   L+S        +D  C+ P + +      F  A + K  +L Y C +   
Sbjct: 58  LEIKSMSRVHLISTEY-----TDNICSIPPVNSTFDSDRFSYASNTKNIMLYYGCPTIPS 112

Query: 158 EKLLRHKL---LAGNCSGDDTV-------LGMFEDDS---DLDSASKQCKESAVAPVAVD 204
           + L    L    + N S  D V       L M    S   ++ S  + C  S + P A +
Sbjct: 113 QFLPTLGLSYQFSCNISRTDMVGYYLTRNLSMSATGSFAANISSYLESCNHSVLIP-AYE 171

Query: 205 MNGEGIGDH---IGIEEMVRKGFLLKWKASD--CRACKESGGSCGFDADTFHFQCYCPDR 259
                I  H     +   + +GF L+W A+D  C  CK SGG CG++ DT  F CY    
Sbjct: 172 SAVRSIESHPTAANLTNALHRGFWLQWTANDSLCNKCKFSGGQCGYNTDTSKFTCYFVTL 231

Query: 260 RHAKFCTASGDGKLKLKAKVALIIDNSVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYAD 319
                   +    + L ++  L       FW++   +  NIE  + N  SL PKRY Y++
Sbjct: 232 AMYTMIAVT---IIVLCSRRGLSRGRMTSFWRQNAQHNLNIETIIMNSHSLTPKRYTYSE 288

Query: 320 IKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN 379
           IKKMTNSF +KLGQGG+GGVYKG+L DG+ VA+KVL  +KG+GE+F+NEV SISRTSHVN
Sbjct: 289 IKKMTNSFVDKLGQGGFGGVYKGELPDGRPVAVKVLKNSKGDGEEFVNEVVSISRTSHVN 348

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           IVTLLGFCFE  +RALIYE++ NGSL+KFI+ +  L     L+WE LY+IAVGI RGLEY
Sbjct: 349 IVTLLGFCFERTKRALIYEYMPNGSLDKFIYRQTSLHGKYNLQWEKLYEIAVGIGRGLEY 408

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           LHRGCNTRI+HFDIKPHNILLD DFCPKISDFGLAK+C+  ES+VSMTGARGT GYIAPE
Sbjct: 409 LHRGCNTRIVHFDIKPHNILLDTDFCPKISDFGLAKLCKREESMVSMTGARGTAGYIAPE 468

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 559
           VFC+NFG VSYKSDVYSYGMMV EM G K N ++   +SSEI+ P+ +Y   E EE   L
Sbjct: 469 VFCKNFGGVSYKSDVYSYGMMVLEMVGGKRNIDIGESQSSEIFLPNCMY---ESEEVSSL 525

Query: 560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFL 614
            G+  +E +E  +KM+ V LWC+QTNP DRPSM +VVEMLEGSL  LQ PP+PFL
Sbjct: 526 HGVITDETEETIKKMVTVGLWCVQTNPLDRPSMTKVVEMLEGSLQFLQTPPKPFL 580

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769927|emb|CAN76446.1| hypothetical protein VITISV_010117 [Vitis vinifera]

 Score =  532 bits (1370), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 257/403 (63%), Positives = 314/403 (77%), Gaps = 29/403 (7%)

Query: 230 ASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGK-LKLKAKVALIIDN--- 285
           + +CR C  SGG C  +   F              C  +G+ K LKL   +A+ I     
Sbjct: 598 SRECRECHFSGGQCRDEEGKFR-------------CAHTGNDKTLKLALGLAISITGIGI 644

Query: 286 ------------SVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQ 333
                         IF +K+T N+ N+E FLRN+ SLAPKRYRY++++KMT+SFK+++G+
Sbjct: 645 PLALTFYFSKKFRSIFKEKQTGNHLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGE 704

Query: 334 GGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR 393
           GGYG VYKGKLL+G  VA+KVL+ETKGNGE+FINE+ASISRTSHVNIV+LLGFCF+G +R
Sbjct: 705 GGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKR 764

Query: 394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI 453
           ALIYEF+ NGSLEKFI++K+   T  KL WE LY IA+GIARGLEYLHRGCNTRILH DI
Sbjct: 765 ALIYEFMPNGSLEKFIYDKNSSMTYHKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDI 824

Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
           KPHNILL++DFCPKISDFGL+K+C  +ESI+SM+GARGT GYIAPEVFCRNFG+VS KSD
Sbjct: 825 KPHNILLNQDFCPKISDFGLSKLCTRKESIISMSGARGTAGYIAPEVFCRNFGDVSPKSD 884

Query: 514 VYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           VYSYGMMV EM G + N +  ++ +SEIYFPHW+YKRLEL+E+LGLQG  NEE++  ARK
Sbjct: 885 VYSYGMMVLEMVGGRKNTDDGINHTSEIYFPHWIYKRLELDEELGLQGFMNEEERTSARK 944

Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
           MI+VSLWCIQTNPS+RP MN VV+MLEGSL+SLQIPP+PFL S
Sbjct: 945 MIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKPFLYS 987

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|145839451|gb|ABP96804.1| receptor-like protein kinase [Capsicum annuum]

 Score =  531 bits (1369), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 292/588 (49%), Positives = 375/588 (63%), Gaps = 34/588 (5%)

Query: 49  TCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVL 108
           +CG+  ++SFPF +  Q E  CG    +  C+DK  P ++L    ++      +D+ SV 
Sbjct: 33  SCGNFTNLSFPFSLSAQPE--CGILRMS-GCDDKPFPKIRLLPGRDWYYALQQHDS-SVW 88

Query: 109 VSNAAFSETNSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNSSSP--EKLLRHKLL 166
           + +     T +   C     KN SLP    ++ +         C+S+    ++   + + 
Sbjct: 89  LGDQKLQTTLTQHKCQAFN-KNFSLPNSPSISFNMININNFIKCSSTQKKNDRFAGYNMY 147

Query: 167 AGNCSGDDTVLGMFEDDSDLDSASKQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLL 226
            G C G      +  DD     A       ++  + +  N   + + +G E      FL+
Sbjct: 148 NG-CEGFSIYYKLTRDDDKNIEAHNLPTNCSLIKLPIHKNDGDLFNRLGPE------FLV 200

Query: 227 KWKASD-CRACKESGGSCGFDADTFHFQCYCPDRRHAK----------FCTASGDGKLKL 275
           +WK SD C  C   GG C  D  T  F C       +K          F  A+G     +
Sbjct: 201 EWKLSDDCSECHHYGGRCQTDK-TNKFYCLKDVAEVSKLPAGISKRFWFLAATGASLFTV 259

Query: 276 KAKVALIIDNSVIFWKK-------KTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFK 328
              V L    + + W K       K  ++RNIE FL+NYGS APKRY Y DIK++T+ FK
Sbjct: 260 GLLVLLFFFRNKVLWYKYIRLWGSKVEDHRNIEEFLKNYGSYAPKRYNYTDIKRITSRFK 319

Query: 329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCF 388
           NKL QGG+G VY+G L +G  VA+KVLNE KG+GE+FINEVASISRTSHVN+V+L+GFCF
Sbjct: 320 NKLVQGGFGTVYRGSLGNGSQVAVKVLNELKGSGENFINEVASISRTSHVNVVSLVGFCF 379

Query: 389 EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 448
           EG +RAL+YEF+ NGSLEKFI+E+   +T ++L W  LYKIA+GIARGLEYLHRGC TRI
Sbjct: 380 EGRKRALVYEFMPNGSLEKFIYEERS-DTVRQLGWPTLYKIALGIARGLEYLHRGCTTRI 438

Query: 449 LHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV 508
           LHFDIKPHNILLDEDFCPKISDFGLAK+C   ESIVSM GARGTIGYIAPE+ CRN G V
Sbjct: 439 LHFDIKPHNILLDEDFCPKISDFGLAKLCMKNESIVSMLGARGTIGYIAPEIVCRNLGGV 498

Query: 509 SYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDK 568
           S+KSD YSYGMMV EM G + N +   DR+SEIYFPHW+Y+R+EL+EDL L GI NEE+ 
Sbjct: 499 SHKSDAYSYGMMVLEMIGGRKNVDAGADRTSEIYFPHWLYQRIELDEDLQLVGIMNEEEN 558

Query: 569 EYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
           E ARKM++ SLWCIQT+PS+RPSM++VVEMLEG LDSLQIPP+P+L S
Sbjct: 559 ECARKMVIASLWCIQTDPSNRPSMSKVVEMLEGKLDSLQIPPKPYLYS 606

Source: Capsicum annuum

Species: Capsicum annuum

Genus: Capsicum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359472674|ref|XP_002279652.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  530 bits (1364), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 259/403 (64%), Positives = 314/403 (77%), Gaps = 29/403 (7%)

Query: 230 ASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGK-LKLKAKVALIIDN--- 285
           + +CR C  SGG C  D   F              C  +G+ K LKL   +A+ I     
Sbjct: 234 SRECRKCHFSGGQCRDDEGKFR-------------CAHTGNDKTLKLALGLAISITGIGI 280

Query: 286 ------------SVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQ 333
                         IF +K+T N+ N+E FLRN+ SLAPKRYRY++++KMT+SFK+++G+
Sbjct: 281 PLALTFYFSKKFRSIFKEKQTGNHLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGE 340

Query: 334 GGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR 393
           GGYG VYKGKLL+G  VA+KVL+ETKGNGE+FINE+ASISRTSHVNIV+LLGFCF+G +R
Sbjct: 341 GGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKR 400

Query: 394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI 453
           ALIYEF+ NGSLEKFI++K+   T  KL WE LY IA+GIARGLEYLHRGCNTRILH DI
Sbjct: 401 ALIYEFMPNGSLEKFIYDKNSSMTYDKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDI 460

Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
           KPHNILL++DFCPKISDFGL+K+C  +ESIVSM+GARGT GYIAPEVFCRNFG+VS KSD
Sbjct: 461 KPHNILLNQDFCPKISDFGLSKLCTRKESIVSMSGARGTAGYIAPEVFCRNFGDVSPKSD 520

Query: 514 VYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           VYSYGMMV EM G + N +  ++ +SEIYFPHW+YKRLEL+E+LGLQG  NEE++  ARK
Sbjct: 521 VYSYGMMVLEMVGGRKNIDDGINHTSEIYFPHWIYKRLELDEELGLQGFMNEEERTSARK 580

Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
           MI+VSLWCIQTNPS+RP MN VV+MLEGSL+SLQIPP+PFL S
Sbjct: 581 MIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKPFLYS 623

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147795963|emb|CAN69599.1| hypothetical protein VITISV_039936 [Vitis vinifera]

 Score =  530 bits (1364), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 259/403 (64%), Positives = 314/403 (77%), Gaps = 29/403 (7%)

Query: 230 ASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGK-LKLKAKVALIIDN--- 285
           + +CR C  SGG C  D   F              C  +G+ K LKL   +A+ I     
Sbjct: 221 SRECRKCHFSGGQCRDDEGKFR-------------CAHTGNDKTLKLALGLAISITGIGI 267

Query: 286 ------------SVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQ 333
                         IF +K+T N+ N+E FLRN+ SLAPKRYRY++++KMT+SFK+++G+
Sbjct: 268 PLALTFYFSKKFRSIFKEKQTGNHLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGE 327

Query: 334 GGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR 393
           GGYG VYKGKLL+G  VA+KVL+ETKGNGE+FINE+ASISRTSHVNIV+LLGFCF+G +R
Sbjct: 328 GGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKR 387

Query: 394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI 453
           ALIYEF+ NGSLEKFI++K+   T  KL WE LY IA+GIARGLEYLHRGCNTRILH DI
Sbjct: 388 ALIYEFMPNGSLEKFIYDKNSSMTYDKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDI 447

Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
           KPHNILL++DFCPKISDFGL+K+C  +ESIVSM+GARGT GYIAPEVFCRNFG+VS KSD
Sbjct: 448 KPHNILLNQDFCPKISDFGLSKLCTRKESIVSMSGARGTAGYIAPEVFCRNFGDVSPKSD 507

Query: 514 VYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           VYSYGMMV EM G + N +  ++ +SEIYFPHW+YKRLEL+E+LGLQG  NEE++  ARK
Sbjct: 508 VYSYGMMVLEMVGGRKNIDDGINHTSEIYFPHWIYKRLELDEELGLQGFMNEEERTSARK 567

Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
           MI+VSLWCIQTNPS+RP MN VV+MLEGSL+SLQIPP+PFL S
Sbjct: 568 MIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKPFLYS 610

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297734241|emb|CBI15488.3| unnamed protein product [Vitis vinifera]

 Score =  523 bits (1348), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 311/653 (47%), Positives = 407/653 (62%), Gaps = 58/653 (8%)

Query: 16  SPLTSFCMFILYLLLARTVSGKIDPQYLACVAK--TCGDGQSISFPFYIENQQEAYCGYP 73
           SP+T F +FI       T     + QY  C ++   CGD + I +PF+ + + + +CG  
Sbjct: 22  SPITFFSIFI-------TSFCDDNQQYEECTSRLYECGDMKGIGYPFWGDGRPQ-FCG-Q 72

Query: 74  GFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSL 133
           GF L C D   P++ + S   + V  I    +++ ++   F +    P        N +L
Sbjct: 73  GFELKCQDDDYPLIAIGS-LEFRVLNISNSTYAMRIARKDFWDQTC-PKEFQSTTLNYTL 130

Query: 134 PADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSG------DDTVLGMFEDDSDLD 187
              F  A   +   L Y C      +L     ++ N +G      D TV    E    LD
Sbjct: 131 ---FDYAGTDRNLTLFYGCPDEVLSQLPATWNISNNFTGSVEGINDTTVFYADEAFLGLD 187

Query: 188 ---SASKQCKESAVAPV---AVD-MNGEGIGDHI----GIEEMVRKGFLLKWKASD--CR 234
              +  + CK +   PV   A+D +N    G  +    G+E+ +  GF + +      C 
Sbjct: 188 QHLAILRTCKINVTLPVLGAAIDELNANRTGGEVSNGEGLEKALNMGFDVDYSVVTGLCV 247

Query: 235 ACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAKVALIIDNS-------- 286
            C  SGG CG  + T  F C C D+ +   C  S    +     +A++            
Sbjct: 248 QCNASGGICG-SSSTSQFSCLCRDKSYPYSCQKSESANIPKTIMMAVVAAGVGTLFASIL 306

Query: 287 VIF--------------WKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLG 332
           +IF              W+K++   +NIE F+RNYGS APKRY Y+++KKMTN+FK+KLG
Sbjct: 307 IIFCFKRKISKHRLMFIWRKRSDADQNIEEFVRNYGSQAPKRYSYSNVKKMTNAFKDKLG 366

Query: 333 QGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHR 392
           QGGYGGVYKGKL DG  VA+KVLN +KGNG++FINEVASISRTSHVNIV LLGFCFEG +
Sbjct: 367 QGGYGGVYKGKLGDGHLVAVKVLNTSKGNGDEFINEVASISRTSHVNIVRLLGFCFEGGK 426

Query: 393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFD 452
           +ALIYEF+SNGSLE F+  ++PL+ ++ L WE LY+IAVGIARGLEYLH GC T+ILHFD
Sbjct: 427 KALIYEFMSNGSLENFLGSENPLKVSKHLGWEKLYQIAVGIARGLEYLHCGCRTKILHFD 486

Query: 453 IKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS 512
           +KPHNILLD+DF PKISDFGLAK+C  +ESI+SM+ ARGTIGY+APEVFCRNFG+VS+KS
Sbjct: 487 VKPHNILLDQDFSPKISDFGLAKLCPPKESIISMSAARGTIGYVAPEVFCRNFGQVSHKS 546

Query: 513 DVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           DVYSYGMMV EM G + N N  V  +SE YFPHW+YK LE +EDLGL+GIEN+E+ E  R
Sbjct: 547 DVYSYGMMVLEMVGGRQNVNGTVGHTSETYFPHWIYKHLEQQEDLGLEGIENKEENEITR 606

Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDFSS 625
           KMI+V LWCIQTNPS RP M++V+EMLEGS+++LQIPP+PFL S    P  SS
Sbjct: 607 KMIVVGLWCIQTNPSHRPCMSKVIEMLEGSIEALQIPPKPFLSSPPRFPIDSS 659

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491461|ref|XP_002277015.2| PREDICTED: uncharacterized protein LOC100261246 [Vitis vinifera]

 Score =  520 bits (1339), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 311/653 (47%), Positives = 407/653 (62%), Gaps = 58/653 (8%)

Query: 16   SPLTSFCMFILYLLLARTVSGKIDPQYLACVAK--TCGDGQSISFPFYIENQQEAYCGYP 73
            SP+T F +FI       T     + QY  C ++   CGD + I +PF+ + + + +CG  
Sbjct: 1318 SPITFFSIFI-------TSFCDDNQQYEECTSRLYECGDMKGIGYPFWGDGRPQ-FCGQ- 1368

Query: 74   GFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRIKNVSL 133
            GF L C D   P++ + S   + V  I    +++ ++   F +    P        N +L
Sbjct: 1369 GFELKCQDDDYPLIAIGS-LEFRVLNISNSTYAMRIARKDFWDQTC-PKEFQSTTLNYTL 1426

Query: 134  PADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSG------DDTVLGMFEDDSDLD 187
               F  A   +   L Y C      +L     ++ N +G      D TV    E    LD
Sbjct: 1427 ---FDYAGTDRNLTLFYGCPDEVLSQLPATWNISNNFTGSVEGINDTTVFYADEAFLGLD 1483

Query: 188  ---SASKQCKESAVAPV---AVD-MNGEGIGDHI----GIEEMVRKGFLLKWKASD--CR 234
               +  + CK +   PV   A+D +N    G  +    G+E+ +  GF + +      C 
Sbjct: 1484 QHLAILRTCKINVTLPVLGAAIDELNANRTGGEVSNGEGLEKALNMGFDVDYSVVTGLCV 1543

Query: 235  ACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAKVALIIDNS-------- 286
             C  SGG CG  + T  F C C D+ +   C  S    +     +A++            
Sbjct: 1544 QCNASGGICG-SSSTSQFSCLCRDKSYPYSCQKSESANIPKTIMMAVVAAGVGTLFASIL 1602

Query: 287  VIF--------------WKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLG 332
            +IF              W+K++   +NIE F+RNYGS APKRY Y+++KKMTN+FK+KLG
Sbjct: 1603 IIFCFKRKISKHRLMFIWRKRSDADQNIEEFVRNYGSQAPKRYSYSNVKKMTNAFKDKLG 1662

Query: 333  QGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHR 392
            QGGYGGVYKGKL DG  VA+KVLN +KGNG++FINEVASISRTSHVNIV LLGFCFEG +
Sbjct: 1663 QGGYGGVYKGKLGDGHLVAVKVLNTSKGNGDEFINEVASISRTSHVNIVRLLGFCFEGGK 1722

Query: 393  RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFD 452
            +ALIYEF+SNGSLE F+  ++PL+ ++ L WE LY+IAVGIARGLEYLH GC T+ILHFD
Sbjct: 1723 KALIYEFMSNGSLENFLGSENPLKVSKHLGWEKLYQIAVGIARGLEYLHCGCRTKILHFD 1782

Query: 453  IKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS 512
            +KPHNILLD+DF PKISDFGLAK+C  +ESI+SM+ ARGTIGY+APEVFCRNFG+VS+KS
Sbjct: 1783 VKPHNILLDQDFSPKISDFGLAKLCPPKESIISMSAARGTIGYVAPEVFCRNFGQVSHKS 1842

Query: 513  DVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
            DVYSYGMMV EM G + N N  V  +SE YFPHW+YK LE +EDLGL+GIEN+E+ E  R
Sbjct: 1843 DVYSYGMMVLEMVGGRQNVNGTVGHTSETYFPHWIYKHLEQQEDLGLEGIENKEENEITR 1902

Query: 573  KMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDFSS 625
            KMI+V LWCIQTNPS RP M++V+EMLEGS+++LQIPP+PFL S    P  SS
Sbjct: 1903 KMIVVGLWCIQTNPSHRPCMSKVIEMLEGSIEALQIPPKPFLSSPPRFPIDSS 1955

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	638
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.620	0.443	0.498	2.7e-109
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.935	0.935	0.390	1.5e-106
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.605	0.579	0.485	4e-104
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.876	0.829	0.399	2.4e-99
TAIR|locus:2176707	579	AT5G38250 [Arabidopsis thalian	0.401	0.442	0.612	4.3e-94
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.490	0.366	0.552	6.3e-92
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.509	0.488	0.554	6.3e-92
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.507	0.405	0.538	2.7e-91
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.463	0.364	0.568	1.7e-89
TAIR|locus:2176697	588	AT5G38240 [Arabidopsis thalian	0.401	0.435	0.583	1.9e-89

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 961 (343.3 bits), Expect = 2.7e-109, Sum P(2) = 2.7e-109
 Identities = 222/445 (49%), Positives = 279/445 (62%)

Query:   231 SDCRACKESGGSCGFDADTFHFQCYCPD------------RRHAKFC------TASGDGX 272
             SDC  C+ SGG+CG++  +  F CYC D            RRH +F       T    G 
Sbjct:   443 SDCERCRGSGGACGYNQTSSGFGCYCKDGKCGYEYDDGFFRRHRRFIATLVRYTFIALGA 502

Query:   273 XXXXXXXXXII----DNSVIFWKKKTYNYRNIEAFLRNYGSLAP-KRYRYADIKKMTNSF 327
                      ++        IF K+KT +    E  L+   +L P K Y YA++KKMT SF
Sbjct:   503 LTGVVIVFLVLLCPCFRVQIFRKRKTSD----EVRLQKLKALIPLKHYTYAEVKKMTKSF 558

Query:   328 KNXXXXXXXXXXXXXXXXXXQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGF 386
                                   VA+KVL ++KG +GEDFINEVAS+S+TSHVNIV+LLGF
Sbjct:   559 TEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGF 618

Query:   387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
             C EG RRA+IYEF+ NGSL+KFI +K  +  N  LK   LY IA+G+ARGLEYLH GC T
Sbjct:   619 CCEGSRRAIIYEFLGNGSLDKFISDKSSV--NLDLK--TLYGIALGVARGLEYLHYGCKT 674

Query:   447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
             RI+HFDIKP N+LLD++ CPK+SDFGLAK+CE +ESI+S+   RGTIGYIAPE+  R +G
Sbjct:   675 RIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYG 734

Query:   507 EVSYKSDVYSYGMMVFEMTG----EKNNANVAVDRSSEIYFPHWVYKRLE------LE-- 554
              VS+KSDVYSYGM+V EM G    E+ + N   D SS IYFP W+YK LE      +E  
Sbjct:   735 SVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSS-IYFPEWIYKDLEKANIKDIEKT 793

Query:   555 EDLGL--QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRP 612
             E+ GL   GI +EE+ E ARKM LV LWCIQ++PSDRP MN+VVEM+EGSLD+L++PPRP
Sbjct:   794 ENGGLIENGISSEEE-EIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRP 852

Query:   613 FLLSSGSQPDFSSILVRQTESSMAT 637
              +L   S    S       ESS A+
Sbjct:   853 -VLQQISASSVSDSFWNSEESSSAS 876

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 1054 (376.1 bits), Expect = 1.5e-106, P = 1.5e-106
 Identities = 249/637 (39%), Positives = 356/637 (55%)

Query:    10 LIISKFSPLTSFCMFILYLLLARTVSGKIDPQYLACVAK-TCGDGQSISFPFYIENQQEA 68
             L + + + L+   +++L+++ +  +S  +D +   C     CG    + +PF+  +++E 
Sbjct:     4 LSLYQTNSLSYTIIWMLFVIPSCVLS--VDERQKHCSPTFRCGKQTDLYYPFWSPDREE- 60

Query:    69 YCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSDPACTFPRI 128
              CG+P F ++C+  G+      S   + V ++ Y++  + +    +   N  P    P  
Sbjct:    61 -CGHPVFKVNCS--GDFAEFTISTVKFHVLEMNYESRIIRLVRTEYLN-NLCP--WHPEN 114

Query:   129 KNVSLPADFQLAPDQKQAVLLYNCNSSSPEKLLRHKLLAGNCSGDDTVLGM--FEDDSD- 185
             ++++         D +     YNC+  + ++L    +    C  D+ V G   F      
Sbjct:   115 RSINQEV-LPFLQDTELGTFYYNCSGPTVDELANGYIRQLGC--DEEVGGKSYFVSSPSH 171

Query:   186 ------LDSASKQCKESAVAPVAVD-MNXXXXXXXXXXXXMVRK-GFLLKWKASDCRACK 237
                   LD  S  C+ +   PV+   M              V   GF L +  SDC  C 
Sbjct:   172 PGNRAILDGLSASCERNVDIPVSRSAMETTATNQSLEAIKKVLDVGFELGFN-SDCSLCV 230

Query:   238 ESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGXXXX-XXXXXXIIDNSVI---FWKKK 293
              S G+CGF+  +  F CYC D  H   C   G G           +I   ++   F K++
Sbjct:   231 ASKGACGFNQSSKAFVCYCKDEPHEHTCGKMGIGIGLGCGFLGATLITVCLLCFFFQKRR 290

Query:   294 T-YNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNXXXXXXXXXXXXXXXXXXQNVAI 352
             T ++ R  +  L+  G +  K+Y YA+++K+T  F +                  + VA+
Sbjct:   291 TSHHLRPRDNNLK--GLVQLKQYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAV 348

Query:   353 KVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEK 412
             K+L + K NGEDFINEVAS+S+TSHVNIV+LLGFC+EG +RA++YEF+ NGSL++F+ EK
Sbjct:   349 KILKDFKSNGEDFINEVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEK 408

Query:   413 HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 472
               L     L    LY+IA+G+ARGL+YLH GC TRI+HFDIKP NILLD+ FCPK+SDFG
Sbjct:   409 KSLN----LDVSTLYRIALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFG 464

Query:   473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNA- 531
             LAK+CE RESI+S+  ARGTIGYIAPEVF   +G VS+KSDVYSYGM+V EM G KN   
Sbjct:   465 LAKLCEKRESILSLLDARGTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEI 524

Query:   532 -NVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE-NEEDKEYARKMILVSLWCIQTNPSDR 589
                A   SS  YFP W+YK LE  ED    G E + EDKE A+KM LV LWCIQ +P +R
Sbjct:   525 EETAASNSSSAYFPDWIYKNLENGEDTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNR 584

Query:   590 PSMNRVVEMLEGSLDSLQIPPRPFL-LSSGSQPDFSS 625
             P MNR+VEM+EGSLD L++PP+P +  S+   P  SS
Sbjct:   585 PPMNRIVEMMEGSLDVLEVPPKPSIHYSAEPLPQLSS 621

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 938 (335.3 bits), Expect = 4.0e-104, Sum P(2) = 4.0e-104
 Identities = 202/416 (48%), Positives = 264/416 (63%)

Query:   223 GFLLKWKASDCRACKESGGSCGFDADTFHFQCYC------PDRRHA--K--FCT--ASGD 270
             GF L+   SDCR C +S G+CGF   +  F CY       P R     K  F      G 
Sbjct:   227 GFALEVN-SDCRTCIDSKGACGFSQTSSRFVCYYRQEPQNPTRNKVILKLFFIVIYVLGI 285

Query:   271 GXXXXXXXXXXIID---NSVIFWKKKTYNYRNI----EAFLRNYGSLAP-KRYRYADIKK 322
             G          ++    N +I  ++KT N   +    ++  +N  +L P K Y YA +  
Sbjct:   286 GAASFAMMGVILVVTCLNCLIRRQRKTLNDPRMRTSDDSRQQNLKALIPLKHYSYAQVTS 345

Query:   323 MTNSFKNXXXXXXXXXXXXXXXXXXQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVT 382
             +T SF                    ++VA+KVL E++GNGEDFINEVAS+S+TSHVNIVT
Sbjct:   346 ITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGNGEDFINEVASMSQTSHVNIVT 405

Query:   383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
             LLGFC EG++RA+IYEF+ NGSL+KFI  K     +  + W  LY IA+G+ARGLEYLH 
Sbjct:   406 LLGFCSEGYKRAIIYEFMENGSLDKFISSKK----SSTMDWRELYGIALGVARGLEYLHH 461

Query:   443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
             GC TRI+HFDIKP N+LLD++  PK+SDFGLAK+CE +ESI+S+   RGTIGYIAPEVF 
Sbjct:   462 GCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTRGTIGYIAPEVFS 521

Query:   503 RNFGEVSYKSDVYSYGMMVFEMTGEKNNANV--AVDRSSEIYFPHWVYKRLELEED-LGL 559
             R +G VS+KSDVYSYGM+V ++ G +N  +       +S +YFP W+Y+ LE   +   +
Sbjct:   522 RVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEWIYRDLEKAHNGKSI 581

Query:   560 Q-GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFL 614
             +  I NEED E A+KM LV LWCIQ  P DRP+MNRVVEM+EG+LD+L++PPRP L
Sbjct:   582 ETAISNEED-EIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLDALEVPPRPVL 636

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 986 (352.1 bits), Expect = 2.4e-99, P = 2.4e-99
 Identities = 245/613 (39%), Positives = 343/613 (55%)

Query:    49 TCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHSVL 108
             +CG+ +++ +PF+I  ++  YCG+P F L C+  G   L ++S  N+ +  + YD+ +  
Sbjct:    76 SCGNQRNLYYPFWIPGRE--YCGHPDFKLDCSG-GFAELNIAS-VNFRILNMSYDSSNKR 131

Query:   109 VSNAAFSET--NSDPACTFPRIKNVSLPADFQLAPDQKQAVLLYNC--NSSS----PEKL 160
             ++ + +       +P    P I+ V      Q + D +   L Y+C  NSS+    P   
Sbjct:   132 LARSDYLNDLCPPNPLNDEPLIETV-----LQFSADTELLTLYYDCQLNSSATSPFPSSY 186

Query:   161 L--------RHKLLAGNCSGDDTVLGMFEDDSDLDSASKQCKESAVAPVAVD-MNXXXXX 211
                      R   +  N S    +L  F     L++  + CK     P +   +N     
Sbjct:   187 FGELGCDEGRSYYVTRNLSSP--LLDRFR--GVLNNLREMCKRKVSVPASGPALNTLQTN 242

Query:   212 XXXXXXXM-VRKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGD 270
                    M +  GF L+   S+C  C  SGGSCG++ ++               CT  G 
Sbjct:   243 PNSNNLKMALEHGFELQ-DNSNCSMCVLSGGSCGYNQNSMAIIIGI----FVALCTIGG- 296

Query:   271 GXXXXXXXXXXIIDNSVIFWKKKTYNYRNIEAFLRNYGSLAP-KRYRYADIKKMTNSFKN 329
                              IF  +KT + R  E  L+   +L P K Y YA +K+MT SF  
Sbjct:   297 --FIAFLVLLCPCCKVRIFRNRKTSDDRRQEK-LK---ALIPLKHYTYAQVKRMTKSFAE 350

Query:   330 XXXXXXXXXXXXXXXXXXQNVAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLLGFCF 388
                               + VA+KVL E+KGN  EDFINEV+S+S+TSHVNIV+LLGFC 
Sbjct:   351 VVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFINEVSSMSQTSHVNIVSLLGFCS 410

Query:   389 EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 448
             EG RRA+IYEF+ NGSL+KFI EK    T+  L    LY IA+G+ARGLEYLH GC TRI
Sbjct:   411 EGSRRAIIYEFLENGSLDKFISEK----TSVILDLTALYGIALGVARGLEYLHYGCKTRI 466

Query:   449 LHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV 508
             +HFDIKP N+LLD++  PK+SDFGLAK+CE +ES++S+   RGTIGYIAPE+  R +G V
Sbjct:   467 VHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTIGYIAPEMISRVYGSV 526

Query:   509 SYKSDVYSYGMMVFEMTGEKNNANVAVDRS--SEIYFPHWVYKRLELEEDLGLQGIE--- 563
             S+KSDVYSYGM+VFEM G +       + +  S +YFP W+YK LE  ++  L+ IE   
Sbjct:   527 SHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKDLEKADNGDLEHIEIGI 586

Query:   564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDF 623
             + E++E A+KM LV LWCIQ++PSDRP MN+VVEM+EGSLD+L++PPRP L      P  
Sbjct:   587 SSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPVLQQIHVGPLL 646

Query:   624 SSILVRQTESSMA 636
              S  + +  SS++
Sbjct:   647 ESSWITEESSSIS 659

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)]

 Score = 836 (299.3 bits), Expect = 4.3e-94, Sum P(2) = 4.3e-94
 Identities = 166/271 (61%), Positives = 206/271 (76%)

Query:   348 QNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
             + VA+KVL ++KGN EDFINEVAS+S+TSHVNIVTLLGFC+EG +RA+IYEF+ NGSL++
Sbjct:   296 RKVAVKVLKDSKGNCEDFINEVASMSQTSHVNIVTLLGFCYEGSKRAIIYEFLENGSLDQ 355

Query:   408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
              ++          L    LY IA+G+ARGLEYLH GC TRI+HFDIKP N+LLDE+  PK
Sbjct:   356 SLN----------LDVSTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDENLRPK 405

Query:   468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE 527
             ++DFGLAK+CE +ESI+S+   RGTIGYIAPE+F R +G VS+KSDVYSYGM+V EM G 
Sbjct:   406 VADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRMYGSVSHKSDVYSYGMLVLEMIGA 465

Query:   528 KNNANV--AVDRSSEIYFPHWVYKRLELEEDLGL--QGIENEEDKEYARKMILVSLWCIQ 583
             +N   V  A   +S  YFP W+YK LE  ++  L   G+  EE+K  A+KMILV LWCIQ
Sbjct:   466 RNKERVQNADPNNSSAYFPDWIYKDLENFDNTRLLGDGLTREEEKN-AKKMILVGLWCIQ 524

Query:   584 TNPSDRPSMNRVVEMLEGSLDSLQIPPRPFL 614
               PSDRPSMN+VVEM+EGSLDSL  PP+P L
Sbjct:   525 FRPSDRPSMNKVVEMMEGSLDSLDPPPKPLL 555

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 916 (327.5 bits), Expect = 6.3e-92, P = 6.3e-92
 Identities = 184/333 (55%), Positives = 238/333 (71%)

Query:   291 KKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNXXXXXXXXXXXXXXX--XXXQ 348
             +K   N  NIEA +        KRY +  +KKMTNSF +                    +
Sbjct:   491 RKSELNDENIEAVVML------KRYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGR 544

Query:   349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
             ++A+K+L E+KGNGE+FINE+ S+SR SHVNIV+L GFC+EG +RA+IYEF+ NGSL+KF
Sbjct:   545 DIALKILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKF 604

Query:   409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
             I E   + T  K++W+ LY IAVG+ARGLEYLH  C ++I+HFDIKP NIL+DED CPKI
Sbjct:   605 ISEN--MST--KIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKI 660

Query:   469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
             SDFGLAK+C+ +ESI+SM  ARGT+GYIAPE+F +N+G VS+KSDVYSYGM+V EM G  
Sbjct:   661 SDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGAT 720

Query:   529 NNANV---AVDRSSEIYFPHWVYKRLELEEDLGLQG---IENEEDKEYARKMILVSLWCI 582
                 V   A D+SS +YFP WVY+ LE +E + L     IE EE+++  ++M LV LWCI
Sbjct:   721 KREEVETSATDKSS-MYFPDWVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCI 779

Query:   583 QTNPSDRPSMNRVVEMLEGS-LDSLQIPPRPFL 614
             QTNPSDRP M +VVEMLEGS L++LQ+PP+P L
Sbjct:   780 QTNPSDRPPMRKVVEMLEGSRLEALQVPPKPLL 812

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 916 (327.5 bits), Expect = 6.3e-92, P = 6.3e-92
 Identities = 187/337 (55%), Positives = 241/337 (71%)

Query:   293 KTYNYRNIEAFLRNYGSLAP-KRYRYADIKKMTNSFKNXXXXXXXXXXXXXXXXXX-QNV 350
             +T N RN E   +N  ++A  KRY Y  +KKMTNSF +                   ++V
Sbjct:   298 RTKNMRNSEWNDQNVEAVAMLKRYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDV 357

Query:   351 AIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIH 410
             A+K+L  ++GNGE+FINEVAS+SRTSHVNIV+LLGFC+E ++RA+IYEF+ NGSL+K+I 
Sbjct:   358 AVKILKVSEGNGEEFINEVASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYIS 417

Query:   411 EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD 470
                 + T  K++WE LY +AVGI+RGLEYLH  C TRI+HFDIKP NIL+DE+ CPKISD
Sbjct:   418 AN--MST--KMEWERLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISD 473

Query:   471 FGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNN 530
             FGLAK+C+ +ESI+SM   RGT GYIAPE+F +NFG VS+KSDVYSYGM+V EM G KN 
Sbjct:   474 FGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAKNI 533

Query:   531 ANVAVDRSSE--IYFPHWVYKRLELEEDLGLQG--IENEEDKEYARKMILVSLWCIQTNP 586
               V    S+   +YFP WVYK  E  E   + G  I +EE+K  A+K++LV+LWCIQ NP
Sbjct:   534 EKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDEEEK-IAKKLVLVALWCIQMNP 592

Query:   587 SDRPSMNRVVEMLEGSLDSLQIPPRPFLLS-SGSQPD 622
             SDRP M +V+EMLEG+L++LQ+PP P L S   + PD
Sbjct:   593 SDRPPMIKVIEMLEGNLEALQVPPNPLLFSPEETVPD 629

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 910 (325.4 bits), Expect = 2.7e-91, P = 2.7e-91
 Identities = 180/334 (53%), Positives = 234/334 (70%)

Query:   287 VIFWKKKTYNYRNIEAFLRNYGSLAP-KRYRYADIKKMTNSFKNXXXXXXXXXXXXXXX- 344
             VI  K +  N R  +   +N  ++   KR+ Y  +KKMT SF+N                
Sbjct:   420 VIVGKVRANNMRKSDLNEKNMEAVVMLKRFSYVQVKKMTKSFENVLGKGGFGTVYKGKLP 479

Query:   345 XXXQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
                ++VA+K+L E+  +GEDFINE+AS+SRTSH NIV+LLGFC+EG ++A+IYE + NGS
Sbjct:   480 DGSRDVAVKILKESNEDGEDFINEIASMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGS 539

Query:   405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
             L+KFI +      + K++W+ LY IAVG++ GLEYLH  C +RI+HFDIKP NIL+D D 
Sbjct:   540 LDKFISKN----MSAKMEWKTLYNIAVGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDL 595

Query:   465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             CPKISDFGLAK+C+  ESI+SM  ARGTIGYIAPEVF +NFG VS+KSDVYSYGM+V EM
Sbjct:   596 CPKISDFGLAKLCKNNESIISMLHARGTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEM 655

Query:   525 TGEKN--NANVAVDRSSEIYFPHWVYKRLELEEDLGLQG--IENEEDKEYARKMILVSLW 580
              G +N   A  A   ++ +YFP W+YK LE  E +      I  EED++  +KM+LV LW
Sbjct:   656 IGARNIGRAQNAGSSNTSMYFPDWIYKDLEKGEIMSFLADQITEEEDEKIVKKMVLVGLW 715

Query:   581 CIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFL 614
             CIQTNP DRP M++VVEMLEGSL++LQIPP+P L
Sbjct:   716 CIQTNPYDRPPMSKVVEMLEGSLEALQIPPKPLL 749

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 893 (319.4 bits), Expect = 1.7e-89, P = 1.7e-89
 Identities = 171/301 (56%), Positives = 217/301 (72%)

Query:   313 KRYRYADIKKMTNSFKNXXXXXXXXXXXXXXXXXXQNVAIKVLNETKGNGEDFINEVASI 372
             K+Y YA++KK+T SF +                  + VA+KVL + KGNG+DFINEV S+
Sbjct:   484 KQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSM 543

Query:   373 SRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVG 432
             S+TSHVNIV+LLGFC+EG +RA+I EF+ +GSL++FI     L  N       LY IA+G
Sbjct:   544 SQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVT----TLYGIALG 599

Query:   433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
             IARGLEYLH GC TRI+HFDIKP NILLD++FCPK++DFGLAK+CE RESI+S+   RGT
Sbjct:   600 IARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGT 659

Query:   493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE 552
             IGYIAPEV  R +G +S+KSDVYSYGM+V +M G +N         S  YFP W+YK LE
Sbjct:   660 IGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLE 719

Query:   553 LEEDLGLQGIE-NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPR 611
               +   + G E NEED +  +KMILVSLWCI+  PSDRP MN+VVEM+EGSLD+L++PP+
Sbjct:   720 NGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPK 779

Query:   612 P 612
             P
Sbjct:   780 P 780

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)]

 Score = 801 (287.0 bits), Expect = 1.9e-89, Sum P(2) = 1.9e-89
 Identities = 158/271 (58%), Positives = 202/271 (74%)

Query:   348 QNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
             + VA+K+L ++ GN EDFINEVASIS+TSHVNIV+LLGFCFE  +RA++YEF+ NGSL++
Sbjct:   304 RKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEKSKRAIVYEFLENGSLDQ 363

Query:   408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
                       +  L    LY IA+G+ARG+EYLH GC  RI+HFDIKP N+LLDE+  PK
Sbjct:   364 ----------SSNLDVSTLYGIALGVARGIEYLHFGCKKRIVHFDIKPQNVLLDENLKPK 413

Query:   468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE 527
             ++DFGLAK+CE +ESI+S+   RGTIGYIAPE+F R +G VS+KSDVYSYGM+V EMTG 
Sbjct:   414 VADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSHKSDVYSYGMLVLEMTGA 473

Query:   528 KNNANV--AVDRSSEIYFPHWVYKRLELEEDLGL--QGIENEEDKEYARKMILVSLWCIQ 583
             +N   V  A   +S  YFP W++K LE  + + L   G+  EE+ + A+KMILV LWCIQ
Sbjct:   474 RNKERVQNADSNNSSAYFPDWIFKDLENGDYVKLLADGLTREEE-DIAKKMILVGLWCIQ 532

Query:   584 TNPSDRPSMNRVVEMLEGSLDSLQIPPRPFL 614
               PSDRPSMN+VV M+EG+LDSL  PP+P L
Sbjct:   533 FRPSDRPSMNKVVGMMEGNLDSLDPPPKPLL 563

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00030383001 SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (960 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	638
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-49
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-34
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-29
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-28
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-27
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-23
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-23
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-21
pfam14380	94	pfam14380, WAK_assoc, Wall-associated receptor kin	6e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-21
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-07
pfam13947	106	pfam13947, GUB_WAK_bind, Wall-associated receptor	1e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  171 bits (435), Expect = 2e-49
 Identities = 69/198 (34%), Positives = 111/198 (56%), Gaps = 15/198 (7%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLN--ETKGNGEDFINEVASISRTSHVNIVTLLGFC 387
           LG+GG+G VY  +    G+ VAIK++   ++    E+ + E+  + + +H NIV L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 447
            + +   L+ E+   GSL+  + E        KL  + + +I + I  GLEYLH   +  
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKEN-----EGKLSEDEILRILLQILEGLEYLH---SNG 112

Query: 448 ILHFDIKPHNILLDED-FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
           I+H D+KP NILLD D    K++DFGL+K+    +S+  +    GT  Y+APEV     G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL-LGKG 169

Query: 507 EVSYKSDVYSYGMMVFEM 524
             S KSD++S G++++E+
Sbjct: 170 YYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  171 bits (437), Expect = 3e-49
 Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 36/283 (12%)

Query: 326 SFKNKLGQGGYGGVYKGKLLD-----GQNVAIKVLNETKGNG--EDFINEVASISRTSHV 378
           +   KLG+G +G VYKGKL          VA+K L E       E+F+ E   + +  H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           N+V LLG C E     ++ E++  G L  ++ +  P     KL    L   A+ IARG+E
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGME 116

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YL        +H D+   N L+ E+   KISDFGL++     +      G +  I ++AP
Sbjct: 117 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD-LYDDDYYRKRGGKLPIRWMAP 172

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           E      G+ + KSDV+S+G++++E+   GE+    ++ +          V + L+    
Sbjct: 173 ESL--KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLEYLK---- 217

Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
               G    +      ++  + L C   +P DRP+ + +VE+L
Sbjct: 218 ---NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  167 bits (426), Expect = 1e-47
 Identities = 82/283 (28%), Positives = 134/283 (47%), Gaps = 35/283 (12%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDG-----QNVAIKVLNETKGNG--EDFINEVASISRTSHV 378
           +   KLG+G +G VYKG L          VA+K L E       E+F+ E   + +  H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           NIV LLG C E     ++ E++  G L  ++ +  P    ++L    L   A+ IARG+E
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP----KELSLSDLLSFALQIARGME 117

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YL        +H D+   N L+ E+   KISDFGL++     +    + G +  I ++AP
Sbjct: 118 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD-LYDDDYYKVKGGKLPIRWMAP 173

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           E      G+ + KSDV+S+G++++E+   GE+    ++            V +   L++ 
Sbjct: 174 ESL--KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---------VLEY--LKKG 220

Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
             L    N   + Y      + L C   +P DRP+ + +VE+L
Sbjct: 221 YRLPKPPNCPPELYK-----LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  164 bits (417), Expect = 2e-46
 Identities = 87/281 (30%), Positives = 125/281 (44%), Gaps = 43/281 (15%)

Query: 330 KLGQGGYGGVYKGKLL-DGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLG 385
           KLG G +G VYK K    G+ VA+K+L    E     +    E+  + R SH NIV L+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
              +     L+ E+   G L  ++    PL        +   KIA+ I RGLEYLH    
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS------EDEAKKIALQILRGLEYLHS--- 116

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
             I+H D+KP NILLDE+   KI+DFGLAK      S  S+T   GT  Y+APEV     
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEV-LLGG 173

Query: 506 GEVSYKSDVYSYGMMVFEM-TGE-------KNNANVAVDR-SSEIYFPHWVYKRLELEED 556
                K DV+S G++++E+ TG+         +    + R                 EE 
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE- 232

Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                         A+ +I     C+  +PS RP+   +++
Sbjct: 233 --------------AKDLI---KKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  164 bits (417), Expect = 3e-46
 Identities = 84/283 (29%), Positives = 133/283 (46%), Gaps = 32/283 (11%)

Query: 329 NKLGQGGYGGVYKGKLLDGQN----VAIKVLNETKGNGE--DFINEVASISRTSHVNIVT 382
            KLG+G +G VYKGKL         VA+K L E     E  DF+ E   + +  H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEK---HPLETNQKLKWEVLYKIAVGIARGLEY 439
           LLG C E     L+ E++  G L  ++ +     P      L  + L   A+ IA+G+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           L    + + +H D+   N L+ ED   KISDFGL++     +     TG +  I ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDL 557
                 G  + KSDV+S+G++++E+   G      ++            V + L      
Sbjct: 178 SL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---------NEEVLEYLR----- 221

Query: 558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
             +G    + +    ++  + L C Q +P DRP+ + +VE LE
Sbjct: 222 --KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (416), Expect = 3e-46
 Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 65/297 (21%)

Query: 327 FKNKLGQGGYGGVYKGKLLD-----GQNVAIKVLNE--TKGNGEDFINEVASISRTSHVN 379
              KLG+G +G VYKG L          VA+K L E  ++   E+F+ E + + + SH N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           IV LLG C +G    ++ E++  G L  F+ +       +KL  + L ++A+ IA+G+EY
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-----GEKLTLKDLLQMALQIAKGMEY 117

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           L        +H D+   N L+ E+   KISDFGL++     +      G +  I ++APE
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL 557
                 G+ + KSDV+S+G++++E+   GE+               P             
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQ---------------P------------- 204

Query: 558 GLQGIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNRVVEML 599
              G+ NEE  E                    +++   C   +P DRP+ + +VE L
Sbjct: 205 -YPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQ--CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  152 bits (386), Expect = 5e-42
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 327 FKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTL 383
              KLG+G +G VY  +    G+ VAIKV+ + K     E  + E+  + +  H NIV L
Sbjct: 3   ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
                +  +  L+ E+   G L   + ++  L +  + +          I   LEYLH  
Sbjct: 63  YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEAR-----FYLRQILSALEYLHS- 115

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
               I+H D+KP NILLDED   K++DFGLA+     +    +T   GT  Y+APEV   
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLG 170

Query: 504 NFGEVSYKSDVYSYGMMVFEM-TGE 527
                    D++S G++++E+ TG+
Sbjct: 171 K--GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (342), Expect = 6e-36
 Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 32/213 (15%)

Query: 329 NKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLL 384
             LG+G +G VY     D G+ +A+K +  +  + E+      E+  +S   H NIV   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 385 GFCF-EGHRRALIY-EFVSNGSLEKFIHEKHPLE-------TNQKLKWEVLYKIAVGIAR 435
           G    E      I+ E+VS GSL   + +   L        T Q             I  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ-------------ILE 112

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
           GL YLH      I+H DIK  NIL+D D   K++DFG AK     E+       RGT  +
Sbjct: 113 GLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGE 527
           +APEV  R   E    +D++S G  V EM TG+
Sbjct: 170 MAPEV-IRG-EEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  129 bits (326), Expect = 8e-34
 Identities = 70/201 (34%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTL 383
               K+G+GG+G VYK +    G+ VAIKV+  E+K   E  INE+  + +  H NIV  
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G   +     ++ EF S GSL+  +       TNQ L    +  +   + +GLEYLH  
Sbjct: 63  YGSYLKKDELWIVMEFCSGGSLKDLLKS-----TNQTLTESQIAYVCKELLKGLEYLH-- 115

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
            +  I+H DIK  NILL  D   K+ DFGL+      ++  +M    GT  ++APEV   
Sbjct: 116 -SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI-- 169

Query: 504 NFGEVSYKSDVYSYGMMVFEM 524
           N     YK+D++S G+   E+
Sbjct: 170 NGKPYDYKADIWSLGITAIEL 190

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  124 bits (312), Expect = 5e-32
 Identities = 77/280 (27%), Positives = 130/280 (46%), Gaps = 25/280 (8%)

Query: 320 IKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN 379
           I     +F  +LG G +G V+ GK     +VAIK++ E   + +DFI E   + + SH N
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPN 60

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           +V L G C +     ++ E+++NG L  ++ E+       KL  E L  +   +   +EY
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER-----KGKLGTEWLLDMCSDVCEAMEY 115

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           L        +H D+   N L+ ED   K+SDFGLA+     +   S  G +  + +  PE
Sbjct: 116 LESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPE 171

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 559
           VF  ++   S KSDV+S+G++++E+              SE   P+  +   E+ E +  
Sbjct: 172 VF--DYSRFSSKSDVWSFGVLMWEVF-------------SEGKMPYERFSNSEVVESV-S 215

Query: 560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
            G      K    ++  +   C    P DRP+  +++  L
Sbjct: 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  120 bits (303), Expect = 2e-30
 Identities = 80/290 (27%), Positives = 132/290 (45%), Gaps = 32/290 (11%)

Query: 327 FKNKLGQGGYGGVYKGK---LLDGQN--VAIKVLNETKGNGE--DFINEVASISRTSHVN 379
           F  +LG+G +G V   +   L D     VA+K LN +       DF  E+  +    H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 380 IVTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
           IV   G C +   R+  LI E++ +GSL  ++           LK  +L+  +  I +G+
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLF--SSQICKGM 122

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-EGRESIVSMTGARGTIGYI 496
           +YL    + R +H D+   NIL++ +   KISDFGLAK+  E ++           I + 
Sbjct: 123 DYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM--TGEKNN---ANVAVDRSSEIYFPHWVYKRL 551
           APE  C    + S  SDV+S+G+ ++E+   G+ +    A               V + L
Sbjct: 180 APE--CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI-VTRLL 236

Query: 552 E-LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
           E L+E   L    +  D+ Y    ++   W  +  P DRPS   ++ +++
Sbjct: 237 ELLKEGERLPRPPSCPDEVY---DLMKLCW--EAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 2e-29
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 22/216 (10%)

Query: 320 IKKMTNSFKNK-LGQGGYGGVYKGKLL-DGQN----VAIKVLNETKG--NGEDFINEVAS 371
           I K T   K K LG G +G VYKG  + +G+     VAIKVL E       ++ ++E   
Sbjct: 3   ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62

Query: 372 ISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYKIA 430
           ++   H ++V LLG C    +  LI + +  G L  ++   K  + +   L W       
Sbjct: 63  MASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------C 115

Query: 431 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR 490
           V IA+G+ YL      R++H D+   N+L+      KI+DFGLAK+ +  E      G +
Sbjct: 116 VQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 491 GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MT 525
             I ++A E         ++KSDV+SYG+ V+E MT
Sbjct: 173 VPIKWMALE--SILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (299), Expect = 3e-29
 Identities = 88/315 (27%), Positives = 133/315 (42%), Gaps = 33/315 (10%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVL----NETKGNGEDFINEVASISRTSH-VNIVTLL 384
           KLG+G +G VY  +  D + VA+KVL           E F+ E+  ++  +H  NIV L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            F  +     L+ E+V  GSLE  + +         L       I   I   LEYLH   
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIG---RKGPLSESEALFILAQILSALEYLHSK- 120

Query: 445 NTRILHFDIKPHNILLDED-FCPKISDFGLAKICEGRESIVS----MTGARGTIGYIAPE 499
              I+H DIKP NILLD D    K+ DFGLAK+     S  S     + + GT GY+APE
Sbjct: 121 --GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 500 VF-CRNFGEVSYKSDVYSYGMMVFEM-TG----EKNNANVAVDRSSEIYFPHWVYKRLEL 553
           V    +    S  SD++S G+ ++E+ TG    E    + A  ++ +I         L  
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI-ILELPTPSLAS 237

Query: 554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM-LEGSLDSLQIPPRP 612
                   + ++   +  +K+       +  +P +R S +  +   L   L   +     
Sbjct: 238 PLSPSNPELISKAASDLLKKL-------LAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Query: 613 FLLSSGSQPDFSSIL 627
            L    S P   S+ 
Sbjct: 291 LLKPDDSAPLRLSLP 305

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 4e-29
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 10/195 (5%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE 389
           KLG G +G V+ G       VA+K L     + E F+ E   + +  H  +V L   C E
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 390 GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 449
                ++ E++S GSL  F+         +KL+   L  +A  IA G+ YL        +
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKS----GEGKKLRLPQLVDMAAQIAEGMAYLES---RNYI 125

Query: 450 HFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS 509
           H D+   NIL+ E+   KI+DFGLA++ E  E      GA+  I + APE    N+G  +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE-GAKFPIKWTAPEAA--NYGRFT 182

Query: 510 YKSDVYSYGMMVFEM 524
            KSDV+S+G+++ E+
Sbjct: 183 IKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 6e-29
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 19/200 (9%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
               +G+G +G V  G    GQ VA+K L +     + F+ E + ++   H N+V LLG 
Sbjct: 10  LGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 387 CFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
             +G+   ++ E+++ GSL  ++    +  +   Q+L +      A+ +  G+EYL    
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF------ALDVCEGMEYLE--- 119

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
               +H D+   N+L+ ED   K+SDFGLAK     E+       +  + + APE   R 
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-RE 173

Query: 505 FGEVSYKSDVYSYGMMVFEM 524
             + S KSDV+S+G++++E+
Sbjct: 174 -KKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  115 bits (289), Expect = 7e-29
 Identities = 73/274 (26%), Positives = 131/274 (47%), Gaps = 25/274 (9%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           +   ++G G +G V+ G  L+ + VAIK + E   + EDFI E   + + SH  +V L G
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
            C E     L++EF+ +G L  ++  +       K   E L  + + +  G+ YL     
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQ-----RGKFSQETLLGMCLDVCEGMAYLESSN- 120

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
             ++H D+   N L+ E+   K+SDFG+ +     +   S TG +  + + +PEVF  +F
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVF--SF 175

Query: 506 GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 565
            + S KSDV+S+G++++E+              SE   P+      E+ E +   G    
Sbjct: 176 SKYSSKSDVWSFGVLMWEVF-------------SEGKTPYENRSNSEVVETIN-AGFRLY 221

Query: 566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
           + +  ++ +  +   C +  P DRPS + ++  L
Sbjct: 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  114 bits (288), Expect = 1e-28
 Identities = 84/276 (30%), Positives = 137/276 (49%), Gaps = 25/276 (9%)

Query: 326 SFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLL 384
           + K+KLG G YG VY+G        VA+K L E     E+F+ E A +    H N+V LL
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G C       +I EF++ G+L  ++ E +     Q++   VL  +A  I+  +EYL +  
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEK-- 122

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
               +H D+   N L+ E+   K++DFGL+++  G ++  +  GA+  I + APE    N
Sbjct: 123 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 180

Query: 505 FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 564
             + S KSDV+++G++++E+     +    +D S        VY+ LE       +G   
Sbjct: 181 --KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE-------KGYRM 224

Query: 565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
           E  +    K+  +   C Q NPSDRPS   + +  E
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  111 bits (278), Expect = 2e-27
 Identities = 72/229 (31%), Positives = 115/229 (50%), Gaps = 20/229 (8%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           +F  +LG G +G V+ GK      VAIK +NE   + EDFI E   + + SH  +V L G
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
            C +     ++ EF+ NG L  ++ ++       KL  ++L  +   +  G+EYL R   
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLER--- 118

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
              +H D+   N L+      K+SDFG+ +     E   S +GA+  + +  PEVF  NF
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVF--NF 175

Query: 506 GEVSYKSDVYSYGMMVFEMTGE-------KNNANV--AVDRSSEIYFPH 545
            + S KSDV+S+G++++E+  E       K+N  V   + R   +Y P 
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 4e-27
 Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 47/285 (16%)

Query: 329 NKLGQGGYGGVYKGKLL--DGQ--NVAIKVL--NETKGNGEDFINEVASISRTSHVNIVT 382
            +LG G +G V KG  L   G+   VA+K L         ++F+ E + +++  H  IV 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           L+G C +G    L+ E    G L K++ +K        LK     ++A  +A G+ YL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLK-----ELAHQVAMGMAYLE- 112

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVF 501
             +   +H D+   N+LL      KISDFG+++ +  G +   + T  R  + + APE  
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE-- 168

Query: 502 CRNFGEVSYKSDVYSYGMMVFEMT-------GEKNNANVAVDRSSEIYFPHWVYKRLELE 554
           C N+G+ S KSDV+SYG+ ++E         GE   A V                 LE  
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI--------------AMLE-- 212

Query: 555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
                 G      +E  +++  + L C +  P DRP+ + +    
Sbjct: 213 -----SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  110 bits (277), Expect = 5e-27
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 15/203 (7%)

Query: 328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTL 383
             ++G+G +G VY  +   DG+   +K ++ +  +    ED +NEV  + + +H NI+  
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
                E  +  ++ E+   G L + I ++   +  +    E +    V +   L+YLH  
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQ--KKEGKPFPEEQILDWFVQLCLALKYLHS- 121

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGYIAPEVFC 502
              +ILH DIKP NI L  +   K+ DFG++K+     S V +     GT  Y++PE+ C
Sbjct: 122 --RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSPEL-C 175

Query: 503 RNFGEVSYKSDVYSYGMMVFEMT 525
           +N    +YKSD++S G +++E+ 
Sbjct: 176 QNKP-YNYKSDIWSLGCVLYELC 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 7e-27
 Identities = 80/284 (28%), Positives = 138/284 (48%), Gaps = 46/284 (16%)

Query: 331 LGQGGYGGVYKGKL-LDGQN---VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLL 384
           +G G +G V +G+L L G+    VAIK L     + +  DF+ E + + +  H NI+ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G   +     +I E++ NGSL+KF+ E      + K     L  +  GIA G++YL    
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE-----NDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
               +H D+   NIL++ +   K+SDFGL++  E  E+  +  G +  I + APE     
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI--A 181

Query: 505 FGEVSYKSDVYSYGMMVFE-MT-GEKNNANVAVDRSSEIYFPHW------VYKRLELEED 556
           + + +  SDV+S+G++++E M+ GE+               P+W      V K   +E+ 
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGER---------------PYWDMSNQDVIK--AVEDG 224

Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
             L    +     Y + M    L C Q + ++RP+ +++V  L+
Sbjct: 225 YRLPPPMDCPSALY-QLM----LDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  109 bits (275), Expect = 7e-27
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 12/198 (6%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNVAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFC 387
            KLG G +G V++G   +   VAIK+L ++     +DF  EV ++ R  H ++++L   C
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 447
             G    +I E +  GSL  F+         Q L    L  +A  +A G+ YL       
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 448 ILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGE 507
            +H D+   NIL+ ED   K++DFGLA++   +E +   +  +    + APE    + G 
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAA--SHGT 180

Query: 508 VSYKSDVYSYGMMVFEMT 525
            S KSDV+S+G++++EM 
Sbjct: 181 FSTKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  109 bits (273), Expect = 1e-26
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 42/276 (15%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLG 385
           KLG+G YG VYK K L D Q  A+K ++    ++   ED +NE+  ++  +H NI++   
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
              +G++  ++ E+   G L K I ++        +  + +++I + + RGL+ LH    
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRK--LIPEQEIWRIFIQLLRGLQALH---E 121

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGYIAPEVFCRN 504
            +ILH D+K  NILL  +   KI D G++K+ +       M   + GT  Y+APEV+   
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTPHYMAPEVWKGR 176

Query: 505 FGEVSYKSDVYSYGMMVFEMTGEKN--NANVAVDRSSEI---YFPHWVYKRLELEEDLGL 559
               SYKSD++S G +++EM        A    D   ++    +P               
Sbjct: 177 --PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP-------------- 220

Query: 560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRV 595
             I       Y++ +       +Q  P  RP+ +++
Sbjct: 221 --IPP----IYSQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  107 bits (269), Expect = 4e-26
 Identities = 80/283 (28%), Positives = 119/283 (42%), Gaps = 49/283 (17%)

Query: 331 LGQGGYGGVYKG-KLLDGQNVAIKVLN------ETKGNGEDFINEVASISRTSHVNIVTL 383
           LG G +G VY+G  L DG   A+K ++        +   +    E+A +S+  H NIV  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           LG   E     +  E V  GSL K       L+        V+      I  GLEYLH  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKL------LKKYGSFPEPVIRLYTRQILLGLEYLH-- 119

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
            +   +H DIK  NIL+D +   K++DFG+AK         S    +G+  ++APEV   
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEV-IA 174

Query: 504 NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK------RLELEEDL 557
             G     +D++S G  V EM   K          S++     V+K         + + L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK-------PPWSQLEGVAAVFKIGRSKELPPIPDHL 227

Query: 558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
             +       K++  K       C+Q +PS RP+     E+LE
Sbjct: 228 SDEA------KDFILK-------CLQRDPSLRPT---AAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 6e-26
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 32/212 (15%)

Query: 327 FKNKLGQGGYGGVYKG-KLLDGQNVAIK---VLNETKGNGEDFINEVASISRTSHVNIVT 382
             + +G+G +G VYKG  L  G  VAIK   +    +   +  + E+  +    H NIV 
Sbjct: 4   LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIA---RGLEY 439
            +G         +I E+  NGSL + I +  P   +          +AV +    +GL Y
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---------VAVYVYQVLQGLAY 114

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA----KICEGRESIVSMTGARGTIGY 495
           LH      ++H DIK  NIL  +D   K++DFG+A     + +   S+V      GT  +
Sbjct: 115 LH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV------GTPYW 165

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TG 526
           +APEV        S  SD++S G  V E+ TG
Sbjct: 166 MAPEVI--EMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  106 bits (268), Expect = 7e-26
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 21/201 (10%)

Query: 330 KLGQGGYGGVYKGKL-LDGQNVAIKVLN--ETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            LGQG  G VYK +    G+  A+K ++    +   +  + E+ ++       +V   G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
            ++    +++ E++  GSL   + +K       K+   VL  IA  I +GL+YLH     
Sbjct: 68  FYKEGEISIVLEYMDGGSLAD-LLKKVG-----KIPEPVLAYIARQILKGLDYLHT--KR 119

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTIGYIAPEVFCR 503
            I+H DIKP N+L++     KI+DFG++K+ E      ++       GT+ Y++PE    
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN-----TLDQCNTFVGTVTYMSPERI-- 172

Query: 504 NFGEVSYKSDVYSYGMMVFEM 524
                SY +D++S G+ + E 
Sbjct: 173 QGESYSYAADIWSLGLTLLEC 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 2e-24
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 14/197 (7%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNET--KGNGEDFINEVASISRTSHVNIVTLLGFC 387
           K+G+G +G VYKG L     VA+K    T        F+ E   + +  H NIV L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNT 446
            +     ++ E V  GSL  F+ +K       +L  + L ++++  A G+EYL  + C  
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKK-----KNRLTVKKLLQMSLDAAAGMEYLESKNC-- 114

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
             +H D+   N L+ E+   KISDFG+++  EG    VS    +  I + APE    N+G
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL--NYG 170

Query: 507 EVSYKSDVYSYGMMVFE 523
             + +SDV+SYG++++E
Sbjct: 171 RYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  101 bits (253), Expect = 1e-23
 Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLL 384
               K+G+G  G VYK      G+ VAIK +   K N E  INE+  +    H NIV   
Sbjct: 22  KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYY 81

Query: 385 G-FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
             +        ++ E++  GSL   I  ++ +  N+    ++ Y +   + +GLEYLH  
Sbjct: 82  DSYLVGDEL-WVVMEYMDGGSLTDII-TQNFVRMNEP---QIAY-VCREVLQGLEYLH-- 133

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLA----KICEGRESIVSMTGARGTIGYIAPE 499
            +  ++H DIK  NILL +D   K++DFG A    K    R S+V      GT  ++APE
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYWMAPE 186

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEMT-GE 527
           V  R   +   K D++S G+M  EM  GE
Sbjct: 187 VIKRK--DYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =   99 bits (249), Expect = 2e-23
 Identities = 66/230 (28%), Positives = 120/230 (52%), Gaps = 22/230 (9%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           +F  +LG G +G V  GK     +VAIK++ E   + ++FI E   + + SH  +V L G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            C +     ++ E++SNG L  ++ E     + +Q      L ++   +  G+ YL    
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ------LLEMCKDVCEGMAYLE--- 117

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
           + + +H D+   N L+D+  C K+SDFGL++     E   S+ G++  + +  PEV    
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVL--L 174

Query: 505 FGEVSYKSDVYSYGMMVFE------MTGEKNNANVAVDRSSE---IYFPH 545
           + + S KSDV+++G++++E      M  E+ N +  V++ S+   +Y PH
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH 224

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  100 bits (251), Expect = 2e-23
 Identities = 67/202 (33%), Positives = 113/202 (55%), Gaps = 20/202 (9%)

Query: 331 LGQGGYGGVYKGKLL-DGQNV----AIKVLNETKGNGE--DFINEVASISRTSHVNIVTL 383
           LG G +G VYKG  + +G+ V    AIK+LNET G     +F++E   ++   H ++V L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           LG C     + L+ + + +G L  ++HE K  + +   L W       V IA+G+ YL  
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
               R++H D+   N+L+      KI+DFGLA++ EG E   +  G +  I ++A E  C
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--C 182

Query: 503 RNFGEVSYKSDVYSYGMMVFEM 524
            ++ + +++SDV+SYG+ ++E+
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWEL 204

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 32/209 (15%)

Query: 328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTL 383
             KLG+G YG VYK +    G+ VA+K +   NE +G     + E++ +    H NIV L
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKH-PLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           L       +  L++E+     L+K++ ++  PL  N  +K      I   + RGL Y H 
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IK-----SIMYQLLRGLAYCHS 116

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE--GR---ESIVSMTGARGTIGYIA 497
               RILH D+KP NIL++ D   K++DFGLA+      R     +V       T+ Y A
Sbjct: 117 H---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-------TLWYRA 166

Query: 498 PEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           PE+     G   Y +  D++S G +  EM
Sbjct: 167 PEIL---LGSKHYSTAVDIWSVGCIFAEM 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 99.1 bits (248), Expect = 3e-23
 Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 29/228 (12%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLG 385
           LG+G +G V   +  D   + A+KVL       +   E  + E   +SR +H  IV L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 386 FCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           + F+   +  L+ E+   G L   + ++         +    Y  A  I   LEYLH   
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRF----SEERARFY--AAEIVLALEYLHS-- 111

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKI-CEGRESIVSMTGARGTIGYIAPEVFCR 503
              I++ D+KP NILLD D   K++DFGLAK          +     GT  Y+APEV   
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---GTPEYLAPEVLLG 167

Query: 504 NFGEVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDRSSEIYFP 544
                    D +S G++++EM         E             + FP
Sbjct: 168 --KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP 213

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 99.1 bits (247), Expect = 5e-23
 Identities = 79/305 (25%), Positives = 137/305 (44%), Gaps = 51/305 (16%)

Query: 320 IKKMTNSFKNKLGQGGYGGVYKGKLLDGQN------VAIKVLNETKGNG--EDFINEVAS 371
           +++ T   K +LG+G +G V+ G+    +       VA+K L ET  N   +DF  E   
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 372 ISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI--HEKH------PLETNQKLKW 423
           ++   H NIV   G C EG    +++E++ +G L KF+  H         P     +L  
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI 483
             L +IAV IA G+ YL    +   +H D+   N L+  D   KI DFG+++       +
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR------DV 172

Query: 484 VSMTGAR--GT----IGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAV 535
            +    R  G     I ++ PE +  R F   + +SDV+S+G++++E+ T  K       
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVVLWEIFTYGKQ------ 223

Query: 536 DRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRV 595
                   P +     E+ E +  QG   +  +    ++  + L C + +P  R ++  +
Sbjct: 224 --------PWYGLSNEEVIECIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274

Query: 596 VEMLE 600
            E L+
Sbjct: 275 HERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 98.4 bits (245), Expect = 5e-23
 Identities = 65/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE 389
           KLG G +G V+ G       VAIK L +   + E F+ E   + +  H  +V L      
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70

Query: 390 GHRRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
              +  IY   E++ NGSL  F+          KL    L  +A  IA G+ ++ R    
Sbjct: 71  --TQEPIYIITEYMENGSLVDFLKT----PEGIKLTINKLIDMAAQIAEGMAFIER---K 121

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
             +H D++  NIL+ E  C KI+DFGLA++ E  E   +  GA+  I + APE    N+G
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYG 178

Query: 507 EVSYKSDVYSYGMMVFEM 524
             + KSDV+S+G+++ E+
Sbjct: 179 TFTIKSDVWSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 98.7 bits (246), Expect = 5e-23
 Identities = 84/292 (28%), Positives = 131/292 (44%), Gaps = 55/292 (18%)

Query: 331 LGQGGYGGVYKGKLLD-GQN-VAIKVLN-----------ETKGNGEDFINEVASISRT-S 376
           LG G +G VYK +  + GQN +A+K +N           E   +  D ++EV  I     
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR 435
           H NIV       E  R  ++ + +    L E F   K   E  Q+   E ++ I V +  
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK---EKKQRFTEERIWNIFVQMVL 124

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
            L YLH+    RI+H D+ P+NI+L ED    I+DFGLAK  +  ES   +T   GTI Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPES--KLTSVVGTILY 179

Query: 496 IAPEVFCRN--FGEVSYKSDVYSYGMMVFEMTG------EKNNANVAVDRSSEIYFPHWV 547
             PE+  +N  +GE   K+DV+++G ++++M          N  ++A      +Y P   
Sbjct: 180 SCPEIV-KNEPYGE---KADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--- 232

Query: 548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
                L E +            Y+  +  V   C+  +   RP + +V  M+
Sbjct: 233 -----LPEGM------------YSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.1 bits (244), Expect = 7e-23
 Identities = 73/284 (25%), Positives = 140/284 (49%), Gaps = 37/284 (13%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV 378
           +++K+T      +G+G +G V +G+   GQ VA+K + +     + F+ E A +++  H 
Sbjct: 4   NLQKLT--LGEIIGEGEFGAVLQGEYT-GQKVAVKNI-KCDVTAQAFLEETAVMTKLHHK 59

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           N+V LLG     +   ++ E +S G+L  F+  +     +       L + ++ +A G+E
Sbjct: 60  NLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQ----LLQFSLDVAEGME 114

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YL    + +++H D+   NIL+ ED   K+SDFGLA++  G   + +   ++  + + AP
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDN---SKLPVKWTAP 166

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE--D 556
           E       + S KSDV+SYG++++E+                  +    Y ++ L+E  +
Sbjct: 167 EAL--KHKKFSSKSDVWSYGVLLWEV----------------FSYGRAPYPKMSLKEVKE 208

Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
              +G   E  +     + ++   C +T P  RPS +++ E LE
Sbjct: 209 CVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 8e-23
 Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 36/288 (12%)

Query: 331 LGQGGYGGVYKGKLL--DG--QNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTL 383
           LG+G +G V +G+L   DG    VA+K +     T    E+F++E A +    H N++ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 384 LGFCFEGHRRA------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
           +G CFE           +I  F+ +G L  F+         +KL  + L K  V IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIA 497
           EYL    N   +H D+   N +L ED    ++DFGL+K     +       A+  + +IA
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
            E         + KSDV+++G+ ++E+   G+     V    + EIY       RL+  E
Sbjct: 184 IESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYPGV---ENHEIYDYLRHGNRLKQPE 238

Query: 556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           D          D+ Y    ++ S W  + +P DRP+  ++ E+LE  L
Sbjct: 239 DC--------LDELYD---LMYSCW--RADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 97.6 bits (244), Expect = 2e-22
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 37/223 (16%)

Query: 327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNE---TKGNGEDFIN-EVASISRTS-HVNI 380
           F   +G+G +  V   K     +  AIK+L++    K     ++  E   ++R + H  I
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64

Query: 381 VTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           + L  + F+       + E+  NG L ++I           L  +     A  I   LEY
Sbjct: 65  IKLY-YTFQDEENLYFVLEYAPNGELLQYIR------KYGSLDEKCTRFYAAEILLALEY 117

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI--------------CEGRESIVS 485
           LH   +  I+H D+KP NILLD+D   KI+DFG AK+                    I  
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 486 MTGAR----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                    GT  Y++PE+   N       SD+++ G ++++M
Sbjct: 175 NRRRFASFVGTAEYVSPELL--NEKPAGKSSDLWALGCIIYQM 215

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 25/217 (11%)

Query: 327 FKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKGNG---EDFINEVASISRTSH 377
           F  +LG+G +G VYKG+L          +VAIK L E        ++F  E   +S   H
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKE-NAEPKVQQEFRQEAELMSDLQH 67

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLY 427
            NIV LLG C +     +++E++++G L +F+    P                L      
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 428 KIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMT 487
            IA+ IA G+EYL    +   +H D+   N L+ E    KISDFGL++     +     +
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184

Query: 488 GARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            +   + ++ PE     +G+ + +SD++S+G++++E+
Sbjct: 185 KSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 12/207 (5%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV 378
           +I + +     KLG G +G V++G   +   VA+K L     + +DF+ E   + +  H 
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
            ++ L   C       ++ E +  GSL +++         + LK   L  +A  +A G+ 
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG----GAGRALKLPQLIDMAAQVASGMA 117

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV-SMTGARGTIGYIA 497
           YL        +H D+   N+L+ E+   K++DFGLA++   +E I  +  GA+  I + A
Sbjct: 118 YLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVI--KEDIYEAREGAKFPIKWTA 172

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           PE     +   S KSDV+S+G+++ E+
Sbjct: 173 PEAA--LYNRFSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 28/210 (13%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCF 388
           +G+G YG VYK +    GQ VAIK+++  +   E+   E   + + S H NI T  G  F
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-AF 72

Query: 389 -------EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
                     +  L+ E    GS+   +  K   +  ++LK E +  I     RGL YLH
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT-IG---YIA 497
                +++H DIK  NILL ++   K+ DFG++        + S  G R T IG   ++A
Sbjct: 131 E---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA------QLDSTLGRRNTFIGTPYWMA 181

Query: 498 PEVF-CRNFGEVSY--KSDVYSYGMMVFEM 524
           PEV  C    + SY  +SDV+S G+   E+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 79/290 (27%), Positives = 115/290 (39%), Gaps = 56/290 (19%)

Query: 330 KLGQGGYGGVYKGKLLDGQ----NVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTL 383
           KLG G +G V +G+          VA+K L   K     +DF+ E A +    H N++ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G     H   ++ E    GSL   + +              L   AV IA G+ YL   
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGH----FLISTLCDYAVQIANGMRYLE-- 114

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFC 502
            + R +H D+   NILL  D   KI DFGL + + +  +  V     +    + APE   
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--S 171

Query: 503 RNFGEVSYKSDVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 560
                 S+ SDV+ +G+ ++EM   GE+               P W           GL 
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEE---------------P-WA----------GLS 205

Query: 561 GIENEE--DKEYAR---------KMILVSLWCIQTNPSDRPSMNRVVEML 599
           G +  +  DKE  R          +  V L C   NP+DRP+   + E L
Sbjct: 206 GSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 11/196 (5%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE 389
           KLGQG +G V+ G       VAIK L     + E F+ E   + +  H  +V L     E
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 390 GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 449
                ++ E++S GSL  F+      E  + L+   L  +A  IA G+ Y+ R      +
Sbjct: 73  -EPIYIVTEYMSKGSLLDFLKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 124

Query: 450 HFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS 509
           H D++  NIL+ E+   K++DFGLA++ E  E   +  GA+  I + APE     +G  +
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFT 181

Query: 510 YKSDVYSYGMMVFEMT 525
            KSDV+S+G+++ E+T
Sbjct: 182 IKSDVWSFGILLTELT 197

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 23/211 (10%)

Query: 329 NKLGQGGYGGVYKGKL--LDGQN----VAIKVLNE--TKGNGEDFINEVASISRTSHVNI 380
             LG G +G VY+G     DG      VA+K L E  ++ +  DF+ E   +S+ +H NI
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP-LETNQKLKWEVLYKIAVGIARGLEY 439
           V L+G  FE   R ++ E ++ G L+ F+ E  P  E    L  + L   A  +A+G +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCP------KISDFGLAKICEGRESIVSMTGARGTI 493
           L        +H DI   N LL    C       KI+DFG+A+             A   I
Sbjct: 132 LE---ENHFIHRDIAARNCLLT---CKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 494 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            ++ PE F    G  + K+DV+S+G++++E+
Sbjct: 186 KWMPPEAFLD--GIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.6 bits (235), Expect = 1e-21
 Identities = 74/233 (31%), Positives = 109/233 (46%), Gaps = 37/233 (15%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNVAIKVL-------NETKGNGEDFINEVASISRTSHVNIV 381
             LG+G YG VY G    GQ +A+K +          +   E    EV  +    HVNIV
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
             LG C + +  ++  EFV  GS+   ++   PL         V  K    I  G+ YLH
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE------PVFCKYTKQILDGVAYLH 119

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA--------RGTI 493
             C   ++H DIK +N++L  +   K+ DFG A+    R + V + G          GT 
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR----RLAWVGLHGTHSNMLKSMHGTP 172

Query: 494 GYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYF 543
            ++APEV      E  Y  KSD++S G  VFEM TG+   A+  +DR + +++
Sbjct: 173 YWMAPEV----INESGYGRKSDIWSIGCTVFEMATGKPPLAS--MDRLAAMFY 219

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 35/277 (12%)

Query: 330 KLGQGGYGGVYKGKL-LDGQNVAIKVLNET--KGNGEDFINEVASISRTSHVNIVTLLGF 386
           ++G+G +G V+ G+L  D   VA+K   ET        F+ E   + + SH NIV L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
           C +     ++ E V  G    F+  + P     +LK + L ++    A G+EYL      
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESKH-- 114

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTI--GYIAPEVFCRN 504
             +H D+   N L+ E    KISDFG+++  E  + + + TG    I   + APE    N
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEAL--N 169

Query: 505 FGEVSYKSDVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 562
           +G  S +SDV+S+G++++E    G    AN++  ++ E            +E+ + L   
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-----------IEQGVRLPCP 218

Query: 563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
           E   D  Y      +   C + +P  RPS + V + L
Sbjct: 219 ELCPDAVYR-----LMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 329 NKLGQGGYGGVYKGKLLD-GQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLL 384
           NK+G G +G VY    LD G+ +A+K +          ++  +E+  +    H N+V   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 385 GFCFEGHR-RALIY-EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           G   E HR +  I+ E+ S G+LE+ +     L+ +      V+    + +  GL YLH 
Sbjct: 66  GV--EVHREKVYIFMEYCSGGTLEELLEHGRILDEH------VIRVYTLQLLEGLAYLH- 116

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSM-TGARGTIGYIAPEV 500
             +  I+H DIKP NI LD +   K+ DFG A  +     ++        GT  Y+APEV
Sbjct: 117 --SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 501 FCRNFGEVSYKS-DVYSYGMMVFEM-TGEK 528
                G+   ++ D++S G +V EM TG++
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLN-ETKGNGED--FINEVASISRTSHVNIVTLL 384
             +G+G +G V K +   DG+ +  K ++       E    ++EV  +    H NIV   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62

Query: 385 GFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
            +      R+     ++ E+   G L + I  +   +  + ++ E +++I   +   L  
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 440 LHRGC--NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIA 497
            H        +LH D+KP NI LD +   K+ DFGLAKI     S    T   GT  Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK-TYV-GTPYYMS 178

Query: 498 PEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
           PE         SY  KSD++S G +++E+
Sbjct: 179 PEQLNHM----SYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 26/202 (12%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCF 388
           KLG+G YG VYK    + GQ VAIKV+   + + ++ I E++ + +     IV   G  F
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 389 EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 448
           +     ++ E+   GS+   +       TN+ L  E +  I     +GLEYLH   + + 
Sbjct: 69  KNTDLWIVMEYCGAGSVSDIMKI-----TNKTLTEEEIAAILYQTLKGLEYLH---SNKK 120

Query: 449 LHFDIKPHNILLDEDFCPKISDFGLAKICEG----RESIVSMTGARGTIGYIAPEVFCRN 504
           +H DIK  NILL+E+   K++DFG++         R +++      GT  ++APEV    
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI------GTPFWMAPEV---- 170

Query: 505 FGEVSY--KSDVYSYGMMVFEM 524
             E+ Y  K+D++S G+   EM
Sbjct: 171 IQEIGYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 94.2 bits (235), Expect = 4e-21
 Identities = 71/205 (34%), Positives = 99/205 (48%), Gaps = 31/205 (15%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIK-VLNETKGNGEDFIN-----EVASISRTSHVN 379
              KLG+G Y  VYK +    G+ VAIK +    +   +D IN     E+  +    H N
Sbjct: 4   KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63

Query: 380 IVTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
           I+ LL   F GH+    L++EF+    LEK I +K  + T   +K        +   RGL
Sbjct: 64  IIGLLD-VF-GHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK-----SYMLMTLRGL 115

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--EGRESIVSMTGARGTIGY 495
           EYLH      ILH D+KP+N+L+  D   K++DFGLA+      R+    MT    T  Y
Sbjct: 116 EYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK----MTHQVVTRWY 168

Query: 496 IAPEVFCRNFGEVSYKS--DVYSYG 518
            APE+    FG   Y    D++S G
Sbjct: 169 RAPELL---FGARHYGVGVDMWSVG 190

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 73/293 (24%), Positives = 136/293 (46%), Gaps = 46/293 (15%)

Query: 331 LGQGGYGGVYKGKLLD------GQNVAIKVLNETKGNGE--DFINEVASISRT-SHVNIV 381
           LG+G +G V K + +          VA+K+L +     +  D ++E+  +     H NI+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP----------LETNQKLKWEVLYKIAV 431
            LLG C +     ++ E+ ++G+L  F+  + P              + L  + L   A 
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG 491
            +ARG+E+L    + + +H D+   N+L+ ED   KI+DFGLA+     +     T  R 
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 492 TIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYK 549
            + ++APE +F R +   +++SDV+S+G++++E  T                      Y 
Sbjct: 197 PVKWMAPEALFDRVY---THQSDVWSFGVLLWEIFT-----------------LGGSPYP 236

Query: 550 RLELEE--DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
            + +EE   L  +G   E+ +   +++  +   C    PS RP+  ++VE L+
Sbjct: 237 GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 25/271 (9%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE 389
           KLGQG +G V+ G       VAIK L       E F+ E   + +  H  +V L     E
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 390 GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 449
                ++ EF+  GSL  F+ E       + LK   L  +A  IA G+ Y+ R      +
Sbjct: 73  -EPIYIVTEFMGKGSLLDFLKEG----DGKYLKLPQLVDMAAQIADGMAYIER---MNYI 124

Query: 450 HFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS 509
           H D++  NIL+ ++   KI+DFGLA++ E  E   +  GA+  I + APE     +G  +
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFT 181

Query: 510 YKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKE 569
            KSDV+S+G+++ E+  +             + +P  V + +  + + G +    +   E
Sbjct: 182 IKSDVWSFGILLTELVTK-----------GRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230

Query: 570 YARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
              +++ +   C + +P +RP+   +   LE
Sbjct: 231 SLHELMKL---CWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|222721 pfam14380, WAK_assoc, Wall-associated receptor kinase C-terminal

 Score = 87.5 bits (217), Expect = 6e-21
 Identities = 34/95 (35%), Positives = 44/95 (46%), Gaps = 6/95 (6%)

Query: 168 GNCSGDDTVLGMFEDDSDLDSASKQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLLK 227
              SGD +   +F  D         C  S V PV     G  +G   G EE++R+GF L+
Sbjct: 4   SGDSGDYSSYFVFPSDDLSGG----CSRSVVVPVLGSALGADLGSGDGYEEVLREGFELE 59

Query: 228 WK--ASDCRACKESGGSCGFDADTFHFQCYCPDRR 260
           W     DC  C+ SGG CG+D  +  F C CPD  
Sbjct: 60  WNVDPGDCSECEASGGRCGYDQTSEFFGCLCPDGP 94

This WAK_assoc domain is cysteine-rich and lies C-terminal to the binding domain, GUB_WAK_bind, pfam13947. Length = 94

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.6 bits (227), Expect = 9e-21
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 17/197 (8%)

Query: 331 LGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGED--FINEVASISRTSHVNIVTLLGFCF 388
           LG+G +G V+KG L D   VA+K   E         F++E   + +  H NIV L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 389 EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTR 447
           +     ++ E V  G    F+ +K       +LK + L K A+  A G+ YL  + C   
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKK-----KDELKTKQLVKFALDAAAGMAYLESKNC--- 114

Query: 448 ILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT-IGYIAPEVFCRNFG 506
            +H D+   N L+ E+   KISDFG+++  +  + I S +G +   I + APE    N+G
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL--NYG 169

Query: 507 EVSYKSDVYSYGMMVFE 523
             S +SDV+SYG++++E
Sbjct: 170 RYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 92.8 bits (230), Expect = 1e-20
 Identities = 69/224 (30%), Positives = 117/224 (52%), Gaps = 29/224 (12%)

Query: 317 YADIKKMTNSFKNKLGQGGYGGVYKGKLL-DG--QNVAIKVLNE--TKGNGEDFINEVAS 371
           + DIK     F++ +G+G +G V K ++  DG   + AIK + E  +K +  DF  E+  
Sbjct: 6   WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 372 ISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN----------QK 420
           + +   H NI+ LLG C       L  E+  +G+L  F+ +   LET+            
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
           L  + L   A  +ARG++YL +    + +H D+   NIL+ E++  KI+DFGL++   G+
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQ 174

Query: 481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           E  V  T  R  + ++A E    N+   +  SDV+SYG++++E+
Sbjct: 175 EVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 85/292 (29%), Positives = 132/292 (45%), Gaps = 54/292 (18%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQ-NVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTL 383
               +G G    VY    L     VAIK ++  K     ++   EV ++S+ +H N+V  
Sbjct: 5   LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQK------LKWEVLYKIAVGIARGL 437
                 G    L+  ++S GSL   +   +P     +      LK EVL        +GL
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-EVL--------KGL 115

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICEG-------RESIVSMTGA 489
           EYLH   N +I H DIK  NILL ED   KI+DFG+ A + +G       R++ V     
Sbjct: 116 EYLHS--NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV----- 167

Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVY 548
            GT  ++APEV  +  G   +K+D++S+G+   E+ TG    +          Y P  V 
Sbjct: 168 -GTPCWMAPEVMEQVHG-YDFKADIWSFGITAIELATGAAPYSK---------YPPMKVL 216

Query: 549 KRLELEEDLGLQGIENEEDKEYA---RKMILVSLWCIQTNPSDRPSMNRVVE 597
                 +   L+     + K+Y+   RKMI +   C+Q +PS RP+   +++
Sbjct: 217 MLTLQNDPPSLE--TGADYKKYSKSFRKMISL---CLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 11/195 (5%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE 389
           KLG G +G V+ G       VA+K L     + E F+ E   + +  H  +V L     E
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 390 GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 449
                ++ E++S GSL  F+ +       + LK   L  +A  +A G+ Y+ R      +
Sbjct: 73  -EPIYIVTEYMSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIER---MNYI 124

Query: 450 HFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS 509
           H D++  NIL+ +    KI+DFGLA++ E  E   +  GA+  I + APE     +G  +
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFT 181

Query: 510 YKSDVYSYGMMVFEM 524
            KSDV+S+G+++ E+
Sbjct: 182 IKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 78/285 (27%), Positives = 130/285 (45%), Gaps = 31/285 (10%)

Query: 331 LGQGGYGGVYKGKLLDGQN---VAIKVLNE---TKGNGEDFINEVASISRTSHVNIVTLL 384
           LG+G +G V +G+L    +   VA+K +     T+   EDF++E   +    H N++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 385 GFCFEGHRR------ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           G C +           +I  F+ +G L  F+      +  Q L  ++L K    IA G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YL    +   +H D+   N +L+E+    ++DFGL+K     +       A+  + +IA 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 558
           E         + KSDV+S+G+ ++E+          V+ +SEIY       RL+   D  
Sbjct: 184 ESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVE-NSEIYDYLRQGNRLKQPPDC- 239

Query: 559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           L G+       Y+   ++ S W    NP DRPS   +   LE +L
Sbjct: 240 LDGL-------YS---LMSSCW--LLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 53/287 (18%)

Query: 329 NKLGQGGYGGVYKGKLL-DGQNVAIKV----LNETKGNGEDFINEVASISRTSHVNIVTL 383
            +LG G  G V K      G+ +A+K     +NE        + E+  + + +   IV  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNSPYIVGF 64

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G  +     ++  E++  GSL+K + E        ++   +L KIAV + +GL YLH  
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKE-----VQGRIPERILGKIAVAVLKGLTYLHE- 118

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGYIAPEVFC 502
              +I+H D+KP NIL++     K+ DFG++      + + S+     GT  Y+APE   
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPE--- 169

Query: 503 RNFGEV-SYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR-----LELEED 556
           R  G   S KSD++S G+ + E+         A  R     FP+           EL   
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIEL---------ATGR-----FPYPPENDPPDGIFEL--- 212

Query: 557 LGLQGIENEE-----DKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
             LQ I NE        +++         C+  +P +RPS   ++E 
Sbjct: 213 --LQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLG 385
           K+G+G YG VYK +  L G+ VAIK +    E++G  +  + E+  +   +H NI+ LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                    L++EF+    L K I ++        +K   LY++     +GL + H    
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKS-YLYQLL----QGLAFCHS--- 116

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
             ILH D+KP N+L++ +   K++DFGLA+       +   T    T  Y APE+     
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELL---L 171

Query: 506 GEVSYKS--DVYSYGMMVFEM 524
           G+  Y +  D++S G +  E+
Sbjct: 172 GDKGYSTPVDIWSVGCIFAEL 192

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 10/206 (4%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV 378
           +I + +     KLG G +G V+ G   +   VA+K L     + + F+ E   +    H 
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 61

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
            +V L     +     +I E+++ GSL  F+      +   K+    L   +  IA G+ 
Sbjct: 62  KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS----DEGGKVLLPKLIDFSAQIAEGMA 117

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           Y+ R      +H D++  N+L+ E    KI+DFGLA++ E  E   +  GA+  I + AP
Sbjct: 118 YIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 173

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM 524
           E    NFG  + KSDV+S+G++++E+
Sbjct: 174 EAI--NFGSFTIKSDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 47/218 (21%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLL 384
              ++G G YG VYK + +  G+ VAIKV+    G+  + I  E++ +    H NIV   
Sbjct: 7   LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYKIAVGIA-------RG 436
           G      +  ++ E+   GSL+      + PL   Q             IA       +G
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ-------------IAYVCRETLKG 113

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG--------LAKICEGRESIVSMTG 488
           L YLH    T  +H DIK  NILL ED   K++DFG        +AK    R+S +    
Sbjct: 114 LAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK----RKSFI---- 162

Query: 489 ARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
             GT  ++APEV      +  Y  K D+++ G+   E+
Sbjct: 163 --GTPYWMAPEVAAVE-RKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.0 bits (224), Expect = 6e-20
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 19/201 (9%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLG 385
           ++G+G +G V+K K  + G+ VA+K +   +  G      + E+ ++    H  +V LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
               G    L+ E++ +   E    E+ PL    ++K          + +G+ Y+H    
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPL-PEAQVK-----SYMRMLLKGVAYMH---A 117

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
             I+H D+KP N+L+  D   KI+DFGLA++    E     +    T  Y APE+    +
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELL---Y 173

Query: 506 GEVSYKS--DVYSYGMMVFEM 524
           G   Y    D+++ G +  E+
Sbjct: 174 GARKYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 37/214 (17%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIK---VLNETKGNGEDFINEVA---SISRTSHVNIV 381
            ++G+G YG VYK + L  G+ VA+K   V    +G     + E+A    +    H NIV
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 382 TLLGFCFEGHRR------ALIYEFVSNGSLEKFIHEKHP---LETNQKLKWEVLYKIAVG 432
            LL  C  G R        L++E V    L  ++  K P   L     +K  ++ ++   
Sbjct: 65  RLLDVC-HGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPE-TIKD-LMRQLL-- 117

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
             RG+++LH   + RI+H D+KP NIL+  D   KI+DFGLA+I       +++T    T
Sbjct: 118 --RGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVT 169

Query: 493 IGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           + Y APEV  +     SY +  D++S G +  E+
Sbjct: 170 LWYRAPEVLLQ----SSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 61/207 (29%), Positives = 114/207 (55%), Gaps = 19/207 (9%)

Query: 331 LGQGGYGGVYKGKL-LDGQN---VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLL 384
           +G G +G V++G L + G+    VAIK L    T+   +DF++E + + + SH NI+ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G   +     +I E++ NG+L+K++ +      + +     L  +  GIA G++YL    
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDH-----DGEFSSYQLVGMLRGIAAGMKYL---S 124

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCR 503
           +   +H D+   NIL++ +   K+SDFGL+++ E   E   + +G +  I + APE    
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI-- 182

Query: 504 NFGEVSYKSDVYSYGMMVFEMT--GEK 528
            + + +  SDV+S+G++++E+   GE+
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 89.7 bits (222), Expect = 2e-19
 Identities = 75/294 (25%), Positives = 141/294 (47%), Gaps = 46/294 (15%)

Query: 331 LGQGGYG--------GVYKGKLLDGQNVAIKVLNE--TKGNGEDFINEVASISRT-SHVN 379
           LG+G +G        G+ K K      VA+K+L +  T  +  D ++E+  +     H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP------LET----NQKLKWEVLYKI 429
           I+ LLG C +     ++ E+ S G+L +++  + P       +T     ++L ++ L   
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     +     T  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY 548
           R  + ++APE +F R +   +++SDV+S+G++++E+     +                 Y
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEIFTLGGSP----------------Y 237

Query: 549 KRLELEEDLGL--QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
             + +EE   L  +G   ++      ++ ++   C    PS RP+  ++VE L+
Sbjct: 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)

Query: 328 KNKLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTL 383
            NK+G+G +G V+K  +  D +  A+K ++ +K N    E+ I+E   +++     I+  
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIH--EKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
                +  +  ++ E+  NG L K +      PL  +Q      +++  + I  GL +LH
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ------VWRFFIQILLGLAHLH 118

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
              + +ILH DIK  N+ LD     KI D G+AK+     +  + T   GT  Y++PE+ 
Sbjct: 119 ---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANT-IVGTPYYLSPEL- 172

Query: 502 CRN--FGEVSYKSDVYSYGMMVFEM 524
           C +  + E   KSDV++ G++++E 
Sbjct: 173 CEDKPYNE---KSDVWALGVVLYEC 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 72/294 (24%), Positives = 141/294 (47%), Gaps = 46/294 (15%)

Query: 331 LGQGGYG--------GVYKGKLLDGQNVAIKVL--NETKGNGEDFINEVASISRTS-HVN 379
           LG+G +G        G+ K K  +   VA+K+L  + T+ +  D ++E+  +     H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLE----------TNQKLKWEVLYKI 429
           I+ LLG C +     +I E+ S G+L +++  + P             ++++ ++ L   
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
              +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     +     T  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY 548
           R  + ++APE +F R +   +++SDV+S+G++++E+     +                 Y
Sbjct: 200 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLGGSP----------------Y 240

Query: 549 KRLELEEDLGL--QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
             + +EE   L  +G   ++      ++ ++   C    PS RP+  ++VE L+
Sbjct: 241 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 21/199 (10%)

Query: 332 GQGGYGGVYKGKLLDGQNV-AIKVLNETK----GNGEDFINEVASISRTSHVNIVTL-LG 385
           G+G +G V   +  D + + A+K +N+ K    G+  + +NE   +   +H  +V L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
           F  +     L+ + +  G L      ++ L    K   E +      I   LEYLH   +
Sbjct: 69  FQ-DEENMYLVVDLLLGGDL------RYHLSQKVKFSEEQVKFWICEIVLALEYLH---S 118

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
             I+H DIKP NILLDE     I+DF +A          S +   GT GY+APEV CR  
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQ- 174

Query: 506 GEVSYKSDVYSYGMMVFEM 524
              S   D +S G+  +E 
Sbjct: 175 -GYSVAVDWWSLGVTAYEC 192

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 77/302 (25%), Positives = 126/302 (41%), Gaps = 71/302 (23%)

Query: 331 LGQGGYGGVYKGKLLD------GQNVAIKVLNETKGNGE--DFINEVASISR--TSHVNI 380
           LGQG +G VY+G             VAIK +NE     E  +F+NE AS+ +    H ++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE-ASVMKEFNCH-HV 71

Query: 381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN----QKLKWEVLYKIAVGIARG 436
           V LLG    G    ++ E ++ G L+ ++  + P   N         +   ++A  IA G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           + YL      + +H D+   N ++ ED   KI DFG+ +     +           + ++
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 497 APE-----VFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL 551
           APE     VF       + KSDV+S+G++++EM      A +A                 
Sbjct: 189 APESLKDGVF-------TTKSDVWSFGVVLWEM------ATLA----------------- 218

Query: 552 ELEEDLGLQGIENEE------DKEYAR-------KMILVSLWCIQTNPSDRPSMNRVVEM 598
               +   QG+ NEE      D  +         K++ +   C Q NP  RP+   +V  
Sbjct: 219 ----EQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274

Query: 599 LE 600
           L+
Sbjct: 275 LK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 35/213 (16%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKV--LNET---------KGNGEDFINEVASISRTSHV 378
           +G+G YG VY    +  G+ +A+K   L  T         K   +   +E+ ++    H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLE-------TNQKLKWEVLYKIAV 431
           NIV  LGF       ++  E+V  GS+   +      E       T Q L+         
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE--------- 119

Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG 491
               GL YLH   +  ILH D+K  N+L+D D   KISDFG++K  +           +G
Sbjct: 120 ----GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172

Query: 492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           ++ ++APEV        S K D++S G +V EM
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 24/208 (11%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLG 385
           K+G+G YG VYKG+    GQ VA+K +   +E +G     I E++ +    H NIV L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
              +  R  LI+EF+S   L+K++     L   Q +  E++      I +G+ + H    
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDS---LPKGQYMDAELVKSYLYQILQGILFCHS--- 119

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAK---ICEGRESIVSMTGARGTIGYIAPEVFC 502
            R+LH D+KP N+L+D     K++DFGLA+   I      +   T    T+ Y APEV  
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-----PVRVYTHEVVTLWYRAPEVL- 173

Query: 503 RNFGEVSYKS--DVYSYGMMVFEMTGEK 528
              G   Y +  D++S G +  EM  +K
Sbjct: 174 --LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGE---DFINEVASISRTSHVNIVTLL 384
           ++LG+G  G V K +L +   + A+K +  T  N +     + E+          IV   
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 385 GFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           G   +       +  E+   GSL+     K   +   ++  +VL KIA  + +GL YLH 
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIY--KKVKKRGGRIGEKVLGKIAESVLKGLSYLH- 122

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA-RGTIGYIAPEVF 501
             + +I+H DIKP NILL      K+ DFG++      E + S+ G   GT  Y+APE  
Sbjct: 123 --SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-----ELVNSLAGTFTGTSFYMAPERI 175

Query: 502 CRNFGEVSYKSDVYSYGMMVFEMTG 526
                  S  SDV+S G+ + E+  
Sbjct: 176 --QGKPYSITSDVWSLGLTLLEVAQ 198

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 79/297 (26%), Positives = 145/297 (48%), Gaps = 46/297 (15%)

Query: 331 LGQGGYG--------GVYKGKLLDGQNVAIKVL--NETKGNGEDFINEVASISRT-SHVN 379
           LG+G +G        G+ K K      VA+K+L  + T+ +  D I+E+  +     H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP--LE--------TNQKLKWEVLYKI 429
           I+ LLG C +     +I E+ S G+L +++  + P  +E          ++L ++ L   
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     +     T  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHW 546
           R  + ++APE +F R +   +++SDV+S+G++++E+   G      V V+          
Sbjct: 203 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 250

Query: 547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           ++K L+       +G   ++      ++ ++   C    PS RP+  ++VE L+  L
Sbjct: 251 LFKLLK-------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 71/287 (24%), Positives = 124/287 (43%), Gaps = 35/287 (12%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV 378
           +I + +   + KLG G +G V+         VA+K +     + E F+ E   +    H 
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
            +V L     +     +I EF++ GSL  F+      +   K     L   +  IA G+ 
Sbjct: 62  KLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKS----DEGSKQPLPKLIDFSAQIAEGMA 116

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           ++ +      +H D++  NIL+      KI+DFGLA++ E  E   +  GA+  I + AP
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM-----TGEKNNANVAVDRSSEIYFPHWVYKRLEL 553
           E    NFG  + KSDV+S+G+++ E+           +N  V R+              L
Sbjct: 173 EAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--------------L 216

Query: 554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
           E    +   EN  ++ Y      + + C +  P +RP+   +  +L+
Sbjct: 217 ERGYRMPRPENCPEELYN-----IMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 76/295 (25%), Positives = 126/295 (42%), Gaps = 58/295 (19%)

Query: 331 LGQGGYGGVYKGKLL------DGQNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVT 382
           LG+G +G V+  K            V +K L +TK      +F  E+    + SH N+V 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFI---------HEKHPLETNQKLKWEVLYKIAVGI 433
           LLG C E     +I E+   G L++F+          +  PL T QK+       +   I
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV------ALCTQI 126

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK------ICEGRESIVSMT 487
           A G+++L    N R +H D+   N L+      K+S   L+K        + R +++   
Sbjct: 127 ALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP-- 181

Query: 488 GARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPH 545
                + ++APE       + S KSDV+S+G++++E+   GE     ++ +         
Sbjct: 182 -----LRWLAPE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------- 226

Query: 546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
            V  RL+    L L   E    + Y    ++   W +  NP DRPS + +V  L 
Sbjct: 227 -VLNRLQ-AGKLELPVPEGCPSRLYK---LMTRCWAV--NPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 77/289 (26%), Positives = 134/289 (46%), Gaps = 44/289 (15%)

Query: 326 SFKNKLGQGGYGGVYKGKLL-DG--QNVAIKVLNE--TKGNGEDFINEVASISRTS-HVN 379
            F++ +G+G +G V +  +  DG   N AIK+L E  ++ +  DF  E+  + +   H N
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 380 IVTLLGFCFEGHRRALIY---EFVSNGSLEKFIHEKHPLETN----------QKLKWEVL 426
           I+ LLG C     R  +Y   E+   G+L  F+ +   LET+            L  + L
Sbjct: 65  IINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
            + A  +A G++YL      + +H D+   N+L+ E+   KI+DFGL++   G E  V  
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175

Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW 546
           T  R  + ++A E    N+   + KSDV+S+G++++E+                   P+ 
Sbjct: 176 TMGRLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIVSLGGT-------------PYC 220

Query: 547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRV 595
                EL E L  QG   E+ +    ++  +   C +  P +RP   ++
Sbjct: 221 GMTCAELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.9 bits (211), Expect = 4e-18
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 28/205 (13%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFIN--EVASISR-TSHVNIVTLLG 385
           +LG G +G VY  +  + G+ VAIK + +   + E+ +N  EV S+ +   H NIV L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR-GC 444
              E      ++E++  G+L + + ++      +     V+  I   I +GL ++H+ G 
Sbjct: 66  VFRENDELYFVFEYM-EGNLYQLMKDR----KGKPFSESVIRSIIYQILQGLAHIHKHG- 119

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM---TGARGTIGYIAPEVF 501
                H D+KP N+L+      KI+DFGLA     RE I S    T    T  Y APE+ 
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLA-----RE-IRSRPPYTDYVSTRWYRAPEIL 170

Query: 502 CRNFGEVSYKS--DVYSYGMMVFEM 524
            R+    SY S  D+++ G ++ E+
Sbjct: 171 LRS---TSYSSPVDIWALGCIMAEL 192

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 25/208 (12%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLG 385
           K+G+G YG VYK +  L G+ VA+K +    E +G     I E++ +   +H NIV LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                ++  L++EF+ +  L+K++ +  P      L   ++      + +G+ Y H   +
Sbjct: 66  VVHSENKLYLVFEFL-DLDLKKYM-DSSP---LTGLDPPLIKSYLYQLLQGIAYCH---S 117

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM---TGARGTIGYIAPEVFC 502
            R+LH D+KP N+L+D +   K++DFGLA     R   V +   T    T+ Y APE+  
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLA-----RAFGVPVRTYTHEVVTLWYRAPEIL- 171

Query: 503 RNFGEVSYKS--DVYSYGMMVFEMTGEK 528
              G   Y +  D++S G +  EM   +
Sbjct: 172 --LGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 84.2 bits (208), Expect = 5e-18
 Identities = 77/285 (27%), Positives = 137/285 (48%), Gaps = 47/285 (16%)

Query: 331 LGQGGYGGVYKGKL-LDGQN---VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLL 384
           +G G +G V  G+L L G+    VAIK L    T+    DF++E + + +  H NI+ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G   +     ++ E++ NGSL+ F+  KH    + +     L  +  GIA G++YL    
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL-RKH----DGQFTVIQLVGMLRGIASGMKYL---S 123

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCR 503
           +   +H D+   NIL++ +   K+SDFGL+++ E   E+  +  G +  I + APE    
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA- 182

Query: 504 NFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHW------VYKRLELEE 555
            + + +  SDV+SYG++++E+   GE+               P+W      V K +E   
Sbjct: 183 -YRKFTSASDVWSYGIVMWEVMSYGER---------------PYWEMSNQDVIKAIE--- 223

Query: 556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
               +G       +    +  + L C Q + ++RP   ++V +L+
Sbjct: 224 ----EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 19/201 (9%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLG 385
           K+G+G YG VYK +  L G+ VA+K +    ET+G     I E++ +   +H NIV LL 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                ++  L++EF+ +  L+KF+           L    L+++  G+A    + H   +
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCH---S 118

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF--CR 503
            R+LH D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 504 NFGEVSYKSDVYSYGMMVFEM 524
            +   S   D++S G +  EM
Sbjct: 177 YY---STAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 84.3 bits (208), Expect = 5e-18
 Identities = 72/262 (27%), Positives = 122/262 (46%), Gaps = 38/262 (14%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKGNG---EDFINEV 369
           +I   T  F  +LG+  +G VYKG L         Q VAIK L + K  G   E+F +E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD-KAEGPLREEFKHEA 59

Query: 370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP------LETNQKLKW 423
              SR  H NIV LLG   +    ++I+ + S+  L +F+  + P       + ++ +K 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 424 EV----LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG 479
            +       I   IA G+E+L    +  ++H D+   N+L+ +    KISD GL +    
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--------TGEKNNA 531
            +    M  +   I +++PE     +G+ S  SD++SYG++++E+         G  N  
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234

Query: 532 NVAVDRSSEIYF-----PHWVY 548
            + + R+ ++       P WVY
Sbjct: 235 VIEMIRNRQVLPCPDDCPAWVY 256

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 78/289 (26%), Positives = 135/289 (46%), Gaps = 53/289 (18%)

Query: 331 LGQGGYGGVYKGKL-LDGQN---VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLL 384
           +G G +G V +G+L L G+    VAIK L    T+    DF++E + + +  H NI+ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G   +     +I EF+ NG+L+ F+ +     T  +L       +  GIA G++YL    
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYL---S 123

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG---TIGYIAPEVF 501
               +H D+   NIL++ +   K+SDFGL++  E   S  + T + G    I + APE  
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 502 CRNFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 559
              + + +  SDV+SYG++++E+   GE+               P+W         D+  
Sbjct: 184 A--YRKFTSASDVWSYGIVMWEVMSYGER---------------PYW---------DMSN 217

Query: 560 QGIENEEDKEY--------ARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
           Q + N  +++Y           +  + L C Q + + RP   ++V  L+
Sbjct: 218 QDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 21/204 (10%)

Query: 331 LGQGGYGGVYKGKLLD--GQNV--AIKVLN--ETKGNGEDFINEVASISRTSHVNIVTLL 384
           +G+G +G VY G L+D  GQ +  A+K LN        E F+ E   +   SH N+++LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 385 GFCFEGHRRALI-YEFVSNGSLEKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           G C       L+   ++ +G L  FI  E H    N  +K   L    + +A+G+EYL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETH----NPTVK--DLIGFGLQVAKGMEYL-- 114

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEV 500
             + + +H D+   N +LDE F  K++DFGLA+    +E  S+ + TGA+  + ++A E 
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM 524
                 + + KSDV+S+G++++E+
Sbjct: 174 LQTQ--KFTTKSDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 22/204 (10%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN-----ETKGNGEDFINEVASISRTSHVNIVTL 383
           K+G+G +  VYK   LLDG+ VA+K +      + K   +D + E+  + +  H N++  
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR-QDCLKEIDLLKQLDHPNVIKY 67

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           L    E +   ++ E    G L + I  KH  +  + +    ++K  V +   LE++H  
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTIWKYFVQLCSALEHMH-- 123

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG---YIAPEV 500
            + RI+H DIKP N+ +      K+ D GL     GR      T A   +G   Y++PE 
Sbjct: 124 -SKRIMHRDIKPANVFITATGVVKLGDLGL-----GRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM 524
              N    ++KSD++S G +++EM
Sbjct: 178 IHEN--GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 63/216 (29%), Positives = 114/216 (52%), Gaps = 28/216 (12%)

Query: 331 LGQGGYGGVYKGKL--LDGQN------VAIKVL--NETKGNGEDFINEVASISRTS-HVN 379
           LG+G +G V + +   +D         VA+K+L  N T  +  D I+E+  +     H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN----------QKLKWEVLYKI 429
           I+ LLG C +     +I E+ + G+L +F+  + P   +          ++L ++ L   
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  +ARG+EYL    + R +H D+   N+L+ ED   KI+DFGLA+     +     +  
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 524
           R  + ++APE +F R +   +++SDV+S+G++++E+
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 82/305 (26%), Positives = 139/305 (45%), Gaps = 74/305 (24%)

Query: 330 KLGQGGYGGVY--KGKLLDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLL 384
           K+G+G +G +Y  K K  D ++  IK ++ TK      E    EV  +++  H NIVT  
Sbjct: 7   KIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPL--ETNQKLKWEVLYKIAVGIARGLEYLHR 442
               E  R  ++ E+   G L K I+ +  +    +Q L W       V I+ GL+++H 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIH- 118

Query: 443 GCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICEGRESIVSMTGARGTIG---YIAP 498
             + +ILH DIK  NI L ++    K+ DFG+A+         SM  A   +G   Y++P
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-----SMELAYTCVGTPYYLSP 171

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEMTG-----EKNNANVAVDRSSEIYF----PHWVYK 549
           E+ C+N    + K+D++S G +++E+       E NN +  V +  + YF    P++   
Sbjct: 172 EI-CQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR- 228

Query: 550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIP 609
                 DL               + ++  L+  + +P DRPS+  +++            
Sbjct: 229 ------DL---------------RSLISQLF--KVSPRDRPSITSILK------------ 253

Query: 610 PRPFL 614
            RPFL
Sbjct: 254 -RPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.8 bits (215), Expect = 1e-17
 Identities = 74/282 (26%), Positives = 133/282 (47%), Gaps = 26/282 (9%)

Query: 328 KNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
           +N + +G  G  YKGK + +G    +K +N+         +E+A + +  H NIV L+G 
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS---SEIADMGKLQHPNIVKLIGL 751

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
           C       LI+E++   +L + +         + L WE   KIA+GIA+ L +LH  C+ 
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVL---------RNLSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
            ++  ++ P  I++D    P +       +C   +  +S         Y+APE   R   
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS-------AYVAPET--RETK 853

Query: 507 EVSYKSDVYSYGMMVFEMTGEKNNANVAVD-RSSEIYFPHWVYKRLELEE--DLGLQGIE 563
           +++ KSD+Y +G+++ E+   K+ A+       S + +  + Y    L+   D  ++G  
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913

Query: 564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
           +    E    M L +L C  T+P+ RP  N V++ LE +  S
Sbjct: 914 SVNQNEIVEVMNL-ALHCTATDPTARPCANDVLKTLESASRS 954

Length = 968

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 24/204 (11%)

Query: 331 LGQGGYGGVYKGKLL-DGQN----VAIKVLNET---KGNGEDFINEVASISRTSHVNIVT 382
           LG G +G VYKG  + DG+N    VAIKVL E    K N E  ++E   ++      +  
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE-ILDEAYVMAGVGSPYVCR 73

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
           LLG C     + L+ + +  G L  ++ E K  + +   L W       V IA+G+ YL 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-V 500
                R++H D+   N+L+      KI+DFGLA++ +  E+     G +  I ++A E +
Sbjct: 127 ---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM 524
             R F   +++SDV+SYG+ V+E+
Sbjct: 184 LHRRF---THQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 42/279 (15%)

Query: 331 LGQGGYG-GVYKGKLLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGF 386
           LG+G +G      +  D   V  K +N T+       D +NE+  +S   H NI+     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 387 CFEGHRRALI-YEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            F      LI  E+ + G+L +K + +K  L   + + W  L++I   ++    Y+H+  
Sbjct: 68  -FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-YLFQIVSAVS----YIHK-- 119

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKIC----EGRESIVSMTGARGTIGYIAPEV 500
              ILH DIK  NI L +    K+ DFG++KI        E++V      GT  Y++PE+
Sbjct: 120 -AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV------GTPYYMSPEL 172

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 560
            C+   + ++KSD+++ G +++E+   K       D ++           L L   + +Q
Sbjct: 173 -CQGV-KYNFKSDIWALGCVLYELLTLKR----TFDATNP----------LNLVVKI-VQ 215

Query: 561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
           G        Y+ ++I +    +Q +P  RP+ + V++  
Sbjct: 216 GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 82.3 bits (203), Expect = 4e-17
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 25/216 (11%)

Query: 320 IKKMTNSFKNK-LGQGGYGGVYKGKLL-DGQN----VAIKVLNET---KGNGEDFINEVA 370
           I K T   K K LG G +G VYKG  + +G+     VAIK L E    K N E  ++E  
Sbjct: 3   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAY 61

Query: 371 SISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYKI 429
            ++   + ++  LLG C     + LI + +  G L  ++ E K  + +   L W      
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 114

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
            V IA+G+ YL      R++H D+   N+L+      KI+DFGLAK+    E      G 
Sbjct: 115 CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171

Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 524
           +  I ++A E +  R +   +++SDV+SYG+ V+E+
Sbjct: 172 KVPIKWMALESILHRIY---THQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 29/211 (13%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLN------ETKGNGEDFINEVASISRTSHVNIVTL 383
           LGQG +G VY    +D G+ +A+K +       ETK        E+  +    H  IV  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G   +    ++  E++  GS++  +     L         V  K    I  G+EYLH  
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTET------VTRKYTRQILEGVEYLHS- 122

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAK----ICEGRESIVSMTGARGTIGYIAPE 499
               I+H DIK  NIL D     K+ DFG +K    IC    S   M    GT  +++PE
Sbjct: 123 --NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC---SSGTGMKSVTGTPYWMSPE 177

Query: 500 VFCRNFGEVSY--KSDVYSYGMMVFEMTGEK 528
           V     GE  Y  K+DV+S G  V EM  EK
Sbjct: 178 VIS---GE-GYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 68/204 (33%), Positives = 94/204 (46%), Gaps = 22/204 (10%)

Query: 331 LGQGGYGGV----YKGKLLD-GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTL 383
           LG+G +G V    Y       G+ VA+K L    G  N   +  E+  +    H NIV  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 384 LGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
            G C E   +   LI E+V  GSL  ++  KH L   Q      L   A  I  G+ YLH
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQ------LLLFAQQICEGMAYLH 124

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEV 500
              +   +H D+   N+LLD D   KI DFGLAK + EG E           + + A E 
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE- 180

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM 524
            C    + SY SDV+S+G+ ++E+
Sbjct: 181 -CLKENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 70/206 (33%), Positives = 97/206 (47%), Gaps = 21/206 (10%)

Query: 331 LGQGGYGGVYKGKLLDGQ-NVAIKVLNETKGN-GEDFINEVASISRTSHVNIVTLLGFCF 388
           LG+G YG VY  + L  Q  +AIK + E      +    E+A  S   H NIV  LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 389 EGHRRALIYEFVSNGSLEKFIHEK-HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 447
           E     +  E V  GSL   +  K  PL+ N+    + +      I  GL+YLH   + +
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE----QTIIFYTKQILEGLKYLH---DNQ 128

Query: 448 ILHFDIKPHNILLDE-DFCPKISDFGLAKICEGRESIVSMTGA-RGTIGYIAPEVF---C 502
           I+H DIK  N+L++      KISDFG +K   G   I   T    GT+ Y+APEV     
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG---INPCTETFTGTLQYMAPEVIDKGP 185

Query: 503 RNFGEVSYKSDVYSYGMMVFEMTGEK 528
           R +G     +D++S G  + EM   K
Sbjct: 186 RGYGA---PADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 66/213 (30%), Positives = 112/213 (52%), Gaps = 30/213 (14%)

Query: 331 LGQGGYGGVYKGKLL-DG--QNVAIKVLNE--TKGNGEDFINEVASISRTSH-VNIVTLL 384
           +G+G +G V K ++  DG   + AIK + E  +K +  DF  E+  + +  H  NI+ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 385 GFCFEGHRRALIY---EFVSNGSLEKFIHEKHPLETN----------QKLKWEVLYKIAV 431
           G C     R  +Y   E+  +G+L  F+ +   LET+            L  + L   A 
Sbjct: 63  GAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG 491
            +ARG++YL +    + +H D+   NIL+ E++  KI+DFGL++   G+E  V  T  R 
Sbjct: 120 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 173

Query: 492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            + ++A E    N+   +  SDV+SYG++++E+
Sbjct: 174 PVRWMAIESL--NYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 28/219 (12%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLL-GFC 387
           LG G +G VYK +  + G   A K++  E++   EDF+ E+  +S   H NIV L   + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 388 FEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
           +E     LI EF   G+L+  + E +  L   Q      +  +   +   L +LH   + 
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELERGLTEPQ------IRYVCRQMLEALNFLH---SH 122

Query: 447 RILHFDIKPHNILLDEDFCPKISDFG----LAKICEGRESIVSMTGARGTIGYIAPEVF- 501
           +++H D+K  NILL  D   K++DFG         + R++ +      GT  ++APEV  
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEVVA 176

Query: 502 CRNFGEVSY--KSDVYSYGMMVFEMT-GEKNNANVAVDR 537
           C  F +  Y  K+D++S G+ + E+   E  +  +   R
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 25/205 (12%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGF 386
           +LG G +G VYK K  + G   A KV+ ETK   E  D++ E+  ++  +H  IV LLG 
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
            +   +  ++ EF   G+++  +     LE ++ L    +  I   +   L+YLH   + 
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIM-----LELDRGLTEPQIQVICRQMLEALQYLH---SM 129

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLA----KICEGRESIVSMTGARGTIGYIAPE-VF 501
           +I+H D+K  N+LL  D   K++DFG++    K  + R+S +      GT  ++APE V 
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVM 183

Query: 502 CRNFGEV--SYKSDVYSYGMMVFEM 524
           C    +    YK+D++S G+ + EM
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 17/200 (8%)

Query: 330 KLGQGGYGGVYKG--KLLDGQ-NVAIKVL--NETKGNGEDFINEVASISRTSHVNIVTLL 384
           +LG G +G V KG  K+   Q +VAIKVL     K   ++ + E   + +  +  IV ++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G C E     L+ E  S G L KF+  K    T   +  E+++++++G    ++YL    
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV-ELMHQVSMG----MKYLE--- 112

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV-SMTGARGTIGYIAPEVFCR 503
               +H D+   N+LL      KISDFGL+K     +S   + +  +  + + APE  C 
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE--CI 170

Query: 504 NFGEVSYKSDVYSYGMMVFE 523
           NF + S +SDV+SYG+ ++E
Sbjct: 171 NFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 74/291 (25%), Positives = 138/291 (47%), Gaps = 41/291 (14%)

Query: 330 KLGQGGYGGVYKG---KLLDGQ---NVAIKVLNETKGNGE--DFINEVASISRTSHVNIV 381
           +LGQG +G VY+G    ++ G+    VA+K +NE+    E  +F+NE + +   +  ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK----WEVLYKIAVGIARGL 437
            LLG   +G    ++ E +++G L+ ++    P   N   +     + + ++A  IA G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG--TIGY 495
            YL+     + +H D+   N ++  DF  KI DFG+ +  +  E+     G +G   + +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 187

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           +APE      G  +  SD++S+G++++E+T                      Y+ L  E+
Sbjct: 188 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQP----------------YQGLSNEQ 229

Query: 556 DLGL---QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
            L      G  ++ D    R   L+ + C Q NP  RP+   +V +L+  L
Sbjct: 230 VLKFVMDGGYLDQPDNCPERVTDLMRM-CWQFNPKMRPTFLEIVNLLKDDL 279

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 21/208 (10%)

Query: 327 FKNKLGQGGYGGVYKGK---LLD--GQNVAIKVLNE-TKGNGEDFINEVASISRTSHVNI 380
           F  +LG+G +G V   +   L D  G+ VA+K L   T  +  DF  E+  +    H NI
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 381 VTLLGFCFEGHRRA--LIYEFVSNGSLEKF-IHEKHPLETNQKLKWEVLYKIAVGIARGL 437
           V   G C+   RR   L+ E++  GSL  +    +  L+  + L    LY  A  I +G+
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LY--ASQICKGM 121

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-EGRESIVSMTGARGTIGYI 496
           EYL    + R +H D+   NIL++ +   KI DFGL K+  + +E           I + 
Sbjct: 122 EYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           APE    +  + S  SDV+S+G++++E+
Sbjct: 179 APESLTES--KFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGE---DFINEVASISRTSHVNIVTLLG 385
            +G+G YG V K K  + GQ VAIK   E++ +       + E+  + +  H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN--QKLKWEVLYKIAVGIARGLEYLHRG 443
                 R  L++EFV +  L+      + L+ +  +K  +++L        RG+E+ H  
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL--------RGIEFCH-- 117

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
            +  I+H DIKP NIL+ +    K+ DFG A+       +   T    T  Y APE+   
Sbjct: 118 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELL-- 172

Query: 504 NFGEVSYKS--DVYSYGMMVFEM-TGE 527
             G+  Y    D+++ G +V EM TGE
Sbjct: 173 -VGDTKYGRAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 32/212 (15%)

Query: 331 LGQGGYGGVYKG-KLLDGQNVAIK--VLNETKGNGED--------FINEVASISRTSHVN 379
           +G G +G VY G     G+ +A+K   L     + +D           E+A +    H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV-GIARGLE 438
           IV  LG   +     +  E+V  GS+   ++     E       E L +  V  I +GL 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE-------ETLVRNFVRQILKGLN 120

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR----GTIG 494
           YLH   N  I+H DIK  NIL+D     KISDFG++K  E         GAR    G++ 
Sbjct: 121 YLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 495 YIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
           ++APEV      + SY  K+D++S G +V EM
Sbjct: 178 WMAPEV----VKQTSYTRKADIWSLGCLVVEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 21/216 (9%)

Query: 318 ADIKKMTNSFKNK-LGQGGYGGVYKGKLL-DGQN----VAIKVLNETKGNG--EDFINEV 369
           A I K T   K K LG G +G V+KG  + +G +    VAIK + +  G    ++  + +
Sbjct: 1   ARILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHM 60

Query: 370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYK 428
            ++    H  IV LLG C  G    L+ +    GSL   + + +  L+  + L W     
Sbjct: 61  LAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----- 114

Query: 429 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTG 488
             V IA+G+ YL       ++H ++   NILL  D   +I+DFG+A +    +     + 
Sbjct: 115 -CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            +  I ++A E     FG  +++SDV+SYG+ V+EM
Sbjct: 171 HKTPIKWMALESI--LFGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 77/281 (27%), Positives = 122/281 (43%), Gaps = 61/281 (21%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGNG-EDFINEVASISRTSHV---NIVTLL 384
           +G+G YG VY+GK +  G+ VA+K++N +T  +   D   EVA +S+       NI    
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 385 GFCFEGHRRALIYEFVSNGSLEKF-----IHEKHPLETNQKLKWEVLYKIAVGIAR---- 435
           G   +G R  +I E+   GS+        I EK+               I+V I R    
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY---------------ISV-IIREVLV 112

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR----G 491
            L+Y+H+     ++H DIK  NIL+      K+ DFG+A        +   +  R    G
Sbjct: 113 ALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAA------LLNQNSSKRSTFVG 163

Query: 492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKR 550
           T  ++APEV          K+D++S G+ ++EM TG    ++V   R+  +  P     R
Sbjct: 164 TPYWMAPEVI-TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKSKPPR 221

Query: 551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
           L              ED  Y++ +      C+   P +R S
Sbjct: 222 L--------------EDNGYSKLLREFVAACLDEEPKERLS 248

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 21/204 (10%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIK-VLNETKGNGEDF--INEVASISRTSHVNIVTLL 384
            ++G+G YG VYK +    G+ VA+K +  E +  G     I E+  + +  H NIV L 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 385 GFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
                  + +  +++E++ +  L   +       T  ++K          +  GL+YLH 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK-----CYMKQLLEGLQYLH- 117

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
             +  ILH DIK  NIL++ D   K++DFGLA+    R S    T    T+ Y  PE+  
Sbjct: 118 --SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELL- 173

Query: 503 RNFGEVSYKS--DVYSYGMMVFEM 524
              G   Y    D++S G ++ E+
Sbjct: 174 --LGATRYGPEVDMWSVGCILAEL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 25/201 (12%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLG 385
           LG G +G V   +        A+K+L++ K       E  +NE   +    H  +V L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
              +     L+ E+V  G L  F H    L  + +    V    A  +   LEYLH   +
Sbjct: 69  SFQDDSNLYLVMEYVPGGEL--FSH----LRKSGRFPEPVARFYAAQVVLALEYLH---S 119

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRN 504
             I++ D+KP N+LLD D   KI+DFG AK  +GR   +      GT  Y+APE+   + 
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-----GTPEYLAPEIILSKG 174

Query: 505 FGEVSYKS-DVYSYGMMVFEM 524
           +G    K+ D ++ G++++EM
Sbjct: 175 YG----KAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 23/216 (10%)

Query: 327 FKNKLGQGGYGGVYKGKL-LDG----QNVAIKVLNETKGNGE--DFINEVASISRTSHVN 379
           F  +LG+  +G +YKG L L G    Q VAIK L +     +  +F  E + ++   H N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLE-----------TNQKLKWEVLYK 428
           IV LLG   +     +++E+++ G L +F+  + P                 L       
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 429 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTG 488
           IA+ IA G+EYL    +   +H D+   NIL+ E    KISD GL++     +       
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +   I ++ PE     +G+ S  SD++S+G++++E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 33/209 (15%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFI------NEVASISRTSHVNIVT 382
            +G+G YG V K +    G+ VAIK   + K + +D         EV  + +  H NIV 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIK---KFKESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP----LETNQKLKWEVLYKIAVGIARGLE 438
           L        R  L++E+V    LE    E  P     +  +   W++L        + + 
Sbjct: 65  LKEAFRRKGRLYLVFEYVERTLLELL--EASPGGLPPDAVRSYIWQLL--------QAIA 114

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           Y H      I+H DIKP NIL+ E    K+ DFG A+    R +   +T    T  Y AP
Sbjct: 115 YCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAP 170

Query: 499 EVFCRNFGEVSYKS--DVYSYGMMVFEMT 525
           E+     G+ +Y    DV++ G ++ E+ 
Sbjct: 171 ELL---VGDTNYGKPVDVWAIGCIMAELL 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 19/209 (9%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKG-KLLDGQNVAIKVLN-ETKGNGEDFINEVASISRTS 376
           D KK    F+ K+GQG  G VY    +  GQ VAIK +N + +   E  INE+  +    
Sbjct: 16  DPKKKYTRFE-KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74

Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H NIV  L     G    ++ E+++ GSL   + E   ++  Q      +  +     + 
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQ------IAAVCRECLQA 127

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICEGRESIVSMTGARGTIGY 495
           LE+LH   + +++H DIK  NILL  D   K++DFG  A+I   +    +M    GT  +
Sbjct: 128 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYW 181

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +APEV  R       K D++S G+M  EM
Sbjct: 182 MAPEVVTRK--AYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 34/285 (11%)

Query: 331 LGQGGYGGVYKGKLLD-------GQNVAIKVLNETKGNGE--DFINEVASISRTSHVNIV 381
           LG G +G VY+G   D          VA+K L +   + E  +F+ E   +S  +H NIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQK-LKWEVLYKIAVGIARGLEYL 440
            LLG C     + +I E +  G L  ++ +          L  + L  I + +A+G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 441 HRGCNTRILHFDIKPHNILLDED--FCP---KISDFGLAKICEGRESIVSMTGARGTIGY 495
            +      +H D+   N L+ E         KI DFGLA+     +           + +
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           +APE      G+ + +SDV+S+G++++E+         A++    +           +  
Sbjct: 180 MAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH---------VTA 228

Query: 556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
              LQ  EN  DK Y      +   C   +PS+RP+ +R+ E+L+
Sbjct: 229 GGRLQKPENCPDKIYQ-----LMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 37/230 (16%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN-----------------VAIKVL--NETKGNGEDFIN 367
           FK KLG+G +G V+  ++++ Q+                 VA+K+L  +  K    DF+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 368 EVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQK------- 420
           EV  +SR    NI+ LLG C +     +I E++ NG L +F+   H  +  +        
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 421 ------LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 474
                 + +  L  +A+ IA G++YL    +   +H D+   N L+ E+   KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +     +       A   I ++A E  C   G+ +  SDV+++G+ ++E+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWE--CILMGKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 28/207 (13%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLN--ETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            +G+G +G VYK       Q VAIKV++  E +   ED   E+  +S+     I    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
             +G +  +I E+   GS    +          KL    +  I   +  GLEYLH     
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKP-------GKLDETYIAFILREVLLGLEYLHEE--- 117

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-----GTIGYIAPEVF 501
             +H DIK  NILL E+   K++DFG++         ++ T ++     GT  ++APEV 
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM-TGE 527
            +       K+D++S G+   E+  GE
Sbjct: 171 KQ--SGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 43/225 (19%)

Query: 331 LGQGGYGGVYKGK---LLDGQN---VAIKVLNETKGNG--EDFINEVASISRTSHVNIVT 382
           +GQG +G V++ +   LL  +    VA+K+L E        DF  E A ++   H NIV 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQ----------------KLKWEVL 426
           LLG C  G    L++E+++ G L +F+  + P                      L     
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
             IA  +A G+ YL      + +H D+   N L+ E+   KI+DFGL++      +I S 
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR------NIYSA 183

Query: 487 TGARGT------IGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 524
              + +      I ++ PE +F   +   + +SDV++YG++++E+
Sbjct: 184 DYYKASENDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 35/228 (15%)

Query: 320 IKKMTNSFKNKLGQGGYGGVYKGK---LLDGQN---VAIKVLNETKGNG-EDFINEVASI 372
           IK+     K +LG+G +G V+  +   LL  Q+   VA+K L E   +  +DF  E   +
Sbjct: 2   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61

Query: 373 SRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP----LETNQ-----KLKW 423
           +   H +IV   G C EG    +++E++ +G L +F+    P    L   +     +L  
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI 483
             +  IA  IA G+ YL    +   +H D+   N L+ +    KI DFG+++       I
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------DI 172

Query: 484 VSM----TGARGT--IGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 524
            S      G R    I ++ PE +  R F   + +SD++S+G++++E+
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKF---TTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 22/212 (10%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQ----NVAIKV--LNETKGNGEDFINEVASISRTSHVN 379
           +    +G+G +G VY+G  +  +     VA+K      +    E F+ E   + +  H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQ-KLKWEVLYKIAVGIARGLE 438
           IV L+G   E +   ++ E    G L  +      L+ N+  L    L   +  ++  L 
Sbjct: 69  IVKLIGVITE-NPVWIVMELAPLGELRSY------LQVNKYSLDLASLILYSYQLSTALA 121

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YL    + R +H DI   N+L+    C K+ DFGL++  E  ES    +  +  I ++AP
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAP 177

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFE--MTGEK 528
           E    NF   +  SDV+ +G+ ++E  M G K
Sbjct: 178 ESI--NFRRFTSASDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 77.3 bits (191), Expect = 8e-16
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 24/205 (11%)

Query: 331 LGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGEDFINEVAS----ISRTSHVNIVTLLG 385
           + +G YG V+   K   G   AIKV+ +     ++ +++V +    +S+     +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 386 FCFEG-HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           + F+G     L+ E++  G L   +     L+       +V       I   LEYLH   
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVARIYIAEIVLALEYLHS-N 112

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKI-CEGRESIVSMTGAR-----GTIGYIAP 498
              I+H D+KP NIL+D +   K++DFGL+K+    R+  ++          GT  YIAP
Sbjct: 113 G--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFE 523
           EV     G  S   D +S G +++E
Sbjct: 171 EVI-LGQGH-SKTVDWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 78.3 bits (194), Expect = 1e-15
 Identities = 74/276 (26%), Positives = 114/276 (41%), Gaps = 61/276 (22%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN------EVASISRTSHVN 379
               +G G YG V        G+ VAIK ++      +D I+      E+  +    H N
Sbjct: 4   LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHEN 60

Query: 380 IVTLLGF-------CFEGHRRALIYEFVSN---GSLEKFIHEKHPLETNQKLKWEVLYKI 429
           I+ LL          F       +Y  V+      L K I    PL T+  +++  LY+I
Sbjct: 61  IIGLLDILRPPSPEDFND-----VY-IVTELMETDLHKVIKSPQPL-TDDHIQY-FLYQI 112

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS-MTG 488
                RGL+YLH   N  ++H D+KP NIL++ +   KI DFGLA+  +  E     +T 
Sbjct: 113 L----RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP-HWV 547
              T  Y APE+   +    +   D++S G +  E+   K              FP    
Sbjct: 166 YVVTRWYRAPELLL-SSSRYTKAIDIWSVGCIFAELLTRK------------PLFPGRDY 212

Query: 548 YKRLEL---------EEDLGLQGIENEEDKEYARKM 574
             +L L         EED  L+ I +E+ + Y + +
Sbjct: 213 IDQLNLIVEVLGTPSEED--LKFITSEKARNYLKSL 246

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 39/218 (17%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIK---VLNETKGNGEDFINEVASISRTS---HVNIVT 382
           ++G G YG VYK +    G  VA+K   V     G     + EVA + R     H NIV 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 383 LLGFCFEGH-----RRALIYEFVSN---GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIA 434
           L+  C         +  L++E V       L+K      P ET + L  + L        
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL-------- 118

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CEGRESIVSMTGARGT 492
           RGL++LH  C   I+H D+KP NIL+      K++DFGLA+I  C+     +++T    T
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-----MALTPVVVT 170

Query: 493 IGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
           + Y APEV  ++    +Y +  D++S G +  EM   K
Sbjct: 171 LWYRAPEVLLQS----TYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 26/208 (12%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSH-VNIVTLLGFCF 388
           +G G YG VYKG+ +  GQ  AIKV++ T    E+   E+  + + SH  NI T  G   
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 389 EGH------RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           + +      +  L+ EF   GS+   I           LK E +  I   I RGL +LH+
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE---GRESIVSMTGARGTIGYIAPE 499
               +++H DIK  N+LL E+   K+ DFG++   +   GR +        GT  ++APE
Sbjct: 130 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 181

Query: 500 VF-CRNFGEVSY--KSDVYSYGMMVFEM 524
           V  C    + +Y  KSD++S G+   EM
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 19/201 (9%)

Query: 330 KLGQGGYGGVYKG--KLLDGQN-VAIKVLNETKGNG---EDFINEVASISRTSHVNIVTL 383
           +LG G +G V KG  K+   +  VA+K+L     +    ++ + E   + +  +  IV +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           +G C E     L+ E    G L KF      L+ N+ +  + + ++   ++ G++YL   
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKF------LQKNKHVTEKNITELVHQVSMGMKYLEE- 113

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV-SMTGARGTIGYIAPEVFC 502
             T  +H D+   N+LL      KISDFGL+K     E+   + T  +  + + APE  C
Sbjct: 114 --TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169

Query: 503 RNFGEVSYKSDVYSYGMMVFE 523
            N+ + S KSDV+S+G++++E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 21/209 (10%)

Query: 330 KLGQGGYGGVYKG------KLLDGQNVAIKVLNETKGNGE--DFINEVASISRTSHVNIV 381
           +LGQG +G VY+G      K      VAIK +NE     E  +F+NE + +   +  ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP-LETNQKLKWEVLYKI---AVGIARGL 437
            LLG   +G    +I E ++ G L+ ++    P +E N       L K+   A  IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG--TIGY 495
            YL+     + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   + +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 187

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           ++PE      G  +  SDV+S+G++++E+
Sbjct: 188 MSPESL--KDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 20/203 (9%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGF 386
           LG+G YG V K + +  G  +A+K +  T  + E    + ++    R+      VT  G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 387 CF-EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
            F EG     I   V + SL+KF   K   +    +  ++L KIAV I + LEYLH    
Sbjct: 69  LFREGD--VWICMEVMDTSLDKFY--KKVYDKGLTIPEDILGKIAVSIVKALEYLHS--K 122

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR--ESIVSMTGARGTIGYIAPEVF-- 501
             ++H D+KP N+L++ +   K+ DFG++    G   +S+     A G   Y+APE    
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDA-GCKPYMAPERINP 177

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM 524
             N      KSDV+S G+ + E+
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 51/293 (17%)

Query: 330 KLGQGGYGGVYKGKLLD--GQNVAIK---VLNETKGNGEDFINEVASISRTS---HVNIV 381
           ++G+G YG V+K + L   G+ VA+K   V    +G     I EVA +       H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 382 TLLGFCFEGH-----RRALIYEFVSNG---SLEKFIHEKHPLETNQKLKWEVLYKIAVGI 433
            L   C         +  L++E V       L+K      P ET + + +++L       
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL------- 120

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTI 493
            RGL++LH   + R++H D+KP NIL+      K++DFGLA+I   + ++ S+     T+
Sbjct: 121 -RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTL 173

Query: 494 GYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGEKN--NANVAVDRSSEIYFPHWVYK 549
            Y APEV  ++    SY +  D++S G +  EM   K     +  VD+  +I     +  
Sbjct: 174 WYRAPEVLLQS----SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229

Query: 550 RLELEEDLGL----------QGIEN-EEDKEYARKMILVSLWCIQTNPSDRPS 591
             +   D+ L          Q IE    D +   K +L+   C+  NP+ R S
Sbjct: 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK--CLTFNPAKRIS 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 29/208 (13%)

Query: 329 NKLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLLGF 386
            K+G+G  G V        G+ VA+K ++  K    E   NEV  +    H NIV +   
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
              G    ++ EF+  G+L   +       T+ ++  E +  + + + + L +LH     
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIATVCLAVLKALSFLH---AQ 134

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGL-AKICEG---RESIVSMTGARGTIGYIAPEVFC 502
            ++H DIK  +ILL  D   K+SDFG  A++ +    R+S+V      GT  ++APEV  
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVIS 188

Query: 503 RN-FG-EVSYKSDVYSYGMMVFEMT-GE 527
           R  +G EV    D++S G+MV EM  GE
Sbjct: 189 RLPYGTEV----DIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)

Query: 331 LGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEG 390
           +G+G +G V  G    G  VA+K + +     + F+ E + +++  H N+V LLG   E 
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71

Query: 391 HRRALIY-EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 449
                I  E+++ GSL  ++  +        L  + L K ++ +   +EYL        +
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124

Query: 450 HFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS 509
           H D+   N+L+ ED   K+SDFGL K     E+  +    +  + + APE       + S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK--KFS 177

Query: 510 YKSDVYSYGMMVFEM 524
            KSDV+S+G++++E+
Sbjct: 178 TKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 38/213 (17%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
           KLG+G Y  VYKG+    G+ VA+K   L+  +G     I E++ +    H NIV L   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 387 CFEGHRRALIYEFVSNGSLEKFIH---EKHPLETNQ--KLKWEVLYKIAVGIARGLEYLH 441
               ++  L++E++    L+K++     +  L+ N      +++L        +G+ + H
Sbjct: 67  IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL--------KGIAFCH 117

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-----ICEGRESIVSMTGARGTIGYI 496
                R+LH D+KP N+L+++    K++DFGLA+     +      +V       T+ Y 
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-------TLWYR 167

Query: 497 APEVFCRNFGEVSYKS--DVYSYGMMVFEM-TG 526
           AP+V     G  +Y +  D++S G ++ EM TG
Sbjct: 168 APDVL---LGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.1 bits (189), Expect = 2e-15
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 21/211 (9%)

Query: 318 ADIKKMTNSFKNKLGQGGYGGVYKG-KLLDGQNVAIKVLN-ETKGNGEDFINEVASISRT 375
            D KK    F+ K+GQG  G VY    +  GQ VAIK +N + +   E  INE+  +   
Sbjct: 15  GDPKKKYTRFE-KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN 73

Query: 376 SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR 435
            + NIV  L     G    ++ E+++ GSL   + E   ++  Q      +  +     +
Sbjct: 74  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQ------IAAVCRECLQ 126

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICEGRESIVSMTGARGTIG 494
            L++LH   + +++H DIK  NILL  D   K++DFG  A+I   +    +M    GT  
Sbjct: 127 ALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPY 180

Query: 495 YIAPEVFCRN-FGEVSYKSDVYSYGMMVFEM 524
           ++APEV  R  +G    K D++S G+M  EM
Sbjct: 181 WMAPEVVTRKAYGP---KVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 33/221 (14%)

Query: 331 LGQGGYGGVYKG-----KLLDG-QNVAIKVLNETKGNGE--DFINEVASISRTSHVNIVT 382
           LG+G +G V K      K   G   VA+K+L E   + E  D ++E   + + +H +++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN------------------QKLKWE 424
           L G C +     LI E+   GSL  F+ E   +  +                  + L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
            L   A  I+RG++YL      +++H D+   N+L+ E    KISDFGL++     +S V
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 485 SMTGARGTIGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEM 524
             +  R  + ++A E     F  + + +SDV+S+G++++E+
Sbjct: 185 KRSKGRIPVKWMAIESL---FDHIYTTQSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 326 SFKNKLGQGGYGGVYK------GKLLDGQNVAIKVLNETKGNGED--FINEVASISRT-S 376
           SF   LG G +G V +       K      VA+K+L  T  + E    ++E+  +S   +
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97

Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H NIV LLG C  G    +I E+   G L  F+  K        L  E L   +  +A+G
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK----RESFLTLEDLLSFSYQVAKG 153

Query: 437 LEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
           + +L  + C    +H D+   N+LL      KI DFGLA+      + V    AR  + +
Sbjct: 154 MAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +APE         +++SDV+SYG++++E+
Sbjct: 210 MAPESIFNCV--YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 24/223 (10%)

Query: 320 IKKMTNSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNE-TKGNGEDFINEVASI 372
           IK+     K +LG+G +G V+  +        D   VA+K L + T    +DF  E   +
Sbjct: 2   IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61

Query: 373 SRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIH----------EKHPLETNQKLK 422
           +   H +IV   G C +G    +++E++ +G L KF+           +  P +   +L 
Sbjct: 62  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
              +  IA  IA G+ YL    +   +H D+   N L+  +   KI DFG+++     + 
Sbjct: 122 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Query: 483 IVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 524
                     I ++ PE +  R F   + +SDV+S+G++++E+
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 79.1 bits (195), Expect = 3e-15
 Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 40/219 (18%)

Query: 347 GQNVAIKVLNETKGNGED----FINEVASISRTSHVNIVTLL--GFCFEGHRRALIYEFV 400
           G  VAIK+L       E     F  E A  +R  H NIV LL  G    G   A ++E+V
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61

Query: 401 SNGSLEKFIHEKHPL--ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 458
              +L + +     L      +L  +VL  +A    +G           I+H D+KP NI
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG-----------IVHRDLKPQNI 110

Query: 459 LL---DEDFCPKISDFGLAKICEGRESIVSMTGAR-----GTIGYIAPEVFCRNFGE-VS 509
           ++         K+ DFG+  +  G       T  R     GT  Y APE   R  GE V+
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-R--GEPVT 167

Query: 510 YKSDVYSYGMMVFE-MTGEK--NNANVAVDRSSEIYFPH 545
             SD+Y++G++  E +TG++    A+VA     EI +  
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGASVA-----EILYQQ 201

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 76/288 (26%), Positives = 136/288 (47%), Gaps = 57/288 (19%)

Query: 327 FKNKLGQGGYGGVYKG-KLLDGQNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTL 383
           ++  LG G  G VYK   LL  + +A+KV  L+ T    +  ++E+  + +     I+  
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G  F  +R ++  EF+  GSL+ +          +K+   VL +IAV + +GL YL   
Sbjct: 65  YGAFFVENRISICTEFMDGGSLDVY----------RKIPEHVLGRIAVAVVKGLTYL--- 111

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM-TGARGTIGYIAPEVFC 502
            + +ILH D+KP N+L++     K+ DFG++      + + S+     GT  Y+APE   
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-----TQLVNSIAKTYVGTNAYMAPE--- 163

Query: 503 RNFGE-VSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG--- 558
           R  GE     SDV+S G+   E+         A+ R     FP+      +++++ G   
Sbjct: 164 RISGEQYGIHSDVWSLGISFMEL---------ALGR-----FPY-----PQIQKNQGSLM 204

Query: 559 ----LQGIENEE-----DKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
               LQ I +E+       +++ K +     C++  P +RP+   +++
Sbjct: 205 PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.3 bits (187), Expect = 4e-15
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 21/211 (9%)

Query: 318 ADIKKMTNSFKNKLGQGGYGGVYKG-KLLDGQNVAIKVLN-ETKGNGEDFINEVASISRT 375
            D KK    F+ K+GQG  G VY    +  GQ VAI+ +N + +   E  INE+  +   
Sbjct: 16  GDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74

Query: 376 SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR 435
            + NIV  L     G    ++ E+++ GSL   + E   ++  Q      +  +     +
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQ------IAAVCRECLQ 127

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICEGRESIVSMTGARGTIG 494
            LE+LH   + +++H DIK  NILL  D   K++DFG  A+I   +    +M    GT  
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPY 181

Query: 495 YIAPEVFCRN-FGEVSYKSDVYSYGMMVFEM 524
           ++APEV  R  +G    K D++S G+M  EM
Sbjct: 182 WMAPEVVTRKAYGP---KVDIWSLGIMAIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 76.3 bits (187), Expect = 4e-15
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 21/220 (9%)

Query: 320 IKKMTNSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKGNG-EDFINEVASI 372
           IK+     K +LG+G +G V+  +        D   VA+K L +   N  +DF  E   +
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61

Query: 373 SRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP-----LETN--QKLKWEV 425
           +   H +IV   G C EG    +++E++ +G L KF+    P      E N   +L    
Sbjct: 62  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           +  IA  IA G+ YL    +   +H D+   N L+ E+   KI DFG+++     +    
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178

Query: 486 MTGARGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEM 524
                  I ++ PE +  R F   + +SDV+S G++++E+
Sbjct: 179 GGHTMLPIRWMPPESIMYRKF---TTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 28/221 (12%)

Query: 327 FKNKLGQGGYGGVY----KGKL---------LDGQN--VAIKVL--NETKGNGEDFINEV 369
            K KLG+G +G V+    +G            DGQ   VA+K+L  + TK    DF+ E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQK------LKW 423
             +SR  + NI+ LLG C       +I E++ NG L +F+ ++    T         +  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI 483
             L  +AV IA G++YL    +   +H D+   N L+   +  KI+DFG+++     +  
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                A   I ++A E      G+ +  SDV+++G+ ++EM
Sbjct: 186 RIQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 29/205 (14%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
           KLG+G Y  VYKG+  L GQ VA+K   L   +G     I E + +    H NIVTL   
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHP---LETNQKLKWEVLYKIAVGIARGLEYLHRG 443
                   L++E++    L++++ +         N +L    L+++     RGL Y H+ 
Sbjct: 72  IHTKKTLTLVFEYLDT-DLKQYM-DDCGGGLSMHNVRL---FLFQLL----RGLAYCHQ- 121

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVF 501
              R+LH D+KP N+L+ E    K++DFGLA+     +S+ S T +    T+ Y  P+V 
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNEVVTLWYRPPDVL 175

Query: 502 CRNFGEVSYKS--DVYSYGMMVFEM 524
               G   Y +  D++  G + +EM
Sbjct: 176 ---LGSTEYSTSLDMWGVGCIFYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 17/199 (8%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNET---KGNGEDF-INEVASISRTSHVNIVTLLG 385
           LG+GG+G V   ++   G+  A K L++    K  GE   +NE   + + S   IV+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
           + FE      +   + NG   K+ H  +  E        + Y  A  I  GLE+LH    
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKY-HIYNVGEPGFPEARAIFY--AAQIICGLEHLH---Q 113

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
            RI++ D+KP N+LLD+    +ISD GLA   +G + I    G  GT GY+APEV     
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAPEVLQG-- 168

Query: 506 GEVSYKSDVYSYGMMVFEM 524
               +  D ++ G  ++EM
Sbjct: 169 EVYDFSVDWFALGCTLYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.9 bits (187), Expect = 6e-15
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 32/214 (14%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIK---VLNETKGNGEDFINEVASISRTSHVNIVTLL 384
            K+GQG +G V+K +     Q VA+K   + NE +G     + E+  +    H N+V L+
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 385 GFC------FEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKW--EVLYKIAVGIA 434
             C      +  ++ +  L++EF          H+   L +N+ +K+    + K+   + 
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRESIVSMTGARGT 492
            GL Y+HR    +ILH D+K  NIL+ +D   K++DFGLA+             T    T
Sbjct: 130 NGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 493 IGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEM 524
           + Y  PE+    R++G      D++  G ++ EM
Sbjct: 187 LWYRPPELLLGERDYGP---PIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 26/208 (12%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSH-VNIVTLLGFCF 388
           +G G YG VYKG+ +  GQ  AIKV++ T+   E+   E+  + + SH  NI T  G   
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 389 E----GH--RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           +    GH  +  L+ EF   GS+   +           LK + +  I   I RGL +LH 
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNT----KGNALKEDWIAYICREILRGLAHLHA 139

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE---GRESIVSMTGARGTIGYIAPE 499
               +++H DIK  N+LL E+   K+ DFG++   +   GR +        GT  ++APE
Sbjct: 140 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 191

Query: 500 VF-CRNFGEVS--YKSDVYSYGMMVFEM 524
           V  C    + +  Y+SD++S G+   EM
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 331 LGQGGYGGVYK-GKLLDGQNVAIKVLNETKGNGEDFINEVASI-SRTSHVNIVTLLGFCF 388
           +G+G YG VYK     DG   A+K+L+      E+   E   + S  +H N+V   G  +
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 389 E-----GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           +     G +  L+ E  + GS+ + +  K  L   Q+L   ++  I  G   GL++LH  
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELV--KGLLICGQRLDEAMISYILYGALLGLQHLH-- 145

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICEGRESIVSMTGARGTIGYIAPEVF- 501
            N RI+H D+K +NILL  +   K+ DFG+ A++   R   +    + GT  ++APEV  
Sbjct: 146 -NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIA 201

Query: 502 CRNFGEVSY--KSDVYSYGMMVFEM 524
           C    + SY  + DV+S G+   E+
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 48/289 (16%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKV-----LNETKGNGEDFINEVASISRTSHVN 379
             + K+G+G +  VY+   LLDG  VA+K      L + K    D I E+  + + +H N
Sbjct: 5   RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPN 63

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           ++       E +   ++ E    G L + I  KH  +  + +  + ++K  V +   LE+
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG---YI 496
           +H   + R++H DIKP N+ +      K+ D GL     GR      T A   +G   Y+
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGL-----GRFFSSKTTAAHSLVGTPYYM 173

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEMT-------GEKNNANVAVDRSSEIYFPHWVYK 549
           +PE    N    ++KSD++S G +++EM        G+K N      +  +  +P     
Sbjct: 174 SPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP----- 226

Query: 550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
                       + ++   E  R+++ +   CI  +P  RP +  V ++
Sbjct: 227 -----------PLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 52/283 (18%)

Query: 330 KLGQGGYG-GVYKGKLLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLG 385
           K+G+G +G  +      DG+   IK +N +K +    E+   EVA +S   H NIV    
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKH--PLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
              E     ++ ++   G L K I+ +       +Q L W       V I   L+++H  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVH-- 118

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG---YIAPEV 500
            + +ILH DIK  NI L +D   K+ DFG+A++        ++  AR  IG   Y++PE+
Sbjct: 119 -DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSPEI 172

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEMTGEK------NNANVAVDRSSEIYFPHWVYKRLELE 554
            C N    + KSD+++ G +++EM   K      N  N+ +      Y P   +   +L 
Sbjct: 173 -CEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDL- 229

Query: 555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                             + ++  L+  + NP DRPS+N ++E
Sbjct: 230 ------------------RNLVSQLF--KRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 31/231 (13%)

Query: 331 LGQGGYGGVYKGKLL----DGQNVAIKVLNE---TKGNGEDFINEVASISRTSHVNIVTL 383
           LG+G +G V + +L       Q VA+K+L     +  + E+F+ E A +    H N++ L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 384 LGFCFEGHRRA--------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR 435
           +G       RA        +I  F+ +G L  F+      E    L  + L +  + IA 
Sbjct: 67  IGVSL--RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICEG---RESIVSMTGARG 491
           G+EYL    +   +H D+   N +L+E+    ++DFGL+ KI  G   R+   S    + 
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS----KL 177

Query: 492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY 542
            + ++A E    N       SDV+++G+ ++E+          V+ +SEIY
Sbjct: 178 PVKWLALESLADNVYTT--HSDVWAFGVTMWEIMTRGQTPYAGVE-NSEIY 225

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 26/209 (12%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLG 385
           K+G+G YG VYK +  +  + +A+K +    E +G     I E++ +    H NIV L  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                 R  L++E++ +  L+K +        N +L    LY+I  GIA    Y H   +
Sbjct: 69  VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCH---S 120

Query: 446 TRILHFDIKPHNILLDEDFCP-KISDFGLAK---ICEGRESIVSMTGARGTIGYIAPEVF 501
            R+LH D+KP N+L+D      K++DFGLA+   I      + + T    T+ Y APE+ 
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-----PVRTFTHEVVTLWYRAPEIL 175

Query: 502 CRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
               G   Y +  D++S G +  EM  +K
Sbjct: 176 ---LGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 71/268 (26%), Positives = 116/268 (43%), Gaps = 35/268 (13%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLL 384
           ++G G +G VY  + + + + VAIK ++    ++    +D I EV  + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G     H   L+ E+    + +     K PL+  +      +  +  G  +GL YLH   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE------IAAVTHGALQGLAYLH--- 132

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV-FCR 503
           +  ++H D+K  NILL E    K+ DFG A I       V      GT  ++APEV    
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAM 186

Query: 504 NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 563
           + G+   K DV+S G+   E+  E+      ++  S +Y        +   E   LQ   
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSALY-------HIAQNESPALQ--- 235

Query: 564 NEEDKEYARKMILVSLWCIQTNPSDRPS 591
           +    EY R  +     C+Q  P DRP+
Sbjct: 236 SGHWSEYFRNFVDS---CLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 23/208 (11%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGF 386
           +G+G +G V K      G  +A+K +  T    E    + ++  + R+S    IV   G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 387 CF-EGHRRALIYEFVSNGSLEKF---IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
            F EG     I   + + SL+KF   ++E         +  E+L KIAV   + L YL  
Sbjct: 72  LFREGD--CWICMELMDISLDKFYKYVYEV----LKSVIPEEILGKIAVATVKALNYLKE 125

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
               +I+H D+KP NILLD +   K+ DFG   I       ++ T   G   Y+APE   
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERID 180

Query: 503 RNFGEVSY--KSDVYSYGMMVFEM-TGE 527
            +  +  Y  +SDV+S G+ ++E+ TG+
Sbjct: 181 PSARD-GYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 48/287 (16%)

Query: 328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLN-----ETKGNGEDFINEVASISRTSHVNIV 381
           + K+G+G +  VY+   LLD + VA+K +      + K   +D + E+  + + +H N++
Sbjct: 7   EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVI 65

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
             L    E +   ++ E    G L + I  K+  +  + +    ++K  V +   +E++H
Sbjct: 66  KYLDSFIEDNELNIVLELADAGDLSQMI--KYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG---YIAP 498
              + R++H DIKP N+ +      K+ D GL     GR      T A   +G   Y++P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGL-----GRFFSSKTTAAHSLVGTPYYMSP 175

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEMT-------GEKNNANVAVDRSSEIYFPHWVYKRL 551
           E    N    ++KSD++S G +++EM        G+K N      +  +  +P       
Sbjct: 176 ERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP------- 226

Query: 552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
                     +  E   E  R+  LVS+ CI  +P  RP +  V ++
Sbjct: 227 ---------PLPTEHYSEKLRE--LVSM-CIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 38/275 (13%)

Query: 329 NKLGQGGYGGVYKGKLLDGQN---VAIKV--LNETKGNGEDFINEVASISRTSHVNIVTL 383
            ++G+G +G VYKG  +D +    VAIK+  L E +   ED   E+  +S+     I   
Sbjct: 10  ERIGKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G   +G +  +I E++  GS    + +  PLE         +  I   I +GL+YLH  
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEET------YIATILREILKGLDYLH-- 118

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
            + R +H DIK  N+LL E    K++DFG+A   +  ++ +      GT  ++APEV  +
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 504 NFGEVSYKSDVYSYGMMVFEMT-GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 562
           +     +K+D++S G+   E+  GE  N+++          P  V   +       L+G 
Sbjct: 176 S--AYDFKADIWSLGITAIELAKGEPPNSDL---------HPMRVLFLIPKNSPPTLEGQ 224

Query: 563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
            ++  KE+          C+  +P  RP+   +++
Sbjct: 225 YSKPFKEFVEA-------CLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLL 384
           ++G G +G VY  + +   + VAIK ++    ++    +D I EV  + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G     H   L+ E+    + +     K PL+  +      +  I  G  +GL YLH   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVE------IAAICHGALQGLAYLH--- 132

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV-FCR 503
           +   +H DIK  NILL E    K++DFG A +     S V      GT  ++APEV    
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAM 186

Query: 504 NFGEVSYKSDVYSYGMMVFEMTGEK 528
           + G+   K DV+S G+   E+   K
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 29/205 (14%)

Query: 330 KLGQGGYGGVYKGKL-LDGQNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
           KLG+G Y  VYKGK  ++G+ VA+KV  L E +G     I E + +    H NIV L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHP---LETNQKLKWEVLYKIAVGIARGLEYLHRG 443
                   L++E+V    L +++ +KHP      N KL    L+++     RGL Y+H+ 
Sbjct: 72  IHTKETLTLVFEYVHT-DLCQYM-DKHPGGLHPENVKL---FLFQLL----RGLSYIHQ- 121

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVF 501
               ILH D+KP N+L+ +    K++DFGLA+     +S+ S T +    T+ Y  P+V 
Sbjct: 122 --RYILHRDLKPQNLLISDTGELKLADFGLARA----KSVPSHTYSNEVVTLWYRPPDVL 175

Query: 502 CRNFGEVSYKS--DVYSYGMMVFEM 524
               G   Y +  D++  G +  EM
Sbjct: 176 ---LGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 72/291 (24%), Positives = 123/291 (42%), Gaps = 58/291 (19%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG-------EDFINEVASISRTSHVNIVT 382
           LG G +   Y+ + +  G  +A+K +   +          E    E+  ++R +H +I+ 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 383 LLG-FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
           +LG  C + H    + E+++ GS+   + +    +        V+      + RGL YLH
Sbjct: 68  MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEA------VIINYTEQLLRGLSYLH 120

Query: 442 RGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICEGRESIVSMTGAR-------G 491
                +I+H D+K  N+L+D   +    +I+DFG A     R +    TGA        G
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRL--RIADFGAA----ARLA-AKGTGAGEFQGQLLG 170

Query: 492 TIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKN--NANVAVDRSSEIYFPHWVY 548
           TI ++APEV     +G      DV+S G ++ EM   K   NA    +  + I+      
Sbjct: 171 TIAFMAPEVLRGEQYGR---SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227

Query: 549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
               + E L   G+ +            V+L C++  P DRP      E+L
Sbjct: 228 TAPSIPEHLS-PGLRD------------VTLRCLELQPEDRPP---SRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 35/276 (12%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLL 384
           ++G G +G VY  + +   + VAIK ++    ++    +D I EV  + R  H N +   
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G     H   L+ E+    + +     K PL+  +      +  I  G  +GL YLH   
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE------IAAITHGALQGLAYLH--- 142

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV-FCR 503
           +  ++H DIK  NILL E    K++DFG A I     S V      GT  ++APEV    
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAM 196

Query: 504 NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 563
           + G+   K DV+S G+   E+  E+      ++  S +Y        +   E   LQ   
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSALY-------HIAQNESPTLQ--- 245

Query: 564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
           + E  +Y R  +     C+Q  P DRP+   +++ +
Sbjct: 246 SNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 71.8 bits (176), Expect = 5e-14
 Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 32/271 (11%)

Query: 331 LGQGGYGGVYKGKLLDGQN-VAIKVLNE---TKGNGEDFINEVASISRTSHVNIVTLLGF 386
           +G+G +G V+  +    Q  V IK +     TK       NE   +   SH NI+     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
             E     ++ E+   G+L ++I ++     N  L  + +    V I   L ++H     
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKR----CNSLLDEDTILHFFVQILLALHHVH---TK 120

Query: 447 RILHFDIKPHNILLDE-DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
            ILH D+K  NILLD+     KI DFG++KI   +    ++    GT  YI+PE+ C   
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPEL-CEG- 175

Query: 506 GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 565
              + KSD+++ G +++E+   K     A + ++    P  V K         + G    
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKR----AFEAAN---LPALVLKI--------MSGTFAP 220

Query: 566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVV 596
               Y+  +  + L  +  +PS RP +++++
Sbjct: 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 20/209 (9%)

Query: 322 KMTNSFK-NKLGQGGYGGVYKGKLLDGQN-VAIKV--LNETKGNGEDFINEVASISRTSH 377
           KM    K  KLG+G Y  V+KG+    +N VA+K   L   +G     I EV+ +    H
Sbjct: 4   KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
            NIVTL           L++E++ +  L++++ +   + +   +K   LY+I     RGL
Sbjct: 64  ANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI-FLYQIL----RGL 117

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG--TIGY 495
            Y HR    ++LH D+KP N+L++E    K++DFGLA+     +S+ + T +    T+ Y
Sbjct: 118 AYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNEVVTLWY 170

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             P+V   +  E S + D++  G + FEM
Sbjct: 171 RPPDVLLGS-SEYSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 26/202 (12%)

Query: 330 KLGQGGYGGV-YKGKLLDGQNVAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFC 387
           K+G+G  G V    +   G+ VA+K ++  K    + + NEV  +    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 447
             G    ++ EF+  G+L   +       T+ ++  E +  + + + R L YLH   N  
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIATVCLSVLRALSYLH---NQG 138

Query: 448 ILHFDIKPHNILLDEDFCPKISDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
           ++H DIK  +ILL  D   K+SDFG    ++K    R+S+V      GT  ++APEV  R
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVISR 192

Query: 504 -NFGEVSYKSDVYSYGMMVFEM 524
             +G    + D++S G+MV EM
Sbjct: 193 LPYGT---EVDIWSLGIMVIEM 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.5 bits (175), Expect = 9e-14
 Identities = 71/290 (24%), Positives = 128/290 (44%), Gaps = 53/290 (18%)

Query: 331 LGQGGYGGVYKGKL-LDGQN---VAIKVLNETKGNGED--FINEVASISRTSHVNIVTLL 384
           LG G +G + +G L L  +    VAI  L     + +   F+ E  ++ +  H NIV L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G    G+   ++ E++SNG+L+ F+  KH      +L    L  +  G+A G++YL    
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL-RKH----EGQLVAGQLMGMLPGLASGMKYL---S 124

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCR 503
               +H  +  H +L++ D   KIS F   ++ E + E+I +    +  + + APE    
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAI-- 180

Query: 504 NFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
            +   S  SDV+S+G++++E+   GE+               P+W         D+  Q 
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGER---------------PYW---------DMSGQD 216

Query: 562 -IENEED-------KEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
            I+  ED       +     +  + L C Q    +RP  +++  +L   +
Sbjct: 217 VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 9e-14
 Identities = 71/209 (33%), Positives = 109/209 (52%), Gaps = 31/209 (14%)

Query: 331 LGQGGYGGVYKGKLL----DGQNVAIKVLNETKGNGEDFI---NEVASISRTSHVNIVTL 383
           LGQG +G V+  + +     GQ  A+KVL +      D +    E   ++  +H  IV L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 384 -LGFCFEGHRRALIYEFVSNGSLEKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
              F  EG +  LI +F+  G L  F    K  + T + +K+ +       +A  L++LH
Sbjct: 64  HYAFQTEG-KLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYL-----AELALALDHLH 115

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTIGYIAP 498
              +  I++ D+KP NILLDE+   K++DFGL+K     ESI     A    GT+ Y+AP
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMAP 167

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM-TG 526
           EV  R  G  +  +D +S+G+++FEM TG
Sbjct: 168 EVVNRR-GH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 32/215 (14%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNE---TKGNGEDFINEVAS 371
           RY D++         +G G +G V   +  L GQNVAIK + +   T    +    E+  
Sbjct: 11  RYVDLQP--------VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKL 62

Query: 372 ISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV 431
           +    H NI++L            IY FV+    E    + H L T++ L+ + +     
Sbjct: 63  LKHLRHENIISLSDIFIS--PLEDIY-FVT----ELLGTDLHRLLTSRPLEKQFIQYFLY 115

Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG 491
            I RGL+Y+H   +  ++H D+KP NIL++E+   KI DFGLA+I + +     MTG   
Sbjct: 116 QILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVS 167

Query: 492 TIGYIAPEVFC--RNFGEVSYKSDVYSYGMMVFEM 524
           T  Y APE+    + +     + D++S G +  EM
Sbjct: 168 TRYYRAPEIMLTWQKYDV---EVDIWSAGCIFAEM 199

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.7 bits (175), Expect = 1e-13
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)

Query: 318 ADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGNGEDFINEVASISRT 375
            D KK    ++ K+GQG  G V+    +  GQ VAIK +N + +   E  INE+  +   
Sbjct: 15  GDPKKKYTRYE-KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73

Query: 376 SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR 435
            + NIV  L     G    ++ E+++ GSL   + E    E         +  +     +
Sbjct: 74  KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQ-------IAAVCRECLQ 126

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICEGRESIVSMTGARGTIG 494
            LE+LH     +++H DIK  N+LL  D   K++DFG  A+I   +    +M    GT  
Sbjct: 127 ALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPY 180

Query: 495 YIAPEVFCRN-FGEVSYKSDVYSYGMMVFEM 524
           ++APEV  R  +G    K D++S G+M  EM
Sbjct: 181 WMAPEVVTRKAYGP---KVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 21/201 (10%)

Query: 331 LGQGGYGGV------YKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLL 384
           LG+GG+G V        GK+   + +  K + + KG     +NE   + + +   +V+L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA-LNEKQILEKVNSRFVVSL- 65

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            + +E      +   + NG   KF H  H  E   +    V Y  A  I  GLE LH+  
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKF-HIYHMGEAGFEEGRAVFY--AAEICCGLEDLHQ-- 120

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLA-KICEGRESIVSMTGARGTIGYIAPEVFCR 503
             RI++ D+KP NILLD+    +ISD GLA  + EG+    ++ G  GT+GY+APEV  +
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEV-VK 174

Query: 504 NFGEVSYKSDVYSYGMMVFEM 524
           N    ++  D ++ G +++EM
Sbjct: 175 N-ERYTFSPDWWALGCLLYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 78/278 (28%), Positives = 123/278 (44%), Gaps = 37/278 (13%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVASISRTSHVNIVT 382
           F   +G+G YG V   +   DG+   IK LN    +  +      E   +S+  H NIV 
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 383 LLGFCFEGHRRAL--IYEFVSNGSLEKFIHEKHP--LETNQKLKWEVLYKIAVGIARGLE 438
                +EG    L  +  F   G L   + E+    L  NQ ++W       V IA  L+
Sbjct: 64  YRE-SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQ 116

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YLH      ILH D+K  N+ L      K+ D G+A++ E +  + S     GT  Y++P
Sbjct: 117 YLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--IGTPYYMSP 171

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 558
           E+F       +YKSDV++ G  V+EM   K+  N A D +S +Y       R+       
Sbjct: 172 ELFSNK--PYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSLVY-------RI------- 214

Query: 559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVV 596
           ++G      K+Y+ ++  +    +   P  RPS+  ++
Sbjct: 215 IEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 25/205 (12%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLL-GF 386
           +LG G +G VYK +  +   +A   + +TK   E  D++ E+  ++   H NIV LL  F
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
            +E +   LI EF + G+++  +     LE  + L    +  +       L YLH     
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVM-----LELERPLTEPQIRVVCKQTLEALNYLH---EN 122

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLA----KICEGRESIVSMTGARGTIGYIAPE-VF 501
           +I+H D+K  NIL   D   K++DFG++    +  + R+S +      GT  ++APE V 
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVM 176

Query: 502 CRNFGE--VSYKSDVYSYGMMVFEM 524
           C    +    YK+DV+S G+ + EM
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 31/206 (15%)

Query: 330 KLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGEDF--INEVASISRTSHVNIVTLLGF 386
           KLG+G Y  VYKG   ++GQ VA+KV++     G  F  I E + +    H NIV L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEK----HPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
                    ++E++    L +++ +     HP   N +L           + RGL Y+H 
Sbjct: 72  IHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP--YNVRL-------FMFQLLRGLAYIHG 121

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEV 500
                ILH D+KP N+L+      K++DFGLA+     +SI S T +    T+ Y  P+V
Sbjct: 122 ---QHILHRDLKPQNLLISYLGELKLADFGLAR----AKSIPSQTYSSEVVTLWYRPPDV 174

Query: 501 FCRNFGEVSYKS--DVYSYGMMVFEM 524
                G   Y S  D++  G +  EM
Sbjct: 175 L---LGATDYSSALDIWGAGCIFIEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 38/289 (13%)

Query: 329 NKLGQGGYGGVY-KGKLLDGQNVAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTL 383
           +++G G +G VY        + VA+K ++    +T    +D I EV  + +  H N +  
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G   + H   L+ E+    + +     K PL+  +      +  I  G  +GL YLH  
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVE------IAAITHGALQGLAYLHSH 140

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV-FC 502
               ++H DIK  NILL E    K++DFG A       S V      GT  ++APEV   
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILA 191

Query: 503 RNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 562
            + G+   K DV+S G+   E+  E+      ++  S +Y        +   +   LQ  
Sbjct: 192 MDEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSALY-------HIAQNDSPTLQ-- 241

Query: 563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPR 611
            NE    +   +     +C+Q  P +RP+     E+L         P R
Sbjct: 242 SNEWTDSFRGFVD----YCLQKIPQERPAS---AELLRHDFVRRDRPAR 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 30/251 (11%)

Query: 329 NKLGQGGYGGVYKGKLLDGQN-VAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           +KLG+G Y  VYKG+     N VA+K   L   +G     I EV+ +    H NIVTL  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                    L++E++ +  L++++ +         +K   L+++     RGL Y HR   
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL-FLFQLL----RGLNYCHR--- 122

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCR 503
            ++LH D+KP N+L++E    K++DFGLA+     +SI + T +    T+ Y  P++   
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYSNEVVTLWYRPPDIL-- 176

Query: 504 NFGEVSYKS--DVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 560
             G   Y +  D++  G + +EM TG        V+        H++++ L    +    
Sbjct: 177 -LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL-----HFIFRILGTPTEETWP 230

Query: 561 GI-ENEEDKEY 570
           GI  NEE K Y
Sbjct: 231 GILSNEEFKSY 241

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 22/204 (10%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN--EVASISR-TSHVNIVTLL 384
            K+G+G +  V K +    G+  AIK + +   + E   N  E+ ++ R + H NI+ L+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 385 GFCFE--GHRRALIYEFVSNGSLEKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
              F+    R AL++E + + +L + I   K PL   +   +  +Y++     + L+++H
Sbjct: 65  EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSY--MYQLL----KSLDHMH 117

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
           R     I H DIKP NIL+ +D   K++DFG    C G  S    T    T  Y APE  
Sbjct: 118 R---NGIFHRDIKPENILIKDD-ILKLADFG---SCRGIYSKPPYTEYISTRWYRAPECL 170

Query: 502 CRNFGEVSYKSDVYSYGMMVFEMT 525
             + G    K D+++ G + FE+ 
Sbjct: 171 LTD-GYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 41/211 (19%)

Query: 329 NKLGQGGYGGVYK------GKLLDGQNVAIKVLNETKGNGEDFI-----NEVASISRTSH 377
           N++G G  G VYK      G+L      A+KV+    GN ED +      E+  +   +H
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLY-----ALKVI---YGNHEDTVRRQICREIEILRDVNH 131

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLE--KFIHEKHPLETNQKLKWEVLYKIAVGIAR 435
            N+V             ++ EF+  GSLE      E+             L  +A  I  
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF------------LADVARQILS 179

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
           G+ YLHR     I+H DIKP N+L++     KI+DFG+++I    +++     + GTI Y
Sbjct: 180 GIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAY 234

Query: 496 IAPEVFCR--NFGEVS-YKSDVYSYGMMVFE 523
           ++PE      N G    Y  D++S G+ + E
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 59/238 (24%)

Query: 326 SFKNKLGQGGYGGVY------------KGKLLDGQN-----VAIKVL--NETKGNGEDFI 366
           +F  KLG+G +G V+            K    +        VA+KVL  + +    EDF+
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQK-----L 421
            EV  +SR S  NI  LLG C       +I E++ NG L +F+ +     +        L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 422 KWEVLYKIAVGIARGLEYL------HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA- 474
            +  L  +A  IA G+ YL      HR   TR         N L+ +++  KI+DFG++ 
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATR---------NCLVGKNYTIKIADFGMSR 178

Query: 475 --------KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                   ++ +GR        A   I ++A E      G+ + KSDV+++G+ ++E+
Sbjct: 179 NLYSSDYYRV-QGR--------APLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 24/201 (11%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFC 387
           K+G+G  G V   +    G+ VA+K+++  K    + + NEV  +    H N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 447
             G    ++ EF+  G+L   + +        +L  E +  +   + + L YLH   +  
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLH---SQG 137

Query: 448 ILHFDIKPHNILLDEDFCPKISDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
           ++H DIK  +ILL  D   K+SDFG    ++K    R+S+V      GT  ++APEV  R
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISR 191

Query: 504 NFGEVSYKSDVYSYGMMVFEM 524
                  + D++S G+MV EM
Sbjct: 192 T--PYGTEVDIWSLGIMVIEM 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 33/211 (15%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGED-------FINEVASISRTSHVNIV 381
           K+G+G YG V+K +  + GQ VAIK   E+    ED        + E+  + +  H N+V
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES----EDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 382 TLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
            L+   F   R+  L++E+  +  L +   EK+P    + +   ++ KI     + + + 
Sbjct: 64  NLIE-VFRRKRKLHLVFEYCDHTVLNEL--EKNP----RGVPEHLIKKIIWQTLQAVNFC 116

Query: 441 HR-GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           H+  C    +H D+KP NIL+ +    K+ DFG A+I  G       T    T  Y APE
Sbjct: 117 HKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPE 170

Query: 500 VFCRNFGEVSYKS--DVYSYGMMVFEM-TGE 527
           +     G+  Y    DV++ G +  E+ TG+
Sbjct: 171 LLV---GDTQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 27/174 (15%)

Query: 326 SFKNKLGQGGYGGVY------------KGKLLDGQN-----VAIKVLNE--TKGNGEDFI 366
           +FK KLG+G +G V+            K   LD        VA+K+L E   K    DF+
Sbjct: 8   TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67

Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQK-----L 421
            E+  +SR    NI+ LL  C       +I E++ NG L +F+    P E  +K     +
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 422 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 475
            +  L  +A  IA G++YL    +   +H D+   N L+ +++  KI+DFG+++
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 23/203 (11%)

Query: 329 NKLGQGGYGGVYKGKL-LDGQNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           +KLG+G Y  V+KG+  L    VA+K   L   +G     I EV+ +    H NIVTL  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                    L++E++ +  L++++     L +   +K  +       + RGL Y H+   
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQ-----LLRGLSYCHK--- 121

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCR 503
            +ILH D+KP N+L++E    K++DFGLA+     +S+ + T +    T+ Y  P+V   
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNEVVTLWYRPPDVL-- 175

Query: 504 NFGEVSYKS--DVYSYGMMVFEM 524
             G   Y +  D++  G +++EM
Sbjct: 176 -LGSTEYSTPIDMWGVGCILYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 15/183 (8%)

Query: 347 GQNVAIKVLN-ETKGNG-EDFINEVASISRTSHVNIVTLLGFCFEGHRRA--LIYEFVSN 402
           G+ VA+K L  E+ GN   D   E+  +    H NIV   G C E       LI EF+ +
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
           GSL++++    P   N K+  +   K AV I +G++YL    + + +H D+   N+L++ 
Sbjct: 93  GSLKEYL----PRNKN-KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVES 144

Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGT-IGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           +   KI DFGL K  E  +   ++     + + + APE  C    +    SDV+S+G+ +
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE--CLIQSKFYIASDVWSFGVTL 202

Query: 522 FEM 524
           +E+
Sbjct: 203 YEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 28/283 (9%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNVA---IKVLNETKGNGED--FINEVASISRTSHVNIVTL 383
           +++G G +G V  G+   G + A   +K L  +    E   F+ EV      +H N++  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           LG C E     L+ EF   G L+ ++     +      K +VL ++A  +A GL +LH+ 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLHQ- 118

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES-IVSMTGARGTIGYIAPEVFC 502
                +H D+   N  L  D   KI D+GLA + +  E   ++       + ++APE+  
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV- 174

Query: 503 RNFG------EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
              G      + + KS+++S G+ ++E+           D S E      V K++  E+D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELF--TAADQPYPDLSDE-----QVLKQVVREQD 227

Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
           + L   + + D +Y+ +   V  +C   +P  RP+   V E+L
Sbjct: 228 IKLP--KPQLDLKYSDRWYEVMQFC-WLDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 73/274 (26%), Positives = 128/274 (46%), Gaps = 38/274 (13%)

Query: 330 KLGQGGYGGVYKGKLLDGQN---VAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLL 384
           K+G+G +G V+KG  +D +    VAIK+  L E +   ED   E+  +S+     +    
Sbjct: 11  KIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G   +  +  +I E++  GS    + E  PL+  Q      +  I   I +GL+YLH   
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQ------IATILREILKGLDYLH--- 118

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
           + + +H DIK  N+LL E    K++DFG+A   +  ++ +      GT  ++APEV  ++
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 505 FGEVSYKSDVYSYGMMVFEMT-GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 563
                 K+D++S G+   E+  GE  +        SE++ P  V   +       L+G  
Sbjct: 177 --AYDSKADIWSLGITAIELAKGEPPH--------SELH-PMKVLFLIPKNNPPTLEGNY 225

Query: 564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
           ++  KE+          C+   PS RP+   +++
Sbjct: 226 SKPLKEFVEA-------CLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 39/98 (39%), Positives = 55/98 (56%), Gaps = 9/98 (9%)

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
           I RGL+YLH   +  ILH DIKP N+L++ +   KI DFGLA++ E  ES   MT    T
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVT 167

Query: 493 IGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
             Y APE+    R++       D++S G +  E+ G +
Sbjct: 168 QYYRAPEILMGSRHYTS---AVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 25/199 (12%)

Query: 333 QGGYGGVYKG-KLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN----IVTLLGFC 387
           +G +G VY   K   G   AIKVL ++    ++ +  V +      +      V  L + 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 388 FE-GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCN 445
           F+      L+ E+++ G     I     L       W   Y     +  G+E LH RG  
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGGLP----EDWAKQY--IAEVVLGVEDLHQRG-- 117

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
             I+H DIKP N+L+D+    K++DFGL++     +  V      GT  Y+APE      
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETILGVG 169

Query: 506 GEVSYKSDVYSYGMMVFEM 524
            +    SD +S G ++FE 
Sbjct: 170 DDKM--SDWWSLGCVIFEF 186

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 19/200 (9%)

Query: 331 LGQGGYGGVYKGKL-LDGQNVAIKVLNET---KGNGEDF-INEVASISRTSHVNIVTLLG 385
           LG+GG+G V   ++   G+  A K L +    K  GE   +NE   + + +   +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
           + +E      +   + NG   KF H  +        +  V Y  A  I  GLE LHR   
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKF-HIYNMGNPGFDEERAVFY--AAEITCGLEDLHR--- 120

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLA-KICEGRESIVSMTGARGTIGYIAPEVFCRN 504
            RI++ D+KP NILLD+    +ISD GLA +I EG     ++ G  GT+GY+APEV    
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEVV--K 174

Query: 505 FGEVSYKSDVYSYGMMVFEM 524
               ++  D +  G +++EM
Sbjct: 175 NERYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 31/210 (14%)

Query: 331 LGQGGYGGVYKGKLLDGQN----VAIKVLNETK--GNGEDFINEVAS---ISRTSHVNIV 381
           LG+GGYG V++ + + G +     A+KVL +     N +D  +  A    +    H  IV
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 382 TLLGFCFE-GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
            L+ + F+ G +  LI E++S G L  F+H    LE       +        I+  LE+L
Sbjct: 64  DLI-YAFQTGGKLYLILEYLSGGEL--FMH----LEREGIFMEDTACFYLSEISLALEHL 116

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV--SMTGAR-GTIGYIA 497
           H+     I++ D+KP NILLD     K++DFGL K     ESI   ++T    GTI Y+A
Sbjct: 117 HQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-----ESIHEGTVTHTFCGTIEYMA 168

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEM-TG 526
           PE+  R+ G      D +S G ++++M TG
Sbjct: 169 PEILMRS-GH-GKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 23/202 (11%)

Query: 331 LGQGGYGGV------YKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLL 384
           LG+GG+G V        GK+   + +  K + + KG     +NE   + + +   +V L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA-LNEKQILEKVNSQFVVNL- 65

Query: 385 GFCFEGHRR-ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            + +E      L+   ++ G L+  I+       N   + E     A  I  GLE LHR 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNM----GNPGFEEERALFYAAEILCGLEDLHR- 120

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICEGRESIVSMTGARGTIGYIAPEVFC 502
                ++ D+KP NILLD+    +ISD GLA KI EG     S+ G  GT+GY+APEV  
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVL- 173

Query: 503 RNFGEVSYKSDVYSYGMMVFEM 524
            N    +   D +  G +++EM
Sbjct: 174 -NNQRYTLSPDYWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 26/204 (12%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETK---GNGEDF-INE--VASISRTSHVNIVTL 383
           +G+GG+G VY  +  D G+  A+K L++ +     GE   +NE  + S+  T     +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 384 LGFCFEG-HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           + + F    + + I + ++ G L   +  +H + +  ++++      A  I  GLE++H 
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRF-----YAAEIILGLEHMH- 114

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
             N  +++ D+KP NILLDE    +ISD GLA     ++   S+    GT GY+APEV  
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 168

Query: 503 RNFGEVSYKS--DVYSYGMMVFEM 524
           +    V+Y S  D +S G M+F++
Sbjct: 169 KG---VAYDSSADWFSLGCMLFKL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 18/200 (9%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFI---NEVASISRTSHVNIVTLLG 385
           ++G G YG VYK + ++ G+  AIKV+    G  EDF     E+  +    H NIV   G
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                 +  +  EF   GSL+   H   PL  +Q      +  ++    +GL YLH   +
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ------IAYVSRETLQGLYYLH---S 124

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC-RN 504
              +H DIK  NILL ++   K++DFG++   +   +I       GT  ++APEV     
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 505 FGEVSYKSDVYSYGMMVFEM 524
            G  +   D+++ G+   E+
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 26/202 (12%)

Query: 330 KLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFC 387
           K+G+G  G V    +   G+ VA+K ++  K    + + NEV  +    H N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 447
             G    ++ EF+  G+L   +       T+ ++  E +  + + + + L  LH      
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLKALSVLH---AQG 136

Query: 448 ILHFDIKPHNILLDEDFCPKISDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
           ++H DIK  +ILL  D   K+SDFG    ++K    R+S+V      GT  ++APE+  R
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELISR 190

Query: 504 -NFGEVSYKSDVYSYGMMVFEM 524
             +G    + D++S G+MV EM
Sbjct: 191 LPYGP---EVDIWSLGIMVIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 7e-12
 Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 37/193 (19%)

Query: 330 KLGQGGYGGVYKGKLL---DGQNVAIKVLNETKGNGEDF----INEVASISRTSHVNIVT 382
            +G+G YG VYK K     DG+  AIK     K            E+A +    H N+V+
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 383 LLGFCFEGHRRA--LIYEFVSNGSLEKFIH-----EKHPLETN--QKLKWEVLYKIAVGI 433
           L+    E   ++  L++++  +  L + I      ++  +  +  + L W++L       
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL------- 118

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICEGRESIVSMTGA 489
             G+ YLH   +  +LH D+KP NIL+     E    KI D GLA++      +  +   
Sbjct: 119 -NGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF--NAPLKPLADL 172

Query: 490 RG---TIGYIAPE 499
                TI Y APE
Sbjct: 173 DPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 16/199 (8%)

Query: 330 KLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGEDFIN-EVASISRTSHVNIVTLLGFC 387
           ++G G YG VYK   L  G+  A+K++    G+    I  E+  +    H NIV   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 447
               +  +  E+   GSL+   H   PL   Q      +  +     +GL YLH      
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQ------IAYVCRETLQGLAYLHSKGK-- 127

Query: 448 ILHFDIKPHNILLDEDFCPKISDFGL-AKICEGRESIVSMTGARGTIGYIAPEVFC-RNF 505
            +H DIK  NILL ++   K++DFG+ AKI     +I       GT  ++APEV      
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKIT---ATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 506 GEVSYKSDVYSYGMMVFEM 524
           G  +   D+++ G+   E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 22/211 (10%)

Query: 329 NKLGQGGYGGVYKGKLLDG---QNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTL 383
            ++G+G +G V+KG  +D    Q VAIK+  L E +   ED   E+  +S+     +   
Sbjct: 10  ERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G   +G +  +I E++  GS    +    P +  Q      +  +   I +GL+YLH  
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLRAG-PFDEFQ------IATMLKEILKGLDYLH-- 118

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
            + + +H DIK  N+LL E    K++DFG+A   +  ++ +      GT  ++APEV  +
Sbjct: 119 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIQQ 175

Query: 504 NFGEVSYKSDVYSYGMMVFEMT-GEKNNANV 533
           +      K+D++S G+   E+  GE  N+++
Sbjct: 176 S--AYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 43/225 (19%)

Query: 380 IVTLLG-FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           IV+  G F  E +   +  EF+  GSL++   +  P+        E+L KIAV +  GL 
Sbjct: 65  IVSFYGAFLNENNI-CMCMEFMDCGSLDRIYKKGGPIPV------EILGKIAVAVVEGLT 117

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA-RGTIGYIA 497
           YL+     RI+H DIKP NIL++     K+ DFG++      E I S+     GT  Y++
Sbjct: 118 YLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-----ELINSIADTFVGTSTYMS 170

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEMT------GEKNNANVAVDRSSEIYFPHWVYKRL 551
           PE      G+ + KSDV+S G+ + E+          N  +   D    I         L
Sbjct: 171 PERI--QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI---------L 219

Query: 552 ELEEDLGLQGIENEE-----DKEYARKMILVSLWCIQTNPSDRPS 591
           +L     LQ I  E        ++   +      C+  +P++RP+
Sbjct: 220 DL-----LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 36/212 (16%)

Query: 331 LGQGGYGGVYKGKL-LDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF 386
           +G G YG V        G+ VAIK L+   ++  + +    E+  +    H N++ LL  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 387 CFEGHRRALIYEFVSNGSLEKF------IH----EKHPLETNQKLKWEVLYKIAVGIARG 436
                       F    SLE F       H    + + +   QKL  + +  +   I RG
Sbjct: 83  ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           L+Y+H   +  I+H D+KP NI ++ED   KI DFGLA+  +       MTG   T  Y 
Sbjct: 131 LKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYR 182

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM-TGE 527
           APE+   N+   +   D++S G ++ E+ TG+
Sbjct: 183 APEIML-NWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 14/205 (6%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGE-----DFINEVASISRTSHVNIVTLL 384
           ++G G +G V  G++  G   A  V+ E + +        F+ E        H N++  L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G C E     L+ EF   G L+ ++      E         L ++A  IA GL +LH+  
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE-LMTPDPTTLQRMACEIALGLLHLHK-- 118

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
               +H D+   N LL  D   KI D+GL+      +  V+       + +IAPE+    
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 505 FGEV-----SYKSDVYSYGMMVFEM 524
            G +     + +S+V+S G+ ++E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 14/127 (11%)

Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           L   IH   PL T + +++  LY++     RGL+Y+H      ++H D+KP N+L++ED 
Sbjct: 94  LHHIIHSDQPL-TEEHIRY-FLYQLL----RGLKYIHSAN---VIHRDLKPSNLLVNEDC 144

Query: 465 CPKISDFGLAKICEGRESIVS---MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
             +I DFG+A+             MT    T  Y APE+   +  E +   D++S G + 
Sbjct: 145 ELRIGDFGMAR-GLSSSPTEHKYFMTEYVATRWYRAPELLL-SLPEYTTAIDMWSVGCIF 202

Query: 522 FEMTGEK 528
            EM G +
Sbjct: 203 AEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 45/219 (20%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIK---VLNETKGNGEDFINEVASISRTSHVN-IVTLL 384
           K+G+G YG VYK +    G+ VA+K   +  + +G     + E++ +   S    IV LL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 385 GF--CFEGHRRALIY---EFVSNGSLEKFI-----HEKHPLETN--QKLKWEVLYKIAVG 432
                 E + +  +Y   E++ +  L+KF+         PL     +   +++L      
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLL------ 120

Query: 433 IARGLEYLH-RGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICEGRE---SIVSMT 487
             +G+ + H  G    ++H D+KP N+L+D+     KI+D GL     GR     + S T
Sbjct: 121 --KGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGL-----GRAFSIPVKSYT 169

Query: 488 GARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
               T+ Y APEV     G   Y +  D++S G +  EM
Sbjct: 170 HEIVTLWYRAPEVL---LGSTHYSTPVDIWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 22/202 (10%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETK---GNGEDF-INE--VASISRTSHVNIVTL 383
           +G+GG+G VY  +  D G+  A+K L++ +     GE   +NE  + S+  T     +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 384 LGFCFEG-HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           + + F    +   I + ++ G L   +  +H + + +++++      A  I  GLE++H 
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRF-----YATEIILGLEHMH- 114

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
             N  +++ D+KP NILLDE    +ISD GLA     ++   S+    GT GY+APEV  
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 168

Query: 503 RNFGEVSYKSDVYSYGMMVFEM 524
           +     S  +D +S G M+F++
Sbjct: 169 KGTAYDS-SADWFSLGCMLFKL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 36/218 (16%)

Query: 330 KLGQGGYGGVYKGKLL---DGQNVAIKVLNETKGNGEDFINEVASISRT----------- 375
           +LGQG YG V   +     + + VAIK +        +  ++     R            
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKIT-------NVFSKKILAKRALRELKLLRHFR 59

Query: 376 SHVNIVTL--LGFCFEGHRRAL-IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVG 432
            H NI  L  +   F G+   L +YE +    L + I    PL T+   +   +Y+I   
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPL-TDAHFQS-FIYQIL-- 115

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS--MTGAR 490
              GL+Y+H   +  +LH D+KP N+L++ D   KI DFGLA+         +  MT   
Sbjct: 116 --CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 491 GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
            T  Y APE+   +F   +   DV+S G ++ E+ G K
Sbjct: 171 ATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 16/204 (7%)

Query: 331 LGQGGYGGVY------KGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLL 384
           LG+GG+G V        GKL   + +  K L + KG  E  + E   +++  H   +  L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY-EGAMVEKRILAKV-HSRFIVSL 58

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            + F+      +   + NG   ++ H  +  E N              I  GLE+LH+  
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRY-HIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-- 115

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
             RI++ D+KP N+LLD D   +ISD GLA   E ++      G  GT G++APE+    
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGE 172

Query: 505 FGEVSYKSDVYSYGMMVFEMTGEK 528
             E  +  D ++ G+ ++EM   +
Sbjct: 173 --EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 25/203 (12%)

Query: 331 LGQGGYGGV------YKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLL 384
           LG+GG+G V        GK+   + +  K + + KG     +NE   + + +   +V+L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKRILEKVNSRFVVSL- 65

Query: 385 GFCFEGHRRALIYEFVSNGSLEKF--IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
            + +E      +   + NG   KF   +  +P    Q+    + Y  A  +  GLE L R
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR---AIFY--AAELCCGLEDLQR 120

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICEGRESIVSMTGARGTIGYIAPEVF 501
               RI++ D+KP NILLD+    +ISD GLA +I EG     ++ G  GT+GY+APEV 
Sbjct: 121 ---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEVI 173

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM 524
             N  + ++  D +  G +++EM
Sbjct: 174 --NNEKYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 66/212 (31%), Positives = 92/212 (43%), Gaps = 29/212 (13%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLN------ETKGNGEDFINEVASISRTSHVNIVTL 383
           LGQG +G VY     D G+ +A+K +       ET         E+  +    H  IV  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 384 LGFCFEGHRRAL--IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
            G   +   R L    E +  GS+      K  L++   L   V  K    I  G+ YLH
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSI------KDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK----ICEGRESIVSMTGARGTIGYIA 497
              +  I+H DIK  NIL D     K+ DFG +K    IC     + S+T   GT  +++
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWMS 177

Query: 498 PEVFC-RNFGEVSYKSDVYSYGMMVFEMTGEK 528
           PEV     +G    K+D++S G  V EM  EK
Sbjct: 178 PEVISGEGYGR---KADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 32/208 (15%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLG 385
           K+G+G YG V+K K  +  + VA+K +   ++ +G     + E+  +    H NIV L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                 +  L++E+     L+K+         N  +  E++      + +GL + H   +
Sbjct: 67  VLHSDKKLTLVFEYCDQ-DLKKYFDS-----CNGDIDPEIVKSFMFQLLKGLAFCH---S 117

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKI------CEGRESIVSMTGARGTIGYIAPE 499
             +LH D+KP N+L++++   K++DFGLA+       C   E +        T+ Y  P+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--------TLWYRPPD 169

Query: 500 VFCRNFGEVSYKS--DVYSYGMMVFEMT 525
           V    FG   Y +  D++S G +  E+ 
Sbjct: 170 VL---FGAKLYSTSIDMWSAGCIFAELA 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.2 bits (154), Expect = 9e-11
 Identities = 75/265 (28%), Positives = 115/265 (43%), Gaps = 50/265 (18%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGF 386
           +G+G YG V   K     + VAIK +     N  D    + E+  +    H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 387 CFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
               HR A     ++YE +    L + I     L ++   ++  LY++     RGL+Y+H
Sbjct: 73  MPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTL-SDDHCQY-FLYQLL----RGLKYIH 125

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
              +  +LH D+KP N+LL+ +   KI DFGLA+    +     MT    T  Y APE+ 
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPELL 180

Query: 502 --CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY-KRLEL----- 553
             C  +       DV+S G +  E+ G K              FP   Y  +L+L     
Sbjct: 181 LNCSEYTTA---IDVWSVGCIFAELLGRKP------------LFPGKDYVHQLKLITELL 225

Query: 554 ----EEDLGLQGIENEEDKEYARKM 574
               EEDLG   I NE+ + Y R +
Sbjct: 226 GSPSEEDLGF--IRNEKARRYIRSL 248

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 31/206 (15%)

Query: 331 LGQGGYGGV----YKGKLLDGQNVAIKVLNETKGNGEDFI----NEVASISRTSHVNIVT 382
           LG+G +G V     KG     +  A+KVL +     +D +     E   ++       +T
Sbjct: 3   LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 383 LLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
            L  CF+   R   + E+V+ G L   I      +  +       Y  A  I  GL++LH
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA----RFY--AAEIVLGLQFLH 113

Query: 442 -RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRESIVSMTGARGTIGYIAP 498
            RG    I++ D+K  N+LLD +   KI+DFG+ K  I  G    V+ +   GT  YIAP
Sbjct: 114 ERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTTSTFCGTPDYIAP 165

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM 524
           E+   ++       D ++ G++++EM
Sbjct: 166 EIL--SYQPYGPAVDWWALGVLLYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 23/203 (11%)

Query: 328 KNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET---KGNGEDFINEVASI-SRTSHVNIVT 382
              LG G +G V   K    G+  AIK L +    K      + +  SI    SH  IV 
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           ++    + +R   + EFV  G  E F H    L    +   +V       +    EYLH 
Sbjct: 83  MMCSFQDENRVYFLLEFVVGG--ELFTH----LRKAGRFPNDVAKFYHAELVLAFEYLH- 135

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF- 501
             +  I++ D+KP N+LLD     K++DFG AK    R   +      GT  Y+APEV  
Sbjct: 136 --SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-----GTPEYLAPEVIQ 188

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM 524
            +  G+     D ++ G++++E 
Sbjct: 189 SKGHGKA---VDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 329 NKLGQGGYGGVYKGKLLD-GQNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLL 384
           N++G+G YG VY+ +    G+ VA+K +   NE  G     + E+  +    H NIV L 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 385 GFCFEGHRRA--LIYEFVSN--GSLEKFIHEKHPLETNQKLKWEVLYK-IAVGIARGLEY 439
                 H  +  L+ E+      SL         L+       E   K + + + RGL+Y
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQDLASL---------LDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           LH      I+H D+K  N+LL +  C KI+DFGLA+          MT    T+ Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG--LPAKPMTPKVVTLWYRAPE 178

Query: 500 VFCRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
           +     G  +Y +  D+++ G ++ E+   K
Sbjct: 179 LL---LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 44/213 (20%)

Query: 331 LGQGGYGGV----YKGKLLDGQNVAIKVLNETKGNGEDFI--NEVASI----------SR 374
           LG+G +G V    YK     G+  AIK L +      D I  +EV S+          + 
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALKK-----GDIIARDEVESLMCEKRIFETANS 58

Query: 375 TSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGI 433
             H  +V L   CF+       + E+ + G L   IH     E        V Y  A  +
Sbjct: 59  ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE-----PRAVFY--AACV 110

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTI 493
             GL+YLH     +I++ D+K  N+LLD +   KI+DFGL K   G     S     GT 
Sbjct: 111 VLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC--GTP 165

Query: 494 GYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM 524
            ++APEV      E SY   V  +  G++++EM
Sbjct: 166 EFLAPEVLT----ETSYTRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 25/202 (12%)

Query: 330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVAS----ISRTSHVNIVTLL 384
           ++GQGGYG V+  K  D G+ VA+K + ++     + +  V +    ++ T    +V LL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 385 GFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            + F+      L  E+V  G     ++    L  +    +      AV     L Y+HR 
Sbjct: 68  -YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHR- 125

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFC 502
                   D+KP N L+D     K++DFGL+K I     S+V      G+  Y+APEV  
Sbjct: 126 --------DLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEVL- 170

Query: 503 RNFGEVSYKSDVYSYGMMVFEM 524
                  +  D +S G M++E 
Sbjct: 171 -RGKGYDFTVDYWSLGCMLYEF 191

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 19/205 (9%)

Query: 331 LGQGGYGGVYK-GKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCF 388
           +G+G YG V+K     +G   A+K+L+      E+   E   +   S H N+V   G  +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 389 E-----GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           +     G +  L+ E  + GS+   +  K  L+  ++++  ++  I      GL++LH  
Sbjct: 86  KKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEALMGLQHLH-- 141

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICEGRESIVSMTGARGTIGYIAPEVF- 501
              + +H D+K +NILL  +   K+ DFG+ A++   R   +    + GT  ++APEV  
Sbjct: 142 -VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIA 197

Query: 502 CRNFGEVSY--KSDVYSYGMMVFEM 524
           C    + +Y  + DV+S G+   E+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 52/168 (30%), Positives = 78/168 (46%), Gaps = 33/168 (19%)

Query: 330 KLGQGGYGGVYKG-KLLDGQNVAIK---VLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           KLG+G +G VYK  ++  G+ VA+K   + NE  G     + E+  + +  H N+V L+ 
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74

Query: 386 FCFE-----GHRRALIYEFVS-------NGSLEKFIHEKHPLETNQKLKWEV--LYKIAV 431
              E       +R  +Y  V+       +G LE           N  +K     +    +
Sbjct: 75  MAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLE-----------NPSVKLTESQIKCYML 122

Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG 479
            +  G+ YLH   N  ILH DIK  NIL+D     KI+DFGLA+  +G
Sbjct: 123 QLLEGINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 61/222 (27%), Positives = 91/222 (40%), Gaps = 53/222 (23%)

Query: 328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDF---------INEVASISRTSH 377
            + +G+G YG V        G  VAIK +         F         + E+  + R  H
Sbjct: 10  LSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILRRFKH 62

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKF-----IHE-----KHPLETNQKLKWE--- 424
            NI+              I + +   S E F     + E      + L   Q L  +   
Sbjct: 63  ENIIG-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQ 109

Query: 425 -VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-EGRES 482
             LY+I     RGL+Y+H   N  +LH D+KP N+LL+ +   KI DFGLA+I     + 
Sbjct: 110 YFLYQIL----RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162

Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
              +T    T  Y APE+   N    +   D++S G ++ EM
Sbjct: 163 TGFLTEYVATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEM 203

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 22/205 (10%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQ--NVAIKVLNETKGNGEDFINEVAS----ISRTSHVN 379
           +F   LG G +G V      +     VAIK   ++K   +  ++ V S    ++  +H  
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
            V L G   +     L+ EFV  G    F      L  N++   +V    A  I    EY
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEFFTF------LRRNKRFPNDVGCFYAAQIVLIFEY 146

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           L    +  I++ D+KP N+LLD+D   K++DFG AK+ + R   +      GT  YIAPE
Sbjct: 147 LQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-----GTPEYIAPE 198

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM 524
           +   N G     +D ++ G+ ++E+
Sbjct: 199 ILL-NVGH-GKAADWWTLGIFIYEI 221

Length = 340

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 67/213 (31%), Positives = 91/213 (42%), Gaps = 31/213 (14%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLN------ETKGNGEDFINEVASISRTSHVNIVTL 383
           LGQG +G VY    +D G+ +A K +       ET         E+  +    H  IV  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 384 LGFCFEGHRR---ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
            G C          +  E++  GS+      K  L+    L   V  K    I  G+ YL
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSV------KDQLKAYGALTESVTRKYTRQILEGMSYL 122

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK----ICEGRESIVSMTGARGTIGYI 496
           H   +  I+H DIK  NIL D     K+ DFG +K    IC     I S+T   GT  ++
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT---GTPYWM 176

Query: 497 APEVFC-RNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +PEV     +G    K+DV+S G  V EM  EK
Sbjct: 177 SPEVISGEGYGR---KADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 40/212 (18%)

Query: 331 LGQGGYGGVYKGKLL-DGQNVAIKVLNE---TKGNGEDFI-NEVASISRTSHVNIVTLLG 385
           LG GG+G V   K+    +  A+K + +    +   ++ I +E   +   +H  IV L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 386 FCFEGHR----RALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
                +R    +  IY   E+   G L   + ++   +     ++   + IA  +    E
Sbjct: 59  -----YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-----EYTARFYIA-CVVLAFE 107

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE---SIVSMTGARGTIGY 495
           YLH   N  I++ D+KP N+LLD +   K+ DFG AK  +  +   +        GT  Y
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPEY 158

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTG 526
           +APE+   N G   +  D +S G++++E +TG
Sbjct: 159 VAPEI-ILNKGY-DFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 46/234 (19%)

Query: 327 FKNK-LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDF---------------INEV 369
            K   LG+G YG V K    L G+ VAIK +   + + +                 + E+
Sbjct: 12  QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPL-ETNQKLKWEVLYK 428
             ++   H NI+ L+    EG    L+ + ++   L+K +  K  L E+  K        
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKC------- 123

Query: 429 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC----------- 477
           I + I  GL  LH       +H D+ P NI ++     KI+DFGLA+             
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 478 -EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
            E  +    MT    T+ Y APE+     G   Y    D++S G +  E+   K
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELL---MGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 29/210 (13%)

Query: 333 QGGYGGVYKGKLLDGQ-NVAIKVLNETKGNGED------FINEVASISRTSHVNIVTLLG 385
           +G +G ++ G L+D +     +V  +T  +          + E   +   SH NI+ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 386 FCFEGHRRALI-YEFVSNGSLEKFIHE-KHPLETN-QKLKWEVLYKIAVGIARGLEYLHR 442
            C E      + Y +++ G+L+ F+ + +     N Q L  + L  +A+ IA G+ YLH+
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI-------CEGRESIVSMTGARGTIGY 495
                ++H DI   N ++DE+   KI+D  L++        C G             + +
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG-------DNENRPVKW 185

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +A E         S  SDV+S+G++++E+ 
Sbjct: 186 MALESLVNKE--YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 33/213 (15%)

Query: 331 LGQGGYGGVYKGKLLDGQN----VAIKVLNET-----KGNGEDFINEVASISRTSHVNIV 381
           LG G YG V+  + + G +     A+KVL +          E    E   +        +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 382 TLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVG-IARGLEY 439
             L + F+   +  LI ++V+ G L  F H    L   +    E   ++ +  I   L++
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGEL--FTH----LYQREHFT-ESEVRVYIAEIVLALDH 120

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-----GTIG 494
           LH+     I++ DIK  NILLD +    ++DFGL+K        ++    R     GTI 
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE------FLAEEEERAYSFCGTIE 171

Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTG 526
           Y+APEV     G      D +S G++ FE +TG
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 60.7 bits (148), Expect = 7e-10
 Identities = 64/246 (26%), Positives = 111/246 (45%), Gaps = 72/246 (29%)

Query: 313 KRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLD---GQNVAIKVLNETKGNGED----- 364
           ++Y   +I +       KLG+G YG V+K   +D    + VA+K + +   N  D     
Sbjct: 7   RKY---EILQ-------KLGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTF 54

Query: 365 ----FINEVASISRTSHVNIVTLLGFCFEGHRRA------LIYEF-------VSNGSLEK 407
               F+ E+       H NIV LL       +        L++E+       V   ++ +
Sbjct: 55  REIMFLQEL-----GDHPNIVKLLNV----IKAENDKDIYLVFEYMETDLHAVIRANILE 105

Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
            +H+++           ++Y++     + L+Y+H G    ++H D+KP NILL+ D   K
Sbjct: 106 DVHKRY-----------IMYQLL----KALKYIHSG---NVIHRDLKPSNILLNSDCRVK 147

Query: 468 ISDFGLAK-ICEGRESIVS--MTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVF 522
           ++DFGLA+ + E  E+  +  +T    T  Y APE+     G   Y    D++S G ++ 
Sbjct: 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL---LGSTRYTKGVDMWSVGCILG 204

Query: 523 EMTGEK 528
           EM   K
Sbjct: 205 EMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 29/210 (13%)

Query: 328 KNKLGQGGYGGVY--KGKLLDGQNVAIKVLNETKGNGEDFINEVAS-------ISRTSHV 378
           + +LG+G +G VY  K K    +   +KVL E    GE   NE          +S+  H 
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEE-RLKVLKEIP-VGELNPNETVQANQEAQLLSKLDHP 62

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE-KHPLET---NQKLKWEVLYKIAVGIA 434
            IV       E     +I E+     L+  + E KH  +T   NQ  +W       + + 
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLL 116

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
            G+ Y+H+    RILH D+K  NI L  +   KI DFG++++  G  S    T   GT  
Sbjct: 117 LGVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG--SCDLATTFTGTPY 170

Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           Y++PE   ++ G  S KSD++S G +++EM
Sbjct: 171 YMSPEAL-KHQGYDS-KSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 38/216 (17%)

Query: 331 LGQGGYGGVYKGKLLD---------GQNVAIKVLNETKGNGEDFIN----EVASISR-TS 376
           LG+G    +Y G L                IKV+ +        I+    E AS+ R  S
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEK-HPLETNQKLKWEVLYKIAVGIAR 435
           H +IV L G C       ++ EFV  G L+ F+H K   L T  K      +K+A  +A 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK------FKVAKQLAS 116

Query: 436 GLEYLHRGCNTRILHFDIKPHNILL-----DEDFCP--KISDFGLAKICEGRESIVSMTG 488
            L YL    +  ++H ++   NILL     D +  P  K+SD G+      R+  V    
Sbjct: 117 ALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE--- 170

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
               I +IAPE    +   +S  +D +S+G  ++E+
Sbjct: 171 ---RIPWIAPEC-VEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 39/215 (18%)

Query: 331 LGQGGYGGVYKGKLL---DGQN--------VAIKVLNETKGNGEDFINEVASISRTSHVN 379
           LGQG +  +YKG L    D           V +KVL     +   F    + +S+ SH +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLE 438
           +V L G C       ++ E+V  G L+ F+H EK+ +  + KL       +A  +A  L 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKL------DVAKQLASALH 115

Query: 439 YLHRGCNTRILHFDIKPHNILL----DEDFCP---KISDFGLAKICEGRESIVSMTGARG 491
           YL    + +++H ++   NIL+      +      K+SD G+      RE  V       
Sbjct: 116 YLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------ 166

Query: 492 TIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            I +IAPE   RN G+ S     D +S+G  + E+
Sbjct: 167 RIPWIAPE-CIRN-GQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 28/172 (16%)

Query: 433 IARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG 491
           +ARG+E+L  R C    +H D+   NILL E+   KI DFGLA+        V    AR 
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 492 TIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR 550
            + ++APE +F + +   + +SDV+S+G++++E+         ++  S         Y  
Sbjct: 238 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEI--------FSLGASP--------YPG 278

Query: 551 LELEEDL--GLQGIENEEDKEYARKMIL-VSLWCIQTNPSDRPSMNRVVEML 599
           ++++E+    L+        EYA   I  + L C   NP DRP+ + +VE+L
Sbjct: 279 VQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 43/210 (20%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN---------- 379
           +G G +G V+  +  +     A+KV+          I EV  + +  HV+          
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMA---------IPEVIRLKQEQHVHNEKRVLKEVS 59

Query: 380 ---IVTLLGFCFEGHRRAL--IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIA 434
              I+ L  F  E  +R L  + E+V  G L  ++        +  L +      A  I 
Sbjct: 60  HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------ASEIV 111

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
             LEYLH   +  I++ D+KP NILLD++   K++DFG AK  + R+   ++    GT  
Sbjct: 112 CALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWTLC---GTPE 163

Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           Y+APEV  ++ G  +   D ++ G++++EM
Sbjct: 164 YLAPEVI-QSKGH-NKAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 31/213 (14%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVL------NETKGNGEDFINEVASISRTSHVNIVTL 383
           LG+G +G VY     D G+ +A+K +       ET         E+  +    H  IV  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 384 LGFCFEGH---RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
            G C       + ++  E++  GS+      K  L+    L   V  +    I +G+ YL
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSI------KDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK----ICEGRESIVSMTGARGTIGYI 496
           H   +  I+H DIK  NIL D     K+ DFG +K    IC     I S+T   GT  ++
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT---GTPYWM 176

Query: 497 APEVFC-RNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +PEV     +G    K+DV+S    V EM  EK
Sbjct: 177 SPEVISGEGYGR---KADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 20/200 (10%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISR----TSHVNIVTLLG 385
           LG+G +G V   +    G+  A+K+L +     +D +    + SR    T H   +T L 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLK 61

Query: 386 FCFEGHRR-ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           + F+   R   + E+V+ G L  F H    L   +    +        I   L+YLH G 
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL--FFH----LSRERVFSEDRTRFYGAEIVSALDYLHSG- 114

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
             +I++ D+K  N++LD+D   KI+DFGL K  EG     +M    GT  Y+APEV   N
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDN 170

Query: 505 FGEVSYKSDVYSYGMMVFEM 524
             +     D +  G++++EM
Sbjct: 171 --DYGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 15/205 (7%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNG-----EDFINEVASISRTSHVNIVTLL 384
           ++G G +G V   ++     VA  V+ E K N       +F+ +        H NI+  L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G C E     L++E+   G L+ ++ ++     N +L   +L ++A  IA G+ ++H+  
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL--LLQRMACEIAAGVTHMHK-- 117

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
               LH D+   N  L  D   K+ D+G+       + I +       + ++APE+    
Sbjct: 118 -HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 505 FG-----EVSYKSDVYSYGMMVFEM 524
            G     E +  S+V++ G+ ++E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 22/201 (10%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISR----TSHVNIVTLLG 385
           LG+G +G V   +    G+  A+K+L +     +D +    + SR    T H   +T L 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 61

Query: 386 FCFEGHRR-ALIYEFVSNGSLEKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           + F+ H R   + E+ + G L  F H  +  + T ++ ++         I   LEYLH  
Sbjct: 62  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-----YGAEIVSALEYLH-- 112

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
            +  +++ DIK  N++LD+D   KI+DFGL K  EG     +M    GT  Y+APEV   
Sbjct: 113 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 169

Query: 504 NFGEVSYKSDVYSYGMMVFEM 524
           N  +     D +  G++++EM
Sbjct: 170 N--DYGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 12/108 (11%)

Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+ V I + L YL       ++H D+KP NILLD     K+ DFG++    GR  + 
Sbjct: 115 ILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GR-LVD 167

Query: 485 SM--TGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM-TGE 527
           S   T + G   Y+APE          Y  ++DV+S G+ + E+ TG+
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 34/214 (15%)

Query: 327 FKNKLGQGGYGGVYK------GKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNI 380
             ++LG+G YG VYK      G  +  + + ++ L+E+K N    I E+  + +     I
Sbjct: 5   VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQ--IIMELDILHKAVSPYI 61

Query: 381 VTLLG-FCFEGHRRALIY--EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
           V   G F  EG   A+    E++  GSL+K        E    +  +VL +I   + +GL
Sbjct: 62  VDFYGAFFIEG---AVYMCMEYMDAGSLDKLYAGGVATE---GIPEDVLRRITYAVVKGL 115

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG--- 494
           ++L    N  I+H D+KP N+L++ +   K+ DFG++       S+     A+  IG   
Sbjct: 116 KFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--SL-----AKTNIGCQS 166

Query: 495 YIAPEVF----CRNFGEVSYKSDVYSYGMMVFEM 524
           Y+APE             + +SDV+S G+ + EM
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 27/204 (13%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNET---KGNGEDFINEVAS--ISRTSHVNIVTLL 384
           +G+G +G V   K   DG+  A+KVL +    K   +  I    +  +    H  +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 385 GFCFEGHRRA-LIYEFVSNGSLEKFIH---EKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
            + F+   +   + ++V+ G L  F H   E+   E   +         A  IA  L YL
Sbjct: 62  HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARF-------YAAEIASALGYL 112

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
           H   +  I++ D+KP NILLD      ++DFGL K  EG E   + +   GT  Y+APEV
Sbjct: 113 H---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEV 167

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM 524
             +         D +  G +++EM
Sbjct: 168 LRKQ--PYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 16/160 (10%)

Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           I E+  +   +   IV   G  +     ++  E +  GSL++ + E       +++  E+
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA------KRIPEEI 104

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           L K+++ + RGL YL      +I+H D+KP NIL++     K+ DFG++      + I S
Sbjct: 105 LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLIDS 157

Query: 486 MTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           M  +  GT  Y++PE         S +SD++S G+ + E+
Sbjct: 158 MANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 41/224 (18%)

Query: 314 RYRYADIKKMTNSFKNKLGQGGYGGV-YKGKLLDGQNVAIKVLN---ETKGNGEDFINEV 369
             RY D+K+        +G G YG V        G  VAIK L    +++   +    E+
Sbjct: 14  PDRYRDLKQ--------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYREL 65

Query: 370 ASISRTSHVNIVTLLGFCFEG-------HRRALIYEFVSN--GSLEKFIHEKHPLETNQK 420
             +    H N++ LL   F         H   L+  F+    G L K  HEK   +  Q 
Sbjct: 66  RLLKHMKHENVIGLLD-VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQF 122

Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
           L +++L        +GL+Y+H      I+H D+KP N+ ++ED   KI DFGLA     R
Sbjct: 123 LVYQML--------KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA-----R 166

Query: 481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           ++   MTG   T  Y APEV   N+   +   D++S G ++ EM
Sbjct: 167 QTDSEMTGYVVTRWYRAPEVIL-NWMHYTQTVDIWSVGCIMAEM 209

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 17/199 (8%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISR---TSHVNIVTLLGF 386
           LG+G +G V   K    G+  A+K+L +     +D +    + +R    S    +T L +
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 387 CFEGHRR-ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
            F+ H R   + E+ + G L  F H    L   +    +        I   L+YLH    
Sbjct: 63  SFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFYGAEIVSALDYLH--SE 114

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
             +++ D+K  N++LD+D   KI+DFGL K  EG +   +M    GT  Y+APEV   N 
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDN- 171

Query: 506 GEVSYKSDVYSYGMMVFEM 524
            +     D +  G++++EM
Sbjct: 172 -DYGRAVDWWGLGVVMYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 45/228 (19%)

Query: 398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
           E +  GSL++       L+   ++   +L KI++ + RGL YL      +I+H D+KP N
Sbjct: 79  EHMDGGSLDQV------LKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSN 130

Query: 458 ILLDEDFCPKISDFGLAKICEGRESIVSMTGA-RGTIGYIAPEVFCRNFG-EVSYKSDVY 515
           IL++     K+ DFG++      + I SM  +  GT  Y++PE   R  G   + +SD++
Sbjct: 131 ILVNSRGEIKLCDFGVSG-----QLIDSMANSFVGTRSYMSPE---RLQGTHYTVQSDIW 182

Query: 516 SYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMI 575
           S G+ + EM         A+ R     +P      +   +   L+ +      E   K  
Sbjct: 183 SLGLSLVEM---------AIGR-----YP------IPPPDAKELEAMFGRPVSEGEAKES 222

Query: 576 LVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDF 623
              +     +P D P    + E+L+  ++    PP P L S     +F
Sbjct: 223 HRPV---SGHPPDSPRPMAIFELLDYIVNE---PP-PKLPSGAFSDEF 263

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 28/207 (13%)

Query: 399 FVSNGSLEKFIHEKHPLETNQK--LKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKP 455
           FV   SL     E+   E   K  L  E L   +  +A+G+E+L  R C    +H D+  
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHRDLAA 207

Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            NILL E+   KI DFGLA+        V    AR  + ++APE +F R +   + +SDV
Sbjct: 208 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDV 264

Query: 515 YSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           +S+G++++E+   G      V +D            +RL+       +G           
Sbjct: 265 WSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYTTP 309

Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEML 599
           +M    L C    PS RP+ + +VE L
Sbjct: 310 EMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 31/256 (12%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFINEVAS----ISRTSHVNIVTLLG 385
           +G+G Y  V   +L     + A+KV+ +   + ++ I+ V +      + S    +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 386 FCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RG 443
            CF+   R  L+ E+V+ G L    H    ++  +KL  E     A  I   L +LH RG
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL--MFH----MQRQRKLPEEHARFYAAEICIALNFLHERG 116

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
               I++ D+K  N+LLD D   K++D+G+ K  EG     + +   GT  YIAPE+   
Sbjct: 117 ----IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEIL-- 168

Query: 504 NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDR---SSEIYF-------PHWVYKRLEL 553
              E  +  D ++ G+++FEM   ++  ++  D    ++E Y        P  + + L +
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSV 228

Query: 554 EEDLGLQGIENEEDKE 569
           +    L+G  N++ KE
Sbjct: 229 KASHVLKGFLNKDPKE 244

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 45/227 (19%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGF 386
           +G+G +G V+  +  D   V A+KVL ++   K N    +     I   +    +  L +
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68

Query: 387 CFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR-GC 444
            F+      L+ E++  G L   +  K         +    Y     +   L+ +H+ G 
Sbjct: 69  SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETARFY--IAELVLALDSVHKLGF 122

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAK----------ICEGRESIVSMTGAR---- 490
               +H DIKP NIL+D D   K++DFGL K                +++          
Sbjct: 123 ----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178

Query: 491 -------------GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                        GT  YIAPEV          + D +S G++++EM
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEM 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 37/216 (17%)

Query: 329 NKLGQGGYGGVYKGKLLD-GQNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLL 384
            ++G+G YG VYK +  D G+ VA+K +   NE +G     I E+  + + +H NIV L 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 385 GFC--------FEGHRRA--LIYEFVSN---GSLE-KFIHEKHPLETNQKLKWEVLYKIA 430
                      F+  + A  L++E++ +   G LE   +H     +  +    ++L    
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE--DHIKSFMKQLL---- 126

Query: 431 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR 490
                GL Y H       LH DIK  NILL+     K++DFGLA++    ES    T   
Sbjct: 127 ----EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKV 178

Query: 491 GTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            T+ Y  PE+     GE  Y    DV+S G ++ E+
Sbjct: 179 ITLWYRPPELL---LGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 38/222 (17%)

Query: 331 LGQGGYGGVYKGKLLDGQNV----AIKVLNETKGNGEDFINEVASISRT--SHVN----I 380
           LG G YG V+  + + G +     A+KVL +     +    E     R    HV     +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 381 VTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVG-IARGLE 438
           VTL  + F+   +  LI ++VS G  E F H    L        E   +   G I   LE
Sbjct: 68  VTL-HYAFQTEAKLHLILDYVSGG--EMFTH----LYQRDNFS-EDEVRFYSGEIILALE 119

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRESIVSMTGARGTIGYI 496
           +LH+     I++ DIK  NILLD +    ++DFGL+K  + E +E   S     GTI Y+
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC---GTIEYM 173

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFE---------MTGEKN 529
           APE+  R  G      D +S G+++FE         + GE+N
Sbjct: 174 APEII-RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 32/222 (14%)

Query: 319 DIKKMTN-SFK--NKLGQGGYGGVYKGKLLD-GQNVAIK-VLNETKGNGEDFINEVASIS 373
           DI +  N S+K  N +G G +G VY+   +D  + VAIK VL + +        E+  + 
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMK 114

Query: 374 RTSHVNIVTLLGF----CFEGHRRAL----IYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
             +H+NI+ L  +    CF+ + + +    + EF+   ++ K++  KH    N  L   +
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYM--KHYARNNHALPLFL 171

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICEGRESIV 484
           +   +  + R L Y+H   +  I H D+KP N+L+D +    K+ DFG AK     +  V
Sbjct: 172 VKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228

Query: 485 SMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           S   +R    Y APE+     G  +Y +  D++S G ++ EM
Sbjct: 229 SYICSR---FYRAPELM---LGATNYTTHIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 29/205 (14%)

Query: 331 LGQGGYGGVYKGKLL-DGQNVAIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLG 385
           LG+G +G V   +L   G+  A+KVL +       + E  + E   +S   +   +T L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 386 FCFEGHRRAL-IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RG 443
            CF+   R   + EFV+ G L   I +    +  +   +      A  I   L +LH +G
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY------AAEITSALMFLHDKG 116

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRESIVSMTGARGTIGYIAPEVF 501
               I++ D+K  N+LLD +   K++DFG+ K  I  G     + +   GT  YIAPE+ 
Sbjct: 117 ----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEI- 167

Query: 502 CRNFGEVSYKSDV--YSYGMMVFEM 524
                E+ Y   V  ++ G++++EM
Sbjct: 168 ---LQEMLYGPSVDWWAMGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 30/165 (18%)

Query: 368 EVASISRTSHVNIVTLLGFCFEG--------HRRALIYEFVSNGSLEKFIHEKHPLETNQ 419
           E   +   +H +++ +      G        H  + +Y +++            PL  +Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK--------RSRPLPIDQ 158

Query: 420 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG 479
            L       I   I  GL YLH     RI+H D+K  NI +++     I D G A+    
Sbjct: 159 ALI------IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV 208

Query: 480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                +  G  GT+   APEV  R+  + + K+D++S G+++FEM
Sbjct: 209 VAP--AFLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 56/231 (24%), Positives = 108/231 (46%), Gaps = 34/231 (14%)

Query: 331 LGQGGYGGVYKGK---LLDGQN-----VAIKVLNETKGN-GEDFINEVASISRTSHVNIV 381
           LGQG +  ++KG    + D        V +KVL+++  N  E F    + +S+ SH ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYL 440
              G C  G    ++ E+V  GSL+ ++ + K+ +  + KL      ++A  +A  L +L
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL------EVAKQLAWALHFL 116

Query: 441 HRGCNTRILHFDIKPHNILL--DEDFCP------KISDFGLAKICEGRESIVSMTGARGT 492
               +  + H ++   N+LL  +ED         K+SD G++     +E ++        
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE------R 167

Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF 543
           I ++ PE    N   +S  +D +S+G  ++E+    +    A+D   ++ F
Sbjct: 168 IPWVPPECI-ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF 217

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.9 bits (140), Expect = 1e-08
 Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 35/223 (15%)

Query: 330 KLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGE----DFINEVASISRTSHVNIVTLL 384
            +G+GG G VY     +  + VA+K + E           F+ E    +   H  IV + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 385 GFCFEGHRRALIYEFVSNGSLE---KFIHEKHPLETNQKLKWEV--LYKIAVGIARGLEY 439
             C +G        ++   +L+   K + +K  L      K  V     I   I   +EY
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 440 LH-RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI-----VSMTGAR--- 490
           +H +G    +LH D+KP NILL       I D+G A   +  E       V         
Sbjct: 129 VHSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 491 --------GTIGYIAPEVFCRNFG-EVSYKSDVYSYGMMVFEM 524
                   GT  Y+APE   R  G   S  +D+Y+ G+++++M
Sbjct: 185 MTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 25/203 (12%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNET---KGNGEDF-INEVASISRTSHVNIVTLLG 385
           LG+GG+G V   ++ + G+  A K L++    K +GE   + E   + + +   IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 386 FCFEGHRR-ALIYEFVSNGSLEKFIHE--KHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           + FE      L+   ++ G L+  I+   +  LE  +     V++  A  I  G+ +LH 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER-----VIHYSA-QITCGILHLH- 112

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICEGRESIVSMTGARGTIGYIAPEVF 501
             +  I++ D+KP N+LLD+    ++SD GLA ++ +G+    ++T   GT GY+APE+ 
Sbjct: 113 --SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEIL 166

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM 524
                  SY  D ++ G  ++EM
Sbjct: 167 KEE--PYSYPVDWFAMGCSIYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 43/212 (20%)

Query: 331 LGQGGYGGV---YKGKLLDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLL 384
           +G G YG V   Y  +L   Q VA+K L+   ++  +      E+  +    H N++ LL
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN------------QKLKWEVLYKIAVG 432
                         F    S+E F +E + L TN            QKL  E +  +   
Sbjct: 81  DV------------FTPATSIENF-NEVY-LVTNLMGADLNNIVKCQKLSDEHVQFLIYQ 126

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
           + RGL+Y+H   +  I+H D+KP N+ ++ED   +I DFGLA     R++   MTG   T
Sbjct: 127 LLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA-----RQADDEMTGYVAT 178

Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             Y APE+   N+   +   D++S G ++ E+
Sbjct: 179 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 69/262 (26%), Positives = 111/262 (42%), Gaps = 40/262 (15%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGF 386
           +G+G YG V        G+ VAIK +N+   +  D    + E+  +    H +IV +   
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE----VLYKIAVGIARGLEYLHR 442
                RR     +V    +E  +H+   ++ N  L  E     LY++     R L+Y+H 
Sbjct: 68  MLPPSRREFKDIYVVFELMESDLHQV--IKANDDLTPEHHQFFLYQLL----RALKYIH- 120

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVF 501
                + H D+KP NIL + D   KI DFGLA++      + +  T    T  Y APE+ 
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFP-HWVYKRLELEEDL-- 557
              F + +   D++S G +  E+ TG+               FP   V  +L+L  DL  
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKP-------------LFPGKNVVHQLDLITDLLG 225

Query: 558 -----GLQGIENEEDKEYARKM 574
                 +  + NE+ + Y   M
Sbjct: 226 TPSPETISRVRNEKARRYLSSM 247

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 51/171 (29%), Positives = 88/171 (51%), Gaps = 26/171 (15%)

Query: 433 IARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG 491
           +ARG+E+L  R C    +H D+   NILL E+   KI DFGLA+        V    AR 
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 492 TIGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVY 548
            + ++APE     F +V + +SDV+S+G++++E+   G      V ++            
Sbjct: 239 PLKWMAPESI---FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--------FC 287

Query: 549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
           +R  L++   ++  EN   + Y    I+++ W  Q +P +RP+ + +VE+L
Sbjct: 288 QR--LKDGTRMRAPENATPEIYR---IMLACW--QGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)

Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 115 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 167

Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 168 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 211

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 20/148 (13%)

Query: 381 VTLLGFCFEG-HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           +T L  CF+   R   + E+V+ G L   I +    +  Q     V Y  A  I+ GL +
Sbjct: 63  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA----VFY--AAEISVGLFF 116

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTIGYI 496
           LHR     I++ D+K  N++LD +   KI+DFG+ K     E +V     R   GT  YI
Sbjct: 117 LHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYI 168

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           APE+    +       D ++YG++++EM
Sbjct: 169 APEIIA--YQPYGKSVDWWAYGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 63/234 (26%), Positives = 106/234 (45%), Gaps = 19/234 (8%)

Query: 298 RNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNV-AIKVLN 356
           +NI+ FL  Y  +  ++ R   +K         +G+G +G V   +    Q V A+K+L+
Sbjct: 19  KNIDNFLNRYEKIV-RKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS 77

Query: 357 E---TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEK 412
           +    K +   F  E   I   ++   V  L   F+  +   ++ E++  G L   +   
Sbjct: 78  KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY 137

Query: 413 HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 472
              E     KW   Y   V +A  L+ +H   +  ++H D+KP N+LLD+    K++DFG
Sbjct: 138 DVPE-----KWAKFYTAEVVLA--LDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG 187

Query: 473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
                +    +V    A GT  YI+PEV     G+  Y  + D +S G+ +FEM
Sbjct: 188 TCMKMD-ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 55.3 bits (134), Expect = 3e-08
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 42/214 (19%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDF----INEVASISRTSHVNIVTL 383
           N++ +G YG VY+ +    G+ VA+K L   K   E F    + E+  + +  H NIVT 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLKLQHPNIVT- 68

Query: 384 LGFCFEGHRRALIYEFVSNGSLEK-FI------HE-KHPLETNQK--LKWEVLYK-IAVG 432
                       + E V   +L+K ++      H+ K  +ET ++  L+ EV  K + + 
Sbjct: 69  ------------VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV--KCLMLQ 114

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
           +  G+ +LH      ILH D+K  N+LL+     KI DFGLA+       +   T    T
Sbjct: 115 LLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQLVVT 169

Query: 493 IGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
           + Y APE+     G   Y    D++S G +  E+
Sbjct: 170 LWYRAPELL---LGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 28/204 (13%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFINEVASISRTSHV------NIVTL 383
           LG+G +G V   +        A+K+L +     +D   EVA     S V        +T 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKD---EVAHTLTESRVLQNTRHPFLTA 59

Query: 384 LGFCFEGHRR-ALIYEFVSNGSLEKFIHEKHP-LETNQKLKWEVLYKIAVGIARGLEYLH 441
           L + F+ H R   + E+ + G L  F H     + +  + ++         I   L YLH
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARF-----YGAEIVSALGYLH 112

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
                 +++ D+K  N++LD+D   KI+DFGL K  EG     +M    GT  Y+APEV 
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL 167

Query: 502 CRN-FGEVSYKSDVYSYGMMVFEM 524
             N +G      D +  G++++EM
Sbjct: 168 EDNDYGRA---VDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 30/153 (19%)

Query: 381 VTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           +T L  CF+   R   + E+V+ G L   I +        K K       A  IA GL +
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFF 116

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTIGYI 496
           LH   +  I++ D+K  N++LD +   KI+DFG+ K     E+I      R   GT  YI
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFCGTPDYI 168

Query: 497 APEVFCRNFGEVSYKS-----DVYSYGMMVFEM 524
           APE+       ++Y+      D +++G++++EM
Sbjct: 169 APEI-------IAYQPYGKSVDWWAFGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.1 bits (132), Expect = 4e-08
 Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 23/207 (11%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFINEVAS----ISRTSHVNIVTLLG 385
           +G+G Y  V   +L   + + A+KV+ +   N ++ I+ V +      + S+   +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 386 FCFEGHRRAL-IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RG 443
            CF+   R   + E+V+ G L    H    ++  +KL  E     +  I+  L YLH RG
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL--MFH----MQRQRKLPEEHARFYSAEISLALNYLHERG 116

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-C 502
               I++ D+K  N+LLD +   K++D+G+ K  EG     + +   GT  YIAPE+   
Sbjct: 117 ----IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 503 RNFGEVSYKSDVYSYGMMVFEMTGEKN 529
            ++G   +  D ++ G+++FEM   ++
Sbjct: 171 EDYG---FSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 32/168 (19%)

Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI---AVGIARGLEYLHRGCNTRILHF 451
            + EF++ G L   I +K   +         LY+    A  I  GL++LH   +  I++ 
Sbjct: 73  FVMEFLNGGDLMFHIQDKGRFD---------LYRATFYAAEIVCGLQFLH---SKGIIYR 120

Query: 452 DIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTIGYIAPEVFCRNFGEV 508
           D+K  N++LD D   KI+DFG+ K     E++     A    GT  YIAPE+      + 
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRASTFCGTPDYIAPEIL--QGLKY 173

Query: 509 SYKSDVYSYGMMVFEMT-------GEKNNANVAVDRSSEIYFPHWVYK 549
           ++  D +S+G++++EM        G+  +      R    ++P W+ K
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITK 221

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.5 bits (131), Expect = 7e-08
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 32/206 (15%)

Query: 331 LGQGGYGGVYKG-KLLDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLL-- 384
           +G G YG V        G+ VAIK L+   +++   +    E+  +    H N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 385 ------GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
                 G  F+     + Y       L+K +      +  Q L +++L         GL+
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQML--------CGLK 131

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           Y+H      I+H D+KP N+ ++ED   KI DFGLA     R +   MTG   T  Y AP
Sbjct: 132 YIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWYRAP 183

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM 524
           EV   N+   +   D++S G ++ EM
Sbjct: 184 EVIL-NWMHYNQTVDIWSVGCIMAEM 208

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 27/204 (13%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFINEVASISRTSHV-----NIVTLL 384
           +G+G Y  V   +L   + + A+KV+ +   N ++ I+ V +     HV     N   L+
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQT---EKHVFETASNHPFLV 59

Query: 385 GF--CFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
           G   CF+   R   + EFVS G L    H    ++  +KL  E     +  I+  L +LH
Sbjct: 60  GLHSCFQTESRLFFVIEFVSGGDL--MFH----MQRQRKLPEEHARFYSAEISLALNFLH 113

Query: 442 -RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
            RG    I++ D+K  N+LLD +   K++D+G+ K  EG     + +   GT  YIAPE+
Sbjct: 114 ERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEI 167

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM 524
                 +  +  D ++ G+++FEM
Sbjct: 168 L--RGEDYGFSVDWWALGVLMFEM 189

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.4 bits (131), Expect = 8e-08
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 31/242 (12%)

Query: 296 NYRNIEAFLRNY----GSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNV- 350
             +NI+ FL  Y      +   R +  D   +       +G+G +G V   +    + V 
Sbjct: 17  KNKNIDNFLSRYEKAAEKITKLRMKAEDFDVI-----KVIGRGAFGEVQLVRHKSSKQVY 71

Query: 351 AIKVLNE---TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLE 406
           A+K+L++    K +   F  E   I   ++   +  L + F+  +   ++ E++  G L 
Sbjct: 72  AMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV 131

Query: 407 KFIHEKHPLETNQKL--KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
                   L +N  +  KW   Y   V +A  L+ +H   +   +H D+KP N+LLD+  
Sbjct: 132 N-------LMSNYDIPEKWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSG 179

Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVF 522
             K++DFG   +      +V    A GT  YI+PEV     G+  Y  + D +S G+ ++
Sbjct: 180 HLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238

Query: 523 EM 524
           EM
Sbjct: 239 EM 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 27/204 (13%)

Query: 331 LGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFIN----EVASISRTSHVNIVTLLG 385
           LG+G +G V+  +L    Q  AIK L +     +D +     E   +S       +T L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61

Query: 386 FCFEGHRRALIY--EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           +C    +  L +  E+++ G L   I   H  +    L     Y  A  I  GL++LH  
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFD----LPRATFY--AAEIICGLQFLH-- 113

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAK---ICEGRESIVSMTGARGTIGYIAPEV 500
            +  I++ D+K  NILLD D   KI+DFG+ K   + + +          GT  YIAPE+
Sbjct: 114 -SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-----GTPDYIAPEI 167

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM 524
                 + +   D +S+G++++EM
Sbjct: 168 LLGQ--KYNTSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 54.3 bits (130), Expect = 9e-08
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 16/160 (10%)

Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  ++
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQI 104

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++      + I S
Sbjct: 105 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLIDS 157

Query: 486 MTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           M  +  GT  Y++PE         S +SD++S G+ + EM
Sbjct: 158 MANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 27/212 (12%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDF--INEVASISRTSHVNIVTLLG-F 386
           K+G+G YG VYK K  DG++     L + +G G       E+A +    H N+++L   F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 387 CFEGHRRA-LIYEFVSNG--SLEKFIH----EKHPLETNQKLKWEVLYKIAVGIARGLEY 439
                R+  L++++  +    + KF       K P++  + +   +LY+I  GI     Y
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI----HY 123

Query: 440 LHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICEGR-ESIVSMTGARGTIG 494
           LH      +LH D+KP NIL+     E    KI+D G A++     + +  +     T  
Sbjct: 124 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 495 YIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           Y APE+     G   Y    D+++ G +  E+
Sbjct: 181 YRAPELL---LGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 26/187 (13%)

Query: 421 LKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG 479
           L  E L   +  +A+G+ +L  + C    +H D+   NILL      KI DFGLA+    
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 480 RESIVSMTGARGTIGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEM--TGEKNNANVAVD 536
             + V    AR  + ++APE     F  V +++SDV+SYG++++E+   G      + VD
Sbjct: 267 DSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323

Query: 537 RSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVV 596
                      YK ++       +G      +    +M  +   C   +P  RP+  ++V
Sbjct: 324 SK--------FYKMIK-------EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368

Query: 597 EMLEGSL 603
           +++E  L
Sbjct: 369 QLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding

 Score = 49.9 bits (120), Expect = 1e-07
 Identities = 24/69 (34%), Positives = 32/69 (46%), Gaps = 6/69 (8%)

Query: 48  KTCGDGQSISFPFYIENQQEAYCGY-PGFNLSCNDKGNPVLKLSSDTNYIVEKILYDNHS 106
             CG+  SI +PF I       C   PGF L+CN+  +P   L  + NY V  I   N +
Sbjct: 6   DRCGN-VSIPYPFGIGPG----CARDPGFELTCNNTTSPPRLLLGNGNYEVLSISLANGT 60

Query: 107 VLVSNAAFS 115
           V V +   S
Sbjct: 61  VRVLDPISS 69

This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 52/229 (22%)

Query: 331 LGQGGYGGVYKGKLL-----------------------DGQN--VAIKVLNETKGNGEDF 365
           LGQG    +Y G+L                        +G+   V +KVL+ +  +    
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 366 INEVASI-SRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
             E AS+ S+ SH+++  + G C  G    ++ EFV +G L+  + +       +K +  
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-------EKGRVP 115

Query: 425 VLYKIAVG--IARGLEYLHRGCNTRILHFDIKPHNIL-----LDEDFCP--KISDFGLAK 475
           V +KI V   +A  L YL    +  ++H ++   NIL     L E   P  K+SD G++ 
Sbjct: 116 VAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF 172

Query: 476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
               RE  V        I +IAPE        +S  +D +S+G  + E+
Sbjct: 173 TALSREERVE------RIPWIAPECV-PGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 19/234 (8%)

Query: 298 RNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNV-AIKVLN 356
           +NI+ FL  Y     K  R   +K         +G+G +G V   +    + V A+K+L+
Sbjct: 19  KNIDNFLNRYKDTINK-IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS 77

Query: 357 E---TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEK 412
           +    K +   F  E   I   ++   V  L + F+  R   ++ E++  G L   +   
Sbjct: 78  KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY 137

Query: 413 HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG 472
              E     KW   Y   V +A  L+ +H   +   +H D+KP N+LLD+    K++DFG
Sbjct: 138 DVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Query: 473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
              +   +E +V    A GT  YI+PEV     G+  Y  + D +S G+ ++EM
Sbjct: 188 TC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 70/263 (26%), Positives = 114/263 (43%), Gaps = 33/263 (12%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDF--INEVASISRTSHVNIVTLLG-F 386
           K+G+G YG VYK K  DG++     L + +G G       E+A +    H N++ L   F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 387 CFEGHRRA-LIYEFVSNG--SLEKFIH----EKHPLETNQKLKWEVLYKIAVGIARGLEY 439
                R+  L++++  +    + KF       K P++  + +   +LY+I  GI     Y
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI----HY 123

Query: 440 LHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICEGR-ESIVSMTGARGTIG 494
           LH      +LH D+KP NIL+     E    KI+D G A++     + +  +     T  
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 495 YIAPEVFCRNFGEVSYKS--DVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRL 551
           Y APE+     G   Y    D+++ G +  E +T E        D  +   F H      
Sbjct: 181 YRAPELL---LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH-----D 232

Query: 552 ELEEDLGLQGIENEEDKEYARKM 574
           +L+    + G   ++D E  RKM
Sbjct: 233 QLDRIFSVMGFPADKDWEDIRKM 255

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLG 385
           +G+G +G VY+ +  D + + A+KVL++     K      I E   + RT       ++G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 386 FCFEGHRRA---LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
             F     +   L+ +++S G L  F H +     ++       + IA  +   LE+LH+
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSED---RAKFYIA-ELVLALEHLHK 114

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
                I++ D+KP NILLD      + DFGL+K         +     GT  Y+APEV  
Sbjct: 115 ---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEYLAPEVLL 169

Query: 503 RNFGEVSYKSDVYSYGMMVFEM 524
              G  +   D +S G++VFEM
Sbjct: 170 DEKG-YTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 20/200 (10%)

Query: 331 LGQGGYG-GVYKGKLLDGQNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLL-GF 386
           +G+G +G  +    +   Q  A+K   L ++    ED   E   +++  H NIV     F
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 387 CFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGC 444
             +GH   ++ E+   G L +K   ++  L      L+W       V +  G++++H   
Sbjct: 68  EADGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHE-- 118

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
             R+LH DIK  NI L ++   K+ DFG A++     +        GT  Y+ PE++  N
Sbjct: 119 -KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEIW-EN 174

Query: 505 FGEVSYKSDVYSYGMMVFEM 524
               + KSD++S G +++E+
Sbjct: 175 M-PYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 23/202 (11%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFIN----EVASISRTSHVNIVTLLG 385
           LG+G +G V   +L     V AIKVL +     +D ++    E   ++  +    +T L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 386 FCFEGHRRAL-IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            CF+   R   + E+V+ G L   I      +  +       Y   V +A  L +LHR  
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS----RFYAAEVTLA--LMFLHR-- 114

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
              +++ D+K  NILLD +   K++DFG+ K  EG  + V+ T   GT  YIAPE+    
Sbjct: 115 -HGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEI---- 167

Query: 505 FGEVSYKSDV--YSYGMMVFEM 524
             E+ Y   V  ++ G++++EM
Sbjct: 168 LQELEYGPSVDWWALGVLMYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 22/162 (13%)

Query: 396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
           + E+++ G L   I      +          Y  A  I  GL++LH+     I++ D+K 
Sbjct: 74  VMEYLNGGDLMFHIQSSGRFD----EARARFY--AAEIICGLQFLHK---KGIIYRDLKL 124

Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-DV 514
            N+LLD+D   KI+DFG+ K     E   S     GT  YIAPE+     G+   +S D 
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGKASTFC--GTPDYIAPEIL---KGQKYNESVDW 179

Query: 515 YSYGMMVFEM-------TGEKNNANVAVDRSSEIYFPHWVYK 549
           +S+G++++EM        GE  +       +   +FP W+ K
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISK 221

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 35/222 (15%)

Query: 331 LGQGGYGGVYKGKLLDGQNV----AIKVLN-----ETKGNGEDFINEVASISRTSHVNIV 381
           LG G YG V+  + + G +     A+KVL      +     E    E   +        +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 382 TLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVG-IARGLEY 439
             L + F+   +  LI ++++ G L  F H    L   ++ K E   +I  G I   LE+
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGEL--FTH----LSQRERFK-EQEVQIYSGEIVLALEH 120

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRESIVSMTGARGTIGYIA 497
           LH+     I++ DIK  NILLD +    ++DFGL+K    +  E   S     GTI Y+A
Sbjct: 121 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC---GTIEYMA 174

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEM---------TGEKNN 530
           P++     G      D +S G++++E+          GEKN+
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 28/205 (13%)

Query: 331 LGQGGYGGVYKGKLLDGQN-VAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGF 386
           +G+G YG V K +  + +  VAIK   +++ N    E  + E+  +      NIV L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK-- 66

Query: 387 CFEGHRRA----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
             E  RR     L++E+V    LE  + E+ P     +     +Y++     + + + H+
Sbjct: 67  --EAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI----KAIHWCHK 118

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVF 501
                I+H DIKP N+L+  +   K+ DFG A+ + EG  +  + T    T  Y +PE+ 
Sbjct: 119 ---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--NYTEYVATRWYRSPELL 173

Query: 502 CRNFGEVSYKS-DVYSYGMMVFEMT 525
               G    K+ D++S G ++ E++
Sbjct: 174 ---LGAPYGKAVDMWSVGCILGELS 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 45/196 (22%), Positives = 89/196 (45%), Gaps = 26/196 (13%)

Query: 339 VYKGKLLDGQNVAIKVL----NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGH--- 391
           +YKG   + + V I+         K   +   NE+ ++ R    NI+ + GF  +     
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 392 -RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILH 450
            R +LI E+ + G L +       L+  + L ++    +A+   +GL  L++  N    +
Sbjct: 95  PRLSLILEYCTRGYLREV------LDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146

Query: 451 FDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR--GTIGYIAPEVFCRNFGEV 508
            ++   + L+ E++  KI       IC G E I+S    +    + Y + ++    F E 
Sbjct: 147 KNLTSVSFLVTENYKLKI-------ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY 199

Query: 509 SYKSDVYSYGMMVFEM 524
           + K D+YS G++++E+
Sbjct: 200 TIKDDIYSLGVVLWEI 215

Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 44/193 (22%), Positives = 91/193 (47%), Gaps = 26/193 (13%)

Query: 416 ETNQKLKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 474
           E +  L  + L + +  +A+G+++L  + C    +H D+   N+LL +    KI DFGLA
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLA 259

Query: 475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEM--TGEKNNA 531
           +      + V    AR  + ++APE     F  V + +SDV+SYG++++E+   G+    
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESI---FDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316

Query: 532 NVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
            + V+           YK ++       +G +         ++  +   C    P++RP+
Sbjct: 317 GILVNSK--------FYKMVK-------RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT 361

Query: 592 MNRVVEMLEGSLD 604
            +++ ++++  L 
Sbjct: 362 FSQISQLIQRQLG 374

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 19/200 (9%)

Query: 331 LGQGGYGGVYKGKL-LDGQNVAIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLG 385
           +G+G +G V   K  LDG+  A+KVL +     +   +  + E   + +      +  L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 386 FCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           + F+   +   + +FV+ G L  F H    L+  +          A  IA  L YLH   
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL--FFH----LQRERSFPEPRARFYAAEIASALGYLH--- 113

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
           +  I++ D+KP NILLD      ++DFGL K  EG     + T   GT  Y+APEV  + 
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 505 FGEVSYKSDVYSYGMMVFEM 524
                   D +  G +++EM
Sbjct: 172 --PYDNTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 44/196 (22%)

Query: 347 GQNVAIKVLNETKGNGEDFIN---------EVASISRTSHVNIVTLLGFCFEGHRRA--- 394
           GQNVAIK L+        F N         E+  +   +H NI+ LL   F   +     
Sbjct: 41  GQNVAIKKLSRP------FQNVTHAKRAYRELVLMKLVNHKNIIGLLN-VFTPQKSLEEF 93

Query: 395 ----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILH 450
               L+ E + + +L + I     ++ + +    +LY++  GI    ++LH   +  I+H
Sbjct: 94  QDVYLVMELM-DANLCQVIQ----MDLDHERMSYLLYQMLCGI----KHLH---SAGIIH 141

Query: 451 FDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY 510
            D+KP NI++  D   KI DFGLA+          MT    T  Y APEV     G + Y
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVI---LG-MGY 194

Query: 511 KS--DVYSYGMMVFEM 524
           K   D++S G ++ EM
Sbjct: 195 KENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 11/90 (12%)

Query: 437 LEYLHRGCNTRILHFDIKPHNILLD--EDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
           ++Y+H      I+H DIK  N+L++  ED C  + DFG A    G  S     G  GT+ 
Sbjct: 273 IDYIHG---EGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 495 YIAPEVFCRNFGEVSYKS-DVYSYGMMVFE 523
             APEV     G+    S D++S G+++FE
Sbjct: 328 TNAPEVLA---GDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 25/203 (12%)

Query: 331 LGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLG 385
           +G+G +G V   K   DG   A+KVL +     K      + E   + +      +  L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 386 FCFE-GHRRALIYEFVSNGSLEKFIH---EKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
           + F+   +   + ++V+ G L  F H   E+  LE   +         A  +A  + YLH
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARF-------YAAEVASAIGYLH 113

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
              +  I++ D+KP NILLD      ++DFGL K  EG E   + +   GT  Y+APEV 
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVL 168

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM 524
            +         D +  G +++EM
Sbjct: 169 RKE--PYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 43/233 (18%)

Query: 326 SFK--NKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVAS----ISRTSHV 378
            FK    LG+G  G V+  +L   G+  A+KVL++ +    + +  V +    ++   H 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
            + TL           L+ ++   G L + + ++ P    + L  EV    A  +   LE
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLL-QRQP---GKCLSEEVARFYAAEVLLALE 117

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--------------------- 477
           YLH      I++ D+KP NILL E     +SDF L+K                       
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 478 -EGRESIVSMTGAR-----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
               E+       R     GT  YIAPEV     G      D ++ G++++EM
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVI-SGDGH-GSAVDWWTLGILLYEM 225

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 4/43 (9%)

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKI 476
           RGL+Y+H   +  +LH D+KP N+ ++ ED   KI DFGLA+I
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 20/109 (18%)

Query: 429 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--DFCPKISDFGLA----KICEGRES 482
           I   + R ++YLH     RI+H DIK  NI ++   D C  + DFG A     I   +  
Sbjct: 187 IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVC--LGDFGAACFPVDINANK-- 239

Query: 483 IVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNN 530
                G  GTI   APE+  R+ +G      D++S G+++FEM    ++
Sbjct: 240 ---YYGWAGTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATCHDS 282

Length = 391

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 30/106 (28%)

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMT--------- 487
           LEYLH   N  I+H D+KP N+L+      K++DFGL+KI      ++S+T         
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI-----GLMSLTTNLYEGHIE 165

Query: 488 -GAR--------GTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFE 523
              R        GT  YIAPEV  R  +G+     D ++ G++++E
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 14/145 (9%)

Query: 381 VTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           +T L  CF+   R   + E+V+ G L   I +        K    V Y  A  IA GL +
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRF----KEPHAVFY--AAEIAIGLFF 116

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           LH   +  I++ D+K  N++LD +   KI+DFG+ K  E     V+     GT  YIAPE
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE 171

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM 524
           +    +       D +++G++++EM
Sbjct: 172 IIA--YQPYGKSVDWWAFGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 35/214 (16%)

Query: 331 LGQGGYGGV-YKGKLLDGQNVAIKVLNETKGNGEDFIN----EVASISRTSHVNIVTLLG 385
           LG G  G V    ++ DG+  A+KV+ + +G  E   N    EV  +      +IV    
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVV-DMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95

Query: 386 FCFEGHRR------------ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGI 433
            C E   +            AL+ ++ + G L + I  K   +TN+  +      + + +
Sbjct: 96  -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI--KSRAKTNRTFREHEAGLLFIQV 152

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR--- 490
              + ++H   +  ++H DIK  NILL  +   K+ DFG +K+     + VS    R   
Sbjct: 153 LLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKM---YAATVSDDVGRTFC 206

Query: 491 GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           GT  Y+APE++ R     S K+D++S G++++E+
Sbjct: 207 GTPYYVAPEIWRRK--PYSKKADMFSLGVLLYEL 238

Length = 496

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 39/225 (17%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKG--KLLDGQNVAIKVLN---ETKGNGEDFINEVA 370
           RY ++K         +G G  G V      +LD +NVAIK L+   + + + +    E+ 
Sbjct: 18  RYQNLKP--------IGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELV 68

Query: 371 SISRTSHVNIVTLLGF-----CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
            +   +H NI++LL         E  +   +   + + +L + I     +E + +    +
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYL 124

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           LY++  GI    ++LH   +  I+H D+KP NI++  D   KI DFGLA+      +   
Sbjct: 125 LYQMLCGI----KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFM 174

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
           MT    T  Y APEV       + YK   D++S G ++ EM   K
Sbjct: 175 MTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)

Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYK-IAVG-----IARGLEYLHRGCNTRI 448
           LI E+ S G L K I         Q+LK  + ++   VG     I   L+ +H   + ++
Sbjct: 142 LIMEYGSGGDLNKQI--------KQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKM 190

Query: 449 LHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV 508
           +H D+K  NI L      K+ DFG +K      S+   +   GT  Y+APE++ R     
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RY 248

Query: 509 SYKSDVYSYGMMVFEM 524
           S K+D++S G++++E+
Sbjct: 249 SKKADMWSLGVILYEL 264

Length = 478

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 52/188 (27%), Positives = 90/188 (47%), Gaps = 28/188 (14%)

Query: 347 GQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYE 398
           G NVA+K L+   + + + +    E+  +   +H NI++LL         E  +   +  
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 458
            + + +L + IH    +E + +    +LY++  GI    ++LH   +  I+H D+KP NI
Sbjct: 106 ELMDANLCQVIH----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNI 154

Query: 459 LLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYS 516
           ++  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S
Sbjct: 155 VVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWS 207

Query: 517 YGMMVFEM 524
            G ++ E+
Sbjct: 208 VGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 5/92 (5%)

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
           +ARG+E+L    +   +H D+   N+LL +    KI DFGLA+      + VS       
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           + ++APE    N    +  SDV+SYG++++E+
Sbjct: 303 VKWMAPESIFDNL--YTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 45.9 bits (108), Expect = 6e-05
 Identities = 62/242 (25%), Positives = 98/242 (40%), Gaps = 34/242 (14%)

Query: 316 RYADIKKMTNSFK--NKLGQGGYGGVYKGKLLDGQNV----AIKVLNETKGNGEDFINEV 369
           +Y D +   N ++   K+G G +G V+  K    Q      AI      +      + EV
Sbjct: 4   KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEV 63

Query: 370 ASISRTSHVNIVTLLG-FCFEGHRRALI-YEFVSNGSLEKFIHEKHPLETNQKLKWEVLY 427
             +    H NIV  +  F  + +++  I  EF   G L + I + + +    K++   + 
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG--KIEEHAIV 121

Query: 428 KIAVGIARGLEYLHR---GCN-TRILHFDIKPHNILLDEDF-----------------CP 466
            I   +   L Y H    G N  R+LH D+KP NI L                       
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
           KI DFGL+K   G ES+       GT  Y +PE+          KSD+++ G +++E+  
Sbjct: 182 KIGDFGLSKNI-GIESMAH--SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 527 EK 528
            K
Sbjct: 239 GK 240

Length = 1021

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 7/95 (7%)

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  IA  L YLH   +  I++ D+KP NILLD      ++DFGL K  E  E   + +  
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTF 156

Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            GT  Y+APEV  +         D +  G +++EM
Sbjct: 157 CGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 35/125 (28%), Positives = 48/125 (38%), Gaps = 49/125 (39%)

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--------------------- 475
           L Y+HR         DIKP N+LLD     K+SDFGL                       
Sbjct: 120 LGYIHR---------DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 476 ----ICEGRES---IVSMTGAR--------GTIGYIAPEVFCRN-FGEVSYKSDVYSYGM 519
               I +   S     +    R        GT  YIAPEVF +  + +     D +S G+
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE---CDWWSLGV 227

Query: 520 MVFEM 524
           +++EM
Sbjct: 228 IMYEM 232

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 47/196 (23%), Positives = 79/196 (40%), Gaps = 35/196 (17%)

Query: 347 GQNVAIKVLNETKGNGEDF---INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           G  V +++ +      E      NEV       H NI+T       G    +I  F++ G
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR-GCNTRILHFDIKPHNILLDE 462
           S    +    P   ++ L   +L+    G  RGL YLH+ G     +H +IK  +IL+  
Sbjct: 85  SANSLLKTYFPEGMSEALIGNILF----GALRGLNYLHQNGY----IHRNIKASHILISG 136

Query: 463 DFCPKISDFGLAKICEGRESIVSMT--GARGTIGY------------IAPEVFCRNFGEV 508
           D        GL  +  G   + S+   G +  + Y            ++PE+  ++    
Sbjct: 137 D--------GLVSL-SGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY 187

Query: 509 SYKSDVYSYGMMVFEM 524
           + KSD+YS G+   E+
Sbjct: 188 NVKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 44/195 (22%)

Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           +NVAIK L+   + + + +    E+  +   +H NI+ LL              F    S
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97

Query: 405 LEKF-----IHEKHPLETNQKLKWEV--------LYKIAVGIARGLEYLHRGCNTRILHF 451
           LE+F     + E       Q ++ E+        LY++  GI    ++LH   +  I+H 
Sbjct: 98  LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI----KHLH---SAGIIHR 150

Query: 452 DIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYK 511
           D+KP NI++  D   KI DFGLA+      +   MT    T  Y APEV       + YK
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYK 203

Query: 512 S--DVYSYGMMVFEM 524
              D++S G ++ EM
Sbjct: 204 ENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.9 bits (102), Expect = 2e-04
 Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 25/138 (18%)

Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           LI +++ +G L   + ++  L    ++K     KI   +   L  LH      I+H DIK
Sbjct: 86  LIMDYIKDGDLFDLLKKEGKLSE-AEVK-----KIIRQLVEALNDLH---KHNIIHNDIK 136

Query: 455 PHNILLDEDFCPK----ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY 510
             N+L D     K    + D+GL KI  G  S        GT+ Y +PE    +  +VS+
Sbjct: 137 LENVLYDR---AKDRIYLCDYGLCKI-IGTPSCY-----DGTLDYFSPEKIKGHNYDVSF 187

Query: 511 KSDVYSYGMMVFEM-TGE 527
             D ++ G++ +E+ TG+
Sbjct: 188 --DWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 21/49 (42%), Positives = 32/49 (65%), Gaps = 3/49 (6%)

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE 481
           +A  L+YLHR     I+H D+KP N+L+  +   K++DFGL+K+   RE
Sbjct: 113 VALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 25/206 (12%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNE---TKGNGEDFINEVASISRTSHVNIVTLLGF 386
           +G+G +G V   KL +   V A+K+LN+    K        E   +        +T L +
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 387 CFEGHRRA-LIYEFVSNGSLEKFI---HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
            F+      L+ ++   G L   +    ++ P +  +    E++  IA+     L Y+HR
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV--IAIDSVHQLHYVHR 126

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFG-LAKICEGRESIVSMTGARGTIGYIAPEVF 501
                    DIKP NIL+D +   +++DFG   K+ E  +  V  + A GT  YI+PE+ 
Sbjct: 127 ---------DIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSSVAVGTPDYISPEIL 175

Query: 502 -CRNFGEVSY--KSDVYSYGMMVFEM 524
                G+  Y  + D +S G+ ++EM
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 27/132 (20%)

Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILHFDIKPHNILLDED 463
           L  ++    PL   Q         I   +   L YLH RG    I+H D+K  NI LDE 
Sbjct: 172 LFTYVDRSGPLPLEQ------AITIQRRLLEALAYLHGRG----IIHRDVKTENIFLDEP 221

Query: 464 FCPKISDFGLAKICEGRESIVSMT--GARGTIGYIAPEV-----FCRNFGEVSYKSDVYS 516
               + DFG A  C+      +    G  GT+   +PE+     +C        K+D++S
Sbjct: 222 ENAVLGDFGAA--CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA-------KTDIWS 272

Query: 517 YGMMVFEMTGEK 528
            G+++FEM+ + 
Sbjct: 273 AGLVLFEMSVKN 284

Length = 392

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 26/81 (32%), Positives = 45/81 (55%), Gaps = 4/81 (4%)

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR--- 503
             +H DIKP N+LLD +   +++DFG + +   ++  V  + A GT  YI+PE+      
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 504 NFGEVSYKSDVYSYGMMVFEM 524
             G+   + D +S G+ ++EM
Sbjct: 181 GMGKYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 46/213 (21%), Positives = 79/213 (37%), Gaps = 38/213 (17%)

Query: 331 LGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFI---NEVASISRTSHVNIVTLLGFC 387
                   + K K      VA+K +N    + ED      E+ +  +  H NI+  +   
Sbjct: 10  FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TS 67

Query: 388 F-EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR-GCN 445
           F       ++   ++ GS E  +    P    + L    +  I   +   L+Y+H  G  
Sbjct: 68  FIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYIHSKGF- 122

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM--------------TGARG 491
              +H  +K  +ILL  D        G   +   R S VSM                +  
Sbjct: 123 ---IHRSVKASHILLSGD--------GKVVLSGLRYS-VSMIKHGKRQRVVHDFPKSSVK 170

Query: 492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            + +++PEV  +N    + KSD+YS G+   E+
Sbjct: 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 30/105 (28%), Positives = 54/105 (51%), Gaps = 7/105 (6%)

Query: 421 LKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG 479
           L +  L   +  +A G+E+L  + C    +H D+   N+L+ E    KI DFGLA+    
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMR 291

Query: 480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             + +S       + ++APE    N    +  SDV+S+G++++E+
Sbjct: 292 DSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 48/183 (26%), Positives = 70/183 (38%), Gaps = 55/183 (30%)

Query: 381 VTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           V  + + F+  R   LI EF+  G +   + +K  L       +     +A+     L +
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE------------------ 481
           +HR         DIKP N+LLD     K+SDFGL   C G +                  
Sbjct: 123 IHR---------DIKPDNLLLDAKGHVKLSDFGL---CTGLKKAHRTEFYRNLTHNPPSD 170

Query: 482 -SIVSMTGAR-----------------GTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMV 521
            S  +M   R                 GT  YIAPEVF     +  Y    D +S G+++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM----QTGYNKLCDWWSLGVIM 226

Query: 522 FEM 524
           +EM
Sbjct: 227 YEM 229

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.0 bits (98), Expect = 7e-04
 Identities = 44/168 (26%), Positives = 65/168 (38%), Gaps = 54/168 (32%)

Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           LI EF+  G +   + +K  L   +   +     +A+     L ++HR         DIK
Sbjct: 78  LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR---------DIK 128

Query: 455 PHNILLDEDFCPKISDFGLAKICEGRE-------------------SIVSMTGAR----- 490
           P N+LLD     K+SDFGL   C G +                   +  +M   R     
Sbjct: 129 PDNLLLDSKGHVKLSDFGL---CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185

Query: 491 ------------GTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
                       GT  YIAPEVF +      Y    D +S G++++EM
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVFMQT----GYNKLCDWWSLGVIMYEM 229

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 41.7 bits (98), Expect = 8e-04
 Identities = 29/80 (36%), Positives = 43/80 (53%), Gaps = 5/80 (6%)

Query: 449 LHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC--RNFG 506
           +H DIKP N+L+D     K++DFG A      + + S     GT  YIAPEV       G
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDG 182

Query: 507 EVSY--KSDVYSYGMMVFEM 524
           + +Y  + D +S G++ +EM
Sbjct: 183 KGTYGVECDWWSLGVIAYEM 202

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 31/220 (14%)

Query: 331 LGQGGYGGVY----------------KGKLLDGQNVAIKVLNETKGNGEDFINEVASISR 374
           +G GG+G VY                K + L+ + + ++ L        D I    +I  
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79

Query: 375 TSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYK-IAVGI 433
             H+ I    G C    R  + Y F+    LEK +     +    K K + L K I   +
Sbjct: 80  IDHLGIPKYYG-CGSFKRCRMYYRFIL---LEKLVENTKEIFKRIKCKNKKLIKNIMKDM 135

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRE---SIVSMTG 488
              LEY+H      I H DIKP NI++D +    I D+G+A   I  G+    S      
Sbjct: 136 LTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL 192

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
            RGT+ Y   +    N   V+ + D+ S G  + +  G K
Sbjct: 193 HRGTLYYAGLD--AHNGACVTRRGDLESLGYCMLKWAGIK 230

Length = 294

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 35/131 (26%), Positives = 49/131 (37%), Gaps = 50/131 (38%)

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL----------------------- 473
           +E +H       +H DIKP NIL+D D   K++DFGL                       
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 474 -------AKICEGRESIVSMTGAR-----------GTIGYIAPEVFCRNFGEVSYKS--D 513
                  ++I   R   +     R           GT  YIAPEV  R      Y    D
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR----TGYTQLCD 226

Query: 514 VYSYGMMVFEM 524
            +S G++++EM
Sbjct: 227 WWSVGVILYEM 237

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 30/120 (25%), Positives = 45/120 (37%), Gaps = 47/120 (39%)

Query: 449 LHFDIKPHNILLDEDFCPKISDFGLA-------------KICEGRESIVSMTGAR----- 490
           +H DIKP NIL+D     K+SDFGL+             K+ +G+ +   +         
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 491 ---------------------------GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
                                      GT  YIAPE+F +       + D +S G ++FE
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	638
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
PRK10345	210	hypothetical protein; Provisional	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
PF13947	106	GUB_WAK_bind: Wall-associated receptor kinase gala	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.75
smart00090	237	RIO RIO-like kinase.	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
PF14380	94	WAK_assoc: Wall-associated receptor kinase C-termi	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.3
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
KOG1243	690	consensus Protein kinase [General function predict	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.09
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.02
KOG3087	229	consensus Serine/threonine protein kinase [General	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
COG4248	637	Uncharacterized protein with protein kinase and he	98.97
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.89
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.82
PRK09902	216	hypothetical protein; Provisional	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.41
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.32
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.31
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.3
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.22
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.17
PF01636	239	APH: Phosphotransferase enzyme family This family	98.17
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.16
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.13
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.97
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.94
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.94
PLN02876	822	acyl-CoA dehydrogenase	97.89
PRK10593	297	hypothetical protein; Provisional	97.86
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.79
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.65
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.62
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.6
PRK05231	319	homoserine kinase; Provisional	97.53
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.52
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.31
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.23
PLN02236	344	choline kinase	96.98
KOG2270	520	consensus Serine/threonine protein kinase involved	96.82
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.75
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.65
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.65
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.62
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.61
PRK11768	325	serine/threonine protein kinase; Provisional	96.61
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.29
COG2334	331	Putative homoserine kinase type II (protein kinase	96.28
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.23
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.23
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.08
PLN02756	418	S-methyl-5-thioribose kinase	96.03
PRK06148	1013	hypothetical protein; Provisional	95.72
PTZ00384	383	choline kinase; Provisional	95.4
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.33
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.06
PTZ00296	442	choline kinase; Provisional	95.06
PRK12396	409	5-methylribose kinase; Reviewed	94.65

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=408.53  Aligned_cols=286  Identities=42%  Similarity=0.761  Sum_probs=237.4

Q ss_pred             CCcccchHHHHHHHhhhh--cccCcCcceeEEEEEEcCCCEEEEEEecccCCc-hhhHHHHHHHHhhcCCcceEEEEeEE
Q 006620          311 APKRYRYADIKKMTNSFK--NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN-GEDFINEVASISRTSHVNIVTLLGFC  387 (638)
Q Consensus       311 ~~~~~~~~~i~~~~~~~~--~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~  387 (638)
                      ..+.|++.+++++|++|.  ++||+|+||.||+|...+++.||||++...... ..+|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            467899999999999995  799999999999999989999999988876654 56799999999999999999999999


Q ss_pred             EeCc-eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCce
Q 006620          388 FEGH-RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP  466 (638)
Q Consensus       388 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~  466 (638)
                      .+.+ ..+||+||+++|+|.++|+....   . .++|.++.+|+.++|+||+|||......||||||||+|||||+++.+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~---~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG---E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCC---C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9988 59999999999999999997541   1 78999999999999999999999776789999999999999999999


Q ss_pred             EEcccccceeccC-CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhH
Q 006620          467 KISDFGLAKICEG-RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH  545 (638)
Q Consensus       467 kl~DFg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~  545 (638)
                      ||+|||+|+.... ...... .. .||.+|+|||++..  +..+.|+|||||||+|+||+||+++.+.... ..+..+..
T Consensus       217 KlsDFGLa~~~~~~~~~~~~-~~-~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~~  291 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVST-TV-MGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLVE  291 (361)
T ss_pred             EccCccCcccCCccccceee-ec-CCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHHH
Confidence            9999999976654 222111 11 78999999999965  4899999999999999999999998876542 22333667


Q ss_pred             HHHHHhhhh--hhccccCCC-CchhH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          546 WVYKRLELE--EDLGLQGIE-NEEDK-EYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       546 ~~~~~~~~~--~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      |....+...  ..+.++.+. ..... .....+..++.+|++.+|++||+|.||+++|+.+...
T Consensus       292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            765544442  233344433 22221 5667799999999999999999999999999765544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-47  Score=367.83  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=209.3

Q ss_pred             cchHHHHHHHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecc--cCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCc
Q 006620          315 YRYADIKKMTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGH  391 (638)
Q Consensus       315 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  391 (638)
                      .+..+++.     .+.||+|..|+|||++++ +++.+|+|++..  +....+++.+|++++++.+||+||++||.|..+.
T Consensus        76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            44555553     467999999999999965 578899999943  3344578899999999999999999999999988


Q ss_pred             -eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcc
Q 006620          392 -RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD  470 (638)
Q Consensus       392 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  470 (638)
                       ...++||||++|+|++++...      +++++..+.+|+.+|++||.|||..  ++||||||||+|||+++.|.|||+|
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecc
Confidence             599999999999999999875      5699999999999999999999952  8999999999999999999999999


Q ss_pred             cccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH
Q 006620          471 FGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       471 Fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      ||.++.+.+.    .....+||..|||||.+.+.  .|+.++||||||++++|+++|+-|+.........     +.   
T Consensus       223 FGVS~~lvnS----~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-----~~---  288 (364)
T KOG0581|consen  223 FGVSGILVNS----IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-----IF---  288 (364)
T ss_pred             ccccHHhhhh----hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-----HH---
Confidence            9999987655    23567899999999999886  8999999999999999999999998765211111     11   


Q ss_pred             hhhhhhccccCCCCchhH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          551 LELEEDLGLQGIENEEDK-EYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       +....+.. +.....+. .++.++.+|+..||+.||.+|||++|+++
T Consensus       289 -~Ll~~Iv~-~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  289 -ELLCAIVD-EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -HHHHHHhc-CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             11111111 11222222 47889999999999999999999999996

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-46  Score=385.71  Aligned_cols=269  Identities=26%  Similarity=0.382  Sum_probs=219.7

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecc----cCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +|...+.||+|||+.+|.++. ..|+.||+|++.+    .....+.+.+|+++.++|+|||||+++++|++.+..|+|+|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            345578999999999999996 7799999999976    34556789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      +|+.++|.++++..      ..+++.+++.+++||+.||.|||+   .+|+|||||..|+|++++.+|||+|||+|..+.
T Consensus        99 LC~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   99 LCHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             ecCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence            99999999999854      679999999999999999999999   999999999999999999999999999999887


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....  .....+|||.|+|||++...  ..+..+||||+||++|.||.|++||+...-        ...+..+.....  
T Consensus       170 ~~~E--rk~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~~~Y--  235 (592)
T KOG0575|consen  170 YDGE--RKKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKLNEY--  235 (592)
T ss_pred             Cccc--ccceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHhcCc--
Confidence            5532  23456799999999999864  678999999999999999999999985421        111222222111  


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCcccCCCCCCCC
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDF  623 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~~~~~~~~  623 (638)
                            ..+...+.++.+||.++|+.||.+|||+++|+.+  ..+++--+|.+.+...-...|.+
T Consensus       236 ------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h--~Ff~~g~~p~~lp~~~l~~~p~~  292 (592)
T KOG0575|consen  236 ------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH--PFFKSGFTPARLPSSCLTMVPRF  292 (592)
T ss_pred             ------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC--HhhhCCCcCCCCCccccccCCcC
Confidence                  1122567788999999999999999999999963  33344444544444333333333

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-47  Score=372.60  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=204.6

Q ss_pred             hhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCC--------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKG--------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      -+.+.||+|+||.|-+|. .++++.||||++++.+.        ....+.+|+++|++|+|||||++++++...+..|+|
T Consensus       175 ii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmV  254 (475)
T KOG0615|consen  175 IISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMV  254 (475)
T ss_pred             EeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEE
Confidence            347899999999999998 56799999999976431        122357999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC---CceEEccccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---FCPKISDFGL  473 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFg~  473 (638)
                      |||+.||+|.+.+-.+      +.+.+..-+.++.|++.|+.|||+   .||+||||||+|||+..+   -.+||+|||+
T Consensus       255 lE~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  255 LEYVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999876      467788889999999999999999   999999999999999655   7799999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCC-ccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGE-VSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      |+......   .+.+.+|||.|.|||++.+..-. +..++|+||+||+||-+++|.+||........       ..+.+.
T Consensus       326 AK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~eQI~  395 (475)
T KOG0615|consen  326 AKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LKEQIL  395 (475)
T ss_pred             hhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HHHHHh
Confidence            99876433   34667899999999999765323 34589999999999999999999976543210       111111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .+.    -...+.....++++..+||.+||..||++|||+.|+++
T Consensus       396 ~G~----y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  396 KGR----YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cCc----ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            111    01223456678999999999999999999999999986

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-45  Score=374.34  Aligned_cols=259  Identities=32%  Similarity=0.501  Sum_probs=212.7

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCc-eEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGH-RRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  402 (638)
                      +.+.||+|+||+||+|.+.....||||++......   .++|.+|+.+|.+++|||||+++|++.+.. ...+||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            35669999999999999965555999999764322   458999999999999999999999999887 79999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecccCCCceEECCCC-ceEEcccccceeccCC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR-ILHFDIKPHNILLDEDF-CPKISDFGLAKICEGR  480 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~-iiH~Dikp~NIll~~~~-~~kl~DFg~~~~~~~~  480 (638)
                      |+|.++++..    ....+++..+.+|+.+||+||.|||+   .+ ||||||||+|||++.++ .+||+|||+++.....
T Consensus       125 GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  125 GSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999874    12679999999999999999999999   77 99999999999999997 9999999999876543


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .  .......||+.|||||++.+....++.|+||||||+++|||+||+.||......       .....       ....
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~-------v~~~  261 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASA-------VVVG  261 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHH-------HHhc
Confidence            2  123346799999999999842237999999999999999999999999865431       01111       1122


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      ..+...+......+..++.+||+.||+.||++.+++..|+.+......
T Consensus       262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            233333344677889999999999999999999999999987665543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-45  Score=373.59  Aligned_cols=255  Identities=29%  Similarity=0.491  Sum_probs=218.7

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.+.||+|-||+||+|.++....||+|.++......+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+|
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            46789999999999999998888999999998777778999999999999999999999999998899999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .++|+..    ....+...+.+.++.|||+|++||++   +++|||||..+||||+++..+||+|||+|+...++. +..
T Consensus       289 l~yLr~~----~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~  360 (468)
T KOG0197|consen  289 LDYLRTR----EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTA  360 (468)
T ss_pred             HHHhhhc----CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCc-eee
Confidence            9999972    23678999999999999999999999   999999999999999999999999999999555444 334


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      ..+..-+..|.|||.+.-  +.++.|||||||||+||||+| |+.|+..+...        .+.+.+       ..+.+.
T Consensus       361 ~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------ev~~~l-------e~GyRl  423 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------EVLELL-------ERGYRL  423 (468)
T ss_pred             cCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHH--------HHHHHH-------hccCcC
Confidence            455666889999999964  489999999999999999998 56666544321        111211       345556


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ..+..++.++.+++..||+.+|++|||++.+...|++....
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            66777889999999999999999999999999999886553

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-46  Score=348.05  Aligned_cols=260  Identities=26%  Similarity=0.439  Sum_probs=212.1

Q ss_pred             hhhhcccCcCcceeEEEEE-EcCCCEEEEEEeccc---CCchhhHHHHHHHHhhcCCcceEEEEe-EEEeCce-EEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLG-FCFEGHR-RALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~e  398 (638)
                      +.+.++||.|.||+|||+. ..++..+|.|.++-.   ....+....|+.+|++|+|||||++++ .+.++.. ++||||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            3456899999999999997 678999999988633   234567899999999999999999998 4444444 889999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecccCCCceEECCCCceEEcccccceec
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ++.+|+|...++..+  +..+.+++..+|+++.|++.||.++|..... -|+||||||.||+++.+|.|||+|||+++.+
T Consensus       101 ~c~~GDLsqmIk~~K--~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFK--KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             hhcccCHHHHHHHHH--hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999998764  4457899999999999999999999985433 3999999999999999999999999999988


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ....+.  ....+|||.||+||.+.+.  .|+.|+||||+||++|||..-.+||....       +.. ..+++..    
T Consensus       179 ~s~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~-L~~KI~q----  242 (375)
T KOG0591|consen  179 SSKTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLS-LCKKIEQ----  242 (375)
T ss_pred             cchhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCccccc-------HHH-HHHHHHc----
Confidence            766542  3557899999999999876  89999999999999999999999997541       111 1122222    


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                        ...+.-....++.++.++|..|+.+||+.||+...+++.+...++
T Consensus       243 --gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~  287 (375)
T KOG0591|consen  243 --GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD  287 (375)
T ss_pred             --CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence              222223346789999999999999999999997777776666544

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=354.66  Aligned_cols=195  Identities=29%  Similarity=0.474  Sum_probs=173.7

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.++||+|+||+||+|++ +++..||||.+...+   ...+....|+.+|+.++|||||++++++..++.++||||||.|
T Consensus        14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g   93 (429)
T KOG0595|consen   14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG   93 (429)
T ss_pred             ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence            456799999999999995 457899999987653   3456678999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC------CceEEccccccee
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED------FCPKISDFGLAKI  476 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~------~~~kl~DFg~~~~  476 (638)
                      |+|.++|+..      +.+++.+++.++.|||.||++||+   ++||||||||+|||++..      -.+||+|||+|+.
T Consensus        94 GDLs~yi~~~------~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   94 GDLSDYIRRR------GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999986      479999999999999999999999   999999999999999754      5689999999998


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCccc
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAV  535 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~  535 (638)
                      +....-   ....+|++-|||||++...  +|+.|+|+||+|+++||+++|+.||+...
T Consensus       165 L~~~~~---a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  165 LQPGSM---AETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             CCchhH---HHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            875442   3556799999999999754  89999999999999999999999998543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=349.75  Aligned_cols=236  Identities=23%  Similarity=0.296  Sum_probs=198.6

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.||+|+||+|+.++. ++++.||+|++++.+    ...+...+|..+|.+++||.||+++..|++.+.+|+|+||+.
T Consensus        29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~  108 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN  108 (357)
T ss_pred             eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence            578999999999999984 558899999998653    345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      ||.|..+|++.      +.++++.+..++.+|+.||.|||+   ++||||||||+|||||++|.++|+|||+++......
T Consensus       109 GGeLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  109 GGELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             CccHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            99999999875      579999999999999999999999   999999999999999999999999999999654433


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ..  ....+||+.|||||++.+.  .++..+|.||||+++|||++|.+||......       .+ .+.+....      
T Consensus       180 ~~--t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------~~-~~~I~~~k------  241 (357)
T KOG0598|consen  180 DA--TRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------KM-YDKILKGK------  241 (357)
T ss_pred             Cc--cccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHH-------HH-HHHHhcCc------
Confidence            22  2447899999999999876  8999999999999999999999999865421       11 11111111      


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCC
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRP  590 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP  590 (638)
                       ....+.-.+.+..+++.+.|+.||++|-
T Consensus       242 -~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence             1222223466788999999999999995

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=355.18  Aligned_cols=261  Identities=25%  Similarity=0.359  Sum_probs=208.6

Q ss_pred             HhhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCchhh--HHHHHHHHhhcC-CcceEEEEeEEEeCc-eEEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED--FINEVASISRTS-HVNIVTLLGFCFEGH-RRALIYE  398 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~e  398 (638)
                      .|...++||.|.||.||+|+ ..++..||||.+++.....++  -++|+..|++++ ||||+++.+++.+.+ .+++|||
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE   90 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE   90 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence            45567899999999999998 456889999999876544443  478999999999 999999999999888 9999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      ||+ .+|.++++.++     ..+++..++.|+.||++||+|+|+   +|+.|||+||+|||+..+..+||+|||+|+.+.
T Consensus        91 ~Md-~NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   91 FMD-CNLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             hhh-hhHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence            995 49999999864     789999999999999999999999   999999999999999988899999999999887


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch----------hHHHH
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF----------PHWVY  548 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~----------~~~~~  548 (638)
                      ....   ++..+.|.+|+|||++... +.|+.+.|||++|||++|+.+-++.|.....- ++++-          ..|..
T Consensus       162 SkpP---YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  162 SKPP---YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cCCC---cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHHHHHHHhCCCccccchh
Confidence            6654   4556789999999999865 68999999999999999999999988764431 11110          00100


Q ss_pred             -HHhhhhhhccccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          549 -KRLELEEDLGLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       549 -~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       ..+.....+.+......    .....+.++.+++.+|+++||.+|||++|++++
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence             01111111222222111    112257788999999999999999999999974

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.2e-44  Score=335.56  Aligned_cols=258  Identities=21%  Similarity=0.342  Sum_probs=202.8

Q ss_pred             hcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          328 KNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      ..++|+|+||+|||++.+ +|+.||||.+..+.++   .+-.++|+++|++++|+|+|.++++|.....++||+||++. 
T Consensus         7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-   85 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-   85 (396)
T ss_pred             hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-
Confidence            467999999999999965 5999999999766543   35678999999999999999999999999999999999977 


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      ++.+-|....     ..++.+.+.+++.|+++|+.|+|+   .++|||||||+|||++.+|.+||+|||+|+.+..... 
T Consensus        86 TvL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   86 TVLHELERYP-----NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             HHHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            6666666653     568999999999999999999999   8999999999999999999999999999998874222 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh------hc
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE------DL  557 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~  557 (638)
                       .++..+.|.+|+|||++.+. -+|..++|||++||++.||++|.+.|....+-. ..+.-......+....      ..
T Consensus       157 -~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  157 -NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             -hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHHHHHHHHcccCHHHHHHhccCC
Confidence             34667789999999999886 389999999999999999999999887655422 1111111111111100      00


Q ss_pred             cccCCC-----C--c---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          558 GLQGIE-----N--E---EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~-----~--~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .+.++.     .  .   .....+.-+++++..||+.||++|++-++++.+
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111111     1  1   112345568899999999999999999998753

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=354.10  Aligned_cols=273  Identities=25%  Similarity=0.368  Sum_probs=214.5

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .|.+.||+|+|++|++|+. ..++.||||++.+..    .....+..|-+.|.+| .||.|++|+..|.++..+|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            3689999999999999984 568999999997642    2234567888999999 699999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.++|++.      +.+++...+.++.||+.||+|||+   .|||||||||+|||||++|++||+|||.|+.+..
T Consensus       156 A~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  156 APNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cCCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999986      579999999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCce-----------eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHH
Q 006620          480 RESI-----------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY  548 (638)
Q Consensus       480 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  548 (638)
                      ....           ......+||-.|.+||++...  ..+..+|+|+||||||+|+.|.+||.....        ....
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------yliF  296 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANE--------YLIF  296 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccH--------HHHH
Confidence            3322           112447899999999999765  788999999999999999999999975432        1111


Q ss_pred             HHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH-------hcccCCCCCCCCCcccCCCCCC
Q 006620          549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML-------EGSLDSLQIPPRPFLLSSGSQP  621 (638)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L-------~~~~~~~~~~~~p~~~~~~~~~  621 (638)
                      +++   ..+.     -+.+...++.+.+|+.+.|..||.+|+|+++|-++-       +++..+-+.+-.|+...+...+
T Consensus       297 qkI---~~l~-----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~~~~s~  368 (604)
T KOG0592|consen  297 QKI---QALD-----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKPATSISP  368 (604)
T ss_pred             HHH---HHhc-----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCCcccCCc
Confidence            111   1111     111223346788999999999999999999998763       3433333333344444443344


Q ss_pred             CCCe
Q 006620          622 DFSS  625 (638)
Q Consensus       622 ~~~~  625 (638)
                      .+.+
T Consensus       369 e~~s  372 (604)
T KOG0592|consen  369 EYYS  372 (604)
T ss_pred             ccCc
Confidence            4433

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4e-42  Score=318.68  Aligned_cols=268  Identities=26%  Similarity=0.350  Sum_probs=207.8

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .++||+|.||.||+|+ ..+|+.||||.++...   +.....++|+..|+.++|+||+.++++|...+.+.||+||++. 
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-   85 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-   85 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence            5789999999999998 5679999999987543   2245779999999999999999999999999999999999965 


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|+..++...     ..++...+..++.++++||+|+|+   +.|+||||||.|+|++++|.+||+|||+++.+......
T Consensus        86 dLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   86 DLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             cHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9999998764     679999999999999999999999   99999999999999999999999999999988654433


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh---------
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE---------  554 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  554 (638)
                      .  ...+-|..|+|||++.|. ..|+..+||||.|||+.||+-|.+-|....+-.    .-....+.+..-         
T Consensus       158 ~--~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDid----QL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID----QLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             c--ccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHH----HHHHHHHHcCCCCcccCcccc
Confidence            2  223568999999999876 589999999999999999999988776544311    111111111000         


Q ss_pred             --hh-ccccCCC----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCc
Q 006620          555 --ED-LGLQGIE----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPF  613 (638)
Q Consensus       555 --~~-~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~  613 (638)
                        .+ ...+..+    .......+.++.+|+.+|+..||.+|+|++|++++  .-+++.+.|..|.
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~~  294 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPPS  294 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCChh
Confidence              00 0001000    11122345667999999999999999999999973  3344444444333

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-42  Score=346.23  Aligned_cols=259  Identities=24%  Similarity=0.316  Sum_probs=203.5

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEEEEecc
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALIYEFVS  401 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~  401 (638)
                      .++||+|+||.||+|+ ..+|+.||+|.+..+.   +......+|+.+|++|+||||++|.+...+.  ..+|||+|||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            4689999999999998 5679999999987554   3345678999999999999999999998876  68999999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      . +|.-++....     ..+++.++..++.||++||+|+|+   +||.|||||.+|||||.+|.+||+|||+|+++....
T Consensus       202 h-DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  202 H-DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             c-hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            7 9998887643     679999999999999999999999   999999999999999999999999999999876554


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc---------chhHHHHHHhh
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI---------YFPHWVYKRLE  552 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~  552 (638)
                      .. .++..+-|..|+|||++.|. ..|+.++|+||.||||.||++|++.+.......+-.         .-..|....+.
T Consensus       273 ~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  273 SA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             Cc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            32 25666779999999999987 479999999999999999999999887543311100         00011100010


Q ss_pred             hhhhcc----ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 LEEDLG----LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 ~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....+.    ......+.....+...++|+..+|..||.+|.|+.++++
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            000000    000111223345667889999999999999999999985

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=335.66  Aligned_cols=260  Identities=25%  Similarity=0.411  Sum_probs=213.1

Q ss_pred             hhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      |++.+.||.|..++||+|+ ...++.||||+++-++  ...+.+.+|+..++.++||||++++..|..++.+++||.||.
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            3467899999999999998 5668999999998654  334678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC-
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR-  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~-  480 (638)
                      +|++.++++...+    ..+++..+..|++++++||.|||+   .|.||||||+.||||+++|.|||+|||.+..+-.. 
T Consensus       108 ~GS~ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  108 GGSLLDIIKTYYP----DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             CCcHHHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999998642    459999999999999999999999   99999999999999999999999999987655332 


Q ss_pred             Cceeee-cccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh-hhcc
Q 006620          481 ESIVSM-TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE-EDLG  558 (638)
Q Consensus       481 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  558 (638)
                      ...... ...+||+.|||||++......|+.|+||||||++..||.+|..||.....      . ......+... ..+.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------m-kvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------M-KVLLLTLQNDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------H-HHHHHHhcCCCCCcc
Confidence            222222 56789999999999766666899999999999999999999999974321      0 1111111111 0112


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ......+..+.+.+.+.+++..||+.||++|||+++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            3344455666778899999999999999999999999864

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=340.77  Aligned_cols=253  Identities=28%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCc--eEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGH--RRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~  402 (638)
                      ..+.||+|+||+||++... +|+..|||....... ..+...+|+.+|.+++|||||+.+|......  .+++.|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            4688999999999999854 489999998865421 1456789999999999999999999755444  68899999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-CCceEEcccccceeccC-C
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICEG-R  480 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~~~~~~-~  480 (638)
                      |+|.+++.+.+     ..|++..+..+++|+++||+|||+   +||+|+||||+|||++. ++.+||+|||+++.... .
T Consensus       101 GsL~~~~~~~g-----~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen  101 GSLSDLIKRYG-----GKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             CcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            99999999864     369999999999999999999999   99999999999999999 79999999999987664 1


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .........+||+.|||||++... .....++|||||||++.||+||++||....      ....+.....       ..
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig-------~~  238 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIG-------RE  238 (313)
T ss_pred             ccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHh-------cc
Confidence            111223456799999999999741 133359999999999999999999987531      0111111111       11


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ......+..++.+..+|+.+|++.+|++|||+++++++---
T Consensus       239 ~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  239 DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            11123444577889999999999999999999999986543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-42  Score=349.38  Aligned_cols=243  Identities=27%  Similarity=0.390  Sum_probs=206.8

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccCCc-hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGN-GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .++||+|+.|.||.|+ ..+++.||||++...... .+.+++|+.+|+..+|+|||++++.|...+.+++||||++||+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            3579999999999997 567889999999876544 45779999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .|.+...       .+++.++..|++++++||+|||.   ++|+|||||.+|||++.+|.+||+|||++..+...+.  .
T Consensus       358 TDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  358 TDVVTKT-------RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             hhhhhcc-------cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999874       49999999999999999999999   9999999999999999999999999999998876554  3


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      ....+|||.|||||++..+  .|..+.||||||+++.||+-|++||-....      +...  ..+...     ......
T Consensus       426 R~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAl--yLIa~n-----g~P~lk  490 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRAL--YLIATN-----GTPKLK  490 (550)
T ss_pred             cccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCCh------HHHH--HHHhhc-----CCCCcC
Confidence            4667899999999999775  899999999999999999999999875332      1110  001111     111122


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....++..+.+|+.+||+.|+++|++++|||+
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            44556788999999999999999999999996

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=317.43  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=205.4

Q ss_pred             HHHHhcCCCCCcccchHHHHHHHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcC
Q 006620          302 AFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTS  376 (638)
Q Consensus       302 ~~l~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~  376 (638)
                      ++...........+.+++.+     +.+.||.|+||.|.+++.+ ++..+|+|++++.+    .+.+...+|..+|+.+.
T Consensus        28 ~~~~~~~~~~~~~~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~  102 (355)
T KOG0616|consen   28 DFPKKWANTPQNPYSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS  102 (355)
T ss_pred             hhhhhhcCCCCCCcchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc
Confidence            34333333333336655543     4688999999999999954 57899999998653    34567789999999999


Q ss_pred             CcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 006620          377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH  456 (638)
Q Consensus       377 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~  456 (638)
                      ||.++++++.+.+.+.+++||||++||.|..++++.      +++++..++.++.||+.||+|||+   .+|++|||||+
T Consensus       103 ~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPE  173 (355)
T KOG0616|consen  103 HPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPE  173 (355)
T ss_pred             CceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChH
Confidence            999999999999999999999999999999999986      578999999999999999999999   99999999999


Q ss_pred             ceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccC
Q 006620          457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVD  536 (638)
Q Consensus       457 NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~  536 (638)
                      |||+|.+|.+||+|||.|+......     .+.+|||.|+|||++..+  .+..++|.|+|||++|||+.|.+||.....
T Consensus       174 NiLlD~~G~iKitDFGFAK~v~~rT-----~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  174 NLLLDQNGHIKITDFGFAKRVSGRT-----WTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             HeeeccCCcEEEEeccceEEecCcE-----EEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            9999999999999999999876542     456799999999999876  789999999999999999999999976542


Q ss_pred             CCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCC
Q 006620          537 RSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDR  589 (638)
Q Consensus       537 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  589 (638)
                              ...++++-.. .+.       .+.-.+.++.+|+...|+.|-++|
T Consensus       247 --------~~iY~KI~~~-~v~-------fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  247 --------IQIYEKILEG-KVK-------FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --------HHHHHHHHhC-ccc-------CCcccCHHHHHHHHHHHhhhhHhh
Confidence                    1222322221 111       223345578889999999999999

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.6e-41  Score=349.10  Aligned_cols=262  Identities=27%  Similarity=0.424  Sum_probs=201.6

Q ss_pred             hhhhcccCcCcceeEEEEEE------cCCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeC-ceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL------LDGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEG-HRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~~  394 (638)
                      +.+.++||+|+||.||+|..      .+++.||||+++....  ....+.+|+.++.++ +||||+++++++... ...+
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (338)
T cd05102           9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM   88 (338)
T ss_pred             ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence            44678999999999999974      2246799999875432  235688999999999 899999999988764 4578


Q ss_pred             EEEEeccCCCHHHHhhhcCCCC--------------------------------------------------------CC
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLE--------------------------------------------------------TN  418 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------~~  418 (638)
                      +||||+++|+|.+++.......                                                        ..
T Consensus        89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (338)
T cd05102          89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK  168 (338)
T ss_pred             EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence            9999999999999997532100                                                        01


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecC
Q 006620          419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP  498 (638)
Q Consensus       419 ~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aP  498 (638)
                      ..+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus       169 ~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         169 SPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence            348889999999999999999999   99999999999999999999999999999865433322222334467889999


Q ss_pred             ceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHH
Q 006620          499 EVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILV  577 (638)
Q Consensus       499 E~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  577 (638)
                      |++.+.  .++.++||||||+++|||++ |..||......       ...........       ....+...+.++.++
T Consensus       246 E~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~-------~~~~~~~~~~~l~~l  309 (338)
T cd05102         246 ESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGT-------RMRAPENATPEIYRI  309 (338)
T ss_pred             HHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCC-------CCCCCCCCCHHHHHH
Confidence            998764  68899999999999999996 99998653221       00111111110       111122345678899


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          578 SLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       578 i~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      +.+||+.||++|||+.+|++.|++++.+
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-40  Score=339.96  Aligned_cols=244  Identities=26%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CC--chhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KG--NGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|.||+|+.|.. .+++.||+|+++..    ..  ..+.+.+|+.++++++ ||||+++++++......++|
T Consensus        19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv   98 (370)
T KOG0583|consen   19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV   98 (370)
T ss_pred             eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence            44678999999999999974 56899999987654    11  2345668999999999 99999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC-CceEEcccccce
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAK  475 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFg~~~  475 (638)
                      |||+.||+|.+++...      +++.+..+..++.|+++|++|+|+   +||+||||||+|||++.+ +.+||+|||++.
T Consensus        99 mEy~~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   99 MEYCSGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEecCCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999984      578899999999999999999999   999999999999999999 999999999999


Q ss_pred             ecc-CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          476 ICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       476 ~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ... ...   .....+||+.|+|||++.+....-..++||||+||+||.|++|+.||+....       +. ....+...
T Consensus       170 ~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~-l~~ki~~~  238 (370)
T KOG0583|consen  170 ISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PN-LYRKIRKG  238 (370)
T ss_pred             ccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HH-HHHHHhcC
Confidence            874 222   2356789999999999987621235799999999999999999999986321       11 11111111


Q ss_pred             hhccccCCCCchhHHH-HHHHHHHHHHcccCCCCCCCCHHHHH
Q 006620          555 EDLGLQGIENEEDKEY-ARKMILVSLWCIQTNPSDRPSMNRVV  596 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl  596 (638)
                       ....       +... +.++..|+.+||..||.+|+|+.+++
T Consensus       239 -~~~~-------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 -EFKI-------PSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -CccC-------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence             1111       1112 67889999999999999999999999

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=344.90  Aligned_cols=260  Identities=30%  Similarity=0.492  Sum_probs=210.0

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.++||+|.||+||+|++-  ..||||+++.+.   ...++|.+|+.++++-+|.||+-+.|+|..+.. .+|..+|+|.
T Consensus       396 l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs  472 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS  472 (678)
T ss_pred             ccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence            4789999999999999973  579999998653   345789999999999999999999999998777 9999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|..+|+-.+     ..+...+..+|++|+++|+.|||.   ++|||||||..||++.++++|||+|||++..-......
T Consensus       473 SLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  473 SLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             hhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            9999998754     678999999999999999999999   99999999999999999999999999999765433222


Q ss_pred             eeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .......|...|||||+++-. .-++++++||||||+++|||++|.-||.. ..+. .+.+..        ++.. +..-
T Consensus       545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~d-qIifmV--------GrG~-l~pd  613 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRD-QIIFMV--------GRGY-LMPD  613 (678)
T ss_pred             cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChh-heEEEe--------cccc-cCcc
Confidence            233445678899999998532 23789999999999999999999999983 2221 111100        0000 0111


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      .........+++.+|+..||..++++||.+.+|+..|+.++..++.
T Consensus       614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk  659 (678)
T KOG0193|consen  614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK  659 (678)
T ss_pred             chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence            1223445678899999999999999999999999999988776544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-40  Score=337.25  Aligned_cols=245  Identities=22%  Similarity=0.296  Sum_probs=198.4

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ...||+|+||.||+|+ ..+|..+|+|+++++    +.+.+.+..|-.+|....+|.||+|+..|++.+.+||||||++|
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            5789999999999998 556999999999875    35567788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC--
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR--  480 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~--  480 (638)
                      |++..+|.+.      ..|+++.+..++.+++.||+.||+   .|+|||||||+|+|||..|.+||+|||++.-+...  
T Consensus       226 GD~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  226 GDMMTLLMRK------DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             ccHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            9999999875      579999999999999999999999   99999999999999999999999999998533210  


Q ss_pred             --------------------Cce-----ee------------------ecccccccceecCceeccccCCccccCCeeeH
Q 006620          481 --------------------ESI-----VS------------------MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSY  517 (638)
Q Consensus       481 --------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvwsl  517 (638)
                                          +..     ..                  ....+|||.|+|||++.+.  .|+..+|.|||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSL  374 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSL  374 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHH
Confidence                                000     00                  0123599999999999987  68999999999


Q ss_pred             HHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh-hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 006620          518 GMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE-EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS---MN  593 (638)
Q Consensus       518 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~  593 (638)
                      |||+||||.|.+||.....        ...+.++... ..+..+     .....+.++.+||.+||. ||++|--   ++
T Consensus       375 G~ImyEmLvGyPPF~s~tp--------~~T~rkI~nwr~~l~fP-----~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETP--------QETYRKIVNWRETLKFP-----EEVDLSDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhhhccCC-----CcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            9999999999999986543        2222222221 112221     122234789999999999 9999965   55


Q ss_pred             HHHH
Q 006620          594 RVVE  597 (638)
Q Consensus       594 evl~  597 (638)
                      ||-+
T Consensus       441 EIK~  444 (550)
T KOG0605|consen  441 EIKK  444 (550)
T ss_pred             HHhc
Confidence            5543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.2e-41  Score=358.51  Aligned_cols=261  Identities=28%  Similarity=0.475  Sum_probs=215.1

Q ss_pred             hhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      ..+.+.||+|+||+||+|+..      +.+.||||.+++....  .++|.+|++++..++|||||+++|+|..++..++|
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv  567 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV  567 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence            346789999999999999743      3458999999877654  56899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEE
Q 006620          397 YEFVSNGSLEKFIHEKHPLET--------NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI  468 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  468 (638)
                      +|||..|+|.++|....+...        ...|+..+.+.|+.|||.|++||-+   +.+|||||..+|+||.++..|||
T Consensus       568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEe
Confidence            999999999999987653211        2348999999999999999999999   89999999999999999999999


Q ss_pred             cccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHH
Q 006620          469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWV  547 (638)
Q Consensus       469 ~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  547 (638)
                      +|||+++.+-..+.+.......-+++|||||.|.-  +.+|++||||||||+|||+++ |+.|+.....+          
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~----------  712 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ----------  712 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchH----------
Confidence            99999997766555443323344789999999864  489999999999999999997 66676543321          


Q ss_pred             HHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                       +.++..    ..+...+.+...+.++.+|+..||+.+|++||+++||-..|+..-..
T Consensus       713 -EVIe~i----~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  713 -EVIECI----RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -HHHHHH----HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence             111111    12223556667889999999999999999999999999999986544

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.6e-40  Score=336.02  Aligned_cols=263  Identities=25%  Similarity=0.364  Sum_probs=214.8

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      |.+.+.||+|.||.||||+. .+.+.||+|.+.+....   ...+.+|++++++++||||+.++++|+...++++|.||+
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a   83 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA   83 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence            34567899999999999984 45789999999765433   346789999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      .| +|..+|...      ..++++.+..|+.+++.||.|||+   .+|+|||+||+|||++.++.+|++|||+|+.+...
T Consensus        84 ~g-~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   84 VG-DLFTILEQD------GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hh-hHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            77 999999875      579999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..  .....+|||-|||||+..+.  .++..+|+||+||++||+.+|++||....       +...+..       +.-.
T Consensus       154 t~--vltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~-------I~~d  215 (808)
T KOG0597|consen  154 TS--VLTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKS-------ILKD  215 (808)
T ss_pred             ce--eeeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHH-------HhcC
Confidence            43  34567899999999999864  89999999999999999999999986432       1111111       1111


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhcccCCCCCCCCCcccCC
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM--LEGSLDSLQIPPRPFLLSS  617 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~p~~~~~  617 (638)
                      .  ...+...+..+..|+...|+.||..|.+..+++.+  .++.......|..|+..+.
T Consensus       216 ~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~sp  272 (808)
T KOG0597|consen  216 P--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSP  272 (808)
T ss_pred             C--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCc
Confidence            1  12233667889999999999999999999999874  4554444445555555544

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-39  Score=310.81  Aligned_cols=269  Identities=23%  Similarity=0.271  Sum_probs=205.3

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEEEEecc
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEFVS  401 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  401 (638)
                      .++|++|+||.||+|++ ++++.||+|.++.++..   .-..++|+.+|.+.+|||||.+-.+...  -+..|+|||||+
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E  160 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE  160 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence            57899999999999995 56889999999866532   2356899999999999999999988764  456999999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      . +|..++....     .++...++..++.|+++||+|||+   ..|+||||||+|+|+++.|.+||+|||+|+.+....
T Consensus       161 h-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  161 H-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             h-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            6 9999998764     678999999999999999999999   899999999999999999999999999999876542


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                        ..++..+-|..|+|||++.+. ..|+++.|+||+|||+.||+++++-|.....    +..-......+..-.....++
T Consensus       232 --k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE----~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  232 --KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSE----IDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             --ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCch----HHHHHHHHHHhCCCccccCCC
Confidence              234556679999999999886 5899999999999999999999998865432    111111111110000000000


Q ss_pred             C--------------C-----CchhH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCcc
Q 006620          562 I--------------E-----NEEDK-EYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFL  614 (638)
Q Consensus       562 ~--------------~-----~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~  614 (638)
                      .              .     ..... ..++.-++|+..+|..||.+|.|+++.+++  ..+.+.+.|-.|-.
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~  375 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSM  375 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhh
Confidence            0              0     00000 044677899999999999999999999873  44555444444433

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-40  Score=342.95  Aligned_cols=243  Identities=23%  Similarity=0.302  Sum_probs=205.4

Q ss_pred             hhcccCcCcceeEEEEE-EcCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.||.|+.|.|-.|+ ..+|+.+|||++.+..    .....+.+|+.+|+.++|||++++|+++++..++|+|+||++
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~   95 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP   95 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence            46789999999999998 5679999999997542    233467789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|-|.++|-..      +.+++.++.+++.||+.|+.|+|.   .+|+||||||+|+|||+.+++||+|||+|..-..+.
T Consensus        96 gGELFdylv~k------G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   96 GGELFDYLVRK------GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             CchhHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999876      578999999999999999999999   999999999999999999999999999998755444


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      -   ..+.+|.|.|.+||++.|. .....++||||.|||||.||||+.||++..-       .... .++..+       
T Consensus       167 l---LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LL-lKV~~G-------  227 (786)
T KOG0588|consen  167 L---LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLL-LKVQRG-------  227 (786)
T ss_pred             c---ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHH-HHHHcC-------
Confidence            2   3557799999999999987 3457899999999999999999999984321       1111 111111       


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       .-+.+..++.++.+|+++||.+||++|.|++||+++
T Consensus       228 -~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 -VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence             112234567789999999999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-39  Score=330.01  Aligned_cols=246  Identities=19%  Similarity=0.282  Sum_probs=198.7

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCc----hhhHHHHHHHHhhcCCcceEEEEeEEEe----CceEEEEEEec
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN----GEDFINEVASISRTSHVNIVTLLGFCFE----GHRRALIYEFV  400 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  400 (638)
                      ..||+|++|.||+|+. +++.||||+++.....    .+.+.+|+.++++++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5789999999999998 6889999999765433    3567799999999999999999999877    34678999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++...      ..+++.....++.|++.||+|||+.  .+++||||||+||++++++.+||+|||+++.....
T Consensus       105 ~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~  176 (283)
T PHA02988        105 TRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP  176 (283)
T ss_pred             CCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence            999999999764      4588899999999999999999971  38889999999999999999999999998865432


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .     ....|+..|+|||++.+....++.++|||||||++|||++|+.||.....       ............     
T Consensus       177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~~~~~~i~~~~~-----  239 (283)
T PHA02988        177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------KEIYDLIINKNN-----  239 (283)
T ss_pred             c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCC-----
Confidence            2     22457899999999976445789999999999999999999999974321       111111111110     


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                        ....+...+.++.+++.+||+.||++|||++++++.|++.
T Consensus       240 --~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        240 --SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             --CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence              1111123466789999999999999999999999999874

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.6e-39  Score=331.35  Aligned_cols=264  Identities=24%  Similarity=0.384  Sum_probs=198.8

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-----------------CCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-----------------GQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLG  385 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~  385 (638)
                      +.+.++||+|+||.||++.+.+                 +..||+|++....  ....++.+|++++.+++||||+++++
T Consensus         7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   86 (304)
T cd05096           7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG   86 (304)
T ss_pred             CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence            3457899999999999997532                 2369999987543  22457889999999999999999999


Q ss_pred             EEEeCceEEEEEEeccCCCHHHHhhhcCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 006620          386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPL-------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFD  452 (638)
Q Consensus       386 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~D  452 (638)
                      ++.+.+..++||||+++++|.+++......             .....+++..++.++.|++.||+|||+   .+|+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~d  163 (304)
T cd05096          87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRD  163 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccC
Confidence            999999999999999999999999764311             112357888999999999999999999   9999999


Q ss_pred             cCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcC--CCC
Q 006620          453 IKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE--KNN  530 (638)
Q Consensus       453 ikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg--~~p  530 (638)
                      |||+|||+++++.+||+|||+++...............++..|+|||++.+.  .++.++||||||+++|||+++  ..|
T Consensus       164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccCCCC
Confidence            9999999999999999999999876544332222334467899999998654  688999999999999999864  455


Q ss_pred             CCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          531 ANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      |......  +  .............    .......+...+..+.+++.+||+.||++|||+++|.+.|++
T Consensus       242 ~~~~~~~--~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDE--Q--VIENAGEFFRDQG----RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHH--H--HHHHHHHHhhhcc----ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            5432211  0  0011101000000    000011112235678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=341.17  Aligned_cols=256  Identities=27%  Similarity=0.427  Sum_probs=206.6

Q ss_pred             hhcccCcCcceeEEEEEEcC--C--CE-EEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLLD--G--QN-VAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      +.++||+|+||.||+|++..  +  .. ||||..+..    +....++++|+++|++++|||||+++|+......+++||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            35899999999999998533  2  23 899988742    345678999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      |+|.||+|.++|+++.     ..++..+...++.+.|.||+|||+   +++|||||-.+|+|++.++.+||+|||+++.-
T Consensus       241 El~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EecCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            9999999999999874     469999999999999999999999   99999999999999999999999999998854


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ....  .......-+..|+|||.+...  .++.++|||||||++||+++ |..|+......        .+...      
T Consensus       313 ~~~~--~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~k------  374 (474)
T KOG0194|consen  313 SQYV--MKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAK------  374 (474)
T ss_pred             ccee--eccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHH------
Confidence            3111  111122357899999999764  89999999999999999998 67787654421        11111      


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      +...+.+...+...+.++..++.+|+..+|++||+|.++.+.|+.+.+....
T Consensus       375 I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  375 IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            1112222333334567788889999999999999999999999987776553

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=332.26  Aligned_cols=251  Identities=27%  Similarity=0.465  Sum_probs=208.1

Q ss_pred             cccchHHHHHHHhhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCce
Q 006620          313 KRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHR  392 (638)
Q Consensus       313 ~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  392 (638)
                      ..+.|++|.+.     +-||+|+.|.||.|++ .++.||||.++..+      ..++.-|++|+||||+.+.|+|....-
T Consensus       119 WeiPFe~IsEL-----eWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPc  186 (904)
T KOG4721|consen  119 WEIPFEEISEL-----EWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPC  186 (904)
T ss_pred             ccCCHHHhhhh-----hhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCce
Confidence            34556666553     4599999999999998 46889999876433      257888999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      ++||||||..|.|.+.|+..      ..+.......|..+||.|+.|||.   +.|||||||.-||||..+..|||+|||
T Consensus       187 yCIiMEfCa~GqL~~VLka~------~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFG  257 (904)
T KOG4721|consen  187 YCIIMEFCAQGQLYEVLKAG------RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFG  257 (904)
T ss_pred             eEEeeeccccccHHHHHhcc------CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEecccc
Confidence            99999999999999999875      578889999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      -++......+.   -...||..|||||++.+.  +.+.|+|||||||+|||||||+-||...+..  .+.     +.   
T Consensus       258 TS~e~~~~STk---MSFaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--AII-----wG---  322 (904)
T KOG4721|consen  258 TSKELSDKSTK---MSFAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--AII-----WG---  322 (904)
T ss_pred             chHhhhhhhhh---hhhhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchh--eeE-----Ee---
Confidence            99877655332   345689999999999875  8899999999999999999999998754421  110     00   


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      .+    -..+....+..+++.+.-|+++||+..|..||++.+++.+|+-+-
T Consensus       323 VG----sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  323 VG----SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             cc----CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            00    112233345567788999999999999999999999999998653

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=306.62  Aligned_cols=261  Identities=23%  Similarity=0.316  Sum_probs=207.2

Q ss_pred             hhcccCcCcceeEEEEE-EcCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc-----eEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGH-----RRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~  399 (638)
                      +.+.||+|||+.||.++ ..+++.||+|++.-.. .+.+...+|++..++++|||+++++++...+.     ..||+++|
T Consensus        25 i~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Py  104 (302)
T KOG2345|consen   25 IQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPY  104 (302)
T ss_pred             EeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence            57899999999999998 6778999999887554 56678899999999999999999998876443     48999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      ...|+|.+.+....  .++..+++.+++.|+.++++||++||+.. ..+.||||||.|||+.+.+.++|.|||.+....-
T Consensus       105 y~~Gsl~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i  181 (302)
T KOG2345|consen  105 YKRGSLLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI  181 (302)
T ss_pred             hccccHHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccce
Confidence            99999999998754  33467999999999999999999999921 2499999999999999999999999999875431


Q ss_pred             C----C---ceeeecccccccceecCceecccc-CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          480 R----E---SIVSMTGARGTIGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       480 ~----~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      .    .   ..........|..|+|||++.-.. ..+++++|||||||+||+|+-|..||+..........+.-..    
T Consensus       182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n----  257 (302)
T KOG2345|consen  182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN----  257 (302)
T ss_pred             EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec----
Confidence            1    0   001112234688999999995432 357899999999999999999999998765543333221100    


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                              ..........+++.+.++|.+||++||.+||++.+++..++.+
T Consensus       258 --------~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  258 --------AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --------cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                    0111112223788999999999999999999999999998875

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-39  Score=328.22  Aligned_cols=249  Identities=25%  Similarity=0.360  Sum_probs=198.8

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      ...+.||+|+||+||++.. .+++.||+|++....    .....+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            3467899999999999985 568999999986432    22345788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++....    ...+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++......
T Consensus        83 ~~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          83 NGGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             CCCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999998886532    2458999999999999999999999   99999999999999999999999999999876433


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||........    ..........       
T Consensus       156 ~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~-------  219 (285)
T cd05631         156 ET---VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKE-------  219 (285)
T ss_pred             Ce---ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhc-------
Confidence            32   2345689999999999764  788999999999999999999999975432110    0111111100       


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  598 (638)
                       .........+.++.+|+.+||+.||++||+     +++++++
T Consensus       220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             011122234667889999999999999997     7888863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-41  Score=330.61  Aligned_cols=243  Identities=26%  Similarity=0.363  Sum_probs=204.7

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEeccc--CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET--KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      .+.||+|.||.||+|.+ ..++.||+|++..+  ....+++.+|+.++.+++++||.++|+.+..+..+.++|||+.||+
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs   97 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS   97 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence            47899999999999985 45889999999754  3456788999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      +.+.++..      ..+.+..+.-|+++++.||.|||.   ++.+|||||+.|||+..+|.+||+|||.+..+.....  
T Consensus        98 v~~lL~~~------~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   98 VLDLLKSG------NILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hhhhhccC------CCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            99999875      334777788899999999999999   9999999999999999999999999999987765443  


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      .....+|||.|||||++.+.  .|+.|+||||||++++||++|.+|+.....-.--.               +..+..++
T Consensus       167 rr~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf---------------lIpk~~PP  229 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF---------------LIPKSAPP  229 (467)
T ss_pred             ccccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE---------------eccCCCCC
Confidence            23667899999999999864  79999999999999999999999987554311100               11122222


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .....+++.+.+|+..||+.||+.||++.+++++
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            2233678889999999999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.8e-39  Score=341.23  Aligned_cols=259  Identities=28%  Similarity=0.452  Sum_probs=200.7

Q ss_pred             hhhhcccCcCcceeEEEEEE------cCCCEEEEEEecccC--CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL------LDGQNVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      +.+.+.||+|+||+||+|..      .++..||||+++...  ...+.+.+|+.+++.+ +||||+++++++......++
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l  116 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV  116 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence            34678999999999999963      235689999987543  2345688999999999 79999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCC------------------------------------------------------------
Q 006620          396 IYEFVSNGSLEKFIHEKHPL------------------------------------------------------------  415 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~------------------------------------------------------------  415 (638)
                      ||||+++|+|.+++......                                                            
T Consensus       117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (375)
T cd05104         117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID  196 (375)
T ss_pred             eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence            99999999999999753210                                                            


Q ss_pred             ---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeee
Q 006620          416 ---------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM  486 (638)
Q Consensus       416 ---------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~  486 (638)
                               .....+++..+..++.||++||+|||+   .+++||||||+|||++.++.+||+|||+++...........
T Consensus       197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence                     011357899999999999999999999   99999999999999999999999999999876543322222


Q ss_pred             cccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       487 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      ....++..|+|||++.+.  .++.++||||||+++|||++ |..||.......   ..    ...+...       ....
T Consensus       274 ~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~----~~~~~~~-------~~~~  337 (375)
T cd05104         274 GNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KF----YKMIKEG-------YRML  337 (375)
T ss_pred             CCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HH----HHHHHhC-------ccCC
Confidence            223456789999998764  78899999999999999997 888876432110   01    1111110       0011


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      .+...+.++.+++.+||+.||++|||+++|++.|++.
T Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1112345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.8e-39  Score=312.47  Aligned_cols=258  Identities=26%  Similarity=0.340  Sum_probs=199.4

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcc-eEEEEeEEEeCc------eEEEE
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVN-IVTLLGFCFEGH------RRALI  396 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~~~lv  396 (638)
                      .++||+|+||+||+|+ ..+|+.||+|.+..+.+   .....++|+.++++++|+| |+++++++...+      .+++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            4679999999999998 45688999999976544   3456789999999999999 999999999877      88999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +||++. +|.+++.......  ..++...+..++.||+.||+|||+   ++|+||||||+|||++++|.+||+|||+|+.
T Consensus        96 fe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   96 FEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             EEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            999955 9999998864221  357778999999999999999999   9999999999999999999999999999996


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh-
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE-  555 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  555 (638)
                      ..-..  ..+...++|..|+|||++.+. ..|+...||||+|||++||+++++-|.......    .-....+.+.... 
T Consensus       170 ~~ip~--~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~----ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  170 FSIPM--RTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID----QLFRIFRLLGTPNE  242 (323)
T ss_pred             hcCCc--ccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH----HHHHHHHHcCCCCc
Confidence            54222  124556789999999999886 369999999999999999999998887654311    1111111111100 


Q ss_pred             ----------hcc--ccCCC--Cc---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          556 ----------DLG--LQGIE--NE---EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       556 ----------~~~--~~~~~--~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                                +..  .....  ..   .......+..+++.+||+.+|.+|.|++.++++
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                      000  00000  00   001111367899999999999999999999975

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-40  Score=300.45  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=208.3

Q ss_pred             CcccchHHHHHHHhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeE
Q 006620          312 PKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGF  386 (638)
Q Consensus       312 ~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~  386 (638)
                      .+.++.++.+     +.+.||+|.||.||.|+. +++-.||+|++.++.    ....++.+|+++...|+||||+++|++
T Consensus        16 ~~~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~   90 (281)
T KOG0580|consen   16 TKTWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY   90 (281)
T ss_pred             ccccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence            3455555543     578999999999999985 457789999997542    334578899999999999999999999


Q ss_pred             EEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCce
Q 006620          387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP  466 (638)
Q Consensus       387 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~  466 (638)
                      |.+....||++||.++|+|...|...+    ...+++...+.++.|+|.||.|+|.   ++||||||||+|+|++..+.+
T Consensus        91 fhd~~riyLilEya~~gel~k~L~~~~----~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~l  163 (281)
T KOG0580|consen   91 FHDSKRIYLILEYAPRGELYKDLQEGR----MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGEL  163 (281)
T ss_pred             eeccceeEEEEEecCCchHHHHHHhcc----cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCe
Confidence            999999999999999999999998643    2568888899999999999999999   999999999999999999999


Q ss_pred             EEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHH
Q 006620          467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW  546 (638)
Q Consensus       467 kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  546 (638)
                      ||+|||.+......    ......||..|.|||...+.  ..+..+|+|++|++.||++.|.+||.....  .+      
T Consensus       164 kiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--~e------  229 (281)
T KOG0580|consen  164 KIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSH--SE------  229 (281)
T ss_pred             eccCCCceeecCCC----CceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhh--HH------
Confidence            99999999865433    23556789999999999876  778999999999999999999999975441  11      


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .++++..        .....+..++.++.++|.+|+..+|.+|.+..|++++
T Consensus       230 tYkrI~k--------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  230 TYKRIRK--------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHHHHH--------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            1122111        1111224567788999999999999999999999874

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.7e-39  Score=340.03  Aligned_cols=260  Identities=26%  Similarity=0.452  Sum_probs=201.6

Q ss_pred             hhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      +.+.+.||+|+||.||+|+..      ++..||||+++....  ..+.+.+|+++++.+ +|+||+++++++......++
T Consensus        40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l  119 (374)
T cd05106          40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV  119 (374)
T ss_pred             ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence            346789999999999998742      235799999975432  235678999999999 79999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCC-------------------------------------------------------------
Q 006620          396 IYEFVSNGSLEKFIHEKHP-------------------------------------------------------------  414 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~-------------------------------------------------------------  414 (638)
                      ||||+++|+|.+++.....                                                             
T Consensus       120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (374)
T cd05106         120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD  199 (374)
T ss_pred             eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence            9999999999999865321                                                             


Q ss_pred             ---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeeccccc
Q 006620          415 ---LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG  491 (638)
Q Consensus       415 ---~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~g  491 (638)
                         ......+++..+++++.|+++||+|||+   ++|+||||||+|||+++++.+||+|||+++...............+
T Consensus       200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~  276 (374)
T cd05106         200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL  276 (374)
T ss_pred             hhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence               0112357889999999999999999999   9999999999999999999999999999986644332222223345


Q ss_pred             ccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHH
Q 006620          492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY  570 (638)
Q Consensus       492 t~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (638)
                      ++.|+|||++.+.  .++.++||||||+++|||++ |+.||.......       .........       .....+...
T Consensus       277 ~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~-------~~~~~~~~~  340 (374)
T cd05106         277 PVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRG-------YQMSRPDFA  340 (374)
T ss_pred             ccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHcc-------cCccCCCCC
Confidence            6789999998654  78999999999999999997 999987543211       001111110       001111123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       571 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      +.++.+++.+||+.||++|||+.+|++.|++++
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.2e-39  Score=334.39  Aligned_cols=241  Identities=22%  Similarity=0.308  Sum_probs=195.0

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.||+|+||.||+++. .+++.||||+++...    .....+.+|++++++++||||+++++++..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999985 468899999987532    23356788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-  150 (323)
T cd05571          81 ELFFHLSRE------RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-  150 (323)
T ss_pred             cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence            999999764      468999999999999999999999   9999999999999999999999999999875322211 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       . ........ ..      
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~-~~~~~~~~-~~------  212 (323)
T cd05571         151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILME-EI------  212 (323)
T ss_pred             -cccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHH-------H-HHHHHHcC-CC------
Confidence             12334689999999999764  6889999999999999999999998643210       0 01111100 01      


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                       ..+..++.++.+++.+||+.||++||     ++++++++
T Consensus       213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence             11223456788999999999999999     79998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1e-38  Score=323.81  Aligned_cols=258  Identities=27%  Similarity=0.455  Sum_probs=204.5

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  395 (638)
                      .+.+.+.||+|+||.||+|...+      ++.||||+++.....  .+.+.+|++++++++|+||+++++++......++
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   85 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM   85 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence            45567899999999999997533      478999998765433  4678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceE
Q 006620          396 IYEFVSNGSLEKFIHEKHP--------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK  467 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  467 (638)
                      ||||+++++|.+++.....        ......+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+|
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEE
Confidence            9999999999999986532        1223558899999999999999999999   9999999999999999999999


Q ss_pred             EcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHH
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHW  546 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  546 (638)
                      |+|||+++...............+++.|+|||++.+.  .++.++||||||+++|||++ |+.||......       ..
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~  233 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EV  233 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HH
Confidence            9999999865433222112233457889999998764  78899999999999999998 99988643221       11


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      . ....       .+.........+..+.+++.+||+.||++||+++||++.|++
T Consensus       234 ~-~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 I-ECIT-------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             H-HHHH-------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1 1111       111111122346678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-39  Score=302.92  Aligned_cols=246  Identities=24%  Similarity=0.344  Sum_probs=204.0

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccCC-----c----hhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEE
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG-----N----GEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  396 (638)
                      ++.||.|..++|-++.. .+++..|+|++.....     .    .++-.+|+.+|+++. ||+|+++.++++.+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            67899999999998874 5688999999864321     1    234567999999986 99999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +|.|+.|.|.|+|.+.      ..+++...++|++|+.+|+.|||.   ++|+||||||+|||+|++.++||+|||.+..
T Consensus       102 Fdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             hhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeec
Confidence            9999999999999875      579999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCceeeecccccccceecCceecccc----CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNF----GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      +...+.   ....+|||+|+|||.+....    ..|+..+|+|++|||+|.|+.|.+||.-..         +.+.-+.-
T Consensus       173 l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---------QmlMLR~I  240 (411)
T KOG0599|consen  173 LEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---------QMLMLRMI  240 (411)
T ss_pred             cCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---------HHHHHHHH
Confidence            887764   35567999999999996542    358889999999999999999999985211         11111111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....   -...++...+++..+.+||.+||++||++|.|++|+++
T Consensus       241 meGk---yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  241 MEGK---YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             Hhcc---cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1111   12345566788999999999999999999999999986

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-38  Score=318.90  Aligned_cols=249  Identities=29%  Similarity=0.458  Sum_probs=200.9

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.+.||+|+||.||++...++..+|+|.+.......+.+.+|++++++++||||+++++++......++||||+++|+|
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L   86 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL   86 (256)
T ss_pred             EEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence            34678999999999999987788999999876555567889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....     ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||.++........ .
T Consensus        87 ~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05114          87 LNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S  157 (256)
T ss_pred             HHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence            99997642     358899999999999999999999   99999999999999999999999999998865433221 1


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      .....++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.....       .... ..+.....       .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~-~~i~~~~~-------~  220 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVV-EMISRGFR-------L  220 (256)
T ss_pred             cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHH-HHHHCCCC-------C
Confidence            1233456789999998754  67889999999999999999 8888864321       1111 11111100       0


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ..+...+.++.+++.+||+.+|++||+++++++.|+
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            111123457899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-38  Score=320.12  Aligned_cols=251  Identities=25%  Similarity=0.424  Sum_probs=204.3

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.++||+|++|.||+|...+++.||+|.+.......+.+.+|+.++++++|+||+++++.+...+..++++||+++++|
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (261)
T cd05072           9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL   88 (261)
T ss_pred             EEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence            45789999999999999987888999999876555567889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....    ...+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||++......... .
T Consensus        89 ~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~  160 (261)
T cd05072          89 LDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-A  160 (261)
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-c
Confidence            99997642    2468889999999999999999999   99999999999999999999999999999876543321 1


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      .....++..|+|||++.+.  .++.++||||||+++|+|++ |+.||......        .........       ...
T Consensus       161 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~-------~~~  223 (261)
T cd05072         161 REGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRG-------YRM  223 (261)
T ss_pred             cCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcC-------CCC
Confidence            2334457789999998654  67889999999999999998 88888643211        011111110       011


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      .....++.++.+++.+||+.+|++||+++++++.|++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1112345678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.5e-39  Score=322.36  Aligned_cols=253  Identities=23%  Similarity=0.388  Sum_probs=200.6

Q ss_pred             HhhhhcccCcCcceeEEEEEEc----CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.+.||+|+||.||+|.+.    .+..||+|+++....  ....+.+|+..+++++||||+++++++..+...++||
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   85 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT   85 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence            4456789999999999999753    356899999876532  2357889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++++|.+++....     ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+|++|||.+...
T Consensus        86 e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          86 EYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999997643     468999999999999999999999   99999999999999999999999999987654


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ...... ......++..|+|||.+.+.  .++.++||||||+++||+++ |+.||......       . ........  
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~-~~~~~~~~--  224 (266)
T cd05064         158 KSEAIY-TTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------D-VIKAVEDG--  224 (266)
T ss_pred             cccchh-cccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------H-HHHHHHCC--
Confidence            322111 11223356789999998664  78899999999999999775 99998643211       1 11111110  


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                           .....+...+..+.+++.+||+.+|++||++++|++.|+++
T Consensus       225 -----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 -----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 11112233566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-39  Score=333.28  Aligned_cols=241  Identities=24%  Similarity=0.332  Sum_probs=196.6

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||+|++....    ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  100 (329)
T PTZ00263         21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV  100 (329)
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence            45789999999999999864 58899999987532    23456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       101 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263        101 VGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             CCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999999864      458899999999999999999999   99999999999999999999999999999876443


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+... .... 
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~-~~~~-  234 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAG-RLKF-  234 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcC-CcCC-
Confidence            2     224589999999999765  678999999999999999999999864321        1111111111 0111 


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  598 (638)
                            +..++.++.+|+.+||+.||++||+     +++++.+
T Consensus       235 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 ------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                  1123456889999999999999987     6777754

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=320.85  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=194.9

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---------------chhhHHHHHHHHhhcCCcceEEEEeEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---------------NGEDFINEVASISRTSHVNIVTLLGFCF  388 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~~~~~  388 (638)
                      |.+.+.||+|.||+|-+|+. .+++.||||++.+...               ..+...+|+.+|++++|||||+|+++..
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            34567899999999999984 5689999999965421               1256789999999999999999999887


Q ss_pred             e--CceEEEEEEeccCCCHHHHhhhcCCCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc
Q 006620          389 E--GHRRALIYEFVSNGSLEKFIHEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC  465 (638)
Q Consensus       389 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~  465 (638)
                      +  .+.+|||+|||..|.+...=.       ... +++.+++++++.++.||+|||.   +|||||||||+|+||+++|.
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p~-------d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCPP-------DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             CcccCceEEEEEeccCCccccCCC-------CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence            5  467899999999887754321       233 8999999999999999999999   99999999999999999999


Q ss_pred             eEEcccccceeccCCC---ceeeecccccccceecCceecccc--CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc
Q 006620          466 PKISDFGLAKICEGRE---SIVSMTGARGTIGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE  540 (638)
Q Consensus       466 ~kl~DFg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~  540 (638)
                      |||+|||.+.......   ........+|||.|+|||...+..  ...+.+.||||+||+||.|+-|+-||.....    
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----  324 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----  324 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----
Confidence            9999999998663221   111123367999999999986521  2346788999999999999999999875431    


Q ss_pred             cchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006620          541 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML  599 (638)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  599 (638)
                          ...+.+      +.-..+......+...++.+||.++|+.||+.|.+..+|..+.
T Consensus       325 ----~~l~~K------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  325 ----LELFDK------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ----HHHHHH------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                111111      1112222222235567889999999999999999999998644

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.9e-39  Score=320.90  Aligned_cols=252  Identities=32%  Similarity=0.509  Sum_probs=203.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      .+.++||+|++|.||+|... +++.||+|++........++.+|++++++++|+||+++++++..+...+++|||+++++
T Consensus         9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (263)
T cd05052           9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN   88 (263)
T ss_pred             EEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence            45789999999999999854 58899999988665556788999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||++......... 
T Consensus        89 L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          89 LLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             HHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            999997643    2458999999999999999999999   99999999999999999999999999999876543221 


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......++..|+|||.+.+.  .++.++||||||+++|||++ |..||.....       ... ......       ...
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~-~~~~~~-------~~~  223 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQV-YELLEK-------GYR  223 (263)
T ss_pred             ccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHH-HHHHHC-------CCC
Confidence            11222346789999988654  67889999999999999998 8888764321       111 111111       011


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ...+...+.++.+++.+||+.+|++||++.++++.|+++
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            112223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.2e-40  Score=317.65  Aligned_cols=258  Identities=26%  Similarity=0.312  Sum_probs=195.4

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCce-----EEEEEEecc
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHR-----RALIYEFVS  401 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e~~~  401 (638)
                      .+++|.|+||.||+|+. .+++.||||....++.-.   -+|+++|+++.|||||++.-+|.....     ..+|||||+
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP  105 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP  105 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence            57899999999999985 447899999887665433   379999999999999999998875322     347999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC-CceEEcccccceeccCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICEGR  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFg~~~~~~~~  480 (638)
                      . +|.++++...  .....++...++-+..||.+||+|||+   .+|+||||||+|+|+|.+ |.+||+|||.|+.+...
T Consensus       106 ~-tL~~~~r~~~--~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  106 E-TLYRVIRHYT--RANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             H-HHHHHHHHHh--hcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            6 9999998532  112567778889999999999999999   999999999999999965 99999999999998877


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHH----HHHhhhhh-
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWV----YKRLELEE-  555 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~-  555 (638)
                      +...++   ..|..|+|||++.|. ..|+.+.||||.||++.||+-|++-|.......+-.......    .+.+.... 
T Consensus       180 epniSY---icSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  180 EPNISY---ICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             CCceeE---EEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            765543   348899999999886 589999999999999999999999998754422110000000    00000000 


Q ss_pred             ---hccccCCC-----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          556 ---DLGLQGIE-----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       556 ---~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                         ....+.+.     .-.......+..+|+.++|+.+|.+|.++.|++.+
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence               00001110     11223446678999999999999999999999853

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=319.29  Aligned_cols=253  Identities=25%  Similarity=0.416  Sum_probs=204.7

Q ss_pred             HhhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.+.+.||+|++|.||+|...+++.||+|.++......+++.+|++++++++||||+++++++...+..+++|||++++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYG   86 (261)
T ss_pred             heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCC
Confidence            34567899999999999999877889999999876555678899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....... 
T Consensus        87 ~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05068          87 SLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-  158 (261)
T ss_pred             cHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence            9999997642    2468999999999999999999999   9999999999999999999999999999987653221 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      ....+...+..|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ..........       .
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~-------~  221 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQG-------Y  221 (261)
T ss_pred             cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcC-------C
Confidence            111222335689999998764  68899999999999999999 8888864321        0011111110       0


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ........+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            011122345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-39  Score=314.18  Aligned_cols=246  Identities=22%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             HhhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCc----hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGN----GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .|++.+.||+|.||+|-+|+ ...|+.||||.+++++-.    .-.+.+|+++|..|+||||+.+|.+|+..+...||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            44567899999999999998 577999999999876422    2356789999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |..+|.|.||+.+.      +.|++..++.+++||++|+.|+|+   .+++|||||.+|||+|.++++||+|||++..+.
T Consensus       134 YaS~GeLYDYiSer------~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  134 YASGGELYDYISER------GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             ecCCccHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            99999999999886      579999999999999999999999   999999999999999999999999999999887


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....   ....+|+|-|.+||++.|. ..-.+.+|-|||||+||.|+.|..||+..+..       ..+ +.+..+.   
T Consensus       205 ~~kf---LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lv-rQIs~Ga---  269 (668)
T KOG0611|consen  205 DKKF---LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLV-RQISRGA---  269 (668)
T ss_pred             cccH---HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHH-HHhhccc---
Confidence            6654   3456789999999999876 23467899999999999999999999865421       111 1111111   


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML  599 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  599 (638)
                         .   ...+.+.+..-||++||.+||++|.|+.+|..+.
T Consensus       270 ---Y---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  270 ---Y---REPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ---c---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence               0   1111233566799999999999999999999875

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=332.08  Aligned_cols=249  Identities=20%  Similarity=0.273  Sum_probs=200.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.++||+|+||.||+|+.. +++.||||+++...    .....+.+|++++.+++||||+++++++......++||||+
T Consensus         4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   83 (333)
T cd05600           4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV   83 (333)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence            45689999999999999965 58899999997542    23456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~  154 (333)
T cd05600          84 PGGDFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY  154 (333)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence            999999999764      458899999999999999999999   99999999999999999999999999999865431


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                           .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .....+.........
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~~~~  219 (333)
T cd05600         155 -----ANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--------ETWENLKYWKETLQR  219 (333)
T ss_pred             -----cCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHH--------HHHHHHHhccccccC
Confidence                 2345689999999999765  7889999999999999999999998743211        011111110000000


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ..........+.++.+++.+||+.+|++||++++++++
T Consensus       220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            01111112346778999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=328.49  Aligned_cols=238  Identities=19%  Similarity=0.269  Sum_probs=191.4

Q ss_pred             cCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          331 LGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       331 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ||+|+||+||+|+.. +++.||+|++...    ......+.+|+.++++++||||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999864 5789999998643    23345678899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++...      ..+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  149 (312)
T cd05585          81 FHHLQRE------GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K  149 (312)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence            9999764      458899999999999999999999   9999999999999999999999999999885432221  1


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....       .... ..... ..       ..
T Consensus       150 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~-~~~~~-~~-------~~  211 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMY-RKILQ-EP-------LR  211 (312)
T ss_pred             cccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHH-HHHHc-CC-------CC
Confidence            2345689999999999764  688999999999999999999999964321       1111 11110 00       11


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPS---MNRVVE  597 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  597 (638)
                      .+...+.++.+++.+||+.||++||+   +.+++.
T Consensus       212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            12234567889999999999999986   455554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-38  Score=330.52  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=198.5

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +...+.||+|+||.||+++.. ++..||+|++.....  ..+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   86 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   86 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence            345678999999999999864 578899999875432  23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||++.......
T Consensus        87 ~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          87 GGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            99999999764      3588999999999999999999971  369999999999999999999999999987654322


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhH----------------
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH----------------  545 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~----------------  545 (638)
                          .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...........+..                
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence                1334689999999999764  688999999999999999999999964322100000000                


Q ss_pred             ----------------HHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          546 ----------------WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       546 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                                      ...........+............++.++.+|+.+||+.||++|||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                            00000000000000000011112356678999999999999999999999974

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=311.43  Aligned_cols=260  Identities=25%  Similarity=0.282  Sum_probs=200.2

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEeccc---CCchhhHHHHHHHHhhcCCcceEEEEeEEEe-----CceEEEEEE
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFE-----GHRRALIYE  398 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e  398 (638)
                      .+.||+|+||.|+.+.. .+|+.||||.+...   ....++..+|+.+|+.++|+||+.+.+++..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            46799999999999984 56899999988742   2334678899999999999999999998875     457899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      +| +.+|...|+.+      ..++.+.+..++.|++.||.|+|+   .+|+||||||.|++++.+..+||+|||+|+...
T Consensus       107 lM-etDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  107 LM-ETDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             HH-hhHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecc
Confidence            99 55999999875      459999999999999999999999   999999999999999999999999999999886


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch-------hHHHHHHh
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF-------PHWVYKRL  551 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~  551 (638)
                      ........+..+.|..|.|||++... ..|+.+.||||+|||+.||++|++-|...+...+-...       .......+
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            54222334667789999999999654 68999999999999999999999998765432110000       00111111


Q ss_pred             hhh---hhcc-ccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          552 ELE---EDLG-LQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       552 ~~~---~~~~-~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ...   ..+. ......    .........+.+|+.+||..||.+|+|++|.+++
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            100   0000 011110    0111334568899999999999999999999973

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=329.31  Aligned_cols=241  Identities=23%  Similarity=0.273  Sum_probs=196.2

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||+|++....    ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   83 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV   83 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence            35688999999999999864 58899999986432    23456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..+..++.|+++||+|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          84 PGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999999764      458899999999999999999999   99999999999999999999999999999866432


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        ......+... ..   
T Consensus       155 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~-~~---  215 (291)
T cd05612         155 T-----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAG-KL---  215 (291)
T ss_pred             c-----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-Cc---
Confidence            2     234589999999998764  678999999999999999999999864321        1111111111 01   


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  598 (638)
                          ..+......+.+++.+||+.||++||+     +++++++
T Consensus       216 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 ----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                111123457889999999999999995     8888865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.5e-38  Score=316.63  Aligned_cols=249  Identities=25%  Similarity=0.470  Sum_probs=201.1

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.+.||+|+||+||+|...++..+|+|.+.......+.+.+|+.++++++||||+++++++......++||||+++++|
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   86 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL   86 (256)
T ss_pred             EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence            45788999999999999887777899999876555567889999999999999999999999988889999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....     ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.++........ .
T Consensus        87 ~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05113          87 LNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S  157 (256)
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence            99997643     368999999999999999999999   99999999999999999999999999998866443321 2


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      .....++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.....       ... .......       ...
T Consensus       158 ~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~-~~~~~~~-------~~~  220 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SET-VEKVSQG-------LRL  220 (256)
T ss_pred             cCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHH-HHHHhcC-------CCC
Confidence            2233456789999998754  67889999999999999998 8888753221       111 1111111       011


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ......+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            111123567899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-38  Score=328.35  Aligned_cols=241  Identities=22%  Similarity=0.307  Sum_probs=195.0

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.||+|+||.||+++. .+++.||+|++....    .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999985 468899999997532    23456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-  150 (328)
T cd05593          81 ELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-  150 (328)
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence            999988764      468999999999999999999999   9999999999999999999999999999875432211 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                       ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......       ... ..... ...      
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~-~~~~~-~~~------  212 (328)
T cd05593         151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLF-ELILM-EDI------  212 (328)
T ss_pred             -ccccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHH-HHhcc-CCc------
Confidence             12335689999999999764  6789999999999999999999998643211       100 11100 000      


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                       ..+..++.++.+++.+||+.||++||     ++++++++
T Consensus       213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         213 -KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence             11123456788999999999999997     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5e-39  Score=322.21  Aligned_cols=249  Identities=30%  Similarity=0.542  Sum_probs=194.3

Q ss_pred             hhcccCcCcceeEEEEEEc-----CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLL-----DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.||.|.||.||+|.+.     .+..|+||+++....  ..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999876     256899999965433  257899999999999999999999999988889999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.++|....    ...+++..++.|+.|+++||+|||+   .+++|+||+++||++++++.+||+|||++.....
T Consensus        83 ~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             -TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            99999999999862    2568999999999999999999999   8999999999999999999999999999988744


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...............|+|||.+.+.  .++.++||||||+++|||++ |+.|+.....       ... ...+.....  
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-------~~~-~~~~~~~~~--  223 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-------EEI-IEKLKQGQR--  223 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-------HHH-HHHHHTTEE--
T ss_pred             ccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc-------ccc-ccccccccc--
Confidence            3333333445578899999999765  58999999999999999999 6777654321       111 111111111  


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML  599 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  599 (638)
                           ...+..++..+.+++.+||+.+|++|||+++|++.|
T Consensus       224 -----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 -----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 112223466788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-38  Score=328.10  Aligned_cols=241  Identities=23%  Similarity=0.319  Sum_probs=194.2

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.||+|+||.||+++. .+++.||+|+++...    .....+.+|++++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999985 468899999987532    23346678999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-  150 (323)
T cd05595          81 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  150 (323)
T ss_pred             cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence            999988764      468999999999999999999999   9999999999999999999999999999875322221 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       . ....... ...      
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~-~~~~~~~-~~~------  212 (323)
T cd05595         151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------R-LFELILM-EEI------  212 (323)
T ss_pred             -ccccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhc-CCC------
Confidence             12335689999999999764  6789999999999999999999998643211       0 0011100 001      


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                       ..+..++.++.+++.+||+.||++||     ++.+++++
T Consensus       213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence             01123456788999999999999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-40  Score=301.11  Aligned_cols=247  Identities=23%  Similarity=0.323  Sum_probs=202.1

Q ss_pred             hhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.+.+.||+|.|+.|+++. ..+|+.+|+|+++..+   ..-+++.+|+.+-+.|+||||+++++...+....|+|+|+|
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            3456889999999999986 4568999999886532   34577889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC---CCCceEEcccccceec
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKIC  477 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFg~~~~~  477 (638)
                      .|++|..-|-..      -.+++..+...++||++||+|.|.   .+|||||+||+|+++.   ...-+||+|||++...
T Consensus        93 ~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   93 TGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             cchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999997766543      357888899999999999999999   9999999999999994   3456999999999988


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ....   ...+.+|||+|+|||++...  +++..+|||+.||+||-|+.|.+||......        ..++.+.... .
T Consensus       164 ~~g~---~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------rlye~I~~g~-y  229 (355)
T KOG0033|consen  164 NDGE---AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYEQIKAGA-Y  229 (355)
T ss_pred             CCcc---ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------HHHHHHhccc-c
Confidence            7332   35778899999999999765  8999999999999999999999999864321        1122222211 1


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                         .........++.+..+|+++||..||.+|.|+.|.++
T Consensus       230 ---d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 ---DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ---CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence               1122234456778899999999999999999998875

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.9e-38  Score=315.40  Aligned_cols=248  Identities=26%  Similarity=0.427  Sum_probs=195.7

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      +.||+|+||.||+|.. .+++.||+|......  .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999985 468899999876432  2345788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          81 LTFLRTEG-----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99997542     458899999999999999999999   9999999999999999999999999999876543221111


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      ......+..|+|||.+.+.  .++.++||||||+++|||++ |..|+......        ........       ....
T Consensus       153 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~-------~~~~  215 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQ-------GVRL  215 (252)
T ss_pred             CCCCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHc-------CCCC
Confidence            1112235679999998654  67889999999999999997 88887543211        01111110       1111


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ..+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            1222345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=354.40  Aligned_cols=259  Identities=29%  Similarity=0.500  Sum_probs=211.7

Q ss_pred             hhcccCcCcceeEEEEEEcC--CC----EEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLLD--GQ----NVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.||+|+||.||.|...+  +.    .||||.+++..  ....+|++|..+|+.++|||||+++|++.+....++++|
T Consensus       696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le  775 (1025)
T KOG1095|consen  696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE  775 (1025)
T ss_pred             eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence            46789999999999998543  33    48999988754  445789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          399 FVSNGSLEKFIHEKHPLE-TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||++|+|..+|++.+... ....++...++.++.+||+|+.||++   +++|||||..+|+||++...|||+|||+|+.+
T Consensus       776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDI  852 (1025)
T ss_pred             hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence            999999999999874322 24568999999999999999999999   99999999999999999999999999999966


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      .+.+.+.......-+..|||||.+..  +.++.|+|||||||++||++| |..||.......        +...      
T Consensus       853 y~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~~~------  916 (1025)
T KOG1095|consen  853 YDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VLLD------  916 (1025)
T ss_pred             hhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HHHH------
Confidence            65554433333345689999999976  489999999999999999997 567776443210        0010      


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      . ..+-+.+.+..++..+.+++.+||+.+|++||++..|++.+.++...
T Consensus       917 ~-~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  917 V-LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             H-HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            0 11114455566788899999999999999999999999998876543

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-38  Score=315.90  Aligned_cols=249  Identities=29%  Similarity=0.478  Sum_probs=200.9

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.+.||+|+||.||++.+.+++.+|+|++.........+.+|++++++++||||+++++++......++||||+++++|
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL   86 (256)
T ss_pred             chhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence            35788999999999999987777899999876555556788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....     ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++........ .
T Consensus        87 ~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~  157 (256)
T cd05059          87 LNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S  157 (256)
T ss_pred             HHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence            99998643     368999999999999999999999   99999999999999999999999999998865433211 1


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      .....++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||......       . ........       ...
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~-~~~~~~~~-------~~~  220 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------E-VVESVSAG-------YRL  220 (256)
T ss_pred             cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------H-HHHHHHcC-------CcC
Confidence            1222345689999998764  67889999999999999998 78888643211       0 01111111       111


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ..+...+.++.+++.+||+.+|++|||+.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            112234667999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-38  Score=326.33  Aligned_cols=258  Identities=25%  Similarity=0.346  Sum_probs=194.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.++||+|+||+||+|+.. +++.||||++....  .....+.+|+.++++++||||+++++++.++...++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH   86 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence            345789999999999999864 68899999987543  223467889999999999999999999999999999999995


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                       ++|.+++....     ..+++..+..++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||++.......
T Consensus        87 -~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          87 -TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             -cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence             68888887643     458899999999999999999999   999999999999999999999999999987543222


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh--------
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL--------  553 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  553 (638)
                      .  ......+|+.|+|||++.+. ..++.++||||+||++|||++|+.||..........  .. .......        
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~-~~~~~~~~~~~~~~~  231 (303)
T cd07869         158 H--TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL--ER-IFLVLGTPNEDTWPG  231 (303)
T ss_pred             c--cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH--HH-HHHHhCCCChhhccc
Confidence            1  12345678999999998654 357889999999999999999999997543211000  00 0000000        


Q ss_pred             ---hhhccccCC---CCchh------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 ---EEDLGLQGI---ENEED------KEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ---~~~~~~~~~---~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                         .........   .....      ...+.++.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence               000000000   00000      012356789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.9e-38  Score=314.66  Aligned_cols=254  Identities=28%  Similarity=0.472  Sum_probs=204.9

Q ss_pred             HHHhhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          322 KMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       322 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ...+++.++||+|+||.||+|...+++.||+|.+.......+.+.+|+.++++++|+||+++++++. .+..+++|||++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            4455678999999999999999888899999999876666778999999999999999999999864 567899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++.......
T Consensus        84 ~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          84 NGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999987642    2468999999999999999999999   999999999999999999999999999998765332


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .. ......++..|+|||++.+.  .++.++||||||+++|||++ |+.||.....       +... ......      
T Consensus       157 ~~-~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~-~~~~~~------  219 (260)
T cd05067         157 YT-AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-------PEVI-QNLERG------  219 (260)
T ss_pred             cc-cccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCCh-------HHHH-HHHHcC------
Confidence            21 11233457789999998654  67889999999999999998 9999864321       1111 111110      


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                       .........+.++.+++.+||+.+|++||++++++..|+.
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 -YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             0111112335679999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.2e-38  Score=318.63  Aligned_cols=256  Identities=26%  Similarity=0.460  Sum_probs=203.1

Q ss_pred             hhhcccCcCcceeEEEEEEcC-C-----CEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD-G-----QNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.||+|+||.||+|.... +     +.||+|.++....  ....+.+|+.++++++||||+++++++......+++|
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            357899999999999998533 2     5799999875432  2356889999999999999999999999989999999


Q ss_pred             EeccCCCHHHHhhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceE
Q 006620          398 EFVSNGSLEKFIHEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK  467 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  467 (638)
                      ||+++++|.+++.......          ....+++..++.++.|+++||+|||+   .+++|+||||+||++++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEE
Confidence            9999999999998653211          11458899999999999999999999   9999999999999999999999


Q ss_pred             EcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHH
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHW  546 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  546 (638)
                      |+|||+++...............+++.|+|||.+.+.  .++.++|||||||++|||++ |..||......        .
T Consensus       165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--------~  234 (283)
T cd05048         165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------E  234 (283)
T ss_pred             ECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------H
Confidence            9999999865443322222334568899999998654  68899999999999999998 99888643211        1


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ....+.       .......+..++.++.+|+.+||+.||.+||++++|+++|+.
T Consensus       235 ~~~~i~-------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIR-------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHH-------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            111111       111112234556789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-38  Score=330.06  Aligned_cols=243  Identities=24%  Similarity=0.306  Sum_probs=197.4

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC--CCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD--GQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.+.||+|+||.||+|...+  +..||+|++....    ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            34567899999999999998543  3589999986432    23456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       111 Ey~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        111 EFVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999865      458899999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ....     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+.... .
T Consensus       182 ~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~~-~  245 (340)
T PTZ00426        182 DTRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEGI-I  245 (340)
T ss_pred             CCCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcCC-C
Confidence            4322     234689999999999764  678899999999999999999999974321        11111111110 0


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                             ..+...+..+.+++.+||+.||++|+     ++++++++
T Consensus       246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                   01122345678999999999999995     89998875

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.3e-38  Score=333.28  Aligned_cols=260  Identities=25%  Similarity=0.420  Sum_probs=202.9

Q ss_pred             hhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCC--chhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKG--NGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  396 (638)
                      .+.++||+|+||+||+|....      +..||||+++....  ..+.+.+|+++++++. ||||+++++++.+....++|
T Consensus        40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv  119 (400)
T cd05105          40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII  119 (400)
T ss_pred             ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence            357899999999999997421      24699999975432  3457889999999996 99999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCC-------------------------------------------------------------
Q 006620          397 YEFVSNGSLEKFIHEKHPL-------------------------------------------------------------  415 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~-------------------------------------------------------------  415 (638)
                      |||+++|+|.++|......                                                             
T Consensus       120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (400)
T cd05105         120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK  199 (400)
T ss_pred             EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence            9999999999998764210                                                             


Q ss_pred             -----------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCce
Q 006620          416 -----------------------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP  466 (638)
Q Consensus       416 -----------------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~  466 (638)
                                                   .....+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~  276 (400)
T cd05105         200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIV  276 (400)
T ss_pred             hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEE
Confidence                                         011347888999999999999999999   999999999999999999999


Q ss_pred             EEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhH
Q 006620          467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPH  545 (638)
Q Consensus       467 kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  545 (638)
                      ||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||......       .
T Consensus       277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-------~  347 (400)
T cd05105         277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-------S  347 (400)
T ss_pred             EEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchh-------H
Confidence            99999999876443322222334467889999998764  67899999999999999996 88888643211       0


Q ss_pred             HHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ........       +.........+.++.+++.+||+.+|++|||+.+|.++|+++++
T Consensus       348 ~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 TFYNKIKS-------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHHhc-------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11111111       11111223456788999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-38  Score=324.42  Aligned_cols=261  Identities=20%  Similarity=0.247  Sum_probs=196.3

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.+.+.||+|+||+||+++.. +++.||+|+++...   ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            345788999999999999964 57899999987542   23456789999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +++.+..+....      ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          83 EKNMLELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            987666544321      468999999999999999999999   99999999999999999999999999999876433


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch-------hHHHHHHhhh
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF-------PHWVYKRLEL  553 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~  553 (638)
                      ... ......||+.|+|||++.+.  .++.++|||||||++|||++|++||............       +.........
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         154 SNA-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccc-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            211 12334689999999998764  6789999999999999999999999754321100000       0000000000


Q ss_pred             hh---hccccCCC--C----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 EE---DLGLQGIE--N----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ~~---~~~~~~~~--~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..   ........  .    ......+.++.+|+.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00   00000000  0    011124667999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.4e-38  Score=326.96  Aligned_cols=256  Identities=25%  Similarity=0.425  Sum_probs=200.8

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCC----EEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQ----NVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      +...+.||+|+||+||+|++. +++    .||+|+++...  ...+++.+|+.+++.++||||++++|++... ..++++
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            345688999999999999853 333    48999987543  2346788999999999999999999998764 567999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++..
T Consensus        88 e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          88 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999998753     458899999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      .............++..|+|||++.+.  .++.++||||||+++|||++ |+.||......       . ......... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~-~~~~~~~~~-  228 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------E-ISSILEKGE-  228 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHhCCC-
Confidence            654433333334457789999998664  78899999999999999997 89988643210       1 011111110 


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                            ....+.....++.+++.+||+.+|++||++.+++..|.++....
T Consensus       229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                  01111123456889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.6e-38  Score=323.76  Aligned_cols=261  Identities=22%  Similarity=0.318  Sum_probs=195.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      |.+.++||+|+||+||+|+.. +++.||+|+++...  .....+.+|++++++++||||+++++++......++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            345688999999999999854 58899999986542  233467899999999999999999999999999999999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      + +|.+++....     ..+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        87 ~-~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          87 S-DLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             c-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            5 9999987643     457899999999999999999999   999999999999999999999999999997654322


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch-------hHHHHHHhhhh
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF-------PHWVYKRLELE  554 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~  554 (638)
                      .  ......+++.|+|||++.+. ..++.++||||+||++|||++|++||............       +...+......
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         158 K--TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             c--cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            1  12334578999999998653 35788999999999999999999998653321100000       00000000000


Q ss_pred             h---hccccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 E---DLGLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~---~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .   ..........    .......++.+|+.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0   0000000000    01123456889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-38  Score=315.41  Aligned_cols=252  Identities=28%  Similarity=0.485  Sum_probs=201.5

Q ss_pred             hhhcccCcCcceeEEEEEEcC----CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||+||+|++..    ...||||+++....  ...++.+|+.++++++||||+++++.+...+..+++|||
T Consensus         7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   86 (266)
T cd05033           7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY   86 (266)
T ss_pred             eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence            457899999999999998642    35799999875432  345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....     ..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||+++....
T Consensus        87 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          87 MENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             CCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999997643     468999999999999999999999   9999999999999999999999999999987753


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...........++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......       . .......     
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~-~~~~~~~-----  223 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------D-VIKAVED-----  223 (266)
T ss_pred             cccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHH-------H-HHHHHHc-----
Confidence            2222222233456789999998754  68899999999999999998 88887533211       1 1111110     


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                        ..........+..+.+++.+||+.+|++||++++|+++|+++
T Consensus       224 --~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 --GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              001111223456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.8e-38  Score=314.21  Aligned_cols=253  Identities=29%  Similarity=0.454  Sum_probs=202.6

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.++||+|+||+||+|.+.+...||+|+++......+.+.+|++++++++||||+++++.+. ....++||||+++++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~   86 (262)
T cd05071           8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS   86 (262)
T ss_pred             eeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence            4567899999999999998777678999999865555667899999999999999999999874 456789999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||.++.........
T Consensus        87 L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          87 LLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             HHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999997642    2457899999999999999999999   999999999999999999999999999998765433211


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                       .....++..|+|||++.+.  .++.++||||||+++|||++ |+.||......        ........       ...
T Consensus       160 -~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~-------~~~  221 (262)
T cd05071         160 -RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVER-------GYR  221 (262)
T ss_pred             -ccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhc-------CCC
Confidence             1233457789999988654  68899999999999999999 77787643211        11111110       111


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      .......+..+.+++.+|++.+|++||+++++++.|+..+
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            1112345677899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.8e-38  Score=320.33  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=204.3

Q ss_pred             HhhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      .+.+.+.||+|+||+||++...      ++..+|+|.+.... ...+.+.+|++++++++||||+++++++......++|
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   85 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            3445789999999999999742      24568999887543 2345788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEc
Q 006620          397 YEFVSNGSLEKFIHEKHPL-------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS  469 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  469 (638)
                      +||+++++|.+++......       .....+++..++.++.|++.||+|||+   ++++||||||+||++++++.+||+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~  162 (288)
T cd05093          86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG  162 (288)
T ss_pred             EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEec
Confidence            9999999999999764310       112358999999999999999999999   999999999999999999999999


Q ss_pred             ccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHH
Q 006620          470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVY  548 (638)
Q Consensus       470 DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  548 (638)
                      |||+++...............++..|+|||++.+.  .++.++||||||+++|+|++ |..||......       . ..
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~-~~  232 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------E-VI  232 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HH
Confidence            99999866443322222233457789999998654  67889999999999999998 88887543211       0 11


Q ss_pred             HHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ........       .......+.++.+++.+||+.||.+|||++++++.|+++.+.
T Consensus       233 ~~i~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         233 ECITQGRV-------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHHcCCc-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11111110       011112345789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.7e-37  Score=322.05  Aligned_cols=249  Identities=21%  Similarity=0.314  Sum_probs=192.6

Q ss_pred             cccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+++.. +++.||+|+++...    .....+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999854 57899999987532    2234567888888776 799999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.|++.||+|||+   ++|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~  151 (329)
T cd05618          81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  151 (329)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence            9999988764      468999999999999999999999   9999999999999999999999999999875322211


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc-ccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS-EIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                        ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||........ ......+........ ..    
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~----  222 (329)
T cd05618         152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QI----  222 (329)
T ss_pred             --ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-CC----
Confidence              12335689999999999764  678899999999999999999999964322111 111111221211111 11    


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPS------MNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  598 (638)
                         ..+...+.++.+++.+||+.||++||+      +.+++++
T Consensus       223 ---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         223 ---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               111234567889999999999999998      4566544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.5e-38  Score=316.51  Aligned_cols=256  Identities=26%  Similarity=0.421  Sum_probs=197.2

Q ss_pred             hhcccCcCcceeEEEEEEcC-CC--EEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEE
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-GQ--NVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRA  394 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  394 (638)
                      +.++||+|+||.||+|...+ ++  .+|+|.++...   ...+.+.+|++++++++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            46789999999999998644 33  58999886542   2345788899999999999999999987532      2468


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccc
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      +++||+++|+|.+++...+.......+++..+..++.|+++||+|||+   ++|+||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence            999999999999988643322223568999999999999999999999   99999999999999999999999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      +...............+++.|++||.+.+.  .++.++||||||+++|||++ |+.||......        ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~  229 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------EIYDYLRQ  229 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHc
Confidence            876543322222223457789999998764  68899999999999999998 78888642210        11111111


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ...       .......+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus       230 ~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNR-------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            110       111123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-38  Score=324.65  Aligned_cols=248  Identities=27%  Similarity=0.377  Sum_probs=210.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCce-EEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHR-RALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~  399 (638)
                      |.+.+++|+|+||.++.++. .+++.|++|.+.-.+   ...+...+|+.++++++|||||.+.+.+..++. .+|||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            45678999999999999974 457799999987543   334477899999999999999999999999888 8999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++||+|.+.|.+.+    +..++++.+..++.|++.|+.|||+   ++|.|||||+.|||++.++.|||+|||+|+.+..
T Consensus        86 ~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             cCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999998864    4679999999999999999999998   9999999999999999999999999999998876


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ....  ....+||+.|+.||++.+.  +|..|+|||||||++|||++-+++|.....       ...+.+.        .
T Consensus       159 ~~~~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki--------~  219 (426)
T KOG0589|consen  159 EDSL--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKI--------N  219 (426)
T ss_pred             chhh--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHH--------h
Confidence            6522  2456799999999999886  899999999999999999999999875432       2222111        1


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .......+..++.++..++..||+.+|+.||++.+++.+
T Consensus       220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            222344556678899999999999999999999999976

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.8e-38  Score=327.87  Aligned_cols=250  Identities=24%  Similarity=0.284  Sum_probs=195.9

Q ss_pred             hhhcccCcCcceeEEEEEE----cCCCEEEEEEecccC-----CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL----LDGQNVAIKVLNETK-----GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  395 (638)
                      .+.++||+|+||+||+++.    .+++.||+|++....     ...+.+.+|+.++++++ |+||+++++++..+...++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            3568899999999999875    357899999986432     22346778999999995 9999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++|+|.+++...      ..+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        83 v~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          83 ILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999764      458899999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ......... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.........    .........  
T Consensus       154 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~--  225 (332)
T cd05614         154 EFLSEEKER-TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILK--  225 (332)
T ss_pred             cccccCCCc-cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhc--
Confidence            654332211 1234689999999998754 24688999999999999999999999744322111    111111110  


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                         .   ....+..++..+.+++.+||+.||++||     ++++++++
T Consensus       226 ---~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 ---C---DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ---C---CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence               0   0111123456788999999999999999     67788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.6e-38  Score=325.07  Aligned_cols=241  Identities=26%  Similarity=0.330  Sum_probs=193.0

Q ss_pred             cccCcCcceeEEEEEE----cCCCEEEEEEecccC-----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          329 NKLGQGGYGGVYKGKL----LDGQNVAIKVLNETK-----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      ++||+|+||.||+++.    .+++.||||+++...     .....+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    347889999987532     2234567899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++...      ..+.+..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          82 LSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             CCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            9999999999764      457888999999999999999999   9999999999999999999999999999875432


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ....  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       ... ...... ..  
T Consensus       153 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~-~~~~~~-~~--  217 (323)
T cd05584         153 EGTV--THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTI-DKILKG-KL--  217 (323)
T ss_pred             CCCc--ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHH-HHHHcC-CC--
Confidence            2211  1234689999999999764  6788999999999999999999998743211       111 111100 00  


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                           ..+...+.++.+++.+||+.+|++||     ++++++++
T Consensus       218 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 -----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                 11122356788999999999999999     78888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-38  Score=332.79  Aligned_cols=255  Identities=20%  Similarity=0.225  Sum_probs=193.6

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      |.+.+.||+|+||.||++.. .+++.||+|...     ...+.+|++++++++||||+++++++..+...++|+|++. +
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~  167 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T  167 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence            45678999999999999985 458899999753     2456789999999999999999999999999999999995 6


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++...      ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       168 ~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        168 DLYCYLAAK------RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            898888764      458899999999999999999999   9999999999999999999999999999975432211 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccc----hhHHH------------
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY----FPHWV------------  547 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~----~~~~~------------  547 (638)
                      .......||+.|+|||++.+.  .++.++|||||||++|||++|+.|+...........    +....            
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            112345689999999999764  688999999999999999999987653322111000    00000            


Q ss_pred             ------HHHh-hhhhh-ccccCCC--CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          548 ------YKRL-ELEED-LGLQGIE--NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       548 ------~~~~-~~~~~-~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            .... ..... .......  .......+.++.+|+.+||+.||++|||++|+++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  0000 00000 0000001  1122245667899999999999999999999995

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.1e-38  Score=313.79  Aligned_cols=251  Identities=29%  Similarity=0.494  Sum_probs=204.8

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.++||.|+||+||+|...+++.+++|++..... ..+.+.+|+.+++.++|+||+++++++......++||||++++
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG   87 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence            456789999999999999987889999999876544 4567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....    ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.+.........
T Consensus        88 ~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          88 SLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             CHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999998643    2568999999999999999999999   89999999999999999999999999999866433211


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        .....++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.....        ........       ...
T Consensus       161 --~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~-------~~~  221 (261)
T cd05148         161 --SSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQIT-------AGY  221 (261)
T ss_pred             --ccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHH-------hCC
Confidence              1234467789999998654  67889999999999999998 7888864321        00111111       111


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ....+...+..+.+++.+||+.||++|||++++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            111122345678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.3e-38  Score=327.17  Aligned_cols=261  Identities=22%  Similarity=0.331  Sum_probs=197.4

Q ss_pred             HHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          323 MTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       323 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      ..+.+.++||+|+||.||++... +++.+|+|++.....  ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            34556789999999999999864 578899998875432  235688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++...      ..+++..+..++.|+++||+|||+.  .+++|+||||+|||+++++.+||+|||++.....
T Consensus        85 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          85 MDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999764      4588899999999999999999971  4799999999999999999999999999876533


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh--------------H
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP--------------H  545 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~--------------~  545 (638)
                      ..    .....|+..|+|||++.+.  .++.++|||||||++|+|++|+.||.............              .
T Consensus       157 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         157 SM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            21    1234689999999999764  67889999999999999999999986433211000000              0


Q ss_pred             ------HH--H--------HHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          546 ------WV--Y--------KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       546 ------~~--~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            ..  .        ........+.............+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                  00  0        0000000000000000001123467889999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=313.39  Aligned_cols=256  Identities=27%  Similarity=0.465  Sum_probs=199.3

Q ss_pred             hhcccCcCcceeEEEEEEcC----CCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCce------E
Q 006620          327 FKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHR------R  393 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~  393 (638)
                      +.+.||+|+||.||+|....    +..||+|+++....   ..+.+.+|++.++.++||||+++++++.....      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            46789999999999998532    36799999875432   23578899999999999999999998876554      7


Q ss_pred             EEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      ++++||+++++|.+++...........+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccc
Confidence            8999999999999998664322223568999999999999999999999   8999999999999999999999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      ++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||......       . ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~-~~~~~~  229 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------E-IYDYLR  229 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHH
Confidence            9876544322211223346789999998654  67899999999999999998 88887543210       1 111111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      .       +.....+...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus       230 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 H-------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             c-------CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0       011112223466889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-37  Score=318.10  Aligned_cols=258  Identities=26%  Similarity=0.469  Sum_probs=202.3

Q ss_pred             hhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  396 (638)
                      .+.+.||+|+||.||++...+      ...+|+|++.....  ....+.+|+++++++ +|+||+++++++..+...+++
T Consensus        15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li   94 (293)
T cd05053          15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV   94 (293)
T ss_pred             EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence            456889999999999997532      35799999875432  234678999999999 799999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCce
Q 006620          397 YEFVSNGSLEKFIHEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP  466 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~  466 (638)
                      |||+++++|.++++....          ......+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~  171 (293)
T cd05053          95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVM  171 (293)
T ss_pred             EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeE
Confidence            999999999999976431          1234568999999999999999999999   999999999999999999999


Q ss_pred             EEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhH
Q 006620          467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPH  545 (638)
Q Consensus       467 kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  545 (638)
                      ||+|||+++...............++..|+|||++.+.  .++.++|||||||++|||++ |..||.....       ..
T Consensus       172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~  242 (293)
T cd05053         172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-------EE  242 (293)
T ss_pred             EeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCH-------HH
Confidence            99999999876544332222333456789999998654  67899999999999999997 8888753221       01


Q ss_pred             HHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                       ........       .....+...+.++.+++.+||+.+|++|||++++++.|+.++
T Consensus       243 -~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 -LFKLLKEG-------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -HHHHHHcC-------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence             11111111       111112233567889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-37  Score=322.56  Aligned_cols=249  Identities=21%  Similarity=0.305  Sum_probs=193.8

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+++. .+++.||||+++...    .....+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999985 458899999997532    2234577899999888 699999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++...      ..+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+++.......
T Consensus        81 g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  151 (329)
T cd05588          81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD  151 (329)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence            9999988764      468999999999999999999999   9999999999999999999999999999875322111


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc-ccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS-EIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||+....... ......+........ ...   
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~---  223 (329)
T cd05588         152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-QIR---  223 (329)
T ss_pred             --ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-CCC---
Confidence              12335689999999999764  678899999999999999999999974322111 111112222211111 111   


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPS------MNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  598 (638)
                          .+..++.++.+++.+||+.||++|++      +++++++
T Consensus       224 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 ----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                11223557889999999999999997      5677643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.5e-38  Score=326.99  Aligned_cols=251  Identities=20%  Similarity=0.243  Sum_probs=198.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+++. .+++.||+|+++....    ..+.+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ   83 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence            4578999999999999985 4688999999975422    3456778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++....     ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          84 PGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999998753     468999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CceeeecccccccceecCceeccc----cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRN----FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ... ......||+.|+|||++...    ...++.++|||||||++|||++|+.||......       ............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~  227 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRF  227 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCc
Confidence            332 22334689999999998631    135778999999999999999999998643211       111111111000


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      +.     ......++.++.+|+.+||+ +|++|||+++++++
T Consensus       228 ~~-----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         228 LK-----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             cC-----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            10     11112345678899999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9e-38  Score=330.96  Aligned_cols=249  Identities=20%  Similarity=0.233  Sum_probs=192.3

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.||+|+||+||+|+. .+++.||||++....    ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            467899999999999985 457899999996532    234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        85 gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          85 GGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999999764      458899999999999999999999   999999999999999999999999999976431100


Q ss_pred             ce---------------------------------------------eeecccccccceecCceeccccCCccccCCeee
Q 006620          482 SI---------------------------------------------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYS  516 (638)
Q Consensus       482 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvws  516 (638)
                      ..                                             .......||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceee
Confidence            00                                             001124689999999998764  6889999999


Q ss_pred             HHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHH--cccCCCCCCCCHHH
Q 006620          517 YGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLW--CIQTNPSDRPSMNR  594 (638)
Q Consensus       517 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~e  594 (638)
                      |||++|||++|+.||.......       .............     ......++.++.+++.+  |+..+|..||++++
T Consensus       234 lG~il~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~-----~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTE-------TQLKVINWENTLH-----IPPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHH-------HHHHHHccccccC-----CCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            9999999999999997533210       0001000000111     11111235677788887  44556667999999


Q ss_pred             HHHH
Q 006620          595 VVEM  598 (638)
Q Consensus       595 vl~~  598 (638)
                      ++++
T Consensus       302 ~l~h  305 (381)
T cd05626         302 IKAH  305 (381)
T ss_pred             HhcC
Confidence            9975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.1e-37  Score=318.16  Aligned_cols=260  Identities=24%  Similarity=0.423  Sum_probs=204.4

Q ss_pred             hhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.+.||+|+||.||+|+..      ++..+++|.+..... ..+.+.+|++++++++|+||+++++++......++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            35688999999999999742      245689998865443 23578899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEE
Q 006620          399 FVSNGSLEKFIHEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI  468 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  468 (638)
                      |+++++|.+++.....          ......+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEE
Confidence            9999999999976431          1122458999999999999999999999   99999999999999999999999


Q ss_pred             cccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHH
Q 006620          469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWV  547 (638)
Q Consensus       469 ~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  547 (638)
                      +|||++................++..|+|||++.+.  .++.++||||||+++|||++ |+.||......       . .
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~-~  234 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------E-V  234 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H-H
Confidence            999999765443322222334567889999998764  67889999999999999998 99987543211       1 1


Q ss_pred             HHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      .+....       +.........+..+.+++.+||+.+|++|||+++|+++|+++.+.
T Consensus       235 ~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 IECITQ-------GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHhC-------CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            111111       111111223456788999999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.8e-38  Score=327.40  Aligned_cols=262  Identities=22%  Similarity=0.287  Sum_probs=194.3

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC-----ceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG-----HRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  395 (638)
                      |.+.++||+|+||.||+|+. .+++.||||++....   .....+.+|++++++++||||+++++++...     ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            34578999999999999985 468899999987432   2334678999999999999999999988643     24799


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+. ++|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        82 v~e~~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          82 VFELME-SDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEecCC-CCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence            999995 6999998764      458999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchhHH
Q 006620          476 ICEGRES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFPHW  546 (638)
Q Consensus       476 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~  546 (638)
                      ....... ........||+.|+|||++.+....++.++|||||||++|||++|++||.........        ......
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6532221 1122345689999999998653346788999999999999999999998653321000        000000


Q ss_pred             HHHHhhh------hhhccccCCCCc---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          547 VYKRLEL------EEDLGLQGIENE---EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       547 ~~~~~~~------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      . ..+..      ...+. ......   .......++.+++.+||+.||++|||+++++++
T Consensus       232 ~-~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         232 I-SRVRNEKARRYLSSMR-KKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             H-HHhhhhhHHHHHHhhc-ccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0 00000      00000 000000   001234567899999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=329.06  Aligned_cols=236  Identities=25%  Similarity=0.351  Sum_probs=195.1

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEec
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.+.||+|.||+|+++..+ +++.+|||++++.    +...+....|.+++.... ||.++.++.+|++.+++++||||+
T Consensus       372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~  451 (694)
T KOG0694|consen  372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV  451 (694)
T ss_pred             EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence            5789999999999999854 5789999999875    355677788888888776 999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      .||++..+.+.       ..+++..+..++..|+.||.|||+   +|||+||||.+|||||.+|.+||+|||+++.....
T Consensus       452 ~Ggdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  452 AGGDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             CCCcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99995444332       579999999999999999999999   99999999999999999999999999999975432


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..  ...+..|||.|+|||++.+.  .|+.++|.|||||+|||||.|..||.....+  +      +...+..     +.
T Consensus       522 g~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--e------~FdsI~~-----d~  584 (694)
T KOG0694|consen  522 GD--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--E------VFDSIVN-----DE  584 (694)
T ss_pred             CC--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHH--H------HHHHHhc-----CC
Confidence            22  34667899999999999875  8999999999999999999999999855421  1      1111111     01


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSM  592 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  592 (638)
                         ...+.-++++...+++++|+.+|++|--+
T Consensus       585 ---~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 ---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence               11233457789999999999999999755

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2e-37  Score=310.90  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=201.4

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.++||+|+||.||+|...++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~   86 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS   86 (260)
T ss_pred             hhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence            3467889999999999999878888999999876556678899999999999999999999875 456789999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+......... 
T Consensus        87 L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          87 LLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            999997642    2458999999999999999999999   89999999999999999999999999999876543221 


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||......       .. ......       ...
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~-~~~~~~-------~~~  221 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------EV-LEQVER-------GYR  221 (260)
T ss_pred             cccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------HH-HHHHHc-------CCC
Confidence            11223356789999988653  68899999999999999998 88888643211       11 111110       111


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ...+...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11223445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=326.27  Aligned_cols=245  Identities=25%  Similarity=0.387  Sum_probs=191.3

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.++||+|+||+||+|+. .+++.||||++.....  ....+.+|++++++++|+||+++++++...+..++||||++++
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            357899999999999985 4688999999865432  2457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+.          ....+..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....... 
T Consensus       158 ~L~~~----------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        158 SLEGT----------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             ccccc----------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            98642          235667888999999999999999   9999999999999999999999999999987643321 


Q ss_pred             eeecccccccceecCceecccc---CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          484 VSMTGARGTIGYIAPEVFCRNF---GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                       ......||..|+|||++....   ...+.++|||||||++|||++|+.||......  +  ....... ..       .
T Consensus       224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~--~~~~~~~-~~-------~  290 (353)
T PLN00034        224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--D--WASLMCA-IC-------M  290 (353)
T ss_pred             -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--c--HHHHHHH-Hh-------c
Confidence             123456899999999884321   13456899999999999999999999732211  1  1111000 00       0


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ..........+.++.+|+.+||+.||++|||++|++++
T Consensus       291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01111222446678999999999999999999999974

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-37  Score=316.97  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=200.8

Q ss_pred             hhhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|+||+||+|...+      ++.||||+++.....  .+.+.+|+.++.+++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            4567889999999999998532      468999999754322  35678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCce
Q 006620          397 YEFVSNGSLEKFIHEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP  466 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~  466 (638)
                      +||+++++|.+++.....          ......+++..+..++.|+++||+|||+   .+++||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence            999999999999864321          0112358889999999999999999999   999999999999999999999


Q ss_pred             EEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhH
Q 006620          467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPH  545 (638)
Q Consensus       467 kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  545 (638)
                      ||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |..||.....       ..
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~  234 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QD  234 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence            99999998866544332223344567899999998653  67889999999999999998 7777653221       11


Q ss_pred             HHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      . ...+...       .........+..+.+++.+||+.+|++||++++|++.|+.
T Consensus       235 ~-~~~i~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 V-IEMIRNR-------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H-HHHHHcC-------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1 1111111       0111122456678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.4e-38  Score=325.56  Aligned_cols=242  Identities=21%  Similarity=0.296  Sum_probs=193.6

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.||+|+||+||+++. .+++.||+|+++...    .....+.+|+++++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468899999987532    23356678999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++...      ..+++..+..++.||+.||+|||+.  .+|+||||||+|||+++++.+||+|||+++........
T Consensus        81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  152 (325)
T cd05594          81 ELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  152 (325)
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence            999988764      4689999999999999999999961  69999999999999999999999999998754322211


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                        .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       .. ...... ....     
T Consensus       153 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~-~~~i~~-~~~~-----  214 (325)
T cd05594         153 --MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KL-FELILM-EEIR-----  214 (325)
T ss_pred             --cccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHH-------HH-HHHHhc-CCCC-----
Confidence              2234589999999998764  6789999999999999999999998643211       00 011100 0010     


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                        .+..++.++.+++.+||+.||++|+     ++++++++
T Consensus       215 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 --FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence              1122456788999999999999996     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6e-38  Score=341.03  Aligned_cols=251  Identities=20%  Similarity=0.238  Sum_probs=198.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cC-CCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LD-GQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.+.||+|++|.||+|.. .+ ++.||+|.+..... ....+.+|+.+++.++||||+++++++..++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            44578999999999999974 33 57888887654332 23456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|.+++....  .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       149 gg~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        149 GGDLNKQIKQRL--KEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999886532  223568899999999999999999999   999999999999999999999999999998765433


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....       ...... ....       
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~-~~~~-------  286 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQ-VLYG-------  286 (478)
T ss_pred             ccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH-HHhC-------
Confidence            22222345689999999998764  688999999999999999999999864321       111111 1000       


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....+..++.++.+++.+||+.||++||++++++.
T Consensus       287 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        287 KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            011112234567899999999999999999999875

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-37  Score=316.66  Aligned_cols=265  Identities=27%  Similarity=0.392  Sum_probs=198.1

Q ss_pred             hhhcccCcCcceeEEEEEE-----cCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-----LDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  396 (638)
                      .+.+.||+|+||+||++..     .+++.||+|+++....  ....+.+|++++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            3568899999999988642     3577899999875432  346788999999999999999999988653  467899


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++...       .+++..++.++.|++.||+|||+   ++++||||||+||++++++.+||+|||+++.
T Consensus        87 ~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccc
Confidence            9999999999999753       48999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCceee-ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          477 CEGRESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       477 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ......... .....++..|+|||.+.+.  .++.++||||||+++|||++|..|+........+...............
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            654322111 1222356779999998654  6789999999999999999999987543221000000000000000000


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ...........+...+.++.+++.+||+.+|++|||+++|++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            00011111112233467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-37  Score=315.87  Aligned_cols=257  Identities=23%  Similarity=0.408  Sum_probs=198.3

Q ss_pred             hhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|+||.||+|...      .++.||+|++.....  ...++.+|+.+++.++||||+++++++..+...++|
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   87 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI   87 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence            345789999999999998753      245799998864332  234688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLE----TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      |||+++++|.+++...+...    ....+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg  164 (277)
T cd05062          88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCC
Confidence            99999999999997643211    12346788999999999999999999   899999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      +++...............+++.|+|||++.+.  .++.++||||||+++|||++ |..||.....       .... ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~-~~~  234 (277)
T cd05062         165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVL-RFV  234 (277)
T ss_pred             CccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHH-HHH
Confidence            98865443322222223457889999998754  68899999999999999998 6778754321       1111 100


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ....   ..    ......+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       235 ~~~~---~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 MEGG---LL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HcCC---cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            0000   00    1112234578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=328.92  Aligned_cols=249  Identities=24%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||||+++...    .....+.+|++++..++||||+++++++.++...++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM   83 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence            45689999999999999864 68899999987532    33457888999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..++.++.|++.||+|||+   .||+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          84 PGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999864      468899999999999999999999   99999999999999999999999999999865433


Q ss_pred             C---------------------------ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCc
Q 006620          481 E---------------------------SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANV  533 (638)
Q Consensus       481 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~  533 (638)
                      .                           .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCC
Confidence            2                           00112335689999999999765  788999999999999999999999875


Q ss_pred             ccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 006620          534 AVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS-MNRVVEM  598 (638)
Q Consensus       534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  598 (638)
                      ....       .................     ...++.++.+++.+||+ +|++||+ +++++++
T Consensus       233 ~~~~-------~~~~~i~~~~~~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         233 DTLQ-------ETYNKIINWKESLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCHH-------HHHHHHhccCCcccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            4311       01111111001111111     11146778899999998 9999999 9999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-37  Score=316.18  Aligned_cols=260  Identities=25%  Similarity=0.421  Sum_probs=199.6

Q ss_pred             hhhhcccCcCcceeEEEEEE-----cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-----LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  395 (638)
                      +...++||+|+||.||+++.     .+++.||+|.++...  ...+.+.+|++++++++|||++++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            34568899999999999974     246789999987543  2235788999999999999999999998775  56889


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++++|.+++.+..     ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        86 v~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence            999999999999997642     458999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCC--------cccchhHH
Q 006620          476 ICEGRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS--------SEIYFPHW  546 (638)
Q Consensus       476 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~--------~~~~~~~~  546 (638)
                      ........ .......++..|+|||.+.+.  .++.++||||||+++|||++++.|........        .+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            76543321 112234567789999998654  67889999999999999999876543221110        00000110


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      . ....       ..........++.++.+|+.+||+.+|++|||++++++.|+++
T Consensus       236 ~-~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 V-RVLE-------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             H-HHHH-------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0 0000       0111111223567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.4e-38  Score=325.64  Aligned_cols=261  Identities=28%  Similarity=0.443  Sum_probs=200.6

Q ss_pred             hhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEe-CceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFE-GHRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~~~  394 (638)
                      +++.+.||+|+||.||+|+..      +++.||+|+++....  ..+.+..|+++++++ +|+||+++++++.. +...+
T Consensus         9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~   88 (337)
T cd05054           9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM   88 (337)
T ss_pred             hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence            446789999999999999632      246899999875432  234677899999999 79999999998865 45678


Q ss_pred             EEEEeccCCCHHHHhhhcCCC-------------------------------------------------------CCCC
Q 006620          395 LIYEFVSNGSLEKFIHEKHPL-------------------------------------------------------ETNQ  419 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------~~~~  419 (638)
                      +++||+++++|.+++......                                                       ....
T Consensus        89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (337)
T cd05054          89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE  168 (337)
T ss_pred             EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence            999999999999998653210                                                       0013


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCc
Q 006620          420 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE  499 (638)
Q Consensus       420 ~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE  499 (638)
                      .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.+.............++..|+|||
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence            68999999999999999999999   999999999999999999999999999998764433222223345677899999


Q ss_pred             eeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHH
Q 006620          500 VFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS  578 (638)
Q Consensus       500 ~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  578 (638)
                      ++.+.  .++.++|||||||++|||++ |..||......  +     .........       .....+.....++.+++
T Consensus       246 ~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~-----~~~~~~~~~-------~~~~~~~~~~~~~~~l~  309 (337)
T cd05054         246 SIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--E-----EFCRRLKEG-------TRMRAPEYATPEIYSIM  309 (337)
T ss_pred             HhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--H-----HHHHHHhcc-------CCCCCCccCCHHHHHHH
Confidence            98764  78999999999999999997 99888643211  0     001111110       11111223456789999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          579 LWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       579 ~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      .+||+.+|++||++.||+++|++++.
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-37  Score=316.20  Aligned_cols=247  Identities=24%  Similarity=0.338  Sum_probs=195.0

Q ss_pred             cCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          331 LGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       331 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ||+|+||+||++.. .+++.||+|++....    ...+.+..|++++++++|+||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999985 468899999986432    1224567899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....  .....+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++.........  
T Consensus        81 ~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--  153 (280)
T cd05608          81 RYHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--  153 (280)
T ss_pred             HHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence            98886432  123568999999999999999999999   99999999999999999999999999999866543321  


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.........    .....      .. ... ...
T Consensus       154 ~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~------~~-~~~-~~~  219 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQ------RI-LND-SVT  219 (280)
T ss_pred             ccccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHH------hh-ccc-CCC
Confidence            2345689999999999764  7788999999999999999999999754321110    00000      00 000 011


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                      .+..++.++.+++.+||+.||++||     ++++++++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            1234567788999999999999999     67778764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.7e-37  Score=311.05  Aligned_cols=256  Identities=22%  Similarity=0.416  Sum_probs=203.8

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||.||+|+. .+++.||||.+....    .....+.+|++++++++||||+++++++.+.+..++++||+
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence            3568899999999999985 468899999875422    22346788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++....  .....+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          85 DAGDLSQMIKYFK--KQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCcHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999986532  112458899999999999999999999   99999999999999999999999999998876533


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..  ......+++.|+|||.+.+.  .++.++|+||||+++|||++|+.||......     ..... ..+.      ..
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~-~~~~------~~  223 (267)
T cd08228         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLC-QKIE------QC  223 (267)
T ss_pred             hH--HHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHH-HHHh------cC
Confidence            21  11234578899999998764  6788999999999999999999998643211     01111 1111      11


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ..........+..+.+++.+||+.+|++||++.+|++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111222334567789999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=324.60  Aligned_cols=253  Identities=30%  Similarity=0.490  Sum_probs=214.7

Q ss_pred             hhcccCcCcceeEEEEEEcC-CCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+++||-|.||.||.|.|+. .-.||||.++.+....++|++|+.+|+.++|||+|+|+|+|..+..+|||.|||..|+|
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL  350 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL  350 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence            47899999999999999865 45799999999988999999999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .|||++...    ..++...++.++.||.+|++||..   +++|||||..+|+|+.++..|||+|||+++++..+.. ..
T Consensus       351 LdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TA  422 (1157)
T KOG4278|consen  351 LDYLRECNR----SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TA  422 (1157)
T ss_pred             HHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-ec
Confidence            999988542    456777889999999999999999   9999999999999999999999999999999876653 34


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      ..+..-++-|.|||-+.-+  .++.|+|||+|||+|||+.| |-.|+...+.        ..++..+       ..+.+.
T Consensus       423 HAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY~LL-------EkgyRM  485 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYGLL-------EKGYRM  485 (1157)
T ss_pred             ccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHHHHH-------hccccc
Confidence            4566678899999998543  78889999999999999987 5667654331        1122222       233444


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ..+..++..+.+|++.||+++|.+||++.|+-+.++.++.
T Consensus       486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            4555677889999999999999999999999998887654

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-37  Score=322.65  Aligned_cols=241  Identities=23%  Similarity=0.293  Sum_probs=192.5

Q ss_pred             cccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+|+.. +++.||||+++...    ...+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999864 47899999987532    2334567888888866 699999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          81 GDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence            9999998764      458899999999999999999999   9999999999999999999999999999875432221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .....+... ...    
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~-~~~----  214 (321)
T cd05591         152 --TTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHD-DVL----  214 (321)
T ss_pred             --cccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcC-CCC----
Confidence              12345689999999998764  6889999999999999999999999743211        011111110 000    


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRP-------SMNRVVEM  598 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  598 (638)
                         .+...+.++.+++.+||+.||++||       ++++++++
T Consensus       215 ---~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 ---YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence               1112356788999999999999999       78888755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.6e-38  Score=323.15  Aligned_cols=235  Identities=23%  Similarity=0.306  Sum_probs=188.6

Q ss_pred             cccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+|+.. +++.||||++...    ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 5789999998753    23345667888888776 699999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++...      ..+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          81 GDLMFHIQKS------RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             chHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence            9999998764      458899999999999999999999   9999999999999999999999999999875432221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       . ..+.+... ..     
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~-~~~~i~~~-~~-----  213 (320)
T cd05590         152 --TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------D-LFEAILND-EV-----  213 (320)
T ss_pred             --cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------H-HHHHHhcC-CC-----
Confidence              12334689999999998764  6788999999999999999999999743211       1 11111110 00     


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSM  592 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  592 (638)
                        ..+...+.++.+++.+||+.||++||++
T Consensus       214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 --VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence              0111245678899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.8e-37  Score=309.77  Aligned_cols=251  Identities=29%  Similarity=0.469  Sum_probs=200.7

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.++||+|++|.||+|....+..+|+|.+.......+.+.+|++++++++|+|++++++++. ....+++|||+++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~   86 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS   86 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence            3457889999999999999877778999998765555567899999999999999999999875 456789999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+......... 
T Consensus        87 L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          87 LLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             HHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            999997642    2458899999999999999999999   89999999999999999999999999999876433221 


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......       . .......       ...
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~~-------~~~  221 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------E-VLEQVER-------GYR  221 (260)
T ss_pred             ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHc-------CCC
Confidence            12233457789999988654  67889999999999999998 88888643211       0 0011110       011


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      .......+..+.+++.+||+.+|++||++++|++.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11123456778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.6e-37  Score=316.76  Aligned_cols=259  Identities=26%  Similarity=0.445  Sum_probs=202.6

Q ss_pred             hhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.||+|+||+||+|...      ....+++|.+.....  ..+.+.+|+.+++.++||||+++++.+...+..++++
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            35688999999999999753      124689998865432  2356889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceE
Q 006620          398 EFVSNGSLEKFIHEKHPL------------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL  459 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIl  459 (638)
                      ||+.+++|.+++......                  .....+++..++.++.|++.||+|||+   .+++||||||+||+
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence            999999999998764211                  112458899999999999999999999   99999999999999


Q ss_pred             ECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCC
Q 006620          460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRS  538 (638)
Q Consensus       460 l~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~  538 (638)
                      +++++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.....  
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            999999999999999865433322222333457789999988654  68899999999999999998 8888854321  


Q ss_pred             cccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                            .........       ......+...+.++.+++.+||+.+|++||+++++++.|++++.
T Consensus       236 ------~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ------ERLFNLLKT-------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ------HHHHHHHhC-------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                  111111111       01111122345678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-37  Score=313.39  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=194.2

Q ss_pred             cCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          331 LGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       331 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ||+|+||+||+++. .+++.||+|++....    .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999985 458999999986432    1223456799999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....    ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++........   
T Consensus        81 ~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---  150 (277)
T cd05607          81 KYHIYNVG----ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---  150 (277)
T ss_pred             HHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence            99886543    2458899999999999999999999   9999999999999999999999999999987654332   


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....|+..|+|||++.+.  .++.++||||+||++|||++|+.||.........   ........        ......
T Consensus       151 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~---~~~~~~~~--------~~~~~~  217 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK---EELKRRTL--------EDEVKF  217 (277)
T ss_pred             eeccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH---HHHHHHhh--------cccccc
Confidence            2334579999999998765  5889999999999999999999998643221110   01100000        000011


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ....++.++.+++.+||+.||++||+++|+++.+.
T Consensus       218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            11235667899999999999999999987765444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-38  Score=316.63  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=200.0

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccC---CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK---GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      |...++||+||.+.||++...+.+.||+|.+....   ....-|.+|+..|.+|+ |.+|++|++|-..++.+|+|||+-
T Consensus       363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G  442 (677)
T KOG0596|consen  363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG  442 (677)
T ss_pred             hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence            44568899999999999998888889888765433   23467899999999997 999999999999999999999987


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                       ..+|..+|++..     ..++...++.+..||+.|+.++|+   .||||-||||.|+|+ -.|.+||+|||+|..+..+
T Consensus       443 -d~DL~kiL~k~~-----~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  443 -DIDLNKILKKKK-----SIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             -cccHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence             459999998864     334434789999999999999999   999999999999998 4679999999999999988


Q ss_pred             CceeeecccccccceecCceeccccC---------CccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFG---------EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      .+.......+||+.||+||.+.....         ..++++||||||||||+|+.|++||.....         . +.++
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~-~aKl  582 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------Q-IAKL  582 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------H-HHHH
Confidence            88887788899999999999853211         267899999999999999999999873221         1 1111


Q ss_pred             hhh----hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 ELE----EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...    ..+.++.....      .++.++++.||++||.+||++.+||+
T Consensus       583 ~aI~~P~~~Iefp~~~~~------~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 HAITDPNHEIEFPDIPEN------DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HhhcCCCccccccCCCCc------hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            111    11222222222      22889999999999999999999995

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.4e-37  Score=314.33  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=199.5

Q ss_pred             hhhcccCcCcceeEEEEEE-----cCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-----LDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      ++.+.||+|+||+||+|..     .+++.+++|.+.....  ....+.+|++++++++||||+++++++......++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   87 (283)
T cd05090           8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE   87 (283)
T ss_pred             eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence            4578999999999999974     2356899999875332  23567889999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceE
Q 006620          399 FVSNGSLEKFIHEKHPL-----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK  467 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  467 (638)
                      |+++++|.+++......           .....+++..+..++.|++.||+|||+   ++++||||||+||++++++.+|
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~k  164 (283)
T cd05090          88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVK  164 (283)
T ss_pred             cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEE
Confidence            99999999998643210           012358899999999999999999999   8999999999999999999999


Q ss_pred             EcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHH
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHW  546 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  546 (638)
                      |+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |..||.....        ..
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~~  234 (283)
T cd05090         165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------QE  234 (283)
T ss_pred             eccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence            9999999876443332222334457789999998654  68899999999999999998 8888753221        11


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ..+.......       ...+..++.++.+++.+||+.||++||++.+|+++|+.
T Consensus       235 ~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRKRQL-------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCc-------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111111110       11112345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.6e-37  Score=320.48  Aligned_cols=240  Identities=22%  Similarity=0.301  Sum_probs=189.1

Q ss_pred             cccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhh-cCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+|+.. +++.||||+++...    ...+.+..|..++.. .+||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 57889999987532    233455667777665 4799999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  151 (316)
T cd05592          81 GDLMFHIQSS------GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG  151 (316)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence            9999999764      458899999999999999999999   9999999999999999999999999999986533221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       . ....+...        
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------~-~~~~i~~~--------  211 (316)
T cd05592         152 --KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------E-LFDSILND--------  211 (316)
T ss_pred             --ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHcC--------
Confidence              12345689999999999764  6889999999999999999999998743210       1 11111100        


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMN-RVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  597 (638)
                      ....+...+.++.+++.+||+.||++||++. ++++
T Consensus       212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            0111122456788999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7e-38  Score=340.64  Aligned_cols=252  Identities=24%  Similarity=0.311  Sum_probs=198.6

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc--------e
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGH--------R  392 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~  392 (638)
                      |.+.+.||+|+||+||+|+. .+++.||||++....   .....+.+|+..+..++|+||+++++.+....        .
T Consensus        34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~  113 (496)
T PTZ00283         34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM  113 (496)
T ss_pred             EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence            34578999999999999984 568999999986543   22346788999999999999999988775432        3


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      .++||||+++|+|.+++....  .....+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       114 i~lV~Ey~~~gsL~~~l~~~~--~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        114 IALVLDYANAGDLRQEIKSRA--KTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             EEEEEeCCCCCcHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence            679999999999999997643  223568999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      +++...............||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....       .........
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~~  259 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTLA  259 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc
Confidence            99876533222222345689999999999764  688999999999999999999999864321       111111110


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                              +.....+...+.++.+++.+||+.||++||++.+++++
T Consensus       260 --------~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 --------GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                    11111222345678999999999999999999999864

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.4e-37  Score=313.59  Aligned_cols=252  Identities=26%  Similarity=0.398  Sum_probs=195.3

Q ss_pred             hhcccCcCcceeEEEEEEc-CCC----EEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQ----NVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.||+|+||+||+|.+. +++    .+++|.+.....  ...++..|+..+++++||||+++++++. +...++++||
T Consensus        11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~   89 (279)
T cd05111          11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL   89 (279)
T ss_pred             eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence            4678999999999999853 344    477787754322  2346677888899999999999999875 4567889999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++....     ..+++..+..++.|+++||+|||+   ++++||||||+||++++++.+||+|||+++....
T Consensus        90 ~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          90 SPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             CCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999998643     468999999999999999999999   9999999999999999999999999999987644


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...........++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .....+...... 
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~-  230 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------EVPDLLEKGERL-  230 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcC-
Confidence            3322223344567899999998654  68899999999999999998 99888643211        011111111111 


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                            ........++.+++.+||..+|++|||+.|+++.|+.+..
T Consensus       231 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 ------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                  1111123467889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-37  Score=327.47  Aligned_cols=252  Identities=19%  Similarity=0.256  Sum_probs=198.7

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.+.++||+|+||+||+++.. +++.||+|++....    .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            3455789999999999999854 58899999986432    233456789999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++...       .+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||++....
T Consensus       124 y~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         124 YMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             CCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999998753       47888899999999999999999   999999999999999999999999999998664


Q ss_pred             CCCceeeecccccccceecCceecccc--CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ..... ......||+.|+|||++.+..  ..++.++|||||||++|||++|+.||......       . ....+.... 
T Consensus       194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~-~~~~i~~~~-  263 (370)
T cd05596         194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMDHK-  263 (370)
T ss_pred             CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------H-HHHHHHcCC-
Confidence            33211 123456899999999986531  24788999999999999999999999753210       0 111111100 


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSD--RPSMNRVVEM  598 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  598 (638)
                         ..........++.++.+++.+||+.+|++  |+++++++++
T Consensus       264 ---~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 ---NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ---CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence               00111111234678889999999999988  9999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=316.61  Aligned_cols=247  Identities=26%  Similarity=0.308  Sum_probs=206.7

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC-CCEEEEEEecccCC----chhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKG----NGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .|.+.+.||.|.||.||+++.+. |+.+|+|++.+...    ..+.+.+|+.+|+++. |||||.+++.+.+....++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            34567899999999999998654 99999999976543    2358899999999999 999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC----CCceEEccccc
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE----DFCPKISDFGL  473 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~----~~~~kl~DFg~  473 (638)
                      |++.||.|.+.+...       .+++..+..++.|+++|++|||+   .||+||||||+|+|+..    ++.+|++|||+
T Consensus       116 EL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999874       28999999999999999999999   99999999999999953    35799999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      +.......   .....+||+.|+|||++...  .++..+||||+||++|.|+.|.+||.........        ..+..
T Consensus       186 a~~~~~~~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~--------~~i~~  252 (382)
T KOG0032|consen  186 AKFIKPGE---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF--------LAILR  252 (382)
T ss_pred             ceEccCCc---eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH--------HHHHc
Confidence            99887632   34667899999999999754  7899999999999999999999999865431110        01111


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      . .   .....+....++..+.++++.||..||..|+|+.++++
T Consensus       253 ~-~---~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  253 G-D---FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             C-C---CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1 1   12233445566888999999999999999999999998

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.2e-37  Score=319.43  Aligned_cols=240  Identities=24%  Similarity=0.307  Sum_probs=190.3

Q ss_pred             cccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhh-cCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+|+.. +++.||||+++...    ...+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 47899999987542    233456677788776 4899999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          81 GDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence            9999999764      458899999999999999999999   9999999999999999999999999999875432221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+....       
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~-------  212 (316)
T cd05619         152 --KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIRMDN-------  212 (316)
T ss_pred             --ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-------
Confidence              11334589999999998764  688999999999999999999999864321        01111111110       


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMN-RVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  597 (638)
                       ...+.....++.+++.+||+.||++||++. ++++
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         213 -PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence             001112456788999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=328.81  Aligned_cols=249  Identities=21%  Similarity=0.245  Sum_probs=195.3

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++....    .....+.+|+++++.++||||+++++++.++...++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL   83 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence            34688999999999999864 58899999997532    23345778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        84 ~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          84 PGGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            999999999764      458999999999999999999999   99999999999999999999999999998764321


Q ss_pred             Ccee------------------------------------eecccccccceecCceeccccCCccccCCeeeHHHHHHHH
Q 006620          481 ESIV------------------------------------SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM  524 (638)
Q Consensus       481 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~el  524 (638)
                      ....                                    ......||+.|+|||++.+.  .++.++|||||||++|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el  232 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHh
Confidence            1100                                    00123589999999998664  688999999999999999


Q ss_pred             hcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 006620          525 TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS---MNRVVEM  598 (638)
Q Consensus       525 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  598 (638)
                      ++|..||......       ............+...     ....++.++.+++.+|+. +|.+|++   +++++++
T Consensus       233 ~~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         233 LVGYPPFCSDNPQ-------ETYRKIINWKETLQFP-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             hcCCCCCCCCCHH-------HHHHHHHcCCCccCCC-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999999643211       1111111111111111     111245678899999997 9999998   8888774

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=328.06  Aligned_cols=248  Identities=22%  Similarity=0.270  Sum_probs=192.7

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.++||+|+||+||+++. .+++.||||++....    ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~   83 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL   83 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence            3468899999999999985 468899999986432    23356788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          84 PGGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999764      458899999999999999999999   99999999999999999999999999998643211


Q ss_pred             Cce------------e---------------------------------eecccccccceecCceeccccCCccccCCee
Q 006620          481 ESI------------V---------------------------------SMTGARGTIGYIAPEVFCRNFGEVSYKSDVY  515 (638)
Q Consensus       481 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvw  515 (638)
                      ...            .                                 ......||+.|+|||++.+.  .++.++|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Diw  232 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeE
Confidence            000            0                                 00123589999999998764  688999999


Q ss_pred             eHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh-hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCC---CC
Q 006620          516 SYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL-ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDR---PS  591 (638)
Q Consensus       516 slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps  591 (638)
                      ||||++|||++|+.||......        .....+ .....+...     ....++.++.+++.+||+ +|.+|   ++
T Consensus       233 SlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         233 SLGAIMFECLIGWPPFCSENSH--------ETYRKIINWRETLYFP-----DDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             ecchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCccCCC-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999999999643211        011111 101111111     111245678899999998 77765   59


Q ss_pred             HHHHHHH
Q 006620          592 MNRVVEM  598 (638)
Q Consensus       592 ~~evl~~  598 (638)
                      +.+++++
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9998875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.1e-37  Score=328.50  Aligned_cols=248  Identities=19%  Similarity=0.240  Sum_probs=191.4

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.++||+|+||+||+|+. .+++.||||++....    ...+.+.+|+.++++++||||+++++.+.++...++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            468899999999999985 457899999987532    234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|.+++.+.      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        85 gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          85 GGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999764      458889999999999999999999   999999999999999999999999999975331100


Q ss_pred             c---------------------------------------------eeeecccccccceecCceeccccCCccccCCeee
Q 006620          482 S---------------------------------------------IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYS  516 (638)
Q Consensus       482 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvws  516 (638)
                      .                                             ........||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEe
Confidence            0                                             0001124689999999999764  6889999999


Q ss_pred             HHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 006620          517 YGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS---MN  593 (638)
Q Consensus       517 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~  593 (638)
                      |||++|||++|++||......       ............     ........++.++.+++.+|+ .+|++|++   +.
T Consensus       234 lGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~-----~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPL-------ETQMKVINWQTS-----LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHH-------HHHHHHHccCCC-----cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            999999999999999753211       000011110001     111111234566778888876 49999997   77


Q ss_pred             HHHHH
Q 006620          594 RVVEM  598 (638)
Q Consensus       594 evl~~  598 (638)
                      +++++
T Consensus       301 ei~~h  305 (382)
T cd05625         301 EIKAH  305 (382)
T ss_pred             HHhcC
Confidence            77753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=314.87  Aligned_cols=249  Identities=26%  Similarity=0.348  Sum_probs=198.2

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +..++||+|+||+||++.. .+++.||+|++....    .....+.+|+.++++++||||+++++.+..++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence            4567899999999999985 468899999986532    12245678999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++....    ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++......
T Consensus        83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          83 NGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             CCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999886532    2468999999999999999999999   99999999999999999999999999999876433


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..   .....|++.|+|||++.+.  .++.++||||+|+++|||++|+.||.......   .. ......+.        
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~-~~~~~~~~--------  218 (285)
T cd05605         156 ET---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KR-EEVERRVK--------  218 (285)
T ss_pred             Cc---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhh---HH-HHHHHHhh--------
Confidence            32   1234689999999998754  68889999999999999999999997432210   00 00001000        


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                      .........++..+.+++.+||+.||++||     ++++++++
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         219 EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            011112234567788999999999999999     88888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.2e-37  Score=320.70  Aligned_cols=236  Identities=23%  Similarity=0.288  Sum_probs=186.4

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHH-HHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVA-SISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+|+. .+++.||||++....    .....+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999986 468899999986532    22234455554 46778999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence            9999999764      468899999999999999999999   9999999999999999999999999999875432221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....       ... ....... ..     
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~-~~~i~~~-~~-----  213 (323)
T cd05575         152 --TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEM-YDNILNK-PL-----  213 (323)
T ss_pred             --ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCH-------HHH-HHHHHcC-CC-----
Confidence              12334689999999998764  688999999999999999999999864321       111 1111100 00     


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMN  593 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  593 (638)
                        ......+.++.+++.+||+.||++||++.
T Consensus       214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 --RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              01112356788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.3e-37  Score=327.53  Aligned_cols=258  Identities=24%  Similarity=0.395  Sum_probs=200.8

Q ss_pred             hhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  397 (638)
                      +.++||+|+||.||+|++.      .++.||||+++....  ..+.+.+|++++.++. ||||+++++++......++|+
T Consensus        41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~  120 (401)
T cd05107          41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT  120 (401)
T ss_pred             hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence            4689999999999999853      245899999976432  2346889999999998 999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCC--------------------------------------------------------------
Q 006620          398 EFVSNGSLEKFIHEKHPL--------------------------------------------------------------  415 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~--------------------------------------------------------------  415 (638)
                      ||+++|+|.++++..+..                                                              
T Consensus       121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (401)
T cd05107         121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK  200 (401)
T ss_pred             eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence            999999999999764310                                                              


Q ss_pred             ------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc
Q 006620          416 ------------------------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC  465 (638)
Q Consensus       416 ------------------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~  465 (638)
                                                    .....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~  277 (401)
T cd05107         201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKL  277 (401)
T ss_pred             hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCE
Confidence                                          011347888899999999999999999   99999999999999999999


Q ss_pred             eEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchh
Q 006620          466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFP  544 (638)
Q Consensus       466 ~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~  544 (638)
                      +||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......       
T Consensus       278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-------  348 (401)
T cd05107         278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-------  348 (401)
T ss_pred             EEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-------
Confidence            999999999865433221122233467889999998754  67889999999999999998 88887543211       


Q ss_pred             HHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      ......+..       +.....+...+.++.+++.+||+.+|++||++++|++.|++++
T Consensus       349 ~~~~~~~~~-------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 EQFYNAIKR-------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHHc-------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111111111       1111112234567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-37  Score=302.58  Aligned_cols=268  Identities=23%  Similarity=0.275  Sum_probs=209.9

Q ss_pred             hhcccCcCcceeEEEEEEcC-CCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.++||.|.-|+||+++..+ +..+|+|++.+..    ....+...|-+||+.+.||.++.||+.++.++..+++||||+
T Consensus        81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp  160 (459)
T KOG0610|consen   81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP  160 (459)
T ss_pred             HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence            45789999999999999755 5889999997642    233466779999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      ||+|..+.+++.    .+.+++..++.++.+++-||+|||.   .|||.|||||+||||.++|.+.|+||.++.......
T Consensus       161 GGdL~~LrqkQp----~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  161 GGDLHSLRQKQP----GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             CccHHHHHhhCC----CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999998754    5789999999999999999999999   999999999999999999999999999874321100


Q ss_pred             ---------------------------------ce---------------------eeecccccccceecCceeccccCC
Q 006620          482 ---------------------------------SI---------------------VSMTGARGTIGYIAPEVFCRNFGE  507 (638)
Q Consensus       482 ---------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~  507 (638)
                                                       ..                     ......+||-+|+|||++.|.  .
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--G  311 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--G  311 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--C
Confidence                                             00                     001124689999999999986  5


Q ss_pred             ccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCC
Q 006620          508 VSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPS  587 (638)
Q Consensus       508 ~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  587 (638)
                      .+.++|.|+|||++|||+.|..||.....+.   .+...+.      +.+.+.     .....+..+.+||++.|..||+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---Tl~NIv~------~~l~Fp-----~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---TLRNIVG------QPLKFP-----EEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchh---hHHHHhc------CCCcCC-----CCCcchhHHHHHHHHHhccChh
Confidence            6889999999999999999999998765421   1211111      111111     1225677899999999999999


Q ss_pred             CCCC----HHHHHHH--HhcccCCCCCCCCCcccCC
Q 006620          588 DRPS----MNRVVEM--LEGSLDSLQIPPRPFLLSS  617 (638)
Q Consensus       588 ~RPs----~~evl~~--L~~~~~~~~~~~~p~~~~~  617 (638)
                      +|..    +.||-++  .++....+-.-.+|++++.
T Consensus       378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~  413 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPK  413 (459)
T ss_pred             hhhccccchHHhhcCccccCCChhheeccCCCcCCC
Confidence            9988    6666653  4555555555555555443

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-37  Score=329.03  Aligned_cols=249  Identities=20%  Similarity=0.250  Sum_probs=193.0

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+++. .+++.||||++....    .....+.+|++++++++|+||+++++.+.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence            4568999999999999985 458899999986432    23456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..+...
T Consensus        84 ~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          84 PGGDMMSLLIRL------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            999999999764      458889999999999999999999   99999999999999999999999999997532100


Q ss_pred             Cc-----------------------------------------eeeecccccccceecCceeccccCCccccCCeeeHHH
Q 006620          481 ES-----------------------------------------IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM  519 (638)
Q Consensus       481 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGv  519 (638)
                      ..                                         ........||+.|+|||++.+.  .++.++|||||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv  232 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccc
Confidence            00                                         0001124689999999999764  6789999999999


Q ss_pred             HHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC---CHHHHH
Q 006620          520 MVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP---SMNRVV  596 (638)
Q Consensus       520 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl  596 (638)
                      ++|||++|+.||......       .............     .......++.++.+++.+|+ .+|++|+   ++.+++
T Consensus       233 ilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~-----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         233 ILYEMLVGQPPFLADTPA-------ETQLKVINWETTL-----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             eeeehhhCCCCCCCCCHH-------HHHHHHhccCccc-----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            999999999999754321       0000100000001     01111224556778888876 4999999   889988


Q ss_pred             HH
Q 006620          597 EM  598 (638)
Q Consensus       597 ~~  598 (638)
                      ++
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            76

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.1e-38  Score=323.71  Aligned_cols=237  Identities=26%  Similarity=0.304  Sum_probs=190.4

Q ss_pred             cccCcCcceeEEEEEE----cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          329 NKLGQGGYGGVYKGKL----LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.||+|+||.||+++.    .+++.||+|++....   .....+.+|++++++++||||+++++++.++...++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    357899999997532   223456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          82 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            99999999764      458999999999999999999999   999999999999999999999999999988654332


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       . ........ ..    
T Consensus       153 ~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~-~~~~i~~~-~~----  215 (318)
T cd05582         153 K--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------E-TMTMILKA-KL----  215 (318)
T ss_pred             C--ceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH-------H-HHHHHHcC-CC----
Confidence            1  12234689999999998764  6788999999999999999999998643210       0 01111000 00    


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNR  594 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  594 (638)
                         ..+...+.++.+++.+||+.||++||++.+
T Consensus       216 ---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 ---GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence               111224567889999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.1e-37  Score=308.02  Aligned_cols=246  Identities=25%  Similarity=0.409  Sum_probs=194.3

Q ss_pred             ccCcCcceeEEEEEE---cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          330 KLGQGGYGGVYKGKL---LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +||+|+||+||+|.+   .+++.+|+|+++....   ..+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999964   3467899999865432   2457889999999999999999999875 45678999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++...      ..+++..+..++.|++.||+|||+   ++++||||||+||++++++.+||+|||+++........
T Consensus        81 ~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          81 PLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            999999754      358899999999999999999999   99999999999999999999999999999876543322


Q ss_pred             e-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          484 V-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       484 ~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      . ......++..|+|||.+...  .++.++||||||+++|||++ |+.||......       . ....+...       
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~-~~~~i~~~-------  214 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------E-VTQMIESG-------  214 (257)
T ss_pred             eeecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHCC-------
Confidence            1 11223346789999988643  67889999999999999998 89998643221       0 11111111       


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      .....+...+.++.+++.+||+.||++||++.+|.+.|++.
T Consensus       215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            11111223456788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.6e-37  Score=323.39  Aligned_cols=197  Identities=25%  Similarity=0.332  Sum_probs=171.2

Q ss_pred             HhhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCchhhHHHHHHHHhhcC-C-----cceEEEEeEEEeCceEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTS-H-----VNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv  396 (638)
                      +|.+.+.||+|+||.|.+|. ..+++.||||++++.+.-..+...|+.+|.+++ |     -|+|+++++|...++.+||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            34567899999999999998 456999999999988877777889999999997 4     3899999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC--CCceEEcccccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--DFCPKISDFGLA  474 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFg~~  474 (638)
                      +|.+ ..+|.++|+.++    ...++...++.|+.||+.||..||+   .+|||.||||+||||.+  ...+||+|||.|
T Consensus       267 fELL-~~NLYellK~n~----f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNK----FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ehhh-hhhHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999 459999999876    2559999999999999999999999   99999999999999953  337999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCccc
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAV  535 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~  535 (638)
                      ......-.     ....+..|+|||++.|.  +|+.+.||||||||++||++|.+.|....
T Consensus       339 c~~~q~vy-----tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  339 CFESQRVY-----TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cccCCcce-----eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCC
Confidence            87544321     34458899999999986  89999999999999999999988776543

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.2e-37  Score=319.87  Aligned_cols=241  Identities=22%  Similarity=0.295  Sum_probs=193.1

Q ss_pred             cccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+|+.. +++.||||+++...    .....+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 47899999997542    2345667888888887 699999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          81 GDLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence            9999998764      468999999999999999999999   9999999999999999999999999999875322221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .  .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......        .....+... ..     
T Consensus       152 ~--~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~-~~-----  213 (318)
T cd05570         152 T--TSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILED-EV-----  213 (318)
T ss_pred             c--ccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcC-CC-----
Confidence            1  1234589999999999764  6889999999999999999999999643210        011111100 00     


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSM-----NRVVEM  598 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  598 (638)
                        ..+...+.++.+++.+||+.||++||++     .+++++
T Consensus       214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence              1112345678899999999999999999     888764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-37  Score=314.25  Aligned_cols=257  Identities=26%  Similarity=0.378  Sum_probs=190.4

Q ss_pred             hhhhcccCcCcceeEEEEEEc--CCCEEEEEEecccC---CchhhHHHHHHHHhhc---CCcceEEEEeEEEe-----Cc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL--DGQNVAIKVLNETK---GNGEDFINEVASISRT---SHVNIVTLLGFCFE-----GH  391 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  391 (638)
                      |.+.+.||+|+||+||+|+..  +++.||+|+++...   .....+.+|+++++++   +||||+++++++..     ..
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            345688999999999999853  46789999986543   2234566777777766   59999999998863     45


Q ss_pred             eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccc
Q 006620          392 RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF  471 (638)
Q Consensus       392 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF  471 (638)
                      ..++||||+. ++|.+++....    ...+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            6899999996 59999997643    2458999999999999999999999   99999999999999999999999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH-
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR-  550 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-  550 (638)
                      |+++......   ......||+.|+|||++.+.  .++.++|||||||++|||++|++||.......   .+....... 
T Consensus       155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~  226 (290)
T cd07862         155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIG  226 (290)
T ss_pred             cceEeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhC
Confidence            9998654332   12344589999999998654  68889999999999999999999987543211   000000000 


Q ss_pred             ------hhhhhhc---cccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          551 ------LELEEDL---GLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       551 ------~~~~~~~---~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            ......+   ........    ........+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                  0000000   00000000    11124566789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.6e-37  Score=325.23  Aligned_cols=252  Identities=19%  Similarity=0.263  Sum_probs=196.6

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.+.+.||+|+||.||+++.. +++.||+|++....    .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            3455789999999999999864 57899999986421    233457789999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++...       .+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||++....
T Consensus       124 y~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         124 YMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             CCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999753       47889999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCceeeecccccccceecCceecccc--CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      .... .......||+.|+|||++.+..  +.++.++||||+||++|||++|+.||......       . ....+.... 
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~-~~~~i~~~~-  263 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------G-TYSKIMDHK-  263 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCC-
Confidence            3322 1223456899999999986532  23788999999999999999999999643210       0 111111000 


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSD--RPSMNRVVEM  598 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  598 (638)
                         ..........++..+.+++.+||+.++.+  |+++++++++
T Consensus       264 ---~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 ---NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence               00111112234667888999999855543  8899999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.7e-37  Score=320.27  Aligned_cols=239  Identities=22%  Similarity=0.313  Sum_probs=189.6

Q ss_pred             cccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||.||+|+.. +++.||+|+++...    ...+....|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999864 57899999987542    2344567787777654 799999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05620          81 GDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN  151 (316)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence            9999998764      458899999999999999999999   9999999999999999999999999999875322211


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        ...+.....    ..  
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~----~~--  213 (316)
T cd05620         152 --RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVD----TP--  213 (316)
T ss_pred             --ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC----CC--
Confidence              12345689999999999764  6889999999999999999999999643210        111111110    00  


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMN-RVV  596 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  596 (638)
                        ..+...+.++.+++.+||+.||++||++. +++
T Consensus       214 --~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 --HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              11112456788999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-37  Score=312.95  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=200.7

Q ss_pred             hhhhcccCcCcceeEEEEEEcC------CCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|+||.||+|...+      +..||+|.+....  .....+.+|+.+++.++||||+++++++......++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   87 (277)
T cd05032           8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV   87 (277)
T ss_pred             eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence            3457899999999999998532      3689999986543  2234688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLE----TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      |||+++++|.+++.......    ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg  164 (277)
T cd05032          88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcc
Confidence            99999999999997643211    12357889999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      +++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......        ...+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~~~~  234 (277)
T cd05032         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVLKFV  234 (277)
T ss_pred             cchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHHHHH
Confidence            98866443322222334467899999998654  68899999999999999998 88887532211        011111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ....       ....+...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus       235 ~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 IDGG-------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hcCC-------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1110       111112235678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=324.69  Aligned_cols=245  Identities=29%  Similarity=0.423  Sum_probs=204.5

Q ss_pred             ccCcCcceeEEEEEEcC-CCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHHH
Q 006620          330 KLGQGGYGGVYKGKLLD-GQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK  407 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  407 (638)
                      .||+|.||+||.|++.+ ...+|||.+.... ...+...+|+.+.++++|.|||+++|.+.+++.+-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999644 5578999986543 445678899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-CCCceEEcccccceeccCCCcee
Q 006620          408 FIHEKHPLETNQKL--KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       408 ~l~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      +|+..-     +++  .+.++..+.+||++||.|||+   ..|||||||-+|||++ -.|.+||+|||-++.+..-... 
T Consensus       662 LLrskW-----GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-  732 (1226)
T KOG4279|consen  662 LLRSKW-----GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-  732 (1226)
T ss_pred             HHHhcc-----CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCcc-
Confidence            998753     455  788999999999999999999   8999999999999995 6889999999999877654432 


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                       .....||..|||||++......|..++|||||||++.||.||++||........      .+++       .-+-...+
T Consensus       733 -TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFk-------VGmyKvHP  798 (1226)
T KOG4279|consen  733 -TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFK-------VGMYKVHP  798 (1226)
T ss_pred             -ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhh-------hcceecCC
Confidence             244568999999999977666799999999999999999999999974432110      0111       11122335


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      +.+.+.+.+...+|.+|+.+||.+||+++++++
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            566778899999999999999999999999985

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.5e-37  Score=305.69  Aligned_cols=246  Identities=27%  Similarity=0.426  Sum_probs=196.6

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      ++||+|+||.||+|...+++.+|+|++......  ...+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            369999999999999878899999998754322  346889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeee
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM  486 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~  486 (638)
                      +++....     ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......... .
T Consensus        81 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~  151 (250)
T cd05085          81 SFLRKKK-----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-S  151 (250)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-C
Confidence            9987543     457899999999999999999999   999999999999999999999999999987644322111 1


Q ss_pred             cccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       487 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||......       . ........       ....
T Consensus       152 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~-~~~~~~~~-------~~~~  214 (250)
T cd05085         152 GLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------Q-AREQVEKG-------YRMS  214 (250)
T ss_pred             CCCCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------H-HHHHHHcC-------CCCC
Confidence            122346789999998653  68889999999999999998 88888643211       1 11111111       0111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      .....+.++.+++.+||+.+|++||++.++++.|+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11224567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.9e-37  Score=306.38  Aligned_cols=247  Identities=26%  Similarity=0.409  Sum_probs=194.0

Q ss_pred             ccCcCcceeEEEEEEc---CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          330 KLGQGGYGGVYKGKLL---DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      .||+|+||.||+|.+.   ++..||+|++.....  ..+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999753   345799999875432  2356889999999999999999999875 457899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....     ..+++..+++++.|+++||+|||+   ++++||||||+||+++.++.+||+|||++..........
T Consensus        81 L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          81 LNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            999997543     468999999999999999999999   999999999999999999999999999998654332211


Q ss_pred             -eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          485 -SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       485 -~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                       ......++..|+|||.+.+.  .++.++||||||+++|||++ |..||......       . ....+...       .
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~-------~  215 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------E-VMSFIEQG-------K  215 (257)
T ss_pred             eccCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------H-HHHHHHCC-------C
Confidence             11222346789999998654  67889999999999999996 99998644221       0 11111111       1


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ....+...+.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus       216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            1111223456788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.5e-37  Score=308.32  Aligned_cols=252  Identities=25%  Similarity=0.446  Sum_probs=202.5

Q ss_pred             HhhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.+.++||+|+||.||++...++..+|+|.+.......+.+.+|++++++++|+||+++++.+.. ...+++|||++++
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~   85 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKG   85 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCC
Confidence            345678999999999999997777889999987655556778899999999999999999999887 7789999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+.........
T Consensus        86 ~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          86 SLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             cHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999997642    2457889999999999999999999   89999999999999999999999999999866543221


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                       ......++..|+|||++...  .++.++|+||||+++|+|++ |+.||......       . .......       ..
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~-~~~~~~~-------~~  220 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------E-VIRALER-------GY  220 (260)
T ss_pred             -cccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------H-HHHHHhC-------CC
Confidence             12233456789999998654  67889999999999999998 88888643210       0 0111111       01


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ........+.++.+++.+||+.+|++||++.++++.|++
T Consensus       221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111122345678899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-37  Score=314.80  Aligned_cols=265  Identities=24%  Similarity=0.380  Sum_probs=197.2

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC---------------CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD---------------GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGF  386 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~  386 (638)
                      .+.+.++||+|+||.||+++..+               ...||+|+++....  ..+.+.+|++++++++|+|+++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            44567899999999999987532               12589999875432  23568899999999999999999999


Q ss_pred             EEeCceEEEEEEeccCCCHHHHhhhcCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE
Q 006620          387 CFEGHRRALIYEFVSNGSLEKFIHEKHPL------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL  460 (638)
Q Consensus       387 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll  460 (638)
                      +......++||||+++++|.+++......      .....+++..++.++.|++.||+|||+   .+++|+||||+||++
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill  162 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLV  162 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEE
Confidence            99999999999999999999999653210      111247889999999999999999999   999999999999999


Q ss_pred             CCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc--CCCCCCcccCCC
Q 006620          461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG--EKNNANVAVDRS  538 (638)
Q Consensus       461 ~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt--g~~p~~~~~~~~  538 (638)
                      ++++.+||+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++  +..||...... 
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-  239 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-  239 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence            99999999999999865433322222233457789999998654  68999999999999999988  44555432211 


Q ss_pred             cccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                            ............. ............+..+.+++.+||+.+|++|||+++|++.|++
T Consensus       240 ------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 ------QVIENTGEFFRNQ-GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ------HHHHHHHHhhhhc-cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence                  0000000000000 0000011111234679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-37  Score=309.09  Aligned_cols=252  Identities=29%  Similarity=0.485  Sum_probs=203.4

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.++||+|+||+||+|...+++.||||.+.......+++.+|+.++++++|+||+++++++......++||||+++++
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   87 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS   87 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence            34578999999999999998778899999998766666789999999999999999999999998899999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.+......... 
T Consensus        88 L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-  159 (261)
T cd05034          88 LLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-  159 (261)
T ss_pred             HHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh-
Confidence            999997642    2468999999999999999999999   89999999999999999999999999998876532211 


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||......        ........       ...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~-------~~~  222 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVER-------GYR  222 (261)
T ss_pred             hhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHc-------CCC
Confidence            11222346789999998754  67889999999999999998 89888543210        01111110       001


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ...+...+.++.+++.+||+.+|++||+++++++.|++
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            11111235678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-37  Score=307.18  Aligned_cols=252  Identities=32%  Similarity=0.554  Sum_probs=203.1

Q ss_pred             cccCcCcceeEEEEEEcC----CCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||.||+|....    +..|++|++......  .+.+.+|++.+++++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998643    778999999765433  56788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          403 GSLEKFIHEKHPL---ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       403 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++|.+++......   .....+++..++.++.|+++||+|||+   ++++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875210   112568999999999999999999999   9999999999999999999999999999987765


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...........+++.|+|||.+.+.  .++.++||||+|+++|+|++ |..||.....       .. .......     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~-~~~~~~~-----  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EE-VLEYLRK-----  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HH-HHHHHHc-----
Confidence            4322223445578899999998764  68899999999999999998 5888865421       11 1111111     


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                        ......+...+.++.+++.+||+.+|++|||+++++++|+
T Consensus       223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 --GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1111122234678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2e-37  Score=326.17  Aligned_cols=248  Identities=22%  Similarity=0.265  Sum_probs=191.1

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.||+|+||+||+++. .+++.||||++....    .....+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus         5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (363)
T cd05628           5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP   84 (363)
T ss_pred             EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence            468899999999999985 458899999997532    223567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|.+++...      ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        85 gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          85 GGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999864      468999999999999999999999   999999999999999999999999999987543211


Q ss_pred             ce---------------------------------eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCC
Q 006620          482 SI---------------------------------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK  528 (638)
Q Consensus       482 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~  528 (638)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCC
Confidence            00                                 001234689999999999764  6889999999999999999999


Q ss_pred             CCCCcccCCCcccchhHHHHHHhhh-hhhccccCCCCchhHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 006620          529 NNANVAVDRSSEIYFPHWVYKRLEL-EEDLGLQGIENEEDKEYARKMILVSLWCIQ--TNPSDRPSMNRVVEM  598 (638)
Q Consensus       529 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~  598 (638)
                      .||.....        ......+.. ...+....     ....+.++.+++.+++.  .++..||+++||+++
T Consensus       234 ~Pf~~~~~--------~~~~~~i~~~~~~~~~p~-----~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETP--------QETYKKVMNWKETLIFPP-----EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCH--------HHHHHHHHcCcCcccCCC-----cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            99964321        111111111 11111111     11234566777777554  233356899999886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.5e-37  Score=318.06  Aligned_cols=262  Identities=26%  Similarity=0.443  Sum_probs=202.5

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC--------CCEEEEEEecccC--CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCce
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD--------GQNVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHR  392 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  392 (638)
                      .+.+.+.||+|+||.||+++...        ...+|+|+++...  ....++.+|+++++++ +||||+++++++.....
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   98 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            45568899999999999997422        2469999987543  2335678899999999 69999999999999999


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE  462 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~  462 (638)
                      .++||||+++++|.+++......          .....+++..++.++.|++.||+|||+   .+++||||||+||+++.
T Consensus        99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~  175 (307)
T cd05098          99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE  175 (307)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEcC
Confidence            99999999999999999875321          112458999999999999999999999   99999999999999999


Q ss_pred             CCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCccc
Q 006620          463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEI  541 (638)
Q Consensus       463 ~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  541 (638)
                      ++.+||+|||.++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |..||.....     
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----  248 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  248 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence            999999999998765432221111222345789999998664  67899999999999999998 7788753211     


Q ss_pred             chhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          542 YFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                        .. ........       .....+...+.++.+++.+||+.+|++|||+.+|++.|++++..
T Consensus       249 --~~-~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         249 --EE-LFKLLKEG-------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             --HH-HHHHHHcC-------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence              11 11111111       11111223456788999999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.7e-37  Score=313.16  Aligned_cols=264  Identities=26%  Similarity=0.402  Sum_probs=200.3

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-----------------CCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-----------------GQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLG  385 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~  385 (638)
                      +.+.+.||+|+||.||+|...+                 +..||+|++....  ...+.+.+|++++++++||||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   86 (296)
T cd05051           7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG   86 (296)
T ss_pred             CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            3457899999999999987532                 2458999987543  23457889999999999999999999


Q ss_pred             EEEeCceEEEEEEeccCCCHHHHhhhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE
Q 006620          386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPL-----ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL  460 (638)
Q Consensus       386 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll  460 (638)
                      ++..+...++++|++++++|.+++......     .....+++..++.++.|+++||+|||+   .+++|+||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili  163 (296)
T cd05051          87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceee
Confidence            999999999999999999999999765311     112368999999999999999999999   999999999999999


Q ss_pred             CCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc--CCCCCCcccCCC
Q 006620          461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG--EKNNANVAVDRS  538 (638)
Q Consensus       461 ~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt--g~~p~~~~~~~~  538 (638)
                      +.++.++|+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++  +..||.....  
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--  239 (296)
T ss_pred             cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence            99999999999999865443322223344567899999998654  68899999999999999998  5666643221  


Q ss_pred             cccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                           ............... ...........+.++.+++.+||+.||++|||+.+|++.|++
T Consensus       240 -----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 -----QQVIENAGHFFRDDG-RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -----HHHHHHHHhcccccc-ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                 111111111000000 000011122345679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-37  Score=320.81  Aligned_cols=244  Identities=23%  Similarity=0.298  Sum_probs=192.7

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCC-cceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSH-VNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||.||+|+.. +++.||||++...    ....+.+..|.+++..+.| ++|+++++++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            45688999999999999854 4779999998753    2334567889999999876 4688999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          83 VNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999999764      458899999999999999999999   9999999999999999999999999999875322


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......       . ....+...     
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~-~~~~i~~~-----  216 (324)
T cd05587         154 GGK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------E-LFQSIMEH-----  216 (324)
T ss_pred             CCC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHcC-----
Confidence            211  12234589999999999764  6789999999999999999999999643210       0 11111100     


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSM-----NRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  598 (638)
                         ....+...+.++.+++.+||+.||++|++.     ++++++
T Consensus       217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               011112345678899999999999999976     566543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=332.03  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=216.6

Q ss_pred             hcccCcCcceeEEEEEEcC----CCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          328 KNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.||.|.||.|++|+++-    ...||||.++...  +++.+|+.|+.+|.+..||||++|.|+....+..++|.|||+
T Consensus       634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME  713 (996)
T KOG0196|consen  634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME  713 (996)
T ss_pred             EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence            4689999999999998643    3479999998754  445689999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|..+|+.+.     +.+++.++.-++++||.|++||-+   .++|||||..+|||++.+...|++|||+++.++++.
T Consensus       714 NGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  714 NGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             CCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            999999999874     669999999999999999999999   999999999999999999999999999999886554


Q ss_pred             -ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHh-cCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          482 -SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT-GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       482 -~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                       ......+.+-+.+|.|||.+.-  ..+|.++||||+|+++||.+ .|++|+..+...        .+.+.+       .
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--------dVIkaI-------e  848 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVIKAI-------E  848 (996)
T ss_pred             CccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchH--------HHHHHH-------H
Confidence             3333334445789999999964  48899999999999999966 588888765431        122222       2


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      ++.+...+.+++..+.+|++.||+.|-.+||.+.+|+..|++++.+...
T Consensus       849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            4455666778899999999999999999999999999999998665443

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.6e-37  Score=311.26  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=198.4

Q ss_pred             hhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.||+|++|.||+|.+.+      +..||+|.......  ....+.+|+.++++++|+||+++++++.+....++||
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL   88 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence            346899999999999998643      56789998865432  2356889999999999999999999999988999999


Q ss_pred             EeccCCCHHHHhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC---ceEEccccc
Q 006620          398 EFVSNGSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFGL  473 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFg~  473 (638)
                      ||+++++|.+++...+.. .....+++..+..++.||+.||+|||+   .+++|+||||+||+++.++   .+||+|||+
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCcc
Confidence            999999999999876422 122368999999999999999999999   8999999999999998654   599999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      ++................+..|+|||++.+.  .++.++|||||||++|||++ |..||......       .. .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~-~~~~~  235 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EV-MEFVT  235 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HH-HHHHH
Confidence            9876433222111222335689999998754  68999999999999999996 88888643221       11 11111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ..       .....+...+..+.+++.+||+.+|++|||+.+|+++|+.
T Consensus       236 ~~-------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         236 GG-------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             cC-------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            00       0111122345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.4e-37  Score=312.72  Aligned_cols=262  Identities=23%  Similarity=0.369  Sum_probs=204.6

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC-----CCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEe-CceEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD-----GQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFE-GHRRAL  395 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  395 (638)
                      .+.+.+.||+|+||.||+|...+     +..|++|++....  ...+.+.+|+.++++++|+||+++++++.. +...++
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   86 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV   86 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence            44567899999999999998655     6789999887543  224567899999999999999999998776 467889


Q ss_pred             EEEeccCCCHHHHhhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          396 IYEFVSNGSLEKFIHEKHPL--ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      ++||+++++|.+++......  .....+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||+
T Consensus        87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCC
Confidence            99999999999999764311  122568999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      ++.+.............++..|+|||++.+.  .++.++||||||+++||+++ |+.||......       .. .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~-~~~~~  233 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-------EM-AAYLK  233 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-------HH-HHHHH
Confidence            9866444332222333467789999998764  67899999999999999998 99998643210       11 11111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ..       .........+.++.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus       234 ~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         234 DG-------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             cC-------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            11       01111122356788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.3e-37  Score=311.19  Aligned_cols=253  Identities=26%  Similarity=0.431  Sum_probs=198.4

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCC----EEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQ----NVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.++||+|+||+||+|.+ .+++    .||+|+++...  ...+.+.+|+.+++.++||||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~   88 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ   88 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence            3568999999999999984 3444    48999986533  234578899999999999999999999875 45779999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++....     ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        89 ~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          89 LMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             cCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999997643     468999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ............+++.|+|||.+.+.  .++.++||||||+++|||++ |..||......        .....+...   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~---  227 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKG---  227 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCC---
Confidence            44333222333456789999998654  68899999999999999998 88887643210        011111111   


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                          .........+.++.+++.+||+.||++||++.++++.|+.+..
T Consensus       228 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         228 ----ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ----CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                1111122345678899999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.4e-37  Score=315.28  Aligned_cols=255  Identities=27%  Similarity=0.445  Sum_probs=200.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      +.+.+.||+|+||.||++...      .+..||+|+++....  ..+.+.+|+++++++ +||||+++++++...+..++
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  116 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV  116 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence            445789999999999999741      244799998875432  235688999999999 79999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++++|.++++...    ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++
T Consensus       117 v~e~~~~~~L~~~i~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         117 ITEYCCYGDLLNFLRRKR----ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             EEEcCCCCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999997643    1348999999999999999999999   899999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ...............++..|+|||.+.+.  .++.++||||+|+++|||++ |..||......       ......... 
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~~~~~~~-  259 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKFYKLIKE-  259 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHHHHHHHc-
Confidence            66543322222233457889999998664  67889999999999999998 89887643210       001111110 


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                            +.........+.++.+++.+||+.+|++|||+.+|++.|+++
T Consensus       260 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 ------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  111111122356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-37  Score=320.72  Aligned_cols=242  Identities=24%  Similarity=0.347  Sum_probs=190.0

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHH---hhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASI---SRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.||+|+||.||+|.. .+++.||||+++...    ...+.+.+|++++   ++++||||+++++++...+..++|||
T Consensus         3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence            467899999999999985 458899999997532    2234556666554   56679999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++++|..++..       ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        83 ~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          83 YAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             CCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999988864       358999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....  ......|++.|+|||++.+.  .++.++|||||||++|||++|+.||......       . ....+... .. 
T Consensus       153 ~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~-~~~~i~~~-~~-  218 (324)
T cd05589         153 GFGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------E-VFDSIVND-EV-  218 (324)
T ss_pred             CCCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhC-CC-
Confidence            2221  12345689999999998764  6788999999999999999999998643211       0 11111110 00 


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                            ..+..++.++.+++.+||+.||++||     ++++++++
T Consensus       219 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         219 ------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                  01123456788999999999999999     57777664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.2e-37  Score=327.17  Aligned_cols=257  Identities=19%  Similarity=0.247  Sum_probs=192.5

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.+.||+|+||.||+++.. .++.||||...     ...+.+|++++++++|+||+++++++..++..++|||++. +
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~  244 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S  244 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence            345789999999999999864 47889999632     2346789999999999999999999999999999999995 6


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..++.|+.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++........
T Consensus       245 ~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        245 DLYTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            9999887542     468999999999999999999999   99999999999999999999999999999876443222


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc--cc--
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL--GL--  559 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--  559 (638)
                      .......||+.|+|||++.+.  .++.++|||||||++|||++|..++.................+.+......  ..  
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            222345689999999999764  688999999999999999988765432221111111111111111110000  00  


Q ss_pred             -------------------cCCCC---chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 -------------------QGIEN---EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 -------------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                                         .....   ........++.+|+.+||+.||++|||+.|+++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                               00000   000122346889999999999999999999997

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.8e-37  Score=308.18  Aligned_cols=256  Identities=23%  Similarity=0.421  Sum_probs=204.1

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|++|.||++.. .+++.+|||.+....    ....++.+|+.+++.++|+||+++++++..++..+++|||+
T Consensus         5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08229           5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA   84 (267)
T ss_pred             hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence            4568899999999999984 578999999876432    23357889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++....  .....+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          85 DAGDLSRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCCHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999987532  123568999999999999999999999   99999999999999999999999999998866433


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ...  .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......     .... ....      ..
T Consensus       160 ~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~-~~~~------~~  223 (267)
T cd08229         160 TTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLC-KKIE------QC  223 (267)
T ss_pred             Ccc--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchH-----HHHh-hhhh------cC
Confidence            221  1234578899999998664  67889999999999999999999986432110     0000 0000      01


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ..........+.++.+++.+||+.+|++|||+++|++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            111112234567899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.3e-37  Score=323.93  Aligned_cols=277  Identities=19%  Similarity=0.270  Sum_probs=204.8

Q ss_pred             hHHHHHHhcCCCCCcccchHHHHHHHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHh
Q 006620          299 NIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASIS  373 (638)
Q Consensus       299 ~~~~~l~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~  373 (638)
                      +++.|++.+..... .++-.++....+.+.+.||+|+||.||+++.. +++.||+|++....    .....+.+|+.+++
T Consensus        20 ~~~~~~~~~~~~~~-~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~   98 (371)
T cd05622          20 NIDNFLNRYKDTIN-KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA   98 (371)
T ss_pred             hHHHHHHHhhhHhh-HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHH
Confidence            55556655432211 11112223334556789999999999999864 57899999986421    22345778999999


Q ss_pred             hcCCcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 006620          374 RTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI  453 (638)
Q Consensus       374 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Di  453 (638)
                      .++||||+++++.+.++...++||||+++|+|.+++...       .+++..+..++.||+.||+|||+   ++|+||||
T Consensus        99 ~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDL  168 (371)
T cd05622          99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDV  168 (371)
T ss_pred             hCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence            999999999999999999999999999999999998753       47888999999999999999999   99999999


Q ss_pred             CCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceecccc--CCccccCCeeeHHHHHHHHhcCCCCC
Q 006620          454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGEKNNA  531 (638)
Q Consensus       454 kp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslGvil~elltg~~p~  531 (638)
                      ||+|||++.++.+||+|||++......... ......||+.|+|||++.+..  +.++.++|||||||++|||++|+.||
T Consensus       169 kp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf  247 (371)
T cd05622         169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  247 (371)
T ss_pred             CHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence            999999999999999999999876433221 123456899999999986532  23788999999999999999999999


Q ss_pred             CcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 006620          532 NVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD--RPSMNRVVEML  599 (638)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  599 (638)
                      .....       . .....+....    ..........++..+.+++.+||+.++.+  |+++++++++.
T Consensus       248 ~~~~~-------~-~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         248 YADSL-------V-GTYSKIMNHK----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCCCH-------H-HHHHHHHcCC----CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            74321       0 0111111100    00111112245677889999999843433  67999998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.3e-37  Score=318.20  Aligned_cols=242  Identities=24%  Similarity=0.338  Sum_probs=190.1

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+++. .+++.||+|+++...    ...+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999985 457899999997542    2234577899998888 599999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          81 GDLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence            9999988764      468999999999999999999999   9999999999999999999999999999875322211


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........ .............. ..     
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~-----  220 (327)
T cd05617         152 --TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEK-PI-----  220 (327)
T ss_pred             --ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhC-CC-----
Confidence              12335689999999999764  778999999999999999999999964332111 11112222211111 01     


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSM  592 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  592 (638)
                        ..+...+..+.+++.+||+.||++|+++
T Consensus       221 --~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         221 --RIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence              1112234567899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-37  Score=305.33  Aligned_cols=247  Identities=28%  Similarity=0.463  Sum_probs=195.7

Q ss_pred             cccCcCcceeEEEEEEcC----CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ++||+|+||.||+|++..    +..+|+|.+.....  ..+.+.+|+.+++++.|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997422    26899999876554  4467889999999999999999999876 4567999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.......
T Consensus        80 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          80 GPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            9999999864      358899999999999999999999   8999999999999999999999999999987644332


Q ss_pred             eee-ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          483 IVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       483 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ... .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......       . .........     
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~-~~~~~~~~~-----  215 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------E-VIAMLESGE-----  215 (257)
T ss_pred             ccccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------H-HHHHHHcCC-----
Confidence            211 1122235689999998654  68889999999999999998 89998643211       1 111111111     


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                        ....+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       216 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 --RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence              1112223456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.4e-37  Score=318.87  Aligned_cols=263  Identities=26%  Similarity=0.458  Sum_probs=203.4

Q ss_pred             HHhhhhcccCcCcceeEEEEEEcC--------CCEEEEEEecccC--CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCc
Q 006620          323 MTNSFKNKLGQGGYGGVYKGKLLD--------GQNVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGH  391 (638)
Q Consensus       323 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  391 (638)
                      ..+.+.+.||+|+||.||+|+...        ...||+|+++...  ...+++.+|+++++++ +||||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            345567899999999999997421        2368999887543  2345788999999999 7999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC
Q 006620          392 RRALIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD  461 (638)
Q Consensus       392 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~  461 (638)
                      ..++++||+++++|.+++......          .....+++..+..++.|+++||+|||+   .+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence            999999999999999999864321          123458889999999999999999999   9999999999999999


Q ss_pred             CCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcc
Q 006620          462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSE  540 (638)
Q Consensus       462 ~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~  540 (638)
                      .++.+||+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |..||.....    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence            9999999999999876543322222223345789999998664  68889999999999999998 7888753221    


Q ss_pred             cchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          541 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                         ... ......       ......+...+.++.+++.+||+.+|++|||+.++++.|+++...
T Consensus       243 ---~~~-~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         243 ---EEL-FKLLKE-------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             ---HHH-HHHHHc-------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence               111 111111       011111223356788999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-37  Score=315.75  Aligned_cols=263  Identities=25%  Similarity=0.458  Sum_probs=203.8

Q ss_pred             HHHhhhhcccCcCcceeEEEEEEc--------CCCEEEEEEecccC--CchhhHHHHHHHHhhc-CCcceEEEEeEEEeC
Q 006620          322 KMTNSFKNKLGQGGYGGVYKGKLL--------DGQNVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEG  390 (638)
Q Consensus       322 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  390 (638)
                      ...+.+.+.||+|+||.||+|+..        ++..||+|.+....  ...+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            334456789999999999999731        23479999987542  2345788999999999 799999999999999


Q ss_pred             ceEEEEEEeccCCCHHHHhhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE
Q 006620          391 HRRALIYEFVSNGSLEKFIHEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL  460 (638)
Q Consensus       391 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll  460 (638)
                      ...++||||+++++|.+++...+...          ....+++..+..++.|+++||+|||+   .+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence            99999999999999999998753211          12458889999999999999999999   999999999999999


Q ss_pred             CCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCc
Q 006620          461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSS  539 (638)
Q Consensus       461 ~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~  539 (638)
                      +.++.+||+|||+++...............+++.|+|||++.+.  .++.++||||||+++|+|++ |..||....    
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~----  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence            99999999999999876543322222333457789999998664  67899999999999999998 677764321    


Q ss_pred             ccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          540 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                         ... ........       .........+.++.+++.+||+.+|++|||+.++++.|++++.
T Consensus       245 ---~~~-~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         245 ---VEE-LFKLLKEG-------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ---HHH-HHHHHHcC-------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence               111 11111111       1111122345678899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.4e-36  Score=306.28  Aligned_cols=257  Identities=25%  Similarity=0.364  Sum_probs=192.4

Q ss_pred             cccCcCcceeEEEEEEcC---CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKLLD---GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.||+|+||.||+|...+   +..+|+|.++....  ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998543   35789998875432  2346888999999999999999999999989999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++...... .....++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.........
T Consensus        81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          81 DLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             cHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999764321 12356778888999999999999999   99999999999999999999999999998765433322


Q ss_pred             eeecccccccceecCceeccccC-----CccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFG-----EVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~-----~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .......++..|+|||++.+...     .++.++||||||+++|||++ |+.||.......      ... .... ....
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~-~~~~  228 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ------VLT-YTVR-EQQL  228 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH------HHH-HHhh-cccC
Confidence            22233456788999999864311     35789999999999999996 999986432210      000 0000 0000


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ..  ............+.+++.+|+ .+|++|||+++|++.|+
T Consensus       229 ~~--~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 KL--PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CC--CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00  001111123456778999998 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.5e-37  Score=311.22  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=199.1

Q ss_pred             hhcccCcCcceeEEEEEEc------CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.++||+|+||.||++...      ++..+|+|.+.... ...+.+.+|++++++++|+||+++++++......++++||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   88 (280)
T cd05092           9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY   88 (280)
T ss_pred             eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence            4789999999999999632      34578999876543 2345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcc
Q 006620          400 VSNGSLEKFIHEKHPL---------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD  470 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  470 (638)
                      +++++|.+++......         .....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~d  165 (280)
T cd05092          89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGD  165 (280)
T ss_pred             CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEECC
Confidence            9999999999764310         112358999999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHH
Q 006620          471 FGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       471 Fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      ||++................+++.|+|||.+.+.  .++.++||||||+++|||++ |.+||......       ... .
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~-~  235 (280)
T cd05092         166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EAI-E  235 (280)
T ss_pred             CCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HHH-H
Confidence            9999865443322222233457889999998764  68899999999999999998 88887532211       001 1


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ....       ......+..++..+.+++.+||+.||++||++++|++.|++
T Consensus       236 ~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 CITQ-------GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHc-------CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            1110       01111122345678899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.7e-37  Score=305.78  Aligned_cols=249  Identities=27%  Similarity=0.502  Sum_probs=200.3

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.+.||+|+||.||++.+.+++.+|+|++.........+.+|++++++++|||++++++++......++|+||+++++|
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   86 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL   86 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence            35688999999999999877788999999876655567889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....     ..++++.++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+......... .
T Consensus        87 ~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~  157 (256)
T cd05112          87 SDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S  157 (256)
T ss_pred             HHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence            99997643     458899999999999999999999   89999999999999999999999999998865433211 1


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      .....++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......       ... ........       .
T Consensus       158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~-~~~~~~~~-------~  220 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVV-ETINAGFR-------L  220 (256)
T ss_pred             cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHH-HHHhCCCC-------C
Confidence            1223356789999998754  68889999999999999998 88888643211       111 11111000       0


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ..+...+.++.+++.+||+.+|++|||+++++++|+
T Consensus       221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            011113467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.2e-37  Score=311.25  Aligned_cols=264  Identities=26%  Similarity=0.429  Sum_probs=202.2

Q ss_pred             hhhcccCcCcceeEEEEEEc-----CCCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-----DGQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  396 (638)
                      .+.+.||+|+||.||++++.     +++.+|||++......  .+.+.+|++++++++|+||+++++++..  ....+++
T Consensus         7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05038           7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI   86 (284)
T ss_pred             hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence            35688999999999999853     3678999999866543  5688999999999999999999999887  5678999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+..
T Consensus        87 ~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          87 MEYLPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EecCCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999998653     358999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhH---HHHHHhh
Q 006620          477 CEGRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH---WVYKRLE  552 (638)
Q Consensus       477 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~  552 (638)
                      ....... .......++..|++||.+.+.  .++.++||||||++++||++|+.|+............+.   .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            7533221 111223346679999988654  678899999999999999999988764332111100000   0000000


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      .   ..............+.++.+++.+||+.+|++|||+.+|+++|+++
T Consensus       237 ~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 E---LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             H---HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            0   0001111111223346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-36  Score=314.82  Aligned_cols=202  Identities=24%  Similarity=0.371  Sum_probs=163.5

Q ss_pred             hcccCcCcceeEEEEEEc---CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEEEEeccC
Q 006620          328 KNKLGQGGYGGVYKGKLL---DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEFVSN  402 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  402 (638)
                      .++||+|+||+||+|+..   +++.||+|.+.... ....+.+|++++++++||||+++++++..  +...++++||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            468999999999999854   45789999986543 23457899999999999999999998864  456789999985 


Q ss_pred             CCHHHHhhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE----CCCCceEEcccccce
Q 006620          403 GSLEKFIHEKHPL---ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAK  475 (638)
Q Consensus       403 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFg~~~  475 (638)
                      ++|.+++......   .....+++..+..++.||++||+|||+   .+|+||||||+|||+    +..+.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            5898888653211   122458999999999999999999999   999999999999999    466789999999998


Q ss_pred             eccCCCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCccc
Q 006620          476 ICEGRES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAV  535 (638)
Q Consensus       476 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~  535 (638)
                      ....... ........||+.|+|||++.+. ..++.++||||+||++|||++|++||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            7643321 1122345689999999998763 357889999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7e-37  Score=308.12  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=198.4

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.++||+|+||.||+|+. .+++.||+|++.... .....+.+|+.++++++||||+++++++..+...++|+||+++
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~   90 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG   90 (267)
T ss_pred             cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence            44578999999999999985 568899999987543 3345677899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+||++++++.+||+|||++........
T Consensus        91 ~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          91 GSLQDIYHVT------GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            9999998754      458899999999999999999999   9999999999999999999999999999986643221


Q ss_pred             eeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                        ......+++.|+|||.+... ...++.++||||||+++|||++|+.|+..........          ..... ....
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----------~~~~~-~~~~  228 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----------LMSKS-NFQP  228 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----------eeecC-CCCC
Confidence              12334578899999988532 2346789999999999999999999985432111000          00000 0000


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML  599 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  599 (638)
                      ........++..+.+++.+||+.+|++|||+++++++|
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00111223456889999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-36  Score=304.46  Aligned_cols=257  Identities=24%  Similarity=0.425  Sum_probs=204.8

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.+.||+|++|.||+|... +++.||+|.++...    ...+.+.+|++++++++|+|++++++++...+..++||||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            345789999999999999865 78999999886421    2345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....  .....+++..++.++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          84 ADAGDLSRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             CCCCCHHHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999987642  223568999999999999999999999   9999999999999999999999999999886543


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ....  .....+++.|+|||.+.+.  .++.++||||||+++|+|++|+.||......     ..... .....      
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~------  222 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLC-KKIEK------  222 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHHHH-hhhhc------
Confidence            3211  1234578899999998654  6788999999999999999999998643211     11111 11000      


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ...........+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            0011111224566788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=302.62  Aligned_cols=247  Identities=29%  Similarity=0.472  Sum_probs=197.5

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      ++||+|++|.||++...+++.|++|.+.....  ....+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999976699999998876433  3457889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeee
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM  486 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~  486 (638)
                      +++....     ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+............
T Consensus        81 ~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          81 TFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9997643     457899999999999999999999   89999999999999999999999999999865432221111


Q ss_pred             cccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       487 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....+..|+|||.+.+.  .++.++|+||||+++|||++ |..||......        .........       ....
T Consensus       153 ~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~~~-------~~~~  215 (251)
T cd05041         153 GLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIESG-------YRMP  215 (251)
T ss_pred             ccCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHhcC-------CCCC
Confidence            222346679999998654  68899999999999999998 77777543211        001111110       0111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      .+...+.++.+++.+||+.+|++|||+.||++.|+
T Consensus       216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            12234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.6e-37  Score=308.61  Aligned_cols=253  Identities=26%  Similarity=0.449  Sum_probs=197.8

Q ss_pred             cccCcCcceeEEEEEEcC-------CCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          329 NKLGQGGYGGVYKGKLLD-------GQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.||+|+||.||+|+..+       ++.+|+|.+....  .....+.+|++++++++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998543       2579999876543  3456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-----ceEEccccc
Q 006620          400 VSNGSLEKFIHEKHPLE-TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-----CPKISDFGL  473 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-----~~kl~DFg~  473 (638)
                      +++++|.+++....... ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997643211 23458899999999999999999999   8999999999999998877     899999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      ++...............++..|+|||++.+.  .++.++||||||+++|||++ |+.||......       .. .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~~-~~~~~  227 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EV-LQHVT  227 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------HH-HHHHh
Confidence            9765433322222233457889999998754  68899999999999999998 99888633210       00 11111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ..       .........+..+.+++.+||+.+|++||++++|++.|++
T Consensus       228 ~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 AG-------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cC-------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            10       1111223346678899999999999999999999998864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.9e-37  Score=318.08  Aligned_cols=243  Identities=22%  Similarity=0.290  Sum_probs=191.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++....    ...+.+..|..++..+ +|++|+++++++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            35688999999999999864 57799999987542    2234566788888777 489999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          83 VNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999998764      458899999999999999999999   9999999999999999999999999999875432


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .....+... .   
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~-~---  217 (323)
T cd05616         154 DGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEH-N---  217 (323)
T ss_pred             CCC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-C---
Confidence            221  12345689999999999764  7899999999999999999999999743211        011111110 0   


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSM-----NRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  597 (638)
                          ...+...+.++.+++.+||+.+|++|++.     +++++
T Consensus       218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence                01122345678899999999999999984     55554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.5e-37  Score=319.47  Aligned_cols=240  Identities=21%  Similarity=0.261  Sum_probs=187.4

Q ss_pred             cccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHH-HHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVA-SISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+|+.. +++.||+|++....    .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999864 57789999986532    12234444444 56778999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.||++||+|||+   .||+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          81 GELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            9999999764      457888899999999999999999   9999999999999999999999999999875432221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       .. ...+... ..     
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~-~~~i~~~-~~-----  213 (325)
T cd05602         152 --TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EM-YDNILNK-PL-----  213 (325)
T ss_pred             --CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHH-------HH-HHHHHhC-Cc-----
Confidence              12345689999999999764  6889999999999999999999999643210       11 1111100 00     


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ......+..+.+++.+||+.||++||++.+.+.
T Consensus       214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         214 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence              111234567889999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-36  Score=310.68  Aligned_cols=264  Identities=25%  Similarity=0.395  Sum_probs=197.8

Q ss_pred             hhhhcccCcCcceeEEEEEEc-----------------CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-----------------DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLG  385 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~  385 (638)
                      +.+.++||+|+||+||++...                 +...||+|++.....  ....+.+|++++++++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            346789999999999998532                 234689999875432  3457889999999999999999999


Q ss_pred             EEEeCceEEEEEEeccCCCHHHHhhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE
Q 006620          386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLE-----TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL  460 (638)
Q Consensus       386 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll  460 (638)
                      ++...+..++||||+++++|.+++.......     ....+++..+..++.|++.||+|||+   .+++|+||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili  163 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEE
Confidence            9999999999999999999999998653211     12358889999999999999999999   999999999999999


Q ss_pred             CCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc--CCCCCCcccCCC
Q 006620          461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG--EKNNANVAVDRS  538 (638)
Q Consensus       461 ~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt--g~~p~~~~~~~~  538 (638)
                      ++++.++|+|||+++.+.............+++.|++||...+.  .++.++||||||+++|||++  |..||...... 
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-  240 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence            99999999999999865443322112223346789999987653  68899999999999999998  56676532211 


Q ss_pred             cccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                            ............. ........+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus       241 ------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 ------QVIENTGEFFRDQ-GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ------HHHHHHHHHHhhc-cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                  1111100000000 0000001112234678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-36  Score=315.37  Aligned_cols=252  Identities=19%  Similarity=0.249  Sum_probs=194.7

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.++||+|+||+||+++.. +++.||+|++....    .....+.+|..++..++|+||+++++++.+.+..++||||+
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~   83 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY   83 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            45689999999999999854 57889999986531    22345778899999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++....     ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          84 VGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999998643     468899999999999999999999   99999999999999999999999999999876543


Q ss_pred             CceeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh-hhh
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL-EED  556 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  556 (638)
                      ... ......||+.|+|||++.+.   .+.++.++||||||+++|||++|+.||......       . ....+.. ...
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~-~~~~i~~~~~~  226 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHEER  226 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------H-HHHHHHcCCCc
Confidence            322 12334689999999998642   125678999999999999999999999643210       0 1111110 000


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSD--RPSMNRVVEM  598 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  598 (638)
                      ...    .......+.++.+++.+||..++++  |+++++++++
T Consensus       227 ~~~----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 FQF----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccC----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            101    1111234667889999999866554  4688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=304.48  Aligned_cols=247  Identities=26%  Similarity=0.477  Sum_probs=201.4

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.+.||.|+||.||+|... ++.||+|.+.......+.+.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   86 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS   86 (256)
T ss_pred             ccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence            345789999999999999874 7899999998765556788999999999999999999999998999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.++.......  
T Consensus        87 L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          87 LVDYLRSRG----RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            999998643    2368999999999999999999999   9999999999999999999999999999986632221  


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                         ....+..|+|||.+.+.  .++.++||||||++++||++ |+.||.....        .........       ...
T Consensus       158 ---~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~-------~~~  217 (256)
T cd05039         158 ---SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEK-------GYR  217 (256)
T ss_pred             ---cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhc-------CCC
Confidence               22346789999998653  67889999999999999997 8888753321        111111111       011


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ...+...+.++.+++.+||+.+|++|||+++++++|++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            11122345778899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.4e-37  Score=316.11  Aligned_cols=236  Identities=22%  Similarity=0.261  Sum_probs=185.2

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHH-HHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVA-SISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||.||+|+. .+++.||+|++....    .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999986 458899999986432    22334555554 57889999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.||++||+|||+   .+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          81 GELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence            9999888754      458889999999999999999999   9999999999999999999999999999875322221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....       ... ...+... .      
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~-~~~i~~~-~------  212 (321)
T cd05603         152 --TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQM-YDNILHK-P------  212 (321)
T ss_pred             --ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHH-HHHHhcC-C------
Confidence              12334689999999998764  688899999999999999999999864321       111 1111100 0      


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMN  593 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  593 (638)
                       ...+.....++.+++.+||+.||++||++.
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 -LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             111122355788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.4e-37  Score=310.84  Aligned_cols=259  Identities=24%  Similarity=0.421  Sum_probs=198.4

Q ss_pred             hhhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.++||+|+||.||+|...+      +..||+|.++....  ....+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   87 (288)
T cd05061           8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV   87 (288)
T ss_pred             ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            4457899999999999996432      44799998865432  234678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLE----TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      |||+++|+|.+++.......    ....+++..+..++.|++.||+|||+   ++++||||||+||++++++.+||+|||
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg  164 (288)
T cd05061          88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFG  164 (288)
T ss_pred             EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCC
Confidence            99999999999997643211    12345677889999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      +++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||.....       .... ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~-~~~  234 (288)
T cd05061         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVL-KFV  234 (288)
T ss_pred             ccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHH-HHH
Confidence            98865433322221223356789999998654  67899999999999999998 6778753221       1111 110


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      ....       ........+..+.+++.+||+.+|++|||+.++++.|+..+
T Consensus       235 ~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 MDGG-------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HcCC-------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            0000       00111123467899999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.5e-37  Score=307.56  Aligned_cols=253  Identities=27%  Similarity=0.455  Sum_probs=198.3

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-C---CEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-G---QNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +++.+.||+|+||.||+|.... +   ..||||+++...  ....++..|+.++++++||||+++++++..+...++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            3467899999999999998543 3   369999987542  234578999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++++|.+++....     ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        86 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          86 FMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             cCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999997643     458999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeeccc---ccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          479 GRESIVSMTGA---RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       479 ~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ...........   ..+..|+|||.+.+.  .++.++||||||+++|||++ |..||......       . ....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~-~~~~i~~~  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------D-VINAIEQD  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------H-HHHHHHcC
Confidence            33221111111   124579999998654  67899999999999999886 99888643211       0 11111100


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                             .......+.+..+.+++.+||+.+|++||++++|+..|+++
T Consensus       228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 -------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   01111123456788999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-37  Score=309.88  Aligned_cols=250  Identities=30%  Similarity=0.463  Sum_probs=196.7

Q ss_pred             hhhcccCcCcceeEEEEEEcC-CCEEEEEEecccCCchh---hHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGE---DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ++.+.||+|+||+||+++... ++.||+|++........   ...+|+.++++++||||+++++++......++|||+++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            456899999999999999654 56899999987653332   33569999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..+..++.|+++||++||+   .+++|+||||+||++++++.++|+|||.+.......
T Consensus        82 ~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   82 GGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             TEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             ccccccccccc------cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999843      568999999999999999999999   999999999999999999999999999998642222


Q ss_pred             ceeeecccccccceecCceec-cccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          482 SIVSMTGARGTIGYIAPEVFC-RNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                        .......++..|+|||++. +  ...+.++||||+|+++++|++|+.|+.........    ................
T Consensus       153 --~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~  224 (260)
T PF00069_consen  153 --ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL----EIIEKILKRPLPSSSQ  224 (260)
T ss_dssp             --SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH----HHHHHHHHTHHHHHTT
T ss_pred             --ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhh----hhhhhccccccccccc
Confidence              1234566899999999987 3  37889999999999999999999998754111100    0011111100000000


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                           .......++.+++.+||+.||++||++.++++
T Consensus       225 -----~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 -----QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -----SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -----ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 00011268999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=306.23  Aligned_cols=252  Identities=28%  Similarity=0.466  Sum_probs=194.8

Q ss_pred             cccCcCcceeEEEEEEcC-CC--EEEEEEecccC--CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLLD-GQ--NVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||.||+|+..+ +.  .+++|.++...  ...+.+.+|+++++++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998644 43  46888887432  3345788999999999 799999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          403 GSLEKFIHEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       403 gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      ++|.+++...+...          ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999997653211          12358899999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      ++.......   .......+..|+|||++...  .++.++||||||+++|||++ |..||.....       ... ....
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~-~~~~  224 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AEL-YEKL  224 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HHH-HHHH
Confidence            986322111   11112235679999998654  67889999999999999997 9999854321       111 1111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      ...       ...........++.+++.+||+.+|.+|||+.++++.|++++
T Consensus       225 ~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 PQG-------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             hCC-------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            110       011111223457889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=307.49  Aligned_cols=244  Identities=22%  Similarity=0.373  Sum_probs=206.8

Q ss_pred             hhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|.|+.|-+|+ .-+|+.||||++.+.+-+   ...+.+|++.|+.++|||||+||++......+|||+|.-+
T Consensus        21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD  100 (864)
T KOG4717|consen   21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD  100 (864)
T ss_pred             hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence            346789999999999998 468999999999876533   3578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE-CCCCceEEcccccceeccCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL-DEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll-~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +|+|.|||.+..     ..+.++.+.+++.||+.|+.|+|+   ..+|||||||+||.+ .+-|-|||+|||++-.+...
T Consensus       101 ~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen  101 GGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             CchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999998764     679999999999999999999999   899999999999875 67889999999999887766


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      +.   ....+|+..|-|||++.|. ..-.+++||||||||||.|+.|++||....+..           .+....    .
T Consensus       173 ~k---L~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------TLTmIm----D  233 (864)
T KOG4717|consen  173 KK---LTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------TLTMIM----D  233 (864)
T ss_pred             ch---hhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------hhhhhh----c
Confidence            54   3556789999999999886 234678999999999999999999998654421           111111    1


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       -.-..+..++++..+||..||..||.+|.+.++|+.
T Consensus       234 -CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  234 -CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             112345677899999999999999999999999985

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-36  Score=306.41  Aligned_cols=252  Identities=26%  Similarity=0.439  Sum_probs=198.8

Q ss_pred             hhhcccCcCcceeEEEEEEcC-C---CEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD-G---QNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      ...+.||+|+||.||+|+... +   ..+|+|.++...  ...+.+.+|++++++++|+|++++++++......++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            347899999999999998642 3   369999886543  2345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          88 MENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999997643     468999999999999999999999   8999999999999999999999999999986643


Q ss_pred             CCceee-ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          480 RESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       480 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ...... ......+..|+|||++.+.  .++.++||||||+++|||++ |+.||.....       ... ...+...   
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~-~~~i~~~---  226 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEV-MKAINDG---  226 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHH-HHHHhcC---
Confidence            322111 1112235679999998654  67899999999999999997 9999864321       011 1111110   


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                          .......+.+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                11111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.1e-37  Score=313.99  Aligned_cols=258  Identities=28%  Similarity=0.475  Sum_probs=198.2

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCC--EEEEEEecccC--CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQ--NVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||.||+|.+. ++.  .+++|.++...  .....+.+|++++.++ +|+||+++++++...+..++|+||
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   89 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   89 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence            45789999999999999864 344  45777765432  2335678899999999 799999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEc
Q 006620          400 VSNGSLEKFIHEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS  469 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  469 (638)
                      +++++|.+++.......          ....+++..++.++.|+++||+|||+   .+++||||||+|||+++++.+||+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeC
Confidence            99999999998654221          12358899999999999999999999   999999999999999999999999


Q ss_pred             ccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHH
Q 006620          470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVY  548 (638)
Q Consensus       470 DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  548 (638)
                      |||++.......   ......++..|+|||++.+.  .++.++||||||+++|||+| |..||......       . ..
T Consensus       167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~-~~  233 (303)
T cd05088         167 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------E-LY  233 (303)
T ss_pred             ccccCcccchhh---hcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChH-------H-HH
Confidence            999986432111   11112236679999988654  67889999999999999998 99988643211       0 11


Q ss_pred             HHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                      ......       .........+.++.+++.+||+.+|++||+++++++.|++++..-
T Consensus       234 ~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         234 EKLPQG-------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HHHhcC-------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            111110       111111223457889999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.5e-37  Score=312.21  Aligned_cols=258  Identities=27%  Similarity=0.469  Sum_probs=199.2

Q ss_pred             hhhcccCcCcceeEEEEEEcC-CC--EEEEEEecccC--CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD-GQ--NVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||.||+|+..+ +.  .+++|.++...  ...+.+.+|++++.++ +||||+++++++......++++||
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            356889999999999998643 33  47888887432  2345788999999999 699999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEc
Q 006620          400 VSNGSLEKFIHEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS  469 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  469 (638)
                      +++++|.+++.......          ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEEC
Confidence            99999999997643211          12358899999999999999999999   999999999999999999999999


Q ss_pred             ccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHH
Q 006620          470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVY  548 (638)
Q Consensus       470 DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  548 (638)
                      |||++......   ........+..|+|||++.+.  .++.++|||||||++|||++ |+.||.....       ... .
T Consensus       162 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~-~  228 (297)
T cd05089         162 DFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AEL-Y  228 (297)
T ss_pred             CcCCCccccce---eccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH-H
Confidence            99998643211   111112235679999998654  67899999999999999997 9999864321       111 1


Q ss_pred             HHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                      .....       ......+..++.++.+++.+||+.+|.+|||++++++.|++++...
T Consensus       229 ~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         229 EKLPQ-------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHhc-------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111       1111112234567889999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.4e-36  Score=303.64  Aligned_cols=247  Identities=23%  Similarity=0.395  Sum_probs=200.3

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc---CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|++|.||+|.. .+++.|++|.+...   .....++.+|++++++++||||+++++++...+..++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE   82 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence            3568899999999999985 45889999998643   2345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....    ...+++..++.++.|+++||.|||+   .+++|+||||+||++++++.++|+|||+++......
T Consensus        83 ~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          83 NGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999998742    2568999999999999999999999   999999999999999999999999999988765432


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ..  .....|++.|+|||++.+.  .++.++|+||||+++++|++|+.||.....       .... ....       ..
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~-~~~~-------~~  216 (256)
T cd08529         156 NF--ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALI-LKII-------RG  216 (256)
T ss_pred             ch--hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHH-HHHH-------cC
Confidence            21  1234578899999998764  678899999999999999999999864331       0111 1100       11


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ........+..++.+++.+||+.+|++||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1111222456788999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.1e-37  Score=317.66  Aligned_cols=239  Identities=24%  Similarity=0.285  Sum_probs=187.1

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHH-HHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVA-SISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+|+. .+++.||+|++....    .....+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 468899999986532    22334555554 46778999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.||++||+|||+   .||+||||||+|||+++++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  151 (325)
T cd05604          81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD  151 (325)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence            9999988764      468999999999999999999999   9999999999999999999999999999875322211


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       .. ....... ....   
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~-~~~~~~~-~~~~---  215 (325)
T cd05604         152 --TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EM-YDNILHK-PLVL---  215 (325)
T ss_pred             --CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHH-------HH-HHHHHcC-CccC---
Confidence              12334689999999999764  6788999999999999999999998643210       11 1111100 0100   


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVV  596 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  596 (638)
                          ....+..+.+++.+||+.+|++||++.+.+
T Consensus       216 ----~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         216 ----RPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ----CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                112355678999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-36  Score=313.69  Aligned_cols=261  Identities=26%  Similarity=0.467  Sum_probs=200.9

Q ss_pred             hhhcccCcCcceeEEEEEEc--------CCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL--------DGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  394 (638)
                      .+.++||+|+||.||++...        ....+|+|+++....  ....+.+|+++++++ +||||+++++++......+
T Consensus        15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   94 (314)
T cd05099          15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY   94 (314)
T ss_pred             eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence            45789999999999999742        234789999875432  235678899999999 5999999999999999999


Q ss_pred             EEEEeccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC
Q 006620          395 LIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF  464 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~  464 (638)
                      ++|||+++++|.+++......          .....+++..+..++.|++.||+|||+   .|++||||||+||++++++
T Consensus        95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCC
Confidence            999999999999999764321          112458999999999999999999999   9999999999999999999


Q ss_pred             ceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccch
Q 006620          465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYF  543 (638)
Q Consensus       465 ~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  543 (638)
                      .+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||.....       
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-------  242 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-------  242 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCCH-------
Confidence            9999999999866433221111222345679999998654  68899999999999999998 7888753221       


Q ss_pred             hHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          544 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                       ..........       .........+.++.+++.+||+.+|++|||+.++++.|+++....
T Consensus       243 -~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         243 -EELFKLLREG-------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             -HHHHHHHHcC-------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence             1111111111       001111233557889999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=303.67  Aligned_cols=248  Identities=26%  Similarity=0.293  Sum_probs=197.1

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      ...+.||+|++|.||++.. .+++.||+|++.....      ....+.+|++++++++||||+++++++..+...++|+|
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   84 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME   84 (263)
T ss_pred             cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence            3468999999999999985 4588999999864321      23467889999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++...
T Consensus        85 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          85 YMPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             ECCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999999764      358889999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceee-ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ....... .....++..|+|||++.+.  .++.++||||||+++|||++|+.||......      .. .....      
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~-~~~~~------  220 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AA-IFKIA------  220 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchH------HH-HHHHh------
Confidence            3221111 1234568899999999775  5889999999999999999999998643210      00 00000      


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       ........+......+.+++.+||+.+|++|||+.+++++
T Consensus       221 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 -TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             0011111222345678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.1e-37  Score=310.94  Aligned_cols=256  Identities=25%  Similarity=0.423  Sum_probs=198.5

Q ss_pred             hhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.||+|+||.||+|...      +++.||+|++.....  ...++.+|+.++++++||||+++++++..+...++++
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (288)
T cd05050           8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF   87 (288)
T ss_pred             eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence            35688999999999999853      467899999875432  2456888999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC
Q 006620          398 EFVSNGSLEKFIHEKHPL----------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD  461 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~  461 (638)
                      ||+++++|.+++......                .....+++..++.++.|++.||+|||+   .+++||||||+||+++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~  164 (288)
T cd05050          88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVG  164 (288)
T ss_pred             ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEec
Confidence            999999999999754311                112357889999999999999999999   9999999999999999


Q ss_pred             CCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcc
Q 006620          462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSE  540 (638)
Q Consensus       462 ~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~  540 (638)
                      .++.+||+|||++.................+..|+|||.+.+.  .++.++||||||+++|||++ |..||.....    
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~----  238 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAH----  238 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999998865433221112223346789999988654  68899999999999999997 7777743211    


Q ss_pred             cchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          541 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                         .... .......       ....+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       239 ---~~~~-~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 ---EEVI-YYVRDGN-------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HHHH-HHHhcCC-------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               1111 1111110       001112345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.8e-36  Score=305.91  Aligned_cols=250  Identities=28%  Similarity=0.408  Sum_probs=196.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeC------ceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEG------HRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~lv  396 (638)
                      +.+.+.||+|+||.||+|.. .+++.||+|++.........+.+|+.+++++ +|+||+++++++...      ...+++
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   87 (272)
T cd06637           8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV   87 (272)
T ss_pred             hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence            34467899999999999985 4578999999976665667788999999998 699999999998753      467899


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++..
T Consensus        88 ~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          88 MEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            99999999999998642    2468999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCceeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      ......  ......|+..|+|||++.+.   ...++.++|||||||++|||++|+.||.......      ..  .... 
T Consensus       161 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------~~--~~~~-  229 (272)
T cd06637         161 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------AL--FLIP-  229 (272)
T ss_pred             cccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------HH--HHHh-
Confidence            543221  12335688999999998532   2357889999999999999999999986432110      00  0000 


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       .    ...........+.++.+|+.+||+.+|++|||+.++++
T Consensus       230 -~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 -R----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -c----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             0    00111111234567889999999999999999999986

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-36  Score=308.51  Aligned_cols=263  Identities=26%  Similarity=0.428  Sum_probs=196.1

Q ss_pred             hhhcccCcCcceeEEEEEE-----cCCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-----LDGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  397 (638)
                      .+.+.||+|+||+||++..     .+++.||+|++..... ..+.+.+|++++++++||||+++++++..  ....++|+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            3568899999999999974     2477899999875432 34578899999999999999999998754  34678999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++++|.+++....     ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||++...
T Consensus        87 e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          87 EYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            9999999999997643     458999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCceeee-cccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc-----ccchhHHHHHHh
Q 006620          478 EGRESIVSM-TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS-----EIYFPHWVYKRL  551 (638)
Q Consensus       478 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~  551 (638)
                      ......... ....++..|+|||.+.+.  .++.++||||||+++|||++|..++......-.     ............
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            543322111 112234569999998654  678899999999999999998766432211000     000000000000


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      .    ..............+.++.+++.+||+.+|++|||+++|++.|+.+
T Consensus       237 ~----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 E----LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             H----HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0    0000111111223456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-36  Score=309.53  Aligned_cols=247  Identities=24%  Similarity=0.346  Sum_probs=196.1

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ..+.||+|+||+||++.. .+++.||+|.+.....    ....+.+|+.++++++|+|++++++.+.+.+..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            457899999999999985 4688999998865321    12456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....    ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++.......
T Consensus        84 g~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          84 GGDLKFHIYHMG----EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             CCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999986542    2458999999999999999999999   999999999999999999999999999987654333


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .   .....|+..|+|||++.+.  .++.++||||+|+++|+|++|+.||.........    .........        
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----~~~~~~~~~--------  219 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKE--------  219 (285)
T ss_pred             c---ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----HHHHhhhhh--------
Confidence            2   1234689999999999764  6889999999999999999999999753321100    000000000        


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  597 (638)
                      ........+..++.+|+.+||+.||++|||     ++|+++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            000111234567889999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.7e-37  Score=318.79  Aligned_cols=261  Identities=27%  Similarity=0.405  Sum_probs=198.2

Q ss_pred             hhhhcccCcCcceeEEEEEE------cCCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeC-ceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL------LDGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEG-HRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~~  394 (638)
                      +.+.+.||+|+||+||+|..      .+++.||||+++....  ....+.+|+.++.++ +||||+++++++... ...+
T Consensus         9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (343)
T cd05103           9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   88 (343)
T ss_pred             hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence            45678999999999999973      2467899999975432  234678999999999 689999999988654 4678


Q ss_pred             EEEEeccCCCHHHHhhhcCCCC----------------------------------------------------------
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLE----------------------------------------------------------  416 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------------------  416 (638)
                      ++|||+++|+|.+++.......                                                          
T Consensus        89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (343)
T cd05103          89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ  168 (343)
T ss_pred             EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence            9999999999999997532100                                                          


Q ss_pred             ---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeeccccccc
Q 006620          417 ---TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTI  493 (638)
Q Consensus       417 ---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~  493 (638)
                         ....+++..+..++.|+++||+|||+   .+|+||||||+||++++++.+||+|||++................++.
T Consensus       169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         169 EDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence               01247888899999999999999999   999999999999999999999999999998654332222222334567


Q ss_pred             ceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHH
Q 006620          494 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR  572 (638)
Q Consensus       494 ~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (638)
                      .|+|||.+.+.  .++.++||||||+++|+|++ |..||......       ............       ...+.....
T Consensus       246 ~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~-------~~~~~~~~~  309 (343)
T cd05103         246 KWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTR-------MRAPDYTTP  309 (343)
T ss_pred             ceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCC-------CCCCCCCCH
Confidence            89999998654  68899999999999999996 88887643211       001111111100       011111245


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          573 KMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       573 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ++.+++.+||+.+|++|||+.+|+++|++++.
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            68899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.5e-36  Score=302.11  Aligned_cols=246  Identities=26%  Similarity=0.461  Sum_probs=196.1

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEE-eCceEEEEEEeccCCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCF-EGHRRALIYEFVSNGS  404 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~gs  404 (638)
                      .+.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++++++|+|++++++++. .+...++++||+++++
T Consensus         9 ~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~   86 (256)
T cd05082           9 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   86 (256)
T ss_pred             eeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence            4578999999999999976 47889999986543 3467889999999999999999999764 4567899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++........  
T Consensus        87 L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--  157 (256)
T cd05082          87 LVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--  157 (256)
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccCC--
Confidence            999998643    2458899999999999999999999   9999999999999999999999999999886543321  


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                         ...++..|+|||++.+.  .++.++||||||+++|||++ |+.||.....       .... .....       ...
T Consensus       158 ---~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~~~-~~~~~-------~~~  217 (256)
T cd05082         158 ---TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVV-PRVEK-------GYK  217 (256)
T ss_pred             ---CCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHH-HHHhc-------CCC
Confidence               22346789999998654  68889999999999999997 8888753221       1111 11111       011


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      .......+..+.+++.+||+.+|++|||++++++.|+++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            111223456788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=315.01  Aligned_cols=253  Identities=19%  Similarity=0.242  Sum_probs=193.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+++. .+++.||+|++...    ....+.+.+|+.+++.++|+||+++++++.++...++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (331)
T cd05597           4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY   83 (331)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence            4578899999999999985 45889999998642    223456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++.+..     ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          84 VGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999997642     468999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .... .....||+.|+|||++...   .+.++.++|||||||++|||++|+.||.....       ..............
T Consensus       156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~  227 (331)
T cd05597         156 GTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKEHF  227 (331)
T ss_pred             CCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCcc
Confidence            2211 1224589999999998631   23567899999999999999999999864321       11111110000001


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPS--DRPSMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~  598 (638)
                      ..    .......+.++.+++.+||..+++  .||++++++++
T Consensus       228 ~~----~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 QF----PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cC----CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11    111122456778888888765443  37899999876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=326.88  Aligned_cols=258  Identities=21%  Similarity=0.269  Sum_probs=189.8

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeC--------ceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEG--------HRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~l  395 (638)
                      +.+.++||+|+||+||+|.. .+++.||||++....   ....+|+.++++++||||+++++++...        ...++
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            34578999999999999985 458899999886443   2345799999999999999999987532        24668


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-ceEEcccccc
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLA  474 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFg~~  474 (638)
                      ||||+++ +|.+++....  .....+++..++.++.||++||+|||+   ++|+||||||+|||++.++ .+||+|||++
T Consensus       145 vmE~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        145 VMEFIPQ-TVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEecCCc-cHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            9999975 8888776432  123568999999999999999999999   9999999999999998654 7999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH-----
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK-----  549 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----  549 (638)
                      +........   ....||+.|+|||++.+. ..++.++|||||||++|||++|.+||.......   .+......     
T Consensus       219 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~~~p~  291 (440)
T PTZ00036        219 KNLLAGQRS---VSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRIIQVLGTPT  291 (440)
T ss_pred             hhccCCCCc---ccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence            876543322   234579999999998654 357899999999999999999999997543211   00000000     


Q ss_pred             --Hhhh----hhhccccCCCCc-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          550 --RLEL----EEDLGLQGIENE-----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       550 --~~~~----~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        ....    ...+........     .+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence              0000    000111111111     111234678999999999999999999999854

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.2e-36  Score=302.68  Aligned_cols=248  Identities=29%  Similarity=0.408  Sum_probs=196.7

Q ss_pred             cccCcCcceeEEEEEEcC--CC--EEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLLD--GQ--NVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ++||+|++|.||+|.+.+  ++  .||||.+.....  ..+.+.+|++++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  32  689999876544  34678899999999999999999999988 889999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++.....    ..+++..++.++.|+++||+|||+   ++++|+||||+||+++.++.+||+|||+++.......
T Consensus        80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999987531    468999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             ee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       483 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .. ......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......       ..........      
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~------  217 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKIDKEG------  217 (257)
T ss_pred             ceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcC------
Confidence            11 11234567899999998654  67889999999999999998 99998533211       1111111000      


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                       .........+..+.+++.+||+.+|++||++.++++.|.
T Consensus       218 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 -ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             001111234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-36  Score=304.51  Aligned_cols=257  Identities=25%  Similarity=0.416  Sum_probs=190.8

Q ss_pred             cccCcCcceeEEEEEEcC---CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKLLD---GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.||+|+||+||+|...+   ...+++|.+.....  ....+.+|++.++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997433   34688887764332  2346789999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++...... .....++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||++.........
T Consensus        81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          81 DLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             cHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999875421 12345678899999999999999999   99999999999999999999999999998754333222


Q ss_pred             eeecccccccceecCceeccc-----cCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          484 VSMTGARGTIGYIAPEVFCRN-----FGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .......+++.|+|||++...     ...++.++||||||+++|||++ |..||......       ........ ....
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~-~~~~  228 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVR-EQDI  228 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhh-ccCc
Confidence            222334457789999987432     1256789999999999999998 67777543211       00011111 1111


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ..  ........++..+.+++..|+ .||++|||+++|++.|.
T Consensus       229 ~~--~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         229 KL--PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cC--CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            01  011122234566778888888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.9e-37  Score=323.96  Aligned_cols=257  Identities=19%  Similarity=0.238  Sum_probs=195.3

Q ss_pred             hhhhcccCcCcceeEEEEEEc---CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL---DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.++||+|+||.||++...   .++.||+|.+...    ....+|++++++++||||+++++++......++|||++.
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  169 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK  169 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence            456789999999999999743   3568999987643    234689999999999999999999999999999999995


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                       ++|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus       170 -~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        170 -CDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             -CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence             6898988543      568999999999999999999999   999999999999999999999999999998665443


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh--------
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL--------  553 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  553 (638)
                      .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||...........+.... +....        
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~-~~~~~~~~~~~~~  316 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-RCMQVHPLEFPQN  316 (392)
T ss_pred             ccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH-HHhccCccccCCc
Confidence            33333455789999999999764  68899999999999999999999986544322111111100 00000        


Q ss_pred             --------hhhccccC---CC-Cc--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          554 --------EEDLGLQG---IE-NE--EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       554 --------~~~~~~~~---~~-~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                              ........   .. ..  .......++.++|.+||+.||++|||+.|++.+
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    00000000   00 00  001234567889999999999999999999963

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-36  Score=311.87  Aligned_cols=260  Identities=23%  Similarity=0.340  Sum_probs=195.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||+|+||+||+|+.. +++.||+|+++...  .....+.+|++++++++||||+++++++..++..++||||+++
T Consensus         9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   88 (309)
T cd07872           9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK   88 (309)
T ss_pred             EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence            45688999999999999854 57889999987543  2234678899999999999999999999999999999999975


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                       +|.+++....     ..+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++.......
T Consensus        89 -~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          89 -DLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             -CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence             8988887643     458899999999999999999999   9999999999999999999999999999976543221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh-------HHHHHHhhhhh
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP-------HWVYKRLELEE  555 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~  555 (638)
                        ......+|+.|+|||++.+. ..++.++||||||+++|+|++|++||.............       ...+.......
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             --ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence              12234578999999998653 357889999999999999999999996543211000000       00000000000


Q ss_pred             ---hccccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 ---DLGLQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ---~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                         .........    ......+.++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence               000000000    011124567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-36  Score=304.20  Aligned_cols=239  Identities=24%  Similarity=0.383  Sum_probs=186.2

Q ss_pred             cccCcCcceeEEEEEEcC-------------CCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEE
Q 006620          329 NKLGQGGYGGVYKGKLLD-------------GQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  394 (638)
                      +.||+|+||.||+|+...             ...|++|++..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997432             22588998765432 3357788999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc-------eE
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-------PK  467 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~-------~k  467 (638)
                      +||||+++++|..++....     ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.       +|
T Consensus        81 lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999887542     468999999999999999999999   99999999999999986654       89


Q ss_pred             EcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHh-cCCCCCCcccCCCcccchhHH
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT-GEKNNANVAVDRSSEIYFPHW  546 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~  546 (638)
                      ++|||++......      ....++..|+|||.+... ..++.++||||||+++|||+ +|+.|+......       ..
T Consensus       153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~  218 (262)
T cd05077         153 LSDPGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EK  218 (262)
T ss_pred             eCCCCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HH
Confidence            9999998754322      223468889999988532 36788999999999999997 677776532210       00


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML  599 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  599 (638)
                        ..... ..  .. ..    .....++.+++.+||+.||++||++++|++.|
T Consensus       219 --~~~~~-~~--~~-~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         219 --ERFYE-GQ--CM-LV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --HHHHh-cC--cc-CC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              00000 00  00 00    11245688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.5e-36  Score=303.70  Aligned_cols=246  Identities=25%  Similarity=0.404  Sum_probs=193.8

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.||+|+||.||+|+. .+++.||+|++....  ...+.+.+|++++++++||||+++++++...+..++|+||++++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   84 (279)
T cd06619           5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG   84 (279)
T ss_pred             heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence            467899999999999985 568899999986542  22356889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|..+          ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.......  
T Consensus        85 ~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          85 SLDVY----------RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             ChHHh----------hcCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            99654          236788899999999999999999   999999999999999999999999999998654332  


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                        .....||..|+|||.+.+.  .++.++||||||+++|+|++|+.||................ ......   ..... 
T Consensus       150 --~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~---~~~~~-  220 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDE---DPPVL-  220 (279)
T ss_pred             --ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhcc---CCCCC-
Confidence              2335689999999999764  68899999999999999999999987543222111111110 100000   00111 


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        .....+.++.+++.+||+.+|++||++++++++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              111234578899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=318.37  Aligned_cols=240  Identities=24%  Similarity=0.299  Sum_probs=186.3

Q ss_pred             cCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhc---CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          331 LGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRT---SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       331 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ||+|+||+||+|+.. +++.||||++....    ........|..++.+.   +||||+++++.+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999854 58899999986432    1223445666776655   699999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++...      ..+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  151 (330)
T cd05586          81 GELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK  151 (330)
T ss_pred             ChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence            9999998764      468999999999999999999999   9999999999999999999999999999875432221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.....       .. ....+.... ..   .
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~-~~~~i~~~~-~~---~  216 (330)
T cd05586         152 --TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQ-MYRNIAFGK-VR---F  216 (330)
T ss_pred             --CccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCH-------HH-HHHHHHcCC-CC---C
Confidence              12345689999999998653 2478899999999999999999999864321       01 111111110 00   1


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRP----SMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~  597 (638)
                      .   ...++.++.+++.+||+.||++||    ++.++++
T Consensus       217 ~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         217 P---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             C---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            1   112456778999999999999998    4666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3e-36  Score=303.53  Aligned_cols=252  Identities=26%  Similarity=0.463  Sum_probs=198.8

Q ss_pred             hhhcccCcCcceeEEEEEEc-C---CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-D---GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||.||+|+.. +   +..+|+|.++....  ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (267)
T cd05066           7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY   86 (267)
T ss_pred             EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence            35689999999999999853 2   33799998865432  345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          87 MENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999997643     458999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCcee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          480 RESIV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       480 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ..... ......++..|+|||.+.+.  .++.++|+||||+++||+++ |+.||......       . ....+...   
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~-~~~~~~~~---  225 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------D-VIKAIEEG---  225 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------H-HHHHHhCC---
Confidence            32211 11222345689999999764  68899999999999999886 99887643211       0 01111110   


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                          .........+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 ----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                01111123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=311.85  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=208.1

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .++++||+|-||.|..+....+..||||+++...  ....+|.+|+++|.+++||||++|+|+|..++.+++|+||+++|
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG  620 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG  620 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence            3578999999999999998778999999998654  33478999999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|..++..+..    ..+.-....+|+.||++||+||.+   .+++||||.++|+|++.++.+||+|||+++.+-..+.+
T Consensus       621 DLnqFl~ahea----pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  621 DLNQFLSAHEL----PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             cHHHHHHhccC----cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999988641    113445567799999999999999   99999999999999999999999999999977666655


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc--CCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG--EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ......+-+++|||+|.+..  +.++.++|||+||+++||+++  .+.||....++       +.+.+.-..   +...+
T Consensus       694 ~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-------~vven~~~~---~~~~~  761 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-------QVVENAGEF---FRDQG  761 (807)
T ss_pred             eeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-------HHHHhhhhh---cCCCC
Confidence            44444566889999998865  489999999999999999764  56676544321       111111111   11111


Q ss_pred             --CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          562 --IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       562 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                        .....+.-++.++.+++.+||+.+-++||+++++...|++.
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence              11223445677889999999999999999999999998864

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-36  Score=303.17  Aligned_cols=251  Identities=27%  Similarity=0.463  Sum_probs=191.5

Q ss_pred             cccCcCcceeEEEEEEcC----CCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEE-eCceEEEEEEecc
Q 006620          329 NKLGQGGYGGVYKGKLLD----GQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCF-EGHRRALIYEFVS  401 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  401 (638)
                      +.||+|+||.||+|...+    +..+|+|.+....  ...+.+.+|+.+++.++||||+++++++. .+...++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998532    3579999885432  23457788999999999999999999776 4556789999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....     ..+++..+..++.|+++||+|||+   .+++||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          81 HGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999997643     346777889999999999999999   899999999999999999999999999997654322


Q ss_pred             ce--eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcC-CCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          482 SI--VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE-KNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       482 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ..  .......++..|+|||.+.+.  .++.++||||||+++|||++| .+||.....       .... .....     
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~-~~~~~-----  217 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDIT-VYLLQ-----  217 (262)
T ss_pred             ceeecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHH-HHHhc-----
Confidence            11  111233457789999998654  688899999999999999995 455543211       0111 11110     


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                        ..........+..+.+++.+||+.+|++||++.+|++.|++++.
T Consensus       218 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         218 --GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             --CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence              00111112234578899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-36  Score=313.02  Aligned_cols=253  Identities=19%  Similarity=0.224  Sum_probs=194.7

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.++||+|+||+||+++.. +++.+|+|++.+.    ......+.+|+.++..++|+||+++++.+.+....++||||+
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            45689999999999999864 4778999998642    122345778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++.+..     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          84 VGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999998643     468999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ... ......||+.|+|||++.+.   ...++.++|||||||++|||++|+.||.....       ..............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~  227 (332)
T cd05623         156 GTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKERF  227 (332)
T ss_pred             Ccc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCccc
Confidence            221 12335689999999998631   23578899999999999999999999964321       11111111100001


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSD--RPSMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  598 (638)
                      .    ........+.++.+++.+||..++.+  |+++++++++
T Consensus       228 ~----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 Q----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             c----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0    11112234667888999988664444  6899999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.8e-36  Score=300.62  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=200.7

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-CCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.++||+|++|.||+|+..+ ++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||++++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   83 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG   83 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence            3456789999999999999654 78999999876543 678899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..+..++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++........ 
T Consensus        84 ~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          84 SVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             cHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999997643     568999999999999999999999   8999999999999999999999999999887654321 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                       ......++..|+|||++.+.  .++.++||||||+++|+|++|+.||.........           .....  .....
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----------~~~~~--~~~~~  218 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----------FMIPN--KPPPT  218 (256)
T ss_pred             -ccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----------hhhcc--CCCCC
Confidence             11233478899999998764  6788999999999999999999998743221100           00000  00011


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......+..++.+++.+||+.+|++|||++++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            1123345667899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=313.57  Aligned_cols=241  Identities=27%  Similarity=0.380  Sum_probs=200.6

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.||.|+||.||-|++ .+.+.||||.+.-+..    .-+++++|+..|++++|||++.+-|+|..+...+||||||- |
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence            5699999999999984 5678999999875432    23578999999999999999999999999999999999995 5


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +-.|++.-..     +++-+..+..|..+.+.||+|||+   .+.||||||..|||+++.|.|||+|||.+.......  
T Consensus       111 SAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--  180 (948)
T KOG0577|consen  111 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--  180 (948)
T ss_pred             cHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence            8888887654     678999999999999999999999   999999999999999999999999999998766543  


Q ss_pred             eeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                          ..+|||.|||||++.-. -|+|+-++||||||++..||...++|...+..-           ..+.   .+.....
T Consensus       181 ----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-----------SALY---HIAQNes  242 (948)
T KOG0577|consen  181 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALY---HIAQNES  242 (948)
T ss_pred             ----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-----------HHHH---HHHhcCC
Confidence                46789999999988432 268999999999999999999999997654321           1110   1111222


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      +.....+++..+..|+..||+.-|++|||.++++++
T Consensus       243 PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            233456788999999999999999999999988864

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-36  Score=316.83  Aligned_cols=188  Identities=24%  Similarity=0.375  Sum_probs=160.0

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.+.||+|+||.||+|+.. +++.||+|+...     .....|+.++++++||||+++++++......++|+|++. +
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  141 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-S  141 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-C
Confidence            456789999999999999864 467899997533     234579999999999999999999999999999999995 5


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..+..|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       142 ~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  212 (357)
T PHA03209        142 DLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-  212 (357)
T ss_pred             cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence            8999887643     568999999999999999999999   9999999999999999999999999999875432221 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNA  531 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~  531 (638)
                        .....||+.|+|||++.+.  .++.++|||||||++|||+++..++
T Consensus       213 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 --FLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcc
Confidence              2345689999999999764  6889999999999999999865554

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-36  Score=305.59  Aligned_cols=258  Identities=25%  Similarity=0.331  Sum_probs=200.8

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+++.++||+|+||+||++.. .+++.||+|++....  ...+.+.+|+++++.++||||+++++++......++|+||+
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM   85 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence            345678999999999999985 458899999886543  23467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..+..++.|++.||.|||+.  .+++||||||+||++++++.++|+|||++......
T Consensus        86 ~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          86 DCGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999998764      4589999999999999999999962  58999999999999999999999999998754322


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..    ....|+..|+|||++.+.  .++.++|||||||++|+|++|+.||............+.........   ....
T Consensus       158 ~~----~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~  228 (284)
T cd06620         158 IA----DTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ---IVQE  228 (284)
T ss_pred             cc----CccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH---Hhhc
Confidence            21    234679999999998654  78889999999999999999999998554322111111111111110   0000


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ..........+.++.+++.+||+.||++|||++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            01111112355678999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-36  Score=305.12  Aligned_cols=254  Identities=27%  Similarity=0.445  Sum_probs=200.6

Q ss_pred             hhhcccCcCcceeEEEEEEcC-CC----EEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD-GQ----NVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.+.||+|+||+||+|...+ ++    .+|+|++.....  ...++.+|+.++++++||||+++++++.. ...++|+|
T Consensus        10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   88 (279)
T cd05057          10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ   88 (279)
T ss_pred             EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence            456899999999999998543 33    589998876543  34578899999999999999999999887 78899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||.++...
T Consensus        89 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          89 LMPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             cCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            999999999998653     458999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ............++..|+|||.+...  .++.++|+||||+++|||++ |+.||.....       ... ...+....  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~-~~~~~~~~--  228 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------VEI-PDLLEKGE--  228 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------HHH-HHHHhCCC--
Confidence            44332222233346789999988653  67889999999999999998 9999864321       111 11111111  


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                           ....+......+.+++.+||..+|++||++.++++.|+++.+.
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         229 -----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence                 0111112334678999999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-36  Score=319.75  Aligned_cols=260  Identities=23%  Similarity=0.275  Sum_probs=194.4

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc-----eEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGH-----RRALIY  397 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~  397 (638)
                      ..++||+|+||+||++.. .+++.||||++....   .....+.+|+++++.++|+||+++++++....     ..++|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            467899999999999985 468999999986532   22356789999999999999999999998776     789999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+. ++|.+++...      ..+++..+..++.||++||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        84 e~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          84 ELMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             eccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9996 5888888653      468999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc---------cchhHHHH
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE---------IYFPHWVY  548 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~---------~~~~~~~~  548 (638)
                      ...... ......+++.|+|||++.+. ..++.++||||+||++|||++|+.||.........         .....+..
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            433221 12334578999999998764 35788999999999999999999999654321000         00000000


Q ss_pred             HHhhhhhhccccCC-CC------chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          549 KRLELEEDLGLQGI-EN------EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       549 ~~~~~~~~~~~~~~-~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ........+..... ..      ......+.++.+|+.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            00000000000000 00      0011235678899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-36  Score=315.09  Aligned_cols=238  Identities=24%  Similarity=0.309  Sum_probs=189.4

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      ++.+.||+|+||+||+|+. .+++.||||++....    ...+.+..|..+++.+. |++|+++++++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey   82 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY   82 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence            4578899999999999985 458899999987532    23345778888888876 57788899999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        83 ~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          83 VNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999999764      458999999999999999999999   9999999999999999999999999999875432


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||.....        ......+... ..  
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~-~~--  218 (323)
T cd05615         154 DGV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEH-NV--  218 (323)
T ss_pred             CCc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-CC--
Confidence            221  12334589999999998764  688999999999999999999999874321        1111111110 00  


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSM  592 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  592 (638)
                           ..+...+.++.+++.+||+.+|++|++.
T Consensus       219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 1112345678899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.8e-36  Score=301.43  Aligned_cols=252  Identities=22%  Similarity=0.328  Sum_probs=196.9

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.++||+|+||.||+|+. .+++.||+|+++... .....+.+|+.+++.++||||+++++.+...+..++|+||+++
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~   90 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG   90 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence            34578899999999999985 458899999987543 2334677899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....... 
T Consensus        91 ~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          91 GSLQDIYHVT------GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            9999998764      468999999999999999999999   899999999999999999999999999987654322 


Q ss_pred             eeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                       .......|+..|+|||++... ...++.++|+|||||++|+|++|+.||.......       .... ... .......
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------~~~~-~~~-~~~~~~~  230 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------ALFL-MTK-SNFQPPK  230 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-------hHHh-hhc-cCCCCCc
Confidence             112344689999999987421 2357889999999999999999999985432110       0000 000 0000000


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        ......++..+.+++.+||+.+|++||++++|+++
T Consensus       231 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 --LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             --ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence              01111245568899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.2e-36  Score=301.19  Aligned_cols=247  Identities=22%  Similarity=0.316  Sum_probs=198.4

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||+|+||.||++.. .+++.+|+|.++...  ...+.+.+|+.++++++|+||+++++.+.++...++++||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            3568999999999999985 468899999986432  3346778899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+........
T Consensus        83 ~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          83 GDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            99999987532    2458899999999999999999999   9999999999999999999999999999986643322


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .  .....|++.|+|||++.+.  .++.++|+||||+++|+|++|+.||.....       .... .....       +.
T Consensus       156 ~--~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~-~~~~~-------~~  216 (255)
T cd08219         156 Y--ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLI-LKVCQ-------GS  216 (255)
T ss_pred             c--cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCH-------HHHH-HHHhc-------CC
Confidence            1  1234578899999998764  688899999999999999999999864321       1111 11100       11


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ....+..++..+.+++.+||+.||++||++.+++..
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            111122345678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-36  Score=319.73  Aligned_cols=247  Identities=22%  Similarity=0.282  Sum_probs=191.4

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.||+|+||+||+++.. +++.||||++...    ......+.+|+.++.+++||||+++++.+.+.+..++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627           5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            4678999999999999854 5889999998643    2234567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|.+++.+.      ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        85 gg~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          85 GGDMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999764      458899999999999999999999   999999999999999999999999999987543211


Q ss_pred             ce---------------------------------eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCC
Q 006620          482 SI---------------------------------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK  528 (638)
Q Consensus       482 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~  528 (638)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCC
Confidence            00                                 001134689999999999764  6889999999999999999999


Q ss_pred             CCCCcccCCCcccchhHHHHHHhhh-hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 006620          529 NNANVAVDRSSEIYFPHWVYKRLEL-EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS---MNRVVEM  598 (638)
Q Consensus       529 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  598 (638)
                      .||......        .....+.. ...+....     ....+.++.+++.+++. ||++|++   +++++++
T Consensus       234 ~Pf~~~~~~--------~~~~~i~~~~~~~~~p~-----~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         234 PPFCSETPQ--------ETYRKVMNWKETLVFPP-----EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCCHH--------HHHHHHHcCCCceecCC-----CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            999643221        11111111 11111111     11235567888888764 9999986   5565543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.2e-36  Score=313.89  Aligned_cols=264  Identities=18%  Similarity=0.238  Sum_probs=193.6

Q ss_pred             hhcccCcC--cceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          327 FKNKLGQG--GYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.++||+|  +|++||++.. .+++.||||++.....   ..+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999985 5688999999875432   2345677999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++....    ...+++..++.++.|++.||+|||+   ++|+||||||+||+++.++.++++||+........
T Consensus        82 ~~~~l~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          82 AYGSAKDLICTHF----MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             CCCcHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            9999999997642    1358999999999999999999999   99999999999999999999999999865433211


Q ss_pred             Ccee-----eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc-----chhHH----
Q 006620          481 ESIV-----SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI-----YFPHW----  546 (638)
Q Consensus       481 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~-----~~~~~----  546 (638)
                      ....     ......++..|+|||++.+....++.++|||||||++|||++|+.||..........     ..+..    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence            1100     011234677899999997643467899999999999999999999996432210000     00000    


Q ss_pred             --HHHHhhhhh-----h--c------------cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          547 --VYKRLELEE-----D--L------------GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       547 --~~~~~~~~~-----~--~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ..+......     +  .            ............+..++.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence              000000000     0  0            0000001112234567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-36  Score=339.44  Aligned_cols=255  Identities=23%  Similarity=0.328  Sum_probs=195.8

Q ss_pred             HHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEE
Q 006620          323 MTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALI  396 (638)
Q Consensus       323 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  396 (638)
                      ..+.+.++||+|+||+||+++.. .++.+|+|++....   .....+..|+.++++++||||+++++++..  ...++||
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            34556789999999999999864 46789999986432   234578899999999999999999998864  4568999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEecccCCCceEECC----------
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC----NTRILHFDIKPHNILLDE----------  462 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----~~~iiH~Dikp~NIll~~----------  462 (638)
                      |||+++++|.++|....  .....+++..++.|+.||+.||+|||+..    .++||||||||+||||+.          
T Consensus        93 MEY~~gGSL~~lL~k~~--~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCY--KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EeCCCCCcHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            99999999999997642  12246999999999999999999999822    135999999999999964          


Q ss_pred             -------CCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCccc
Q 006620          463 -------DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAV  535 (638)
Q Consensus       463 -------~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~  535 (638)
                             .+.+||+|||++........   .....||+.|+|||++.+....++.++|||||||+||||++|+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   23489999999986643321   13346899999999986543467889999999999999999999996432


Q ss_pred             CCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          536 DRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .      .... ...+.....        ......+.++.+||.+||+.+|++||++.+++.
T Consensus       248 ~------~~ql-i~~lk~~p~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 N------FSQL-ISELKRGPD--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             c------HHHH-HHHHhcCCC--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            1      1111 111111110        111123567889999999999999999999984

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=327.32  Aligned_cols=254  Identities=22%  Similarity=0.265  Sum_probs=198.7

Q ss_pred             hhcccCcCcceeEEEEEEcCC-CEEEEEEecc-cCCchhhHHHHHHHHhhcC-CcceEEEEeEEE-e------CceEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLLDG-QNVAIKVLNE-TKGNGEDFINEVASISRTS-HVNIVTLLGFCF-E------GHRRALI  396 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-~------~~~~~lv  396 (638)
                      +.+.|.+|||+.||.|.+..+ ..||+|++-. +....+...+|+++|++|+ |+|||.+++... .      .-.++|+
T Consensus        41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL  120 (738)
T KOG1989|consen   41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL  120 (738)
T ss_pred             EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence            467899999999999997665 9999998754 3344577899999999998 999999999322 1      1346789


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      ||||.||.|-|++...-    ...|++.++++|+.++++|+++||.. ...|||||||-+||||+.++..||+|||.+..
T Consensus       121 mEyC~gg~Lvd~mn~Rl----q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  121 MEYCKGGSLVDFMNTRL----QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             hhhccCCcHHHHHHHHH----hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            99999999999998653    24599999999999999999999983 24599999999999999999999999999874


Q ss_pred             ccCCC-ceee------ecccccccceecCceecccc-CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHH
Q 006620          477 CEGRE-SIVS------MTGARGTIGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY  548 (638)
Q Consensus       477 ~~~~~-~~~~------~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  548 (638)
                      ..... ....      .-....|+.|+|||.+.--. -.+++|+|||+|||+||-|+-...||+....  ..+       
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--laI-------  266 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--LAI-------  266 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--eeE-------
Confidence            32221 1000      01123699999999884211 2689999999999999999999999975421  000       


Q ss_pred             HHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                               ......-.....++..+.+||+.||+.||.+||++-+|+.++..+.
T Consensus       267 ---------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  267 ---------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             ---------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                     0011112223567899999999999999999999999999997753

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-35  Score=301.80  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=196.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      ++.+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|+++++.++|||++++++++......++|+||++++
T Consensus         8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643           8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            45678999999999999864 47788999886543 33457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++........ 
T Consensus        88 ~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          88 AVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            9999887532     468999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             eeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          484 VSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                       ......+++.|+|||++...   ...++.++|||||||++|||++|++||......       ..... .....     
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~-~~~~~-----  224 (282)
T cd06643         159 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLK-IAKSE-----  224 (282)
T ss_pred             -ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHH-HhhcC-----
Confidence             12334578999999998521   235778999999999999999999998643210       00001 00000     


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......+..++.++.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011122235667899999999999999999999885

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.6e-36  Score=305.18  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=195.3

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ..+.||+|+||+||++.. .+++.||+|++....    .....+.+|++++++++|+||+++++.+..++..++||||++
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence            357899999999999985 468899999986542    122456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....    ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++.......
T Consensus        84 ~~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          84 GGDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             CccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            999999887532    2468999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .   .....|+..|+|||++.+.  .++.++|+||||+++|+|++|+.||.......    ............       
T Consensus       157 ~---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~----~~~~~~~~~~~~-------  220 (285)
T cd05632         157 S---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV----KREEVDRRVLET-------  220 (285)
T ss_pred             c---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhhhcc-------
Confidence            1   1334689999999998664  68889999999999999999999987432110    000111111000       


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  598 (638)
                       ........+.++.+|+.+||+.||++||+     +.+++++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 -EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence             00111234556789999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.8e-36  Score=304.28  Aligned_cols=254  Identities=23%  Similarity=0.391  Sum_probs=199.3

Q ss_pred             hhhhcccCcCcceeEEEEEEcC----CCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.++||+|+||.||+|...+    ...|+||......  ...+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e   86 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME   86 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence            4467899999999999998533    2468999886543  234578899999999999999999998875 45789999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          87 LAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             cCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            999999999997643     458999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ...... .....++..|+|||.+...  .++.++||||||+++|||++ |..||......       ... .........
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~-~~~~~~~~~  227 (270)
T cd05056         159 DESYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------DVI-GRIENGERL  227 (270)
T ss_pred             ccccee-cCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHH-HHHHcCCcC
Confidence            443221 1223345689999998654  67899999999999999885 99998644321       000 111111111


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                             ..+...+..+.+++.+|+..+|++|||+.++++.|+.+..+
T Consensus       228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   11223456788999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-36  Score=308.08  Aligned_cols=255  Identities=27%  Similarity=0.381  Sum_probs=189.6

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhc---CCcceEEEEeEEEe-----CceE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRT---SHVNIVTLLGFCFE-----GHRR  393 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~~~  393 (638)
                      .+.+.||+|+||+||+|+.. +++.||+|+++...   .....+.+|+++++++   +||||+++++++..     ....
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~   82 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV   82 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence            45688999999999999854 58899999987532   1223456777777665   69999999998864     3457


Q ss_pred             EEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      ++++||+++ +|.+++....    ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        83 ~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          83 TLVFEHVDQ-DLRTYLDKVP----PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             EEEEccccc-CHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence            899999975 8999887642    2458999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      ++.......   .....+|..|+|||++.+.  .++.++||||+||++|+|++|++||.......   .+... ......
T Consensus       155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~-~~~~~~  225 (288)
T cd07863         155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKI-FDLIGL  225 (288)
T ss_pred             cccccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHH-HHHhCC
Confidence            986643321   1334578999999998764  68899999999999999999999986432110   00000 000000


Q ss_pred             ------hhhcc-----ccCCC----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 ------EEDLG-----LQGIE----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ------~~~~~-----~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            .....     .....    ......+..++.+++.+||+.||++|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  00000     00000    0111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.2e-36  Score=301.44  Aligned_cols=247  Identities=28%  Similarity=0.401  Sum_probs=196.7

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCC-------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG-------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      ..+.||+|+||+||+|...+++.+|+|.+.....       ....+.+|++++++++|+||+++++++.+....++++||
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF   83 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence            4678999999999999987889999998864321       124578899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++.+.      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          84 VPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999764      357899999999999999999999   8999999999999999999999999999876532


Q ss_pred             CC----ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          480 RE----SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       480 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ..    .........++..|+|||++.+.  .++.++||||||+++|+|++|+.||......      .... . ...  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~-~-~~~--  222 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AAMF-Y-IGA--  222 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChH------HHHH-H-hhh--
Confidence            11    11111234578999999998764  6788999999999999999999998643211      0000 0 000  


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                         ...........+..++.+++.+||+.+|++||++.++++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 ---HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               001111122335677899999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.4e-36  Score=309.74  Aligned_cols=259  Identities=22%  Similarity=0.322  Sum_probs=196.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||+|+||.||++... ++..+|+|.+.....  ....+.+|++++++++||||+++++++.+++..++|+||+++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~   83 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   83 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence            35688999999999999854 578899998865422  235678999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.|+++||+|||+.  .+++|+||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          84 GSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999764      4588999999999999999999971  489999999999999999999999999987553322 


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHH---------------
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWV---------------  547 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~---------------  547 (638)
                         .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||...........+....               
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             ---cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence               1234678999999998654  67889999999999999999999986432211000000000               


Q ss_pred             -------HHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 -------YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                             ......................+..++.+++.+||+.+|++|||+++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   000000000000000000111245678999999999999999999999963

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4e-36  Score=310.61  Aligned_cols=201  Identities=24%  Similarity=0.368  Sum_probs=162.2

Q ss_pred             hcccCcCcceeEEEEEEc---CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEEEEeccC
Q 006620          328 KNKLGQGGYGGVYKGKLL---DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEFVSN  402 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  402 (638)
                      ..+||+|+||+||+|+..   +++.||+|.+.... ....+.+|++++++++||||+++++++..  +...++|+||+.+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            368999999999999864   35689999886543 23467899999999999999999998854  5678899999864


Q ss_pred             CCHHHHhhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE----CCCCceEEcccccce
Q 006620          403 GSLEKFIHEKHPL---ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAK  475 (638)
Q Consensus       403 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFg~~~  475 (638)
                       +|.+++......   .....+++..++.++.|+++||+|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             888887643211   122458999999999999999999999   999999999999999    567799999999998


Q ss_pred             eccCCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcc
Q 006620          476 ICEGRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVA  534 (638)
Q Consensus       476 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~  534 (638)
                      ........ .......+|+.|+|||++.+. ..++.++|||||||++|||++|++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            76433211 122345679999999998653 35788999999999999999999999644

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7e-36  Score=305.56  Aligned_cols=245  Identities=26%  Similarity=0.346  Sum_probs=196.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.+.||+|++|.||+|+. .+++.|++|.+.... ...+.+.+|+.+++.++|+|++++++.+..+...++||||++++
T Consensus        23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~  102 (296)
T cd06654          23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (296)
T ss_pred             eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence            3467899999999999985 468899999887543 33467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++..       ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus       103 ~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         103 SLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999865       347889999999999999999999   99999999999999999999999999998765433211


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                        .....+++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......      .+ .....      .....
T Consensus       173 --~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~-~~~~~------~~~~~  235 (296)
T cd06654         173 --RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------AL-YLIAT------NGTPE  235 (296)
T ss_pred             --cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hH-HHHhc------CCCCC
Confidence              1234578999999998754  67889999999999999999999996433210      00 00000      00001


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......+...+.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            1122345567889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.1e-36  Score=305.56  Aligned_cols=262  Identities=27%  Similarity=0.350  Sum_probs=195.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|++|.||+|+.. +++.||||++....   .....+.+|+.++++++||||+++++++.++...++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS   82 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence            34678999999999999864 68899999986432   223567899999999999999999999999999999999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                       ++|.+++....   ....+++..++.++.|+++||+|||+   .+++|+||||+||++++++.+||+|||++.......
T Consensus        83 -~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          83 -MDLKKYLDSLP---KGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             -CCHHHHHhcCC---CCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence             58999887542   12568999999999999999999999   999999999999999999999999999987653322


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh-------HHHHHHhhhh
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP-------HWVYKRLELE  554 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~  554 (638)
                      .  ......+++.|+|||.+.+. ..++.++||||||+++|+|++|++||.............       ...+......
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 R--VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             c--cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            1  12234568899999988654 256889999999999999999999986432110000000       0000000000


Q ss_pred             hhc--cc----cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 EDL--GL----QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~~~--~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...  ..    ..........++.++.+++.+||+.||++|||+++|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000  00    00001111224667889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.8e-36  Score=302.25  Aligned_cols=247  Identities=28%  Similarity=0.369  Sum_probs=194.5

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ...||+|+||.||+|+. .+++.|++|.+..... ..+.+.+|+.++++++|+||+++++++..++..++|+||+++++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            46899999999999985 4577899998865432 345788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-CCceEEcccccceeccCCCc
Q 006620          406 EKFIHEKHPLETNQKL--KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~~~~~~~~~  482 (638)
                      .+++....     ..+  ++..+..++.|+++||+|||+   .+|+||||||+||+++. ++.++|+|||.+........
T Consensus        93 ~~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          93 SALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             HHHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            99998642     234  788899999999999999999   99999999999999976 67999999999876543222


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .  .....+++.|+|||++.+....++.++||||||+++|+|++|+.||.........    .+  .. .      ....
T Consensus       165 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~----~~--~~-~------~~~~  229 (268)
T cd06624         165 C--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA----MF--KV-G------MFKI  229 (268)
T ss_pred             c--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh----Hh--hh-h------hhcc
Confidence            1  1223478999999998654334788999999999999999999998643221100    00  00 0      0001


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....+.....++.+++.+||+.+|++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            11122335567889999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-36  Score=305.47  Aligned_cols=239  Identities=23%  Similarity=0.383  Sum_probs=186.0

Q ss_pred             ccCcCcceeEEEEEEcC-------------------------CCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEE
Q 006620          330 KLGQGGYGGVYKGKLLD-------------------------GQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTL  383 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l  383 (638)
                      +||+|+||.||+|....                         ...|++|++..... ...++.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13588998865432 23578889999999999999999


Q ss_pred             EeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC
Q 006620          384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED  463 (638)
Q Consensus       384 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~  463 (638)
                      ++++......++||||+++++|.+++....     ..+++..+..++.|+++||+|||+   ++|+||||||+||++++.
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEecc
Confidence            999999999999999999999999987542     568899999999999999999999   999999999999999754


Q ss_pred             C-------ceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHH-hcCCCCCCccc
Q 006620          464 F-------CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAV  535 (638)
Q Consensus       464 ~-------~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~el-ltg~~p~~~~~  535 (638)
                      +       .+|++|||.+......      ....++..|+|||.+.+. ..++.++||||||+++||| ++|+.||....
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            3       3899999987644322      123467889999988653 3678999999999999998 57888886432


Q ss_pred             CCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          536 DRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ...    ....    ...  ..   ....    ....++.+++.+||+.+|++|||+++|++.|+
T Consensus       227 ~~~----~~~~----~~~--~~---~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         227 PSE----KERF----YEK--KH---RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             hHH----HHHH----HHh--cc---CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            211    0000    000  00   0111    12346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-38  Score=294.62  Aligned_cols=246  Identities=24%  Similarity=0.364  Sum_probs=206.9

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      +.++||+|+||.||||.++ .|+.+|||.+..+. +.+++++|+.++++...|++|++||.+.....+++|||||-.|++
T Consensus        37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi  115 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI  115 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence            4678999999999999854 58999999886553 567899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .|.++-.+     +.|++..+..+++..+.||+|||.   ..-||||||..|||++-+|.+||+|||.+-.+.+.-  ..
T Consensus       116 SDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AK  185 (502)
T KOG0574|consen  116 SDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AK  185 (502)
T ss_pred             HHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hh
Confidence            99998764     789999999999999999999999   888999999999999999999999999998765432  23


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....|||.|||||++..-  .|..++||||||++..||..|++|+.....-..-+..|             ......-.
T Consensus       186 RNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-------------T~PPPTF~  250 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-------------TKPPPTFK  250 (502)
T ss_pred             hCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-------------CCCCCCCC
Confidence            4556799999999999764  68899999999999999999999987654311110000             00111112


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .+..++.++.+++++||-.+|++|.|+.+++++
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            355778899999999999999999999999875

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.2e-36  Score=328.65  Aligned_cols=255  Identities=16%  Similarity=0.221  Sum_probs=184.6

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCC------cceEEEEeEEEeC-ceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSH------VNIVTLLGFCFEG-HRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~lv~  397 (638)
                      .+.++||+|+||+||+|.. .+++.||||+++...........|++++++++|      .+++++++++... ...++||
T Consensus       132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~  211 (467)
T PTZ00284        132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM  211 (467)
T ss_pred             EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence            4568999999999999985 457889999997544344456667777777654      4589999988764 4678899


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-------------
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-------------  464 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-------------  464 (638)
                      |++ +++|.+++.+.      ..+++..+..|+.||+.||+|||+.  .+|+||||||+|||++.++             
T Consensus       212 ~~~-g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        212 PKY-GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             ecc-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCC
Confidence            988 77999988764      4689999999999999999999971  4999999999999998665             


Q ss_pred             ---ceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc
Q 006620          465 ---CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI  541 (638)
Q Consensus       465 ---~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~  541 (638)
                         .+||+|||.+......     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||+.........
T Consensus       283 ~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             CCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence               4999999987643222     2345689999999999765  78899999999999999999999997543210000


Q ss_pred             -------chh-HHHHH--------HhhhhhhccccCCC-----------CchhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006620          542 -------YFP-HWVYK--------RLELEEDLGLQGIE-----------NEEDKEYARKMILVSLWCIQTNPSDRPSMNR  594 (638)
Q Consensus       542 -------~~~-~~~~~--------~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  594 (638)
                             .++ .|...        .......+ .....           ..........+.+||.+||++||++|||++|
T Consensus       356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQL-RPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHcCCCCHHHHhhccchhHHHHhhhcccc-cccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence                   000 01000        00000000 00000           0000011345779999999999999999999


Q ss_pred             HHH
Q 006620          595 VVE  597 (638)
Q Consensus       595 vl~  597 (638)
                      +++
T Consensus       435 ~L~  437 (467)
T PTZ00284        435 MTT  437 (467)
T ss_pred             Hhc
Confidence            996

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.4e-36  Score=303.44  Aligned_cols=253  Identities=21%  Similarity=0.339  Sum_probs=195.4

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEE-----eCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCF-----EGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~lv~e  398 (638)
                      .+.+.||+|+||.||+++. .+++.+|+|++.........+.+|+.+++++ +||||+++++++.     .+...++|||
T Consensus        21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e  100 (286)
T cd06638          21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE  100 (286)
T ss_pred             eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence            3467899999999999985 4578999999876544456778899999999 6999999999884     3456899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++++|.+++....  .....+++..+..++.|+++||.|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus       101 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638         101 LCNGGSVTDLVKGFL--KRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             ecCCCCHHHHHHHhh--ccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            999999999886532  223568899999999999999999999   899999999999999999999999999988664


Q ss_pred             CCCceeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ....  ......|++.|+|||++...   ...++.++||||+||++|||++|+.|+......      ... .. ..  .
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------~~~-~~-~~--~  243 (286)
T cd06638         176 STRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------RAL-FK-IP--R  243 (286)
T ss_pred             cCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------HHH-hh-cc--c
Confidence            3321  12334589999999998532   134788999999999999999999998643211      000 00 00  0


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .   .......+..+..++.+++.+||+.||++|||+.||+++
T Consensus       244 ~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         244 N---PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             c---CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0   000001111234578899999999999999999999975

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-36  Score=301.80  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=197.3

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC-----------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG-----------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  394 (638)
                      ..+.||+|++|.||+|.. .+++.||+|.++....           ..+.+.+|+.++++++|+|++++++++......+
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (272)
T cd06629           5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS   84 (272)
T ss_pred             ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence            467899999999999985 4688999998753211           1235678999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccc
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      +|+||+++++|.+++...      ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          85 IFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             EEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999764      458889999999999999999999   89999999999999999999999999998


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      +...............++..|+|||.+......++.++|+||||+++|+|++|..||.....      .... ...... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~-~~~~~~-  227 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAM-FKLGNK-  227 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHH-HHhhcc-
Confidence            76543222222233457899999999865422478899999999999999999999853221      0000 010000 


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        .............++.++.+++.+||+.+|++|||+++|+++
T Consensus       228 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         228 --RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             --ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence              001111112223456788999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.6e-36  Score=335.65  Aligned_cols=261  Identities=25%  Similarity=0.345  Sum_probs=200.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.++||+|+||.||+|+.. +++.||||++.....    ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~   84 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI   84 (932)
T ss_pred             EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence            35689999999999999864 588999999875422    2356889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCC---C--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          401 SNGSLEKFIHEKHP---L--ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       401 ~~gsL~~~l~~~~~---~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      +|++|.+++.....   .  .....+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcce
Confidence            99999999975321   0  112346778889999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCc----------------eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc
Q 006620          476 ICEGRES----------------IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS  539 (638)
Q Consensus       476 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~  539 (638)
                      .......                ........||+.|+|||++.+.  .++.++|||||||++|||++|+.||....... 
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-  238 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGRK-  238 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence            6621110                0001124689999999998764  67899999999999999999999986532211 


Q ss_pred             ccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhcccC
Q 006620          540 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-SMNRVVEMLEGSLD  604 (638)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~  604 (638)
                       .     ...     ... ..........+++..+.+++.+||+.||++|| +++++++.|+..+.
T Consensus       239 -i-----~~~-----~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 -I-----SYR-----DVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             -h-----hhh-----hhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence             0     000     000 00000011124456788999999999999995 77888888877654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=285.60  Aligned_cols=266  Identities=21%  Similarity=0.338  Sum_probs=208.1

Q ss_pred             chHHHHHHHhhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCc-hhhHHHHHHHHhhcC-CcceEEEEeEEEeCce
Q 006620          316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGN-GEDFINEVASISRTS-HVNIVTLLGFCFEGHR  392 (638)
Q Consensus       316 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  392 (638)
                      +++++-+.|.   +.||+|+|+.|-.++ ..++.+||||++.+..+. +..+.+|++++.+.+ |+||+.|+++|+++..
T Consensus        74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            4556655554   679999999999987 678999999999877544 568899999999987 9999999999999999


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC---ceEEc
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKIS  469 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~  469 (638)
                      +|||||-|.||+|..+|++.      ..+++.++.+++..|+.||.+||.   +||.||||||+|||..+..   -+||+
T Consensus       151 FYLVfEKm~GGplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKR------KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             EEEEEecccCchHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence            99999999999999999886      579999999999999999999999   9999999999999985443   48999


Q ss_pred             ccccceeccCCC-----ceeeecccccccceecCceec---cccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCC---
Q 006620          470 DFGLAKICEGRE-----SIVSMTGARGTIGYIAPEVFC---RNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS---  538 (638)
Q Consensus       470 DFg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~---~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~---  538 (638)
                      ||.+..-+....     ........+|+-.|||||+..   +....|..++|.||||||||-||.|.+||...=+..   
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            999876443211     122234567899999999863   332357889999999999999999999997643321   


Q ss_pred             --cccc--hhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          539 --SEIY--FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       539 --~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        .+..  -....++.+..+    .-..+......++.+..+++...|-.|+.+|-++.+++.
T Consensus       302 drGe~Cr~CQ~~LFesIQEG----kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEG----KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCCccHHHHHHHHHHHhcc----CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              1110  011112222111    112334456678889999999999999999998877764

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.4e-35  Score=301.06  Aligned_cols=250  Identities=25%  Similarity=0.356  Sum_probs=196.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +++.++||.|+||.||+|+.. +++.|++|++.... ...+.+.+|+.++++++||||+++++.+..+...++||||+++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG   93 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence            445788999999999999864 48899999987543 2345788899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|..++.+..     ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        94 ~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          94 GAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            99998886542     458999999999999999999999   9999999999999999999999999999875432211


Q ss_pred             eeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          483 IVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                        ......+++.|+|||++.+.   ...++.++|||||||++|||++|+.||......        .........     
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~-----  230 (292)
T cd06644         166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKS-----  230 (292)
T ss_pred             --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcC-----
Confidence              11234578899999998532   124678999999999999999999998643210        000111000     


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..........++.++.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00011122344567889999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-36  Score=300.78  Aligned_cols=240  Identities=23%  Similarity=0.393  Sum_probs=189.2

Q ss_pred             cccCcCcceeEEEEEEcCCC-----------EEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          329 NKLGQGGYGGVYKGKLLDGQ-----------NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      +.||+|+||.||+|...+..           .+++|++.........+.+|+.++++++||||+++++++.. ...++|+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46999999999999865432           57888876554446788999999999999999999999988 7789999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-------ceEEcc
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-------CPKISD  470 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-------~~kl~D  470 (638)
                      ||+++++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++       .+||+|
T Consensus        80 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          80 EYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence            9999999999998753     368899999999999999999999   9999999999999999887       799999


Q ss_pred             cccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcC-CCCCCcccCCCcccchhHHHHH
Q 006620          471 FGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE-KNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       471 Fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      ||++......      ....++..|+|||++.+....++.++||||||+++|||++| ..|+.......       . ..
T Consensus       152 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------~-~~  217 (259)
T cd05037         152 PGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------K-ER  217 (259)
T ss_pred             CCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------H-HH
Confidence            9998865431      22345778999999865433678899999999999999984 66665432110       0 00


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      .....     ......    ....+.+++.+||+.+|++|||+.++++.|+
T Consensus       218 ~~~~~-----~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         218 FYQDQ-----HRLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHhcC-----CCCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00000     000000    0167889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-35  Score=312.16  Aligned_cols=256  Identities=24%  Similarity=0.260  Sum_probs=190.0

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc------eEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGH------RRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  395 (638)
                      .+.+.||+|+||.||+++. .+++.||||++....   .....+.+|+.+++.++||||+++++++....      ..++
T Consensus        24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  103 (359)
T cd07876          24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL  103 (359)
T ss_pred             EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence            4568999999999999985 458899999986432   23456789999999999999999999986543      4789


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+.+ +|.+.+..        .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       104 v~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876         104 VMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             EEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            9999965 67766642        37888999999999999999999   999999999999999999999999999997


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc--------ccchhHHH
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS--------EIYFPHWV  547 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~  547 (638)
                      ......   ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||........        ......+.
T Consensus       172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         172 TACTNF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccCc---cCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            643322   12335679999999999764  788999999999999999999999975432100        00000000


Q ss_pred             HHHhhhhhh-----ccccCC-------------CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 YKRLELEED-----LGLQGI-------------ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 ~~~~~~~~~-----~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .........     ....+.             ..........++.+|+.+||+.||++|||++|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000000     000000             000111234568899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-35  Score=296.95  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||.|+||.||.++. .+++.+++|.+....   .....+.+|++++++++|+||+++++++.+....+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            4568999999999999984 558899999876432   334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....    ...+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          83 GGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             CCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999998642    2468999999999999999999999   899999999999999999999999999998764433


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .  ......+++.|+|||.+.+.  .++.++||||||+++|||++|+.||.....       ...... ...       +
T Consensus       156 ~--~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~-~~~-------~  216 (256)
T cd08221         156 S--MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVK-IVQ-------G  216 (256)
T ss_pred             c--cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHH-HHc-------C
Confidence            2  12334579999999998764  578899999999999999999999864321       111111 110       1


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .........+.++.+++.+||+.+|++||++++++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         217 NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1111123456678899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-35  Score=299.44  Aligned_cols=245  Identities=25%  Similarity=0.396  Sum_probs=195.3

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc----------hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN----------GEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  395 (638)
                      +...||+|++|.||+|.. .+++.||+|.+......          .+.+.+|+.++++++||||+++++++......++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            467899999999999985 45789999988643211          1457789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ++||+++++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.+||+|||.++
T Consensus        84 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          84 FLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999764      457888999999999999999999   899999999999999999999999999988


Q ss_pred             eccCCCcee----eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          476 ICEGRESIV----SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       476 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      .........    ......|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......       ....   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~---  222 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIF---  222 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHH---
Confidence            765321110    11123478899999998764  6788999999999999999999998743210       0000   


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....     ......+...+..+.+++.+||+.||++||++.++++
T Consensus       223 ~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         223 KIGE-----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHhc-----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0000     1111222345677889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-35  Score=300.64  Aligned_cols=256  Identities=24%  Similarity=0.409  Sum_probs=195.7

Q ss_pred             hhcccCcCcceeEEEEEEc----CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc------eE
Q 006620          327 FKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGH------RR  393 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  393 (638)
                      +.+.||+|+||+||+|.+.    +++.||||++....   ...+++.+|++++++++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4678999999999999743    35789999987543   23456789999999999999999999886532      24


Q ss_pred             EEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      ++++||+++++|.+++...........+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccc
Confidence            7889999999999988643322223458899999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      ++...............+++.|++||.+.+.  .++.++||||||+++|||++ |++||......       . ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------~-~~~~~~  229 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------E-IYNYLI  229 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-------H-HHHHHH
Confidence            9866443322222233456789999998654  67889999999999999998 78887533210       0 111111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      .....       ......+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       230 ~~~~~-------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 KGNRL-------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCCcC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10000       01112356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.1e-36  Score=307.72  Aligned_cols=252  Identities=29%  Similarity=0.508  Sum_probs=195.5

Q ss_pred             hhcccCcCcceeEEEEEEc-CCC----EEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQ----NVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      ..+.||+|+||.||+|.+. +++    .+|+|++......  ..++.+|+.++++++||||+++++++... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            3578999999999999853 444    4788988654322  34678999999999999999999988754 46789999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++....
T Consensus        90 ~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          90 MPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             cCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999997643     468899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...........++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......        ............ 
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~-  230 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDLLEKGERL-  230 (303)
T ss_pred             cccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCC-
Confidence            4332222334457789999998654  68899999999999999997 88887543210        011111111101 


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                            .........+.+++.+||..+|++||+++++++.|+.+..
T Consensus       231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  0111234567899999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-35  Score=296.71  Aligned_cols=248  Identities=30%  Similarity=0.531  Sum_probs=198.2

Q ss_pred             hhcccCcCcceeEEEEEEcC-----CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-----GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.||.|+||.||+++..+     +..||+|++.....  ..+.+.+|++.+++++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            46789999999999998643     37899999976543  456888999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++.....
T Consensus        83 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       83 MEGGDLLDYLRKNR----PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             cCCCCHHHHHHhhh----hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999998643    1228999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...... ....+++.|+|||.+.+.  .++.++||||+|+++++|++ |++||.....       .... .......   
T Consensus       156 ~~~~~~-~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~-~~~~~~~---  221 (258)
T smart00219      156 DDYYKK-KGGKLPIRWMAPESLKDG--KFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVL-EYLKKGY---  221 (258)
T ss_pred             cccccc-ccCCCcccccChHHhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHH-HHHhcCC---
Confidence            432221 123367899999998543  67899999999999999998 7777754211       1111 1111111   


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML  599 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  599 (638)
                          ........+.++.+++.+||+.+|++|||+.++++.|
T Consensus       222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                1111122566789999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-35  Score=302.59  Aligned_cols=252  Identities=24%  Similarity=0.352  Sum_probs=195.4

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeC-----ceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEG-----HRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~e~  399 (638)
                      +.+.||+|+||.||++.. .+++.+|+|++.........+.+|+.+++++ +|||++++++++...     ...++|+||
T Consensus        26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey  105 (291)
T cd06639          26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL  105 (291)
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence            467899999999999985 4688999999876554556778899999998 799999999998754     358999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.++++...  .....+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.....
T Consensus       106 ~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         106 CNGGSVTELVKGLL--ICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             CCCCcHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            99999999987532  123568999999999999999999999   9999999999999999999999999999886543


Q ss_pred             CCceeeecccccccceecCceecccc---CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNF---GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ....  .....|+..|+|||.+....   ..++.++|||||||++|||++|+.||......       ..... ..  ..
T Consensus       181 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------~~~~~-~~--~~  248 (291)
T cd06639         181 TRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------KTLFK-IP--RN  248 (291)
T ss_pred             cccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------HHHHH-Hh--cC
Confidence            2211  12345788999999985431   13678999999999999999999998643211       00000 00  00


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      . ...  ..........+.+++.+||+.+|++||++.+++++
T Consensus       249 ~-~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         249 P-PPT--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             C-CCC--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0 000  11122345578999999999999999999999963

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=295.29  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=199.6

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.+.||+|+||.||+|.. .+++.+++|++.... ...+.+.+|++++++++||||+++++.+......+++|||++++
T Consensus         6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~   85 (262)
T cd06613           6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG   85 (262)
T ss_pred             EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence            4568899999999999986 457889999987543 34567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||.+........ 
T Consensus        86 ~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          86 SLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             cHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            9999987642     468899999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             eeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                       ......++..|+|||.+.+. ...++.++||||||+++|+|++|+.||.......      . .. .... ..  ....
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~-~~-~~~~-~~--~~~~  224 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------A-LF-LISK-SN--FPPP  224 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------H-HH-HHHh-cc--CCCc
Confidence             12334578899999998642 1256789999999999999999999986432110      0 00 0000 00  0111


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .......++.++.+++.+||+.+|++|||+++|+.
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11223345678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.1e-35  Score=297.66  Aligned_cols=256  Identities=20%  Similarity=0.379  Sum_probs=187.7

Q ss_pred             cccCcCcceeEEEEEEcCCC---EEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKLLDGQ---NVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.||+|+||+||++...++.   .+++|.+....  ...+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999754433   45677665433  23467899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++.+...  ....+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||++.........
T Consensus        81 ~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          81 DLKSYLSQEQW--HRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             cHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            99999986431  12356777889999999999999999   99999999999999999999999999998643222111


Q ss_pred             eeecccccccceecCceecccc-----CCccccCCeeeHHHHHHHHhcC-CCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          484 VSMTGARGTIGYIAPEVFCRNF-----GEVSYKSDVYSYGMMVFEMTGE-KNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~-----~~~s~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .......++..|+|||++....     ..++.++||||||+++|||+++ ..||.....       .......... ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~-~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKD-QQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhh-ccc
Confidence            1123345788999999985321     2357799999999999999964 566643221       1111111111 100


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ..  ........+...+.+++..|| .+|++||++++|++.|.
T Consensus       228 ~~--~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KL--FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cc--CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            00  011111224566788999999 68999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.4e-36  Score=308.72  Aligned_cols=260  Identities=22%  Similarity=0.328  Sum_probs=195.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||+|+||.||+|+.. +++.||+|.+....  .....+.+|+.++++++||||+++++++......++|+||++ 
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-   87 (301)
T cd07873           9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   87 (301)
T ss_pred             EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence            45688999999999999864 57899999986443  233467889999999999999999999999999999999997 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....     ..+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||++........
T Consensus        88 ~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          88 KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            59999887643     458899999999999999999999   9999999999999999999999999999876433221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh-------HHHHHHhhhhh
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP-------HWVYKRLELEE  555 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~  555 (638)
                        ......+++.|+|||.+.+. ..++.++||||||+++|||++|++||.............       ...+.......
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             --cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence              11234568899999998654 357889999999999999999999997543210000000       00000000000


Q ss_pred             h---ccccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 D---LGLQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~---~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .   ........    ......+.++.+|+.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0   00000000    011124557889999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-35  Score=296.55  Aligned_cols=245  Identities=28%  Similarity=0.488  Sum_probs=195.5

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.+.||+|+||.||++.. +++.||+|+++... ..+.+.+|+.++++++|||++++++++..+ ..++||||+++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~   84 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN   84 (254)
T ss_pred             ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence            34678999999999999975 67889999986543 346788999999999999999999988654 4789999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......   
T Consensus        85 L~~~l~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          85 LVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             HHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999997643    2458899999999999999999999   999999999999999999999999999987643221   


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                        .....+..|+|||.+.+.  .++.++|+||||+++|||++ |+.||.....       ... ......       ...
T Consensus       155 --~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~-~~~~~~-------~~~  215 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEV-KECVEK-------GYR  215 (254)
T ss_pred             --CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHH-HHHHhC-------CCC
Confidence              122346789999998653  68889999999999999997 8888864321       111 111111       111


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ......++.++.+++.+||+.+|++||++++|++.|+.
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            11123345678899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.7e-35  Score=296.08  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=196.8

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe-CceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE-GHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  399 (638)
                      |.+.+.||+|++|.||++... +++.||+|.+....   ...+.+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            346789999999999999854 57889999986532   233567889999999999999999998764 4467899999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....    ...+++..+..++.|++.||++||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          82 CEGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             cCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999998642    2458999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...  ......+++.|+|||++.+.  .++.++||||||+++++|++|+.||.....       ........        
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~--------  215 (257)
T cd08223         155 QCD--MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRII--------  215 (257)
T ss_pred             cCC--ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHH--------
Confidence            322  12334578999999998764  678899999999999999999999863221       11111100        


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .+.........+.++.+++.+||+.+|++|||+.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         216 EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             hcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            011111223456788999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.9e-36  Score=301.84  Aligned_cols=243  Identities=25%  Similarity=0.396  Sum_probs=195.7

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      ..+.||+|+||.||+|.. .+++.||+|++....  ...+.+.+|++++++++||||+++++.+..+...++|+||++++
T Consensus         8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06642           8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence            457799999999999985 457889999987432  23457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++..       ..+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++........ 
T Consensus        88 ~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          88 SALDLLKP-------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             cHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            99999864       358899999999999999999999   9999999999999999999999999999886643321 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                       ......++..|+|||++.+.  .++.++||||||+++|||++|+.|+.......        ......       ....
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~-------~~~~  218 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIP-------KNSP  218 (277)
T ss_pred             -hhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhh-------cCCC
Confidence             11223578899999998764  67889999999999999999999976432110        000000       0111


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .......+.++.+++.+||+.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            11122345678899999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=298.70  Aligned_cols=243  Identities=26%  Similarity=0.372  Sum_probs=197.4

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.||.|++|.||+|+.. +++.||+|++....  .....+.+|+++++.++|+||+++++++.++...++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG   83 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence            45678999999999999854 58899999986543  2345678999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...       .+++..++.++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++.......
T Consensus        84 ~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          84 GSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             CcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            9999998753       58999999999999999999999   9999999999999999999999999999987654321


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......+++.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       . .......       ..
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~-~~~~~~~-------~~  214 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPM-------R-VLFLIPK-------NN  214 (274)
T ss_pred             --ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchH-------H-HHHHhhh-------cC
Confidence              12334578899999999765  5889999999999999999999998643210       0 0000000       01


Q ss_pred             CCchh-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEED-KEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..... ..++.++.+++.+||+.+|++|||++++++
T Consensus       215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11111 115667889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.9e-35  Score=297.13  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=197.8

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      ..++||+|+||.||+|... +++.||+|++....  .....+.+|+.+++++.|+||+++++++.++...++||||++++
T Consensus         8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640           8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            4577999999999999864 57899999987543  23457888999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++..       ..+++..+..++.|+++||+|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        88 ~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          88 SALDLLRA-------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             cHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            99999865       347888999999999999999999   99999999999999999999999999999766543211


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                        .....++..|+|||++.+.  ..+.++|+||||+++|||++|+.|+.......        .....       .....
T Consensus       158 --~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~-------~~~~~  218 (277)
T cd06640         158 --RNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLI-------PKNNP  218 (277)
T ss_pred             --cccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhhhh-------hcCCC
Confidence              1234578899999998654  67889999999999999999999986433210        00000       01112


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .......+..+.+++.+||+.+|++||++++++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            22334567788999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=299.24  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=198.1

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.++||.|++|+||++... +++.+|+|++.... ...+.+.+|++++++++||||+++++.+..+...++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            445788999999999999864 58899999987543 2345788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....     ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        87 ~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          87 GALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999987643     468999999999999999999999   9999999999999999999999999998875433221


Q ss_pred             eeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          483 IVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                        ......+++.|+|||.+...   ...++.++||||||+++|+|++|+.||......       ... ......     
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~-~~~~~~-----  223 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVL-LKILKS-----  223 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHH-HHHhcC-----
Confidence              11234578999999997532   124677999999999999999999998643211       000 011000     


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .......+..++.++.+++.+||+.+|++||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         224 EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            00011112234567889999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-35  Score=302.93  Aligned_cols=246  Identities=26%  Similarity=0.338  Sum_probs=197.6

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.+.||+|++|.||+++. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||+++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  100 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence            34568899999999999985 568999999987543 3345678899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++.+       ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus       101 ~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656         101 GSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999865       347889999999999999999999   9999999999999999999999999999886543322


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .  .....+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||..........       . ..     .....
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------~-~~-----~~~~~  233 (297)
T cd06656         171 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------L-IA-----TNGTP  233 (297)
T ss_pred             C--cCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------e-ec-----cCCCC
Confidence            1  1234578899999998764  67889999999999999999999996433211000       0 00     00000


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....+...+..+.+++.+||+.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11122334567889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=306.96  Aligned_cols=252  Identities=25%  Similarity=0.449  Sum_probs=209.3

Q ss_pred             hhhcccCcCcceeEEEEEEcC---CC--EEEEEEeccc--CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD---GQ--NVAIKVLNET--KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~---~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .++++||+|-||.||+|.+.+   |+  .||||..+.+  ....+.|+.|..+|+++.||||++++|+|.+ ...++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            347899999999999997432   33  5899988764  3557899999999999999999999999976 46789999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      .++-|.|.++|+.+.     ..|+...+..++.||..||+|||+   ++.+||||..+|||+.+..-|||+|||+++.++
T Consensus       471 L~~~GELr~yLq~nk-----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  471 LAPLGELREYLQQNK-----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             cccchhHHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            999999999999875     679999999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHh-cCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT-GEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ....+... ...-++-|||||.+.  +..++.++|||.|||.+||++ -|..||.......- +       ..       
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-I-------~~-------  604 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-I-------GH-------  604 (974)
T ss_pred             ccchhhcc-ccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccce-E-------EE-------
Confidence            76654432 334478899999984  458999999999999999976 58889876543210 0       00       


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ...+.+...+..++..+..|+.+||..+|.+||.+.++...|+.++.
T Consensus       605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            12344455566677889999999999999999999999998876544

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.3e-36  Score=301.72  Aligned_cols=240  Identities=21%  Similarity=0.355  Sum_probs=186.6

Q ss_pred             cccCcCcceeEEEEEEcC--------CCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          329 NKLGQGGYGGVYKGKLLD--------GQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.||+|+||.||+|....        ...+++|++.... ...+.+.+|+.++++++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997532        2348888876443 2345788899999999999999999999998999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc--------eEEccc
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--------PKISDF  471 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~--------~kl~DF  471 (638)
                      +++|+|.+++....     ..+++..++.++.|++.||+|||+   ++|+||||||+||+++.++.        ++++||
T Consensus        81 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          81 VKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             CCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            99999999998653     368899999999999999999999   99999999999999987665        699999


Q ss_pred             ccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCC-CCCCcccCCCcccchhHHHHHH
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK-NNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      |.+......      ....+++.|+|||++.+. ..++.++||||||+++|||++|. .|+......       .. ...
T Consensus       153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~~-~~~  217 (258)
T cd05078         153 GISITVLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------KK-LQF  217 (258)
T ss_pred             ccccccCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------HH-HHH
Confidence            988754332      223468889999998653 35788999999999999999995 444322110       00 000


Q ss_pred             hhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ..  ...       ..+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       218 ~~--~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 YE--DRH-------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HH--ccc-------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00  000       011112356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.4e-36  Score=303.98  Aligned_cols=258  Identities=21%  Similarity=0.291  Sum_probs=194.3

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|+||.||+|+.. +++.||+|++....   .....+.+|++++++++||||+++++++.+....++|+||+.
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD   82 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence            35678999999999999864 58899999986532   223467789999999999999999999999999999999996


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                       ++|.+++....     ..+++..++.++.||++||+|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        83 -~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          83 -QDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             -CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence             58888887543     468999999999999999999999   999999999999999999999999999988654322


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHH----------HHHHh
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW----------VYKRL  551 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~  551 (638)
                      .  ......+++.|+|||++.+. ..++.++||||||+++|+|++|+.|+........  .+...          .....
T Consensus       154 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         154 R--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             C--CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHh
Confidence            1  12334568899999998653 3568899999999999999999988643322110  00000          00000


Q ss_pred             hhhhhcc-ccCCC-----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 ELEEDLG-LQGIE-----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~~~~~~-~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....... .....     .......+.++.+++.+||+.||++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000 00000     0111234677889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-35  Score=302.18  Aligned_cols=260  Identities=22%  Similarity=0.319  Sum_probs=196.2

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ++.+.||+|++|.||+|+.. +++.||+|++....   ...+.+.+|++++++++|+|++++++++..+...++||||++
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   83 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD   83 (286)
T ss_pred             eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence            45678999999999999865 58899999986543   223467899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|..++...      ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          84 HTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            98888776543      458999999999999999999999   999999999999999999999999999998765433


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHH-------HHHhhhh
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWV-------YKRLELE  554 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~  554 (638)
                      ..  .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||................       .......
T Consensus       155 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         155 DD--YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             cc--ccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            21  1234468899999998653 357889999999999999999999987543211000000000       0000000


Q ss_pred             h---hccccCCC--C---chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 E---DLGLQGIE--N---EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~---~~~~~~~~--~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .   ........  .   ......+..+.+++.+||+.+|++||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0   00000000  0   011234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.9e-35  Score=299.04  Aligned_cols=254  Identities=27%  Similarity=0.410  Sum_probs=197.1

Q ss_pred             hhcccCcCcceeEEEEEEc------CCCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      ..+.||+|+||+||+|+..      +.+.+++|.+......  .+++.+|++++++++|+||+++++++.+....++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            4578999999999999853      2457999988754433  4678999999999999999999999999899999999


Q ss_pred             eccCCCHHHHhhhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          399 FVSNGSLEKFIHEKHPLE---TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      |+++++|.+++.......   ....+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccccc
Confidence            999999999997653111   11268999999999999999999999   899999999999999999999999999987


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ...... ........++..|+|||.+.+.  ..+.++||||||+++|+|++ |..||.....       .... ......
T Consensus       166 ~~~~~~-~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~-~~~~~~  234 (275)
T cd05046         166 DVYNSE-YYKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVL-NRLQAG  234 (275)
T ss_pred             ccCccc-ccccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHH-HHHHcC
Confidence            543222 1122334567789999988654  57889999999999999998 7777753221       1111 111100


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                       ..     ........+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       235 -~~-----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 -KL-----ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -Cc-----CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence             00     01111234567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-35  Score=300.32  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=198.3

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +++.+.||+|+||.||+++.. +++.||+|.+....  .....+.+|++++++++|+||+++++.+......++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            346788999999999999865 68899999886532  223578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....   ....+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          83 AGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             CCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            999999987631   124689999999999999999999961  589999999999999999999999999987653322


Q ss_pred             ceeeecccccccceecCceecccc----CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNF----GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .    ....+++.|+|||.+.+..    ..++.++|+|||||++|+|++|+.||......       . ........   
T Consensus       158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~-~~~~~~~~---  222 (286)
T cd06622         158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-------N-IFAQLSAI---  222 (286)
T ss_pred             c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-------h-HHHHHHHH---
Confidence            1    2335788999999985431    13578999999999999999999998643211       0 01111110   


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       ........+..+..++.+++.+||+.+|++||++++++.
T Consensus       223 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         223 -VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence             011112223346778899999999999999999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.9e-35  Score=300.29  Aligned_cols=250  Identities=28%  Similarity=0.410  Sum_probs=195.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEe------CceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFE------GHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~lv  396 (638)
                      +.+.+.||+|+||.||+|+. .+++.+|+|++.........+..|+.+++++ +|+||+++++++..      ....+++
T Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   97 (282)
T cd06636          18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV   97 (282)
T ss_pred             hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence            34568899999999999985 4578999999876655556788899999998 69999999999853      4578999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++....    ...+++..+..++.|+++||+|||+   .+++|+||+|+||++++++.++|+|||++..
T Consensus        98 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          98 MEFCGAGSVTDLVKNTK----GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEeCCCCcHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            99999999999997643    2458888999999999999999999   9999999999999999999999999999875


Q ss_pred             ccCCCceeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      ......  ......|++.|+|||.+...   ...++.++||||||+++|||++|+.||........       .   ...
T Consensus       171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-------~---~~~  238 (282)
T cd06636         171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-------L---FLI  238 (282)
T ss_pred             hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-------h---hhH
Confidence            532211  12334578999999988532   13577899999999999999999999864321100       0   000


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .    ...........++.++.+++.+||+.||++|||+.||++
T Consensus       239 ~----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 P----RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             h----hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0    001111122245668999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.3e-35  Score=301.69  Aligned_cols=244  Identities=26%  Similarity=0.351  Sum_probs=196.5

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.||.|++|.||+|.. .+++.|++|.+.... ...+.+.+|+.+++.++|||++++++++......++|+||+++++
T Consensus        23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  102 (296)
T cd06655          23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS  102 (296)
T ss_pred             EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence            467899999999999985 568899999886543 334677899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++..       ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......... 
T Consensus       103 L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655         103 LTDVVTE-------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             HHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            9999865       348899999999999999999999   99999999999999999999999999998765433221 


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                       .....++..|+|||.+.+.  .++.++|||||||++|+|++|+.||.......      . . .......     ....
T Consensus       172 -~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~-~-~~~~~~~-----~~~~  235 (296)
T cd06655         172 -RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------A-L-YLIATNG-----TPEL  235 (296)
T ss_pred             -CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-H-HHHHhcC-----Cccc
Confidence             1234578899999998754  67889999999999999999999986543210      0 0 0000000     0001


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....++..+.+++.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            122234567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.7e-35  Score=296.93  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=197.0

Q ss_pred             hhhcccCcCcceeEEEEEEcC--CCEEEEEEecccC-----------CchhhHHHHHHHHhh-cCCcceEEEEeEEEeCc
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD--GQNVAIKVLNETK-----------GNGEDFINEVASISR-TSHVNIVTLLGFCFEGH  391 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~  391 (638)
                      .+.+.||+|+||.||+|....  ++.+|+|.+....           ....++.+|+.++.+ ++||||+++++++..++
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            346789999999999999654  6789999875321           122456778887765 78999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccc
Q 006620          392 RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF  471 (638)
Q Consensus       392 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF  471 (638)
                      ..+++|||+++++|.+++....  .....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.+||+||
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999986532  123568999999999999999999995  168999999999999999999999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      |.+.......   ......++..|+|||.+.+.  .++.++||||||+++|+|++|+.||.....       ...... .
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~-~  225 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATK-I  225 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHH-H
Confidence            9998765433   22345678999999999754  678999999999999999999999863321       111101 0


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ..      ...........+..+.+++.+||+.||++||++.|+..+++.
T Consensus       226 ~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         226 VE------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             hh------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            00      000011111345678899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=297.18  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=198.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCc------eEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGH------RRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~lv  396 (638)
                      +.+.+.||+|++|+||+|... +++.+++|++.......+.+.+|+++++++ +|+||+++++++....      ..++|
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv   87 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV   87 (275)
T ss_pred             eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence            345789999999999999864 578999999887665667889999999999 6999999999997644      48999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++....  .....+++..+..++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++..
T Consensus        88 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          88 MELCGGGSVTDLVKGLR--KKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEcCCCCcHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            99999999999987642  123568999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCceeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      ......  ......++..|+|||++...   ...++.++||||||+++|+|++|+.||......       .....   .
T Consensus       163 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~---~  230 (275)
T cd06608         163 LDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RALFK---I  230 (275)
T ss_pred             cccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HHHHH---h
Confidence            543221  12334578899999987542   124678999999999999999999998643211       00000   0


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...   ..........++.++.+++.+||+.||++|||++++++
T Consensus       231 ~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRN---PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hcc---CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            000   00111122346678899999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.9e-35  Score=296.25  Aligned_cols=246  Identities=25%  Similarity=0.300  Sum_probs=190.3

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC------CchhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK------GNGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  396 (638)
                      ...+.||+|+||.||+|.. .+++.|++|++....      .....+.+|+.++++++||||+++++++..  ....+++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~   84 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF   84 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence            3468899999999999985 458899999886432      123457889999999999999999998875  3577899


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +||+++++|.+++...      ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        85 ~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          85 MEYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            9999999999999764      347889999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          477 CEGRES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       477 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ...... ........++..|+|||.+.+.  .++.++||||||+++|||++|+.||......       .....      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~------  220 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFK------  220 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHH------
Confidence            532211 1111234578899999998764  6788999999999999999999998643210       00000      


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       ..........+......+.+++ +||..+|++||+++||++
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 -IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence             0011111122233455666777 688899999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-36  Score=311.73  Aligned_cols=255  Identities=23%  Similarity=0.277  Sum_probs=189.3

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  395 (638)
                      ...+.||+|+||+||+|.. .+++.||||++....   .....+.+|+.++++++||||+++++++...      ...++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   97 (343)
T cd07878          18 QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYL   97 (343)
T ss_pred             hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEE
Confidence            3467899999999999985 467899999987532   2234677899999999999999999987543      34688


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ++|++ +++|.+++..       ..+++..+..++.|+++||+|||+   .+|+||||||+||++++++.+||+|||+++
T Consensus        98 ~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          98 VTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             EeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence            99988 7799888764       358999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchhHHH
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFPHWV  547 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~  547 (638)
                      ......     ....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........-        ...+...
T Consensus       167 ~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07878         167 QADDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL  240 (343)
T ss_pred             ecCCCc-----CCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            654322     334679999999998653 36788999999999999999999998643211000        0000000


Q ss_pred             HHHhhhhh---hc-cccCCCCchh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 YKRLELEE---DL-GLQGIENEED----KEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 ~~~~~~~~---~~-~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       .......   .. ..........    ......+.+|+.+||+.||++|||++|++++
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         241 -KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             -HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000000   00 0000000000    0123357799999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2e-35  Score=295.58  Aligned_cols=246  Identities=28%  Similarity=0.388  Sum_probs=198.4

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.++||+|+||.||+++. .+++.||+|.+....   ....++.+|+.++++++||||+++++++...+..++|+||++
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE   82 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence            4568999999999999985 468899999986432   234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          83 GGDLYKKINAQR----GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999997642    2457899999999999999999999   899999999999999999999999999998664432


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ..  .....|++.|+|||++.+.  ..+.++|+||||+++++|++|+.||.....       ........        .+
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~--------~~  216 (256)
T cd08218         156 EL--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKII--------RG  216 (256)
T ss_pred             hh--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHh--------cC
Confidence            11  1223478899999998764  678899999999999999999999864321       11111111        11


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...........++.+++.+||+.+|++||++.+|++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         217 SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            111222345667899999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-35  Score=295.45  Aligned_cols=244  Identities=30%  Similarity=0.381  Sum_probs=196.7

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC------CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK------GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      ..+.||+|++|+||+|... +++.|++|++....      ...+.+.+|++++++++|+||+++++++......++++||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            4578999999999999865 68899999986532      1335688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++...      ..+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.+||+|||.+.....
T Consensus        84 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          84 VPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999764      358899999999999999999999   8999999999999999999999999999887644


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ..   ......++..|++||.+.... .++.++|+||||+++|+|++|+.||.....       .......   ....  
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~---~~~~--  218 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKI---GRSK--  218 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHH---Hhcc--
Confidence            33   123345788999999986541 378899999999999999999999864321       0111110   0000  


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        .....+..+..++.+++.+||+.+|++||++++++.
T Consensus       219 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 --ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              011112234567889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-35  Score=311.56  Aligned_cols=256  Identities=25%  Similarity=0.263  Sum_probs=190.0

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  395 (638)
                      .+.+.||+|+||.||++.. ..++.||||++....   .....+.+|+.+++.++||||+++++++...      ...++
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l   99 (355)
T cd07874          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL   99 (355)
T ss_pred             eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence            3468899999999999985 458899999987542   2235677899999999999999999988643      35689


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++ +|.+.+..        .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       100 v~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874         100 VMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             Ehhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            9999965 77777653        37888999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchhHHH
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFPHWV  547 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~  547 (638)
                      .......   .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||........-        ...+...
T Consensus       168 ~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         168 TAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cCCCccc---cCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            6543221   2345689999999999764  6889999999999999999999998643211000        0000000


Q ss_pred             HH-------Hhhhhhh---ccccC--------CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 YK-------RLELEED---LGLQG--------IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 ~~-------~~~~~~~---~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ..       .......   +....        ...........++.+|+.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00       0000000   00000        0001111234578899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.6e-35  Score=312.10  Aligned_cols=256  Identities=24%  Similarity=0.250  Sum_probs=190.1

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  395 (638)
                      .+.+.||+|+||.||+++. ..++.||||++....   .....+.+|+.+++.++||||+++++++...      ...++
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l  106 (364)
T cd07875          27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI  106 (364)
T ss_pred             eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence            3468899999999999985 457899999987532   2345678899999999999999999987643      35799


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++ +|.+.+..        .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       107 v~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         107 VMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             EEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            9999965 78777753        37888999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc--------ccchhHHH
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS--------EIYFPHWV  547 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~  547 (638)
                      .......   .....+|+.|+|||++.+.  .++.++|||||||++|+|++|+.||........        ....+.+.
T Consensus       175 ~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         175 TAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccCCCCc---ccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            6543221   2344689999999999764  688999999999999999999999965332100        00000000


Q ss_pred             HHHhhh-----hhhccccCC-------------CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 YKRLEL-----EEDLGLQGI-------------ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 ~~~~~~-----~~~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ......     .........             ..........++.+++.+||+.||++|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000     000000000             000111124568899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.5e-35  Score=301.86  Aligned_cols=257  Identities=26%  Similarity=0.305  Sum_probs=195.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc------hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN------GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.+.||+|++|.||+|... +++.||||.+......      ...+..|++++++++|+||+++++++.+....++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            34678999999999999854 5889999998754322      2456789999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+ +++|.+++....     ..+++..+..++.||++||+|||+   ++++|+||||+||+++.++.+||+|||+++...
T Consensus        83 ~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          83 FM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             cc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            99 889999997642     368999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH---------
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK---------  549 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------  549 (638)
                      .....  .....+++.|+|||.+.+. ..++.++||||||+++|||++|.++|.......   .+......         
T Consensus       154 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  227 (298)
T cd07841         154 SPNRK--MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENW  227 (298)
T ss_pred             CCCcc--ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhh
Confidence            43221  2233467889999988543 357889999999999999999987775432210   00000000         


Q ss_pred             -Hhhhh-hhccccCCC----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 -RLELE-EDLGLQGIE----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 -~~~~~-~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       ..... .........    .......+.++.+++.+||+.+|++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence             00000 000000000    0011233567889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=279.59  Aligned_cols=246  Identities=21%  Similarity=0.247  Sum_probs=199.9

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEe----CceEEEEEEecc
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFE----GHRRALIYEFVS  401 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~  401 (638)
                      .++||-|-.|+|..+.. .+++.+|+|++.+.    ....+|+++.-.. .|||||.+++++..    ..-+.+|||.|+
T Consensus        67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            37899999999999874 56889999999765    3445788775444 49999999998864    344568999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC---CCCceEEcccccceecc
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICE  478 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFg~~~~~~  478 (638)
                      ||.|...++..+    ...+++.++..|+.||..|+.|||+   .+|.||||||+|+|..   .+-.+||+|||+|+...
T Consensus       143 GGeLfsriq~~g----~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  143 GGELFSRIQDRG----DQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             chHHHHHHHHcc----cccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            999999999865    3679999999999999999999999   9999999999999995   46679999999999765


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...   .....+-||.|.|||++...  .|...+|+||+||++|-|+.|.+||......    .+......++..+    
T Consensus       216 ~~~---~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~~g----  282 (400)
T KOG0604|consen  216 EPG---DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIRTG----  282 (400)
T ss_pred             CCc---cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhhcc----
Confidence            432   34556679999999999654  6889999999999999999999999876552    2223333333322    


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .-..+.+....++++..++|+.+|+.+|++|.|+++++.
T Consensus       283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            123445667788999999999999999999999999986

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.6e-36  Score=282.56  Aligned_cols=268  Identities=23%  Similarity=0.308  Sum_probs=200.1

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-----CCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe-CceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-----GQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE-GHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  395 (638)
                      |+....||+|.||.||+|...+     .+.+|||.++.++   +......+|+.+++.++|||++.|..++.. +...++
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            3456789999999999995322     2379999997653   334678999999999999999999999987 788899


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC----CceEEccc
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED----FCPKISDF  471 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~----~~~kl~DF  471 (638)
                      ++||.+. +|...|+-.+... ...++...+..|+.||+.|+.|||+   .=|+||||||.|||+..+    |.|||+||
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~-~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASK-AKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccch-hccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence            9999977 9999998765433 3689999999999999999999999   779999999999999765    99999999


Q ss_pred             ccceeccCCCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc--chhHHHH
Q 006620          472 GLAKICEGRES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI--YFPHWVY  548 (638)
Q Consensus       472 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~--~~~~~~~  548 (638)
                      |+++.+.+.-. .......+-|..|+|||++.|. ..||.+.|||++|||+.||+|-++.|.........-  +....+.
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99998765322 2233445569999999999986 589999999999999999999999886544322211  1111111


Q ss_pred             HHhhhhh---hcc---ccCCC---------------CchhHH-------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          549 KRLELEE---DLG---LQGIE---------------NEEDKE-------YARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       549 ~~~~~~~---~~~---~~~~~---------------~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      +.++...   +-.   +...+               .-....       -....++|+.++|+.||.+|.|+++.+++
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            1111100   000   00000               000001       11236789999999999999999999874

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-35  Score=295.41  Aligned_cols=245  Identities=26%  Similarity=0.408  Sum_probs=195.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc--CCchhhHHHHHHHHhhcC---CcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET--KGNGEDFINEVASISRTS---HVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||.||+|.. .+++.||+|++...  ....+.+.+|+.++++++   |||++++++++..+...++||||
T Consensus         4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~   83 (277)
T cd06917           4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY   83 (277)
T ss_pred             hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence            3467899999999999985 56889999998653  233456788999999987   99999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++..       ..+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          84 AEGGSVRTLMKA-------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             CCCCcHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999864       258899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...  ......|+..|+|||.+.+. ..++.++|+||||+++|+|++|+.||......       ... ...   .....
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~-~~~---~~~~~  219 (277)
T cd06917         154 NSS--KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAM-MLI---PKSKP  219 (277)
T ss_pred             Ccc--ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhh-hcc---ccCCC
Confidence            432  12334578899999988643 25688999999999999999999998643211       000 000   00000


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...   ....++.++.+++.+||+.||++||++.++++
T Consensus       220 ~~~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         220 PRL---EDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCC---CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111   11124567899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.5e-35  Score=298.82  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=198.4

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|++|.||+|.. .+++.||+|++....   ...+.+.+|+.++++++||||+++++++..+...++|+||+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence            4568899999999999985 468899999987543   23457889999999999999999999999999999999999 


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....     ..+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          82 PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            999999997643     568999999999999999999999   999999999999999999999999999988765432


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh---------
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE---------  552 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------  552 (638)
                      . .......++..|+|||.+.+. ..++.++||||+|++++||++|.++|.......   .+ ........         
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~  227 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QL-AIVFRTLGTPNEETWPG  227 (286)
T ss_pred             C-CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HH-HHHHHHcCCCChHHHhh
Confidence            1 112334678999999998653 356889999999999999999987775432110   00 00000000         


Q ss_pred             --h---hhhccccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          553 --L---EEDLGLQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       553 --~---~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        .   ...+.......    ....+...++.+++.+||+.+|++||++++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0   00000000000    0111235788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.6e-35  Score=294.30  Aligned_cols=249  Identities=25%  Similarity=0.406  Sum_probs=196.7

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC-------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG-------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      ..+.||+|++|.||++.. .+++.||+|++.....       ..+.+.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            357899999999999984 5688999999864331       23567899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-ceEEcccccceec
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKIC  477 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFg~~~~~  477 (638)
                      |+++++|.+++...      ..+++..+..++.|++.||+|||+   ++++|+||+|+||+++.++ .+||+|||.+...
T Consensus        84 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          84 WMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             ccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999764      458899999999999999999999   9999999999999998765 5999999998766


Q ss_pred             cCCCcee--eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          478 EGRESIV--SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       478 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      .......  ......++..|+|||.+.+.  .++.++||||+|+++++|++|+.||.......    ........     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~-----  223 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----HLALIFKI-----  223 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----hHHHHHHH-----
Confidence            4331110  11223578899999998654  67889999999999999999999986432211    01111000     


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        .........+.....++.+++.+||+.+|++||++.++++
T Consensus       224 --~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 --ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              0011112233456678899999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-35  Score=301.55  Aligned_cols=243  Identities=25%  Similarity=0.353  Sum_probs=194.2

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      .+||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.+++.++|||++++++.+..++..++|+||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            4799999999999985 468899999986533 33457889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeee
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM  486 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~  486 (638)
                      +++..       ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++........  ..
T Consensus       107 ~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  174 (297)
T cd06659         107 DIVSQ-------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR  174 (297)
T ss_pred             HHHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence            98764       348899999999999999999999   8999999999999999999999999999875543221  12


Q ss_pred             cccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCch
Q 006620          487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE  566 (638)
Q Consensus       487 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (638)
                      ....|+..|+|||++.+.  .++.++||||||+++|||++|+.||......      ..  ...+....     ......
T Consensus       175 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~--~~~~~~~~-----~~~~~~  239 (297)
T cd06659         175 KSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QA--MKRLRDSP-----PPKLKN  239 (297)
T ss_pred             cceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH--HHHHhccC-----CCCccc
Confidence            234578999999998764  6788999999999999999999998643210      00  00111000     000111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       567 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ......++.+++.+||+.+|++||++++++++
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            12335568899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=300.10  Aligned_cols=260  Identities=24%  Similarity=0.334  Sum_probs=192.6

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.||+|++|+||+|... +++.||||.+.....  ....+.+|++++++++|+||+++++++.+++..++||||+.+
T Consensus         8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (291)
T cd07844           8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT   87 (291)
T ss_pred             eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence            34688999999999999864 678999999865432  234567899999999999999999999999999999999975


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                       +|.+++....     ..+++..+..++.|+++||.|||+   .+++||||||+||++++++.+||+|||+++.......
T Consensus        88 -~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          88 -DLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             -CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence             9999987653     468899999999999999999999   9999999999999999999999999999875432211


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh--------HHHHHHhhhh
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP--------HWVYKRLELE  554 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~  554 (638)
                        ......++..|+|||++.+. ..++.++||||+|+++|+|++|+.||.............        ..........
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             --cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence              11223468899999988653 357889999999999999999999986443111000000        0000000000


Q ss_pred             h---hccccCCCCch----hHHH--HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 E---DLGLQGIENEE----DKEY--ARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~---~~~~~~~~~~~----~~~~--~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .   ...........    ....  ..++.+++.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0   00000000000    0011  256789999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.5e-35  Score=297.59  Aligned_cols=241  Identities=26%  Similarity=0.359  Sum_probs=195.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|++|.||++... +++.+|+|++....    ...+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV   83 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence            45689999999999999854 58899999986532    23456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        84 ~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          84 PGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999765      468899999999999999999999   99999999999999999999999999999876543


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .     ....+++.|+|||.+.+.  ..+.++||||||+++|+|++|+.||.....        ......... ...   
T Consensus       155 ~-----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~---  215 (290)
T cd05580         155 T-----YTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILE-GKV---  215 (290)
T ss_pred             C-----CCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-CCc---
Confidence            1     234578999999998654  678899999999999999999999864331        111111110 000   


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                          ..+......+.+++.+||+.+|++|+     ++++++++
T Consensus       216 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         216 ----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                11112356788999999999999999     77777743

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.3e-35  Score=294.31  Aligned_cols=252  Identities=23%  Similarity=0.384  Sum_probs=198.0

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  399 (638)
                      ++.+.||.|+||.||++.. .+++.+|+|++....   ...+.+.+|++++++++|+||+++++++..  ....++++||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            4567899999999999985 467899999986532   233567889999999999999999998764  4567899999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC--NTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      +++++|.+++....  .....+++..++.++.|+++||+|||..+  ..+++|+||+|+||+++.++.+||+|||++...
T Consensus        83 ~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          83 CEGGDLAQLIQKCK--KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             ccCCCHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            99999999997642  22357899999999999999999999211  189999999999999999999999999999876


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ......  .....+++.|+|||.+.+.  .++.++|+||||+++++|++|+.||.....       .... ....     
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~-~~~~-----  223 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLA-SKIK-----  223 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHH-HHHh-----
Confidence            544321  1334679999999998764  678899999999999999999999874321       1111 1111     


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        ...........+.++.+++.+||+.+|++||++++|+++
T Consensus       224 --~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 --EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              111111223456788999999999999999999999973

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.9e-35  Score=292.87  Aligned_cols=245  Identities=24%  Similarity=0.275  Sum_probs=191.4

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC------CchhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK------GNGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALIY  397 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  397 (638)
                      +.+.||+|+||.||+++. .+++.||||.+....      ...+.+.+|++++++++||||+++++++.+.  ...+++|
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence            468899999999999985 458899999875322      1234677899999999999999999988763  4678999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++++|.+++...      ..+++..+.+++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++...
T Consensus        86 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          86 EHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            999999999999764      347888899999999999999999   99999999999999999999999999998865


Q ss_pred             cCCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          478 EGRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       478 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ...... .......++..|+|||.+.+.  .++.++||||||+++|+|++|+.||......       .....       
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~-------  220 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFK-------  220 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HHHHH-------
Confidence            422111 112234578899999998764  6788999999999999999999998632110       00000       


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..........+......+.+++.+|+. +|++||++++|++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            001111122334556778899999995 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.4e-35  Score=292.27  Aligned_cols=245  Identities=27%  Similarity=0.401  Sum_probs=196.5

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|++|.||++.. .+++.+|||++....   ...+.+.+|++++++++|||++++++.+..++..++|+||++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP   82 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence            4578999999999999985 468899999986542   234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC-CceEEcccccceeccCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICEGR  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFg~~~~~~~~  480 (638)
                      +++|.+++....    ...+++..+..++.|+++||+|||+   .+++|+||+|+||+++++ +.+||+|||.+......
T Consensus        83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          83 GGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999997643    2458999999999999999999999   999999999999999754 46899999999876543


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ...   ....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||.....       +........        
T Consensus       156 ~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~~--------  215 (256)
T cd08220         156 SKA---YTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIMS--------  215 (256)
T ss_pred             ccc---cccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHHh--------
Confidence            221   234578899999998754  678899999999999999999999864321       111111100        


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..........+.++.+++.+||+.+|++|||+.++++
T Consensus       216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         216 GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0011112234667889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-34  Score=295.04  Aligned_cols=256  Identities=24%  Similarity=0.328  Sum_probs=196.2

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~  401 (638)
                      ..++||.|++|.||++.. .+++.+|+|++.....  ....+.+|++++++++||||+++++++...  ...++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            467899999999999996 4578999999875433  346789999999999999999999988653  46899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....  .....+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          85 GGSLDSIYKKVK--KRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             CCCHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999886532  123568899999999999999999999   999999999999999999999999999987553322


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .    ....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||.........  .... ..............
T Consensus       160 ~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~  230 (287)
T cd06621         160 A----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG--PIEL-LSYIVNMPNPELKD  230 (287)
T ss_pred             c----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC--hHHH-HHHHhcCCchhhcc
Confidence            1    123468899999998654  6788999999999999999999998755321000  0111 11111000000000


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      . .......+..+.+++.+||+.+|++|||+.|+++
T Consensus       231 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 E-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             C-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0 0111234667899999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-34  Score=290.74  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=200.7

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.||.|++|+||+|.. .++..+++|++....  .....+.+|++.++.++|+|++++++.+...+..++|+|++++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   83 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG   83 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence            4578899999999999985 457899999986543  2446788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++.....   ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          84 GSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             CcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999986431   2468999999999999999999999   9999999999999999999999999999876654332


Q ss_pred             ee--eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          483 IV--SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       483 ~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..  ......|+..|+|||++... ...+.++|+||||+++++|++|+.||.......       ...+.....    ..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~----~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQND----PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcCC----CC
Confidence            21  11234578999999998654 357889999999999999999999986432210       001111100    00


Q ss_pred             CCCCc-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENE-EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..... ....++.++.+++.+||+.||++||++++|++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111 11245677899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-35  Score=302.16  Aligned_cols=260  Identities=25%  Similarity=0.344  Sum_probs=196.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ++.++||+|+||.||+|... +++.||+|++.....   ..+.+.+|++++++++||||+++++++..+...++|+||++
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD   83 (286)
T ss_pred             eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence            45689999999999999965 588999998865322   23567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.++....      ..+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        84 ~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          84 HTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            98888876543      348999999999999999999999   899999999999999999999999999988764433


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccc-------hhHHHHHHhhhh
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY-------FPHWVYKRLELE  554 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~  554 (638)
                      .  ......++..|+|||++.+. ..++.++||||||+++|||++|++||...........       +...........
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             c--ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            2  12334578899999998653 3567899999999999999999998864321100000       000000000000


Q ss_pred             h---hccccCCCC-----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 E---DLGLQGIEN-----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~---~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .   .........     .....++..+.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0   000000000     011234567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.6e-35  Score=294.46  Aligned_cols=250  Identities=25%  Similarity=0.388  Sum_probs=198.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.||+|++|.||++... +++.+|+|++....  .....+.+|++++++++||||+++++.+......++++||+++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            35678999999999999865 58899999987653  2345788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....     ..+++..+..++.|+++||+|||+  ..+++|+||||+||++++++.++|+|||.+........
T Consensus        84 ~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          84 GSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999998653     568899999999999999999997  36999999999999999999999999999876543221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .    ...++..|+|||.+.+.  .++.++||||||+++|+|++|+.||.........  ....... ..      ....
T Consensus       157 ~----~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~-~~------~~~~  221 (265)
T cd06605         157 K----TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFELLQY-IV------NEPP  221 (265)
T ss_pred             h----cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHHHHHH-Hh------cCCC
Confidence            1    14578899999998765  7889999999999999999999998754321111  0111111 00      0001


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .......++.++.+++.+||..+|++|||+.+++.
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            11111126677899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=305.66  Aligned_cols=246  Identities=26%  Similarity=0.416  Sum_probs=204.5

Q ss_pred             hhcccCcCcceeEEEEEEcC--CC--EEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          327 FKNKLGQGGYGGVYKGKLLD--GQ--NVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +-++||+|.||.|++|.|..  |+  .||||.++.+..  ...+|++|+.+|.+|+|+|+++|||+..+ ....+|+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            45789999999999998643  33  689999987654  35789999999999999999999999887 7788999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +.|+|.+.|++..    ...|....+-.++.|||.||.||..   ++.|||||..+|+||.....|||+|||+.+-+...
T Consensus       193 plGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             ccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            9999999998832    3678889999999999999999999   99999999999999999999999999999988766


Q ss_pred             Cceeeecc-cccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          481 ESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       481 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      +....+.. ..-...|+|||.+..  ..++.++|||+|||++|||++ |+.||.....        ..+.+       ..
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~-------~i  328 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILK-------NI  328 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHH-------hc
Confidence            65554443 334678999999965  488999999999999999997 4667654321        11111       11


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      +.+.+...++.+++++.++++.||..+|++|||+..|.+
T Consensus       329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            244555667778999999999999999999999999974

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-34  Score=291.01  Aligned_cols=251  Identities=24%  Similarity=0.385  Sum_probs=198.8

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ...+.||+|+||.||+|.. .+++.|++|+++....   ..+.+.+|++++++++|+||+++++.+...+..++|+||++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS   82 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence            4568899999999999985 4688999999876544   35678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          83 GGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999764      357889999999999999999999   999999999999999999999999999988765433


Q ss_pred             ceee--ecccccccceecCceecccc-CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          482 SIVS--MTGARGTIGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       482 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....  .....+++.|+|||++.+.. ...+.++||||||+++++|++|+.||.......      ..... .....   
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~~-~~~~~---  223 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMFH-VGAGH---  223 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHHH-HhcCC---
Confidence            2111  12345788999999987642 237889999999999999999999986432110      00000 00000   


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        .............+.+++.+||+.+|++|||+.+++.
T Consensus       224 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 --KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              0001111223567789999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.8e-34  Score=296.84  Aligned_cols=245  Identities=27%  Similarity=0.374  Sum_probs=194.1

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +...++||+|+||+||+|... +++.||+|++.....    ..+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            345678999999999999854 588999999864321    234678999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +. |+|.+++....     ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++.....
T Consensus        97 ~~-g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          97 CL-GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             hC-CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            96 58888776532     458999999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCceeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ..      ...+++.|+|||++.+. .+.++.++||||||+++|||++|+.||......       ..... ..      
T Consensus       168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------~~~~~-~~------  227 (307)
T cd06607         168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH-IA------  227 (307)
T ss_pred             CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------HHHHH-Hh------
Confidence            22      23468899999988531 235788999999999999999999998643211       00000 00      


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ...........++..+.+++.+||+.+|++||++.+|+.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         228 QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0011111223456788999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=317.46  Aligned_cols=255  Identities=26%  Similarity=0.424  Sum_probs=214.7

Q ss_pred             hcccCcCcceeEEEEEE-cCCC----EEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQ----NVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .++||+|+||+||+|.+ .+++    +||||++......  ..++++|+-+|.++.|||++||+|+|.... ..||++|+
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            57899999999999974 4443    6899998765443  578999999999999999999999998765 88999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +.|+|.|+++.++     ..+.....+.|..|||+||.|||.   ++++||||-.+||||.+-..+||.|||+++.....
T Consensus       780 P~G~LlDyvr~hr-----~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  780 PLGCLLDYVREHR-----DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             ccchHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999875     678889999999999999999999   99999999999999999999999999999998877


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ..........-.+-|||-|.+...  .++.++|||||||++||++| |..|++....+               ...++..
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---------------eI~dlle  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---------------EIPDLLE  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHH---------------HhhHHHh
Confidence            766666666668889999998654  89999999999999999886 77777654321               1112222


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      .+.+..++...+.++..++.+||..|+..||+++++...+.++..+.+.
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr  963 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR  963 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence            3344555666788899999999999999999999999999988776554

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.6e-34  Score=292.52  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=199.2

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      .+.+.||+|++|.||+|... +++.+++|++.......+.+.+|++.+++++|+|++++++.+......++|+||+++++
T Consensus        22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~  101 (286)
T cd06614          22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS  101 (286)
T ss_pred             hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence            34678999999999999865 58899999997655455678899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....     ..+++..+..++.|++.||+|||+   .|++|+||+|+||+++.++.++|+|||.+........  
T Consensus       102 L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  171 (286)
T cd06614         102 LTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--  171 (286)
T ss_pred             HHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence            999998752     368999999999999999999999   9999999999999999999999999998875543221  


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      ......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.|+......       ... ......   ...  ..
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~-~~~~~~---~~~--~~  236 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RAL-FLITTK---GIP--PL  236 (286)
T ss_pred             hhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHH-HHHHhc---CCC--CC
Confidence            11233468899999998654  6789999999999999999999998643211       000 000000   000  11


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....+..++.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            112225677899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-34  Score=292.21  Aligned_cols=245  Identities=24%  Similarity=0.360  Sum_probs=196.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.++||+|+||.||+|.. .+++.||+|++....  .....+.+|+.++++++||||+++++.+..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            34567899999999999985 467899999976433  233567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++..       ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        86 ~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          86 GGSALDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            9999999864       358899999999999999999999   999999999999999999999999999987664332


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .  ......++..|+|||.+.+.  ..+.++|+||||+++|+|++|..|+......       ... ....       ..
T Consensus       156 ~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~-~~~~-------~~  216 (277)
T cd06641         156 I--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVL-FLIP-------KN  216 (277)
T ss_pred             h--hhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHH-HHHh-------cC
Confidence            1  11234578899999998654  6788999999999999999999998632210       000 1010       01


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ........++.++.+++.+||+.+|++||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1111222345678899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-34  Score=294.77  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=191.7

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHH-HhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVAS-ISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.||+|+||.||+++.. +++.||+|+++....  ....+..|+.. ++.++||||+++++++..+...+++|||++ 
T Consensus         5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-   83 (283)
T cd06617           5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-   83 (283)
T ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence            4678999999999999864 589999999875432  23455666665 566789999999999999999999999996 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      ++|.+++....  .....+++..++.++.|++.||+|||+   + +++||||||+||++++++.+||+|||++.......
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          84 TSLDKFYKKVY--DKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             ccHHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            69998887643  223568999999999999999999998   6 99999999999999999999999999988654322


Q ss_pred             ceeeecccccccceecCceecccc--CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      .   .....++..|+|||.+.+..  ..++.++|+||||+++|+|++|+.||......     .... .....       
T Consensus       159 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~-~~~~~-------  222 (283)
T cd06617         159 A---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQL-KQVVE-------  222 (283)
T ss_pred             c---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHH-HHHHh-------
Confidence            1   12245788999999886421  24688999999999999999999998642211     1111 01000       


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..........++.++.+++.+||+.+|++||+++++++
T Consensus       223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00001111235678899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-34  Score=293.87  Aligned_cols=242  Identities=24%  Similarity=0.321  Sum_probs=187.6

Q ss_pred             ccCcCcceeEEEEEE-cCCCEEEEEEecccCCc----hhhHHHHHHHHhh---cCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          330 KLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN----GEDFINEVASISR---TSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .||+|+||.||++.. .+++.+|+|++......    ...+.+|..+++.   .+||||+++++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999985 45889999998654211    1233445444333   469999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          81 GGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            99999998764      458999999999999999999999   999999999999999999999999999987554322


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .    ....|++.|+|||.+.+. ..++.++||||+|+++|+|++|+.||.........     ..... ..       .
T Consensus       152 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~-~~-------~  213 (279)
T cd05633         152 P----HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRM-TL-------T  213 (279)
T ss_pred             c----cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-----HHHHH-hh-------c
Confidence            1    234589999999988532 25788999999999999999999999754321110     11000 00       0


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                      .....+...+.++.+++.+||+.||++||     |+++++++
T Consensus       214 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            11112233567889999999999999999     69999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-35  Score=305.67  Aligned_cols=242  Identities=24%  Similarity=0.382  Sum_probs=195.0

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEE---EEecc--cCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCce--EEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAI---KVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHR--RALIYE  398 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vav---K~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  398 (638)
                      |...||+|+|-+||||.+. +|..||-   |.-+.  .....+.|..|+.+|+.|+||||+++|+++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4678999999999999863 4666763   32222  22344789999999999999999999999987655  778999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-CCCceEEcccccceec
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKIC  477 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFg~~~~~  477 (638)
                      .+..|+|..|+++.      +.++...+..|++||++||.|||+. ..+|||||||-+||+|+ ..|.|||+|+|+|+..
T Consensus       124 L~TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  124 LFTSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             cccCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            99999999999987      4678889999999999999999995 46899999999999996 6789999999999987


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .....    ....|||.|||||+...   .|...+||||||+.++||+|+.-||..-.       -+..+++++..+.  
T Consensus       197 r~s~a----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------n~AQIYKKV~SGi--  260 (632)
T KOG0584|consen  197 RKSHA----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECT-------NPAQIYKKVTSGI--  260 (632)
T ss_pred             hcccc----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhC-------CHHHHHHHHHcCC--
Confidence            65542    33679999999999863   68999999999999999999999976322       3444555544332  


Q ss_pred             cccCCCCchhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          558 GLQGIENEEDKE-YARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       558 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                           .+..... --.++.+||.+||.. .++|||+.|+|+
T Consensus       261 -----KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  261 -----KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                 2211111 123688999999999 999999999996

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-34  Score=298.23  Aligned_cols=253  Identities=21%  Similarity=0.262  Sum_probs=196.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||.||++... .++.|++|.+....    ...+.+.+|+++++.++||||+++++.+..+...++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            35688999999999999854 47899999987543    22356778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          84 EGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999764      358899999999999999999999   89999999999999999999999999988642111


Q ss_pred             Cc-------------eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHH
Q 006620          481 ES-------------IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWV  547 (638)
Q Consensus       481 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  547 (638)
                      ..             ........++..|+|||.+.+.  .++.++|+||||+++|||++|+.||.....       ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~  225 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELF  225 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHH
Confidence            00             0011123468899999998654  678999999999999999999999863221       1111


Q ss_pred             HHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                       ...... ....    .......+.++.+++.+||+.+|++||+..++.+.|+..
T Consensus       226 -~~~~~~-~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         226 -GQVISD-DIEW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             -HHHHhc-ccCC----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence             111100 0000    111113466789999999999999999977777766663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-35  Score=300.20  Aligned_cols=266  Identities=23%  Similarity=0.326  Sum_probs=196.4

Q ss_pred             hhhcccCcCcceeEEEEEEc---CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL---DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  396 (638)
                      .+.++||+|++|.||+|...   +++.||+|++....    ...+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            45678999999999999864   47899999987632    2345678899999999999999999999988  889999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC----CCceEEcccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE----DFCPKISDFG  472 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~----~~~~kl~DFg  472 (638)
                      |||+++ +|.+++..... .....+++..++.++.|++.||+|||+   .+++||||||+||+++.    ++.+||+|||
T Consensus        83 ~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EeCCCc-CHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            999965 78887765431 112468999999999999999999999   99999999999999998    9999999999


Q ss_pred             cceeccCCCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc-chhHHHHH-
Q 006620          473 LAKICEGRES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI-YFPHWVYK-  549 (638)
Q Consensus       473 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~-  549 (638)
                      ++........ ........++..|+|||.+.+. ..++.++||||||+++++|++|++||.......... ........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            9986643322 1122334578899999987653 357889999999999999999999997654432100 00000000 


Q ss_pred             Hhhh--------------h-------hhccccCCCCch-hH------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLEL--------------E-------EDLGLQGIENEE-DK------EYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~~--------------~-------~~~~~~~~~~~~-~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....              .       ............ ..      ....++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000              0       000000001000 00      23456889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-34  Score=290.77  Aligned_cols=241  Identities=22%  Similarity=0.309  Sum_probs=193.5

Q ss_pred             cCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          331 LGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       331 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ||.|++|.||+++.. +++.||+|++....    ...+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999964 48899999987543    2345788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++.+.      ..+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||.+........   
T Consensus        81 ~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---  148 (262)
T cd05572          81 WTILRDR------GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---  148 (262)
T ss_pred             HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---
Confidence            9999864      348899999999999999999999   9999999999999999999999999999987654321   


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....+++.|++||.+.+.  .++.++|+||+|+++|+|++|..||.......     .........       ......
T Consensus       149 ~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~-------~~~~~~  214 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEIYNDILK-------GNGKLE  214 (262)
T ss_pred             cccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HHHHHHHhc-------cCCCCC
Confidence            1223578899999998654  67889999999999999999999987543210     111111110       000111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVE  597 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  597 (638)
                      .+.....++.+++.+||+.+|++||+     ++|+++
T Consensus       215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            11222567899999999999999999     777775

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-34  Score=288.07  Aligned_cols=247  Identities=30%  Similarity=0.400  Sum_probs=201.2

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEEEEec
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~  400 (638)
                      ..+.||+|++|.||+|... +++.|++|++....   ...+.+.+|++.+++++|+||+++++.+...  ...++++||+
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   83 (260)
T cd06606           4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV   83 (260)
T ss_pred             eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence            3578999999999999965 68899999987654   3456788999999999999999999999988  8899999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..++.++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||.+......
T Consensus        84 ~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          84 SGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999864      368999999999999999999999   99999999999999999999999999999877654


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..........++..|+|||.+.+.  ..+.++||||||+++++|++|+.||......      ......       +...
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~-------~~~~  219 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYK-------IGSS  219 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHh-------cccc
Confidence            321112334578899999998764  5788999999999999999999998754310      011100       0001


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......+...+.++.+++.+|++.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            1111222334678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=298.54  Aligned_cols=249  Identities=23%  Similarity=0.273  Sum_probs=196.4

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      ++.+.||+|++|+||++... +++.||+|.+.....    ..+.+.+|++++++++|+||+++++.+......++||||+
T Consensus         4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            34678999999999999864 488999999875432    3356788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      .+++|.+++....    ...+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          84 PGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             CCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999987542    2568999999999999999999999   89999999999999999999999999998754322


Q ss_pred             Ccee---------------------------eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCc
Q 006620          481 ESIV---------------------------SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANV  533 (638)
Q Consensus       481 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~  533 (638)
                      ....                           ......||..|+|||++.+.  .++.++||||||+++|+|++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence            1100                           01123578899999999764  678899999999999999999999864


Q ss_pred             ccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 006620          534 AVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS----MNRVVE  597 (638)
Q Consensus       534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  597 (638)
                      ....       .......       ............+.++.+++.+||+.+|++||+    ++++++
T Consensus       235 ~~~~-------~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         235 SNRD-------ETFSNIL-------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CchH-------HHHHHHh-------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            4321       0000000       001111111125678999999999999999999    777776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-34  Score=293.80  Aligned_cols=243  Identities=26%  Similarity=0.371  Sum_probs=191.6

Q ss_pred             cCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          331 LGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       331 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ||+|+||+||++.. .+++.||+|++....    .....+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999985 458899999986432    2234567899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....    ...+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||.+........   
T Consensus        81 ~~~l~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---  150 (277)
T cd05577          81 KYHIYNVG----EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---  150 (277)
T ss_pred             HHHHHHcC----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence            99997653    1468999999999999999999999   9999999999999999999999999999876543221   


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||.........   .. ....      .  ......
T Consensus       151 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~-~~~~------~--~~~~~~  216 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EE-LKRR------T--LEMAVE  216 (277)
T ss_pred             cccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HH-HHhc------c--cccccc
Confidence            1234568899999998764  5888999999999999999999998654321110   00 0000      0  001111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVE  597 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  597 (638)
                      .+...+..+.+++.+||+.+|++||     ++.+++.
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            1223466788999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.5e-35  Score=294.19  Aligned_cols=244  Identities=26%  Similarity=0.340  Sum_probs=198.2

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      ++.++||.|+||.||+++.. +++.||+|++....    ...+.+.+|++++++++||||+++++.+..+...++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            45789999999999999864 58899999987542    23467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      .+++|.+++...      ..+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||.+......
T Consensus        83 ~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          83 LGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999999764      368899999999999999999999   89999999999999999999999999998876543


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..   .....|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......     ...........       
T Consensus       154 ~~---~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-------  216 (258)
T cd05578         154 TL---TTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET-------  216 (258)
T ss_pred             cc---ccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc-------
Confidence            21   2334578899999998764  5789999999999999999999998755432     11111111110       


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSM--NRVV  596 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  596 (638)
                       .....+...+.++.+++.+||+.||.+||++  +|++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence             1111222345788899999999999999999  6655

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-34  Score=285.53  Aligned_cols=246  Identities=30%  Similarity=0.500  Sum_probs=199.4

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      ..+.||+|++|.||++... +++.+++|++..... ..+.+.+|++++++++|+|++++++++......++++||+++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            4578999999999999864 688999999976543 55688999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....     ..+++..+..++.|+++||++||+   .+++|+||+|+||++++++.++|+|||.+........  
T Consensus        84 L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          84 LKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             HHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999998642     468999999999999999999999   9999999999999999999999999999887654432  


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                       .....++..|+|||.+.+.  ..+.++||||||+++++|++|+.||......       .....   .. .......  
T Consensus       154 -~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~---~~-~~~~~~~--  217 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFK---IA-TNGPPGL--  217 (253)
T ss_pred             -ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHH---HH-hcCCCCc--
Confidence             1234578899999998764  5788999999999999999999998643210       00000   00 0000111  


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .....++..+.+++.+||+.||++|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111235678999999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.2e-35  Score=297.89  Aligned_cols=243  Identities=25%  Similarity=0.356  Sum_probs=193.1

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      ..||+|+||.||++.. .+++.||||++.... ...+.+.+|+..+++++|+||+++++.+..++..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            5699999999999985 458899999986543 23456889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeee
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM  486 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~  486 (638)
                      +++..       ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.........  .
T Consensus       108 ~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~  175 (292)
T cd06658         108 DIVTH-------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--R  175 (292)
T ss_pred             HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--C
Confidence            98854       347899999999999999999999   89999999999999999999999999998755332211  1


Q ss_pred             cccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCch
Q 006620          487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE  566 (638)
Q Consensus       487 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (638)
                      ....|+..|+|||.+.+.  .++.++||||||+++|||++|+.||......      .  ........    .... ...
T Consensus       176 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~--~~~~~~~~----~~~~-~~~  240 (292)
T cd06658         176 KSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------Q--AMRRIRDN----LPPR-VKD  240 (292)
T ss_pred             ceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H--HHHHHHhc----CCCc-ccc
Confidence            234578999999998654  6788999999999999999999998643210      0  00111000    0000 011


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       567 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ....+..+.+++.+||+.||++|||+++++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            12345568899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1e-34  Score=295.12  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=193.4

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ..+.||+|++|.||+|+.. +++.||||++....   .....+.+|++++++++||||+++++++.++...++||||+. 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence            4678999999999999864 58899999886532   223568899999999999999999999999999999999995 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....    ...+++..+..++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++........
T Consensus        83 ~~l~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          83 QDLKKFMDASP----LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            58999887642    2568999999999999999999999   8999999999999999999999999999876543221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh-------HHHHHHhhhhh
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP-------HWVYKRLELEE  555 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~  555 (638)
                      .  .....+++.|+|||++.+. ..++.++||||||+++|||+||+.||.............       ...+.......
T Consensus       156 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 T--YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             c--cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence            1  1223467899999988654 346889999999999999999999986432110000000       00000000000


Q ss_pred             --hccccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 --DLGLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 --~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ..........    .......++.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              0000000000    01123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-34  Score=295.44  Aligned_cols=258  Identities=24%  Similarity=0.296  Sum_probs=190.4

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.||+|+||.||+|.. .+++.||+|++.....  ....+.+|++++++++|+||+++++++..+...++|+||+. +
T Consensus         9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~   87 (291)
T cd07870           9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T   87 (291)
T ss_pred             EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence            467899999999999985 4688999999865432  23467789999999999999999999999999999999995 6


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||+++........
T Consensus        88 ~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          88 DLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            8877776532     457888899999999999999999   89999999999999999999999999998754322211


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHH---------HHHHhhhh
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW---------VYKRLELE  554 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~~  554 (638)
                        .....+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||....... +.....+         ....+...
T Consensus       160 --~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         160 --YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             --CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhhhhc
Confidence              1233468899999998653 246789999999999999999999987443210 0000000         00000000


Q ss_pred             ----hhccccCCCCch-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 ----EDLGLQGIENEE-----DKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ----~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                          ............     .......+.+++.+|++.||++|||+++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                000000000000     0011356789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.1e-34  Score=294.18  Aligned_cols=247  Identities=26%  Similarity=0.344  Sum_probs=197.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.+.||+|+||.||++.. .+++.|++|.+.... ...+.+.+|+.++++++|||++++++.+...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  100 (293)
T cd06647          21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG  100 (293)
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence            34568899999999999985 467899999986432 3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++.+.       .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       101 ~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647         101 GSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999998753       47888999999999999999999   9999999999999999999999999998876543322


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .  .....+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||..........   .     ...     ....
T Consensus       171 ~--~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~---~-----~~~-----~~~~  233 (293)
T cd06647         171 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---L-----IAT-----NGTP  233 (293)
T ss_pred             c--cccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee---e-----hhc-----CCCC
Confidence            1  1234578899999998654  67889999999999999999999997543211000   0     000     0000


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ...........+.+++.+||+.+|++||++.+++.+
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111222345678899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=332.27  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=201.8

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      ..+||.|.||.||.|. ..+|+..|||.++-..   .....+.+|..++..++|||+|+++|+-...+..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            4689999999999998 5678899999876433   33456789999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+.+...      +..++.....+..|+++|++|||+   .|||||||||.||+|+.+|.+|++|||.|..+......
T Consensus      1320 sLa~ll~~g------ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHG------RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             cHHHHHHhc------chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            999999875      456777788899999999999999   99999999999999999999999999999988655311


Q ss_pred             --eeecccccccceecCceecccc-CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          484 --VSMTGARGTIGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       484 --~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                        .......||+.|||||++.+.. ..-..+.||||+||++.||+||+.||...+.+-     .- ++. +       .-
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-----aI-My~-V-------~~ 1456 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-----AI-MYH-V-------AA 1456 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-----HH-HhH-H-------hc
Confidence              1223467999999999997643 234568999999999999999999997554321     00 011 1       12


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      +..++.+...+.+-.+|+.+||+.||+.|.++.|++++
T Consensus      1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            23333444578888999999999999999999988864

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-34  Score=294.33  Aligned_cols=257  Identities=21%  Similarity=0.298  Sum_probs=192.2

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC--chhhHHHHHHHHhhcC-CcceEEEEeEEEeC--ceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG--NGEDFINEVASISRTS-HVNIVTLLGFCFEG--HRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~  399 (638)
                      .+.++||+|+||.||+|.. .+++.||+|+++....  ......+|+.+++++. |+|++++++++.++  +..++|+||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            3567899999999999985 4688999999875422  2234567888998886 99999999999987  889999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++ ++|.+++....     ..+++..++.++.|++.||+|||+   .+++||||+|+||+++. +.+||+|||+++....
T Consensus        82 ~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          82 MD-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             CC-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            96 58888887642     468999999999999999999999   99999999999999999 9999999999987644


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc--------ccchhHHHHHHh
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS--------EIYFPHWVYKRL  551 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~  551 (638)
                      ....   ....++..|+|||++... +.++.++|||||||++|||++|+.||........        ......+ ....
T Consensus       152 ~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  226 (282)
T cd07831         152 KPPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKF  226 (282)
T ss_pred             CCCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhh
Confidence            3321   223468899999987543 3568899999999999999999999965332100        0000000 0000


Q ss_pred             hhhhh--ccccCCC----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 ELEED--LGLQGIE----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~~~~--~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....  .......    .......+.++.+++.+||+.+|++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000  0000000    0011235678999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.9e-35  Score=316.93  Aligned_cols=266  Identities=16%  Similarity=0.198  Sum_probs=183.3

Q ss_pred             hhhhcccCcCcceeEEEEEEcC--CCEEEEE------------------EecccCCchhhHHHHHHHHhhcCCcceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD--GQNVAIK------------------VLNETKGNGEDFINEVASISRTSHVNIVTLL  384 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  384 (638)
                      |.+.++||+|+||+||++....  +...++|                  .+.........+.+|++++++++||||++++
T Consensus       150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  229 (501)
T PHA03210        150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE  229 (501)
T ss_pred             cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence            4457899999999999986432  2222222                  1111222234678999999999999999999


Q ss_pred             eEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC
Q 006620          385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF  464 (638)
Q Consensus       385 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~  464 (638)
                      +++...+..++|+|++. ++|.+++..... ..........+..|+.||+.||+|||+   ++|+||||||+|||++.++
T Consensus       230 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        230 EILRSEANTYMITQKYD-FDLYSFMYDEAF-DWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             EEEEECCeeEEEEeccc-cCHHHHHhhccc-cccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence            99999999999999984 588887765321 112234466788999999999999999   9999999999999999999


Q ss_pred             ceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh
Q 006620          465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP  544 (638)
Q Consensus       465 ~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  544 (638)
                      .+||+|||+++.+....... .....||+.|+|||++.+.  .++.++|||||||++|||++|+.++...........+.
T Consensus       305 ~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999998765433221 2345689999999999764  68899999999999999999875432211111000000


Q ss_pred             HHHH--------------HHhhhhhhccccCCCCch-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          545 HWVY--------------KRLELEEDLGLQGIENEE-----DKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       545 ~~~~--------------~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ....              ..................     ......++.+++.+||+.||++|||+.|++++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            0000              000000000000000000     01123456788999999999999999999863

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.9e-34  Score=294.32  Aligned_cols=248  Identities=27%  Similarity=0.370  Sum_probs=195.1

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      ...+.||+|+||.||+++. .+++.||+|++.....    ....+.+|++++++++|||++++++++..+...++||||+
T Consensus        28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  107 (317)
T cd06635          28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC  107 (317)
T ss_pred             hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCC
Confidence            3467899999999999985 4588999999864422    2346788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      .+ +|.+++....     ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++......
T Consensus       108 ~g-~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         108 LG-SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CC-CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            64 8888876542     468999999999999999999999   99999999999999999999999999998754332


Q ss_pred             CceeeecccccccceecCceecc-ccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                            ....+++.|+|||++.. ..+.++.++||||||+++|||++|+.||......       ..... ..      .
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~-~~------~  238 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH-IA------Q  238 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------HHHHH-HH------h
Confidence                  22357889999999743 1235788999999999999999999998643210       00000 00      0


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ..........++..+.+++.+||+.+|++||++.++++++-..
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            1111112223456788999999999999999999999866543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5e-34  Score=296.33  Aligned_cols=262  Identities=20%  Similarity=0.301  Sum_probs=192.7

Q ss_pred             cccCcC--cceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQG--GYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ..||+|  +||+||++++ .+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  9999999986 4689999999875432   235678899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....    ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++||+.+........
T Consensus        84 ~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          84 GSANSLLKTYF----PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             CCHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            99999998753    2358899999999999999999999   9999999999999999999999999986543221110


Q ss_pred             e--ee---ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc--------------ch
Q 006620          483 I--VS---MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI--------------YF  543 (638)
Q Consensus       483 ~--~~---~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~--------------~~  543 (638)
                      .  ..   .....++..|+|||++.+....++.++||||||+++|||++|+.||..........              ..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence            0  00   01112456799999997654457899999999999999999999986543210000              00


Q ss_pred             hHHHHHHh----hhh----h---------hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          544 PHWVYKRL----ELE----E---------DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       544 ~~~~~~~~----~~~----~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      +.......    ...    .         ...............+..+.+|+++||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00000000    000    0         000011122234456778999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.8e-34  Score=294.71  Aligned_cols=261  Identities=21%  Similarity=0.251  Sum_probs=194.4

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  398 (638)
                      +.+.+.||+|+||.||+|... +++.+|+|.++....   ....+.+|++++++++||||+++++++...  ...++|+|
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            345688999999999999864 578999999875432   223567899999999999999999998877  88999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++ +|.+++....     ..+++..++.++.|+++||+|||+   .+++|+||||+||++++++.+||+|||++....
T Consensus        87 ~~~~-~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          87 YVEH-DLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             hcCc-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            9974 9999987643     368999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh-------HHHHHHh
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP-------HWVYKRL  551 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~  551 (638)
                      ....  ......+++.|+|||.+.+. ..++.++|+||||+++|+|++|++||.............       ...+...
T Consensus       158 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         158 SPLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             CCcc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            4321  12334568899999998654 246889999999999999999999986432210000000       0000000


Q ss_pred             hh---hhh-----ccccCCCCchhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 EL---EED-----LGLQGIENEEDKE-YARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~---~~~-----~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..   ...     ............. .+..+.+++.+||+.+|++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00   000     0000000011111 3567889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.1e-34  Score=295.37  Aligned_cols=257  Identities=22%  Similarity=0.294  Sum_probs=192.2

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  399 (638)
                      .+.+.||+|+||.||+|.. .+++.||+|+++....   ....+.+|+.++++++|+||+++++++...  +..++||||
T Consensus        10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (309)
T cd07845          10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY   89 (309)
T ss_pred             eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence            3467899999999999986 4588999999864322   123467899999999999999999998754  568999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +.+ +|.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||++.....
T Consensus        90 ~~~-~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          90 CEQ-DLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             CCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            964 8999887643     568999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHH----------H
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY----------K  549 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~----------~  549 (638)
                      ...  ......+++.|+|||.+.+. ..++.++||||||+++|||++|++||........   +.....          .
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWP  234 (309)
T ss_pred             ccC--CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhch
Confidence            321  12233457889999998653 3578899999999999999999999864332110   000000          0


Q ss_pred             Hhhh---hhhccccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLEL---EEDLGLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~~---~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....   ............    .....+.++.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000   000000000000    01123567889999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.2e-34  Score=338.57  Aligned_cols=255  Identities=26%  Similarity=0.458  Sum_probs=196.8

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      .+.||+|+||.||+|+. .+++.||||.++.....   ..+|++.+++++|||||+++|++.+....++||||+++|+|.
T Consensus       695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~  771 (968)
T PLN00113        695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS  771 (968)
T ss_pred             ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence            56899999999999986 57889999998754332   235688999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeee
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM  486 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~  486 (638)
                      ++++.         ++|..+.+|+.|+++||+|||..+..+|+||||||+||+++.++..++. |+........      
T Consensus       772 ~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------  835 (968)
T PLN00113        772 EVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------  835 (968)
T ss_pred             HHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------
Confidence            99953         7899999999999999999995444899999999999999998888875 6654432211      


Q ss_pred             cccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh--hhccccCC--
Q 006620          487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE--EDLGLQGI--  562 (638)
Q Consensus       487 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--  562 (638)
                      ....+|+.|+|||++.+.  .++.++|||||||++|||++|+.||+......  .....|........  ........  
T Consensus       836 ~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        836 TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCC--CcHHHHHHHhcCccchhheeCccccC
Confidence            123578999999998764  78999999999999999999999996543322  12333332211110  01111111  


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ......+...++.+++.+||+.||++||||+||++.|+++...
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            1112234456788999999999999999999999999987553

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.1e-34  Score=287.20  Aligned_cols=249  Identities=26%  Similarity=0.383  Sum_probs=201.2

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ++.+.||+|++|.||+|... +++.|++|++.....  ..+.+.+|+..+.+++|+|++++++++......++|+||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            35689999999999999865 489999999876542  356789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..++.++.|+++||+|||+.  .+++|+||+|+||+++.++.++|+|||.+........
T Consensus        84 ~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          84 GSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999864      4689999999999999999999972  6899999999999999999999999999987654332


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      ..  ....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......    ........ ..      .. .
T Consensus       156 ~~--~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~-~~------~~-~  219 (264)
T cd06623         156 QC--NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQA-IC------DG-P  219 (264)
T ss_pred             cc--cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHH-Hh------cC-C
Confidence            21  234578899999998664  7788999999999999999999998654320    01111111 11      00 1


Q ss_pred             CCchhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          563 ENEEDKE-YARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       563 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ....... ++..+.+++.+||+.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1111222 56789999999999999999999999973

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=303.80  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=201.8

Q ss_pred             hhhcccCcCcceeEEEEEEcC-CCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      ++...||.|+||+||+|..++ +-..|.|++.... ...++++-|+++|....||+||+|++.|+..+.+.++.|||.||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence            345679999999999998655 3345778876543 44678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      -....+-..+     ..|++.++.-+++|+++||.|||+   .+|||||||..|||+.-+|.++|+|||.+......  .
T Consensus       115 AVDaimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~  184 (1187)
T KOG0579|consen  115 AVDAIMLELG-----RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R  184 (1187)
T ss_pred             hHhHHHHHhc-----cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence            9999987764     789999999999999999999999   99999999999999999999999999998754322  2


Q ss_pred             eeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          484 VSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .......|||.|||||+....   ..+|..++||||||++|.||..+.+|-....        +..+.-.+..     -.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKiaK-----Se  251 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAK-----SE  251 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHhh-----cC
Confidence            234567899999999998653   2378999999999999999999998854211        1111111110     01


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ......+..++..+.+++.+||..||..||++.+++++
T Consensus       252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            11123456778899999999999999999999998863

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.1e-34  Score=290.83  Aligned_cols=243  Identities=24%  Similarity=0.344  Sum_probs=194.1

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.++++++|||++++++++...+..++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            36899999999999985 468899999886443 2345678999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++..       ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||.+........  .
T Consensus       104 ~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~  171 (285)
T cd06648         104 TDIVTH-------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R  171 (285)
T ss_pred             HHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence            999876       247889999999999999999999   9999999999999999999999999998875543221  1


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.....      . .. ........   ..  ...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~-~~-~~~~~~~~---~~--~~~  236 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------L-QA-MKRIRDNL---PP--KLK  236 (285)
T ss_pred             cccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCH------H-HH-HHHHHhcC---CC--CCc
Confidence            1234578999999998664  678899999999999999999999864221      0 00 11111110   00  011


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....+..+.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11224567899999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=295.40  Aligned_cols=262  Identities=23%  Similarity=0.303  Sum_probs=196.1

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.+.++||+|++|.||+|... +++.||+|+++...   ...+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            345788999999999999865 57899999987532   23467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +++.+..++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++......
T Consensus        83 ~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          83 ERTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            987666655432      458999999999999999999999   89999999999999999999999999998876544


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccc-------hhHHHHHHhhh
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY-------FPHWVYKRLEL  553 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~  553 (638)
                      ... ......++..|+|||++.+. ..++.++||||||+++|+|++|++||...........       ++.........
T Consensus       154 ~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         154 PAS-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             ccc-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            321 12334578899999998754 2678899999999999999999999864321100000       00000000000


Q ss_pred             hhhc---cccCCCCc------hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 EEDL---GLQGIENE------EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ~~~~---~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....   ........      .+..++.++.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000   00000000      11123677999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.4e-34  Score=294.09  Aligned_cols=260  Identities=22%  Similarity=0.308  Sum_probs=192.6

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcC-CcceEEEEeEEEeCce-----EEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTS-HVNIVTLLGFCFEGHR-----RAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~l  395 (638)
                      ...+.||+|+||.||+|.. .+++.||||++.....   ....+.+|+.+++++. ||||+++++++...+.     .++
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l   83 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL   83 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence            3467899999999999985 4688999998865432   2356788999999995 6999999999987665     899


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-CCceEEcccccc
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLA  474 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~  474 (638)
                      ||||+++ +|.+++...... ....+++..++.++.||++||+|||+   ++++||||||+||+++. ++.+||+|||++
T Consensus        84 v~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          84 VFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence            9999975 899988764321 13468999999999999999999999   99999999999999998 899999999998


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ........  ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||........   ... ........
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~-~~~~~~~~  231 (295)
T cd07837         159 RAFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLH-IFKLLGTP  231 (295)
T ss_pred             eecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH-HHHHhCCC
Confidence            86533211  11223468889999988653 3578899999999999999999999864321100   000 00000000


Q ss_pred             hh------------ccccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 ED------------LGLQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~~------------~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..            ........    ......+.++.++|.+||+.||++||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00            00000000    011234667889999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=293.38  Aligned_cols=260  Identities=24%  Similarity=0.339  Sum_probs=194.4

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.++||.|++|.||+|.. .+++.||+|++....   ...+.+.+|++++++++|||++++++++.++...++++||++ 
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence            467899999999999985 468999999987543   223567899999999999999999999999999999999995 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....    ...+++..++.++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||++........
T Consensus        82 ~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          82 LDLKKYMDSSP----LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            69999987643    1468999999999999999999999   8999999999999999999999999999875532221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch-------hHHHHHHhhhhh
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF-------PHWVYKRLELEE  555 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~  555 (638)
                      .  .....++..|+|||++.+. ..++.++||||||+++|+|++|++||............       ............
T Consensus       155 ~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         155 T--YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             c--cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            1  1223468899999988653 25688999999999999999999998643221000000       000000000000


Q ss_pred             hc--cccCCC----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DL--GLQGIE----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~--~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..  ......    ......++.++.+++.+||+.+|++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00  000000    0111223467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=301.51  Aligned_cols=272  Identities=24%  Similarity=0.276  Sum_probs=197.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeC-----ceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEG-----HRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~  397 (638)
                      .+.++||+|+||.||+|+. .+++.||||++....  .....+.+|+.++++++|+||+++++++...     ...++|+
T Consensus         8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   87 (336)
T cd07849           8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ   87 (336)
T ss_pred             EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence            3568999999999999985 468899999986432  2335678899999999999999999987644     3578999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+.+ +|.+++..       ..+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++...
T Consensus        88 e~~~~-~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          88 ELMET-DLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             hhccc-CHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99964 88888764       358999999999999999999999   99999999999999999999999999998865


Q ss_pred             cCCCcee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc--------chhHHHH
Q 006620          478 EGRESIV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI--------YFPHWVY  548 (638)
Q Consensus       478 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~  548 (638)
                      ....... ......|++.|+|||.+.+. ..++.++||||+|+++|+|++|+.||..........        ..+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            4322111 11234578999999987543 357889999999999999999999986432110000        0000000


Q ss_pred             HHhhh-----hhhccccCCCC--chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhcccCCCCCC
Q 006620          549 KRLEL-----EEDLGLQGIEN--EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM--LEGSLDSLQIP  609 (638)
Q Consensus       549 ~~~~~-----~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~  609 (638)
                      .....     ...........  ......+.++.+++.+||+.+|++|||+.+++++  +++..+....|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence            00000     00000000000  0111235678899999999999999999999997  77766554443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.5e-34  Score=289.31  Aligned_cols=247  Identities=26%  Similarity=0.406  Sum_probs=196.6

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|+||.||++... ++..+|+|.+....   ...+.+.+|++++++++|+||+++++.+......++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            35688999999999999854 57899999986542   334567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-ceEEcccccceeccCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICEGR  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFg~~~~~~~~  480 (638)
                      +++|.+++....    ...+++..+..++.|+++||+|||+   .+++|+||||+||++++++ .+||+|||.+......
T Consensus        83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          83 GGDLMKRINRQR----GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999997643    2357999999999999999999999   8999999999999998875 4699999998866433


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ...  .....|++.|+|||++.+.  .++.++|+||||++++||++|+.||.....       .........        
T Consensus       156 ~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~--------  216 (257)
T cd08225         156 MEL--AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQ--------  216 (257)
T ss_pred             ccc--ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhc--------
Confidence            221  1234578899999988654  678899999999999999999999863321       111111110        


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ..........+.++.+++.+||+.+|++|||+++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         217 GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            01111122345678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.6e-34  Score=291.81  Aligned_cols=254  Identities=26%  Similarity=0.354  Sum_probs=191.3

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ..+.||+|+||.||++.. .+++.||+|.+....  .....+.+|+.++.++. |+||+++++++..+...+++|||+. 
T Consensus         8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-   86 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-   86 (288)
T ss_pred             HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence            357899999999999985 458899999986543  23456788999999996 9999999999999999999999985 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.++...... .....+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||++........
T Consensus        87 ~~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          87 ISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA  163 (288)
T ss_pred             CCHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence            466665432110 1125689999999999999999999971  4999999999999999999999999999876543321


Q ss_pred             eeeecccccccceecCceecccc-CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .   ....|+..|+|||++.+.. ..++.++||||||+++|||++|+.||.....      .    ..............
T Consensus       164 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~----~~~~~~~~~~~~~~  230 (288)
T cd06616         164 K---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------V----FDQLTQVVKGDPPI  230 (288)
T ss_pred             c---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------H----HHHHhhhcCCCCCc
Confidence            1   2235788999999986531 2578899999999999999999999864320      0    00000000000011


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ........++.++.+|+.+||+.+|++|||+++|++
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111122345678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=293.28  Aligned_cols=256  Identities=24%  Similarity=0.305  Sum_probs=194.9

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEEEEec
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~  400 (638)
                      +.++||+|++|.||+|+.. +++.+|+|++....   .....+.+|++++++++|+|++++++++...  ...++|+||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            4678999999999999865 47899999997652   2345688999999999999999999999888  8899999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++ +|.+++....     ..+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++......
T Consensus        83 ~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          83 DH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            75 8998887642     468999999999999999999999   89999999999999999999999999999876544


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh-------
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL-------  553 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  553 (638)
                      .. .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||.......   ... ........       
T Consensus       154 ~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~-~~~~~~~~~~~~~~~  227 (287)
T cd07840         154 NS-ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLE-KIFELCGSPTDENWP  227 (287)
T ss_pred             Cc-ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHH-HHHHHhCCCchhhcc
Confidence            31 112334567889999987654 357889999999999999999999986433210   000 00000000       


Q ss_pred             -------hhhcccc----CCCCchhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 -------EEDLGLQ----GIENEEDKE-YARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 -------~~~~~~~----~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                             .......    ......... .+.++.+++.+||+.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                   0000000    000001111 2667899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.6e-34  Score=288.24  Aligned_cols=241  Identities=24%  Similarity=0.318  Sum_probs=186.7

Q ss_pred             ccCcCcceeEEEEEE-cCCCEEEEEEecccCCc----hhhHHHHHH---HHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          330 KLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN----GEDFINEVA---SISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .||+|+||.||+++. .+++.||+|++......    ...+..|..   .++...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 45889999998653211    122344443   3444579999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||++.......
T Consensus        81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence            99999988754      468999999999999999999999   899999999999999999999999999987554322


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .    ....|+..|+|||.+.+. ..++.++||||+|+++|+|++|+.||.........     ..... ...       
T Consensus       152 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~~~~~-~~~-------  213 (278)
T cd05606         152 P----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRM-TLT-------  213 (278)
T ss_pred             C----cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----HHHHH-hhc-------
Confidence            1    234589999999998643 25788999999999999999999999754321111     00000 000       


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  597 (638)
                      .....+...+.++.+++.+||..+|++||     ++.++++
T Consensus       214 ~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            01111222366889999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.2e-34  Score=293.37  Aligned_cols=259  Identities=17%  Similarity=0.211  Sum_probs=192.2

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEeccc---CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      .+.+|.|+++.|+++.. +++.||||++...   ....+.+.+|++++++++|+||+++++++...+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455566655565554 6899999998754   2334678899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce-
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI-  483 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~-  483 (638)
                      |.+++....    ...+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||.+......... 
T Consensus        86 l~~~l~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          86 CEDLLKTHF----PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             HHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999998643    2458899999999999999999999   99999999999999999999999999988755322110 


Q ss_pred             ----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH---------
Q 006620          484 ----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR---------  550 (638)
Q Consensus       484 ----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  550 (638)
                          .......++..|+|||++.+....++.++||||||+++|||++|+.||........   ........         
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~  235 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM---LLEKVRGTVPCLLDKST  235 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCccccccCc
Confidence                01122346788999999876434578899999999999999999999975322100   00000000         


Q ss_pred             hh-----hhh-------hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          551 LE-----LEE-------DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       551 ~~-----~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..     ...       ..............+..++.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            00     000       000000111123345667889999999999999999999996

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-34  Score=286.06  Aligned_cols=244  Identities=23%  Similarity=0.282  Sum_probs=188.2

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHH-hhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASI-SRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.||+|++|.||+|.. .+++.||+|++.....    ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4699999999999985 4588999999865421    112344454443 445799999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.+||+|||++......  
T Consensus        82 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  150 (260)
T cd05611          82 GDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--  150 (260)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc--
Confidence            9999999764      358899999999999999999999   89999999999999999999999999998754331  


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                          ....+++.|+|||.+.+.  .++.++||||||+++|+|++|..||......       . ........ ...   .
T Consensus       151 ----~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~-~~~---~  212 (260)
T cd05611         151 ----KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------A-VFDNILSR-RIN---W  212 (260)
T ss_pred             ----ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhc-ccC---C
Confidence                223478899999998765  5789999999999999999999998643211       1 11111110 000   1


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      .......++.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            111122346778999999999999999988766655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-34  Score=288.80  Aligned_cols=245  Identities=26%  Similarity=0.354  Sum_probs=194.0

Q ss_pred             cCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          331 LGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       331 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ||+|+||.||+++.. +++.+++|++....    ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999975 48999999986543    2345788899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc---
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES---  482 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~---  482 (638)
                      .+++.+.      ..+++..+..++.|+++||+|||+   .+++|+||+|+||++++++.++|+|||++........   
T Consensus        81 ~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          81 ASLLENV------GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            9999864      368999999999999999999999   9999999999999999999999999999875433211   


Q ss_pred             ---eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          483 ---IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       483 ---~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                         ........++..|++||.+.+.  ..+.++||||||+++|+|++|+.||......       . .......      
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~------  215 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------E-IFQNILN------  215 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhc------
Confidence               1112334578899999998664  5788999999999999999999998643311       1 1111110      


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ...........+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       216 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         216 GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            00011111113677899999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.7e-34  Score=291.67  Aligned_cols=256  Identities=19%  Similarity=0.204  Sum_probs=181.1

Q ss_pred             hhhhcccCcCcceeEEEEEEcC----CCEEEEEEecccCCch------------hhHHHHHHHHhhcCCcceEEEEeEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKGNG------------EDFINEVASISRTSHVNIVTLLGFCF  388 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~------------~~~~~E~~~l~~l~h~niv~l~~~~~  388 (638)
                      +.+.++||+|+||+||+|...+    +..+|+|+........            .....+...+..+.|+|++++++++.
T Consensus        14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   93 (294)
T PHA02882         14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS   93 (294)
T ss_pred             eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence            4467899999999999998644    3466777643322111            11223344556678999999999766


Q ss_pred             eCc----eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC
Q 006620          389 EGH----RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF  464 (638)
Q Consensus       389 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~  464 (638)
                      ...    ..++++|++. .++.+.+...      ...++..+..|+.|+++||+|||+   ++|+||||||+|||++.++
T Consensus        94 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         94 FKRCRMYYRFILLEKLV-ENTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EecCCceEEEEEEehhc-cCHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence            543    3467788774 4777776653      235778899999999999999999   9999999999999999999


Q ss_pred             ceEEcccccceeccCCCce-----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc
Q 006620          465 CPKISDFGLAKICEGRESI-----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS  539 (638)
Q Consensus       465 ~~kl~DFg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~  539 (638)
                      .+||+|||+++........     .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            9999999999866432211     111224589999999998764  689999999999999999999999975532211


Q ss_pred             ccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          540 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ....  ....   ....+.....   .....++++.+++..|++.+|++||+++++++.|+
T Consensus       242 ~~~~--~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHA--AKCD---FIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHH--hHHH---HHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1100  0000   0000100000   11123567889999999999999999999998763

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.1e-34  Score=290.64  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=195.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||.|++|.||+|+.. +++.||||+++...  ...+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK   82 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence            34688999999999999964 58899999987543  2345677899999999999999999999999999999999975


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                       +|.+++....   ....+++..+..++.|+++||+|||+   .+++||||||+||++++++.++|+|||++........
T Consensus        83 -~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          83 -DLKKYMDTHG---VRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             -cHHHHHHhcC---CCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence             8999887643   12468999999999999999999999   9999999999999999999999999999875533211


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh-------HHHHHHhhhhh
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP-------HWVYKRLELEE  555 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~  555 (638)
                        ......++..|++||.+.+. ..++.++||||||+++|+|++|+.||.............       ....+.+....
T Consensus       156 --~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         156 --TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             --ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence              11233468899999988653 246889999999999999999999987543211000000       00000000000


Q ss_pred             hccc--cCCC----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGL--QGIE----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....  ....    .......+.++.+++.+||+.||++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000  0000    0011233567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-34  Score=296.16  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=189.4

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCc--------e
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGH--------R  392 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~  392 (638)
                      +.+.++||+|+||.||+|+. .+++.||||++.....   ....+.+|++++++++||||+++++++....        .
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            34568899999999999985 4688999998864321   2235578999999999999999999987654        4


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      .++||||+. ++|.+++....     ..+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          94 FYLVFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             EEEEEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCC
Confidence            599999996 48888886542     468999999999999999999999   899999999999999999999999999


Q ss_pred             cceeccCCCce--eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhH-----
Q 006620          473 LAKICEGRESI--VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH-----  545 (638)
Q Consensus       473 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-----  545 (638)
                      ++.........  .......++..|+|||.+.+. ..++.++||||||+++|||++|++||..............     
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99866432211  112234568899999988654 2467899999999999999999998864332100000000     


Q ss_pred             --HHHHHh---hhhhhccccCCC-CchhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          546 --WVYKRL---ELEEDLGLQGIE-NEEDK-----EYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       546 --~~~~~~---~~~~~~~~~~~~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ......   ............ .....     .....+.+++.+||+.||++|||++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence              000000   000000000000 00000     01345678999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.1e-34  Score=297.95  Aligned_cols=255  Identities=24%  Similarity=0.289  Sum_probs=191.9

Q ss_pred             hcccCcCcceeEEEEEEc-CCCEEEEEEecccCCch---------------hhHHHHHHHHhhcCCcceEEEEeEEEeCc
Q 006620          328 KNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNG---------------EDFINEVASISRTSHVNIVTLLGFCFEGH  391 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~h~niv~l~~~~~~~~  391 (638)
                      .+.||+|+||+||+|+.. +++.||||++.......               ..+.+|++++++++|+||+++++++..++
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            567999999999999854 58899999986532211               14678999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccc
Q 006620          392 RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF  471 (638)
Q Consensus       392 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF  471 (638)
                      ..++||||+. ++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+||
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCc
Confidence            9999999996 5999998753      458899999999999999999999   99999999999999999999999999


Q ss_pred             ccceeccCCC------------ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc
Q 006620          472 GLAKICEGRE------------SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS  539 (638)
Q Consensus       472 g~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~  539 (638)
                      |++.......            .........++..|+|||.+.+. ..++.++||||||+++|||++|++||........
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9998654111            01111223467889999998653 3568899999999999999999999875432110


Q ss_pred             ccchhHHHHHHhh--------hhhhcc----c-cCCC---CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          540 EIYFPHWVYKRLE--------LEEDLG----L-QGIE---NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       540 ~~~~~~~~~~~~~--------~~~~~~----~-~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                          .........        ....+.    . ....   .......+.++.+++.+||+.+|++|||+++++.
T Consensus       243 ----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 ----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             ----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence                000000000        000000    0 0000   0011123567889999999999999999999995

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=269.08  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=195.4

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +...||.|..|.||+++. ..|...|||.+....  .+.++++..+.++...+ .|.||+.+|+|..+....+.||.|. 
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence            356799999999999985 558899999997653  33456777888776665 8999999999999999999999984 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ..++.+++.-.     .++++..+-++...+++||.||.+  .++|+|||+||+|||+|+.|++||+|||++-.+.+...
T Consensus       175 ~C~ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  175 TCAEKLLKRIK-----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HHHHHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            47777777643     569999999999999999999998  47999999999999999999999999999987655443


Q ss_pred             eeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                         .....|-+.|||||-+... ...|.-++||||||+.++||.||..||..-..+     +.  +...+...+.   ..
T Consensus       248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe--~ltkvln~eP---P~  314 (391)
T KOG0983|consen  248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FE--VLTKVLNEEP---PL  314 (391)
T ss_pred             ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HH--HHHHHHhcCC---CC
Confidence               2345578899999999654 346788999999999999999999998753321     11  1111111111   11


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      + . ....++..+.+|+..||+.|+.+||...+++++
T Consensus       315 L-~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  315 L-P-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             C-C-cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            1 1 112267889999999999999999999999863

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=287.03  Aligned_cols=264  Identities=28%  Similarity=0.404  Sum_probs=201.7

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhh--cCCcceEEEEeEEEeCc----eEEEEEEec
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISR--TSHVNIVTLLGFCFEGH----RRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~  400 (638)
                      +.+.||+|.||.||||.+. ++.||||++...  +.+.|.+|-+++..  ++|+||+++++.-....    .+.||+||.
T Consensus       214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hHHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            5688999999999999984 599999999754  34677788777665  56999999999876554    788999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEecccCCCceEECCCCceEEcccccc
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG------CNTRILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~------~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      +.|+|.++|+.+       .++|....+|+..+++||+|||+.      +...|+|||||.+||||.+++...|+|||+|
T Consensus       291 ~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  291 PKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             cCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            999999999984       599999999999999999999983      4467999999999999999999999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCcc-----ccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHH--H
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS-----YKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW--V  547 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-----~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~--~  547 (638)
                      ..+..........+.+||.+|||||++.+.. .+.     .+.||||+|.+||||++.-..++.  +...+..++..  +
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgai-nl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~--~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI-NLQDRDAFKRIDVYAMGLVLWEIASRCTDADP--GPVPEYQLPFEAEV  440 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhc-ccccHHHHHHHHHHHHHHHHHHHHhhcccccC--CCCCcccCchhHHh
Confidence            9888766655566788999999999997752 222     368999999999999987655442  11222222211  1


Q ss_pred             HHH--hhhhhhcc-ccCCCCch-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          548 YKR--LELEEDLG-LQGIENEE-----DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       548 ~~~--~~~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      -..  +...+.+. .+..+...     .....+.+.+.+..||..||+-|.|+.-+-+.+.++.
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            000  00111111 11111111     1234567889999999999999999999999888753

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-34  Score=286.40  Aligned_cols=247  Identities=28%  Similarity=0.439  Sum_probs=199.6

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.++||+|++|.||++.. .+++.+++|.+....   .....+.+|++++++++|+||+++++++......++|+||++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            3567899999999999975 467899999987532   234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....  .....+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          83 FGDLSKAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             CCCHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999987642  122568999999999999999999999   999999999999999999999999999998765441


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                          .....+++.|+|||.+.+.  .++.++|+||||+++++|++|+.||......       ... ...       ...
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~-~~~-------~~~  216 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLR-YKV-------QRG  216 (256)
T ss_pred             ----cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH-HHH-------hcC
Confidence                1234578899999998664  6788999999999999999999998643211       000 000       011


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ...........++.+++.+||+.+|++||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1112223566789999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.6e-34  Score=297.70  Aligned_cols=263  Identities=23%  Similarity=0.267  Sum_probs=194.4

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEeccc---CCchhhHHHHHHHHhhcCCcceEEEEeEEEeC-----ceEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEG-----HRRALIY  397 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~  397 (638)
                      ..+.||+|+||+||+|+. .+++.||||.+...   ......+.+|+.+++.++|+||+++++++...     ...++|+
T Consensus         9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07858           9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY   88 (337)
T ss_pred             EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence            467899999999999985 46889999998653   22334677899999999999999999987654     3479999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+. ++|.+++...      ..+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        89 e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          89 ELMD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             eCCC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            9995 6899988754      468999999999999999999999   99999999999999999999999999999866


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch--------hHHHH-
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF--------PHWVY-  548 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~--------~~~~~-  548 (638)
                      .....  ......++..|+|||.+.+. ..++.++||||||+++|+|++|++||............        +.... 
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         159 SEKGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             CCCcc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            43321  11234568899999988643 25788999999999999999999998643211000000        00000 


Q ss_pred             ---HHh-hhhhhcccc-CC-CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 006620          549 ---KRL-ELEEDLGLQ-GI-ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM--LEGS  602 (638)
Q Consensus       549 ---~~~-~~~~~~~~~-~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  602 (638)
                         ... ......... .. ........+.++.+++.+||+.+|++|||+++++++  ++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               000 000000000 00 001112356778999999999999999999999987  6554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.1e-34  Score=289.93  Aligned_cols=251  Identities=23%  Similarity=0.285  Sum_probs=194.6

Q ss_pred             hhhcccCcCcceeEEEEEE----cCCCEEEEEEecccC-----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL----LDGQNVAIKVLNETK-----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      .+.+.||+|+||.||+++.    .+++.||+|++....     ...+.+.+|+++++++ +|+||+++++.+..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            3467899999999999975    368899999987532     2335678899999999 59999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      |+||+++++|.+++...      ..+++..+..++.|+++||+|||+   .+++||||+|+||+++.++.+||+|||++.
T Consensus        83 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          83 ILDYINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999764      457889999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ........ ......|+..|+|||.+.+....++.++||||||+++|+|++|+.||.......   ........ ...  
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~-~~~--  226 (290)
T cd05613         154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRR-ILK--  226 (290)
T ss_pred             eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHH-hhc--
Confidence            65433211 112345788999999986543356789999999999999999999986432111   01111111 000  


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                           . ....+......+.+++.+||+.+|++||     ++++++.+
T Consensus       227 -----~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 -----S-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -----c-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                 0 0111223456788999999999999997     67777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-35  Score=287.92  Aligned_cols=240  Identities=26%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      -++||+||||.||-++ ..+|+.||.|.+.+.+    ......++|-.+|.+++.+.||.+--.|.+.+.+++|+..|.|
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            5799999999999997 4569999999886532    2334678999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.-+|.+.+    ...+++..+..++.+|+-||++||+   .+||.||+||+|||+|+.|.++|+|+|+|..+...+.
T Consensus       270 GDLkfHiyn~g----~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  270 GDLKFHIYNHG----NPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             CceeEEeeccC----CCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            99999998764    2579999999999999999999999   9999999999999999999999999999999887764


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                         ..+.+||.+|||||++.+.  .|+...|.|||||++|||+.|+.||.........        +.+...    ....
T Consensus       343 ---~~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--------eEvdrr----~~~~  405 (591)
T KOG0986|consen  343 ---IRGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--------EEVDRR----TLED  405 (591)
T ss_pred             ---cccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--------HHHHHH----Hhcc
Confidence               3556899999999999876  6999999999999999999999999754321110        000000    0111


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCC
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPS  591 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs  591 (638)
                      ..+.+...++++.++....|+.||++|--
T Consensus       406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            12233567788899999999999999953

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-33  Score=282.72  Aligned_cols=248  Identities=25%  Similarity=0.424  Sum_probs=200.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||.|++|.||++... +++.+++|++....   .....+.+|++++++++|+|++++++.+......++|+|+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD   82 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence            34678999999999999864 58899999987543   334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....  .....+++..+..++.++++||+|||+   .+++|+||+|+||++++++.++|+|||.+.......
T Consensus        83 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          83 GGDLSQKIKKQK--KEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             CCcHHHHHHHhh--ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999998753  123679999999999999999999999   899999999999999999999999999998765443


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .  ......|++.|+|||.+.+.  .++.++|+||+|+++++|++|+.||.....       ......... .   ... 
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~-~---~~~-  221 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILK-G---QYP-  221 (258)
T ss_pred             c--eecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhc-C---CCC-
Confidence            1  12334578899999988654  678899999999999999999999864321       111111100 0   011 


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                         ..+.....++.+++.+||..+|++|||+.++++
T Consensus       222 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         222 ---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               111134567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-33  Score=290.93  Aligned_cols=244  Identities=26%  Similarity=0.373  Sum_probs=192.2

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ..+.||+|++|.||+|+.. +++.+|+|.+....    ....++.+|+++++.++|+|++++++++......++|+||+.
T Consensus        19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   98 (308)
T cd06634          19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL   98 (308)
T ss_pred             HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence            3567999999999999854 57889999886432    223467889999999999999999999999999999999996


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                       ++|.+++....     ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++...... 
T Consensus        99 -~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          99 -GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             -CCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence             58888776532     458899999999999999999999   89999999999999999999999999998765432 


Q ss_pred             ceeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                           ....+++.|+|||.+.+. .+.++.++||||||+++|+|++|+.|+......       ..... ..      ..
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~-~~------~~  229 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH-IA------QN  229 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHH-Hh------hc
Confidence                 223468899999997531 135788999999999999999999997543210       00000 00      01


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML  599 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  599 (638)
                      .........++..+.+++.+||+.+|++||++++++++-
T Consensus       230 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            111112234567788999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-35  Score=291.36  Aligned_cols=243  Identities=26%  Similarity=0.334  Sum_probs=200.5

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.||+|.||+||-|+ .++|+.||||++.+.+   ...+...+|+.+|+++.||.||.+.-.|++.+..++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            6899999999999998 4679999999997643   4446788999999999999999999999999999999999955 


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC---CCceEEcccccceeccCC
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICEGR  480 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFg~~~~~~~~  480 (638)
                      +..+.|-..    +.++|++.....++.||+.||+|||.   ++|+|.||||+|||+.+   -.++||+|||.|+.+...
T Consensus       648 DMLEMILSs----EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  648 DMLEMILSS----EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hHHHHHHHh----hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            665655543    23789999999999999999999999   99999999999999954   347999999999998765


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..   ....+|||.|+|||+++++  .|...-|+||+|||+|--++|.-||....+-.+.+.-              ...
T Consensus       721 sF---RrsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN--------------AaF  781 (888)
T KOG4236|consen  721 SF---RRSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN--------------AAF  781 (888)
T ss_pred             hh---hhhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccchhHHhhc--------------ccc
Confidence            43   3456799999999999876  7889999999999999999999999754432222111              112


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..+.....+++.+..+||...|++.-++|-|.+..+.
T Consensus       782 MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  782 MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            2334556677888999999999999999988876554

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.6e-33  Score=293.76  Aligned_cols=262  Identities=23%  Similarity=0.262  Sum_probs=192.8

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc---CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeC--ceEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET---KGNGEDFINEVASISRT-SHVNIVTLLGFCFEG--HRRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~lv~  397 (638)
                      +.+.+.||+|+||.||+|... +++.+|||++...   ......+.+|+.+++++ +||||+++++++...  ...++||
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            445788999999999999864 5789999988542   22335677899999999 999999999988653  4689999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||++ ++|.+++...       .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        89 e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          89 EYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             cccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9997 5999988652       57888899999999999999999   99999999999999999999999999999866


Q ss_pred             cCCCce---eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch-------hHHH
Q 006620          478 EGRESI---VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF-------PHWV  547 (638)
Q Consensus       478 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~  547 (638)
                      ......   .......|+..|+|||++.+. ..++.++||||||+++|+|++|+.||............       ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            433211   112234578999999988653 35788999999999999999999998643221000000       0000


Q ss_pred             HHHh--hhhhhc----ccc--CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 YKRL--ELEEDL----GLQ--GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 ~~~~--~~~~~~----~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ...+  .....+    ...  ..........+.++.+++.+||+.+|++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000  000000    000  00011112246678999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-35  Score=316.23  Aligned_cols=275  Identities=21%  Similarity=0.275  Sum_probs=212.7

Q ss_pred             hhhHHHHHHhcCCCCCcccchHHH--HHHHhhhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHH
Q 006620          297 YRNIEAFLRNYGSLAPKRYRYADI--KKMTNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEV  369 (638)
Q Consensus       297 ~~~~~~~l~~~~~~~~~~~~~~~i--~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~  369 (638)
                      .+++.+|+..+...   .-...++  +..-+.+.+.||+|+||.|..++. .+++.||+|++++.    .....-|.+|-
T Consensus        50 ~k~i~~fl~~~kp~---v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EER  126 (1317)
T KOG0612|consen   50 DKNIAEFLNRYKPI---VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREER  126 (1317)
T ss_pred             hhhHHHHHHHhHHH---HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHh
Confidence            45677777765421   1111111  122234578999999999999996 45889999999862    33445677888


Q ss_pred             HHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 006620          370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL  449 (638)
Q Consensus       370 ~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  449 (638)
                      .+|..-+.+-|+.++-.|.++.++|+||||++||+|-.++.+.      .++++..++.++..|+.||..||+   .|+|
T Consensus       127 Dimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~------~~~pE~~ArFY~aEiVlAldslH~---mgyV  197 (1317)
T KOG0612|consen  127 DIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF------DRLPEDWARFYTAEIVLALDSLHS---MGYV  197 (1317)
T ss_pred             HHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhc------CCChHHHHHHHHHHHHHHHHHHHh---ccce
Confidence            8888888999999999999999999999999999999999875      379999999999999999999999   9999


Q ss_pred             ecccCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccc--c-CCccccCCeeeHHHHHHHHhc
Q 006620          450 HFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN--F-GEVSYKSDVYSYGMMVFEMTG  526 (638)
Q Consensus       450 H~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~s~~~DvwslGvil~ellt  526 (638)
                      ||||||+|||+|..|.+||+|||.+-.+..+... .....+|||.|++||++...  . +.|...+|.||+||++|||+.
T Consensus       198 HRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly  276 (1317)
T KOG0612|consen  198 HRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY  276 (1317)
T ss_pred             eccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc
Confidence            9999999999999999999999999887755543 44678999999999999532  2 578999999999999999999


Q ss_pred             CCCCCCcccCCCcccchhHHHHHHhhhh-hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 006620          527 EKNNANVAVDRSSEIYFPHWVYKRLELE-EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS---MNRVVEM  598 (638)
Q Consensus       527 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  598 (638)
                      |..||....-        ...+.++... ..+.++     ...+++.++.+||.+.+. +|+.|-.   ++++-.+
T Consensus       277 G~TPFYadsl--------veTY~KIm~hk~~l~FP-----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  277 GETPFYADSL--------VETYGKIMNHKESLSFP-----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             CCCcchHHHH--------HHHHHHHhchhhhcCCC-----cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            9999974321        0111221111 111111     233477888899988887 8888987   8887764

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8e-34  Score=297.83  Aligned_cols=256  Identities=24%  Similarity=0.249  Sum_probs=190.5

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  395 (638)
                      ...+.||+|+||.||+|+. .+++.||||++....   .....+.+|+.++++++||||+++++++...      ...++
T Consensus        19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   98 (353)
T cd07850          19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL   98 (353)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence            3468899999999999985 468899999986432   2234677899999999999999999988643      35799


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+. ++|.+.+..        .+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++
T Consensus        99 v~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          99 VMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             EEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            999995 488888753        27888999999999999999999   899999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc--------ccchhHHH
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS--------EIYFPHWV  547 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~  547 (638)
                      .......   .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||........        ......+.
T Consensus       167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         167 TAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             eCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            6543321   2234578899999998764  688999999999999999999999864321100        00000000


Q ss_pred             HH-------Hhhhhhhc---c---------ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 YK-------RLELEEDL---G---------LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 ~~-------~~~~~~~~---~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ..       ........   .         ............+.++.+++.+||+.||++|||++|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00       00000000   0         0000000122345678899999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=287.42  Aligned_cols=258  Identities=22%  Similarity=0.293  Sum_probs=197.3

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ..+.||+|++|.||++... +++.+++|++.....   ....+.+|++++++++|+||+++++++..+...++|+||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            4578999999999999864 688999999875432   245778899999999999999999999999999999999975


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                       +|.+++....     ..+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||.+........
T Consensus        83 -~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          83 -DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             -CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence             8988887642     468999999999999999999999   9999999999999999999999999999987654431


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc--------chhHHHHHHhhh-
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI--------YFPHWVYKRLEL-  553 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~-  553 (638)
                        ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||........-.        ..+.. ...... 
T Consensus       154 --~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  229 (283)
T cd05118         154 --PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV-WPKFTSL  229 (283)
T ss_pred             --cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh-cccchhh
Confidence              12234578889999998653 367889999999999999999999886433210000        00000 000000 


Q ss_pred             --hhhcccc----CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 --EEDLGLQ----GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 --~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        .......    ..........+.++.+++.+||+.||++||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              0000000    0001123346778999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=282.99  Aligned_cols=246  Identities=23%  Similarity=0.271  Sum_probs=192.6

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC------CchhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK------GNGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  396 (638)
                      .+.+.||+|+||.||+|.. .+++.||+|++....      .....+.+|++++++++|+||+++++++.+.  ...+++
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF   84 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence            4578999999999999985 458899999875321      1234678899999999999999999998764  467899


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +||+++++|.+++...      ..+++..+..++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||+++.
T Consensus        85 ~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          85 VEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            9999999999999764      347889999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          477 CEGRES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       477 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ...... ........++..|+|||.+.+.  ..+.++|+||||+++|+|++|+.||.....      . .....      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~-~~~~~------  220 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEA------M-AAIFK------  220 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCH------H-HHHHH------
Confidence            532111 0111234578999999998764  678899999999999999999999864311      0 00000      


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       ..........+....+.+.+++.+||+ +|..||++.+++.
T Consensus       221 -~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 -IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence             001111122334566788999999999 5799999998886

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=281.46  Aligned_cols=244  Identities=26%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|++|.||++... +++.|++|.+.....   ..+.+.+|++++++++|+|++++++++.+....++++||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            35688999999999999854 578999999876542   44678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||.+.......
T Consensus        83 ~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          83 NGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999764      468999999999999999999999   999999999999999999999999999998765443


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ..  .....++..|+|||.+.+.  ..+.++|||++|+++++|++|+.|+.....      ..... . ...       .
T Consensus       154 ~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~-~-~~~-------~  214 (254)
T cd06627         154 KD--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALF-R-IVQ-------D  214 (254)
T ss_pred             cc--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHH-H-Hhc-------c
Confidence            21  2234578899999998664  478899999999999999999999864321      11110 0 000       0


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....+...+..+.+++.+||+.+|++|||+.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            111112234567889999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-34  Score=294.54  Aligned_cols=243  Identities=23%  Similarity=0.324  Sum_probs=201.0

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.||+|.|++|.+|++ .++..||||+++++..+   .+.+.+|+++|+.++|||||+++.+......+|+||||..+
T Consensus        60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence            468899999999999984 56899999999876433   34578999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |.+.+++.+++      +..+..+..+..|+.+|++|+|+   ++|+|||||++||||+.+.++||+|||++..+.....
T Consensus       140 ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  140 GELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             chhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccccc
Confidence            99999999874      56668889999999999999999   9999999999999999999999999999998874432


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                         .....|++.|.|||++.+. ....+++|+||+|+++|.|+.|..||+...-.....       +.+.  ..+..   
T Consensus       211 ---lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-------rvl~--gk~rI---  274 (596)
T KOG0586|consen  211 ---LQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-------RVLR--GKYRI---  274 (596)
T ss_pred             ---ccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccc-------hhee--eeecc---
Confidence               3556789999999999887 366889999999999999999999998644221110       0000  00001   


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                          +.-.+.+..++++++|-.+|.+|++++++.+.
T Consensus       275 ----p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  275 ----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ----cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                11124467789999999999999999998764

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.2e-34  Score=288.79  Aligned_cols=255  Identities=24%  Similarity=0.272  Sum_probs=197.5

Q ss_pred             hhhcccCcCcceeEEEEEE----cCCCEEEEEEecccC-----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL----LDGQNVAIKVLNETK-----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      .+.+.||+|++|.||+++.    .+++.||||+++...     ...+.+.+|+.++.++ +||||+++++.+..+...++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            3467899999999999874    246789999986432     2234678899999999 59999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++++|.+++...      ..+++..+..++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||+++
T Consensus        83 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          83 ILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999998754      458899999999999999999999   999999999999999999999999999987


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ......... .....|+..|+|||.+.+.....+.++||||||+++|||++|..||........   ..........   
T Consensus       154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~---  226 (288)
T cd05583         154 EFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSEISRRILK---  226 (288)
T ss_pred             ccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHHHHHHHHc---
Confidence            654332211 123457889999999866433468899999999999999999999864321110   1111111000   


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                         ..   ...+......+.+++.+||+.+|++|||++++.+.|+..
T Consensus       227 ---~~---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         227 ---SK---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ---cC---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence               00   111122445788999999999999999999888877663

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=279.89  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccCCch--------hhHHHHHHHHhhcCCcceEEEEeEEE-eCceEEEEE
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG--------EDFINEVASISRTSHVNIVTLLGFCF-EGHRRALIY  397 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  397 (638)
                      .+.||+|||+.||||. +...+.||+|+-...+.+.        +...+|.++.+.|.||.||++|+++. +.+.++-|+
T Consensus       468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL  547 (775)
T KOG1151|consen  468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL  547 (775)
T ss_pred             HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence            5689999999999998 4557889999875443322        34578999999999999999999996 556788999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC---CCCceEEcccccc
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLA  474 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFg~~  474 (638)
                      |||+|.+|.-+|+.+      +.+++..++.|+.||+.||.||.. ...+|||.||||.|||+-   .-|.+||+|||++
T Consensus       548 EYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  548 EYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             eecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            999999999999886      568999999999999999999997 346899999999999994   4578999999999


Q ss_pred             eeccCCCce-----eeecccccccceecCceecc--ccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHH
Q 006620          475 KICEGRESI-----VSMTGARGTIGYIAPEVFCR--NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWV  547 (638)
Q Consensus       475 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  547 (638)
                      +.+.++...     .......||.+|++||.+.-  ....++.|+||||+|||+|+-+.|+.||....... +       
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-d-------  692 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-D-------  692 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-H-------
Confidence            988755332     12334569999999998742  23468899999999999999999999997543211 1       


Q ss_pred             HHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        .+.....+....+.-.....++.+...||++||++.-++|.+..++..
T Consensus       693 --ILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  693 --ILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             --HHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence              111111121222222223345667889999999999999999988864

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-33  Score=288.96  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=191.7

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|++|+||+|... +++.||+|.+....   ...+.+.+|++++++++||||+++++++..+...++||||++
T Consensus         5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (294)
T PLN00009          5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD   84 (294)
T ss_pred             EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence            35688999999999999864 68899999986532   223567899999999999999999999999999999999995


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-CCceEEcccccceeccCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICEGR  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~~~~~~~  480 (638)
                       ++|.+++....    ...+++..+..++.||+.||+|||+   ++++|+||+|+||++++ ++.+||+|||++......
T Consensus        85 -~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         85 -LDLKKHMDSSP----DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             -ccHHHHHHhCC----CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence             58888886543    2346788899999999999999999   89999999999999985 567999999999765332


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh-----
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE-----  555 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  555 (638)
                      ..  ......+++.|+|||.+.+. ..++.++||||||+++|+|++|++||.......       ...+......     
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-------~~~~~~~~~~~~~~~  226 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-------ELFKIFRILGTPNEE  226 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHHhCCCChh
Confidence            11  11234568899999988653 357889999999999999999999986532210       0000000000     


Q ss_pred             ---------hcc--ccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 ---------DLG--LQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ---------~~~--~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                               +..  .......    .....+.++.+++.+||+.+|++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     000  0000000    11224567889999999999999999999996

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.4e-34  Score=291.11  Aligned_cols=259  Identities=23%  Similarity=0.302  Sum_probs=192.5

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc--------
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGH--------  391 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  391 (638)
                      .+.+.++||+|+||.||+|... +++.||+|+++...   .....+.+|++++++++||||+++++++.+..        
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            3445789999999999999964 58899999987542   22346778999999999999999999987654        


Q ss_pred             --eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEc
Q 006620          392 --RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS  469 (638)
Q Consensus       392 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  469 (638)
                        ..++|+||+++ +|.+++....     ..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence              78999999976 7877776532     468999999999999999999999   899999999999999999999999


Q ss_pred             ccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH
Q 006620          470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       470 DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      |||.+........ .......++..|+|||.+.+. ...+.++||||||++++||++|++||.......   .+.. ...
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~-~~~  232 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLEL-ISR  232 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHH-HHH
Confidence            9999986654321 111223457789999988643 246889999999999999999999986432110   0000 000


Q ss_pred             Hhhhh-----hhcc-------cc--C----CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLELE-----EDLG-------LQ--G----IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~~~-----~~~~-------~~--~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....     ..+.       ..  .    .........+..+.+++.+||+.+|++||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000     0000       00  0    000011123567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-33  Score=289.09  Aligned_cols=250  Identities=22%  Similarity=0.376  Sum_probs=191.7

Q ss_pred             hhhcccCcCcceeEEEEEEcC-CCEEEEEEecccC--CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETK--GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|++|.||+|...+ ++.||||+++...  .....+.+|+.++.+.. |+||+++++++.+....+++|||+.
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   97 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS   97 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence            357899999999999999754 8899999987543  23345677887776665 9999999999999999999999985


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                       ++|.+++....     ..+++..+..++.|++.||+|||+.  .+++||||+|+||++++++.+||+|||++.......
T Consensus        98 -~~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          98 -TCLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             -cCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence             58888876642     4689999999999999999999961  489999999999999999999999999987654332


Q ss_pred             ceeeecccccccceecCceecccc--CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ..   ....++..|+|||.+.+..  +.++.++||||||+++|+|++|+.||......     . ..........    .
T Consensus       170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~-~~~~~~~~~~----~  236 (296)
T cd06618         170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----F-EVLTKILQEE----P  236 (296)
T ss_pred             cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----H-HHHHHHhcCC----C
Confidence            21   2234688999999986542  34788999999999999999999998642211     0 0010111100    0


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ...  .....+..++.+++.+||+.||++||++++++++
T Consensus       237 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000  1111345678999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.7e-33  Score=281.95  Aligned_cols=234  Identities=21%  Similarity=0.250  Sum_probs=183.1

Q ss_pred             cCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccCCCHHHH
Q 006620          331 LGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF  408 (638)
Q Consensus       331 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~  408 (638)
                      ||+|+||.||+++. .+++.+|+|++........    |+.....+ +||||+++++.+...+..++||||+++++|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            69999999999985 4678899999865432211    22222222 699999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-ceEEcccccceeccCCCceeeec
Q 006620          409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICEGRESIVSMT  487 (638)
Q Consensus       409 l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFg~~~~~~~~~~~~~~~  487 (638)
                      +...      ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++ .++|+|||+++......      
T Consensus       100 l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------  164 (267)
T PHA03390        100 LKKE------GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------  164 (267)
T ss_pred             HHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------
Confidence            9764      368999999999999999999999   8999999999999999888 99999999988664332      


Q ss_pred             ccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchh
Q 006620          488 GARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEED  567 (638)
Q Consensus       488 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  567 (638)
                      ...++..|+|||++.+.  .++.++||||+|+++|||++|+.||......  ......+....          .......
T Consensus       165 ~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~----------~~~~~~~  230 (267)
T PHA03390        165 CYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLESLLKRQ----------QKKLPFI  230 (267)
T ss_pred             cCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHHHHHHhh----------cccCCcc
Confidence            23478999999999764  6788999999999999999999999743321  11111111111          0011122


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 006620          568 KEYARKMILVSLWCIQTNPSDRPS-MNRVVE  597 (638)
Q Consensus       568 ~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  597 (638)
                      ...+..+.+++.+||+.+|++||+ ++++++
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            245677899999999999999996 698884

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=287.57  Aligned_cols=259  Identities=23%  Similarity=0.348  Sum_probs=195.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc--hhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN--GEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|++|+||+|+.. +++.|+||.+......  .....+|+..+++++ |+|++++++++..+...++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            35678999999999999964 4788999998754332  234567999999999 999999999999999999999999 


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....    ...+++..+..++.|++++|.|||+   .+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          81 EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             CCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            789999987643    2468999999999999999999999   999999999999999999999999999998665432


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc---------chhHHHHHHhh
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI---------YFPHWVYKRLE  552 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~  552 (638)
                      .   .....++..|+|||.+.+. ..++.++|+||||++++||++|++||..........         ....|... ..
T Consensus       154 ~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  228 (283)
T cd07830         154 P---YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG-YK  228 (283)
T ss_pred             C---cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH-hh
Confidence            2   1234578899999988653 357889999999999999999999986543211000         00000000 00


Q ss_pred             hhhh--ccccCCCCch----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 LEED--LGLQGIENEE----DKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 ~~~~--~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....  ..........    ......++.+++.+||+.+|++|||++|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000  0000000000    0112467889999999999999999999986

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.9e-34  Score=313.34  Aligned_cols=246  Identities=28%  Similarity=0.413  Sum_probs=184.3

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeC--------------
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEG--------------  390 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------------  390 (638)
                      .+.||+||||.|||++. -||+.||||.+....  .....+.+|+..+.+|+|||||+++..+.+.              
T Consensus       484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~  563 (1351)
T KOG1035|consen  484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS  563 (1351)
T ss_pred             HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence            46899999999999984 589999999987653  3345788999999999999999998422100              


Q ss_pred             --------------------------------------------------------------------------------
Q 006620          391 --------------------------------------------------------------------------------  390 (638)
Q Consensus       391 --------------------------------------------------------------------------------  390 (638)
                                                                                                      
T Consensus       564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d  643 (1351)
T KOG1035|consen  564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD  643 (1351)
T ss_pred             hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence                                                                                            


Q ss_pred             -------------------------ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 006620          391 -------------------------HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN  445 (638)
Q Consensus       391 -------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~  445 (638)
                                               ..+||=||||+..+|.+++..+....     .....++++++|++||+|+|+   
T Consensus       644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-----~~d~~wrLFreIlEGLaYIH~---  715 (1351)
T KOG1035|consen  644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-----QRDEAWRLFREILEGLAYIHD---  715 (1351)
T ss_pred             cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-----hhHHHHHHHHHHHHHHHHHHh---
Confidence                                     12466799999988888888764211     357789999999999999999   


Q ss_pred             CCeEecccCCCceEECCCCceEEcccccceecc----------------CCCceeeecccccccceecCceeccccC-Cc
Q 006620          446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICE----------------GRESIVSMTGARGTIGYIAPEVFCRNFG-EV  508 (638)
Q Consensus       446 ~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~  508 (638)
                      .|||||||||.||+++++..|||+|||+|+...                ........++.+||--|+|||++.+... .|
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999998621                0011112456789999999999976532 68


Q ss_pred             cccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc--hhHHHHHHHHHHHHHcccCCC
Q 006620          509 SYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE--EDKEYARKMILVSLWCIQTNP  586 (638)
Q Consensus       509 s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP  586 (638)
                      +.|+|+||||++++||+.   ||.....+             ......++...++..  ........-..+|++|++.||
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMER-------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP  859 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMER-------------ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP  859 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHH-------------HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence            999999999999999983   45543321             111122221111111  122223345689999999999


Q ss_pred             CCCCCHHHHHH
Q 006620          587 SDRPSMNRVVE  597 (638)
Q Consensus       587 ~~RPs~~evl~  597 (638)
                      .+|||+.|+|.
T Consensus       860 ~kRPtA~eLL~  870 (1351)
T KOG1035|consen  860 SKRPTATELLN  870 (1351)
T ss_pred             ccCCCHHHHhh
Confidence            99999999985

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.7e-34  Score=295.27  Aligned_cols=261  Identities=22%  Similarity=0.282  Sum_probs=193.2

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe----CceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE----GHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  397 (638)
                      .+.+.||+|++|.||+|.. .+++.||+|++....   .....+.+|+.++++++||||+++++++..    ....++|+
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~   87 (334)
T cd07855           8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM   87 (334)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence            3467899999999999985 458899999987542   234567789999999999999999998763    35689999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+. ++|.+++...      ..+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||++...
T Consensus        88 e~~~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          88 DLME-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             ehhh-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9995 5899988754      358999999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCCce--eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchhHHH
Q 006620          478 EGRESI--VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFPHWV  547 (638)
Q Consensus       478 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~  547 (638)
                      ......  .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||........-        ...+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            433211  111234678899999998653 35788999999999999999999999654321000        0000000


Q ss_pred             H----HHhh-hhhhccc-cCCC-CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          548 Y----KRLE-LEEDLGL-QGIE-NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       548 ~----~~~~-~~~~~~~-~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .    .... ....... .... .......+.++.+++.+||+.+|++||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0    0000 0000000 0000 0011234678999999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.5e-33  Score=285.94  Aligned_cols=242  Identities=23%  Similarity=0.323  Sum_probs=191.9

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      .+||+|+||.||++.. .+++.||||++.... .....+.+|+.++++++|+|++++++.+..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999986 468899999886433 23456888999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeee
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM  486 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~  486 (638)
                      +++..       ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........  ..
T Consensus       106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~  173 (292)
T cd06657         106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR  173 (292)
T ss_pred             HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cc
Confidence            98754       347899999999999999999999   8999999999999999999999999999876543221  11


Q ss_pred             cccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCch
Q 006620          487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE  566 (638)
Q Consensus       487 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (638)
                      ....+++.|+|||.+.+.  .++.++|+||+|+++|+|++|..||......       .. .............     .
T Consensus       174 ~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~-~~~~~~~~~~~~~-----~  238 (292)
T cd06657         174 KSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KA-MKMIRDNLPPKLK-----N  238 (292)
T ss_pred             cccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HH-HHHHHhhCCcccC-----C
Confidence            234578899999988653  6788999999999999999999998642210       00 0001000000000     1


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       567 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....+..+.+++.+||+.+|.+||++.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            1223456788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=284.52  Aligned_cols=254  Identities=26%  Similarity=0.367  Sum_probs=191.7

Q ss_pred             hhcccCcCcceeEEEEEEcC-CCEEEEEEecccCC---chhhHHHHHHHHhhc---CCcceEEEEeEEEeCce-----EE
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKG---NGEDFINEVASISRT---SHVNIVTLLGFCFEGHR-----RA  394 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~~  394 (638)
                      +.+.||+|+||.||+|+... ++.||+|+++....   ....+.+|+.+++++   +|+|++++++++...+.     .+
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            46789999999999999754 88999999974322   223566788777666   59999999999988776     89


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccc
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      ++|||+.+ +|.+++....    ...+++..++.++.|+++||+|||+   .+++|+||+|+||+++.++.+||+|||.+
T Consensus        83 l~~e~~~~-~l~~~l~~~~----~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          83 LVFEHVDQ-DLATYLSKCP----KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             EEehhccc-CHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence            99999964 8999887643    1358999999999999999999999   89999999999999999999999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      .........   ....++..|+|||.+.+.  .++.++|+||||+++|||++|++||.......   ...... ......
T Consensus       155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~-~~~~~~  225 (287)
T cd07838         155 RIYSFEMAL---TSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIF-DVIGLP  225 (287)
T ss_pred             eeccCCccc---ccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHH-HHcCCC
Confidence            876443221   223468899999998764  67889999999999999999998886432210   000000 000000


Q ss_pred             hhc-----------cccC----CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 EDL-----------GLQG----IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~~~-----------~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...           ....    ............+.+++.+||+.||++||++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000           0000    001112345677889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.7e-33  Score=286.95  Aligned_cols=242  Identities=26%  Similarity=0.383  Sum_probs=190.7

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .++||+|+||+||+|+. .+++.|++|++.....    ....+.+|++++++++|||++++++++.+....++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            46799999999999985 4588999999864322    22467889999999999999999999999999999999996 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++......  
T Consensus       105 ~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         105 GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            58888876542     468999999999999999999999   89999999999999999999999999988643221  


Q ss_pred             eeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                          ....|+..|+|||++... .+.++.++||||||+++|+|++|+.|+......       ........       ..
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~-------~~  236 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQ-------ND  236 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHh-------cC
Confidence                234578899999998531 235788999999999999999999998644221       00001000       00


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ........++..+.+++.+||+.+|++||++.+++.+
T Consensus       237 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111122344568899999999999999999999953

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=299.54  Aligned_cols=200  Identities=28%  Similarity=0.449  Sum_probs=172.2

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEeccc--CCchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEEEEE
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNET--KGNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRALIYE  398 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  398 (638)
                      .+.||+||||.||+|+ ...|+.||||.++..  ....+...+|+++|++++|+|||+++++-.+.      +...+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            5789999999999999 556999999999874  34567789999999999999999999976653      35679999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC--CCC--ceEEcccccc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDF--CPKISDFGLA  474 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~--~~~--~~kl~DFg~~  474 (638)
                      ||.+|+|...|++-   +....|++...+.++..+..||.|||+   .||+||||||.||++-  ++|  .-||+|||.|
T Consensus        98 yC~gGsL~~~L~~P---EN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSP---ENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ecCCCcHHHHhcCc---ccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999863   334679999999999999999999999   9999999999999983  333  4699999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCC
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDR  537 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~  537 (638)
                      +.++++.   .....+||..|++||+.... +.++..+|.|||||++|+.+||..||-.....
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9988776   35667899999999999742 47889999999999999999999999765543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=279.91  Aligned_cols=267  Identities=18%  Similarity=0.247  Sum_probs=202.8

Q ss_pred             chHHHHHHHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcC--Cc----ceEEEEeEEE
Q 006620          316 RYADIKKMTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTS--HV----NIVTLLGFCF  388 (638)
Q Consensus       316 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~l~~~~~  388 (638)
                      ...++...++.+...+|+|.||.|-.+.+. .+..||||+++....-.++..-|+++++++.  .|    -+|.+.++|.
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            333444445556788999999999999853 3689999999887766778889999999995  23    3788889999


Q ss_pred             eCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-------
Q 006620          389 EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-------  461 (638)
Q Consensus       389 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-------  461 (638)
                      ..++.++|+|.+ |-|+.++|..+.    ..+++...++.|+.|+++++++||+   .+++|.||||+|||+.       
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~----y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENN----YIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCC----ccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEE
Confidence            999999999988 779999999864    4679999999999999999999999   9999999999999982       


Q ss_pred             -------------CCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCC
Q 006620          462 -------------EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK  528 (638)
Q Consensus       462 -------------~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~  528 (638)
                                   ++..++|+|||.|+......     ...+.|..|.|||++.+.  .++.++||||+||||+|+.||.
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccc
Confidence                         13458999999999766554     334568999999999987  7999999999999999999999


Q ss_pred             CCCCcccCCCccc-------chhHHHHHHh-hhh----hhcccc--------------CCC----CchhHHHHHHHHHHH
Q 006620          529 NNANVAVDRSSEI-------YFPHWVYKRL-ELE----EDLGLQ--------------GIE----NEEDKEYARKMILVS  578 (638)
Q Consensus       529 ~p~~~~~~~~~~~-------~~~~~~~~~~-~~~----~~~~~~--------------~~~----~~~~~~~~~~l~~li  578 (638)
                      ..|....+...-.       .+|.....+. ..+    ..+...              ..+    .........++.+|+
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            9988766422110       1111111111 000    001100              000    001122345689999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 006620          579 LWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       579 ~~cl~~dP~~RPs~~evl~  597 (638)
                      .+||..||.+|+|+.|++.
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999995

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.4e-33  Score=282.95  Aligned_cols=249  Identities=26%  Similarity=0.372  Sum_probs=193.0

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-CCEEEEEEecccC------CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETK------GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      |.+.++||+|+||.||+++... +..+++|+++...      .....+..|+.++++++||||+++++++.+....++|+
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            3457889999999999998643 4556666665321      22335667899999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++++|.+++....  .....+++..++.++.|+++||+|||+   .+++|+||+|+||+++. +.+||+|||.+...
T Consensus        82 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          82 EYCEGRDLDCKLEELK--HTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EeCCCCCHHHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence            9999999999987532  123568999999999999999999999   99999999999999975 56999999998876


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ......  .....|++.|+|||.+.+.  .++.++|+||||+++|+|++|..||.....       .... ...      
T Consensus       156 ~~~~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~-~~~------  217 (260)
T cd08222         156 MGSCDL--ATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVV-LRI------  217 (260)
T ss_pred             CCCccc--ccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHH-HHH------
Confidence            443221  2234578899999988653  577899999999999999999999853211       0111 000      


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       ........+..++.++.+++.+||+.+|++||++.+++++
T Consensus       218 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         218 -VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence             0111122234566788999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.8e-33  Score=285.07  Aligned_cols=245  Identities=25%  Similarity=0.378  Sum_probs=196.3

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|++|.||++... +++.||+|++....    ...+.+.+|++++++++ ||||+++++++..++..++|||+
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY   83 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence            45678999999999999854 68899999987532    22356788999999999 99999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++...      ..+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          84 APNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999875      369999999999999999999999   9999999999999999999999999999886543


Q ss_pred             CCce------------------eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc
Q 006620          480 RESI------------------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI  541 (638)
Q Consensus       480 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~  541 (638)
                      ....                  .......++..|+|||.+.+.  .++.++||||||+++++|++|+.||.....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----  227 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----  227 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccH-----
Confidence            3210                  112234578899999988654  678899999999999999999999874431     


Q ss_pred             chhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 006620          542 YFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM----NRVVE  597 (638)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  597 (638)
                         ........   ..     ....+..++..+.+++.+||+.+|++||++    +++++
T Consensus       228 ---~~~~~~~~---~~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 ---YLTFQKIL---KL-----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HHHHHHHH---hc-----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               00011111   00     011112335678899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=271.54  Aligned_cols=242  Identities=24%  Similarity=0.289  Sum_probs=197.6

Q ss_pred             hhcccCcCcceeEEEEE-EcCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      |.+.||+|.||+|.+++ ...++.||||++++.-    .....-+.|-++|+..+||.+..+--.|+..+++++||||..
T Consensus       172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan  251 (516)
T KOG0690|consen  172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN  251 (516)
T ss_pred             HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence            57899999999999998 4568999999998653    333455778899999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      ||.|.-+|.+.      ..++++..+.+..+|+.||.|||+   ++||.||||.+|.|+|++|.+||+|||+++.--...
T Consensus       252 GGeLf~HLsre------r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  252 GGELFFHLSRE------RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             CceEeeehhhh------hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            99999888764      568999999999999999999999   999999999999999999999999999998533222


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                        ......+|||.|+|||++..+  .|..++|.|.+||++|||+.|+.||...+.+.   .+.-      -...++.   
T Consensus       323 --~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeL------Il~ed~k---  386 (516)
T KOG0690|consen  323 --DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFEL------ILMEDLK---  386 (516)
T ss_pred             --ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH---HHHH------HHhhhcc---
Confidence              234567899999999999876  78999999999999999999999998654321   1111      1111222   


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  597 (638)
                          .+..++.+...|+...|..||.+|-     +++||.+
T Consensus       387 ----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  387 ----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence                2234456778888999999999994     4555554

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.3e-33  Score=290.93  Aligned_cols=262  Identities=22%  Similarity=0.292  Sum_probs=189.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCc--------eE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGH--------RR  393 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~~  393 (638)
                      .+.++||+|++|.||+|... +++.+|||++.....   ....+.+|++++++++||||+++++++....        ..
T Consensus        11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   90 (311)
T cd07866          11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV   90 (311)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence            35788999999999999854 588999998864321   2245678999999999999999999875433        46


Q ss_pred             EEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      ++|+||+.+ +|.+.+....     ..+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||+
T Consensus        91 ~lv~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          91 YMVTPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             EEEEecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence            899999965 7877776532     469999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCce---------eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh
Q 006620          474 AKICEGRESI---------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP  544 (638)
Q Consensus       474 ~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  544 (638)
                      +.........         .......+++.|+|||.+.+. ..++.++||||||+++|||++|++||.............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9765432211         111223567889999988653 357889999999999999999999986433211000000


Q ss_pred             -------HHHHHH---hhhhhh-ccccCCCCc---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          545 -------HWVYKR---LELEED-LGLQGIENE---EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       545 -------~~~~~~---~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                             ......   ...... .........   ........+.+++.+||+.||++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                   000000   000000 000000000   01123357889999999999999999999985

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-32  Score=286.57  Aligned_cols=261  Identities=24%  Similarity=0.240  Sum_probs=188.3

Q ss_pred             hhhcccCcCcceeEEEEEEc-C--CCEEEEEEecccC---CchhhHHHHHHHHhhcC-CcceEEEEeEEEeC----ceEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-D--GQNVAIKVLNETK---GNGEDFINEVASISRTS-HVNIVTLLGFCFEG----HRRA  394 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~----~~~~  394 (638)
                      .+.+.||+|+||.||+++.. .  ++.||+|++....   ...+.+.+|++++++++ ||||+++++.+...    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            35678999999999999854 3  6789999986432   22456788999999994 99999999875432    4567


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccc
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      +++|++. ++|.+++...      ..+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||++
T Consensus        83 ~~~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          83 LYEELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEeccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            8889885 6999998654      468999999999999999999999   99999999999999999999999999999


Q ss_pred             eeccCCCce--eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchh
Q 006620          475 KICEGRESI--VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFP  544 (638)
Q Consensus       475 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~  544 (638)
                      +........  .......||..|+|||++.+. ..++.++||||+|+++|+|++|++||........-        ....
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            865432211  111234689999999987653 35788999999999999999999998653311000        0000


Q ss_pred             HHHHHHhhhhh-hc--cccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          545 HWVYKRLELEE-DL--GLQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       545 ~~~~~~~~~~~-~~--~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ........... ..  .......    .........+.+++.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000000 00  0000000    000112457889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-33  Score=282.59  Aligned_cols=259  Identities=26%  Similarity=0.336  Sum_probs=195.4

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.++||+|++|.||+|+.. +++.+|+|++....   ...+.+..|++++++++|+|++++++++......++|+||++ 
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence            3568999999999999864 58999999987642   234567889999999999999999999999999999999997 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.+||+|||.++.......
T Consensus        82 ~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          82 MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            59999998753     468999999999999999999999   8999999999999999999999999999886543321


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch-------hHHHHHHhhhh-
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF-------PHWVYKRLELE-  554 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~-  554 (638)
                        ......++..|+|||.+.+. ..++.++||||||++++||++|++||............       ....+...... 
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             --ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence              12233457789999998653 36788999999999999999999998653311000000       00000000000 


Q ss_pred             -hhccccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 -EDLGLQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 -~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       ..........    .........+.+++.+||+.+|++||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             0000011000    111123567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-33  Score=287.39  Aligned_cols=261  Identities=23%  Similarity=0.252  Sum_probs=196.4

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc-----eEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGH-----RRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  396 (638)
                      .+.++||.|++|.||+|+.. +++.||||++....   ...+.+.+|+.++++++|+||+++++++....     ..+++
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            45688999999999999964 48899999987542   33467889999999999999999999988765     78999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||++ ++|.+++...      ..+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          83 TELME-TDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             ecchh-hhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99997 4899988754      368999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchhHHH
Q 006620          477 CEGRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFPHWV  547 (638)
Q Consensus       477 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~  547 (638)
                      ....... .......++..|+|||++.+. ..++.++|+||||+++|+|++|++||.........        ...+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            6544210 112334578899999999764 26788999999999999999999998654321000        0000000


Q ss_pred             HHHhhhh---hhccccCCC-----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 YKRLELE---EDLGLQGIE-----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 ~~~~~~~---~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       ......   .........     .......+.++.+++.+||+.+|++||++++++++
T Consensus       232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         232 -KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             -hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             000000   000000000     00111245678899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.6e-33  Score=286.72  Aligned_cols=255  Identities=25%  Similarity=0.284  Sum_probs=189.7

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe-CceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  401 (638)
                      +.+.||.|+||.||++.. .+++.||+|++....   ...+.+.+|++++++++||||+++++++.. ....++++||+ 
T Consensus        14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-   92 (328)
T cd07856          14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-   92 (328)
T ss_pred             EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence            468999999999999985 468899999875422   234567889999999999999999999875 56788999998 


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++..       ..+++..+..++.|+++||+|||+   .+++||||+|+||++++++.+||+|||.+.......
T Consensus        93 ~~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~  162 (328)
T cd07856          93 GTDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM  162 (328)
T ss_pred             ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence            5699988864       347888899999999999999999   999999999999999999999999999987543221


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc--------chhHHHHHH---
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI--------YFPHWVYKR---  550 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~---  550 (638)
                           ....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||..........        ....+....   
T Consensus       163 -----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         163 -----TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             -----CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence                 234568899999987542 357889999999999999999999986433210000        000000000   


Q ss_pred             --hhhhhhccccCC-C-CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          551 --LELEEDLGLQGI-E-NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       551 --~~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        ............ . .........++.+++.+||+.+|++||++++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              000000000000 0 00111235678999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-32  Score=286.76  Aligned_cols=255  Identities=22%  Similarity=0.261  Sum_probs=187.2

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRALI  396 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv  396 (638)
                      +.+.||+|+||.||+|.. .+++.||+|++....   ...+.+.+|++++++++||||+++++++...      ...+++
T Consensus        21 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv  100 (345)
T cd07877          21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV  100 (345)
T ss_pred             EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence            367899999999999984 568899999986532   2235678899999999999999999988643      336778


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      ++++ +++|.+++..       ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||++..
T Consensus       101 ~~~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~  169 (345)
T cd07877         101 THLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  169 (345)
T ss_pred             ehhc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence            8876 7899988764       348899999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccc-------hhHHHHH
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY-------FPHWVYK  549 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~~  549 (638)
                      .....     ....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...........       .+.....
T Consensus       170 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         170 TDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             ccccc-----cccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            53321     234578899999988653 3578899999999999999999999864322100000       0000000


Q ss_pred             Hhhhhh--h-c-cccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          550 RLELEE--D-L-GLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       550 ~~~~~~--~-~-~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .+....  . + ........    .......++.+++.+||+.||++||++.+++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000000  0 0 00000000    000124568899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-32  Score=287.52  Aligned_cols=253  Identities=24%  Similarity=0.273  Sum_probs=189.0

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCc------eEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGH------RRALI  396 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv  396 (638)
                      ..+.||+|+||.||++.. .+++.||||++.....   ....+.+|++++++++||||+++++++....      ..++|
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07880          19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV   98 (343)
T ss_pred             EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence            467899999999999984 4688999999864321   2346789999999999999999999987653      45899


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+ +++|.+++..       ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++..
T Consensus        99 ~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          99 MPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             EecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            9998 7799988864       358899999999999999999999   9999999999999999999999999999886


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchhHHHH
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFPHWVY  548 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~  548 (638)
                      .....     ....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||.........        .....+. 
T Consensus       168 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  240 (343)
T cd07880         168 TDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV-  240 (343)
T ss_pred             cccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH-
Confidence            54322     234568899999998653 25788999999999999999999998743221000        0000000 


Q ss_pred             HHhhhh---hh-ccccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          549 KRLELE---ED-LGLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       549 ~~~~~~---~~-~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..+...   .. .........    .......++.+++.+||+.||++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000   00 000000000    11123456889999999999999999999994

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-33  Score=243.74  Aligned_cols=257  Identities=21%  Similarity=0.299  Sum_probs=191.6

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .++||+|.||+|+||+ ..+++.||+|.++.+.   +.....++|+-+++.++|+|||++++....++.+.+|+||| ..
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence            3689999999999998 4558899999987543   33467899999999999999999999999999999999999 45


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|..+.....     +.++.+.++.++.|+++||.+.|+   +++.|||+||+|.|++.+|.+|++|||+++-+.-.-  
T Consensus        86 dlkkyfdsln-----g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   86 DLKKYFDSLN-----GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             HHHHHHHhcC-----CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence            9999988754     678999999999999999999999   999999999999999999999999999998664322  


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcC-CCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE-KNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .-+...+-|..|.+|.++-+. ..|+...|+||-|||+.|+... ++.|...+ ..++..--.+...............+
T Consensus       156 rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCCccccC
Confidence            123344568999999999875 5789999999999999999864 44444322 11111101111000000000000000


Q ss_pred             C----------CchhHH----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 E----------NEEDKE----YARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~----------~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      +          ......    ....=.+++.+.|.-+|.+|.++++.++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            0          001111    2223357888888999999999999885

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-32  Score=286.84  Aligned_cols=258  Identities=23%  Similarity=0.282  Sum_probs=188.3

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRALI  396 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv  396 (638)
                      ..+.||+|+||.||+|+. .+++.||||++....   .....+.+|+.++++++||||+++++++...      ...++|
T Consensus        19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   98 (342)
T cd07879          19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV   98 (342)
T ss_pred             EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence            357899999999999985 468899999986432   2234678999999999999999999988754      346899


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +||+.. +|.+++.        ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        99 ~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          99 MPYMQT-DLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eccccc-CHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            999964 7776642        348899999999999999999999   8999999999999999999999999999876


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchhHHHH
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFPHWVY  548 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~  548 (638)
                      .....     ....++..|+|||.+.+. ..++.++||||||+++|||++|+.||........-        ...+.+..
T Consensus       167 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         167 ADAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            53221     234568899999998653 25788999999999999999999999743210000        00000000


Q ss_pred             HHhhh--hhhcc-ccCCCCch----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 006620          549 KRLEL--EEDLG-LQGIENEE----DKEYARKMILVSLWCIQTNPSDRPSMNRVVEM--LEGS  602 (638)
Q Consensus       549 ~~~~~--~~~~~-~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  602 (638)
                      .....  ..... ........    ......++.+++.+||+.||++||++++++.+  ++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            00000  00000 00000000    01234568899999999999999999999964  5554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=289.41  Aligned_cols=236  Identities=22%  Similarity=0.296  Sum_probs=190.2

Q ss_pred             hhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+...+|.|+|+.|-.+. ..+++..++|++.+...+   ..+|+.++... +||||+++++.+.++.+.++|||.+.|
T Consensus       324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~---~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD---NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             hccccccCCCCccceeeeeccccccchhheeccccccc---cccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            3456779999999999987 456889999999876333   23566555444 599999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE-CCCCceEEcccccceeccCCC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL-DEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll-~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +-|.+.+...+       .....+..|+.+|+.|+.|||.   +|++||||||+|||+ ++.+.++|+|||.++..... 
T Consensus       401 ~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  401 GELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             cHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            98888887642       3336788899999999999999   999999999999999 69999999999999877654 


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                          ....+-|..|.|||++...  .++.++|+||||++||+||+|+.||......       ......+.      .  
T Consensus       470 ----~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~------~--  528 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQ------M--  528 (612)
T ss_pred             ----hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhc------C--
Confidence                2334458899999999854  8999999999999999999999998754432       00111111      1  


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ......++.++.+|+.+||++||.+||+|.++..
T Consensus       529 --~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 --PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              1111456788999999999999999999999985

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=272.89  Aligned_cols=235  Identities=28%  Similarity=0.315  Sum_probs=190.0

Q ss_pred             cCcCcceeEEEEEEc-CCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          331 LGQGGYGGVYKGKLL-DGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       331 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ||+|+||.||++... +++.+|+|++.....    ....+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999864 588999999875432    345788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++...      ..+++..+..++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 ~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (250)
T cd05123          81 FSHLSKE------GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R  149 (250)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence            9999865      358999999999999999999999   9999999999999999999999999999987654321  1


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....++..|+|||.+.+.  ..+.++|+||||+++|+|++|+.||.....       .... ..... ..       ..
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~-~~~~~-~~-------~~  211 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIY-EKILK-DP-------LR  211 (250)
T ss_pred             ccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHH-HHHhc-CC-------CC
Confidence            2334578899999998764  578899999999999999999999864321       1111 11111 00       11


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPSMNR  594 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e  594 (638)
                      .+...+.++.+++.+||..||++||++.+
T Consensus       212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         212 FPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            11122567889999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-32  Score=287.33  Aligned_cols=260  Identities=22%  Similarity=0.225  Sum_probs=187.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeC-------------
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEG-------------  390 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------------  390 (638)
                      .+.+.||.|+||.||+|.. .+++.||+|++.... ...+.+.+|++++++++||||+++++.+...             
T Consensus         8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (342)
T cd07854           8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE   87 (342)
T ss_pred             EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence            3568899999999999985 458899999886543 3345688999999999999999999776543             


Q ss_pred             -ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-CCCceEE
Q 006620          391 -HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKI  468 (638)
Q Consensus       391 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl  468 (638)
                       ...++|+||++ ++|.+++..       ..+++..++.++.|+++||.|||+   .+++||||||+||+++ +++.+||
T Consensus        88 ~~~~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          88 LNSVYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cceEEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence             35789999996 589888864       358899999999999999999999   9999999999999997 5667899


Q ss_pred             cccccceeccCCCcee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc-------
Q 006620          469 SDFGLAKICEGRESIV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE-------  540 (638)
Q Consensus       469 ~DFg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~-------  540 (638)
                      +|||.++......... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.........       
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998653321111 11223568899999987542 35788999999999999999999999644321000       


Q ss_pred             -cchhHHHHHHhhhh-hhcc--ccCCCC---chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          541 -IYFPHWVYKRLELE-EDLG--LQGIEN---EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       541 -~~~~~~~~~~~~~~-~~~~--~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       .............. ....  ......   ........++.+++.+||+.||++|||+++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence             00000000000000 0000  000000   011124567889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-33  Score=288.38  Aligned_cols=254  Identities=24%  Similarity=0.269  Sum_probs=190.1

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCce------EEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHR------RALI  396 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv  396 (638)
                      +.+.||+|++|.||+|+.. +++.||||++....   ...+.+.+|+.++++++|||++++++++...+.      .++|
T Consensus        19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07851          19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV   98 (343)
T ss_pred             EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence            4688999999999999864 57899999986432   233567789999999999999999998776554      8999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +||+ +++|.+++..       ..+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||++..
T Consensus        99 ~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          99 THLM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             EecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            9998 6799999875       358999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc--------ccchhHHHH
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS--------EIYFPHWVY  548 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~  548 (638)
                      ....     .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........        ....+.+..
T Consensus       168 ~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         168 TDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             cccc-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            5432     1334578899999998653 2578899999999999999999999864322100        000000000


Q ss_pred             HHhhh-----hhhccccCCC--CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          549 KRLEL-----EEDLGLQGIE--NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       549 ~~~~~-----~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      +....     ..........  .......+.++.+++.+||+.+|++|||+.+|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00000     0000000000  0001123667899999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.5e-32  Score=271.41  Aligned_cols=219  Identities=22%  Similarity=0.214  Sum_probs=174.5

Q ss_pred             CcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhc
Q 006620          334 GGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEK  412 (638)
Q Consensus       334 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  412 (638)
                      |.+|+||++++ .+++.||+|++....    .+.+|...+....||||+++++++......++||||+++++|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            89999999985 468899999987543    2234555555567999999999999999999999999999999999764


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeecccccc
Q 006620          413 HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT  492 (638)
Q Consensus       413 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt  492 (638)
                            ..+++..+..++.|+++||+|||+   ++++||||||+||+++.++.++++|||.+.......     ....++
T Consensus        80 ------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~  145 (237)
T cd05576          80 ------LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVE  145 (237)
T ss_pred             ------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcC
Confidence                  348999999999999999999999   999999999999999999999999999876554321     223457


Q ss_pred             cceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHH
Q 006620          493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR  572 (638)
Q Consensus       493 ~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (638)
                      ..|+|||.+.+.  .++.++||||+|+++|||++|+.|+.......             .....+       ..+..++.
T Consensus       146 ~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~~-------~~~~~~~~  203 (237)
T cd05576         146 NMYCAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTTL-------NIPEWVSE  203 (237)
T ss_pred             ccccCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------cccccc-------CCcccCCH
Confidence            789999998653  67889999999999999999998765321100             000000       11122456


Q ss_pred             HHHHHHHHcccCCCCCCCCH
Q 006620          573 KMILVSLWCIQTNPSDRPSM  592 (638)
Q Consensus       573 ~l~~li~~cl~~dP~~RPs~  592 (638)
                      .+.+++.+||+.||++||++
T Consensus       204 ~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         204 EARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHccCCHHHhcCC
Confidence            78899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-32  Score=288.98  Aligned_cols=250  Identities=27%  Similarity=0.399  Sum_probs=209.8

Q ss_pred             hhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEe-----CceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFE-----GHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-----~~~~~lv~e  398 (638)
                      .|.+.||.|.+|.||+++ .++++..|+|++.......+++..|.++++... |||++.++|++..     ++.++||||
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME  101 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME  101 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence            457899999999999998 567899999999888777788889999998875 9999999999874     578999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      ||.+||..|+++...    +.++.|+.+..|++.++.||.+||.   ..++|||||-.|||++.++.|||.|||.+..+.
T Consensus       102 fC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  102 FCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             ccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            999999999998753    5789999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCceeeecccccccceecCceecccc---CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNF---GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ...  .......|||.|||||++....   ..|+..+|+||||++..||.-|.+|+-.+..-..-+             .
T Consensus       175 sT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF-------------~  239 (953)
T KOG0587|consen  175 STV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------------L  239 (953)
T ss_pred             ccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-------------c
Confidence            332  2345678999999999996542   246779999999999999999999987665421110             1


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....+......+...++++.++|..||..|-+.||++.++++
T Consensus       240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            111223333456778999999999999999999999999885

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-32  Score=301.26  Aligned_cols=259  Identities=27%  Similarity=0.453  Sum_probs=207.2

Q ss_pred             hhcccCcCcceeEEEEEEcC--------CCEEEEEEecccCC--chhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLLD--------GQNVAIKVLNETKG--NGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  395 (638)
                      +.+.||+|.||.|++|....        ...||||.++....  +.+.+..|+++|+.+. |+||+.++|+|......++
T Consensus       300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~  379 (609)
T KOG0200|consen  300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV  379 (609)
T ss_pred             ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence            45699999999999997321        34799999986543  4568899999999986 9999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcC---CCCCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc
Q 006620          396 IYEFVSNGSLEKFIHEKH---PLETN-------QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC  465 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~---~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~  465 (638)
                      |+||+..|+|.++++..+   .....       ..++...++.++.|||.|++||++   ++++||||-.+|||+.++..
T Consensus       380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCCE
Confidence            999999999999999876   11111       248999999999999999999999   99999999999999999999


Q ss_pred             eEEcccccceeccCCCceeeeccc-ccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccch
Q 006620          466 PKISDFGLAKICEGRESIVSMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYF  543 (638)
Q Consensus       466 ~kl~DFg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  543 (638)
                      +||+|||+++.............. .-+..|||||.+...  .++.++||||||++||||++ |..|+....       .
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-------~  527 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGIP-------P  527 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCCC-------c
Confidence            999999999976655544322111 125569999999764  89999999999999999997 556665311       0


Q ss_pred             hHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          544 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ...+.+.+       .++.+.+.+.....++.++++.||+.+|++||++.++.+.++..+.
T Consensus       528 ~~~l~~~l-------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  528 TEELLEFL-------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHHHHHHH-------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            11111222       2344445555667889999999999999999999999999999543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=3.4e-34  Score=263.40  Aligned_cols=260  Identities=22%  Similarity=0.370  Sum_probs=193.6

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecc--c-CCchhhHHHHHHHHhhcCCcceEEEEeEEEe--------CceEEE
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNE--T-KGNGEDFINEVASISRTSHVNIVTLLGFCFE--------GHRRAL  395 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~--~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~~~l  395 (638)
                      ..+||+|.||.||+|+. ++++.||+|+.--  . .+-....++|+.+|+.++|+|++.++++|..        ...+|+
T Consensus        22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl  101 (376)
T KOG0669|consen   22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL  101 (376)
T ss_pred             HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence            56899999999999985 4577889886532  2 2334567899999999999999999988763        235899


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      |+++|+. +|.-+|....     .+++...+.+++.++.+||.|+|+   ..|+|||+||.|+|++.+|.+||+|||+++
T Consensus       102 Vf~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen  102 VFDFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             eHHHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            9999976 8988887643     678999999999999999999999   899999999999999999999999999997


Q ss_pred             eccCCCc--eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH----
Q 006620          476 ICEGRES--IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK----  549 (638)
Q Consensus       476 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----  549 (638)
                      .+.....  ...++..+-|..|++||.+.|. .+++++.|||.-||++.||.|+.+-+....... .+.+-.....    
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqq-ql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ-QLHLISQLCGSITK  250 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHH-HHHHHHHHhccCCc
Confidence            6643322  1223455569999999999886 589999999999999999999998776543211 1111100000    


Q ss_pred             -------HhhhhhhccccCCCCch---hHHHH------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          550 -------RLELEEDLGLQGIENEE---DKEYA------RKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       550 -------~~~~~~~~~~~~~~~~~---~~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                             .+...+.+..+.+....   ..+..      ++.++|+.++|..||.+|+++.+++.+
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                   01111112111111111   11112      267899999999999999999998864

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=7.3e-32  Score=303.41  Aligned_cols=141  Identities=26%  Similarity=0.411  Sum_probs=126.3

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.++||+|+||+||+|+.. +++.||||+++....    ....+.+|+.+++.++||||+++++.+......++||||+
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~   86 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL   86 (669)
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence            35689999999999999865 588999999875421    2356788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      .+++|.+++...      ..+++..++.|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          87 IGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999764      358889999999999999999999   899999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=6.9e-34  Score=263.57  Aligned_cols=252  Identities=24%  Similarity=0.331  Sum_probs=193.5

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      ..||.|+||+|+|-.+ ..|+..|||.++...  ....+++.|.+...+- +.||||++||....++..++-||.|+ .|
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence            5699999999999875 458999999997543  3445788888876554 58999999999999999999999994 48


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |..+.+.-... ....+++..+-.|..-.+.||.||..  +..|||||+||+|||++..|.+||+|||++-.+.+.-.  
T Consensus       149 lDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--  223 (361)
T KOG1006|consen  149 LDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--  223 (361)
T ss_pred             HHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence            87765543211 13579999999999999999999998  48899999999999999999999999999876543321  


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC-
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE-  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  563 (638)
                       .+...|-..|||||-+......|.-++||||||++|||+.||+-|+.....          +.+.+.+.-.-..+.+. 
T Consensus       224 -kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------vfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  224 -KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------VFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             -hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------HHHHHHHHHcCCCCeecC
Confidence             233446778999999977655688999999999999999999999765432          11111111000011111 


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....+++..+..+|..||..|-.+||...++.+
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1223457788999999999999999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=268.07  Aligned_cols=238  Identities=24%  Similarity=0.298  Sum_probs=192.5

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  397 (638)
                      -.+|...||+|+||+|.+|..+ +.+.||||+++++-    .+.+--+.|-++|.... -|.++.++.+|++-+++|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            3467889999999999999743 46789999998653    33444566777777665 578999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+.||+|--+|+..      +.+.+..+..++.+||-||-+||+   +|||.||||.+|||+|.+|.+||+|||+++.-
T Consensus       430 EyvnGGDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEecCchhhhHHHHh------cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999999876      457788899999999999999999   99999999999999999999999999999854


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      --...  ......|||.|+|||++.-  .+|+.++|.||+||+||||+.|.+||+..+...   .+     ..+..    
T Consensus       501 i~~~~--TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF-----~aI~e----  564 (683)
T KOG0696|consen  501 IFDGV--TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LF-----QAIME----  564 (683)
T ss_pred             ccCCc--ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HH-----HHHHH----
Confidence            32221  2355779999999999964  489999999999999999999999998765321   11     11111    


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRP  590 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  590 (638)
                          .....++..+++..+++...|...|.+|-
T Consensus       565 ----hnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  565 ----HNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ----ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence                11223455678889999999999999993

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=262.59  Aligned_cols=264  Identities=23%  Similarity=0.374  Sum_probs=196.3

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhh--cCCcceEEEEeEEEeC----ceEEEEEEec
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISR--TSHVNIVTLLGFCFEG----HRRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~  400 (638)
                      +.+.||+|.||.||+|++ .|+.||||++...  +...+.+|.++++.  |+|+||+.+++.-..+    ..++||.+|.
T Consensus       215 L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEEecCccccceeeccc-cCCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            367899999999999999 5899999999754  33567788888766  5899999999876543    3578999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG-----CNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      +.|||.|+|.++       .++.+..++++..+|.||++||.+     ....|.|||||..||||.+++...|+|+|+|-
T Consensus       292 e~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  292 EHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             cCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            999999999974       588999999999999999999972     33569999999999999999999999999997


Q ss_pred             eccCCCce--eeecccccccceecCceeccccC----CccccCCeeeHHHHHHHHhcC----------CCCCCcccCCCc
Q 006620          476 ICEGRESI--VSMTGARGTIGYIAPEVFCRNFG----EVSYKSDVYSYGMMVFEMTGE----------KNNANVAVDRSS  539 (638)
Q Consensus       476 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~----~~s~~~DvwslGvil~elltg----------~~p~~~~~~~~~  539 (638)
                      ........  ......+||.+|||||++.....    +--..+||||||+++||++..          ..||........
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            66544222  23355789999999999965321    111368999999999998732          245544433221


Q ss_pred             ccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          540 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      .  +.++ .+.+- .+.++-.........+....+.++++.||..+|.-|-|+-.+-+.|.++..
T Consensus       445 s--~eeM-rkVVC-v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  445 S--FEEM-RKVVC-VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             C--HHHH-hccee-ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            1  1111 11110 011111101111344567889999999999999999999999998887643

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.7e-32  Score=275.50  Aligned_cols=202  Identities=21%  Similarity=0.307  Sum_probs=169.8

Q ss_pred             hcccCcCcceeEEEEE-EcCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.||-|+||+|.+++ .++...||+|.+++..    .+...+..|-.||.....+-||+||-.|.+.+.+|+||||++|
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG  713 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG  713 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence            3579999999999997 4556789999987542    3345677899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc---C
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE---G  479 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~---~  479 (638)
                      |++-.+|-+.      +.+.++.++.++.++..|+++.|.   .|+|||||||+|||||.+|.+||+|||++.-+.   +
T Consensus       714 GDmMSLLIrm------gIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  714 GDMMSLLIRM------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             ccHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            9999998775      568899999999999999999999   999999999999999999999999999985321   1


Q ss_pred             CCce-------------------------------------eeecccccccceecCceeccccCCccccCCeeeHHHHHH
Q 006620          480 RESI-------------------------------------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF  522 (638)
Q Consensus       480 ~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~  522 (638)
                      ...+                                     ......+||+.|+|||++...  .++..+|.||.|||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHH
Confidence            0000                                     001234699999999999765  7899999999999999


Q ss_pred             HHhcCCCCCCcccCCCcc
Q 006620          523 EMTGEKNNANVAVDRSSE  540 (638)
Q Consensus       523 elltg~~p~~~~~~~~~~  540 (638)
                      ||+.|++||.........
T Consensus       863 em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             HHhhCCCCccCCCCCcce
Confidence            999999999866554333

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-33  Score=276.25  Aligned_cols=242  Identities=23%  Similarity=0.308  Sum_probs=200.0

Q ss_pred             hcccCcCcceeEEEEEEcCCC-EEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQ-NVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .-.||-||||.|=+++..... .+|+|++++.    ..+.+.+..|-++|...+.|.||++|..|.+++..|++||-|-|
T Consensus       425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG  504 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG  504 (732)
T ss_pred             hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence            356999999999998864433 4899988753    34556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |.|+..|...      +.++..+...++.-+++|++|||+   ++||.|||||+|++++.+|-+||.|||+|+.+.....
T Consensus       505 GElWTiLrdR------g~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  505 GELWTILRDR------GSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             chhhhhhhhc------CCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            9999999876      568888899999999999999999   9999999999999999999999999999999877664


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .   ...+|||.|.|||++.++  ....++|.||||+++|||++|++||...+.        ...+..+       ++++
T Consensus       576 T---wTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dp--------mktYn~I-------LkGi  635 (732)
T KOG0614|consen  576 T---WTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDP--------MKTYNLI-------LKGI  635 (732)
T ss_pred             e---eeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCch--------HHHHHHH-------Hhhh
Confidence            3   456789999999999876  567899999999999999999999986542        1111111       1111


Q ss_pred             C-CchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006620          563 E-NEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVEM  598 (638)
Q Consensus       563 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  598 (638)
                      . ...+..+.+...+++++..+.+|.+|--     +.+|-++
T Consensus       636 d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  636 DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            1 1234556778889999999999999965     6666655

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=253.94  Aligned_cols=243  Identities=22%  Similarity=0.328  Sum_probs=195.0

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEec
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.+.||+|+|++|..+++ ++.+.||+|++++.    ..+..=+..|-.+..+. +||.+|.++.+|.++.++++|.||+
T Consensus       254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv  333 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV  333 (593)
T ss_pred             eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence            468999999999999985 45788999998754    22333345566666554 5999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +||+|--++++.      +.++++.++.+..+|..||.|||+   +|||.||||.+|+|+|..|.+||+|+|+++.--..
T Consensus       334 ~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  334 NGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             cCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            999998888775      579999999999999999999999   99999999999999999999999999999864332


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..  ......|||.|+|||++.+.  .|...+|.|+|||+++||+.|+.||+.......+.....+....+... +++.+
T Consensus       405 gd--~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-qirip  479 (593)
T KOG0695|consen  405 GD--TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-QIRIP  479 (593)
T ss_pred             Cc--ccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-ccccc
Confidence            22  23567899999999999886  899999999999999999999999998766555555555555543322 22222


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCC
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRP  590 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  590 (638)
                      .       ..+-....+++.-|+.||.+|-
T Consensus       480 r-------slsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  480 R-------SLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             c-------eeehhhHHHHHHhhcCCcHHhc
Confidence            1       1233445677778899999984

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.3e-31  Score=243.18  Aligned_cols=255  Identities=20%  Similarity=0.328  Sum_probs=193.5

Q ss_pred             hhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeC--ceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEG--HRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~  400 (638)
                      +++.+++|+|.++.|+.|. ..+++.++||+++..+  .+.+.+|+.+|+.|. ||||++++++..+.  ....||+||+
T Consensus        40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v  117 (338)
T KOG0668|consen   40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV  117 (338)
T ss_pred             HHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence            4567899999999999998 5678899999998754  356789999999998 99999999998764  4567999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-CCceEEcccccceeccC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICEG  479 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~~~~~~  479 (638)
                      .+.+...+..         .++...+..++.|++.||.|+|+   .||.|||+||.|+++|. ..+++|+|||+|.....
T Consensus       118 ~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  118 NNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             ccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9988877654         36677789999999999999999   99999999999999985 55799999999999887


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch----------hHHHHH
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF----------PHWVYK  549 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~  549 (638)
                      ......   .+.+..|--||++..- ..+..+-|+|||||++..|+-.+.||-...+..++..-          ..++.+
T Consensus       186 ~~eYnV---RVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  186 GKEYNV---RVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             Cceeee---eeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            765433   3346677889999754 57888999999999999999999998655443222110          000000


Q ss_pred             -Hhhhhh---hcc-------ccCC-CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 -RLELEE---DLG-------LQGI-ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 -~~~~~~---~~~-------~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       .+....   ++.       .... ..+...-.+.++.+|+.+.|+.|-++|+|++|.+.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             000000   000       0001 11111223478899999999999999999999985

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=2e-30  Score=256.29  Aligned_cols=237  Identities=27%  Similarity=0.378  Sum_probs=190.4

Q ss_pred             cceeEEEEEEc-CCCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhh
Q 006620          335 GYGGVYKGKLL-DGQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE  411 (638)
Q Consensus       335 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  411 (638)
                      +||.||+|... +++.+++|++......  .+.+.+|++.+++++|+|++++++.+......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999975 4889999999765432  57889999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeeccccc
Q 006620          412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARG  491 (638)
Q Consensus       412 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~g  491 (638)
                      ..      .+++..++.++.+++++|.+||+   .+++|+||+|+||++++++.++|+|||.+.......   ......+
T Consensus        81 ~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~  148 (244)
T smart00220       81 RG------RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG  148 (244)
T ss_pred             cc------CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence            43      28899999999999999999999   899999999999999999999999999998765442   1234557


Q ss_pred             ccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHH
Q 006620          492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYA  571 (638)
Q Consensus       492 t~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  571 (638)
                      +..|++||.+.+.  .++.++|||+||+++++|++|..||......      ... .......     ..........+.
T Consensus       149 ~~~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~-~~~~~~~-----~~~~~~~~~~~~  214 (244)
T smart00220      149 TPEYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LEL-FKKIGKP-----KPPFPPPEWKIS  214 (244)
T ss_pred             CcCCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHH-HHHHhcc-----CCCCccccccCC
Confidence            8899999998653  6788999999999999999999998653110      011 1111000     000001111145


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          572 RKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       572 ~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .++.+++.+||..+|++||++.++++
T Consensus       215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      215 PEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHHccCCchhccCHHHHhh
Confidence            67899999999999999999999996

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=283.41  Aligned_cols=244  Identities=27%  Similarity=0.371  Sum_probs=185.7

Q ss_pred             hcccCcCccee-EEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          328 KNKLGQGGYGG-VYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       328 ~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ++.+|.|+.|+ ||+|.. +++.||||.+-....  .-..+|+..|+.-. |||||++++.-.+....|+..|.|. .+|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL  589 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL  589 (903)
T ss_pred             HHHcccCCCCcEEEEEee-CCceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence            46799999984 699988 689999998765432  34468999998885 9999999999999999999999995 599


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-----CCceEEcccccceeccCC
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICEGR  480 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFg~~~~~~~~  480 (638)
                      .|++.... .+ .........+.++.|+++||++||+   .+||||||||+||||+.     ..+++|+|||+++.+..+
T Consensus       590 ~dlie~~~-~d-~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  590 QDLIESSG-LD-VEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             HHHHhccc-cc-hhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            99998741 11 1111114467889999999999999   99999999999999965     257999999999988766


Q ss_pred             Cceee-ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcC-CCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          481 ESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE-KNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       481 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ..... ..+..||.+|+|||++...  ..+.++||+|+||++|..++| .+||.....+...+.         .-...  
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl---------~~~~~--  731 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL---------TGNYT--  731 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---------cCccc--
Confidence            54433 3566799999999999765  456799999999999998876 889976543321110         00000  


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      +-.+....  +.  ++.+||.+|+.++|..||++.+|+.
T Consensus       732 L~~L~~~~--d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  732 LVHLEPLP--DC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eeeeccCc--hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            11111111  11  7889999999999999999999984

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=4.6e-30  Score=274.60  Aligned_cols=265  Identities=20%  Similarity=0.190  Sum_probs=177.0

Q ss_pred             hhhcccCcCcceeEEEEEE-----------------cCCCEEEEEEecccCCc---------------hhhHHHHHHHHh
Q 006620          326 SFKNKLGQGGYGGVYKGKL-----------------LDGQNVAIKVLNETKGN---------------GEDFINEVASIS  373 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~  373 (638)
                      .+.++||+|+||+||+|..                 .+++.||||.++.....               .+....|+.++.
T Consensus       148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~  227 (507)
T PLN03224        148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA  227 (507)
T ss_pred             eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence            3478999999999999963                 23467999998643211               123345777777


Q ss_pred             hcCCcce-----EEEEeEEEe--------CceEEEEEEeccCCCHHHHhhhcCCC------------------CCCCCCC
Q 006620          374 RTSHVNI-----VTLLGFCFE--------GHRRALIYEFVSNGSLEKFIHEKHPL------------------ETNQKLK  422 (638)
Q Consensus       374 ~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~  422 (638)
                      +++|.++     ++++++|..        ....+|||||+++++|.++++.....                  .....++
T Consensus       228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~  307 (507)
T PLN03224        228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD  307 (507)
T ss_pred             HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence            7776654     667777653        35678999999999999999753210                  0112457


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceec
Q 006620          423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC  502 (638)
Q Consensus       423 ~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  502 (638)
                      +..++.++.|++++|+|||+   .+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||.+.
T Consensus       308 ~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        308 INVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELV  383 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhc
Confidence            78899999999999999999   899999999999999999999999999997654322111 11223478999999875


Q ss_pred             cccC--------------------CccccCCeeeHHHHHHHHhcCCC-CCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          503 RNFG--------------------EVSYKSDVYSYGMMVFEMTGEKN-NANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       503 ~~~~--------------------~~s~~~DvwslGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ....                    ....+.||||+||+++||+++.. |+.....-..+..........+...   ....
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~---~~~~  460 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY---KGQK  460 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh---cccC
Confidence            3210                    11235799999999999999874 5532211000000000000000000   0001


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNP---SDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~  597 (638)
                      .........+....+|+.++|..+|   .+|+|++|+++
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1111223346678899999999766   68999999996

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.6e-30  Score=285.35  Aligned_cols=263  Identities=20%  Similarity=0.217  Sum_probs=163.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-C----CCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeE------EEeCceEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-D----GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF------CFEGHRRA  394 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~~~~  394 (638)
                      .+.++||+|+||.||+|++. +    ++.||||++..... .+...+|  .+++..+.++..+...      .......+
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            45789999999999999864 4    68999998764321 1211221  1222222222222111      24566789


Q ss_pred             EEEEeccCCCHHHHhhhcCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE
Q 006620          395 LIYEFVSNGSLEKFIHEKHPL--------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL  460 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~--------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll  460 (638)
                      +|+||+.+++|.+++......              ..........+..++.|++.||+|||+   ++|+||||||+|||+
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl  288 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIF  288 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEE
Confidence            999999999999998754210              001112234567899999999999999   999999999999999


Q ss_pred             CC-CCceEEcccccceeccCCCceeeecccccccceecCceeccccC--------------------CccccCCeeeHHH
Q 006620          461 DE-DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG--------------------EVSYKSDVYSYGM  519 (638)
Q Consensus       461 ~~-~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~~~DvwslGv  519 (638)
                      +. ++.+||+|||+++.+....... .....+++.|+|||.+.....                    .++.++|||||||
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            85 6899999999998654332221 233567999999996632211                    2344679999999


Q ss_pred             HHHHHhcCCCCCCcccCC------CcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 006620          520 MVFEMTGEKNNANVAVDR------SSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMN  593 (638)
Q Consensus       520 il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  593 (638)
                      +||||+++..+.+.....      ........|.... .......... .............+|+.+||+.||++|||++
T Consensus       368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~  445 (566)
T PLN03225        368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-EPRASPDLRR-GFEVLDLDGGAGWELLKSMMRFKGRQRISAK  445 (566)
T ss_pred             HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-ccccchhhhh-hhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence            999999876553321100      0000011110000 0000000000 0000011123456899999999999999999


Q ss_pred             HHHH
Q 006620          594 RVVE  597 (638)
Q Consensus       594 evl~  597 (638)
                      ++++
T Consensus       446 e~L~  449 (566)
T PLN03225        446 AALA  449 (566)
T ss_pred             HHhC
Confidence            9996

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=253.46  Aligned_cols=153  Identities=25%  Similarity=0.388  Sum_probs=131.1

Q ss_pred             HHHHHhcCCCCCcccchHHHHH-HHhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcC--
Q 006620          301 EAFLRNYGSLAPKRYRYADIKK-MTNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTS--  376 (638)
Q Consensus       301 ~~~l~~~~~~~~~~~~~~~i~~-~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--  376 (638)
                      ++-.+.|...+.+..++.+..+ ..|.+.++||=|.|++||++.+ .+.+.||+|+.+....-.+..+.|+.+|++++  
T Consensus        55 qE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~  134 (590)
T KOG1290|consen   55 QEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG  134 (590)
T ss_pred             ccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence            3345566667788888888887 7888899999999999999984 56789999999876555677889999999985  


Q ss_pred             ---C---cceEEEEeEEEe----CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 006620          377 ---H---VNIVTLLGFCFE----GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT  446 (638)
Q Consensus       377 ---h---~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~  446 (638)
                         |   ..||+|++.|..    +.++++|+|++ |.+|..+|....    .+.++...+++|++||+.||.|||..  .
T Consensus       135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~----YrGlpl~~VK~I~~qvL~GLdYLH~e--c  207 (590)
T KOG1290|consen  135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN----YRGLPLSCVKEICRQVLTGLDYLHRE--C  207 (590)
T ss_pred             CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC----CCCCcHHHHHHHHHHHHHHHHHHHHh--c
Confidence               2   369999999974    56899999999 789999998754    46799999999999999999999994  7


Q ss_pred             CeEecccCCCceEE
Q 006620          447 RILHFDIKPHNILL  460 (638)
Q Consensus       447 ~iiH~Dikp~NIll  460 (638)
                      ||||.||||+|||+
T Consensus       208 gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  208 GIIHTDLKPENVLL  221 (590)
T ss_pred             CccccCCCcceeee
Confidence            99999999999999

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=6.5e-30  Score=248.80  Aligned_cols=256  Identities=20%  Similarity=0.281  Sum_probs=203.9

Q ss_pred             hcccCcCcceeEEEEEEcC------CCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeC-ceEEEEEE
Q 006620          328 KNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEG-HRRALIYE  398 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  398 (638)
                      +..+-+|.||.||.|.+.+      .+.|.+|.++.....  ...++.|--.+..+.|||++.+.+++.++ ...++++.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            5678899999999996543      346778887765544  35788899999999999999999998764 55678899


Q ss_pred             eccCCCHHHHhhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          399 FVSNGSLEKFIHEKHPL--ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      ++.-|+|..+|..-+..  .....++-.++..++.|++.|++|||+   .++||.||..+|.++|+..++||+|=.+++.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence            99999999999843321  223457788889999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      +-..+..-.-.....+..||+||.+..+  .++.++|||||||+||||+| |+.|+-..+..        .+.       
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeIDPf--------Em~-------  508 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--------EME-------  508 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccCHH--------HHH-------
Confidence            6555443333334457889999999876  89999999999999999886 66676533321        111       


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      ....++.+..++.++++++..++.-||+..|++||+.+|++.-|...-
T Consensus       509 ~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  509 HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            112345556677788999999999999999999999999999887653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=226.71  Aligned_cols=200  Identities=31%  Similarity=0.400  Sum_probs=165.4

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      ...||+|++|.|=+-++ .+|+..|+|.+...-.  .....++|+.+..+. ..|.+|.++|.........+.||.|. .
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence            46799999999988874 5789999999876533  345678888886665 59999999999999999999999995 4


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      ||..+.++-  +..+..+++..+-+|+..++.||.|||+  ...+||||+||+|||++.+|+||++|||++-.+.+.-. 
T Consensus       130 Sldkfy~~v--~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-  204 (282)
T KOG0984|consen  130 SLDKFYRKV--LKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-  204 (282)
T ss_pred             hHHHHHHHH--HhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-
Confidence            888877653  2445789999999999999999999999  47899999999999999999999999999987754432 


Q ss_pred             eeecccccccceecCceecccc--CCccccCCeeeHHHHHHHHhcCCCCCCccc
Q 006620          484 VSMTGARGTIGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEMTGEKNNANVAV  535 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslGvil~elltg~~p~~~~~  535 (638)
                        .+...|-..|+|||.+....  ..|+-++||||||+.+.||.+++.|++...
T Consensus       205 --kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  205 --KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             --HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence              12234566899999985432  258889999999999999999999988654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=6e-30  Score=257.04  Aligned_cols=274  Identities=20%  Similarity=0.258  Sum_probs=207.4

Q ss_pred             CCcccchHHHHHHHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcC------CcceEEE
Q 006620          311 APKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTS------HVNIVTL  383 (638)
Q Consensus       311 ~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l  383 (638)
                      +..++.+.|+-...|.+....|+|-|++|..|.+. .++.||||++....--...=+.|+++|++|+      .-|.+++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            44566777777777778888999999999999854 4789999999865433345578999999997      2478999


Q ss_pred             EeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-
Q 006620          384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-  462 (638)
Q Consensus       384 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-  462 (638)
                      +-.|....+++||+|.+ .-+|.++|++.+   ....|....+..++.|+.-||..|..   .||+|.||||+||||++ 
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG---~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYG---RNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhC---cccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccC
Confidence            99999999999999988 459999999864   23557788899999999999999999   99999999999999985 


Q ss_pred             CCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--
Q 006620          463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--  540 (638)
Q Consensus       463 ~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--  540 (638)
                      ...+||+|||.|......+.    +...-+..|.|||++.|.  .|....|+||+||.||||.||+-.|.........  
T Consensus       573 k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl  646 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL  646 (752)
T ss_pred             cceeeeccCccccccccccc----cHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence            45689999999987665442    222235679999999987  7899999999999999999999877654332110  


Q ss_pred             -----cchhHHHHHHhhhh-------------------------------------hhccccCCCCchhHHHHHHHHHHH
Q 006620          541 -----IYFPHWVYKRLELE-------------------------------------EDLGLQGIENEEDKEYARKMILVS  578 (638)
Q Consensus       541 -----~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~~~~~l~~li  578 (638)
                           ..+|.-+.....+.                                     ..+....-...........+.+|+
T Consensus       647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL  726 (752)
T KOG0670|consen  647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL  726 (752)
T ss_pred             HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence                 00111110000000                                     001011111223345677899999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 006620          579 LWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       579 ~~cl~~dP~~RPs~~evl~  597 (638)
                      ..||..||++|.|..+.|+
T Consensus       727 dkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  727 DKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHhccChhhcCCHHHHhc
Confidence            9999999999999999985

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=234.84  Aligned_cols=290  Identities=19%  Similarity=0.253  Sum_probs=215.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeE-EEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGF-CFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~lv~e~~~  401 (638)
                      +.+.+.||+|.||.+-+++++ .++.+++|-+........+|.+|...--.|. |.||+.-|+. |+..+..++++||++
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP  105 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence            445788999999999999864 4778999998877777789999987755555 8999998864 566677788999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE--CCCCceEEcccccceeccC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll--~~~~~~kl~DFg~~~~~~~  479 (638)
                      .|+|.+-+...       .+.+....+++.|+++||.|||+   +++||||||.+|||+  .+..++||+|||+.+....
T Consensus       106 ~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  106 RGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            99999887653       47888899999999999999999   999999999999998  2455899999999875432


Q ss_pred             CCceeeecccccccceecCceecccc---CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNF---GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      .-     .....+..|.+||+.....   -...+.+|||.||++++..+||..||....  ..+.  +.|.+..+.....
T Consensus       176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~--~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDK--PYWEWEQWLKRKN  246 (378)
T ss_pred             ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCc--hHHHHHHHhcccC
Confidence            21     1122366799999874321   135678999999999999999999998322  2222  2233333332221


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc--CCCCCCCCCcccCCCCCCCCCeeEEeecccc
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL--DSLQIPPRPFLLSSGSQPDFSSILVRQTESS  634 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  634 (638)
                      ...+    ......+..+..+-++-|..+|++|--+.++.++-+...  ..+..-.+|-........+.|.++.+|++++
T Consensus       247 ~~~P----~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~d~~S~iysrq~~~~  322 (378)
T KOG1345|consen  247 PALP----KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNIDTASKIYSRQTATS  322 (378)
T ss_pred             ccCc----hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhccccccCCcchhhhcCcCcC
Confidence            1111    112234556677778889999999977777776665533  2455567777888888889999999999988


Q ss_pred             ccc
Q 006620          635 MAT  637 (638)
Q Consensus       635 ~~~  637 (638)
                      .+.
T Consensus       323 ~sg  325 (378)
T KOG1345|consen  323 SSG  325 (378)
T ss_pred             CCC
Confidence            653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=8.4e-28  Score=231.69  Aligned_cols=210  Identities=35%  Similarity=0.612  Sum_probs=182.4

Q ss_pred             cCcCcceeEEEEEEcC-CCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHHH
Q 006620          331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK  407 (638)
Q Consensus       331 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  407 (638)
                      ||+|++|.||++...+ ++.+++|++......  .+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 889999999866542  5678999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-CCceEEcccccceeccCCCceeee
Q 006620          408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICEGRESIVSM  486 (638)
Q Consensus       408 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~~~~~~~~~~~~~  486 (638)
                      ++....     ..+++..+..++.+++++|++||+   .+++|+||+|.||+++. ++.++|+|||.+........  ..
T Consensus        81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~  150 (215)
T cd00180          81 LLKENE-----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL  150 (215)
T ss_pred             HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence            998642     358899999999999999999999   89999999999999998 89999999999987654421  11


Q ss_pred             cccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCch
Q 006620          487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE  566 (638)
Q Consensus       487 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (638)
                      ....+...|++||.+... ...+.+.|+|++|+++++|                                          
T Consensus       151 ~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            234467899999998653 2567899999999999999                                          


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       567 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                           ..+.+++.+|++.+|++||++.++++.
T Consensus       188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                 367889999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=242.67  Aligned_cols=262  Identities=24%  Similarity=0.299  Sum_probs=192.3

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc-----eEEEEEE
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGH-----RRALIYE  398 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e  398 (638)
                      .+-||.|+||.||.+.+ ++|+.||+|.+....   ...+.+.+|+.+|.-.+|.|++..+++.....     ..|++.|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            57899999999999984 569999999876432   22467899999999999999999998776432     3567888


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      .|.. +|.+.|-.-      ..++.+.++-++.||++||+|||+   .+|.||||||.|.|++++-.+||+|||+++..+
T Consensus       138 LmQS-DLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  138 LMQS-DLHKIIVSP------QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHh-hhhheeccC------CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccc
Confidence            8854 888887653      568888899999999999999999   999999999999999999999999999999876


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccc---------hhHHHHH
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY---------FPHWVYK  549 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~---------~~~~~~~  549 (638)
                      ..+... ++..+-|..|+|||++.|. ..|+.+.||||+|||+.||+..+-.|.....-..-..         ...+...
T Consensus       208 ~d~~~h-MTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  208 QRDRLN-MTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             hhhhhh-hHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            554332 3344558899999999986 5799999999999999999988877654332110000         0000000


Q ss_pred             Hhhhhhh-cc-------ccCCC-CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          550 RLELEED-LG-------LQGIE-NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       550 ~~~~~~~-~~-------~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      -...... ++       .+.+- .....+...+...+..+++..||.+|.+.++.+.++--
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            0000000 00       00000 01112233456778889999999999999999887643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=256.26  Aligned_cols=191  Identities=25%  Similarity=0.333  Sum_probs=166.0

Q ss_pred             hcccCcCcceeEEEEEEcC-CCEEEEEEecccCCc---------hhhHHHHHHHHhhcC---CcceEEEEeEEEeCceEE
Q 006620          328 KNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGN---------GEDFINEVASISRTS---HVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  394 (638)
                      .+.+|+|+||.|+.|.++. ...|+||.+.+.+--         ...+-.|+++|..++   |+||+|++++|++++.+|
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            4689999999999998654 568999998765421         224556999999998   999999999999999999


Q ss_pred             EEEEec-cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          395 LIYEFV-SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       395 lv~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      |+||-- ++.+|.++|...      ..+++.++..|..|++.|+++||+   .+|||||||-+|+.++.+|-+||+|||.
T Consensus       646 l~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             EEecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence            999964 577999999875      568999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCC
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNAN  532 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~  532 (638)
                      +.......    +...+||..|.|||++.|. ......-|||++|++||.++..+.||.
T Consensus       717 aa~~ksgp----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSGP----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCCC----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            98776554    4567899999999999886 345778899999999999999988875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=8.6e-28  Score=237.80  Aligned_cols=257  Identities=22%  Similarity=0.339  Sum_probs=191.2

Q ss_pred             hhcccCcCcceeEEEEEEc----CCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ..++||+|.|++||++.+.    ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++..++...+|+||++
T Consensus        40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~  118 (418)
T KOG1167|consen   40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE  118 (418)
T ss_pred             hhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence            3689999999999999743    35689999887653 3356889999999997 9999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-CCCceEEcccccceeccCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFg~~~~~~~~  480 (638)
                      .....+++..         ++...+..+++.++.||+++|.   .|||||||||.|+|.+ ..++-.|.|||+|......
T Consensus       119 H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  119 HDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             ccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            9999998865         5678899999999999999999   9999999999999997 5667899999998721100


Q ss_pred             C-------------c-----------------------------eeeecccccccceecCceeccccCCccccCCeeeHH
Q 006620          481 E-------------S-----------------------------IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYG  518 (638)
Q Consensus       481 ~-------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG  518 (638)
                      +             .                             ........||++|.|||++... +..++++||||.|
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~G  265 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeecc
Confidence            0             0                             0011234599999999999764 5678899999999


Q ss_pred             HHHHHHhcCCCCCCcccCCCcccch------hHHHHHH-hhhhh--------------------hccccC---------C
Q 006620          519 MMVFEMTGEKNNANVAVDRSSEIYF------PHWVYKR-LELEE--------------------DLGLQG---------I  562 (638)
Q Consensus       519 vil~elltg~~p~~~~~~~~~~~~~------~~~~~~~-~~~~~--------------------~~~~~~---------~  562 (638)
                      ||++.+++++.||-...+....+.-      ...+.+. ...+.                    .+....         .
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            9999999999998654442211100      0000000 00000                    000000         0


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ........+..+++++.+||+.||.+|.|+++.|+
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            01111223447889999999999999999999996

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-28  Score=252.40  Aligned_cols=249  Identities=24%  Similarity=0.362  Sum_probs=198.7

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +..++|+|.||.|||+++ ..++..|+|+++.... +..-...|+-+++..+||||+.++|.+.......+.||||.+|+
T Consensus        19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs   98 (829)
T KOG0576|consen   19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS   98 (829)
T ss_pred             heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence            467899999999999995 4588999999986643 33455678889999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |++..+-.      ..+++.++....++.+.+|+|||+   .+=+|||||-.||++++.|.+|++|||.+..+..  +..
T Consensus        99 lQdiy~~T------gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~  167 (829)
T KOG0576|consen   99 LQDIYHVT------GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA  167 (829)
T ss_pred             ccceeeec------ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence            99987764      679999999999999999999999   8999999999999999999999999999876643  233


Q ss_pred             eecccccccceecCcee-ccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~-~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......||+.|||||+- ..+.+.|..++|||++|+...|+-.-.+|......           .+.+.....-..+...
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----------mr~l~LmTkS~~qpp~  236 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----------MRALFLMTKSGFQPPT  236 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----------HHHHHHhhccCCCCCc
Confidence            44667899999999976 23335788999999999999998776666432111           0111111111122222


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..........+-+|++.+|..+|.+||+++.+++
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            2334456777889999999999999999998875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=228.23  Aligned_cols=252  Identities=24%  Similarity=0.231  Sum_probs=183.3

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEEEEE
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRALIYE  398 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  398 (638)
                      ..+|.|.- .|..+.+ -.++.||+|.+....   ...+...+|+..+..++|+||++++.++...      ...|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            45777877 5555542 357899999875432   2235667899999999999999999988743      35689999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      +|. .+|...+..        .++-+++..|..|++.|++|||+   .||+||||||+||++..+..+||.|||+++...
T Consensus       102 ~m~-~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen  102 LMD-ANLCQVILM--------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             hhh-hHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccC
Confidence            995 599998873        26678899999999999999999   999999999999999999999999999998543


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc--------ccchhHHH---
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS--------EIYFPHWV---  547 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~---  547 (638)
                      ..   ...+..+.|..|.|||++.+.  .+...+||||+||++.||++|+-.|.....-.+        +..-+.+.   
T Consensus       170 ~~---~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  170 TD---FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             cc---cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            32   345667788999999999886  589999999999999999999987764322100        00000000   


Q ss_pred             ----HHHhh---------hhhhccccCCC--CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 ----YKRLE---------LEEDLGLQGIE--NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 ----~~~~~---------~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                          .....         ..+.+.+...+  .+..+--...+.+++.+||-.||++|.+++++|++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                00000         00000010011  11111223457789999999999999999999974

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=5.7e-26  Score=221.92  Aligned_cols=197  Identities=32%  Similarity=0.479  Sum_probs=168.4

Q ss_pred             hhcccCcCcceeEEEEEEcC-CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.||+|++|+||++...+ ++.+++|.+.....  ..+.+.+|++.+++++|+|++++++++......++++|+++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            46789999999999999754 88999999976543  3568889999999999999999999999989999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..+..++.+++.+|.+||+   .+++|+||+|.||+++.++.++|+|||.+.........
T Consensus        83 ~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       83 DLFDYLRKKG-----GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999998753     117899999999999999999999   89999999999999999999999999999877544200


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCc
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANV  533 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~  533 (638)
                       ......++..|++||.+. ....++.++|+|+||+++++|++|+.||..
T Consensus       155 -~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 -LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             112334678899999984 223677799999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=3.2e-26  Score=264.15  Aligned_cols=197  Identities=19%  Similarity=0.237  Sum_probs=137.9

Q ss_pred             hcCC-cceEEEEeEE-------EeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 006620          374 RTSH-VNIVTLLGFC-------FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN  445 (638)
Q Consensus       374 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~  445 (638)
                      .++| +||++++++|       ...+.+++++|++ +++|.++|....     ..+++..++.++.||++||+|||+   
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHS---   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHh---
Confidence            3455 5888888877       2334567788987 669999997532     568999999999999999999999   


Q ss_pred             CCeEecccCCCceEECC-------------------CCceEEcccccceeccCCCc--------------eeeecccccc
Q 006620          446 TRILHFDIKPHNILLDE-------------------DFCPKISDFGLAKICEGRES--------------IVSMTGARGT  492 (638)
Q Consensus       446 ~~iiH~Dikp~NIll~~-------------------~~~~kl~DFg~~~~~~~~~~--------------~~~~~~~~gt  492 (638)
                      ++|+||||||+||||+.                   ++.+|++|||+++.......              ........||
T Consensus        99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181         99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence            99999999999999954                   44566667776654211000              0001123578


Q ss_pred             cceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHH
Q 006620          493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR  572 (638)
Q Consensus       493 ~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (638)
                      +.|+|||++.+.  .++.++|||||||+||||++|.+|+.....     ..     ..+...  . .   ..... ....
T Consensus       179 ~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~-----~~~~~~--~-~---~~~~~-~~~~  239 (793)
T PLN00181        179 SWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR-----TM-----SSLRHR--V-L---PPQIL-LNWP  239 (793)
T ss_pred             cceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HH-----HHHHHh--h-c---Chhhh-hcCH
Confidence            899999998764  689999999999999999998877542110     00     000000  0 0   00001 1123


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          573 KMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       573 ~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ....++.+||+.+|.+||++.|++++
T Consensus       240 ~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        240 KEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHHHhCCCChhhCcChHHHhhc
Confidence            45678899999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=8.9e-25  Score=205.36  Aligned_cols=167  Identities=20%  Similarity=0.197  Sum_probs=126.1

Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++...+     ..+++..++.|+.|+++||+|||+   .+      ||+|||++.++.+|+  ||++....... 
T Consensus         1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-
Confidence            68999998643     569999999999999999999999   55      999999999999999  99988764322 


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                            ..||+.|+|||++.+.  .++.++|||||||++|||++|+.||......      ..............  ...
T Consensus        64 ------~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~--~~~  127 (176)
T smart00750       64 ------SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGMPAD--DPR  127 (176)
T ss_pred             ------CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHhccC--Ccc
Confidence                  2578999999999764  6889999999999999999999998643221      11111111110000  000


Q ss_pred             CCchhHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          563 ENEEDKEYAR--KMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       563 ~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ..........  ++.+++.+||+.+|++||++.++++++...
T Consensus       128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            0112233343  689999999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.6e-24  Score=200.47  Aligned_cols=251  Identities=23%  Similarity=0.410  Sum_probs=197.7

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEeccc---CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ++..+|.+...|..|+|+++ |..+++|+++..   .....+|.+|.-.|+...||||+.++|.|.......++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            35678999999999999995 556677777543   33446788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|...|++..    ...++-.++.+++..+++|++|||+.. .-|.---|....+++|++..++|+= +-.+      .
T Consensus       272 gslynvlhe~t----~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~k------f  339 (448)
T KOG0195|consen  272 GSLYNVLHEQT----SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTK------F  339 (448)
T ss_pred             hHHHHHHhcCc----cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccce------e
Confidence            99999999853    345677889999999999999999941 2234446899999999998887741 1111      1


Q ss_pred             eeeecccccccceecCceeccccCC-ccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGE-VSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~-~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .....+..-.|.|++||.++..... .-.++|+|||.+++|||.|.+-||.....              .+.+..+.+++
T Consensus       340 sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp--------------mecgmkialeg  405 (448)
T KOG0195|consen  340 SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP--------------MECGMKIALEG  405 (448)
T ss_pred             eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc--------------hhhhhhhhhcc
Confidence            1122344457899999999765332 34578999999999999999999864332              23334455677


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      ++...+...+..+..|+.-|+..||.+||.+..|+-.||++.
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            777777788899999999999999999999999999999864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=3.2e-22  Score=206.32  Aligned_cols=262  Identities=20%  Similarity=0.231  Sum_probs=192.0

Q ss_pred             HhhhhcccCcCcceeEEEEEEcCC--CEEEEEEecccCCc-hhhHHHHHHHHhhcCC----cceEEEEeEE-EeCceEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLDG--QNVAIKVLNETKGN-GEDFINEVASISRTSH----VNIVTLLGFC-FEGHRRAL  395 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  395 (638)
                      .+.+.++||+|+||.||++.....  ..+|+|+....... ...+..|..++..+..    +++.++++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            344678999999999999986553  57999987764322 2267788888888873    5899999988 47778899


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC-----CceEEcc
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-----FCPKISD  470 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~-----~~~kl~D  470 (638)
                      ||+.+ |.+|.++.....    ...++..++..|+.|++.+|++||+   .|++||||||+|+++...     ..+.|.|
T Consensus        99 VM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             EEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            99988 889999886653    3679999999999999999999999   999999999999999754     4699999


Q ss_pred             cccce--eccCCCce---e--e-ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccc
Q 006620          471 FGLAK--ICEGRESI---V--S-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY  542 (638)
Q Consensus       471 Fg~~~--~~~~~~~~---~--~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~  542 (638)
                      ||+++  ........   .  . ....+||..|.+++...+.  ..+.+.|+||++.++.|++.|..||.......... 
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~-  247 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS-  247 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchHH-
Confidence            99998  33222110   0  1 1345699999999998775  78899999999999999999999985443221110 


Q ss_pred             hhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          543 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       543 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                            .............    .....+.++.++...+-..+..++|....+...|++.....
T Consensus       248 ------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  248 ------KFEKDPRKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             ------HHHHHhhhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                  0000000111110    01111234445555555689999999999999998876654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=9.4e-23  Score=209.45  Aligned_cols=171  Identities=19%  Similarity=0.201  Sum_probs=128.3

Q ss_pred             hhhhcccCcCcceeEEEEEEc--CCCEEEEEEeccc------CCchhhHHHHHHHHhhcCCcceEE-EEeEEEeCceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL--DGQNVAIKVLNET------KGNGEDFINEVASISRTSHVNIVT-LLGFCFEGHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~l  395 (638)
                      |.+.+.||+|+||+||+|++.  +++.||||++...      ....+.+.+|++++++++|+|++. +++.    ...++
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~L   95 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGL   95 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEE
Confidence            345789999999999999854  5677899986532      112456889999999999999985 4432    45799


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc-CCCceEECCCCceEEcccccc
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI-KPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Di-kp~NIll~~~~~~kl~DFg~~  474 (638)
                      ||||++|++|.. +...      .      ...++.|+++||+|||+   .||+|||| ||+|||++.++.+||+|||++
T Consensus        96 VmE~~~G~~L~~-~~~~------~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         96 VRGWTEGVPLHL-ARPH------G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             EEEccCCCCHHH-hCcc------c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            999999999963 2110      1      14678899999999999   99999999 999999999999999999999


Q ss_pred             eeccCCCceee------ecccccccceecCceeccccC----CccccCCee
Q 006620          475 KICEGRESIVS------MTGARGTIGYIAPEVFCRNFG----EVSYKSDVY  515 (638)
Q Consensus       475 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~----~~s~~~Dvw  515 (638)
                      +.+........      .....+++.|++||++.....    ..+...|-|
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            97754332111      134567888999999854311    223346666

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=5.8e-23  Score=188.57  Aligned_cols=272  Identities=18%  Similarity=0.245  Sum_probs=202.9

Q ss_pred             HhhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCchhhHHHHHHHHhhcCC-cceEEEEeEEEeCceEEEEEEecc
Q 006620          324 TNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSH-VNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ++.+.++||+|+||.+|.|. ..+|+.||||+-..... ......|..+.+.+++ ..|..+.-+..+...-.+|||.+ 
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-   93 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-   93 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence            45568999999999999998 66799999998655432 3466789899999884 57777777888888889999998 


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC---CCCceEEcccccceecc
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICE  478 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFg~~~~~~  478 (638)
                      |.+|+++..-..     +.++..+++-++-|++.-++|+|.   +++|||||||+|+|..   .-.++.|+|||+|+.+.
T Consensus        94 GPsLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   94 GPSLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             CccHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            889999987653     678999999999999999999999   9999999999999985   45579999999999775


Q ss_pred             CCCce-----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          479 GRESI-----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       479 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      +..+.     .......||..|.+-....+.  ..+.+.|+-|+|.+|.....|..||.........     ..++.+..
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-----QKyEkI~E  238 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-----QKYEKISE  238 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----HHHHHHHH
Confidence            43321     122345689999998887664  6688999999999999999999999865543221     11122211


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCccc
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLL  615 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~  615 (638)
                      .+   .+-........++.++...+.-|-...-++-|+..-+.+...-++..+.....-.+.
T Consensus       239 kK---~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyD  297 (341)
T KOG1163|consen  239 KK---MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYD  297 (341)
T ss_pred             hh---cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEee
Confidence            11   111112223345667777778888888888888887777776665555544433333

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=5.8e-22  Score=190.10  Aligned_cols=264  Identities=19%  Similarity=0.264  Sum_probs=198.4

Q ss_pred             hhhhcccCcCcceeEEEEE-EcCCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.++||+|.||.++.|+ +-+++.||||.-. .+....+...|.+..+.|. .++|..+|-+..++.+-.||+|.+ |
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            3467899999999999998 6789999999643 3344566778999998886 789999998888888889999998 8


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-----CCceEEcccccceec
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-----DFCPKISDFGLAKIC  477 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFg~~~~~  477 (638)
                      .+|+|+..-.+     +.++..++..++.|++.-++|+|+   +.+|.|||||+|+||..     ...+.|+|||+|+..
T Consensus       108 PSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  108 PSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             cCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            89999987654     679999999999999999999999   99999999999999953     346899999999987


Q ss_pred             cCCCce-----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          478 EGRESI-----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       478 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      .+..+.     .......||-+||+-....++  +.+.+.|+=|||=++...|.|..||..-......     ..++++.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-----~kYeKIG  252 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-----EKYEKIG  252 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----HHHHHhc
Confidence            654332     233445699999999988876  7789999999999999999999999865432211     1122222


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      ..+..   -........++.++..-+.-.-+.+-.+-|+.+-+...+...++.+..
T Consensus       253 e~Kr~---T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  253 ETKRS---TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             ccccc---CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence            11100   000111222344555444444466778889988888777776655443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=8.6e-23  Score=223.51  Aligned_cols=251  Identities=24%  Similarity=0.262  Sum_probs=186.8

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEec----ccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLN----ETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+|.|++|.|+.... ......+.|...    .....   ...+..|+-+-..++|+|++..+....+.....-.|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            57899999998887753 333334444322    11111   11255677777888999998888877776666666999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++ +|..++...      ..+....+..++.|++.|++|||+   .|+.|||+|++|+++..+|.+||+|||.+.....
T Consensus       403 ~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             ccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            999 999999874      357888899999999999999999   9999999999999999999999999999987654


Q ss_pred             CCce--eeecccccccceecCceeccccCCc-cccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          480 RESI--VSMTGARGTIGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       480 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ....  ....+.+|+..|+|||.+.+.  .| ....||||.|+++..|.+|+.||...........  ..     .....
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--~~-----~~~~~  543 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--TN-----NYSDQ  543 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccchh--hh-----ccccc
Confidence            4332  445677899999999999775  44 4578999999999999999999987655433210  00     00001


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....-.......++.+...++.+||+++|.+|.|+++|++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            11111112234456777889999999999999999999986

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.7e-20  Score=193.82  Aligned_cols=260  Identities=28%  Similarity=0.347  Sum_probs=194.6

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCc-ceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG----NGEDFINEVASISRTSHV-NIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.||.|+||.||++...  ..+++|.+.....    ....+.+|+.++..+.|+ +++++.+.+......+++++++.
T Consensus         4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            4578999999999999876  8899999876532    256789999999999988 79999999987777899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-ceEEcccccceeccCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICEGR  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFg~~~~~~~~  480 (638)
                      +++|.+++......   ..+.......++.|++.++.|+|+   .+++|||+||+||+++..+ .++++|||.++.....
T Consensus        82 ~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          82 GGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            99999777654211   368899999999999999999999   8999999999999999888 7999999999865543


Q ss_pred             Ccee----eecccccccceecCceecccc-CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          481 ESIV----SMTGARGTIGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       481 ~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ....    ......|+..|++||.+.+.. ...+...|+|++|++++++++|..|+......    ..............
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~  231 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP  231 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC
Confidence            3221    235567899999999987631 36788999999999999999999996544321    00011111111100


Q ss_pred             hc-cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          556 DL-GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       556 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .. ................+.+++..++..+|..|.+..+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00 00000000002223567889999999999999999887764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=5.1e-21  Score=180.97  Aligned_cols=138  Identities=17%  Similarity=0.187  Sum_probs=107.2

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCC---c-------hhh-----------------HHHHHHHHhhcCCcce
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---N-------GED-----------------FINEVASISRTSHVNI  380 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-------~~~-----------------~~~E~~~l~~l~h~ni  380 (638)
                      .+.||+|++|.||+|...+|+.||||+++....   .       ...                 ...|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            357999999999999977899999999975421   1       011                 2348999999987766


Q ss_pred             EEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecccCCCceE
Q 006620          381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNIL  459 (638)
Q Consensus       381 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiH~Dikp~NIl  459 (638)
                      .....+..  ...++||||++++++...+...      ..+++..+..++.|++.+|.++ |+   .||+||||||+|||
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIl  150 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLL  150 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEE
Confidence            43332222  2238999999987776553322      4588899999999999999999 67   89999999999999


Q ss_pred             ECCCCceEEcccccceec
Q 006620          460 LDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       460 l~~~~~~kl~DFg~~~~~  477 (638)
                      ++ ++.++|+|||++...
T Consensus       151 i~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         151 YH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EE-CCcEEEEEccccccC
Confidence            98 478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=6.5e-21  Score=182.01  Aligned_cols=165  Identities=14%  Similarity=0.164  Sum_probs=126.1

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhh----------HHHHHHHHhhcCCcceEEEEeEEEeC-----
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGED----------FINEVASISRTSHVNIVTLLGFCFEG-----  390 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~-----  390 (638)
                      ...+.||.|+||.||.+.. +++.+|||++.......+.          +.+|+..+.+++|++|..+.+++...     
T Consensus        34 ~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~  112 (232)
T PRK10359         34 KTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTL  112 (232)
T ss_pred             EEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccc
Confidence            3578999999999999755 5778999999754332222          57899999999999999998886643     


Q ss_pred             ---ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceE
Q 006620          391 ---HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK  467 (638)
Q Consensus       391 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  467 (638)
                         ...++||||++|.+|.++..          +++    ....+++.+|..+|+   .|++|||+||.||++++++ ++
T Consensus       113 ~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        113 RYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EE
Confidence               35789999999999988732          222    245689999999999   9999999999999999888 99


Q ss_pred             EcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHh
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT  525 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ell  525 (638)
                      |+|||............              .+....  .+..++|+|+||+++....
T Consensus       175 liDfg~~~~~~e~~a~d--------------~~vler--~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD--------------RIDLER--HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHH--------------HHHHHh--HhcccccccceeEeehHHH
Confidence            99999877543222110              022222  3557999999999876653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.2e-19  Score=172.29  Aligned_cols=140  Identities=18%  Similarity=0.218  Sum_probs=109.7

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCc---------------------------hhhHHHHHHHHhhcCCcce
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN---------------------------GEDFINEVASISRTSHVNI  380 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~ni  380 (638)
                      .+.||+|++|.||+|+..+|+.||||+++.....                           ......|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3579999999999999778999999998754211                           0112478899999999887


Q ss_pred             EEEEeEEEeCceEEEEEEeccCCCHHHH-hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceE
Q 006620          381 VTLLGFCFEGHRRALIYEFVSNGSLEKF-IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL  459 (638)
Q Consensus       381 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIl  459 (638)
                      .....+...  ..++||||++++++... +..       ..++......++.|++++|.+||+  ..||+||||||+||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIl  150 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNIL  150 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEE
Confidence            544433332  24899999998765443 332       346788899999999999999997  269999999999999


Q ss_pred             ECCCCceEEcccccceeccC
Q 006620          460 LDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       460 l~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++ ++.++|+|||++.....
T Consensus       151 l~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EE-CCCEEEEEcccceecCC
Confidence            98 88999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.4e-19  Score=189.02  Aligned_cols=219  Identities=22%  Similarity=0.403  Sum_probs=165.4

Q ss_pred             HhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-Ee
Q 006620          372 ISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI-LH  450 (638)
Q Consensus       372 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i-iH  450 (638)
                      |+.+.|.|+.+++|.+.++.....|.+|+..|+|.|.+....     ..+++-....+++.++.||+|||.   ..| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHN---SPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhc---Ccceee
Confidence            456889999999999999999999999999999999998743     678899999999999999999999   344 99


Q ss_pred             cccCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceecccc--CC---ccccCCeeeHHHHHHHHh
Q 006620          451 FDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF--GE---VSYKSDVYSYGMMVFEMT  525 (638)
Q Consensus       451 ~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~---~s~~~DvwslGvil~ell  525 (638)
                      +.++..|.++|....+||+|||+....................-|.|||.+....  ..   .+.+.||||||++++|++
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            9999999999999999999999988764311111112222356799999997631  11   577899999999999999


Q ss_pred             cCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc-h-hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          526 GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE-E-DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       526 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      +.+.||+........   ...+.. +....   ....++. . ..+...++..++.+||..+|++||+++++...++.+.
T Consensus       153 ~r~~~~~~~~~~~~~---~eii~~-~~~~~---~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDP---DEIILR-VKKGG---SNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             hccCccccccccCCh---HHHHHH-HHhcC---CCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            999999865443322   111111 11101   0111111 1 1144457889999999999999999999999998876


Q ss_pred             CC
Q 006620          604 DS  605 (638)
Q Consensus       604 ~~  605 (638)
                      +.
T Consensus       226 ~~  227 (484)
T KOG1023|consen  226 KG  227 (484)
T ss_pred             cc
Confidence            54

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=1.7e-20  Score=204.74  Aligned_cols=249  Identities=21%  Similarity=0.234  Sum_probs=179.6

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC--chhhHHHHHHH--HhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG--NGEDFINEVAS--ISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||++.|=+|.+|++++|. |+||++-+...  ..+.+.++++-  ....+|||.+.+...-..++..|||-+|+.
T Consensus        26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk  104 (1431)
T KOG1240|consen   26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK  104 (1431)
T ss_pred             eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence            35688999999999999987776 99999865442  23444444333  445679999998888778888899999996


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec--cC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--EG  479 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~--~~  479 (638)
                      + +|.|.|..+      ..+...+.+-|+.|++.||.-+|.   .||+|||||.+|||+.+=.-+.|+||..-+..  ..
T Consensus       105 h-nLyDRlSTR------PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  105 H-NLYDRLSTR------PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             h-hhhhhhccc------hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            6 999998764      467778888999999999999999   99999999999999999889999999876532  11


Q ss_pred             ---CCceeeecccccccceecCceecccc--------C-CccccCCeeeHHHHHHHHhcC-CCCCCcccCCCcccchhHH
Q 006620          480 ---RESIVSMTGARGTIGYIAPEVFCRNF--------G-EVSYKSDVYSYGMMVFEMTGE-KNNANVAVDRSSEIYFPHW  546 (638)
Q Consensus       480 ---~~~~~~~~~~~gt~~y~aPE~~~~~~--------~-~~s~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~  546 (638)
                         .+...-+...+.-..|+|||-+....        . ..+++.||||+||+++||++. +++|....-         .
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL---------~  245 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL---------L  245 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH---------H
Confidence               11222233444456899999875421        1 267789999999999998865 777653210         0


Q ss_pred             HHHHhh-hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          547 VYKRLE-LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       547 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      .++... ......+..+.       ...+..++..|++.||++|.++++.++...+
T Consensus       246 aYr~~~~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  246 AYRSGNADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             hHhccCccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            011000 00000011111       1257789999999999999999999987544

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=2.5e-19  Score=167.24  Aligned_cols=183  Identities=16%  Similarity=0.109  Sum_probs=136.5

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCchh-----hHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEecc
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGE-----DFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ...|++|+||+||.+.. .++.++.+.+.......+     .+.+|+++|+++. |+++++++++    ...+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            46799999999997765 678888887776544222     5789999999996 5889999886    44699999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc-CCCceEECCCCceEEcccccceeccCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI-KPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Di-kp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      |.+|.+.+..       .      ...++.|++++|+++|+   .||+|||| ||+|||+++++.++|+|||++......
T Consensus        82 G~~L~~~~~~-------~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         82 GAAMYQRPPR-------G------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             CccHHhhhhh-------h------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            9998654321       0      13477899999999999   99999999 799999999999999999999865432


Q ss_pred             Cce---ee--------ecccccccceecCceeccccCCcc-ccCCeeeHHHHHHHHhcCCCCCC
Q 006620          481 ESI---VS--------MTGARGTIGYIAPEVFCRNFGEVS-YKSDVYSYGMMVFEMTGEKNNAN  532 (638)
Q Consensus       481 ~~~---~~--------~~~~~gt~~y~aPE~~~~~~~~~s-~~~DvwslGvil~elltg~~p~~  532 (638)
                      ...   ..        ..-...++.|++|+...-. ...+ ...+.++.|..+|.++|++-+..
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            210   00        0112357778888754221 1222 35578899999999999987654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.4e-20  Score=196.22  Aligned_cols=232  Identities=25%  Similarity=0.266  Sum_probs=182.1

Q ss_pred             ccCcCcceeEEEEE----EcCCCEEEEEEecccC---CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEecc
Q 006620          330 KLGQGGYGGVYKGK----LLDGQNVAIKVLNETK---GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+|+|.||.|+.++    .+.+..+|+|++++..   ........|-.++...+ ||.+++++..+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999874    2347789999987542   11224456777788887 9999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|.|...+...      ..+.+.....+...++-|++++|+   .+++|||+|++||+++.+|.+|+.|||+++..-..+
T Consensus        81 gg~lft~l~~~------~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLSKE------VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhccccC------CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            99998887654      457777888889999999999999   999999999999999999999999999998765443


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .      ..||..|||||++.+    ....+|.||||++++||+||..||....           . ..        +..
T Consensus       152 ~------~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~~~-----------~-~~--------Il~  201 (612)
T KOG0603|consen  152 I------ACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGGDT-----------M-KR--------ILK  201 (612)
T ss_pred             h------cccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCchHH-----------H-HH--------Hhh
Confidence            2      168999999999963    4679999999999999999999987510           0 00        011


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCH--HHHHHHHh
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSM--NRVVEMLE  600 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~L~  600 (638)
                      .....+......+.+++..++..+|..|--.  ..+.++.+
T Consensus       202 ~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  202 AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence            1123445567778888999999999999654  34444443

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=1.9e-18  Score=164.85  Aligned_cols=133  Identities=20%  Similarity=0.288  Sum_probs=103.2

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEeccc-CCchhhHHHHHHHHhhc-----CCcceEEEEeEEEeCc---eEE-EEE
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNET-KGNGEDFINEVASISRT-----SHVNIVTLLGFCFEGH---RRA-LIY  397 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~  397 (638)
                      .+.||+|+||.||.  +.+....+||++... ....+.+.+|+.+++++     .||||++++|++.++.   ..+ +|+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            46899999999996  333333479988654 23446789999999999     5799999999999874   333 789


Q ss_pred             Ee--ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecccCCCceEECC----CCceEEcc
Q 006620          398 EF--VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL-EYLHRGCNTRILHFDIKPHNILLDE----DFCPKISD  470 (638)
Q Consensus       398 e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~~~~iiH~Dikp~NIll~~----~~~~kl~D  470 (638)
                      ||  +.+++|.+++.+.       .+++.  ..++.|++.++ +|||+   .+|+||||||+|||++.    ++.++|+|
T Consensus        85 e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             cCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            99  5579999999653       24544  35678888777 99999   99999999999999963    34899999


Q ss_pred             cccc
Q 006620          471 FGLA  474 (638)
Q Consensus       471 Fg~~  474 (638)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=2.7e-19  Score=176.08  Aligned_cols=233  Identities=19%  Similarity=0.301  Sum_probs=144.4

Q ss_pred             hcccCcCcceeEEEEEEcC-CCEEEEEEecccC----CchhhHHHHHHHHhhcCC----------cceEEEEeEEE----
Q 006620          328 KNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETK----GNGEDFINEVASISRTSH----------VNIVTLLGFCF----  388 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~----  388 (638)
                      .+.||.|+++.||.+.+.. ++.+|||+.....    ...+++.+|.-....+.+          -.++.-++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            5789999999999999754 8899999875432    223455555544444222          12222222111    


Q ss_pred             -----eC---c-----eEEEEEEeccCCCHHHHhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccC
Q 006620          389 -----EG---H-----RRALIYEFVSNGSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK  454 (638)
Q Consensus       389 -----~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dik  454 (638)
                           ..   .     ..+++|+-+ .++|.+++..-... .....+....+..+..|+++.+++||+   .|++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence                 11   1     235677777 45888876531100 111234455667788999999999999   999999999


Q ss_pred             CCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccc------cCCccccCCeeeHHHHHHHHhcCC
Q 006620          455 PHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN------FGEVSYKSDVYSYGMMVFEMTGEK  528 (638)
Q Consensus       455 p~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwslGvil~elltg~  528 (638)
                      |+|++++.+|.++|+||+.......  . .. . ...+..|.|||.....      .-.++.+.|.|+||+++|.|..++
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~--~-~~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGT--R-YR-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTE--E-EE-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCc--e-ee-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999999999999987664322  1 11 1 3346789999977432      124688999999999999999999


Q ss_pred             CCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCC
Q 006620          529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDR  589 (638)
Q Consensus       529 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  589 (638)
                      .||+..........               .+.    ... +.++.+..||..+|+.||++|
T Consensus       248 lPf~~~~~~~~~~~---------------~f~----~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW---------------DFS----RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG---------------GGT----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc---------------cch----hcC-CcCHHHHHHHHHHccCCcccC
Confidence            99986544322210               011    112 667889999999999999988

>PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding

Probab=99.77  E-value=1.1e-18  Score=148.26  Aligned_cols=103  Identities=36%  Similarity=0.645  Sum_probs=75.1

Q ss_pred             CCCCCCCCCCCCcccCCCccCCCCCCCCCC-CCceeeccCC-CCceEeecCCCcEEEEEEeccccEEEEEecccccCCCC
Q 006620           43 LACVAKTCGDGQSISFPFYIENQQEAYCGY-PGFNLSCNDK-GNPVLKLSSDTNYIVEKILYDNHSVLVSNAAFSETNSD  120 (638)
Q Consensus        43 ~~C~~~~CG~~~~I~yPF~~~~~~~~~CG~-p~f~L~C~~~-~~~~l~~~~~~~y~V~~I~y~~~~i~v~~~~~~~~~~~  120 (638)
                      +.|+. +|||+ +|+||||+++    +||+ |+|+|+|+++ +.+.|.+.++ .|+|++|+|.+++|+|.++........
T Consensus         2 ~~C~~-~CGnv-~IpYPFgi~~----~C~~~~~F~L~C~~~~~~~~l~l~~~-~~~V~~I~~~~~~i~v~~~~~~~~~~~   74 (106)
T PF13947_consen    2 PGCPS-SCGNV-SIPYPFGIGP----GCGRDPGFELTCNNNTSPPKLLLSSG-NYEVLSISYENGTIRVSDPISSNCYSS   74 (106)
T ss_pred             CCCCC-ccCCE-eecCCCccCC----CCCCCCCcEEECCCCCCCceeEecCC-cEEEEEEecCCCEEEEEeccccceecC
Confidence            47975 99998 9999999985    8999 9999999986 3577777665 899999999999999999854322111


Q ss_pred             CCCCCCCccCCCCCCccccCcCCCceEEEEEcCC
Q 006620          121 PACTFPRIKNVSLPADFQLAPDQKQAVLLYNCNS  154 (638)
Q Consensus       121 ~~C~~~~~~~~~~~~~f~~~~~~~~~~~~~~C~~  154 (638)
                      ..-. ....++++..+|.+++..+. ++++||++
T Consensus        75 ~~~~-~~~~~~~~~~~~~~s~~~N~-~~~~GC~t  106 (106)
T PF13947_consen   75 SSSN-SSNSNLSLNGPFFFSSSSNK-FTVVGCNT  106 (106)
T ss_pred             CCCc-ccccEEeecCCceEccCCcE-EEEECCCC
Confidence            1111 11123444557878776555 56679974

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=7.9e-19  Score=195.83  Aligned_cols=192  Identities=22%  Similarity=0.244  Sum_probs=154.3

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcC---CcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.+.||+|+||+||+|...+++.||+|+-+.....  +|.--.+++.||+   -+.|..+...+...+..+||+||.+
T Consensus       700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~  777 (974)
T KOG1166|consen  700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP  777 (974)
T ss_pred             EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence            3446789999999999999888999999997655432  2323334444554   3455566666666778899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-------CCCceEEcccccc
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-------EDFCPKISDFGLA  474 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-------~~~~~kl~DFg~~  474 (638)
                      .|+|.++++..      +.++|.....++.|++..++.||.   .+|||+||||+|+||.       ....++|+|||-+
T Consensus       778 ~Gtlld~~N~~------~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  778 YGTLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             cccHHHhhccC------CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            99999999853      678999999999999999999999   9999999999999993       3446899999998


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCC
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKN  529 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~  529 (638)
                      --+.--.....+.+..+|-.+--+|...|+  .++++.|.|.|.-+++-||-|+.
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHH
Confidence            655433323345667789999999999886  89999999999999999998873

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=4.2e-18  Score=167.32  Aligned_cols=200  Identities=20%  Similarity=0.260  Sum_probs=139.5

Q ss_pred             CCcceEEEEeEEEe---------------------------CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHH
Q 006620          376 SHVNIVTLLGFCFE---------------------------GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYK  428 (638)
Q Consensus       376 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~  428 (638)
                      .|||||++.+.|.+                           +..+|+||..++. +|++++-.+       ..+.....-
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------~~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------HRSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------CCchHHHHH
Confidence            49999999877652                           3567899998854 999999864       366777888


Q ss_pred             HHHHHHHHHHHHhcCCCCCeEecccCCCceEE--CCCC--ceEEcccccceeccCCCceee----ecccccccceecCce
Q 006620          429 IAVGIARGLEYLHRGCNTRILHFDIKPHNILL--DEDF--CPKISDFGLAKICEGRESIVS----MTGARGTIGYIAPEV  500 (638)
Q Consensus       429 i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll--~~~~--~~kl~DFg~~~~~~~~~~~~~----~~~~~gt~~y~aPE~  500 (638)
                      |+.|+++|+.|||+   +||.|||+|.+|||+  |+++  .++|+|||++--.+.......    ....-|.-.-||||+
T Consensus       346 ~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            99999999999999   999999999999998  3333  579999998754332111111    112235667899999


Q ss_pred             eccccCC----ccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHH
Q 006620          501 FCRNFGE----VSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMIL  576 (638)
Q Consensus       501 ~~~~~~~----~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  576 (638)
                      .....++    .-.|+|.|+.|.+.||+++...||.....    ..+....+..          ......+..++..+.+
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe----m~L~~r~Yqe----------~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE----MLLDTRTYQE----------SQLPALPSRVPPVARQ  488 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch----heechhhhhh----------hhCCCCcccCChHHHH
Confidence            8654332    12489999999999999999999975221    1111111110          0111222334456778


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHh
Q 006620          577 VSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       577 li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                      ++...|+.||++|++..-....|.
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            888899999999998765555543

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=1.3e-17  Score=163.11  Aligned_cols=138  Identities=17%  Similarity=0.172  Sum_probs=107.6

Q ss_pred             hhhcccCcCcceeEEEEE--EcCCCEEEEEEecccCCc-------------------------hhhHHHHHHHHhhcCCc
Q 006620          326 SFKNKLGQGGYGGVYKGK--LLDGQNVAIKVLNETKGN-------------------------GEDFINEVASISRTSHV  378 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~  378 (638)
                      .+.+.||+|++|.||+|.  ..+|+.||||++......                         ...+..|+..+.++.+.
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            356789999999999998  567999999998743210                         01245799999999753


Q ss_pred             --ceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecccCC
Q 006620          379 --NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR-ILHFDIKP  455 (638)
Q Consensus       379 --niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~-iiH~Dikp  455 (638)
                        .+.++++.    ...++||||+++.+|.......      ..+.......++.|++++|++||+   .+ ++||||||
T Consensus       111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp  177 (237)
T smart00090      111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE  177 (237)
T ss_pred             CCCCCeeeEe----cCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence              34445543    2348999999998887665322      235556678999999999999999   89 99999999


Q ss_pred             CceEECCCCceEEcccccceec
Q 006620          456 HNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       456 ~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999988754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=4.7e-17  Score=157.62  Aligned_cols=133  Identities=20%  Similarity=0.288  Sum_probs=112.7

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCC---------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.||+|++|.||+|.. ++..+++|+......         ....+.+|++++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 677899998654321         113567899999999999987777777777888999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      ++|++|.+++....         . .+..++.+++.+|++||+   .+++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986531         1 788999999999999999   9999999999999998 78999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=8.1e-17  Score=154.17  Aligned_cols=136  Identities=21%  Similarity=0.206  Sum_probs=107.3

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC-----------------------chhhHHHHHHHHhhcCCc--c
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG-----------------------NGEDFINEVASISRTSHV--N  379 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~--n  379 (638)
                      +.+.+.||+|+||.||++...+++.||||++.....                       .......|..++..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            445688999999999999987899999998764321                       011356788888888877  4


Q ss_pred             eEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceE
Q 006620          380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL  459 (638)
Q Consensus       380 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIl  459 (638)
                      +.+.++    ....++||||+++++|.+....            .....++.++++++.++|+   .+++||||||+||+
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nil  157 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNIL  157 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEE
Confidence            444444    2345899999999999765431            2356788999999999999   99999999999999


Q ss_pred             ECCCCceEEcccccceeccC
Q 006620          460 LDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       460 l~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++.++|+|||++.....
T Consensus       158 l~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EcCCCcEEEEECCccccCCC
Confidence            99999999999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=4.9e-18  Score=173.98  Aligned_cols=178  Identities=25%  Similarity=0.371  Sum_probs=134.0

Q ss_pred             ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcc
Q 006620          391 HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD  470 (638)
Q Consensus       391 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  470 (638)
                      ..+|+.|+++...+|.++|...+.   ....++...+.++.|++.|++|      ++.+|+|+||.||+...+..+||+|
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgD  399 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGD  399 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhh
Confidence            357889999999999999986542   2456778899999999999999      4899999999999999888999999


Q ss_pred             cccceeccCCC----ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHH
Q 006620          471 FGLAKICEGRE----SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW  546 (638)
Q Consensus       471 Fg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  546 (638)
                      ||+........    .....+...||..||+||++.+.  +|+.|+||||||++|+|++.-   |....           
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~---f~T~~-----------  463 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQ---FSTQF-----------  463 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHH---hccHH-----------
Confidence            99988765444    22334567799999999999886  899999999999999999851   11111           


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVV  596 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  596 (638)
                        +......++....++.....+++. -..|+.+++.+.|++||++.+..
T Consensus       464 --er~~t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  464 --ERIATLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             --HHHHhhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHHh
Confidence              111222233333333344444443 35788999999999999554443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=9.9e-17  Score=153.80  Aligned_cols=129  Identities=24%  Similarity=0.335  Sum_probs=105.5

Q ss_pred             ccCcCcceeEEEEEEcCCCEEEEEEecccCC---------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .||+|++|+||+|.. ++..+++|+......         ....+.+|++++..+.|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 578899998653211         1245678999999999887655444555666778999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +|++|.+++....       .      .++.+++.+|++||+   .+++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN-------D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH-------H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999876531       0      789999999999999   9999999999999998 88999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=3e-16  Score=172.97  Aligned_cols=130  Identities=19%  Similarity=0.309  Sum_probs=107.1

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEec-cc-C-------CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLN-ET-K-------GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~-~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .++||+|+||+||+|.+... .+++|+.. +. .       ...+.+.+|++++++++|++++....++......++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            67899999999999987443 34444322 11 1       112457889999999999999888877777778899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |+++++|.+++..              ...++.|++++|.+||+   .+++||||||+|||+ .++.++|+|||+++.
T Consensus       417 ~~~g~~L~~~l~~--------------~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        417 YIGGKDLKDVLEG--------------NPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             ecCCCcHHHHHHH--------------HHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999998752              45789999999999999   999999999999999 678999999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.63  E-value=1.1e-16  Score=175.22  Aligned_cols=203  Identities=23%  Similarity=0.300  Sum_probs=138.0

Q ss_pred             hcccCcCcceeEEEEEEcC-CCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          328 KNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      .+.|..|++|.||.++++. .+..|+|+-++.     .+++-  ++.....|.+|                     |+=.
T Consensus        88 IklisngAygavylvrh~~trqrfa~kiNkq~-----lilRn--ilt~a~npfvv---------------------gDc~  139 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN-----LILRN--ILTFAGNPFVV---------------------GDCA  139 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcccccc-----hhhhc--cccccCCccee---------------------chhh
Confidence            5788999999999998754 567888543221     11111  22323344433                     3444


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc----
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES----  482 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~----  482 (638)
                      ..++.-      +.++.+.        +.|++|||+   .+|+|||+||+|.++..-|.+|++|||+++..-....    
T Consensus       140 tllk~~------g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  140 TLLKNI------GPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             hhcccC------CCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence            445443      2344332        788999999   9999999999999999999999999999875421111    


Q ss_pred             ---------eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          483 ---------IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       483 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                               ...-...+||+.|+|||++...  .|...+|.|++|+|+||.+.|..||.....+   ..+...+...   
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd~---  274 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDD---  274 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhhh---
Confidence                     1112345799999999999764  7899999999999999999999998765332   1111111111   


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP  590 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  590 (638)
                         +..    .+.......++.+++.+.|+.+|.+|-
T Consensus       275 ---i~w----pE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  275 ---IEW----PEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ---ccc----cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence               111    111333456788999999999999994

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.61  E-value=5.7e-15  Score=144.83  Aligned_cols=134  Identities=19%  Similarity=0.233  Sum_probs=104.9

Q ss_pred             hcccC-cCcceeEEEEEEcCCCEEEEEEecccC--------------CchhhHHHHHHHHhhcCCcce--EEEEeEEEeC
Q 006620          328 KNKLG-QGGYGGVYKGKLLDGQNVAIKVLNETK--------------GNGEDFINEVASISRTSHVNI--VTLLGFCFEG  390 (638)
Q Consensus       328 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  390 (638)
                      ...|| .||.|+||++... ++.++||.+....              .....+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999999874 6789998875311              122457889999999998774  6777765432


Q ss_pred             c----eEEEEEEeccC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc
Q 006620          391 H----RRALIYEFVSN-GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC  465 (638)
Q Consensus       391 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~  465 (638)
                      .    ..++|+|+++| .+|.+++...       .++..    .+.+++.+|++||+   .||+||||||.|||++.++.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGK  180 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCC
Confidence            2    23599999997 6999988642       34443    35789999999999   99999999999999998889


Q ss_pred             eEEccccccee
Q 006620          466 PKISDFGLAKI  476 (638)
Q Consensus       466 ~kl~DFg~~~~  476 (638)
                      ++|+|||.+..
T Consensus       181 v~LIDfg~~~~  191 (239)
T PRK01723        181 FWLIDFDRGEL  191 (239)
T ss_pred             EEEEECCCccc
Confidence            99999998875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=5.8e-15  Score=134.45  Aligned_cols=134  Identities=24%  Similarity=0.212  Sum_probs=113.1

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCC--cceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSH--VNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.||+|.++.||++...+ +.+++|+...... ...+.+|+..++.++|  .++++++++....+..++++||++++.+
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            3679999999999999754 7899999866543 4678899999999986  5899999888877889999999988777


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      ..+             +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        81 ~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            543             4456778899999999999985445799999999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=2.7e-15  Score=142.32  Aligned_cols=137  Identities=22%  Similarity=0.260  Sum_probs=98.3

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCch---hhH----------------------HHHHHHHhhcCCc--ce
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNG---EDF----------------------INEVASISRTSHV--NI  380 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~E~~~l~~l~h~--ni  380 (638)
                      .+.||+|+||+||+|...+++.||||++.......   ...                      ..|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999997789999999987542211   111                      2455555555433  24


Q ss_pred             EEEEeEEEeCceEEEEEEeccCCCHHHH-hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceE
Q 006620          381 VTLLGFCFEGHRRALIYEFVSNGSLEKF-IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL  459 (638)
Q Consensus       381 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIl  459 (638)
                      .+.++.    ...++||||++++++... +....       .. ..+..++.+++.++.++|..  .+++|+||||+||+
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nil  147 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNIL  147 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEE
Confidence            444443    235899999998554321 11110       11 55788999999999999973  68999999999999


Q ss_pred             ECCCCceEEcccccceeccC
Q 006620          460 LDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       460 l~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++ ++.++|+|||.+.....
T Consensus       148 i~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         148 VD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EE-CCcEEEEECcccccccC
Confidence            99 89999999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=3.4e-16  Score=171.80  Aligned_cols=252  Identities=21%  Similarity=0.263  Sum_probs=189.4

Q ss_pred             hhhcccCcCcceeEEEEEEcC--CCEEEEEEecccC---CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD--GQNVAIKVLNETK---GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      ++.+.||+|+|+.|-......  ...+|+|.+....   ........|..+-+.+. |+|++++++.....+..++++++
T Consensus        23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~  102 (601)
T KOG0590|consen   23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY  102 (601)
T ss_pred             cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence            455679999999998876433  4456777665443   12234445777777777 99999999999999999999999


Q ss_pred             ccCCCHHHHhh-hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEecccCCCceEECCCC-ceEEccccccee
Q 006620          400 VSNGSLEKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKI  476 (638)
Q Consensus       400 ~~~gsL~~~l~-~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFg~~~~  476 (638)
                      ..++++.+-+. ..     ....+......++.|+..++.|+| .   .++.|+||||+|.+++..+ .++++|||+|..
T Consensus       103 s~g~~~f~~i~~~~-----~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  103 SDGGSLFSKISHPD-----STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccccccccccccCC-----ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999988883 32     124666678889999999999999 7   8999999999999999999 999999999998


Q ss_pred             ccC-CCceeeeccccc-ccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          477 CEG-RESIVSMTGARG-TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       477 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ... ...........| ++.|.|||...+. .......|+||.|+++..+++|..|++........  +..|....    
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~~----  247 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSWKSNK----  247 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccccc--ceeecccc----
Confidence            876 444445556677 9999999998764 34567899999999999999999998765543321  11111100    


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                           ................+++.+++..+|..|.+.+++-.
T Consensus       248 -----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 -----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -----cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                 00011222334556778888999999999999988764

>PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal

Probab=99.53  E-value=3.1e-14  Score=117.23  Aligned_cols=74  Identities=38%  Similarity=0.836  Sum_probs=64.9

Q ss_pred             ccccCCCceEEEeeeccCCCCCCCCChhhHHHHHhcCeEEEEec--CCCcccccCCCccCCCCCCCceeeccCCCC
Q 006620          187 DSASKQCKESAVAPVAVDMNGEGIGDHIGIEEMVRKGFLLKWKA--SDCRACKESGGSCGFDADTFHFQCYCPDRR  260 (638)
Q Consensus       187 ~~~~~~C~~~~~v~~~~~~~~~~~~~~~~~~~~l~~gf~L~w~~--~~C~~C~~s~g~C~~~~~~~~~~C~c~~g~  260 (638)
                      ......|...+.|||+.........+..+|+++|++||+|+|..  .+|.+|+.|||+|||+.+...|.|+|++|+
T Consensus        19 ~~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~~C~~SgG~Cgy~~~~~~f~C~C~dg~   94 (94)
T PF14380_consen   19 SDLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCRECEASGGRCGYDSNSEQFTCFCSDGP   94 (94)
T ss_pred             cccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCcChhcCCCEeCCCCCCceEEEECCCCC
Confidence            44689999999999998754444457889999999999999994  789999999999999988899999999985

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=1.5e-12  Score=138.88  Aligned_cols=140  Identities=24%  Similarity=0.278  Sum_probs=100.5

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCc---------------------------h--------------hhHHH
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN---------------------------G--------------EDFIN  367 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~--------------~~~~~  367 (638)
                      +.||+|++|.||+|++.+|+.||||+.+..-..                           .              -++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            579999999999999999999999998643100                           0              02445


Q ss_pred             HHHHHhhcC----CcceEEEEeEEE-eCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 006620          368 EVASISRTS----HVNIVTLLGFCF-EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR-GLEYLH  441 (638)
Q Consensus       368 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~-aL~yLH  441 (638)
                      |++.+.++.    |.+-+.+-.++. .....+|||||++|++|.++.....     ..+.   ...++.+++. .+..+|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----AGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----cCCC---HHHHHHHHHHHHHHHHH
Confidence            555555553    333334333332 2345789999999999998875421     1122   3456666665 467888


Q ss_pred             cCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       442 ~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      .   .|++|+|+||.||+++++++++++|||++..+..
T Consensus       275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   8999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=3.7e-13  Score=129.93  Aligned_cols=209  Identities=20%  Similarity=0.268  Sum_probs=140.0

Q ss_pred             HHHHHhhcCCcceEEEEeEEEeC-----ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 006620          368 EVASISRTSHVNIVTLLGFCFEG-----HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR  442 (638)
Q Consensus       368 E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~  442 (638)
                      -+..|-++.|.|||+++.|+.+.     .+..++.||+..|+|..+|++...  ....+......+|+.||+.||.|||+
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs  194 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHS  194 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence            34556667799999999988654     346789999999999999987542  23568888899999999999999998


Q ss_pred             CCCCCeEecccCCCceEECCCCceEEcccccceecc--CCCceeeecccccccceecCceeccccCCccccCCeeeHHHH
Q 006620          443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE--GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMM  520 (638)
Q Consensus       443 ~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvi  520 (638)
                       +...|+|+++.-+.|++..+|-+|++--.-...-.  ............+-++|.+||.-.-  -..+-++|||+||..
T Consensus       195 -~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  195 -CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMC  271 (458)
T ss_pred             -cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHH
Confidence             45789999999999999999999985321111000  0000001112235788999997432  256779999999999


Q ss_pred             HHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006620          521 VFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML  599 (638)
Q Consensus       521 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  599 (638)
                      .+||..++---...    ............       ...++...       .-..++..|++..|..||+|.+++.+.
T Consensus       272 AlemailEiq~tns----eS~~~~ee~ia~-------~i~~len~-------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  272 ALEMAILEIQSTNS----ESKVEVEENIAN-------VIIGLENG-------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HHHHHHheeccCCC----cceeehhhhhhh-------heeeccCc-------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            99998775321110    000000000000       00111111       123678899999999999999998654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.3e-12  Score=137.17  Aligned_cols=245  Identities=20%  Similarity=0.220  Sum_probs=179.1

Q ss_pred             hhhcccCc--CcceeEEEEEE---cCCCEEEEEEecccC---CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEE
Q 006620          326 SFKNKLGQ--GGYGGVYKGKL---LDGQNVAIKVLNETK---GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       326 ~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  396 (638)
                      .....+|.  |.+|.||.+..   .+...+|+|.-+...   .....-.+|+...++++ |+|.++.+..+...+..++-
T Consensus       117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq  196 (524)
T KOG0601|consen  117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ  196 (524)
T ss_pred             ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence            44678899  99999999975   346788988744321   12233456777777776 99999988888888999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecccCCCceEECCC-CceEEccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR----GLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDF  471 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DF  471 (638)
                      +|++ +.+|.++.+...     ..++...++.+..+..+    ||.++|.   .+++|-|+||+||+...+ ...+++||
T Consensus       197 tE~~-~~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  197 TELC-GESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eccc-cchhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence            9988 578988887643     45778888889999888    9999999   899999999999999888 89999999


Q ss_pred             ccceeccCCCceee---ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHH
Q 006620          472 GLAKICEGRESIVS---MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY  548 (638)
Q Consensus       472 g~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  548 (638)
                      |+...+....-...   .....|...|++||+..+   .++...|++++|.+..+..++-........       ..|..
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------~~W~~  337 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKN-------SSWSQ  337 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCC-------CCccc
Confidence            99988865542211   122357788999999875   578899999999999998877654432211       11110


Q ss_pred             HHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .        +-..+..+.......++...+.+|++.+|..|++.+.+..
T Consensus       338 ~--------r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 L--------RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             c--------ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0        0000112222223445556889999999999999887764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=4.5e-12  Score=118.08  Aligned_cols=130  Identities=22%  Similarity=0.179  Sum_probs=96.0

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEEeccCCCHHH
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYEFVSNGSLEK  407 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~  407 (638)
                      +.|+.|.++.||++... ++.|++|+..........+.+|+.+++.+.+.++ .+++...  ....++||||++|.++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence            56889999999999864 7789999986554333456789999998875544 4455443  234579999999988754


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecccCCCceEECCCCceEEccccccee
Q 006620          408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC--NTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       408 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      .  .         .   ....++.+++++|+.||+..  ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus        81 ~--~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 E--D---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             c--c---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            3  0         0   11345678999999999821  12359999999999998 67899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.30  E-value=8.1e-12  Score=134.68  Aligned_cols=139  Identities=18%  Similarity=0.206  Sum_probs=94.3

Q ss_pred             cccCcCcceeEEEEEEcC-CCEEEEEEecccCCc-----------------------------------h------hhHH
Q 006620          329 NKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGN-----------------------------------G------EDFI  366 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----------------------------------~------~~~~  366 (638)
                      +.||+|++|.||+|++.+ |+.||||+.+.....                                   .      -++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999877 999999998743100                                   0      0234


Q ss_pred             HHHHHHhhcC----CcceEEEEeEEEe-CceEEEEEEeccCCCHHHHh--hhcCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 006620          367 NEVASISRTS----HVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFI--HEKHPLETNQKLKWEVLYKIAVGIARGLEY  439 (638)
Q Consensus       367 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~l~~~~~~~i~~qi~~aL~y  439 (638)
                      +|+..+.++.    +.+.+.+-.++.+ ....+|||||++|++|.++-  ...+  .....+....+..++.|+.     
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~~la~~~v~~~~~Qif-----  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMKLLAERGVEVFFTQVF-----  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHHHHHHHHHHHHHHHHH-----
Confidence            4555555543    4444554454443 45678999999999998753  2211  0001233333444444443     


Q ss_pred             HhcCCCCCeEecccCCCceEECCCC----ceEEcccccceeccC
Q 006620          440 LHRGCNTRILHFDIKPHNILLDEDF----CPKISDFGLAKICEG  479 (638)
Q Consensus       440 LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFg~~~~~~~  479 (638)
                        .   .|++|+|+||.||+++.++    ++++.|||+...+..
T Consensus       278 --~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 --R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             --h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence              3   7999999999999999888    999999999987654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=4e-11  Score=112.34  Aligned_cols=135  Identities=16%  Similarity=0.175  Sum_probs=99.1

Q ss_pred             cccCcCcceeEEEEEEcC-------CCEEEEEEecccC-----------Cc------------hhhH----HHHHHHHhh
Q 006620          329 NKLGQGGYGGVYKGKLLD-------GQNVAIKVLNETK-----------GN------------GEDF----INEVASISR  374 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-----------~~------------~~~~----~~E~~~l~~  374 (638)
                      ..||.|.-+.||.|...+       +..+|||+.+...           +.            ...+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       4799999975321           00            1122    279999999


Q ss_pred             cCC--cceEEEEeEEEeCceEEEEEEeccCCCHHH-HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEe
Q 006620          375 TSH--VNIVTLLGFCFEGHRRALIYEFVSNGSLEK-FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL-HRGCNTRILH  450 (638)
Q Consensus       375 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiH  450 (638)
                      +..  -++.+++++    ..-+|||||+.++.+.. .++.       ..++......+..+++.+|..| |+   .+++|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVH  148 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVH  148 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence            863  466677764    45689999997654422 2221       2345566778889999999999 88   89999


Q ss_pred             cccCCCceEECCCCceEEcccccceecc
Q 006620          451 FDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       451 ~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      +||++.||+++ ++.++|+|||.+....
T Consensus       149 GDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999999996 5689999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.22  E-value=1.6e-10  Score=122.60  Aligned_cols=166  Identities=19%  Similarity=0.218  Sum_probs=128.8

Q ss_pred             EEcCCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCC
Q 006620          343 KLLDGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKL  421 (638)
Q Consensus       343 ~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l  421 (638)
                      +..++.+|.|.+.+...+ ..+...+-+..|+.++||||++++.........|||+|.+.  .|..++++.         
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---------  101 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---------  101 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---------
Confidence            345688899998876554 23456677888999999999999999999999999999985  788888764         


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCcee
Q 006620          422 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF  501 (638)
Q Consensus       422 ~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  501 (638)
                      ......-.+.||+.||.+||.  ..+++|++|.-+.|+|++.|..||++|.++........  ......---.|..|+.+
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~  177 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEI  177 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhc
Confidence            255677789999999999986  38999999999999999999999999988765433221  01111123356777765


Q ss_pred             ccccCCccccCCeeeHHHHHHHHhcC
Q 006620          502 CRNFGEVSYKSDVYSYGMMVFEMTGE  527 (638)
Q Consensus       502 ~~~~~~~s~~~DvwslGvil~elltg  527 (638)
                      ...    .-..|.|.||++++|++.|
T Consensus       178 ~~s----~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  178 DPS----EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             Ccc----ccchhhhhHHHHHHHHhCc
Confidence            332    2357999999999999998

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=2.3e-10  Score=111.50  Aligned_cols=141  Identities=18%  Similarity=0.192  Sum_probs=108.6

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCC--chhhHHHHHHHHhhcCC--cceEEEEeEEEeCc---eEEEEEEecc
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG--NGEDFINEVASISRTSH--VNIVTLLGFCFEGH---RRALIYEFVS  401 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  401 (638)
                      +.|+.|..+.||++...+|+.+++|+......  ....+.+|+++++.+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999876678999999765433  34578899999999875  34577777665532   5689999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC-------------------------------------  444 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------------  444 (638)
                      |.++.+.+..       ..++......++.+++++|+.||+..                                     
T Consensus        84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9888775531       23666777788888888888888520                                     


Q ss_pred             ----------------CCCeEecccCCCceEECC--CCceEEccccccee
Q 006620          445 ----------------NTRILHFDIKPHNILLDE--DFCPKISDFGLAKI  476 (638)
Q Consensus       445 ----------------~~~iiH~Dikp~NIll~~--~~~~kl~DFg~~~~  476 (638)
                                      ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            246799999999999988  66789999987764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.09  E-value=1e-09  Score=99.18  Aligned_cols=129  Identities=19%  Similarity=0.277  Sum_probs=95.9

Q ss_pred             ccCcCcceeEEEEEEcCCCEEEEEEecccCC---------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+++|+-+.+|.+.+. +..+++|.-....-         ..+.-.+|+.++.++.--.|.-..=+..+.....++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999763 44577775332211         1235578999998887544433333445667778999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +|..|.+.+...             ...++..+-..+.-||.   .||+|+||.++||++..+ .+.++|||++..
T Consensus        82 ~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA-------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc-------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            999999998764             13466667777788999   999999999999999655 499999999884

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.08  E-value=2e-09  Score=110.76  Aligned_cols=218  Identities=17%  Similarity=0.245  Sum_probs=153.1

Q ss_pred             ceeEEEEE-EcCCCEEEEEEecccCCc-hhhHHHHHHHHhhcCCcceEEEEeEEEe----CceEEEEEEeccC-CCHHHH
Q 006620          336 YGGVYKGK-LLDGQNVAIKVLNETKGN-GEDFINEVASISRTSHVNIVTLLGFCFE----GHRRALIYEFVSN-GSLEKF  408 (638)
Q Consensus       336 ~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~  408 (638)
                      -.+.||+. ..||..|++|+++-.+.. ...-..-+++++++.|+|+|++.+++..    +..+++|++|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            45789997 567999999999433221 1123456788999999999999998873    4568899999985 688887


Q ss_pred             hhhcCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          409 IHEKHP---------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       409 l~~~~~---------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      ......         ......++++.+|.++.|+..||.++|+   .|...+-|.|.+|+++.+.+++|+.-|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            654332         2234568899999999999999999999   8999999999999999888999998887776544


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      +..                |.+..     ..+-|.=.||.+++.|.||..--.....      ...              
T Consensus       446 d~~----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~------~~~--------------  484 (655)
T KOG3741|consen  446 DPT----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDS------TQS--------------  484 (655)
T ss_pred             CCC----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccc------hHH--------------
Confidence            330                11211     2356888899999999999632111000      000              


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML  599 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  599 (638)
                       .........++.++.+++.-....++++ -++++++.++
T Consensus       485 -s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  485 -SHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             -HHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence             0001122345666777777777777776 6777776655

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.02  E-value=1.3e-10  Score=122.22  Aligned_cols=241  Identities=20%  Similarity=0.174  Sum_probs=167.1

Q ss_pred             hhcccCcCcceeEEEEEE--cCCCEEEEEEecccCCc---hhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEec
Q 006620          327 FKNKLGQGGYGGVYKGKL--LDGQNVAIKVLNETKGN---GEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      ....||.|.|+.|++...  .++..|++|.+.+....   ...-..|+-+...+. |.++++.+..+...+..|+=.||+
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~  348 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC  348 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence            356899999999999863  45778999987654221   112245666665554 889999888888888888889999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC-CceEEcccccceeccC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICEG  479 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFg~~~~~~~  479 (638)
                      .++++...+.-.      ..+.+..++++..|++.++.++|+   +.++|+|+||+||++..+ +.-+++|||....+.-
T Consensus       349 ~~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  349 EGGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cCcchhhhhHHH------HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccce
Confidence            999887766332      457778889999999999999999   999999999999999775 8889999998874322


Q ss_pred             CCceeeeccccccccee-cCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYI-APEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...     ...++-++. ..|.+... ..+-.+.|++|||..+.+.+++...-.... ....+                 
T Consensus       420 ~~~-----~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-~~~~i-----------------  475 (524)
T KOG0601|consen  420 SSG-----VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGV-QSLTI-----------------  475 (524)
T ss_pred             ecc-----cccccccccccchhhccc-cccccccccccccccccccccCcccCcccc-cceee-----------------
Confidence            111     111233444 24554433 367789999999999999998875322110 00000                 


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ..+...... ...+.+..+...++..++..||.+.++..+.+-
T Consensus       476 ~~~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  476 RSGDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ecccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            011001111 112556677788889999999999888765543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.02  E-value=3.9e-09  Score=94.80  Aligned_cols=142  Identities=23%  Similarity=0.295  Sum_probs=103.4

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccC---------CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK---------GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      ...|-+|+-+.|+++.+ .|+...||.--...         -......+|++.+.++.--.|.-..-++.+...-.|+||
T Consensus        12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            35688999999999988 57777777532211         122456789999988874444433345566667789999


Q ss_pred             eccC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC---ceEEcccccc
Q 006620          399 FVSN-GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFGLA  474 (638)
Q Consensus       399 ~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFg~~  474 (638)
                      |++| .++.+++.....    ..........++..+-+.+.-||.   .+|||+||..+||++.+++   .+.++|||++
T Consensus        91 ~~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             eccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence            9976 488888877532    223333447888889999999999   8999999999999996443   3589999998


Q ss_pred             eec
Q 006620          475 KIC  477 (638)
Q Consensus       475 ~~~  477 (638)
                      ...
T Consensus       164 ~~s  166 (229)
T KOG3087|consen  164 SVS  166 (229)
T ss_pred             hcc
Confidence            753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=3.3e-09  Score=99.13  Aligned_cols=125  Identities=24%  Similarity=0.301  Sum_probs=83.3

Q ss_pred             eEEEEEEcCCCEEEEEEecccC-------------Cc--------------hhhHHHHHHHHhhcCCc--ceEEEEeEEE
Q 006620          338 GVYKGKLLDGQNVAIKVLNETK-------------GN--------------GEDFINEVASISRTSHV--NIVTLLGFCF  388 (638)
Q Consensus       338 ~Vy~~~~~~~~~vavK~~~~~~-------------~~--------------~~~~~~E~~~l~~l~h~--niv~l~~~~~  388 (638)
                      .||.|...++..+|||+.+...             ..              .....+|.+.|.++..-  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999975321             00              12356799999999855  567776542 


Q ss_pred             eCceEEEEEEecc--CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecccCCCceEECCCCc
Q 006620          389 EGHRRALIYEFVS--NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY-LHRGCNTRILHFDIKPHNILLDEDFC  465 (638)
Q Consensus       389 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~~~~iiH~Dikp~NIll~~~~~  465 (638)
                         .-.|||||++  |..+..+....        ++.+....++.+++..+.. +|.   .|++|+||.+.||+++++ .
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-C
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-e
Confidence               3479999998  65555443322        1133456777788885555 578   899999999999999877 9


Q ss_pred             eEEcccccceecc
Q 006620          466 PKISDFGLAKICE  478 (638)
Q Consensus       466 ~kl~DFg~~~~~~  478 (638)
                      +.|+|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.97  E-value=9.8e-09  Score=103.12  Aligned_cols=270  Identities=16%  Similarity=0.162  Sum_probs=165.6

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEE--------EEeEEEeCceEEEEEE
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVT--------LLGFCFEGHRRALIYE  398 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------l~~~~~~~~~~~lv~e  398 (638)
                      .+-||+|+-+.+|..-.  -+..+.|+........+  ...++.|... .||-+-.        ++|- ..+...-++|.
T Consensus        16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecch--hhchhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEecc
Confidence            57899999999996531  12235577765432211  1222233322 3553322        1221 11233567788


Q ss_pred             eccCC-CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          399 FVSNG-SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       399 ~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      .+++. .+.+++.............|..+++.++.++.+.+-||.   .|.+-+|+.++|+|+++++.|.|.|=..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence            77653 455555544434455668999999999999999999999   99999999999999999999999986655544


Q ss_pred             cCCCceeeecccccccceecCceec-ccc--CCccccCCeeeHHHHHHHHhcC-CCCCCcccCCCcccchhHH--HHHHh
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFC-RNF--GEVSYKSDVYSYGMMVFEMTGE-KNNANVAVDRSSEIYFPHW--VYKRL  551 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~s~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~--~~~~~  551 (638)
                      .+..   .+...+|...|.+||... +.+  ..-+...|.|.|||++++++.| ++||...........-.+.  .....
T Consensus       168 ~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         168 ANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             cCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            3222   245678899999999864 211  1346688999999999997765 9999765544332211110  00000


Q ss_pred             hhhhh--cccc-CCCCchhHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHhcccCCCCC
Q 006620          552 ELEED--LGLQ-GIENEEDKEYARKMILVSLWCIQT--NPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       552 ~~~~~--~~~~-~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      ....+  .-.. ........-...++..+-.+|+..  +++-|||++-++..|..+.+++.+
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            00000  0000 000111122334455566677765  367999999999888776665544

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.89  E-value=2.7e-08  Score=98.80  Aligned_cols=132  Identities=20%  Similarity=0.111  Sum_probs=96.2

Q ss_pred             eeEEEEEEcCCCEEEEEEecccCC------------chhhHHHHHHHHhhcCCcc--eEEEEeEEEe-----CceEEEEE
Q 006620          337 GGVYKGKLLDGQNVAIKVLNETKG------------NGEDFINEVASISRTSHVN--IVTLLGFCFE-----GHRRALIY  397 (638)
Q Consensus       337 g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv~  397 (638)
                      ..|.+... +|+.|.||.......            ....+.+|...+.++...+  .++++++...     ....+||+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            34666655 677899997643220            1114778999888886333  3444555443     23568999


Q ss_pred             EeccCC-CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-------CCceEEc
Q 006620          398 EFVSNG-SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-------DFCPKIS  469 (638)
Q Consensus       398 e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-------~~~~kl~  469 (638)
                      |++++. +|.+++....    ....+......++.+++..++-||+   .||+|+|+++.|||++.       +..+.|+
T Consensus       115 e~l~~~~sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        115 EDLAPTISLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             eeCCCCccHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            999876 8999986431    1334567788999999999999999   99999999999999975       5689999


Q ss_pred             cccccee
Q 006620          470 DFGLAKI  476 (638)
Q Consensus       470 DFg~~~~  476 (638)
                      ||+.++.
T Consensus       188 Dl~r~~~  194 (268)
T PRK15123        188 DLHRAQI  194 (268)
T ss_pred             ECCcccc
Confidence            9997753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.87  E-value=1.4e-08  Score=97.35  Aligned_cols=133  Identities=23%  Similarity=0.244  Sum_probs=95.0

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccC-------------------C----chhhHHHHHHHHhhcCCc--ce
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK-------------------G----NGEDFINEVASISRTSHV--NI  380 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------------~----~~~~~~~E~~~l~~l~h~--ni  380 (638)
                      .+.++||.|.-|.||.|...++.++|||.-+...                   +    ......+|.+.|++|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4568999999999999999999999999753210                   0    112356799999998744  67


Q ss_pred             EEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE
Q 006620          381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL  460 (638)
Q Consensus       381 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll  460 (638)
                      .+.+++    +.-.+|||+++|-.|...-           ++.+....++..|++-+.-+-.   .||||+|+.+-||++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV  235 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV  235 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence            776664    5568999999986664432           1122233333334443333334   799999999999999


Q ss_pred             CCCCceEEccccccee
Q 006620          461 DEDFCPKISDFGLAKI  476 (638)
Q Consensus       461 ~~~~~~kl~DFg~~~~  476 (638)
                      +++|.++++||-.+..
T Consensus       236 ~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         236 TEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ecCCCEEEEeCccccc
Confidence            9999999999976553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.82  E-value=9e-10  Score=121.86  Aligned_cols=240  Identities=18%  Similarity=0.185  Sum_probs=153.2

Q ss_pred             ccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          330 KLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      -+-+|.++.+..++- ..+...++|+......    +.+....+-.++-...+|-+++..--+......+|+++|..+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            456677777776652 2233334443322211    11111222222222334555554444455677899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc------
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE------  478 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~------  478 (638)
                      |...|+..+      ..+.+.....+..+..+++|||.   ..+.|+|++|+|++...++..+++||+......      
T Consensus       891 ~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  891 LPSKLHNSG------CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             chhhhhcCC------CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            999988753      34445556667778899999998   679999999999999999999999998432210      


Q ss_pred             CC-------------------Cce----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCccc
Q 006620          479 GR-------------------ESI----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAV  535 (638)
Q Consensus       479 ~~-------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~  535 (638)
                      ..                   +..    .......||+.|.+||.+.+.  .....+|.|++|+.++|.++|.+||....
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence            00                   000    112234589999999999876  56778999999999999999999998654


Q ss_pred             CCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 006620          536 DRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMN  593 (638)
Q Consensus       536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  593 (638)
                      ...        +.+.+.. .++..    ...+.....++.+++...+..+|.+|-.+.
T Consensus      1040 pq~--------~f~ni~~-~~~~~----p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQ--------IFENILN-RDIPW----PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhh--------hhhcccc-CCCCC----CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            321        1111100 11111    112223345667788888899999997765

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=6.2e-07  Score=84.33  Aligned_cols=137  Identities=15%  Similarity=0.092  Sum_probs=101.8

Q ss_pred             cCcCcceeEEEEEEcCCCEEEEEEeccc-------CCchhhHHHHHHHHhhcCCc--ceEEEEeEEEe----CceEEEEE
Q 006620          331 LGQGGYGGVYKGKLLDGQNVAIKVLNET-------KGNGEDFINEVASISRTSHV--NIVTLLGFCFE----GHRRALIY  397 (638)
Q Consensus       331 lG~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----~~~~~lv~  397 (638)
                      -|.||.+.|+..... |+.+-+|.....       .-....|.+|+..|+++..-  .+.++......    ...-+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            467999999998764 446888876521       12346899999999998632  24454422111    22357899


Q ss_pred             EeccC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc--eEEcccccc
Q 006620          398 EFVSN-GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--PKISDFGLA  474 (638)
Q Consensus       398 e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DFg~~  474 (638)
                      |-+.+ .+|.+++....    ....+......++.+++.+++-||+   .|+.|+|+-+.||+++.++.  ++++||.-+
T Consensus       105 e~L~g~~~L~~~l~~~~----~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        105 EDMAGFISIADWYAQHA----VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EeCCCCccHHHHHhcCC----cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            97753 58999986532    1345777788999999999999999   99999999999999986667  999999765


Q ss_pred             e
Q 006620          475 K  475 (638)
Q Consensus       475 ~  475 (638)
                      +
T Consensus       178 r  178 (216)
T PRK09902        178 R  178 (216)
T ss_pred             c
Confidence            5

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=8.9e-08  Score=102.90  Aligned_cols=141  Identities=21%  Similarity=0.222  Sum_probs=92.1

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCC----------------------c-----h----h----------hHHH
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG----------------------N-----G----E----------DFIN  367 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~-----~----~----------~~~~  367 (638)
                      +-|+.++-|.||+|++.+|+.||||+.+..-.                      .     .    +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999999764310                      0     0    0          1334


Q ss_pred             HHHHHhhcC----CcceEEEEeEEE-eCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 006620          368 EVASISRTS----HVNIVTLLGFCF-EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR  442 (638)
Q Consensus       368 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~  442 (638)
                      |...+.+++    +..-+++-.++. ......|+|||++|..+.+...-....-..+.+.......++.|+..       
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~-------  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-------  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh-------
Confidence            555555443    233344444443 35677899999999999888432210000011222222222233222       


Q ss_pred             CCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       443 ~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                         .|++|.|.+|.||+++.+|++.+.|||+...+..
T Consensus       284 ---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 ---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               6899999999999999999999999999876643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=3.9e-07  Score=87.48  Aligned_cols=107  Identities=21%  Similarity=0.209  Sum_probs=84.1

Q ss_pred             hhhHHHHHHHHhhcCCc--ceEEEEeEEEeC----ceEEEEEEeccC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHH
Q 006620          362 GEDFINEVASISRTSHV--NIVTLLGFCFEG----HRRALIYEFVSN-GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIA  434 (638)
Q Consensus       362 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~  434 (638)
                      .....+|...+.++...  ...+.+++....    ...++|+|++++ .+|.+++....      ..+......++.+++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALA  128 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHH
Confidence            34678888888877633  345566655542    245899999987 48999998742      255667889999999


Q ss_pred             HHHHHHhcCCCCCeEecccCCCceEECCCC---ceEEcccccceec
Q 006620          435 RGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFGLAKIC  477 (638)
Q Consensus       435 ~aL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFg~~~~~  477 (638)
                      +.++-||+   .||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       129 ~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  129 RLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999   9999999999999998877   8999999877643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.56  E-value=2e-08  Score=107.43  Aligned_cols=153  Identities=18%  Similarity=0.300  Sum_probs=101.4

Q ss_pred             HHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee--eec-----ccccccceecCceec
Q 006620          430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV--SMT-----GARGTIGYIAPEVFC  502 (638)
Q Consensus       430 ~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~--~~~-----~~~gt~~y~aPE~~~  502 (638)
                      +.+++.|+.|+|..  .++||++|.|++|.++.++..||+.|+.+........+.  .+.     -..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34456999999994  799999999999999999999999999876554421110  001     112356799999997


Q ss_pred             cccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcc
Q 006620          503 RNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCI  582 (638)
Q Consensus       503 ~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  582 (638)
                      +.  ..+.++|++|+|+++|.+..|+.+.-........   ........    +....+    ....++.++.+=+.+++
T Consensus       183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~~~~~~~~----~~~~~~----~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---YSFSRNLL----NAGAFG----YSNNLPSELRESLKKLL  249 (700)
T ss_pred             cc--cccccccceeeeeEEEEEecCCcchhhccCCcch---hhhhhccc----cccccc----ccccCcHHHHHHHHHHh
Confidence            74  6788999999999999999444432222111100   00000000    000111    12445667888888899


Q ss_pred             cCCCCCCCCHHHHHH
Q 006620          583 QTNPSDRPSMNRVVE  597 (638)
Q Consensus       583 ~~dP~~RPs~~evl~  597 (638)
                      ..++..||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.41  E-value=4.2e-06  Score=81.41  Aligned_cols=141  Identities=17%  Similarity=0.242  Sum_probs=85.7

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcc--eEEEEeEEEeCceEEEEEEeccCCC-H
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN--IVTLLGFCFEGHRRALIYEFVSNGS-L  405 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-L  405 (638)
                      ..||+|..+.||+.   .+..+++|...... ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            57899999999984   24567889876533 3455788999999887433  4677777777777889999998863 2


Q ss_pred             HHH------------------hhhcCCCCCCCCCCHHHH-HHHHH----------HHHH-HHHHHhc-CCCCCeEecccC
Q 006620          406 EKF------------------IHEKHPLETNQKLKWEVL-YKIAV----------GIAR-GLEYLHR-GCNTRILHFDIK  454 (638)
Q Consensus       406 ~~~------------------l~~~~~~~~~~~l~~~~~-~~i~~----------qi~~-aL~yLH~-~~~~~iiH~Dik  454 (638)
                      .+.                  +..-+.... ...+.... ..+-.          .+.+ ..++|.. .....++|+|+.
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            111                  111111100 00111100 00000          0111 1122221 112467999999


Q ss_pred             CCceEECCCCceEEcccccce
Q 006620          455 PHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       455 p~NIll~~~~~~kl~DFg~~~  475 (638)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999887 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.32  E-value=4e-06  Score=89.88  Aligned_cols=142  Identities=20%  Similarity=0.283  Sum_probs=92.2

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCch--------------------------------------hhHHHHH
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNG--------------------------------------EDFINEV  369 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------------------~~~~~E~  369 (638)
                      .+-||.-+.|.||+|++.+|+.||||+-+..-...                                      =+|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999976431100                                      0244555


Q ss_pred             HHHhhc----CCcc---eEEEEeEEEe-CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 006620          370 ASISRT----SHVN---IVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH  441 (638)
Q Consensus       370 ~~l~~l----~h~n---iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH  441 (638)
                      +...+.    .|-+   -|++-.++.+ ....+|+|||++|..+.|.-.-..     ..++...+   +..+.++  |++
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i---~~~l~~~--~~~  315 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-----RGISPHDI---LNKLVEA--YLE  315 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-----cCCCHHHH---HHHHHHH--HHH
Confidence            444433    3555   2233343332 456799999999988776533221     23444433   3333332  222


Q ss_pred             cCCCCCeEecccCCCceEECC----CCceEEcccccceeccC
Q 006620          442 RGCNTRILHFDIKPHNILLDE----DFCPKISDFGLAKICEG  479 (638)
Q Consensus       442 ~~~~~~iiH~Dikp~NIll~~----~~~~kl~DFg~~~~~~~  479 (638)
                      +-...|++|.|-+|.||+++.    ++.+.+-|||+...+..
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            222268999999999999983    67899999999886653

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.31  E-value=6e-06  Score=78.78  Aligned_cols=137  Identities=22%  Similarity=0.307  Sum_probs=93.2

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCc--------------------hhh-----HHHHHHHHhhcC--CcceE
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN--------------------GED-----FINEVASISRTS--HVNIV  381 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~-----~~~E~~~l~~l~--h~niv  381 (638)
                      ..|.+|.-+.||+|...++..+|||+.+.....                    ...     ..+|+..|+++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            467888999999999888999999998643211                    011     245777777775  44445


Q ss_pred             EEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC
Q 006620          382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD  461 (638)
Q Consensus       382 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~  461 (638)
                      +-+++.    .-.|||||+....+     ..+.+. ...+..+....+..++++.+.-|-.  ..++||+||..-|||+.
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~-----pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGL-----PAPRLK-DVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH  201 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCC-----CCCCcc-cCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE
Confidence            555542    34799999954311     111111 1223333566777778777777765  27899999999999998


Q ss_pred             CCCceEEcccccceecc
Q 006620          462 EDFCPKISDFGLAKICE  478 (638)
Q Consensus       462 ~~~~~kl~DFg~~~~~~  478 (638)
                       ++.+.|+||+.|....
T Consensus       202 -~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 -DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CCeEEEEECccccccC
Confidence             8899999999887543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.30  E-value=6.5e-06  Score=77.76  Aligned_cols=129  Identities=16%  Similarity=0.167  Sum_probs=82.3

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCchh----------hHHHHHHHHhhcCC---cceEEEEeE-----EEe
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGE----------DFINEVASISRTSH---VNIVTLLGF-----CFE  389 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~E~~~l~~l~h---~niv~l~~~-----~~~  389 (638)
                      .+.+-......|.+-.. +++.+++|.........+          ...+++..+.++..   .....++.+     +..
T Consensus        36 ~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~  114 (229)
T PF06176_consen   36 IKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY  114 (229)
T ss_pred             EEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence            34555555566666555 678999998865432222          22334444444432   222222222     222


Q ss_pred             CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEc
Q 006620          390 GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS  469 (638)
Q Consensus       390 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  469 (638)
                      ....+++|||++|..|.+...          +++    .++..+++++.-||+   .|+.|+|.+|.|++++++ .++++
T Consensus       115 ~~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iI  176 (229)
T PF06176_consen  115 TSSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRII  176 (229)
T ss_pred             eeEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEE
Confidence            345568999999988876532          222    245567788999999   999999999999999855 59999


Q ss_pred             ccccce
Q 006620          470 DFGLAK  475 (638)
Q Consensus       470 DFg~~~  475 (638)
                      ||+..+
T Consensus       177 D~~~k~  182 (229)
T PF06176_consen  177 DTQGKR  182 (229)
T ss_pred             ECcccc
Confidence            997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.22  E-value=1.8e-05  Score=78.30  Aligned_cols=142  Identities=13%  Similarity=0.106  Sum_probs=85.3

Q ss_pred             cCcCcc-eeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEeccCCCHHHH
Q 006620          331 LGQGGY-GGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF  408 (638)
Q Consensus       331 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~  408 (638)
                      |-.|.. ..||+.... +..+.||+.....  .....+|+++++.+. +--+.+++++...++..++|||+++|.+|.+.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            445555 789999764 4788899875442  345678888888875 44466778777766678899999999877643


Q ss_pred             h----------------hhcCCCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHhc----CCC
Q 006620          409 I----------------HEKHPLET-NQKLKWE--VLYKIAV--------------------GIARGLEYLHR----GCN  445 (638)
Q Consensus       409 l----------------~~~~~~~~-~~~l~~~--~~~~i~~--------------------qi~~aL~yLH~----~~~  445 (638)
                      .                ...+.... ...+...  .......                    .+.+.+..|-.    ...
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            1                11111111 0011100  0000000                    01111222211    112


Q ss_pred             CCeEecccCCCceEECCCCceEEcccccce
Q 006620          446 TRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       446 ~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            569999999999999988778899998665

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.17  E-value=3.9e-07  Score=96.50  Aligned_cols=183  Identities=19%  Similarity=0.083  Sum_probs=132.0

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcc-eEEEEeEEEeCceEEEEEEeccCC-CH
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN-IVTLLGFCFEGHRRALIYEFVSNG-SL  405 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL  405 (638)
                      -+.+++|++++++|.+....+....+.+...    ....-++++|.+++||| .++.++-+..+....++++++.++ +-
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            3457889999999998544555556665443    34456889999999999 667667666677788899998766 22


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      ...+..     ....+..-+...+.+.-++++++||+   ..=+|+|    ||+..+ +..|..||+....+....   .
T Consensus       323 ~~~~~~-----se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~  386 (829)
T KOG0576|consen  323 ALEMTV-----SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K  386 (829)
T ss_pred             cccCCh-----hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---c
Confidence            222111     11234445566777778889999998   4457888    877754 689999999887665543   2


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNAN  532 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~  532 (638)
                      .....+|+.++|||+....  .+....|+|++|+-..+|.-|.+|-.
T Consensus       387 ~~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCCCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence            3445689999999988664  67789999999998888887777643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.17  E-value=1.3e-05  Score=78.47  Aligned_cols=145  Identities=21%  Similarity=0.200  Sum_probs=84.5

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCc--ceEEEEeEEEe---CceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV--NIVTLLGFCFE---GHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~g  403 (638)
                      +.|+.|..+.||+....+ +.+++|+.... .....+.+|..+++.+...  .+.+++.....   ....+++|++++|.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            468899999999999866 69999997655 3445677888888887633  35666664432   33568999999998


Q ss_pred             CHHH----------------HhhhcCCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc--
Q 006620          404 SLEK----------------FIHEKHPL-ETNQKLKWEV---------LYKI------------AVGIAR-GLEYLHR--  442 (638)
Q Consensus       404 sL~~----------------~l~~~~~~-~~~~~l~~~~---------~~~i------------~~qi~~-aL~yLH~--  442 (638)
                      ++.+                .+...+.. ..........         ....            ...+.+ .++.+++  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            7777                22211111 0001111100         0000            111222 2333332  


Q ss_pred             --CCCCCeEecccCCCceEEC-CCCceEEcccccce
Q 006620          443 --GCNTRILHFDIKPHNILLD-EDFCPKISDFGLAK  475 (638)
Q Consensus       443 --~~~~~iiH~Dikp~NIll~-~~~~~kl~DFg~~~  475 (638)
                        .....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              1346799999999999998 66667899998655

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.16  E-value=4.2e-05  Score=72.24  Aligned_cols=127  Identities=24%  Similarity=0.316  Sum_probs=91.5

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccC-----------------CchhhHHHHHHHHhhcC------CcceEEEE
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK-----------------GNGEDFINEVASISRTS------HVNIVTLL  384 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~l~  384 (638)
                      ...||+|+.-.||.-  .+.....||+.....                 ....+..+|+....++.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            357999999999954  445667888886554                 22345667777666665      78899999


Q ss_pred             eEEEeCceEEEEEEeccC------CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCce
Q 006620          385 GFCFEGHRRALIYEFVSN------GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI  458 (638)
Q Consensus       385 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NI  458 (638)
                      |+..++....+|+|.+.+      .+|.+++...       .++. ...+.+.   +-.+||-+   ..|+.+|++|.||
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-------~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NI  149 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-------GLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNI  149 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-------CccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccE
Confidence            999999999999998753      3788888653       3544 3334333   44566777   7899999999999


Q ss_pred             EECC---CC-ceEEcc
Q 006620          459 LLDE---DF-CPKISD  470 (638)
Q Consensus       459 ll~~---~~-~~kl~D  470 (638)
                      ++..   +. .+.|+|
T Consensus       150 v~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  150 VVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEecCCCceEEEEEe
Confidence            9942   22 577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.13  E-value=1e-05  Score=76.08  Aligned_cols=106  Identities=27%  Similarity=0.296  Sum_probs=84.1

Q ss_pred             HHHHHHHhhcCC-cceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 006620          366 INEVASISRTSH-VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC  444 (638)
Q Consensus       366 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~  444 (638)
                      .+|..+++.+++ +++++++|+|-    .++|.||...+++....   ..+.....-+|..+.+|+.++++.+.+|+...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~---~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY---RPLSQFLQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc---cccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            358888888886 69999999984    36799999877665321   01111234689999999999999999999876


Q ss_pred             CCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       445 ~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      ...+.-.|++|+|+-+++++++|++|........
T Consensus        80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             CCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            6678999999999999999999999998765443

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.97  E-value=8.3e-05  Score=73.03  Aligned_cols=143  Identities=20%  Similarity=0.194  Sum_probs=82.1

Q ss_pred             cccCcCcceeEEEEEEcC--CCEEEEEEecccCCchhhHHHHHHHHhhcCCc-ceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          329 NKLGQGGYGGVYKGKLLD--GQNVAIKVLNETKGNGEDFINEVASISRTSHV-NIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      +.|..|-...+|+....+  ++.|++|+........-...+|+.+++.+... -.+++++...  .  .++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence            457778888999998654  67899998765432222345788888888533 3445544332  1  479999998765


Q ss_pred             HH--------------HhhhcCCCCCCC--------CC-CHHHHHHHHH----------------------HHH---HHH
Q 006620          406 EK--------------FIHEKHPLETNQ--------KL-KWEVLYKIAV----------------------GIA---RGL  437 (638)
Q Consensus       406 ~~--------------~l~~~~~~~~~~--------~l-~~~~~~~i~~----------------------qi~---~aL  437 (638)
                      ..              .+.+.+......        .. .++.+..+..                      .+.   ..|
T Consensus        80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  159 (235)
T cd05157          80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL  159 (235)
T ss_pred             CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence            31              112111111110        11 1222222211                      111   111


Q ss_pred             H-HHhcC-CCCCeEecccCCCceEECC-CCceEEcccccce
Q 006620          438 E-YLHRG-CNTRILHFDIKPHNILLDE-DFCPKISDFGLAK  475 (638)
Q Consensus       438 ~-yLH~~-~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~~  475 (638)
                      . .+... ....++|+|+.+.|||+++ ++.+.|+||..+.
T Consensus       160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            1 11111 2357999999999999997 5789999997655

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.94  E-value=5.6e-05  Score=74.26  Aligned_cols=73  Identities=14%  Similarity=0.262  Sum_probs=46.2

Q ss_pred             cccCcCcce-eEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCc---ceEEEEeEEEeC---ceEEEEEEecc
Q 006620          329 NKLGQGGYG-GVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV---NIVTLLGFCFEG---HRRALIYEFVS  401 (638)
Q Consensus       329 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~~  401 (638)
                      +.|+.|+.. .||+.    +..+++|+.... .....+.+|.++++.+...   .+.++++.....   ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            457777766 58875    235778876542 2345788899998887632   344444433322   23478999999


Q ss_pred             CCCHH
Q 006620          402 NGSLE  406 (638)
Q Consensus       402 ~gsL~  406 (638)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            87663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.94  E-value=7.2e-05  Score=67.58  Aligned_cols=127  Identities=20%  Similarity=0.219  Sum_probs=88.6

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      .+.||+|++|.||++.+. +..+|+|+-..+. ....+..|+++|..++--++ .+++.+-.+    ++.|||+.|-+|.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~  100 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLG  100 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchh
Confidence            467999999999999984 5689999876543 44678899999999885554 445554332    3559999998887


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccC-CCceEECCCCceEEccccccee
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK-PHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dik-p~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +.-...         +    .+-+..++++---|-.   .||-|+.|. |...++-.++.+.|+||..|+.
T Consensus       101 ~~~~~~---------~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         101 KLEIGG---------D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcc---------c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            664421         1    2234456666444444   899999986 4444444555999999998873

>PLN02876 acyl-CoA dehydrogenase

Probab=97.89  E-value=0.00012  Score=85.11  Aligned_cols=150  Identities=13%  Similarity=0.228  Sum_probs=92.1

Q ss_pred             hcccCcCcceeEEEEEEcCC---CEEEEEEecccC--CchhhHHHHHHHHhhcC-Ccce--EEEEeEEEeC---ceEEEE
Q 006620          328 KNKLGQGGYGGVYKGKLLDG---QNVAIKVLNETK--GNGEDFINEVASISRTS-HVNI--VTLLGFCFEG---HRRALI  396 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  396 (638)
                      .+.++.|.+..+|+....++   ..+++|+.....  .....+.+|+++++.+. |.++  .+++.++.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            35789999999999876543   367888764322  22346789999999996 6654  7888877654   457899


Q ss_pred             EEeccCCCHHH--------------------HhhhcCCCCC--------CCCCC--HHHHHHHH---------------H
Q 006620          397 YEFVSNGSLEK--------------------FIHEKHPLET--------NQKLK--WEVLYKIA---------------V  431 (638)
Q Consensus       397 ~e~~~~gsL~~--------------------~l~~~~~~~~--------~~~l~--~~~~~~i~---------------~  431 (638)
                      |||++|..+.+                    .|..-+....        .....  ...+..+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998864321                    1111111110        00001  11222111               1


Q ss_pred             HHHHHHHHHhcCCC--------CCeEecccCCCceEECC-CCc-eEEcccccceec
Q 006620          432 GIARGLEYLHRGCN--------TRILHFDIKPHNILLDE-DFC-PKISDFGLAKIC  477 (638)
Q Consensus       432 qi~~aL~yLH~~~~--------~~iiH~Dikp~NIll~~-~~~-~kl~DFg~~~~~  477 (638)
                      .+.+.+++|..+.+        ..++|+|+++.||+++. ++. +-|.||+++..-
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            23344667754322        35999999999999974 333 579999987643

>PRK10593 hypothetical protein; Provisional

Probab=97.86  E-value=0.00026  Score=72.04  Aligned_cols=76  Identities=14%  Similarity=0.075  Sum_probs=57.0

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCC---cceEEEEeEEEe---CceEEEEEEecc
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSH---VNIVTLLGFCFE---GHRRALIYEFVS  401 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~~  401 (638)
                      .+.||.|..+.||+....++ .+++|..+. ......+..|.+.++.+..   -.+.++++.+..   .+..+||||+++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~   96 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR   96 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence            46799999999999876555 477787543 2234578899999988863   367888887754   366899999999


Q ss_pred             CCCH
Q 006620          402 NGSL  405 (638)
Q Consensus       402 ~gsL  405 (638)
                      ++++
T Consensus        97 G~~~  100 (297)
T PRK10593         97 GVSV  100 (297)
T ss_pred             CEec
Confidence            8765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.79  E-value=5.8e-05  Score=85.82  Aligned_cols=198  Identities=17%  Similarity=0.195  Sum_probs=135.3

Q ss_pred             HHHHHHHhhcCCcceEEEEeEEEeCceEE----EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 006620          366 INEVASISRTSHVNIVTLLGFCFEGHRRA----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH  441 (638)
Q Consensus       366 ~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH  441 (638)
                      ..|++.+.++.|+|++.++.|-......-    +..|++...++...+...      ..++.+..+.+..++.+||+|+|
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v------~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV------GSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc------cccCHHHHHHHHHHHhhhHHHHH
Confidence            44667788889999999999877644332    446788888888888764      56889999999999999999999


Q ss_pred             cCCCCCeEecccCCC---ceEECCCCceEEc--ccccceeccCCCceeeecccccccceecCceeccccCCccccCCeee
Q 006620          442 RGCNTRILHFDIKPH---NILLDEDFCPKIS--DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYS  516 (638)
Q Consensus       442 ~~~~~~iiH~Dikp~---NIll~~~~~~kl~--DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvws  516 (638)
                      +   ....|.-+..+   +--.+..+.+.++  ||+.++.........   ....+..+.++|....+....+...|+|.
T Consensus       304 ~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 S---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             H---hccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHH
Confidence            9   54444444444   3334556667777  888887665443221   12235567888887665444555679999


Q ss_pred             HHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006620          517 YGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVV  596 (638)
Q Consensus       517 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  596 (638)
                      +|..+..+..|..+-......       .              .-+...    ......+...+|+.-++++|+++.+++
T Consensus       378 lgll~~~~~~~~~i~~~~~~~-------~--------------~~l~~~----~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSAVP-------V--------------SLLDVL----STSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHHhhhhhcCcccccccch-------h--------------hhhccc----cchhhhhhhhhhcchhhhhccchhhhh
Confidence            999999998876542211100       0              000000    011567788899999999999999999


Q ss_pred             HHHh
Q 006620          597 EMLE  600 (638)
Q Consensus       597 ~~L~  600 (638)
                      .+.-
T Consensus       433 ~~~f  436 (1351)
T KOG1035|consen  433 THPF  436 (1351)
T ss_pred             hchh
Confidence            7653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.76  E-value=0.00029  Score=65.94  Aligned_cols=121  Identities=27%  Similarity=0.407  Sum_probs=85.8

Q ss_pred             hhhcccCcCcc-eeEEEEEEcCCCEEEEEEeccc------------C----------CchhhHHHHHHHHhhcC---Ccc
Q 006620          326 SFKNKLGQGGY-GGVYKGKLLDGQNVAIKVLNET------------K----------GNGEDFINEVASISRTS---HVN  379 (638)
Q Consensus       326 ~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~------------~----------~~~~~~~~E~~~l~~l~---h~n  379 (638)
                      +|.+.||.|.- |.||+++. +|+.||+|+...-            .          .....|..|.+...+|+   +.+
T Consensus        40 ~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~  118 (207)
T PF13095_consen   40 EFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREG  118 (207)
T ss_pred             eeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccC
Confidence            46789999999 99999998 5789999993210            0          01134778888887776   445


Q ss_pred             e--EEEEeEEEeC------------------ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 006620          380 I--VTLLGFCFEG------------------HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY  439 (638)
Q Consensus       380 i--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~y  439 (638)
                      +  |+.+|+..-.                  ....||.||++...               .+.    .+-+.+|.+-|..
T Consensus       119 ~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  119 LWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccc----hhHHHHHHHHHHH
Confidence            5  9999987432                  12356777775432               112    2235667777888


Q ss_pred             HhcCCCCCeEecccCCCceEECCCCceEEcccccc
Q 006620          440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       440 LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      +|+   .||+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            999   99999999999985     4689999853

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.65  E-value=0.00032  Score=69.85  Aligned_cols=140  Identities=14%  Similarity=0.101  Sum_probs=79.4

Q ss_pred             cCcCcceeEEEEEEcCCCEEEEEEecccCCch-hhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEEeccCCCHHH-
Q 006620          331 LGQGGYGGVYKGKLLDGQNVAIKVLNETKGNG-EDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYEFVSNGSLEK-  407 (638)
Q Consensus       331 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~-  407 (638)
                      +..|-.+.+|+... +++.+++|+........ -...+|.++++.+....+ .++++...    -.+|+||++|..+.. 
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            55677889998874 56788899865432221 235678888888864322 34444322    368999999866532 


Q ss_pred             -------------HhhhcCCCCC-CCCCCHH-HHHHHHHH---------HHHHHHHHhcC-----CCCCeEecccCCCce
Q 006620          408 -------------FIHEKHPLET-NQKLKWE-VLYKIAVG---------IARGLEYLHRG-----CNTRILHFDIKPHNI  458 (638)
Q Consensus       408 -------------~l~~~~~~~~-~~~l~~~-~~~~i~~q---------i~~aL~yLH~~-----~~~~iiH~Dikp~NI  458 (638)
                                   .+.+-+.... ...++.. .+..+..+         +...++.+...     ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                         2222221111 1112211 11121111         11122222211     124689999999999


Q ss_pred             EECCCCceEEccccccee
Q 006620          459 LLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       459 ll~~~~~~kl~DFg~~~~  476 (638)
                      ++++++ +.|+||+.+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            998876 78999987653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.62  E-value=0.00076  Score=68.78  Aligned_cols=144  Identities=15%  Similarity=0.152  Sum_probs=84.6

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCc--ceEEEEeE------EEeCceEEEEEEec
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV--NIVTLLGF------CFEGHRRALIYEFV  400 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e~~  400 (638)
                      +.|..|....+|+.... +..+++|+...  ........|++++..+.+.  .+.+++..      ...++..++|++++
T Consensus        20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          20 EGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             ecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45777888899998764 45788898765  2334566788888777532  24444431      22345668999999


Q ss_pred             cCCCHHH-----------Hh---hhcC-CCCCC----CCCCHHHHH----------HHHHHHHHHHHHHhc----CCCCC
Q 006620          401 SNGSLEK-----------FI---HEKH-PLETN----QKLKWEVLY----------KIAVGIARGLEYLHR----GCNTR  447 (638)
Q Consensus       401 ~~gsL~~-----------~l---~~~~-~~~~~----~~l~~~~~~----------~i~~qi~~aL~yLH~----~~~~~  447 (638)
                      +|..+..           .+   +... .....    ....|....          .....+..++.++.+    ....+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            9866432           11   1100 00000    111111110          111123344444443    12357


Q ss_pred             eEecccCCCceEECCCCceEEcccccce
Q 006620          448 ILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       448 iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ++|+|+.|.||++++++.+.|+||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999988777899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.60  E-value=0.0004  Score=71.05  Aligned_cols=142  Identities=25%  Similarity=0.278  Sum_probs=83.9

Q ss_pred             ccCcCcceeEEEEEEcC-------CCEEEEEEecccCCchhhHHHHHHHHhhcCCcc-eEEEEeEEEeCceEEEEEEecc
Q 006620          330 KLGQGGYGGVYKGKLLD-------GQNVAIKVLNETKGNGEDFINEVASISRTSHVN-IVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .|..|-...+|+....+       ++.+++|+............+|.++++.+.... ..++++.+..    .+|+||++
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~   80 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP   80 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence            45566677999987654       578999997765444345678888888876332 3455555432    35899998


Q ss_pred             CCCHHHH--------------hhhcCCCCCCC------CCC--HHHHHH--------------------------HHHHH
Q 006620          402 NGSLEKF--------------IHEKHPLETNQ------KLK--WEVLYK--------------------------IAVGI  433 (638)
Q Consensus       402 ~gsL~~~--------------l~~~~~~~~~~------~l~--~~~~~~--------------------------i~~qi  433 (638)
                      |.++...              +.+.+......      ..+  +..+..                          +...+
T Consensus        81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (302)
T cd05156          81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE  160 (302)
T ss_pred             CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence            8766431              11111111100      111  111111                          11222


Q ss_pred             HHHHHHHhc------CCCCCeEecccCCCceEECCC----CceEEcccccce
Q 006620          434 ARGLEYLHR------GCNTRILHFDIKPHNILLDED----FCPKISDFGLAK  475 (638)
Q Consensus       434 ~~aL~yLH~------~~~~~iiH~Dikp~NIll~~~----~~~kl~DFg~~~  475 (638)
                      ...++.|..      .....++|+|+.|.||+++++    +.++++||..+.
T Consensus       161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            233344432      134679999999999999874    889999998765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.53  E-value=0.002  Score=66.53  Aligned_cols=144  Identities=15%  Similarity=0.214  Sum_probs=77.6

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCc--ceEEEEe------EEEeCceEEEEEEec
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV--NIVTLLG------FCFEGHRRALIYEFV  400 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~e~~  400 (638)
                      +.|+.|....+|+....++ .+++|+..  ....+....|+..++.|...  .+.+.+.      +....+..++++||+
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            3567777789999886555 68899876  22233444555666555321  1333332      122355678999999


Q ss_pred             cCCCHH-----------HHhhhcC----CCCC----CCCCCH-HHHH-H-----------HHHH-HHHHHHHHhc----C
Q 006620          401 SNGSLE-----------KFIHEKH----PLET----NQKLKW-EVLY-K-----------IAVG-IARGLEYLHR----G  443 (638)
Q Consensus       401 ~~gsL~-----------~~l~~~~----~~~~----~~~l~~-~~~~-~-----------i~~q-i~~aL~yLH~----~  443 (638)
                      +|..+.           +.|.+.+    ....    ...+.+ .... +           .+.+ +...++.+.+    .
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            886431           2221111    0100    011111 1111 0           1111 1122233321    1


Q ss_pred             CCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       444 ~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      -..++||+|++|.||+++.+...-|+||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            24689999999999999866556899998765

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.52  E-value=0.0021  Score=65.85  Aligned_cols=145  Identities=18%  Similarity=0.263  Sum_probs=82.2

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCc--ceEEEEeE------EEeCceEEEEEEec
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV--NIVTLLGF------CFEGHRRALIYEFV  400 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e~~  400 (638)
                      +.++.|....+|+....++ .+++|+..... ..+....|++++..|...  .+.+++..      ....+..++++||+
T Consensus        28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             cccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            4567777789999876444 67889875432 234555677777777422  23444331      12245678999999


Q ss_pred             cCCCHH-----------HH---hhhc-CCCCCC--C---CCCHHHHH------------HHHHHHHHHHHHHhc----CC
Q 006620          401 SNGSLE-----------KF---IHEK-HPLETN--Q---KLKWEVLY------------KIAVGIARGLEYLHR----GC  444 (638)
Q Consensus       401 ~~gsL~-----------~~---l~~~-~~~~~~--~---~l~~~~~~------------~i~~qi~~aL~yLH~----~~  444 (638)
                      +|..+.           ..   ++.. ......  .   .-.|....            .....+.+.++++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            885432           11   1110 000000  0   00111100            011123344555532    23


Q ss_pred             CCCeEecccCCCceEECCCCceEEcccccce
Q 006620          445 NTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       445 ~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      +.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            4789999999999999988777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.31  E-value=0.0039  Score=65.42  Aligned_cols=74  Identities=12%  Similarity=0.126  Sum_probs=53.3

Q ss_pred             cccCcCcceeEEEEEEcCC-CEEEEEEeccc--------CCchhhHHHHHHHHhhcC---CcceEEEEeEEEeCceEEEE
Q 006620          329 NKLGQGGYGGVYKGKLLDG-QNVAIKVLNET--------KGNGEDFINEVASISRTS---HVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.||.|....||++...+| +.++||.-...        .-..+....|.+.|+.+.   -.++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5789999999999998776 48999985421        113355677888888764   2457777776  44567899


Q ss_pred             EEeccCCC
Q 006620          397 YEFVSNGS  404 (638)
Q Consensus       397 ~e~~~~gs  404 (638)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.23  E-value=0.0003  Score=69.63  Aligned_cols=131  Identities=18%  Similarity=0.189  Sum_probs=89.9

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccC-------C------------c----hhhHHHHHHHHhhcC-Cc-ce
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK-------G------------N----GEDFINEVASISRTS-HV-NI  380 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~------------~----~~~~~~E~~~l~~l~-h~-ni  380 (638)
                      .+.++||-|.-+.||.+...+|++.++|.-...+       .            +    .-...+|+..|+.+. |. -+
T Consensus        95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV  174 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV  174 (465)
T ss_pred             hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence            4578999999999999999899999999643110       0            0    012456888888876 32 24


Q ss_pred             EEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE
Q 006620          381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL  460 (638)
Q Consensus       381 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll  460 (638)
                      .+.+++    .+.++|||++.+-.|...-+-         .+..++..-+.   .-+--|-.   .|+||+|..-=||++
T Consensus       175 PkpiD~----~RH~Vvmelv~g~Pl~~v~~v---------~d~~~ly~~lm---~~Iv~la~---~GlIHgDFNEFNimv  235 (465)
T KOG2268|consen  175 PKPIDH----NRHCVVMELVDGYPLRQVRHV---------EDPPTLYDDLM---GLIVRLAN---HGLIHGDFNEFNIMV  235 (465)
T ss_pred             CCcccc----cceeeHHHhhcccceeeeeec---------CChHHHHHHHH---HHHHHHHH---cCceecccchheeEE
Confidence            444443    456789999988777654322         22233333222   22334445   899999999999999


Q ss_pred             CCCCceEEcccccce
Q 006620          461 DEDFCPKISDFGLAK  475 (638)
Q Consensus       461 ~~~~~~kl~DFg~~~  475 (638)
                      ++++.++++||-..-
T Consensus       236 ~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQMV  250 (465)
T ss_pred             ecCCCEEEeechHhh
Confidence            999999999997554

>PLN02236 choline kinase

Probab=96.98  E-value=0.0089  Score=62.18  Aligned_cols=144  Identities=22%  Similarity=0.246  Sum_probs=82.9

Q ss_pred             cccCcCcceeEEEEEEcC-----CCEEEEEEecccCCchhhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLLD-----GQNVAIKVLNETKGNGEDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.|-.|-.-.+|+....+     ++.|++|+........-...+|..+++.+...++ .++++.+..+    .|.||+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            345557788999987532     3679999886643322233678888888864333 3556655332    57999987


Q ss_pred             CCHHH--------------HhhhcCCCCC---CCCCCHHHHHHHHHHH-----------------HHHHHHH----hc-C
Q 006620          403 GSLEK--------------FIHEKHPLET---NQKLKWEVLYKIAVGI-----------------ARGLEYL----HR-G  443 (638)
Q Consensus       403 gsL~~--------------~l~~~~~~~~---~~~l~~~~~~~i~~qi-----------------~~aL~yL----H~-~  443 (638)
                      .+|..              .+.+.+....   .....++.+.++..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            66532              1222111111   1112233333333221                 1112222    11 2


Q ss_pred             CCCCeEecccCCCceEECC-CCceEEccccccee
Q 006620          444 CNTRILHFDIKPHNILLDE-DFCPKISDFGLAKI  476 (638)
Q Consensus       444 ~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~~~  476 (638)
                      ....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2357899999999999976 46899999987653

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.82  E-value=0.0051  Score=62.16  Aligned_cols=137  Identities=19%  Similarity=0.226  Sum_probs=94.1

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccC---C-------------------chhh-----HHHHHHHHhhcCCcce
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK---G-------------------NGED-----FINEVASISRTSHVNI  380 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~-------------------~~~~-----~~~E~~~l~~l~h~ni  380 (638)
                      ...|..|.-+.||.|...+|..+|||+.+.+-   .                   +...     ...|++.|.+++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            45788999999999998899999999986431   0                   0011     2357777888764443


Q ss_pred             EEEEeEEEeCceEEEEEEeccCCC-HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceE
Q 006620          381 VTLLGFCFEGHRRALIYEFVSNGS-LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL  459 (638)
Q Consensus       381 v~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIl  459 (638)
                      .-.--+..  ..-+|||+|+.... -.-.|+       ...++...+..+-.|++.-+.-|-+.  .++||.||.--|+|
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLK-------d~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~L  297 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLK-------DASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLL  297 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCCCcCcccc-------cccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhhe
Confidence            21111111  23468999984321 111222       24577777888888888888888773  78999999999999


Q ss_pred             ECCCCceEEccccccee
Q 006620          460 LDEDFCPKISDFGLAKI  476 (638)
Q Consensus       460 l~~~~~~kl~DFg~~~~  476 (638)
                      + .+|.+.|+|-+.+..
T Consensus       298 y-hdG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  298 Y-HDGKLYIIDVSQSVE  313 (520)
T ss_pred             E-ECCEEEEEEcccccc
Confidence            8 678999999887654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.75  E-value=0.01  Score=59.70  Aligned_cols=31  Identities=39%  Similarity=0.579  Sum_probs=25.6

Q ss_pred             CCeEecccCCCceEECCCCc-eEEccccccee
Q 006620          446 TRILHFDIKPHNILLDEDFC-PKISDFGLAKI  476 (638)
Q Consensus       446 ~~iiH~Dikp~NIll~~~~~-~kl~DFg~~~~  476 (638)
                      ..++|+|++|.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999987555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.65  E-value=0.014  Score=59.06  Aligned_cols=144  Identities=19%  Similarity=0.288  Sum_probs=79.9

Q ss_pred             cCcce-eEEEEEEcCCCEEEEEEecc---cCCchhhHHHHHHHHhhcCC--cceEEEEeEEEeCc--eEEEEEEeccCCC
Q 006620          333 QGGYG-GVYKGKLLDGQNVAIKVLNE---TKGNGEDFINEVASISRTSH--VNIVTLLGFCFEGH--RRALIYEFVSNGS  404 (638)
Q Consensus       333 ~G~~g-~Vy~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gs  404 (638)
                      +||++ .+|.... +++.+++. ...   .........+|+.+++.+.-  .-+.+.+++|.++.  ..+.||+|++|..
T Consensus        34 ~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~  111 (321)
T COG3173          34 SGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEV  111 (321)
T ss_pred             cCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEeccee
Confidence            44544 3344433 27788888 331   12334556778888887753  34455667776665  6789999998843


Q ss_pred             HHHHh------------------hhcCCCC--------CCCCCCHHHHHHHHHH--------------HHHHHHHHhcC-
Q 006620          405 LEKFI------------------HEKHPLE--------TNQKLKWEVLYKIAVG--------------IARGLEYLHRG-  443 (638)
Q Consensus       405 L~~~l------------------~~~~~~~--------~~~~l~~~~~~~i~~q--------------i~~aL~yLH~~-  443 (638)
                      +.+.+                  ...+...        ........++..+..+              ......+|+.. 
T Consensus       112 ~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~  191 (321)
T COG3173         112 VWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR  191 (321)
T ss_pred             ccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence            33222                  1111100        0000000111111111              12223333331 


Q ss_pred             ----CCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          444 ----CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       444 ----~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                          ....++|+|+++.||+++.++.+=|.||+++..-.
T Consensus       192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                12469999999999999988889999999987644

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.65  E-value=0.013  Score=59.04  Aligned_cols=73  Identities=16%  Similarity=0.286  Sum_probs=48.5

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcC---CcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.|+.|....+|+.. .+++.+.||+-.  ......|..|.+-|+.|.   --.+.+++++....+..+||+||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            3568889999999987 578899999876  233456788888888884   346788888888777789999999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.62  E-value=0.004  Score=59.94  Aligned_cols=126  Identities=22%  Similarity=0.317  Sum_probs=61.8

Q ss_pred             CCEEEEEEecccCCchhhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEEeccCCCHHH--------------Hhhh
Q 006620          347 GQNVAIKVLNETKGNGEDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYEFVSNGSLEK--------------FIHE  411 (638)
Q Consensus       347 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~  411 (638)
                      ++.|+||+........-...+|..+++.+...++ .++++.+..+    .|.||+++.+|..              .|.+
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            4678999987765555556788888888874333 5556654332    5668887655422              1111


Q ss_pred             cCCCC----CCCCCCHHHHHHH----------------------HHHHHHHHHHHhc-----CCCCCeEecccCCCceEE
Q 006620          412 KHPLE----TNQKLKWEVLYKI----------------------AVGIARGLEYLHR-----GCNTRILHFDIKPHNILL  460 (638)
Q Consensus       412 ~~~~~----~~~~l~~~~~~~i----------------------~~qi~~aL~yLH~-----~~~~~iiH~Dikp~NIll  460 (638)
                      .+...    ....--+..+..+                      ...+.+-+..+.+     .....++|+|+.|.||++
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence            10000    0011112222222                      0111122222211     112468999999999999


Q ss_pred             -CCCCceEEccccccee
Q 006620          461 -DEDFCPKISDFGLAKI  476 (638)
Q Consensus       461 -~~~~~~kl~DFg~~~~  476 (638)
                       +.++.++++||..+..
T Consensus       158 ~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             TSSSSCEEE--GTT-EE
T ss_pred             ccCCCeEEEecHHHHhh
Confidence             8899999999987763

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.61  E-value=0.014  Score=60.30  Aligned_cols=144  Identities=17%  Similarity=0.228  Sum_probs=80.9

Q ss_pred             cccCcCcceeEEEEEEcC----CCEEEEEEecccCCchhhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKGNGEDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.|..|-...+|+....+    +..|++|+........-...+|..+++.+..-++ .++++++. +.   +|.+|+++.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            445557777899886533    2379999886544322234578888888875444 45566553 22   588998776


Q ss_pred             CHHH--------------HhhhcCCCCC--CC-CCCHHHHHHHHHHH-------------------------HHHHHHHh
Q 006620          404 SLEK--------------FIHEKHPLET--NQ-KLKWEVLYKIAVGI-------------------------ARGLEYLH  441 (638)
Q Consensus       404 sL~~--------------~l~~~~~~~~--~~-~l~~~~~~~i~~qi-------------------------~~aL~yLH  441 (638)
                      +|..              .+++.+....  .. .-.+..+.++..++                         +..+..+.
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            5421              2222221111  11 11223332222221                         11122222


Q ss_pred             c--CCCCCeEecccCCCceEECC-CCceEEccccccee
Q 006620          442 R--GCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKI  476 (638)
Q Consensus       442 ~--~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~~~  476 (638)
                      .  ..+.-.+|.|+.+.|||+++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1  11234899999999999974 57899999987653

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.61  E-value=0.033  Score=57.46  Aligned_cols=71  Identities=17%  Similarity=0.134  Sum_probs=45.8

Q ss_pred             CcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcc--eEEEE---e--EEEeCceEEEEEEeccCCC
Q 006620          334 GGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN--IVTLL---G--FCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       334 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~---~--~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.-..||+....+++.+++|+.+.......+...|++.+..+....  ++...   |  ....++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            3456789998877889999998655445566777888777664211  22211   1  1223456778999998754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.29  E-value=0.026  Score=57.83  Aligned_cols=32  Identities=22%  Similarity=0.228  Sum_probs=28.4

Q ss_pred             CCCeEecccCCCceEECCCCceEEccccccee
Q 006620          445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       445 ~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      ..+++|+|+.++|++++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            35899999999999999999999999987663

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.28  E-value=0.047  Score=55.98  Aligned_cols=143  Identities=21%  Similarity=0.344  Sum_probs=83.6

Q ss_pred             ccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcc------eEEEEe----EEEeCceEEEEEEe
Q 006620          330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN------IVTLLG----FCFEGHRRALIYEF  399 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~~~~~lv~e~  399 (638)
                      .|.+ .-..+|+....+++. ++|+.... ....+...|++.++.+.-..      +..+=|    ....+...+-+++|
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            3444 556789988866666 99998876 55667777888888775222      111111    11112367789999


Q ss_pred             ccCCCHHH------------H---hhhc-CCCC--C---CCCCCHHH-------------HHHHHHHHHHHHHHHhc---
Q 006620          400 VSNGSLEK------------F---IHEK-HPLE--T---NQKLKWEV-------------LYKIAVGIARGLEYLHR---  442 (638)
Q Consensus       400 ~~~gsL~~------------~---l~~~-~~~~--~---~~~l~~~~-------------~~~i~~qi~~aL~yLH~---  442 (638)
                      ++|..+..            +   |+.. +...  .   .....|..             -.....++...++.+.+   
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99887762            1   1110 0010  1   11122320             01123334444444443   


Q ss_pred             -CCCCC---eEecccCCCceEECCCCc-eEEcccccce
Q 006620          443 -GCNTR---ILHFDIKPHNILLDEDFC-PKISDFGLAK  475 (638)
Q Consensus       443 -~~~~~---iiH~Dikp~NIll~~~~~-~kl~DFg~~~  475 (638)
                       .....   +||+|+.|.||+++.+.. +.++||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             11223   999999999999998874 8999998664

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.23  E-value=0.028  Score=52.97  Aligned_cols=115  Identities=20%  Similarity=0.165  Sum_probs=72.7

Q ss_pred             CcceeEEEEEEcCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhh
Q 006620          334 GGYGGVYKGKLLDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE  411 (638)
Q Consensus       334 G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  411 (638)
                      ++.++.-+++..-| +..+|.+....-  ....|.++.+++.+++  .|+++..-  .+...-++.|+|-...       
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------  140 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence            45555555554333 344555543322  2345678888888763  46676632  3445568999884311       


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       412 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                                 .... .++.-=+.+|.-.|+++ .+.+|+|-.|+|||-|+.|.+||.|=+.
T Consensus       141 -----------i~~~-N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  141 -----------INFS-NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             -----------cchh-HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence                       1111 22222256788889643 6899999999999999999999999764

The function of this family is unknown.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.23  E-value=0.059  Score=55.54  Aligned_cols=71  Identities=14%  Similarity=0.128  Sum_probs=47.0

Q ss_pred             ccCcCcceeEEEEEEcCC-CEEEEEEeccc--------CCchhhHHHHHHHHhhcC--Cc-ceEEEEeEEEeCceEEEEE
Q 006620          330 KLGQGGYGGVYKGKLLDG-QNVAIKVLNET--------KGNGEDFINEVASISRTS--HV-NIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  397 (638)
                      .||.|--..||++...++ +.|+||.-...        .-..++..-|.+.|+...  -| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478899999999997654 58999975321        122345556777777654  34 45555543  555667999


Q ss_pred             EeccC
Q 006620          398 EFVSN  402 (638)
Q Consensus       398 e~~~~  402 (638)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.08  E-value=0.097  Score=53.65  Aligned_cols=29  Identities=31%  Similarity=0.356  Sum_probs=25.4

Q ss_pred             CCeEecccCCCceEECCCCceEEcccccce
Q 006620          446 TRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       446 ~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            68999999999999987 678999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.03  E-value=0.091  Score=55.17  Aligned_cols=72  Identities=13%  Similarity=0.071  Sum_probs=49.6

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecc-----cC---CchhhHHHHHHHHhhcC---CcceEEEEeEEEeCceEEEE
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNE-----TK---GNGEDFINEVASISRTS---HVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  396 (638)
                      .+.||.|.-..||+.... ++.++||.-..     ..   ........|.+.|+.+.   -.++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            357899999999998864 56799998652     11   12334455677776654   247888888766  446788


Q ss_pred             EEeccC
Q 006620          397 YEFVSN  402 (638)
Q Consensus       397 ~e~~~~  402 (638)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>PRK06148 hypothetical protein; Provisional

Probab=95.72  E-value=0.16  Score=60.66  Aligned_cols=145  Identities=18%  Similarity=0.218  Sum_probs=79.0

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcC-------CcceEEEE-e----EEEe-Cc--eE
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-------HVNIVTLL-G----FCFE-GH--RR  393 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-~----~~~~-~~--~~  393 (638)
                      +.|+ |..-.+|+....+++.+++|+.+... .......|.+.+..|.       -|.+++.. |    .... +.  ..
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            3454 44678899887788899999998643 2223334545555442       23333322 1    1111 12  45


Q ss_pred             EEEEEeccCCCHHHH-----------------hh----hcCCCCCCCCCCHH-----------------HHHHHHHHHHH
Q 006620          394 ALIYEFVSNGSLEKF-----------------IH----EKHPLETNQKLKWE-----------------VLYKIAVGIAR  435 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~-----------------l~----~~~~~~~~~~l~~~-----------------~~~~i~~qi~~  435 (638)
                      +-+++|++|..|.+.                 ++    ..........+.|.                 ..+.++.++++
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            678999999777541                 11    01000001112221                 12223333333


Q ss_pred             HHH-----HHhcCCCCCeEecccCCCceEECCCC--ceE-Eccccccee
Q 006620          436 GLE-----YLHRGCNTRILHFDIKPHNILLDEDF--CPK-ISDFGLAKI  476 (638)
Q Consensus       436 aL~-----yLH~~~~~~iiH~Dikp~NIll~~~~--~~k-l~DFg~~~~  476 (638)
                      ...     .+. .-..++||+|+.+.|||++.++  ++. |+|||-+..
T Consensus       189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            222     122 2246899999999999998775  555 999997653

>PTZ00384 choline kinase; Provisional

Probab=95.40  E-value=0.18  Score=53.15  Aligned_cols=74  Identities=22%  Similarity=0.192  Sum_probs=45.3

Q ss_pred             cccCcCcceeEEEEEEcCC--CE-----EEEEEecccCCchhhHHHHHHHHhhcCCcc-eEEEEeEEEeCceEEEEEEec
Q 006620          329 NKLGQGGYGGVYKGKLLDG--QN-----VAIKVLNETKGNGEDFINEVASISRTSHVN-IVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.|..|-...+|++...++  ..     |.+++........-+-.+|+++++.+...+ -.++++.+..    .++.||+
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI  131 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV  131 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence            4555588889999975432  22     444443222221123357889999887544 4566666543    5899999


Q ss_pred             cCCCHH
Q 006620          401 SNGSLE  406 (638)
Q Consensus       401 ~~gsL~  406 (638)
                      +|.+|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            987654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.33  E-value=0.0019  Score=75.74  Aligned_cols=162  Identities=10%  Similarity=-0.021  Sum_probs=112.9

Q ss_pred             hHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 006620          364 DFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH  441 (638)
Q Consensus       364 ~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH  441 (638)
                      ..+.|...++...|+++...+.--..  ....+.+++++.+|.+.+.|-+.-  ++...+....+.....+.+.+..-.|
T Consensus      1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~--ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGL--EESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcc--ccCCcchhchHHHHHHHHHhccchhh
Confidence            34455556666789988776654332  344578899999999999987642  33344555555544445456666655


Q ss_pred             cC--CCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHH
Q 006620          442 RG--CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM  519 (638)
Q Consensus       442 ~~--~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGv  519 (638)
                      +.  ...-.+|+++|+.|.++..+..+|++++|+.+......  .......+++-|+.|++...-  .++.++|+|..|+
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEI--KFTKRSDILRRSL 1428 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHH
Confidence            52  12347999999999999999999999999998332221  123445678889999887543  5677799999999


Q ss_pred             HHHHHhcCCCCC
Q 006620          520 MVFEMTGEKNNA  531 (638)
Q Consensus       520 il~elltg~~p~  531 (638)
                      .+|+.-.|..+|
T Consensus      1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHhcccHHH
Confidence            999998887654

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.06  E-value=0.11  Score=51.02  Aligned_cols=78  Identities=19%  Similarity=0.133  Sum_probs=55.6

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec-cCCCHHH
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV-SNGSLEK  407 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~-~~gsL~~  407 (638)
                      ..+..|..+.|+.++..+|++.++|+.........+.. ....|+..+-...|++++.-  ...-.+++|.+ ++.+|.+
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~-g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~   84 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEAR-GEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLAS   84 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhh-HHhHhheeCCCCceeeeccc--cccchhhhhhccCCCchhh
Confidence            34567889999999998999999999875543322221 22457777777889999863  34567889998 5557765


Q ss_pred             Hh
Q 006620          408 FI  409 (638)
Q Consensus       408 ~l  409 (638)
                      +.
T Consensus        85 ~~   86 (253)
T PF04655_consen   85 LP   86 (253)
T ss_pred             cc
Confidence            54

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PTZ00296 choline kinase; Provisional

Probab=95.06  E-value=0.21  Score=53.69  Aligned_cols=73  Identities=18%  Similarity=0.179  Sum_probs=46.5

Q ss_pred             cccCcCcceeEEEEEEcC---------CCEEEEEEecccCCchhhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEE
Q 006620          329 NKLGQGGYGGVYKGKLLD---------GQNVAIKVLNETKGNGEDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  398 (638)
                      +.|..|-.-.+|++...+         ++.|++++........-.-.+|..+++.+...+| .++++.+.    -..|.|
T Consensus       111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~e  186 (442)
T PTZ00296        111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEE  186 (442)
T ss_pred             EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEE
Confidence            456667777889887542         4579999986654333344568888877764443 24555543    235789


Q ss_pred             eccCCCH
Q 006620          399 FVSNGSL  405 (638)
Q Consensus       399 ~~~~gsL  405 (638)
                      |++|.+|
T Consensus       187 fi~g~~l  193 (442)
T PTZ00296        187 WLYGDPL  193 (442)
T ss_pred             eeCCccC
Confidence            9988644

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.65  E-value=0.14  Score=53.42  Aligned_cols=72  Identities=15%  Similarity=0.140  Sum_probs=48.8

Q ss_pred             cccCcCcceeEEEEEEcC-CCEEEEEEeccc-------CCchhhHHHHHHHHhhcC--Cc-ceEEEEeEEEeCceEEEEE
Q 006620          329 NKLGQGGYGGVYKGKLLD-GQNVAIKVLNET-------KGNGEDFINEVASISRTS--HV-NIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  397 (638)
                      +.||-|--..||++...+ ++.|+||.-...       .-..++..-|.+.|+...  -| .+.+++.+  +.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            568999999999998743 567999975321       122355667888887764  34 45556643  555667889


Q ss_pred             EeccC
Q 006620          398 EFVSN  402 (638)
Q Consensus       398 e~~~~  402 (638)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            98854

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	638
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-42
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-41
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-28
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-27
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-23
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-22
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-22
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-22
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-22
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-22
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-22
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-22
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-22
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-22
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-22
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-22
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-22
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-22
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-21
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-05
3soa_A	444	Full-Length Human Camkii Length = 444		5e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  169 bits (427), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 152/260 (58%), Gaps = 16/260 (6%)
Query: 350 VAIKVLNETKGNGED--FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K L E +  G +  F  EV  IS   H N++ L GFC     R L+Y +++NGS+  
Sbjct: 65  VAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 124
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
            + E+   E+   L W    +IA+G ARGL YLH  C+ +I+H D+K  NILLDE+F   
Sbjct: 125 CLRERP--ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 182
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TG 526
           + DFGLAK+ + ++  V     RGTIG+IAPE    + G+ S K+DV+ YG+M+ E+ TG
Sbjct: 183 VGDFGLAKLMDYKDXHVX-XAVRGTIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITG 239
Query: 527 EKNNANVAVDRSSEIYFPHWVY-----KRLELEEDLGLQGIENEEDKEYARKMILVSLWC 581
           ++      +    ++    WV      K+LE   D+ LQG  N +D+E   ++I V+L C
Sbjct: 240 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG--NYKDEE-VEQLIQVALLC 296
Query: 582 IQTNPSDRPSMNRVVEMLEG 601
            Q++P +RP M+ VV MLEG
Sbjct: 297 TQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 151/260 (58%), Gaps = 16/260 (6%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K L E  T+G    F  EV  IS   H N++ L GFC     R L+Y +++NGS+  
Sbjct: 57  VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 116
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
            + E+   E+   L W    +IA+G ARGL YLH  C+ +I+H D+K  NILLDE+F   
Sbjct: 117 CLRERP--ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TG 526
           + DFGLAK+ + ++  V     RG IG+IAPE    + G+ S K+DV+ YG+M+ E+ TG
Sbjct: 175 VGDFGLAKLMDYKDXHVX-XAVRGXIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITG 231
Query: 527 EKNNANVAVDRSSEIYFPHWVY-----KRLELEEDLGLQGIENEEDKEYARKMILVSLWC 581
           ++      +    ++    WV      K+LE   D+ LQG  N +D+E   ++I V+L C
Sbjct: 232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG--NYKDEE-VEQLIQVALLC 288
Query: 582 IQTNPSDRPSMNRVVEMLEG 601
            Q++P +RP M+ VV MLEG
Sbjct: 289 TQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 132/233 (56%), Gaps = 18/233 (7%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H ++V+L+GFC E +   LIY+++ NG+L++ ++    L T   + WE   +I +G ARG
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPT-MSMSWEQRLEICIGAARG 151
Query: 437 LEYLHRGCNTR-ILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
           L YLH    TR I+H D+K  NILLDE+F PKI+DFG++K     +        +GT+GY
Sbjct: 152 LHYLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           I PE F +  G ++ KSDVYS+G+++FE+   ++    ++ R   +    W    +E   
Sbjct: 208 IDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWA---VESHN 261
Query: 556 DLGLQGI--ENEEDK---EYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           +  L+ I   N  DK   E  RK    ++ C+  +  DRPSM  V+  LE +L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 131/233 (56%), Gaps = 18/233 (7%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H ++V+L+GFC E +   LIY+++ NG+L++ ++    L T   + WE   +I +G ARG
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPT-MSMSWEQRLEICIGAARG 151
Query: 437 LEYLHRGCNTR-ILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
           L YLH    TR I+H D+K  NILLDE+F PKI+DFG++K              +GT+GY
Sbjct: 152 LHYLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           I PE F +  G ++ KSDVYS+G+++FE+   ++    ++ R   +    W    +E   
Sbjct: 208 IDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWA---VESHN 261
Query: 556 DLGLQGI--ENEEDK---EYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           +  L+ I   N  DK   E  RK    ++ C+  +  DRPSM  V+  LE +L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 123/242 (50%), Gaps = 18/242 (7%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           + F  E+  +++  H N+V LLGF  +G    L+Y ++ NGSL   +     L+    L 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPLS 131
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
           W +  KIA G A G+ +LH   +   +H DIK  NILLDE F  KISDFGLA+  E    
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEI 541
            V  +   GT  Y+APE      GE++ KSD+YS+G+++ E +TG       AVD   E 
Sbjct: 189 TVMXSRIVGTTAYMAPEAL---RGEITPKSDIYSFGVVLLEIITGLP-----AVDEHREP 240
Query: 542 YFPHWVYKRLELEEDLGLQGIE---NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
                + + +E EE      I+   N+ D      M  V+  C+    + RP + +V ++
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 599 LE 600
           L+
Sbjct: 301 LQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 122/242 (50%), Gaps = 18/242 (7%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           + F  E+  +++  H N+V LLGF  +G    L+Y ++ NGSL   +     L+    L 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPLS 131
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
           W +  KIA G A G+ +LH   +   +H DIK  NILLDE F  KISDFGLA+  E    
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEI 541
            V      GT  Y+APE      GE++ KSD+YS+G+++ E +TG       AVD   E 
Sbjct: 189 TVMXXRIVGTTAYMAPEAL---RGEITPKSDIYSFGVVLLEIITGLP-----AVDEHREP 240
Query: 542 YFPHWVYKRLELEEDLGLQGIE---NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
                + + +E EE      I+   N+ D      M  V+  C+    + RP + +V ++
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 599 LE 600
           L+
Sbjct: 301 LQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 122/242 (50%), Gaps = 18/242 (7%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           + F  E+  +++  H N+V LLGF  +G    L+Y ++ NGSL   +     L+    L 
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPLS 125
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
           W +  KIA G A G+ +LH   +   +H DIK  NILLDE F  KISDFGLA+  E    
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEI 541
            V      GT  Y+APE      GE++ KSD+YS+G+++ E +TG       AVD   E 
Sbjct: 183 XVMXXRIVGTTAYMAPEAL---RGEITPKSDIYSFGVVLLEIITGLP-----AVDEHREP 234
Query: 542 YFPHWVYKRLELEEDLGLQGIE---NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
                + + +E EE      I+   N+ D      M  V+  C+    + RP + +V ++
Sbjct: 235 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 294
Query: 599 LE 600
           L+
Sbjct: 295 LQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 118/242 (48%), Gaps = 18/242 (7%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           + F  E+   ++  H N+V LLGF  +G    L+Y +  NGSL   +     L+    L 
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL---LDRLSCLDGTPPLS 122
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
           W    KIA G A G+ +LH   +   +H DIK  NILLDE F  KISDFGLA+  E    
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEI 541
            V  +   GT  Y APE      GE++ KSD+YS+G+++ E +TG       AVD   E 
Sbjct: 180 XVXXSRIVGTTAYXAPEAL---RGEITPKSDIYSFGVVLLEIITGLP-----AVDEHREP 231
Query: 542 YFPHWVYKRLELEEDLGLQGIE---NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
                + + +E EE      I+   N+ D         V+  C+    + RP + +V ++
Sbjct: 232 QLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQL 291
Query: 599 LE 600
           L+
Sbjct: 292 LQ 293

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 45  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 105 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 157
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 158 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 214
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 215 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 260
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 261 RPSFAEIHQAFE 272

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 45  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 104
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 105 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 157
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 158 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 214
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 215 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 260
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 261 RPSFAEIHQAFE 272

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 44  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 104 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 156
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 157 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 213
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 214 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 259
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 260 RPSFAEIHQAFE 271

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 45  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 105 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 157
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 158 ADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 214
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 215 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 260
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 261 RPSFAEIHQAFE 272

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 40  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 100 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 153 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 209
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 210 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 255
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 256 RPSFAEIHQAFE 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 40  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 100 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 153 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 209
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 210 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 255
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 256 RPSFAEIHQAFE 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 41  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 100
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 101 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 153
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 154 ADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 210
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 211 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 256
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 257 RPSFAEIHQAFE 268

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 42  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 102 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 154
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 155 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 211
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 212 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 257
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 258 RPSFAEIHQAFE 269

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 41  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 100
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 101 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 153
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 154 ADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 210
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 211 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 256
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 257 RPSFAEIHQAFE 268

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 42  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 102 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 154
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 155 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 211
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 212 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 257
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 258 RPSFAEIHQAFE 269

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 45  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 105 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 157
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 158 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 214
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 215 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 260
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 261 RPSFAEIHQAFE 272

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 53  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 112
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 113 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 165
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 166 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 222
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 223 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 268
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 269 RPSFAEIHQAFE 280

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 42  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E N      VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 102 LRECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 154
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 155 ADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 211
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 212 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 257
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 258 RPSFAEIHQAFE 269

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 38  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 97
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +     Q++   VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 98  LRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 150
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 151 ADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 207
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D       P  VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 208 MSPYPGID-------PSQVYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 253
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 254 RPSFAEIHQAFE 265

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 38  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +     Q++   VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 98  LRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 150
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 151 ADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 207
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D       P  VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 208 MSPYPGID-------PSQVYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 253
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 254 RPSFAEIHQAFE 265

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 38  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +     Q++   VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 98  LRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 150
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 151 ADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 207
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D       P  VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 208 MSPYPGID-------PSQVYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 253
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 254 RPSFAEIHQAFE 265

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 45  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +     Q++   VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 105 LRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 157
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 158 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 214
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 215 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 260
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 261 RPSFAEIHQAFE 272

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 40  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +     Q++   VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 100 LRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 153 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 209
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 210 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 255
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 256 RPSFAEIHQAFE 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 40  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +     Q++   VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 100 LRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 153 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 209
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 210 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 255
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 256 RPSFAEIHQAFE 267

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 40  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +     Q++   VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 100 LRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 153 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 209
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 210 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 255
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 256 RPSFAEIHQAFE 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  +
Sbjct: 40  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +     Q++   VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 100 LRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+    
Sbjct: 153 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYG 209
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSD
Sbjct: 210 MSPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSD 255
Query: 589 RPSMNRVVEMLE 600
           RPS   + +  E
Sbjct: 256 RPSFAEIHQAFE 267

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 124/251 (49%), Gaps = 24/251 (9%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  ++
Sbjct: 287 VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 346
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
            E +  E N      VL  +A  I+  +EYL +      +H ++   N L+ E+   K++
Sbjct: 347 RECNRQEVNAV----VLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVA 399
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKN 529
           DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+     
Sbjct: 400 DFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGM 456
Query: 530 NANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDR 589
           +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSDR
Sbjct: 457 SPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSDR 502
Query: 590 PSMNRVVEMLE 600
           PS   + +  E
Sbjct: 503 PSFAEIHQAFE 513

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 133/274 (48%), Gaps = 43/274 (15%)
Query: 349 NVAIKVLNETKGNGE---DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+L E   + E   +F+ EVA + R  H NIV  +G   +    +++ E++S GSL
Sbjct: 62  DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 406 EKFIHE---KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
            + +H+   +  L+  ++L       +A  +A+G+ YLH   N  I+H ++K  N+L+D+
Sbjct: 122 YRLLHKSGAREQLDERRRL------SMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDK 174
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            +  K+ DFGL+++     + +S   A GT  ++APEV        + KSDVYS+G++++
Sbjct: 175 KYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILW 230
Query: 523 EMT------GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMIL 576
           E+       G  N A V      +        KRLE+  +L  Q     E          
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKC-------KRLEIPRNLNPQVAAIIEG--------- 274
Query: 577 VSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
               C    P  RPS   ++++L   + S   PP
Sbjct: 275 ----CWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 125/251 (49%), Gaps = 24/251 (9%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L E     E+F+ E A +    H N+V LLG C       +I EF++ G+L  ++
Sbjct: 248 VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
            E +     Q++   VL  +A  I+  +EYL +      +H ++   N L+ E+   K++
Sbjct: 308 RECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVA 360
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKN 529
           DFGL+++  G ++  +  GA+  I + APE    N  + S KSDV+++G++++E+     
Sbjct: 361 DFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGM 417
Query: 530 NANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDR 589
           +    +D S        VY+   LE+D  ++  E   +K Y          C Q NPSDR
Sbjct: 418 SPYPGIDLSQ-------VYEL--LEKDYRMERPEGCPEKVYELMRA-----CWQWNPSDR 463
Query: 590 PSMNRVVEMLE 600
           PS   + +  E
Sbjct: 464 PSFAEIHQAFE 474

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 131/274 (47%), Gaps = 43/274 (15%)
Query: 349 NVAIKVLNETKGNGE---DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+L E   + E   +F+ EVA + R  H NIV  +G   +    +++ E++S GSL
Sbjct: 62  DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 406 EKFIHE---KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
            + +H+   +  L+  ++L       +A  +A+G+ YLH   N  I+H D+K  N+L+D+
Sbjct: 122 YRLLHKSGAREQLDERRRL------SMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDK 174
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            +  K+ DFGL+++       +    A GT  ++APEV        + KSDVYS+G++++
Sbjct: 175 KYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILW 230
Query: 523 EMT------GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMIL 576
           E+       G  N A V      +        KRLE+  +L  Q     E          
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKC-------KRLEIPRNLNPQVAAIIEG--------- 274
Query: 577 VSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
               C    P  RPS   ++++L   + S   PP
Sbjct: 275 ----CWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 118/251 (47%), Gaps = 25/251 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK + E   + EDFI E   + + SH  +V L G C E     L++EF+ +G L  +
Sbjct: 31  KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 90
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +  +  L        E L  + + +  G+ YL   C   ++H D+   N L+ E+   K+
Sbjct: 91  LRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 142
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           SDFG+ +     +   S TG +  + + +PEVF  +F   S KSDV+S+G++++E+  E 
Sbjct: 143 SDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
                          P+      E+ ED+   G    + +  +  +  +   C +  P D
Sbjct: 200 K-------------IPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWKERPED 245
Query: 589 RPSMNRVVEML 599
           RP+ +R++  L
Sbjct: 246 RPAFSRLLRQL 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 118/251 (47%), Gaps = 25/251 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK + E   + EDFI E   + + SH  +V L G C E     L++EF+ +G L  +
Sbjct: 33  KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +  +  L        E L  + + +  G+ YL   C   ++H D+   N L+ E+   K+
Sbjct: 93  LRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 144
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           SDFG+ +     +   S TG +  + + +PEVF  +F   S KSDV+S+G++++E+  E 
Sbjct: 145 SDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEG 201
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
                          P+      E+ ED+   G    + +  +  +  +   C +  P D
Sbjct: 202 K-------------IPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWKERPED 247
Query: 589 RPSMNRVVEML 599
           RP+ +R++  L
Sbjct: 248 RPAFSRLLRQL 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 118/251 (47%), Gaps = 25/251 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK + E   + EDFI E   + + SH  +V L G C E     L++EF+ +G L  +
Sbjct: 36  KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 95
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +  +  L        E L  + + +  G+ YL   C   ++H D+   N L+ E+   K+
Sbjct: 96  LRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 147
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           SDFG+ +     +   S TG +  + + +PEVF  +F   S KSDV+S+G++++E+  E 
Sbjct: 148 SDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEG 204
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
                          P+      E+ ED+   G    + +  +  +  +   C +  P D
Sbjct: 205 K-------------IPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPED 250
Query: 589 RPSMNRVVEML 599
           RP+ +R++  L
Sbjct: 251 RPAFSRLLRQL 261

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 131/260 (50%), Gaps = 31/260 (11%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 36  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 94
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H  ET  K + + L  IA   ARG++YLH      I+H D+K +NI L ED  
Sbjct: 95  ---YHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNT 146
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA +              G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 147 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 206
Query: 524 MTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYA---RKMILVSLW 580
           MTG+   +N+                R ++ E +G   +  +  K  +   ++M  +   
Sbjct: 207 MTGQLPYSNIN--------------NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAE 252
Query: 581 CIQTNPSDRPSMNRVVEMLE 600
           C++    +RPS  R++  +E
Sbjct: 253 CLKKKRDERPSFPRILAEIE 272

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 25/251 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK + E   + +DFI E   + + SH  +V L G C E     L++EF+ +G L  +
Sbjct: 53  KVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 112
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +  +  L        E L  + + +  G+ YL   C   ++H D+   N L+ E+   K+
Sbjct: 113 LRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 164
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           SDFG+ +     +   S TG +  + + +PEVF  +F   S KSDV+S+G++++E+  E 
Sbjct: 165 SDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEG 221
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
                          P+      E+ ED+   G    + +  +  +  +   C +  P D
Sbjct: 222 K-------------IPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWKERPED 267
Query: 589 RPSMNRVVEML 599
           RP+ +R++  L
Sbjct: 268 RPAFSRLLRQL 278

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 117/251 (46%), Gaps = 25/251 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK + E   + EDFI E   + + SH  +V L G C E     L+ EF+ +G L  +
Sbjct: 34  KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +  +  L        E L  + + +  G+ YL   C   ++H D+   N L+ E+   K+
Sbjct: 94  LRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 145
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           SDFG+ +     +   S TG +  + + +PEVF  +F   S KSDV+S+G++++E+  E 
Sbjct: 146 SDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEG 202
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
                          P+      E+ ED+   G    + +  +  +  +   C +  P D
Sbjct: 203 K-------------IPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPED 248
Query: 589 RPSMNRVVEML 599
           RP+ +R++  L
Sbjct: 249 RPAFSRLLRQL 259

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 105/190 (55%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 37  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 96  ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 147
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA +              G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 148 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 207
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 208 MTGQLPYSNI 217

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 104/190 (54%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+     + A++ ++    SL
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSL 90
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 91  ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 142
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA +              G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 203 MTGQLPYSNI 212

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 105/190 (55%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 90
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 91  ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 142
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA +              G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 203 MTGQLPYSNI 212

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 105/190 (55%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 37  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 96  ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 147
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA +              G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 148 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 207
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 208 MTGQLPYSNI 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 105/190 (55%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 34  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 92
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 93  ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 144
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA +              G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 145 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 204
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 205 MTGQLPYSNI 214

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 105/190 (55%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 59  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 117
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 118 ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 169
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA +              G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 170 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 229
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 230 MTGQLPYSNI 239

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 105/190 (55%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 60  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 118
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 119 ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 170
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA +              G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 171 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 230
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 231 MTGQLPYSNI 240

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/178 (35%), Positives = 101/178 (56%), Gaps = 11/178 (6%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           +KV++ T    + F NEVA + +T HVNI+  +G+  + +  A++ ++    SL K +H 
Sbjct: 66  LKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHV 124
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
           +   ET  K +   L  IA   A+G++YLH      I+H D+K +NI L E    KI DF
Sbjct: 125 Q---ET--KFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDF 176
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE-MTGE 527
           GLA +         +    G++ ++APEV   ++    S++SDVYSYG++++E MTGE
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 117/251 (46%), Gaps = 25/251 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK + E   + EDFI E   + + SH  +V L G C E     L++EF+ +G L  +
Sbjct: 33  KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +  +  L        E L  + + +  G+ YL       ++H D+   N L+ E+   K+
Sbjct: 93  LRTQRGL-----FAAETLLGMCLDVCEGMAYLE---EASVIHRDLAARNCLVGENQVIKV 144
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           SDFG+ +     +   S TG +  + + +PEVF  +F   S KSDV+S+G++++E+  E 
Sbjct: 145 SDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEG 201
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
                          P+      E+ ED+   G    + +  +  +  +   C +  P D
Sbjct: 202 K-------------IPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWKERPED 247
Query: 589 RPSMNRVVEML 599
           RP+ +R++  L
Sbjct: 248 RPAFSRLLRQL 258

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 31/260 (11%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+     + A++ ++    SL
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSL 106
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H  ET  K + + L  IA   ARG++YLH      I+H D+K +NI L ED  
Sbjct: 107 ---YHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNT 158
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA                G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218
Query: 524 MTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYA---RKMILVSLW 580
           MTG+   +N+                R ++ E +G   +  +  K  +   ++M  +   
Sbjct: 219 MTGQLPYSNIN--------------NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAE 264
Query: 581 CIQTNPSDRPSMNRVVEMLE 600
           C++    +RPS  R++  +E
Sbjct: 265 CLKKKRDERPSFPRILAEIE 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 130/260 (50%), Gaps = 31/260 (11%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 106
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H  ET  K + + L  IA   ARG++YLH      I+H D+K +NI L ED  
Sbjct: 107 ---YHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNT 158
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA                G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218
Query: 524 MTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYA---RKMILVSLW 580
           MTG+   +N+                R ++ E +G   +  +  K  +   ++M  +   
Sbjct: 219 MTGQLPYSNIN--------------NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAE 264
Query: 581 CIQTNPSDRPSMNRVVEMLE 600
           C++    +RPS  R++  +E
Sbjct: 265 CLKKKRDERPSFPRILAEIE 284

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 101/178 (56%), Gaps = 15/178 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK+LNET G     +F++E   ++   H ++V LLG C     + L+ + + +G L +
Sbjct: 47  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLE 105
Query: 408 FIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           ++HE K  + +   L W       V IA+G+ YL      R++H D+   N+L+      
Sbjct: 106 YVHEHKDNIGSQLLLNW------CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHV 156
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGLA++ EG E   +  G +  I ++A E  C ++ + +++SDV+SYG+ ++E+
Sbjct: 157 KITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFTHQSDVWSYGVTIWEL 212

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 101/178 (56%), Gaps = 15/178 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK+LNET G     +F++E   ++   H ++V LLG C     + L+ + + +G L +
Sbjct: 70  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLE 128
Query: 408 FIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           ++HE K  + +   L W       V IA+G+ YL      R++H D+   N+L+      
Sbjct: 129 YVHEHKDNIGSQLLLNW------CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHV 179
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGLA++ EG E   +  G +  I ++A E  C ++ + +++SDV+SYG+ ++E+
Sbjct: 180 KITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFTHQSDVWSYGVTIWEL 235

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 104/190 (54%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 52  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 110
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 111 ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 162
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA                G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 163 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 222
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 223 MTGQLPYSNI 232

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 104/190 (54%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 90
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 91  ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 142
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA                G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 143 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 203 MTGQLPYSNI 212

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 104/190 (54%), Gaps = 14/190 (7%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +VA+K+LN T    +    F NEV  + +T HVNI+  +G+  +  + A++ ++    SL
Sbjct: 60  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL 118
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
               H  H +ET  K +   L  IA   A+G++YLH      I+H D+K +NI L ED  
Sbjct: 119 ---YHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 170
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI DFGLA                G+I ++APEV   ++    S++SDVY++G++++E 
Sbjct: 171 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 230
Query: 524 MTGEKNNANV 533
           MTG+   +N+
Sbjct: 231 MTGQLPYSNI 240

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 119/252 (47%), Gaps = 24/252 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L E     E+F+ E A +    H N+V LLG C       ++ E++  G+L  +
Sbjct: 59  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDY 118
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           + E +  E        VL  +A  I+  +EYL +      +H D+   N L+ E+   K+
Sbjct: 119 LRECNREEVTAV----VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHVVKV 171
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +DFGL+++  G ++  +  GA+  I + APE    N    S KSDV+++G++++E+    
Sbjct: 172 ADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYG 228
Query: 529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSD 588
            +    +D S        VY  LE       +G   E+ +    K+  +   C + +P+D
Sbjct: 229 MSPYPGIDLSQ-------VYDLLE-------KGYRMEQPEGCPPKVYELMRACWKWSPAD 274
Query: 589 RPSMNRVVEMLE 600
           RPS     +  E
Sbjct: 275 RPSFAETHQAFE 286

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 92/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 34  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDF 92
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      ET + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 93  LKG----ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 145
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 146 ADFGLARLIEDNEX-TARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 199

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F+
Sbjct: 294 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 352
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
                 ET + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K++
Sbjct: 353 KG----ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 405
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 406 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 458

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  + T+ +  D I+E+  +     H NI+ LLG C +     +I E+ S G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 407 KFIHEKHP--LE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           +++  + P  LE          ++L  + L   A  +ARG+EYL    + + +H D+   
Sbjct: 123 EYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 179
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           N+L+ ED   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV+
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 236
Query: 516 SYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           S+G++++E+   G      V V+          ++K L+       +G   ++      +
Sbjct: 237 SFGVLLWEIFTLGGSPYPGVPVEE---------LFKLLK-------EGHRMDKPSNCTNE 280
Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           + ++   C    PS RP+  ++VE L+
Sbjct: 281 LYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 92/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 37  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 95
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      ET + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 96  LKG----ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 148
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 149 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 202

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 98/178 (55%), Gaps = 13/178 (7%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T+    DF+ E   + + SH NI+ L G   +     +I E++ NG+L+K
Sbjct: 76  VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+ EK     + +     L  +  GIA G++YL    N   +H D+   NIL++ +   K
Sbjct: 136 FLREK-----DGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCK 187
Query: 468 ISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL+++ E   E+  + +G +  I + APE    ++ + +  SDV+S+G++++E+
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEV 243

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F+
Sbjct: 211 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 269
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
                 ET + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K++
Sbjct: 270 KG----ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 322
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 323 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 375

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F+
Sbjct: 211 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 269
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
                 ET + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K++
Sbjct: 270 KG----ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 322
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 323 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 375

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  + T+ +  D I+E+  +     H NI+ LLG C +     +I E+ S G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 407 KFIHEKHP--LE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           +++  + P  LE          ++L  + L   A  +ARG+EYL    + + +H D+   
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 179
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           N+L+ ED   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV+
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 236
Query: 516 SYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           S+G++++E+   G      V V+          ++K L+       +G   ++      +
Sbjct: 237 SFGVLLWEIFTLGGSPYPGVPVEE---------LFKLLK-------EGHRMDKPSNCTNE 280
Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           + ++   C    PS RP+  ++VE L+
Sbjct: 281 LYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  + T+ +  D I+E+  +     H NI+ LLG C +     +I E+ S G+L 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 407 KFIHEKHP--LE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           +++  + P  LE          ++L  + L   A  +ARG+EYL    + + +H D+   
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 168
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           N+L+ ED   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV+
Sbjct: 169 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 225
Query: 516 SYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           S+G++++E+   G      V V+          ++K L+       +G   ++      +
Sbjct: 226 SFGVLLWEIFTLGGSPYPGVPVEE---------LFKLLK-------EGHRMDKPSNCTNE 269
Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           + ++   C    PS RP+  ++VE L+
Sbjct: 270 LYMMMRDCWHAVPSQRPTFKQLVEDLD 296

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  + T+ +  D I+E+  +     H NI+ LLG C +     +I E+ S G+L 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 407 KFIHEKHP--LE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           +++  + P  LE          ++L  + L   A  +ARG+EYL    + + +H D+   
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 164
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           N+L+ ED   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV+
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 221
Query: 516 SYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           S+G++++E+   G      V V+          ++K L+       +G   ++      +
Sbjct: 222 SFGVLLWEIFTLGGSPYPGVPVEE---------LFKLLK-------EGHRMDKPSNCTNE 265
Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           + ++   C    PS RP+  ++VE L+
Sbjct: 266 LYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  + T+ +  D I+E+  +     H NI+ LLG C +     +I E+ S G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 407 KFIHEKHP--LE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           +++  + P  LE          ++L  + L   A  +ARG+EYL    + + +H D+   
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 179
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           N+L+ ED   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV+
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 236
Query: 516 SYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           S+G++++E+   G      V V+          ++K L+       +G   ++      +
Sbjct: 237 SFGVLLWEIFTLGGSPYPGVPVEE---------LFKLLK-------EGHRMDKPSNCTNE 280
Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           + ++   C    PS RP+  ++VE L+
Sbjct: 281 LYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  + T+ +  D I+E+  +     H NI+ LLG C +     +I E+ S G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 407 KFIHEKHP--LE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           +++  + P  LE          ++L  + L   A  +ARG+EYL    + + +H D+   
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 179
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           N+L+ ED   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV+
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 236
Query: 516 SYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           S+G++++E+   G      V V+          ++K L+       +G   ++      +
Sbjct: 237 SFGVLLWEIFTLGGSPYPGVPVEE---------LFKLLK-------EGHRMDKPSNCTNE 280
Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           + ++   C    PS RP+  ++VE L+
Sbjct: 281 LYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F+
Sbjct: 211 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFL 269
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
                 ET + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K++
Sbjct: 270 KG----ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 322
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 323 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 375

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  + T+ +  D I+E+  +     H NI+ LLG C +     +I E+ S G+L 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 407 KFIHEKHP--LE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           +++  + P  LE          ++L  + L   A  +ARG+EYL    + + +H D+   
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 171
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           N+L+ ED   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV+
Sbjct: 172 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 228
Query: 516 SYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           S+G++++E+   G      V V+          ++K L+       +G   ++      +
Sbjct: 229 SFGVLLWEIFTLGGSPYPGVPVEE---------LFKLLK-------EGHRMDKPSNCTNE 272
Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           + ++   C    PS RP+  ++VE L+
Sbjct: 273 LYMMMRDCWHAVPSQRPTFKQLVEDLD 299

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  + T+ +  D I+E+  +     H NI+ LLG C +     +I E+ S G+L 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 407 KFIHEKHP--LE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           +++  + P  LE          ++L  + L   A  +ARG+EYL    + + +H D+   
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 172
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           N+L+ ED   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV+
Sbjct: 173 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 229
Query: 516 SYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           S+G++++E+   G      V V+          ++K L+       +G   ++      +
Sbjct: 230 SFGVLLWEIFTLGGSPYPGVPVEE---------LFKLLK-------EGHRMDKPSNCTNE 273
Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           + ++   C    PS RP+  ++VE L+
Sbjct: 274 LYMMMRDCWHAVPSQRPTFKQLVEDLD 300

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  + T+ +  D I+E+  +     H NI+ LLG C +     +I E+ S G+L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 407 KFIHEKHP--LE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
           +++  + P  LE          ++L  + L   A  +ARG+EYL    + + +H D+   
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 220
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           N+L+ ED   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV+
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 277
Query: 516 SYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
           S+G++++E+   G      V V+          ++K L+       +G   ++      +
Sbjct: 278 SFGVLLWEIFTLGGSPYPGVPVEE---------LFKLLK-------EGHRMDKPSNCTNE 321
Query: 574 MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           + ++   C    PS RP+  ++VE L+
Sbjct: 322 LYMMMRDCWHAVPSQRPTFKQLVEDLD 348

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 44  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDF 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 103 LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 155
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 156 ADFGLARLIEDNEX-TARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 209

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 42/274 (15%)
Query: 348 QNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           ++VAIK + E++   + FI E+  +SR +H NIV L G C   +   L+ E+   GSL  
Sbjct: 33  KDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 89
Query: 408 FIHEKHPLE---TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL-DED 463
            +H   PL        + W       +  ++G+ YLH      ++H D+KP N+LL    
Sbjct: 90  VLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 143
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVF 522
              KI DFG A  C+ +     MT  +G+  ++APEVF   N+ E   K DV+S+G++++
Sbjct: 144 TVLKICDFGTA--CDIQ---THMTNNKGSAAWMAPEVFEGSNYSE---KCDVFSWGIILW 195
Query: 523 EMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCI 582
           E+   +   +     +  I +      R  L ++L  + IE+   +            C 
Sbjct: 196 EVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP-KPIESLMTR------------CW 242
Query: 583 QTNPSDRPSMNRVVEML-------EGSLDSLQIP 609
             +PS RPSM  +V+++        G+ + LQ P
Sbjct: 243 SKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 276

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 35  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 93
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 94  LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 146
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 147 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 200

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 44  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDF 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 103 LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 155
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 156 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 209

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 44  RVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 103 LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 155
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 156 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 209

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 42/274 (15%)
Query: 348 QNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           ++VAIK + E++   + FI E+  +SR +H NIV L G C   +   L+ E+   GSL  
Sbjct: 32  KDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 88
Query: 408 FIHEKHPLE---TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL-DED 463
            +H   PL        + W       +  ++G+ YLH      ++H D+KP N+LL    
Sbjct: 89  VLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 142
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVF 522
              KI DFG A  C+ +     MT  +G+  ++APEVF   N+ E   K DV+S+G++++
Sbjct: 143 TVLKICDFGTA--CDIQ---THMTNNKGSAAWMAPEVFEGSNYSE---KCDVFSWGIILW 194
Query: 523 EMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCI 582
           E+   +   +     +  I +      R  L ++L  + IE+   +            C 
Sbjct: 195 EVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP-KPIESLMTR------------CW 241
Query: 583 QTNPSDRPSMNRVVEML-------EGSLDSLQIP 609
             +PS RPSM  +V+++        G+ + LQ P
Sbjct: 242 SKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 44  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 103 LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 155
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 156 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 209

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 24/208 (11%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +VA+K++ E   + ++F  E  ++ + SH  +V   G C + +   ++ E++SNG L  +
Sbjct: 34  DVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93
Query: 409 I--HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           +  H K  LE +Q L  E+ Y +  G+A  LE      + + +H D+   N L+D D C 
Sbjct: 94  LRSHGK-GLEPSQLL--EMCYDVCEGMAF-LE------SHQFIHRDLAARNCLVDRDLCV 143
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
           K+SDFG+ +     +  VS  G +  + + APEVF  ++ + S KSDV+++G++++E+  
Sbjct: 144 KVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVF--HYFKYSSKSDVWAFGILMWEVFS 200
Query: 527 ---------EKNNANVAVDRSSEIYFPH 545
                      +   + V +   +Y PH
Sbjct: 201 LGKMPYDLYTNSEVVLKVSQGHRLYRPH 228

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 33  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 91
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 92  LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 144
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 145 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 198

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 98/190 (51%), Gaps = 21/190 (11%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSH-VNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + AIK + E  +K +  DF  E+  + +  H  NI+ LLG C       L  E+  +G+L
Sbjct: 44  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 103
Query: 406 EKFIHEKHPLETN----------QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
             F+ +   LET+            L  + L   A  +ARG++YL +    + +H D+  
Sbjct: 104 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAA 160
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVY 515
            NIL+ E++  KI+DFGL++   G+E  V  T  R  + ++A E    N+   +  SDV+
Sbjct: 161 RNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVW 215
Query: 516 SYGMMVFEMT 525
           SYG++++E+ 
Sbjct: 216 SYGVLLWEIV 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 98/190 (51%), Gaps = 21/190 (11%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSH-VNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + AIK + E  +K +  DF  E+  + +  H  NI+ LLG C       L  E+  +G+L
Sbjct: 54  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 113
Query: 406 EKFIHEKHPLETN----------QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
             F+ +   LET+            L  + L   A  +ARG++YL +    + +H D+  
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAA 170
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVY 515
            NIL+ E++  KI+DFGL++   G+E  V  T  R  + ++A E    N+   +  SDV+
Sbjct: 171 RNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVW 225
Query: 516 SYGMMVFEMT 525
           SYG++++E+ 
Sbjct: 226 SYGVLLWEIV 235

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 92/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E+++ GSL  F
Sbjct: 41  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDF 99
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      ET + L+   L  ++  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 100 LKG----ETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 152
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 153 ADFGLARLIEDNE-WTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 206

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 92/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E+++ GSL  F
Sbjct: 41  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDF 99
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      ET + L+   L  ++  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 100 LKG----ETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 152
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 153 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 206

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 42/265 (15%)
Query: 350 VAIK--VLNETKGNGE------DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS 401
           VAIK  +L +++G  E      +F  EV  +S  +H NIV L G      R  ++ EFV 
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
Query: 402 NGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
            G L  + + + HP+      KW V  ++ + IA G+EY+ +  N  I+H D++  NI L
Sbjct: 105 CGDLYHRLLDKAHPI------KWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFL 157
Query: 461 ---DED--FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVY 515
              DE+   C K++DFGL++     +S+ S++G  G   ++APE         + K+D Y
Sbjct: 158 QSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 516 SYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           S+ M+++  +TGE               F  + Y +++    +  +G+     ++   ++
Sbjct: 213 SFAMILYTILTGEGP-------------FDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEML 599
             V   C   +P  RP  + +V+ L
Sbjct: 260 RNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 44  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDF 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 103 LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 155
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 156 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 209

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 96/178 (53%), Gaps = 13/178 (7%)
Query: 350 VAIKVL--NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T+    DF+ E + + +  H N+V L G    G    ++ EF+ NG+L+ 
Sbjct: 74  VAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDA 133
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+  KH    + +     L  +  GIA G+ YL    +   +H D+   NIL++ +   K
Sbjct: 134 FLR-KH----DGQFTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCK 185
Query: 468 ISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL+++ E   E++ + TG +  + + APE     + + +  SDV+SYG++++E+
Sbjct: 186 VSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI--QYRKFTSASDVWSYGIVMWEV 241

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 136/271 (50%), Gaps = 38/271 (14%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+TLLG C +     +I E+ S G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNL 128
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 185
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 242
Query: 515 YSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           +S+G++++E+   G      + V+          ++K L+       +G   ++      
Sbjct: 243 WSFGVLMWEIFTLGGSPYPGIPVEE---------LFKLLK-------EGHRMDKPANCTN 286
Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           ++ ++   C    PS RP+  ++VE L+  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F
Sbjct: 44  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D+   NIL+ E+   K+
Sbjct: 103 LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLAAANILVGENLVCKV 155
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 156 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 209

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 145/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 135 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGLA++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 187 KVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 245 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 289 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 338

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S GSL  F+
Sbjct: 212 VAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 270
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
                 E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K++
Sbjct: 271 KG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 323
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGL ++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 324 DFGLGRLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 376

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 97/189 (51%), Gaps = 15/189 (7%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T+    DF++E + + +  H NI+ L G    G    ++ E++ NGSL+ 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+        + +     L  +  G+  G+ YL    +   +H D+   N+L+D +   K
Sbjct: 140 FLRTH-----DGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCK 191
Query: 468 ISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT- 525
           +SDFGL+++ E   ++  + TG +  I + APE     F   S  SDV+S+G++++E+  
Sbjct: 192 VSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLA 249
Query: 526 -GEKNNANV 533
            GE+   N+
Sbjct: 250 YGERPYWNM 258

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 145/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 135 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVC 186
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 245 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 289 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 338

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 97/189 (51%), Gaps = 15/189 (7%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T+    DF++E + + +  H NI+ L G    G    ++ E++ NGSL+ 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+        + +     L  +  G+  G+ YL    +   +H D+   N+L+D +   K
Sbjct: 140 FLRTH-----DGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCK 191
Query: 468 ISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT- 525
           +SDFGL+++ E   ++  + TG +  I + APE     F   S  SDV+S+G++++E+  
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLA 249
Query: 526 -GEKNNANV 533
            GE+   N+
Sbjct: 250 YGERPYWNM 258

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 105/190 (55%), Gaps = 20/190 (10%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 129 REYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 185
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVY---THQSDV 242
Query: 515 YSYGMMVFEM 524
           +S+G++++E+
Sbjct: 243 WSFGVLMWEI 252

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 105/190 (55%), Gaps = 20/190 (10%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 185
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVY---THQSDV 242
Query: 515 YSYGMMVFEM 524
           +S+G++++E+
Sbjct: 243 WSFGVLMWEI 252

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 123/266 (46%), Gaps = 49/266 (18%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T+    DF++E + + +  H N++ L G   +     +I EF+ NGSL+ 
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+      + + +     L  +  GIA G++YL    +   +H D+   NIL++ +   K
Sbjct: 124 FLR-----QNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCK 175
Query: 468 ISDFGLAKICEGRESIVSMTGARG---TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++  E   S  + T A G    I + APE     + + +  SDV+SYG++++E+
Sbjct: 176 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEV 233
Query: 525 T--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY--------ARKM 574
              GE+               P+W         D+  Q + N  +++Y           +
Sbjct: 234 MSYGER---------------PYW---------DMTNQDVINAIEQDYRLPPPMDCPSAL 269
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEMLE 600
             + L C Q + + RP   ++V  L+
Sbjct: 270 HQLMLDCWQKDRNHRPKFGQIVNTLD 295

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S G L  F
Sbjct: 44  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDF 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 103 LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 155
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 156 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 209

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 98/190 (51%), Gaps = 21/190 (11%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSH-VNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + AIK + E  +K +  DF  E+  + +  H  NI+ LLG C       L  E+  +G+L
Sbjct: 51  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 110
Query: 406 EKFIHEKHPLETN----------QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
             F+ +   LET+            L  + L   A  +ARG++YL +    + +H ++  
Sbjct: 111 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAA 167
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVY 515
            NIL+ E++  KI+DFGL++   G+E  V  T  R  + ++A E    N+   +  SDV+
Sbjct: 168 RNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVW 222
Query: 516 SYGMMVFEMT 525
           SYG++++E+ 
Sbjct: 223 SYGVLLWEIV 232

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VAIK L     + E F+ E   + +  H  +V L     E     ++ E++S G L  F
Sbjct: 44  RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDF 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      E  + L+   L  +A  IA G+ Y+ R      +H D++  NIL+ E+   K+
Sbjct: 103 LKG----EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 155
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+T
Sbjct: 156 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELT 209

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 145/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVL--NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 73  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 133 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 184
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 185 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 242
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 243 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 286
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 287 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 336

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 145/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 135 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 245 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 289 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 338

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 145/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVL--NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 135 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 245 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 289 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 338

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 145/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 135 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 245 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 289 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 338

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 145/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 135 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 245 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 289 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 338

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 144/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVL--NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 135 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL ++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 245 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 289 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 338

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 127/265 (47%), Gaps = 42/265 (15%)
Query: 350 VAIK--VLNETKGNGE------DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS 401
           VAIK  +L +++G  E      +F  EV  +S  +H NIV L G      R  ++ EFV 
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
Query: 402 NGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
            G L  + + + HP+      KW V  ++ + IA G+EY+ +  N  I+H D++  NI L
Sbjct: 105 CGDLYHRLLDKAHPI------KWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFL 157
Query: 461 ---DED--FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVY 515
              DE+   C K++DFG ++     +S+ S++G  G   ++APE         + K+D Y
Sbjct: 158 QSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 516 SYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           S+ M+++  +TGE               F  + Y +++    +  +G+     ++   ++
Sbjct: 213 SFAMILYTILTGEGP-------------FDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEML 599
             V   C   +P  RP  + +V+ L
Sbjct: 260 RNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 145/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 63  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 122
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 123 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 174
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 175 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 232
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 233 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 276
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 277 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 326

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 105/190 (55%), Gaps = 20/190 (10%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 231
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 288
Query: 515 YSYGMMVFEM 524
           +S+G++++E+
Sbjct: 289 WSFGVLMWEI 298

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 122/262 (46%), Gaps = 43/262 (16%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T     DF++E + + +  H NI+ L G   +     +I E++ NGSL+ 
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+      + + +     L  +  GI  G++YL    +   +H D+   NIL++ +   K
Sbjct: 120 FLR-----KNDGRFTVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCK 171
Query: 468 ISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT- 525
           +SDFG++++ E   E+  +  G +  I + APE     + + +  SDV+SYG++++E+  
Sbjct: 172 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMS 229
Query: 526 -GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN------EEDKEYARKMILVS 578
            GE+               P+W     ++     ++ IE         D   A   +++ 
Sbjct: 230 YGER---------------PYW-----DMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD 269
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
            W  Q   SDRP   ++V ML+
Sbjct: 270 CW--QKERSDRPKFGQIVNMLD 289

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 145/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+
Sbjct: 46  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 105
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 106 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 157
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 158 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 215
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 216 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 259
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 260 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 309

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 135/271 (49%), Gaps = 38/271 (14%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 56  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 115
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 116 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTA 172
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 173 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 229
Query: 515 YSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           +S+G++++E+   G      + V+          ++K L+       +G   ++      
Sbjct: 230 WSFGVLMWEIFTLGGSPYPGIPVEE---------LFKLLK-------EGHRMDKPANCTN 273
Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           ++ ++   C    PS RP+  ++VE L+  L
Sbjct: 274 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 106/190 (55%), Gaps = 20/190 (10%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 185
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +   + T  R  + ++APE +F R +   +++SDV
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVY---THQSDV 242
Query: 515 YSYGMMVFEM 524
           +S+G++++E+
Sbjct: 243 WSFGVLMWEI 252

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 135/271 (49%), Gaps = 38/271 (14%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 61  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 177
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 178 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 234
Query: 515 YSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           +S+G++++E+   G      + V+          ++K L+       +G   ++      
Sbjct: 235 WSFGVLMWEIFTLGGSPYPGIPVEE---------LFKLLK-------EGHRMDKPANCTN 278
Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           ++ ++   C    PS RP+  ++VE L+  L
Sbjct: 279 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 127/265 (47%), Gaps = 42/265 (15%)
Query: 350 VAIK--VLNETKGNGE------DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS 401
           VAIK  +L +++G  E      +F  EV  +S  +H NIV L G      R  ++ EFV 
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
Query: 402 NGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
            G L  + + + HP+      KW V  ++ + IA G+EY+ +  N  I+H D++  NI L
Sbjct: 105 CGDLYHRLLDKAHPI------KWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFL 157
Query: 461 ---DED--FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVY 515
              DE+   C K++DF L++     +S+ S++G  G   ++APE         + K+D Y
Sbjct: 158 QSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 516 SYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           S+ M+++  +TGE               F  + Y +++    +  +G+     ++   ++
Sbjct: 213 SFAMILYTILTGEGP-------------FDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEML 599
             V   C   +P  RP  + +V+ L
Sbjct: 260 RNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 122/262 (46%), Gaps = 43/262 (16%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T     DF++E + + +  H NI+ L G   +     +I E++ NGSL+ 
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+      + + +     L  +  GI  G++YL    +   +H D+   NIL++ +   K
Sbjct: 105 FLR-----KNDGRFTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCK 156
Query: 468 ISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT- 525
           +SDFG++++ E   E+  +  G +  I + APE     + + +  SDV+SYG++++E+  
Sbjct: 157 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMS 214
Query: 526 -GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN------EEDKEYARKMILVS 578
            GE+               P+W     ++     ++ IE         D   A   +++ 
Sbjct: 215 YGER---------------PYW-----DMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD 254
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
            W  Q   SDRP   ++V ML+
Sbjct: 255 CW--QKERSDRPKFGQIVNMLD 274

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 135/271 (49%), Gaps = 38/271 (14%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 58  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 117
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 118 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 174
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 175 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 231
Query: 515 YSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           +S+G++++E+   G      + V+          ++K L+       +G   ++      
Sbjct: 232 WSFGVLMWEIFTLGGSPYPGIPVEE---------LFKLLK-------EGHRMDKPANCTN 275
Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           ++ ++   C    PS RP+  ++VE L+  L
Sbjct: 276 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 122/262 (46%), Gaps = 43/262 (16%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T     DF++E + + +  H NI+ L G   +     +I E++ NGSL+ 
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+      + + +     L  +  GI  G++YL    +   +H D+   NIL++ +   K
Sbjct: 99  FLR-----KNDGRFTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCK 150
Query: 468 ISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT- 525
           +SDFG++++ E   E+  +  G +  I + APE     + + +  SDV+SYG++++E+  
Sbjct: 151 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMS 208
Query: 526 -GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN------EEDKEYARKMILVS 578
            GE+               P+W     ++     ++ IE         D   A   +++ 
Sbjct: 209 YGER---------------PYW-----DMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD 248
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
            W  Q   SDRP   ++V ML+
Sbjct: 249 CW--QKERSDRPKFGQIVNMLD 268

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 105/190 (55%), Gaps = 20/190 (10%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 69  TVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 185
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 242
Query: 515 YSYGMMVFEM 524
           +S+G++++E+
Sbjct: 243 WSFGVLMWEI 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 135/271 (49%), Gaps = 38/271 (14%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNL 128
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 185
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 242
Query: 515 YSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           +S+G++++E+   G      + V+          ++K L+       +G   ++      
Sbjct: 243 WSFGVLMWEIFTLGGSPYPGIPVEE---------LFKLLK-------EGHRMDKPANCTN 286
Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           ++ ++   C    PS RP+  ++VE L+  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 29/267 (10%)
Query: 349 NVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL-----IYEFV 400
            VA+K +   N ++   E+F++E A +   SH N++ LLG C E   + +     I  F+
Sbjct: 64  KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 401 SNGSLEKFIHEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
             G L  ++     LET  K +  + L K  V IA G+EYL    N   LH D+   N +
Sbjct: 124 KYGDLHTYLLYSR-LETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCM 179
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
           L +D    ++DFGL+K     +       A+  + +IA E         + KSDV+++G+
Sbjct: 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGV 237
Query: 520 MVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSL 579
            ++E+          V ++ E+Y             D  L G   ++ ++   ++  +  
Sbjct: 238 TMWEIATRGMTPYPGV-QNHEMY-------------DYLLHGHRLKQPEDCLDELYEIMY 283
Query: 580 WCIQTNPSDRPSMNRVVEMLEGSLDSL 606
            C +T+P DRP+ + +   LE  L+SL
Sbjct: 284 SCWRTDPLDRPTFSVLRLQLEKLLESL 310

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 144/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E + NGSL+
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 135 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVC 186
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 245 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 289 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 338

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 105/190 (55%), Gaps = 20/190 (10%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I E+ S G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 185
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   +I+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 186 RNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 242
Query: 515 YSYGMMVFEM 524
           +S+G++++E+
Sbjct: 243 WSFGVLMWEI 252

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 95/177 (53%), Gaps = 13/177 (7%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +VAIK++ E   + ++FI E   +   SH  +V L G C +     +I E+++NG L  +
Sbjct: 50  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E +H  +T Q      L ++   +   +EYL    + + LH D+   N L+++    K
Sbjct: 110 LREMRHRFQTQQ------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVK 160
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++     E   S  G++  + +  PEV    + + S KSD++++G++++E+
Sbjct: 161 VSDFGLSRYVLDDEE-TSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEI 214

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 144/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVL--NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E + NGSL+
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 135 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 245 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 289 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 338

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 144/297 (48%), Gaps = 41/297 (13%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E + NGSL+
Sbjct: 46  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 105
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+  KH    + +     L  +  GIA G++YL    +   +H D+   NIL++ +   
Sbjct: 106 SFLR-KH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 157
Query: 467 KISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           K+SDFGL+++ E   E+  +  G +  I + +PE     + + +  SDV+SYG++++E+ 
Sbjct: 158 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 215
Query: 526 --GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQ 583
             GE+               P+W     ++ + +  +G       +    +  + L C Q
Sbjct: 216 SYGER---------------PYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQ 259
Query: 584 TNPSDRPSMNRVVEMLEGSL---DSLQIPPRPFLLSSGSQPDFSSILVRQTESSMAT 637
            + ++RP   ++V +L+  +    SL+I     + S+ ++P  S++L+ Q+   + T
Sbjct: 260 KDRNNRPKFEQIVSILDKLIRNPGSLKI-----ITSAAARP--SNLLLDQSNVDITT 309

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 95/177 (53%), Gaps = 13/177 (7%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +VAIK++ E   + ++FI E   +   SH  +V L G C +     +I E+++NG L  +
Sbjct: 30  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E +H  +T Q      L ++   +   +EYL    + + LH D+   N L+++    K
Sbjct: 90  LREMRHRFQTQQ------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVK 140
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++     E   S  G++  + +  PEV    + + S KSD++++G++++E+
Sbjct: 141 VSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEI 194

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 95/177 (53%), Gaps = 13/177 (7%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +VAIK++ E   + ++FI E   +   SH  +V L G C +     +I E+++NG L  +
Sbjct: 34  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 93
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E +H  +T Q      L ++   +   +EYL    + + LH D+   N L+++    K
Sbjct: 94  LREMRHRFQTQQ------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVK 144
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++     E   S  G++  + +  PEV    + + S KSD++++G++++E+
Sbjct: 145 VSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEI 198

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 10/177 (5%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L     + + F+ E   +    H  +V L           +I E+++ GSL  F
Sbjct: 39  KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDF 98
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      +   K+    L   +  IA G+ Y+ R      +H D++  N+L+ E    KI
Sbjct: 99  LKS----DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKI 151
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE    NFG  + KSDV+S+G++++E+ 
Sbjct: 152 ADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGCFTIKSDVWSFGILLYEIV 205

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 95/177 (53%), Gaps = 13/177 (7%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +VAIK++ E   + ++FI E   +   SH  +V L G C +     +I E+++NG L  +
Sbjct: 50  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E +H  +T Q      L ++   +   +EYL    + + LH D+   N L+++    K
Sbjct: 110 LREMRHRFQTQQ------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVK 160
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++     E   S  G++  + +  PEV    + + S KSD++++G++++E+
Sbjct: 161 VSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEI 214

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 95/177 (53%), Gaps = 13/177 (7%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +VAIK++ E   + ++FI E   +   SH  +V L G C +     +I E+++NG L  +
Sbjct: 35  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E +H  +T Q      L ++   +   +EYL    + + LH D+   N L+++    K
Sbjct: 95  LREMRHRFQTQQ------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVK 145
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++     E   S  G++  + +  PEV    + + S KSD++++G++++E+
Sbjct: 146 VSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEI 199

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 121/256 (47%), Gaps = 31/256 (12%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T+    DF+ E + + +  H NI+ L G   +     ++ E++ NGSL+ 
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT 112
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+      + + +     L  +  GI+ G++YL    +   +H D+   NIL++ +   K
Sbjct: 113 FLK-----KNDGQFTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCK 164
Query: 468 ISDFGLAKICEGR-ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT- 525
           +SDFGL+++ E   E+  +  G +  I + APE     F + +  SDV+SYG++++E+  
Sbjct: 165 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--FRKFTSASDVWSYGIVMWEVVS 222
Query: 526 -GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQT 584
            GE+               P+W     ++ + +  +G       +    +  + L C Q 
Sbjct: 223 YGER---------------PYWEMTNQDVIKAVE-EGYRLPSPMDCPAALYQLMLDCWQK 266
Query: 585 NPSDRPSMNRVVEMLE 600
             + RP  + +V ML+
Sbjct: 267 ERNSRPKFDEIVNMLD 282

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 122/266 (45%), Gaps = 49/266 (18%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T+    DF++E + + +  H N++ L G   +     +I EF+ NGSL+ 
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+      + + +     L  +  GIA G++YL    +   +H  +   NIL++ +   K
Sbjct: 98  FLR-----QNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCK 149
Query: 468 ISDFGLAKICEGRESIVSMTGARG---TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++  E   S  + T A G    I + APE     + + +  SDV+SYG++++E+
Sbjct: 150 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEV 207
Query: 525 T--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY--------ARKM 574
              GE+               P+W         D+  Q + N  +++Y           +
Sbjct: 208 MSYGER---------------PYW---------DMTNQDVINAIEQDYRLPPPMDCPSAL 243
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEMLE 600
             + L C Q + + RP   ++V  L+
Sbjct: 244 HQLMLDCWQKDRNHRPKFGQIVNTLD 269

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 95/177 (53%), Gaps = 13/177 (7%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +VAIK++ E   + ++FI E   +   SH  +V L G C +     +I E+++NG L  +
Sbjct: 41  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 100
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E +H  +T Q      L ++   +   +EYL    + + LH D+   N L+++    K
Sbjct: 101 LREMRHRFQTQQ------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVK 151
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++     E   S  G++  + +  PEV    + + S KSD++++G++++E+
Sbjct: 152 VSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEI 205

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 95/177 (53%), Gaps = 13/177 (7%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +VAIK++ E   + ++FI E   +   SH  +V L G C +     +I E+++NG L  +
Sbjct: 35  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E +H  +T Q      L ++   +   +EYL    + + LH D+   N L+++    K
Sbjct: 95  LREMRHRFQTQQ------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVK 145
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++     E   S  G++  + +  PEV    + + S KSD++++G++++E+
Sbjct: 146 VSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEI 199

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 134/271 (49%), Gaps = 38/271 (14%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I  + S G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNL 128
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 185
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 242
Query: 515 YSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           +S+G++++E+   G      + V+          ++K L+       +G   ++      
Sbjct: 243 WSFGVLMWEIFTLGGSPYPGIPVEE---------LFKLLK-------EGHRMDKPANCTN 286
Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
           ++ ++   C    PS RP+  ++VE L+  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L     + + F+ E   +    H  +V L     +     +I EF++ GSL  F
Sbjct: 38  KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDF 97
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +      +   K+    L   +  IA G+ Y+ R      +H D++  N+L+ E    KI
Sbjct: 98  LKS----DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKI 150
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE    NFG  + KS+V+S+G++++E+ 
Sbjct: 151 ADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGCFTIKSNVWSFGILLYEIV 204

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 133/268 (49%), Gaps = 38/268 (14%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L +  T+ +  D ++E+  +     H NI+ LLG C +     +I  + S G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNL 128
Query: 406 EKFIHEKHP------LETNQKLKWEVLYKIAVG----IARGLEYLHRGCNTRILHFDIKP 455
            +++  + P       + N+  + ++ +K  V     +ARG+EYL    + + +H D+  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 185
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            N+L+ E+   KI+DFGLA+     +     T  R  + ++APE +F R +   +++SDV
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDV 242
Query: 515 YSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           +S+G++++E+   G      + V+          ++K L+       +G   ++      
Sbjct: 243 WSFGVLMWEIFTLGGSPYPGIPVEE---------LFKLLK-------EGHRMDKPANCTN 286
Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEMLE 600
           ++ ++   C    PS RP+  ++VE L+
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 86/174 (49%), Gaps = 22/174 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E+   E    +   H NI+ L G C +     L+ EF   G L + +       + +++ 
Sbjct: 51  ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-------SGKRIP 103
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF--------CPKISDFGLA 474
            ++L   AV IARG+ YLH      I+H D+K  NIL+ +            KI+DFGLA
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
Query: 475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGE 527
           +  E   +  +   A G   ++APEV   +    S  SDV+SYG++++E +TGE
Sbjct: 164 R--EWHRT--TKMSAAGAYAWMAPEVIRASM--FSKGSDVWSYGVLLWELLTGE 211

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K       K+  E LYK           +  +A+G+E+L    + + +H D+
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 174
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQS 231
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 232 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 276
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 277 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VAIK L     + E F+ E   + +  H  +V L     E     ++ E+++ GSL  F+
Sbjct: 36  VAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFL 94
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
            +       + LK   L  +A  +A G+ Y+ R      +H D++  NIL+      KI+
Sbjct: 95  KDGE----GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGNGLICKIA 147
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE     +G  + KSDV+S+G+++ E+ 
Sbjct: 148 DFGLARLIEDNEX-TARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELV 200

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 34/265 (12%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 404 SLEKFIHEKH----PLETNQK--LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
           +L  ++  K     P +   K  L  E L   +  +A+G+E+L    + + +H D+   N
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARN 174
Query: 458 ILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYS 516
           ILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +SDV+S
Sbjct: 175 ILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWS 231
Query: 517 YGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +G++++E+   G      V +D            +RL+       +G           +M
Sbjct: 232 FGVLLWEIFSLGASPYPGVKIDEE--------FXRRLK-------EGTRMRAPDYTTPEM 276
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEML 599
               L C    PS RP+ + +VE L
Sbjct: 277 YQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 108
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K       K+  E LYK           +  +A+G+E+L    + + +H D+
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQS 222
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 223 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 267
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K       K+  E LYK           +  +A+G+E+L    + + +H D+
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 174
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQS 231
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 232 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 276
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 277 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K       K+  E LYK           +  +A+G+E+L    + + +H D+
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 174
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQS 231
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 232 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 276
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 277 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 80  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 139
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 140 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 190
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 191 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 248

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K       K+  E LYK           +  +A+G+E+L    + + +H D+
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQS 222
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 223 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 267
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 37/274 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 59  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 118
Query: 404 SLEKFIHEKH----PLETNQKL-----KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           +L  ++  K     P +T + L       E L   +  +A+G+E+L    + + +H D+ 
Sbjct: 119 NLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLA 175
Query: 455 PHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSD 513
             NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +SD
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSD 232
Query: 514 VYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYA 571
           V+S+G++++E+   G      V +D            +RL+       +G          
Sbjct: 233 VWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYTT 277
Query: 572 RKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
            +M    L C    PS RP+ + +VE L   L +
Sbjct: 278 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 81  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 140
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 141 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 191
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 192 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 249

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 54  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 113
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 114 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 164
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 165 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 222

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 120
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 121 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 171
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 172 KVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 229

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 46  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 104
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 105 --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 157
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 158 DFGLARLIEDNEX-TAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 210

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 95  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K       K+  E LYK           +  +A+G+E+L    + + +H D+
Sbjct: 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 211
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQS 268
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 269 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 313
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 314 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 122 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 173 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 230

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 48  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 106
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 107 --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 159
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 160 DFGLARLIEDNEX-TAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 212

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 42/275 (15%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K     N+ + ++ LYK           +  +A+G+E+L    + + +H D+
Sbjct: 118 NLSTYLRSKR----NEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDL 170
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 171 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQS 227
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 228 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 272
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 273 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 307

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K       K+  E LYK           +  +A+G+E+L    + + +H D+
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQS 222
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 223 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 267
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 93/180 (51%), Gaps = 18/180 (10%)
Query: 350 VAIKVL----NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           VAIK +     E +   + F  EV + S+ SH NIV+++    E     L+ E++   +L
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++I    PL  +  + +         I  G+++ H   + RI+H DIKP NIL+D +  
Sbjct: 99  SEYIESHGPLSVDTAINF------TNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKT 149
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYK-SDVYSYGMMVFEM 524
            KI DFG+AK      S+       GT+ Y +PE   +  GE + + +D+YS G++++EM
Sbjct: 150 LKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPE---QAKGEATDECTDIYSIGIVLYEM 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 122/265 (46%), Gaps = 27/265 (10%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 49  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 107
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 108 --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 160
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKN 529
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+     
Sbjct: 161 DFGLARLIEDNEX-TAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTH-- 215
Query: 530 NANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDR 589
                      I +P      +    + G + +  +   E   +++ +   C +  P DR
Sbjct: 216 ---------GRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL---CWKERPEDR 263
Query: 590 PSMNRVVEMLEGSLDSL--QIPPRP 612
           P+ + +  +LE    +   Q  P+P
Sbjct: 264 PTFDYLRSVLEDFFTATEGQFQPQP 288

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 59  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 118
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 119 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 169
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 170 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 227

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 120
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 121 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 171
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 172 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 229

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K       K+  E LYK           +  +A+G+E+L    + + +H D+
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQS 222
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 223 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 267
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F
Sbjct: 39  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +  K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI
Sbjct: 98  L--KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKI 150
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           +DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 151 ADFGLARLIEDAEX-TAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 204

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 122 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 173 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 230

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 40  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 99  --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 151
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 152 DFGLARLIEDNEX-TAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 204

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 119
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 120 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 170
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 171 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 57  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 116
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G++YL    + + +H D+   N +LDE F  
Sbjct: 117 FIRNETH----NPTVK--DLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 167
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 225

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 42  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 100
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 101 --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 153
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 154 DFGLARLIEDNEX-TAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 206

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 46  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 104
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 105 --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 157
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 158 DFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 41  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 99
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 100 --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 152
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 153 DFGLARLIEDNEX-TAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 40  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 99  --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 151
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 152 DFGLARLIEDNEX-TAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 204

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 45  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 103
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 104 --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 156
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 157 DFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 209

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 50  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 108
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 109 --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 161
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 162 DFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 214

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 16/178 (8%)
Query: 350 VAIKVLNET--KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K   ET        F+ E   + + SH NIV L+G C +     ++ E V  G    
Sbjct: 142 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+  +       +L+ + L ++    A G+EYL   C    +H D+   N L+ E    K
Sbjct: 202 FLRTE-----GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLK 253
Query: 468 ISDFGLAKICEGRESIVSMTGA--RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
           ISDFG+++  E  + + + +G   +  + + APE    N+G  S +SDV+S+G++++E
Sbjct: 254 ISDFGMSR--EEADGVXAASGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 123/275 (44%), Gaps = 38/275 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 60  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYK----------IAVGIARGLEYLHRGCNTRILHFDI 453
           +L  ++  K       K   E LYK           +  +A+G+E+L    + + +H D+
Sbjct: 120 NLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 176
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKS 512
              NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +S
Sbjct: 177 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQS 233
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+S+G++++E+   G      V +D            +RL+       +G         
Sbjct: 234 DVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYT 278
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
             +M    L C    PS RP+ + +VE L   L +
Sbjct: 279 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 313

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 40  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 99  --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 151
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 152 DFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 204

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 35  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 93
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H D++  NIL+ +    KI+
Sbjct: 94  --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 146
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 147 DFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 199

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 36/267 (13%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSH-VNIVTLLGFCFE-GHRRALIYEFVSNG 403
           + VA+K+L E   + E    ++E+  +    H +N+V LLG C + G    +I EF   G
Sbjct: 60  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 404 SLEKFIHEKH----PLETNQK----LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
           +L  ++  K     P +        L  E L   +  +A+G+E+L    + + +H D+  
Sbjct: 120 NLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAA 176
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDV 514
            NILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +SDV
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDV 233
Query: 515 YSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
           +S+G++++E+   G      V +D            +RL+       +G           
Sbjct: 234 WSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYTTP 278
Query: 573 KMILVSLWCIQTNPSDRPSMNRVVEML 599
           +M    L C    PS RP+ + +VE L
Sbjct: 279 EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 16/178 (8%)
Query: 350 VAIKVLNET--KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K   ET        F+ E   + + SH NIV L+G C +     ++ E V  G    
Sbjct: 142 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+  +       +L+ + L ++    A G+EYL   C    +H D+   N L+ E    K
Sbjct: 202 FLRTE-----GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLK 253
Query: 468 ISDFGLAKICEGRESIVSMTGA--RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
           ISDFG+++  E  + + + +G   +  + + APE    N+G  S +SDV+S+G++++E
Sbjct: 254 ISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G+++L    + + +H D+   N +LDE F  
Sbjct: 181 FIRNETH----NPTVK--DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 231
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 289

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI EF+  GSL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           +++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 105 EYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 156
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 119
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G+++L    + + +H D+   N +LDE F  
Sbjct: 120 FIRNETH----NPTVK--DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 170
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 171 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 228

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G+++L    + + +H D+   N +LDE F  
Sbjct: 122 FIRNETH----NPTVK--DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 173 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G+++L    + + +H D+   N +LDE F  
Sbjct: 122 FIRNETH----NPTVK--DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 173 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 230

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 67  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 126
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G+++L    + + +H D+   N +LDE F  
Sbjct: 127 FIRNETH----NPTVK--DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 177
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 178 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 235

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 122
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G+++L    + + +H D+   N +LDE F  
Sbjct: 123 FIRNETH----NPTVK--DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 173
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 174 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 231

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 97/180 (53%), Gaps = 17/180 (9%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSNGSLEK 407
           A+K LN     GE   F+ E   +   SH N+++LLG C       L+   ++ +G L  
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 122
Query: 408 FI-HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           FI +E H    N  +K   L    + +A+G+++L    + + +H D+   N +LDE F  
Sbjct: 123 FIRNETH----NPTVK--DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 173
Query: 467 KISDFGLAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K++DFGLA+    +E  S+ + TGA+  + ++A E       + + KSDV+S+G++++E+
Sbjct: 174 KVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWEL 231

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIKVL +   K + E+ + E   + +  +  IV L+G C +     L+ E    G L 
Sbjct: 39  DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLH 97
Query: 407 KFI---HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           KF+    E+ P+        E+L+++++G    ++YL        +H D+   N+LL   
Sbjct: 98  KFLVGKREEIPVSNVA----ELLHQVSMG----MKYLE---EKNFVHRDLAARNVLLVNR 146
Query: 464 FCPKISDFGLAKICEGRESIVSMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KISDFGL+K     +S  +   A +  + + APE  C NF + S +SDV+SYG+ ++
Sbjct: 147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE--CINFRKFSSRSDVWSYGVTMW 204
Query: 523 E 523
           E
Sbjct: 205 E 205

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 133 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 184
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 185 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 241

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 106 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 157
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 158 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 214

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 108 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 159
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 160 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 105 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 156
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 101 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 152
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 153 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 100 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 151
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 152 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 208

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q VAIK L + K  G   E+F +E    +R  H N+V LLG   +    ++I+ + S+G 
Sbjct: 57  QAVAIKTLKD-KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGD 115
Query: 405 LEKFIHEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           L +F+  + P                L+      +   IA G+EYL    +  ++H D+ 
Sbjct: 116 LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLA 172
Query: 455 PHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDV 514
             N+L+ +    KISD GL +     +    +  +   I ++APE     +G+ S  SD+
Sbjct: 173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDI 230
Query: 515 YSYGMMVFEM--------TGEKNNANVAVDRSSEIY-----FPHWVY 548
           +SYG++++E+         G  N   V + R+ ++       P WVY
Sbjct: 231 WSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVY 277

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 107 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 158
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 159 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           VA+K L +   + + F+ E   + +  H  +V L     +     +I E++ NGSL  F+
Sbjct: 36  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 94
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
             K P  +  KL    L  +A  IA G+ ++        +H +++  NIL+ +    KI+
Sbjct: 95  --KTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNLRAANILVSDTLSCKIA 147
Query: 470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           DFGLA++ E  E   +  GA+  I + APE    N+G  + KSDV+S+G+++ E+ 
Sbjct: 148 DFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 200

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 102 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 153
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 109 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 160
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 161 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 119/266 (44%), Gaps = 49/266 (18%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T+    +F++E + + +  H NI+ L G         ++ EF+ NG+L+ 
Sbjct: 45  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 104
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+     L   Q    + L  +  GIA G+ YL        +H D+   NIL++ +   K
Sbjct: 105 FLR----LNDGQFTVIQ-LVGMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCK 156
Query: 468 ISDFGLAKICEGRESIVSMT---GARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++  E   S  + T   G +  I + APE     F + +  SD +SYG++++E+
Sbjct: 157 VSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA--FRKFTSASDAWSYGIVMWEV 214
Query: 525 T--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY--------ARKM 574
              GE+               P+W         D+  Q + N  +++Y           +
Sbjct: 215 MSFGER---------------PYW---------DMSNQDVINAIEQDYRLPPPPDCPTSL 250
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEMLE 600
             + L C Q + + RP   +VV  L+
Sbjct: 251 HQLMLDCWQKDRNARPRFPQVVSALD 276

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 77  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 136
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 190
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 191 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 247
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 248 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 293
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 294 TQCWQHQPEDRPNFAIILERIE 315

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 102 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 153
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 119/266 (44%), Gaps = 49/266 (18%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK L    T+    +F++E + + +  H NI+ L G         ++ EF+ NG+L+ 
Sbjct: 47  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 106
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+     L   Q    + L  +  GIA G+ YL        +H D+   NIL++ +   K
Sbjct: 107 FLR----LNDGQFTVIQ-LVGMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCK 158
Query: 468 ISDFGLAKICEGRESIVSMT---GARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL++  E   S  + T   G +  I + APE     F + +  SD +SYG++++E+
Sbjct: 159 VSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA--FRKFTSASDAWSYGIVMWEV 216
Query: 525 T--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY--------ARKM 574
              GE+               P+W         D+  Q + N  +++Y           +
Sbjct: 217 MSFGER---------------PYW---------DMSNQDVINAIEQDYRLPPPPDCPTSL 252
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEMLE 600
             + L C Q + + RP   +VV  L+
Sbjct: 253 HQLMLDCWQKDRNARPRFPQVVSALD 278

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q VAIK L + K  G   E+F +E    +R  H N+V LLG   +    ++I+ + S+G 
Sbjct: 40  QAVAIKTLKD-KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGD 98
Query: 405 LEKFIHEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           L +F+  + P                L+      +   IA G+EYL    +  ++H D+ 
Sbjct: 99  LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLA 155
Query: 455 PHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDV 514
             N+L+ +    KISD GL +     +    +  +   I ++APE     +G+ S  SD+
Sbjct: 156 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDI 213
Query: 515 YSYGMMVFEM--------TGEKNNANVAVDRSSEIY-----FPHWVY 548
           +SYG++++E+         G  N   V + R+ ++       P WVY
Sbjct: 214 WSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVY 260

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 176
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 177 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 233
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 234 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 279
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 280 TQCWQHQPEDRPNFAIILERIE 301

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 54  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 113
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 114 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 167
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 168 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 224
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 225 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 270
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 271 TQCWQHQPEDRPNFAIILERIE 292

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 120 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 171
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 120 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 171
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 228

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 113/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E     +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 77  QVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 136
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 190
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 191 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 247
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 248 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 293
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 294 TQCWQHQPEDRPNFAIILERIE 315

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 62  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLK 121
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 175
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 176 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 232
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 233 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 278
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 279 TQCWQHQPEDRPNFAIILERIE 300

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 176
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 177 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 233
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 234 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 279
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 280 TQCWQHQPEDRPNFAIILERIE 301

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 77  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLK 136
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 190
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 191 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 247
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 248 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 293
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 294 TQCWQHQPEDRPNFAIILERIE 315

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 102 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 153
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 62  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 121
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 175
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 176 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 232
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 233 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 278
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 279 TQCWQHQPEDRPNFAIILERIE 300

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K +     + E F+ E   +    H  +V L     +     +I EF++ GSL  F
Sbjct: 41  KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 99
Query: 409 IHE----KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +      K PL          L   +  IA G+ ++ +      +H D++  NIL+    
Sbjct: 100 LKSDEGSKQPLPK--------LIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASL 148
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGLA++ E  E   +  GA+  I + APE    NFG  + KSDV+S+G+++ E+
Sbjct: 149 VCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEI 205
Query: 525 T 525
Sbjct: 206 V 206

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 69  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 128
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 129 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 182
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 183 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 239
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 240 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 285
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 286 TQCWQHQPEDRPNFAIILERIE 307

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 79  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 138
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 139 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 192
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 193 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 249
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 250 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 295
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 296 TQCWQHQPEDRPNFAIILERIE 317

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 176
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 177 PGPGRVAKIGDFGMAQDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 233
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 234 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 279
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 280 TQCWQHQPEDRPNFAIILERIE 301

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K +     + E F+ E   +    H  +V L     +     +I EF++ GSL  F
Sbjct: 214 KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 272
Query: 409 IHE----KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +      K PL          L   +  IA G+ ++ +      +H D++  NIL+    
Sbjct: 273 LKSDEGSKQPLPK--------LIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASL 321
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGLA++ E  E   +  GA+  I + APE    NFG  + KSDV+S+G+++ E+
Sbjct: 322 VCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEI 378
Query: 525 T 525
Sbjct: 379 V 379

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 33/262 (12%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 89  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 148
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 149 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 202
Query: 466 P------KISDFGLAKICEGRESIVSMTG-ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           P      KI DFG+A+    R S     G A   + ++ PE F    G  + K+D +S+G
Sbjct: 203 PGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFG 259
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+              S  Y P+      E+ E +   G   +  K     +  + 
Sbjct: 260 VLLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIM 305
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C Q  P DRP+   ++E +E
Sbjct: 306 TQCWQHQPEDRPNFAIILERIE 327

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 27/197 (13%)
Query: 349 NVAIKVLNETKGNGED--FINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L E   + E    ++E+  +++  SH NIV LLG C       LI+E+   G L
Sbjct: 77  QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
Query: 406 --------EKFIHEKHPLETNQKLK---------WEVLYKIAVGIARGLEYLH-RGCNTR 447
                   EKF  ++   E  ++L+         +E L   A  +A+G+E+L  + C   
Sbjct: 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC--- 193
Query: 448 ILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGE 507
            +H D+   N+L+      KI DFGLA+      + V    AR  + ++APE      G 
Sbjct: 194 -VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GI 250
Query: 508 VSYKSDVYSYGMMVFEM 524
            + KSDV+SYG++++E+
Sbjct: 251 YTIKSDVWSYGILLWEI 267

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 84/183 (45%), Gaps = 21/183 (11%)
Query: 368 EVASISRTSHVNIVTLLGFCFEGHR----RALIYEFVSNGSLEKFIHEKHPLETNQKLKW 423
           EV S+    H NI+  +G    G        LI  F   GSL  F      L+ N  + W
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF------LKAN-VVSW 120
Query: 424 EVLYKIAVGIARGLEYLHR-------GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 476
             L  IA  +ARGL YLH        G    I H DIK  N+LL  +    I+DFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 477 CEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSY-KSDVYSYGMMVFEMTGEKNNANV 533
            E  +S     G  GT  Y+APEV     NF   ++ + D+Y+ G++++E+      A+ 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 534 AVD 536
            VD
Sbjct: 241 PVD 243

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 94/183 (51%), Gaps = 17/183 (9%)
Query: 348 QNVAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEFVSNG 403
           + VA+K L    G     D   E+  +    H NIV   G C E  G+   LI EF+ +G
Sbjct: 51  EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 110
Query: 404 SLEKFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
           SL++++ + K+ +   Q+LK+      AV I +G++YL    + + +H D+   N+L++ 
Sbjct: 111 SLKEYLPKNKNKINLKQQLKY------AVQICKGMDYL---GSRQYVHRDLAARNVLVES 161
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGT-IGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           +   KI DFGL K  E  +   ++   R + + + APE  C    +    SDV+S+G+ +
Sbjct: 162 EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE--CLMQSKFYIASDVWSFGVTL 219
Query: 522 FEM 524
            E+
Sbjct: 220 HEL 222

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 112/261 (42%), Gaps = 31/261 (11%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 80  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 139
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 140 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 193
Query: 466 P------KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
           P      KI DFG+A+             A   + ++ PE F    G  + K+D +S+G+
Sbjct: 194 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGV 251
Query: 520 MVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSL 579
           +++E+              S  Y P+      E+ E +   G   +  K     +  +  
Sbjct: 252 LLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMT 297
Query: 580 WCIQTNPSDRPSMNRVVEMLE 600
            C Q  P DRP+   ++E +E
Sbjct: 298 QCWQHQPEDRPNFAIILERIE 318

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 94/183 (51%), Gaps = 17/183 (9%)
Query: 348 QNVAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEFVSNG 403
           + VA+K L    G     D   E+  +    H NIV   G C E  G+   LI EF+ +G
Sbjct: 39  EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 98
Query: 404 SLEKFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
           SL++++ + K+ +   Q+LK+      AV I +G++YL    + + +H D+   N+L++ 
Sbjct: 99  SLKEYLPKNKNKINLKQQLKY------AVQICKGMDYL---GSRQYVHRDLAARNVLVES 149
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGT-IGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           +   KI DFGL K  E  +   ++   R + + + APE  C    +    SDV+S+G+ +
Sbjct: 150 EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE--CLMQSKFYIASDVWSFGVTL 207
Query: 522 FEM 524
            E+
Sbjct: 208 HEL 210

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 112/261 (42%), Gaps = 31/261 (11%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K L E  ++ +  DF+ E   IS+ +H NIV  +G   +   R ++ E ++ G L+
Sbjct: 103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 162
Query: 407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            F+ E  P  +    L    L  +A  IA G +YL        +H DI   N LL    C
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT---C 216
Query: 466 P------KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
           P      KI DFG+A+             A   + ++ PE F    G  + K+D +S+G+
Sbjct: 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGV 274
Query: 520 MVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSL 579
           +++E+              S  Y P+      E+ E +   G   +  K     +  +  
Sbjct: 275 LLWEIF-------------SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMT 320
Query: 580 WCIQTNPSDRPSMNRVVEMLE 600
            C Q  P DRP+   ++E +E
Sbjct: 321 QCWQHQPEDRPNFAIILERIE 341

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +VAIKVL +   K + E+ + E   + +  +  IV L+G C +     L+ E    G L 
Sbjct: 365 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLH 423
Query: 407 KFI---HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           KF+    E+ P+        E+L+++++G    ++YL        +H ++   N+LL   
Sbjct: 424 KFLVGKREEIPVSNVA----ELLHQVSMG----MKYLE---EKNFVHRNLAARNVLLVNR 472
Query: 464 FCPKISDFGLAKICEGRESIVSMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KISDFGL+K     +S  +   A +  + + APE  C NF + S +SDV+SYG+ ++
Sbjct: 473 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE--CINFRKFSSRSDVWSYGVTMW 530
Query: 523 E 523
           E
Sbjct: 531 E 531

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 124/265 (46%), Gaps = 35/265 (13%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K +NE+    E  +F+NE + +   +  ++V LLG   +G    ++ E +++G L+ 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 408 FIHEKHPLETNQKLK----WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N   +     + + ++A  IA G+ YL+     + +H D+   N ++  D
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 166
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + ++APE      G  +  SD++S+G+++
Sbjct: 167 FTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVL 222
Query: 522 FEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL---QGIENEEDKEYARKMILVS 578
           +E+T                      Y+ L  E+ L      G  ++ D    R   L+ 
Sbjct: 223 WEITSLAEQP----------------YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMR 266
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSL 603
           + C Q NP+ RP+   +V +L+  L
Sbjct: 267 M-CWQFNPNMRPTFLEIVNLLKDDL 290

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 43/274 (15%)
Query: 349 NVAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K+L E     E  D ++E   + + +H +++ L G C +     LI E+   GSL 
Sbjct: 55  TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 407 KFIHEK--------------------HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
            F+ E                     HP E  + L    L   A  I++G++YL      
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDE--RALTMGDLISFAWQISQGMQYL---AEM 169
Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
           +++H D+   NIL+ E    KISDFGL++     +S V  +  R  + ++A E    +  
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI- 228
Query: 507 EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 566
             + +SDV+S+G++++E+     N    +        P  ++  L+        G   E 
Sbjct: 229 -YTTQSDVWSFGVLLWEIVTLGGNPYPGIP-------PERLFNLLK-------TGHRMER 273
Query: 567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
               + +M  + L C +  P  RP    + + LE
Sbjct: 274 PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 29/262 (11%)
Query: 350 VAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  T      E  ++E+  +S    H NIV LLG C  G    +I E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 407 KFIHEK-HPLET-------NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 458
            F+  K   LET       N  L    L   +  +A+G+ +L    +   +H D+   N+
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNV 195
Query: 459 LLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           LL      KI DFGLA+      + +    AR  + ++APE        V  +SDV+SYG
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYG 253
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+     N    +  +S+ Y         +L +D    G +  +     + +  + 
Sbjct: 254 ILLWEIFSLGLNPYPGILVNSKFY---------KLVKD----GYQMAQPAFAPKNIYSIM 300
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C    P+ RP+  ++   L+
Sbjct: 301 QACWALEPTHRPTFQQICSFLQ 322

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 25/258 (9%)
Query: 350 VAIKVLNETK--GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  T      E  ++E+  +S    H NIV LLG C  G    +I E+   G L 
Sbjct: 71  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 130
Query: 407 KFIHEKHPL----ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
            F+  K       E  + L+   L   +  +A+G+ +L    +   +H D+   N+LL  
Sbjct: 131 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTN 187
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
               KI DFGLA+      + +    AR  + ++APE        V  +SDV+SYG++++
Sbjct: 188 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLW 245
Query: 523 EMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCI 582
           E+     N    +  +S+ Y         +L +D    G +  +     + +  +   C 
Sbjct: 246 EIFSLGLNPYPGILVNSKFY---------KLVKD----GYQMAQPAFAPKNIYSIMQACW 292
Query: 583 QTNPSDRPSMNRVVEMLE 600
              P+ RP+  ++   L+
Sbjct: 293 ALEPTHRPTFQQICSFLQ 310

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 116/264 (43%), Gaps = 31/264 (11%)
Query: 350 VAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  T      E  ++E+  +S    H NIV LLG C  G    +I E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 407 KFIHEKHP--LETN--------QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
            F+  K P  LE +        ++L    L   +  +A+G+ +L    +   +H D+   
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAAR 195
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYS 516
           N+LL      KI DFGLA+      + +    AR  + ++APE        V  +SDV+S
Sbjct: 196 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWS 253
Query: 517 YGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMIL 576
           YG++++E+     N    +  +S+ Y         +L +D    G +  +     + +  
Sbjct: 254 YGILLWEIFSLGLNPYPGILVNSKFY---------KLVKD----GYQMAQPAFAPKNIYS 300
Query: 577 VSLWCIQTNPSDRPSMNRVVEMLE 600
           +   C    P+ RP+  ++   L+
Sbjct: 301 IMQACWALEPTHRPTFQQICSFLQ 324

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 43/274 (15%)
Query: 349 NVAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K+L E     E  D ++E   + + +H +++ L G C +     LI E+   GSL 
Sbjct: 55  TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 407 KFIHEK--------------------HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
            F+ E                     HP E  + L    L   A  I++G++YL      
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDE--RALTMGDLISFAWQISQGMQYL---AEM 169
Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
           +++H D+   NIL+ E    KISDFGL++     +S V  +  R  + ++A E    +  
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI- 228
Query: 507 EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 566
             + +SDV+S+G++++E+     N    +        P  ++  L+        G   E 
Sbjct: 229 -YTTQSDVWSFGVLLWEIVTLGGNPYPGIP-------PERLFNLLK-------TGHRMER 273
Query: 567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
               + +M  + L C +  P  RP    + + LE
Sbjct: 274 PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 35/265 (13%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K +NE+    E  +F+NE + +   +  ++V LLG   +G    ++ E +++G L+ 
Sbjct: 47  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 106
Query: 408 FIHEKHPLETNQKLK----WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N   +     + + ++A  IA G+ YL+     + +H D+   N ++  D
Sbjct: 107 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 163
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + ++APE      G  +  SD++S+G+++
Sbjct: 164 FTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVL 219
Query: 522 FEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL---QGIENEEDKEYARKMILVS 578
           +E+T                      Y+ L  E+ L      G  ++ D    R   L+ 
Sbjct: 220 WEITSLAEQP----------------YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMR 263
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSL 603
           + C Q NP  RP+   +V +L+  L
Sbjct: 264 M-CWQFNPKMRPTFLEIVNLLKDDL 287

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 35/265 (13%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K +NE+    E  +F+NE + +   +  ++V LLG   +G    ++ E +++G L+ 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 408 FIHEKHPLETNQKLK----WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N   +     + + ++A  IA G+ YL+     + +H D+   N ++  D
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 166
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + ++APE      G  +  SD++S+G+++
Sbjct: 167 FTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVL 222
Query: 522 FEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL---QGIENEEDKEYARKMILVS 578
           +E+T                      Y+ L  E+ L      G  ++ D    R   L+ 
Sbjct: 223 WEITSLAEQP----------------YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMR 266
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSL 603
           + C Q NP  RP+   +V +L+  L
Sbjct: 267 M-CWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 43  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 102
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 103 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 159
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 160 FTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 215
Query: 522 FEMT 525
           +E+ 
Sbjct: 216 WEIA 219

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ + H     +++    L +    I +G+EYL      R +H D+   NIL++ +   
Sbjct: 105 DYL-QAHA----ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 156
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 25/258 (9%)
Query: 350 VAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  T      E  ++E+  +S    H NIV LLG C  G    +I E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 407 KFIHEKHPL----ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
            F+  K       E  + L+   L   +  +A+G+ +L    +   +H D+   N+LL  
Sbjct: 139 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTN 195
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
               KI DFGLA+      + +    AR  + ++APE        V  +SDV+SYG++++
Sbjct: 196 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLW 253
Query: 523 EMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCI 582
           E+     N    +  +S+ Y         +L +D    G +  +     + +  +   C 
Sbjct: 254 EIFSLGLNPYPGILVNSKFY---------KLVKD----GYQMAQPAFAPKNIYSIMQACW 300
Query: 583 QTNPSDRPSMNRVVEMLE 600
              P+ RP+  ++   L+
Sbjct: 301 ALEPTHRPTFQQICSFLQ 318

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 52  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 111
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 112 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 168
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 169 FTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 224
Query: 522 FEMT 525
           +E+ 
Sbjct: 225 WEIA 228

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR--ALIYEFVSNGSLE 406
           VA+K L + T+ +  DF  E+  +    H NIV   G C+   RR   LI E++  GSL 
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            ++ +KH     +++    L +    I +G+EYL      R +H ++   NIL++ +   
Sbjct: 103 DYL-QKH----KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRV 154
Query: 467 KISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI DFGL K+  + +E           I + APE    +  + S  SDV+S+G++++E+
Sbjct: 155 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 211

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 35/265 (13%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K +NE+    E  +F+NE + +   +  ++V LLG   +G    ++ E +++G L+ 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 408 FIHEKHPLETNQKLK----WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N   +     + + ++A  IA G+ YL+     + +H D+   N ++  D
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 166
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + ++APE      G  +  SD++S+G+++
Sbjct: 167 FTVKIGDFGMTR--DIYETAYYRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVL 222
Query: 522 FEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL---QGIENEEDKEYARKMILVS 578
           +E+T                      Y+ L  E+ L      G  ++ D    R   L+ 
Sbjct: 223 WEITSLAEQP----------------YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMR 266
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSL 603
           + C Q NP  RP+   +V +L+  L
Sbjct: 267 M-CWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 37/261 (14%)
Query: 348 QNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VAIK +N  K   + ++ + E+ ++S+  H NIV+            L+ + +S GS+
Sbjct: 36  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 95
Query: 406 EKFIHEKHPLETNQK----LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
              I  KH +   +     L    +  I   +  GLEYLH+      +H D+K  NILL 
Sbjct: 96  LDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 150
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIG---YIAPEVFCRNFGEVSYKSDVYSYG 518
           ED   +I+DFG++        I      +  +G   ++APEV  +  G   +K+D++S+G
Sbjct: 151 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFG 209
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED-----LGLQGIENEEDKEYA-- 571
           +   E+         A   +    +P      L L+ D      G+Q  + E  K+Y   
Sbjct: 210 ITAIEL---------ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ--DKEMLKKYGKS 258
Query: 572 -RKMILVSLWCIQTNPSDRPS 591
            RKMI +   C+Q +P  RP+
Sbjct: 259 FRKMISL---CLQKDPEKRPT 276

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 37/261 (14%)
Query: 348 QNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VAIK +N  K   + ++ + E+ ++S+  H NIV+            L+ + +S GS+
Sbjct: 41  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100
Query: 406 EKFIHEKHPLETNQK----LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
              I  KH +   +     L    +  I   +  GLEYLH+      +H D+K  NILL 
Sbjct: 101 LDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 155
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIG---YIAPEVFCRNFGEVSYKSDVYSYG 518
           ED   +I+DFG++        I      +  +G   ++APEV  +  G   +K+D++S+G
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFG 214
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED-----LGLQGIENEEDKEYA-- 571
           +   E+         A   +    +P      L L+ D      G+Q  + E  K+Y   
Sbjct: 215 ITAIEL---------ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ--DKEMLKKYGKS 263
Query: 572 -RKMILVSLWCIQTNPSDRPS 591
            RKMI +   C+Q +P  RP+
Sbjct: 264 FRKMISL---CLQKDPEKRPT 281

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 43/274 (15%)
Query: 349 NVAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
            VA+K+L E     E  D ++E   + + +H +++ L G C +     LI E+   GSL 
Sbjct: 55  TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 407 KFIHEK--------------------HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
            F+ E                     HP E  + L    L   A  I++G++YL      
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDE--RALTMGDLISFAWQISQGMQYL---AEM 169
Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
            ++H D+   NIL+ E    KISDFGL++     +S V  +  R  + ++A E    +  
Sbjct: 170 SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI- 228
Query: 507 EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 566
             + +SDV+S+G++++E+     N    +        P  ++  L+        G   E 
Sbjct: 229 -YTTQSDVWSFGVLLWEIVTLGGNPYPGIP-------PERLFNLLK-------TGHRMER 273
Query: 567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
               + +M  + L C +  P  RP    + + LE
Sbjct: 274 PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/178 (35%), Positives = 90/178 (50%), Gaps = 24/178 (13%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI 409
           +A K L   +G+ E   NE+A + +  H NIV L      G    LI + VS G L   I
Sbjct: 51  IAKKALEGKEGSME---NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 107
Query: 410 HEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL---LDEDF 464
            EK  +      +L ++VL          ++YLH   +  I+H D+KP N+L   LDED 
Sbjct: 108 VEKGFYTERDASRLIFQVL--------DAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              ISDFGL+K+ E   S++S   A GT GY+APEV  +     S   D +S G++ +
Sbjct: 157 KIMISDFGLSKM-EDPGSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAY 209

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 35/265 (13%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K +NE+    E  +F+NE + +   +  ++V LLG   +G    ++ E +++G L+ 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 408 FIHEKHPLETNQKLK----WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N   +     + + ++A  IA G+ YL+     + +H D+   N ++  D
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 166
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + ++APE      G  +  SD++S+G+++
Sbjct: 167 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVL 222
Query: 522 FEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL---QGIENEEDKEYARKMILVS 578
           +E+T                      Y+ L  E+ L      G  ++ D    R   L+ 
Sbjct: 223 WEITSLAEQP----------------YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMR 266
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSL 603
           + C Q NP  RP+   +V +L+  L
Sbjct: 267 M-CWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 49  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 108
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 109 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 165
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 166 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 221
Query: 522 FEMT 525
           +E+ 
Sbjct: 222 WEIA 225

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 51  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 110
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 111 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 167
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 168 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 223
Query: 522 FEMT 525
           +E+ 
Sbjct: 224 WEIA 227

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 25/183 (13%)
Query: 348 QNVAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           + VA+K ++  K    + + NEV  +    H N+V +      G    ++ EF+  G+L 
Sbjct: 71  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT 130
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             +       T+ ++  E +  + + + R L YLH   N  ++H DIK  +ILL  D   
Sbjct: 131 DIV-------THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRI 180
Query: 467 KISDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMV 521
           K+SDFG    ++K    R+ +V      GT  ++APEV  R  +G    + D++S G+MV
Sbjct: 181 KLSDFGFCAQVSKEVPKRKXLV------GTPYWMAPEVISRLPYGT---EVDIWSLGIMV 231
Query: 522 FEM 524
            EM
Sbjct: 232 IEM 234

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 118 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 174
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 175 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 230
Query: 522 FEMT 525
           +E+ 
Sbjct: 231 WEIA 234

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 51  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 110
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 111 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 167
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 168 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 223
Query: 522 FEMT 525
           +E+ 
Sbjct: 224 WEIA 227

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 45  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 104
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 105 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 161
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 162 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 217
Query: 522 FEMT 525
           +E+ 
Sbjct: 218 WEIA 221

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 35/265 (13%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K +NE+    E  +F+NE + +   +  ++V LLG   +G    ++ E +++G L+ 
Sbjct: 49  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 108
Query: 408 FIHEKHPLETNQKLK----WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N   +     + + ++A  IA G+ YL+     + +H D+   N ++  D
Sbjct: 109 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 165
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + ++APE      G  +  SD++S+G+++
Sbjct: 166 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVL 221
Query: 522 FEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL---QGIENEEDKEYARKMILVS 578
           +E+T                      Y+ L  E+ L      G  ++ D    R   L+ 
Sbjct: 222 WEITSLAEQP----------------YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMR 265
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSL 603
           + C Q NP  RP+   +V +L+  L
Sbjct: 266 M-CWQFNPKMRPTFLEIVNLLKDDL 289

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 52  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 111
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 112 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 168
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 169 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 224
Query: 522 FEMT 525
           +E+ 
Sbjct: 225 WEIA 228

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 87/179 (48%), Gaps = 23/179 (12%)
Query: 351 AIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-E 406
           AIK++ +T     +    + EVA +    H NI+ L  F  +     L+ E    G L +
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DED 463
           + IH     E +  +       I   +  G+ YLH+     I+H D+KP N+LL   ++D
Sbjct: 126 EIIHRMKFNEVDAAV-------IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKD 175
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGL+ + E ++    M    GT  YIAPEV  + + E   K DV+S G+++F
Sbjct: 176 ALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRKKYDE---KCDVWSIGVILF 228

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K L +   N  +DF  E   ++   H +IV   G C EG    +++E++ +G L KF
Sbjct: 46  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105
Query: 409 IHEKHP-----LETN--QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           +    P      E N   +L    +  IA  IA G+ YL    +   +H D+   N L+ 
Sbjct: 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVG 162
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMM 520
           E+   KI DFG+++     +           I ++ PE +  R F   + +SDV+S G++
Sbjct: 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSLGVV 219
Query: 521 VFEM 524
           ++E+
Sbjct: 220 LWEI 223

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 113/262 (43%), Gaps = 29/262 (11%)
Query: 350 VAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  T      E  ++E+  +S    H NIV LLG C  G    +I E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 407 KFIHEK-HPLET-------NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 458
            F+  K   LET       N       L   +  +A+G+ +L    +   +H D+   N+
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNV 195
Query: 459 LLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
           LL      KI DFGLA+      + +    AR  + ++APE        V  +SDV+SYG
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYG 253
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+     N    +  +S+ Y         +L +D    G +  +     + +  + 
Sbjct: 254 ILLWEIFSLGLNPYPGILVNSKFY---------KLVKD----GYQMAQPAFAPKNIYSIM 300
Query: 579 LWCIQTNPSDRPSMNRVVEMLE 600
             C    P+ RP+  ++   L+
Sbjct: 301 QACWALEPTHRPTFQQICSFLQ 322

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 48  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLL 105
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 106 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 156
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 157 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 213

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 80  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 139
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 140 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 196
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 197 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 252
Query: 522 FEMT 525
           +E+ 
Sbjct: 253 WEIA 256

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIKVL E    K N E  ++E   ++      +  LLG C     + L+ + +  G L 
Sbjct: 49  VAIKVLRENTSPKANKE-ILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLL 106
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
             + E +  L +   L W       + IA+G+ YL    + R++H D+   N+L+     
Sbjct: 107 DHVRENRGRLGSQDLLNW------CMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNH 157
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLA++ +  E+     G +  I ++A E   R     +++SDV+SYG+ V+E+
Sbjct: 158 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR--RFTHQSDVWSYGVTVWEL 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 51  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 108
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 109 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 159
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 160 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 216

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 48  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 107
Query: 408 FIHEKHPLETNQKL----KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N  +        + ++A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 108 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 164
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 165 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 220
Query: 522 FEMT 525
           +E+ 
Sbjct: 221 WEIA 224

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 91/180 (50%), Gaps = 23/180 (12%)
Query: 350 VAIKVLNETKGNGED--FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK + +    G++    NE+A + +  H NIV L      G    LI + VS G L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 408 FIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL---LDE 462
            I EK  +      +L ++VL          ++YLH   +  I+H D+KP N+L   LDE
Sbjct: 106 RIVEKGFYTERDASRLIFQVL--------DAVKYLH---DLGIVHRDLKPENLLYYSLDE 154
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           D    ISDFGL+K+ E   S++S   A GT GY+APEV  +     S   D +S G++ +
Sbjct: 155 DSKIMISDFGLSKM-EDPGSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAY 209

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 408 FIHEKHPLETNQKL----KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N  +        + ++A  IA G+ YL+     + +H D+   N ++ ED
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 174
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 175 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 230
Query: 522 FEMT 525
           +E+ 
Sbjct: 231 WEIA 234

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 91/180 (50%), Gaps = 23/180 (12%)
Query: 350 VAIKVLNETKGNGED--FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK + +    G++    NE+A + +  H NIV L      G    LI + VS G L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 408 FIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL---LDE 462
            I EK  +      +L ++VL          ++YLH   +  I+H D+KP N+L   LDE
Sbjct: 106 RIVEKGFYTERDASRLIFQVL--------DAVKYLH---DLGIVHRDLKPENLLYYSLDE 154
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           D    ISDFGL+K+ E   S++S   A GT GY+APEV  +     S   D +S G++ +
Sbjct: 155 DSKIMISDFGLSKM-EDPGSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAY 209

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 47  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLL 104
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 212

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 47  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 104
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 212

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 48  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 105
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 106 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 156
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 157 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 213

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 91/180 (50%), Gaps = 23/180 (12%)
Query: 350 VAIKVLNETKGNGED--FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK + +    G++    NE+A + +  H NIV L      G    LI + VS G L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 408 FIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL---LDE 462
            I EK  +      +L ++VL          ++YLH   +  I+H D+KP N+L   LDE
Sbjct: 106 RIVEKGFYTERDASRLIFQVL--------DAVKYLH---DLGIVHRDLKPENLLYYSLDE 154
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           D    ISDFGL+K+ E   S++S   A GT GY+APEV  +     S   D +S G++ +
Sbjct: 155 DSKIMISDFGLSKM-EDPGSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAY 209

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 50  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 107
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 158
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 159 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 215

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 54  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 111
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 162
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 163 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 219

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 49  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 106
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 158 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 214

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 39/274 (14%)
Query: 348 QNVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
             VA+K+L  +      E  ++E+  +S   +H+NIV LLG C  G    +I E+   G 
Sbjct: 54  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 405 LEKFIHEKHPLETNQKLKWEVLY------------KIAVGIARGLEYLHRGCNTRILHFD 452
           L  F+  K       K    ++               +  +A+G+ +L    +   +H D
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRD 170
Query: 453 IKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV-SYK 511
           +   NILL      KI DFGLA+  +   + V    AR  + ++APE     F  V +++
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFE 227
Query: 512 SDVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKE 569
           SDV+SYG+ ++E+   G      + VD           YK ++       +G      + 
Sbjct: 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYKMIK-------EGFRMLSPEH 272
Query: 570 YARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
              +M  +   C   +P  RP+  ++V+++E  +
Sbjct: 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 47  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 104
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 212

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 53  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 110
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 111 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 161
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 162 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 218

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 47  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 104
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 212

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 72  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 129
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 130 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 180
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 181 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 237

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 57  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 114
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 115 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 165
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 166 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 222

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 16/177 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLEK 407
            VA+K + +     + F+ E + +++  H N+V LLG   E      ++ E+++ GSL  
Sbjct: 46  KVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 104
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           ++  +        L  + L K ++ +   +EYL        +H D+   N+L+ ED   K
Sbjct: 105 YLRSR----GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 157
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL K     E+  +    +  + + APE       + S KSDV+S+G++++E+
Sbjct: 158 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEI 207

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 49  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 106
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 158 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 54  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 111
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 162
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 163 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 219

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 16/177 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLEK 407
            VA+K + +     + F+ E + +++  H N+V LLG   E      ++ E+++ GSL  
Sbjct: 31  KVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           ++  +        L  + L K ++ +   +EYL        +H D+   N+L+ ED   K
Sbjct: 90  YLRSR----GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 142
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL K     E+  +    +  + + APE       + S KSDV+S+G++++E+
Sbjct: 143 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEI 192

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 16/177 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLEK 407
            VA+K + +     + F+ E + +++  H N+V LLG   E      ++ E+++ GSL  
Sbjct: 218 KVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 276
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           ++  +        L  + L K ++ +   +EYL        +H D+   N+L+ ED   K
Sbjct: 277 YLRSR----GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 329
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL K     E+  +    +  + + APE       + S KSDV+S+G++++E+
Sbjct: 330 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEI 379

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 50  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 107
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 158
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 159 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 215

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 41  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 98
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 99  DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 149
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 206

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 50  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 107
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 158
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 159 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 54  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 111
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 162
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 163 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 219

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 50  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 107
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 158
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 159 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 215

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 35/265 (13%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K +NE+    E  +F+NE + +   +  ++V LLG   +G    ++ E +++G L+ 
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 408 FIHEKHPLETNQKLK----WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N   +     + + ++A  IA G+ YL+     + +H ++   N ++  D
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHD 166
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + ++APE      G  +  SD++S+G+++
Sbjct: 167 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVL 222
Query: 522 FEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL---QGIENEEDKEYARKMILVS 578
           +E+T                      Y+ L  E+ L      G  ++ D    R   L+ 
Sbjct: 223 WEITSLAEQP----------------YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMR 266
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSL 603
           + C Q NP+ RP+   +V +L+  L
Sbjct: 267 M-CWQFNPNMRPTFLEIVNLLKDDL 290

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 47  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 104
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 212

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 35/265 (13%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K +NE+    E  +F+NE + +   +  ++V LLG   +G    ++ E +++G L+ 
Sbjct: 51  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 110
Query: 408 FIHEKHPLETNQKLK----WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P   N   +     + + ++A  IA G+ YL+     + +H ++   N ++  D
Sbjct: 111 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHD 167
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + ++APE      G  +  SD++S+G+++
Sbjct: 168 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVL 223
Query: 522 FEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL---QGIENEEDKEYARKMILVS 578
           +E+T                      Y+ L  E+ L      G  ++ D    R   L+ 
Sbjct: 224 WEITSLAEQP----------------YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMR 267
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSL 603
           + C Q NP+ RP+   +V +L+  L
Sbjct: 268 M-CWQFNPNMRPTFLEIVNLLKDDL 291

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 350 VAIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK +NE     E  +F+NE + +   +  ++V LLG   +G    +I E ++ G L+ 
Sbjct: 45  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 104
Query: 408 FIHEKHP-LETNQKLKWEVLYK---IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           ++    P +E N  L    L K   +A  IA G+ YL+     + +H D+   N  + ED
Sbjct: 105 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAED 161
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARG--TIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++
Sbjct: 162 FTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVL 217
Query: 522 FEMT 525
           +E+ 
Sbjct: 218 WEIA 221

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 349 NVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L  +      E  ++E+  +S   +H+NIV LLG C  G    +I E+   G L
Sbjct: 71  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 130
Query: 406 EKFIHEKHPLETNQKLKWEVLY------------KIAVGIARGLEYLHRGCNTRILHFDI 453
             F+  K       K    ++               +  +A+G+ +L    +   +H D+
Sbjct: 131 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDL 187
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV-SYKS 512
              NILL      KI DFGLA+  +   + V    AR  + ++APE     F  V +++S
Sbjct: 188 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFES 244
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+SYG+ ++E+   G      + VD           YK ++       +G      +  
Sbjct: 245 DVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYKMIK-------EGFRMLSPEHA 289
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
             +M  +   C   +P  RP+  ++V+++E  +
Sbjct: 290 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 322

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 349 NVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L  +      E  ++E+  +S   +H+NIV LLG C  G    +I E+   G L
Sbjct: 78  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 137
Query: 406 EKFIHEKHPLETNQKLKWEVLY------------KIAVGIARGLEYLHRGCNTRILHFDI 453
             F+  K       K    ++               +  +A+G+ +L    +   +H D+
Sbjct: 138 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDL 194
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV-SYKS 512
              NILL      KI DFGLA+  +   + V    AR  + ++APE     F  V +++S
Sbjct: 195 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFES 251
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+SYG+ ++E+   G      + VD           YK ++       +G      +  
Sbjct: 252 DVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYKMIK-------EGFRMLSPEHA 296
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
             +M  +   C   +P  RP+  ++V+++E  +
Sbjct: 297 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 329

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 109
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 110 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 167 XYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 125
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 126 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 183 YYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 125
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 126 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 183 YYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 123
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 124 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 181 YYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 349 NVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L  +      E  ++E+  +S   +H+NIV LLG C  G    +I E+   G L
Sbjct: 78  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 137
Query: 406 EKFIHEKHPLETNQKLKWEVLY------------KIAVGIARGLEYLHRGCNTRILHFDI 453
             F+  K       K    ++               +  +A+G+ +L    +   +H D+
Sbjct: 138 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDL 194
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV-SYKS 512
              NILL      KI DFGLA+  +   + V    AR  + ++APE     F  V +++S
Sbjct: 195 AARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFES 251
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+SYG+ ++E+   G      + VD           YK ++       +G      +  
Sbjct: 252 DVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYKMIK-------EGFRMLSPEHA 296
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
             +M  +   C   +P  RP+  ++V+++E  +
Sbjct: 297 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 329

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 88/183 (48%), Gaps = 23/183 (12%)
Query: 348 QNVAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           + VA+K+++  K    + + NEV  +    H N+V +      G    ++ EF+  G+L 
Sbjct: 71  RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             +       +  +L  E +  +   + + L YLH      ++H DIK  +ILL  D   
Sbjct: 131 DIV-------SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRV 180
Query: 467 KISDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           K+SDFG    ++K    R+ +V      GT  ++APEV  R+    + + D++S G+MV 
Sbjct: 181 KLSDFGFCAQISKDVPKRKXLV------GTPYWMAPEVISRSL--YATEVDIWSLGIMVI 232
Query: 523 EMT 525
           EM 
Sbjct: 233 EMV 235

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 87/177 (49%), Gaps = 16/177 (9%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLEK 407
            VA+K + +     + F+ E + +++  H N+V LLG   E      ++ E+++ GSL  
Sbjct: 37  KVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 95
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           ++  +        L  + L K ++ +   +EYL        +H D+   N+L+ ED   K
Sbjct: 96  YLRSR----GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 148
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           +SDFGL K     E+  +    +  + + APE         S KSDV+S+G++++E+
Sbjct: 149 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE--AAFSTKSDVWSFGILLWEI 198

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 349 NVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VA+K+L  +      E  ++E+  +S   +H+NIV LLG C  G    +I E+   G L
Sbjct: 73  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 132
Query: 406 EKFIHEKHPLETNQKLKWEVLY------------KIAVGIARGLEYLHRGCNTRILHFDI 453
             F+  K       K    ++               +  +A+G+ +L    +   +H D+
Sbjct: 133 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDL 189
Query: 454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV-SYKS 512
              NILL      KI DFGLA+  +   + V    AR  + ++APE     F  V +++S
Sbjct: 190 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFES 246
Query: 513 DVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEY 570
           DV+SYG+ ++E+   G      + VD           YK ++       +G      +  
Sbjct: 247 DVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYKMIK-------EGFRMLSPEHA 291
Query: 571 ARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL 603
             +M  +   C   +P  RP+  ++V+++E  +
Sbjct: 292 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 324

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 103
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 104 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 161 YYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 200

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 109
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 110 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 167 YYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT- 117
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
            E L +I  G+     YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 118 -EFLKQILNGVY----YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPAFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 105
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 106 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 163 YYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 202

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 115
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 116 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 173 YYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 212

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 467
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 468 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 525 YYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 564

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPL---ETNQ 419
           E+   EV  +    H NI+TL           LI E VS G L  F+ EK  L   E  Q
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 119
Query: 420 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA- 474
            LK          I  G+ YLH   + RI HFD+KP NI+L +   P    K+ DFG+A 
Sbjct: 120 FLKQ---------ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 167
Query: 475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           KI  G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 168 KIEAGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ++ + E   + +  +  IV ++G C E     L+ E    G L K+      L+ N+ +K
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVK 468
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
            + + ++   ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+
Sbjct: 469 DKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525
Query: 483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              + T  +  + + APE  C N+ + S KSDV+S+G++++E
Sbjct: 526 YYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 565

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPL---ETNQ 419
           E+   EV  +    H NI+TL           LI E VS G L  F+ EK  L   E  Q
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 112
Query: 420 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA- 474
            LK          I  G+ YLH   + RI HFD+KP NI+L +   P    K+ DFG+A 
Sbjct: 113 FLKQ---------ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
Query: 475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           KI  G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 161 KIEAGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 202

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 44  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 101
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA G+ YL    + R++H D+   N+L+     
Sbjct: 102 DYVREHKDNIGSQYLLNW------CVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQH 152
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 153 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 209

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPL---ETNQ 419
           E+   EV  +    H NI+TL           LI E VS G L  F+ EK  L   E  Q
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 133
Query: 420 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA- 474
            LK          I  G+ YLH   + RI HFD+KP NI+L +   P    K+ DFG+A 
Sbjct: 134 FLKQ---------ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 181
Query: 475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           KI  G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 182 KIEAGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 223

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 29/181 (16%)
Query: 349 NVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
            VA+K +     + E F+ E   +    H  +V L     +     +I EF++ GSL  F
Sbjct: 208 KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 266
Query: 409 IHE----KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +      K PL          L   +  IA G+ ++ +      +H D++  NIL+    
Sbjct: 267 LKSDEGSKQPLPK--------LIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASL 315
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGLA++           GA+  I + APE    NFG  + KSDV+S+G+++ E+
Sbjct: 316 VCKIADFGLARV-----------GAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEI 362
Query: 525 T 525
Sbjct: 363 V 363

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 90/177 (50%), Gaps = 13/177 (7%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           V IKV+ +  G    +   + + +I    H +IV LLG C  G    L+ +++  GSL  
Sbjct: 63  VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLD 121
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
            + +         L  ++L    V IA+G+ YL       ++H ++   N+LL      +
Sbjct: 122 HVRQH-----RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQ 173
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           ++DFG+A +    +  +  + A+  I ++A E    +FG+ +++SDV+SYG+ V+E+
Sbjct: 174 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HFGKYTHQSDVWSYGVTVWEL 228

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 19/180 (10%)
Query: 348 QNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           Q VAI+ +N + +   E  INE+  +    + NIV  L     G    ++ E+++ GSL 
Sbjct: 46  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             + E    E         +  +     + LE+LH   + +++H DIK  NILL  D   
Sbjct: 106 DVVTETCMDEGQ-------IAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV 155
Query: 467 KISDFGL-AKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEM 524
           K++DFG  A+I   +    +M    GT  ++APEV  R  +G    K D++S G+M  EM
Sbjct: 156 KLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEM 209

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 115/264 (43%), Gaps = 44/264 (16%)
Query: 351 AIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI-------------- 396
           AIK +  T+      ++EV  ++  +H  +V       E  RR  +              
Sbjct: 35  AIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE--RRNFVKPMTAVKKKSTLFI 92
Query: 397 -YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
             E+  NG+L   IH ++ L   +   W +  +I       L Y+H   +  I+H D+KP
Sbjct: 93  QMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQIL----EALSYIH---SQGIIHRDLKP 144
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIV------------SMTGARGTIGYIAPEVFCR 503
            NI +DE    KI DFGLAK       I+            ++T A GT  Y+A EV   
Sbjct: 145 MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD- 203
Query: 504 NFGEVSYKSDVYSYGMMVFEM-----TGEKNNANVAVDRSSEIYF-PHWVYKRLELEEDL 557
             G  + K D+YS G++ FEM     TG +    +   RS  I F P +   ++++E+ +
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKI 263
Query: 558 GLQGIENEEDKEYARKMILVSLWC 581
               I+++ +K    + +L S W 
Sbjct: 264 IRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT- 117
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
            E L +I  G+     YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 118 -EFLKQILNGVY----YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 90/177 (50%), Gaps = 13/177 (7%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           V IKV+ +  G    +   + + +I    H +IV LLG C  G    L+ +++  GSL  
Sbjct: 45  VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLD 103
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
            + +         L  ++L    V IA+G+ YL       ++H ++   N+LL      +
Sbjct: 104 HVRQH-----RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQ 155
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           ++DFG+A +    +  +  + A+  I ++A E    +FG+ +++SDV+SYG+ V+E+
Sbjct: 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HFGKYTHQSDVWSYGVTVWEL 210

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT- 117
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
            E L +I  G+     YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 118 -EFLKQILNGVY----YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 51  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 108
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 109 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 159
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFG AK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 160 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +  +
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 119 F------LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +  +
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 119 F------LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 49  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 106
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFG AK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 158 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 38/271 (14%)
Query: 350 VAIKVLNETK--GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VA+K+L  T      E  ++E+  +S    H NIV LLG C  G    +I E+   G L 
Sbjct: 64  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 123
Query: 407 KFIHEKHPL-----------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 449
            F+  K                    E  + L+   L   +  +A+G+ +L    +   +
Sbjct: 124 NFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCI 180
Query: 450 HFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS 509
           H D+   N+LL      KI DFGLA+      + +    AR  + ++APE        V 
Sbjct: 181 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV- 239
Query: 510 YKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKE 569
            +SDV+SYG++++E+     N    +  +S+ Y         +L +D    G +  +   
Sbjct: 240 -QSDVWSYGILLWEIFSLGLNPYPGILVNSKFY---------KLVKD----GYQMAQPAF 285
Query: 570 YARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
             + +  +   C    P+ RP+  ++   L+
Sbjct: 286 APKNIYSIMQACWALEPTHRPTFQQICSFLQ 316

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 84/179 (46%), Gaps = 10/179 (5%)
Query: 348 QNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           + V I  L + K    D I E+  + + +H N++       E +   ++ E    G L +
Sbjct: 63  KKVQIFDLMDAKARA-DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
            I  KH  +  + +    ++K  V +   LE++H   + R++H DIKP N+ +      K
Sbjct: 122 MI--KHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 176
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
           + D GL +    + +  +     GT  Y++PE    N    ++KSD++S G +++EM  
Sbjct: 177 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAA 231

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +  +
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 119 F------LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +  +
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 119 F------LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 19/180 (10%)
Query: 348 QNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           Q VAI+ +N + +   E  INE+  +    + NIV  L     G    ++ E+++ GSL 
Sbjct: 46  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             + E   ++  Q      +  +     + LE+LH   + +++H DIK  NILL  D   
Sbjct: 106 DVVTETC-MDEGQ------IAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV 155
Query: 467 KISDFGL-AKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEM 524
           K++DFG  A+I   +     M    GT  ++APEV  R  +G    K D++S G+M  EM
Sbjct: 156 KLTDFGFCAQITPEQSKRSEMV---GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEM 209

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +  +
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 118 F------LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 169 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 207

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +  +
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 118 F------LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 169 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 207

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 110/272 (40%), Gaps = 34/272 (12%)
Query: 350 VAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K L E   +  +DF  E   ++   H +IV   G C EG    +++E++ +G L +F
Sbjct: 45  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 104
Query: 409 IHEKHP----LETNQ-----KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           +    P    L   +      L    L  +A  +A G+ YL        +H D+   N L
Sbjct: 105 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCL 161
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYSYG 518
           + +    KI DFG+++     +           I ++ PE +  R F   + +SDV+S+G
Sbjct: 162 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFG 218
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+          +  +  I              D   QG E E  +    ++  + 
Sbjct: 219 VVLWEIFTYGKQPWYQLSNTEAI--------------DCITQGRELERPRACPPEVYAIM 264
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
             C Q  P  R S+  V   L+      Q PP
Sbjct: 265 RGCWQREPQQRHSIKDVHARLQA---LAQAPP 293

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +  +
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 119 F------LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 49  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 106
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFG AK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 158 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAI  L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 81  VAIMELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 138
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 139 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 189
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFGLAK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 190 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 246

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 110/272 (40%), Gaps = 34/272 (12%)
Query: 350 VAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K L E   +  +DF  E   ++   H +IV   G C EG    +++E++ +G L +F
Sbjct: 74  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 133
Query: 409 IHEKHP----LETNQ-----KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           +    P    L   +      L    L  +A  +A G+ YL        +H D+   N L
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCL 190
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYSYG 518
           + +    KI DFG+++     +           I ++ PE +  R F   + +SDV+S+G
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFG 247
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+          +  +  I              D   QG E E  +    ++  + 
Sbjct: 248 VVLWEIFTYGKQPWYQLSNTEAI--------------DCITQGRELERPRACPPEVYAIM 293
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
             C Q  P  R S+  V   L+      Q PP
Sbjct: 294 RGCWQREPQQRHSIKDVHARLQA---LAQAPP 322

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 110/272 (40%), Gaps = 34/272 (12%)
Query: 350 VAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K L E   +  +DF  E   ++   H +IV   G C EG    +++E++ +G L +F
Sbjct: 51  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 110
Query: 409 IHEKHP----LETNQ-----KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           +    P    L   +      L    L  +A  +A G+ YL        +H D+   N L
Sbjct: 111 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCL 167
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYSYG 518
           + +    KI DFG+++     +           I ++ PE +  R F   + +SDV+S+G
Sbjct: 168 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFG 224
Query: 519 MMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
           ++++E+          +  +  I              D   QG E E  +    ++  + 
Sbjct: 225 VVLWEIFTYGKQPWYQLSNTEAI--------------DCITQGRELERPRACPPEVYAIM 270
Query: 579 LWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
             C Q  P  R S+  V   L+      Q PP
Sbjct: 271 RGCWQREPQQRHSIKDVHARLQA---LAQAPP 299

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +  +
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 119 F------LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT- 117
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
            E L +I  G+     YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 118 -EFLKQILNGVY----YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +  +
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 119 F------LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 19/180 (10%)
Query: 348 QNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           Q VAI+ +N + +   E  INE+  +    + NIV  L     G    ++ E+++ GSL 
Sbjct: 46  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             + E   ++  Q      +  +     + LE+LH   + +++H DIK  NILL  D   
Sbjct: 106 DVVTETC-MDEGQ------IAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV 155
Query: 467 KISDFGL-AKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEM 524
           K++DFG  A+I   +     M    GT  ++APEV  R  +G    K D++S G+M  EM
Sbjct: 156 KLTDFGFCAQITPEQSKRSXMV---GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEM 209

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 47  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 104
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFG AK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 156 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 212

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 49  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 106
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFG AK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 158 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 214

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 24/178 (13%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
           F+ EV  +    H N++  +G  ++  R   I E++  G+L   I        + +  W 
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-----MDSQYPWS 108
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC------- 477
                A  IA G+ YLH   +  I+H D+  HN L+ E+    ++DFGLA++        
Sbjct: 109 QRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 478 EGRESIVSMTGAR-----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKN 529
           EG  S+      +     G   ++APE+   R++ E   K DV+S+G+++ E+ G  N
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE---KVDVFSFGIVLCEIIGRVN 220

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 88/187 (47%), Gaps = 18/187 (9%)
Query: 350 VAIKVLNE-TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K L + T    +DF  E   ++   H +IV   G C +G    +++E++ +G L KF
Sbjct: 48  VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 107
Query: 409 IH----------EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI 458
           +           +  P +   +L    +  IA  IA G+ YL    +   +H D+   N 
Sbjct: 108 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNC 164
Query: 459 LLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYSY 517
           L+  +   KI DFG+++     +           I ++ PE +  R F   + +SDV+S+
Sbjct: 165 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSF 221
Query: 518 GMMVFEM 524
           G++++E+
Sbjct: 222 GVILWEI 228

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 19/180 (10%)
Query: 348 QNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           Q VAI+ +N + +   E  INE+  +    + NIV  L     G    ++ E+++ GSL 
Sbjct: 47  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             + E   ++  Q      +  +     + LE+LH   + +++H DIK  NILL  D   
Sbjct: 107 DVVTETC-MDEGQ------IAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV 156
Query: 467 KISDFGL-AKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEM 524
           K++DFG  A+I   +     M    GT  ++APEV  R  +G    K D++S G+M  EM
Sbjct: 157 KLTDFGFCAQITPEQSKRSXMV---GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEM 210

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCF--EGHRRALIYEFVSNGSLEKFIHEKHPLETNQK 420
           E F+ E   +   +H N++ L+G     EG    L+  ++ +G L +FI      + N  
Sbjct: 67  EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSP---QRNPT 122
Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
           +K   L    + +ARG+EYL      + +H D+   N +LDE F  K++DFGLA+    R
Sbjct: 123 VK--DLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177
Query: 481 E--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           E  S+     AR  + + A E         + KSDV+S+G++++E+
Sbjct: 178 EYYSVQQHRHARLPVKWTALESL--QTYRFTTKSDVWSFGVLLWEL 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 350 VAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           VAIK L E    K N E  ++E   ++   + ++  LLG C     + LI + +  G L 
Sbjct: 54  VAIKELREATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 111
Query: 407 KFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            ++ E K  + +   L W       V IA+G+ YL    + R++H D+   N+L+     
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 162
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI+DFG AK+    E      G +  I ++A E         +++SDV+SYG+ V+E+
Sbjct: 163 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWEL 219

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 348 QNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNG 403
           + VA+K L    G  +   +  E+  +    H +I+   G C +    +L  + E+V  G
Sbjct: 61  EMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLG 120
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           SL  ++  +H +   Q      L   A  I  G+ YLH       +H D+   N+LLD D
Sbjct: 121 SLRDYL-PRHSIGLAQ------LLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDND 170
Query: 464 FCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLAK + EG E           + + APE  C    +  Y SDV+S+G+ ++
Sbjct: 171 RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLY 228
Query: 523 EM 524
           E+
Sbjct: 229 EL 230

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 103/257 (40%), Gaps = 54/257 (21%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           VAIK ++    ++    +D I EV  + +  H N +   G     H   L+ E+    + 
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 141
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
           +     K PL+  +      +  +  G  +GL YLH   +  ++H D+K  NILL E   
Sbjct: 142 DLLEVHKKPLQEVE------IAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 192
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV-FCRNFGEVSYKSDVYSYGMMVFEM 524
            K+ DFG A I       V      GT  ++APEV    + G+   K DV+S G+   E+
Sbjct: 193 VKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
Query: 525 TGEKN-----NA-----NVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
              K      NA     ++A + S  +   HW                      EY R  
Sbjct: 247 AERKPPLFNMNAMSALYHIAQNESPALQSGHW---------------------SEYFRNF 285
Query: 575 ILVSLWCIQTNPSDRPS 591
           +     C+Q  P DRP+
Sbjct: 286 VDS---CLQKIPQDRPT 299

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 15/169 (8%)
Query: 357 ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNGSLEKFIHEKHP 414
           + +G  E    E+A + +  H N+V L+    + +   L  ++E V+ G + +    K  
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 415 LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 474
            E   +  ++ L K       G+EYLH     +I+H DIKP N+L+ ED   KI+DFG++
Sbjct: 135 SEDQARFYFQDLIK-------GIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-DVYSYGMMVF 522
              +G ++++S T   GT  ++APE         S K+ DV++ G+ ++
Sbjct: 185 NEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 8/168 (4%)
Query: 359 KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN 418
           K   +DF NE+  I+   +   +T  G         +IYE++ N S+ KF      L+ N
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 419 QK--LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 476
               +  +V+  I   +     Y+H   N  I H D+KP NIL+D++   K+SDFG ++ 
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
              ++    + G+RGT  ++ PE F         K D++S G+ ++ M
Sbjct: 202 MVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 103/257 (40%), Gaps = 54/257 (21%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           VAIK ++    ++    +D I EV  + +  H N +   G     H   L+ E+    + 
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
           +     K PL+  +      +  +  G  +GL YLH   +  ++H D+K  NILL E   
Sbjct: 103 DLLEVHKKPLQEVE------IAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 153
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV-FCRNFGEVSYKSDVYSYGMMVFEM 524
            K+ DFG A I       V      GT  ++APEV    + G+   K DV+S G+   E+
Sbjct: 154 VKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
Query: 525 TGEKN-----NA-----NVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
              K      NA     ++A + S  +   HW                      EY R  
Sbjct: 208 AERKPPLFNMNAMSALYHIAQNESPALQSGHW---------------------SEYFRNF 246
Query: 575 ILVSLWCIQTNPSDRPS 591
           +     C+Q  P DRP+
Sbjct: 247 VDS---CLQKIPQDRPT 260

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           ED   EV+ +    H N++TL           LI E V+ G L  F+ EK  L   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT- 117
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
            E L +I  G+     YLH   + +I HFD+KP NI+L +   P    KI DFGLA KI 
Sbjct: 118 -EFLKQILNGVY----YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            G E         GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 170 FGNE----FKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 93/184 (50%), Gaps = 24/184 (13%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           A KV+ ETK   E  D+I E+  ++   H  IV LLG  +   +  ++ EF   G+++  
Sbjct: 48  AAKVI-ETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI 106
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +     LE ++ L    +  +   +   L +LH   + RI+H D+K  N+L+  +   ++
Sbjct: 107 M-----LELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRL 158
Query: 469 SDFGLA----KICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEV--SYKSDVYSYGMMV 521
           +DFG++    K  + R+S +      GT  ++APE V C    +    YK+D++S G+ +
Sbjct: 159 ADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 522 FEMT 525
            EM 
Sbjct: 213 IEMA 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 93/184 (50%), Gaps = 24/184 (13%)
Query: 351 AIKVLNETKGNGE--DFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           A KV+ ETK   E  D+I E+  ++   H  IV LLG  +   +  ++ EF   G+++  
Sbjct: 40  AAKVI-ETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI 98
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +     LE ++ L    +  +   +   L +LH   + RI+H D+K  N+L+  +   ++
Sbjct: 99  M-----LELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRL 150
Query: 469 SDFGLA----KICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEV--SYKSDVYSYGMMV 521
           +DFG++    K  + R+S +      GT  ++APE V C    +    YK+D++S G+ +
Sbjct: 151 ADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 204
Query: 522 FEMT 525
            EM 
Sbjct: 205 IEMA 208

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 82/169 (48%), Gaps = 21/169 (12%)
Query: 359 KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEK--HPLE 416
           KG      NE+A + +  H NIV L       +   L+ + VS G L   I EK  +  +
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEK 120
Query: 417 TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGL 473
               L  +VL          + YLHR     I+H D+KP N+L    DE+    ISDFGL
Sbjct: 121 DASTLIRQVL--------DAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGL 169
Query: 474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           +K+ EG+  +  M+ A GT GY+APEV  +     S   D +S G++ +
Sbjct: 170 SKM-EGKGDV--MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAY 213

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E+   EV+ + +  H NI+TL           LI E VS G L  F+ +K  L   +   
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA +I 
Sbjct: 120 F------IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           +G    V      GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 171 DG----VEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 209

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 89/188 (47%), Gaps = 19/188 (10%)
Query: 348 QNVAIKVLNETKGNGEDFINEVASISRTSH-VNIVTLLGFCFEGH------RRALIYEFV 400
           Q  AIKV++ T    E+   E+  + + SH  NI T  G   + +      +  L+ EF 
Sbjct: 50  QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109
Query: 401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
             GS+   I           LK E +  I   I RGL +LH+    +++H DIK  N+LL
Sbjct: 110 GAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLL 162
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSY--KSDVYSY 517
            E+   K+ DFG++   +   ++       GT  ++APEV  C    + +Y  KSD++S 
Sbjct: 163 TENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220
Query: 518 GMMVFEMT 525
           G+   EM 
Sbjct: 221 GITAIEMA 228

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 348 QNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           Q VAI+ +N + +   E  INE+  +    + NIV  L     G    ++ E+++ GSL 
Sbjct: 47  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             + E   ++  Q      +  +     + LE+LH   + +++H +IK  NILL  D   
Sbjct: 107 DVVTETC-MDEGQ------IAAVCRECLQALEFLH---SNQVIHRNIKSDNILLGMDGSV 156
Query: 467 KISDFGL-AKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEM 524
           K++DFG  A+I   +    +M    GT  ++APEV  R  +G    K D++S G+M  EM
Sbjct: 157 KLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEM 210

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 97/181 (53%), Gaps = 24/181 (13%)
Query: 351 AIKVLNETKGNGEDFIN---EVASISRTSHVNIVTL-LGFCFEGHRRALIYEFVSNGSLE 406
           A+KVL +      D +    E   ++  +H  +V L   F  EG +  LI +F+  G L 
Sbjct: 60  AMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEG-KLYLILDFLRGGDLF 118
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             +  K  + T + +K+ +       +A GL++LH   +  I++ D+KP NILLDE+   
Sbjct: 119 TRL-SKEVMFTEEDVKFYL-----AELALGLDHLH---SLGIIYRDLKPENILLDEEGHI 169
Query: 467 KISDFGLAKICEGRESIVSMTGAR---GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
           K++DFGL+K     E+I     A    GT+ Y+APEV  R  G  S+ +D +SYG+++FE
Sbjct: 170 KLTDFGLSK-----EAIDHEKKAYSFCGTVEYMAPEVVNRQ-GH-SHSADWWSYGVLMFE 222
Query: 524 M 524
           M
Sbjct: 223 M 223

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 350 VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K+L E  +     DF  E A ++   + NIV LLG C  G    L++E+++ G L +
Sbjct: 80  VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 408 FIHEKHP----------LETNQK--------LKWEVLYKIAVGIARGLEYLHRGCNTRIL 449
           F+    P          L T  +        L       IA  +A G+ YL      + +
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV 196
Query: 450 HFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS 509
           H D+   N L+ E+   KI+DFGL++     +   +       I ++ PE    N    +
Sbjct: 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYT 254
Query: 510 YKSDVYSYGMMVFEM 524
            +SDV++YG++++E+
Sbjct: 255 TESDVWAYGVVLWEI 269

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVLNETKGNGE-DFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNGSLE 406
           VA+K L  +  + + DF  E+  +       IV   G  +   R++L  + E++ +G L 
Sbjct: 43  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 102
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+ ++H      +L    L   +  I +G+EYL    + R +H D+   NIL++ +   
Sbjct: 103 DFL-QRH----RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHV 154
Query: 467 KISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGLAK+    ++  V     +  I + APE    N    S +SDV+S+G++++E+
Sbjct: 155 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 348 QNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNG 403
           + VA+K L    G  +   +  E+  +    H +I+   G C +   ++L  + E+V  G
Sbjct: 44  EMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLG 103
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           SL  ++  +H +   Q      L   A  I  G+ YLH   +   +H ++   N+LLD D
Sbjct: 104 SLRDYL-PRHSIGLAQ------LLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDND 153
Query: 464 FCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLAK + EG E           + + APE  C    +  Y SDV+S+G+ ++
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLY 211
Query: 523 EM 524
           E+
Sbjct: 212 EL 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVLNETKGNGE-DFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNGSLE 406
           VA+K L  +  + + DF  E+  +       IV   G  +   R++L  + E++ +G L 
Sbjct: 42  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 101
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+ ++H      +L    L   +  I +G+EYL    + R +H D+   NIL++ +   
Sbjct: 102 DFL-QRH----RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHV 153
Query: 467 KISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGLAK+    ++  V     +  I + APE    N    S +SDV+S+G++++E+
Sbjct: 154 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 350 VAIKVLNETKGNGE-DFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNGSLE 406
           VA+K L  +  + + DF  E+  +       IV   G  +   R++L  + E++ +G L 
Sbjct: 55  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+ ++H      +L    L   +  I +G+EYL    + R +H D+   NIL++ +   
Sbjct: 115 DFL-QRH----RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHV 166
Query: 467 KISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGLAK+    ++  V     +  I + APE    N    S +SDV+S+G++++E+
Sbjct: 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 95
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 96  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 148
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 149 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLSFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 93
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 94  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 147 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 114/264 (43%), Gaps = 44/264 (16%)
Query: 351 AIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI-------------- 396
           AIK +  T+      ++EV  ++  +H  +V       E  RR  +              
Sbjct: 35  AIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE--RRNFVKPMTAVKKKSTLFI 92
Query: 397 -YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
             E+  N +L   IH ++ L   +   W +  +I       L Y+H   +  I+H D+KP
Sbjct: 93  QMEYCENRTLYDLIHSEN-LNQQRDEYWRLFRQIL----EALSYIH---SQGIIHRDLKP 144
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIV------------SMTGARGTIGYIAPEVFCR 503
            NI +DE    KI DFGLAK       I+            ++T A GT  Y+A EV   
Sbjct: 145 MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD- 203
Query: 504 NFGEVSYKSDVYSYGMMVFEM-----TGEKNNANVAVDRSSEIYF-PHWVYKRLELEEDL 557
             G  + K D+YS G++ FEM     TG +    +   RS  I F P +   ++++E+ +
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKI 263
Query: 558 GLQGIENEEDKEYARKMILVSLWC 581
               I+++ +K    + +L S W 
Sbjct: 264 IRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 43  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 101
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 102 SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 154
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 155 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 93
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 94  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 147 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 96/184 (52%), Gaps = 26/184 (14%)
Query: 351 AIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLL-GFCFEGHRRALIYEFVSNGSLEKF 408
           A KV++ +++   ED++ E+  ++   H NIV LL  F +E +   LI EF + G+++  
Sbjct: 66  AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAV 124
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E + PL  +Q      +  +       L YLH   + +I+H D+K  NIL   D   K
Sbjct: 125 MLELERPLTESQ------IQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIK 175
Query: 468 ISDFGLA----KICEGRESIVSMTGARGTIGYIAPE-VFCRNFGE--VSYKSDVYSYGMM 520
           ++DFG++    +  + R+S +      GT  ++APE V C    +    YK+DV+S G+ 
Sbjct: 176 LADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 229
Query: 521 VFEM 524
           + EM
Sbjct: 230 LIEM 233

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 40  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 98
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 99  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 151
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 152 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 205

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 93
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 94  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 147 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E+   EV+ + +  H N++TL           LI E VS G L  F+ +K  L   +   
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA +I 
Sbjct: 120 F------IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           +G    V      GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 171 DG----VEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRA--LIYEFVSNGSL 405
           VA+K L E  G      +  E+  +    H +IV   G C +   ++  L+ E+V  GSL
Sbjct: 41  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 100
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
             ++  +H +   Q      L   A  I  G+ YLH       +H  +   N+LLD D  
Sbjct: 101 RDYL-PRHCVGLAQ------LLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRL 150
Query: 466 PKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI DFGLAK + EG E           + + APE  C    +  Y SDV+S+G+ ++E+
Sbjct: 151 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE--CLKECKFYYASDVWSFGVTLYEL 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRA--LIYEFVSNGSL 405
           VA+K L E  G      +  E+  +    H +IV   G C +   ++  L+ E+V  GSL
Sbjct: 40  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 99
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
             ++  +H +   Q      L   A  I  G+ YLH       +H  +   N+LLD D  
Sbjct: 100 RDYL-PRHCVGLAQ------LLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRL 149
Query: 466 PKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            KI DFGLAK + EG E           + + APE  C    +  Y SDV+S+G+ ++E+
Sbjct: 150 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE--CLKECKFYYASDVWSFGVTLYEL 207

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 24/183 (13%)
Query: 348 QNVAIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q  A+KV+++     K + E  + EV  + +  H NI+ L  F  +     L+ E  + G
Sbjct: 52  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 111
Query: 404 SL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD- 461
            L ++ I  K   E +         +I   +  G+ Y+H+    +I+H D+KP N+LL+ 
Sbjct: 112 ELFDEIISRKRFSEVDAA-------RIIRQVLSGITYMHK---NKIVHRDLKPENLLLES 161
Query: 462 --EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
             +D   +I DFGL+   E  +    M    GT  YIAPEV    + E   K DV+S G+
Sbjct: 162 KSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGTYDE---KCDVWSTGV 215
Query: 520 MVF 522
           +++
Sbjct: 216 ILY 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E+   EV+ + +  H N++TL           LI E VS G L  F+ +K  L   +   
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA +I 
Sbjct: 120 F------IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           +G    V      GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 171 DG----VEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 25/182 (13%)
Query: 350 VAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K ++  K    + + NEV  +    H N+V +      G    ++ EF+  G+L   
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 238
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +       T+ ++  E +  + + + + L  LH      ++H DIK  +ILL  D   K+
Sbjct: 239 V-------THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKL 288
Query: 469 SDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFE 523
           SDFG    ++K    R+ +V      GT  ++APE+  R  +G    + D++S G+MV E
Sbjct: 289 SDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLPYGP---EVDIWSLGIMVIE 339
Query: 524 MT 525
           M 
Sbjct: 340 MV 341

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 96/184 (52%), Gaps = 26/184 (14%)
Query: 351 AIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLL-GFCFEGHRRALIYEFVSNGSLEKF 408
           A KV++ +++   ED++ E+  ++   H NIV LL  F +E +   LI EF + G+++  
Sbjct: 66  AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAV 124
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E + PL  +Q      +  +       L YLH   + +I+H D+K  NIL   D   K
Sbjct: 125 MLELERPLTESQ------IQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIK 175
Query: 468 ISDFGLA----KICEGRESIVSMTGARGTIGYIAPE-VFCRNFGE--VSYKSDVYSYGMM 520
           ++DFG++    +  + R+S +      GT  ++APE V C    +    YK+DV+S G+ 
Sbjct: 176 LADFGVSAKNTRXIQRRDSFI------GTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 229
Query: 521 VFEM 524
           + EM
Sbjct: 230 LIEM 233

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 93  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 141
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 200
Query: 524 M 524
           M
Sbjct: 201 M 201

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 17/182 (9%)
Query: 348 QNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNG 403
           + VA+K L    G  +   +  E+  +    H +I+   G C +   ++L  + E+V  G
Sbjct: 44  EMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLG 103
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           SL  ++  +H +   Q      L   A  I  G+ YLH       +H ++   N+LLD D
Sbjct: 104 SLRDYL-PRHSIGLAQ------LLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDND 153
Query: 464 FCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLAK + EG E           + + APE  C    +  Y SDV+S+G+ ++
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLY 211
Query: 523 EM 524
           E+
Sbjct: 212 EL 213

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E+   EV+ + +  H N++TL           LI E VS G L  F+ +K  L   +   
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA +I 
Sbjct: 120 F------IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           +G    V      GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 171 DG----VEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 209

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E+   EV+ + +  H N++TL           LI E VS G L  F+ +K  L   +   
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA +I 
Sbjct: 120 F------IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           +G    V      GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 171 DG----VEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E+   EV+ + +  H N++TL           LI E VS G L  F+ +K  L   +   
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLA-KIC 477
           +         I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA +I 
Sbjct: 120 F------IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
           +G    V      GT  ++APE+   N+  +  ++D++S G++ +
Sbjct: 171 DG----VEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITY 209

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 118/287 (41%), Gaps = 34/287 (11%)
Query: 349 NVAIKVLNE---TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA------LIYEF 399
            VA+K+L        + E+F+ E A +    H ++  L+G       +       +I  F
Sbjct: 53  KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + +G L  F+      E    L  + L +  V IA G+EYL    +   +H D+   N +
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCM 169
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
           L ED    ++DFGL++     +       ++  + ++A E    N   V   SDV+++G+
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTV--HSDVWAFGV 227
Query: 520 MVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSL 579
            ++E+          ++ ++EIY             +  + G   ++  E   ++  +  
Sbjct: 228 TMWEIMTRGQTPYAGIE-NAEIY-------------NYLIGGNRLKQPPECMEEVYDLMY 273
Query: 580 WCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQPDFSSI 626
            C   +P  RPS   +   LE  L  L +      LS+   P + +I
Sbjct: 274 QCWSADPKQRPSFTCLRMELENILGHLSV------LSTSQDPLYINI 314

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 14/179 (7%)
Query: 350 VAIKVLNETKGNGE-DFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNGSLE 406
           VA+K L  +  + + DF  E+  +       IV   G  +   R  L  + E++ +G L 
Sbjct: 39  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLR 98
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F+ ++H      +L    L   +  I +G+EYL    + R +H D+   NIL++ +   
Sbjct: 99  DFL-QRH----RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHV 150
Query: 467 KISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGLAK+    ++  V     +  I + APE    N    S +SDV+S+G++++E+
Sbjct: 151 KIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           + E+  + +  H N+V LL  C +  R  L++EFV +  L+    E  P      L ++V
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFP----NGLDYQV 125
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           + K    I  G+ + H   +  I+H DIKP NIL+ +    K+ DFG A+       +  
Sbjct: 126 VQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
              A  T  Y APE+     G+V Y    DV++ G +V EM
Sbjct: 183 DEVA--TRWYRAPELLV---GDVKYGKAVDVWAIGCLVTEM 218

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 24/183 (13%)
Query: 348 QNVAIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q  A+KV+++     K + E  + EV  + +  H NI+ L  F  +     L+ E  + G
Sbjct: 75  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 134
Query: 404 SL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD- 461
            L ++ I  K   E +         +I   +  G+ Y+H+    +I+H D+KP N+LL+ 
Sbjct: 135 ELFDEIISRKRFSEVDAA-------RIIRQVLSGITYMHK---NKIVHRDLKPENLLLES 184
Query: 462 --EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
             +D   +I DFGL+   E  +    M    GT  YIAPEV    + E   K DV+S G+
Sbjct: 185 KSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGTYDE---KCDVWSTGV 238
Query: 520 MVF 522
           +++
Sbjct: 239 ILY 241

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGH-----RRALIYEFVSN 402
           +++V N  +G     + EVA + R     H N+V L+  C         +  L++E V  
Sbjct: 36  SVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ 95
Query: 403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
             L  ++ +  P      L  E +  +     RGL++LH  C   I+H D+KP NIL+  
Sbjct: 96  -DLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 147
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
               K++DFGLA+I   + ++  +     T+ Y APEV  ++    +   D++S G +  
Sbjct: 148 GGTVKLADFGLARIYSYQMALAPVV---VTLWYRAPEVLLQS--TYATPVDMWSVGCIFA 202
Query: 523 EMTGEK 528
           EM   K
Sbjct: 203 EMFRRK 208

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 22/202 (10%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGH----RRALIYEFVSNGSL 405
           VA+K+             E+ S     H N++  +     G        LI  F   GSL
Sbjct: 41  VAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSL 100
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR--------GCNTRILHFDIKPHN 457
             ++           + W  L  +A  ++RGL YLH         G    I H D K  N
Sbjct: 101 TDYL-------KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKN 153
Query: 458 ILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSY-KSDV 514
           +LL  D    ++DFGLA   E  +      G  GT  Y+APEV     NF   ++ + D+
Sbjct: 154 VLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 213
Query: 515 YSYGMMVFEMTGEKNNANVAVD 536
           Y+ G++++E+      A+  VD
Sbjct: 214 YAMGLVLWELVSRCKAADGPVD 235

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 24/183 (13%)
Query: 348 QNVAIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q  A+KV+++     K + E  + EV  + +  H NI+ L  F  +     L+ E  + G
Sbjct: 58  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 117
Query: 404 SL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD- 461
            L ++ I  K   E +         +I   +  G+ Y+H+    +I+H D+KP N+LL+ 
Sbjct: 118 ELFDEIISRKRFSEVDAA-------RIIRQVLSGITYMHK---NKIVHRDLKPENLLLES 167
Query: 462 --EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
             +D   +I DFGL+   E  +    M    GT  YIAPEV    + E   K DV+S G+
Sbjct: 168 KSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGTYDE---KCDVWSTGV 221
Query: 520 MVF 522
           +++
Sbjct: 222 ILY 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 25/182 (13%)
Query: 350 VAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K ++  K    + + NEV  +    H N+V +      G    ++ EF+  G+L   
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 118
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +       T+ ++  E +  + + + + L  LH      ++H DIK  +ILL  D   K+
Sbjct: 119 V-------THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKL 168
Query: 469 SDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFE 523
           SDFG    ++K    R+ +V      GT  ++APE+  R  +G    + D++S G+MV E
Sbjct: 169 SDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLPYGP---EVDIWSLGIMVIE 219
Query: 524 MT 525
           M 
Sbjct: 220 MV 221

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 24/183 (13%)
Query: 348 QNVAIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q  A+KV+++     K + E  + EV  + +  H NI+ L  F  +     L+ E  + G
Sbjct: 76  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 135
Query: 404 SL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD- 461
            L ++ I  K   E +         +I   +  G+ Y+H+    +I+H D+KP N+LL+ 
Sbjct: 136 ELFDEIISRKRFSEVDAA-------RIIRQVLSGITYMHK---NKIVHRDLKPENLLLES 185
Query: 462 --EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
             +D   +I DFGL+   E  +    M    GT  YIAPEV    + E   K DV+S G+
Sbjct: 186 KSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGTYDE---KCDVWSTGV 239
Query: 520 MVF 522
           +++
Sbjct: 240 ILY 242

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 32/238 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPL--ETNQK 420
           E+   EVA ++   H NIV       E     ++ ++   G L K I+ +  +  + +Q 
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
           L W       V I   L+++H   + +ILH DIK  NI L +D   ++ DFG+A++    
Sbjct: 128 LDW------FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--- 175
Query: 481 ESIVSMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS 539
            S V +  A  GT  Y++PE+ C N    + KSD+++ G +++E+   K+       ++ 
Sbjct: 176 NSTVELARACIGTPYYLSPEI-CEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233
Query: 540 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
            +      +  + L     L+ + ++                 + NP DRPS+N ++E
Sbjct: 234 VLKIISGSFPPVSLHYSYDLRSLVSQ---------------LFKRNPRDRPSVNSILE 276

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 25/182 (13%)
Query: 350 VAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K ++  K    + + NEV  +    H N+V +      G    ++ EF+  G+L   
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 161
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +       T+ ++  E +  + + + + L  LH      ++H DIK  +ILL  D   K+
Sbjct: 162 V-------THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKL 211
Query: 469 SDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFE 523
           SDFG    ++K    R+ +V      GT  ++APE+  R  +G    + D++S G+MV E
Sbjct: 212 SDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLPYGP---EVDIWSLGIMVIE 262
Query: 524 MT 525
           M 
Sbjct: 263 MV 264

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 25/182 (13%)
Query: 350 VAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K ++  K    + + NEV  +    H N+V +      G    ++ EF+  G+L   
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 116
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +       T+ ++  E +  + + + + L  LH      ++H DIK  +ILL  D   K+
Sbjct: 117 V-------THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKL 166
Query: 469 SDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFE 523
           SDFG    ++K    R+ +V      GT  ++APE+  R  +G    + D++S G+MV E
Sbjct: 167 SDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLPYGP---EVDIWSLGIMVIE 217
Query: 524 MT 525
           M 
Sbjct: 218 MV 219

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+     G   Y +  D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEIL---LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+S   L+KF+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDA 97
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 98  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 150
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 151 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  FCF+   +      +  N
Sbjct: 63  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKN 121
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 122 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 171
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 172 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 229
Query: 522 FEMTG 526
           +++  
Sbjct: 230 YQLVA 234

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGH-----RRALIYEFVSN 402
           +++V N  +G     + EVA + R     H N+V L+  C         +  L++E V  
Sbjct: 36  SVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ 95
Query: 403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
             L  ++ +  P      L  E +  +     RGL++LH  C   I+H D+KP NIL+  
Sbjct: 96  -DLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 147
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
               K++DFGLA+I   + ++  +     T+ Y APEV  ++    +   D++S G +  
Sbjct: 148 GGTVKLADFGLARIYSYQMALFPVV---VTLWYRAPEVLLQS--TYATPVDMWSVGCIFA 202
Query: 523 EMTGEK 528
           EM   K
Sbjct: 203 EMFRRK 208

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 25/182 (13%)
Query: 350 VAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K ++  K    + + NEV  +    H N+V +      G    ++ EF+  G+L   
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +       T+ ++  E +  + + + + L  LH      ++H DIK  +ILL  D   K+
Sbjct: 108 V-------THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKL 157
Query: 469 SDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFE 523
           SDFG    ++K    R+ +V      GT  ++APE+  R  +G    + D++S G+MV E
Sbjct: 158 SDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLPYGP---EVDIWSLGIMVIE 208
Query: 524 MT 525
           M 
Sbjct: 209 MV 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 43  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 101
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 102 SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 154
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+     G   Y +  D++S G +  EM   +
Sbjct: 155 GLARAFG--VPVRTYTHEVVTLWYRAPEIL---LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 25/182 (13%)
Query: 350 VAIKVLNETKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           VA+K ++  K    + + NEV  +    H N+V +      G    ++ EF+  G+L   
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 111
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +       T+ ++  E +  + + + + L  LH      ++H DIK  +ILL  D   K+
Sbjct: 112 V-------THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKL 161
Query: 469 SDFG----LAKICEGRESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFE 523
           SDFG    ++K    R+ +V      GT  ++APE+  R  +G    + D++S G+MV E
Sbjct: 162 SDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLPYGP---EVDIWSLGIMVIE 212
Query: 524 MT 525
           M 
Sbjct: 213 MV 214

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+S   L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDA 95
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 96  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 148
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 149 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 88/184 (47%), Gaps = 21/184 (11%)
Query: 351 AIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EK 407
            IK +N+ +     E    E+  +    H NI+ +     + H   ++ E    G L E+
Sbjct: 51  VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP- 466
            +  +      + L    + ++   +   L Y H   +  ++H D+KP NIL  +D  P 
Sbjct: 111 IVSAQ---ARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILF-QDTSPH 163
Query: 467 ---KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYG-MMVF 522
              KI DFGLA++ +  E     T A GT  Y+APEVF R+   V++K D++S G +M F
Sbjct: 164 SPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKRD---VTFKCDIWSAGVVMYF 217
Query: 523 EMTG 526
            +TG
Sbjct: 218 LLTG 221

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+   +  +H N+V   G   EG+ + L  E+ S G L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 93  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 141
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 200
Query: 524 M 524
           M
Sbjct: 201 M 201

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 16/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  E +G     I E++ +    H NIV+L+          L++EF+    L+K + E
Sbjct: 53  IRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE 111
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                 + ++K   LY++  G+A   ++       RILH D+KP N+L++ D   K++DF
Sbjct: 112 NKTGLQDSQIKI-YLYQLLRGVAHCHQH-------RILHRDLKPQNLLINSDGALKLADF 163
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
           GLA+       + S T    T+ Y AP+V     G   Y +  D++S G +  EM   K
Sbjct: 164 GLARAFG--IPVRSYTHEVVTLWYRAPDVL---MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 31  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 91  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 139
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 198
Query: 524 M 524
           M
Sbjct: 199 M 199

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 7/114 (6%)
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
           ++ L+ N   K E +      +   L+YL    N RI+H D+KP NILLDE     I+DF
Sbjct: 103 RYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDF 159
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEM 524
            +A +      I +M G +    Y+APE+F  R     S+  D +S G+  +E+
Sbjct: 160 NIAAMLPRETQITTMAGTK---PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 57/96 (59%), Gaps = 10/96 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICEGRESIVSMTG 488
           A  I  GLE LHR    RI++ D+KP NILLD+    +ISD GLA  + EG+    ++ G
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKG 344
Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             GT+GY+APEV        ++  D ++ G +++EM
Sbjct: 345 RVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEM 378

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 93  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 141
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 200
Query: 524 M 524
           M
Sbjct: 201 M 201

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 93  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 141
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 200
Query: 524 M 524
           M
Sbjct: 201 M 201

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICE--GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
              KISDFGLA +     RE +++     GT+ Y+APE+  R         DV+S G+++
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-PVDVWSCGIVL 197
Query: 522 FEM 524
             M
Sbjct: 198 TAM 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 97
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 98  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 151 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 38  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 96
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 97  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 149
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 150 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 16/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  E +G     I E++ +    H NIV+L+          L++EF+    L+K + E
Sbjct: 53  IRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE 111
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                 + ++K   LY++  G+A   ++       RILH D+KP N+L++ D   K++DF
Sbjct: 112 NKTGLQDSQIKI-YLYQLLRGVAHCHQH-------RILHRDLKPQNLLINSDGALKLADF 163
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
           GLA+       + S T    T+ Y AP+V     G   Y +  D++S G +  EM   K
Sbjct: 164 GLARAFG--IPVRSYTHEVVTLWYRAPDVL---MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 348 QNVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q  A+KV+N+     +D    + EV  + +  H NI+ L     +     ++ E  + G 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 405 L-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL--- 460
           L ++ I  K   E +         +I   +  G+ Y+H+     I+H D+KP NILL   
Sbjct: 108 LFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHKH---NIVHRDLKPENILLESK 157
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
           ++D   KI DFGL+   +       M    GT  YIAPEV    + E   K DV+S G++
Sbjct: 158 EKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSAGVI 211
Query: 521 VF 522
           ++
Sbjct: 212 LY 213

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 38  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 96
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 97  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 149
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 150 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 93  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 141
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 200
Query: 524 M 524
           M
Sbjct: 201 M 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 97
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 98  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 151 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 93  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 141
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 200
Query: 524 M 524
           M
Sbjct: 201 M 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 95
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 96  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 148
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 149 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 93  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 141
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 200
Query: 524 M 524
           M
Sbjct: 201 M 201

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           +NE   + + +   +V+L  + +E      +   + NG   KF H  H  +        V
Sbjct: 232 LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKF-HIYHMGQAGFPEARAV 289
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICEGRESIV 484
            Y  A  I  GLE LHR    RI++ D+KP NILLD+    +ISD GLA  + EG+    
Sbjct: 290 FY--AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 340
Query: 485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           ++ G  GT+GY+APEV        ++  D ++ G +++EM
Sbjct: 341 TIKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEM 378

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 93  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 141
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 200
Query: 524 M 524
           M
Sbjct: 201 M 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 40  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 98
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 99  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 151
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 152 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 107/260 (41%), Gaps = 51/260 (19%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 96
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 97  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 147
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE- 523
            KI+DFG +  C    S    T   GT+ Y+ PE+   R   E   K D++S G++ +E 
Sbjct: 148 LKIADFGWS--CHAPSS--RRTTLSGTLDYLPPEMIEGRMHDE---KVDLWSLGVLCYEF 200
Query: 524 MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILV 577
           + G    E N       R S  E  FP +V                     E AR +I  
Sbjct: 201 LVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARDLISR 240
Query: 578 SLWCIQTNPSDRPSMNRVVE 597
               ++ NPS RP +  V+E
Sbjct: 241 ---LLKHNPSQRPMLREVLE 257

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 350 VAIK--VLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VA+K   L+  +G     I E++ +    H NIV L       ++  L++EF+ N  L+K
Sbjct: 33  VALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKK 91
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           ++  +    T + L+  ++      + +GL + H     +ILH D+KP N+L+++    K
Sbjct: 92  YMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLK 148
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMT 525
           + DFGLA+       + + +    T+ Y AP+V     G  +Y +  D++S G ++ EM 
Sbjct: 149 LGDFGLARAFG--IPVNTFSSEVVTLWYRAPDVL---MGSRTYSTSIDIWSCGCILAEMI 203
Query: 526 GEK 528
             K
Sbjct: 204 TGK 206

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 92/180 (51%), Gaps = 18/180 (10%)
Query: 351 AIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLL-GFCFEGHRRALIYEFVSNGSLEKF 408
           A KV++ +++   ED++ E+  ++   H NIV LL  F +E +   LI EF + G+++  
Sbjct: 66  AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAV 124
Query: 409 IHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           + E + PL  +Q      +  +       L YLH   + +I+H D+K  NIL   D   K
Sbjct: 125 MLELERPLTESQ------IQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIK 175
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGE--VSYKSDVYSYGMMVFEM 524
           ++DFG++   +    I       GT  ++APE V C    +    YK+DV+S G+ + EM
Sbjct: 176 LADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGH-----RRALIYEFVSN 402
           +++V N  +G     + EVA + R     H N+V L+  C         +  L++E V  
Sbjct: 36  SVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ 95
Query: 403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
             L  ++ +  P      L  E +  +     RGL++LH  C   I+H D+KP NIL+  
Sbjct: 96  -DLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 147
Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
               K++DFGLA+I   +   +++     T+ Y APEV  ++    +   D++S G +  
Sbjct: 148 GGTVKLADFGLARIYSYQ---MALDPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFA 202
Query: 523 EMTGEK 528
           EM   K
Sbjct: 203 EMFRRK 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 93
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 94  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 147 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           + VA+K+++  +     E+   E+      +H N+V   G   EG+ + L  E+ S G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 406 EKFIHEK--HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
              I      P    Q+      +++  G+     YLH      I H DIKP N+LLDE 
Sbjct: 92  FDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH---GIGITHRDIKPENLLLDER 140
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KISDFGLA +         +    GT+ Y+APE+  R         DV+S G+++  
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTA 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 93
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 94  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 147 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 96/178 (53%), Gaps = 20/178 (11%)
Query: 350 VAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-E 406
           +A K++ +T+G  + E+  NE++ +++  H N++ L       +   L+ E+V  G L +
Sbjct: 117 LAAKII-KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL-LDEDFC 465
           + I E + L    +L   +  K    I  G+ ++H+     ILH D+KP NIL ++ D  
Sbjct: 176 RIIDESYNL---TELDTILFMK---QICEGIRHMHQ---MYILHLDLKPENILCVNRDAK 226
Query: 466 P-KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
             KI DFGLA+  + RE    +    GT  ++APEV   +F  VS+ +D++S G++ +
Sbjct: 227 QIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDF--VSFPTDMWSVGVIAY 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 348 QNVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q  A+KV+N+     +D    + EV  + +  H NI+ L     +     ++ E  + G 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 405 L-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL--- 460
           L ++ I  K   E +         +I   +  G+ Y+H+     I+H D+KP NILL   
Sbjct: 108 LFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHKH---NIVHRDLKPENILLESK 157
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
           ++D   KI DFGL+   +       M    GT  YIAPEV    + E   K DV+S G++
Sbjct: 158 EKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSAGVI 211
Query: 521 VF 522
           ++
Sbjct: 212 LY 213

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 348 QNVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q  A+KV+N+     +D    + EV  + +  H NI+ L     +     ++ E  + G 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 405 L-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL--- 460
           L ++ I  K   E +         +I   +  G+ Y+H+     I+H D+KP NILL   
Sbjct: 108 LFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHKH---NIVHRDLKPENILLESK 157
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
           ++D   KI DFGL+   +       M    GT  YIAPEV    + E   K DV+S G++
Sbjct: 158 EKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSAGVI 211
Query: 521 VF 522
           ++
Sbjct: 212 LY 213

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 95
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 96  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 148
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 149 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 348 QNVAIKVLNETKGNGEDFI----NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
             VA+K+LN  K    D +     E+ ++    H +I+ L           ++ E+VS G
Sbjct: 42  HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG 101
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L  +I +      N +L  +   ++   I  G++Y HR     ++H D+KP N+LLD  
Sbjct: 102 ELFDYICK------NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAH 152
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFGL+ +    E    +  + G+  Y APEV          + D++S G++++ 
Sbjct: 153 MNAKIADFGLSNMMSDGE---FLRXSCGSPNYAAPEVISGRL-YAGPEVDIWSSGVILYA 208
Query: 524 M 524
           +
Sbjct: 209 L 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 38  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 96
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 97  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 149
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 150 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA 95
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 96  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 148
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 149 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 366 INEVASISRTS---HVNIVTLLGFCFEGH-----RRALIYEFVSNGSLEKFIHEKHPLET 417
           + EVA + R     H N+V L+  C         +  L++E V    L  ++ +  P   
Sbjct: 59  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP--- 114
Query: 418 NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 477
              L  E +  +     RGL++LH  C   I+H D+KP NIL+      K++DFGLA+I 
Sbjct: 115 -PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
             +   +++T    T+ Y APEV  ++    +   D++S G +  EM   K
Sbjct: 171 SYQ---MALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 28/182 (15%)
Query: 351 AIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL- 405
           AIK++ +    T  N    ++EVA + +  H NI+ L  F  +     L+ E    G L 
Sbjct: 33  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 92
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---E 462
           ++ I  +   E +  +       I   +  G  YLH+     I+H D+KP N+LL+    
Sbjct: 93  DEIILRQKFSEVDAAV-------IMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSR 142
Query: 463 DFCPKISDFGLAKICE--GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
           D   KI DFGL+   E  G+     M    GT  YIAPEV  + + E   K DV+S G++
Sbjct: 143 DALIKIVDFGLSAHFEVGGK-----MKERLGTAYYIAPEVLRKKYDE---KCDVWSCGVI 194
Query: 521 VF 522
           ++
Sbjct: 195 LY 196

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 31/190 (16%)
Query: 352 IKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGH-----RRALIYEFVSNG 403
           ++V    +G     I EVA +       H N+V L   C         +  L++E V   
Sbjct: 45  VRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD 104
Query: 404 ---SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
               L+K      P ET + + +++L        RGL++LH   + R++H D+KP NIL+
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLL--------RGLDFLH---SHRVVHRDLKPQNILV 153
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYG 518
                 K++DFGLA+I   +   +++T    T+ Y APEV  ++    SY +  D++S G
Sbjct: 154 TSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQS----SYATPVDLWSVG 206
Query: 519 MMVFEMTGEK 528
            +  EM   K
Sbjct: 207 CIFAEMFRRK 216

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 28/182 (15%)
Query: 351 AIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL- 405
           AIK++ +    T  N    ++EVA + +  H NI+ L  F  +     L+ E    G L 
Sbjct: 50  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 109
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---E 462
           ++ I  +   E +  +       I   +  G  YLH+     I+H D+KP N+LL+    
Sbjct: 110 DEIILRQKFSEVDAAV-------IMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSR 159
Query: 463 DFCPKISDFGLAKICE--GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
           D   KI DFGL+   E  G+     M    GT  YIAPEV  + + E   K DV+S G++
Sbjct: 160 DALIKIVDFGLSAHFEVGGK-----MKERLGTAYYIAPEVLRKKYDE---KCDVWSCGVI 211
Query: 521 VF 522
           ++
Sbjct: 212 LY 213

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 45/202 (22%)
Query: 354 VLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEG----------------------- 390
           V+   K N E    EV ++++  HVNIV   G C++G                       
Sbjct: 41  VIRRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSK 99
Query: 391 -HRRA------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
              R+      +  EF   G+LE++I ++   + ++ L  E+  +I     +G++Y+H  
Sbjct: 100 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT----KGVDYIH-- 153
Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFC 502
            + +++H D+KP NI L +    KI DFGL    +        T ++GT+ Y++PE +  
Sbjct: 154 -SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISS 209
Query: 503 RNFGEVSYKSDVYSYGMMVFEM 524
           +++G+   + D+Y+ G+++ E+
Sbjct: 210 QDYGK---EVDLYALGLILAEL 228

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 408 FIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           F+   K+ L+    L   +LY  A  ++  L YL    + R +H DI   N+L+  + C 
Sbjct: 100 FLQVRKYSLD----LASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 150
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-- 524
           K+ DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+  
Sbjct: 151 KLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 207
Query: 525 ------TGEKNN 530
                  G KNN
Sbjct: 208 HGVKPFQGVKNN 219

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 22/191 (11%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+  +   + +  L   +LY  A  ++  L YL    + R +H DI   N+L+  + C K
Sbjct: 100 FLQVR---KFSLDLASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK 151
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--- 524
           + DFGL++  E      +  G +  I ++APE    NF   +  SDV+ +G+ ++E+   
Sbjct: 152 LGDFGLSRYMEDSTXXKASKG-KLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMH 208
Query: 525 -----TGEKNN 530
                 G KNN
Sbjct: 209 GVKPFQGVKNN 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 408 FIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           F+   K+ L+    L   +LY  A  ++  L YL    + R +H DI   N+L+  + C 
Sbjct: 100 FLQVRKYSLD----LASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 150
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-- 524
           K+ DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+  
Sbjct: 151 KLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 207
Query: 525 ------TGEKNN 530
                  G KNN
Sbjct: 208 HGVKPFQGVKNN 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 31/190 (16%)
Query: 352 IKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGH-----RRALIYEFVSNG 403
           ++V    +G     I EVA +       H N+V L   C         +  L++E V   
Sbjct: 45  VRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD 104
Query: 404 ---SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
               L+K      P ET + + +++L        RGL++LH   + R++H D+KP NIL+
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLL--------RGLDFLH---SHRVVHRDLKPQNILV 153
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYG 518
                 K++DFGLA+I   +   +++T    T+ Y APEV  ++    SY +  D++S G
Sbjct: 154 TSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQS----SYATPVDLWSVG 206
Query: 519 MMVFEMTGEK 528
            +  EM   K
Sbjct: 207 CIFAEMFRRK 216

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 58  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 116
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 117 GCLLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 166
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+        S  SD+++ G ++
Sbjct: 167 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK--SASKSSDLWALGCII 224
Query: 522 FEMTG 526
           +++  
Sbjct: 225 YQLVA 229

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 31/190 (16%)
Query: 352 IKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGH-----RRALIYEFVSNG 403
           ++V    +G     I EVA +       H N+V L   C         +  L++E V   
Sbjct: 45  VRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD 104
Query: 404 ---SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
               L+K      P ET + + +++L        RGL++LH   + R++H D+KP NIL+
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLL--------RGLDFLH---SHRVVHRDLKPQNILV 153
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYG 518
                 K++DFGLA+I   +   +++T    T+ Y APEV  ++    SY +  D++S G
Sbjct: 154 TSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQS----SYATPVDLWSVG 206
Query: 519 MMVFEMTGEK 528
            +  EM   K
Sbjct: 207 CIFAEMFRRK 216

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 44  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 102
Query: 408 FIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           F+   K+ L+    L   +LY  A  ++  L YL    + R +H DI   N+L+  + C 
Sbjct: 103 FLQVRKYSLD----LASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 153
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-- 524
           K+ DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+  
Sbjct: 154 KLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 210
Query: 525 ------TGEKNN 530
                  G KNN
Sbjct: 211 HGVKPFQGVKNN 222

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 107/261 (40%), Gaps = 37/261 (14%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H   +  L + FE      +   + NG   ++ H  +  E N   +          I  G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRY-HIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           LE+LH+     I++ D+KP N+LLD+D   +ISD GLA   E +       G  GT G++
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFM 356
Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           APE+      E  +  D ++ G+ ++EM   +        R  ++       +  EL++ 
Sbjct: 357 APELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRA---RGEKV-------ENKELKQR 404
Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
           +  Q +   +    A K    +L  +Q +P  R          +GS D L+         
Sbjct: 405 VLEQAVTYPDKFSPASKDFCEAL--LQKDPEKRLGFR------DGSCDGLR--------- 447
Query: 617 SGSQPDFSSILVRQTESSMAT 637
             + P F  I  RQ E+ M T
Sbjct: 448 --THPLFRDISWRQLEAGMLT 466

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 13/135 (9%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++ E+V   +L   +H + P+   + ++          IA   + L+      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---------IADACQALNFSHQNGIIHRDVK 143
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
           P NIL+      K+ DFG+A+ I +   S+       GT  Y++PE    +   V  +SD
Sbjct: 144 PANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 514 VYSYGMMVFE-MTGE 527
           VYS G +++E +TGE
Sbjct: 202 VYSLGCVLYEVLTGE 216

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 107/261 (40%), Gaps = 37/261 (14%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H   +  L + FE      +   + NG   ++ H  +  E N   +          I  G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRY-HIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           LE+LH+     I++ D+KP N+LLD+D   +ISD GLA   E +       G  GT G++
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFM 356
Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           APE+      E  +  D ++ G+ ++EM   +        R  ++       +  EL++ 
Sbjct: 357 APELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRA---RGEKV-------ENKELKQR 404
Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
           +  Q +   +    A K    +L  +Q +P  R          +GS D L+         
Sbjct: 405 VLEQAVTYPDKFSPASKDFCEAL--LQKDPEKRLGFR------DGSCDGLR--------- 447
Query: 617 SGSQPDFSSILVRQTESSMAT 637
             + P F  I  RQ E+ M T
Sbjct: 448 --THPLFRDISWRQLEAGMLT 466

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 97/189 (51%), Gaps = 32/189 (16%)
Query: 354 VLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEG-----------HRRA------LI 396
           V+   K N E    EV ++++  HVNIV   G C++G             R+      + 
Sbjct: 40  VIKRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQ 98
Query: 397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
            EF   G+LE++I ++   + ++ L  E+  +I     +G++Y+H   + ++++ D+KP 
Sbjct: 99  MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT----KGVDYIH---SKKLINRDLKPS 151
Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVY 515
           NI L +    KI DFGL    +          ++GT+ Y++PE +  +++G+   + D+Y
Sbjct: 152 NIFLVDTKQVKIGDFGLVTSLKNDG---KRXRSKGTLRYMSPEQISSQDYGK---EVDLY 205
Query: 516 SYGMMVFEM 524
           + G+++ E+
Sbjct: 206 ALGLILAEL 214

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 69  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 127
Query: 408 FIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           F+   K+ L+    L   +LY  A  ++  L YL    + R +H DI   N+L+  + C 
Sbjct: 128 FLQVRKYSLD----LASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 178
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-- 524
           K+ DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+  
Sbjct: 179 KLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 235
Query: 525 ------TGEKNN 530
                  G KNN
Sbjct: 236 HGVKPFQGVKNN 247

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 96
Query: 408 FIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           F+   K+ L+    L   +LY  A  ++  L YL    + R +H DI   N+L+  + C 
Sbjct: 97  FLQVRKYSLD----LASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 147
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-- 524
           K+ DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+  
Sbjct: 148 KLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 204
Query: 525 ------TGEKNN 530
                  G KNN
Sbjct: 205 HGVKPFQGVKNN 216

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 107/261 (40%), Gaps = 37/261 (14%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H   +  L + FE      +   + NG   ++ H  +  E N   +          I  G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRY-HIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           LE+LH+     I++ D+KP N+LLD+D   +ISD GLA   E +       G  GT G++
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFM 356
Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           APE+      E  +  D ++ G+ ++EM   +        R  ++       +  EL++ 
Sbjct: 357 APELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRA---RGEKV-------ENKELKQR 404
Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
           +  Q +   +    A K    +L  +Q +P  R          +GS D L+         
Sbjct: 405 VLEQAVTYPDKFSPASKDFCEAL--LQKDPEKRLGFR------DGSCDGLR--------- 447
Query: 617 SGSQPDFSSILVRQTESSMAT 637
             + P F  I  RQ E+ M T
Sbjct: 448 --THPLFRDISWRQLEAGMLT 466

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 46  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 104
Query: 408 FIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           F+   K+ L+    L   +LY  A  ++  L YL    + R +H DI   N+L+  + C 
Sbjct: 105 FLQVRKYSLD----LASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 155
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-- 524
           K+ DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+  
Sbjct: 156 KLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 212
Query: 525 ------TGEKNN 530
                  G KNN
Sbjct: 213 HGVKPFQGVKNN 224

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 43  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 101
Query: 408 FIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           F+   K+ L+    L   +LY  A  ++  L YL    + R +H DI   N+L+  + C 
Sbjct: 102 FLQVRKYSLD----LASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 152
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-- 524
           K+ DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+  
Sbjct: 153 KLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 209
Query: 525 ------TGEKNN 530
                  G KNN
Sbjct: 210 HGVKPFQGVKNN 221

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+S   L+ F+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDA 97
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 98  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 151 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 107/261 (40%), Gaps = 37/261 (14%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H   +  L + FE      +   + NG   ++ H  +  E N   +          I  G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRY-HIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           LE+LH+     I++ D+KP N+LLD+D   +ISD GLA   E +       G  GT G++
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFM 356
Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           APE+      E  +  D ++ G+ ++EM   +        R  ++       +  EL++ 
Sbjct: 357 APELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRA---RGEKV-------ENKELKQR 404
Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS 616
           +  Q +   +    A K    +L  +Q +P  R          +GS D L+         
Sbjct: 405 VLEQAVTYPDKFSPASKDFCEAL--LQKDPEKRLGFR------DGSCDGLR--------- 447
Query: 617 SGSQPDFSSILVRQTESSMAT 637
             + P F  I  RQ E+ M T
Sbjct: 448 --THPLFRDISWRQLEAGMLT 466

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+S   L+ F+  
Sbjct: 38  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDA 96
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 97  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 149
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 150 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 203

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 13/135 (9%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++ E+V   +L   +H + P+   + ++          IA   + L+      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---------IADACQALNFSHQNGIIHRDVK 143
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
           P NI++      K+ DFG+A+ I +   S+       GT  Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 514 VYSYGMMVFE-MTGE 527
           VYS G +++E +TGE
Sbjct: 202 VYSLGCVLYEVLTGE 216

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 71/134 (52%), Gaps = 15/134 (11%)
Query: 348 QNVAIKVLN-ETKGNGEDFIN-----EVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS 401
           Q VAIK +    +   +D IN     E+  +   SH NI+ LL         +L+++F+ 
Sbjct: 36  QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 95
Query: 402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
              LE  I +   + T   +K  +L  +     +GLEYLH+     ILH D+KP+N+LLD
Sbjct: 96  T-DLEVIIKDNSLVLTPSHIKAYMLMTL-----QGLEYLHQHW---ILHRDLKPNNLLLD 146
Query: 462 EDFCPKISDFGLAK 475
           E+   K++DFGLAK
Sbjct: 147 ENGVLKLADFGLAK 160

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 399 FVSNGSLEKFIHEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
           FV   SL     E+ P +  +  L  E L   +  +A+G+E+L    + + +H D+   N
Sbjct: 172 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 228
Query: 458 ILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYS 516
           ILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +SDV+S
Sbjct: 229 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWS 285
Query: 517 YGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +G++++E+   G      V +D            +RL+       +G           +M
Sbjct: 286 FGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYTTPEM 330
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEML 599
               L C    PS RP+ + +VE L
Sbjct: 331 YQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 13/135 (9%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++ E+V   +L   +H + P+   + ++          IA   + L+      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---------IADACQALNFSHQNGIIHRDVK 143
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
           P NI++      K+ DFG+A+ I +   S+       GT  Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 514 VYSYGMMVFE-MTGE 527
           VYS G +++E +TGE
Sbjct: 202 VYSLGCVLYEVLTGE 216

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 399 FVSNGSLEKFIHEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
           FV   SL     E+ P +  +  L  E L   +  +A+G+E+L    + + +H D+   N
Sbjct: 174 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 230
Query: 458 ILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYS 516
           ILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +SDV+S
Sbjct: 231 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWS 287
Query: 517 YGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +G++++E+   G      V +D            +RL+       +G           +M
Sbjct: 288 FGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYTTPEM 332
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEML 599
               L C    PS RP+ + +VE L
Sbjct: 333 YQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 13/135 (9%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++ E+V   +L   +H + P+   + ++          IA   + L+      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---------IADACQALNFSHQNGIIHRDVK 143
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
           P NI++      K+ DFG+A+ I +   S+       GT  Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 514 VYSYGMMVFE-MTGE 527
           VYS G +++E +TGE
Sbjct: 202 VYSLGCVLYEVLTGE 216

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 13/135 (9%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++ E+V   +L   +H + P+   + ++          IA   + L+      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---------IADACQALNFSHQNGIIHRDVK 143
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
           P NI++      K+ DFG+A+ I +   S+       GT  Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 514 VYSYGMMVFE-MTGE 527
           VYS G +++E +TGE
Sbjct: 202 VYSLGCVLYEVLTGE 216

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 33/199 (16%)
Query: 350 VAIKVLNETKGNGEDFINE--VASISRTSHVNIVTLL----GFCFEGHRR-ALIYEFVSN 402
           VA+KV   +  N ++FINE  +  +    H NI   +        +G     L+ E+  N
Sbjct: 39  VAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN 96
Query: 403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH----RGCNTR--ILHFDIKPH 456
           GSL K++     L T+    W    ++A  + RGL YLH    RG + +  I H D+   
Sbjct: 97  GSLXKYLS----LHTSD---WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149
Query: 457 NILLDEDFCPKISDFGLA------KICEGRESIVSMTGARGTIGYIAPEVF-----CRNF 505
           N+L+  D    ISDFGL+      ++    E   +     GTI Y+APEV       R+ 
Sbjct: 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDX 209
Query: 506 GEVSYKSDVYSYGMMVFEM 524
                + D+Y+ G++ +E+
Sbjct: 210 ESALKQVDMYALGLIYWEI 228

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
           VT  G  F      +  E + + SL+KF   K  ++  Q +  ++L KIAV I + LE+L
Sbjct: 113 VTFYGALFREGDVWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHL 169
Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
           H   +  ++H D+KP N+L++     K+ DFG++         V+ T   G   Y+APE 
Sbjct: 170 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDS---VAKTIDAGCKPYMAPER 224
Query: 501 FCRNFGEVSY--KSDVYSYGMMVFEMT 525
                 +  Y  KSD++S G+ + E+ 
Sbjct: 225 INPELNQKGYSVKSDIWSLGITMIELA 251

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 348 QNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           Q VAIK +   + + ++ I E++ + +    ++V   G  F+     ++ E+   GS+  
Sbjct: 55  QIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD 113
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
            I  +     N+ L  + +  I     +GLEYLH     R +H DIK  NILL+ +   K
Sbjct: 114 IIRLR-----NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAK 165
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYK--SDVYSYGMMVFEM 524
           ++DFG+A   +  + +       GT  ++APEV      E+ Y   +D++S G+   EM
Sbjct: 166 LADFGVA--GQLTDXMAKRNXVIGTPFWMAPEV----IQEIGYNCVADIWSLGITAIEM 218

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 12/182 (6%)
Query: 350 VAIKVLNETKGN-GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +AIK + E      +    E+A      H NIV  LG   E     +  E V  GSL   
Sbjct: 50  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 109
Query: 409 IHEK-HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCP 466
           +  K  PL+ N+    + +      I  GL+YLH   + +I+H DIK  N+L++      
Sbjct: 110 LRSKWGPLKDNE----QTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVL 162
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
           KISDFG +K   G           GT+ Y+APE+  +        +D++S G  + EM  
Sbjct: 163 KISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 220
Query: 527 EK 528
            K
Sbjct: 221 GK 222

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 399 FVSNGSLEKFIHEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
           FV   SL     E+ P +  +  L  E L   +  +A+G+E+L    + + +H D+   N
Sbjct: 165 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 221
Query: 458 ILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYS 516
           ILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +SDV+S
Sbjct: 222 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWS 278
Query: 517 YGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +G++++E+   G      V +D            +RL+       +G           +M
Sbjct: 279 FGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYTTPEM 323
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEML 599
               L C    PS RP+ + +VE L
Sbjct: 324 YQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 16/179 (8%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           NVA+K   +  T  N E F++E   +    H +IV L+G   E     +I E    G L 
Sbjct: 38  NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGEL- 95
Query: 407 KFIHEKHPLETNQ-KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
                 H LE N+  LK   L   ++ I + + YL    +   +H DI   NIL+    C
Sbjct: 96  -----GHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPEC 147
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            K+ DFGL++  E  E     +  R  I +++PE    NF   +  SDV+ + + ++E+
Sbjct: 148 VKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEI 203

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 399 FVSNGSLEKFIHEKHPLETNQK-LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
           FV   SL     E+ P +  +  L  E L   +  +A+G+E+L    + + +H D+   N
Sbjct: 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 223
Query: 458 ILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYS 516
           ILL E    KI DFGLA+        V    AR  + ++APE +F R +   + +SDV+S
Sbjct: 224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWS 280
Query: 517 YGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +G++++E+   G      V +D            +RL+       +G           +M
Sbjct: 281 FGVLLWEIFSLGASPYPGVKIDEE--------FCRRLK-------EGTRMRAPDYTTPEM 325
Query: 575 ILVSLWCIQTNPSDRPSMNRVVEML 599
               L C    PS RP+ + +VE L
Sbjct: 326 YQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 16/179 (8%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           NVA+K   +  T  N E F++E   +    H +IV L+G   E     +I E    G L 
Sbjct: 54  NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGEL- 111
Query: 407 KFIHEKHPLETNQ-KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
                 H LE N+  LK   L   ++ I + + YL    +   +H DI   NIL+    C
Sbjct: 112 -----GHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPEC 163
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            K+ DFGL++  E  E     +  R  I +++PE    NF   +  SDV+ + + ++E+
Sbjct: 164 VKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEI 219

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 87/179 (48%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++E V    L+KF+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDA 97
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 98  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 151 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
           +E   +S  +H  I+ + G   +  +  +I +++  G L         L  +Q+    V 
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL------LRKSQRFPNPVA 108
Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
              A  +   LEYLH   +  I++ D+KP NILLD++   KI+DFG AK        +  
Sbjct: 109 KFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC- 164
Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
               GT  YIAPEV        +   D +S+G++++EM
Sbjct: 165 ----GTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEM 196

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 87/179 (48%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++E V    L+ F+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDA 93
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 94  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + + T    T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 147 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 94/184 (51%), Gaps = 24/184 (13%)
Query: 348 QNVAIKVLNETKGNGEDFIN---EVASISRTSHVNIVTL-LGFCFEGHRRALIYEFVSNG 403
           Q  A+KVL +      D +    E   +   +H  IV L   F  EG +  LI +F+  G
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGG 111
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L   +  K  + T + +K+ +       +A  L++LH   +  I++ D+KP NILLDE+
Sbjct: 112 DLFTRL-SKEVMFTEEDVKFYL-----AELALALDHLH---SLGIIYRDLKPENILLDEE 162
Query: 464 FCPKISDFGLAKICEGRESIVSMTGAR---GTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
              K++DFGL+K     ESI     A    GT+ Y+APEV  R     S  +D +S+G++
Sbjct: 163 GHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS--ADWWSFGVL 215
Query: 521 VFEM 524
           +FEM
Sbjct: 216 MFEM 219

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 113/257 (43%), Gaps = 26/257 (10%)
Query: 348 QNVAIKVLNETKGNGED--FINEVASISRTSHVN-IVTLLGFCFEGHRRALIYEFVSNGS 404
           Q +A+K +  T    E    + ++  + R+S    IV   G  F      +  E +S  S
Sbjct: 48  QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-S 106
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
            +KF    + +  +  +  E+L KI +   + L +L    N +I+H DIKP NILLD   
Sbjct: 107 FDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSG 163
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVF 522
             K+ DFG++   +  +SI     A G   Y+APE    +     Y  +SDV+S G+ ++
Sbjct: 164 NIKLCDFGISG--QLVDSIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 523 EMTGEKNNANVAVDRSSEIYFPHW--VYKRLELEEDLGLQGIENEEDKEYARKMILVSLW 580
           E+             +    +P W  V+ +L          + N E++E++   I     
Sbjct: 221 ELA------------TGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNL 268
Query: 581 CIQTNPSDRPSMNRVVE 597
           C+  + S RP    +++
Sbjct: 269 CLTKDESKRPKYKELLK 285

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 58  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 116
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 117 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 166
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+        S  SD+++ G ++
Sbjct: 167 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKS--SDLWALGCII 224
Query: 522 FEMTG 526
           +++  
Sbjct: 225 YQLVA 229

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 16/179 (8%)
Query: 349 NVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           NVA+K   +  T  N E F++E   +    H +IV L+G   E     +I E    G L 
Sbjct: 42  NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGEL- 99
Query: 407 KFIHEKHPLETNQ-KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
                 H LE N+  LK   L   ++ I + + YL    +   +H DI   NIL+    C
Sbjct: 100 -----GHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPEC 151
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            K+ DFGL++  E  E     +  R  I +++PE    NF   +  SDV+ + + ++E+
Sbjct: 152 VKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEI 207

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 13/135 (9%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++ E+V   +L   +H + P+   + ++          IA   + L+      I+H D+K
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---------IADACQALNFSHQNGIIHRDVK 160
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
           P NI++      K+ DFG+A+ I +   S+       GT  Y++PE    +   V  +SD
Sbjct: 161 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 218
Query: 514 VYSYGMMVFE-MTGE 527
           VYS G +++E +TGE
Sbjct: 219 VYSLGCVLYEVLTGE 233

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 118/275 (42%), Gaps = 41/275 (14%)
Query: 353 KVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE----GHRRALIYEFVSNGSLEKF 408
           ++L   + + E+   E       +H NI+ L+ +C       H   L+  F   G+L   
Sbjct: 61  RILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNE 120
Query: 409 IH---EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
           I    +K    T  ++ W +L     GI RGLE +H        H D+KP NILL ++  
Sbjct: 121 IERLKDKGNFLTEDQILWLLL-----GICRGLEAIHAKGYA---HRDLKPTNILLGDEGQ 172
Query: 466 PKISDFG-LAKIC---EGRESIVSM---TGARGTIGYIAPEVF-CRNFGEVSYKSDVYSY 517
           P + D G + + C   EG    +++      R TI Y APE+F  ++   +  ++DV+S 
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 518 GMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILV 577
           G +++ M   +   ++   +   +         L ++  L    I        A   +L 
Sbjct: 233 GCVLYAMMFGEGPYDMVFQKGDSV--------ALAVQNQL---SIPQSPRHSSALWQLLN 281
Query: 578 SLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRP 612
           S+  +  +P  RP     + +L   L++LQ PP P
Sbjct: 282 SM--MTVDPHQRPH----IPLLLSQLEALQ-PPAP 309

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+ F+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDA 97
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 98  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 151 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 94/184 (51%), Gaps = 24/184 (13%)
Query: 348 QNVAIKVLNETKGNGEDFIN---EVASISRTSHVNIVTL-LGFCFEGHRRALIYEFVSNG 403
           Q  A+KVL +      D +    E   +   +H  IV L   F  EG +  LI +F+  G
Sbjct: 54  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGG 112
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L   +  K  + T + +K+ +       +A  L++LH   +  I++ D+KP NILLDE+
Sbjct: 113 DLFTRL-SKEVMFTEEDVKFYL-----AELALALDHLH---SLGIIYRDLKPENILLDEE 163
Query: 464 FCPKISDFGLAKICEGRESIVSMTGAR---GTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
              K++DFGL+K     ESI     A    GT+ Y+APEV  R     S  +D +S+G++
Sbjct: 164 GHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS--ADWWSFGVL 216
Query: 521 VFEM 524
           +FEM
Sbjct: 217 MFEM 220

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 56  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 114
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 115 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 164
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 165 EDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK--SACKSSDLWALGCII 222
Query: 522 FEMTG 526
           +++  
Sbjct: 223 YQLVA 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 94/184 (51%), Gaps = 24/184 (13%)
Query: 348 QNVAIKVLNETKGNGEDFIN---EVASISRTSHVNIVTL-LGFCFEGHRRALIYEFVSNG 403
           Q  A+KVL +      D +    E   +   +H  IV L   F  EG +  LI +F+  G
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGG 111
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L   +  K  + T + +K+ +       +A  L++LH   +  I++ D+KP NILLDE+
Sbjct: 112 DLFTRL-SKEVMFTEEDVKFYL-----AELALALDHLH---SLGIIYRDLKPENILLDEE 162
Query: 464 FCPKISDFGLAKICEGRESIVSMTGAR---GTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
              K++DFGL+K     ESI     A    GT+ Y+APEV  R     S  +D +S+G++
Sbjct: 163 GHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS--ADWWSFGVL 215
Query: 521 VFEM 524
           +FEM
Sbjct: 216 MFEM 219

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 107/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G +
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV 100
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            K       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 101 YK------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 151
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 152 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 200
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 201 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 240
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 241 LISR---LLKHNPSQRPMLREVLE 261

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 106/263 (40%), Gaps = 57/263 (21%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G +
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV 100
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            K       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 101 YK------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 151
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
            KI+DFG         S+ + +  R    GT+ Y+ PE+      +   K D++S G++ 
Sbjct: 152 LKIADFGW--------SVHAPSSRRXXLXGTLDYLPPEMIEGRMHDE--KVDLWSLGVLC 201
Query: 522 FE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +E + G    E N       R S  E  FP +V                     E AR +
Sbjct: 202 YEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARDL 241
Query: 575 ILVSLWCIQTNPSDRPSMNRVVE 597
           I      ++ NPS RP +  V+E
Sbjct: 242 ISR---LLKHNPSQRPMLREVLE 261

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 12/182 (6%)
Query: 350 VAIKVLNETKGN-GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           +AIK + E      +    E+A      H NIV  LG   E     +  E V  GSL   
Sbjct: 36  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 95
Query: 409 IHEK-HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCP 466
           +  K  PL+ N+    + +      I  GL+YLH   + +I+H DIK  N+L++      
Sbjct: 96  LRSKWGPLKDNE----QTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVL 148
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
           KISDFG +K   G           GT+ Y+APE+  +        +D++S G  + EM  
Sbjct: 149 KISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 206
Query: 527 EK 528
            K
Sbjct: 207 GK 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 59  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 117
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 118 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 167
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 168 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCII 225
Query: 522 FEMTG 526
           +++  
Sbjct: 226 YQLVA 230

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 22/191 (11%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+  +   + +  L   +LY  A  ++  L YL    + R +H DI   N+L+    C K
Sbjct: 100 FLQVR---KFSLDLASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVK 151
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--- 524
           + DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+   
Sbjct: 152 LGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMH 208
Query: 525 -----TGEKNN 530
                 G KNN
Sbjct: 209 GVKPFQGVKNN 219

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++ + E       +++  E
Sbjct: 61  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA------KRIPEE 114
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+++ + RGL YL      +I+H D+KP NIL++     K+ DFG++      + I 
Sbjct: 115 ILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 167
Query: 485 SMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           SM  +  GT  Y+APE         S +SD++S G+ + E+ 
Sbjct: 168 SMANSFVGTRSYMAPERLQGT--HYSVQSDIWSMGLSLVELA 207

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 55  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 113
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 114 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 163
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 164 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCII 221
Query: 522 FEMTG 526
           +++  
Sbjct: 222 YQLVA 226

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 35  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 93
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 94  GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 143
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 144 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 201
Query: 522 FEMTG 526
           +++  
Sbjct: 202 YQLVA 206

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 18/163 (11%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E+  NE++ +    H NI+ L     +     L+ EF   G L + I  +H  +      
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA- 149
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---FCPKISDFGLAKICEG 479
                 I   I  G+ YLH+     I+H DIKP NILL+        KI DFGL+     
Sbjct: 150 -----NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
                 +    GT  YIAPEV  + + E   K DV+S G++++
Sbjct: 202 D---YKLRDRLGTAYYIAPEVLKKKYNE---KCDVWSCGVIMY 238

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 36  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 94
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 95  GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 144
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 145 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 202
Query: 522 FEMTG 526
           +++  
Sbjct: 203 YQLVA 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 33  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 91
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 92  GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 141
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 142 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 199
Query: 522 FEMTG 526
           +++  
Sbjct: 200 YQLVA 204

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 34  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 92
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 93  GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 142
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 143 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 200
Query: 522 FEMTG 526
           +++  
Sbjct: 201 YQLVA 205

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISR----TSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSL 405
           A+K+L +     +D +    + SR    T H   +T L + F+ H R   + E+ + G L
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL 92
Query: 406 EKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
             F H  +  + T ++ ++         I   LEYLH   +  +++ DIK  N++LD+D 
Sbjct: 93  --FFHLSRERVFTEERARF-----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDG 142
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGL K  EG     +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 143 HIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 198

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 15/179 (8%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           I++  ET+G     I E++ +   +H NIV LL      ++  L++EF+    L+ F+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDA 94
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                    L    L+++     +GL + H   + R+LH D+KP N+L++ +   K++DF
Sbjct: 95  SALTGIPLPLIKSYLFQLL----QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 147
Query: 472 GLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           GLA+       + +      T+ Y APE+   C+ +   S   D++S G +  EM   +
Sbjct: 148 GLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISR----TSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSL 405
           A+K+L +     +D +    + SR    T H   +T L + F+ H R   + E+ + G L
Sbjct: 39  AMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL 97
Query: 406 EKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
             F H  +  + T ++ ++         I   LEYLH   +  +++ DIK  N++LD+D 
Sbjct: 98  --FFHLSRERVFTEERARF-----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDG 147
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGL K  EG     +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 148 HIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 203

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISR----TSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSL 405
           A+K+L +     +D +    + SR    T H   +T L + F+ H R   + E+ + G L
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL 92
Query: 406 EKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
             F H  +  + T ++ ++         I   LEYLH   +  +++ DIK  N++LD+D 
Sbjct: 93  --FFHLSRERVFTEERARF-----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDG 142
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGL K  EG     +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 143 HIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 198

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 22/191 (11%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 479
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+  +   + +  L   +LY  A  ++  L YL    + R +H DI   N+L+  + C K
Sbjct: 480 FLQVR---KFSLDLASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK 531
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--- 524
           + DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+   
Sbjct: 532 LGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMH 588
Query: 525 -----TGEKNN 530
                 G KNN
Sbjct: 589 GVKPFQGVKNN 599

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 56  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 114
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 115 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 164
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 165 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 222
Query: 522 FEMTG 526
           +++  
Sbjct: 223 YQLVA 227

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISR----TSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSL 405
           A+K+L +     +D +    + SR    T H   +T L + F+ H R   + E+ + G L
Sbjct: 37  AMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL 95
Query: 406 EKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
             F H  +  + T ++ ++         I   LEYLH   +  +++ DIK  N++LD+D 
Sbjct: 96  --FFHLSRERVFTEERARF-----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDG 145
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGL K  EG     +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 146 HIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 201

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 58  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 116
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 117 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 166
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 167 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 224
Query: 522 FEMTG 526
           +++  
Sbjct: 225 YQLVA 229

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISR----TSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSL 405
           A+K+L +     +D +    + SR    T H   +T L + F+ H R   + E+ + G L
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL 92
Query: 406 EKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
             F H  +  + T ++ ++         I   LEYLH   +  +++ DIK  N++LD+D 
Sbjct: 93  --FFHLSRERVFTEERARF-----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDG 142
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGL K  EG     +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 143 HIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 198

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 61  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 119
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 120 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 169
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 170 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 227
Query: 522 FEMTG 526
           +++  
Sbjct: 228 YQLVA 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 56  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 114
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 115 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 164
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 165 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 222
Query: 522 FEMTG 526
           +++  
Sbjct: 223 YQLVA 227

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 56  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 114
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 115 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 164
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 165 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 222
Query: 522 FEMTG 526
           +++  
Sbjct: 223 YQLVA 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 40  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 98
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 99  GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 148
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 149 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 206
Query: 522 FEMTG 526
           +++  
Sbjct: 207 YQLVA 211

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 24/183 (13%)
Query: 348 QNVAIKVLNE----TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q  A+KV+++     K + E  + EV  + +  H NI  L  F  +     L+ E  + G
Sbjct: 52  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGG 111
Query: 404 SL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD- 461
            L ++ I  K   E +         +I   +  G+ Y H+    +I+H D+KP N+LL+ 
Sbjct: 112 ELFDEIISRKRFSEVDAA-------RIIRQVLSGITYXHK---NKIVHRDLKPENLLLES 161
Query: 462 --EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
             +D   +I DFGL+   E  +         GT  YIAPEV    + E   K DV+S G+
Sbjct: 162 KSKDANIRIIDFGLSTHFEASKKXKDKI---GTAYYIAPEVLHGTYDE---KCDVWSTGV 215
Query: 520 MVF 522
           +++
Sbjct: 216 ILY 218

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISR----TSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSL 405
           A+K+L +     +D +    + SR    T H   +T L + F+ H R   + E+ + G L
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL 92
Query: 406 EKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
             F H  +  + T ++ ++         I   LEYLH   +  +++ DIK  N++LD+D 
Sbjct: 93  --FFHLSRERVFTEERARF-----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDG 142
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGL K  EG     +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 143 HIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 198

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISR----TSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSL 405
           A+K+L +     +D +    + SR    T H   +T L + F+ H R   + E+ + G L
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL 92
Query: 406 EKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
             F H  +  + T ++ ++         I   LEYLH   +  +++ DIK  N++LD+D 
Sbjct: 93  --FFHLSRERVFTEERARF-----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDG 142
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFGL K  EG     +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 143 HIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 198

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 55  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 113
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 114 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 163
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 164 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 221
Query: 522 FEMTG 526
           +++  
Sbjct: 222 YQLVA 226

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 58  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 116
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 117 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 166
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 167 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 224
Query: 522 FEMTG 526
           +++  
Sbjct: 225 YQLVA 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 58  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 116
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 117 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 166
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 167 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 224
Query: 522 FEMTG 526
           +++  
Sbjct: 225 YQLVA 229

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 58  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 116
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 117 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 166
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 167 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 224
Query: 522 FEMTG 526
           +++  
Sbjct: 225 YQLVA 229

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 348 QNVAIKVLNE---TKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRALI-YEFVSN 402
           +  AIK+L +    K N   ++  E   +SR  H   V L  F F+   +      +  N
Sbjct: 59  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKN 117
Query: 403 GSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
           G L K+I +     ET  +            I   LEYLH      I+H D+KP NILL+
Sbjct: 118 GELLKYIRKIGSFDETCTRF-------YTAEIVSALEYLH---GKGIIHRDLKPENILLN 167
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           ED   +I+DFG AK+              GT  Y++PE+           SD+++ G ++
Sbjct: 168 EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--SACKSSDLWALGCII 225
Query: 522 FEMTG 526
           +++  
Sbjct: 226 YQLVA 230

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 57/263 (21%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 121
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 122 YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 172
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
            KI+DFG         S+ + +  R    GT+ Y+ PE+      +   K D++S G++ 
Sbjct: 173 LKIADFGW--------SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDE--KVDLWSLGVLC 222
Query: 522 FE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +E + G    E N       R S  E  FP +V                     E AR +
Sbjct: 223 YEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARDL 262
Query: 575 ILVSLWCIQTNPSDRPSMNRVVE 597
           I      ++ NPS RP +  V+E
Sbjct: 263 ISR---LLKHNPSQRPMLREVLE 282

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 100
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 101 YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 151
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPE-VFCRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE +  R   E   K D++S G++
Sbjct: 152 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEXIEGRXHDE---KVDLWSLGVL 200
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 201 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 240
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 241 LISR---LLKHNPSQRPXLREVLE 261

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI 483
           E L   +  +ARG+E+L    + + +H D+   NILL E+   KI DFGLA+        
Sbjct: 199 EDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDY 255
Query: 484 VSMTGARGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY 542
           V     R  + ++APE +F + +   S KSDV+SYG++++E+     +            
Sbjct: 256 VRKGDTRLPLKWMAPESIFDKIY---STKSDVWSYGVLLWEIFSLGGSP----------- 301
Query: 543 FPHWVYKRLELEEDLG---LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
                Y  ++++ED      +G+     +    ++  + L C   +P +RP    +VE L
Sbjct: 302 -----YPGVQMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 57/263 (21%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 121
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 122 YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 172
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
            KI+DFG         S+ + +  R    GT+ Y+ PE+      +   K D++S G++ 
Sbjct: 173 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE--KVDLWSLGVLC 222
Query: 522 FE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +E + G    E N       R S  E  FP +V                     E AR +
Sbjct: 223 YEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARDL 262
Query: 575 ILVSLWCIQTNPSDRPSMNRVVE 597
           I      ++ NPS RP +  V+E
Sbjct: 263 ISR---LLKHNPSQRPMLREVLE 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 96
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 97  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 147
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 148 LKIADFGW--------SVHAPSSRRDTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 196
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 197 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 236
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 237 LISR---LLKHNPSQRPMLREVLE 257

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 96
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 97  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 147
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 148 LKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 196
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 197 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 236
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 237 LISR---LLKHNPSQRPMLREVLE 257

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 57/263 (21%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 53  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 112
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 113 YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 163
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
            KI+DFG         S+ + +  R    GT+ Y+ PE+      +   K D++S G++ 
Sbjct: 164 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE--KVDLWSLGVLC 213
Query: 522 FE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +E + G    E N       R S  E  FP +V                     E AR +
Sbjct: 214 YEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARDL 253
Query: 575 ILVSLWCIQTNPSDRPSMNRVVE 597
           I      ++ NPS RP +  V+E
Sbjct: 254 ISR---LLKHNPSQRPMLREVLE 273

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 100
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 101 YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 151
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 152 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 200
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 201 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 240
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 241 LISR---LLKHNPSQRPMLREVLE 261

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 22/191 (11%)
Query: 350 VAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           VAIK       +   E F+ E  ++ +  H +IV L+G   E +   +I E  + G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 479
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK 467
           F+  +   + +  L   +LY  A  ++  L YL    + R +H DI   N+L+    C K
Sbjct: 480 FLQVR---KFSLDLASLILY--AYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVK 531
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM--- 524
           + DFGL++  E   +    +  +  I ++APE    NF   +  SDV+ +G+ ++E+   
Sbjct: 532 LGDFGLSRYMED-STYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMH 588
Query: 525 -----TGEKNN 530
                 G KNN
Sbjct: 589 GVKPFQGVKNN 599

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 98
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 99  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 149
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 150 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 198
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 238
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 239 LISR---LLKHNPSQRPMLREVLE 259

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 351 AIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI-------------- 396
           AIK +  T+      ++EV  ++  +H  +V       E  RR  +              
Sbjct: 35  AIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE--RRNFVKPXTAVKKKSTLFI 92
Query: 397 -YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
             E+  N +L   IH ++ L   +   W +  +I       L Y+H   +  I+H ++KP
Sbjct: 93  QXEYCENRTLYDLIHSEN-LNQQRDEYWRLFRQIL----EALSYIH---SQGIIHRNLKP 144
Query: 456 HNILLDEDFCPKISDFGLAKICEGRESIV------------SMTGARGTIGYIAPEVFCR 503
            NI +DE    KI DFGLAK       I+            ++T A GT  Y+A EV   
Sbjct: 145 XNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLD- 203
Query: 504 NFGEVSYKSDVYSYGMMVFEM-----TGEKNNANVAVDRSSEIYFP 544
             G  + K D YS G++ FE      TG +    +   RS  I FP
Sbjct: 204 GTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRSVSIEFP 249

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 98
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 99  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 149
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 150 LKIADFGW--------SVHAPSSRRAALCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 198
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 238
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 239 LISR---LLKHNPSQRPMLREVLE 259

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 38  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 97
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 98  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 148
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 149 LKIADFGW--------SVHAPSSRRXXLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 197
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 198 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 237
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 238 LISR---LLKHNPSQRPMLREVLE 258

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 31/233 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQK 420
           +DFI EV ++    H N++ L G       + ++ E    GSL   +  H+ H L     
Sbjct: 66  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT-- 122
Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
                L + AV +A G+ YL    + R +H D+   N+LL      KI DFGL +     
Sbjct: 123 -----LSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 481 ESIVSMTGARGT-IGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS 538
           +    M   R     + APE    R F   S+ SD + +G+ ++EM        + ++ S
Sbjct: 175 DDHXVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231
Query: 539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
             ++      +RL   ED   Q I N          ++V  W     P DRP+
Sbjct: 232 QILHKIDKEGERLPRPEDCP-QDIYN----------VMVQCWA--HKPEDRPT 271

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 57/263 (21%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 100
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 101 YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 151
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
            KI+DFG         S+ + +  R    GT+ Y+ PE+      +   K D++S G++ 
Sbjct: 152 LKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE--KVDLWSLGVLC 201
Query: 522 FE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +E + G    E N       R S  E  FP +V                     E AR +
Sbjct: 202 YEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARDL 241
Query: 575 ILVSLWCIQTNPSDRPSMNRVVE 597
           I      ++ NPS RP +  V+E
Sbjct: 242 ISR---LLKHNPSQRPMLREVLE 261

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/257 (21%), Positives = 110/257 (42%), Gaps = 29/257 (11%)
Query: 351 AIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEFVSNGSLEKF 408
            +KV + +     DF  E   +   SH N++ +LG C         LI  ++  GSL   
Sbjct: 40  VLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV 99
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
           +HE     TN  +      K A+ +ARG+ +LH      I    +   ++++DED   +I
Sbjct: 100 LHEG----TNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARI 154
Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-DVYSYGMMVFEMTGE 527
           S   +A +    +S     G      ++APE   +   + + +S D++S+ ++++E+   
Sbjct: 155 S---MADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV-- 205
Query: 528 KNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPS 587
                     + E+ F       +E+   + L+G+        +  +  +   C+  +P+
Sbjct: 206 ----------TREVPFAD--LSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPA 253
Query: 588 DRPSMNRVVEMLEGSLD 604
            RP  + +V +LE   D
Sbjct: 254 KRPKFDMIVPILEKMQD 270

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 96  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 146
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 147 LKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 195
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 235
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 236 LISR---LLKHNPSQRPMLREVLE 256

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 57/263 (21%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 96  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 146
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
            KI+DFG         S+ + +  R    GT+ Y+ PE+      +   K D++S G++ 
Sbjct: 147 LKIADFGW--------SVHAPSSRRTELCGTLDYLPPEMIEGRMHDE--KVDLWSLGVLC 196
Query: 522 FE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM 574
           +E + G    E N       R S  E  FP +V                     E AR +
Sbjct: 197 YEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARDL 236
Query: 575 ILVSLWCIQTNPSDRPSMNRVVE 597
           I      ++ NPS RP +  V+E
Sbjct: 237 ISR---LLKHNPSQRPMLREVLE 256

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 96  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 146
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 147 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 195
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 235
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 236 LISR---LLKHNPSQRPMLREVLE 256

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 31/233 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQK 420
           +DFI EV ++    H N++ L G       + ++ E    GSL   +  H+ H L     
Sbjct: 60  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT-- 116
Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
                L + AV +A G+ YL    + R +H D+   N+LL      KI DFGL +     
Sbjct: 117 -----LSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 168
Query: 481 ESIVSMTGARGT-IGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS 538
           +    M   R     + APE    R F   S+ SD + +G+ ++EM        + ++ S
Sbjct: 169 DDHYVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGS 225
Query: 539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
             ++      +RL   ED   Q I N          ++V  W     P DRP+
Sbjct: 226 QILHKIDKEGERLPRPEDCP-QDIYN----------VMVQCWA--HKPEDRPT 265

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 31/233 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQK 420
           +DFI EV ++    H N++ L G       + ++ E    GSL   +  H+ H L     
Sbjct: 56  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT-- 112
Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
                L + AV +A G+ YL    + R +H D+   N+LL      KI DFGL +     
Sbjct: 113 -----LSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164
Query: 481 ESIVSMTGARGT-IGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS 538
           +    M   R     + APE    R F   S+ SD + +G+ ++EM        + ++ S
Sbjct: 165 DDHXVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221
Query: 539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
             ++      +RL   ED   Q I N          ++V  W     P DRP+
Sbjct: 222 QILHKIDKEGERLPRPEDCP-QDIYN----------VMVQCWA--HKPEDRPT 261

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 31/233 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQK 420
           +DFI EV ++    H N++ L G       + ++ E    GSL   +  H+ H L     
Sbjct: 56  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT-- 112
Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
                L + AV +A G+ YL    + R +H D+   N+LL      KI DFGL +     
Sbjct: 113 -----LSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164
Query: 481 ESIVSMTGARGT-IGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS 538
           +    M   R     + APE    R F   S+ SD + +G+ ++EM        + ++ S
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221
Query: 539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
             ++      +RL   ED   Q I N          ++V  W     P DRP+
Sbjct: 222 QILHKIDKEGERLPRPEDCP-QDIYN----------VMVQCWA--HKPEDRPT 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 96  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 146
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 147 LKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 195
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 235
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 236 LISR---LLKHNPSQRPMLREVLE 256

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 96  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 146
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 147 LKIADFGW--------SVHAPSSRRAALCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 195
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 235
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 236 LISR---LLKHNPSQRPMLREVLE 256

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 31/233 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQK 420
           +DFI EV ++    H N++ L G       + ++ E    GSL   +  H+ H L     
Sbjct: 66  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT-- 122
Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
                L + AV +A G+ YL    + R +H D+   N+LL      KI DFGL +     
Sbjct: 123 -----LSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 481 ESIVSMTGARGT-IGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS 538
           +    M   R     + APE    R F   S+ SD + +G+ ++EM        + ++ S
Sbjct: 175 DDHYVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231
Query: 539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
             ++      +RL   ED   Q I N          ++V  W     P DRP+
Sbjct: 232 QILHKIDKEGERLPRPEDCP-QDIYN----------VMVQCWA--HKPEDRPT 271

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 86/177 (48%), Gaps = 22/177 (12%)
Query: 351 AIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIH 410
           A+KVL +T  + +    E+  + R SH NI+ L          +L+ E V+ G L   I 
Sbjct: 82  ALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV 140
Query: 411 EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPK 467
           EK     +++   + + +I   +A    YLH      I+H D+KP N+L      D   K
Sbjct: 141 EKG--YYSERDAADAVKQILEAVA----YLHENG---IVHRDLKPENLLYATPAPDAPLK 191
Query: 468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF--CRNFGEVSYKSDVYSYGMMVF 522
           I+DFGL+KI E +   V M    GT GY APE+   C    EV    D++S G++ +
Sbjct: 192 IADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEV----DMWSVGIITY 241

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 98
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 99  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 149
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 150 LKIADFGW--------SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 198
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 238
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 239 LISR---LLKHNPSQRPMLREVLE 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 98
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 99  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 149
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 150 LKIADFGW--------SVHAPSSRRXXLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 198
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 238
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 239 LISR---LLKHNPSQRPMLREVLE 259

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 31/233 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQK 420
           +DFI EV ++    H N++ L G       + ++ E    GSL   +  H+ H L     
Sbjct: 60  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT-- 116
Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
                L + AV +A G+ YL    + R +H D+   N+LL      KI DFGL +     
Sbjct: 117 -----LSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 168
Query: 481 ESIVSMTGARGT-IGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS 538
           +    M   R     + APE    R F   S+ SD + +G+ ++EM        + ++ S
Sbjct: 169 DDHYVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGS 225
Query: 539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
             ++      +RL   ED   Q I N          ++V  W     P DRP+
Sbjct: 226 QILHKIDKEGERLPRPEDCP-QDIYN----------VMVQCWA--HKPEDRPT 265

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 96  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 146
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 147 LKIADFGW--------SVHAPSSRRTXLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 195
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 235
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 236 LISR---LLKHNPSQRPMLREVLE 256

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 98
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 99  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 149
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 150 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 198
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 238
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 239 LISR---LLKHNPSQRPMLREVLE 259

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 31/233 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQK 420
           +DFI EV ++    H N++ L G       + ++ E    GSL   +  H+ H L     
Sbjct: 56  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT-- 112
Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
                L + AV +A G+ YL    + R +H D+   N+LL      KI DFGL +     
Sbjct: 113 -----LSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164
Query: 481 ESIVSMTGARGT-IGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS 538
           +    M   R     + APE    R F   S+ SD + +G+ ++EM        + ++ S
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221
Query: 539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
             ++      +RL   ED   Q I N          ++V  W     P DRP+
Sbjct: 222 QILHKIDKEGERLPRPEDCP-QDIYN----------VMVQCWA--HKPEDRPT 261

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 117/254 (46%), Gaps = 45/254 (17%)
Query: 371 SISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
           SI R+ +H ++V   GF  +     ++ E     SL + +H++    T  + ++ +    
Sbjct: 91  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQ-- 147
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE---GRESIVSM 486
              I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA   E    R+ ++  
Sbjct: 148 ---IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC- 200
Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW 546
               GT  YIAPEV  +  G  S++ DV+S G +++ +   K     +  + +       
Sbjct: 201 ----GTPNYIAPEVLSKK-GH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKET------- 247
Query: 547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE---MLEGSL 603
            Y R++  E    + I N       +KM       +QT+P+ RP++N ++       G +
Sbjct: 248 -YLRIKKNEYSIPKHI-NPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSGYI 298
Query: 604 DS------LQIPPR 611
            +      L IPPR
Sbjct: 299 PARLPITCLTIPPR 312

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 35  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 94
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 95  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 145
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 146 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 194
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 195 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 234
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 235 LISR---LLKHNPSQRPMLREVLE 255

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 116/256 (45%), Gaps = 49/256 (19%)
Query: 371 SISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
           SI R+ +H ++V   GF  +     ++ E     SL + +H++    T  + ++ +    
Sbjct: 73  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQ-- 129
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
              I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA       + V   G 
Sbjct: 130 ---IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGE 176
Query: 490 R-----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP 544
           R     GT  YIAPEV  +  G  S++ DV+S G +++ +   K     +  + +     
Sbjct: 177 RKKTLCGTPNYIAPEVLSKK-GH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKET----- 229
Query: 545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE---MLEG 601
              Y R++  E    + I N       +KM       +QT+P+ RP++N ++       G
Sbjct: 230 ---YLRIKKNEYSIPKHI-NPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSG 278
Query: 602 SLDS------LQIPPR 611
            + +      L IPPR
Sbjct: 279 YIPARLPITCLTIPPR 294

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 40  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 99
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 100 YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 150
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 151 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 199
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 200 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 239
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 240 LISR---LLKHNPSQRPMLREVLE 260

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 117/254 (46%), Gaps = 45/254 (17%)
Query: 371 SISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
           SI R+ +H ++V   GF  +     ++ E     SL + +H++    T  + ++ +    
Sbjct: 67  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR--- 122
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE---GRESIVSM 486
              I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA   E    R+ ++  
Sbjct: 123 --QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC- 176
Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW 546
               GT  YIAPEV  +  G  S++ DV+S G +++ +   K     +  + +       
Sbjct: 177 ----GTPNYIAPEVLSKK-GH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKET------- 223
Query: 547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE---MLEGSL 603
            Y R++  E    + I N       +KM       +QT+P+ RP++N ++       G +
Sbjct: 224 -YLRIKKNEYSIPKHI-NPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSGYI 274
Query: 604 DS------LQIPPR 611
            +      L IPPR
Sbjct: 275 PARLPITCLTIPPR 288

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 116/256 (45%), Gaps = 49/256 (19%)
Query: 371 SISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
           SI R+ +H ++V   GF  +     ++ E     SL + +H++    T  + ++ +    
Sbjct: 69  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQ-- 125
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
              I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA       + V   G 
Sbjct: 126 ---IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGE 172
Query: 490 R-----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP 544
           R     GT  YIAPEV  +  G  S++ DV+S G +++ +   K     +  + +     
Sbjct: 173 RKKTLCGTPNYIAPEVLSKK-GH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKET----- 225
Query: 545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE---MLEG 601
              Y R++  E    + I N       +KM       +QT+P+ RP++N ++       G
Sbjct: 226 ---YLRIKKNEYSIPKHI-NPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSG 274
Query: 602 SLDS------LQIPPR 611
            + +      L IPPR
Sbjct: 275 YIPARLPITCLTIPPR 290

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 96  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 146
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 147 LKIADFGW--------SVHAPSSRRXXLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 195
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 235
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 236 LISR---LLKHNPSQRPMLREVLE 256

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 45/254 (17%)
Query: 371 SISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
           SI R+ +H ++V   GF  +     ++ E     SL + +H++    T  + ++ +    
Sbjct: 93  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQ-- 149
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE---GRESIVSM 486
              I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA   E    R+ ++  
Sbjct: 150 ---IVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC- 202
Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW 546
               GT  YIAPEV  +     S++ DV+S G +++ +   K     +  + +       
Sbjct: 203 ----GTPNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKET------- 249
Query: 547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE---MLEGSL 603
            Y R++  E    + I N       +KM       +QT+P+ RP++N ++       G +
Sbjct: 250 -YLRIKKNEYSIPKHI-NPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSGYI 300
Query: 604 DS------LQIPPR 611
            +      L IPPR
Sbjct: 301 PARLPITCLTIPPR 314

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 33  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 92
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 93  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 143
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 144 LKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 192
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 193 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 232
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 233 LISR---LLKHNPSQRPMLREVLE 253

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 40/232 (17%)
Query: 371 SISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
           SI R+ +H ++V   GF  +     ++ E     SL + +H++    T  + ++ +    
Sbjct: 69  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQ-- 125
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
              I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA       + V   G 
Sbjct: 126 ---IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGE 172
Query: 490 R-----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP 544
           R     GT  YIAPEV  +  G  S++ DV+S G +++ +   K     +  + +     
Sbjct: 173 RKKTLCGTPNYIAPEVLSKK-GH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKET----- 225
Query: 545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVV 596
              Y R++  E    + I N       +KM       +QT+P+ RP++N ++
Sbjct: 226 ---YLRIKKNEYSIPKHI-NPVAASLIQKM-------LQTDPTARPTINELL 266

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 30/190 (15%)
Query: 348 QNVAIKVLNETK---GNGED------FINEVASISRTSHVNIVTLLGFCFEGHRRALIYE 398
           + VAIK++++ K   G+  +         E+  + + +H  I+ +  F F+     ++ E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 94
Query: 399 FVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
            +  G L +K +  K   E   KL +   Y++ + +    +YLH      I+H D+KP N
Sbjct: 95  LMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAV----QYLH---ENGIIHRDLKPEN 144
Query: 458 ILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-- 512
           +LL   +ED   KI+DFG +KI  G  S+  M    GT  Y+APEV   + G   Y    
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKIL-GETSL--MRTLCGTPTYLAPEVLV-SVGTAGYNRAV 200
Query: 513 DVYSYGMMVF 522
           D +S G+++F
Sbjct: 201 DCWSLGVILF 210

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 30/190 (15%)
Query: 348 QNVAIKVLNETK---GNGED------FINEVASISRTSHVNIVTLLGFCFEGHRRALIYE 398
           + VAIK++++ K   G+  +         E+  + + +H  I+ +  F F+     ++ E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 94
Query: 399 FVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
            +  G L +K +  K   E   KL +   Y++ + +    +YLH      I+H D+KP N
Sbjct: 95  LMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAV----QYLH---ENGIIHRDLKPEN 144
Query: 458 ILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-- 512
           +LL   +ED   KI+DFG +KI  G  S+  M    GT  Y+APEV   + G   Y    
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKIL-GETSL--MRTLCGTPTYLAPEVLV-SVGTAGYNRAV 200
Query: 513 DVYSYGMMVF 522
           D +S G+++F
Sbjct: 201 DCWSLGVILF 210

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E    E+A      + ++V   GF  +     ++ E     SL + +H++    T  + +
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
           + +   I     +G++YLH   N R++H D+K  N+ L++D   KI DFGLA       +
Sbjct: 146 YFMRQTI-----QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------T 190
Query: 483 IVSMTGAR-----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            +   G R     GT  YIAPEV C+  G  S++ D++S G +++ +
Sbjct: 191 KIEFDGERKKXLCGTPNYIAPEVLCKK-GH-SFEVDIWSLGCILYTL 235

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E    E+A      + ++V   GF  +     ++ E     SL + +H++    T  + +
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
           + +   I     +G++YLH   N R++H D+K  N+ L++D   KI DFGLA       +
Sbjct: 146 YFMRQTI-----QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------T 190
Query: 483 IVSMTGAR-----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            +   G R     GT  YIAPEV C+  G  S++ D++S G +++ +
Sbjct: 191 KIEFDGERKKDLCGTPNYIAPEVLCKK-GH-SFEVDIWSLGCILYTL 235

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 30/190 (15%)
Query: 348 QNVAIKVLNETK---GNGED------FINEVASISRTSHVNIVTLLGFCFEGHRRALIYE 398
           + VAIK++++ K   G+  +         E+  + + +H  I+ +  F F+     ++ E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 94
Query: 399 FVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
            +  G L +K +  K   E   KL     Y++ + +    +YLH      I+H D+KP N
Sbjct: 95  LMEGGELFDKVVGNKRLKEATCKL---YFYQMLLAV----QYLH---ENGIIHRDLKPEN 144
Query: 458 ILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-- 512
           +LL   +ED   KI+DFG +KI  G  S+  M    GT  Y+APEV   + G   Y    
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKIL-GETSL--MRTLCGTPTYLAPEVLV-SVGTAGYNRAV 200
Query: 513 DVYSYGMMVF 522
           D +S G+++F
Sbjct: 201 DCWSLGVILF 210

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 17/95 (17%)
Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---- 490
           +G++YLH   N R++H D+K  N+ L++D   KI DFGLA       + +   G R    
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKTL 202
Query: 491 -GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            GT  YIAPEV C+  G  S++ D++S G +++ +
Sbjct: 203 CGTPNYIAPEVLCKK-GH-SFEVDIWSLGCILYTL 235

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 179
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 180 -RHTADEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 223

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 28/196 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY-EFVS-- 401
           Q VAIK +    +   N +  + E+  +    H NI+ +        R  + Y EF S  
Sbjct: 81  QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDIL----RPTVPYGEFKSVY 136
Query: 402 ------NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
                    L + IH   PL T + +++  LY++     RGL+Y+H   + +++H D+KP
Sbjct: 137 VVLDLMESDLHQIIHSSQPL-TLEHVRY-FLYQLL----RGLKYMH---SAQVIHRDLKP 187
Query: 456 HNILLDEDFCPKISDFGLAK-ICEG-RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
            N+L++E+   KI DFG+A+ +C    E    MT    T  Y APE+   +  E +   D
Sbjct: 188 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML-SLHEYTQAID 246
Query: 514 VYSYGMMVFEMTGEKN 529
           ++S G +  EM   + 
Sbjct: 247 LWSVGCIFGEMLARRQ 262

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 24/198 (12%)
Query: 351 AIKVLNETKGNGEDFINEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           A+KV++++K    D   E+  + R   H NI+TL     +G    L+ E +  G L +K 
Sbjct: 56  AVKVIDKSK---RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI 112
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL-LDEDF--- 464
           + +K   E        VL+ I     + +EYLH   +  ++H D+KP NIL +DE     
Sbjct: 113 LRQKFFSEREASF---VLHTIG----KTVEYLH---SQGVVHRDLKPSNILYVDESGNPE 162
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           C +I DFG AK       ++ MT    T  ++APEV  R   +     D++S G++++ M
Sbjct: 163 CLRICDFGFAKQLRAENGLL-MTPCY-TANFVAPEVLKRQGYDEG--CDIWSLGILLYTM 218
Query: 525 -TGEKNNANVAVDRSSEI 541
             G    AN   D   EI
Sbjct: 219 LAGYTPFANGPSDTPEEI 236

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
           VT  G  F      +  E + + SL+KF   K  ++  Q +  ++L KIAV I + LE+L
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
           H   +  ++H D+KP N+L++     K+ DFG++         V+     G   Y+APE 
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPER 180
Query: 501 FCRNFGEVSY--KSDVYSYGMMVFEMT 525
                 +  Y  KSD++S G+ + E+ 
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELA 207

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           E    E+A      + ++V   GF  +     ++ E     SL + +H++    T  + +
Sbjct: 71  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 129
Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
           + +   I     +G++YLH   N R++H D+K  N+ L++D   KI DFGLA       +
Sbjct: 130 YFMRQTI-----QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------T 174
Query: 483 IVSMTGAR-----GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            +   G R     GT  YIAPEV C+  G  S++ D++S G +++ +
Sbjct: 175 KIEFDGERKKDLCGTPNYIAPEVLCKK-GH-SFEVDIWSLGCILYTL 219

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPL-ETNQKLKWEV 425
           NE+A + +  H NIVTL           L+ + VS G L   I E+    E +  L    
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---- 110
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRES 482
              +   +   ++YLH      I+H D+KP N+L    +E+    I+DFGL+K+    E 
Sbjct: 111 ---VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQ 160
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              M+ A GT GY+APEV  +     S   D +S G++ +
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITY 198

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA---- 177
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 178 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA---- 177
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 178 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 30/190 (15%)
Query: 348 QNVAIKVLNETK---GNGED------FINEVASISRTSHVNIVTLLGFCFEGHRRALIYE 398
           + VAIK++++ K   G+  +         E+  + + +H  I+ +  F F+     ++ E
Sbjct: 35  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 93
Query: 399 FVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
            +  G L +K +  K   E   KL +   Y++ + +    +YLH      I+H D+KP N
Sbjct: 94  LMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAV----QYLH---ENGIIHRDLKPEN 143
Query: 458 ILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-- 512
           +LL   +ED   KI+DFG +KI  G  S+  M    GT  Y+APEV   + G   Y    
Sbjct: 144 VLLSSQEEDCLIKITDFGHSKIL-GETSL--MRTLCGTPTYLAPEVLV-SVGTAGYNRAV 199
Query: 513 DVYSYGMMVF 522
           D +S G+++F
Sbjct: 200 DCWSLGVILF 209

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 179
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 180 -RHTADEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 223

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 179
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 180 -RHTADEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 223

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA---- 183
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 184 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 227

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 24/198 (12%)
Query: 351 AIKVLNETKGNGEDFINEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           A+KV++++K    D   E+  + R   H NI+TL     +G    L+ E +  G L +K 
Sbjct: 56  AVKVIDKSK---RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI 112
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL-LDEDF--- 464
           + +K   E        VL+ I     + +EYLH   +  ++H D+KP NIL +DE     
Sbjct: 113 LRQKFFSEREASF---VLHTIG----KTVEYLH---SQGVVHRDLKPSNILYVDESGNPE 162
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           C +I DFG AK       ++ MT    T  ++APEV  R   +     D++S G++++ M
Sbjct: 163 CLRICDFGFAKQLRAENGLL-MTPCY-TANFVAPEVLKRQGYDEG--CDIWSLGILLYTM 218
Query: 525 -TGEKNNANVAVDRSSEI 541
             G    AN   D   EI
Sbjct: 219 LAGYTPFANGPSDTPEEI 236

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 24/170 (14%)
Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDE-----DFCPKISDFGL-AKICEGRESIVSMTGA 489
           GL +LH   +  I+H D+KPHNIL+            ISDFGL  K+  GR S    +G 
Sbjct: 130 GLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 490 RGTIGYIAPEVFCRNFGE-VSYKSDVYSYGMMVFEMTGEKNNA-NVAVDRSSEIYFPHWV 547
            GT G+IAPE+   +  E  +Y  D++S G + + +  E ++    ++ R + I      
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS 246
Query: 548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
              L  E+       E+   +E   KMI +       +P  RPS   V++
Sbjct: 247 LDCLHPEKH------EDVIARELIEKMIAM-------DPQKRPSAKHVLK 283

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 30/190 (15%)
Query: 348 QNVAIKVLNETK---GNGED------FINEVASISRTSHVNIVTLLGFCFEGHRRALIYE 398
           + VAIK++++ K   G+  +         E+  + + +H  I+ +  F F+     ++ E
Sbjct: 42  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 100
Query: 399 FVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHN 457
            +  G L +K +  K   E   KL +   Y++ + +    +YLH      I+H D+KP N
Sbjct: 101 LMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAV----QYLH---ENGIIHRDLKPEN 150
Query: 458 ILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-- 512
           +LL   +ED   KI+DFG +KI  G  S+  M    GT  Y+APEV   + G   Y    
Sbjct: 151 VLLSSQEEDCLIKITDFGHSKIL-GETSL--MRTLCGTPTYLAPEVLV-SVGTAGYNRAV 206
Query: 513 DVYSYGMMVF 522
           D +S G+++F
Sbjct: 207 DCWSLGVILF 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 28/196 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY-EFVS-- 401
           Q VAIK +    +   N +  + E+  +    H NI+ +        R  + Y EF S  
Sbjct: 80  QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDIL----RPTVPYGEFKSVY 135
Query: 402 ------NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP 455
                    L + IH   PL T + +++  LY++     RGL+Y+H   + +++H D+KP
Sbjct: 136 VVLDLMESDLHQIIHSSQPL-TLEHVRY-FLYQLL----RGLKYMH---SAQVIHRDLKP 186
Query: 456 HNILLDEDFCPKISDFGLAK-ICEG-RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSD 513
            N+L++E+   KI DFG+A+ +C    E    MT    T  Y APE+   +  E +   D
Sbjct: 187 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML-SLHEYTQAID 245
Query: 514 VYSYGMMVFEMTGEKN 529
           ++S G +  EM   + 
Sbjct: 246 LWSVGCIFGEMLARRQ 261

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  +
Sbjct: 113 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQ 166
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++      + I 
Sbjct: 167 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 219
Query: 485 SMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           SM  +  GT  Y++PE         S +SD++S G+ + EM 
Sbjct: 220 SMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMA 259

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGXVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 358 TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNGSLEKFIHEKHPL 415
           T+   +  ++EV  +    H NIV       +     L  + E+   G L   I +    
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--T 102
Query: 416 ETNQKLKWEVLYKIAVGIARGLEYLHR---GCNTRILHFDIKPHNILLDEDFCPKISDFG 472
           +  Q L  E + ++   +   L+  HR   G +T +LH D+KP N+ LD     K+ DFG
Sbjct: 103 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT-VLHRDLKPANVFLDGKQNVKLGDFG 161
Query: 473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
           LA+I     S        GT  Y++PE   R    +SY  KSD++S G +++E+
Sbjct: 162 LARILNHDTSFAK--AFVGTPYYMSPEQMNR----MSYNEKSDIWSLGCLLYEL 209

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
            E+  +S+     I    G   +  +  +I E++  GS    + +  PLE         +
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL-KPGPLEET------YI 118
Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
             I   I +GL+YLH   + R +H DIK  N+LL E    K++DFG+A   +  ++ +  
Sbjct: 119 ATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKR 173
Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT-GEKNNANV 533
               GT  ++APEV  ++     +K+D++S G+   E+  GE  N+++
Sbjct: 174 NXFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLA---- 178
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 179 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLA---- 174
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 175 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 218

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 38  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 97
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 98  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 148
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI++FG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 149 LKIANFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 197
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 198 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 237
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 238 LISR---LLKHNPSQRPMLREVLE 258

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 358 TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNGSLEKFIHEKHPL 415
           T+   +  ++EV  +    H NIV       +     L  + E+   G L   I +    
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--T 102
Query: 416 ETNQKLKWEVLYKIAVGIARGLEYLHR---GCNTRILHFDIKPHNILLDEDFCPKISDFG 472
           +  Q L  E + ++   +   L+  HR   G +T +LH D+KP N+ LD     K+ DFG
Sbjct: 103 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT-VLHRDLKPANVFLDGKQNVKLGDFG 161
Query: 473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
           LA+I    E         GT  Y++PE   R    +SY  KSD++S G +++E+
Sbjct: 162 LARILNHDEDFAK--EFVGTPYYMSPEQMNR----MSYNEKSDIWSLGCLLYEL 209

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 177
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 178 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 221

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 119 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 171
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 172 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 215

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 149 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 201
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 202 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNMTVDIWSVGCIMAEL 245

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 130 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 182
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 183 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 179
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 180 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 223

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 174
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 175 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 184
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 185 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 228

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  +
Sbjct: 78  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQ 131
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++      + I 
Sbjct: 132 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 184
Query: 485 SMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           SM  +  GT  Y++PE         S +SD++S G+ + EM 
Sbjct: 185 SMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMA 224

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 184
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 185 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 228

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 184
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 185 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 228

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 24/198 (12%)
Query: 351 AIKVLNETKGNGEDFINEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           A+K+++++K    D   E+  + R   H NI+TL     +G    ++ E +  G L +K 
Sbjct: 51  AVKIIDKSK---RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI 107
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL-LDEDFCP- 466
           + +K   E        VL+ I     + +EYLH      ++H D+KP NIL +DE   P 
Sbjct: 108 LRQKFFSEREAS---AVLFTIT----KTVEYLH---AQGVVHRDLKPSNILYVDESGNPE 157
Query: 467 --KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             +I DFG AK       ++ MT    T  ++APEV  R   + +   D++S G++++ M
Sbjct: 158 SIRICDFGFAKQLRAENGLL-MTPCY-TANFVAPEVLERQGYDAA--CDIWSLGVLLYTM 213
Query: 525 -TGEKNNANVAVDRSSEI 541
            TG    AN   D   EI
Sbjct: 214 LTGYTPFANGPDDTPEEI 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 174
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 175 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 218

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 174
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 175 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 178
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 179 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 178
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 179 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 177
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 178 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 183
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 184 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 227

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 56/97 (57%), Gaps = 12/97 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I  GLE++H   N  +++ D+KP NILLDE    +ISD GLA     ++   S+   
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 490 RGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            GT GY+APEV  +    V+Y S  D +S G M+F++
Sbjct: 352 -GTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKL 384

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 21/162 (12%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEV 425
            E+  + + +H  I+ +  F F+     ++ E +  G L +K +  K   E   KL    
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---Y 258
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRES 482
            Y++ + +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +KI  G  S
Sbjct: 259 FYQMLLAV----QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 310
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVF 522
           +  M    GT  Y+APEV   + G   Y    D +S G+++F
Sbjct: 311 L--MRTLCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 349

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 83/187 (44%), Gaps = 25/187 (13%)
Query: 348 QNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VAIK +   +E +G     I EV+ +    H NI+ L       HR  LI+E+  N  
Sbjct: 60  ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---D 461
           L+K+      ++ N  +   V+      +  G+ + H   + R LH D+KP N+LL   D
Sbjct: 119 LKKY------MDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSD 169
Query: 462 EDFCP--KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
               P  KI DFGLA+       I   T    T+ Y  PE+     G   Y +  D++S 
Sbjct: 170 ASETPVLKIGDFGLARAFG--IPIRQFTHEIITLWYRPPEIL---LGSRHYSTSVDIWSI 224
Query: 518 GMMVFEM 524
             +  EM
Sbjct: 225 ACIWAEM 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 178
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 179 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 222

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 56/97 (57%), Gaps = 12/97 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I  GLE++H   N  +++ D+KP NILLDE    +ISD GLA     ++   S+   
Sbjct: 297 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 350
Query: 490 RGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            GT GY+APEV  +    V+Y S  D +S G M+F++
Sbjct: 351 -GTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKL 383

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 118 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 170
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 171 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 214

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTV 95
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + +++H DIKP N+LL     
Sbjct: 96  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKKVIHRDIKPENLLLGSAGE 146
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 147 LKIADFGW--------SVHAPSSRRAALCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 195
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 196 CYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFV--------------------TEGARD 235
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 236 LISR---LLKHNPSQRPMLREVLE 256

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 56/97 (57%), Gaps = 12/97 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I  GLE++H   N  +++ D+KP NILLDE    +ISD GLA     ++   S+   
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 490 RGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            GT GY+APEV  +    V+Y S  D +S G M+F++
Sbjct: 352 -GTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKL 384

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 56/97 (57%), Gaps = 12/97 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I  GLE++H   N  +++ D+KP NILLDE    +ISD GLA     ++   S+   
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 490 RGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            GT GY+APEV  +    V+Y S  D +S G M+F++
Sbjct: 352 -GTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKL 384

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 358 TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL--IYEFVSNGSLEKFIHEKHPL 415
           T+   +  ++EV  +    H NIV       +     L  + E+   G L   I +    
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--T 102
Query: 416 ETNQKLKWEVLYKIAVGIARGLEYLHR---GCNTRILHFDIKPHNILLDEDFCPKISDFG 472
           +  Q L  E + ++   +   L+  HR   G +T +LH D+KP N+ LD     K+ DFG
Sbjct: 103 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT-VLHRDLKPANVFLDGKQNVKLGDFG 161
Query: 473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
           LA+I     S        GT  Y++PE   R    +SY  KSD++S G +++E+
Sbjct: 162 LARILNHDTSFAKT--FVGTPYYMSPEQMNR----MSYNEKSDIWSLGCLLYEL 209

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  +
Sbjct: 51  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQ 104
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++      + I 
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 157
Query: 485 SMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           SM  +  GT  Y++PE         S +SD++S G+ + EM 
Sbjct: 158 SMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMA 197

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 192
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 193 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 236

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 139 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 191
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 192 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 235

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 117 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 169
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 170 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 213

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 139 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 191
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 192 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 235

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 21/162 (12%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEV 425
            E+  + + +H  I+ +  F F+     ++ E +  G L +K +  K   E   KL    
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---Y 244
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRES 482
            Y++ + +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +KI  G  S
Sbjct: 245 FYQMLLAV----QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 296
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVF 522
           +  M    GT  Y+APEV   + G   Y    D +S G+++F
Sbjct: 297 L--MRTLCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 335

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 192
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 193 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 236

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 168
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 169 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 212

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  +
Sbjct: 51  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQ 104
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++      + I 
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 157
Query: 485 SMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           SM  +  GT  Y++PE         S +SD++S G+ + EM 
Sbjct: 158 SMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMA 197

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 117 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 169
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 170 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 213

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 143 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 195
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 196 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 239

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 168
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 169 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 212

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 16/178 (8%)
Query: 351 AIKVLNETKGNGEDFINEVASISRT---SHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLE 406
           A+K+L +     +D +    + +R    S    +T L + F+ H R   + E+ + G L 
Sbjct: 39  AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL- 97
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F H    L   +    +        I   L+YLH   N  +++ D+K  N++LD+D   
Sbjct: 98  -FFH----LSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI 150
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGL K  EG +   +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 151 KITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 204

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  +
Sbjct: 51  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQ 104
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++      + I 
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 157
Query: 485 SMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           SM  +  GT  Y++PE         S +SD++S G+ + EM 
Sbjct: 158 SMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMA 197

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  +
Sbjct: 51  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQ 104
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++      + I 
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 157
Query: 485 SMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           SM  +  GT  Y++PE         S +SD++S G+ + EM 
Sbjct: 158 SMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMA 197

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  +
Sbjct: 51  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQ 104
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++      + I 
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 157
Query: 485 SMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           SM  +  GT  Y++PE         S +SD++S G+ + EM 
Sbjct: 158 SMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMA 197

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 16/178 (8%)
Query: 351 AIKVLNETKGNGEDFINEVASISRT---SHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLE 406
           A+K+L +     +D +    + +R    S    +T L + F+ H R   + E+ + G L 
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL- 235
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F H    L   +    +        I   L+YLH   N  +++ D+K  N++LD+D   
Sbjct: 236 -FFH----LSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI 288
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGL K  EG +   +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 289 KITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 342

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 29/183 (15%)
Query: 350 VAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL +T+    G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 40  LALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 99
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            + + +    +  +   +         +A  L Y H   + R++H DIKP N+LL  +  
Sbjct: 100 YRELQKLSRFDEQRTATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSNGE 150
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 151 LKIADFGW--------SVHAPSSRRDTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 199
Query: 521 VFE 523
            +E
Sbjct: 200 CYE 202

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 108/264 (40%), Gaps = 59/264 (22%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E  G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 98
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            +       L+   K   +        +A  L Y H   + R++H DIKP N+LL     
Sbjct: 99  YR------ELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGE 149
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI++FG         S+ + +  R    GT+ Y+ PE+   R   E   K D++S G++
Sbjct: 150 LKIANFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVL 198
Query: 521 VFE-MTG----EKNNANVAVDRSS--EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK 573
            +E + G    E N       R S  E  FP +V                     E AR 
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--------------------TEGARD 238
Query: 574 MILVSLWCIQTNPSDRPSMNRVVE 597
           +I      ++ NPS RP +  V+E
Sbjct: 239 LISR---LLKHNPSQRPMLREVLE 259

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 16/178 (8%)
Query: 351 AIKVLNETKGNGEDFINEVASISRT---SHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLE 406
           A+K+L +     +D +    + +R    S    +T L + F+ H R   + E+ + G L 
Sbjct: 38  AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL- 96
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F H    L   +    +        I   L+YLH   N  +++ D+K  N++LD+D   
Sbjct: 97  -FFH----LSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI 149
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGL K  EG +   +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 150 KITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 203

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 16/178 (8%)
Query: 351 AIKVLNETKGNGEDFINEVASISRT---SHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLE 406
           A+K+L +     +D +    + +R    S    +T L + F+ H R   + E+ + G L 
Sbjct: 180 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL- 238
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F H    L   +    +        I   L+YLH   N  +++ D+K  N++LD+D   
Sbjct: 239 -FFH----LSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI 291
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGL K  EG +   +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 292 KITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 345

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA     R +   MTG   T
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVAT 181
Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             Y APE+   N+   +   D++S G ++ E+
Sbjct: 182 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 212

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H +I+TL+          L+++ +  G L  ++ EK  L   +         I   +   
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET------RSIMRSLLEA 212
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           + +LH      I+H D+KP NILLD++   ++SDFG +   E  E +  +    GT GY+
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPGYL 266
Query: 497 APEVFCRNFGEV----SYKSDVYSYGMMVFEM 524
           APE+   +  E       + D+++ G+++F +
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTL 298

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 16/178 (8%)
Query: 351 AIKVLNETKGNGEDFINEVASISRT---SHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLE 406
           A+K+L +     +D +    + +R    S    +T L + F+ H R   + E+ + G L 
Sbjct: 37  AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL- 95
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
            F H    L   +    +        I   L+YLH   N  +++ D+K  N++LD+D   
Sbjct: 96  -FFH----LSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI 148
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           KI+DFGL K  EG +   +M    GT  Y+APEV   N  +     D +  G++++EM
Sbjct: 149 KITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEM 202

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 348 QNVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA------LIYEF 399
           + VAIK   +  +  N E +  E+  + + +H N+V+         + A      L  E+
Sbjct: 41  EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 100
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
              G L K++++    E    LK   +  +   I+  L YLH     RI+H D+KP NI+
Sbjct: 101 CEGGDLRKYLNQ---FENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIV 154
Query: 460 LD---EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYS 516
           L    +    KI D G AK  +  E         GT+ Y+APE+  +    V+   D +S
Sbjct: 155 LQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYLAPELLEQKKYTVTV--DYWS 209
Query: 517 YGMMVFE-MTG 526
           +G + FE +TG
Sbjct: 210 FGTLAFECITG 220

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 21/179 (11%)
Query: 350 VAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL +T+    G       EV   S   H NI+ L G+  +  R  LI E+   G++
Sbjct: 40  LALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 99
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            + + +    +  +   +         +A  L Y H   + R++H DIKP N+LL  +  
Sbjct: 100 YRELQKLSRFDEQRTATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSNGE 150
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE 523
            KI+DFG +            T   GT+ Y+ PE+   R   E   K D++S G++ +E
Sbjct: 151 LKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDE---KVDLWSLGVLCYE 202

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
           + RGL+Y+H   +  I+H D+KP N+ ++ED   +I DFGLA     R++   MTG   T
Sbjct: 140 LLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLA-----RQADEEMTGYVAT 191
Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             Y APE+   N+   +   D++S G ++ E+
Sbjct: 192 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 222

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 348 QNVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA------LIYEF 399
           + VAIK   +  +  N E +  E+  + + +H N+V+         + A      L  E+
Sbjct: 40  EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
              G L K++++    E    LK   +  +   I+  L YLH     RI+H D+KP NI+
Sbjct: 100 CEGGDLRKYLNQ---FENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIV 153
Query: 460 LD---EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYS 516
           L    +    KI D G AK  +  E         GT+ Y+APE+  +    V+   D +S
Sbjct: 154 LQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYLAPELLEQKKYTVTV--DYWS 208
Query: 517 YGMMVFE-MTG 526
           +G + FE +TG
Sbjct: 209 FGTLAFECITG 219

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 59/107 (55%), Gaps = 9/107 (8%)
Query: 418 NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 477
           +Q L  E +  +   + RGL+Y+H   +  I+H D+KP N+ ++ED   +I DFGLA   
Sbjct: 125 SQALSDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLA--- 178
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             R++   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 179 --RQADEEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 222

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H N++     L     E  R   I + +   
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET 130
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +        +Q+L  + +      I RGL+Y+H   +  +LH D+KP N+L++  
Sbjct: 131 DLYKLL-------KSQQLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLINTT 180
Query: 464 FCPKISDFGLAKICEGRESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA+I +        +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 181 CDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 239
Query: 523 EMTGEK 528
           EM   +
Sbjct: 240 EMLSNR 245

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  +
Sbjct: 70  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQ 123
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
           +L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++      + I 
Sbjct: 124 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 176
Query: 485 SMTGA-RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
           SM  +  GT  Y++PE         S +SD++S G+ + EM 
Sbjct: 177 SMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMA 216

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
           + RGL+Y+H   +  I+H D+KP N+ ++ED   +I DFGLA     R++   MTG   T
Sbjct: 132 LLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA-----RQADEEMTGYVAT 183
Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             Y APE+   N+   +   D++S G ++ E+
Sbjct: 184 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 214

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 348 QNVAIKVLNETKGNGEDFIN----EVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
             VA+K+LN  K    D +     E+ ++    H +I+ L           ++ E+VS G
Sbjct: 37  HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG 96
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L  +I +   +E  +        ++   I   ++Y HR     ++H D+KP N+LLD  
Sbjct: 97  ELFDYICKHGRVEEMEA------RRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAH 147
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFGL+ +    E + +  G+     Y APEV          + D++S G++++ 
Sbjct: 148 MNAKIADFGLSNMMSDGEFLRTSCGSP---NYAAPEVISGRL-YAGPEVDIWSCGVILYA 203
Query: 524 M 524
           +
Sbjct: 204 L 204

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 116/259 (44%), Gaps = 42/259 (16%)
Query: 349 NVAIK-VLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           N A K V+   + + E    E+ ++S   H  +V L     + +   +IYEF+S G L +
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP- 466
            + ++H      K+  +   +    + +GL ++H       +H D+KP NI+        
Sbjct: 244 KVADEH-----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNE 295
Query: 467 -KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF--- 522
            K+ DFGL    + ++S+   T   GT  + APEV       V Y +D++S G++ +   
Sbjct: 296 LKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV--AEGKPVGYYTDMWSVGVLSYILL 350
Query: 523 ----EMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVS 578
                  GE ++  +   +S +              +D    GI +E+ K++ RK++L  
Sbjct: 351 SGLSPFGGENDDETLRNVKSCDWNM-----------DDSAFSGI-SEDGKDFIRKLLLA- 397
Query: 579 LWCIQTNPSDRPSMNRVVE 597
                 +P+ R ++++ +E
Sbjct: 398 ------DPNTRMTIHQALE 410

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI D+GLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 16/177 (9%)
Query: 349 NVAIK-VLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEK 407
           N A K V+   + + E    E+ ++S   H  +V L     + +   +IYEF+S G L +
Sbjct: 78  NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 137
Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP- 466
            + ++H      K+  +   +    + +GL ++H       +H D+KP NI+        
Sbjct: 138 KVADEH-----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNE 189
Query: 467 -KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            K+ DFGL    + ++S+   T   GT  + APEV       V Y +D++S G++ +
Sbjct: 190 LKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV--AEGKPVGYYTDMWSVGVLSY 241

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N    +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NAMHYNQTVDIWSVGCIMAEL 216

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 25/191 (13%)
Query: 368 EVASISRTSHVNIVTLLG-FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
           E+A +SR  H NI+ +L  F  +G  + ++ +  S   L  FI ++HP   ++ L   + 
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHP-RLDEPLASYIF 136
Query: 427 YKI--AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
            ++  AVG  R  + +HR         DIK  NI++ EDF  K+ DFG A   E  +   
Sbjct: 137 RQLVSAVGYLRLKDIIHR---------DIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187
Query: 485 SMTGARGTIGYIAPEVFCRNFGEVSYKS---DVYSYGMMVFEMTGEKNN-ANVAVDRSSE 540
           +     GTI Y APEV   N     Y+    +++S G+ ++ +  E+N    +     + 
Sbjct: 188 TFC---GTIEYCAPEVLMGN----PYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA 240
Query: 541 IYFPHWVYKRL 551
           I+ P+ V K L
Sbjct: 241 IHPPYLVSKEL 251

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 64/128 (50%), Gaps = 9/128 (7%)
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + SL+KF   K  ++  Q +  ++L KIAV I + LE+LH   +  ++H D+KP N+L
Sbjct: 114 LXDTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVL 169
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSY 517
           ++     K  DFG++         V+     G   Y APE       +  Y  KSD++S 
Sbjct: 170 INALGQVKXCDFGISGYLVDD---VAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSL 226
Query: 518 GMMVFEMT 525
           G+   E+ 
Sbjct: 227 GITXIELA 234

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 351 AIKVLNE---TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLE 406
           A+K+L++    K +   F  E   I   ++   V  L + F+  R   ++ E++  G L 
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 157
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             +      E     KW   Y   V +A  L+ +H   +   +H D+KP N+LLD+    
Sbjct: 158 NLMSNYDVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHL 207
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
           K++DFG   +   +E +V    A GT  YI+PEV     G+  Y  + D +S G+ ++EM
Sbjct: 208 KLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 348 QNVAIKVLNETKGNGEDFIN----EVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
             VA+K+LN  K    D +     E+ ++    H +I+ L           ++ E+VS G
Sbjct: 37  HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG 96
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L  +I +   +E  +        ++   I   ++Y HR     ++H D+KP N+LLD  
Sbjct: 97  ELFDYICKHGRVEEMEA------RRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAH 147
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFGL+ +    E    +  + G+  Y APEV          + D++S G++++ 
Sbjct: 148 MNAKIADFGLSNMMSDGE---FLRDSCGSPNYAAPEVISGRL-YAGPEVDIWSCGVILYA 203
Query: 524 M 524
           +
Sbjct: 204 L 204

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 351 AIKVLNE---TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLE 406
           A+K+L++    K +   F  E   I   ++   V  L + F+  R   ++ E++  G L 
Sbjct: 103 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 162
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             +      E     KW   Y   V +A  L+ +H   +   +H D+KP N+LLD+    
Sbjct: 163 NLMSNYDVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHL 212
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
           K++DFG   +   +E +V    A GT  YI+PEV     G+  Y  + D +S G+ ++EM
Sbjct: 213 KLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           I EV+ +    H NIVTL           L++E++ +  L++++ +   +     +K   
Sbjct: 48  IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKL-- 104
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
                  + RGL Y HR    ++LH D+KP N+L++E    K++DFGLA+     +SI +
Sbjct: 105 ---FLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARA----KSIPT 154
Query: 486 MT--GARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM-TGEKNNANVAVDRSSE 540
            T      T+ Y  P++     G   Y +  D++  G + +EM TG        V+    
Sbjct: 155 KTYDNEVVTLWYRPPDIL---LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL- 210
Query: 541 IYFPHWVYKRLELEEDLGLQGI-ENEEDKEY 570
               H++++ L    +    GI  NEE K Y
Sbjct: 211 ----HFIFRILGTPTEETWPGILSNEEFKTY 237

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 192
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   M G   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 193 -RHTDDEMXGXVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 236

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 30/184 (16%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
            + E+++ G L   I   H  + ++   +      A  I  GL++LH   +  I++ D+K
Sbjct: 95  FVMEYLNGGDLMYHIQSCHKFDLSRATFY------AAEIILGLQFLH---SKGIVYRDLK 145
Query: 455 PHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDV 514
             NILLD+D   KI+DFG+ K  E            GT  YIAPE+      + ++  D 
Sbjct: 146 LDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAPEILLGQ--KYNHSVDW 201
Query: 515 YSYGMMVFEMT-------GEKNNANVAVDRSSEIYFPHWVYKRL----------ELEEDL 557
           +S+G++++EM        G+         R    ++P W+ K            E E+ L
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 261
Query: 558 GLQG 561
           G++G
Sbjct: 262 GVRG 265

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 9/107 (8%)
Query: 418 NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 477
           +QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGL    
Sbjct: 119 SQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLC--- 172
Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 --RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 351 AIKVLNE---TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLE 406
           A+K+L++    K +   F  E   I   ++   V  L + F+  R   ++ E++  G L 
Sbjct: 103 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 162
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
             +      E     KW   Y   V +A  L+ +H   +   +H D+KP N+LLD+    
Sbjct: 163 NLMSNYDVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHL 212
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVFEM 524
           K++DFG   +   +E +V    A GT  YI+PEV     G+  Y  + D +S G+ ++EM
Sbjct: 213 KLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 86/190 (45%), Gaps = 25/190 (13%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF----- 399
           + VAIK L+   +++   +    E+  +    H N++ LL            Y+F     
Sbjct: 50  EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
                L+K +  K   E  Q L +++L        +GL+Y+H      ++H D+KP N+ 
Sbjct: 110 FMQTDLQKIMGLKFSEEKIQYLVYQML--------KGLKYIHSAG---VVHRDLKPGNLA 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
           ++ED   KI DFGLA     R +   MTG   T  Y APEV   ++   +   D++S G 
Sbjct: 159 VNEDCELKILDFGLA-----RHADAEMTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGC 212
Query: 520 MVFEMTGEKN 529
           ++ EM   K 
Sbjct: 213 IMAEMLTGKT 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 143 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 195
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   M G   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 196 -RHTDDEMXGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 239

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   M G   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMAGFVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   M G   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMAGFVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 55  VAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 115 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 164
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 165 XDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 223
Query: 523 EMTGEK 528
           EM   +
Sbjct: 224 EMLSNR 229

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 30/184 (16%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
            + E+++ G L   I   H  + ++   +      A  I  GL++LH   +  I++ D+K
Sbjct: 96  FVMEYLNGGDLMYHIQSCHKFDLSRATFY------AAEIILGLQFLH---SKGIVYRDLK 146
Query: 455 PHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDV 514
             NILLD+D   KI+DFG+ K  E            GT  YIAPE+      + ++  D 
Sbjct: 147 LDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEILLGQ--KYNHSVDW 202
Query: 515 YSYGMMVFEMT-------GEKNNANVAVDRSSEIYFPHWVYKRL----------ELEEDL 557
           +S+G++++EM        G+         R    ++P W+ K            E E+ L
Sbjct: 203 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 262
Query: 558 GLQG 561
           G++G
Sbjct: 263 GVRG 266

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 95/191 (49%), Gaps = 22/191 (11%)
Query: 351 AIKVLNETKGNGEDFINEVAS----ISRTSHVNIVTLLGFCFEGHRRAL-IYEFVSNGSL 405
           A+KV+ +   N ++ I+ V +      + S+   +  L  CF+   R   + E+V+ G L
Sbjct: 34  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 93
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILHFDIKPHNILLDEDF 464
               H    ++  +KL  E     +  I+  L YLH RG    I++ D+K  N+LLD + 
Sbjct: 94  --MFH----MQRQRKLPEEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEG 143
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE 523
             K++D+G+ K  EG     + +   GT  YIAPE+    ++G   +  D ++ G+++FE
Sbjct: 144 HIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG---FSVDWWALGVLMFE 198
Query: 524 MTGEKNNANVA 534
           M   ++  ++ 
Sbjct: 199 MMAGRSPFDIV 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 95/191 (49%), Gaps = 22/191 (11%)
Query: 351 AIKVLNETKGNGEDFINEVAS----ISRTSHVNIVTLLGFCFEGHRRAL-IYEFVSNGSL 405
           A+KV+ +   N ++ I+ V +      + S+   +  L  CF+   R   + E+V+ G L
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILHFDIKPHNILLDEDF 464
               H    ++  +KL  E     +  I+  L YLH RG    I++ D+K  N+LLD + 
Sbjct: 98  --MFH----MQRQRKLPEEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEG 147
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE 523
             K++D+G+ K  EG     + +   GT  YIAPE+    ++G   +  D ++ G+++FE
Sbjct: 148 HIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG---FSVDWWALGVLMFE 202
Query: 524 MTGEKNNANVA 534
           M   ++  ++ 
Sbjct: 203 MMAGRSPFDIV 213

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 95/191 (49%), Gaps = 22/191 (11%)
Query: 351 AIKVLNETKGNGEDFINEVAS----ISRTSHVNIVTLLGFCFEGHRRAL-IYEFVSNGSL 405
           A+KV+ +   N ++ I+ V +      + S+   +  L  CF+   R   + E+V+ G L
Sbjct: 49  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 108
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILHFDIKPHNILLDEDF 464
               H    ++  +KL  E     +  I+  L YLH RG    I++ D+K  N+LLD + 
Sbjct: 109 --MFH----MQRQRKLPEEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEG 158
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE 523
             K++D+G+ K  EG     + +   GT  YIAPE+    ++G   +  D ++ G+++FE
Sbjct: 159 HIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG---FSVDWWALGVLMFE 213
Query: 524 MTGEKNNANVA 534
           M   ++  ++ 
Sbjct: 214 MMAGRSPFDIV 224

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA    
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---- 168
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   M G   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 169 -RHTDDEMAGFVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 212

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 17/165 (10%)
Query: 415 LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 474
           L  ++KL  + +  +   + +GL Y+H      I+H D+KP N+ ++ED   KI DFGLA
Sbjct: 119 LMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKN--NAN 532
                R++   M G   T  Y APEV   N+   +   D++S G ++ EM   K     +
Sbjct: 176 -----RQADSEMXGXVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 533 VAVDRSSEIYF-----PHWVYKRLELEEDLG-LQGIENEEDKEYA 571
             +D+  EI       P    +RL+ +E    ++G+   E K++A
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA 274

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 18/181 (9%)
Query: 348 QNVAIKVLNE---TKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q VA+K++N+    K + +  I  E++ +    H +I+ L           ++ E+  N 
Sbjct: 39  QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE 98
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
             +  +      E   +  ++        I   +EY HR    +I+H D+KP N+LLDE 
Sbjct: 99  LFDYIVQRDKMSEQEARRFFQ-------QIISAVEYCHR---HKIVHRDLKPENLLLDEH 148
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFGL+ I      + +  G+     Y APEV          + DV+S G++++ 
Sbjct: 149 LNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVISGKL-YAGPEVDVWSCGVILYV 204
Query: 524 M 524
           M
Sbjct: 205 M 205

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 111 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 160
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 161 XDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 219
Query: 523 EMTGEK 528
           EM   +
Sbjct: 220 EMLSNR 225

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 18/181 (9%)
Query: 348 QNVAIKVLNE---TKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q VA+K++N+    K + +  I  E++ +    H +I+ L           ++ E+  N 
Sbjct: 34  QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE 93
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
             +  +      E   +  ++        I   +EY HR    +I+H D+KP N+LLDE 
Sbjct: 94  LFDYIVQRDKMSEQEARRFFQ-------QIISAVEYCHR---HKIVHRDLKPENLLLDEH 143
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFGL+ I      + +  G+     Y APEV          + DV+S G++++ 
Sbjct: 144 LNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVISGKL-YAGPEVDVWSCGVILYV 199
Query: 524 M 524
           M
Sbjct: 200 M 200

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 18/181 (9%)
Query: 348 QNVAIKVLNE---TKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q VA+K++N+    K + +  I  E++ +    H +I+ L           ++ E+  N 
Sbjct: 30  QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE 89
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
             +  +      E   +  ++        I   +EY HR    +I+H D+KP N+LLDE 
Sbjct: 90  LFDYIVQRDKMSEQEARRFFQ-------QIISAVEYCHR---HKIVHRDLKPENLLLDEH 139
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFGL+ I      + +  G+     Y APEV          + DV+S G++++ 
Sbjct: 140 LNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVISGKL-YAGPEVDVWSCGVILYV 195
Query: 524 M 524
           M
Sbjct: 196 M 196

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 18/181 (9%)
Query: 348 QNVAIKVLNE---TKGNGEDFI-NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q VA+K++N+    K + +  I  E++ +    H +I+ L           ++ E+  N 
Sbjct: 40  QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE 99
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
             +  +      E   +  ++        I   +EY HR    +I+H D+KP N+LLDE 
Sbjct: 100 LFDYIVQRDKMSEQEARRFFQ-------QIISAVEYCHR---HKIVHRDLKPENLLLDEH 149
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFGL+ I      + +  G+     Y APEV          + DV+S G++++ 
Sbjct: 150 LNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVISGKL-YAGPEVDVWSCGVILYV 205
Query: 524 M 524
           M
Sbjct: 206 M 206

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 111 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 160
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 161 XDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 219
Query: 523 EMTGEK 528
           EM   +
Sbjct: 220 EMLSNR 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 89/187 (47%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++ VGI    ++LH      I+H D+KP NI+
Sbjct: 110 LMDANLSQVIQ----MELDHERMSYLLYQMLVGI----KHLHSAG---IIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEM 524
           G+++ EM
Sbjct: 212 GVIMGEM 218

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            I E+  +   +   IV   G  +     ++  E +  GSL++       L+   ++  +
Sbjct: 54  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV------LKKAGRIPEQ 107
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRES 482
           +L K+++ + +GL YL      +I+H D+KP NIL++     K+ DFG++   I E    
Sbjct: 108 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE 165
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
            V      GT  Y++PE         S +SD++S G+ + EM 
Sbjct: 166 FV------GTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMA 200

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 89/187 (47%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++ VGI    ++LH      I+H D+KP NI+
Sbjct: 110 LMDANLSQVIQ----MELDHERMSYLLYQMLVGI----KHLHSAG---IIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEM 524
           G+++ EM
Sbjct: 212 GVIMGEM 218

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 111 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 160
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 161 XDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 219
Query: 523 EMTGEK 528
           EM   +
Sbjct: 220 EMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 115 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 164
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 165 XDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 223
Query: 523 EMTGEK 528
           EM   +
Sbjct: 224 EMLSNR 229

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 92/189 (48%), Gaps = 17/189 (8%)
Query: 348 QNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           Q VAIK+  L E +   ED   E+  +S+     +    G   +G +  +I E++  GS 
Sbjct: 49  QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSA 108
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
              +    P +  Q      +  +   I +GL+YLH   + + +H DIK  N+LL E   
Sbjct: 109 LDLLRA-GPFDEFQ------IATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGD 158
Query: 466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
            K++DFG+A   +  ++ +      GT  ++APEV  ++      K+D++S G+   E+ 
Sbjct: 159 VKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELA 214
Query: 526 -GEKNNANV 533
            GE  N+++
Sbjct: 215 KGEPPNSDM 223

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 24/198 (12%)
Query: 351 AIKVLNETKGNGEDFINEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           A+K+++++K    D   E+  + R   H NI+TL     +G    ++ E    G L +K 
Sbjct: 51  AVKIIDKSK---RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKI 107
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL-LDEDFCP- 466
           + +K   E        VL+ I     + +EYLH      ++H D+KP NIL +DE   P 
Sbjct: 108 LRQKFFSEREAS---AVLFTIT----KTVEYLH---AQGVVHRDLKPSNILYVDESGNPE 157
Query: 467 --KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE- 523
             +I DFG AK       ++       T  ++APEV  R   + +   D++S G++++  
Sbjct: 158 SIRICDFGFAKQLRAENGLLXTPCY--TANFVAPEVLERQGYDAA--CDIWSLGVLLYTX 213
Query: 524 MTGEKNNANVAVDRSSEI 541
           +TG    AN   D   EI
Sbjct: 214 LTGYTPFANGPDDTPEEI 231

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI  FGLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 15/110 (13%)
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE--- 481
           V   I + IA  +E+LH   +  ++H D+KP NI    D   K+ DFGL    +  E   
Sbjct: 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 482 -------SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                  +  +  G  GT  Y++PE    N    S+K D++S G+++FE+
Sbjct: 222 TVLTPMPAYATHXGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFEL 269

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 111 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 160
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 161 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 219
Query: 523 EMTGEK 528
           EM   +
Sbjct: 220 EMLSNR 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 15/110 (13%)
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE--- 481
           V   I + IA  +E+LH   +  ++H D+KP NI    D   K+ DFGL    +  E   
Sbjct: 119 VCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 482 -------SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                  +    TG  GT  Y++PE    N    S+K D++S G+++FE+
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 350 VAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           VAIK++++      G  +   NEV    +  H +I+ L  +  + +   L+ E   NG +
Sbjct: 39  VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM 98
Query: 406 EKFIHEK-HPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
            +++  +  P   N+   +  +++I  G+     YLH   +  ILH D+   N+LL  + 
Sbjct: 99  NRYLKNRVKPFSENEARHF--MHQIITGML----YLH---SHGILHRDLTLSNLLLTRNM 149
Query: 465 CPKISDFGLA-KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
             KI+DFGLA ++    E   ++    GT  YI+PE+  R+   +  +SDV+S G M + 
Sbjct: 150 NIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRSAHGL--ESDVWSLGCMFYT 204
Query: 524 M 524
           +
Sbjct: 205 L 205

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI D GLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 53  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 112
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 113 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 162
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 163 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 221
Query: 523 EMTGEK 528
           EM   +
Sbjct: 222 EMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 59  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 118
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 119 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 168
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 169 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 227
Query: 523 EMTGEK 528
           EM   +
Sbjct: 228 EMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 111 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 160
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 161 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 219
Query: 523 EMTGEK 528
           EM   +
Sbjct: 220 EMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 56  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 115
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 116 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 165
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 166 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 224
Query: 523 EMTGEK 528
           EM   +
Sbjct: 225 EMLSNR 230

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
            E+  +S+     +    G   +  +  +I E++  GS    + E  PL+  Q      +
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQ------I 121
Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
             I   I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A   +  ++ +  
Sbjct: 122 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKR 176
Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
               GT  ++APEV  ++      K+D++S G+   E+
Sbjct: 177 NXFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIEL 212

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 57  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 116
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 117 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 166
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 167 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 225
Query: 523 EMTGEK 528
           EM   +
Sbjct: 226 EMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 48  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 107
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 108 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 157
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 158 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 216
Query: 523 EMTGEK 528
           EM   +
Sbjct: 217 EMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 115 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 164
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 223
Query: 523 EMTGEK 528
           EM   +
Sbjct: 224 EMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 49  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 108
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 109 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 158
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 159 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 217
Query: 523 EMTGEK 528
           EM   +
Sbjct: 218 EMLSNR 223

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 95/191 (49%), Gaps = 22/191 (11%)
Query: 351 AIKVLNETKGNGEDFINEVAS----ISRTSHVNIVTLLGFCFEGHRRAL-IYEFVSNGSL 405
           A++V+ +   N ++ I+ V +      + S+   +  L  CF+   R   + E+V+ G L
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILHFDIKPHNILLDEDF 464
               H    ++  +KL  E     +  I+  L YLH RG    I++ D+K  N+LLD + 
Sbjct: 141 --MFH----MQRQRKLPEEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEG 190
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFE 523
             K++D+G+ K  EG     + +   GT  YIAPE+    ++G   +  D ++ G+++FE
Sbjct: 191 HIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG---FSVDWWALGVLMFE 245
Query: 524 MTGEKNNANVA 534
           M   ++  ++ 
Sbjct: 246 MMAGRSPFDIV 256

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI D GLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 49  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 108
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 109 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 158
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 159 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 217
Query: 523 EMTGEK 528
           EM   +
Sbjct: 218 EMLSNR 223

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 32/130 (24%)
Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDFGLAK----ICEGRESIVS 485
           I  G+ YLH+     I+H D+KP NILL   +     KI DFG+++     CE RE +  
Sbjct: 140 ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-- 194
Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-------TGEKNN------AN 532
                GT  Y+APE+   N+  ++  +D+++ G++ + +        GE N       + 
Sbjct: 195 -----GTPEYLAPEIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 533 VAVDRSSEIY 542
           V VD S E +
Sbjct: 248 VNVDYSEETF 257

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 350 VAIKVLNETKGN-GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           V +KVL++   N  E F    + +S+ SH ++V   G CF G    L+ EFV  GSL+ +
Sbjct: 43  VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTY 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVG--IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           + +        K    +L+K+ V   +A  + +L       ++H ++   NILL  +   
Sbjct: 103 LKK-------NKNCINILWKLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDR 152
Query: 467 KISDFGLAKICEGRESIVSMTG--ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K  +    K+ +   SI  +     +  I ++ PE    N   ++  +D +S+G  ++E+
Sbjct: 153 KTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEI 211
Query: 525 TGEKNNANVAVDRSSEIYF 543
               +    A+D   ++ F
Sbjct: 212 CSGGDKPLSALDSQRKLQF 230

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 25/190 (13%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF----- 399
           + VAIK L+   +++   +    E+  +    H N++ LL            Y+F     
Sbjct: 68  EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
                L+K +  +   E  Q L +++L        +GL+Y+H   +  ++H D+KP N+ 
Sbjct: 128 FMQTDLQKIMGMEFSEEKIQYLVYQML--------KGLKYIH---SAGVVHRDLKPGNLA 176
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
           ++ED   KI DFGLA     R +   MTG   T  Y APEV   ++   +   D++S G 
Sbjct: 177 VNEDCELKILDFGLA-----RHADAEMTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGC 230
Query: 520 MVFEMTGEKN 529
           ++ EM   K 
Sbjct: 231 IMAEMLTGKT 240

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DF LA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 54/274 (19%)
Query: 349 NVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
            VAI++++  + N +    F  EV +  +T H N+V  +G C      A+I       +L
Sbjct: 57  EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 406 EKFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
              + + K  L+ N+        +IA  I +G+ YLH      ILH D+K  N+  D   
Sbjct: 117 YSVVRDAKIVLDVNKT------RQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGK 167
Query: 465 CPKISDFGLAKICEGRESIVSMTGAR--------GTIGYIAPEVFCRNFGEV-------S 509
              I+DFGL  I     S V   G R        G + ++APE+  +   +        S
Sbjct: 168 VV-ITDFGLFSI-----SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221
Query: 510 YKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI---ENEE 566
             SDV++ G + +E+   +                 W +K    E  +   G     N  
Sbjct: 222 KHSDVFALGTIWYELHARE-----------------WPFKTQPAEAIIWQMGTGMKPNLS 264
Query: 567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
                +++  + L+C      +RP+  ++++MLE
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   +   +   
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGA 130
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 131 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 180
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 181 XDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 239
Query: 523 EMTGEK 528
           EM   +
Sbjct: 240 EMLSNR 245

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH      I+H D+KP NI+
Sbjct: 110 LMDANLXQVIQ----MELDHERMSYLLYQMLXGI----KHLHSAG---IIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           QKL  + +  +   I RGL+Y+H   +  I+H D+KP N+ ++ED   KI D GLA    
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLA---- 172
Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            R +   MTG   T  Y APE+   N+   +   D++S G ++ E+
Sbjct: 173 -RHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAEL 216

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 130
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 131 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 180
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +T    T  Y APE+   + G  +   D++S G ++ 
Sbjct: 181 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 239
Query: 523 EMTGEK 528
           EM   +
Sbjct: 240 EMLSNR 245

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE-GRESIVSMTGARG 491
           I RGL+Y+H   +  +LH D+KP N+LL+     KI DFGLA++ +   +    +T    
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           T  Y APE+   + G  +   D++S G ++ EM   +
Sbjct: 192 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
            E+  +S+     +    G   +  +  +I E++  GS    + E  PL+  Q      +
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQ------I 106
Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
             I   I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A   +  ++ +  
Sbjct: 107 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKR 161
Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
               GT  ++APEV  ++      K+D++S G+   E+
Sbjct: 162 NXFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIEL 197

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
            E+  +S+     +    G   +  +  +I E++  GS    + E  PL+  Q      +
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQ------I 106
Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
             I   I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A   +  ++ +  
Sbjct: 107 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKR 161
Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
               GT  ++APEV  ++      K+D++S G+   E+
Sbjct: 162 NTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIEL 197

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    K++DFGLAK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 20/148 (13%)
Query: 381 VTLLGFCFEG-HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           +T L  CF+   R   + E+V+ G L   I +    +  Q     V Y  A  I+ GL +
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA----VFY--AAEISIGLFF 135
Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTIGYI 496
           LH+     I++ D+K  N++LD +   KI+DFG+ K     E ++     R   GT  YI
Sbjct: 136 LHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMMDGVTTREFCGTPDYI 187
Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           APE+    +       D ++YG++++EM
Sbjct: 188 APEIIA--YQPYGKSVDWWAYGVLLYEM 213

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 16/168 (9%)
Query: 366 INEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKL 421
           + E+  + R  H NI+     +     E  +   I + +    L K +  +H   +N  +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHI 130
Query: 422 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE-GR 480
            +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+     KI DFGLA++ +   
Sbjct: 131 CY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +    +T    T  Y APE+   + G  +   D++S G ++ EM   +
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
            E+  +S+     +    G   +  +  +I E++  GS    + E  PL+  Q      +
Sbjct: 74  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQ------I 126
Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
             I   I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A   +  ++ +  
Sbjct: 127 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKR 181
Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
               GT  ++APEV  ++      K+D++S G+   E+
Sbjct: 182 NTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIEL 217

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE-GRESIVSMTGARG 491
           I RGL+Y+H   +  +LH D+KP N+LL+     KI DFGLA++ +   +    +T    
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           T  Y APE+   + G  +   D++S G ++ EM   +
Sbjct: 192 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE-GRESIVSMTGARG 491
           I RGL+Y+H   +  +LH D+KP N+LL+     KI DFGLA++ +   +    +T    
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 492 TIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           T  Y APE+   + G  +   D++S G ++ EM   +
Sbjct: 194 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 54/98 (55%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   ++    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA---- 199
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VAIK++++T+ N    +    EV  +   +H NIV L           LI E+ S G 
Sbjct: 41  REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +  +      L  + ++K +        I   ++Y H+    RI+H D+K  N+LLD D 
Sbjct: 101 VFDY------LVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADM 151
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFG +        + +  GA     Y APE+F     +   + DV+S G++++ +
Sbjct: 152 NIKIADFGFSNEFTVGGKLDAFCGAP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTL 207
Query: 525 T 525
Sbjct: 208 V 208

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 348 QNVAIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q  A K++N  K +  D   +   A I R   H NIV L     E     LI++ V+ G 
Sbjct: 48  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 107
Query: 405 L-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           L E  +  ++  E +           +  I + LE +       ++H D+KP N+LL   
Sbjct: 108 LFEDIVAREYYSEADA----------SHCIQQILEAVLHCHQMGVVHRDLKPENLLLASK 157
Query: 464 F---CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGM 519
                 K++DFGLA   EG +   +  G  GT GY++PEV  ++ +G+     D+++ G+
Sbjct: 158 LKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGK---PVDLWACGV 212
Query: 520 MVF 522
           +++
Sbjct: 213 ILY 215

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/258 (21%), Positives = 101/258 (39%), Gaps = 33/258 (12%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFC--FEGHRRALIYEFVSNGSLEKFI 409
           +KV + +     DF  E   +   SH N++ +LG C         LI  +   GSL   +
Sbjct: 41  LKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVL 100
Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS 469
           HE     TN  +      K A+  ARG  +LH      I    +   ++ +DED   +IS
Sbjct: 101 HEG----TNFVVDQSQAVKFALDXARGXAFLH-TLEPLIPRHALNSRSVXIDEDXTARIS 155
Query: 470 --DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-DVYSYGMMVFEMTG 526
             D   +    GR              ++APE   +   + + +S D +S+ ++++E+  
Sbjct: 156 XADVKFSFQSPGRXY---------APAWVAPEALQKKPEDTNRRSADXWSFAVLLWELV- 205
Query: 527 EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNP 586
                      + E+ F        E+   + L+G+        +  +  +   C   +P
Sbjct: 206 -----------TREVPFAD--LSNXEIGXKVALEGLRPTIPPGISPHVSKLXKICXNEDP 252
Query: 587 SDRPSMNRVVEMLEGSLD 604
           + RP  + +V +LE   D
Sbjct: 253 AKRPKFDXIVPILEKXQD 270

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH      I+H D+KP NI+
Sbjct: 110 LMDANLXQVIQ----MELDHERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 27/189 (14%)
Query: 351 AIKVLNETKGNG----------EDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEF 399
           A+K+++ T G            E  + EV  + + S H NI+ L           L+++ 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           +  G L  ++ EK  L   +        KI   +   +  LH+     I+H D+KP NIL
Sbjct: 106 MKKGELFDYLTEKVTLSEKET------RKIMRALLEVICALHK---LNIVHRDLKPENIL 156
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CR---NFGEVSYKSDVY 515
           LD+D   K++DFG +   +  E + S+    GT  Y+APE+  C    N      + D++
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLRSVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 516 SYGMMVFEM 524
           S G++++ +
Sbjct: 214 STGVIMYTL 222

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++ VGI    ++LH      I+H D+KP NI+
Sbjct: 110 LMDANLSQVIQ----MELDHERMSYLLYQMLVGI----KHLHSAG---IIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG----MGYKENVDIWSV 211
Query: 518 GMMVFEM 524
           G ++ EM
Sbjct: 212 GCIMGEM 218

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+DE    +++DFG AK  +GR   +     
Sbjct: 134 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC---- 186
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 187 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 220

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    K++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    K++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    K++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    K++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 36/186 (19%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF----------VS 401
           I++  E +G     I E++ +    H NIV L        R  L++E           V 
Sbjct: 34  IRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC 93
Query: 402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
            G LE    +   L+                +  G+ Y H   + R+LH D+KP N+L++
Sbjct: 94  EGGLESVTAKSFLLQ----------------LLNGIAYCH---DRRVLHRDLKPQNLLIN 134
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGM 519
            +   KI+DFGLA+       +   T    T+ Y AP+V     G   Y +  D++S G 
Sbjct: 135 REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVL---MGSKKYSTTIDIWSVGC 189
Query: 520 MVFEMT 525
           +  EM 
Sbjct: 190 IFAEMV 195

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 36/186 (19%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF----------VS 401
           I++  E +G     I E++ +    H NIV L        R  L++E           V 
Sbjct: 34  IRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC 93
Query: 402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
            G LE    +   L+                +  G+ Y H   + R+LH D+KP N+L++
Sbjct: 94  EGGLESVTAKSFLLQ----------------LLNGIAYCH---DRRVLHRDLKPQNLLIN 134
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGM 519
            +   KI+DFGLA+       +   T    T+ Y AP+V     G   Y +  D++S G 
Sbjct: 135 REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVL---MGSKKYSTTIDIWSVGC 189
Query: 520 MVFEMT 525
           +  EM 
Sbjct: 190 IFAEMV 195

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 13/132 (9%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++ E++  G L   +      E     KW   Y   V +A  L+ +H   +  ++H D+K
Sbjct: 152 MVMEYMPGGDLVNLMSNYDVPE-----KWAKFYTAEVVLA--LDAIH---SMGLIHRDVK 201
Query: 455 PHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KS 512
           P N+LLD+    K++DFG     +    +V    A GT  YI+PEV     G+  Y  + 
Sbjct: 202 PDNMLLDKHGHLKLADFGTCMKMD-ETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGREC 260
Query: 513 DVYSYGMMVFEM 524
           D +S G+ +FEM
Sbjct: 261 DWWSVGVFLFEM 272

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX---- 199
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 28/182 (15%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           +++ ++ +G     + E+  +    H NIV L        +  L++EF  +  L+K+   
Sbjct: 35  VRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDS 93
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                 N  L  E++      + +GL + H   +  +LH D+KP N+L++ +   K++DF
Sbjct: 94  -----CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLADF 145
Query: 472 GLAKI------CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFE 523
           GLA+       C   E +        T+ Y  P+V    FG   Y +  D++S G +  E
Sbjct: 146 GLARAFGIPVRCYSAEVV--------TLWYRPPDVL---FGAKLYSTSIDMWSAGCIFAE 194
Query: 524 MT 525
           + 
Sbjct: 195 LA 196

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 115 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 164
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +     T  Y APE+   + G  +   D++S G ++ 
Sbjct: 165 CDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 223
Query: 523 EMTGEK 528
           EM   +
Sbjct: 224 EMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 350 VAIKVLN--ETKGNGEDFINEVASISRTSHVNIV----TLLGFCFEGHRRALIYEFVSNG 403
           VAIK ++  E +   +  + E+  + R  H NI+     +     E  +   I + +   
Sbjct: 56  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 115
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L K +  +H   +N  + +  LY+I     RGL+Y+H   +  +LH D+KP N+LL+  
Sbjct: 116 DLYKLLKTQH--LSNDHICY-FLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTT 165
Query: 464 FCPKISDFGLAKICE-GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              KI DFGLA++ +   +    +     T  Y APE+   + G  +   D++S G ++ 
Sbjct: 166 CDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILA 224
Query: 523 EMTGEK 528
           EM   +
Sbjct: 225 EMLSNR 230

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 36/186 (19%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF----------VS 401
           I++  E +G     I E++ +    H NIV L        R  L++E           V 
Sbjct: 34  IRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC 93
Query: 402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
            G LE    +   L+                +  G+ Y H   + R+LH D+KP N+L++
Sbjct: 94  EGGLESVTAKSFLLQ----------------LLNGIAYCH---DRRVLHRDLKPQNLLIN 134
Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGM 519
            +   KI+DFGLA+       +   T    T+ Y AP+V     G   Y +  D++S G 
Sbjct: 135 REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVL---MGSKKYSTTIDIWSVGC 189
Query: 520 MVFEMT 525
           +  EM 
Sbjct: 190 IFAEMV 195

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 17/163 (10%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
            E+ + +  +   IV L G   EG    +  E +  GSL + + E+  L  ++      L
Sbjct: 134 EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDR-----AL 188
Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-PKISDFGLAKIC---EG-RE 481
           Y +   +  GLEYLH   + RILH D+K  N+LL  D     + DFG A +C   +G  +
Sbjct: 189 YYLGQAL-EGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGK 243
Query: 482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           S+++     GT  ++APEV          K DV+S   M+  M
Sbjct: 244 SLLTGDYIPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHM 284

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH      I+H D+KP NI+
Sbjct: 110 LMDANLXQVIQ----MELDHERMSYLLYQMLXGI----KHLHSAG---IIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    +++DFGLAK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 15/163 (9%)
Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           + E+ + +  S   IV L G   EG    +  E +  GSL + I +   L  ++      
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-----A 152
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-PKISDFGLAKICEG---RE 481
           LY +   +  GLEYLH     RILH D+K  N+LL  D     + DFG A   +     +
Sbjct: 153 LYYLGQAL-EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208
Query: 482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           S+++     GT  ++APEV          K D++S   M+  M
Sbjct: 209 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHM 249

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 80/183 (43%), Gaps = 27/183 (14%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           VA+K +       E+   E+ +     H NIV            A+I E+ S G L E+ 
Sbjct: 48  VAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI 107
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-- 466
            +     E   +  ++ L         G+ Y H   + +I H D+K  N LLD    P  
Sbjct: 108 CNAGRFSEDEARFFFQQLLS-------GVSYCH---SMQICHRDLKLENTLLDGSPAPRL 157
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIG---YIAPEVFCRNF--GEVSYKSDVYSYGMMV 521
           KI DFG +K      S V  +  + T+G   YIAPEV  R    G++   +DV+S G+ +
Sbjct: 158 KICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI---ADVWSCGVTL 208
Query: 522 FEM 524
           + M
Sbjct: 209 YVM 211

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
            E+ + +  +   IV L G   EG    +  E +  GSL + + E+  L  ++      L
Sbjct: 115 EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDR-----AL 169
Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-PKISDFGLAKICEGRESIVS 485
           Y +   +  GLEYLH   + RILH D+K  N+LL  D     + DFG A +C   + +  
Sbjct: 170 YYLGQAL-EGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGK 224
Query: 486 --MTG--ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             +TG    GT  ++APEV          K DV+S   M+  M
Sbjct: 225 DLLTGDYIPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHM 265

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 15/163 (9%)
Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           + E+ + +  S   IV L G   EG    +  E +  GSL + I +   L  ++      
Sbjct: 112 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-----A 166
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-PKISDFGLAKICEG---RE 481
           LY +   +  GLEYLH     RILH D+K  N+LL  D     + DFG A   +     +
Sbjct: 167 LYYLGQAL-EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 222
Query: 482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           S+++     GT  ++APEV          K D++S   M+  M
Sbjct: 223 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHM 263

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    K++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    K++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    K++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    K++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    K++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    K++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH      I+H D+KP NI+
Sbjct: 103 LMDANLXQVIQ----MELDHERMSYLLYQMLXGI----KHLHSAG---IIHRDLKPSNIV 151
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 152 VKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 204
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 205 GCIMGEMVRHK 215

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 15/163 (9%)
Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           + E+ + +  S   IV L G   EG    +  E +  GSL + I +   L  ++      
Sbjct: 114 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-----A 168
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-PKISDFGLAKICEG---RE 481
           LY +   +  GLEYLH     RILH D+K  N+LL  D     + DFG A   +     +
Sbjct: 169 LYYLGQAL-EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 224
Query: 482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           S+++     GT  ++APEV          K D++S   M+  M
Sbjct: 225 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHM 265

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 27/189 (14%)
Query: 351 AIKVLNETKGNG----------EDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEF 399
           A+K+++ T G            E  + EV  + + S H NI+ L           L+++ 
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 92
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           +  G L  ++ EK  L   +        KI   +   +  LH+     I+H D+KP NIL
Sbjct: 93  MKKGELFDYLTEKVTLSEKET------RKIMRALLEVICALHK---LNIVHRDLKPENIL 143
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CR---NFGEVSYKSDVY 515
           LD+D   K++DFG +   +  E +  +    GT  Y+APE+  C    N      + D++
Sbjct: 144 LDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMW 200
Query: 516 SYGMMVFEM 524
           S G++++ +
Sbjct: 201 STGVIMYTL 209

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---- 200
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VAIK++++T+ N    +    EV  +   +H NIV L           LI E+ S G 
Sbjct: 38  REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 97
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +  +      L  + ++K +        I   ++Y H+    RI+H D+K  N+LLD D 
Sbjct: 98  VFDY------LVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADM 148
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFG +        + +  G+     Y APE+F     +   + DV+S G++++ +
Sbjct: 149 NIKIADFGFSNEFTVGGKLDTFCGSP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTL 204
Query: 525 T 525
Sbjct: 205 V 205

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 348 QNVAIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q  A K++N  K +  D   +   A I R   H NIV L     E     L+++ V+ G 
Sbjct: 57  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 116
Query: 405 L-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-- 461
           L E  +  ++  E +       +++I       LE ++      I+H D+KP N+LL   
Sbjct: 117 LFEDIVAREYYSEADAS---HCIHQI-------LESVNHIHQHDIVHRDLKPENLLLASK 166
Query: 462 -EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGM 519
            +    K++DFGLA   +G +   +  G  GT GY++PEV  ++ +G+     D+++ G+
Sbjct: 167 CKGAAVKLADFGLAIEVQGEQQ--AWFGFAGTPGYLSPEVLRKDPYGK---PVDIWACGV 221
Query: 520 MVF 522
           +++
Sbjct: 222 ILY 224

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 133 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---- 185
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 186 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 219

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 140 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 192
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 193 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 226

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 142 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 194
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 195 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 228

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 140 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 192
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 193 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 226

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPE-VFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE +  + + +     D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 234

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH      I+H D+KP NI+
Sbjct: 110 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 27/189 (14%)
Query: 351 AIKVLNETKGNG----------EDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEF 399
           A+K+++ T G            E  + EV  + + S H NI+ L           L+++ 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           +  G L  ++ EK  L   +        KI   +   +  LH+     I+H D+KP NIL
Sbjct: 106 MKKGELFDYLTEKVTLSEKET------RKIMRALLEVICALHK---LNIVHRDLKPENIL 156
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CR---NFGEVSYKSDVY 515
           LD+D   K++DFG +   +  E +  +    GT  Y+APE+  C    N      + D++
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 516 SYGMMVFEM 524
           S G++++ +
Sbjct: 214 STGVIMYTL 222

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 220
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 221 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 254

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 29/196 (14%)
Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRAL-IYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
           + E   +S   +   +T L  CF+   R   + EFV+ G L   I +    +  +   + 
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY- 129
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRES 482
                A  I   L +LH   +  I++ D+K  N+LLD +   K++DFG+ K  IC G   
Sbjct: 130 -----AAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--- 178
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM-------TGEKNNANV 533
            V+     GT  YIAPE+      E+ Y    D ++ G++++EM         E  +   
Sbjct: 179 -VTTATFCGTPDYIAPEI----LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
Query: 534 AVDRSSEIYFPHWVYK 549
               + E+ +P W+++
Sbjct: 234 EAILNDEVVYPTWLHE 249

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEV 425
           NE++ +++  H  ++ L     + +   LI EF+S G L ++   E + +   + + +  
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-- 154
Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP--KISDFGLAKICEGRESI 483
                     GL+++H      I+H DIKP NI+ +       KI DFGLA      E I
Sbjct: 155 ----MRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-I 206
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
           V +T A  T  + APE+  R    V + +D+++ G++
Sbjct: 207 VKVTTA--TAEFAAPEIVDRE--PVGFYTDMWAIGVL 239

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 350 VAIKVLNETKGN-GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           V +KVL++   N  E F    + +S+ SH ++V   G C  G    L+ EFV  GSL+ +
Sbjct: 43  VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102
Query: 409 IHEKHPLETNQKLKWEVLYKIAVG--IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP 466
           + +        K    +L+K+ V   +A  + +L       ++H ++   NILL  +   
Sbjct: 103 LKK-------NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDR 152
Query: 467 KISDFGLAKICEGRESIVSMTG--ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           K  +    K+ +   SI  +     +  I ++ PE    N   ++  +D +S+G  ++E+
Sbjct: 153 KTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEI 211
Query: 525 TGEKNNANVAVDRSSEIYF 543
               +    A+D   ++ F
Sbjct: 212 CSGGDKPLSALDSQRKLQF 230

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 220
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 221 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 254

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 367 NEVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKW 423
            E+  + +  H NIV L  F +  G ++ ++Y  +    + + ++   +H     Q L  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRES 482
             +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 179 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 216

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+++D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPEIIISK--GYNKAVDWWALGVLIYEMAA 233

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 18/181 (9%)
Query: 348 QNVAIKVLNETKGNGEDFI----NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG 403
           Q VA+K ++       D       E++ +    H +I+ L           ++ E+ + G
Sbjct: 35  QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGG 93
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
            L  +I EK  +  ++  ++         I   +EY HR    +I+H D+KP N+LLD++
Sbjct: 94  ELFDYIVEKKRMTEDEGRRF------FQQIICAIEYCHR---HKIVHRDLKPENLLLDDN 144
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFGL+ I      + +  G+     Y APEV          + DV+S G++++ 
Sbjct: 145 LNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVINGKL-YAGPEVDVWSCGIVLYV 200
Query: 524 M 524
           M
Sbjct: 201 M 201

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH      I+H D+KP NI+
Sbjct: 110 LMDANLSQVIQ----MELDHERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEM 524
           G ++ EM
Sbjct: 212 GCIMGEM 218

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VA+K++++T+ N    +    EV  +   +H NIV L           L+ E+ S G 
Sbjct: 40  KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +  +      L  + ++K +        I   ++Y H+     I+H D+K  N+LLD D 
Sbjct: 100 VFDY------LVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADM 150
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFG +        + +  GA     Y APE+F     +   + DV+S G++++ +
Sbjct: 151 NIKIADFGFSNEFTFGNKLDAFCGAP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTL 206
Query: 525 T 525
Sbjct: 207 V 207

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 361 NGEDFIN-EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLE 416
            G+ F N E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H   
Sbjct: 55  QGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 417 TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAK 475
             Q L    +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
                E  VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 172 QLVRGEPNVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 216

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G+++++M  
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYQMAA 233

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 28/182 (15%)
Query: 352 IKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE 411
           +++ ++ +G     + E+  +    H NIV L        +  L++EF     L+K+   
Sbjct: 35  VRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS 93
Query: 412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF 471
                 N  L  E++      + +GL + H   +  +LH D+KP N+L++ +   K+++F
Sbjct: 94  -----CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANF 145
Query: 472 GLAKI------CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFE 523
           GLA+       C   E +        T+ Y  P+V    FG   Y +  D++S G +  E
Sbjct: 146 GLARAFGIPVRCYSAEVV--------TLWYRPPDVL---FGAKLYSTSIDMWSAGCIFAE 194
Query: 524 MT 525
           + 
Sbjct: 195 LA 196

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 361 NGEDFIN-EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLE 416
            G+ F N E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H   
Sbjct: 55  QGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 417 TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAK 475
             Q L    +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
                E  VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 172 QLVRGEPNVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 148 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 196
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 197 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 249
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 250 GCIMGEMVRHK 260

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 23/183 (12%)
Query: 348 QNVAIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q  A K++N  K +  D   +   A I R   H NIV L     E     L+++ V+ G 
Sbjct: 30  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 405 L-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL--- 460
           L E  +  ++  E +           +  I + LE ++      I+H D+KP N+LL   
Sbjct: 90  LFEDIVAREYYSEADA----------SHCIQQILESVNHCHLNGIVHRDLKPENLLLASK 139
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGM 519
            +    K++DFGLA   +G +   +  G  GT GY++PEV  ++ +G+     D+++ G+
Sbjct: 140 SKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRKDPYGK---PVDMWACGV 194
Query: 520 MVF 522
           +++
Sbjct: 195 ILY 197

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 27/173 (15%)
Query: 366 INEVASISRTSHVNIVTLLGF----CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKL 421
           + E+  +    H NI+T+        FE      I + +    L + I       + Q L
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-------STQML 109
Query: 422 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE--- 478
             + +        R ++ LH G N  ++H D+KP N+L++ +   K+ DFGLA+I +   
Sbjct: 110 SDDHIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 479 -------GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                  G++S   MT    T  Y APEV   +  + S   DV+S G ++ E+
Sbjct: 167 ADNSEPTGQQS--GMTEXVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 157 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 214 VSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 250

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 19/156 (12%)
Query: 372 ISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV 431
           +    H  IV L+     G +  LI E++S G L  F+     LE       +       
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQ----LEREGIFMEDTACFYLA 128
Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR- 490
            I+  L +LH+     I++ D+KP NI+L+     K++DFGL K     ESI   T    
Sbjct: 129 EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHX 180
Query: 491 --GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             GTI Y+APE+  R+    +   D +S G ++++M
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAV--DWWSLGALMYDM 214

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 78/171 (45%), Gaps = 16/171 (9%)
Query: 361 NGEDFIN-EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLE 416
            G+ F N E+  + +  H NIV L  F +  G ++  +Y  +    +   ++   +H   
Sbjct: 55  QGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSR 114
Query: 417 TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAK 475
             Q L    +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
                E  VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 172 QLVRGEPNVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 216

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 19/156 (12%)
Query: 372 ISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV 431
           +    H  IV L+     G +  LI E++S G L  F+     LE       +       
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQ----LEREGIFMEDTACFYLA 128
Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR- 490
            I+  L +LH+     I++ D+KP NI+L+     K++DFGL K     ESI   T    
Sbjct: 129 EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHT 180
Query: 491 --GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             GTI Y+APE+  R+    +   D +S G ++++M
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAV--DWWSLGALMYDM 214

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 110 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 110
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 111 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 159
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 160 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 212
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 213 GCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 49  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 108
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 109 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 157
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 158 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 210
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 211 GCIMGEMVRHK 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 23/183 (12%)
Query: 348 QNVAIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q  A K++N  K +  D   +   A I R   H NIV L     E     L+++ V+ G 
Sbjct: 30  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 405 L-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL--- 460
           L E  +  ++  E +           +  I + LE ++      I+H D+KP N+LL   
Sbjct: 90  LFEDIVAREYYSEADA----------SHCIQQILESVNHCHLNGIVHRDLKPENLLLASK 139
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGM 519
            +    K++DFGLA   +G +   +  G  GT GY++PEV  ++ +G+     D+++ G+
Sbjct: 140 SKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRKDPYGK---PVDMWACGV 194
Query: 520 MVF 522
           +++
Sbjct: 195 ILY 197

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 157 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 214 VSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 250

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 150
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 151 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 207
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 208 VSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 244

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 148 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 196
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 197 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 249
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 250 GCIMGEMVRHK 260

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 130
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 131 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 187
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 188 VSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 224

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           VA+K +   +   E+   E+ +     H NIV            A++ E+ S G L E+ 
Sbjct: 47  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 106
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-- 466
            +     E   +  ++ L         G+ Y H     ++ H D+K  N LLD    P  
Sbjct: 107 CNAGRFSEDEARFFFQQLIS-------GVSYAH---AMQVAHRDLKLENTLLDGSPAPRL 156
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF--GEVSYKSDVYSYGMMVFEM 524
           KI+DFG +K         S   A GT  YIAPEV  +    G+V   +DV+S G+ ++ M
Sbjct: 157 KIADFGYSKASVLHSQPKS---AVGTPAYIAPEVLLKKEYDGKV---ADVWSCGVTLYVM 210

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 103
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 104 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 152
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 153 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 205
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 206 GCIMGEMVRHK 216

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH      I+H D+KP NI+
Sbjct: 110 LMDANLSQVIQ----MELDHERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEM 524
           G ++ EM
Sbjct: 212 GCIMGEM 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 110 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 110
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 111 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 159
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 160 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 212
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 213 GCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 103
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 104 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 152
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 153 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 205
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 206 GCIMGEMVRHK 216

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 141
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 142 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 198
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 199 VSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 235

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 82/185 (44%), Gaps = 26/185 (14%)
Query: 350 VAIKVLNETKGNGEDFINEVASISR-TSHVNIVTLLGFCFEGHRRA------LIYEFVSN 402
           VAIK + + K     F N    I R   H N+V L  F +    +       L+ E+V  
Sbjct: 67  VAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
                +   +H  +  Q +   ++      + R L Y+H   +  I H DIKP N+LLD 
Sbjct: 123 TV---YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDP 176
Query: 463 DF-CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGM 519
                K+ DFG AKI    E  VS   +R    Y APE+    FG  +Y +  D++S G 
Sbjct: 177 PSGVLKLIDFGSAKILIAGEPNVSXICSR---YYRAPELI---FGATNYTTNIDIWSTGC 230
Query: 520 MVFEM 524
           ++ E+
Sbjct: 231 VMAEL 235

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 158
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 159 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 215
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 216 VSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 252

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI++LL         E  +   +   
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 103 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 151
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 152 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 204
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 205 GCIMGEMVRHK 215

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 135 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 191
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 192 VSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 135
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 136 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 192
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 193 VSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 229

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 135 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 191
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 192 VSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 128 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 184
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 185 VSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 221

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 160
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 161 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 217
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 218 VSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 254

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 27/173 (15%)
Query: 366 INEVASISRTSHVNIVTLLGF----CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKL 421
           + E+  +    H NI+T+        FE      I + +    L + I       + Q L
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-------STQML 109
Query: 422 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE--- 478
             + +        R ++ LH G N  ++H D+KP N+L++ +   K+ DFGLA+I +   
Sbjct: 110 SDDHIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 479 -------GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                  G++S   MT    T  Y APEV   +  + S   DV+S G ++ E+
Sbjct: 167 ADNSEPTGQQS--GMTEYVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 367 NEVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKW 423
            E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L  
Sbjct: 63  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 122
Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRES 482
             +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E 
Sbjct: 123 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 179
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 180 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 83/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VA+K++++T+ N    +    EV  +   +H NIV L           L+ E+ S G 
Sbjct: 40  KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +  +      L  + ++K +        I   ++Y H+     I+H D+K  N+LLD D 
Sbjct: 100 VFDY------LVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADM 150
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFG +        + +  G+     Y APE+F     +   + DV+S G++++ +
Sbjct: 151 NIKIADFGFSNEFTFGNKLDTFCGSP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTL 206
Query: 525 T 525
Sbjct: 207 V 207

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 22/192 (11%)
Query: 348 QNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGH----RRALIYEFVSNG 403
           + VA+KV   T+        E+       H NI+  +    +G     +  LI ++  NG
Sbjct: 61  EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC-----NTRILHFDIKPHNI 458
           SL  ++        +  L  + + K+A     GL +LH           I H D+K  NI
Sbjct: 121 SLYDYLK-------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173
Query: 459 LLDEDFCPKISDFGLAK--ICEGRESIVSMTGARGTIGYIAPEV----FCRNFGEVSYKS 512
           L+ ++    I+D GLA   I +  E  +      GT  Y+ PEV      RN  +    +
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233
Query: 513 DVYSYGMMVFEM 524
           D+YS+G++++E+
Sbjct: 234 DMYSFGLILWEV 245

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 83/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VA+K++++T+ N    +    EV  +   +H NIV L           L+ E+ S G 
Sbjct: 40  KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +  +      L  + ++K +        I   ++Y H+     I+H D+K  N+LLD D 
Sbjct: 100 VFDY------LVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADM 150
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFG +        + +  G+     Y APE+F     +   + DV+S G++++ +
Sbjct: 151 NIKIADFGFSNEFTFGNKLDTFCGSP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTL 206
Query: 525 T 525
Sbjct: 207 V 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+AP +        +   D ++ G++++EM  
Sbjct: 200 -GTPEYLAPAIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 367 NEVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKW 423
            E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRES 482
             +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 179 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 216

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 110 LMDANLSQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEM 524
           G ++ EM
Sbjct: 212 GCIMGEM 218

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 368 EVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKWE 424
           E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L   
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 201
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESI 483
            +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 202 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 258
Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 259 VSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 295

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 367 NEVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKW 423
            E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRES 482
             +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 179 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 28/187 (14%)
Query: 349 NVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEFV 400
           NVA+K L+   + + + +    E+  +   +H NI++LL         E  +   +   +
Sbjct: 49  NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 108
Query: 401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
            + +L + IH    +E + +    +LY++  GI    ++LH   +  I+H D+KP NI++
Sbjct: 109 MDANLCQVIH----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIVV 157
Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYG 518
             D   KI DFGLA+          MT    T  Y APEV       + YK   D++S G
Sbjct: 158 KSDCTLKILDFGLARTASTN---FMMTPYVVTRYYRAPEVILG----MGYKENVDIWSVG 210
Query: 519 MMVFEMT 525
            ++ E+ 
Sbjct: 211 CIMGELV 217

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 138
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 139 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 191
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 192 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 367 NEVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKW 423
            E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRES 482
             +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 179 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 216

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 367 NEVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHE--KHPLETNQKLKW 423
            E+  + +  H NIV L  F +  G ++  +Y  +    + + ++   +H     Q L  
Sbjct: 66  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 125
Query: 424 EVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRES 482
             +      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG AK     E 
Sbjct: 126 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 182
Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
            VS   +R    Y APE+    FG   Y S  DV+S G ++ E+
Sbjct: 183 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAEL 220

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 137
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 190
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 191 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 223

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 138
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 139 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 191
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 192 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 224

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 22/179 (12%)
Query: 351 AIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL-E 406
           A K++N  K +  DF  +   A I R   H NIV L     E     L+++ V+ G L E
Sbjct: 58  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 117
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---ED 463
             +  +   E +       + +I   IA    Y H   +  I+H ++KP N+LL    + 
Sbjct: 118 DIVAREFYSEADAS---HCIQQILESIA----YCH---SNGIVHRNLKPENLLLASKAKG 167
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              K++DFGLA      E+     G  GT GY++PEV  ++    S   D+++ G++++
Sbjct: 168 AAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILY 221

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 137
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 190
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 191 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 32/191 (16%)
Query: 348 QNVAIKVLNETKGNG------EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS 401
           Q  A+K+++  K         ED   E +      H +IV LL          +++EF+ 
Sbjct: 50  QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 109
Query: 402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVG------IARGLEYLHRGCNTRILHFDIKP 455
              L          E  ++     +Y  AV       I   L Y H   +  I+H D+KP
Sbjct: 110 GADL--------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKP 158
Query: 456 HNILL--DEDFCP-KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYK 511
            N+LL   E+  P K+ DFG+A I  G   +V+  G  GT  ++APEV  R  +G+    
Sbjct: 159 ENVLLASKENSAPVKLGDFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVKREPYGK---P 213
Query: 512 SDVYSYGMMVF 522
            DV+  G+++F
Sbjct: 214 VDVWGCGVILF 224

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 22/179 (12%)
Query: 351 AIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL-E 406
           A K++N  K +  DF  +   A I R   H NIV L     E     L+++ V+ G L E
Sbjct: 35  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 94
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---ED 463
             +  +   E +       + +I   IA    Y H   +  I+H ++KP N+LL    + 
Sbjct: 95  DIVAREFYSEADAS---HCIQQILESIA----YCH---SNGIVHRNLKPENLLLASKAKG 144
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              K++DFGLA      E+     G  GT GY++PEV  ++    S   D+++ G++++
Sbjct: 145 AAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILY 198

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 348 QNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLGFC---FEGHRRA-----LI 396
           Q VA+K +   NE +G     + E+  +    H N+V L+  C      + R      L+
Sbjct: 44  QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLV 103
Query: 397 YEFVSNGSLEKFIHEKHPLETNQKLKWEV--LYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++F          H+   L +N  +K+ +  + ++   +  GL Y+HR    +ILH D+K
Sbjct: 104 FDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMK 152
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGAR-GTIGYIAPEVFCRNFGEVSYKS 512
             N+L+  D   K++DFGLA+     + S  +    R  T+ Y  PE+     GE  Y  
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL---LGERDYGP 209
Query: 513 --DVYSYGMMVFEM 524
             D++  G ++ EM
Sbjct: 210 PIDLWGAGCIMAEM 223

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 22/179 (12%)
Query: 351 AIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL-E 406
           A K++N  K +  DF  +   A I R   H NIV L     E     L+++ V+ G L E
Sbjct: 34  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 93
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---ED 463
             +  +   E +       + +I   IA    Y H   +  I+H ++KP N+LL    + 
Sbjct: 94  DIVAREFYSEADAS---HCIQQILESIA----YCH---SNGIVHRNLKPENLLLASKAKG 143
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              K++DFGLA      E+     G  GT GY++PEV  ++    S   D+++ G++++
Sbjct: 144 AAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILY 197

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 348 QNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLGFC---FEGHRRA-----LI 396
           Q VA+K +   NE +G     + E+  +    H N+V L+  C      + R      L+
Sbjct: 44  QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 103
Query: 397 YEFVSNGSLEKFIHEKHPLETNQKLKWEV--LYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++F          H+   L +N  +K+ +  + ++   +  GL Y+HR    +ILH D+K
Sbjct: 104 FDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMK 152
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGAR-GTIGYIAPEVFCRNFGEVSYKS 512
             N+L+  D   K++DFGLA+     + S  +    R  T+ Y  PE+     GE  Y  
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL---LGERDYGP 209
Query: 513 --DVYSYGMMVFEM 524
             D++  G ++ EM
Sbjct: 210 PIDLWGAGCIMAEM 223

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 137
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 190
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 191 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 223

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 81/182 (44%), Gaps = 18/182 (9%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VA+K++++T+ N    +    EV      +H NIV L           L+ E+ S G 
Sbjct: 40  KEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGE 99
Query: 405 L-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           + +  +      E   + K+         I   ++Y H+     I+H D+K  N+LLD D
Sbjct: 100 VFDYLVAHGRXKEKEARAKFR-------QIVSAVQYCHQKF---IVHRDLKAENLLLDAD 149
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFG +        + +  GA     Y APE+F     +   + DV+S G++++ 
Sbjct: 150 XNIKIADFGFSNEFTFGNKLDAFCGAP---PYAAPELFQGKKYD-GPEVDVWSLGVILYT 205
Query: 524 MT 525
           + 
Sbjct: 206 LV 207

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 158
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 159 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 211
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 212 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 244

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 139
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 140 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 192
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 193 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 225

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 137
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 190
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 191 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 223

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 137
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 190
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 191 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 223

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 379 NIVTLLGFCFEGHRR--ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           NIV LL    + H +  +LI+E+V+N   +      +P  T+  +++ +       + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL----YPTLTDYDIRYYI-----YELLKA 137
Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICE-GRESIVSMTGARGTIG 494
           L+Y H   +  I+H D+KPHN+++D +    ++ D+GLA+    G+E  V +        
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---- 190
Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +  PE+   +  +  Y  D++S G M   M   K
Sbjct: 191 FKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 223

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +G    +     
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC---- 220
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT  Y+APE+        +   D ++ G++++EM  
Sbjct: 221 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAA 254

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 18/148 (12%)
Query: 380 IVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
            +T L  CF+   R   + E+V+ G L   I +    +        V Y  A  IA GL 
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFY--AAEIAIGLF 456
Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRESIVSMTGARGTIGYI 496
           +L    +  I++ D+K  N++LD +   KI+DFG+ K  I +G    V+     GT  YI
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDYI 509
Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           APE+    +       D +++G++++EM
Sbjct: 510 APEIIA--YQPYGKSVDWWAFGVLLYEM 535

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 22/179 (12%)
Query: 351 AIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL-E 406
           A K++N  K +  DF  +   A I R   H NIV L     E     L+++ V+ G L E
Sbjct: 35  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 94
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---ED 463
             +  +   E +       + +I   IA    Y H   +  I+H ++KP N+LL    + 
Sbjct: 95  DIVAREFYSEADAS---HCIQQILESIA----YCH---SNGIVHRNLKPENLLLASKAKG 144
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
              K++DFGLA      E+     G  GT GY++PEV  ++    S   D+++ G++++
Sbjct: 145 AAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILY 198

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 348 QNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLGFC---FEGHRRA-----LI 396
           Q VA+K +   NE +G     + E+  +    H N+V L+  C      + R      L+
Sbjct: 44  QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 103
Query: 397 YEFVSNGSLEKFIHEKHPLETNQKLKWEV--LYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++F          H+   L +N  +K+ +  + ++   +  GL Y+HR    +ILH D+K
Sbjct: 104 FDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMK 152
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGAR-GTIGYIAPEVFCRNFGEVSYKS 512
             N+L+  D   K++DFGLA+     + S  +    R  T+ Y  PE+     GE  Y  
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL---LGERDYGP 209
Query: 513 --DVYSYGMMVFEM 524
             D++  G ++ EM
Sbjct: 210 PIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 348 QNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLLGFC---FEGHRRA-----LI 396
           Q VA+K +   NE +G     + E+  +    H N+V L+  C      + R      L+
Sbjct: 43  QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 102
Query: 397 YEFVSNGSLEKFIHEKHPLETNQKLKWEV--LYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           ++F          H+   L +N  +K+ +  + ++   +  GL Y+HR    +ILH D+K
Sbjct: 103 FDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMK 151
Query: 455 PHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGAR-GTIGYIAPEVFCRNFGEVSYKS 512
             N+L+  D   K++DFGLA+     + S  +    R  T+ Y  PE+     GE  Y  
Sbjct: 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL---LGERDYGP 208
Query: 513 --DVYSYGMMVFEM 524
             D++  G ++ EM
Sbjct: 209 PIDLWGAGCIMAEM 222

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 83/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VA++++++T+ N    +    EV  +   +H NIV L           L+ E+ S G 
Sbjct: 40  KEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +  +      L  + ++K +        I   ++Y H+     I+H D+K  N+LLD D 
Sbjct: 100 VFDY------LVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADM 150
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFG +        + +  G+     Y APE+F     +   + DV+S G++++ +
Sbjct: 151 NIKIADFGFSNEFTFGNKLDTFCGSP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTL 206
Query: 525 T 525
Sbjct: 207 V 207

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 110 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEM 524
           G ++ EM
Sbjct: 212 GCIMGEM 218

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 22/187 (11%)
Query: 351 AIKVLNETKGNGEDFI-NEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKF 408
           A+K++ +  G+    +  EV ++ +   + NI+ L+ F  +  R  L++E +  GS+   
Sbjct: 42  AVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAH 101
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDFCP 466
           I ++      +        ++   +A  L++LH      I H D+KP NIL +  E   P
Sbjct: 102 IQKQKHFNEREA------SRVVRDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSP 152
Query: 467 -KISDFGLAKICEGRESIVSMTGAR-----GTIGYIAP---EVFCRNFGEVSYKSDVYSY 517
            KI DF L    +   S   +T        G+  Y+AP   EVF         + D++S 
Sbjct: 153 VKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSL 212
Query: 518 GMMVFEM 524
           G++++ M
Sbjct: 213 GVVLYIM 219

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 10/97 (10%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  I    EYLH   +  +++ D+KP N+L+D+    +++DFG AK  +GR   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG 526
            GT   +APE+        +   D ++ G++++EM  
Sbjct: 200 -GTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAA 233

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 55  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 114
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 115 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 163
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 164 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDLWSV 216
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 217 GCIMGEMVCHK 227

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 83/182 (45%), Gaps = 18/182 (9%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VA+K++++T+ N    +    EV  +   +H NIV L           L+ E+ S G 
Sbjct: 33  KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 92
Query: 405 LEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           +  ++     + E   + K+         I   ++Y H+     I+H D+K  N+LLD D
Sbjct: 93  VFDYLVAHGWMKEKEARAKFR-------QIVSAVQYCHQKF---IVHRDLKAENLLLDAD 142
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
              KI+DFG +        + +  G+     Y APE+F     +   + DV+S G++++ 
Sbjct: 143 MNIKIADFGFSNEFTFGNKLDTFCGSP---PYAAPELFQGKKYD-GPEVDVWSLGVILYT 198
Query: 524 MT 525
           + 
Sbjct: 199 LV 200

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 18/148 (12%)
Query: 380 IVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
            +T L  CF+   R   + E+V+ G L   I +    +        V Y  A  IA GL 
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFY--AAEIAIGLF 135
Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICEGRESIVSMTGARGTIGYI 496
           +L    +  I++ D+K  N++LD +   KI+DFG+ K  I +G    V+     GT  YI
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDYI 188
Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           APE+    +       D +++G++++EM
Sbjct: 189 APEIIA--YQPYGKSVDWWAFGVLLYEM 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 23/183 (12%)
Query: 348 QNVAIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q  A  ++N  K +  D   +   A I R   H NIV L     E     LI++ V+ G 
Sbjct: 37  QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 96
Query: 405 L-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           L E  +  ++  E +           +  I + LE +       ++H ++KP N+LL   
Sbjct: 97  LFEDIVAREYYSEADA----------SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK 146
Query: 464 F---CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGM 519
                 K++DFGLA   EG +   +  G  GT GY++PEV  ++ +G+     D+++ G+
Sbjct: 147 LKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGK---PVDLWACGV 201
Query: 520 MVF 522
           +++
Sbjct: 202 ILY 204

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 71/141 (50%), Gaps = 18/141 (12%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR---GCNTR--IL 449
           LI  +  +GSL  F+         Q L+  +  ++AV  A GL +LH    G   +  I 
Sbjct: 83  LITHYHEHGSLYDFLQR-------QTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIA 135
Query: 450 HFDIKPHNILLDEDFCPKISDFGLAKI-CEGRESIVSMTGAR-GTIGYIAPEVF---CRN 504
           H D K  N+L+  +    I+D GLA +  +G + +      R GT  Y+APEV     R 
Sbjct: 136 HRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRT 195
Query: 505 FGEVSYK-SDVYSYGMMVFEM 524
               SYK +D++++G++++E+
Sbjct: 196 DCFESYKWTDIWAFGLVLWEI 216

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 83/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VA+K++++T+ N    +    EV  +   +H NIV L           L+ E+ S G 
Sbjct: 41  REVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGE 100
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +  +      L  + ++K +        I   ++Y H+     I+H D+K  N+LLD D 
Sbjct: 101 VFDY------LVAHGRMKEKEARAKFRQIVSAVQYCHQKY---IVHRDLKAENLLLDGDM 151
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFG +        + +  G+     Y APE+F     +   + DV+S G++++ +
Sbjct: 152 NIKIADFGFSNEFTVGNKLDTFCGSP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTL 207
Query: 525 T 525
Sbjct: 208 V 208

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 52  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 111
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 112 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 160
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+       +V     R    Y APEV       + YK   D++S 
Sbjct: 161 VKSDCTLKILDFGLARTAGTSFMMVPFVVTR---YYRAPEVIL----GMGYKENVDIWSV 213
Query: 518 GMMVFEM 524
           G ++ EM
Sbjct: 214 GCIMGEM 220

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 103
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 104 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 152
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 153 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG----MGYKENVDLWSV 205
Query: 518 GMMVFEMTGEK 528
           G ++ EM   K
Sbjct: 206 GCIMGEMVCHK 216

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 4/78 (5%)
Query: 450 HFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS 509
           H D+KP NIL+  D    + DFG+A      E +  +    GT+ Y APE F  +    +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYXAPERFSES--HAT 213
Query: 510 YKSDVYSYGMMVFE-MTG 526
           Y++D+Y+   +++E +TG
Sbjct: 214 YRADIYALTCVLYECLTG 231

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 111 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 159
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 160 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 212
Query: 518 GMMVFEM 524
           G ++ EM
Sbjct: 213 GCIMGEM 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 110 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEM 524
           G ++ EM
Sbjct: 212 GCIMGEM 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 348 QNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           + VA++++++T+ N    +    EV  +   +H NIV L           L+ E+ S G 
Sbjct: 40  KEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
           +  +      L  + ++K +        I   ++Y H+     I+H D+K  N+LLD D 
Sbjct: 100 VFDY------LVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADM 150
Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
             KI+DFG +        +    G+     Y APE+F     +   + DV+S G++++ +
Sbjct: 151 NIKIADFGFSNEFTFGNKLDEFCGSP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTL 206
Query: 525 T 525
Sbjct: 207 V 207

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 28/187 (14%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 110 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSY 517
           +  D   KI DFGLA+      +   MT    T  Y APEV       + YK   D++S 
Sbjct: 159 VKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSV 211
Query: 518 GMMVFEM 524
           G ++ EM
Sbjct: 212 GCIMGEM 218

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 26/186 (13%)
Query: 349 NVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEFV 400
           NVA+K L+   + + + +    E+  +   +H NI++LL         E  +   +   +
Sbjct: 51  NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
            + +L + IH    +E + +    +LY++  GI    ++LH   +  I+H D+KP NI++
Sbjct: 111 MDANLCQVIH----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIVV 159
Query: 461 DEDFCPKISDFGLAKI-CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM 519
             D   KI DFGLA+  C        MT    T  Y APEV     G  +   D++S G 
Sbjct: 160 KSDCTLKILDFGLARTACTN----FMMTPYVVTRYYRAPEVIL-GMGYAA-NVDIWSVGC 213
Query: 520 MVFEMT 525
           ++ E+ 
Sbjct: 214 IMGELV 219

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 366 INEVASISRTSHVNIVTLLGF----CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKL 421
           + E+  +    H NI+T+        FE      I + +    L + I       + Q L
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-------STQML 109
Query: 422 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE--- 478
             + +        R ++ LH G N  ++H D+KP N+L++ +   K+ DFGLA+I +   
Sbjct: 110 SDDHIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 479 -------GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
                  G++S   M     T  Y APEV   +  + S   DV+S G ++ E+
Sbjct: 167 ADNSEPTGQQS--GMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 27/183 (14%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           VA+K +   +   E+   E+ +     H NIV            A++ E+ S G L E+ 
Sbjct: 46  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 105
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-- 466
            +     E   +  ++ L         G+ Y H     ++ H D+K  N LLD    P  
Sbjct: 106 CNAGRFSEDEARFFFQQLIS-------GVSYCH---AMQVCHRDLKLENTLLDGSPAPRL 155
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIG---YIAPEVFCRNF--GEVSYKSDVYSYGMMV 521
           KI DFG +K      S V  +  + T+G   YIAPEV  +    G+V   +DV+S G+ +
Sbjct: 156 KICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV---ADVWSCGVTL 206
Query: 522 FEM 524
           + M
Sbjct: 207 YVM 209

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 23/180 (12%)
Query: 351 AIKVLNETKGNGEDF--INEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSL-E 406
           A K++N  K +  D   +   A I R   H NIV L     E     L+++ V+ G L E
Sbjct: 33  AAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFE 92
Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---ED 463
             +  ++  E +           +  I + LE +       ++H D+KP N+LL    + 
Sbjct: 93  DIVAREYYSEADA----------SHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKG 142
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVF 522
              K++DFGLA   +G +   +  G  GT GY++PEV  +  +G+     D+++ G++++
Sbjct: 143 AAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRKEAYGK---PVDIWACGVILY 197

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 15/170 (8%)
Query: 361 NGEDFIN-EVASISRTSHVNIVTLLGFCF--EGHRRALIYEFVSNGSLEKFIHEKHPLET 417
           NGE  +  E+  + R  H N++ L+   +  E  +  ++ E+   G  E        L++
Sbjct: 48  NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEM-------LDS 100
Query: 418 NQKLKWEV--LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 475
             + ++ V   +     +  GLEYLH   +  I+H DIKP N+LL      KIS  G+A+
Sbjct: 101 VPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157
Query: 476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
                 +  +   ++G+  +  PE+         +K D++S G+ ++ +T
Sbjct: 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNIT 207

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 40/197 (20%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 110 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGE------VSYKS- 512
           +  D   KI DFGLA+               GT   + PEV  R +        + YK  
Sbjct: 159 VKSDCTLKILDFGLARTA-------------GTSFMMEPEVVTRYYRAPEVILGMGYKEN 205
Query: 513 -DVYSYGMMVFEMTGEK 528
            D++S G ++ EM   K
Sbjct: 206 VDIWSVGCIMGEMVCHK 222

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 21/183 (11%)
Query: 348 QNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS 404
           Q VAIK   E++ +    +  + E+  + +  H N+V LL       R  L++E+  +  
Sbjct: 29  QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV 88
Query: 405 LEKFIHEKHPLETNQKLKWEVLYK-IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED 463
           L       H L+  Q+   E L K I     + + + H+      +H D+KP NIL+ + 
Sbjct: 89  L-------HELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKH 138
Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMV 521
              K+ DFG A++  G         A  T  Y +PE+     G+  Y    DV++ G + 
Sbjct: 139 SVIKLCDFGFARLLTGPSDYYDDEVA--TRWYRSPELLV---GDTQYGPPVDVWAIGCVF 193
Query: 522 FEM 524
            E+
Sbjct: 194 AEL 196

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
           A  IA  L YLH   +  I++ D+KP NILLD      ++DFGL K  E  E   + +  
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTF 199
Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
            GT  Y+APEV  +         D +  G +++EM
Sbjct: 200 CGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEM 232

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 58/117 (49%), Gaps = 11/117 (9%)
Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA-KICEGRESI 483
           +L K+ V I + L YL       ++H D+KP NILLDE    K+ DFG++ ++ + +   
Sbjct: 125 ILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182
Query: 484 VSMTGARGTIGYIAPEVF---CRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVD 536
            S     G   Y+APE          +   ++DV+S G+ + E+ TG+    N   D
Sbjct: 183 RSA----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 40/197 (20%)
Query: 348 QNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLGF-----CFEGHRRALIYEF 399
           +NVAIK L+   + + + +    E+  +   +H NI+ LL         E  +   I   
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 459
           + + +L + I     +E + +    +LY++  GI    ++LH   +  I+H D+KP NI+
Sbjct: 110 LMDANLCQVIQ----MELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIV 158
Query: 460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGE------VSYKS- 512
           +  D   KI DFGLA+               GT   + PEV  R +        + YK  
Sbjct: 159 VKSDCTLKILDFGLARTA-------------GTSFMMEPEVVTRYYRAPEVILGMGYKEN 205
Query: 513 -DVYSYGMMVFEMTGEK 528
            D++S G ++ EM   K
Sbjct: 206 VDLWSVGCIMGEMVCHK 222

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 29/183 (15%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E +G       E+   S   H NI+ +  +  +  R  L+ EF   G L
Sbjct: 42  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            K       L+ + +   +        +A  L Y H     +++H DIKP N+L+     
Sbjct: 102 YK------ELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGE 152
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   +   E   K D++  G++
Sbjct: 153 LKIADFGW--------SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDE---KVDLWCAGVL 201
Query: 521 VFE 523
            +E
Sbjct: 202 CYE 204

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 59/126 (46%), Gaps = 16/126 (12%)
Query: 402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL- 460
           NGS+  F   +  L+  Q+ K  ++  I   I   L YLH   N  I H DIKP N L  
Sbjct: 151 NGSIHGF---RESLDFVQREK--LISNIMRQIFSALHYLH---NQGICHRDIKPENFLFS 202
Query: 461 -DEDFCPKISDFGLA----KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVY 515
            ++ F  K+ DFGL+    K+  G      MT   GT  ++APEV          K D +
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNG--EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 516 SYGMMV 521
           S G+++
Sbjct: 261 SAGVLL 266

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 29/183 (15%)
Query: 350 VAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           +A+KVL     E +G       E+   S   H NI+ +  +  +  R  L+ EF   G L
Sbjct: 43  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 102
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            K       L+ + +   +        +A  L Y H     +++H DIKP N+L+     
Sbjct: 103 YK------ELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGE 153
Query: 466 PKISDFGLAKICEGRESIVSMTGAR----GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMM 520
            KI+DFG         S+ + +  R    GT+ Y+ PE+   +   E   K D++  G++
Sbjct: 154 LKIADFGW--------SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDE---KVDLWCAGVL 202
Query: 521 VFE 523
            +E
Sbjct: 203 CYE 205

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 32/191 (16%)
Query: 348 QNVAIKVLNETKGNG------EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS 401
           Q  A+K+++  K         ED   E +      H +IV LL          +++EF+ 
Sbjct: 50  QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 109
Query: 402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVG------IARGLEYLHRGCNTRILHFDIKP 455
              L          E  ++     +Y  AV       I   L Y H   +  I+H D+KP
Sbjct: 110 GADL--------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKP 158
Query: 456 HNILL--DEDFCP-KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYK 511
           H +LL   E+  P K+  FG+A I  G   +V+  G  GT  ++APEV  R  +G+    
Sbjct: 159 HCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVKREPYGK---P 213
Query: 512 SDVYSYGMMVF 522
            DV+  G+++F
Sbjct: 214 VDVWGCGVILF 224

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 32/191 (16%)
Query: 348 QNVAIKVLNETKGNG------EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS 401
           Q  A+K+++  K         ED   E +      H +IV LL          +++EF+ 
Sbjct: 52  QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 111
Query: 402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVG------IARGLEYLHRGCNTRILHFDIKP 455
              L          E  ++     +Y  AV       I   L Y H   +  I+H D+KP
Sbjct: 112 GADL--------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKP 160
Query: 456 HNILL--DEDFCP-KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN-FGEVSYK 511
           H +LL   E+  P K+  FG+A I  G   +V+  G  GT  ++APEV  R  +G+    
Sbjct: 161 HCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVKREPYGK---P 215
Query: 512 SDVYSYGMMVF 522
            DV+  G+++F
Sbjct: 216 VDVWGCGVILF 226

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 25/182 (13%)
Query: 350 VAIKVL----NETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           VA+KVL     E +G       E+   +   H NI+ L  + ++  R  LI E+   G L
Sbjct: 51  VALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL 110
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
            K       L+ +     +    I   +A  L Y H     +++H DIKP N+LL     
Sbjct: 111 YK------ELQKSCTFDEQRTATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGE 161
Query: 466 PKISDFGLAKICEG--RESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVF 522
            KI+DFG +       R+++       GT+ Y+ PE+   R   E   K D++  G++ +
Sbjct: 162 LKIADFGWSVHAPSLRRKTMC------GTLDYLPPEMIEGRMHNE---KVDLWCIGVLCY 212
Query: 523 EM 524
           E+
Sbjct: 213 EL 214

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 27/183 (14%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           VA+K +   +    +   E+ +     H NIV            A++ E+ S G L E+ 
Sbjct: 47  VAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 106
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-- 466
            +     E   +  ++ L         G+ Y H     ++ H D+K  N LLD    P  
Sbjct: 107 CNAGRFSEDEARFFFQQLIS-------GVSYCH---AMQVCHRDLKLENTLLDGSPAPRL 156
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIG---YIAPEVFCRNF--GEVSYKSDVYSYGMMV 521
           KI DFG +K      S V  +  + T+G   YIAPEV  +    G+V   +DV+S G+ +
Sbjct: 157 KICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV---ADVWSCGVTL 207
Query: 522 FEM 524
           + M
Sbjct: 208 YVM 210

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 22/188 (11%)
Query: 348 QNVAIKVLNETKGNGEDFI-NEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSNGSL 405
           Q  A+K++ +  G+    +  EV  + +   H N++ L+ F  E  R  L++E +  GS+
Sbjct: 39  QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98
Query: 406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--D 463
              IH++       +L+  V+ +    +A  L++LH   N  I H D+KP NIL +    
Sbjct: 99  LSHIHKRRHF---NELEASVVVQ---DVASALDFLH---NKGIAHRDLKPENILCEHPNQ 149
Query: 464 FCP-KISDFGLAKICE--GRESIVS---MTGARGTIGYIAPEV---FCRNFGEVSYKSDV 514
             P KI DFGL    +  G  S +S   +    G+  Y+APEV   F         + D+
Sbjct: 150 VSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDL 209
Query: 515 YSYGMMVF 522
           +S G++++
Sbjct: 210 WSLGVILY 217

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 30/146 (20%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEF-VSNGSLEKFIHEKHPLETNQKLKWE-----VLYKIA 430
           H N++    +C E   R L     + N +L+  +  K+  + N KL+ E     +L +IA
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 431 VGIARGLEYLHRGCNTRILHFDIKPHNILLD-------------EDFCPKISDFGL-AKI 476
            G+A    +LH   + +I+H D+KP NIL+              E+    ISDFGL  K+
Sbjct: 126 SGVA----HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 477 CEGRESI-VSMTGARGTIGYIAPEVF 501
             G+ S   ++    GT G+ APE+ 
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELL 204

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 25/148 (16%)
Query: 395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVG-IARGLEYLHRGCNTRILHFDI 453
           LI ++++ G L   + ++     ++        +I VG I   LE+LH+     I++ DI
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHE-------VQIYVGEIVLALEHLHK---LGIIYRDI 185
Query: 454 KPHNILLDEDFCPKISDFGLAK--ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYK 511
           K  NILLD +    ++DFGL+K  + +  E         GTI Y+AP++           
Sbjct: 186 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC---GTIEYMAPDIVRGGDSGHDKA 242
Query: 512 SDVYSYGMMVFEMT---------GEKNN 530
            D +S G++++E+          GEKN+
Sbjct: 243 VDWWSLGVLMYELLTGASPFTVDGEKNS 270

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 31/168 (18%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEF-VSNGSLEKFIHEKHPLETNQKLKWE-----VLYKIA 430
           H N++    +C E   R L     + N +L+  +  K+  + N KL+ E     +L +IA
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 431 VGIARGLEYLHRGCNTRILHFDIKPHNILLD-------------EDFCPKISDFGLAKIC 477
            G+A    +LH   + +I+H D+KP NIL+              E+    ISDFGL K  
Sbjct: 144 SGVA----HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 478 EGRESIV--SMTGARGTIGYIAPEVFCRNFGEVSYKS-DVYSYGMMVF 522
           +  +     ++    GT G+ APE+   +      +S D++S G + +
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY 244

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/47 (44%), Positives = 32/47 (68%), Gaps = 4/47 (8%)
Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKICE 478
           + RGL+Y+H   +  +LH D+KP N+ ++ ED   KI DFGLA+I +
Sbjct: 129 LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 31/168 (18%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEF-VSNGSLEKFIHEKHPLETNQKLKWE-----VLYKIA 430
           H N++    +C E   R L     + N +L+  +  K+  + N KL+ E     +L +IA
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 431 VGIARGLEYLHRGCNTRILHFDIKPHNILLD-------------EDFCPKISDFGLAKIC 477
            G+A    +LH   + +I+H D+KP NIL+              E+    ISDFGL K  
Sbjct: 144 SGVA----HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 478 EGRESIV--SMTGARGTIGYIAPEVFCRNFGEVSYKS-DVYSYGMMVF 522
           +  +     ++    GT G+ APE+   +      +S D++S G + +
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY 244

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 15/100 (15%)
Query: 429 IAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG-LAKICEGRESIVSMT 487
           IA+     L Y+HR         DIKP NIL+D +   +++DFG   K+ E  +  V  +
Sbjct: 186 IAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSS 234
Query: 488 GARGTIGYIAPEVF-CRNFGEVSY--KSDVYSYGMMVFEM 524
            A GT  YI+PE+      G+  Y  + D +S G+ ++EM
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 424 EVLYKIAVGIARGLEYLHR---GCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           E + K+A+  A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +
Sbjct: 126 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 185
Query: 479 GRESIVSMTGAR--GTIGYIAPEVF-----CRNFGEVSYKSDVYSYGMMVFEM 524
                + +      GT  Y+APEV       ++F E   ++D+Y+ G++ +E+
Sbjct: 186 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF-ESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 424 EVLYKIAVGIARGLEYLHR---GCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           E + K+A+  A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198
Query: 479 GRESIVSMTGAR--GTIGYIAPEVF-----CRNFGEVSYKSDVYSYGMMVFEM 524
                + +      GT  Y+APEV       ++F E   ++D+Y+ G++ +E+
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF-ESFKRADIYAMGLVFWEI 250

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 13/114 (11%)
Query: 424 EVLYKIAVGIARGLEYLHR---GCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           E + K+A+  A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +
Sbjct: 101 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 160
Query: 479 GRESIVSMTGAR--GTIGYIAPEVF-----CRNFGEVSYKSDVYSYGMMVFEMT 525
                + +      GT  Y+APEV       ++F E   ++D+Y+ G++ +E+ 
Sbjct: 161 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF-ESFKRADIYAMGLVFWEIA 213

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 27/183 (14%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           VA+K +   +   E+   E+ +     H NIV            A++ E+ S G L E+ 
Sbjct: 47  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 106
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-- 466
            +     E   +  ++ L         G+ Y H     ++ H D+K  N LLD    P  
Sbjct: 107 CNAGRFSEDEARFFFQQLIS-------GVSYCH---AMQVCHRDLKLENTLLDGSPAPRL 156
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIG---YIAPEVFCRNF--GEVSYKSDVYSYGMMV 521
           KI  FG +K      S V  +  + T+G   YIAPEV  +    G+V   +DV+S G+ +
Sbjct: 157 KICAFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV---ADVWSCGVTL 207
Query: 522 FEM 524
           + M
Sbjct: 208 YVM 210

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 13/114 (11%)
Query: 424 EVLYKIAVGIARGLEYLHR---GCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           E + K+A+  A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +
Sbjct: 106 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 165
Query: 479 GRESIVSMTGAR--GTIGYIAPEVF-----CRNFGEVSYKSDVYSYGMMVFEMT 525
                + +      GT  Y+APEV       ++F E   ++D+Y+ G++ +E+ 
Sbjct: 166 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF-ESFKRADIYAMGLVFWEIA 218

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 13/114 (11%)
Query: 424 EVLYKIAVGIARGLEYLHR---GCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           E + K+A+  A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159
Query: 479 GRESIVSMTGAR--GTIGYIAPEVF-----CRNFGEVSYKSDVYSYGMMVFEMT 525
                + +      GT  Y+APEV       ++F E   ++D+Y+ G++ +E+ 
Sbjct: 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF-ESFKRADIYAMGLVFWEIA 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 13/114 (11%)
Query: 424 EVLYKIAVGIARGLEYLHR---GCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           E + K+A+  A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +
Sbjct: 103 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 162
Query: 479 GRESIVSMTGAR--GTIGYIAPEVF-----CRNFGEVSYKSDVYSYGMMVFEMT 525
                + +      GT  Y+APEV       ++F E   ++D+Y+ G++ +E+ 
Sbjct: 163 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF-ESFKRADIYAMGLVFWEIA 215

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 30/146 (20%)
Query: 377 HVNIVTLLGFCFEGHRRALIYEF-VSNGSLEKFIHEKHPLETNQKLKWE-----VLYKIA 430
           H N++    +C E   R L     + N +L+  +  K+  + N KL+ E     +L +IA
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 431 VGIARGLEYLHRGCNTRILHFDIKPHNILLD-------------EDFCPKISDFGLAKIC 477
            G+A    +LH   + +I+H D+KP NIL+              E+    ISDFGL K  
Sbjct: 126 SGVA----HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 478 EGRESIV--SMTGARGTIGYIAPEVF 501
           +  +     ++    GT G+ APE+ 
Sbjct: 179 DSGQXXFRXNLNNPSGTSGWRAPELL 204

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 27/183 (14%)
Query: 350 VAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKF 408
           VA+K +   +   E+   E+ +     H NIV            A++ E+ S G L E+ 
Sbjct: 47  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 106
Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-- 466
            +     E   +  ++ L         G+ Y H     ++ H D+K  N LLD    P  
Sbjct: 107 CNAGRFSEDEARFFFQQLIS-------GVSYCH---AMQVCHRDLKLENTLLDGSPAPRL 156
Query: 467 KISDFGLAKICEGRESIVSMTGARGTIG---YIAPEVFCRNF--GEVSYKSDVYSYGMMV 521
           KI  FG +K      S V  +  + T+G   YIAPEV  +    G+V   +DV+S G+ +
Sbjct: 157 KICAFGYSK------SSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKV---ADVWSCGVTL 207
Query: 522 FEM 524
           + M
Sbjct: 208 YVM 210

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	638
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-112
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-94
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-72
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-71
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-66
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-65
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-62
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-62
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-61
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-61
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-53
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  338 bits (868), Expect = e-112
 Identities = 113/297 (38%), Positives = 174/297 (58%), Gaps = 12/297 (4%)

Query: 312 PKRYRYADIKKMTNSF--KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGED--FIN 367
            KR+   +++  +++F  KN LG+GG+G VYKG+L DG  VA+K L E +  G +  F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 368 EVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLY 427
           EV  IS   H N++ L GFC     R L+Y +++NGS+   + E+    +   L W    
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQ 134

Query: 428 KIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMT 487
           +IA+G ARGL YLH  C+ +I+H D+K  NILLDE+F   + DFGLAK+ + +++ V+ T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-T 193

Query: 488 GARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHW 546
             RGTIG+IAPE      G+ S K+DV+ YG+M+ E+ TG++      +    ++    W
Sbjct: 194 AVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 547 VYKRLELEEDLGL--QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG 601
           V   L+ ++   L    ++     E   ++I V+L C Q++P +RP M+ VV MLEG
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  296 bits (759), Expect = 1e-95
 Identities = 108/308 (35%), Positives = 166/308 (53%), Gaps = 30/308 (9%)

Query: 313 KRYRYADIKKMTNSF--KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGED-FINEV 369
            R    D+++ TN+F  K  +G G +G VYKG L DG  VA+K        G + F  E+
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
            ++S   H ++V+L+GFC E +   LIY+++ NG+L++ ++          + WE   +I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEI 144

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-EGRESIVSMTG 488
            +G ARGL YLH      I+H D+K  NILLDE+F PKI+DFG++K   E  ++ +S T 
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TV 200

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRS---SEIYFP 544
            +GT+GYI PE F +  G ++ KSDVYS+G+++FE+          A+ +S     +   
Sbjct: 201 VKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARS-----AIVQSLPREMVNLA 253

Query: 545 HWVYKRLE---LEE--DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
            W  +      LE+  D  L     +   E  RK    ++ C+  +  DRPSM  V+  L
Sbjct: 254 EWAVESHNNGQLEQIVDPNLAD---KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

Query: 600 EGSLDSLQ 607
           E +L  LQ
Sbjct: 311 EYAL-RLQ 317

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  291 bits (748), Expect = 2e-94
 Identities = 93/318 (29%), Positives = 152/318 (47%), Gaps = 40/318 (12%)

Query: 309 SLAPKRYRYADIKKMTNSFK--------NKLGQGGYGGVYKGKLLDGQNVAIKVLNETK- 359
                 + + ++K +TN+F         NK+G+GG+G VYKG  ++   VA+K L     
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 67

Query: 360 -----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP 414
                   + F  E+  +++  H N+V LLGF  +G    L+Y ++ NGSL   +     
Sbjct: 68  ITTEELKQQ-FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-- 124

Query: 415 LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 474
            +    L W +  KIA G A G+ +LH       +H DIK  NILLDE F  KISDFGLA
Sbjct: 125 -DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180

Query: 475 KIC-EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNAN 532
           +   +  +++++ +   GT  Y+APE      GE++ KSD+YS+G+++ E+ TG      
Sbjct: 181 RASEKFAQTVMT-SRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPA--- 233

Query: 533 VAVDRS-SEIYFPHWVYKRLELEEDLGLQGIE----NEEDKEYARKMILVSLWCIQTNPS 587
             VD             +    +E+  ++       N+ D      M  V+  C+    +
Sbjct: 234 --VDEHREPQLLLDIKEEI--EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKN 289

Query: 588 DRPSMNRVVEMLEGSLDS 605
            RP + +V ++L+    S
Sbjct: 290 KRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  234 bits (599), Expect = 5e-72
 Identities = 75/308 (24%), Positives = 118/308 (38%), Gaps = 33/308 (10%)

Query: 317 YADIKKMTNSFK--NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISR 374
             ++   +   +      +G +G V+K +L   + VA+K+             EV S+  
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPG 74

Query: 375 TSHVNIVTLLGFCFEGHRRA----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIA 430
             H NI+  +G    G        LI  F   GSL  F+           + W  L  IA
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-------ANVVSWNELCHIA 127

Query: 431 VGIARGLEYLH-------RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI 483
             +ARGL YLH        G    I H DIK  N+LL  +    I+DFGLA   E  +S 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 484 VSMTGARGTIGYIAPEVF---CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE 540
               G  GT  Y+APEV         +   + D+Y+ G++++E+      A+  VD    
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-EYM 246

Query: 541 IYFPHWVYKRLELEE---DLGLQGIENEEDKEYARKMILVSLW-----CIQTNPSDRPSM 592
           + F   + +   LE+    +  +         + +   +  L      C   +   R S 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 593 NRVVEMLE 600
             V E + 
Sbjct: 307 GCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  231 bits (591), Expect = 4e-71
 Identities = 82/293 (27%), Positives = 143/293 (48%), Gaps = 38/293 (12%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTL 383
            K K+G G +G V++ +   G +VA+K+L E   +     +F+ EVA + R  H NIV  
Sbjct: 41  IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           +G   +    +++ E++S GSL + +H+       ++L       +A  +A+G+ YLH  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKS---GAREQLDERRRLSMAYDVAKGMNYLH-N 155

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
            N  I+H ++K  N+L+D+ +  K+ DFGL+       + +S   A GT  ++APEV   
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS--RLKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 504 NFGEVSYKSDVYSYGMMVFEM-TGEK-----NNANVAVDRSSEIYFPHWVYKRLELEEDL 557
                + KSDVYS+G++++E+ T ++     N A V      +        KRLE+  +L
Sbjct: 214 E--PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-------CKRLEIPRNL 264

Query: 558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
                    + + A  +      C    P  RPS   ++++L   + S   PP
Sbjct: 265 ---------NPQVAAII----EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  217 bits (554), Expect = 5e-66
 Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 47/292 (16%)

Query: 327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNG--------EDFINEVASISRTSH 377
           ++ ++G+GG+G V+KG+L+ D   VAIK L      G        ++F  EV  +S  +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
            NIV L G         ++ EFV  G L   + +K        +KW V  ++ + IA G+
Sbjct: 83  PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-----AHPIKWSVKLRLMLDIALGI 135

Query: 438 EYLHRGCNTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICEGRESIVSMTGARGT 492
           EY+    N  I+H D++  NI L         C K++DFGL+     ++S+ S++G  G 
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGN 189

Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYK-- 549
             ++APE         + K+D YS+ M+++ + TGE            +I F + + +  
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY---SYGKIKFINMIREEG 246

Query: 550 -RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
            R  + ED                 +      C   +P  RP  + +V+ L 
Sbjct: 247 LRPTIPEDC---------PPRLRNVI----ELCWSGDPKKRPHFSYIVKELS 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  216 bits (553), Expect = 2e-65
 Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 44/304 (14%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            +  +G+G +G V K K    ++VAIK +       + FI E+  +SR +H NIV L G 
Sbjct: 12  VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
           C       L+ E+   GSL   +H   PL               +  ++G+ YLH     
Sbjct: 70  CLNPV--CLVMEYAEGGSLYNVLHGAEPLP---YYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 447 RILHFDIKPHNILLDEDF-CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
            ++H D+KP N+LL       KI DFG A      +    MT  +G+  ++APEVF  + 
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGS- 178

Query: 506 GEVSYKSDVYSYGMMVFEM-TGEK-----NNANVAVDRSSEIYFPHWVYK--RLELEEDL 557
              S K DV+S+G++++E+ T  K           +  +        V+   R  L ++L
Sbjct: 179 -NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA--------VHNGTRPPLIKNL 229

Query: 558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSS 617
                     K     M      C   +PS RPSM  +V+++   +        P     
Sbjct: 230 ---------PKPIESLM----TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276

Query: 618 GSQP 621
               
Sbjct: 277 QHSL 280

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  207 bits (528), Expect = 2e-62
 Identities = 61/287 (21%), Positives = 116/287 (40%), Gaps = 45/287 (15%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVT 382
           +F  KL +   G ++KG+   G ++ +KVL     +     DF  E   +   SH N++ 
Sbjct: 13  NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 383 LLGFCFE--GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
           +LG C         LI  ++  GSL   +HE     TN  +      K A+ +ARG+ +L
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEG----TNFVVDQSQAVKFALDMARGMAFL 127

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
           H      I    +   ++++DED   +IS   +              G      ++APE 
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179

Query: 501 FC-RNFGEVSYKSDVYSYGMMVFEM-TGEK-----NNANVAVDRSSEIYFPHWVYKRLEL 553
              +        +D++S+ ++++E+ T E      +N  + +  + E         R  +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-------RPTI 232

Query: 554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
              +             ++ M +    C+  +P+ RP  + +V +LE
Sbjct: 233 PPGI---------SPHVSKLMKI----CMNEDPAKRPKFDMIVPILE 266

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  206 bits (527), Expect = 3e-62
 Identities = 75/293 (25%), Positives = 119/293 (40%), Gaps = 53/293 (18%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVL-----NETKGNGEDFINEVASISRTSHVNIV 381
            +  +G GG+G VY+     G  VA+K        +     E+   E    +   H NI+
Sbjct: 11  LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
            L G C +     L+ EF   G L + +         +++  ++L   AV IARG+ YLH
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLS-------GKRIPPDILVNWAVQIARGMNYLH 122

Query: 442 RGCNTRILHFDIKPHNILLDEDFCP--------KISDFGLAKICEGRESIVSMTGARGTI 493
                 I+H D+K  NIL+ +            KI+DFGLA+         +   A G  
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAY 178

Query: 494 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEK-----NNANVAVDRSSEIYFPHWV 547
            ++APEV        S  SDV+SYG++++E+ TGE      +   VA   +         
Sbjct: 179 AWMAPEVI--RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL----- 231

Query: 548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
              L +              + +A+ M      C   +P  RPS   +++ L 
Sbjct: 232 --ALPIPSTC---------PEPFAKLM----EDCWNPDPHSRPSFTNILDQLT 269

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  208 bits (531), Expect = 5e-62
 Identities = 73/321 (22%), Positives = 116/321 (36%), Gaps = 44/321 (13%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINE--VASISRTSHVNIVTL 383
                +G+G YG VYKG L D + VA+KV   +  N ++FINE  +  +    H NI   
Sbjct: 16  KLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARF 72

Query: 384 LGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           +               L+ E+  NGSL K++             W    ++A  + RGL 
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-------LHTSDWVSSCRLAHSVTRGLA 125

Query: 439 YLH------RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI------CEGRESIVSM 486
           YLH            I H D+   N+L+  D    ISDFGL+            E   + 
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 487 TGARGTIGYIAPEVF-----CRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSE 540
               GTI Y+APEV       R+      + D+Y+ G++ +E+     +          +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

Query: 541 IYFPHWVYKRLELEEDLGLQGIENE---------EDKEYARKMILVSLWCIQTNPSDRPS 591
           + F   V      E+   L   E +         E+    R +      C   +   R +
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305

Query: 592 MNRVVEMLEGSLDSLQIPPRP 612
                E +   +   +     
Sbjct: 306 AQXAEERMAELMMIWERNKSV 326

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  205 bits (525), Expect = 1e-61
 Identities = 82/288 (28%), Positives = 134/288 (46%), Gaps = 45/288 (15%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGE---DFINEVASISRTSHVNIVTL 383
              ++G G +G VYKGK     +VA+K+LN T    +    F NEV  + +T HVNI+  
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           +G+       A++ ++    SL   +H         K + + L  IA   ARG++YLH  
Sbjct: 86  MGYSTAPQL-AIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHA- 138

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC- 502
            +  I+H D+K +NI L ED   KI DFGLA                G+I ++APEV   
Sbjct: 139 KS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 503 RNFGEVSYKSDVYSYGMMVFE-MTGEK-----NNANVAVDRSSEIYFPHWV----YKRLE 552
           ++    S++SDVY++G++++E MTG+      NN +  +           +        +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII----------EMVGRGSLSPD 246

Query: 553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
           L +      + +   K   R M      C++    +RPS  R++  +E
Sbjct: 247 LSK------VRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEIE 284

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  205 bits (523), Expect = 4e-61
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 46/291 (15%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTL 383
               +G+G +G VY G+   G+ VAI++++   + +   + F  EV +  +T H N+V  
Sbjct: 37  IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           +G C      A+I       +L   + +         L      +IA  I +G+ YLH  
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLH-- 147

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKI---CEGRESIVSMTGARGTIGYIAPEV 500
               ILH D+K  N+  D      I+DFGL  I    +       +    G + ++APE+
Sbjct: 148 -AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 501 FCRNFGEV-------SYKSDVYSYGMMVFEM-TGE---KNNANVAVDRSSEIYFPHWVYK 549
             +   +        S  SDV++ G + +E+   E   K     A+     I+      K
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-----IWQMGTGMK 260

Query: 550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
               +  +          KE +  +    L+C      +RP+  ++++MLE
Sbjct: 261 PNLSQIGM---------GKEISDIL----LFCWAFEQEERPTFTKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  190 bits (485), Expect = 2e-55
 Identities = 70/307 (22%), Positives = 121/307 (39%), Gaps = 37/307 (12%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
              ++G+G YG V+ GK   G+ VA+KV   T+        E+       H NI+  +  
Sbjct: 41  MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 387 CFEGHRR----ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH- 441
             +G        LI ++  NGSL  ++        +  L  + + K+A     GL +LH 
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK-------STTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 442 ----RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV--SMTGARGTIGY 495
                     I H D+K  NIL+ ++    I+D GLA       + V        GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 496 IAPEVF-----CRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYK 549
           + PEV        +F +    +D+YS+G++++E+     +   V      ++ +   V  
Sbjct: 213 MPPEVLDESLNRNHF-QSYIMADMYSFGLILWEVARRCVSGGIV---EEYQLPYHDLVPS 268

Query: 550 RLELEEDLGLQGIEN---EEDKEYARKMILVSLW-----CIQTNPSDRPSMNRVVEMLEG 601
               E+   +  I+         ++    L  +      C   NP+ R +  RV + L  
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

Query: 602 SLDSLQI 608
             +S  I
Sbjct: 329 MSESQDI 335

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  186 bits (474), Expect = 3e-54
 Identities = 65/300 (21%), Positives = 116/300 (38%), Gaps = 39/300 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINE--VASISRTSHVNIVTLL 384
               +G+G YG V++G    G+NVA+K+ +    + + +  E  + +     H NI+  +
Sbjct: 12  LLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFI 68

Query: 385 GFCFEGHRRA----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
                    +    LI  +   GSL  ++           L      +I + IA GL +L
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-------LTTLDTVSCLRIVLSIASGLAHL 121

Query: 441 H-----RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV--SMTGARGTI 493
           H           I H D+K  NIL+ ++    I+D GLA +     + +        GT 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 494 GYIAPEVFCR--NFGEVSY--KSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVY 548
            Y+APEV              + D++++G++++E+     +N  V      +  F   V 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV---EDYKPPFYDVVP 238

Query: 549 KRLELEEDLGLQGIEN---EEDKEYARKMILVSLW-----CIQTNPSDRPSMNRVVEMLE 600
                E+   +  ++         +     L SL      C   NPS R +  R+ + L 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  185 bits (472), Expect = 9e-54
 Identities = 62/310 (20%), Positives = 112/310 (36%), Gaps = 55/310 (17%)

Query: 327 FKNKLGQGGYGGVYKGKLLD-GQNVAIKVL-NETKGNGEDFINEVASISRTSHVNIVTLL 384
               LG+G +G   K    + G+ + +K L    +     F+ EV  +    H N++  +
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G  ++  R   I E++  G+L   I        + +  W      A  IA G+ YLH   
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSM-----DSQYPWSQRVSFAKDIASGMAYLHS-M 127

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI------------VSMTGARGT 492
           N  I+H D+  HN L+ E+    ++DFGLA++    ++                    G 
Sbjct: 128 N--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEK-------NNANVAVDRSSEIYFP 544
             ++APE+   N      K DV+S+G+++ E +              +  ++        
Sbjct: 186 PYWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235

Query: 545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD 604
              +       +             +        + C   +P  RPS  ++   LE    
Sbjct: 236 VRGFLDRYCPPNC---------PPSFFPIT----VRCCDLDPEKRPSFVKLEHWLETLRM 282

Query: 605 SL--QIPPRP 612
            L   +P  P
Sbjct: 283 HLAGHLPLGP 292

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  185 bits (471), Expect = 2e-53
 Identities = 61/298 (20%), Positives = 118/298 (39%), Gaps = 35/298 (11%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            +  +G+G +G V++GK   G+ VA+K+ +  +        E+       H NI+  +  
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 387 CFEGHRRA----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH- 441
             + +       L+ ++  +GSL  +++          +  E + K+A+  A GL +LH 
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHM 157

Query: 442 ----RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV--SMTGARGTIGY 495
                     I H D+K  NIL+ ++    I+D GLA   +     +  +     GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 496 IAPEVF----CRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKR 550
           +APEV          E   ++D+Y+ G++ +E+                ++ +   V   
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH---EDYQLPYYDLVPSD 274

Query: 551 LELEEDLGLQGIENE--------EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
             +EE   +   +          +  E  R M  +   C   N + R +  R+ + L 
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  149 bits (378), Expect = 1e-40
 Identities = 77/296 (26%), Positives = 116/296 (39%), Gaps = 59/296 (19%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
               LGQG +G V K +  LD +  AIK +  T+      ++EV  ++  +H  +V    
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69

Query: 386 FCFEGHRRAL----------IY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVG 432
              E                ++   E+  NG+L   IH +     N   + +  +++   
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-----NLNQQRDEYWRLFRQ 124

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS------- 485
           I   L Y+H   +  I+H D+KP NI +DE    KI DFGLAK       I+        
Sbjct: 125 ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 486 -----MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-----TGEKNNANVAV 535
                +T A GT  Y+A EV     G  + K D+YS G++ FEM     TG +    +  
Sbjct: 182 GSSDNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240

Query: 536 DRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
            RS  I FP                           +K+I      I  +P+ RP 
Sbjct: 241 LRSVSIEFPPDFDDNKMKV----------------EKKII---RLLIDHDPNKRPG 277

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  148 bits (376), Expect = 1e-40
 Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 50/281 (17%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVASISRTSHVNIVT 382
           F  ++G+G +  VYKG        VA   L + K    +   F  E   +    H NIV 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 383 LLGFCFEGHRRA----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
                    +      L+ E +++G+L+ ++         + +K +VL      I +GL+
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR------FKVMKIKVLRSWCRQILKGLQ 143

Query: 439 YLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKICEG--RESIVSMTGARGTIGY 495
           +LH      I+H D+K  NI +       KI D GLA +      ++++      GT  +
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI------GTPEF 196

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGE---KNNANVAVDRSSEIYFPHWVYKRL 551
           +APE++   + E     DVY++GM + EM T E       N A            +Y+R+
Sbjct: 197 MAPEMYEEKYDE---SVDVYAFGMCMLEMATSEYPYSECQNAAQ-----------IYRRV 242

Query: 552 ELEE-DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
                      +   E KE           CI+ N  +R S
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEG-------CIRQNKDERYS 276

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  147 bits (373), Expect = 4e-39
 Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 53/291 (18%)

Query: 326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVT 382
               ++G+G +G V+ G+L  D   VA+K   E         F+ E   + + SH NIV 
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           L+G C +     ++ E V  G    F+  +       +L+ + L ++    A G+EYL  
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTE-----GARLRVKTLLQMVGDAAAGMEYLES 231

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
                 +H D+   N L+ E    KISDFG+++         S    +  + + APE   
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL- 287

Query: 503 RNFGEVSYKSDVYSYGMMVFEMT--GEK-----NNANV--AVDRSSEIYFPH----WVYK 549
            N+G  S +SDV+S+G++++E    G       +N      V++   +  P      V++
Sbjct: 288 -NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346

Query: 550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
                                      +   C    P  RPS + + + L+
Sbjct: 347 ---------------------------LMEQCWAYEPGQRPSFSTIYQELQ 370

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  142 bits (359), Expect = 4e-38
 Identities = 68/314 (21%), Positives = 123/314 (39%), Gaps = 60/314 (19%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            LG+GG+G V++ K  +D  N AIK   L   +   E  + EV ++++  H  IV     
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 387 CFEGH---------RRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIA 434
             E +          +  +Y   +     +L+ +++ +    T ++ +  V   I + IA
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR---CTIEERERSVCLHIFLQIA 128

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI----------CEGRESIV 484
             +E+LH   +  ++H D+KP NI    D   K+ DFGL                  +  
Sbjct: 129 EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM----TGEKNNANVAVDRSSE 540
             TG  GT  Y++PE    N    S+K D++S G+++FE+    + +        D  + 
Sbjct: 186 RHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNL 243

Query: 541 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
            + P +  K                        M+      +  +P +RP    ++E   
Sbjct: 244 KFPPLFTQKYPCE------------------YVMV---QDMLSPSPMERPEAINIIEN-- 280

Query: 601 GSLDSLQIPPRPFL 614
              + L  P +  L
Sbjct: 281 AVFEDLDFPGKTVL 294

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  142 bits (361), Expect = 5e-38
 Identities = 74/310 (23%), Positives = 117/310 (37%), Gaps = 69/310 (22%)

Query: 326 SFKNKLGQGGYGGVYKGKL-LDGQN----VAIKVLNE--TKGNGEDFINEVASISRTSHV 378
                LG G +G VYKG    +G+     VAIK L E  +    ++ ++E   ++   + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           ++  LLG C       LI + +  G L  ++ E         +  + L    V IA+G+ 
Sbjct: 78  HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMN 131

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YL      R++H D+   N+L+      KI+DFGLAK+    E      G +  I ++A 
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFE-MT-GEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           E         +++SDV+SYG+ V+E MT G K               P+           
Sbjct: 189 ESI--LHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYD---------- 221

Query: 557 LGLQGIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNRVVEMLEG 601
               GI   E      K               MI+   W    +   RP    ++     
Sbjct: 222 ----GIPASEISSILEKGERLPQPPICTIDVYMIMRKCW--MIDADSRPKFRELIIEFS- 274

Query: 602 SLDSLQIPPR 611
                + P R
Sbjct: 275 --KMARDPQR 282

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  140 bits (354), Expect = 4e-37
 Identities = 76/332 (22%), Positives = 123/332 (37%), Gaps = 72/332 (21%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDG-----QNVAIKVLNE--TKGNGEDFINEVASISRTSHV 378
                LG G +G VYKG  +         VAIK L E  +    ++ ++E   ++   + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           ++  LLG C       LI + +  G L  ++ E         +  + L    V IA+G+ 
Sbjct: 78  HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMN 131

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YL    + R++H D+   N+L+      KI+DFGLAK+    E      G +  I ++A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFE-MT-GEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           E         +++SDV+SYG+ V+E MT G K               P+           
Sbjct: 189 ESI--LHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYD---------- 221

Query: 557 LGLQGIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNRVVEMLE- 600
               GI   E      K               MI+V  W    +   RP    ++     
Sbjct: 222 ----GIPASEISSILEKGERLPQPPICTIDVYMIMVKCW--MIDADSRPKFRELIIEFSK 275

Query: 601 -----GSLDSLQIPPRPFLLSSGSQPDFSSIL 627
                     +Q   R  L S      + +++
Sbjct: 276 MARDPQRYLVIQGDERMHLPSPTDSNFYRALM 307

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (349), Expect = 5e-37
 Identities = 53/199 (26%), Positives = 104/199 (52%), Gaps = 11/199 (5%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           +   +LG G +G V  GK     +VA+K++ E   + ++F  E  ++ + SH  +V   G
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
            C + +   ++ E++SNG L  ++           L+   L ++   +  G+ +L     
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLES--- 122

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
            + +H D+   N L+D D C K+SDFG+ +     + + S  G +  + + APEVF  ++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVF--HY 179

Query: 506 GEVSYKSDVYSYGMMVFEM 524
            + S KSDV+++G++++E+
Sbjct: 180 FKYSSKSDVWAFGILMWEV 198

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  143 bits (362), Expect = 6e-37
 Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 59/292 (20%)

Query: 327 FKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
            K+KLG G YG VY+G        VA+K L E     E+F+ E A +    H N+V LLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
            C       +I EF++ G+L  ++ E +     Q++   VL  +A  I+  +EYL +   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK--- 336

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
              +H ++   N L+ E+   K++DFGL+++  G        GA+  I + APE     +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESL--AY 393

Query: 506 GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE 565
            + S KSDV+++G++++E+              +    P+               GI+  
Sbjct: 394 NKFSIKSDVWAFGVLLWEIA-------------TYGMSPYP--------------GIDLS 426

Query: 566 EDKEYARK-----------------MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           +  E   K                 M      C Q NPSDRPS   + +  E
Sbjct: 427 QVYELLEKDYRMERPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFE 474

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  137 bits (347), Expect = 9e-37
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 11/199 (5%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           +F  ++G G +G V+ G  L+   VAIK + E   + EDFI E   + + SH  +V L G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
            C E     L+ EF+ +G L  ++  +           E L  + + +  G+ YL     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEE--- 122

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
             ++H D+   N L+ E+   K+SDFG+ +     +   S TG +  + + +PEVF  +F
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVF--SF 179

Query: 506 GEVSYKSDVYSYGMMVFEM 524
              S KSDV+S+G++++E+
Sbjct: 180 SRYSSKSDVWSFGVLMWEV 198

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  137 bits (347), Expect = 2e-36
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 20/205 (9%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFI----NEVASISRTSHVNIVTLL 384
           KLG GG   VY  +  +    VAIK +       E+ +     EV + S+ SH NIV+++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
               E     L+ E++   +L ++I    PL  +  +           I  G+++ H   
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN------FTNQILDGIKHAHD-- 129

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGYIAPEVFCR 503
             RI+H DIKP NIL+D +   KI DFG+AK     E+ ++ T    GT+ Y +PE    
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 504 NFGEVSYKSDVYSYGMMVFEM-TGE 527
                   +D+YS G++++EM  GE
Sbjct: 187 --EATDECTDIYSIGIVLYEMLVGE 209

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  136 bits (345), Expect = 3e-36
 Identities = 82/295 (27%), Positives = 128/295 (43%), Gaps = 63/295 (21%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDG-QNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLL 384
           + K+KLG G YG VY+G        VA+K L E     E+F+ E A +    H N+V LL
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G C       +I EF++ G+L  ++ E +     Q++   VL  +A  I+  +EYL +  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK-- 129

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
               +H D+   N L+ E+   K++DFGL+++  G        GA+  I + APE     
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESL--A 185

Query: 505 FGEVSYKSDVYSYGMMVFE-MT-GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 562
           + + S KSDV+++G++++E  T G                 P+               GI
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS---------------PYP--------------GI 216

Query: 563 ENEEDKEYARK-----------------MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           +  +  E   K                 M      C Q NPSDRPS   + +  E
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFE 267

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  135 bits (342), Expect = 6e-36
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 11/199 (5%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           +F  +LG G +G V  GK     +VAIK++ E   + ++FI E   +   SH  +V L G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
            C +     +I E+++NG L  ++ E        + + + L ++   +   +EYL     
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLES--- 138

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
            + LH D+   N L+++    K+SDFGL++     E   S  G++  + +  PEV    +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVL--MY 195

Query: 506 GEVSYKSDVYSYGMMVFEM 524
            + S KSD++++G++++E+
Sbjct: 196 SKFSSKSDIWAFGVLMWEI 214

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  136 bits (344), Expect = 7e-36
 Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 42/301 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLLD-----GQNVAIKVLNETKG--NGEDFINEVASISRTSHVN 379
               LG+G +G V            G+ VA+K L    G  +   +  E+  +    H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 380 IVTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
           I+   G C +    +  L+ E+V  GSL  ++           +    L   A  I  G+
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-------RHSIGLAQLLLFAQQICEGM 147

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYI 496
            YLH       +H D+   N+LLD D   KI DFGLAK + EG E           + + 
Sbjct: 148 AYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           APE  C    +  Y SDV+S+G+ ++E +T   ++ +        I         L L  
Sbjct: 205 APE--CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL-- 260

Query: 556 DLGLQGIENEE---------DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL 606
               + +E  E          + Y    ++ + W  +T  S RP+   ++ +L+   +  
Sbjct: 261 ---TELLERGERLPRPDKCPAEVY---HLMKNCW--ETEASFRPTFENLIPILKTVHEKY 312

Query: 607 Q 607
           Q
Sbjct: 313 Q 313

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  136 bits (344), Expect = 8e-36
 Identities = 69/334 (20%), Positives = 118/334 (35%), Gaps = 73/334 (21%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNE---TKGNGEDFINEVASISRTSHV 378
           +    LG+G +G V + +L         VA+K+L        + E+F+ E A +    H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 379 NIVTLLGFCFEGHRRA------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVG 432
           ++  L+G       +       +I  F+ +G L  F+      E    L  + L +  V 
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 433 IARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
           IA G+EYL    +   +H D+   N +L ED    ++DFGL++     +       ++  
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202

Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRL 551
           + ++A E         +  SDV+++G+ ++E MT                          
Sbjct: 203 VKWLALESL--ADNLYTVHSDVWAFGVTMWEIMT-------------------------- 234

Query: 552 ELEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMN 593
                 G     GIEN E   Y                   ++   W    +P  RPS  
Sbjct: 235 -----RGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCW--SADPKQRPSFT 287

Query: 594 RVVEMLE---GSLDSLQIPPRPFLLSSGSQPDFS 624
            +   LE   G L  L     P  ++        
Sbjct: 288 CLRMELENILGHLSVLSTSQDPLYINIERAHHHH 321

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  135 bits (342), Expect = 8e-36
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 40/301 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLL-----DGQNVAIKVLNE-TKGNGEDFINEVASISRTSHVNI 380
           F  +LG+G +G V   +        G+ VA+K L   T+ +  DF  E+  +    H NI
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 381 VTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           V   G C+   RR   LI E++  GSL  ++ +        ++    L +    I +G+E
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 128

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIA 497
           YL      R +H D+   NIL++ +   KI DFGL K + + +E           I + A
Sbjct: 129 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           PE       + S  SDV+S+G++++E+    EK+ +  A                  L  
Sbjct: 186 PE--SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL-- 241

Query: 556 DLGLQGIENEE---------DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL 606
              ++ ++N           D+ Y   MI+   W    N + RPS   +   ++   D++
Sbjct: 242 ---IELLKNNGRLPRPDGCPDEIY---MIMTECW--NNNVNQRPSFRDLALRVDQIRDNM 293

Query: 607 Q 607
            
Sbjct: 294 A 294

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  136 bits (344), Expect = 1e-35
 Identities = 75/301 (24%), Positives = 126/301 (41%), Gaps = 40/301 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLL-----DGQNVAIKVLNE-TKGNGEDFINEVASISRTSHVNI 380
           F  +LG+G +G V   +        G+ VA+K L   T+ +  DF  E+  +    H NI
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 381 VTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           V   G C+   RR   LI E++  GSL  ++ +        ++    L +    I +G+E
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 159

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIA 497
           YL      R +H D+   NIL++ +   KI DFGL K + + +E           I + A
Sbjct: 160 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           PE       + S  SDV+S+G++++E+    EK+ +  A                  L  
Sbjct: 217 PE--SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL-- 272

Query: 556 DLGLQGIENEE---------DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL 606
              ++ ++N           D+ Y   MI+   W    N + RPS   +   ++   D +
Sbjct: 273 ---IELLKNNGRLPRPDGCPDEIY---MIMTECW--NNNVNQRPSFRDLALRVDQIRDQM 324

Query: 607 Q 607
            
Sbjct: 325 A 325

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  135 bits (342), Expect = 2e-35
 Identities = 68/338 (20%), Positives = 130/338 (38%), Gaps = 72/338 (21%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN-----VAIKVLNETKG--NGEDFINEVASISRTSHVN 379
               LG G +G V+KG  +         V IKV+ +  G  + +   + + +I    H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           IV LLG C       L+ +++  GSL   + +         L  ++L    V IA+G+ Y
Sbjct: 77  IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYY 130

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           L       ++H ++   N+LL      +++DFG+A +    +  +  + A+  I ++A E
Sbjct: 131 LEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFE-MT-GEKNNANVAVDRSSEIYFPHWVYKRLELEEDL 557
               +FG+ +++SDV+SYG+ V+E MT G +               P+            
Sbjct: 188 SI--HFGKYTHQSDVWSYGVTVWELMTFGAE---------------PYA----------- 219

Query: 558 GLQGIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNRVVEMLE-- 600
              G+   E  +   K               M++V  W    + + RP+   +       
Sbjct: 220 ---GLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCW--MIDENIRPTFKELANEFTRM 274

Query: 601 ----GSLDSLQIPPRPFLLSSGSQPDFSSILVRQTESS 634
                    ++    P +         ++  + + E  
Sbjct: 275 ARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELE 312

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  138 bits (349), Expect = 2e-35
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 11/198 (5%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            + KLG G +G V+         VA+K +     + E F+ E   +    H  +V L   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
             +     +I EF++ GSL  F+          K     L   +  IA G+ ++ +    
Sbjct: 252 VTKEPIY-IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---R 303

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
             +H D++  NIL+      KI+DFGLA++ E  E      GA+  I + APE    NFG
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAI--NFG 360

Query: 507 EVSYKSDVYSYGMMVFEM 524
             + KSDV+S+G+++ E+
Sbjct: 361 SFTIKSDVWSFGILLMEI 378

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (338), Expect = 2e-35
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
               +LG G +G V+ G       VA+K L +   + + F+ E   + +  H  +V L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
              +     +I E++ NGSL  F+          KL    L  +A  IA G+ ++     
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
              +H D++  NIL+ +    KI+DFGLA++ E  E      GA+  I + APE    N+
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAI--NY 184

Query: 506 GEVSYKSDVYSYGMMVFEM 524
           G  + KSDV+S+G+++ E+
Sbjct: 185 GTFTIKSDVWSFGILLTEI 203

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (349), Expect = 2e-35
 Identities = 75/293 (25%), Positives = 121/293 (41%), Gaps = 63/293 (21%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            + KLGQG +G V+ G       VAIK L     + E F+ E   + +  H  +V L   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
             E     ++ E++S GSL  F+  +      + L+   L  +A  IA G+ Y+ R    
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---M 299

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
             +H D++  NIL+ E+   K++DFGLA++ E  E      GA+  I + APE     +G
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYG 356

Query: 507 EVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 564
             + KSDV+S+G+++ E+T  G                 P+               G+ N
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRV---------------PYP--------------GMVN 387

Query: 565 EEDKEYARK-----------------MILVSLWCIQTNPSDRPSMNRVVEMLE 600
            E  +   +                 M      C +  P +RP+   +   LE
Sbjct: 388 REVLDQVERGYRMPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLE 436

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  134 bits (340), Expect = 3e-35
 Identities = 64/300 (21%), Positives = 115/300 (38%), Gaps = 53/300 (17%)

Query: 327 FKNKLGQGGYGGVYKGKLL-----DGQNVAIKVLNETKGNGE-DFINEVASISRTSHVNI 380
           + ++LG+G +G V   +        G  VA+K L  +  + + DF  E+  +       I
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 381 VTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           V   G  +   R++  L+ E++ +G L  F+          +L    L   +  I +G+E
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGME 141

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI-VSMTGARGTIGYIA 497
           YL      R +H D+   NIL++ +   KI+DFGLAK+    +   V     +  I + A
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           PE    +    S +SDV+S+G++++E+    +K                           
Sbjct: 199 PE--SLSDNIFSRQSDVWSFGVVLYELFTYCDK---------------SCSPSAEFLRMM 241

Query: 556 DLGLQGIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNRVVEMLE 600
                        E   +                ++   W    +P DRPS + +   L+
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQLD 299

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (350), Expect = 4e-35
 Identities = 75/293 (25%), Positives = 121/293 (41%), Gaps = 63/293 (21%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            + KLGQG +G V+ G       VAIK L     + E F+ E   + +  H  +V L   
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
             E     ++ E++S GSL  F+  +      + L+   L  +A  IA G+ Y+ R    
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---M 382

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
             +H D++  NIL+ E+   K++DFGLA++ E  E      GA+  I + APE     +G
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYG 439

Query: 507 EVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN 564
             + KSDV+S+G+++ E+T  G                 P+               G+ N
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRV---------------PYP--------------GMVN 470

Query: 565 EEDKEYARK-----------------MILVSLWCIQTNPSDRPSMNRVVEMLE 600
            E  +   +                 M      C +  P +RP+   +   LE
Sbjct: 471 REVLDQVERGYRMPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLE 519

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  133 bits (338), Expect = 5e-35
 Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 69/313 (22%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNE---TKGNGEDFINEVASISRTSHV 378
                LG+G +G V +G L         VA+K +     ++   E+F++E A +   SH 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 379 NIVTLLGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGI 433
           N++ LLG C E   +      +I  F+  G L  ++         + +  + L K  V I
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTI 493
           A G+EYL    N   LH D+   N +L +D    ++DFGL+K     +       A+  +
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213

Query: 494 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRLE 552
            +IA E         + KSDV+++G+ ++E  T                           
Sbjct: 214 KWIAIESL--ADRVYTSKSDVWAFGVTMWEIAT--------------------------- 244

Query: 553 LEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNR 594
                G+    G++N E  +Y                   I+ S W  +T+P DRP+ + 
Sbjct: 245 ----RGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCW--RTDPLDRPTFSV 298

Query: 595 VVEMLEGSLDSLQ 607
           +   LE  L+SL 
Sbjct: 299 LRLQLEKLLESLP 311

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  133 bits (336), Expect = 5e-35
 Identities = 60/288 (20%), Positives = 115/288 (39%), Gaps = 60/288 (20%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFC 387
             +G GG+G V+K K  +DG+   IK +       E    EV ++++  HVNIV   G C
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNG-C 72

Query: 388 FEGHRRA-----------------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIA 430
           ++G                     +  EF   G+LE++I ++      +KL   +  ++ 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELF 128

Query: 431 VGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR 490
             I +G++Y+H   + ++++ D+KP NI L +    KI DFGL    +            
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--- 182

Query: 491 GTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKN--NANVAVDRSSEIYFPHWV 547
           GT+ Y++PE       +   + D+Y+ G+++ E+          +       +       
Sbjct: 183 GTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF 240

Query: 548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRV 595
            K+                     + ++      +   P DRP+ + +
Sbjct: 241 DKKE--------------------KTLL---QKLLSKKPEDRPNTSEI 265

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  133 bits (337), Expect = 6e-35
 Identities = 65/295 (22%), Positives = 114/295 (38%), Gaps = 52/295 (17%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLLGFC 387
           KLG+GG+  V   + L DG   A+K +   +    E+   E       +H NI+ L+ +C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 388 FEGHRRA----LIYEFVSNGSLEKFIHEKHPLETNQKLK-WEVLYKIAVGIARGLEYLHR 442
                      L+  F   G+L   I  +   +    L   ++L  + +GI RGLE +H 
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQIL-WLLLGICRGLEAIHA 152

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA-------RGTIGY 495
                  H D+KP NILL ++  P + D G                        R TI Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 496 IAPEVF-CRNFGEVSYKSDVYS-----YGMMV----FEMTGEKNNANVAVDRSSEIYFPH 545
            APE+F  ++   +  ++DV+S     Y MM     ++M  +K ++       +++  P 
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-VQNQLSIP- 267

Query: 546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
                               +   ++  +  +    +  +P  RP +  ++  LE
Sbjct: 268 --------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  132 bits (335), Expect = 9e-35
 Identities = 70/294 (23%), Positives = 121/294 (41%), Gaps = 40/294 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLL-----DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVN 379
               LG+G +G V   +        G+ VA+K L    G  +  D   E+  +    H N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 380 IVTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
           IV   G C E       LI EF+ +GSL++++ +        K+  +   K AV I +G+
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGM 139

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI-VSMTGARGTIGYI 496
           +YL      + +H D+   N+L++ +   KI DFGL K  E  +            + + 
Sbjct: 140 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           APE  C    +    SDV+S+G+ + E +T   ++++        I   H       L  
Sbjct: 197 APE--CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL-- 252

Query: 556 DLGLQGIENEE---------DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
              +  ++  +         D+ Y    ++   W  +  PS+R S   ++E  E
Sbjct: 253 ---VNTLKEGKRLPCPPNCPDEVY---QLMRKCW--EFQPSNRTSFQNLIEGFE 298

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (333), Expect = 1e-34
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 328 KNKLGQGGYGGVYKGKLLDGQN---VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVT 382
             +LG G +G V +G     +    VAIKVL +   K + E+ + E   + +  +  IV 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           L+G C +     L+ E    G L KF+  K      +++    + ++   ++ G++YL  
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE 128

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI-VSMTGARGTIGYIAPEVF 501
                 +H D+   N+LL      KISDFGL+K     +S   + +  +  + + APE  
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM 524
             NF + S +SDV+SYG+ ++E 
Sbjct: 186 --NFRKFSSRSDVWSYGVTMWEA 206

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  132 bits (334), Expect = 2e-34
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 22/209 (10%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFI----NEVASISRTSHVNIVTLL 384
            LG GG   V+  + L D ++VA+KVL         F      E  + +  +H  IV + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 385 GFCFEGHRRALIY----EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
                      +     E+V   +L   +H + P+   + ++      +     + L + 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFS 132

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGYIAPE 499
           H+     I+H D+KP NI++      K+ DFG+A+      + V+ T A  GT  Y++PE
Sbjct: 133 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM-TGE 527
                   V  +SDVYS G +++E+ TGE
Sbjct: 190 QARG--DSVDARSDVYSLGCVLYEVLTGE 216

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (333), Expect = 2e-34
 Identities = 73/316 (23%), Positives = 125/316 (39%), Gaps = 71/316 (22%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNE--TKGNGEDFINEVASI 372
               +   F   +G+G +G VY G LLD        A+K LN     G    F+ E   +
Sbjct: 21  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80

Query: 373 SRTSHVNIVTLLGFCFEGHRRAL-IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV 431
              SH N+++LLG C       L +  ++ +G L  FI  +           + L    +
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGL 135

Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE--SIVSMTGA 489
            +A+G++YL    + + +H D+   N +LDE F  K++DFGLA+    +E  S+ + TGA
Sbjct: 136 QVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192

Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MT-GEKNNANVAVDRSSEIYFPHWV 547
           +  + ++A E       + + KSDV+S+G++++E MT G                 P+  
Sbjct: 193 KLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAP---------------PYP- 234

Query: 548 YKRLELEEDLGLQGIENEEDKEYARK-----------------MILVSLWCIQTNPSDRP 590
                         +   +   Y  +                 M    L C       RP
Sbjct: 235 -------------DVNTFDITVYLLQGRRLLQPEYCPDPLYEVM----LKCWHPKAEMRP 277

Query: 591 SMNRVVEMLEGSLDSL 606
           S + +V  +     + 
Sbjct: 278 SFSELVSRISAIFSTF 293

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  130 bits (330), Expect = 2e-34
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
                +G+G +G V  G    G  VA+K +       + F+ E + +++  H N+V LLG
Sbjct: 24  KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 386 FCFEGHRRALI-YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
              E      I  E+++ GSL  ++  +        L  + L K ++ +   +EYL    
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG-- 135

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
               +H D+   N+L+ ED   K+SDFGL      +E+  +    +  + + APE     
Sbjct: 136 -NNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEAL--R 187

Query: 505 FGEVSYKSDVYSYGMMVFEM 524
             + S KSDV+S+G++++E+
Sbjct: 188 EKKFSTKSDVWSFGILLWEI 207

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  131 bits (332), Expect = 3e-34
 Identities = 68/284 (23%), Positives = 120/284 (42%), Gaps = 46/284 (16%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG----EDFINEVASISRTSHVNIVTLL 384
           K+G+G +  VY+   LLDG  VA+K +            D I E+  + + +H N++   
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
               E +   ++ E    G L + I  KH  +  + +    ++K  V +   LE++H   
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMH--- 153

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTIGYIAPEVF 501
           + R++H DIKP N+ +      K+ D GL +           T A    GT  Y++PE  
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----KTTAAHSLVGTPYYMSPER- 207

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDRSSEIYFPHWVYKRLELE 554
               G  ++KSD++S G +++EM        G+K N      +  +  +P        L 
Sbjct: 208 IHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-------PLP 259

Query: 555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
            D             Y+ ++  +   CI  +P  RP +  V ++
Sbjct: 260 SD------------HYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  132 bits (333), Expect = 3e-34
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNE--TKGNGEDFINEVASISRTSHVNI 380
            +  +G G  G V  G+L         VAIK L    T+    DF++E + + +  H NI
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
           + L G    G    ++ E++ NGSL+ F+        + +     L  +  G+  G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-----DGQFTIMQLVGMLRGVGAGMRYL 167

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMT-GARGTIGYIAPE 499
                   +H D+   N+L+D +   K+SDFGL+++ E        T G +  I + APE
Sbjct: 168 SD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM 524
                F   S  SDV+S+G++++E+
Sbjct: 225 AI--AFRTFSSASDVWSFGVVMWEV 247

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (329), Expect = 4e-34
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 18/205 (8%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNE--TKGNGEDFINEVASISRTSHVN 379
                +G+G +G V++G  +  +N    VAIK      +    E F+ E  ++ +  H +
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           IV L+G     +   +I E  + G L  F+  +        L    L   A  ++  L Y
Sbjct: 78  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAY 131

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           L      R +H DI   N+L+  + C K+ DFGL++  E   +    +  +  I ++APE
Sbjct: 132 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 187

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM 524
               NF   +  SDV+ +G+ ++E+
Sbjct: 188 SI--NFRRFTSASDVWMFGVCMWEI 210

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  131 bits (331), Expect = 7e-34
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 18/206 (8%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN-----VAIKVLNE--TKGNGEDFINEVASISRTSHVN 379
            +  +G G +G VYKG L          VAIK L    T+    DF+ E   + + SH N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           I+ L G   +     +I E++ NG+L+KF+ EK       +     L  +  GIA G++Y
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKY 162

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR-ESIVSMTGARGTIGYIAP 498
           L        +H D+   NIL++ +   K+SDFGL+++ E   E+  + +G +  I + AP
Sbjct: 163 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM 524
           E    ++ + +  SDV+S+G++++E+
Sbjct: 220 EAI--SYRKFTSASDVWSFGIVMWEV 243

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  133 bits (336), Expect = 8e-34
 Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 47/290 (16%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-- 376
            + K++   K+ LG G  G +    + D ++VA+K +            EV  + R S  
Sbjct: 20  IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL--PECFSFADREVQ-LLRESDE 76

Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H N++       +   + +  E  +  +L++++ +K       +        +      G
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-----TLLQQTTSG 130

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICE-GRESIVSMTGAR 490
           L +LH   +  I+H D+KPHNIL+            ISDFGL K    GR S    +G  
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187

Query: 491 GTIGYIAPEVFCRNFGE-VSYKSDVYSYGMMVFEMT-------GEKNNANVAVDRSSEIY 542
           GT G+IAPE+   +  E  +Y  D++S G + + +        G+         R + I 
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------QRQANIL 241

Query: 543 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM 592
                   L  E+           +   AR++I      I  +P  RPS 
Sbjct: 242 LGACSLDCLHPEKH----------EDVIARELI---EKMIAMDPQKRPSA 278

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  130 bits (329), Expect = 8e-34
 Identities = 67/310 (21%), Positives = 122/310 (39%), Gaps = 69/310 (22%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN------VAIKVLNE--TKGNGEDFINEVASISRTSHV 378
              +LGQG +G VY+G             VAIK +NE  +     +F+NE + +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQK----LKWEVLYKIAVGIA 434
           ++V LLG   +G    +I E ++ G L+ ++    P   N           + ++A  IA
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
            G+ YL+     + +H D+   N ++ EDF  KI DFG+ +     +           + 
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRLEL 553
           +++PE      G  +  SDV+S+G++++E  T                            
Sbjct: 206 WMSPESL--KDGVFTTYSDVWSFGVVLWEIAT---------------------------- 235

Query: 554 EEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNRV 595
              L  Q   G+ NE+   +  +                ++   W  Q NP  RPS   +
Sbjct: 236 ---LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCW--QYNPKMRPSFLEI 290

Query: 596 VEMLEGSLDS 605
           +  ++  ++ 
Sbjct: 291 ISSIKEEMEP 300

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  129 bits (327), Expect = 1e-33
 Identities = 67/307 (21%), Positives = 121/307 (39%), Gaps = 67/307 (21%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNE--TKGNGEDFINEVASISRTSHVNI 380
               +G+G +G VY G+ +D        AIK L+        E F+ E   +   +H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 381 VTLLGFCFEGHRRALI-YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           + L+G          +   ++ +G L +FI              + L    + +ARG+EY
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEY 139

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE--SIVSMTGARGTIGYIA 497
           L      + +H D+   N +LDE F  K++DFGLA+    RE  S+     AR  + + A
Sbjct: 140 LAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFE-MT-GEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
            E         + KSDV+S+G++++E +T G                 P+          
Sbjct: 197 LESL--QTYRFTTKSDVWSFGVLLWELLTRGAP---------------PYR--------- 230

Query: 556 DLGLQGIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNRVVEMLE 600
                 I+  +   +  +                ++   W  + +P+ RP+   +V  +E
Sbjct: 231 -----HIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCW--EADPAVRPTFRVLVGEVE 283

Query: 601 GSLDSLQ 607
             + +L 
Sbjct: 284 QIVSALL 290

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  129 bits (326), Expect = 1e-33
 Identities = 74/320 (23%), Positives = 118/320 (36%), Gaps = 91/320 (28%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDG------QNVAIKVLNE--TKGNGEDFINEVASISRTSH 377
            F  +LG+  +G VYKG L         Q VAIK L +       E+F +E    +R  H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN----------QKLKWEVLY 427
            N+V LLG   +    ++I+ + S+G L +F+  + P                L+     
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 428 KIAVGIARGLEYL------HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE 481
            +   IA G+EYL      H+         D+   N+L+ +    KISD GL +     +
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHK---------DLATRNVLVYDKLNVKISDLGLFREVYAAD 182

Query: 482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSE 540
               +  +   I ++APE     +G+ S  SD++SYG++++E  +               
Sbjct: 183 YYKLLGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVFS--------------- 225

Query: 541 IYFPHWVYKRLELEEDLGLQ---GIENEEDKEYARK-----------------MILVSLW 580
                            GLQ   G  N++  E  R                  M    + 
Sbjct: 226 ----------------YGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALM----IE 265

Query: 581 CIQTNPSDRPSMNRVVEMLE 600
           C    PS RP    +   L 
Sbjct: 266 CWNEFPSRRPRFKDIHSRLR 285

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  132 bits (335), Expect = 1e-33
 Identities = 64/296 (21%), Positives = 116/296 (39%), Gaps = 73/296 (24%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
               +G+G +G V  G    G  VA+K +       + F+ E + +++  H N+V LLG 
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 387 CFEGHRRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
             E   +  +Y   E+++ GSL  ++  +        L  + L K ++ +   +EYL   
Sbjct: 255 IVEE--KGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG- 307

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
                +H D+   N+L+ ED   K+SDFGL      +E+  +    +  + + APE    
Sbjct: 308 --NNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEAL-- 358

Query: 504 NFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
              + S KSDV+S+G++++E+   G                 P+                
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRV---------------PYP--------------R 389

Query: 562 IENEEDKEYARK-----------------MILVSLWCIQTNPSDRPSMNRVVEMLE 600
           I  ++      K                 M      C   + + RP+  ++ E LE
Sbjct: 390 IPLKDVVPRVEKGYKMDAPDGCPPAVYDVM----KNCWHLDAATRPTFLQLREQLE 441

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  128 bits (323), Expect = 3e-33
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 18/205 (8%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNE--TKGNGEDFINEVASISRTSHVN 379
                LG+G +G VY+G   + +     VA+K   +  T  N E F++E   +    H +
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           IV L+G   E     +I E    G L  ++           LK   L   ++ I + + Y
Sbjct: 75  IVKLIGII-EEEPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAY 128

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           L        +H DI   NIL+    C K+ DFGL++  E  E     +  R  I +++PE
Sbjct: 129 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPE 184

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM 524
               NF   +  SDV+ + + ++E+
Sbjct: 185 SI--NFRRFTTASDVWMFAVCMWEI 207

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  128 bits (325), Expect = 3e-33
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 22/206 (10%)

Query: 330 KLGQGGYGGVYKGK--LLDGQNVAIKVLNETKGNGEDFI----NEVASISRTSHVNIVTL 383
            +G+GG G VY+ +  + + + VA+K+++ET  +   F      E  +  R    ++V +
Sbjct: 41  LVGRGGMGDVYEAEDTVRE-RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
             F     +  +    ++   L   +  + PL   + +       I   I   L+  H  
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA------IVRQIGSALDAAHA- 152

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGYIAPEVFC 502
                 H D+KP NIL+  D    + DFG+A      +  ++  G   GT+ Y+APE F 
Sbjct: 153 --AGATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFS 208

Query: 503 RNFGEVSYKSDVYSYGMMVFEM-TGE 527
                 +Y++D+Y+   +++E  TG 
Sbjct: 209 E--SHATYRADIYALTCVLYECLTGS 232

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  128 bits (323), Expect = 3e-33
 Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 19/202 (9%)

Query: 330 KLGQGGYGGVYKGKLLDG---QNVAIKVLNE---TKGNGEDFINEVASISRTSHVNIVTL 383
           +LG G +G V KG        + VA+K+L          ++ + E   + +  +  IV +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           +G C E     L+ E    G L K+      L+ N+ +K + + ++   ++ G++YL   
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKY------LQQNRHVKDKNIIELVHQVSMGMKYLEE- 135

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI-VSMTGARGTIGYIAPEVFC 502
             +  +H D+   N+LL      KISDFGL+K     E+   + T  +  + + APE   
Sbjct: 136 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI- 192

Query: 503 RNFGEVSYKSDVYSYGMMVFEM 524
            N+ + S KSDV+S+G++++E 
Sbjct: 193 -NYYKFSSKSDVWSFGVLMWEA 213

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (324), Expect = 3e-33
 Identities = 68/329 (20%), Positives = 119/329 (36%), Gaps = 93/329 (28%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN------VAIKVLNE-TKGNGEDFINEVASISRTSHV 378
             K +LG+G +G V+  +  +         VA+K L + T    +DF  E   ++   H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKF----------IHEKHPLETNQKLKWEVLYK 428
           +IV   G C +G    +++E++ +G L KF          + +  P +   +L    +  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 429 IAVGIARGLEYL------HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES 482
           IA  IA G+ YL      HR   TR         N L+  +   KI DFG+++     + 
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATR---------NCLVGANLLVKIGDFGMSRDVYSTDY 188

Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEI 541
                     I ++ PE     + + + +SDV+S+G++++E  T                
Sbjct: 189 YRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFT---------------- 230

Query: 542 YFPHWVYKRLELEEDLGLQ---GIENEEDKEYARK-----------------MILVSLWC 581
                           G Q    + N E  E   +                 M    L C
Sbjct: 231 ---------------YGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVM----LGC 271

Query: 582 IQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
            Q  P  R ++  + ++L       +  P
Sbjct: 272 WQREPQQRLNIKEIYKILH---ALGKATP 297

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  130 bits (328), Expect = 3e-33
 Identities = 69/314 (21%), Positives = 126/314 (40%), Gaps = 67/314 (21%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNE--TKGNGEDFINEVASI 372
               +   F   +G+G +G VY G LLD        A+K LN     G    F+ E   +
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144

Query: 373 SRTSHVNIVTLLGFCFEGHR-RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV 431
              SH N+++LLG C        ++  ++ +G L  FI  +           + L    +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGL 199

Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE--SIVSMTGA 489
            +A+G+++L    + + +H D+   N +LDE F  K++DFGLA+    +E  S+ + TGA
Sbjct: 200 QVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256

Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MT-GEKNNANVAVDRSSEIYFPHWV 547
           +  + ++A E       + + KSDV+S+G++++E MT G                 P+  
Sbjct: 257 KLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAP---------------PYP- 298

Query: 548 YKRLELEEDLGLQGIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSM 592
                         +   +   Y  +                +++  W        RPS 
Sbjct: 299 -------------DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW--HPKAEMRPSF 343

Query: 593 NRVVEMLEGSLDSL 606
           + +V  +     + 
Sbjct: 344 SELVSRISAIFSTF 357

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  129 bits (326), Expect = 3e-33
 Identities = 75/330 (22%), Positives = 123/330 (37%), Gaps = 71/330 (21%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN------VAIKVLNE--TKGNGEDFINEVASISRTSH 377
           +    LG G +G VY+G++    N      VA+K L E  ++ +  DF+ E   IS+ +H
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN-QKLKWEVLYKIAVGIARG 436
            NIV  +G   +   R ++ E ++ G L+ F+ E  P  +    L    L  +A  IA G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 437 LEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICEGRESIVSMTGARGTI 493
            +YL        +H DI   N LL         KI DFG+A+             A   +
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209

Query: 494 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRLE 552
            ++ PE F    G  + K+D +S+G++++E  +                           
Sbjct: 210 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFS--------------------------- 240

Query: 553 LEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNR 594
               LG        N+E  E+                   I+   W  Q  P DRP+   
Sbjct: 241 ----LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCW--QHQPEDRPNFAI 294

Query: 595 VVEMLEGSLDSLQI--PPRPFLLSSGSQPD 622
           ++E +E       +     P       + +
Sbjct: 295 ILERIEYCTQDPDVINTALPIEYGPLVEEE 324

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  130 bits (328), Expect = 3e-33
 Identities = 87/326 (26%), Positives = 145/326 (44%), Gaps = 61/326 (18%)

Query: 326 SFKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNE--TKGNGEDFINEVASISRTSHVN 379
           S    +G G +G V  G+L        +VAIK L    T+    DF+ E + + +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           I+ L G   +     ++ E++ NGSL+ F+ +        +     L  +  GIA G++Y
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKY 162

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR-ESIVSMTGARGTIGYIAP 498
           L        +H D+   NIL++ +   K+SDFGL ++ E   E+  +  G +  I + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFE-MT-GEK-----NNANV--AVDRSSEIYFPHWVYK 549
           E     + + +  SDV+SYG++++E M+ GE+     +N +V  AVD             
Sbjct: 220 EAI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----------Y 267

Query: 550 RLELEED--LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE------G 601
           RL    D    L  +           M    L C Q + ++RP   ++V +L+      G
Sbjct: 268 RLPPPMDCPAALYQL-----------M----LDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

Query: 602 SLDSL-QIPPRP-FLLSSGSQPDFSS 625
           SL  +     RP  LL   S  D ++
Sbjct: 313 SLKIITSAAARPSNLLLDQSNVDITT 338

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  129 bits (325), Expect = 5e-33
 Identities = 70/284 (24%), Positives = 118/284 (41%), Gaps = 52/284 (18%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLG 385
           K+G+G +G     K   DG+   IK +N    +    E+   EVA ++   H NIV    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 386 FCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
              E     ++ ++   G L K I   +    + +Q L W       V I   L+++H  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD- 143

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE----SIVSMTGARGTIGYIAPE 499
              +ILH DIK  NI L +D   ++ DFG+A++         + +      GT  Y++PE
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI------GTPYYLSPE 195

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM-TG----EKNNANVAVDRSSEIYFPHWVYKRLELE 554
           + C N    + KSD+++ G +++E+ T     E  +    V +     FP          
Sbjct: 196 I-CENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV-------- 245

Query: 555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
                          Y+  +  +     + NP DRPS+N ++E 
Sbjct: 246 ------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (322), Expect = 5e-33
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 16/203 (7%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIK-VLNETKGNGEDFINEVASISRTSHVNIVTLLGFCF 388
           LG+G YG VY G+ L     +AIK +        +    E+A      H NIV  LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 389 EGHRRALIYEFVSNGSLEKFIHEKH-PLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 447
           E     +  E V  GSL   +  K  PL+ N+    + +      I  GL+YLH   + +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE----QTIGFYTKQILEGLKYLH---DNQ 142

Query: 448 ILHFDIKPHNILLD-EDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
           I+H DIK  N+L++      KISDFG +K +        + T   GT+ Y+APE+  +  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPEIIDKGP 199

Query: 506 GEVSYKSDVYSYGMMVFEM-TGE 527
                 +D++S G  + EM TG+
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  127 bits (321), Expect = 6e-33
 Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 20/208 (9%)

Query: 326 SFKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNE----TKGNGEDFINEVASISRTSH 377
               KLG G +G V +G+         +VA+K L           +DFI EV ++    H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
            N++ L G         ++ E    GSL   + +              L + AV +A G+
Sbjct: 81  RNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGM 134

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMT-GARGTIGYI 496
            YL      R +H D+   N+LL      KI DFGL +     +    M    +    + 
Sbjct: 135 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           APE         S+ SD + +G+ ++EM
Sbjct: 192 APESL--KTRTFSHASDTWMFGVTLWEM 217

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (322), Expect = 9e-33
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 25/208 (12%)

Query: 328 KNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
           + ++G+G +G V++ K    G   A+K +       E    E+ + +  S   IV L G 
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE----ELVACAGLSSPRIVPLYGA 118

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKW--EVLYKIAVGIARGLEYLHRGC 444
             EG    +  E +  GSL + I +   L  ++ L +  + L         GLEYLH   
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL--------EGLEYLH--- 167

Query: 445 NTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESIVSMTGA---RGTIGYIAPEV 500
             RILH D+K  N+LL  D     + DFG A   +      S+       GT  ++APEV
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM-TGE 527
                     K D++S   M+  M  G 
Sbjct: 228 -VMGKP-CDAKVDIWSSCCMMLHMLNGC 253

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (322), Expect = 1e-32
 Identities = 55/289 (19%), Positives = 114/289 (39%), Gaps = 58/289 (20%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGED---FINEVASISRTSH--VNIVTL 383
            ++G GG   V++      Q  AIK +N  + + +    + NE+A +++       I+ L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
             +        ++ E   N  L  ++ +K      + +           +   +  +H+ 
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ- 126

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-- 501
               I+H D+KP N L+ +    K+ DFG+A   +   + V      GT+ Y+ PE    
Sbjct: 127 --HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 502 -------CRNFGEVSYKSDVYSYGMMVFEM-TG----EKNNANVA-----VDRSSEIYFP 544
                   ++  ++S KSDV+S G +++ M  G    ++    ++     +D + EI FP
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243

Query: 545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMN 593
                               ++ ++  +        C++ +P  R S+ 
Sbjct: 244 DIP----------------EKDLQDVLKC-------CLKRDPKQRISIP 269

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  127 bits (320), Expect = 1e-32
 Identities = 55/289 (19%), Positives = 111/289 (38%), Gaps = 58/289 (20%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGED---FINEVASISRTSH--VNIVTL 383
            ++G GG   V++      Q  AIK +N  + + +    + NE+A +++       I+ L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
             +        ++ E   N  L  ++ +K      + +           +   +  +H+ 
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ- 145

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
               I+H D+KP N L+ +    K+ DFG+A   +   + V      GT+ Y+ PE    
Sbjct: 146 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 504 NFGE---------VSYKSDVYSYGMMVFEM-TG----EKNNANVA-----VDRSSEIYFP 544
                        +S KSDV+S G +++ M  G    ++    ++     +D + EI FP
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262

Query: 545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMN 593
                               ++     + ++     C++ +P  R S+ 
Sbjct: 263 DIP----------------EKD----LQDVL---KCCLKRDPKQRISIP 288

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  127 bits (320), Expect = 1e-32
 Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 26/215 (12%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVT 382
              + LGQG    V++G+    G   AIKV N        +  + E   + + +H NIV 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 383 LLGFCFEGHRRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           L     E           EF   GSL   + E         L       +   +  G+ +
Sbjct: 72  LFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEP---SNAYGLPESEFLIVLRDVVGGMNH 127

Query: 440 LHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
           L       I+H +IKP NI+     D     K++DFG A+  E  E  VS+    GT  Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEY 181

Query: 496 IAPEVFCRNFGEVSY------KSDVYSYGMMVFEM 524
           + P+++ R      +        D++S G+  +  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (321), Expect = 1e-32
 Identities = 76/312 (24%), Positives = 130/312 (41%), Gaps = 82/312 (26%)

Query: 327 FKNKLGQGGYGGVYKGKLLDG---QNVAIKVLNE--TKGNGEDFINEVASISR-TSHVNI 380
           F++ +G+G +G V K ++       + AIK + E  +K +  DF  E+  + +   H NI
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQ----------KLKWEVLYKIA 430
           + LLG C       L  E+  +G+L  F+ +   LET+            L  + L   A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 431 VGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
             +ARG++YL  +      +H D+   NIL+ E++  KI+DFGL++   G+E  V  T  
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 201

Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVY 548
           R  + ++A E    N+   +  SDV+SYG++++E ++                       
Sbjct: 202 RLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVS----------------------- 236

Query: 549 KRLELEEDLGLQ---GIENEEDKEYARK-----------------MILVSLWCIQTNPSD 588
                   LG     G+   E  E   +                 M      C +  P +
Sbjct: 237 --------LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLM----RQCWREKPYE 284

Query: 589 RPSMNRVVEMLE 600
           RPS  +++  L 
Sbjct: 285 RPSFAQILVSLN 296

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  126 bits (319), Expect = 3e-32
 Identities = 65/316 (20%), Positives = 113/316 (35%), Gaps = 85/316 (26%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDG------QNVAIKVLNE-TKGNGEDFINEVASISRTSHV 378
             K +LG+G +G V+  +  +         VA+K L E ++   +DF  E   ++   H 
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKF---------IHEKHPLETNQKLKWEVLYKI 429
           +IV   G C EG    +++E++ +G L +F         +           L    L  +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 430 AVGIARGLEYL------HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI 483
           A  +A G+ YL      HR   TR         N L+ +    KI DFG+++     +  
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATR---------NCLVGQGLVVKIGDFGMSRDIYSTDYY 214

Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIY 542
                    I ++ PE     + + + +SDV+S+G++++E  T                 
Sbjct: 215 RVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFGVVLWEIFT----------------- 255

Query: 543 FPHWVYKRLELEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQT 584
                          G Q    + N E  +   +                I+   W  Q 
Sbjct: 256 --------------YGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCW--QR 299

Query: 585 NPSDRPSMNRVVEMLE 600
            P  R S+  V   L+
Sbjct: 300 EPQQRHSIKDVHARLQ 315

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (320), Expect = 4e-32
 Identities = 75/330 (22%), Positives = 122/330 (36%), Gaps = 71/330 (21%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN------VAIKVLNE--TKGNGEDFINEVASISRTSH 377
           +    LG G +G VY+G++    N      VA+K L E  ++ +  DF+ E   IS+ +H
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP-LETNQKLKWEVLYKIAVGIARG 436
            NIV  +G   +   R ++ E ++ G L+ F+ E  P       L    L  +A  IA G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 437 LEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICEGRESIVSMTGARGTI 493
            +YL        +H DI   N LL         KI DFG+A+             A   +
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250

Query: 494 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFPHWVYKRLE 552
            ++ PE F    G  + K+D +S+G++++E  +                           
Sbjct: 251 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFS--------------------------- 281

Query: 553 LEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQTNPSDRPSMNR 594
               LG        N+E  E+                   I+   W  Q  P DRP+   
Sbjct: 282 ----LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCW--QHQPEDRPNFAI 335

Query: 595 VVEMLEGSLDSLQI--PPRPFLLSSGSQPD 622
           ++E +E       +     P       + +
Sbjct: 336 ILERIEYCTQDPDVINTALPIEYGPLVEEE 365

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  125 bits (316), Expect = 5e-32
 Identities = 59/282 (20%), Positives = 98/282 (34%), Gaps = 53/282 (18%)

Query: 330 KLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGED---FINEVASISR-TSHVNIVTLL 384
           +LG G YG V+K     DG+  A+K         +D    + EV S  +   H   V L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
               EG    L  E     SL++             L    ++         L +LH   
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAW-----GASLPEAQVWGYLRDTLLALAHLH--- 174

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTIGYIAPEVF 501
           +  ++H D+KP NI L      K+ DFGL         + +        G   Y+APE+ 
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE------LGTAGAGEVQEGDPRYMAPELL 228

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 560
             ++G     +DV+S G+ + E+                            E  + L  Q
Sbjct: 229 QGSYG---TAADVFSLGLTILEVACNM----------------ELPHG--GEGWQQLR-Q 266

Query: 561 GIENEEDKEY----ARKMILVSLWCIQTNPSDRPSMNRVVEM 598
           G    E         R ++   +  ++ +P  R +   ++ +
Sbjct: 267 GYLPPEFTAGLSSELRSVL---VMMLEPDPKLRATAEALLAL 305

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  129 bits (326), Expect = 1e-31
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 328 KNKLGQGGYGGVYKGKLLDGQN---VAIKVLNE--TKGNGEDFINEVASISRTSHVNIVT 382
             +LG G +G V +G     +    VAIKVL +   K + E+ + E   + +  +  IV 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           L+G C +     L+ E    G L KF+  K      +++    + ++   ++ G++YL  
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE 454

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI-VSMTGARGTIGYIAPEVF 501
                 +H ++   N+LL      KISDFGL+K     +S   + +  +  + + APE  
Sbjct: 455 ---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM 524
             NF + S +SDV+SYG+ ++E 
Sbjct: 512 --NFRKFSSRSDVWSYGVTMWEA 532

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (327), Expect = 1e-31
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 40/210 (19%)

Query: 330 KLGQGGYGGVYKGK--LLDGQNVAIKVLNETKGNGED------FINEVASISRTSHVNIV 381
            +  GG G +Y      ++G+ V +K L  +     D       + E   ++   H +IV
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----GDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 382 TLLGFCFEG--HRRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
            +  F      H   + Y   E+V   SL++   +K P+        E +    + I   
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-------EAI-AYLLEILPA 194

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGY 495
           L YLH      +++ D+KP NI+L E+   K+ D G           ++  G   GT G+
Sbjct: 195 LSYLHS---IGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-------RINSFGYLYGTPGF 243

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEMT 525
            APE+  R     +  +D+Y+ G  +  +T
Sbjct: 244 QAPEI-VR--TGPTVATDIYTVGRTLAALT 270

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  124 bits (314), Expect = 1e-31
 Identities = 78/353 (22%), Positives = 132/353 (37%), Gaps = 68/353 (19%)

Query: 289 FWKKK---TYNYRNIEAFLRN-YGSLAPKRYRYAD---IKKMTNSFKNKLGQGGYGGVYK 341
            +K+K      ++ IE++  N Y  + P +  Y +     +    F   LG G +G V +
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64

Query: 342 GKLLDGQN------VAIKVLNETKGNGE--DFINEVASISR-TSHVNIVTLLGFCFEGHR 392
                         VA+K+L  T    E    ++E+  +S    H NIV LLG C  G  
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124

Query: 393 RALIYEFVSNGSLEKFIHEKHPLE--------TNQKLKWEVLYKIAVGIARGLEYLHRGC 444
             +I E+   G L  F+  K  +          N       L   +  +A+G+ +L    
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-- 182

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
               +H D+   N+LL      KI DFGLA+      + +    AR  + ++APE     
Sbjct: 183 -KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI--F 239

Query: 505 FGEVSYKSDVYSYGMMVFE-MT-------GEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
               + +SDV+SYG++++E  +       G   N+                YK ++    
Sbjct: 240 DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--------------FYKLVK---- 281

Query: 557 LGLQGI-----ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD 604
               G             Y    I+ + W     P+ RP+  ++   L+    
Sbjct: 282 ---DGYQMAQPAFAPKNIY---SIMQACW--ALEPTHRPTFQQICSFLQEQAQ 326

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  123 bits (310), Expect = 1e-31
 Identities = 61/285 (21%), Positives = 102/285 (35%), Gaps = 45/285 (15%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVASISRTSHVNIVTLLG 385
            +G G YG   K +   DG+ +  K L+       +    ++EV  +    H NIV    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 386 FCFEGHRRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH- 441
                     +Y   E+   G L   I      +  Q L  E + ++   +   L+  H 
Sbjct: 73  -RIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 442 -RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
                  +LH D+KP N+ LD     K+ DFGLA+I     S        GT  Y++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQ 187

Query: 501 FCRNFGEVSY--KSDVYSYGMMVFEM-TGEK----NNANVAVDRSSEIYFPHWVYKRLEL 553
                  +SY  KSD++S G +++E+          +      +  E  F          
Sbjct: 188 -MNR---MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI------- 236

Query: 554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
                           Y+ ++  +    +      RPS+  ++E 
Sbjct: 237 -------------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (310), Expect = 2e-31
 Identities = 62/289 (21%), Positives = 102/289 (35%), Gaps = 60/289 (20%)

Query: 330 KLGQGGYGGVYKG-KLLDGQNVAIKVLN---ETKGNGEDFINEVASISRTS-HVNIVTLL 384
           K+G G +G V+K  K LDG   AIK          + ++ + EV + +    H ++V   
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
               E     +  E+ + GSL   I E +        K   L  + + + RGL Y+H   
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENY--RIMSYFKEAELKDLLLQVGRGLRYIH--- 132

Query: 445 NTRILHFDIKPHNILLDEDFCP-------------------KISDFGLAKICEGRESIVS 485
           +  ++H DIKP NI +     P                   KI D G        +    
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE- 191

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK---NNANVAVDRSSEIY 542
                G   ++A EV   N+     K+D+++  + V    G +    N +       +  
Sbjct: 192 -----GDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAEPLPRNGD-QWHEIRQGR 244

Query: 543 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS 591
            P        + + L  +  E            L+    I  +P  RPS
Sbjct: 245 LP-------RIPQVLSQEFTE------------LLK-VMIHPDPERRPS 273

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  123 bits (311), Expect = 2e-31
 Identities = 79/337 (23%), Positives = 133/337 (39%), Gaps = 68/337 (20%)

Query: 306 NYGSLAPKRYRYAD---IKKMTNSFKNKLGQGGYGGVYKGKLLDGQN------VAIKVLN 356
           NY  + P +  Y       +   SF   LG G +G V +              VA+K+L 
Sbjct: 3   NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62

Query: 357 E--TKGNGEDFINEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKH 413
                   E  ++E+  +S   +H+NIV LLG C  G    +I E+   G L  F+  K 
Sbjct: 63  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122

Query: 414 PLETNQK------------LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
                 K            L  E L   +  +A+G+ +L        +H D+   NILL 
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179

Query: 462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
                KI DFGLA+  +   + V    AR  + ++APE         +++SDV+SYG+ +
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFL 237

Query: 522 FEM--------TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI-----ENEEDK 568
           +E+         G   ++                YK ++       +G      E+   +
Sbjct: 238 WELFSLGSSPYPGMPVDSK--------------FYKMIK-------EGFRMLSPEHAPAE 276

Query: 569 EYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
            Y    I+ + W    +P  RP+  ++V+++E  +  
Sbjct: 277 MY---DIMKTCW--DADPLKRPTFKQIVQLIEKQISE 308

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  124 bits (312), Expect = 5e-31
 Identities = 54/289 (18%), Positives = 110/289 (38%), Gaps = 58/289 (20%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGED---FINEVASISRTSH--VNIVTL 383
            ++G GG   V++      Q  AIK +N  + + +    + NE+A +++       I+ L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
             +        ++ E   N  L  ++ +K      + +           +   +  +H+ 
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ- 173

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-- 501
               I+H D+KP N L+ +    K+ DFG+A   +   + V      G + Y+ PE    
Sbjct: 174 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 502 -------CRNFGEVSYKSDVYSYGMMVFEM-------TGEKNNANVA---VDRSSEIYFP 544
                   ++  ++S KSDV+S G +++ M           N  +     +D + EI FP
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290

Query: 545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMN 593
                               ++ ++  +        C++ +P  R S+ 
Sbjct: 291 DIP----------------EKDLQDVLKC-------CLKRDPKQRISIP 316

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  127 bits (320), Expect = 6e-31
 Identities = 65/300 (21%), Positives = 110/300 (36%), Gaps = 70/300 (23%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNE--TKGNGEDFINEVASISRTSHVN 379
                +G+G +G V++G  +  +N    VAIK      +    E F+ E  ++ +  H +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           IV L+G     +   +I E  + G L  F+  +        L    L   A  ++  L Y
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAY 506

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           L      R +H DI   N+L+  + C K+ DFGL++  E   +    +  +  I ++APE
Sbjct: 507 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 562

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEMT--GEKNNANVAVDRSSEIYFPHWVYKRLELEEDL 557
               NF   +  SDV+ +G+ ++E+   G K               P             
Sbjct: 563 SI--NFRRFTSASDVWMFGVCMWEILMHGVK---------------PFQ----------- 594

Query: 558 GLQGIENEEDKEYARK-----------------MILVSLWCIQTNPSDRPSMNRVVEMLE 600
              G++N +                        M      C   +PS RP    +   L 
Sbjct: 595 ---GVKNNDVIGRIENGERLPMPPNCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLS 647

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  123 bits (310), Expect = 7e-31
 Identities = 30/305 (9%), Positives = 71/305 (23%), Gaps = 60/305 (19%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLG 385
           L  G    V+  + ++  ++ A+KV       ++   E       + +R    +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 386 FC----------FEGHRRA----------------LIYEFVSNGSLEKFIHE-KHPLETN 418
                        +                     L+    S   LE             
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
                  L+ +   + R    L       ++H    P N+ +  D    + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TG-----EKNNAN 532
            R    S       + Y   E    +    ++  + +  G+ ++ +              
Sbjct: 246 TRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

Query: 533 VAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM 592
               +   +  P            L           ++ + +I      +  +   R   
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLP----------DFVKTLI---GRFLNFDRRRRLLP 347

Query: 593 NRVVE 597
              +E
Sbjct: 348 LEAME 352

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  122 bits (308), Expect = 8e-31
 Identities = 72/325 (22%), Positives = 133/325 (40%), Gaps = 78/325 (24%)

Query: 326 SFKNKLGQGGYGGVYKGKLLD--------GQNVAIKVLNE--TKGNGEDFINEVASISR- 374
           +    LG+G +G V   + +            VA+K+L +  T+ +  D ++E+  +   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 375 TSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN----------QKLKWE 424
             H NI+ LLG C +     +I E+ S G+L +++  + P              +++ ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
            L      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     +   
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYF 543
             T  R  + ++APE         +++SDV+S+G++++E  T                  
Sbjct: 215 KTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFT------------------ 254

Query: 544 PHWVYKRLELEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQTN 585
                        LG     GI  EE  +  ++               M++   W     
Sbjct: 255 -------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCW--HAV 299

Query: 586 PSDRPSMNRVVEMLEGSLDSLQIPP 610
           PS RP+  ++VE L+  L       
Sbjct: 300 PSQRPTFKQLVEDLDRILTLTTNEE 324

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (307), Expect = 9e-31
 Identities = 70/328 (21%), Positives = 120/328 (36%), Gaps = 87/328 (26%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN------VAIKVLNE--TKGNGEDFINEVASISRTSHV 378
               LG+G +G V K      +       VA+K+L E  +     D ++E   + + +H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN------------------QK 420
           +++ L G C +     LI E+   GSL  F+ E   +                     + 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
           L    L   A  I++G++YL      +++H D+   NIL+ E    KISDFGL++     
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSS 539
           +S V  +  R  + ++A E         + +SDV+S+G++++E +T              
Sbjct: 204 DSYVKRSQGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIVT-------------- 247

Query: 540 EIYFPHWVYKRLELEEDLGLQ---GIENEEDKEYARK-----------------MILVSL 579
                            LG     GI  E      +                  M    L
Sbjct: 248 -----------------LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLM----L 286

Query: 580 WCIQTNPSDRPSMNRVVEMLEGSLDSLQ 607
            C +  P  RP    + + LE  +   +
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMMVKRR 314

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  122 bits (308), Expect = 9e-31
 Identities = 71/336 (21%), Positives = 121/336 (36%), Gaps = 99/336 (29%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDG------QNVAIKVLNE--TKGNGEDFINEVASISRTSH 377
            +   +G+G +G V++ +            VA+K+L E  +     DF  E A ++   +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN------------------Q 419
            NIV LLG C  G    L++E+++ G L +F+    P                       
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 420 KLKWEVLYKIAVGIARGLEYL------HRGCNTRILHFDIKPHNILLDEDFCPKISDFGL 473
            L       IA  +A G+ YL      HR         D+   N L+ E+   KI+DFGL
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHR---------DLATRNCLVGENMVVKIADFGL 220

Query: 474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNAN 532
           ++     +   +       I ++ PE     +   + +SDV++YG++++E  +       
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFS------- 271

Query: 533 VAVDRSSEIYFPHWVYKRLELEEDLGLQ---GIENEEDKEYARK---------------- 573
                                    GLQ   G+ +EE   Y R                 
Sbjct: 272 ------------------------YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYN 307

Query: 574 -MILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI 608
            M      C    P+DRPS   +  +L+   +  + 
Sbjct: 308 LM----RLCWSKLPADRPSFCSIHRILQRMCERAEG 339

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  123 bits (310), Expect = 1e-30
 Identities = 74/336 (22%), Positives = 132/336 (39%), Gaps = 78/336 (23%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN--------VAIKVLNE--TKGNGEDFINEVASISR- 374
                LG+G +G V   + +            VA+K+L    T+ +  D I+E+  +   
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 375 TSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN----------QKLKWE 424
             H NI+ LLG C +     +I E+ S G+L +++  + P              ++L  +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
            L   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     +   
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYF 543
             T  R  + ++APE         +++SDV+S+G++++E  T                  
Sbjct: 249 KTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFT------------------ 288

Query: 544 PHWVYKRLELEEDLGLQ---GIENEEDKEYARK---------------MILVSLWCIQTN 585
                        LG     G+  EE  +  ++               M++   W     
Sbjct: 289 -------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCW--HAV 333

Query: 586 PSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSSGSQP 621
           PS RP+  ++VE L+  +         +        
Sbjct: 334 PSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHD 369

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  123 bits (310), Expect = 1e-30
 Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 27/218 (12%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVT 382
              + LGQG    V++G+    G   AIKV N        +  + E   + + +H NIV 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 383 LLGFCFEGHRRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           L     E           EF   GSL   + E         L       +   +  G+ +
Sbjct: 72  LFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEP---SNAYGLPESEFLIVLRDVVGGMNH 127

Query: 440 LHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
           L       I+H +IKP NI+     D     K++DFG A+  E  E  VS+    GT  Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEY 181

Query: 496 IAPEVFCRNFGEVSY------KSDVYSYGMMVFEM-TG 526
           + P+++ R      +        D++S G+  +   TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (312), Expect = 1e-30
 Identities = 69/308 (22%), Positives = 125/308 (40%), Gaps = 57/308 (18%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-H 377
            +K +    +  LG G  G V       G+ VA+K +       +  + E+  ++ +  H
Sbjct: 12  SLKNLVV-SEKILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH 68

Query: 378 VNIVTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV-LYKIAVGIA 434
            N++    +C E   R   +  E   N +L+  +  K+  + N KL+ E     +   IA
Sbjct: 69  PNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLD-------------EDFCPKISDFGLAKICEGRE 481
            G+ +LH   + +I+H D+KP NIL+              E+    ISDFGL K  +  +
Sbjct: 126 SGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 482 S--IVSMTGARGTIGYIAPEVFCRNFGEV-----SYKSDVYSYGMMVFEMT-------GE 527
           S    ++    GT G+ APE+   +         +   D++S G + + +        G+
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

Query: 528 KNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPS 587
           K +    + R   I+        L+  + L  + +  E     A  +I      I  +P 
Sbjct: 243 KYSRESNIIR--GIF-------SLDEMKCLHDRSLIAE-----ATDLI---SQMIDHDPL 285

Query: 588 DRPSMNRV 595
            RP+  +V
Sbjct: 286 KRPTAMKV 293

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  122 bits (308), Expect = 1e-30
 Identities = 71/316 (22%), Positives = 129/316 (40%), Gaps = 82/316 (25%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN--------VAIKVLNE--TKGNGEDFINEVASISR-T 375
               LG+G +G V   + +            VA+K+L +  T+ +  D ++E+  +    
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 376 SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN----------QKLKWEV 425
            H NI+ LLG C +     +I E+ S G+L +++  + P              +++ ++ 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           L      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     +    
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MTGEKNNANVAVDRSSEIYFP 544
            T  R  + ++APE         +++SDV+S+G++++E  T                   
Sbjct: 262 TTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFT------------------- 300

Query: 545 HWVYKRLELEEDLGLQ---GIENEEDKEYARK-----------------MILVSLWCIQT 584
                       LG     GI  EE  +  ++                 M      C   
Sbjct: 301 ------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMM----RDCWHA 344

Query: 585 NPSDRPSMNRVVEMLE 600
            PS RP+  ++VE L+
Sbjct: 345 VPSQRPTFKQLVEDLD 360

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  121 bits (306), Expect = 2e-30
 Identities = 69/331 (20%), Positives = 128/331 (38%), Gaps = 43/331 (12%)

Query: 298 RNIEAFLRNYGSLAPKRYRYADIKKMTNSFK--NKLGQGGYGGVYKGKLLDGQNVAIKVL 355
            +++  L NY +L        +  K  N ++    L QG +  +   +  D +  A+K  
Sbjct: 4   GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKY 62

Query: 356 N------------------ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LI 396
                                K   +DF NE+  I+   +   +T  G     +    +I
Sbjct: 63  EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYII 121

Query: 397 YEFVSNGSLEKFIHEKHPLE--TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK 454
           YE++ N S+ KF      L+      +  +V+  I   +     Y+H   N  I H D+K
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVK 179

Query: 455 PHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDV 514
           P NIL+D++   K+SDFG ++    ++    + G+RGT  ++ PE F         K D+
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDI 235

Query: 515 YSYGMMVFEM-TG-----EKNNANVAVDR--SSEIYFPHWVYKRLELEEDLGLQGIENEE 566
           +S G+ ++ M         K +     +   +  I +P      L    +       N  
Sbjct: 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFL 295

Query: 567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
             E     + + L   + NP++R +    ++
Sbjct: 296 SNE-DIDFLKLFL---RKNPAERITSEDALK 322

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  119 bits (301), Expect = 2e-30
 Identities = 60/316 (18%), Positives = 114/316 (36%), Gaps = 78/316 (24%)

Query: 326 SFKNKLGQGGYGGVYKGKL--------LDGQNVAIKVLNE-TKGNGEDFINEVASISRTS 376
            F   LGQG +  ++KG          L    V +KVL++  +   E F    + +S+ S
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
           H ++V   G C  G    L+ EFV  GSL+ ++ +         +      ++A  +A  
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAA 125

Query: 437 LEYL------HRGCNTRILHFDIKPHNILLDEDFCP--------KISDFGLAKICEGRES 482
           + +L      H          ++   NILL  +           K+SD G++     ++ 
Sbjct: 126 MHFLEENTLIHG---------NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD- 175

Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT--GEK-----NNANV-- 533
                  +  I ++ PE    N   ++  +D +S+G  ++E+   G+K     ++     
Sbjct: 176 -----ILQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229

Query: 534 AVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMN 593
             +   ++  P                     +  E A  +      C+   P  RPS  
Sbjct: 230 FYEDRHQLPAP---------------------KAAELANLI----NNCMDYEPDHRPSFR 264

Query: 594 RVVEMLEGSLDSLQIP 609
            ++  L        +P
Sbjct: 265 AIIRDLNSLFTPDLVP 280

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  120 bits (303), Expect = 4e-30
 Identities = 78/322 (24%), Positives = 127/322 (39%), Gaps = 73/322 (22%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLG 385
           LG+GG+   ++    D  +  A K++ ++        E    E++     +H ++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 386 FCFEGHRRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
             FE +    ++   E     SL +    +  L      + E  Y +   I  G +YLHR
Sbjct: 109 -FFEDNDF--VFVVLELCRRRSLLELHKRRKALT-----EPEARYYL-RQIVLGCQYLHR 159

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-----GTIGYIA 497
               R++H D+K  N+ L+ED   KI DFGLA       + V   G R     GT  YIA
Sbjct: 160 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIA 209

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEM-TG----EKNNANVAVDR--SSEIYFPHWVYKR 550
           PEV  +     S++ DV+S G +++ +  G    E +       R   +E   P  +   
Sbjct: 210 PEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI--- 264

Query: 551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE---MLEGSL---- 603
                               A  +I      +QT+P+ RP++N ++       G +    
Sbjct: 265 -----------------NPVAASLI---QKMLQTDPTARPTINELLNDEFFTSGYIPARL 304

Query: 604 --DSLQIPPRPFLLSSGSQPDF 623
               L IPPR  +  S   P  
Sbjct: 305 PITCLTIPPRFSIAPSSLDPSN 326

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  122 bits (306), Expect = 5e-30
 Identities = 43/364 (11%), Positives = 106/364 (29%), Gaps = 82/364 (22%)

Query: 309 SLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN 367
           S   +R R      +       LGQ       +      G++  + V   T+    + I 
Sbjct: 71  SELGERPRTLVRGTV-------LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123

Query: 368 E--------------------------VASISRTSHVNIVTLLGFCFEGHRRALIYEFV- 400
           +                          +             ++    +     ++  F  
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183

Query: 401 ---SNGSLEKFIHE-KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPH 456
                 +L+ F         T++ L      ++ + + R L  LH      ++H  ++P 
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPV 240

Query: 457 NILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR---NFGEVSYKSD 513
           +I+LD+     ++ F      +G  ++  +          A  +      +   +++  D
Sbjct: 241 DIVLDQRGGVFLTGFEHLVR-DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD 299

Query: 514 VYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYAR 572
            ++ G+ ++ +   +     +     + +    W+++               +   +  R
Sbjct: 300 TWTLGLAIYWIWCAD-----LPNTDDAALGGSEWIFR-------------SCKNIPQPVR 341

Query: 573 KMILVSLWCIQTNPSDRPSMNRVVE---------MLEGSLDSLQIPPRP-----FLLSSG 618
            ++      ++    DR    + +E          L  +L   Q    P        S  
Sbjct: 342 ALL---EGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGT 398

Query: 619 SQPD 622
           SQPD
Sbjct: 399 SQPD 402

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  119 bits (300), Expect = 5e-30
 Identities = 76/310 (24%), Positives = 123/310 (39%), Gaps = 73/310 (23%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLG 385
           LG+GG+   ++    D  +  A K++ ++        E    E++     +H ++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 386 FCFEGHRRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
             FE +    ++   E     SL +    +  L        E  Y +   I  G +YLHR
Sbjct: 83  -FFEDNDF--VFVVLELCRRRSLLELHKRRKALTEP-----EARYYL-RQIVLGCQYLHR 133

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-----GTIGYIA 497
               R++H D+K  N+ L+ED   KI DFGLA       + V   G R     GT  YIA
Sbjct: 134 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIA 183

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEM-TG----EKNNANVAVDR--SSEIYFPHWVYKR 550
           PEV  +     S++ DV+S G +++ +  G    E +       R   +E   P  +   
Sbjct: 184 PEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI--- 238

Query: 551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE---MLEGSL---- 603
                               A  +I      +QT+P+ RP++N ++       G +    
Sbjct: 239 -----------------NPVAASLI---QKMLQTDPTARPTINELLNDEFFTSGYIPARL 278

Query: 604 --DSLQIPPR 611
               L IPPR
Sbjct: 279 PITCLTIPPR 288

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  119 bits (301), Expect = 8e-30
 Identities = 76/319 (23%), Positives = 123/319 (38%), Gaps = 70/319 (21%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN------VAIKVLNE--TKGNGEDFINEVASISR-TS 376
            F   LG G +G V                VA+K+L E       E  ++E+  +++  S
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107

Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV----------- 425
           H NIV LLG C       LI+E+   G L  ++  K    +  ++++E            
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 426 ------LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG 479
                 L   A  +A+G+E+L        +H D+   N+L+      KI DFGLA+    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MT-------GEKNNA 531
             + V    AR  + ++APE      G  + KSDV+SYG++++E  +       G   +A
Sbjct: 225 DSNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282

Query: 532 NVAVDRSSEIYFPHWVYKRLELEEDLGLQGI-----ENEEDKEYARKMILVSLWCIQTNP 586
           N               YK ++        G          ++ Y   +I+ S W    + 
Sbjct: 283 N--------------FYKLIQ-------NGFKMDQPFYATEEIY---IIMQSCW--AFDS 316

Query: 587 SDRPSMNRVVEMLEGSLDS 605
             RPS   +   L   L  
Sbjct: 317 RKRPSFPNLTSFLGCQLAD 335

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  118 bits (297), Expect = 9e-30
 Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 61/286 (21%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLG 385
           LG+G + GVY+ + +  G  VAIK++++      G  +   NEV    +  H +I+ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 386 FCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLK-WEVLYKIAVGIARGLEYLHRG 443
             FE      L+ E   NG + +++  +      +     E  + +   I  G+ YLH  
Sbjct: 79  -YFEDSNYVYLVLEMCHNGEMNRYLKNR-----VKPFSENEARHFMH-QIITGMLYLHS- 130

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-----GTIGYIAP 498
               ILH D+   N+LL  +   KI+DFGLA       + + M   +     GT  YI+P
Sbjct: 131 --HGILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLCGTPNYISP 181

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM-TG----EKNNANVAVDR--SSEIYFPHWVYKRL 551
           E+  R+      +SDV+S G M + +  G    + +     +++   ++   P ++    
Sbjct: 182 EIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL---- 235

Query: 552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                              A+ +I   L   + NP+DR S++ V++
Sbjct: 236 ----------------SIEAKDLIHQLL---RRNPADRLSLSSVLD 262

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  121 bits (306), Expect = 1e-29
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 25/208 (12%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLN----ETKGNGEDFINEVASISRTSHVNI 380
             +  LG+G +G V   K  + GQ  A+KV++    + K + E  + EV  + +  H NI
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 381 VTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           + L  F  +     L+ E  + G L ++ I  K   E +         +I   +  G+ Y
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITY 141

Query: 440 LHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           +H     +I+H D+KP N+LL    +D   +I DFGL+   E  +    M    GT  YI
Sbjct: 142 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYI 195

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           APEV    + E   K DV+S G++++ +
Sbjct: 196 APEVLHGTYDE---KCDVWSTGVILYIL 220

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  117 bits (296), Expect = 2e-29
 Identities = 74/313 (23%), Positives = 124/313 (39%), Gaps = 64/313 (20%)

Query: 326 SFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNE--TKGNGEDFINEVASISR-TS 376
                LG+G +G V +            + VA+K+L E  T       ++E+  +     
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 377 HVNIVTLLGFCF-EGHRRALIYEFVSNGSLEKFIHEKHPLETN----------QKLKWEV 425
           H+N+V LLG C   G    +I EF   G+L  ++  K                  L  E 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           L   +  +A+G+E+L    + + +H D+   NILL E    KI DFGLA+        V 
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFE-MT-------GEKNNANVAVDR 537
              AR  + ++APE         + +SDV+S+G++++E  +       G K +       
Sbjct: 207 KGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----- 259

Query: 538 SSEIYFPHWVYKRLELEEDLGLQGI-----ENEEDKEYARKMILVSLWCIQTNPSDRPSM 592
                      +RL+       +G      +    + Y     ++  W     PS RP+ 
Sbjct: 260 ---------FCRRLK-------EGTRMRAPDYTTPEMY---QTMLDCW--HGEPSQRPTF 298

Query: 593 NRVVEMLEGSLDS 605
           + +VE L   L +
Sbjct: 299 SELVEHLGNLLQA 311

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (292), Expect = 3e-29
 Identities = 70/286 (24%), Positives = 110/286 (38%), Gaps = 60/286 (20%)

Query: 329 NKLGQGGYGGVYKGKLLD-GQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTL 383
             LG+G +G VY  +       +A+KVL + +    G       EV   S   H NI+ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G+  +  R  LI E+   G++ + + +        K   +        +A  L Y H  
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYCHS- 127

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-----GTIGYIAP 498
              R++H DIKP N+LL      KI+DFG +               R     GT+ Y+ P
Sbjct: 128 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------RRTDLCGTLDYLPP 176

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM-TG----EKNNANVAVDR--SSEIYFPHWVYKRL 551
           E+          K D++S G++ +E   G    E N       R    E  FP +V    
Sbjct: 177 EMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 230

Query: 552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                        E  ++   ++       ++ NPS RP +  V+E
Sbjct: 231 ------------TEGARDLISRL-------LKHNPSQRPMLREVLE 257

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (294), Expect = 3e-29
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 31/209 (14%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            +LG G +G VYK K    G   A KV+  +++   ED+I E+  ++   H  IV LLG 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHE-KHPLETNQKLKWEVLYKIAV---GIARGLEYLHR 442
            +   +  ++ EF   G+++  + E    L   Q         I V    +   L +LH 
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---------IQVVCRQMLEALNFLH- 134

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFG----LAKICEGRESIVSMTGARGTIGYIAP 498
             + RI+H D+K  N+L+  +   +++DFG      K  + R+S +      GT  ++AP
Sbjct: 135 --SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAP 186

Query: 499 EV-FCRNFGEVSY--KSDVYSYGMMVFEM 524
           EV  C    +  Y  K+D++S G+ + EM
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEM 215

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  120 bits (302), Expect = 4e-29
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIV 381
               KLG G YG V   +  +     AIK++ +T  +       + EVA +    H NI+
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 382 TLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
            L  F  +     L+ E    G L ++ IH     E +          I   +  G+ YL
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------VIIKQVLSGVTYL 152

Query: 441 HRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIA 497
           H      I+H D+KP N+LL   ++D   KI DFGL+ + E ++    M    GT  YIA
Sbjct: 153 H---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIA 206

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           PEV  + + E   K DV+S G+++F +
Sbjct: 207 PEVLRKKYDE---KCDVWSIGVILFIL 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (293), Expect = 9e-29
 Identities = 39/218 (17%), Positives = 72/218 (33%), Gaps = 28/218 (12%)

Query: 327 FKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKGNGEDF---INEVASISRTSH 377
             + LG+G +  VY+    D       Q   +KV      N  +F      +  +  +  
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--PANPWEFYIGTQLMERLKPSMQ 126

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
              +         +   L+ E  S G+L   I+        + +   ++   A+ +   +
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMI 185

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCP-----------KISDFGLAKICEGRESIVSM 486
           E +H      I+H DIKP N +L   F              + D G +   +        
Sbjct: 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           T    T G+   E+        +Y+ D +     V+ M
Sbjct: 243 TAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCM 278

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  119 bits (299), Expect = 1e-28
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIV 381
           +    LG+G +G V K K  +  Q  A+KV+N+           + EV  + +  H NI+
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 382 TLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
            L     +     ++ E  + G L ++ I  K   E +         +I   +  G+ Y+
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYM 137

Query: 441 HRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIA 497
           H      I+H D+KP NILL   ++D   KI DFGL+   +       M    GT  YIA
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIA 191

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEM 524
           PEV    + E   K DV+S G++++ +
Sbjct: 192 PEVLRGTYDE---KCDVWSAGVILYIL 215

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  118 bits (298), Expect = 1e-28
 Identities = 63/218 (28%), Positives = 88/218 (40%), Gaps = 35/218 (16%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLN--------------ETKGNGEDFINEVA 370
               KLG G YG V   K        AIKV+                 +   E+  NE++
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 371 SISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKI 429
            +    H NI+ L     +     L+ EF   G L E+ I+     E +          I
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-------NI 151

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSM 486
              I  G+ YLH      I+H DIKP NILL   +     KI DFGL+           +
Sbjct: 152 MKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---L 205

Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM 524
               GT  YIAPEV  + + E   K DV+S G++++ +
Sbjct: 206 RDRLGTAYYIAPEVLKKKYNE---KCDVWSCGVIMYIL 240

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  114 bits (287), Expect = 2e-28
 Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 39/275 (14%)

Query: 329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGE--DFINEVASISRTS-HVNIVTLL 384
            +LG+G YG V K + +  GQ +A+K +  T  + E    + ++    RT      VT  
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           G  F      +  E + + SL+KF   K  ++  Q +  ++L KIAV I + LE+LH   
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHS-- 127

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
              ++H D+KP N+L++     K+ DFG++      + +     A G   Y+APE     
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDA-GCKPYMAPERINPE 184

Query: 505 FGEVSY--KSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
             +  Y  KSD++S G+ + E+                   FP   Y          L+ 
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILR---------------FP---YDSWGTPFQQ-LKQ 225

Query: 562 IENEE-----DKEYARKMILVSLWCIQTNPSDRPS 591
           +  E        +++ + +  +  C++ N  +RP+
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 260

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  114 bits (288), Expect = 3e-28
 Identities = 65/319 (20%), Positives = 118/319 (36%), Gaps = 55/319 (17%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFI-NEVASISR-TSHVNIVTLLGF 386
            L +GG+  VY+ + +  G+  A+K L   +      I  EV  + + + H NIV     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 387 CFEGHRRA-------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
              G   +       L+   +  G L +F+ +    E+   L  + + KI     R +++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM---ESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR--------- 490
           +HR     I+H D+K  N+LL      K+ DFG A               R         
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 491 -GTIGYIAPEVF-CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY 548
             T  Y  PE+    +   +  K D+++ G +++ +                       +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL----------------------CF 248

Query: 549 KRLELEEDLGLQGIEN------EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS 602
           ++   E+   L+ I N        D +Y     L+    +Q NP +R S+  VV  L+  
Sbjct: 249 RQHPFEDGAKLR-IVNGKYSIPPHDTQYTVFHSLIR-AMLQVNPEERLSIAEVVHQLQEI 306

Query: 603 LDSLQIPPRPFLLSSGSQP 621
             +  + P+  +     Q 
Sbjct: 307 AAARNVNPKSPITELLEQN 325

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  113 bits (286), Expect = 3e-28
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 30/205 (14%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            K+GQG  G VY    +  GQ VAI+ +N + +   E  INE+  +    + NIV  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV---GIARGLEYLHRG 443
              G    ++ E+++ GSL   + E   ++  Q         IA       + LE+LH  
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQ---------IAAVCRECLQALEFLH-- 133

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICEG---RESIVSMTGARGTIGYIAPE 499
            + +++H DIK  NILL  D   K++DFG  A+I      R ++V      GT  ++APE
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPE 186

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM 524
           V  R       K D++S G+M  EM
Sbjct: 187 VVTRK--AYGPKVDIWSLGIMAIEM 209

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  113 bits (285), Expect = 6e-28
 Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 34/278 (12%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTLLGF 386
            +G G    V         + VAIK +N  K     ++ + E+ ++S+  H NIV+    
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV---GIARGLEYLHRG 443
                   L+ + +S GS+   I        ++    +    IA     +  GLEYLH+ 
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVLEGLEYLHK- 139

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGL-AKICEGRESIVSMTGARGT-IG---YIAP 498
                +H D+K  NILL ED   +I+DFG+ A +  G +  ++    R T +G   ++AP
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD--ITRNKVRKTFVGTPCWMAP 195

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEED- 556
           EV  +  G   +K+D++S+G+   E+ TG               Y P  V   L L+ D 
Sbjct: 196 EVMEQVRG-YDFKADIWSFGITAIELATGAAPYHK---------YPPMKVL-MLTLQNDP 244

Query: 557 --LGLQGIENEEDKEYARKMI-LVSLWCIQTNPSDRPS 591
             L     + E  K+Y +    ++SL C+Q +P  RP+
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPT 281

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (286), Expect = 6e-28
 Identities = 64/336 (19%), Positives = 113/336 (33%), Gaps = 89/336 (26%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            +G+GG+G V++ K  +D  N AIK   L   +   E  + EV ++++  H  IV     
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 387 CFEGHRRALIYE------------------------FVSNGSLEKFIHEKHPLETNQKLK 422
             E        E                         V    ++ F  +    +      
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 423 WEVLY------------------------------KIAVGIARGLEYLHRGCNTRILHFD 452
              LY                               I + IA  +E+LH   +  ++H D
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRD 189

Query: 453 IKPHNILLDEDFCPKISDFGLAKI----------CEGRESIVSMTGARGTIGYIAPEVFC 502
           +KP NI    D   K+ DFGL                  +  + TG  GT  Y++PE   
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249

Query: 503 RNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 562
            N    S+K D++S G+++FE+    +     V   +++       + L+          
Sbjct: 250 GN--NYSHKVDIFSLGLILFELLYSFSTQMERVRIITDV-------RNLKFPLLF----- 295

Query: 563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
              +       M+      +  +P++RP    ++E 
Sbjct: 296 --TQKYPQEHMMV---QDMLSPSPTERPEATDIIEN 326

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  114 bits (287), Expect = 6e-28
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 27/205 (13%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLN----ETKGNGEDFINEVASISRTSHVNIVTL 383
            ++G G +G VY  + + + + VAIK ++    ++    +D I EV  + +  H N +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV---GIARGLEYL 440
            G     H   L+ E+    + +     K PL+  +         IA    G  +GL YL
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE---------IAAVTHGALQGLAYL 170

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
           H   +  ++H D+K  NILL E    K+ DFG A I     S V      GT  ++APEV
Sbjct: 171 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEV 221

Query: 501 -FCRNFGEVSYKSDVYSYGMMVFEM 524
               + G+   K DV+S G+   E+
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIEL 246

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  113 bits (284), Expect = 1e-27
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 30/205 (14%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            K+G+G  G V   +    G+ VA+K+++   +   E   NEV  +    H N+V +   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV---GIARGLEYLHRG 443
              G    ++ EF+  G+L   + +   L   Q         IA     + + L YLH  
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQ---------IATVCEAVLQALAYLH-- 158

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFG----LAKICEGRESIVSMTGARGTIGYIAPE 499
               ++H DIK  +ILL  D   K+SDFG    ++K    R+S+V      GT  ++APE
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPE 211

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM 524
           V  R+    + + D++S G+MV EM
Sbjct: 212 VISRS--LYATEVDIWSLGIMVIEM 234

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (281), Expect = 1e-27
 Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 29/209 (13%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLN--ETKGNGEDFINEVASISRTSHVNIVT 382
            FK KLG G +G V+  +    G    IK +N   ++   E    E+  +    H NI+ 
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLY--KIAVGIAR----G 436
           +     + H   ++ E    G L + I                         + +     
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA--------LSEGYVAELMKQMMNA 136

Query: 437 LEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTI 493
           L Y H   +  ++H D+KP NIL          KI DFGLA++ +  E     T A GT 
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190

Query: 494 GYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            Y+APEVF R+      K D++S G++++
Sbjct: 191 LYMAPEVFKRDVTF---KCDIWSAGVVMY 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 1e-27
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 38/215 (17%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFC 387
            +G G YG VYKG+ +  GQ  AIKV++ T    E+   E+  + + S H NI T  G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90

Query: 388 FEGHRRA------LIYEFVSNGSLEKFIH--EKHPLETNQKLKWEVLYKIAV---GIARG 436
            + +         L+ EF   GS+   I   + + L+            IA     I RG
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW---------IAYICREILRG 141

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGT-IG- 494
           L +LH     +++H DIK  N+LL E+   K+ DFG++        +    G R T IG 
Sbjct: 142 LSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QLDRTVGRRNTFIGT 192

Query: 495 --YIAPEVF-CRNFGEVSY--KSDVYSYGMMVFEM 524
             ++APEV  C    + +Y  KSD++S G+   EM
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (286), Expect = 2e-27
 Identities = 41/216 (18%), Positives = 79/216 (36%), Gaps = 29/216 (13%)

Query: 329 NKLGQG--GYGGVYKGK-LLDGQNVAIKVLNETKGNGEDF---INEVASISRTSHVNIVT 382
             +G+G      V   +    G+ V ++ +N    + E       E+      +H NIV 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQKLKWEVLYKIAV---GIARGL 437
                   +   ++  F++ GS +  I  H    +             IA    G+ + L
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---------IAYILQGVLKAL 141

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG----LAKICEGRESIVSMTGAR-GT 492
           +Y+H       +H  +K  +IL+  D    +S       +    + +  +          
Sbjct: 142 DYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 493 IGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGE 527
           + +++PEV  +N      KSD+YS G+   E+  G 
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  116 bits (292), Expect = 2e-27
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 25/211 (11%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVTL 383
            K +LG GG+G V +      G+ VAIK   +  +  N E +  E+  + + +H N+V+ 
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 384 L------GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
                            L  E+   G L K++++    E    LK   +  +   I+  L
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF---ENCCGLKEGPIRTLLSDISSAL 134

Query: 438 EYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
            YLH     RI+H D+KP NI+L    +    KI D G AK  +  E     T   GT+ 
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQ 188

Query: 495 YIAPEVF-CRNFGEVSYKSDVYSYGMMVFEM 524
           Y+APE+   + +       D +S+G + FE 
Sbjct: 189 YLAPELLEQKKYTV---TVDYWSFGTLAFEC 216

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  111 bits (279), Expect = 3e-27
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 24/204 (11%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVT 382
               LG+G +G V K K  +  Q  A+KV+N+           + EV  + +  H NI+ 
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 383 LLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
           L     +     ++ E  + G L ++ I  K   E +         +I   +  G+ Y+H
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMH 138

Query: 442 RGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
                 I+H D+KP NILL   ++D   KI DFGL+   +       M    GT  YIAP
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAP 192

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVF 522
           EV    + E   K DV+S G++++
Sbjct: 193 EVLRGTYDE---KCDVWSAGVILY 213

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (281), Expect = 3e-27
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 20/208 (9%)

Query: 330 KLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGE--DFINEVASISRTS-HVNIVTLLG 385
           ++G+G YG V K      GQ +A+K +  T    E    + ++  + R+S    IV   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
             F      +  E + + S +KF    + +  +  +  E+L KI +   + L +L    N
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKE--N 144

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG---YIAPEVFC 502
            +I+H DIKP NILLD     K+ DFG++        +V         G   Y+APE   
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQ------LVDSIAKTRDAGCRPYMAPERID 198

Query: 503 RNFGEVSY--KSDVYSYGMMVFEM-TGE 527
            +     Y  +SDV+S G+ ++E+ TG 
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (282), Expect = 3e-27
 Identities = 63/288 (21%), Positives = 117/288 (40%), Gaps = 40/288 (13%)

Query: 329 NKLGQGGYGGVYKGKLL-DGQNVAIKV--LNETKGNGEDFINEVASISRTSHVNIVTLLG 385
           ++LG G  G V+K      G  +A K+  L          I E+  +   +   IV   G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
             +     ++  E +  GSL++ + +   +        ++L K+++ + +GL YL     
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPE------QILGKVSIAVIKGLTYLRE--K 150

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGYIAPEVFCRN 504
            +I+H D+KP NIL++     K+ DFG++      + I SM  +  GT  Y++PE     
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT 205

Query: 505 FGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE 563
               S +SD++S G+ + EM  G                +P       + +E   + G +
Sbjct: 206 --HYSVQSDIWSMGLSLVEMAVGR---------------YP---IPPPDAKELELMFGCQ 245

Query: 564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPR 611
            E D              +     D      + E+L+  ++  + PP+
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN--EPPPK 291

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (278), Expect = 5e-27
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 32/209 (15%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN--ETKGNGEDFINEVASISRTSHVNIVTLLGF 386
           K+G+G +G V+KG      + VAIK+++  E +   ED   E+  +S+     +    G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV---GIARGLEYLHRG 443
             +  +  +I E++  GS    +    PL+  Q         IA     I +GL+YLH  
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQ---------IATILREILKGLDYLH-- 136

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFG----LAKICEGRESIVSMTGARGTIGYIAPE 499
            + + +H DIK  N+LL E    K++DFG    L      R + V      GT  ++APE
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPE 189

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM-TGE 527
           V  +       K+D++S G+   E+  GE
Sbjct: 190 VIKQ--SAYDSKADIWSLGITAIELARGE 216

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  111 bits (278), Expect = 7e-27
 Identities = 58/243 (23%), Positives = 82/243 (33%), Gaps = 48/243 (19%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLN------ETKGNGEDFINEVASISRTSHVN 379
            K  +GQG YG V            AIK++N          + E    EV  + +  H N
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVG------- 432
           I  L     +     L+ E    G L   ++      T +     V  +I          
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 433 ---------------------------IARGLEYLHRGCNTRILHFDIKPHNILL--DED 463
                                      I   L YLH   N  I H DIKP N L   ++ 
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206

Query: 464 FCPKISDFGLAKICEGRES--IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMV 521
           F  K+ DFGL+K      +     MT   GT  ++APEV          K D +S G+++
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 522 FEM 524
             +
Sbjct: 267 HLL 269

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (276), Expect = 9e-27
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 30/205 (14%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFC 387
            KLG+G YG VYK      GQ VAIK +   + + ++ I E++ + +    ++V   G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKH-PLETNQKLKWEVLYKIAV---GIARGLEYLHRG 443
           F+     ++ E+   GS+   I  ++  L  ++         IA       +GLEYLH  
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE---------IATILQSTLKGLEYLH-- 142

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFG----LAKICEGRESIVSMTGARGTIGYIAPE 499
              R +H DIK  NILL+ +   K++DFG    L      R +++      GT  ++APE
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPE 195

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM 524
           V        +  +D++S G+   EM
Sbjct: 196 VIQE--IGYNCVADIWSLGITAIEM 218

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  109 bits (274), Expect = 9e-27
 Identities = 60/279 (21%), Positives = 112/279 (40%), Gaps = 50/279 (17%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLG 385
           LG+G +G VY  +       +A+KVL +++    G       E+   S   H NI+ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
           +  +  R  L+ EF   G L  +      L+ + +   +        +A  L Y H    
Sbjct: 82  YFHDRKRIYLMLEFAPRGEL--YKE----LQKHGRFDEQRSATFMEELADALHYCHE--- 132

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
            +++H DIKP N+L+      KI+DFG +       S+   T   GT+ Y+ PE+     
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMC-GTLDYLPPEMIEGK- 187

Query: 506 GEVSYKSDVYSYGMMVFEM-TG----EKNNANVAVDR--SSEIYFPHWVYKRLELEEDLG 558
                K D++  G++ +E   G    +  +      R  + ++ FP ++           
Sbjct: 188 -THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL----------- 235

Query: 559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                ++  K+   K+       ++ +P  R  +  V+E
Sbjct: 236 -----SDGSKDLISKL-------LRYHPPQRLPLKGVME 262

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  111 bits (280), Expect = 1e-26
 Identities = 52/238 (21%), Positives = 91/238 (38%), Gaps = 30/238 (12%)

Query: 291 KKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQN 349
             K  +Y      +       P   +   +         +LG G +G V++      G+ 
Sbjct: 20  GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYD-YYDILEELGSGAFGVVHRCVEKATGRV 78

Query: 350 VAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL-EK 407
              K +N           NE++ +++  H  ++ L     + +   LI EF+S G L ++
Sbjct: 79  FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 138

Query: 408 FIHEKHPL-ETNQKLKWEVLYKIAVGIAR----GLEYLHRGCNTRILHFDIKPHNILL-- 460
              E + + E              +   R    GL+++H      I+H DIKP NI+   
Sbjct: 139 IAAEDYKMSE-----------AEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCET 184

Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
            +    KI DFGLA      E    +     T  + APE+  R    V + +D+++ G
Sbjct: 185 KKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREP--VGFYTDMWAIG 237

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  109 bits (274), Expect = 1e-26
 Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 30/206 (14%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLL 384
            +N +G+G +G V            A K + +      + F  E+  +    H NI+ L 
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 385 GFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR----GLEY 439
               +     L+ E  + G L E+ +H++   E             A  I +     + Y
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRE-----------SDAARIMKDVLSAVAY 121

Query: 440 LHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
            H      + H D+KP N L      D   K+ DFGLA   +  +    M    GT  Y+
Sbjct: 122 CH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYV 175

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVF 522
           +P+V    +G    + D +S G+M++
Sbjct: 176 SPQVLEGLYGP---ECDEWSAGVMMY 198

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  110 bits (277), Expect = 2e-26
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 31/202 (15%)

Query: 328 KNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLLG 385
              LG G +G V+K +    G  +A K++        E+  NE++ +++  H N++ L  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 386 FCFEGHRR-ALIYEFVSNGSL-EKFIHEKHPL-ETNQKLKWEVLYKIAVGIAR----GLE 438
             FE      L+ E+V  G L ++ I E + L E              +   +    G+ 
Sbjct: 154 A-FESKNDIVLVMEYVDGGELFDRIIDESYNLTE-----------LDTILFMKQICEGIR 201

Query: 439 YLHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           ++H      ILH D+KP NIL    +    KI DFGLA+  + RE    +    GT  ++
Sbjct: 202 HMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFL 255

Query: 497 APEVFCRNFGEVSYKSDVYSYG 518
           APEV   +F  VS+ +D++S G
Sbjct: 256 APEVVNYDF--VSFPTDMWSVG 275

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  108 bits (273), Expect = 3e-26
 Identities = 43/202 (21%), Positives = 76/202 (37%), Gaps = 28/202 (13%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLL 384
                LG+G +G V++       +    K +     +      E++ ++   H NI+ L 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLY--KIAVGIAR----GLE 438
                     +I+EF+S   + + I+                   +  V         L+
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTS-----------AFELNEREIVSYVHQVCEALQ 116

Query: 439 YLHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           +LH   +  I HFDI+P NI+         KI +FG A+  +  +   +         Y 
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYY 170

Query: 497 APEVFCRNFGEVSYKSDVYSYG 518
           APEV   +   VS  +D++S G
Sbjct: 171 APEVHQHDV--VSTATDMWSLG 190

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  107 bits (269), Expect = 5e-26
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 25/201 (12%)

Query: 327 FKNKLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGED---FINEVASISRTSHVNIVT 382
            K +LG+G +  V +      G   A K++N  K +  D      E     +  H NIV 
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           L     E     L+++ V+ G L + I  +      +             I   + Y H 
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCH- 122

Query: 443 GCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
             +  I+H ++KP N+LL    +    K++DFGLA      E   +  G  GT GY++PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPE 177

Query: 500 VFCRNFGEVSY--KSDVYSYG 518
           V  ++     Y    D+++ G
Sbjct: 178 VLKKD----PYSKPVDIWACG 194

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  108 bits (271), Expect = 6e-26
 Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 36/210 (17%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG-------EDFINEVASISRTSH 377
               +LG G +  V K +    G   A K + + +          E+   EV+ + +  H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR- 435
            N++TL           LI E VS G L +    ++   E           + A    + 
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-----------EEATSFIKQ 123

Query: 436 ---GLEYLHRGCNTRILHFDIKPHNILL---DEDFCP-KISDFGLAKICEGRESIVSMTG 488
              G+ YLH     +I HFD+KP NI+L   +      K+ DFGLA   E          
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
             GT  ++APE+       +  ++D++S G
Sbjct: 178 IFGTPEFVAPEIVNYEP--LGLEADMWSIG 205

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  108 bits (272), Expect = 8e-26
 Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 36/210 (17%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG-------EDFINEVASISRTSH 377
               +LG G +  V K +    G   A K + + +          E+   EV+ + +  H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR- 435
            NI+TL           LI E VS G L +    ++   E           + A    + 
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-----------EEATSFIKQ 123

Query: 436 ---GLEYLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLAKICEGRESIVSMTG 488
              G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA   E          
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
             GT  ++APE+       +  ++D++S G
Sbjct: 178 IFGTPEFVAPEIVNYEP--LGLEADMWSIG 205

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  106 bits (267), Expect = 9e-26
 Identities = 53/210 (25%), Positives = 82/210 (39%), Gaps = 36/210 (17%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG-------EDFINEVASISRTSH 377
               +LG G +  V K +    G+  A K + + + +        E+   EV  +    H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR- 435
            NI+TL           LI E VS G L +    ++   E             A    + 
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-----------DEATQFLKQ 116

Query: 436 ---GLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICEGRESIVSMTG 488
              G+ YLH     RI HFD+KP NI+L      +   K+ DFG+A   E          
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKN 170

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
             GT  ++APE+       +  ++D++S G
Sbjct: 171 IFGTPEFVAPEIVNYEP--LGLEADMWSIG 198

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (263), Expect = 5e-25
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 34/204 (16%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLL 384
           F   LG G +  V+  K  L G+  A+K + ++         NE+A + +  H NIVTL 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 385 GFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR----GLEY 439
                     L+ + VS G L ++ +      E           K A  + +     ++Y
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTE-----------KDASLVIQQVLSAVKY 121

Query: 440 LHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           LH      I+H D+KP N+L    +E+    I+DFGL+K+ +       M+ A GT GY+
Sbjct: 122 LH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYV 174

Query: 497 APEVFCRNFGEVSY--KSDVYSYG 518
           APEV  +      Y    D +S G
Sbjct: 175 APEVLAQK----PYSKAVDCWSIG 194

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (264), Expect = 5e-25
 Identities = 52/210 (24%), Positives = 81/210 (38%), Gaps = 36/210 (17%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLN-------ETKGNGEDFINEVASISRTSH 377
               +LG G +  V K +    G   A K +            + ED   EV+ +    H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR- 435
            N++TL           LI E V+ G L +    ++   E           + A    + 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-----------EEATEFLKQ 122

Query: 436 ---GLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKICEGRESIVSMTG 488
              G+ YLH   + +I HFD+KP NI+L          KI DFGLA   +          
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKN 176

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
             GT  ++APE+       +  ++D++S G
Sbjct: 177 IFGTPEFVAPEIVNYEP--LGLEADMWSIG 204

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (265), Expect = 5e-25
 Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 35/214 (16%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG------EDFINEVASISRTSHVN 379
               +G+G +  V +      GQ  A+K+++  K         ED   E +      H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLY--KIAVGIAR-- 435
           IV LL          +++EF+    L   I ++             +Y   +A    R  
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA--------DAGFVYSEAVASHYMRQI 139

Query: 436 --GLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGAR 490
              L Y H   +  I+H D+KPH +LL   +     K+  FG+A      ES +   G  
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRV 194

Query: 491 GTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMVF 522
           GT  ++APEV  R      Y    DV+  G+++F
Sbjct: 195 GTPHFMAPEVVKRE----PYGKPVDVWGCGVILF 224

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (265), Expect = 5e-25
 Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 35/206 (16%)

Query: 327 FKNKLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVT 382
            K +LG+G +  V +      G   A K++N  K +    +    E     +  H NIV 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 383 LLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR----GL 437
           L     E     L+++ V+ G L E  +  +   E             A    +     +
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-----------ADASHCIQQILESI 141

Query: 438 EYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
            Y H   +  I+H ++KP N+LL    +    K++DFGLA      E   +  G  GT G
Sbjct: 142 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPG 195

Query: 495 YIAPEVFCRNFGEVSY--KSDVYSYG 518
           Y++PEV  ++     Y    D+++ G
Sbjct: 196 YLSPEVLKKD----PYSKPVDIWACG 217

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  106 bits (265), Expect = 6e-25
 Identities = 38/315 (12%), Positives = 92/315 (29%), Gaps = 84/315 (26%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFI----NEVASISRTSHV------- 378
           LGQ       +      G++  + V   T+    + I     EV  +     +       
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 379 ---------------NIVTLLGFCFEGHRRALIYEFV----SNGSLEKFIHE-KHPLETN 418
                              ++    +     ++  F        +L+ F         T+
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 419 QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE 478
           + L      ++ + + R L  LH      ++H  ++P +I+LD+     ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254

Query: 479 GRESIVSMTGARGTIGYIAPEVFCRNFGE---------VSYKSDVYSYGMMVFEM----- 524
            R+    ++    + G+  PE+  R             +++  D ++ G++++ +     
Sbjct: 255 -RDGARVVS--SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 525 --TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCI 582
             T +           S    P                        +  R ++      +
Sbjct: 312 PITKDAALGGSEWIFRSCKNIP------------------------QPVRALL---EGFL 344

Query: 583 QTNPSDRPSMNRVVE 597
           +    DR    + +E
Sbjct: 345 RYPKEDRLLPLQAME 359

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  107 bits (270), Expect = 8e-25
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 29/207 (14%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG-EDFINEVASISRTSHVNIVTL 383
               +LG G +G V++      G N A K +     +  E    E+ ++S   H  +V L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219

Query: 384 LGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPL-ETNQKLKWEVLYKIAVGIAR----GL 437
                + +   +IYEF+S G L EK   E + + E             AV   R    GL
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-----------DEAVEYMRQVCKGL 268

Query: 438 EYLHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
            ++H       +H D+KP NI+         K+ DFGL    + ++   S+    GT  +
Sbjct: 269 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEF 322

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            APEV       V Y +D++S G++ +
Sbjct: 323 AAPEVA--EGKPVGYYTDMWSVGVLSY 347

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  106 bits (266), Expect = 1e-24
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 34/207 (16%)

Query: 326 SFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIV 381
               +LG+G +  V +   +L GQ  A  ++N  K +    +    E        H NIV
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 382 TLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR----G 436
            L     E     LI++ V+ G L E  +  ++  E             A    +     
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE-----------ADASHCIQQILEA 122

Query: 437 LEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTI 493
           + + H      ++H ++KP N+LL    +    K++DFGLA   EG +      G  GT 
Sbjct: 123 VLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTP 177

Query: 494 GYIAPEVFCRNFGEVSY--KSDVYSYG 518
           GY++PEV  ++     Y    D+++ G
Sbjct: 178 GYLSPEVLRKD----PYGKPVDLWACG 200

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (263), Expect = 2e-24
 Identities = 55/243 (22%), Positives = 92/243 (37%), Gaps = 40/243 (16%)

Query: 308 GSLAPKRYRYADIKKMTNS-----------FKNKLGQGGYGGVYKGK-LLDGQNVAIKVL 355
                K + + D+     S               LG G  G V         + VAI+++
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168

Query: 356 N---------ETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLE 406
           +                +   E+  + + +H  I+ +  F F+     ++ E +  G L 
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF 227

Query: 407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DED 463
             +         ++LK          +   ++YLH      I+H D+KP N+LL   +ED
Sbjct: 228 DKVVGN------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEED 278

Query: 464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYGMMV 521
              KI+DFG +KI         M    GT  Y+APEV   + G   Y    D +S G+++
Sbjct: 279 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVL-VSVGTAGYNRAVDCWSLGVIL 334

Query: 522 FEM 524
           F  
Sbjct: 335 FIC 337

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  102 bits (257), Expect = 3e-24
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 28/208 (13%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG----------EDFINEVASISRT 375
            K  LG+G    V +       +  A+K+++ T G            E  + EV  + + 
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 376 S-HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIA 434
           S H NI+ L           L+++ +  G L  ++ EK        L  +   KI   + 
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALL 134

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
             +  LH      I+H D+KP NILLD+D   K++DFG +   +  E    +    GT  
Sbjct: 135 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 188

Query: 495 YIAPEVF--CRNFGEVSY--KSDVYSYG 518
           Y+APE+     N     Y  + D++S G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTG 216

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  101 bits (254), Expect = 8e-24
 Identities = 43/216 (19%), Positives = 82/216 (37%), Gaps = 30/216 (13%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVAS 371
              +          +LG+G +  V +      GQ  A K L + +   +     ++E+A 
Sbjct: 22  SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV 81

Query: 372 ISRTSHV-NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLY-KI 429
           +        ++ L           LI E+ + G +      +           E++    
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE---------LAEMVSEND 132

Query: 430 AVGIAR----GLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRES 482
            + + +    G+ YLH      I+H D+KP NILL         KI DFG+++       
Sbjct: 133 VIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC- 188

Query: 483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYG 518
              +    GT  Y+APE+   +   ++  +D+++ G
Sbjct: 189 --ELREIMGTPEYLAPEILNYDP--ITTATDMWNIG 220

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (253), Expect = 1e-23
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 31/212 (14%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLN---------ETKGNGEDFINEVASISRTS 376
               LG G  G V         + VAIK+++                +   E+  + + +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73

Query: 377 HVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR 435
           H  I+ +  F F+     ++ E +  G L +K +  K   E   K            +  
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-------LYFYQMLL 125

Query: 436 GLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGT 492
            ++YLH      I+H D+KP N+LL   +ED   KI+DFG +KI         M    GT
Sbjct: 126 AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGT 179

Query: 493 IGYIAPEVFCRNFGEVSY--KSDVYSYGMMVF 522
             Y+APEV   + G   Y    D +S G+++F
Sbjct: 180 PTYLAPEVL-VSVGTAGYNRAVDCWSLGVILF 210

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  102 bits (256), Expect = 1e-23
 Identities = 65/248 (26%), Positives = 108/248 (43%), Gaps = 56/248 (22%)

Query: 298 RNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIK-VLN 356
           + I+    +  +   +   Y + K         +G G +G V++ KL++   VAIK VL 
Sbjct: 23  KVIKVLASDGKTGEQREIAYTNCKV--------IGNGSFGVVFQAKLVESDEVAIKKVLQ 74

Query: 357 ETKGNGEDFIN-EVASISRTSHVNIVTLLGFCFEGHRRA------LIYEFVSNGSLEKFI 409
           + +     F N E+  +    H N+V L  F +    +       L+ E+V   ++ +  
Sbjct: 75  DKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS 128

Query: 410 HEKHPLETNQKLKWEV----LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC 465
             +H  +  Q +   +    +Y+    + R L Y+H   +  I H DIKP N+LLD    
Sbjct: 129 --RHYAKLKQTMPMLLIKLYMYQ----LLRSLAYIH---SIGICHRDIKPQNLLLDPPSG 179

Query: 466 P-KISDFGLAKICEGRESIVSMTGARGTIGYI------APEVFCRNFGEVSYKS--DVYS 516
             K+ DFG AKI    E  VS         YI      APE+    FG  +Y +  D++S
Sbjct: 180 VLKLIDFGSAKILIAGEPNVS---------YICSRYYRAPELI---FGATNYTTNIDIWS 227

Query: 517 YGMMVFEM 524
            G ++ E+
Sbjct: 228 TGCVMAEL 235

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  101 bits (253), Expect = 2e-23
 Identities = 47/208 (22%), Positives = 85/208 (40%), Gaps = 29/208 (13%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG---------EDFINEVASISRTS 376
            K+ +G+G    V +      G   A+K++  T             E    E   + + +
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 377 -HVNIVTLLGFCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIA 434
            H +I+TL+          L+++ +  G L +    +    E   +        I   + 
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-------SIMRSLL 210

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
             + +LH      I+H D+KP NILLD++   ++SDFG +   E  E    +    GT G
Sbjct: 211 EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPG 264

Query: 495 YIAPEVFCRNFGEV----SYKSDVYSYG 518
           Y+APE+   +  E       + D+++ G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACG 292

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (251), Expect = 2e-23
 Identities = 62/285 (21%), Positives = 111/285 (38%), Gaps = 47/285 (16%)

Query: 330 KLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGE--DFINEVASISRTS-HVNIVTLLG 385
           ++G G  G V+K +    G  +A+K +  +    E    + ++  + ++     IV   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                    +  E +     EK             +   +L K+ V I + L YL     
Sbjct: 92  TFITNTDVFIAMELM-GTCAEKLK-----KRMQGPIPERILGKMTVAIVKALYYLKE--K 143

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRN 504
             ++H D+KP NILLDE    K+ DFG++          +   + G   Y+APE     +
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 505 FGEVSY--KSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
             +  Y  ++DV+S G+ + E+ TG+               FP   YK  + + ++ L  
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ---------------FP---YKNCKTDFEV-LTK 241

Query: 562 IENEE------DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
           +  EE         ++         C+  +   RP  N   ++LE
Sbjct: 242 VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN---KLLE 283

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  101 bits (254), Expect = 3e-23
 Identities = 73/241 (30%), Positives = 103/241 (42%), Gaps = 57/241 (23%)

Query: 306 NYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLD-GQNVAIK-VLNETKGNGE 363
             G   P+   Y D K         +G G +G VY+ KL D G+ VAIK VL + +    
Sbjct: 45  GQGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---- 92

Query: 364 DFIN-EVASISRTSHVNIVTLLGFCFEGHRRA------LIYEFVSNGSLEKFIHEKHPLE 416
            F N E+  + +  H NIV L  F +    +       L+ ++V   ++ +    +H   
Sbjct: 93  -FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSR 148

Query: 417 TNQKLKWEV----LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDF 471
             Q L        +Y++     R L Y+H      I H DIKP N+LLD D    K+ DF
Sbjct: 149 AKQTLPVIYVKLYMYQLF----RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 201

Query: 472 GLAKICEGRESIVSMTGARGTIGYI------APEVFCRNFGEVSYKS--DVYSYGMMVFE 523
           G AK     E  VS         YI      APE+    FG   Y S  DV+S G ++ E
Sbjct: 202 GSAKQLVRGEPNVS---------YICSRYYRAPELI---FGATDYTSSIDVWSAGCVLAE 249

Query: 524 M 524
           +
Sbjct: 250 L 250

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (250), Expect = 4e-23
 Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 34/215 (15%)

Query: 315 YRYADIKKMTNSFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASIS 373
                +       +++LG+G    VY+ K     +  A+KVL     + +    E+  + 
Sbjct: 46  SNRDALSD-FFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVRTEIGVLL 103

Query: 374 RTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEK-HPLETNQKLKWEVLYKIAVG 432
           R SH NI+ L          +L+ E V+ G L   I EK +  E           + A  
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE-----------RDAAD 152

Query: 433 IAR----GLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVS 485
             +     + YLH      I+H D+KP N+L      D   KI+DFGL+KI E +     
Sbjct: 153 AVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---L 206

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSY--KSDVYSYG 518
           M    GT GY APE+        +Y  + D++S G
Sbjct: 207 MKTVCGTPGYCAPEILRGC----AYGPEVDMWSVG 237

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 44/189 (23%), Positives = 74/189 (39%), Gaps = 30/189 (15%)

Query: 327 FKNKLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLL 384
            K  +G G Y    +          A+K+++++K +  +   E+  + R   H NI+TL 
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLK 82

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIAR----GLEY 439
               +G    ++ E +  G L   I  +    E           + A  +       +EY
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-----------REASAVLFTITKTVEY 131

Query: 440 LHRGCNTRILHFDIKPHNILL---DEDFCP-KISDFGLAKICEGRESIVSMTGARGTIGY 495
           LH      ++H D+KP NIL      +    +I DFG AK       +  +     T  +
Sbjct: 132 LH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANF 186

Query: 496 IAPEVFCRN 504
           +APEV  R 
Sbjct: 187 VAPEVLERQ 195

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 30/209 (14%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETK----GNGEDFIN-EVASISRTSHVNIVTLL 384
           LG+G YG V +          A+K+L + K     NGE  +  E+  + R  H N++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71

Query: 385 GFCFEGHRRA------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
               +           ++ E+   G  E            ++      +     +  GLE
Sbjct: 72  ---VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-----KRFPVCQAHGYFCQLIDGLE 123

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YLH      I+H DIKP N+LL      KIS  G+A+      +  +   ++G+  +  P
Sbjct: 124 YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 499 EVFCRNFGEVSY---KSDVYSYGMMVFEM 524
           E+     G  ++   K D++S G+ ++ +
Sbjct: 181 EIAN---GLDTFSGFKVDIWSAGVTLYNI 206

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 23/205 (11%)

Query: 328 KNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG-EDFINEVASISR-TSHVNIVTLL 384
           ++ LG+G +  V     L+  Q  A+K++ +  G+       EV  + +   H N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            F  E  R  L++E +  GS+   IH++     N+     V+  +A      L++LH   
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHF--NELEASVVVQDVA----SALDFLH--- 128

Query: 445 NTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGAR-----GTIGYI 496
           N  I H D+KP NIL    ++    KI DF L    +       ++        G+  Y+
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 497 APEVFCRNFGEV-SY--KSDVYSYG 518
           APEV      E   Y  + D++S G
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLG 213

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN-----EVASISRTSHVNIVT 382
            KLG G Y  VYKG     G  VA+K   E K + E+        E++ +    H NIV 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALK---EVKLDSEEGTPSTAIREISLMKELKHENIVR 67

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           L       ++  L++EF+ N  L+K++  +    T + L+  ++      + +GL + H 
Sbjct: 68  LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CEGRESIVSMTGARGTIGYIAPEV 500
               +ILH D+KP N+L+++    K+ DFGLA+           + +    T+ Y AP+V
Sbjct: 127 N---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN----TFSSEVVTLWYRAPDV 179

Query: 501 FCRNFGEVSYKS--DVYSYGMMVFEM 524
                G  +Y +  D++S G ++ EM
Sbjct: 180 L---MGSRTYSTSIDIWSCGCILAEM 202

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 30/208 (14%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN---------EVASISRTSHVNI 380
           LG G +G V+        + V +K + + K   + +I          E+A +SR  H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 381 VTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           + +L   FE      L+ E   +G L+ F      ++ + +L   +   I   +   + Y
Sbjct: 92  IKVLDI-FENQGFFQLVMEKHGSG-LDLFAF----IDRHPRLDEPLASYIFRQLVSAVGY 145

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           L       I+H DIK  NI++ EDF  K+ DFG A   E  +         GTI Y APE
Sbjct: 146 LRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPE 199

Query: 500 VFCRNFGEVSY---KSDVYSYGMMVFEM 524
           V   N     Y   + +++S G+ ++ +
Sbjct: 200 VLMGN----PYRGPELEMWSLGVTLYTL 223

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 68/311 (21%), Positives = 111/311 (35%), Gaps = 77/311 (24%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISR-----------TSHV 378
           LG+GG+G V+ G  L D   VAIKV+   +  G   +++  +                H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 379 NIVTLLGFCFEGHRRALIY---EFVSNGS-LEKFIHEKHPLETNQKLKWEVLYKIAVGIA 434
            ++ LL + FE   +       E       L  +I EK        L           + 
Sbjct: 99  GVIRLLDW-FE--TQEGFMLVLERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVV 149

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESIVSMTGARGTI 493
             +++ H      ++H DIK  NIL+D      K+ DFG   +          T   GT 
Sbjct: 150 AAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTR 202

Query: 494 GYIAPEVFCRNFGEVSY---KSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIY-----FP 544
            Y  PE   R+     Y    + V+S G+++++M  G+     +  +R  EI      FP
Sbjct: 203 VYSPPEWISRH----QYHALPATVWSLGILLYDMVCGD-----IPFERDQEILEAELHFP 253

Query: 545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE---MLEG 601
             V                + +       +I     C+   PS RPS+  ++    M   
Sbjct: 254 AHV----------------SPD----CCALI---RRCLAPKPSSRPSLEEILLDPWMQTP 290

Query: 602 SLDSLQIPPRP 612
           + D    P + 
Sbjct: 291 AEDVPLNPSKG 301

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 68/289 (23%), Positives = 109/289 (37%), Gaps = 68/289 (23%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN-------EVASISRTSHV--NI 380
           LG GG+G VY G  + D   VAIK + + + +    +        EV  + + S     +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 381 VTLLGFCFEGHRRA-LIYEFVSN-GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           + LL + FE      LI E       L  FI E+        L+ E+       +   + 
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVR 163

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESIVSMTGARGTIGYIA 497
           + H      +LH DIK  NIL+D +    K+ DFG   + +        T   GT  Y  
Sbjct: 164 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 216

Query: 498 PEVFCRNFGEVSY---KSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIY-----FPHWVY 548
           PE    +     Y    + V+S G+++++M  G+     +  +   EI      F   V 
Sbjct: 217 PEWIRYH----RYHGRSAAVWSLGILLYDMVCGD-----IPFEHDEEIIRGQVFFRQRV- 266

Query: 549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                          + E     + +I    WC+   PSDRP+   +  
Sbjct: 267 ---------------SSE----CQHLI---RWCLALRPSDRPTFEEIQN 293

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 24/203 (11%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLN----ETKGNGEDFINEVASISRTSHVNIVTLLG 385
           +G+G +G V   +  D + + A+K +N      +    +   E+  +    H  +V L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81

Query: 386 FCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV--LYKIAVGIARGLEYLHR 442
           + F+      ++ + +  G L    H    L+ N   K E   L+     +   L+YL  
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDL--RYH----LQQNVHFKEETVKLF--ICELVMALDYLQN 133

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
               RI+H D+KP NILLDE     I+DF +A +      I +M    GT  Y+APE+F 
Sbjct: 134 ---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFS 187

Query: 503 RNFGEVSYKS-DVYSYGMMVFEM 524
              G     + D +S G+  +E+
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYEL 210

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 94.5 bits (236), Expect = 2e-21
 Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 29/206 (14%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNVAIKVLN-ETKGNGEDF--INEVASISRTSHVNIVTLLG 385
            K+G+G YG VYK K   G+ VA+K +  + +  G     I E++ +    H NIV+L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86

Query: 386 FCFEGHRRALIYEFVSNGSLEKFI-HEKHPLETNQ--KLKWEVLYKIAVGIARGLEYLHR 442
                    L++EF+    L+K +   K  L+ +Q     +++L        RG+ + H+
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL--------RGVAHCHQ 137

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CEGRESIVSMTGARGTIGYIAPEV 500
               RILH D+KP N+L++ D   K++DFGLA+      R    S T    T+ Y AP+V
Sbjct: 138 ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----SYTHEVVTLWYRAPDV 190

Query: 501 FCRNFGEVSYKS--DVYSYGMMVFEM 524
                G   Y +  D++S G +  EM
Sbjct: 191 L---MGSKKYSTSVDIWSIGCIFAEM 213

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 63/240 (26%), Positives = 95/240 (39%), Gaps = 43/240 (17%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFC 387
           LG+G YG V      +  + VA+K+++  +     E+   E+      +H N+V   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR--------GLEY 439
            EG+ + L  E+ S G L   I     +                  A+        G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--------------AQRFFHQLMAGVVY 120

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           LH      I H DIKP N+LLDE    KISDFGLA +         +    GT+ Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 500 VFCRNFGEVSY---KSDVYSYGMMVFEM-TG------EKNNANVAVDR-SSEIYFPHWVY 548
           +  R      +     DV+S G+++  M  G        ++     D    + Y   W  
Sbjct: 178 LLKRR----EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 92.6 bits (231), Expect = 7e-21
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 30/207 (14%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGNGEDF--INEVASISRTSHVNIVTLL 384
            K+G+G YG V+K K     + VA+K +  +    G     + E+  +    H NIV L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKH---PLETNQKLKWEVLYKIAVGIARGLEYLH 441
                  +  L++EF     L+K+    +     E  +   +++L        +GL + H
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL--------KGLGFCH 118

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CEGRESIVSMTGARGTIGYIAPE 499
                 +LH D+KP N+L++ +   K+++FGLA+      R      +    T+ Y  P+
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR----CYSAEVVTLWYRPPD 171

Query: 500 VFCRNFGEVSYKS--DVYSYGMMVFEM 524
           V    FG   Y +  D++S G +  E+
Sbjct: 172 VL---FGAKLYSTSIDMWSAGCIFAEL 195

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 32/203 (15%)

Query: 328 KNKLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLG 385
           K  LG G  G V +      GQ  A+K+L ++         EV    + S   +IV +L 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILD 89

Query: 386 FCFE--GHRRALIY---EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
             +E   H +  +    E +  G L   I E+      ++   E++  I       +++L
Sbjct: 90  V-YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG----TAIQFL 144

Query: 441 HRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIA 497
           H   +  I H D+KP N+L    ++D   K++DFG AK          +     T  Y+A
Sbjct: 145 H---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVA 197

Query: 498 PEVFCRNFGEVSY--KSDVYSYG 518
           PEV         Y    D++S G
Sbjct: 198 PEVLGPE----KYDKSCDMWSLG 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 29/206 (14%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNVAIKVLN-ETKGNGEDF--INEVASISRTSHVNIVTLLG 385
            K+G+G YG VYK +   G+  A+K +  E +  G     I E++ +    H NIV L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 386 FCFEGHRRALIYEFVSNGSLEKFI-HEKHPLETNQ--KLKWEVLYKIAVGIARGLEYLHR 442
                 R  L++E +    L+K +   +  LE+        ++L         G+ Y H 
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL--------NGIAYCHD 118

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CEGRESIVSMTGARGTIGYIAPEV 500
               R+LH D+KP N+L++ +   KI+DFGLA+      R      T    T+ Y AP+V
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR----KYTHEIVTLWYRAPDV 171

Query: 501 FCRNFGEVSYKS--DVYSYGMMVFEM 524
                G   Y +  D++S G +  EM
Sbjct: 172 L---MGSKKYSTTIDIWSVGCIFAEM 194

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 34/203 (16%)

Query: 328 KNKLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLG 385
              LG+G +    K       Q  A+K++++      +   E+ ++     H NIV L  
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME--ANTQKEITALKLCEGHPNIVKLHE 73

Query: 386 FCFEGHRRALIYEFVSNGSL-EKFIHEKHPLETNQKLKWEVLYKIAVGIAR----GLEYL 440
              +     L+ E ++ G L E+   +KH  E             A  I R     + ++
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKHFSE-----------TEASYIMRKLVSAVSHM 122

Query: 441 HRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIA 497
           H   +  ++H D+KP N+L    +++   KI DFG A++         +     T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAA 177

Query: 498 PEVFCRNFGEVSY--KSDVYSYG 518
           PE+  +N     Y    D++S G
Sbjct: 178 PELLNQN----GYDESCDLWSLG 196

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 63/240 (26%), Positives = 95/240 (39%), Gaps = 43/240 (17%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFC 387
           LG+G YG V      +  + VA+K+++  +     E+   E+      +H N+V   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR--------GLEY 439
            EG+ + L  E+ S G L   I     +                  A+        G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--------------AQRFFHQLMAGVVY 120

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           LH      I H DIKP N+LLDE    KISDFGLA +         +    GT+ Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 500 VFCRNFGEVSY---KSDVYSYGMMVFEM-TG------EKNNANVAVDR-SSEIYFPHWVY 548
           +  R      +     DV+S G+++  M  G        ++     D    + Y   W  
Sbjct: 178 LLKRR----EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 53/232 (22%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGKLLD-GQNVAIK-VLNETK-GNGEDFINEVASI 372
           R+   +          GQG +G V  GK    G +VAIK V+ + +  N E  +  +  +
Sbjct: 24  RFQVERM--------AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDL 73

Query: 373 SRTSHVNIVTLLGFCFEGHRRA-------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           +   H NIV L  + +    R        ++ E+V + +L +    ++           +
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC--RNYYRRQVAPPPIL 130

Query: 426 ----LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGR 480
               L+++     R +  LH      + H DIKPHN+L++E     K+ DFG AK     
Sbjct: 131 IKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185

Query: 481 ESIVSMTGARGTIGYI------APEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           E  V+         YI      APE+    FG   Y +  D++S G +  EM
Sbjct: 186 EPNVA---------YICSRYYRAPELI---FGNQHYTTAVDIWSVGCIFAEM 225

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 34/211 (16%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGNGEDF--INEVASISRTSHVNIVTLL 384
            KLG+G YG VYK    +  + VAIK +  E +  G     I EV+ +    H NI+ L 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQ--KLKWEVLYKIAVGIARGLEYLHR 442
                 HR  LI+E+  N  L+K++ +   +         ++++         G+ + H 
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI--------NGVNFCHS 150

Query: 443 GCNTRILHFDIKPHNILLDEDFCP-----KISDFGLAKI--CEGRESIVSMTGARGTIGY 495
               R LH D+KP N+LL           KI DFGLA+      R      T    T+ Y
Sbjct: 151 R---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR----QFTHEIITLWY 203

Query: 496 IAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
             PE+     G   Y +  D++S   +  EM
Sbjct: 204 RPPEIL---LGSRHYSTSVDIWSIACIWAEM 231

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 20/202 (9%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIK-VLNETKGNGEDFIN--EVASISRTSHVNIVTLL 384
            K+G+G YG V+K +    GQ VAIK  L          I   E+  + +  H N+V LL
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
                  R  L++E+  + ++   +           +K      I     + + + H+  
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-----SITWQTLQAVNFCHK-- 120

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
               +H D+KP NIL+ +    K+ DFG A++               T  Y +PE+    
Sbjct: 121 -HNCIHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRWYRSPELL--- 174

Query: 505 FGEVSYKS--DVYSYGMMVFEM 524
            G+  Y    DV++ G +  E+
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAEL 196

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 51/229 (22%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETK--------------------GNGEDFINEV 369
           +G+G YG V       D    A+KVL++ K                    G        +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 370 ASISR-------TSHVNIVTLLGFCFE---GHRRALIY---EFVSNGSLEKFIHEKHPLE 416
             + +         H N+V L     E         +Y   E V+ G + +         
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVP------- 129

Query: 417 TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI 476
           T + L  +        + +G+EYLH     +I+H DIKP N+L+ ED   KI+DFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVS-YKSDVYSYGMMVFEM 524
            +G +++  ++   GT  ++APE         S    DV++ G+ ++  
Sbjct: 187 FKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 35/220 (15%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN-EVASIS 373
            Y  ++K        LG+G Y  V++   + + + V +K+L   K   +  I  E+  I 
Sbjct: 37  DYQLVRK--------LGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREI-KIL 84

Query: 374 R--TSHVNIVTLLG-FCFEGHRR-ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
                  NI+TL         R  AL++E V+N   ++   +       +   +E+L   
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEIL--- 140

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLAKICEGRESIVSMTG 488
                + L+Y H      I+H D+KPHN+++D +    ++ D+GLA   E          
Sbjct: 141 -----KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNV 189

Query: 489 ARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
              +  +  PE+   ++    Y  D++S G M+  M   K
Sbjct: 190 RVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRK 228

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 23/201 (11%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN---EVASISRTSHVNIVTLLGF 386
           +G+G +  V   + +L G+ VAIK++++T+ N         EV  +   +H NIV L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
                   LI E+ S G +  ++          ++K +        I   ++Y H+    
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQKR-- 134

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
            I+H D+K  N+LLD D   KI+DFG +           +    G   Y APE+F     
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGK-- 188

Query: 507 EVSY---KSDVYSYGMMVFEM 524
              Y   + DV+S G++++ +
Sbjct: 189 --KYDGPEVDVWSLGVILYTL 207

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 90.7 bits (226), Expect = 6e-20
 Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 35/222 (15%)

Query: 319 DIKKMTNSFK--NKLGQGGYGGVYKGK-LLDGQNVAIK-VLNETKGNGEDFIN-----EV 369
           D+K     ++  + LG+G +  VYK +     Q VAIK +    +   +D IN     E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFI-HEKHPLETNQ--KLKWEVL 426
             +   SH NI+ LL         +L+++F+    LE  I      L  +         L
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--EGRESIV 484
                   +GLEYLH+     ILH D+KP+N+LLDE+   K++DFGLAK      R    
Sbjct: 123 --------QGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---- 167

Query: 485 SMTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           + T    T  Y APE+    FG   Y    D+++ G ++ E+
Sbjct: 168 AYTHQVVTRWYRAPELL---FGARMYGVGVDMWAVGCILAEL 206

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.4 bits (225), Expect = 7e-20
 Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 20/202 (9%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIK-VLNETKGNGEDFIN--EVASISRTSHVNIVTLL 384
             +G+G YG V K +    G+ VAIK  L          I   E+  + +  H N+V LL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
             C +  R  L++EFV + ++   + E  P      L ++V+ K    I  G+ + H   
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDL-ELFP----NGLDYQVVQKYLFQIINGIGFCHS-- 142

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
              I+H DIKP NIL+ +    K+ DFG A+                T  Y APE+    
Sbjct: 143 -HNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYDDEVATRWYRAPELL--- 196

Query: 505 FGEVSYKS--DVYSYGMMVFEM 524
            G+V Y    DV++ G +V EM
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEM 218

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 40/217 (18%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIK-VLNETKGNGEDFIN-----EVA---SISRTSHV 378
            ++G G YG VYK +    G  VA+K V     G G   +      EVA    +    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 379 NIVTLLGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKH----PLETNQKLKWEVLYKI 429
           N+V L+  C            L++E V    L  ++ +      P ET + L  + L   
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL--- 130

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
                RGL++LH      I+H D+KP NIL+      K++DFGLA+I    +  +++T  
Sbjct: 131 -----RGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQ--MALTPV 179

Query: 490 RGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
             T+ Y APEV        +Y +  D++S G +  EM
Sbjct: 180 VVTLWYRAPEVL---LQS-TYATPVDMWSVGCIFAEM 212

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.5 bits (227), Expect = 2e-19
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 30/206 (14%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNET---KGNGEDF-INE---VASISRTSHVNIVT 382
           +G+GG+G VY  +  D G+  A+K L++       GE   +NE   ++ +S      IV 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 383 LLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
           +  + F    +   I + ++ G L    H    L  +       +   A  I  GLE++H
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDL--HYH----LSQHGVFSEADMRFYAAEIILGLEHMH 309

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGYIAPEV 500
                 +++ D+KP NILLDE    +ISD GLA      +       A  GT GY+APEV
Sbjct: 310 N---RFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPEV 361

Query: 501 FCRNFGEVSYKSDV--YSYGMMVFEM 524
             +      Y S    +S G M+F++
Sbjct: 362 LQKGVA---YDSSADWFSLGCMLFKL 384

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 29/206 (14%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED-----FINEVASISRTSHVNIVT 382
           +KLG+G Y  VYKGK  L    VA+K   E +   E+      I EV+ +    H NIVT
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           L           L++E++    L++++ +   +     +K          + RGL Y HR
Sbjct: 65  LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK-----LFLFQLLRGLAYCHR 118

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CEGRESIVSMTGARGTIGYIAPEV 500
               ++LH D+KP N+L++E    K++DFGLA+      +    +      T+ Y  P++
Sbjct: 119 ---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK----TYDNEVVTLWYRPPDI 171

Query: 501 FCRNFGEVSYKS--DVYSYGMMVFEM 524
                G   Y +  D++  G + +EM
Sbjct: 172 L---LGSTDYSTQIDMWGVGCIFYEM 194

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 54/205 (26%), Positives = 81/205 (39%), Gaps = 32/205 (15%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE 389
           +G G +G     +  L  + VA+K +       E+   E+ +     H NIV        
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 390 GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRIL 449
               A+I E+ S G L + I          +   +        +  G+ Y H     +I 
Sbjct: 88  PTHLAIIMEYASGGELYERICNA------GRFSEDEARFFFQQLLSGVSYCHS---MQIC 138

Query: 450 HFDIKPHNILLDEDFCP--KISDFGLAKICEGRESIVSMTGAR-----GTIGYIAPEVFC 502
           H D+K  N LLD    P  KI DFG +K         S+  ++     GT  YIAPEV  
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKS--------SVLHSQPKSTVGTPAYIAPEVLL 190

Query: 503 RNFGEVSY---KSDVYSYGMMVFEM 524
           R      Y    +DV+S G+ ++ M
Sbjct: 191 RQ----EYDGKIADVWSCGVTLYVM 211

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 24/204 (11%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNE---TKGNGEDF-INEVASISRTSHVNIVTLLG 385
           LG+GG+G V+  ++   G+  A K LN+    K  G    + E   +++     IV+L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 386 FCFE-GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIARGLEYLHR 442
           + FE      L+   ++ G +    H  +  E N   +    + Y     I  GLE+LH+
Sbjct: 252 YAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFY--TAQIVSGLEHLHQ 307

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
                I++ D+KP N+LLD+D   +ISD GLA   E +       G  GT G++APE+  
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 503 RNFGEVSYKSDV--YSYGMMVFEM 524
                  Y   V  ++ G+ ++EM
Sbjct: 363 GE----EYDFSVDYFALGVTLYEM 382

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.0 bits (221), Expect = 4e-19
 Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 31/204 (15%)

Query: 327 FKNKLGQGGYGGVYKG-KLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLL 384
               LG G  G V +       +  A+K+L +          EV    R S   +IV ++
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 121

Query: 385 GFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
              +E          ++ E +  G L   I ++      ++   E++  I       ++Y
Sbjct: 122 DV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG----EAIQY 176

Query: 440 LHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           LH   +  I H D+KP N+L      +   K++DFG AK         S+T    T  Y+
Sbjct: 177 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYV 230

Query: 497 APEVFCRNFGEVSY--KSDVYSYG 518
           APEV         Y    D++S G
Sbjct: 231 APEVLGPE----KYDKSCDMWSLG 250

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 27/204 (13%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNE---TKGNGEDF-INEVASISRTSHVNIVTLLG 385
           LG+GG+G V   ++   G+  A K L +    K  GE   +NE   + + +   +V+L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250

Query: 386 FCFE-GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           + +E      L+   ++ G L    H  H  +        V Y  A  I  GLE LHR  
Sbjct: 251 YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFY--AAEICCGLEDLHR-- 304

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGAR-GTIGYIAPEVFC 502
             RI++ D+KP NILLD+    +ISD GLA  + EG          R GT+GY+APEV  
Sbjct: 305 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTIKGRVGTVGYMAPEVVK 358

Query: 503 RNFGEVSYKSDV--YSYGMMVFEM 524
                  Y      ++ G +++EM
Sbjct: 359 NE----RYTFSPDWWALGCLLYEM 378

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 28/229 (12%), Positives = 61/229 (26%), Gaps = 64/229 (27%)

Query: 308 GSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGK--LLDGQNVAIKVLNETKGNGED- 364
             +A  RYR               G       ++     LD Q VA+  ++      +D 
Sbjct: 26  ARIANGRYRLLI----------FHGGVPPLQFWQALDTALDRQ-VALTFVDPQGVLPDDV 74

Query: 365 ---FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEK-HPLETNQK 420
               ++    +SR     +  +L          ++ E++  GSL++       P+     
Sbjct: 75  LQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA--- 131

Query: 421 LKWEVLYKIAVGIARGLEYLHR-GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG 479
                  +    +A   +  HR G    +      P  + +  D        G   +   
Sbjct: 132 ------IRAMQSLAAAADAAHRAG----VALSIDHPSRVRVSID--------GDVVL--- 170

Query: 480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGE 527
                           +            + + D+   G  ++ +    
Sbjct: 171 -----------AYPATMPD---------ANPQDDIRGIGASLYALLVNR 199

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 34/215 (15%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIK-VLNETKGNGEDF--INEVASISRTSHVNIVTLL 384
            K+GQG +G V+K +    GQ VA+K VL E +  G     + E+  +    H N+V L+
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82

Query: 385 GFCFEGHRRA--------LIYEFVSNGSLEKFIHEKH-PLETNQ--KLKWEVLYKIAVGI 433
             C               L+++F  +  L   +         ++  ++   +L       
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL------- 134

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--EGRESIVSMTGARG 491
             GL Y+HR    +ILH D+K  N+L+  D   K++DFGLA+             T    
Sbjct: 135 -NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190

Query: 492 TIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
           T+ Y  PE+     GE  Y    D++  G ++ EM
Sbjct: 191 TLWYRPPELL---LGERDYGPPIDLWGAGCIMAEM 222

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 22/202 (10%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNET---KGNGEDFIN-EVASISRTSHVNIVTLLG 385
           LG+G +  V   + L      AIK+L +    K N   ++  E   +SR  H   V L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96

Query: 386 FCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV--LYKIAVGIARGLEYLHR 442
           F F+   +      +  NG L    +    +             Y     I   LEYLH 
Sbjct: 97  FTFQDDEKLYFGLSYAKNGEL--LKY----IRKIGSFDETCTRFY--TAEIVSALEYLH- 147

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
                I+H D+KP NILL+ED   +I+DFG AK+              GT  Y++PE+  
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205

Query: 503 RNFGEVSYKSDVYSYGMMVFEM 524
                    SD+++ G +++++
Sbjct: 206 EK--SACKSSDLWALGCIIYQL 225

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.1 bits (211), Expect = 7e-18
 Identities = 57/242 (23%), Positives = 103/242 (42%), Gaps = 35/242 (14%)

Query: 298 RNIEAFLRNYGSLAPK----RYRYAD--IKKMTNSFKNKLGQGGYGGVYKGKLLDGQNV- 350
           +NI+ FL  Y     K    R +  D  + K+       +G+G +G V   +    + V 
Sbjct: 45  KNIDNFLSRYKDTINKIRDLRMKAEDYEVVKV-------IGRGAFGEVQLVRHKSTRKVY 97

Query: 351 AIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSL 405
           A+K+L++     + +   F  E   ++  +   +V L  + F+  R   ++ E++  G L
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL 156

Query: 406 EKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
                   + +       W   Y     +   L+ +H   +   +H D+KP N+LLD+  
Sbjct: 157 --VNLMSNYDVPEK----WARFY--TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSG 205

Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDV--YSYGMMVF 522
             K++DFG          +   T A GT  YI+PEV     G+  Y  +   +S G+ ++
Sbjct: 206 HLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264

Query: 523 EM 524
           EM
Sbjct: 265 EM 266

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 83.0 bits (206), Expect = 9e-18
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 44/212 (20%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN----EVASISRTSHVNIVTLLG 385
           LG G +G V  G+  L G  VA+K+LN  K    D +     E+ ++    H +I+ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76

Query: 386 FCFE----GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
             ++         ++ E+VS G L  +I +        +++     ++   I   ++Y H
Sbjct: 77  --YQVISTPTDFFMVMEYVSGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCH 128

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR------GTIGY 495
           R     ++H D+KP N+LLD     KI+DFGL+ +         M+         G+  Y
Sbjct: 129 R---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM---------MSDGEFLRTSCGSPNY 176

Query: 496 IAPEVFCRNFGEVSY---KSDVYSYGMMVFEM 524
            APEV         Y   + D++S G++++ +
Sbjct: 177 AAPEVISGR----LYAGPEVDIWSCGVILYAL 204

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 28/231 (12%)

Query: 310 LAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDF--IN 367
           L+ +R R  D+ +       K+G+G YG VYK K  DG++     L + +G G       
Sbjct: 11  LSSERERVEDLFEYEGC---KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR 67

Query: 368 EVASISRTSHVNIVTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQK---LK 422
           E+A +    H N+++L         R   L++++  +  L   I      + N+K   L 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLP 126

Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDFGLAKICE 478
             ++  +   I  G+ YLH      +LH D+KP NIL+  +       KI+D G A++  
Sbjct: 127 RGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF- 182

Query: 479 GRESIVSMTGARG---TIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEM 524
               +  +        T  Y APE+     G   Y    D+++ G +  E+
Sbjct: 183 -NSPLKPLADLDPVVVTFWYRAPELL---LGARHYTKAIDIWAIGCIFAEL 229

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 56/185 (30%), Positives = 89/185 (48%), Gaps = 24/185 (12%)

Query: 329 NKLGQGGYGGVYKGK--LLDGQNVAIK-VLNETKGNGEDF--INEVA---SISRTSHVNI 380
            ++G+G YG V+K +     G+ VA+K V  +T   G     I EVA    +    H N+
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76

Query: 381 VTLLGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR 435
           V L   C            L++E V    L  ++ +K P      +  E +  +   + R
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVP---EPGVPTETIKDMMFQLLR 131

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGY 495
           GL++LH     R++H D+KP NIL+      K++DFGLA+I    +  +++T    T+ Y
Sbjct: 132 GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQ--MALTSVVVTLWY 185

Query: 496 IAPEV 500
            APEV
Sbjct: 186 RAPEV 190

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 49/254 (19%), Positives = 89/254 (35%), Gaps = 71/254 (27%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGKLLD-GQNVAIK-VLNETKGNGEDFIN-EVASI 372
           +Y+  K         LG G +G V +   ++ G+  A+K VL + +     + N E+  +
Sbjct: 8   KYSLGKT--------LGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIM 54

Query: 373 SRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV------- 425
               HVNI+ L+ + +             +   +           ++ +           
Sbjct: 55  KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114

Query: 426 ---------LYKIAVG-------------------IARGLEYLHRGCNTRILHFDIKPHN 457
                    L+K+                      + R + ++H   +  I H DIKP N
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQN 171

Query: 458 ILLDEDFCP-KISDFGLAKICEGRESIVSMTGARGTIGYI------APEVFCRNFGEVSY 510
           +L++      K+ DFG AK     E  V+         YI      APE+      E + 
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEPSVA---------YICSRFYRAPELML-GATEYTP 221

Query: 511 KSDVYSYGMMVFEM 524
             D++S G +  E+
Sbjct: 222 SIDLWSIGCVFGEL 235

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 40/210 (19%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN----EVASISRTSHVNIVTLLG 385
           LG G +G V  GK  L G  VA+K+LN  K    D +     E+ ++    H +I+ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQ--KLKWEVLYKIAVGIARGLEYLHRG 443
                    ++ E+VS G L  +I +   L+  +  +L  ++L         G++Y HR 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--------GVDYCHR- 134

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR------GTIGYIA 497
               ++H D+KP N+LLD     KI+DFGL+ +         M+         G+  Y A
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNM---------MSDGEFLRTSCGSPNYAA 183

Query: 498 PEVFCRNFGEVSY---KSDVYSYGMMVFEM 524
           PEV         Y   + D++S G++++ +
Sbjct: 184 PEVISGR----LYAGPEVDIWSSGVILYAL 209

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 45/213 (21%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFI---NEVASI-------SRTSHVN 379
           LG+G +G V   K    G+  A+K+L +      + I   +EVA           + H  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKK------EVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 380 IVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIARG 436
           +  L  + F+ H R   + E+ + G L  F H    L   +    +    Y     I   
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFY--GAEIVSA 260

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTI 493
           L+YLH   N  +++ D+K  N++LD+D   KI+DFGL K     E I      +   GT 
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTP 313

Query: 494 GYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM 524
            Y+APEV   N     Y   V  +  G++++EM
Sbjct: 314 EYLAPEVLEDN----DYGRAVDWWGLGVVMYEM 342

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 51/245 (20%), Positives = 90/245 (36%), Gaps = 29/245 (11%)

Query: 298 RNIEAFLRNYGSLAPKRYRYADIKKMTNS---FKNKLGQGGYGGVYKGKLLDGQNV-AIK 353
           + +  FL+    +  +        ++          +G+G +  V   K+     V A+K
Sbjct: 37  KYVADFLQWAEPIVVRLKE----VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMK 92

Query: 354 VLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLEKF 408
           ++N+     +G    F  E   +       I  L  F F+      L+ E+   G L   
Sbjct: 93  IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL--L 149

Query: 409 IHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI 468
                        +    Y     I   ++ +H       +H DIKP NILLD     ++
Sbjct: 150 TLLSKF-GERIPAEMARFY--LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRL 203

Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKS-----DVYSYGMMVFE 523
           +DFG         ++ S+  A GT  Y++PE+     G     S     D ++ G+  +E
Sbjct: 204 ADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262

Query: 524 M-TGE 527
           M  G+
Sbjct: 263 MFYGQ 267

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 47/217 (21%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFI---NEVASI-------SRTSHVN 379
           LG+G +G V   +        A+K+L +      + I   +EVA           T H  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRK------EVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 380 IVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIARG 436
           +  L  + F+ H R   + E+ + G L  F H    L   +    E    Y     I   
Sbjct: 67  LTALK-YAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFY--GAEIVSA 117

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTI 493
           LEYLH   +  +++ DIK  N++LD+D   KI+DFGL K     E I      +   GT 
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTP 169

Query: 494 GYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM-TGE 527
            Y+APEV   N     Y   V  +  G++++EM  G 
Sbjct: 170 EYLAPEVLEDN----DYGRAVDWWGLGVVMYEMMCGR 202

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 55/231 (23%), Positives = 86/231 (37%), Gaps = 40/231 (17%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGED---FINEVASI 372
            Y   +         +  G YG V  G   +G  VAIK +  T  +G       +     
Sbjct: 23  PYTVQRF--------ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74

Query: 373 SRT----------SHVNIVTLLGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLET 417
            R            H NI+ L          A     L+ E +    L + IH++  + +
Sbjct: 75  -RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132

Query: 418 NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 477
            Q +++  +Y I      GL  LH      ++H D+ P NILL ++    I DF LA+  
Sbjct: 133 PQHIQY-FMYHIL----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
                  + T       Y APE+    F   +   D++S G ++ EM   K
Sbjct: 185 TADA---NKTHYVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 43/217 (19%)

Query: 331 LGQGGYGGVY---KGKLLDGQNV-AIKVLNETKGNGEDFINEVASI-------SRTSHVN 379
           LG+GGYG V+   K    +   + A+KVL   K        + A             H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 380 IVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIARG 436
           IV L+ + F+   +  LI E++S G L  F+     LE       +    Y     I+  
Sbjct: 83  IVDLI-YAFQTGGKLYLILEYLSGGEL--FMQ----LEREGIFMEDTACFY--LAEISMA 133

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTI 493
           L +LH      I++ D+KP NI+L+     K++DFGL K     ESI   T      GTI
Sbjct: 134 LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHTFCGTI 185

Query: 494 GYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM-TGE 527
            Y+APE+  R+     +   V  +S G ++++M TG 
Sbjct: 186 EYMAPEILMRS----GHNRAVDWWSLGALMYDMLTGA 218

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.4 bits (196), Expect = 6e-16
 Identities = 60/247 (24%), Positives = 98/247 (39%), Gaps = 35/247 (14%)

Query: 298 RNIEAFLRNYGSLAPK----RYRYAD--IKKMTNSFKNKLGQGGYGGVYKGKLLDGQNV- 350
           +NI  +L        K    R    D  I K+       +G+G +G V   KL +   V 
Sbjct: 50  KNILEYLEWAKPFTSKVKQMRLHREDFEILKV-------IGRGAFGEVAVVKLKNADKVF 102

Query: 351 AIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSL 405
           A+K+LN+     +     F  E   +       I TL  + F+      L+ ++   G L
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDL 161

Query: 406 EKFIH-EKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF 464
                  K   E     +    Y     +   ++ +H       +H DIKP NIL+D + 
Sbjct: 162 --LTLLSKF--EDRLPEEMARFY--LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNG 212

Query: 465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-CRNFGEVSYKSDV--YSYGMMV 521
             +++DFG         ++ S   A GT  YI+PE+      G+  Y  +   +S G+ +
Sbjct: 213 HIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271

Query: 522 FEM-TGE 527
           +EM  GE
Sbjct: 272 YEMLYGE 278

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 39/222 (17%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEV--------ASISRTSHV-- 378
           KLG G +  V+  K +++  +VA+K++   K   E   +E+        A  ++   +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 379 -NIVTLLG-FCFEGHRRA---LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGI 433
            +I+ LL  F  +G       +++E +   +L   I +      ++ +    + +I+  +
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYE----HRGIPLIYVKQISKQL 140

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP------KISDFGLAKICEGRESIVSMT 487
             GL+Y+HR C   I+H DIKP N+L++    P      KI+D G A  C   E   +  
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 488 GARGTIGYIAPEVFCRNFG-EVSYKSDVYSYGMMVFEM-TGE 527
             R    Y +PEV     G      +D++S   ++FE+ TG+
Sbjct: 197 QTR---EYRSPEVL---LGAPWGCGADIWSTACLIFELITGD 232

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 37/208 (17%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN----EVASISRTSHVNIVTLLG 385
           LG+G +G V         Q VA+K ++       D       E++ +    H +I+ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                    ++ E+   G L  +I EK      +++  +   +    I   +EY HR   
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHR--- 126

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR------GTIGYIAPE 499
            +I+H D+KP N+LLD++   KI+DFGL+ I         MT         G+  Y APE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNI---------MTDGNFLKTSCGSPNYAAPE 177

Query: 500 VFCRNFGEVSY---KSDVYSYGMMVFEM 524
           V         Y   + DV+S G++++ M
Sbjct: 178 VINGK----LYAGPEVDVWSCGIVLYVM 201

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 48/218 (22%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFI---NEVASI--------SRTSHV 378
           LG+G +G V   ++ +  ++ A+KVL +      D I   ++V              +H 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKK------DVILQDDDVECTMTEKRILSLARNHP 84

Query: 379 NIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIAR 435
            +  L   CF+   R   + EFV+ G L    H    ++ +++        Y  A  I  
Sbjct: 85  FLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFH----IQKSRRFDEARARFY--AAEIIS 135

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GT 492
            L +LH      I++ D+K  N+LLD +   K++DFG+ K     E I +        GT
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGT 187

Query: 493 IGYIAPEVFCRNFGEVSY-KS-DVYSYGMMVFEM-TGE 527
             YIAPE+         Y  + D ++ G++++EM  G 
Sbjct: 188 PDYIAPEILQEM----LYGPAVDWWAMGVLLYEMLCGH 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 48/218 (22%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFI---NEVASI--------SRTSHV 378
           +G+G Y  V   +L     + A+KV+ +      + +    ++  +          ++H 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKK------ELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 379 NIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIAR 435
            +V L   CF+   R   + E+V+ G L    H    ++  +KL  E    Y  +  I+ 
Sbjct: 71  FLVGLH-SCFQTESRLFFVIEYVNGGDL--MFH----MQRQRKLPEEHARFY--SAEISL 121

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GT 492
            L YLH      I++ D+K  N+LLD +   K++D+G+ K     E +          GT
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGT 173

Query: 493 IGYIAPEVFCRNFGEVSY-KS-DVYSYGMMVFEM-TGE 527
             YIAPE+         Y  S D ++ G+++FEM  G 
Sbjct: 174 PNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAGR 207

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 48/218 (22%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFI---NEVASI--------SRTSHV 378
           LG+G +G V   +      + A+K+L +      D +   ++V                 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 379 NIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIAR 435
            +  L   CF+   R   + E+V+ G L    H    ++   + K    V Y  A  IA 
Sbjct: 82  FLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYH----IQQVGRFKEPHAVFY--AAEIAI 132

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GT 492
           GL +L    +  I++ D+K  N++LD +   KI+DFG+ K     E+I      +   GT
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGT 184

Query: 493 IGYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM-TGE 527
             YIAPE+         Y   V  +++G++++EM  G+
Sbjct: 185 PDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAGQ 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 49/218 (22%)

Query: 331 LGQGGYGGVYKGKLLDGQNV----AIKVLNETKGNGEDFI---NEVASIS------RTSH 377
           LGQG +G V+  K + G +     A+KVL   K      +   + V +          +H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLK--K----ATLKVRDRVRTKMERDILVEVNH 85

Query: 378 VNIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIA 434
             IV L  + F+   +  LI +F+  G L  F      L        E    Y     +A
Sbjct: 86  PFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTR----LSKEVMFTEEDVKFY--LAELA 136

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---G 491
             L++LH   +  I++ D+KP NILLDE+   K++DFGL+K     ESI     A    G
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFCG 188

Query: 492 TIGYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM-TG 526
           T+ Y+APEV  R      +      +S+G+++FEM TG
Sbjct: 189 TVEYMAPEVVNRR----GHTQSADWWSFGVLMFEMLTG 222

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 48/218 (22%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFI---NEVASI--------SRTSHV 378
           +G+G Y  V   +L     + A++V+ +      + +    ++  +          ++H 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKK------ELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 379 NIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIAR 435
            +V L   CF+   R   + E+V+ G L    H    ++  +KL  E    Y  +  I+ 
Sbjct: 114 FLVGLH-SCFQTESRLFFVIEYVNGGDL--MFH----MQRQRKLPEEHARFY--SAEISL 164

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GT 492
            L YLH      I++ D+K  N+LLD +   K++D+G+ K     E +          GT
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGT 216

Query: 493 IGYIAPEVFCRNFGEVSY-KS-DVYSYGMMVFEM-TGE 527
             YIAPE+         Y  S D ++ G+++FEM  G 
Sbjct: 217 PNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAGR 250

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 36/223 (16%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVAS 371
            Y             +G G YG V        G+ VAIK L+    +         E+  
Sbjct: 25  TYVSPTH--------VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL 76

Query: 372 ISRTSHVNIVTLLGFCFEGHRRA------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           +    H N++ LL                L+  F+    L+K +       + +K+++ +
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKF-SEEKIQY-L 131

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           +Y++     +GL+Y+H      ++H D+KP N+ ++ED   KI DFGLA     R +   
Sbjct: 132 VYQML----KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAE 179

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           MTG   T  Y APEV   ++   +   D++S G ++ EM   K
Sbjct: 180 MTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 47/214 (21%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNETKGNGEDFI---NEVASI--------SRTSHV 378
           +G+G +G V   +    +   A+KVL   K      I    E   I            H 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQ--K----KAILKKKEEKHIMSERNVLLKNVKHP 99

Query: 379 NIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIAR 435
            +V L  F F+   +   + ++++ G L  F H    L+  +         Y  A  IA 
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGEL--FYH----LQRERCFLEPRARFY--AAEIAS 150

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GT 492
            L YLH   +  I++ D+KP NILLD      ++DFGL K     E+I   +      GT
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCGT 202

Query: 493 IGYIAPEVFCRNFGEVSYKSDV--YSYGMMVFEM 524
             Y+APEV  +      Y   V  +  G +++EM
Sbjct: 203 PEYLAPEVLHKQ----PYDRTVDWWCLGAVLYEM 232

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 75.3 bits (186), Expect = 7e-15
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 49/215 (22%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFI---NEVASI--------SRTSHV 378
           LG+G +G V+  +     Q  AIK L +      D +   ++V               H 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKK------DVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 379 NIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWE--VLYKIAVGIAR 435
            +  +    F+       + E+++ G L    H    +++  K        Y  A  I  
Sbjct: 79  FLTHMF-CTFQTKENLFFVMEYLNGGDL--MYH----IQSCHKFDLSRATFY--AAEIIL 129

Query: 436 GLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICEGRESIVSMTGAR---G 491
           GL++LH   +  I++ D+K  NILLD+D    KI+DFG+ K     E+++         G
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCK-----ENMLGDAKTNTFCG 180

Query: 492 TIGYIAPEVFCRNFGEVSY-KS-DVYSYGMMVFEM 524
           T  YIAPE+         Y  S D +S+G++++EM
Sbjct: 181 TPDYIAPEILLGQ----KYNHSVDWWSFGVLLYEM 211

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 75.0 bits (185), Expect = 9e-15
 Identities = 59/244 (24%), Positives = 104/244 (42%), Gaps = 30/244 (12%)

Query: 292 KKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNS---FKNKLGQGGYGGVYKGKLLDGQ 348
           KK     +++ FL        K++                  LG G +G V   K  +  
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 349 NV-AIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA-LIYEFVSN 402
           N  A+K+L++         E  +NE   +   +   +V L  F F+ +    ++ E+V+ 
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAG 125

Query: 403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE 462
           G +  F H    L    +         A  I    EYLH   +  +++ D+KP N+L+D+
Sbjct: 126 GEM--FSH----LRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ 176

Query: 463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY-KS-DVYSYGMM 520
               +++DFG AK  +GR    + T   GT   +APE+         Y K+ D ++ G++
Sbjct: 177 QGYIQVTDFGFAKRVKGR----TWT-LCGTPEALAPEIILSK----GYNKAVDWWALGVL 227

Query: 521 VFEM 524
           ++EM
Sbjct: 228 IYEM 231

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.8 bits (186), Expect = 2e-14
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 43/212 (20%)

Query: 331 LGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFI---NEVASI--------SRTSHV 378
           LG+G +G V   +     +  A+K+L +      D +   ++V                 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 379 NIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
            +  L   CF+   R   + E+V+ G L    H    ++   + K       A  IA GL
Sbjct: 403 FLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYH----IQQVGRFKEPHAVFYAAEIAIGL 455

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR---GTIG 494
            +L    +  I++ D+K  N++LD +   KI+DFG+ K     E+I      +   GT  
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPD 507

Query: 495 YIAPEVFCRNFGEVSY-KS-DVYSYGMMVFEM 524
           YIAPE+         Y KS D +++G++++EM
Sbjct: 508 YIAPEIIAYQ----PYGKSVDWWAFGVLLYEM 535

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 43/227 (18%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVAS 371
            Y D++         +G G YG V        G  VAIK L     +         E+  
Sbjct: 26  VYRDLQP--------VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 77

Query: 372 ISRTSHVNIVTLLGFCFEGHRRA------LIYEFVSNGSLEKFIHEKHPLETNQKLKWE- 424
           +    H N++ LL                L+  F+    L K +        ++KL  + 
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-------HEKLGEDR 129

Query: 425 ---VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE 481
              ++Y++     +GL Y+H      I+H D+KP N+ ++ED   KI DFGLA     R+
Sbjct: 130 IQFLVYQML----KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA-----RQ 177

Query: 482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +   MTG   T  Y APEV   N+   +   D++S G ++ EM   K
Sbjct: 178 ADSEMTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 41/243 (16%)

Query: 331 LGQGGYGGVYKGKLLDGQNV----AIKVLNETKGNGEDFINEVASI-------SRTSHVN 379
           LG G YG V+  + + G +     A+KVL   K                           
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLK--KATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 380 IVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV--LYKIAVGIARG 436
            +  L + F+   +  LI ++++ G L  F H    L   ++       +Y     I   
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL--FTH----LSQRERFTEHEVQIY--VGEIVLA 171

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGAR-GTIGY 495
           LE+LH      I++ DIK  NILLD +    ++DFGL+K  E             GTI Y
Sbjct: 172 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEY 226

Query: 496 IAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TG--------EKNNANVAVDR--SSEIYFP 544
           +AP++            D +S G++++E+ TG        EKN+      R   SE  +P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286

Query: 545 HWV 547
             +
Sbjct: 287 QEM 289

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 43/229 (18%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN------- 367
           RY ++          +G+G YG V      L+   VAIK ++        F +       
Sbjct: 28  RYTNLSY--------IGEGAYGMVCSAYDNLNKVRVAIKKIS-------PFEHQTYCQRT 72

Query: 368 --EVASISRTSHVNIVTLLGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQK 420
             E+  + R  H NI+ +                ++ + +    L K +     L +N  
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-TQHL-SNDH 129

Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
           + +  LY+I     RGL+Y+H      +LH D+KP N+LL+     KI DFGLA++ +  
Sbjct: 130 ICY-FLYQIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181

Query: 481 ESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
                 +T    T  Y APE+   N    +   D++S G ++ EM   +
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.6 bits (179), Expect = 4e-14
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 31/204 (15%)

Query: 331 LGQGGYGGVYKGKLLDGQNV-AIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLG 385
           LG G +G V+  +        A+KVL +         E   +E   +S  +H  I+ +  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72

Query: 386 FCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV--LYKIAVGIARGLEYLHR 442
             F+  ++  +I +++  G L  F      L  +Q+    V   Y  A  +   LEYLH 
Sbjct: 73  GTFQDAQQIFMIMDYIEGGEL--FSL----LRKSQRFPNPVAKFY--AAEVCLALEYLH- 123

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
             +  I++ D+KP NILLD++   KI+DFG AK         + T   GT  YIAPEV  
Sbjct: 124 SKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYT-LCGTPDYIAPEVVS 176

Query: 503 RNFGEVSY-KS-DVYSYGMMVFEM 524
                  Y KS D +S+G++++EM
Sbjct: 177 TK----PYNKSIDWWSFGILIYEM 196

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 27/168 (16%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVAS 371
           RY             +G G YG V +    L+ + VAIK +     +  D    + E+A 
Sbjct: 54  RYEIRHL--------IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI 105

Query: 372 ISRTSHVNIVTLLGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
           ++R +H ++V +L               ++ E   +   +K       L T   +K  +L
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYL-TELHIKT-LL 162

Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA 474
           Y +      G++Y+H      ILH D+KP N L+++D   K+ DFGLA
Sbjct: 163 YNLL----VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 22/164 (13%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLL 384
               LG G  G V +       +  A+K+L +          EV    R S   +IV ++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 77

Query: 385 GFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
              +E          ++ E +  G L   I ++      ++   E++  I   I     Y
Sbjct: 78  DV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ----Y 132

Query: 440 LHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGR 480
           LH   +  I H D+KP N+L      +   K++DFG AK   G 
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 35/223 (15%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVAS 371
           RY ++K         +G G  G V      +  +NVAIK L+    N         E+  
Sbjct: 26  RYQNLKP--------IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 77

Query: 372 ISRTSHVNIVTLLG-FCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           +   +H NI+ LL  F  +          ++ E +   +L + I  +  L  ++++ + +
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMEL-DHERMSY-L 132

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           LY++      G+++LH      I+H D+KP NI++  D   KI DFGLA+      +   
Sbjct: 133 LYQML----CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFM 182

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           MT    T  Y APEV            D++S G ++ EM    
Sbjct: 183 MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGG 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 46/235 (19%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN------E 368
           RY D+K         LG GG G V+        + VAIK     K    D  +      E
Sbjct: 12  RYMDLKP--------LGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALRE 58

Query: 369 VASISRTSHVNIVTLLG-FCFEGHRRALIYEFVSNGS------------LEKFIHEKHPL 415
           +  I R  H NIV +       G +       ++  +            L   +  + PL
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE-QGPL 117

Query: 416 ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-KISDFGLA 474
              +  +   +Y++     RGL+Y+H      +LH D+KP N+ ++ +    KI DFGLA
Sbjct: 118 -LEEHARL-FMYQLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLA 168

Query: 475 KICEGRESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           +I +   S    ++    T  Y +P +   +    +   D+++ G +  EM   K
Sbjct: 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 35/223 (15%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVAS 371
           RY ++          +G G YG V        G  VA+K L+    +         E+  
Sbjct: 30  RYQNLSP--------VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81

Query: 372 ISRTSHVNIVTLLGFCFEGHRRA------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           +    H N++ LL                L+   +    L   +  +  L T+  +++ +
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KL-TDDHVQF-L 137

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           +Y+I     RGL+Y+H      I+H D+KP N+ ++ED   KI DFGLA     R +   
Sbjct: 138 IYQIL----RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTADE 185

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
           MTG   T  Y APE+   N+   +   D++S G ++ E+   +
Sbjct: 186 MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 60/262 (22%), Positives = 94/262 (35%), Gaps = 79/262 (30%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVA-----SISRTSHVN---I 380
           KLG G +  V+    +   + VA+KV+   +   E  ++E+        S  +  N   +
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 381 VTLLGFCFE-----GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIAR 435
           V LL   F+     G    +++E V    L K+I + +     Q L    + KI   + +
Sbjct: 104 VQLLD-DFKISGVNGTHICMVFE-VLGHHLLKWIIKSN----YQGLPLPCVKKIIQQVLQ 157

Query: 436 GLEYLHRGCNTRILHFDIKPHNILL----------------------------------- 460
           GL+YLH  C   I+H DIKP NILL                                   
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 461 --------------DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
                          E    KI+D G A       +    T       Y + EV   +  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGS-- 268

Query: 507 EVSYKSDVYSYGMMVFEM-TGE 527
             +  +D++S   M FE+ TG+
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 9e-13
 Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 26/200 (13%)

Query: 410 HEKHPLETNQKLKWEVLYKIAVGIARGLEYL-HRGCNTRILHFDIKPHNILLDEDFCPKI 468
            E         L  E L   +  +A+G+E+L  R C    +H D+   NILL E    KI
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKI 234

Query: 469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT--G 526
            DFGLA+        V    AR  + ++APE         + +SDV+S+G++++E+   G
Sbjct: 235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLG 292

Query: 527 EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMI-LVSLWCIQTN 585
                 V +D            +RL+       +G       +Y    +    L C    
Sbjct: 293 ASPYPGVKIDEE--------FCRRLK-------EGTRMRA-PDYTTPEMYQTMLDCWHGE 336

Query: 586 PSDRPSMNRVVEMLEGSLDS 605
           PS RP+ + +VE L   L +
Sbjct: 337 PSQRPTFSELVEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 10/107 (9%)

Query: 326 SFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKGNGE--DFINEVAS-ISRTS 376
                LG+G +G V +            + VA+K+L E   + E    ++E+   I    
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 377 HVNIVTLLGFCF-EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
           H+N+V LLG C   G    +I EF   G+L  ++  K       K K
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 57/259 (22%), Positives = 95/259 (36%), Gaps = 51/259 (19%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVAS 371
            Y             +G+G YG VY        +NVAIK +N    +  D    + E+  
Sbjct: 27  NYIIKHL--------IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI 78

Query: 372 ISRTSHVNIVTLLGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
           ++R     I+ L                ++ E   +  L+K       L T + +K  +L
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFL-TEEHIKT-IL 135

Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS- 485
           Y +      G  ++H      I+H D+KP N LL++D   K+ DFGLA+     +     
Sbjct: 136 YNLL----LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 486 -------------------MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-T 525
                              +T    T  Y APE+        +   D++S G +  E+  
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL-LQENYTKSIDIWSTGCIFAELLN 247

Query: 526 GEKNNANVAVDRSSEIYFP 544
             +++ N   +R     FP
Sbjct: 248 MLQSHINDPTNR--FPLFP 264

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 39/225 (17%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED---FINEVAS 371
           RY ++K         +G G  G V      +  +NVAIK L+    N         E+  
Sbjct: 63  RYQNLKP--------IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 114

Query: 372 ISRTSHVNIVTLLG-FCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           +   +H NI++LL  F  +          L+ E + + +L + I  +  L  ++++ + +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMEL-DHERMSY-L 169

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           LY++      G+++LH      I+H D+KP NI++  D   KI DFGLA+      +   
Sbjct: 170 LYQML----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFM 219

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKS--DVYSYGMMVFEMTGEK 528
           MT    T  Y APEV         YK   D++S G ++ EM   K
Sbjct: 220 MTPYVVTRYYRAPEVILGM----GYKENVDIWSVGCIMGEMVRHK 260

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 52/237 (21%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISR 374
            +             LG+G YG V        G+ VAIK +         F   + ++ R
Sbjct: 12  DFQLKSL--------LGEGAYGVVCSATHKPTGEIVAIKKIEP-------FDKPLFAL-R 55

Query: 375 T----------SHVNIVTLLGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLETNQ 419
           T           H NI+T+                +I E +    L + I     L ++ 
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIS-TQML-SDD 112

Query: 420 KLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG 479
            +++  +Y+      R ++ LH      ++H D+KP N+L++ +   K+ DFGLA+I + 
Sbjct: 113 HIQY-FIYQTL----RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

Query: 480 RESIVS--------MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK 528
             +  S        M     T  Y APEV      + S   DV+S G ++ E+   +
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRR 220

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 59/234 (25%), Positives = 99/234 (42%), Gaps = 55/234 (23%)

Query: 315 YRYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN----EV 369
           YRY  +K         +G+G +G V K       Q+VA+K++     N + F      E+
Sbjct: 97  YRYEVLKV--------IGKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEI 144

Query: 370 ASISR------TSHVNIVTLLG-FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLK 422
             +         + +N++ +L  F F  H   + +E +S  +L + I +       Q   
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHI-CMTFELLSM-NLYELIKKNK----FQGFS 198

Query: 423 WEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP--KISDFGLAKICEGR 480
             ++ K A  I + L+ LH+    RI+H D+KP NILL +      K+ DFG +  C   
Sbjct: 199 LPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEH 253

Query: 481 ESIVSMTGARGTIGYI------APEVFCRNFGEVSYKSDVYSYGMMVFEM-TGE 527
           + + +         YI      APEV            D++S G ++ E+ TG 
Sbjct: 254 QRVYT---------YIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGY 296

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 60/246 (24%), Positives = 102/246 (41%), Gaps = 60/246 (24%)

Query: 316 RYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISR 374
           +Y  +KK        LG+G YG V+K      G+ VA+K + +       F N   +  R
Sbjct: 10  KYELVKK--------LGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDA-QR 54

Query: 375 T-----------SHVNIVTLLGFCFEGHRRA--LIYEFVSNGSLEKFIHEKHPLETNQKL 421
           T            H NIV LL      + R   L+++++    L   I     L      
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-IL-EPVHK 111

Query: 422 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE 481
           ++ V+Y++     + ++YLH G    +LH D+KP NILL+ +   K++DFGL++      
Sbjct: 112 QY-VVYQLI----KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163

Query: 482 SIVS-------------------MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF 522
            + +                   +T    T  Y APE+      + +   D++S G ++ 
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILG 222

Query: 523 EMTGEK 528
           E+   K
Sbjct: 223 EILCGK 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.3 bits (145), Expect = 5e-10
 Identities = 33/249 (13%), Positives = 63/249 (25%), Gaps = 74/249 (29%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVL---------NETKGNGEDFINEVA---------S 371
           K+G+G +G V++    D   VAIK++            +   E+ + E+           
Sbjct: 27  KIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 372 ISRTSHVNIVTLLGFC------------------------------FEGHRRALIYEFVS 401
                    + L                                  F+  +  ++ EF  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD 461
            G   + +  K                I   +   L            H D+   N+LL 
Sbjct: 146 GGIDLEQMRTK-------LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLK 196

Query: 462 EDFCPKISDFGLAK-------------ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEV 508
           +    K+      K             I      +            +  ++F    G+ 
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT---GDG 253

Query: 509 SYKSDVYSY 517
            Y+ D+Y  
Sbjct: 254 DYQFDIYRL 262

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 36/183 (19%), Positives = 66/183 (36%), Gaps = 38/183 (20%)

Query: 321 KKMTNSFKN------KLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGN----------- 361
           K + +   N      K+G GG+G +Y        +  A  V+  E + N           
Sbjct: 29  KVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQ 88

Query: 362 ---GEDFINEVASISRTSHVNIVTLLGF----CFEGHRRALIYEFVSNGSLEKFIHEKHP 414
               +D I +     +  ++ I    G           R ++ E +    L+K       
Sbjct: 89  RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKI------ 141

Query: 415 LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI--SDFG 472
              N   K   + ++ + +   LEY+H       +H DIK  N+LL      ++  +D+G
Sbjct: 142 SGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYG 198

Query: 473 LAK 475
           L+ 
Sbjct: 199 LSY 201

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 39/217 (17%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDF----INEVASISR------TSH 377
           + +G+G +G V K    ++ + VAIK++     N + F      EV  +           
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 378 VNIVTLLG-FCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQKLKWEVLYKIAVGIA 434
             IV L   F F  H   L++E +S  +L   +       +  N         K A  + 
Sbjct: 116 YYIVHLKRHFMFRNHL-CLVFEMLSY-NLYDLLRNTNFRGVSLNL------TRKFAQQMC 167

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCP--KISDFGLAKICEGRESIVSMTGARGT 492
             L +L       I+H D+KP NILL        KI DFG +  C+  + I     +R  
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSR-- 222

Query: 493 IGYIAPEVFCRNFG-EVSYKSDVYSYGMMVFEM-TGE 527
             Y +PEV     G       D++S G ++ EM TGE
Sbjct: 223 -FYRSPEVL---LGMPYDLAIDMWSLGCILVEMHTGE 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 41/156 (26%), Positives = 62/156 (39%), Gaps = 23/156 (14%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSH-VNIVTLLGFC 387
           K+G G +G +  GK L   + VAIK+    K        E     +      I  +  F 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 388 FEGHRRALIYEFVSNGSLE---KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
             G   A++ E +   SLE           L+T       VL  IA+ +   +EY+H   
Sbjct: 75  PCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKT-------VL-MIAIQLISRMEYVH--- 122

Query: 445 NTRILHFDIKPHNILLDEDFCPK-----ISDFGLAK 475
           +  +++ D+KP N L+            I DF LAK
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 30/170 (17%), Positives = 61/170 (35%), Gaps = 33/170 (19%)

Query: 330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETK------------------GNGEDFINEVAS 371
            +GQGG+G +Y   +   ++V        K                      + I +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 372 ISRTSHVNIVTLLGFCFEGHR----RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLY 427
             +  ++ +    G           R +I +   +  L+K           ++   + + 
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYE-----ANAKRFSRKTVL 155

Query: 428 KIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 475
           ++++ I   LEY+H       +H DIK  N+LL+     ++   D+GLA 
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 31/186 (16%), Positives = 63/186 (33%), Gaps = 43/186 (23%)

Query: 319 DIKKMTNSFK--NKLGQGGYGGVYKGK---------LLDGQNVAIKV-------LNETK- 359
           D       +K  +   +   G +Y+               Q  ++K+        NE   
Sbjct: 38  DKSG--RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF 95

Query: 360 ---GNGEDFINEVASISRTSHVNIVTLLGF-CFEGHRRALIYEFVSNGSLEKFIHEKH-- 413
                    +N+   +  T  + I T +GF   +   R L+   +   SL+  +      
Sbjct: 96  FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKH 154

Query: 414 --PLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI--S 469
                +       VL ++A  +   LE+LH       +H ++   NI +D +   ++  +
Sbjct: 155 VLSERS-------VL-QVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLA 203

Query: 470 DFGLAK 475
            +G A 
Sbjct: 204 GYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 35/156 (22%), Positives = 63/156 (40%), Gaps = 23/156 (14%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASI-SRTSHVNIVTLLGFC 387
           ++G+G +G +++G  LL+ Q VAIK     + +     +E  +         I  +  F 
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 388 FEGHRRALIYEFVSNGSLE---KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            EG    L+ + +   SLE        K  ++T       V    A  +   ++ +H   
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT-------VA-MAAKQMLARVQSIH--- 123

Query: 445 NTRILHFDIKPHNILLDEDFCPK-----ISDFGLAK 475
              +++ DIKP N L+            + DFG+ K
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 45/154 (29%), Positives = 64/154 (41%), Gaps = 21/154 (13%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSH-VNIVTLLGFC 387
           K+G G +G +Y G  +  G+ VAIK+    K        E          V I T+    
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 388 FEGHRRALIYEFVSNGSLE---KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            EG    ++ E +   SLE    F   K  L+T       VL  +A  +   +EY+H   
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKT-------VL-LLADQMISRIEYIH--- 122

Query: 445 NTRILHFDIKPHNILLDEDFCPK---ISDFGLAK 475
           +   +H D+KP N L+          I DFGLAK
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 45/154 (29%), Positives = 64/154 (41%), Gaps = 21/154 (13%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISR-TSHVNIVTLLGFC 387
           K+G G +G +Y G  +   + VAIK+ N  K      + E            I  +  F 
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 388 FEGHRRALIYEFVSNGSLE---KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
            EG    L+ + +   SLE    F   K  L+T       VL  +A  +   +E++H   
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKT-------VL-MLADQMINRVEFVH--- 120

Query: 445 NTRILHFDIKPHNILLDEDFCPK---ISDFGLAK 475
           +   LH DIKP N L+          I DFGLAK
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 53/244 (21%), Positives = 89/244 (36%), Gaps = 75/244 (30%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFIN----EVASISR-----TSHVN 379
           K+G G +G V   + + + +  A+KV+     N + +      E   + +      ++ N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNN 97

Query: 380 IVTLLG-FCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQKLKWEVLYKIAVGIARG 436
           IV   G F +  H   LI+E +   SL + I  +  +            +    + I + 
Sbjct: 98  IVKYHGKFMYYDHM-CLIFEPLGP-SLYEIITRNNYNGFHIED------IKLYCIEILKA 149

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCP-------------------------KISDF 471
           L YL +     + H D+KP NILLD+ +                           K+ DF
Sbjct: 150 LNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 472 GLAKICEGRESIVSMTGARGTIGYI------APEVFCRNFG-EVSYKSDVYSYGMMVFEM 524
           G A      +   S          I      APEV            SD++S+G ++ E+
Sbjct: 207 GCA--TFKSDYHGS---------IINTRQYRAPEVI---LNLGWDVSSDMWSFGCVLAEL 252

Query: 525 -TGE 527
            TG 
Sbjct: 253 YTGS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 44/240 (18%), Positives = 79/240 (32%), Gaps = 71/240 (29%)

Query: 330 KLGQGGYGGVYKG--KLLDGQNVAIKVLNETKGNGEDFIN----EVASISR------TSH 377
            LG+G +G V +          VA+K++     N   +      E+  + +       + 
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENK 81

Query: 378 VNIVTLLG-FCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQKLKWEVLYKIAVGIA 434
              V +   F F GH   + +E +   +  +F+  +   P           +  +A  + 
Sbjct: 82  FLCVLMSDWFNFHGHM-CIAFELLGK-NTFEFLKENNFQPYPLPH------VRHMAYQLC 133

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-------------------KISDFGLAK 475
             L +LH     ++ H D+KP NIL                          +++DFG A 
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189

Query: 476 ICEGRESIVSMTGARGTIGYI------APEVFCRNFG-EVSYKSDVYSYGMMVFEM-TGE 527
                E   +          +       PEV         +   DV+S G ++FE   G 
Sbjct: 190 -TFDHEHHTT---------IVATRHYRPPEVI---LELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 51/240 (21%), Positives = 85/240 (35%), Gaps = 71/240 (29%)

Query: 330 KLGQGGYGGVYKGK--LLDGQNVAIKVLNETKGNGEDFIN----EVASISR------TSH 377
            LG+G +G V +       G++VA+K++     N + +      E+  +         S 
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNST 76

Query: 378 VNIVTLLG-FCFEGHRRALIYEFVSNGSLEKFI--HEKHPLETNQKLKWEVLYKIAVGIA 434
              V +L  F   GH   +++E +   S   FI  +   P   +       + K+A  I 
Sbjct: 77  FRCVQMLEWFEHHGHI-CIVFELLGL-STYDFIKENGFLPFRLDH------IRKMAYQIC 128

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCP-------------------KISDFGLAK 475
           + + +LH     ++ H D+KP NIL  +                       K+ DFG A 
Sbjct: 129 KSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184

Query: 476 ICEGRESIVSMTGARGTIGYI------APEVFCRNFG-EVSYKSDVYSYGMMVFEM-TGE 527
                E   +          +      APEV         S   DV+S G ++ E   G 
Sbjct: 185 -TYDDEHHST---------LVSTRHYRAPEVI---LALGWSQPCDVWSIGCILIEYYLGF 231

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 4e-05
 Identities = 80/625 (12%), Positives = 150/625 (24%), Gaps = 245/625 (39%)

Query: 29  LLARTVSGKIDP-----QYLACVAKTCGDGQSISFPFYIENQQEAYCGYPGFNLSCNDKG 83
           L++   + +  P      Y+    +   D Q  +  + +   Q      P   L      
Sbjct: 94  LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA-KYNVSRLQ------PYLKLR----- 141

Query: 84  NPVLKLSSDTNYIVE------KILYDNHSVLVSNAAFSETNSDPACTFP------RIKNV 131
             +L+L    N +++      K      + +  +   S       C          +KN 
Sbjct: 142 QALLELRPAKNVLIDGVLGSGK------TWVALDVCLSY---KVQCKMDFKIFWLNLKNC 192

Query: 132 SLPAD---------FQLAPDQKQAV-----LLYNCNSSSPEK--LLRHK-----LLAGNC 170
           + P           +Q+ P+          +    +S   E   LL+ K     LL    
Sbjct: 193 NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL---- 248

Query: 171 SGDDTVLGMFEDD----SDLDSASKQCK------ESAVAPVAVDMNGEGIGDHIGIEEMV 220
                VL     +       ++ +  CK         V     D        HI ++   
Sbjct: 249 -----VL----LNVQNAKAWNAFNLSCKILLTTRFKQVT----DFLSAATTTHISLDHH- 294

Query: 221 RKGFLLKWKASDCRACKESGGSCGFDADTFHFQCYCPDRRHAKFCTASGDGKLKLKAK-- 278
                            E                        K         L  +    
Sbjct: 295 SMTLTPD----------EV-------KSLL-----------LK-YLDCRPQDLPREVLTT 325

Query: 279 ----VALIIDNSVIFWKKKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFK---NKL 331
               +++I                     +R+  +     +++ +  K+T   +   N L
Sbjct: 326 NPRRLSII------------------AESIRDGLAT-WDNWKHVNCDKLTTIIESSLNVL 366

Query: 332 GQGGYGGVYK--GKLLDGQNVAIKVL-----NETKGNGEDFINEVASISRTSHVNIVTLL 384
               Y  ++          ++   +L     +  K +    +N++               
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL--------------- 411

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
                 H+ +L+ +     ++   I   + LE   KL                  LHR  
Sbjct: 412 ------HKYSLVEKQPKESTI--SIPSIY-LELKVKL-------------ENEYALHR-- 447

Query: 445 NTRIL----------HFDIKP-------------H--NILLDEDFC--PKI-SDFGL--A 474
              I+            D+ P             H  NI   E       +  DF     
Sbjct: 448 --SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQ 505

Query: 475 KICEGRESIVSMTGARGTI-------GYIAP------------EVFCRNFGEVSYKS--- 512
           KI     +  +      T+        YI                F     E    S   
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYT 565

Query: 513 DVYSYGMMVFEMTGEKNNANVAVDR 537
           D+    +M  E       A+  V R
Sbjct: 566 DLLRIALM-AEDEAIFEEAHKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 1e-04
 Identities = 51/444 (11%), Positives = 124/444 (27%), Gaps = 117/444 (26%)

Query: 245 FDADTFHFQCY-CPDRRHAKFCTASGDGKLKLKAKVALIIDNSVIFWKKKTYNYRNIEAF 303
           F  +   F C    D   +       D  +  K  V+  +    +FW   +     ++ F
Sbjct: 29  FVDN---FDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL---RLFWTLLSKQEEMVQKF 82

Query: 304 L-----RNYGSLAPK-RYRYAD---IKKMTNSFKNKLGQGGY----GGVYKGKLL----- 345
           +      NY  L    +        + +M    +++L           V + +       
Sbjct: 83  VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ 142

Query: 346 ------DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE------GHRR 393
                   +NV   +++   G+G+ ++     +  +  V         F+       +  
Sbjct: 143 ALLELRPAKNV---LIDGVLGSGKTWV--ALDVCLSYKV----QCKMDFKIFWLNLKNCN 193

Query: 394 ----------ALIYEFVSNGSLEKFIHEKHPLETNQ------KLKWEVLYKIAVGIARGL 437
                      L+Y+   N +          L  +       +L     Y+  + +   +
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV 253

Query: 438 EYLHRGCNTRIL-HFDIKPHNILLDEDFCPKI----SDFGLA-KICEGRESIVSMTGARG 491
                  N +    F++           C KI        +   +     + +S+     
Sbjct: 254 ------QNAKAWNAFNLS----------C-KILLTTRFKQVTDFLSAATTTHISLDHHSM 296

Query: 492 TIGYIAPEV--FCRNFGEVSYKS---DVYSYGMMVFEMTGE--KNNANVAVDRSSEIYFP 544
                  EV      + +   +    +V +       +  E  ++             + 
Sbjct: 297 --TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA----TWD--NWK 348

Query: 545 HWVYKRLELEEDLGLQGIENEEDKEYARKM------------ILVSLWCIQTNPSDRPSM 592
           H    +L    +  L  +E  E ++   ++            +L  +W    +      M
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF---DVIKSDVM 405

Query: 593 NRVVEMLEGSLDSLQIPPRPFLLS 616
             V ++ + SL  ++  P+   +S
Sbjct: 406 VVVNKLHKYSL--VEKQPKESTIS 427

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	638
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.67
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.02
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.59
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.38
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.28
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.01
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.98
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.73
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.6
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.54
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.48
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.39
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.37
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.35
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.31
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.25
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.19
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.17
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.15
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.7
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.69
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.35
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.31
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.11
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.11

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-53  Score=428.44  Aligned_cols=260  Identities=29%  Similarity=0.464  Sum_probs=202.6

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.++||+|+||+||+|++.  ..||||+++....   ..+.|.+|++++++++|||||+++|++.+ +..+|||||+++|
T Consensus        40 l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gG  116 (307)
T 3omv_A           40 LSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGS  116 (307)
T ss_dssp             EEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred             EeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence            5789999999999999864  3699999875432   34678999999999999999999998764 5689999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.++|+...     ..+++..+..|+.|+|+||+|||+   ++||||||||+||||++++.+||+|||+|+........
T Consensus       117 sL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          117 SLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             BHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999998653     569999999999999999999999   99999999999999999999999999999876544333


Q ss_pred             eeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .......||+.|||||++.+. .+.++.++|||||||+||||+||+.||......       ......+...  .... .
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~--~~~p-~  258 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRG--YASP-D  258 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTT--CCCC-C
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcC--CCCC-C
Confidence            334556799999999999653 236899999999999999999999999753321       1111111111  1011 1


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      .......++.++.+|+.+||+.||++|||++||+++|+.+...++
T Consensus       259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            112223456788999999999999999999999999988755543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.9e-54  Score=435.83  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=211.8

Q ss_pred             HHhhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEE
Q 006620          323 MTNSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       323 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  394 (638)
                      ...+|.++||+|+||+||+|++.      +++.||||+++...  ...++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34457889999999999999862      46789999997543  33568999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC
Q 006620          395 LIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF  464 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~  464 (638)
                      |||||+++|+|.++|......          .....+++..+.+|+.|||+||+|||+   ++||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence            999999999999999764321          113469999999999999999999999   9999999999999999999


Q ss_pred             ceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccch
Q 006620          465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYF  543 (638)
Q Consensus       465 ~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  543 (638)
                      .+||+|||+++...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....       
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------  253 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------  253 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------
Confidence            9999999999876554433334556799999999999764  79999999999999999998 8999875321       


Q ss_pred             hHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          544 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                       ..+...+..       +...+.+.+++.++.+|+.+||+.||++|||++||+++|+..
T Consensus       254 -~~~~~~i~~-------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          254 -QDVVEMIRN-------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -HHHHHHHHT-------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -HHHHHHHHc-------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             111111111       111222334567889999999999999999999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.2e-54  Score=434.87  Aligned_cols=260  Identities=24%  Similarity=0.414  Sum_probs=210.7

Q ss_pred             hhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.++||+|+||+||+|++.      +++.||||+++.... ..++|.+|+++|++++|||||+++|++.+++..+||||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            35789999999999999863      367899999976432 34679999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccc
Q 006620          399 FVSNGSLEKFIHEKHP-------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF  471 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF  471 (638)
                      |+++|+|.++|+..+.       ......+++..++.|+.|+++||+|||+   ++|+||||||+|||+++++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCc
Confidence            9999999999986431       1223579999999999999999999999   99999999999999999999999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHH
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      |+|+...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....        ..+...
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~~  242 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIEC  242 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHH
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH
Confidence            999876555444333445689999999999765  78999999999999999998 8999875321        111122


Q ss_pred             hhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      +....       ....+..++.++.+|+.+||+.||++|||+++|++.|+++.+.
T Consensus       243 i~~~~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          243 ITQGR-------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCC-------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            21111       1122234567889999999999999999999999999986543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.9e-53  Score=434.33  Aligned_cols=259  Identities=24%  Similarity=0.399  Sum_probs=203.2

Q ss_pred             hhcccCcCcceeEEEEEEc------CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.++||+|+||+||+|++.      +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus        45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey  124 (329)
T 4aoj_A           45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY  124 (329)
T ss_dssp             EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5789999999999999864      36789999997643 2346799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcc
Q 006620          400 VSNGSLEKFIHEKHPL---------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD  470 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  470 (638)
                      +++|+|.++|+.....         .....+++..++.|+.|+++||+|||+   ++||||||||+||||++++.+||+|
T Consensus       125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~D  201 (329)
T 4aoj_A          125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGD  201 (329)
T ss_dssp             CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcc
Confidence            9999999999875321         123569999999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHH
Q 006620          471 FGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       471 Fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      ||+++...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....        ..+..
T Consensus       202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~  271 (329)
T 4aoj_A          202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEAID  271 (329)
T ss_dssp             CC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHHHH
T ss_pred             cccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence            9999976554433333456789999999999765  78999999999999999999 8999875321        11111


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      .+....       ....+..++.++.+|+.+||+.||++|||++||+++|+.+...
T Consensus       272 ~i~~g~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CITQGR-------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHTC-------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHcCC-------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            121111       1122234567889999999999999999999999999987554

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-52  Score=428.09  Aligned_cols=263  Identities=23%  Similarity=0.238  Sum_probs=212.7

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      +.++||+|+||+||+|++ .+++.||||+++....    ..+|+.++++++|||||++++++.+++..||||||++||+|
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            467899999999999996 4589999999976432    24799999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-ceEEcccccceeccCCCce-
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICEGRESI-  483 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFg~~~~~~~~~~~-  483 (638)
                      .++|+..      ..+++..+..++.||++||+|||+   ++||||||||+||||+.++ .+||+|||+|+........ 
T Consensus       138 ~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          138 GQLIKQM------GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999875      469999999999999999999999   9999999999999999887 6999999999977543221 


Q ss_pred             --eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          484 --VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       484 --~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                        ......+||+.|||||++.+.  .++.++|||||||++|||++|++||......  +. ... +..    .. .... 
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~-~~~-i~~----~~-~~~~-  276 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PL-CLK-IAS----EP-PPIR-  276 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CC-HHH-HHH----SC-CGGG-
T ss_pred             ceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HH-HHH-HHc----CC-CCch-
Confidence              122335799999999999875  7899999999999999999999999754321  11 111 100    00 0000 


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCcccCC
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSS  617 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~~  617 (638)
                         ..+..++.++.+||.+||+.||++|||+.||+++|...+.+.....+|+....
T Consensus       277 ---~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          277 ---EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             ---GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             ---hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence               11223567789999999999999999999999999999888877778876443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-51  Score=422.75  Aligned_cols=246  Identities=22%  Similarity=0.292  Sum_probs=204.4

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++.+||||||++|
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            345678999999999999964 68999999997543 3456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++..       ..+++..++.++.||++||+|||+   ++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus       156 g~L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          156 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            999999976       358999999999999999999999   9999999999999999999999999999997754432


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .  ....+||+.|+|||++.+.  .|+.++|||||||++|||++|++||.....        ......+....     ..
T Consensus       226 ~--~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~-----~~  288 (346)
T 4fih_A          226 R--RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNL-----PP  288 (346)
T ss_dssp             C--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSS-----CC
T ss_pred             c--ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCC-----CC
Confidence            2  3456799999999999765  789999999999999999999999974321        01111111110     01


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .......++.++.+||.+||+.||++|||++|+++
T Consensus       289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11122345678899999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.4e-52  Score=419.56  Aligned_cols=245  Identities=22%  Similarity=0.332  Sum_probs=205.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      |.+.+.||+|+||+||+|+. .+++.||||++.+.    ....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            45678999999999999985 56899999999753    33456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++||+|.++|.+.      ..+++..++.++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.+..
T Consensus       114 ~~gG~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          114 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999875      469999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ..........+||+.|+|||++.+.  .++.++||||+||++|||++|+.||.....        ......+... ....
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~-~~~~  253 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKL-EYDF  253 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT-CCCC
T ss_pred             CCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-CCCC
Confidence            4443344567899999999999875  789999999999999999999999974321        1111111111 1111


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVV  596 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  596 (638)
                             +..++.++.+||.+||+.||++|||++|++
T Consensus       254 -------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 -------PEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                   123456789999999999999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.7e-52  Score=427.10  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=198.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      |.+.++||+|+||+||+|+. .+++.||||+++....   ..+.+.+|++++++++|||||++++++.+++..||||||+
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~  105 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC  105 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            34578999999999999986 4689999999975432   3457899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +||+|.++|...+    ...+++..++.|+.||+.||+|||+   ++|+||||||+||||++++.+||+|||+|+.....
T Consensus       106 ~gg~L~~~i~~~~----~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          106 EGGDLFKRINAQK----GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             TTCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCcHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            9999999997643    2467999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..  .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....       .... ..+....   . 
T Consensus       179 ~~--~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~-~~i~~~~---~-  242 (350)
T 4b9d_A          179 VE--LARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLV-LKIISGS---F-  242 (350)
T ss_dssp             HH--HHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHH-HHHHHTC---C-
T ss_pred             cc--cccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHH-HHHHcCC---C-
Confidence            21  12345699999999999875  789999999999999999999999975321       1111 1111110   1 


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                         ......++.++.+||.+||+.||++|||++|++++
T Consensus       243 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          243 ---PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               11122356788999999999999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4e-51  Score=410.68  Aligned_cols=242  Identities=26%  Similarity=0.390  Sum_probs=195.6

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe----CceEEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE----GHRRALIYE  398 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e  398 (638)
                      +.++||+|+||+||+|++. +++.||||++....   ...+.+.+|++++++++|||||++++++.+    +..++||||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            5678999999999999864 58899999997543   234578999999999999999999999875    356899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCceEEC-CCCceEEcccccce
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLD-EDFCPKISDFGLAK  475 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--iiH~Dikp~NIll~-~~~~~kl~DFg~~~  475 (638)
                      |+++|+|.+++.+.      ..+++..++.|+.||++||+|||+   ++  |+||||||+||||+ +++.+||+|||+|+
T Consensus       110 y~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          110 LMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            99999999999875      468999999999999999999999   77  99999999999997 47999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ......    ....+||+.|+|||++.+   .++.++|||||||++|||+||+.||.....       .......+... 
T Consensus       181 ~~~~~~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i~~~-  245 (290)
T 3fpq_A          181 LKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSG-  245 (290)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTT-
T ss_pred             eCCCCc----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHHHcC-
Confidence            654332    234579999999999864   589999999999999999999999964321       11111111111 


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                           ......+...+.++.+|+.+||+.||++|||++|+++
T Consensus       246 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 -----VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0111122223457889999999999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-50  Score=412.25  Aligned_cols=269  Identities=24%  Similarity=0.328  Sum_probs=200.8

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCc----eEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGH----RRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~  402 (638)
                      +.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||+++|++.+++    .++|||||+++
T Consensus         7 L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~   85 (303)
T 3hmm_A            7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence            478999999999999998 6899999999765433233345666677889999999999998653    57999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG-----CNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      |+|.++|+..       .++++.+.+++.|+++||+|||+.     +..+|+||||||+||||++++.+||+|||+++..
T Consensus        86 gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           86 GSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999863       489999999999999999999972     1239999999999999999999999999999877


Q ss_pred             cCCCcee--eecccccccceecCceecccc----CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccc-------hh
Q 006620          478 EGRESIV--SMTGARGTIGYIAPEVFCRNF----GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY-------FP  544 (638)
Q Consensus       478 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~  544 (638)
                      .......  ......||+.|+|||++.+..    ..++.++|||||||++|||+||++|+...........       ..
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            6544322  123457999999999996531    2467899999999999999999988754332211100       00


Q ss_pred             HHHHHHhhhhhhccccCCCC-chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          545 HWVYKRLELEEDLGLQGIEN-EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ........ ...+ ....+. ....+.++.+.+|+.+||+.||++|||++||++.|+++.++
T Consensus       239 ~~~~~~~~-~~~~-rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVC-EQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHT-TSCC-CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHh-cccC-CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            11111110 0000 011111 12234667889999999999999999999999999986543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=423.72  Aligned_cols=246  Identities=22%  Similarity=0.296  Sum_probs=204.0

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      |.+.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+++.+|||||||+|
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            34578999999999999996 458999999997543 3456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++..       ..+++..++.|+.||++||+|||+   ++||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus       233 G~L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          233 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CcHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            999999976       358999999999999999999999   9999999999999999999999999999997754432


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        .....+||+.|||||++.+.  .|+.++|||||||++|||++|++||.....        ......+......     
T Consensus       303 --~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~~~-----  365 (423)
T 4fie_A          303 --RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLPP-----  365 (423)
T ss_dssp             --CBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCC-----
T ss_pred             --cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCC-----
Confidence              23456799999999999765  789999999999999999999999964321        1111111111000     


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .......++.++.+||.+||+.||++|||++|+++
T Consensus       366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11112234678899999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-50  Score=402.85  Aligned_cols=243  Identities=24%  Similarity=0.365  Sum_probs=188.6

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      |.+.+.||+|+||+||+|+. .+++.||||+++...    ...+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   94 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY   94 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            45678999999999999985 568999999997542    2345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      + +|+|.+++.+.      ..+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+....
T Consensus        95 ~-~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           95 A-GNELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             C-CEEHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             C-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9 67999999875      469999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...   .....||+.|+|||++.+. ...+.++||||+||++|||++|+.||.....       .. ....+... ... 
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~-~~~~i~~~-~~~-  230 (275)
T 3hyh_A          165 GNF---LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PV-LFKNISNG-VYT-  230 (275)
T ss_dssp             -------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHT-CCC-
T ss_pred             CCc---cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHHcC-CCC-
Confidence            332   2346799999999999765 2346799999999999999999999974321       11 11111111 111 


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            .+..++.++.+|+.+||+.||++|||++|+++
T Consensus       231 ------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 ------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  11234567889999999999999999999997

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.2e-51  Score=420.46  Aligned_cols=262  Identities=27%  Similarity=0.407  Sum_probs=211.3

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCC--chhhHHHHHHHHhhcCC-cceEEEEeEEEeC-ceE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKG--NGEDFINEVASISRTSH-VNIVTLLGFCFEG-HRR  393 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~~~  393 (638)
                      .+.+.++||+|+||+||+|++..      ++.||||+++....  ..+.+.+|+++|.++.| ||||+++|+|.+. ..+
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~  144 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  144 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence            44567899999999999998543      25799999976543  34578999999999975 8999999999764 568


Q ss_pred             EEEEEeccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED  463 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~  463 (638)
                      ++|||||++|+|.++|+.....          .....+++..+..|+.|||+||+|||+   ++||||||||+|||++++
T Consensus       145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCC
Confidence            9999999999999999864311          113458999999999999999999999   999999999999999999


Q ss_pred             CceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccc
Q 006620          464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIY  542 (638)
Q Consensus       464 ~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  542 (638)
                      +.+||+|||+|+...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||......     
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-----  294 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----  294 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-----
Confidence            99999999999987665555555667799999999999775  78999999999999999998 89999754321     


Q ss_pred             hhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          543 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       543 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                        ......+....       ....+...+.++.+++.+||+.||++|||++||+++|+++++
T Consensus       295 --~~~~~~i~~g~-------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          295 --EEFCRRLKEGT-------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             --HHHHHHHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHcCC-------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence              11122222211       111222345678899999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.3e-50  Score=407.13  Aligned_cols=244  Identities=26%  Similarity=0.302  Sum_probs=192.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc----CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      |++.+.||+|+||+||+|+..    +++.||||+++...   .....+.+|++++++++|||||++++++.+++..|+||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            346789999999999999852    36789999997542   23346788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||++||+|.+++.+.      ..+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+..
T Consensus       106 Ey~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          106 DFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             CCCTTCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EcCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999875      469999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .....  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||.....       .. ....+... ..
T Consensus       177 ~~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~-~~~~i~~~-~~  243 (304)
T 3ubd_A          177 IDHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KE-TMTMILKA-KL  243 (304)
T ss_dssp             ----C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHC-CC
T ss_pred             cCCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HH-HHHHHHcC-CC
Confidence            43322  22456799999999999765  789999999999999999999999974321       11 11111111 11


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM-----NRVVE  597 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  597 (638)
                      .       .+..++.++.+|+.+||+.||++|||+     +|+++
T Consensus       244 ~-------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 G-------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C-------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C-------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1       112346678999999999999999984     56664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.6e-48  Score=393.78  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=186.0

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCc----------
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGH----------  391 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------  391 (638)
                      +++.+.||+|+||+||+|+. .+++.||||+++....  ..+.+.+|+++|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            34578999999999999986 4689999999875433  2357889999999999999999999987544          


Q ss_pred             --eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEc
Q 006620          392 --RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS  469 (638)
Q Consensus       392 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  469 (638)
                        .+|+||||+++|+|.+++......   ...++..++.|+.||++||+|||+   ++|+||||||+|||++.++.+||+
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence              368999999999999999875422   235667789999999999999999   999999999999999999999999


Q ss_pred             ccccceeccCCCce----------eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc
Q 006620          470 DFGLAKICEGRESI----------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS  539 (638)
Q Consensus       470 DFg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~  539 (638)
                      |||+|+........          ......+||+.|+|||++.+.  .++.++|||||||++|||++   ||.....   
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~---  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQME---  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccH---
Confidence            99999876543221          112345799999999999875  78999999999999999996   6542210   


Q ss_pred             ccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          540 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                           .  ...+....    ..............+.+|+.+||+.||++|||+.|+++
T Consensus       233 -----~--~~~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 -----R--VRTLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -----H--HHHHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----H--HHHHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 0  00011111    11112233444556788999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=392.18  Aligned_cols=259  Identities=23%  Similarity=0.274  Sum_probs=197.0

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEe------CceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFE------GHRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~  394 (638)
                      |.+.+.||+|+||+||+|++ .+|+.||||+++....   ..+.+.+|+++|++++|||||++++++..      .+..|
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            34578999999999999986 4689999999976433   23567899999999999999999998764      36789


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccc
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      |||||+. |+|.+++...      ..+++..+..++.||+.||+|||+   +||+||||||+|||++.++.+||+|||+|
T Consensus       136 ivmE~~~-g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEECCS-EEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEeCCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence            9999995 6899999764      569999999999999999999999   99999999999999999999999999999


Q ss_pred             eeccCCC--ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          475 KICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       475 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      +.+....  ........+||+.|+|||++.+. ..++.++||||+||++|||++|++||.......   .+.........
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~  281 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGT  281 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCC
Confidence            8764322  11223456899999999998764 357899999999999999999999997543210   00000000000


Q ss_pred             hhhh--------------ccccCCCCch----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 LEED--------------LGLQGIENEE----DKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 ~~~~--------------~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....              ..........    ....+.++.+||.+||+.||++|||++|+++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000              0000000000    1123567889999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.2e-46  Score=389.93  Aligned_cols=197  Identities=19%  Similarity=0.319  Sum_probs=166.5

Q ss_pred             hhhhcccCcCcceeEEEEEEc----CCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      |.+.++||+|+||+||+|+.+    .++.||||++.... ....+.+|+++|+++ +||||+++++++.+.+..++||||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~  101 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY  101 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence            445789999999999999753    36789999986543 345678999999998 599999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC-CceEEcccccceecc
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICE  478 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFg~~~~~~  478 (638)
                      +++|+|.++++         .+++..++.++.||++||+|||+   +||+||||||+|||++.+ +.+||+|||+|+...
T Consensus       102 ~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          102 LEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             CCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            99999999984         37899999999999999999999   999999999999999876 799999999998654


Q ss_pred             CCCc--------------------------eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCC
Q 006620          479 GRES--------------------------IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNAN  532 (638)
Q Consensus       479 ~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~  532 (638)
                      ....                          .......+||+.|+|||++.+. ..++.++||||+||++|||++|+.||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            3211                          0112345799999999999764 358899999999999999999999996


Q ss_pred             ccc
Q 006620          533 VAV  535 (638)
Q Consensus       533 ~~~  535 (638)
                      ...
T Consensus       249 ~~~  251 (361)
T 4f9c_A          249 KAS  251 (361)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-45  Score=400.93  Aligned_cols=245  Identities=24%  Similarity=0.321  Sum_probs=196.5

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHH---HHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINE---VASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++++.    ........+|   +.+++.++|||||++++++.+.+.+|+||
T Consensus       192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm  271 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL  271 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence            4578999999999999986 45899999999643    2222333344   56677788999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||++||+|.++|.+.      ..+++..++.++.||+.||+|||+   +|||||||||+||||+.+|.+||+|||+|+..
T Consensus       272 Ey~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          272 DLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             CCCCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            999999999999875      469999999999999999999999   99999999999999999999999999999977


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .....    ...+||+.|+|||++.+. ..++.++|||||||++|||++|++||........    .. ...... ....
T Consensus       343 ~~~~~----~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~----~~-i~~~i~-~~~~  411 (689)
T 3v5w_A          343 SKKKP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HE-IDRMTL-TMAV  411 (689)
T ss_dssp             SSCCC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH----HH-HHHHHH-HCCC
T ss_pred             CCCCC----CCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HH-HHHhhc-CCCC
Confidence            55432    346799999999999642 2688999999999999999999999975432211    01 111110 0011


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVE  597 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  597 (638)
                             ..+..++.++.+||.+||+.||++|++     ++||++
T Consensus       412 -------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 -------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                   112234677899999999999999998     677765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.2e-45  Score=401.17  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=205.3

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      |.+.+.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+...+++||||++|
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g  238 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            45678999999999999986 468999999987643 2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC--CCceEEcccccceeccCC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--DFCPKISDFGLAKICEGR  480 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFg~~~~~~~~  480 (638)
                      |+|.++|....     ..+++..+..++.||++||+|||+   ++|+||||||+|||++.  .+.+||+|||+++.+...
T Consensus       239 g~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          239 GELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999997543     569999999999999999999999   99999999999999975  489999999999987655


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ...   ...+||+.|+|||++.+.  .++.++|||||||++|||++|++||......       . ....+...    ..
T Consensus       311 ~~~---~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~-~~~~i~~~----~~  373 (573)
T 3uto_A          311 QSV---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------E-TLRNVKSC----DW  373 (573)
T ss_dssp             SEE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHHHTT----CC
T ss_pred             Cce---eeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------H-HHHHHHhC----CC
Confidence            432   345689999999999875  7899999999999999999999999754321       1 11111110    01


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .........++.++.+||.+||+.||++|||++|++++
T Consensus       374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11122333456788999999999999999999999873

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.5e-43  Score=362.70  Aligned_cols=266  Identities=27%  Similarity=0.358  Sum_probs=207.6

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCc----eEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGH----RRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~  401 (638)
                      .+.++||+|+||+||+|+.. ++.||||++...........+|+.++++++||||+++++++....    ..++||||++
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~  105 (322)
T 3soc_A           27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE  105 (322)
T ss_dssp             EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             hhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence            45789999999999999874 789999999766555556677999999999999999999998744    4799999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEecccCCCceEECCCCceEEccc
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT----------RILHFDIKPHNILLDEDFCPKISDF  471 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~----------~iiH~Dikp~NIll~~~~~~kl~DF  471 (638)
                      +|+|.++++..       .+++..++.++.|+++||+|||+   .          +|+||||||+|||++.++.+||+||
T Consensus       106 ~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          106 KGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             TCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999763       48999999999999999999999   7          9999999999999999999999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceecccc---CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh----
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF---GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP----  544 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~----  544 (638)
                      |+++...............||+.|+|||++.+..   ..++.++||||||+++|||++|+.||.............    
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            9998776554433344567899999999987521   246678999999999999999999997654322111100    


Q ss_pred             ----HHHHHHhhhhhhccccCCCC-chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          545 ----HWVYKRLELEEDLGLQGIEN-EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       545 ----~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                          ..........  ........ ......+.++.+++.+||+.||++|||+++|++.|+++.+
T Consensus       256 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          256 HPSLEDMQEVVVHK--KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             SCCHHHHHHHHTTS--CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcc--cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                0000000000  00011111 1122456779999999999999999999999999998643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.8e-43  Score=364.09  Aligned_cols=286  Identities=39%  Similarity=0.687  Sum_probs=225.1

Q ss_pred             CcccchHHHHHHHhhh--hcccCcCcceeEEEEEEcCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEE
Q 006620          312 PKRYRYADIKKMTNSF--KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFC  387 (638)
Q Consensus       312 ~~~~~~~~i~~~~~~~--~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~  387 (638)
                      ...+++.++.....+|  .+.||+|+||+||+|+..+++.||||++.....  ....+.+|++++++++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            4567777777766665  689999999999999987899999999876432  234688999999999999999999999


Q ss_pred             EeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceE
Q 006620          388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK  467 (638)
Q Consensus       388 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  467 (638)
                      ......++||||+++++|.+++....  .....+++..+..++.|+++||+|||+.+..+|+||||||+|||++.++.+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERP--ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCS--TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999998754  2235699999999999999999999992112999999999999999999999


Q ss_pred             EcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCC-CcccchhHH
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDR-SSEIYFPHW  546 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~-~~~~~~~~~  546 (638)
                      |+|||+++........ ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||+..... ........+
T Consensus       175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             eccCccccccCccccc-ccccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            9999999877544332 23445689999999999764  6889999999999999999999999643211 122222233


Q ss_pred             HHHHhhhh--hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          547 VYKRLELE--EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       547 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ........  ................+..+.+++.+||+.||++|||+++|+++|++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            22211111  111122223344567788999999999999999999999999999973

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.4e-43  Score=360.14  Aligned_cols=270  Identities=35%  Similarity=0.593  Sum_probs=217.6

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      +.+.||+|+||+||+|++.+++.||||++.... ...+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL  122 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred             ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence            367899999999999998889999999987543 3456789999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....  .....+++..++.++.|+++||+|||+   ++|+||||||+||+++.++.+||+|||+++..........
T Consensus       123 ~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  197 (321)
T 2qkw_B          123 KRHLYGSD--LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL  197 (321)
T ss_dssp             GGGSSSSC--CCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred             HHHHhccC--CCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99997643  223468999999999999999999999   9999999999999999999999999999987554332222


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh--hhccccCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE--EDLGLQGIE  563 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  563 (638)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||........ .....+........  .........
T Consensus       198 ~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
T 2qkw_B          198 STVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWAVESHNNGQLEQIVDPNLA  274 (321)
T ss_dssp             BCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC-CCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred             ccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHHH-HHHHHHhhhccccccHHHhcChhhc
Confidence            2345589999999998764  688999999999999999999999976543322 12222222211111  111122333


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      .......+..+.+++.+||+.||++|||+++|+++|+.+++
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            34456778899999999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.2e-43  Score=353.03  Aligned_cols=255  Identities=24%  Similarity=0.451  Sum_probs=212.0

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.+.||+|+||+||+|+..+++.||||+++......+++.+|++++++++||||+++++++.+....++||||+++++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC   89 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence            44678999999999999998888899999998777667889999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++......... 
T Consensus        90 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  160 (268)
T 3sxs_A           90 LLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-  160 (268)
T ss_dssp             HHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred             HHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence            999998753     458999999999999999999999   99999999999999999999999999999876554332 


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||......       . .........       .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~-~~~~~~~~~-------~  223 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------E-VVLKVSQGH-------R  223 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------H-HHHHHHTTC-------C
T ss_pred             cccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChH-------H-HHHHHHcCC-------C
Confidence            33455678889999999764  68899999999999999999 99998643321       1 111111111       1


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ...+...+.++.+++.+||+.||++|||+++++++|+.+.+.
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            111112345788999999999999999999999999997654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.8e-42  Score=352.41  Aligned_cols=279  Identities=33%  Similarity=0.549  Sum_probs=224.1

Q ss_pred             CcccchHHHHHHHhhhh--------cccCcCcceeEEEEEEcCCCEEEEEEecccC-----CchhhHHHHHHHHhhcCCc
Q 006620          312 PKRYRYADIKKMTNSFK--------NKLGQGGYGGVYKGKLLDGQNVAIKVLNETK-----GNGEDFINEVASISRTSHV  378 (638)
Q Consensus       312 ~~~~~~~~i~~~~~~~~--------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~  378 (638)
                      ...+++.++.+++.+|.        ++||+|+||+||+|.. +++.||||++....     ...+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            46788899999998884        5699999999999987 67899999986532     2346788999999999999


Q ss_pred             ceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCce
Q 006620          379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI  458 (638)
Q Consensus       379 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NI  458 (638)
                      ||+++++++.+.+..++||||+++++|.+++....   ....+++..++.++.|+++||+|||+   .+++||||||+||
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Ni  164 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANI  164 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHE
Confidence            99999999999999999999999999999997542   23569999999999999999999999   9999999999999


Q ss_pred             EECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCC
Q 006620          459 LLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS  538 (638)
Q Consensus       459 ll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~  538 (638)
                      +++.++.+||+|||++................||+.|+|||++.+   .++.++||||||+++|+|++|+.||.......
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  241 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ  241 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence            999999999999999987655443333344578999999999864   47889999999999999999999997654322


Q ss_pred             cccchhHHHHHHhhhh---hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          539 SEIYFPHWVYKRLELE---EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       539 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      .   ...+........   ... ............+..+.+++.+||+.||++|||+++|+++|+++..
T Consensus       242 ~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          242 L---LLDIKEEIEDEEKTIEDY-IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             B---TTHHHHHHHTTSCCHHHH-SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             H---HHHHHHHhhhhhhhhhhh-ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1   111111111100   111 1112233455677889999999999999999999999999998643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.2e-43  Score=359.66  Aligned_cols=262  Identities=28%  Similarity=0.481  Sum_probs=199.0

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.+.||+|+||+||+|+. +++.||||++......   .+.+.+|++++++++||||+++++++......++||||++
T Consensus        39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  117 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS  117 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred             ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence            34578999999999999987 6889999998765422   3568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCceEECCCCceEEcccccceeccC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|.+++....   ....+++..++.++.|+++||+|||+   .+  |+||||||+||+++.++.+||+|||+++....
T Consensus       118 ~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          118 RGSLYRLLHKSG---AREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             TCBHHHHHHSTT---HHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             CCcHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999998642   11248999999999999999999999   88  99999999999999999999999999986543


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       ... .....      
T Consensus       192 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~-~~~~~------  253 (309)
T 3p86_A          192 TFL--SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVV-AAVGF------  253 (309)
T ss_dssp             ------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHH-HHHHH------
T ss_pred             ccc--ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH-HHHHh------
Confidence            321  12345689999999999765  6789999999999999999999999743211       111 11100      


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPR  611 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~  611 (638)
                      .......+..++.++.+++.+||+.||++|||+++|++.|+.++++...||.
T Consensus       254 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~  305 (309)
T 3p86_A          254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN  305 (309)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred             cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence            0111112223456788999999999999999999999999999887654443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.5e-43  Score=352.97  Aligned_cols=254  Identities=27%  Similarity=0.487  Sum_probs=210.4

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.+.||+|+||+||+|+..+++.||+|++.......+.+.+|++++++++||||+++++++.+....++||||+++++
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   91 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             ceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence            34578999999999999998888899999998777667889999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++....... .
T Consensus        92 L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  162 (269)
T 4hcu_A           92 LSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  162 (269)
T ss_dssp             HHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             HHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence            999997643     568999999999999999999999   9999999999999999999999999999986643321 1


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||......       . ........       ..
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-------~-~~~~~~~~-------~~  225 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------E-VVEDISTG-------FR  225 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H-HHHHHHTT-------CC
T ss_pred             cccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-------H-HHHHHhcC-------cc
Confidence            22344568899999999764  68899999999999999999 89998643211       1 11111111       11


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ...+...+.++.+++.+||+.||++|||+++++++|+++.+
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            11112235678899999999999999999999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.4e-43  Score=366.19  Aligned_cols=260  Identities=25%  Similarity=0.452  Sum_probs=208.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc--------CCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL--------DGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRR  393 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  393 (638)
                      +.+.+.||+|+||+||+|++.        ++..||||+++....  ..+.+.+|+++++++ +||||+++++++.+.+..
T Consensus        83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  162 (370)
T 2psq_A           83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL  162 (370)
T ss_dssp             EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred             CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence            345789999999999999852        245799999976532  345789999999999 899999999999999999


Q ss_pred             EEEEEeccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED  463 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~  463 (638)
                      ++||||+++|+|.+++......          .....+++..++.++.||++||+|||+   ++|+||||||+|||++.+
T Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTT
T ss_pred             EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCC
Confidence            9999999999999999875421          112458999999999999999999999   999999999999999999


Q ss_pred             CceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccc
Q 006620          464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIY  542 (638)
Q Consensus       464 ~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  542 (638)
                      +.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......     
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-----  312 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-----  312 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence            99999999999876554333233445678899999999764  78999999999999999999 99998653211     


Q ss_pred             hhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          543 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       543 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                        .. ...+...       .....+..++.++.+++.+||+.||++|||+.|+++.|++++.
T Consensus       313 --~~-~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          313 --EL-FKLLKEG-------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             --GH-HHHHHTT-------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HH-HHHHhcC-------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              11 1111111       1111222345678999999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8e-43  Score=360.33  Aligned_cols=259  Identities=25%  Similarity=0.436  Sum_probs=206.9

Q ss_pred             HhhhhcccCcCcceeEEEEEEc----CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.+.||+|+||+||+|++.    .+..||||+++...  ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  129 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT  129 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence            3445789999999999999864    34469999997643  23457899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       130 e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          130 EYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             ECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             eCCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999997643     569999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          478 EGRES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       478 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ..... ........+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......       . ........ 
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~-~~~~~~~~-  270 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------D-VISSVEEG-  270 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------H-HHHHHHTT-
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------H-HHHHHHcC-
Confidence            54322 2222334568899999999764  78899999999999999999 99998643221       1 11111111 


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                            .....+..++.++.+++.+||+.||++|||+++|++.|++++....
T Consensus       271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                  1111222345678999999999999999999999999999876544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.5e-42  Score=350.95  Aligned_cols=246  Identities=26%  Similarity=0.358  Sum_probs=202.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.++||+|+||+||+|+. .+++.||||++.... ...+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  101 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence            34578999999999999985 568899999986543 3456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...       .+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus       102 ~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A          102 GSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999863       48999999999999999999999   9999999999999999999999999999987654432


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       ..... .....     ..
T Consensus       172 ~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~-~~~~~-----~~  234 (297)
T 3fxz_A          172 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYL-IATNG-----TP  234 (297)
T ss_dssp             C--BCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHH-HHHHC-----SC
T ss_pred             c--cCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH-HHhCC-----CC
Confidence            2  2445689999999999765  7899999999999999999999999643211       00111 00000     01


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....+..++..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11122345667899999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=351.03  Aligned_cols=258  Identities=24%  Similarity=0.405  Sum_probs=207.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.++||+|+||+||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.++...++||||++++
T Consensus        13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~   92 (310)
T 3s95_A           13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG   92 (310)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence            35789999999999999964 58899999886533 34567899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++........
T Consensus        93 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           93 TLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             BHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999998753     569999999999999999999999   99999999999999999999999999999876443221


Q ss_pred             e------------eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          484 V------------SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       484 ~------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      .            ......||+.|+|||++.+.  .++.++||||||+++|||++|..|+...............  ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~--~~~  240 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR--GFL  240 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH--HHH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh--ccc
Confidence            1            11145689999999999764  7889999999999999999999998754433222211110  000


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                      ..   .        .+..++.++.+++.+||+.||++|||++++++.|+++...+
T Consensus       241 ~~---~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          241 DR---Y--------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HH---T--------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cc---c--------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00   0        01122456889999999999999999999999999876543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-42  Score=351.59  Aligned_cols=255  Identities=24%  Similarity=0.430  Sum_probs=207.6

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.+.||+|+||+||++...+++.||||++.......+++.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  105 (283)
T 3gen_A           26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC  105 (283)
T ss_dssp             EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred             HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence            34578999999999999998888899999998777667889999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+||+++.++.+||+|||+++....... .
T Consensus       106 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  176 (283)
T 3gen_A          106 LLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  176 (283)
T ss_dssp             HHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred             HHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence            999998643     469999999999999999999999   9999999999999999999999999999986643321 1


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||......        .....+...       ..
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~-------~~  239 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQG-------LR  239 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTT-------CC
T ss_pred             cccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcc-------cC
Confidence            22344568899999999764  68899999999999999998 99998643311        111111111       11


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ...+...+..+.+++.+||+.||++|||+++++++|++++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            111122345788999999999999999999999999987643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.1e-43  Score=368.31  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=205.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.||+|+||+||+|++. +++.||||+++....  ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus       117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  196 (377)
T 3cbl_A          117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG  196 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence            45789999999999999975 688999999875432  235788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       197 g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          197 GDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999998653     458999999999999999999999   9999999999999999999999999999986543322


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ........+++.|+|||++.+.  .++.++||||||+++|||++ |+.||......        .........       
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~-------  331 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTREFVEKG-------  331 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHHHHHHTT-------
T ss_pred             eecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC-------
Confidence            1111223357889999999754  68899999999999999998 99998654321        111111111       


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      .....+...+.++.+++.+||+.||++|||+++|++.|+++.+
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            1111122345678899999999999999999999999998653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-41  Score=349.28  Aligned_cols=258  Identities=24%  Similarity=0.322  Sum_probs=206.6

Q ss_pred             cccchHHHHHHHhh------------hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCc
Q 006620          313 KRYRYADIKKMTNS------------FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK-GNGEDFINEVASISRTSHV  378 (638)
Q Consensus       313 ~~~~~~~i~~~~~~------------~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~  378 (638)
                      ..+++++++.++..            ..++||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34555555555432            3468999999999999975 68999999997544 3456788999999999999


Q ss_pred             ceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCce
Q 006620          379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI  458 (638)
Q Consensus       379 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NI  458 (638)
                      ||+++++++...+..++||||+++++|.+++..       ..+++..+..++.|+++||+|||+   .+|+||||||+||
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NI  172 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI  172 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHE
Confidence            999999999999999999999999999999875       358999999999999999999999   9999999999999


Q ss_pred             EECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCC
Q 006620          459 LLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS  538 (638)
Q Consensus       459 ll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~  538 (638)
                      +++.++.+||+|||++.........  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....  
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~--  246 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSP--  246 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--
T ss_pred             EECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence            9999999999999999876543221  2345689999999999764  788999999999999999999999864321  


Q ss_pred             cccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            ......+....   ..  ........+.++.+++.+||+.||++|||++++++
T Consensus       247 ------~~~~~~~~~~~---~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 ------VQAMKRLRDSP---PP--KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ------HHHHHHHHHSS---CC--CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------HHHHHHHhcCC---CC--CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  01111111110   00  11112234567889999999999999999999996

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-42  Score=355.68  Aligned_cols=244  Identities=23%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|+||+||+|++ .+++.||||++.....   ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus        18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~   97 (328)
T 3fe3_A           18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS   97 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence            3578999999999999996 5789999999976432   23567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           98 GGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             TCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            99999999875      458999999999999999999999   999999999999999999999999999998765443


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .   .....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.....       ... ....... ...   
T Consensus       169 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~-~~~i~~~-~~~---  232 (328)
T 3fe3_A          169 K---LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KEL-RERVLRG-KYR---  232 (328)
T ss_dssp             G---GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH-HHHHHHC-CCC---
T ss_pred             c---cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHH-HHHHHhC-CCC---
Confidence            2   2456789999999999765 2335799999999999999999999975321       111 1111111 010   


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                          .+...+.++.+|+.+||+.||++|||++|++++
T Consensus       233 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          233 ----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                111235678899999999999999999999874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5e-42  Score=353.95  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=201.3

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++....  ...+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~   89 (323)
T 3tki_A           10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   89 (323)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence            35789999999999999865 68899999986543  2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        90 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           90 GELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999764      458999999999999999999999   9999999999999999999999999999987654433


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      ........||+.|+|||++.+. ...+.++||||||+++|+|++|+.||.........  ...+     ..      ...
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~-----~~------~~~  226 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW-----KE------KKT  226 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHH-----HT------TCT
T ss_pred             ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHH-----hc------ccc
Confidence            3333456789999999999764 23477999999999999999999999754432111  1111     10      011


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .......++.++.+|+.+||+.||++|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            111123346678899999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=364.50  Aligned_cols=274  Identities=25%  Similarity=0.410  Sum_probs=214.5

Q ss_pred             HHhhhhcccCcCcceeEEEEEEc--------CCCEEEEEEecccCCc--hhhHHHHHHHHhhc-CCcceEEEEeEEEeCc
Q 006620          323 MTNSFKNKLGQGGYGGVYKGKLL--------DGQNVAIKVLNETKGN--GEDFINEVASISRT-SHVNIVTLLGFCFEGH  391 (638)
Q Consensus       323 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  391 (638)
                      ..+.+.++||+|+||+||+|+..        +++.||||+++.....  .+.+.+|+++++++ +||||+++++++...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            34456789999999999999852        2357999999765332  35788999999999 8999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC
Q 006620          392 RRALIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD  461 (638)
Q Consensus       392 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~  461 (638)
                      ..++||||+++|+|.+++......          .....+++..++.++.|+++||+|||+   .+|+||||||+|||++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence            999999999999999999875421          112469999999999999999999999   9999999999999999


Q ss_pred             CCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcc
Q 006620          462 EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSE  540 (638)
Q Consensus       462 ~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~  540 (638)
                      .++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.....    
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~----  299 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  299 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999999876554333333445678999999999764  78999999999999999999 9999864321    


Q ss_pred             cchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCcccC
Q 006620          541 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS  616 (638)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~  616 (638)
                         .. ....+....       ....+..++.++.+++.+||+.||++|||+++|+++|++++........+...+
T Consensus       300 ---~~-~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  364 (382)
T 3tt0_A          300 ---EE-LFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHH  364 (382)
T ss_dssp             ---HH-HHHHHHTTC-------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC------
T ss_pred             ---HH-HHHHHHcCC-------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence               11 111111111       111122345678999999999999999999999999999877665555444433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.2e-42  Score=375.89  Aligned_cols=257  Identities=31%  Similarity=0.500  Sum_probs=213.5

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-CCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.++||+|+||+||+|++.. ++.||||+++......+++.+|+.++++++||||+++++++......++||||+++|
T Consensus       222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g  301 (495)
T 1opk_A          222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG  301 (495)
T ss_dssp             EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence            4467899999999999999754 789999999877767788999999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....    ...+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       302 ~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          302 NLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             BHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             CHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            9999998743    2468999999999999999999999   999999999999999999999999999998765433 2


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .......+++.|+|||++.+.  .++.++||||||+++|||++ |+.||......       . +...+..       ..
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~~-------~~  436 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------Q-VYELLEK-------DY  436 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------G-HHHHHHT-------TC
T ss_pred             eecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHc-------CC
Confidence            223445578899999999764  68899999999999999999 89998754321       0 1111111       11


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                      ....+..++.++.+|+.+||+.||++|||+.+|++.|++++...
T Consensus       437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            11122234567889999999999999999999999999987553

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-42  Score=352.15  Aligned_cols=247  Identities=20%  Similarity=0.260  Sum_probs=203.4

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      .+.+.||+|+||+||+|+.. +++.||+|++.........+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus         8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~   87 (321)
T 1tki_A            8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence            45789999999999999864 57899999998665556678899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC--CCceEEcccccceeccCCCc
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--DFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.  ++.+||+|||+++.......
T Consensus        88 L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           88 IFERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             HHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            999997642     469999999999999999999999   99999999999999986  78999999999998765443


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .   ....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       ... ..+....    ...
T Consensus       160 ~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~-~~i~~~~----~~~  222 (321)
T 1tki_A          160 F---RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QII-ENIMNAE----YTF  222 (321)
T ss_dssp             E---EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHH-HHHHHTC----CCC
T ss_pred             c---ccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------HHH-HHHHcCC----CCC
Confidence            2   334589999999999764  6789999999999999999999999753211       111 1111000    001


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .......++.++.+++.+||+.||++|||+.|+++
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11122245678899999999999999999999997

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.4e-41  Score=355.10  Aligned_cols=247  Identities=23%  Similarity=0.323  Sum_probs=201.6

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC-------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG-------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      |.+.+.||+|+||+||+|+.. +++.||+|+++....       ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            345789999999999999864 588999999975432       236788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC----ceEEcccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDFG  472 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFg  472 (638)
                      |||+++|+|.+++...      ..+++..+..++.||++||+|||+   .||+||||||+|||++.++    .+||+|||
T Consensus        94 ~e~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           94 LELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EECCCSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999764      468999999999999999999999   9999999999999998776    79999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      +++.......   .....||+.|+|||++.+.  .++.++|||||||++|+|++|.+||......       . ....+.
T Consensus       165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~-~~~~i~  231 (361)
T 2yab_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLANIT  231 (361)
T ss_dssp             SCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHHH
T ss_pred             CceEcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHH
Confidence            9987765432   2345689999999999764  6889999999999999999999999653211       1 111111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..    ...........++.++.+||.+||+.||++|||++|+++
T Consensus       232 ~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          232 AV----SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TT----CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hc----CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00    000111122344677899999999999999999999985

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=366.74  Aligned_cols=264  Identities=26%  Similarity=0.388  Sum_probs=207.8

Q ss_pred             hhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.++||+|+||+||+|++.      +++.||||+++...  .....+.+|+.++++++||||+++++++......++|
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  152 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL  152 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence            345789999999999999843      35689999997543  2334688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC---ceEEcccc
Q 006620          397 YEFVSNGSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFG  472 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFg  472 (638)
                      |||+++|+|.+++...+.. .....+++..++.++.|+++||+|||+   ++|+||||||+|||++.++   .+||+|||
T Consensus       153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            9999999999999876422 223569999999999999999999999   9999999999999998554   59999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      +++...............||+.|+|||++.+.  .++.++|||||||++|||++ |+.||......        .....+
T Consensus       230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~~~~~i  299 (367)
T 3l9p_A          230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVLEFV  299 (367)
T ss_dssp             HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHH
T ss_pred             cccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH
Confidence            99865332222222345578999999999764  78999999999999999998 99998653211        111111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      ...       ........++..+.+|+.+||+.||++|||+.+|+++|+........
T Consensus       300 ~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          300 TSG-------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             HTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             HcC-------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence            111       11111223456788999999999999999999999999987665443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.1e-41  Score=344.67  Aligned_cols=256  Identities=27%  Similarity=0.347  Sum_probs=198.6

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||+|+||+||+|+..+++.||+|++.....   ..+.+.+|++++++++||||+++++++.++...++||||+++
T Consensus        24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  103 (311)
T 3niz_A           24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK  103 (311)
T ss_dssp             EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE
T ss_pred             HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC
Confidence            35789999999999999988899999999875432   235788999999999999999999999999999999999975


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                       +|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       104 -~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          104 -DLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             -EHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             -CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence             8988887653     569999999999999999999999   9999999999999999999999999999987653322


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh-------
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE-------  555 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  555 (638)
                        ......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||........   ..... .......       
T Consensus       175 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~-~~~~~~~~~~~~~~  247 (311)
T 3niz_A          175 --SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIF-SILGTPNPREWPQV  247 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHH-HHHCCCCTTTSGGG
T ss_pred             --cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHH-HHHCCCChHHhhhh
Confidence              22345689999999998653 3678999999999999999999999975443211   11111 1000000       


Q ss_pred             -------hccccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 -------DLGLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 -------~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                             ..........    ....++.++.+|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                   0000000000    11123567889999999999999999999996

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-41  Score=345.07  Aligned_cols=268  Identities=21%  Similarity=0.287  Sum_probs=209.8

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc--eEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGH--RRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~  400 (638)
                      .+.++||+|+||+||+|+.. +++.||||++....  ...+.+.+|++++++++||||+++++++....  ..++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (319)
T 4euu_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (319)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence            35789999999999999965 48899999997543  33567889999999999999999999998755  789999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE----CCCCceEEccccccee
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKI  476 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFg~~~~  476 (638)
                      ++++|.+++....   ....+++..++.++.|+++||+|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        92 ~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           92 PCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             TTCBHHHHHHSGG---GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             CCCCHHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999998753   12349999999999999999999999   999999999999999    7888899999999987


Q ss_pred             ccCCCceeeecccccccceecCceeccc------cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRN------FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      .......   ....||+.|+|||++...      ...++.++||||||+++|||++|+.||.........   .......
T Consensus       166 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~  239 (319)
T 4euu_A          166 LEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKI  239 (319)
T ss_dssp             CCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC---HHHHHHH
T ss_pred             cCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh---HHHHHHH
Confidence            7654432   345689999999998521      236889999999999999999999999754332211   1111111


Q ss_pred             hhhhhh-------------cc---ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          551 LELEED-------------LG---LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       551 ~~~~~~-------------~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ......             ..   ...............+.+++.+||+.||++|||++|++++.++..-.
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            111000             00   00111233467788899999999999999999999999999875443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.9e-41  Score=348.64  Aligned_cols=262  Identities=19%  Similarity=0.227  Sum_probs=207.1

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++..+...++||||+ ++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (330)
T 2izr_A           12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP   89 (330)
T ss_dssp             EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence            3578999999999999985 568899999987543 345688999999999 8999999999999999999999999 99


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc-----eEEcccccceecc
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-----PKISDFGLAKICE  478 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DFg~~~~~~  478 (638)
                      +|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.     +||+|||+++...
T Consensus        90 ~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           90 SLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             CHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            9999998743     579999999999999999999999   99999999999999998887     9999999998765


Q ss_pred             CCCcee-----eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          479 GRESIV-----SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       479 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      ......     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.........    .. ...+..
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~----~~-~~~i~~  234 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK----ER-YQKIGD  234 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH----HH-HHHHHH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccHH----HH-HHHHHh
Confidence            433211     12345789999999999764  6899999999999999999999999765322111    11 111111


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      ......   ........+ ++.+++.+||+.||++||++++|++.|+++.+....
T Consensus       235 ~~~~~~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          235 TKRATP---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HHHHSC---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hhccCC---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            000000   000011123 789999999999999999999999999987665543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.3e-42  Score=372.12  Aligned_cols=256  Identities=25%  Similarity=0.432  Sum_probs=209.9

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.++||+|+||+||+|.+.+++.||||+++......+.+.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus       190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~  268 (454)
T 1qcf_A          190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS  268 (454)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred             eEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence            3457899999999999999988889999999877667788999999999999999999999886 667899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus       269 L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~  340 (454)
T 1qcf_A          269 LLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  340 (454)
T ss_dssp             HHHHHHSHH----HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-H
T ss_pred             HHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-e
Confidence            999998542    1358899999999999999999999   9999999999999999999999999999987643321 1


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......+|+.|+|||++...  .++.++||||||+++|||++ |+.||.....       .. +...+...       ..
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~-~~~~i~~~-------~~  403 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PE-VIRALERG-------YR  403 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HH-HHHHHHHT-------CC
T ss_pred             ccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHcC-------CC
Confidence            12334568899999999754  78999999999999999999 9999874321       11 11111111       11


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                      ...+..++.++.+++.+||+.||++|||+++|++.|+++....
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            1112234667899999999999999999999999999987654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-41  Score=346.73  Aligned_cols=259  Identities=25%  Similarity=0.359  Sum_probs=203.0

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+. .+++.||+|++.....    ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   93 (294)
T 4eqm_A           14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI   93 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence            4578999999999999985 4588999999865332    2356789999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 ~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           94 EGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             CSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            999999999875      468999999999999999999999   99999999999999999999999999999866433


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ... ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       ..........    ..
T Consensus       165 ~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~----~~  230 (294)
T 4eqm_A          165 SLT-QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDS----VP  230 (294)
T ss_dssp             -----------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSC----CC
T ss_pred             ccc-ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcc----CC
Confidence            221 12335689999999999765  6788999999999999999999999753311       1111111000    00


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhcccCCCC
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRP-SMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~  607 (638)
                      .........++..+.+++.+||+.||++|| +++++.+.|++.+.+-.
T Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            000011123456789999999999999998 99999999999776543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.9e-42  Score=369.78  Aligned_cols=258  Identities=29%  Similarity=0.445  Sum_probs=205.8

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.++||+|+||+||+|.+.+++.||||+++......+++.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus       186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs  264 (452)
T 1fmk_A          186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS  264 (452)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred             ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence            34578999999999999998888889999998766667789999999999999999999999876 67899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..+..++.|+++||+|||+   ++|+||||||+|||+++++.+||+|||+++....... .
T Consensus       265 L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~  336 (452)
T 1fmk_A          265 LLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  336 (452)
T ss_dssp             HHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence            999997532    2458999999999999999999999   9999999999999999999999999999987654322 1


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......        .+...+...       ..
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~-------~~  399 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERG-------YR  399 (452)
T ss_dssp             ------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTT-------CC
T ss_pred             cccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC-------CC
Confidence            22344578899999998764  78999999999999999999 89998643211        111111111       11


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      ...+..++..+.+++.+||+.||++|||+++|++.|++++.....
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            112224466789999999999999999999999999998776543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.2e-41  Score=342.79  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=199.0

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhh--cCCcceEEEEeEEEe----CceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISR--TSHVNIVTLLGFCFE----GHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~lv~e~  399 (638)
                      .+.+.||+|+||+||+|+. +++.||||++...  ....+.+|.+++..  ++||||+++++++..    ....++||||
T Consensus        11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~   87 (301)
T 3q4u_A           11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY   87 (301)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred             EEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence            4578999999999999988 6889999998654  33455667777666  789999999998765    3458899999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecccCCCceEECCCCceEEccc
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH--------RGCNTRILHFDIKPHNILLDEDFCPKISDF  471 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiH~Dikp~NIll~~~~~~kl~DF  471 (638)
                      +++|+|.++++.       ..+++..++.++.|+++||+|||        +   .+|+||||||+|||++.++.+||+||
T Consensus        88 ~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           88 HEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             CTTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ccCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeC
Confidence            999999999964       35899999999999999999999        7   89999999999999999999999999


Q ss_pred             ccceeccCCCceee--ecccccccceecCceeccccC----CccccCCeeeHHHHHHHHhcC----------CCCCCccc
Q 006620          472 GLAKICEGRESIVS--MTGARGTIGYIAPEVFCRNFG----EVSYKSDVYSYGMMVFEMTGE----------KNNANVAV  535 (638)
Q Consensus       472 g~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~----~~s~~~DvwslGvil~elltg----------~~p~~~~~  535 (638)
                      |+++..........  .....||+.|+|||++.+...    .++.++||||||+++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            99987655443221  233468999999999875421    345799999999999999999          67765433


Q ss_pred             CCCcccchhHHHHHHhhhhhhccccCCC-CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          536 DRSSEIYFPHWVYKRLELEEDLGLQGIE-NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      .....  ..... ......  ....... .......+.++.+++.+||+.||++|||+++|++.|+++
T Consensus       238 ~~~~~--~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPS--FEDMR-KVVCVD--QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCC--HHHHH-HHHTTS--CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcc--hhhhh-HHHhcc--CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            22211  11111 111000  0011111 112345678899999999999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.7e-42  Score=355.82  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=199.0

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCC----EEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQ----NVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      +.+.++||+|+||+||+|++. +++    .||+|.+....  ...+.+.+|+.++++++||||+++++++..+. .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~   95 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence            445789999999999999853 344    35888775432  34567899999999999999999999998754 78999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++|+|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        96 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           96 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             ECCTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999998753     569999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      .............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.......    .    ...+...  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~----~~~~~~~--  235 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----I----SSILEKG--  235 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----H----HHHHHTT--
T ss_pred             cCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----H----HHHHHcC--
Confidence            655444334455678899999999764  78999999999999999999 999987543211    1    1111111  


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                           .....+...+.++.+++.+||+.||++|||+++++++|+.+..+
T Consensus       236 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          236 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -----CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             -----CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                 11111223456788999999999999999999999999887653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.5e-42  Score=354.53  Aligned_cols=264  Identities=23%  Similarity=0.392  Sum_probs=193.9

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-CC---EEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceE----
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-GQ---NVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR----  393 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  393 (638)
                      +.+.+.||+|+||+||+|++.. ++   .||||+++...   ...+.+.+|++++++++||||+++++++......    
T Consensus        25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (323)
T 3qup_A           25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP  104 (323)
T ss_dssp             CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred             eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence            4457899999999999998544 32   79999997542   3346789999999999999999999999877655    


Q ss_pred             --EEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccc
Q 006620          394 --ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF  471 (638)
Q Consensus       394 --~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF  471 (638)
                        ++||||+++++|.+++...........+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus       105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeec
Confidence              8999999999999999765422233469999999999999999999999   99999999999999999999999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHH
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      |+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......       . ...
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~-~~~  251 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------I-YNY  251 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------H-HHH
T ss_pred             cccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHH-------H-HHH
Confidence            999876544433333445578899999999764  68899999999999999999 899987543210       0 111


Q ss_pred             hhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      ....       ........++.++.+++.+||+.||++|||+.++++.|++++.....
T Consensus       252 ~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~  302 (323)
T 3qup_A          252 LIGG-------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV  302 (323)
T ss_dssp             HHTT-------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             HhcC-------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence            1111       11111223456789999999999999999999999999998775443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.6e-42  Score=352.65  Aligned_cols=262  Identities=25%  Similarity=0.399  Sum_probs=205.0

Q ss_pred             hhhhcccCcCcceeEEEEEE-----cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-----LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  395 (638)
                      +.+.++||+|+||+||+|++     .+++.||||++....  ...+.+.+|++++++++||||+++++++...  ...++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  102 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL  102 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence            44578999999999999983     357899999997543  3346789999999999999999999999876  66899


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++.
T Consensus       103 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          103 IMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence            999999999999997653     569999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCC-------CcccchhHHH
Q 006620          476 ICEGRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDR-------SSEIYFPHWV  547 (638)
Q Consensus       476 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~-------~~~~~~~~~~  547 (638)
                      ........ .......||..|+|||++.+.  .++.++||||||+++|+|++|+.|+......       ..........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            87654432 223345688899999999764  6788999999999999999999886432110       0000000000


Q ss_pred             HHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      .....       .......+..++.++.+++.+||+.||++|||++++++.|++++
T Consensus       253 ~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNTLK-------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHH-------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHh-------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            01111       11111122344678899999999999999999999999999865

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.2e-41  Score=342.28  Aligned_cols=271  Identities=17%  Similarity=0.222  Sum_probs=213.6

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++......++||||+ ++
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   90 (298)
T 1csn_A           13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP   90 (298)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence            4578999999999999985 568899999986543 345688999999999 6999999999999999999999999 99


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc-----eEEcccccceecc
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-----PKISDFGLAKICE  478 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DFg~~~~~~  478 (638)
                      +|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+||+++.++.     +||+|||+++...
T Consensus        91 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           91 SLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            9999998753     469999999999999999999999   99999999999999987766     9999999998775


Q ss_pred             CCCce-----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          479 GRESI-----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       479 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      .....     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||....................  
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  238 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--  238 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH--
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc--
Confidence            44321     112345689999999998764  689999999999999999999999976443221111111110000  


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCcccC
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS  616 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~  616 (638)
                        ....    ......++.++.+++.+||+.||++|||+++|++.|+++++++.....-.+.+
T Consensus       239 --~~~~----~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          239 --STPL----RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             --HSCH----HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             --CccH----HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence              0000    00111345688999999999999999999999999999988766554444433

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.1e-41  Score=350.60  Aligned_cols=244  Identities=23%  Similarity=0.320  Sum_probs=201.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||||+++..    ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~   87 (337)
T 1o6l_A            8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            45789999999999999864 5889999999753    344567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           88 NGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             TTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999875      468999999999999999999999   99999999999999999999999999999864332


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....        ......+.. ....  
T Consensus       159 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~-~~~~--  223 (337)
T 1o6l_A          159 GA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILM-EEIR--  223 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCCC--
T ss_pred             CC--cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CCCC--
Confidence            21  12345689999999999764  689999999999999999999999964321        111111111 1111  


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                           .+..++.++.+++.+||+.||++||     ++++++++
T Consensus       224 -----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 -----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                 1123456789999999999999999     89999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=346.31  Aligned_cols=282  Identities=25%  Similarity=0.314  Sum_probs=205.8

Q ss_pred             cCCCCCcccchHHHHHHHhhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhc--CCcceEEEE
Q 006620          307 YGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRT--SHVNIVTLL  384 (638)
Q Consensus       307 ~~~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~  384 (638)
                      ............+.....+.+.++||+|+||+||+|+.. ++.||||++....  ...+..|.+++..+  +||||++++
T Consensus        21 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~   97 (337)
T 3mdy_A           21 SGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFI   97 (337)
T ss_dssp             HCSCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             CCCCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEE
Confidence            333333444444444556667899999999999999874 8999999986543  23445566665554  899999999


Q ss_pred             eEEEeC----ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEecc
Q 006620          385 GFCFEG----HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT--------RILHFD  452 (638)
Q Consensus       385 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~--------~iiH~D  452 (638)
                      +++...    ...++||||+++|+|.++++..       .+++..++.++.|++.||+|||+   .        +|+|||
T Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~D  167 (337)
T 3mdy_A           98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRD  167 (337)
T ss_dssp             EEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSC
T ss_pred             EEEccCCCCCCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecc
Confidence            999887    7899999999999999999763       58999999999999999999998   6        999999


Q ss_pred             cCCCceEECCCCceEEcccccceeccCCCcee--eecccccccceecCceeccccCCccc------cCCeeeHHHHHHHH
Q 006620          453 IKPHNILLDEDFCPKISDFGLAKICEGRESIV--SMTGARGTIGYIAPEVFCRNFGEVSY------KSDVYSYGMMVFEM  524 (638)
Q Consensus       453 ikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~------~~DvwslGvil~el  524 (638)
                      |||+|||++.++.+||+|||+++.........  ......||+.|+|||++.+.  ..+.      ++||||||+++|||
T Consensus       168 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el  245 (337)
T 3mdy_A          168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEV  245 (337)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred             cchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHH
Confidence            99999999999999999999998765433221  11245689999999999764  2333      48999999999999


Q ss_pred             hcCC----------CCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006620          525 TGEK----------NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNR  594 (638)
Q Consensus       525 ltg~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  594 (638)
                      ++|.          .||.........  .... ..... ................++.++.+++.+||+.||++|||+++
T Consensus       246 ~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          246 ARRCVSGGIVEEYQLPYHDLVPSDPS--YEDM-REIVC-IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCC--HHHH-HHHHT-TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HhccCcccccccccccHhhhcCCCCc--hhhh-HHHHh-hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence            9994          444332221111  1111 11110 00000000011123367888999999999999999999999


Q ss_pred             HHHHHhcccCCCC
Q 006620          595 VVEMLEGSLDSLQ  607 (638)
Q Consensus       595 vl~~L~~~~~~~~  607 (638)
                      |+++|+++.++..
T Consensus       322 ll~~L~~l~~~~~  334 (337)
T 3mdy_A          322 VKKTLAKMSESQD  334 (337)
T ss_dssp             HHHHHHHHHHTTT
T ss_pred             HHHHHHHHHhhcc
Confidence            9999999876643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.6e-42  Score=357.00  Aligned_cols=275  Identities=23%  Similarity=0.341  Sum_probs=206.9

Q ss_pred             hhhhcccCcCcceeEEEEEE-----cCCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEE--eCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-----LDGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCF--EGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv  396 (638)
                      +.+.+.||+|+||+||+|++     .+++.||||++..... ..+.+.+|++++++++||||+++++++.  .....++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv  104 (327)
T 3lxl_A           25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV  104 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred             hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence            34578999999999999984     3578999999976532 3456889999999999999999999987  45668999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          105 MEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence            99999999999998753     458999999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCcee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc-------ccchhHHHH
Q 006620          477 CEGRESIV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS-------EIYFPHWVY  548 (638)
Q Consensus       477 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~  548 (638)
                      ........ ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||........       .........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            75443322 22345688899999999764  678999999999999999999999864332100       000000000


Q ss_pred             HHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCcccC
Q 006620          549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS  616 (638)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~  616 (638)
                      ...       ...........++.++.+++.+||+.||++|||+++|+++|+.+.........+...+
T Consensus       255 ~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  315 (327)
T 3lxl_A          255 ELL-------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTA  315 (327)
T ss_dssp             HHH-------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------------
T ss_pred             HHh-------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccccccc
Confidence            101       1111122233456778999999999999999999999999999887766544444433

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-41  Score=350.12  Aligned_cols=260  Identities=26%  Similarity=0.428  Sum_probs=209.9

Q ss_pred             hhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.||+|+||.||+|...      +++.||||++.....  ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  105 (314)
T 2ivs_A           26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV  105 (314)
T ss_dssp             EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence            45789999999999999852      347899999975432  3367889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceE
Q 006620          398 EFVSNGSLEKFIHEKHPLE------------------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL  459 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIl  459 (638)
                      ||+++++|.+++.......                  ....+++..++.++.|+++||+|||+   ++|+||||||+||+
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIl  182 (314)
T 2ivs_A          106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNIL  182 (314)
T ss_dssp             ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred             eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEE
Confidence            9999999999998754211                  12348999999999999999999999   99999999999999


Q ss_pred             ECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCC
Q 006620          460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRS  538 (638)
Q Consensus       460 l~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~  538 (638)
                      +++++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.......
T Consensus       183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  260 (314)
T 2ivs_A          183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER  260 (314)
T ss_dssp             EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999877655544444455678999999999764  68899999999999999999 999986543210


Q ss_pred             cccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                              .........       ....+..++.++.+++.+||+.||++|||+.+++++|++++..
T Consensus       261 --------~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          261 --------LFNLLKTGH-------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             --------HHHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------HHHHhhcCC-------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence                    111111111       1111223456789999999999999999999999999987653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=347.25  Aligned_cols=248  Identities=24%  Similarity=0.320  Sum_probs=201.7

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC-------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG-------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  395 (638)
                      .+.+.+.||+|+||+||+|+.. +++.||+|++.....       ..+.+.+|+.++++++||||+++++++.+....++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3456789999999999999864 588999999875432       24678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC----ceEEccc
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDF  471 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DF  471 (638)
                      ||||+++++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++    .+||+||
T Consensus        92 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEECCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEcCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999764      468999999999999999999999   9999999999999998877    8999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      |+++.......   .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       ... ..+
T Consensus       163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~-~~~  229 (326)
T 2y0a_A          163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETL-ANV  229 (326)
T ss_dssp             TTCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHH-HHH
T ss_pred             CCCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------HHH-HHH
Confidence            99987754332   2345689999999998654  6889999999999999999999999643211       111 111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...    ............+..+.+|+.+||+.||++|||++++++
T Consensus       230 ~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          230 SAV----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHT----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             Hhc----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            100    001111112234567889999999999999999999997

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.4e-42  Score=361.36  Aligned_cols=256  Identities=25%  Similarity=0.447  Sum_probs=194.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc----CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.+.||+|+||+||+|+..    ++..||||+++....  ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE  126 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence            445789999999999999864    467899999975432  34578999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       127 ~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          127 YMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             CCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999998653     568999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          479 GRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       479 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ..... .......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ......+...  
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~~~--  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVDEG--  266 (373)
T ss_dssp             ---------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHHTT--
T ss_pred             cCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC--
Confidence            43221 112223457789999999764  78899999999999999997 9999864321        1111111111  


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ..     ......++.++.+++.+||+.||++||++++|++.|++++.+
T Consensus       267 ~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          267 YR-----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             EE-----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC-----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            11     111123456789999999999999999999999999987654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.8e-42  Score=343.01  Aligned_cols=253  Identities=27%  Similarity=0.485  Sum_probs=209.0

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.+.||+|+||.||+|+..+++.||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (267)
T 3t9t_A           11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL   90 (267)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence            45789999999999999988888999999987766667899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....     ..+++..++.++.|+++||+|||+   ++++||||||+||+++.++.+||+|||++........ ..
T Consensus        91 ~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  161 (267)
T 3t9t_A           91 SDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  161 (267)
T ss_dssp             HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred             HHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-cc
Confidence            99998753     568999999999999999999999   9999999999999999999999999999986543221 11


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      .....+++.|+|||++.+.  .++.++||||||+++|+|++ |+.||.....       .. ....+...       ...
T Consensus       162 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~-~~~~i~~~-------~~~  224 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SE-VVEDISTG-------FRL  224 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHHHTT-------CCC
T ss_pred             cccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCH-------HH-HHHHHhcC-------CcC
Confidence            2334568899999999764  67899999999999999999 8988864321       11 11111111       011


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ..+...+.++.+++.+||+.||++|||+++++++|+++.+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1112235678899999999999999999999999998754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=352.98  Aligned_cols=264  Identities=27%  Similarity=0.411  Sum_probs=206.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccC--CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETK--GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      +.+.+.||+|+||+||+|+..      +++.||||++....  ...+.+.+|+.+++++ +||||+++++++...+..++
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  126 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  126 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence            445789999999999999852      35579999997542  3456789999999999 89999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCce
Q 006620          396 IYEFVSNGSLEKFIHEKHPL-----------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI  458 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NI  458 (638)
                      ||||+++|+|.+++......                 .....+++..++.++.||++||+|||+   .+|+||||||+||
T Consensus       127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NI  203 (344)
T 1rjb_A          127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV  203 (344)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGE
T ss_pred             EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhE
Confidence            99999999999999875321                 011348999999999999999999999   9999999999999


Q ss_pred             EECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCC
Q 006620          459 LLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDR  537 (638)
Q Consensus       459 ll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~  537 (638)
                      |++.++.+||+|||++................||+.|+|||++.+.  .++.++||||||+++|||++ |+.||......
T Consensus       204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            9999999999999999876554443344555678999999998764  78899999999999999998 99998754321


Q ss_pred             CcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          538 SSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                             ..........       .....+...+.++.+++.+||+.||++|||+.+|+++|+.++....
T Consensus       282 -------~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          282 -------ANFYKLIQNG-------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             -------HHHHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             -------HHHHHHHhcC-------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence                   1111111111       1111122345678999999999999999999999999999877644

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.7e-41  Score=353.32  Aligned_cols=246  Identities=21%  Similarity=0.311  Sum_probs=195.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.++||+|+||+||+|+.. +++.||||+++...    ...+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus        55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~  134 (396)
T 4dc2_A           55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY  134 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence            45789999999999999965 47899999997542    2334678899999887 799999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       135 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          135 VNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999875      468999999999999999999999   9999999999999999999999999999986332


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc-cchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE-IYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  558 (638)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......... ..........+.. ..+.
T Consensus       206 ~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~  280 (396)
T 4dc2_A          206 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIR  280 (396)
T ss_dssp             TTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCCC
T ss_pred             CCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cccC
Confidence            221  12456789999999999775  7899999999999999999999999643321111 0111111111111 1111


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM  592 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  592 (638)
                             .+..++.++.+|+.+||+.||++||++
T Consensus       281 -------~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 -------IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                   112345678899999999999999996

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.1e-42  Score=348.80  Aligned_cols=269  Identities=25%  Similarity=0.420  Sum_probs=202.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-----cCCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-----LDGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  396 (638)
                      +.+.++||+|+||+||+|++     .+++.||||++..... ..+.+.+|++++++++||||+++++++...  ...++|
T Consensus        12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   91 (295)
T 3ugc_A           12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI   91 (295)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred             hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence            34678999999999999984     2578999999875432 346788999999999999999999998653  458999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           92 MEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EECCTTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEeCCCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            99999999999998753     458999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCC-----cccchhHHHHHH
Q 006620          477 CEGRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS-----SEIYFPHWVYKR  550 (638)
Q Consensus       477 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~  550 (638)
                      ....... .......++..|+|||++.+.  .++.++||||||+++|||++|..|+.......     ............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            6543321 122334578889999999765  78999999999999999999998876432110     000000000000


Q ss_pred             hhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      ...   + ........+..++.++.+++.+||+.||++|||++||++.|+++.+++.
T Consensus       242 ~~~---~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          242 IEL---L-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHH---H-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHH---H-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            000   0 1111112233456789999999999999999999999999999877653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.6e-41  Score=351.69  Aligned_cols=252  Identities=20%  Similarity=0.263  Sum_probs=201.4

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC------CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK------GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      .|.+.+.||+|+||+||+|+. .+++.||||++....      ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            455678999999999999986 468999999986421      2356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc---eEEccccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDFGL  473 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFg~  473 (638)
                      |||+++++|.+++....  .....+++..++.++.||++||+|||+   ++|+||||||+|||++.++.   +||+|||+
T Consensus       105 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRA--DAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EECCSSCBHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EeCCCCCCHHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999998886542  112458999999999999999999999   99999999999999976554   99999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      +........  ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        . ....+..
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~-~~~~i~~  246 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKE--------R-LFEGIIK  246 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------H-HHHHHHH
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------H-HHHHHHc
Confidence            987754432  12345689999999999764  688999999999999999999999975321        0 1111111


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .. .   .........++.++.+|+.+||+.||++|||+.++++
T Consensus       247 ~~-~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          247 GK-Y---KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TC-C---CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CC-C---CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00 0   0111111234678899999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.5e-41  Score=341.75  Aligned_cols=250  Identities=27%  Similarity=0.459  Sum_probs=199.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc--------hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN--------GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      .+.+.||+|+||+||+|++ .+++.||||++......        .+.+.+|++++++++||||+++++++.+..  ++|
T Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv   99 (287)
T 4f0f_A           22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV   99 (287)
T ss_dssp             EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred             eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence            4578999999999999986 46889999998643321        157889999999999999999999987655  699


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCceEECCCCc-----eEEc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLDEDFC-----PKIS  469 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--iiH~Dikp~NIll~~~~~-----~kl~  469 (638)
                      |||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+  |+||||||+||+++.++.     +||+
T Consensus       100 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A          100 MEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             EECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             EEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            99999999999987643     569999999999999999999999   88  999999999999987776     9999


Q ss_pred             ccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH
Q 006620          470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       470 DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      |||+++.....     .....||+.|+|||++.+....++.++||||||+++|||++|+.||........     .....
T Consensus       172 Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~  241 (287)
T 4f0f_A          172 DFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-----KFINM  241 (287)
T ss_dssp             CCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-----HHHHH
T ss_pred             CCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-----HHHHH
Confidence            99999854332     234568999999999854434678899999999999999999999975432210     00000


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      . .      ........+..++.++.+++.+||+.||++|||++++++.|+++
T Consensus       242 ~-~------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          242 I-R------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             H-H------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             H-h------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            0 0      01111122233456789999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1e-41  Score=345.84  Aligned_cols=257  Identities=32%  Similarity=0.508  Sum_probs=212.5

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC-CCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.+.||+|+||+||+|.+.+ ++.||+|++.......+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   93 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   93 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence            34567899999999999999654 78899999987776778899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....    ...+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus        94 ~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           94 GNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             EEHHHHHHHCC----TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             CcHHHHHHhcc----cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999998743    2568999999999999999999999   9999999999999999999999999999987654432


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                       .......+|+.|+|||++.+.  .++.++||||||+++|+|++ |..||......       . ........       
T Consensus       167 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-------~-~~~~~~~~-------  228 (288)
T 3kfa_A          167 -TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------Q-VYELLEKD-------  228 (288)
T ss_dssp             -EEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------G-HHHHHHTT-------
T ss_pred             -ccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHhcc-------
Confidence             233455678899999999764  68899999999999999999 89888654321       0 11111111       


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      .....+..++.++.+++.+||+.||++|||++++++.|++++.+
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            11111223456789999999999999999999999999987553

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=354.04  Aligned_cols=263  Identities=24%  Similarity=0.395  Sum_probs=207.2

Q ss_pred             hhhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|+||.||+|+..+      ++.||||+++....  ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  128 (343)
T 1luf_A           49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL  128 (343)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence            3457899999999999998643      47899999976432  245788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCce
Q 006620          397 YEFVSNGSLEKFIHEKHPLE------------------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI  458 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NI  458 (638)
                      |||+++++|.+++.......                  ....+++..++.++.||++||+|||+   ++|+||||||+||
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NI  205 (343)
T 1luf_A          129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC  205 (343)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceE
Confidence            99999999999998743110                  12569999999999999999999999   9999999999999


Q ss_pred             EECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCC
Q 006620          459 LLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDR  537 (638)
Q Consensus       459 ll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~  537 (638)
                      +++.++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..... 
T Consensus       206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~-  282 (343)
T 1luf_A          206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-  282 (343)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred             EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence            9999999999999999866443322223445679999999998764  68899999999999999999 9999864321 


Q ss_pred             CcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          538 SSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                            .. ....+....       ....+..++.++.+++.+||+.||++|||+.+++++|+++.+...
T Consensus       283 ------~~-~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          283 ------EE-VIYYVRDGN-------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             ------HH-HHHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             ------HH-HHHHHhCCC-------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence                  11 111111111       111122345678999999999999999999999999999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=359.74  Aligned_cols=249  Identities=22%  Similarity=0.303  Sum_probs=200.9

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .|.+.+.||+|+||+||+|.. .+++.||+|++.....   ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   91 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL   91 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence            345678999999999999985 4688999999876542   335688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC---CCCceEEccccccee
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKI  476 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFg~~~~  476 (638)
                      +++|+|.+++...      ..+++..+..++.||++||+|||+   ++|+||||||+|||++   .++.+||+|||++..
T Consensus        92 ~~gg~L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           92 VTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CBCCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999875      468999999999999999999999   9999999999999998   568899999999987


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ......  ......||+.|+|||++.+.  .++.++||||+||++|+|++|++||.....        ......+.... 
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~-  229 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAGA-  229 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC-
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhCC-
Confidence            654432  22446789999999999764  689999999999999999999999964321        11111111110 


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .   .........++.++.+|+.+||+.||++|||+.|+++
T Consensus       230 ~---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          230 Y---DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             C---CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C---CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0   1111112234667899999999999999999999997

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8e-42  Score=358.05  Aligned_cols=261  Identities=27%  Similarity=0.405  Sum_probs=205.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCce-EE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHR-RA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~  394 (638)
                      +.+.+.||+|+||.||+|++.      +++.||||+++....  ..+.+.+|+++++++ +||||+++++++.+.+. .+
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~  103 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  103 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence            445789999999999999742      357899999976433  235689999999999 79999999999987554 89


Q ss_pred             EEEEeccCCCHHHHhhhcCCCC----------------------------------------------------------
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLE----------------------------------------------------------  416 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------------------  416 (638)
                      +||||+++|+|.+++.......                                                          
T Consensus       104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3vhe_A          104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE  183 (359)
T ss_dssp             EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence            9999999999999998753200                                                          


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeecccccccc
Q 006620          417 --TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG  494 (638)
Q Consensus       417 --~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~  494 (638)
                        ....+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++...............||+.
T Consensus       184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          184 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             chhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence              01228999999999999999999999   9999999999999999999999999999987655444444455678999


Q ss_pred             eecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHH
Q 006620          495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARK  573 (638)
Q Consensus       495 y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  573 (638)
                      |+|||++.+.  .++.++||||||+++|||++ |+.||......       ............       ...+...+.+
T Consensus       261 y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~-------~~~~~~~~~~  324 (359)
T 3vhe_A          261 WMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTR-------MRAPDYTTPE  324 (359)
T ss_dssp             GCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHHHHHHHHTCC-------CCCCTTCCHH
T ss_pred             eEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HHHHHHHHcCCC-------CCCCCCCCHH
Confidence            9999999764  78899999999999999998 99998654321       111111111111       1111223567


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          574 MILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       574 l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      +.+++.+||+.||++|||+++|+++|++++.
T Consensus       325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            8899999999999999999999999998754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-41  Score=343.12  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=209.3

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.+.||+|+||+||+|+..+++.||||++.......+.+.+|++++++++||||+++++++. .+..++||||+++++
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~   93 (279)
T 1qpc_A           15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS   93 (279)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred             hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence            3457899999999999999888889999999877666788999999999999999999999876 456899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||++........ .
T Consensus        94 L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           94 LVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             HHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             HHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            999997532    1358999999999999999999999   9999999999999999999999999999987754432 2


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......+++.|+|||++.+.  .++.++||||||+++|||++ |+.||.....       .. ........       ..
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~-~~~~~~~~-------~~  228 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PE-VIQNLERG-------YR  228 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH-HHHHHHTT-------CC
T ss_pred             cccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HH-HHHHHhcc-------cC
Confidence            22345578899999999754  67899999999999999999 8988864321       11 11111111       11


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                      ......++.++.+++.+||+.||++|||++++++.|++++.....
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            111223456789999999999999999999999999998766544

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-41  Score=351.39  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=199.8

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCE----EEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQN----VAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.+.||+|+||+||+|++. +++.    ||+|++....  ...+.+.+|+.++++++||||+++++++. +...++|||
T Consensus        16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   94 (325)
T 3kex_A           16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ   94 (325)
T ss_dssp             EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred             eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence            35689999999999999854 4444    7888775432  23456789999999999999999999886 566899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           95 YLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             CCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             eCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999997642     468889999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.......        ...........
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~  236 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------VPDLLEKGERL  236 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------HHHHHHTTCBC
T ss_pred             cccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCCCC
Confidence            55443334455678899999999764  68999999999999999999 999987543210        11111111111


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                             ..+...+.++.+++.+||+.||++|||+++++++|+++...
T Consensus       237 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          237 -------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             -------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             -------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   11111344678899999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.7e-41  Score=348.40  Aligned_cols=264  Identities=27%  Similarity=0.436  Sum_probs=211.6

Q ss_pred             HhhhhcccCcCcceeEEEEEE------cCCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL------LDGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  394 (638)
                      .+.+.+.||+|+||+||+|++      .+++.||||+++....  ..+.+.+|+.+++++ +||||+++++++..++..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  103 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence            344678999999999999984      2357899999976543  346788999999999 8999999999999999999


Q ss_pred             EEEEeccCCCHHHHhhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC
Q 006620          395 LIYEFVSNGSLEKFIHEKHPL------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE  462 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~  462 (638)
                      +||||+++|+|.+++......            .....+++..++.++.|+++||+|||+   .+++||||||+||+++.
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTH  180 (313)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEET
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcC
Confidence            999999999999999875421            112358999999999999999999999   99999999999999999


Q ss_pred             CCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCccc
Q 006620          463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEI  541 (638)
Q Consensus       463 ~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  541 (638)
                      ++.+||+|||++................+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......    
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  254 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----  254 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred             CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence            999999999999877655444334455678899999998764  78899999999999999998 99998654321    


Q ss_pred             chhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          542 YFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                         ..........       .........+.++.+++.+||+.||++|||+++++++|++++.+.
T Consensus       255 ---~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          255 ---SKFYKMIKEG-------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             ---HHHHHHHHHT-------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ---hHHHHHhccC-------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence               1111111111       011111234567899999999999999999999999999876653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.5e-40  Score=344.06  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=195.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc----------
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGH----------  391 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------  391 (638)
                      +.+.+.||+|+||.||+|+.. +++.||||+++...  ...+.+.+|+.++++++||||+++++++.+..          
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~   87 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE   87 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence            345789999999999999975 68999999987543  33467899999999999999999999986543          


Q ss_pred             -----------------------------------------------eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHH
Q 006620          392 -----------------------------------------------RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE  424 (638)
Q Consensus       392 -----------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~  424 (638)
                                                                     ..++||||+++++|.+++......   ...++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~  164 (332)
T 3qd2_B           88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---EDREHG  164 (332)
T ss_dssp             --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GGSCHH
T ss_pred             hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cchhhH
Confidence                                                           378999999999999999876422   345777


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce----------eeecccccccc
Q 006620          425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI----------VSMTGARGTIG  494 (638)
Q Consensus       425 ~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~----------~~~~~~~gt~~  494 (638)
                      .++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            899999999999999999   99999999999999999999999999999877544211          12234568999


Q ss_pred             eecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHH
Q 006620          495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKM  574 (638)
Q Consensus       495 y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  574 (638)
                      |+|||++.+.  .++.++||||||+++|||++|..|+....             ......    ..............++
T Consensus       242 y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~~-------------~~~~~~----~~~~~~~~~~~~~~~~  302 (332)
T 3qd2_B          242 YMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMERV-------------RIITDV----RNLKFPLLFTQKYPQE  302 (332)
T ss_dssp             GSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------------HHHHHH----HTTCCCHHHHHHCHHH
T ss_pred             ccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHHH-------------HHHHHh----hccCCCcccccCChhH
Confidence            9999999764  78999999999999999999876532110             000000    1112233344556778


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHH
Q 006620          575 ILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       575 ~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .+++.+||+.||++|||++|+++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCCCcCCCHHHHhh
Confidence            89999999999999999999996

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.8e-41  Score=352.73  Aligned_cols=250  Identities=23%  Similarity=0.290  Sum_probs=192.2

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      |.+.+.||+|+||+||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  101 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG  101 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence            346789999999999999965 6889999999876666678899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc--eEEcccccceeccCCC
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--PKISDFGLAKICEGRE  481 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DFg~~~~~~~~~  481 (638)
                      +|.+++...      ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.  +||+|||+++......
T Consensus       102 ~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A          102 ELYERICNA------GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            999999765      458999999999999999999999   99999999999999987665  9999999997543222


Q ss_pred             ceeeecccccccceecCceeccccCCc-cccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEV-SYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .   .....||+.|+|||++.+.  .+ +.++||||||+++|+|++|+.||........   ............      
T Consensus       173 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~------  238 (361)
T 3uc3_A          173 Q---PKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVK------  238 (361)
T ss_dssp             -----------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTC------
T ss_pred             C---CCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCC------
Confidence            1   2334689999999999764  44 4458999999999999999999975433211   111111111110      


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       ........++.++.+|+.+||+.||++|||+.|++++
T Consensus       239 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 -YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             0111111235678899999999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-41  Score=350.07  Aligned_cols=267  Identities=25%  Similarity=0.387  Sum_probs=206.7

Q ss_pred             hhhcccCcCcceeEEEEEE-----cCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-----LDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  396 (638)
                      .+.++||+|+||+||++.+     .+++.||||+++....  ..+.+.+|++++++++||||+++++++.+  ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            4578999999999988864     2578899999976542  24578899999999999999999999987  4678999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++...       .+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++..
T Consensus       114 ~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             ECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            9999999999999763       48999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCcee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc---cchhHHHHHHhh
Q 006620          477 CEGRESIV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE---IYFPHWVYKRLE  552 (638)
Q Consensus       477 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~  552 (638)
                      ........ ......+|+.|+|||++.+.  .++.++||||||+++|+|++|+.||.........   ..........  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  259 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR--  259 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH--
T ss_pred             ccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH--
Confidence            76543322 22345578899999999764  6788999999999999999999998643211000   0000000000  


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      .. ..............++.++.+++.+||+.||++|||++++++.|+++.+.++
T Consensus       260 ~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          260 LT-ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HH-HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            00 0011111222233456789999999999999999999999999998766544

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.6e-41  Score=361.95  Aligned_cols=248  Identities=25%  Similarity=0.460  Sum_probs=203.0

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCc-eEEEEEEeccCCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGH-RRALIYEFVSNGS  404 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gs  404 (638)
                      .+.++||+|+||+||+|.+. ++.||||+++... ..+.+.+|+.++++++||||+++++++.... ..++||||+++|+
T Consensus       196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~  273 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  273 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred             EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence            35689999999999999874 7899999998654 4578999999999999999999999987765 7899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++......   
T Consensus       274 L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  343 (450)
T 1k9a_A          274 LVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  343 (450)
T ss_dssp             HHHHHHHHC----TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence            999998753    1347999999999999999999999   999999999999999999999999999998654322   


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                        ....+++.|+|||++.+.  .++.++||||||+++|||++ |+.||.......        +...+..       +..
T Consensus       344 --~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~-------~~~  404 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEK-------GYK  404 (450)
T ss_dssp             -----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHT-------TCC
T ss_pred             --cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHc-------CCC
Confidence              223568899999999764  78999999999999999998 999987543211        1111111       111


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ...+..++.++.+++.+||+.||++|||+.+|++.|+++..
T Consensus       405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            12223456788999999999999999999999999998654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=343.53  Aligned_cols=246  Identities=23%  Similarity=0.346  Sum_probs=192.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---------------------------chhhHHHHHHHHhhcCC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---------------------------NGEDFINEVASISRTSH  377 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~l~h  377 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++.....                           ..+.+.+|++++++++|
T Consensus        16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   95 (298)
T 2zv2_A           16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH   95 (298)
T ss_dssp             EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred             EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence            4578999999999999986 4588999999865421                           13568899999999999


Q ss_pred             cceEEEEeEEEe--CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 006620          378 VNIVTLLGFCFE--GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKP  455 (638)
Q Consensus       378 ~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp  455 (638)
                      |||+++++++.+  ....++||||+++++|.+++..       ..+++..++.++.|+++||+|||+   .+|+||||||
T Consensus        96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp  165 (298)
T 2zv2_A           96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP  165 (298)
T ss_dssp             TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred             CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence            999999999986  5688999999999999886543       469999999999999999999999   9999999999


Q ss_pred             CceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccC-CccccCCeeeHHHHHHHHhcCCCCCCcc
Q 006620          456 HNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG-EVSYKSDVYSYGMMVFEMTGEKNNANVA  534 (638)
Q Consensus       456 ~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~~DvwslGvil~elltg~~p~~~~  534 (638)
                      +|||++.++.+||+|||+++........  .....||+.|+|||++.+... ..+.++||||||+++|+|++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999877544322  244578999999999975421 1467899999999999999999998643


Q ss_pred             cCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          535 VDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       535 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..       ... ...+... ....     .....++.++.+++.+||+.||++|||++|+++
T Consensus       244 ~~-------~~~-~~~~~~~-~~~~-----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RI-------MCL-HSKIKSQ-ALEF-----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SH-------HHH-HHHHHHC-CCCC-----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cH-------HHH-HHHHhcc-cCCC-----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            21       111 1111110 0111     111234567889999999999999999999985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.1e-41  Score=349.04  Aligned_cols=243  Identities=22%  Similarity=0.312  Sum_probs=199.1

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++...    ......+.+|+.++++++||||+++++++.+....++||||+
T Consensus        12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~   91 (336)
T 3h4j_B           12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA   91 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence            4578999999999999996 56889999998643    233457889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                       +|+|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        92 -~g~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           92 -GGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             -CEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             -CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence             78999998775      468999999999999999999999   89999999999999999999999999999876544


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..   .....||+.|+|||++.+. ...+.++||||||+++|+|++|+.||..........              .+  .
T Consensus       162 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------------~i--~  221 (336)
T 3h4j_B          162 NF---LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------KV--N  221 (336)
T ss_dssp             BT---TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------------CC--C
T ss_pred             cc---cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------------HH--H
Confidence            32   2345689999999999764 223689999999999999999999997543221100              00  0


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ......+...+.++.+|+.+||+.||++|||++|++++
T Consensus       222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            00011122345678899999999999999999999863

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.2e-41  Score=350.63  Aligned_cols=277  Identities=16%  Similarity=0.174  Sum_probs=208.7

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCCc------------hhhHHHHHHHHhhcCCcceEEEEe
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKGN------------GEDFINEVASISRTSHVNIVTLLG  385 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~  385 (638)
                      .+.+.++||+|+||+||+|.+.+      ++.||||++......            ...+..|+..++.++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            34467899999999999998754      478999998754311            123455666777888999999999


Q ss_pred             EEEeC----ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC
Q 006620          386 FCFEG----HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD  461 (638)
Q Consensus       386 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~  461 (638)
                      ++...    ...++||||+ +++|.+++....     ..+++..++.|+.||++||+|||+   .+|+||||||+|||++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence            98875    5589999999 999999998753     569999999999999999999999   9999999999999998


Q ss_pred             --CCCceEEcccccceeccCCCcee-----eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcc
Q 006620          462 --EDFCPKISDFGLAKICEGRESIV-----SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVA  534 (638)
Q Consensus       462 --~~~~~kl~DFg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~  534 (638)
                        .++.+||+|||+++.........     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence              88999999999998765332211     11234589999999999765  6899999999999999999999999854


Q ss_pred             cCCCcccchhHHHHHHhhh-hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCc
Q 006620          535 VDRSSEIYFPHWVYKRLEL-EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPF  613 (638)
Q Consensus       535 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~  613 (638)
                      .....   ........... ...+......   ....+.++.+++.+||+.+|++||++++|++.|++++++........
T Consensus       265 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~  338 (364)
T 3op5_A          265 LKDPK---YVRDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK  338 (364)
T ss_dssp             TTCHH---HHHHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             ccCHH---HHHHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence            32111   11111111000 0000000000   01235678899999999999999999999999999988877766666


Q ss_pred             ccCC
Q 006620          614 LLSS  617 (638)
Q Consensus       614 ~~~~  617 (638)
                      +.+.
T Consensus       339 ~dw~  342 (364)
T 3op5_A          339 LDLS  342 (364)
T ss_dssp             CCC-
T ss_pred             cceE
Confidence            6655

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=341.11  Aligned_cols=250  Identities=22%  Similarity=0.257  Sum_probs=196.6

Q ss_pred             chHHHHHHHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc---hhhHHHHHHHHhhc-CCcceEEEEeEEEeC
Q 006620          316 RYADIKKMTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN---GEDFINEVASISRT-SHVNIVTLLGFCFEG  390 (638)
Q Consensus       316 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  390 (638)
                      +..++....+.+.++||+|+||+||+|+.. +++.||||++......   ......|+..+.++ +||||+++++++.++
T Consensus        50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~  129 (311)
T 3p1a_A           50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG  129 (311)
T ss_dssp             SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence            334444555666889999999999999975 6899999998654322   23455666666555 899999999999999


Q ss_pred             ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcc
Q 006620          391 HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD  470 (638)
Q Consensus       391 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  470 (638)
                      +..++||||+ +++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~D  200 (311)
T 3p1a_A          130 GILYLQTELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGD  200 (311)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECC
T ss_pred             CEEEEEEecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEcc
Confidence            9999999999 679999998753     569999999999999999999999   8999999999999999999999999


Q ss_pred             cccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH
Q 006620          471 FGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       471 Fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      ||++........   .....||+.|+|||++.+   .++.++||||||+++|||++|..++.....           ...
T Consensus       201 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~  263 (311)
T 3p1a_A          201 FGLLVELGTAGA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQ  263 (311)
T ss_dssp             CTTCEECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHH
T ss_pred             ceeeeecccCCC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHH
Confidence            999987654332   234558999999999865   578999999999999999999766543211           011


Q ss_pred             hhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      +.      ...........++.++.+++.+||+.||++|||++|+++
T Consensus       264 ~~------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          264 LR------QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HT------TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Hh------ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            10      111111222345678999999999999999999999996

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.5e-41  Score=351.32  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=201.5

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.+.||+|+||+||+++.. +++.||||++...    ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   96 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL   96 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence            345789999999999999864 5789999998643    23456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +.+|+|.+++...      ..+++..++.++.||+.||+|||+   .||+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           97 LLGGDLRYHLQQN------VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CTTEEHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999999864      469999999999999999999999   9999999999999999999999999999987754


Q ss_pred             CCceeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...   .....||+.|+|||++.+. ...++.++|||||||++|||++|+.||........    ... ....... .  
T Consensus       168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~----~~~-~~~~~~~-~--  236 (384)
T 4fr4_A          168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS----KEI-VHTFETT-V--  236 (384)
T ss_dssp             TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH----HHH-HHHHHHC-C--
T ss_pred             CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH----HHH-HHHHhhc-c--
Confidence            432   2446789999999998643 13578999999999999999999999975433211    111 1111100 0  


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPS-MNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  597 (638)
                           ...+..++.++.+|+.+||+.||++||+ +++|++
T Consensus       237 -----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 -----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 1111234567899999999999999998 777664

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.4e-41  Score=339.62  Aligned_cols=256  Identities=24%  Similarity=0.325  Sum_probs=196.5

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.||+|+||+||+|+..+++.||+|++.....   ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (288)
T 1ob3_A            5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence            45789999999999999987799999999865432   236788999999999999999999999999999999999975


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                       +|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+||+++.++.+||+|||+++.......
T Consensus        85 -~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           85 -DLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             -EHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             -CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence             9999997643     568999999999999999999999   9999999999999999999999999999986643221


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh--------
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE--------  554 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  554 (638)
                        ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||.......   .... ........        
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~-~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMR-IFRILGTPNSKNWPNV  228 (288)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHHCCCCTTTSTTG
T ss_pred             --ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-HHHHHCCCChhhchhh
Confidence              12344679999999998653 357899999999999999999999997532210   0000 00000000        


Q ss_pred             h---hc--cccCCC----CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 E---DL--GLQGIE----NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~---~~--~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .   ..  ......    ......++.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0   00  000000    0011234567889999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1e-40  Score=353.60  Aligned_cols=268  Identities=17%  Similarity=0.210  Sum_probs=203.0

Q ss_pred             hhhhcccCcC--cceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQG--GYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      |.+.++||+|  +||+||+|+.. +++.||||++.....   ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  106 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS  106 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence            4467899999  99999999965 689999999976532   23567789999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++++|.+++....    ...+++..++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||.+....
T Consensus       107 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          107 FMAYGSAKDLICTHF----MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             CCTTCBHHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             ccCCCCHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999998753    2458999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCce-----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          479 GRESI-----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       479 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      .....     .......||+.|+|||++.+....++.++|||||||++|||++|+.||.........  . .........
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~-~~~~~~~~~  256 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--L-EKLNGTVPC  256 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--H-HC-------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--H-HHhcCCCCc
Confidence            22111     111234689999999999764346889999999999999999999999754322110  0 000000000


Q ss_pred             --------hhh-----------------cc--------ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--
Q 006620          554 --------EED-----------------LG--------LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM--  598 (638)
Q Consensus       554 --------~~~-----------------~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--  598 (638)
                              ...                 ..        ...........++.++.+|+.+||+.||++|||++|++++  
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence                    000                 00        0000011223456678999999999999999999999975  


Q ss_pred             Hhcc
Q 006620          599 LEGS  602 (638)
Q Consensus       599 L~~~  602 (638)
                      +++.
T Consensus       337 f~~~  340 (389)
T 3gni_B          337 FKQI  340 (389)
T ss_dssp             GGGC
T ss_pred             HHHH
Confidence            5544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-41  Score=339.37  Aligned_cols=246  Identities=28%  Similarity=0.463  Sum_probs=190.2

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccC-----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK-----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|.+ .++.||||++....     ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (271)
T 3dtc_A           10 TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA   88 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred             eeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence            4578999999999999997 48899999986542     22467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEecccCCCceEECC--------CCceEEc
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR---ILHFDIKPHNILLDE--------DFCPKIS  469 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~---iiH~Dikp~NIll~~--------~~~~kl~  469 (638)
                      ++++|.+++..       ..+++..++.++.|+++||+|||+   ++   |+||||||+||+++.        ++.+||+
T Consensus        89 ~~~~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           89 RGGPLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             TTEEHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             CCCCHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            99999999864       458999999999999999999999   77   999999999999985        7789999


Q ss_pred             ccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH
Q 006620          470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       470 DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      |||+++.......    ....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       .....
T Consensus       159 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~  225 (271)
T 3dtc_A          159 DFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYG  225 (271)
T ss_dssp             CCCC-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHH
T ss_pred             cCCcccccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHh
Confidence            9999986654332    234689999999999764  6889999999999999999999998743211       00000


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                       ..      ........+..++.++.+++.+||+.||++|||++|++++|+++
T Consensus       226 -~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 -VA------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -HH------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -hh------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence             00      11111112223456789999999999999999999999999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.5e-41  Score=345.07  Aligned_cols=250  Identities=20%  Similarity=0.277  Sum_probs=181.8

Q ss_pred             hcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          328 KNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.||+|+||+||+|+.. +++.||||++...  ....+.+|+.+++++. ||||+++++++.+....++||||+++++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            368999999999999964 5889999998653  3456788999999997 99999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC---ceEEcccccceeccCCCc
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDFGLAKICEGRES  482 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFg~~~~~~~~~~  482 (638)
                      .+++...      ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++   .+||+|||+++.......
T Consensus        94 ~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           94 FERIKKK------KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             HHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            9999875      468999999999999999999999   9999999999999997655   899999999987654332


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.............. ....+...    ....
T Consensus       165 --~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~----~~~~  235 (325)
T 3kn6_A          165 --PLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKG----DFSF  235 (325)
T ss_dssp             ---------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTT----CCCC
T ss_pred             --cccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcC----CCCC
Confidence              22345679999999999764  688999999999999999999999976443211111111 11111110    0111


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .......++.++.+|+.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            22233456778999999999999999999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.5e-41  Score=350.98  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=201.7

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .|.+.+.||+|+||.||+|... +++.||+|++.....   ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~  109 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL  109 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            3456789999999999999864 588999999976432   235678999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC---CceEEccccccee
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---FCPKISDFGLAKI  476 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFg~~~~  476 (638)
                      +++|+|.+++...      ..+++..++.++.||++||+|||+   .+|+||||||+|||++.+   +.+||+|||++..
T Consensus       110 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          110 VTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999764      468999999999999999999999   999999999999999764   4599999999987


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ......   .....||+.|+|||++.+.  .++.++|||||||++|+|++|++||......       . ....+.... 
T Consensus       181 ~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~-~~~~i~~~~-  246 (362)
T 2bdw_A          181 VNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------R-LYAQIKAGA-  246 (362)
T ss_dssp             CTTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHTC-
T ss_pred             ecCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhCC-
Confidence            654332   2345689999999999764  6889999999999999999999998643210       1 111111110 


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                         ..........++.++.+|+.+||+.||++|||+.+++++
T Consensus       247 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 ---YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               011112223456778999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.7e-41  Score=348.61  Aligned_cols=264  Identities=25%  Similarity=0.450  Sum_probs=209.9

Q ss_pred             HhhhhcccCcCcceeEEEEEEc--------CCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCce
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL--------DGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHR  392 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  392 (638)
                      .+.+.+.||+|+||+||+|++.        +++.||||+++....  ..+.+.+|+++++++ +||||+++++++...+.
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  115 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  115 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence            3456789999999999999863        467899999976532  245788999999999 89999999999999999


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE  462 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~  462 (638)
                      .++||||+++++|.+++.......          ....+++..++.++.|+++||+|||+   .+|+||||||+||+++.
T Consensus       116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTE  192 (334)
T ss_dssp             CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECT
T ss_pred             eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcC
Confidence            999999999999999998754211          12358999999999999999999999   99999999999999999


Q ss_pred             CCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCccc
Q 006620          463 DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEI  541 (638)
Q Consensus       463 ~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  541 (638)
                      ++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.....     
T Consensus       193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----  265 (334)
T 2pvf_A          193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  265 (334)
T ss_dssp             TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             CCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence            999999999999877655444334445678999999998764  68899999999999999999 9999864321     


Q ss_pred             chhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          542 YFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                        .. ....+....       ....+..++.++.+++.+||+.||++|||++++++.|++++....
T Consensus       266 --~~-~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          266 --EE-LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             --HH-HHHHHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             --HH-HHHHHhcCC-------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence              11 111111111       111122345678899999999999999999999999999866433

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.4e-41  Score=343.44  Aligned_cols=259  Identities=29%  Similarity=0.482  Sum_probs=192.6

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.++||+|+||+||+|+..  ..||||+++.....   .+.+.+|++++++++||||++++++. .....++||||++
T Consensus        26 y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~  102 (289)
T 3og7_A           26 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE  102 (289)
T ss_dssp             CEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred             eeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecC
Confidence            446789999999999999864  36999999765432   35688999999999999999999965 5567899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus       103 ~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          103 GSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             CCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999997643     568999999999999999999999   999999999999999999999999999998665433


Q ss_pred             ceeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .........||+.|+|||++... ...++.++||||||+++|+|++|+.||......       ...........   ..
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~---~~  244 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGS---LS  244 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHHHHTS---CC
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcccc---cC
Confidence            33333445689999999998521 236788999999999999999999999754321       11111111110   11


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      .........++.++.+++.+||+.||++|||++++++.|+++.+
T Consensus       245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11111122345678999999999999999999999999998765

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7e-41  Score=344.16  Aligned_cols=241  Identities=26%  Similarity=0.352  Sum_probs=199.7

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||||+++..    ....+.+.+|..+++.++||||+++++++.+....++||||+
T Consensus         9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   88 (318)
T 1fot_A            9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI   88 (318)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence            45789999999999999864 6899999999753    234567789999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           89 EGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999875      468999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....       .. ....+... .... 
T Consensus       160 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~-~~~~i~~~-~~~~-  222 (318)
T 1fot_A          160 T-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MK-TYEKILNA-ELRF-  222 (318)
T ss_dssp             B-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHHC-CCCC-
T ss_pred             c-----ccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HH-HHHHHHhC-CCCC-
Confidence            2     345689999999999764  688999999999999999999999964321       01 11111110 1111 


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                            +..++.++.+++.+||+.||++||     ++++++++
T Consensus       223 ------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          223 ------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                  122456788999999999999999     88998853

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6e-41  Score=358.28  Aligned_cols=252  Identities=19%  Similarity=0.229  Sum_probs=202.0

Q ss_pred             hhcccCcCcceeEEEEEEcC-CCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.++||+|+||+||+|+..+ ++.||||+++..    ......+.+|..++.+++||||+++++++.+.+..++||||++
T Consensus        78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~  157 (437)
T 4aw2_A           78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV  157 (437)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence            46899999999999999754 788999999752    2333458899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       158 gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          158 GGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             TCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999998642     569999999999999999999999   999999999999999999999999999998765443


Q ss_pred             ceeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      .. ......||+.|+|||++...   .+.++.++|||||||++|||++|+.||......       ............+.
T Consensus       230 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~  301 (437)
T 4aw2_A          230 TV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKERFQ  301 (437)
T ss_dssp             CE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHHHCC
T ss_pred             Cc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------HHHHhhhhcccccc
Confidence            32 22446799999999998621   236889999999999999999999999753211       11111111111121


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSD--RPSMNRVVEM  598 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  598 (638)
                      ....    ...++.++.+||.+||..+|++  ||+++|++++
T Consensus       302 ~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          302 FPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             CCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             CCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            1111    1124567889999999988888  9999999874

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=352.74  Aligned_cols=244  Identities=22%  Similarity=0.288  Sum_probs=195.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.+.||+|+||+||+|+.. +++.||||+++..    ....+.+.+|.++++++ +||||+++++++.+.+..++|||
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E  104 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME  104 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence            345789999999999999864 5889999999753    23445678899999988 69999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          105 FVNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999875      468999999999999999999999   999999999999999999999999999998543


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .....+... ...
T Consensus       176 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~-~~~  242 (353)
T 3txo_A          176 CNGV--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND-EVV  242 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCC
T ss_pred             cCCc--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-CCC
Confidence            2221  22345689999999999765  6889999999999999999999999754311        111111111 111


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM------NRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  597 (638)
                      .       +..++.++.+++.+||+.||++||++      +++++
T Consensus       243 ~-------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 Y-------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             C-------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             C-------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1       11245678899999999999999998      67765

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-40  Score=352.86  Aligned_cols=249  Identities=19%  Similarity=0.264  Sum_probs=201.8

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.++||+|+||+||+|+.. +++.||||+++..    ....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  151 (410)
T 3v8s_A           72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM  151 (410)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            34689999999999999965 5889999998652    234456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++...       .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       152 ~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          152 PGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             TTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            999999999763       48999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CceeeecccccccceecCceeccccC--CccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh-hhhc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFG--EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL-EEDL  557 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  557 (638)
                      .. .......||+.|+|||++.+..+  .++.++|||||||++|||++|+.||......       . ....+.. ...+
T Consensus       222 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~-~~~~i~~~~~~~  292 (410)
T 3v8s_A          222 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMNHKNSL  292 (410)
T ss_dssp             SE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHTHHHHC
T ss_pred             Cc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------h-HHHHHHhccccc
Confidence            32 22345679999999999976421  2788999999999999999999999743211       1 1111111 1111


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSD--RPSMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  598 (638)
                      ....     ...++.++.+||.+||+.+|++  ||+++||+++
T Consensus       293 ~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 TFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            1111     1124567889999999999988  9999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.1e-40  Score=340.90  Aligned_cols=257  Identities=20%  Similarity=0.268  Sum_probs=194.5

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      .+.||+|+||+||+|+. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++++
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence            36799999999999984 468999999997654 3456789999999885 69999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc---eEEcccccceeccCCC
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDFGLAKICEGRE  481 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFg~~~~~~~~~  481 (638)
                      |.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.   +||+|||++.......
T Consensus        98 L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           98 ILSHIHKR------RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             HHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            99999875      458999999999999999999999   99999999999999987766   9999999987654221


Q ss_pred             c-----eeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch----h---HH
Q 006620          482 S-----IVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF----P---HW  546 (638)
Q Consensus       482 ~-----~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~----~---~~  546 (638)
                      .     ........||+.|+|||++.+.   ...++.++||||||+++|||++|+.||............    +   ..
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence            1     1112234589999999998641   125788999999999999999999999765432211100    0   00


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....+...    ...........++.++.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          249 LFESIQEG----KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHC----CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhcc----CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            11111100    000111111234667899999999999999999999997

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=350.62  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=195.8

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCE----EEEEEeccc--CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQN----VAIKVLNET--KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.++||+|+||+||+|++. +++.    ||+|.+...  ....+.+.+|+.++++++||||+++++++..+. .++|+|
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~   96 (327)
T 3lzb_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ   96 (327)
T ss_dssp             EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred             eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence            45789999999999999853 4554    577766543  234568899999999999999999999998755 789999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      ++.+|+|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           97 LMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             CCSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             ecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999998753     569999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.......    .    ...+...   
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~----~~~~~~~---  235 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----I----SSILEKG---  235 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----H----HHHHHTT---
T ss_pred             CccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----H----HHHHHcC---
Confidence            54433333445678899999999764  78899999999999999999 999987543211    1    1111111   


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                          .....+...+.++.+++.+||+.||++|||++|+++.|+++...
T Consensus       236 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          236 ----ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                11111223455788999999999999999999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.8e-40  Score=336.07  Aligned_cols=257  Identities=21%  Similarity=0.294  Sum_probs=197.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.++||+|+||+||+|+.. +++.||||++.....   ..+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (292)
T 3o0g_A            5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence            45789999999999999964 588999999975432   23678899999999999999999999999999999999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      + +|.+.+....     ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~-~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           85 Q-DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             E-EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             C-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            5 6777666532     569999999999999999999999   999999999999999999999999999998764332


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh------
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE------  555 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  555 (638)
                      .  ......||+.|+|||++.+. ..++.++||||||+++|||++|+.|+........  ..... ........      
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i-~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          156 R--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRI-FRLLGTPTEEQWPS  229 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHH-HHHHCCCCTTTCTT
T ss_pred             c--cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHH-HHHhCCCChhhhhh
Confidence            2  22445689999999998764 2478999999999999999998888643322110  00000 00000000      


Q ss_pred             --hc---c------ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 --DL---G------LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 --~~---~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ..   .      ............+.++.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence              00   0      000001111234567889999999999999999999996

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-41  Score=339.63  Aligned_cols=258  Identities=25%  Similarity=0.386  Sum_probs=207.5

Q ss_pred             cccCcCcceeEEEEEEc---CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          329 NKLGQGGYGGVYKGKLL---DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.||+|+||+||+|.+.   +++.||||+++...  ...+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            48999999999999753   56789999997643  2346788999999999999999999998 556789999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        95 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           95 PLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  166 (287)
T ss_dssp             EHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             CHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence            9999997543     569999999999999999999999   99999999999999999999999999999877544332


Q ss_pred             e-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          484 V-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       484 ~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      . ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......       . ....+...       
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~-~~~~i~~~-------  229 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------E-VMAFIEQG-------  229 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------H-HHHHHHTT-------
T ss_pred             eeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------H-HHHHHhcC-------
Confidence            2 12334568999999999754  68899999999999999998 99998654321       1 11111111       


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRP  612 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p  612 (638)
                      .....+..++.++.+++.+||+.||++||++.+++++|++++.+...+..+
T Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~  280 (287)
T 1u59_A          230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  280 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred             CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence            111112234668899999999999999999999999999987765554433

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.4e-41  Score=346.38  Aligned_cols=263  Identities=26%  Similarity=0.419  Sum_probs=196.4

Q ss_pred             hhhhcccCcCcceeEEEEEEcC----CCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCc-----e
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGH-----R  392 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  392 (638)
                      +.+.+.||+|+||+||+|....    ++.||||+++....   ..+.+.+|+.++++++||||+++++++....     .
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  115 (313)
T 3brb_A           36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK  115 (313)
T ss_dssp             EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred             eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence            3457889999999999997542    34799999875432   2356889999999999999999999998755     3


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      .++||||+++++|.+++...........+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||
T Consensus       116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecC
Confidence            49999999999999999654432334679999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      +++...............+++.|+|||.+.+.  .++.++||||||+++|+|++ |+.||......       ... ...
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~-~~~  262 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-------EMY-DYL  262 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------GHH-HHH
T ss_pred             cceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHH-HHH
Confidence            99876544322223344578899999999764  78899999999999999999 88888654321       011 111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      ..       ......+..++.++.+++.+||+.||++|||+++++++|++++++++
T Consensus       263 ~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          263 LH-------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HT-------TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             Hc-------CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            11       11111222345678999999999999999999999999999876543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-40  Score=347.57  Aligned_cols=242  Identities=21%  Similarity=0.279  Sum_probs=200.8

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.+.||+|+||+||+|+.. +++.||||++...    ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  122 (350)
T 1rdq_E           43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence            345789999999999999964 5889999998653    23456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       123 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          123 VAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             CTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999875      458999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ..     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....        ......+... ... 
T Consensus       194 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~-~~~-  256 (350)
T 1rdq_E          194 RT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSG-KVR-  256 (350)
T ss_dssp             CB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCC-
T ss_pred             Cc-----ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcC-CCC-
Confidence            32     334689999999999764  688999999999999999999999974321        1111111111 111 


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  598 (638)
                            .+..++.++.+++.+||+.||++||+     +++|+++
T Consensus       257 ------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          257 ------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                  11234567899999999999999998     8888763

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.7e-40  Score=341.72  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=191.8

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||+|+||+||+|+. .+++.||||+++...  ...+.+.+|++++++++||||+++++++..++..++||||++ 
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-   86 (317)
T 2pmi_A            8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-   86 (317)
T ss_dssp             -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred             eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence            4568899999999999985 458899999987543  234678899999999999999999999999999999999997 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++...........+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  163 (317)
T 2pmi_A           87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN  163 (317)
T ss_dssp             CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred             CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence            5999999765433334569999999999999999999999   9999999999999999999999999999987643321


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh--------
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE--------  554 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  554 (638)
                        ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......   .. ..........        
T Consensus       164 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~-~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          164 --TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QL-KLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             --CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH-HHHHHHHCSCCTTTCGGG
T ss_pred             --cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HH-HHHHHHhCCCChhHhhhh
Confidence              12345689999999998653 357899999999999999999999997543210   00 0000000000        


Q ss_pred             hhc-----cccCCCCc---------hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 EDL-----GLQGIENE---------EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~~~-----~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...     ........         .....+.++.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000     00000000         00123567899999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.6e-41  Score=346.54  Aligned_cols=271  Identities=25%  Similarity=0.350  Sum_probs=197.3

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHH--HhhcCCcceEEEEeEEEe-----CceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVAS--ISRTSHVNIVTLLGFCFE-----GHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~~lv~e  398 (638)
                      .+.+.||+|+||+||+|+. +++.||||++....  ...+..|.++  +..++||||+++++.+..     ....++|||
T Consensus        16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   92 (336)
T 3g2f_A           16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME   92 (336)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred             heeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence            3578999999999999987 68999999997543  2344444444  555889999999986543     335789999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEecccCCCceEECCCCceEEc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT---------RILHFDIKPHNILLDEDFCPKIS  469 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~---------~iiH~Dikp~NIll~~~~~~kl~  469 (638)
                      |+++|+|.+++...       ..++..++.++.|+++||+|||+   .         +|+||||||+|||++.++.+||+
T Consensus        93 ~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           93 YYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             CCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             cCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEe
Confidence            99999999999764       35889999999999999999999   7         99999999999999999999999


Q ss_pred             ccccceeccCCCc------eeeecccccccceecCceecccc-----CCccccCCeeeHHHHHHHHhcCCCCCCcccCCC
Q 006620          470 DFGLAKICEGRES------IVSMTGARGTIGYIAPEVFCRNF-----GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS  538 (638)
Q Consensus       470 DFg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-----~~~s~~~DvwslGvil~elltg~~p~~~~~~~~  538 (638)
                      |||+++.......      ........||+.|+|||++.+..     ..++.++||||||+++|||++|+.|+.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            9999987654321      11223456899999999987521     246679999999999999999977765433211


Q ss_pred             c-ccchh---------HHHHHHhhhhh-hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          539 S-EIYFP---------HWVYKRLELEE-DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       539 ~-~~~~~---------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      . .....         ........... ...... ........+.++.+++.+||+.||++|||++|+++.|++++....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            1 11000         00000000000 000000 011123467789999999999999999999999999999877665


Q ss_pred             CCC
Q 006620          608 IPP  610 (638)
Q Consensus       608 ~~~  610 (638)
                      ...
T Consensus       322 ~~~  324 (336)
T 3g2f_A          322 RNK  324 (336)
T ss_dssp             C--
T ss_pred             hcc
Confidence            533

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=373.86  Aligned_cols=257  Identities=29%  Similarity=0.450  Sum_probs=210.2

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.++||+|+||+||+|.+.+++.||||+++......+++.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus       269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs  347 (535)
T 2h8h_A          269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS  347 (535)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred             hhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence            34578999999999999998888889999998766667789999999999999999999999876 67899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..++.|+.||++||+|||+   ++|+||||||+|||+++++.+||+|||+++....... .
T Consensus       348 L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~  419 (535)
T 2h8h_A          348 LLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  419 (535)
T ss_dssp             HHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-H
T ss_pred             HHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-e
Confidence            999997532    2458999999999999999999999   9999999999999999999999999999986643221 1


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                      ......++..|+|||++.+.  .++.++||||||+++|||++ |+.||......        .+...+...       ..
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--------~~~~~i~~~-------~~  482 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERG-------YR  482 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--------HHHHHHHTT-------CC
T ss_pred             cccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC-------CC
Confidence            12334568899999998764  78999999999999999999 89998643211        111111111       11


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      ...+..++.++.+|+.+||+.||++|||+++|++.|++++....
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            11222346678899999999999999999999999999877654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=343.63  Aligned_cols=261  Identities=27%  Similarity=0.444  Sum_probs=201.0

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.+.||+|+||+||+|+. .++.||||++... ...+.+.+|++++++++||||+++++++.+  ..++||||+++++|
T Consensus        11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L   86 (307)
T 2eva_A           11 EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL   86 (307)
T ss_dssp             EEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred             eeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence            3578999999999999987 4788999998643 345678999999999999999999998763  47899999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc-eEEcccccceeccCCCcee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC-PKISDFGLAKICEGRESIV  484 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~-~kl~DFg~~~~~~~~~~~~  484 (638)
                      .+++.....   ...+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++.......   
T Consensus        87 ~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~---  160 (307)
T 2eva_A           87 YNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---  160 (307)
T ss_dssp             HHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             HHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence            999986531   134788999999999999999999855468999999999999988876 7999999997654322   


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                        ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||........     ... .....       ....
T Consensus       161 --~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~-~~~~~-------~~~~  223 (307)
T 2eva_A          161 --TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-----RIM-WAVHN-------GTRP  223 (307)
T ss_dssp             ------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-----HHH-HHHHT-------TCCC
T ss_pred             --ccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-----HHH-HHHhc-------CCCC
Confidence              234589999999999764  788999999999999999999999975432110     000 00010       0111


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCc
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPF  613 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~  613 (638)
                      .....++..+.+++.+||+.||++|||++++++.|+++...++....|.
T Consensus       224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence            1122345678899999999999999999999999999877766544443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=349.29  Aligned_cols=245  Identities=25%  Similarity=0.329  Sum_probs=195.5

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.||+|+||.||+|+. .+++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            46799999999999986 468899999997653 3456789999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE--CCCCceEEcccccceeccCCCce
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL--DEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll--~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      .+++....     ..+++..++.++.||++||+|||+   .+|+||||||+|||+  +.++.+||+|||+++....... 
T Consensus       174 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-  244 (373)
T 2x4f_A          174 FDRIIDES-----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-  244 (373)
T ss_dssp             HHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence            99997642     458999999999999999999999   999999999999999  6778999999999997754432 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                        .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       ..........     ....
T Consensus       245 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~-----~~~~  308 (373)
T 2x4f_A          245 --LKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACR-----WDLE  308 (373)
T ss_dssp             --CCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTC-----CCSC
T ss_pred             --cccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcc-----CCCC
Confidence              2334689999999998654  6888999999999999999999999753311       1111111100     0111


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......++.++.+|+.+||+.||++|||++|+++
T Consensus       309 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1222345678899999999999999999999997

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.7e-40  Score=342.70  Aligned_cols=246  Identities=21%  Similarity=0.306  Sum_probs=194.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC----chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG----NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||+||+|+.. +++.||||+++....    ..+.+.+|..+++++ +||||+++++++.+....++||||
T Consensus        12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~   91 (345)
T 3a8x_A           12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   91 (345)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence            45789999999999999964 588999999975432    234578899999887 799999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           92 VNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999875      458999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc-chhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI-YFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  558 (638)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......... .........+... ...
T Consensus       163 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~  237 (345)
T 3a8x_A          163 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIR  237 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCC
T ss_pred             CCC--cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCC
Confidence            221  12445789999999999764  68899999999999999999999996532211110 0111111111111 111


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM  592 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  592 (638)
                             .+..++.++.+++.+||+.||++||++
T Consensus       238 -------~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 -------IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                   112345678899999999999999996

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.9e-41  Score=339.03  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=192.3

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC----CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.+.||+|+||+||+|+...    +..||+|++.....  ..+.+.+|+.++++++||||+++++++. ++..++||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   94 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   94 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence            34467899999999999998643    44699999875432  3457889999999999999999999874 56789999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        95 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           95 ELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             ECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             ecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999998653     468999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ...... ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.......       . ...+.... 
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------~-~~~i~~~~-  234 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------V-IGRIENGE-  234 (281)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------H-HHHHHTTC-
T ss_pred             Cccccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------H-HHHHHcCC-
Confidence            543321 12334567899999999764  68899999999999999996 899987543211       0 11111111 


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                            ....+..++.++.+++.+||+.||++|||+.++++.|+++++
T Consensus       235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                  111122345678899999999999999999999999998654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.7e-41  Score=347.52  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=192.2

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCC--cceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN---GEDFINEVASISRTSH--VNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||++...+++.||||++......   .+.+.+|+.++++++|  |||+++++++..+...++||| +
T Consensus        12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~   90 (343)
T 3dbq_A           12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C   90 (343)
T ss_dssp             EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred             EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-C
Confidence            457899999999999999888999999998754332   3567899999999986  999999999999999999999 4


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      .+++|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+|||++ ++.+||+|||+++.....
T Consensus        91 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           91 GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             CSEEHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            588999999875      468999999999999999999999   9999999999999996 678999999999877554


Q ss_pred             CceeeecccccccceecCceeccc---------cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRN---------FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      ..........||+.|+|||++.+.         ...++.++||||||+++|||++|+.||......      ........
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~  234 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  234 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHH
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------HHHHHHHh
Confidence            433333456789999999998641         136788999999999999999999999643221      00111111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .....       ...+...+.++.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~-------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPNHE-------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTTSC-------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcc-------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            11111       11111123568899999999999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5e-41  Score=348.78  Aligned_cols=243  Identities=22%  Similarity=0.306  Sum_probs=198.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||+||+|+.. +++.||||+++..    ....+.+..|..++.++ +||||+++++++.+.+..++||||
T Consensus        20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~   99 (345)
T 1xjd_A           20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY   99 (345)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            45789999999999999964 5889999999754    33456678899999877 899999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A          100 LNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            9999999999875      458999999999999999999999   9999999999999999999999999999986433


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+.... .. 
T Consensus       171 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-~~-  236 (345)
T 1xjd_A          171 GDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN-PF-  236 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CC-
T ss_pred             CCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC-CC-
Confidence            221  12445789999999999764  689999999999999999999999974321        11111111110 10 


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMN-RVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  597 (638)
                            .+..++.++.+++.+||+.||++||++. +|++
T Consensus       237 ------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          237 ------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                  1122456788999999999999999997 6653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=353.96  Aligned_cols=251  Identities=21%  Similarity=0.243  Sum_probs=200.5

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.||+|+||+||+++.. +++.||||++++.    ....+.+.+|..++.+++||||+++++++.+.+..++||||++
T Consensus        65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~  144 (412)
T 2vd5_A           65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV  144 (412)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence            4689999999999999964 6899999999753    2234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|.+++.+.+     ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       145 gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          145 GGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             SCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            999999998753     469999999999999999999999   999999999999999999999999999998775543


Q ss_pred             ceeeecccccccceecCceeccc-----cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRN-----FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      .. ......||+.|+|||++...     ...++.++|||||||++|||++|+.||......       ............
T Consensus       217 ~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~  288 (412)
T 2vd5_A          217 TV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------ETYGKIVHYKEH  288 (412)
T ss_dssp             CE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHHH
T ss_pred             cc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcccC
Confidence            32 22345799999999998631     136789999999999999999999999753211       111111111111


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDR---PSMNRVVEM  598 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~  598 (638)
                      ....    .....++.++.+||.+||+ +|++|   |+++|++++
T Consensus       289 ~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          289 LSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             cCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1111    1122346788999999999 99998   589998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-40  Score=348.45  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=201.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.+.||+|+||+||+|... +++.||+|++.... .....+.+|++++++++||||+++++++.+....++||||+++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g  132 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence            445789999999999999864 58899999987543 2345788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC--CCceEEcccccceeccCC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--DFCPKISDFGLAKICEGR  480 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|.+++....     ..+++..++.++.||++||+|||+   .+|+||||||+|||++.  ++.+||+|||+++.....
T Consensus       133 g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          133 GELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999997642     468999999999999999999999   99999999999999974  578999999999987654


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ...   ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       ... ..+... ..   
T Consensus       205 ~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~-~~i~~~-~~---  267 (387)
T 1kob_A          205 EIV---KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETL-QNVKRC-DW---  267 (387)
T ss_dssp             SCE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHH-HHHHHC-CC---
T ss_pred             cce---eeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------HHH-HHHHhC-CC---
Confidence            432   234589999999999764  6889999999999999999999999753210       111 111110 00   


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .........++.++.+|+.+||+.||++|||+++++++
T Consensus       268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            01111222346678999999999999999999999974

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9e-40  Score=332.77  Aligned_cols=271  Identities=19%  Similarity=0.251  Sum_probs=210.2

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEE-EeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFC-FEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~g  403 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.++++++|++++..+..+ ......++||||+ ++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (296)
T 3uzp_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   89 (296)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence            3578999999999999995 568899999987554 335688999999999988765555544 6677889999999 89


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE---CCCCceEEcccccceeccCC
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+|||+   +.++.+||+|||++......
T Consensus        90 ~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           90 SLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            9999998543     569999999999999999999999   999999999999999   48889999999999876554


Q ss_pred             Ccee-----eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          481 ESIV-----SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       481 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ....     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||........................
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            3211     12345689999999999764  6889999999999999999999999865433322222222111111100


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCcccC
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLS  616 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~  616 (638)
                              ......++.++.+++.+||+.||++|||+++|++.|++++.....+..-.+.+
T Consensus       240 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw  292 (296)
T 3uzp_A          240 --------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW  292 (296)
T ss_dssp             --------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred             --------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence                    00112235678999999999999999999999999999887766544433433

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=344.09  Aligned_cols=239  Identities=25%  Similarity=0.327  Sum_probs=198.3

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  394 (638)
                      |.+.+.||+|+||+||+|+. .+++.||||+++....         ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  105 (335)
T 3dls_A           26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ  105 (335)
T ss_dssp             EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEE
Confidence            44578999999999999985 5688999999976431         2346788999999999999999999999999999


Q ss_pred             EEEEeccCC-CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          395 LIYEFVSNG-SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       395 lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      +||||+.+| +|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       106 lv~e~~~~g~~l~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          106 LVMEKHGSGLDLFAFIDRH------PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEECCTTSCBHHHHHHTC------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            999999766 999999865      468999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      ++........   ....||+.|+|||++.+. ...+.++||||||+++|+|++|+.||.........             
T Consensus       177 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------------  239 (335)
T 3dls_A          177 AAYLERGKLF---YTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA-------------  239 (335)
T ss_dssp             CEECCTTCCB---CEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT-------------
T ss_pred             ceECCCCCce---eccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh-------------
Confidence            9877654432   334589999999999764 23378999999999999999999999643211000             


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        ..       ..+..++.++.+|+.+||+.||++|||+++++++
T Consensus       240 --~~-------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 --AI-------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             --CC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             --cc-------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00       0011135678899999999999999999999984

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.9e-40  Score=333.53  Aligned_cols=266  Identities=19%  Similarity=0.265  Sum_probs=206.9

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEE-EeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFC-FEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~  402 (638)
                      +.+.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.++++++|++++..++.+ ......++||||+ +
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   88 (296)
T 4hgt_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   88 (296)
T ss_dssp             CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             eEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence            34578999999999999985 568899999876543 234678999999999987766655554 6778889999999 9


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE---CCCCceEEcccccceeccC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||+   +.++.+||+|||+++....
T Consensus        89 ~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           89 PSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            99999998643     469999999999999999999999   999999999999999   7899999999999987754


Q ss_pred             CCcee-----eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          480 RESIV-----SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       480 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      .....     ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.......................
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            43211     12345689999999999765  688999999999999999999999986544332222222111111110


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCC
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP  610 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  610 (638)
                      .        ......++.++.+++.+||+.||++|||+++|++.|++++.+.....
T Consensus       239 ~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~  286 (296)
T 4hgt_A          239 I--------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             H--------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred             h--------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence            0        00111235678999999999999999999999999999877665443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=346.09  Aligned_cols=246  Identities=26%  Similarity=0.309  Sum_probs=185.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      .+.+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++......++||||+++++
T Consensus        56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  134 (349)
T 2w4o_A           56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE  134 (349)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence            45789999999999999975 47899999997653 34567889999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC---CCceEEcccccceeccCCC
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFg~~~~~~~~~  481 (638)
                      |.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.   ++.+||+|||+++......
T Consensus       135 L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          135 LFDRIVEK------GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             HHHHHTTC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            99999764      458999999999999999999999   99999999999999975   8899999999998764432


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       ......+.... .   .
T Consensus       206 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~-~---~  269 (349)
T 2w4o_A          206 L---MKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCE-Y---Y  269 (349)
T ss_dssp             ----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTC-C---C
T ss_pred             c---cccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCC-C---c
Confidence            1   2345689999999999764  6889999999999999999999998643321       11111111110 0   0


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ........++.++.+|+.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111112234667889999999999999999999997

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-40  Score=339.05  Aligned_cols=259  Identities=25%  Similarity=0.437  Sum_probs=200.9

Q ss_pred             hhhhcccCcCcceeEEEEEEcC----CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEE-eCceEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCF-EGHRRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  397 (638)
                      +.+.+.||+|+||+||+|+..+    ...+|+|++.....  ..+.+.+|+.++++++||||+++++++. .+...++||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            3457899999999999998533    22589999876433  3457889999999999999999999865 456789999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++++|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+||+++.++.+||+|||+++..
T Consensus       107 e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          107 PYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             ECCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             eCCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence            9999999999997643     568999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCc--eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcC-CCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          478 EGRES--IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE-KNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       478 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      .....  ........+|+.|+|||.+.+.  .++.++||||||+++|+|++| .+||.......    ...    .....
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~----~~~~~  248 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITV----YLLQG  248 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----HHH----HHHTT
T ss_pred             cccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----HHH----HHhcC
Confidence            54321  1122345678899999999764  688999999999999999995 55554332111    000    01111


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                             .....+...+.++.+++.+||+.||++|||++++++.|++++.++..
T Consensus       249 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          249 -------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                   11111122356788999999999999999999999999998876553

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-40  Score=354.57  Aligned_cols=249  Identities=25%  Similarity=0.393  Sum_probs=203.3

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++....    ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~   98 (476)
T 2y94_A           19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV   98 (476)
T ss_dssp             EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45789999999999999964 68999999996532    33467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        99 ~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           99 SGGELFDYICKN------GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             SSEEHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999764      468999999999999999999999   99999999999999999999999999999877554


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..   .....||+.|+|||++.+. ...+.++||||||+++|+|++|+.||.....       ... ...+.... .   
T Consensus       170 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~-~~~i~~~~-~---  233 (476)
T 2y94_A          170 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTL-FKKICDGI-F---  233 (476)
T ss_dssp             CC---BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHH-HHHHHTTC-C---
T ss_pred             cc---ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHH-HHHHhcCC-c---
Confidence            32   2345689999999999764 2346899999999999999999999975322       111 11111110 0   


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhccc
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE--MLEGSL  603 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  603 (638)
                          ..+...+.++.+|+.+||+.||++|||++++++  .+++.+
T Consensus       234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence                011123457889999999999999999999997  355433

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.6e-40  Score=330.78  Aligned_cols=250  Identities=26%  Similarity=0.350  Sum_probs=201.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.+.||+|+||.||+|+.. +++.||||++....  ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence            345789999999999999864 68899999986543  334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           89 GGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             TEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             CCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999998754      458999999999999999999999   999999999999999999999999999998764433


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      .........||+.|+|||++.+. ...+.++||||||+++|+|++|+.||.........  ...+     ....      
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~-----~~~~------  225 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW-----KEKK------  225 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHH-----HTTC------
T ss_pred             chhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHh-----hhcc------
Confidence            22223445689999999998764 23477999999999999999999999754432111  1111     1100      


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ........++..+.+++.+||+.||++|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            001112234567889999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-40  Score=334.46  Aligned_cols=250  Identities=23%  Similarity=0.395  Sum_probs=201.1

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeC--ceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEG--HRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|++ +++.||||+++....   ..+.+.+|+.++++++||||+++++++.+.  ...++||||+
T Consensus        13 ~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (271)
T 3kmu_A           13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM   91 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred             HHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence            4578999999999999998 488999999976532   235788999999999999999999999877  7889999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCceEECCCCceEEcccccceecc
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      ++++|.+++....    ...+++..++.++.|+++||+|||+   .+  ++||||||+||+++.++.++|.|||++....
T Consensus        92 ~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           92 PYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             TTCBHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             CCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            9999999998743    2368999999999999999999999   78  9999999999999999999999998876432


Q ss_pred             CCCceeeecccccccceecCceecccc-CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .       ....||+.|+|||++.+.. ..++.++||||||+++|||++|+.||......       ........     
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~-----  225 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVAL-----  225 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHH-----
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHh-----
Confidence            2       2345799999999987541 23344899999999999999999998643211       11111111     


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                        .......+..++.++.+++.+||+.||++|||++++++.|+++.+
T Consensus       226 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 --EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence              111112222346678999999999999999999999999998654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.8e-41  Score=344.65  Aligned_cols=261  Identities=23%  Similarity=0.397  Sum_probs=207.4

Q ss_pred             hhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|+||+||+|+..      +++.||||++.....  ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  106 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  106 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence            345789999999999999754      367899999975443  234688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          397 YEFVSNGSLEKFIHEKHPL----ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      |||+++++|.+++......    .....+++..++.++.|+++||+|||+   ++|+||||||+||+++.++.+||+|||
T Consensus       107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCc
Confidence            9999999999999764210    112457899999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      +++...............+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||.....       .. .....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~-~~~~~  253 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQ-VLRFV  253 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HH-HHHHH
T ss_pred             cccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCH-------HH-HHHHH
Confidence            99866544333333344578899999998764  68899999999999999999 8888864321       11 11111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ...       ........++.++.+++.+||+.||++|||+.+++++|++.+..
T Consensus       254 ~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          254 MEG-------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HcC-------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            111       01111223456788999999999999999999999999997663

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-41  Score=345.27  Aligned_cols=255  Identities=23%  Similarity=0.398  Sum_probs=198.6

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC-C-------CEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD-G-------QNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  394 (638)
                      .+.+.+.||+|+||+||+|+... +       +.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI   88 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence            34467899999999999998543 3       469999986543 34567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc--------e
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--------P  466 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~--------~  466 (638)
                      +||||+++++|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.        +
T Consensus        89 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           89 LVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             EEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999998753     448999999999999999999999   99999999999999988877        9


Q ss_pred             EEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHH
Q 006620          467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW  546 (638)
Q Consensus       467 kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  546 (638)
                      ||+|||++......      ....||+.|+|||++.+. ..++.++||||||+++|||++|..|+......      .. 
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~-  226 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QR-  226 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HH-
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccch------HH-
Confidence            99999998754332      223478899999999763 36889999999999999999965544322211      00 


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIP  609 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  609 (638)
                      ........  ....   .    ..+.++.+++.+||+.||++|||+++++++|++++.....+
T Consensus       227 ~~~~~~~~--~~~~---~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          227 KLQFYEDR--HQLP---A----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             HHHHHHTT--CCCC---C----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             HHHHhhcc--CCCC---C----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence            00101100  0011   1    11346789999999999999999999999999987754443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=344.18  Aligned_cols=255  Identities=27%  Similarity=0.453  Sum_probs=197.9

Q ss_pred             hhcccCcCcceeEEEEEEcC-----CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-----GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.||+|+||+||+|....     +..||||+++....  ....+.+|+.++++++||||+++++++...+..++||||
T Consensus        48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  127 (333)
T 1mqb_A           48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY  127 (333)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence            46889999999999998543     23599999975432  235688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus       128 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          128 MENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             CTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999998643     568999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          480 RESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       480 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .... .......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ......+...   
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~---  266 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDG---  266 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT---
T ss_pred             ccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCC---
Confidence            3211 112233468899999999764  68899999999999999998 9999864321        1111111111   


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                          ........++.++.+++.+||+.||++||++.++++.|++++...
T Consensus       267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                111112234567889999999999999999999999999876543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.1e-40  Score=337.81  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=201.8

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC-------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG-------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  395 (638)
                      .+.+.+.||+|+||+||+|+.. +++.||||++.....       ..+.+.+|+.++++++||||+++++++.+....++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3456789999999999999964 588999999875432       24678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC----ceEEccc
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDF  471 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DF  471 (638)
                      ||||+++++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++    .+||+||
T Consensus        93 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EECCCCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999764      468999999999999999999999   9999999999999999887    7999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      |++........   .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       ... ..+
T Consensus       164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~-~~i  230 (321)
T 2a2a_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETL-ANI  230 (321)
T ss_dssp             TTCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHH-HHH
T ss_pred             ccceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------HHH-HHH
Confidence            99987654432   2345689999999998764  6889999999999999999999999643210       111 111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...    ............+..+.+++.+||+.||++|||++++++
T Consensus       231 ~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          231 TSV----SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HTT----CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Hhc----ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            100    001111112234567899999999999999999999997

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.9e-41  Score=343.76  Aligned_cols=257  Identities=21%  Similarity=0.298  Sum_probs=191.9

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc----hhhHHHHHHHHhhcCCcceEEEEeEEEeCce----EEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN----GEDFINEVASISRTSHVNIVTLLGFCFEGHR----RAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~l  395 (638)
                      |.+.+.||+|+||+||+|++ .+++.||||++......    ...+.+|+.++++++||||+++++++.....    .++
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l   93 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   93 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence            34578999999999999995 56889999999764322    2467899999999999999999999876543    499


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++++|.+++...      ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        94 v~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           94 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             EEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            99999999999999875      468999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          476 ICEGRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       476 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ........ .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       ..........
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~  235 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVRED  235 (311)
T ss_dssp             -----------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCC
Confidence            76543221 122335689999999999764  7889999999999999999999999653321       1111111000


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHHhcccC
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNR-VVEMLEGSLD  604 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-vl~~L~~~~~  604 (638)
                           ..........++.++.+++.+||+.||++||++.+ +...+.+...
T Consensus       236 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          236 -----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             -----CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             -----CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                 00000011224667899999999999999996555 5555655443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-40  Score=344.09  Aligned_cols=258  Identities=24%  Similarity=0.234  Sum_probs=198.1

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc------CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET------KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      +.+.+.||+|+||+||+|+. .+++.||+|++...      ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  107 (345)
T 3hko_A           28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM  107 (345)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence            44578999999999999986 45789999998643      234567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 006620          398 EFVSNGSLEKFIHEKHPLE----------------------------------TNQKLKWEVLYKIAVGIARGLEYLHRG  443 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~----------------------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~  443 (638)
                      ||+++|+|.+++.......                                  ....+++..++.++.|+++||+|||+ 
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-  186 (345)
T 3hko_A          108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-  186 (345)
T ss_dssp             ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-
Confidence            9999999999996321000                                  01224677889999999999999999 


Q ss_pred             CCCCeEecccCCCceEECCCC--ceEEcccccceeccCCCc--eeeecccccccceecCceeccccCCccccCCeeeHHH
Q 006620          444 CNTRILHFDIKPHNILLDEDF--CPKISDFGLAKICEGRES--IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGM  519 (638)
Q Consensus       444 ~~~~iiH~Dikp~NIll~~~~--~~kl~DFg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGv  519 (638)
                        .+|+||||||+||+++.++  .+||+|||+++.......  ........||+.|+|||++.+....++.++||||||+
T Consensus       187 --~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          187 --QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             --TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             --CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence              9999999999999998776  899999999987643221  1123445689999999999754347889999999999


Q ss_pred             HHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          520 MVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       520 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ++|||++|+.||......       .........     ...........++.++.+++.+||+.||++|||+.++++
T Consensus       265 il~el~~g~~pf~~~~~~-------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDA-------DTISQVLNK-----KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHH-------HHHHHHHHC-----CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHCCCCCCCCChH-------HHHHHHHhc-----ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999643321       111111110     011112222335678899999999999999999999997

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.5e-40  Score=343.56  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.+.||+|+||+||+++.. +++.||||++.....   ...+|++++.++ +||||+++++++.++...++||||+++
T Consensus        24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g  100 (342)
T 2qr7_A           24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG  100 (342)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence            445789999999999999864 588999999976543   345788888888 699999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC----CceEEcccccceecc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED----FCPKISDFGLAKICE  478 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~----~~~kl~DFg~~~~~~  478 (638)
                      |+|.+++...      ..+++..+..++.||++||+|||+   +||+||||||+|||+.++    +.+||+|||+++...
T Consensus       101 g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A          101 GELLDKILRQ------KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CBHHHHHHTC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999764      468999999999999999999999   999999999999998432    359999999998765


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      .....  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......     .......+.... ..
T Consensus       172 ~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~~-~~  241 (342)
T 2qr7_A          172 AENGL--LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSGK-FS  241 (342)
T ss_dssp             CTTCC--BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHCC-CC
T ss_pred             CCCCc--eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccCC-cc
Confidence            44321  2345689999999999764  57889999999999999999999997532211     111111111111 11


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                         ........++.++.+|+.+||+.||++|||+.+++++
T Consensus       242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               1111123356778999999999999999999999863

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.9e-40  Score=339.27  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=197.6

Q ss_pred             Hhhhh-cccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEE
Q 006620          324 TNSFK-NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       324 ~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+. +.||+|+||+||+|+.. +++.||||++....   .....+.+|+.+++++. ||||+++++++......++||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            33344 78999999999999864 58999999987543   23467889999999995 699999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC---CCceEEcccccc
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLA  474 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFg~~  474 (638)
                      ||+++++|.+++....    ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||++
T Consensus       109 e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             ECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             EecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            9999999999986532    2569999999999999999999999   99999999999999987   789999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      +.......   .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       .. ...+...
T Consensus       182 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~-~~~i~~~  248 (327)
T 3lm5_A          182 RKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ET-YLNISQV  248 (327)
T ss_dssp             EEC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH-HHHHHHT
T ss_pred             cccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HH-HHHHHhc
Confidence            87654332   2335689999999999764  7889999999999999999999999653321       11 0111110


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                          ...........++..+.+++.+||+.||++|||+++++++
T Consensus       249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          249 ----NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ----CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ----ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                1111122223346678899999999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=338.63  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             hhcccCcCcceeEEEEEEcC-CC---EEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceE-EEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-GQ---NVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRR-ALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~  399 (638)
                      ..++||+|+||+||+|++.+ ++   .||+|++.....  ..+.+.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus        25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  104 (298)
T 3pls_A           25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred             cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence            35889999999999998533 33   699999876443  346788999999999999999999999876655 899999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +.+++|.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus       105 ~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          105 MCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             ccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999998643     568999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCc--eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          480 RES--IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       480 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ...  ........+|+.|+|||.+.+.  .++.++||||||+++|+|++|+.|+.......   ...    .......  
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~----~~~~~~~--  245 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLT----HFLAQGR--  245 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHH----HHHHTTC--
T ss_pred             CcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHH----HHhhcCC--
Confidence            321  1122345678999999999764  68899999999999999999665543322110   011    1111111  


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                           ....+...+.++.+++.+||+.||++|||++++++.|+++++++..
T Consensus       246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                 1111223456788999999999999999999999999998877654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=334.59  Aligned_cols=257  Identities=26%  Similarity=0.360  Sum_probs=196.0

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC------CchhhHHHHHHHHhhcC---CcceEEEEeEEEeCc--
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK------GNGEDFINEVASISRTS---HVNIVTLLGFCFEGH--  391 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~--  391 (638)
                      .|.+.++||+|+||+||+|++ .+++.||||++....      .....+.+|++++++++   ||||+++++++....  
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            345678999999999999995 568899999987432      12346677888777765   999999999998755  


Q ss_pred             ---eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEE
Q 006620          392 ---RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI  468 (638)
Q Consensus       392 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  468 (638)
                         ..++||||+. ++|.+++....    ...+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           90 REIKVTLVFEHVD-QDLRTYLDKAP----PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             SEEEEEEEEECCC-CBHHHHHHTCC----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEE
T ss_pred             CceeEEEEehhhh-cCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEE
Confidence               5789999996 59999998753    2349999999999999999999999   99999999999999999999999


Q ss_pred             cccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHH
Q 006620          469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY  548 (638)
Q Consensus       469 ~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  548 (638)
                      +|||+++.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|++||.......    ......
T Consensus       162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~  232 (308)
T 3g33_A          162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIF  232 (308)
T ss_dssp             CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----HHHHHH
T ss_pred             eeCccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH
Confidence            99999986643332   2445689999999999764  68999999999999999999999996533210    000011


Q ss_pred             HHhhhhhhcc-----------ccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          549 KRLELEEDLG-----------LQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       549 ~~~~~~~~~~-----------~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..........           ......    ....+++.++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1100000000           000000    011134567889999999999999999999995

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.3e-40  Score=343.83  Aligned_cols=195  Identities=26%  Similarity=0.312  Sum_probs=171.4

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcC-----CcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTS-----HVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.++||+|+||+||+|+. .+++.||||+++......+.+..|++++++++     ||||+++++++...+..++|||
T Consensus        37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e  116 (360)
T 3llt_A           37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE  116 (360)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence            44578999999999999986 46889999999865555567788999999986     9999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC----------------
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE----------------  462 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~----------------  462 (638)
                      |+ +++|.+++....    ...+++..++.++.||++||+|||+   .+|+||||||+|||++.                
T Consensus       117 ~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~  188 (360)
T 3llt_A          117 PL-GPSLYEIITRNN----YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDG  188 (360)
T ss_dssp             CC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred             CC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccccc
Confidence            99 899999998753    2458999999999999999999999   99999999999999975                


Q ss_pred             ---------CCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCc
Q 006620          463 ---------DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANV  533 (638)
Q Consensus       463 ---------~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~  533 (638)
                               ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||..
T Consensus       189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          189 KKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             CEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                     7899999999998754332     345689999999999765  789999999999999999999999975


Q ss_pred             c
Q 006620          534 A  534 (638)
Q Consensus       534 ~  534 (638)
                      .
T Consensus       262 ~  262 (360)
T 3llt_A          262 H  262 (360)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.6e-40  Score=329.36  Aligned_cols=246  Identities=20%  Similarity=0.263  Sum_probs=200.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc-CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET-KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.+.||+|+||+||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (277)
T 3f3z_A           11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG   90 (277)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence            445789999999999999864 4678999998754 34567889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE---CCCCceEEcccccceeccC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++|.+++...      ..+++..++.++.|+++||+|||+   ++++||||||+||++   +.++.+||+|||++.....
T Consensus        91 ~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           91 GELFERVVHK------RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999999875      458999999999999999999999   999999999999999   7889999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...   .....||+.|+|||++.+   .++.++||||||+++|+|++|+.||......       . ........    .
T Consensus       162 ~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~~~~~~~~----~  223 (277)
T 3f3z_A          162 GKM---MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------E-VMLKIREG----T  223 (277)
T ss_dssp             TSC---BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHC----C
T ss_pred             ccc---hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhC----C
Confidence            432   234568999999999864   4788999999999999999999999653211       0 11111110    0


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..........++.++.+++.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00111111234678899999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.5e-40  Score=350.05  Aligned_cols=250  Identities=21%  Similarity=0.311  Sum_probs=193.8

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC---chhhHHHHHHHHhhcC--CcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---NGEDFINEVASISRTS--HVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      |.+.+.||+|+||+||++...+++.||||++.....   ..+.+.+|++++++++  ||||+++++++...+..++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            445789999999999999987799999999975432   2357889999999997  5999999999999999999999 


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +.+++|.+++...      ..+++..++.++.||++||+|||+   .+|+||||||+|||++ ++.+||+|||+++....
T Consensus       137 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          137 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            5688999999875      368899999999999999999999   9999999999999995 57999999999987754


Q ss_pred             CCceeeecccccccceecCceeccc---------cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRN---------FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      ...........||+.|+|||++.+.         ...++.++|||||||++|||++|+.||......      .......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~~~  280 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAI  280 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HHHHHHH
Confidence            4433333456799999999998641         125788999999999999999999999643211      0111111


Q ss_pred             hhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ..........       ...+.++.+|+.+||+.||++|||+.|++++
T Consensus       281 ~~~~~~~~~~-------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          281 IDPNHEIEFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HCTTSCCCCC-------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hCccccCCCC-------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1111111111       1124578899999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-40  Score=334.33  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=195.5

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.++||+|+||+||+++. .+++.+|+|++....  ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            455689999999999999986 458899999987653  33567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE---CCCCceEEcccccceec
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKIC  477 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFg~~~~~  477 (638)
                      ++++|.+++....  .....+++..++.++.|+++||+|||+   .+|+||||||+||++   +.++.+||+|||++...
T Consensus       103 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          103 EGGELLERIVSAQ--ARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             SCCBHHHHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCcHHHHHHhhh--hcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999986532  112569999999999999999999999   999999999999999   45688999999999876


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .....   .....||+.|+|||++.+   .++.++||||||+++|||++|+.||.....       ... ........  
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~~~-~~~~~~~~--  241 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------EEV-QQKATYKE--  241 (285)
T ss_dssp             ------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH-HHHHHHCC--
T ss_pred             CCccc---CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCH-------HHH-HhhhccCC--
Confidence            54332   234568999999999853   578899999999999999999999974321       111 11111100  


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ... .......+.++.+++.+||+.||++|||++|+++
T Consensus       242 --~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 --PNY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --CCC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --ccc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000 0011113467889999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.3e-39  Score=336.89  Aligned_cols=277  Identities=23%  Similarity=0.328  Sum_probs=211.3

Q ss_pred             CcccchHHHHHHHhhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhh--cCCcceEEEEeEEEe
Q 006620          312 PKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISR--TSHVNIVTLLGFCFE  389 (638)
Q Consensus       312 ~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~  389 (638)
                      ..++...+.....+.+.+.||+|+||+||+|+. +++.||||++...  ....+.+|++++..  ++||||+++++++..
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            344444455555666789999999999999988 5899999998643  34567788888887  789999999999988


Q ss_pred             Cc----eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecccCCCc
Q 006620          390 GH----RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH--------RGCNTRILHFDIKPHN  457 (638)
Q Consensus       390 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiH~Dikp~N  457 (638)
                      ..    ..++||||+++|+|.+++...       .+++..++.++.|+++||+|||        +   .+|+||||||+|
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~N  177 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKN  177 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGG
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHH
Confidence            76    789999999999999999763       4899999999999999999999        7   899999999999


Q ss_pred             eEECCCCceEEcccccceeccCCCcee--eecccccccceecCceeccccC----CccccCCeeeHHHHHHHHhcC----
Q 006620          458 ILLDEDFCPKISDFGLAKICEGRESIV--SMTGARGTIGYIAPEVFCRNFG----EVSYKSDVYSYGMMVFEMTGE----  527 (638)
Q Consensus       458 Ill~~~~~~kl~DFg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~s~~~DvwslGvil~elltg----  527 (638)
                      ||++.++.+||+|||++..........  ......||+.|+|||++.+...    .++.++||||||+++|||++|    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            999999999999999998776544322  2234568999999999865311    234689999999999999999    


Q ss_pred             ------CCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 006620          528 ------KNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE-EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE  600 (638)
Q Consensus       528 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  600 (638)
                            +.||.........  ...+. ..... ... ....... ...+....+.+++.+||+.||++|||+++|+++|+
T Consensus       258 ~~~~~~~~p~~~~~~~~~~--~~~~~-~~~~~-~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPS--VEEMR-KVVCE-QKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCC--HHHHH-HHHTT-SCC-CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             CcccccccCccccCcCccc--HHHHH-HHHHH-HHh-CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence                  5565443221111  11111 11110 000 0111111 22356778999999999999999999999999999


Q ss_pred             cccCCC
Q 006620          601 GSLDSL  606 (638)
Q Consensus       601 ~~~~~~  606 (638)
                      ++.++.
T Consensus       333 ~i~~~~  338 (342)
T 1b6c_B          333 QLSQQE  338 (342)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            876553

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-40  Score=348.57  Aligned_cols=268  Identities=21%  Similarity=0.288  Sum_probs=210.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCc--eEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGH--RRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~  400 (638)
                      .+.++||+|+||+||+|++. +++.||||++....  ...+.+.+|++++++++||||+++++++....  ..++||||+
T Consensus        12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~   91 (396)
T 4eut_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred             EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence            35789999999999999965 48899999997543  33567789999999999999999999998755  779999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE----CCCCceEEccccccee
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAKI  476 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFg~~~~  476 (638)
                      ++++|.+++....   ....+++..++.++.|+++||+|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        92 ~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           92 PCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             TTEEHHHHTTSGG---GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             CCCCHHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999998643   12349999999999999999999999   999999999999999    7788899999999987


Q ss_pred             ccCCCceeeecccccccceecCceeccc------cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRN------FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      ......   .....||+.|+|||++.+.      ...++.++||||||+++|||++|+.||.........   .......
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~---~~~~~~~  239 (396)
T 4eut_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKI  239 (396)
T ss_dssp             CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC---HHHHHHH
T ss_pred             ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch---HHHHHHH
Confidence            655432   2345689999999998641      125778999999999999999999999754332211   1111111


Q ss_pred             hhhhhh-------------cc---ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          551 LELEED-------------LG---LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       551 ~~~~~~-------------~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ......             +.   ...............+.+++.+||+.||++||+++++++.+++++..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111000             00   00111123356788899999999999999999999999999987664

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-40  Score=349.63  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=194.3

Q ss_pred             hhhcccCcCcceeEEEEEEcC--C--CEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEe-CceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD--G--QNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFE-GHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  398 (638)
                      .+.+.||+|+||+||+|+..+  +  ..||||+++...  ...+.+.+|+.++++++||||+++++++.. ++..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            346889999999999998532  2  368999987543  234678999999999999999999998754 557899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       172 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          172 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             CCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999997643     568899999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCce--eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          479 GRESI--VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       479 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      .....  .......+|+.|+|||++.+.  .++.++||||||+++|||++ |.+||.......    ...    ......
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~----~~~~~~  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITV----YLLQGR  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHH----HHHTTC
T ss_pred             ccccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHH----HHHcCC
Confidence            33211  112334578899999999764  78899999999999999999 667775433211    111    111111


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                             ....+..++..+.+++.+||+.||++|||++++++.|++++..+..
T Consensus       314 -------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          314 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                   1111223456788999999999999999999999999998877653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.7e-40  Score=344.34  Aligned_cols=245  Identities=21%  Similarity=0.283  Sum_probs=198.7

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-CCEEEEEEeccc----CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNET----KGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.+.||+|+||+||+|+... ++.||||+++..    ....+.+.+|..++..+ +||||+++++++.+.+..++|||
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E  101 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  101 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence            3457899999999999999754 789999999753    23456778999999887 79999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||+   +||+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A          102 YVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999875      458999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....        ......+... ...
T Consensus       173 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~-~~~  239 (353)
T 2i0e_A          173 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH-NVA  239 (353)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCC
T ss_pred             cCCc--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC-CCC
Confidence            2221  12445789999999999764  689999999999999999999999974321        1111111111 111


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVEM  598 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  598 (638)
                             .+..++.++.+|+.+||+.||++||+     +++++++
T Consensus       240 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          240 -------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                   11234667899999999999999995     5676653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.6e-40  Score=341.05  Aligned_cols=263  Identities=18%  Similarity=0.201  Sum_probs=196.2

Q ss_pred             HhhhhcccCcCcceeEEEEEEc----CCCEEEEEEecccCC------------chhhHHHHHHHHhhcCCcceEEEEeEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETKG------------NGEDFINEVASISRTSHVNIVTLLGFC  387 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~~~  387 (638)
                      .+.+.+.||+|+||+||+|+..    +++.+|||+......            ....+.+|+..++.++||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            3456789999999999999975    567899999875432            123467788899999999999999999


Q ss_pred             Ee----CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC
Q 006620          388 FE----GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED  463 (638)
Q Consensus       388 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~  463 (638)
                      ..    ....++||||+ +++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.+
T Consensus       118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERL-GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEESSSCEEEEEEEECE-EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred             ccccCCCcEEEEEEecc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence            88    78899999999 99999999865      368999999999999999999999   999999999999999877


Q ss_pred             C--ceEEcccccceeccCCCce-----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccC
Q 006620          464 F--CPKISDFGLAKICEGRESI-----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVD  536 (638)
Q Consensus       464 ~--~~kl~DFg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~  536 (638)
                      +  .+||+|||+++........     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            7  9999999999876432211     111345689999999999764  689999999999999999999999964322


Q ss_pred             CCcccchhHHHHHHhhhh-hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          537 RSSEIYFPHWVYKRLELE-EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       537 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ....  ... ........ ........   ....++.++.+++.+||+.||++|||+++|++.|+++..
T Consensus       266 ~~~~--~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          266 DPVA--VQT-AKTNLLDELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             CHHH--HHH-HHHHHHHTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             ccHH--HHH-HHHhhcccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1110  000 00000000 00000000   001345679999999999999999999999999998643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.6e-40  Score=341.87  Aligned_cols=245  Identities=23%  Similarity=0.284  Sum_probs=190.4

Q ss_pred             hhhhcccCcCcceeEEEEEE----cCCCEEEEEEecccC-----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL----LDGQNVAIKVLNETK-----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  395 (638)
                      +.+.+.||+|+||+||+++.    .+++.||||+++...     .....+.+|++++++++||||+++++++...+..++
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   98 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL   98 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence            34578999999999999986    468899999997542     233567889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++++|.+++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           99 ILEYLSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEeCCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999875      458899999999999999999999   999999999999999999999999999997


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      .......  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....       .... ..+... 
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~-~~i~~~-  236 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKTI-DKILKC-  236 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHH-HHHHHT-
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHHH-HHHHhC-
Confidence            5433221  12345689999999999764  678999999999999999999999975321       1111 111110 


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                      ...       .+..++.++.+++.+||+.||++||     ++++++++
T Consensus       237 ~~~-------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          237 KLN-------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             CCC-------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CCC-------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            011       1112456788999999999999999     77788763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-39  Score=330.06  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=202.5

Q ss_pred             HHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEe------------
Q 006620          323 MTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE------------  389 (638)
Q Consensus       323 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------------  389 (638)
                      ..+.+.+.||+|+||.||+|+.. +++.||+|++....   +.+.+|++++++++||||+++++++..            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            34556789999999999999975 68999999987543   467799999999999999999998864            


Q ss_pred             ----CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc
Q 006620          390 ----GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC  465 (638)
Q Consensus       390 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~  465 (638)
                          ....++||||+++++|.+++....    ...+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCC
Confidence                455789999999999999997642    2568999999999999999999999   99999999999999999999


Q ss_pred             eEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhH
Q 006620          466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH  545 (638)
Q Consensus       466 ~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~  545 (638)
                      +||+|||++........   .....||+.|+|||++.+.  .++.++||||||+++|+|++|..|+....         .
T Consensus       161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~  226 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETS---------K  226 (284)
T ss_dssp             EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------H
T ss_pred             EEECcchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhHH---------H
Confidence            99999999987755432   2334689999999999764  67899999999999999999988764211         0


Q ss_pred             HHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCC
Q 006620          546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP  610 (638)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  610 (638)
                       ......      .....    ..++.++.+++.+||+.||++|||+.|++++|+...+......
T Consensus       227 -~~~~~~------~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~  280 (284)
T 2a19_B          227 -FFTDLR------DGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE  280 (284)
T ss_dssp             -HHHHHH------TTCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred             -HHHHhh------ccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence             011111      00011    1234567899999999999999999999999999877655443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-40  Score=341.52  Aligned_cols=261  Identities=27%  Similarity=0.407  Sum_probs=206.7

Q ss_pred             hhhhcccCcCcceeEEEEEE------cCCCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCc-eEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL------LDGQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGH-RRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~  394 (638)
                      +.+.+.||+|+||+||+|++      .+++.||||++.....  ..+.+.+|+.+++++ +||||+++++++...+ ..+
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~  108 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  108 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence            44578999999999999974      2357899999976543  235788999999999 6999999999987754 589


Q ss_pred             EEEEeccCCCHHHHhhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLE----------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF  464 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~  464 (638)
                      +||||+++++|.+++.......          ....+++..++.++.|+++||+|||+   .+|+||||||+||+++.++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCC
Confidence            9999999999999998754210          01238899999999999999999999   9999999999999999999


Q ss_pred             ceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccch
Q 006620          465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYF  543 (638)
Q Consensus       465 ~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  543 (638)
                      .+||+|||+++...............||+.|+|||++.+.  .++.++||||||+++|||++ |+.||......      
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------  257 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------  257 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS------
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchh------
Confidence            9999999999877655444444556688999999999764  78899999999999999998 99998653321      


Q ss_pred             hHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          544 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                       .............       ..+...+.++.+++.+||+.||++|||+.+|+++|+++++
T Consensus       258 -~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          258 -EEFCRRLKEGTRM-------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             -HHHHHHHHHTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHhccCccC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             1111111111111       1111235578899999999999999999999999998754

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.2e-40  Score=335.83  Aligned_cols=257  Identities=19%  Similarity=0.281  Sum_probs=197.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc----hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN----GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++......    .+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus        37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 2h34_A           37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI  116 (309)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence            45789999999999999964 6889999999754322    356889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++......
T Consensus       117 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          117 NGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             CCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999875      458999999999999999999999   99999999999999999999999999999866543


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ... ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .........  .   
T Consensus       188 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~--~---  251 (309)
T 2h34_A          188 KLT-QLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQA--I---  251 (309)
T ss_dssp             ----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSC--C---
T ss_pred             ccc-cccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccC--C---
Confidence            211 22345689999999998764  6788999999999999999999998743211        111111110  0   


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhcccCCCC
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRP-SMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~  607 (638)
                      .........++.++.+++.+||+.||++|| +++++++.|++.+....
T Consensus       252 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          252 PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            000111223456788999999999999999 99999999999877654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.8e-40  Score=339.38  Aligned_cols=262  Identities=27%  Similarity=0.453  Sum_probs=204.3

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCE--EEEEEeccc--CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQN--VAIKVLNET--KGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.+.||+|+||.||+|+.. +++.  +|+|++...  ....+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  106 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE  106 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence            346789999999999999854 4554  499988753  23446788999999999 89999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEE
Q 006620          399 FVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKI  468 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  468 (638)
                      |+++++|.+++......          .....+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEE
Confidence            99999999999865310          122468999999999999999999999   99999999999999999999999


Q ss_pred             cccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHH
Q 006620          469 SDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWV  547 (638)
Q Consensus       469 ~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  547 (638)
                      +|||+++......   ......+++.|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ...
T Consensus       184 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~  250 (327)
T 1fvr_A          184 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL  250 (327)
T ss_dssp             CCTTCEESSCEEC---CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH
T ss_pred             cccCcCccccccc---cccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HHH
Confidence            9999987432211   11233468899999998764  67899999999999999998 9999864321        111


Q ss_pred             HHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 006620          548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIP  609 (638)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  609 (638)
                      ...+...       .....+..++.++.+++.+||+.||++|||+++++++|++++.+....
T Consensus       251 ~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  305 (327)
T 1fvr_A          251 YEKLPQG-------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  305 (327)
T ss_dssp             HHHGGGT-------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             HHHhhcC-------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence            1111111       111112234567899999999999999999999999999987765543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.8e-40  Score=359.68  Aligned_cols=249  Identities=25%  Similarity=0.338  Sum_probs=203.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++...    ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus       187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~  266 (576)
T 2acx_A          187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM  266 (576)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence            34689999999999999864 6899999999653    234456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++....    ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       267 ~gg~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          267 NGGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             CSCBHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            9999999998643    2459999999999999999999999   99999999999999999999999999999887654


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||........    ...+...+...      
T Consensus       340 ~~---~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~i~~~------  404 (576)
T 2acx_A          340 QT---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKEV------  404 (576)
T ss_dssp             CC---EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHHHHHC------
T ss_pred             cc---ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHHhhcc------
Confidence            43   2345789999999999764  688999999999999999999999976433211    11111111110      


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                        ....+..++.++.+|+.+||+.||++||     +++||+++
T Consensus       405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence              0111123456789999999999999999     78888764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=346.34  Aligned_cols=252  Identities=23%  Similarity=0.275  Sum_probs=200.1

Q ss_pred             hhhcccCcCcceeEEEEEE----cCCCEEEEEEecccC-----CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL----LDGQNVAIKVLNETK-----GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      .+.+.||+|+||+||+++.    .+++.||||+++...     ...+.+.+|+++++++ +||||+++++++......++
T Consensus        57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  136 (355)
T 1vzo_A           57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL  136 (355)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence            4578999999999999986    368899999987532     3345677899999999 69999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++++|.+++...      ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       137 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          137 ILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EeecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999875      458999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ........ ......||+.|+|||++.+....++.++||||||+++|||++|+.||........   ...........  
T Consensus       208 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~--  281 (355)
T 1vzo_A          208 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKS--  281 (355)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHC--
T ss_pred             ecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHHhcc--
Confidence            76433221 1234568999999999976434578899999999999999999999975432211   11111111110  


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEML  599 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  599 (638)
                         .    ...+..++..+.+|+.+||+.||++||     ++++++++.
T Consensus       282 ---~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 ---E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence               0    111123456788999999999999999     999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-39  Score=330.18  Aligned_cols=246  Identities=22%  Similarity=0.306  Sum_probs=199.4

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|+||+||+|... +++.||+|++.....   ..+.+.+|+.++++++||||+++++++......++||||++
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   88 (284)
T 3kk8_A            9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   88 (284)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence            35789999999999999864 588999999976432   23567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc---eEEcccccceecc
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDFGLAKICE  478 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFg~~~~~~  478 (638)
                      +++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.   +||+|||++....
T Consensus        89 ~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           89 GGELFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             SCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999998875      458999999999999999999999   99999999999999976655   9999999998765


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....   .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       . .........   
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~-~~~~~~~~~---  223 (284)
T 3kk8_A          160 DSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------R-LYAQIKAGA---  223 (284)
T ss_dssp             SSCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHTC---
T ss_pred             cCcc---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchh-------H-HHHHHHhcc---
Confidence            4432   2345689999999999764  6889999999999999999999998643211       1 111111110   


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       ..........++.++.+++.+||+.||++|||++|+++
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          224 -YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             01111112234567889999999999999999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1e-39  Score=346.43  Aligned_cols=246  Identities=22%  Similarity=0.290  Sum_probs=188.6

Q ss_pred             cccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhh-cCCcceEEEEeEEEe----CceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISR-TSHVNIVTLLGFCFE----GHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+++.. +++.||||+++..    ..+.+|++++.+ .+||||+++++++..    ....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            68999999999999864 5889999998642    456788888744 579999999999876    5678999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC---CCceEEcccccceeccC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICEG  479 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFg~~~~~~~  479 (638)
                      |+|.+++....    ...+++..++.|+.||++||+|||+   .+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       144 g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          144 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             CcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            99999998642    2469999999999999999999999   99999999999999987   78999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.............    ..+... ....
T Consensus       217 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----~~i~~~-~~~~  286 (400)
T 1nxk_A          217 HNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIRMG-QYEF  286 (400)
T ss_dssp             -------------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH----HHHHHT-CCCC
T ss_pred             CCc---cccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH----HHHHcC-cccC
Confidence            322   2345689999999999664  78899999999999999999999997654322111111    111111 0111


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                         .......++.++.+|+.+||+.||++|||+++++++
T Consensus       287 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          287 ---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ---CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               111112346778999999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.8e-41  Score=347.51  Aligned_cols=263  Identities=26%  Similarity=0.401  Sum_probs=202.8

Q ss_pred             hhhhcccCcCcceeEEEEEE------cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL------LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|+||+||+|++      .+++.||||++....  .....+.+|+.++++++||||+++++++......++|
T Consensus        32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (327)
T 2yfx_A           32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL  111 (327)
T ss_dssp             CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEE
Confidence            44678999999999999983      246789999996543  2345788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC---CCceEEcccc
Q 006620          397 YEFVSNGSLEKFIHEKHPL-ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFG  472 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFg  472 (638)
                      |||+++++|.+++...... .....+++..++.++.|+++||+|||+   .+|+||||||+|||++.   +..+||+|||
T Consensus       112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg  188 (327)
T 2yfx_A          112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFG  188 (327)
T ss_dssp             EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccc
Confidence            9999999999999875422 222458999999999999999999999   99999999999999984   4569999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      ++................+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||......       . .....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~-~~~~~  258 (327)
T 2yfx_A          189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------E-VLEFV  258 (327)
T ss_dssp             HHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------H-HHHHH
T ss_pred             cccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------H-HHHHH
Confidence            99865444332233345678999999998764  68899999999999999998 88888643210       1 11111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      ....       .......++..+.+++.+||+.||++|||+.+|+++|+.+.....
T Consensus       259 ~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          259 TSGG-------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             HTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             hcCC-------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            1111       111122345678899999999999999999999999998766543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.5e-40  Score=334.37  Aligned_cols=255  Identities=25%  Similarity=0.395  Sum_probs=202.0

Q ss_pred             hhc-ccCcCcceeEEEEEEc---CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKN-KLGQGGYGGVYKGKLL---DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+ .||+|+||+||+|.+.   +++.||||+++....   ..+.+.+|++++++++||||+++++++ ..+..++||||
T Consensus        20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~   98 (291)
T 1xbb_A           20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM   98 (291)
T ss_dssp             EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred             hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence            445 8999999999999642   367899999975432   246788999999999999999999998 56778999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++...      ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        99 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           99 AELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             CTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999874      458999999999999999999999   9999999999999999999999999999987755


Q ss_pred             CCceee-ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          480 RESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       480 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ...... .....+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||......        .....+....  
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~--  237 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGE--  237 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTC--
T ss_pred             CCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC--
Confidence            443221 2233467899999999764  67889999999999999999 99998753321        1111111111  


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQI  608 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  608 (638)
                           ....+..++.++.+++.+||+.||++|||+.++++.|++++.+...
T Consensus       238 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          238 -----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence                 1111223466789999999999999999999999999998765443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.7e-40  Score=330.71  Aligned_cols=244  Identities=26%  Similarity=0.400  Sum_probs=180.8

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++....    ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (278)
T 3cok_A           14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC   93 (278)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence            3578999999999999986 568999999986432    23467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        94 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           94 HNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             TTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             CCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999998643     568999999999999999999999   99999999999999999999999999999876533


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ...  .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||........       . ..      ....
T Consensus       166 ~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~-~~------~~~~  227 (278)
T 3cok_A          166 HEK--HYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------L-NK------VVLA  227 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSS
T ss_pred             CCc--ceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------H-HH------Hhhc
Confidence            211  1234689999999998764  678899999999999999999999975432110       0 00      0000


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..  ..+..++.++.+++.+||+.||++|||++++++
T Consensus       228 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 DY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            00  111224567889999999999999999999985

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=334.27  Aligned_cols=260  Identities=20%  Similarity=0.304  Sum_probs=195.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.++||+|+||+||+|+.. +++.||||++......   .+.+.+|++++++++||||+++++++...+..++||||++
T Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (311)
T 4agu_A            6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD   85 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence            35789999999999999964 4889999998655432   3567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~l~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           86 HTVLHELDRYQ------RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEHHHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             CchHHHHHhhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999988754      458999999999999999999999   999999999999999999999999999998765433


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhH-------HHHHHhhhh
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH-------WVYKRLELE  554 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~  554 (638)
                      ..  .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||..............       .........
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          157 DY--YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             -----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             cc--cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            21  2345689999999998753 3678999999999999999999999975432110000000       000000000


Q ss_pred             hh---ccccCC--CCc---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 ED---LGLQGI--ENE---EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~~---~~~~~~--~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..   ......  ...   ....++.++.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00   000000  000   01234567889999999999999999999996

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-40  Score=343.85  Aligned_cols=261  Identities=26%  Similarity=0.429  Sum_probs=206.5

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-C-----CEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-G-----QNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      +.+.+.||+|+||+||+|.... +     +.||+|++.....  ..+.+.+|+.+++++ +||||+++++++...+..++
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  127 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV  127 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence            4457899999999999998643 2     4799999976532  345788999999999 89999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceE
Q 006620          396 IYEFVSNGSLEKFIHEKHPLE--------TNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK  467 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~--------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  467 (638)
                      ||||+++|+|.+++.......        ....+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEE
Confidence            999999999999997642110        12458999999999999999999999   9999999999999999999999


Q ss_pred             EcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHH
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHW  546 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  546 (638)
                      |+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |..||.......       .
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~  275 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-------K  275 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-------H
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-------H
Confidence            9999999876544433333445678899999998764  68899999999999999998 888987543211       1


Q ss_pred             HHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          547 VYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ..........       ...+...+.++.+++.+||+.||++|||+++|+++|+++..
T Consensus       276 ~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          276 FYKLVKDGYQ-------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HHHHHHHTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCC-------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            1111111110       11111234678899999999999999999999999987643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=346.75  Aligned_cols=275  Identities=16%  Similarity=0.157  Sum_probs=209.9

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC---------CCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEE------------
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD---------GQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVT------------  382 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------  382 (638)
                      .+.+.+.||+|+||+||+|+...         ++.||||++...    +.+.+|++++++++||||++            
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            34467899999999999998653         789999998754    46789999999999999987            


Q ss_pred             ---EEeEEEe-CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCce
Q 006620          383 ---LLGFCFE-GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI  458 (638)
Q Consensus       383 ---l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NI  458 (638)
                         +++++.. +...++||||+ +++|.+++....    ...+++..++.++.|+++||+|||+   ++|+||||||+||
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI  190 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI  190 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence               6777776 77889999999 999999998742    2569999999999999999999999   9999999999999


Q ss_pred             EECCCC--ceEEcccccceeccCCCcee-----eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCC
Q 006620          459 LLDEDF--CPKISDFGLAKICEGRESIV-----SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNA  531 (638)
Q Consensus       459 ll~~~~--~~kl~DFg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~  531 (638)
                      |++.++  .+||+|||+++.........     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCc
Confidence            999988  99999999998765332111     11334689999999999764  6889999999999999999999999


Q ss_pred             CcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 006620          532 NVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPR  611 (638)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~  611 (638)
                      .........  ..............+....   .....++.++.+++.+||+.||++|||+++|++.|++++++......
T Consensus       269 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~  343 (352)
T 2jii_A          269 TNCLPNTED--IMKQKQKFVDKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPY  343 (352)
T ss_dssp             GGGTTCHHH--HHHHHHHHHHSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTT
T ss_pred             ccCCcCHHH--HHHHHHhccCChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcC
Confidence            765421111  1111100000000000000   00112356789999999999999999999999999999888776655


Q ss_pred             CcccCC
Q 006620          612 PFLLSS  617 (638)
Q Consensus       612 p~~~~~  617 (638)
                      ..+.+.
T Consensus       344 ~~~dw~  349 (352)
T 2jii_A          344 DPIGLP  349 (352)
T ss_dssp             SCCCCC
T ss_pred             ccccCc
Confidence            544443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.1e-40  Score=340.00  Aligned_cols=265  Identities=22%  Similarity=0.395  Sum_probs=197.1

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.+.||+|+||.||+|.. .+++.||||++....    ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  113 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL  113 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence            44578999999999999985 568999999987532    2345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....  .....+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus       114 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          114 ADAGDLSRMIKHFK--KQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             CCSCBHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             CCCCCHHHHHHHhc--ccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999997532  112568999999999999999999999   9999999999999999999999999999986644


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ....  .....|++.|+|||++.+.  .++.++||||||+++|+|++|+.||......     ..... ......     
T Consensus       189 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~-----  253 (310)
T 2wqm_A          189 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLC-KKIEQC-----  253 (310)
T ss_dssp             ------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CC-----HHHHH-HHHHTT-----
T ss_pred             CCcc--ccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchh-----HHHHH-HHhhcc-----
Confidence            3221  2334589999999998764  6889999999999999999999998643211     11111 111111     


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCC
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP  610 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  610 (638)
                       .........++.++.+++.+||+.||++|||+++|++.|+++......|+
T Consensus       254 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          254 -DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             -CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             -cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence             11111112345678999999999999999999999999999866555444

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.1e-40  Score=337.40  Aligned_cols=267  Identities=22%  Similarity=0.321  Sum_probs=196.8

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||+|+||+||+|+.. +++.||||++......  ...+.+|++++++++||||+++++++...+..++||||++ 
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-   83 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   83 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred             EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence            45789999999999999965 6889999998754322  2355689999999999999999999999999999999997 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           84 KDLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             EEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            59999998753     568999999999999999999999   9999999999999999999999999999986543322


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh-------
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE-------  555 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  555 (638)
                        ......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.......    .............       
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             ---------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTG
T ss_pred             --ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhchhh
Confidence              22345679999999998653 367899999999999999999999997543211    0000001000000       


Q ss_pred             -------hccccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhcccCCCCC
Q 006620          556 -------DLGLQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE--MLEGSLDSLQI  608 (638)
Q Consensus       556 -------~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~~  608 (638)
                             .........    .....++.++.+|+.+||+.||++|||++|+++  .+.+.......
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  294 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK  294 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence                   000000000    011124567889999999999999999999997  34444443333

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2e-39  Score=327.96  Aligned_cols=248  Identities=24%  Similarity=0.345  Sum_probs=198.5

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC-------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG-------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  395 (638)
                      .+.+.+.||+|+||+||+|+.. +++.||+|+++....       ..+.+.+|+.++++++||||+++++++.+....++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            3456789999999999999965 588999999875421       24678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC----ceEEccc
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDF  471 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DF  471 (638)
                      ||||+++++|.+++...      ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++    .+||+||
T Consensus        86 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999764      468999999999999999999999   9999999999999998777    8999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      |++........   .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       .. ....
T Consensus       157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~-~~~~  223 (283)
T 3bhy_A          157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQ-------ET-LTNI  223 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HH-HHHH
T ss_pred             ccceeccCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HH-HHHh
Confidence            99987654332   2334689999999998754  6889999999999999999999998653211       00 1111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...    ............+..+.+++.+||+.||++|||+.++++
T Consensus       224 ~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          224 SAV----NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HTT----CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Hhc----ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            100    001111122234567889999999999999999999997

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.1e-40  Score=343.90  Aligned_cols=245  Identities=27%  Similarity=0.370  Sum_probs=197.3

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +...+.||+|+||+||+|+. .+++.||||++.....    ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  135 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY  135 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence            34468899999999999985 5688999999975432    235688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +. |+|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          136 CL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             CS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             CC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            97 68988887543     568999999999999999999999   8999999999999999999999999999986543


Q ss_pred             CCceeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      .      ....||+.|+|||++.+. .+.++.++||||||+++|||++|+.||.....       ......... ..   
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~-~~---  269 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQ-NE---  269 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH-SC---
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHh-cC---
Confidence            2      234689999999998531 24688899999999999999999999864321       111111111 10   


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                         ........++..+.+++.+||+.||++|||+++++++
T Consensus       270 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          270 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               0111112345678899999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.4e-40  Score=333.45  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=197.9

Q ss_pred             hhhcccCcCcceeEEEEEEcC----CCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .+.+.||+|+||+||+|++.+    +..||+|++....  ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus        15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   93 (281)
T 3cc6_A           15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL   93 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence            457899999999999998543    2359999987643  234678899999999999999999998765 456899999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           94 YPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             CTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            99999999998753     568999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      .... ......+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||.......    .    .......... 
T Consensus       166 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~----~~~~~~~~~~-  233 (281)
T 3cc6_A          166 EDYY-KASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----V----IGVLEKGDRL-  233 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----H----HHHHHHTCCC-
T ss_pred             cccc-ccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHH----H----HHHHhcCCCC-
Confidence            3321 12334578899999999754  68899999999999999998 999986433211    1    1111111111 


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                            ..+..++..+.+++.+||+.||++|||+.+++++|++++
T Consensus       234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence                  111223567889999999999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=342.46  Aligned_cols=252  Identities=17%  Similarity=0.171  Sum_probs=202.5

Q ss_pred             hhhcccCcCcceeEEEEE------EcCCCEEEEEEecccCCchhhHHHHHHHHhhcC---CcceEEEEeEEEeCceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGK------LLDGQNVAIKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  396 (638)
                      .+.++||+|+||+||+|.      ..+++.||||+++..  ...++..|++++++++   |+||+++++++...+..++|
T Consensus        68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv  145 (365)
T 3e7e_A           68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV  145 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred             EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence            356889999999999993      446889999998654  3456778888888887   99999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-----------CCc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-----------DFC  465 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-----------~~~  465 (638)
                      |||+++|+|.+++...... ....+++..++.|+.||++||+|||+   .+|+||||||+|||++.           ++.
T Consensus       146 ~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          146 GELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             ECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             EeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCC
Confidence            9999999999999864311 13569999999999999999999999   99999999999999988           899


Q ss_pred             eEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhH
Q 006620          466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH  545 (638)
Q Consensus       466 ~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~  545 (638)
                      +||+|||+++...............||+.|+|||++.+.  .++.++|||||||++|||++|+.||..........    
T Consensus       222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----  295 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP----  295 (365)
T ss_dssp             EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE----
T ss_pred             EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCceee----
Confidence            999999999876533333344567799999999999775  68999999999999999999999986543211100    


Q ss_pred             HHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHhcccCC
Q 006620          546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDR-PSMNRVVEMLEGSLDS  605 (638)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~~  605 (638)
                              .  ......      ...+.+.+++..||+.+|.+| |+++++.+.|++.+..
T Consensus       296 --------~--~~~~~~------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          296 --------E--GLFRRL------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             --------C--SCCTTC------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --------c--hhcccc------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                    0  000111      114456788999999999999 6889999888886554

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=367.23  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=199.9

Q ss_pred             ccCcCcceeEEEEEEc---CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          330 KLGQGGYGGVYKGKLL---DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +||+|+||+||+|.+.   ++..||||+++...  ...+++.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999764   45679999997643  345789999999999999999999999876 56899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce-
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI-  483 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~-  483 (638)
                      |.+++....     ..+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++........ 
T Consensus       422 L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          422 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             HHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            999997643     569999999999999999999999   99999999999999999999999999999876433221 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .......+|+.|+|||++.+.  .++.++|||||||++|||++ |+.||......       . +...+...       .
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~-~~~~i~~~-------~  556 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------E-VMAFIEQG-------K  556 (613)
T ss_dssp             --------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------H-HHHHHHTT-------C
T ss_pred             eeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------H-HHHHHHcC-------C
Confidence            112233457899999999764  78999999999999999998 99999754321       1 11111111       1


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      ....+..++.++.+++.+||+.||++||++++|++.|+..+.++.
T Consensus       557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            112223456788999999999999999999999999998765443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.4e-40  Score=331.60  Aligned_cols=241  Identities=27%  Similarity=0.387  Sum_probs=194.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++....    .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (279)
T 3fdn_A           12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA   91 (279)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence            35789999999999999864 47789999986432    23457889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++......
T Consensus        92 ~~~~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           92 PLGTVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             TTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999999999875      458999999999999999999999   99999999999999999999999999998654433


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .    .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.....       .. ........ .    
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~-~~~~~~~~-~----  223 (279)
T 3fdn_A          163 R----RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QE-TYKRISRV-E----  223 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHHT-C----
T ss_pred             c----ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HH-HHHHHHhC-C----
Confidence            2    2334689999999998764  678899999999999999999999864321       11 11111110 0    


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                         ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       224 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          224 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               0111223567889999999999999999999997

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.9e-40  Score=345.87  Aligned_cols=259  Identities=23%  Similarity=0.301  Sum_probs=186.2

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCc--eEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTS-HVNIVTLLGFCFEGH--RRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~  397 (638)
                      |.+.+.||+|+||+||+|.+ .+++.||||++....   .....+.+|+.+++++. ||||+++++++...+  ..++||
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~   90 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF   90 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence            44578999999999999985 468899999986432   23456789999999998 999999999997544  789999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||++ ++|.+++..       ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        91 e~~~-~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           91 DYME-TDLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             ECCS-EEHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             cccC-cCHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            9997 599999976       358999999999999999999999   99999999999999999999999999999875


Q ss_pred             cCCC-------------------ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCC
Q 006620          478 EGRE-------------------SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS  538 (638)
Q Consensus       478 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~  538 (638)
                      ....                   .........||+.|+|||++.+. ..++.++|||||||++|||++|++||.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            4311                   01122345799999999998763 368999999999999999999999997543210


Q ss_pred             cccchhHHH----------------------HHHhhhhhhccccCCCCchh------------HHHHHHHHHHHHHcccC
Q 006620          539 SEIYFPHWV----------------------YKRLELEEDLGLQGIENEED------------KEYARKMILVSLWCIQT  584 (638)
Q Consensus       539 ~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~cl~~  584 (638)
                         .+....                      ....................            ...+.++.+|+.+||+.
T Consensus       239 ---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          239 ---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             ---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             ---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence               000000                      00000000000000000000            02345788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 006620          585 NPSDRPSMNRVVEM  598 (638)
Q Consensus       585 dP~~RPs~~evl~~  598 (638)
                      ||++|||++|++++
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.4e-39  Score=338.51  Aligned_cols=249  Identities=21%  Similarity=0.323  Sum_probs=199.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc---------hhhHHHHHHHHhhc-CCcceEEEEeEEEeCceE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN---------GEDFINEVASISRT-SHVNIVTLLGFCFEGHRR  393 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  393 (638)
                      +.+.+.||+|+||.||+|++. +|+.||||++......         .+.+.+|+.+++++ +||||+++++++......
T Consensus        96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  175 (365)
T 2y7j_A           96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM  175 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred             cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence            344689999999999999975 6899999998754321         34578899999999 799999999999999999


Q ss_pred             EEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      ++||||+++++|.+++...      ..+++..+..++.|++.||+|||+   .|++||||||+||+++.++.+||+|||+
T Consensus       176 ~lv~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          176 FLVFDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             EEEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCc
Confidence            9999999999999999864      468999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccc----cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRN----FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      +........   .....||+.|+|||++.+.    ...++.++||||||+++|+|++|+.||.....        .....
T Consensus       247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~~~~~  315 (365)
T 2y7j_A          247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------ILMLR  315 (365)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH
T ss_pred             ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------HHHHH
Confidence            987765432   2345689999999998643    12578899999999999999999999864321        00111


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .+.... .   ..........+..+.+++.+||+.||++|||++++++
T Consensus       316 ~i~~~~-~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 MIMEGQ-Y---QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHTC-C---CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCC-C---CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111000 0   0001111233567889999999999999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.5e-40  Score=369.14  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=198.2

Q ss_pred             cccCcCcceeEEEEEEc---CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLL---DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ++||+|+||+||+|.+.   .++.||||+++....   ..+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   357899999976432   24688999999999999999999999864 568899999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++...      ..+++..++.|+.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       454 g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          454 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             CCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            9999999764      468999999999999999999999   9999999999999999999999999999987654332


Q ss_pred             e-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          483 I-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       483 ~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      . .......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......        .+...+...      
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~------  588 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKG------  588 (635)
T ss_dssp             ----------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTT------
T ss_pred             ccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC------
Confidence            1 122334568899999999764  78999999999999999998 99999754321        111111111      


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                       .....+..++.++.+++.+||+.||++|||+++|++.|++.+.+
T Consensus       589 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          589 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence             11112223467889999999999999999999999999986543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.4e-39  Score=328.75  Aligned_cols=243  Identities=26%  Similarity=0.395  Sum_probs=194.6

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe----CceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE----GHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  397 (638)
                      .+.+.||+|+||+||+|.. .++..||+|++....   ...+.+.+|+.++++++||||+++++++..    ....++||
T Consensus        29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  108 (290)
T 1t4h_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence            3467899999999999986 457889999987543   234568899999999999999999999875    45689999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCceEEC-CCCceEEcccccc
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLD-EDFCPKISDFGLA  474 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--iiH~Dikp~NIll~-~~~~~kl~DFg~~  474 (638)
                      ||+++++|.+++...      ..+++..++.++.|+++||+|||+   .+  ++||||||+||+++ .++.+||+|||++
T Consensus       109 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          109 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EecCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            999999999999875      458999999999999999999999   78  99999999999997 8899999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ........    ....||+.|+|||++.+   .++.++||||||+++|+|++|+.||......      .. ........
T Consensus       180 ~~~~~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~-~~~~~~~~  245 (290)
T 1t4h_A          180 TLKRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQ-IYRRVTSG  245 (290)
T ss_dssp             GGCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HH-HHHHHTTT
T ss_pred             cccccccc----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HH-HHHHHhcc
Confidence            76544322    23458999999998864   5789999999999999999999998643321      11 11111110


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            ..........+.++.+++.+||+.||++|||++++++
T Consensus       246 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 ------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                  0111112223457889999999999999999999996

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.6e-40  Score=337.34  Aligned_cols=261  Identities=24%  Similarity=0.338  Sum_probs=200.8

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEe----CceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFE----GHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  399 (638)
                      .+.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|++++++++||||+++++++..    ....++||||
T Consensus        32 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~  111 (317)
T 2buj_A           32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF  111 (317)
T ss_dssp             EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred             EEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEe
Confidence            4578999999999999996 568999999886543 344678899999999999999999999873    4578899999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++....  .....+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++.....
T Consensus       112 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          112 FKRGTLWNEIERLK--DKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             CTTCBHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             CCCCcHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            99999999998642  123579999999999999999999999   8999999999999999999999999999876432


Q ss_pred             CCce-------eeecccccccceecCceecccc-CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          480 RESI-------VSMTGARGTIGYIAPEVFCRNF-GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       480 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      ....       .......||+.|+|||++.+.. ..++.++||||||+++|||++|+.||..........  ...    .
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~----~  260 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV--ALA----V  260 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH--HHH----H
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh--hHH----h
Confidence            1100       0012234699999999986531 236889999999999999999999986432211111  000    0


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ..  ..     .......++.++.+++.+||+.||++|||+++++++|+++..
T Consensus       261 ~~--~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          261 QN--QL-----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HC--C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hc--cC-----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            00  00     011112345678999999999999999999999999998643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.3e-39  Score=352.65  Aligned_cols=247  Identities=28%  Similarity=0.382  Sum_probs=197.4

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      |.+.++||+|+||+||+|+.. +++.||||++....   .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus        39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  118 (494)
T 3lij_A           39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY  118 (494)
T ss_dssp             EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence            445789999999999999964 58899999987542   33567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC---CCceEEcccccceec
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKIC  477 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFg~~~~~  477 (638)
                      ++|+|.+++...      ..+++..++.++.||++||+|||+   .+|+||||||+|||++.   ++.+||+|||++...
T Consensus       119 ~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          119 KGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999998775      458999999999999999999999   99999999999999975   455999999999877


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .....   .....||+.|+|||++.+   .++.++||||+||++|+|++|++||......       . ....+....  
T Consensus       190 ~~~~~---~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~~~~i~~~~--  253 (494)
T 3lij_A          190 ENQKK---MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------E-ILRKVEKGK--  253 (494)
T ss_dssp             BTTBC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHTC--
T ss_pred             CCCcc---ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCC--
Confidence            64432   234568999999999853   6889999999999999999999999753321       1 111111110  


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        ..........++.++.+|+.+||+.||++|||+++++++
T Consensus       254 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          254 --YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             --CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence              011112223456778999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.3e-40  Score=345.31  Aligned_cols=245  Identities=22%  Similarity=0.265  Sum_probs=189.3

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHH-HhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVAS-ISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.+.||+|+||+||+|+.. +++.||||+++...    .....+.+|..+ ++.++||||+++++++.+.+..++|||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E  119 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD  119 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence            345789999999999999964 47899999997543    223456667766 567899999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          120 YINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999875      468899999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....       .. ....+... ...
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~-~~~~i~~~-~~~  257 (373)
T 2r5t_A          191 EHNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AE-MYDNILNK-PLQ  257 (373)
T ss_dssp             CCCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HH-HHHHHHHS-CCC
T ss_pred             cCCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HH-HHHHHHhc-ccC
Confidence            2221  12445789999999999764  688999999999999999999999964321       11 11111111 111


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .       +..++.++.+|+.+||+.||++||++.+.++.
T Consensus       258 ~-------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          258 L-------KPNITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             C-------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             C-------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence            1       11245678899999999999999998644433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-39  Score=327.31  Aligned_cols=242  Identities=23%  Similarity=0.327  Sum_probs=199.1

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.+.||+|+||.||+|+.. +++.||||++...    ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   95 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF   95 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence            345789999999999999864 5778999998643    23346788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.+++...      ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        96 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           96 APRGELYKELQKH------GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999875      358999999999999999999999   9999999999999999999999999999976543


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ..    .....|++.|+|||++.+.  .++.++||||||+++|+|++|+.||......       .. ...... ...  
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~-~~~~~~-~~~--  229 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ET-HRRIVN-VDL--  229 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HH-HHHHHT-TCC--
T ss_pred             cc----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HH-HHHHhc-ccc--
Confidence            32    1345689999999999764  6789999999999999999999998643211       11 111110 001  


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                           ..+..++.++.+++.+||+.||++|||++++++
T Consensus       230 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 -----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 111224567889999999999999999999996

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-39  Score=354.67  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=201.1

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.||+|+||+||+|+.. +++.||||++....    ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus       189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~  268 (543)
T 3c4z_A          189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN  268 (543)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence            3578999999999999964 58999999996532    334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      ||+|.+++....  .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       269 gg~L~~~l~~~~--~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~  343 (543)
T 3c4z_A          269 GGDIRYHIYNVD--EDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ  343 (543)
T ss_dssp             TCBHHHHHHTSS--TTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCCHHHHHHHhh--cccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence            999999997643  123569999999999999999999999   999999999999999999999999999998765443


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ..  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||........   ... ....+... ..    
T Consensus       344 ~~--~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~-~~~~i~~~-~~----  410 (543)
T 3c4z_A          344 TK--TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKE-LKQRVLEQ-AV----  410 (543)
T ss_dssp             CC--BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHH-HHHHHHHC-CC----
T ss_pred             cc--cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHH-HHHHHhhc-cc----
Confidence            21  2345789999999999764  789999999999999999999999975432111   111 11111110 01    


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSM-----NRVVE  597 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  597 (638)
                         ..+..++.++.+|+.+||+.||++||++     ++|++
T Consensus       411 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          411 ---TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence               1112345678899999999999999975     56654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.2e-39  Score=352.11  Aligned_cols=248  Identities=25%  Similarity=0.356  Sum_probs=201.5

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc---CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET---KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      .|.+.++||+|+||+||+|+.. +++.||||++...   ......+.+|++++++++||||+++++++.+....++||||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  102 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL  102 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence            4566899999999999999864 6889999998643   33456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC---CCCceEEccccccee
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKI  476 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFg~~~~  476 (638)
                      +.+++|.+++...      ..+++..++.++.||++||+|||+   ++|+||||||+|||++   .++.+||+|||+++.
T Consensus       103 ~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          103 YTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999775      458999999999999999999999   9999999999999995   456799999999986


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ......   .....||+.|+|||++.+   .++.++|||||||++|+|++|++||......       . ....+.... 
T Consensus       174 ~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~~~~i~~~~-  238 (486)
T 3mwu_A          174 FQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------D-ILKRVETGK-  238 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHTC-
T ss_pred             CCCCCc---cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCC-
Confidence            654332   244568999999999865   5889999999999999999999999643210       1 111111110 


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                         ..........++.++.+|+.+||+.||++|||+.+++++
T Consensus       239 ---~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          239 ---YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ---CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ---CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               011122233456788999999999999999999999974

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-39  Score=352.48  Aligned_cols=192  Identities=26%  Similarity=0.384  Sum_probs=150.3

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeC-----ceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEG-----HRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  395 (638)
                      +.+.+.||+|+||+||+|+.. +++.||||++.....   ..+.+.+|+.++++++||||+++++++...     ...++
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            345789999999999999854 688999999865432   235788999999999999999999998543     56899


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+ +++|.+++...      ..+++..++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       135 v~e~~-~~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          135 VLEIA-DSDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EECCC-SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEecc-ccchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccch
Confidence            99998 56999999764      469999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCce-------------------------eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcC
Q 006620          476 ICEGRESI-------------------------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGE  527 (638)
Q Consensus       476 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg  527 (638)
                      ........                         ......+||+.|+|||++... ..++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHh
Confidence            76422110                         123445789999999987443 3689999999999999999994

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.8e-39  Score=354.09  Aligned_cols=245  Identities=27%  Similarity=0.346  Sum_probs=197.3

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--------------CchhhHHHHHHHHhhcCCcceEEEEeEEEeC
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--------------GNGEDFINEVASISRTSHVNIVTLLGFCFEG  390 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  390 (638)
                      .+.++||+|+||+||+|+.. +++.||||++....              ...+.+.+|+.++++++||||+++++++.+.
T Consensus        39 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  118 (504)
T 3q5i_A           39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK  118 (504)
T ss_dssp             EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            35789999999999999964 57899999987542              2345788999999999999999999999999


Q ss_pred             ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC---ceE
Q 006620          391 HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPK  467 (638)
Q Consensus       391 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~k  467 (638)
                      ...++||||+++|+|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++   .+|
T Consensus       119 ~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          119 KYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             CEEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999775      458999999999999999999999   9999999999999998765   699


Q ss_pred             EcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHH
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWV  547 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  547 (638)
                      |+|||+++.......   .....||+.|+|||++.+   .++.++||||+|+++|+|++|++||......       . .
T Consensus       190 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~  255 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-------D-I  255 (504)
T ss_dssp             ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-H
T ss_pred             EEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------H-H
Confidence            999999987765432   234568999999999864   5889999999999999999999999753321       1 1


Q ss_pred             HHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          548 YKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...+....    ..........++.++.+|+.+||+.||++|||++|+++
T Consensus       256 ~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          256 IKKVEKGK----YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHCC----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCC----CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11111110    00011112234678999999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-39  Score=348.71  Aligned_cols=249  Identities=21%  Similarity=0.276  Sum_probs=188.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---------CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---------GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  394 (638)
                      +.+.++||+|+||+||+|.. .+++.||||++....         .....+.+|++++++++||||+++++++. .+..+
T Consensus       137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~  215 (419)
T 3i6u_A          137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYY  215 (419)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEE
T ss_pred             EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceE
Confidence            44578999999999999986 457899999987532         11235789999999999999999999875 45689


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC---ceEEccc
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF---CPKISDF  471 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DF  471 (638)
                      +||||+++++|.+++...      ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++   .+||+||
T Consensus       216 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          216 IVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             EEEECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             EEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeec
Confidence            999999999999988764      468999999999999999999999   9999999999999996544   5999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceecc-ccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      |+++.......   .....||+.|+|||++.+ ....++.++||||||+++|+|++|+.||.......   .....    
T Consensus       287 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~----  356 (419)
T 3i6u_A          287 GHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQ----  356 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHHHH----
T ss_pred             ccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHHHH----
Confidence            99987654322   234568999999999853 12367889999999999999999999997543211   11111    


Q ss_pred             hhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          551 LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....    ..........++.++.+|+.+||+.||++|||++|+++
T Consensus       357 i~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 ITSGK----YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHTTC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCC----CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11000    00111122234678899999999999999999999997

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.8e-40  Score=348.05  Aligned_cols=279  Identities=24%  Similarity=0.271  Sum_probs=205.1

Q ss_pred             HHhcCCCCCcccchHHHHHHHhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcC------
Q 006620          304 LRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTS------  376 (638)
Q Consensus       304 l~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------  376 (638)
                      ...+.......+...++....|.+.++||+|+||+||+|+. .+++.||||+++......+.+.+|+.++++++      
T Consensus        18 ~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~   97 (397)
T 1wak_A           18 PNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND   97 (397)
T ss_dssp             ----CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTC
T ss_pred             cccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCC
Confidence            33443333344444444444566788999999999999985 45789999999866555677889999999986      


Q ss_pred             --CcceEEEEeEEE----eCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeE
Q 006620          377 --HVNIVTLLGFCF----EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RIL  449 (638)
Q Consensus       377 --h~niv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~ii  449 (638)
                        |+||+++++++.    .....++||||+ +++|.+++....    ...+++..++.++.||++||+|||+   + +|+
T Consensus        98 ~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~---~~giv  169 (397)
T 1wak_A           98 PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN----YQGLPLPCVKKIIQQVLQGLDYLHT---KCRII  169 (397)
T ss_dssp             GGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEE
T ss_pred             CCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence              788999999988    556889999999 667777776532    2469999999999999999999999   8 999


Q ss_pred             ecccCCCceEECCCC-------------------------------------------------ceEEcccccceeccCC
Q 006620          450 HFDIKPHNILLDEDF-------------------------------------------------CPKISDFGLAKICEGR  480 (638)
Q Consensus       450 H~Dikp~NIll~~~~-------------------------------------------------~~kl~DFg~~~~~~~~  480 (638)
                      ||||||+|||++.++                                                 .+||+|||++......
T Consensus       170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~  249 (397)
T 1wak_A          170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH  249 (397)
T ss_dssp             CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC
T ss_pred             cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc
Confidence            999999999998775                                                 7999999999876533


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHH--HHHHhhh-----
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHW--VYKRLEL-----  553 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~-----  553 (638)
                           .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...............  .......     
T Consensus       250 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~  322 (397)
T 1wak_A          250 -----FTEDIQTRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL  322 (397)
T ss_dssp             -----SCSCCSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHH
T ss_pred             -----CccCCCCCcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHH
Confidence                 2345689999999999765  6889999999999999999999999765432211000000  0000000     


Q ss_pred             ------hhh-cc----ccCC--------------CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 ------EED-LG----LQGI--------------ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ------~~~-~~----~~~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            ... ..    ....              ........+.++.+|+.+||+.||++|||++|+++
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             hhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                  000 00    0000              00123456778999999999999999999999996

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.4e-39  Score=334.94  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=196.4

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe--------Cce
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE--------GHR  392 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~  392 (638)
                      |.+.++||+|+||+||+|+. .+++.||||++....   .....+.+|++++++++||||+++++++..        .+.
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   98 (351)
T 3mi9_A           19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   98 (351)
T ss_dssp             EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred             eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence            44578999999999999996 568999999986543   224577899999999999999999999987        446


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      .++||||+++ +|.+.+....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        99 ~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           99 IYLVFDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             EEEEEECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence            8999999975 8888887543     469999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCC--ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH
Q 006620          473 LAKICEGRE--SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       473 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      +++......  .........||+.|+|||++.+. ..++.++||||||+++|||++|++||.......    ........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~  244 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQL  244 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHH
Confidence            998765322  11223445689999999998654 357899999999999999999999987543210    00000000


Q ss_pred             hhhh--------------hhccc-cCCCCchhHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          551 LELE--------------EDLGL-QGIENEEDKE-----YARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       551 ~~~~--------------~~~~~-~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....              ..+.. ..........     ...++.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0000              00000 0000111111     1346889999999999999999999996

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.5e-39  Score=329.94  Aligned_cols=247  Identities=24%  Similarity=0.354  Sum_probs=198.6

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.+.||+|+||+||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS   89 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence            3445789999999999999864 688999999976532 34568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE---CCCCceEEcccccceecc
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICE  478 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFg~~~~~~  478 (638)
                      +++|.+++...      ..+++..++.++.|+++||+|||+   .+++||||||+||++   +.++.+||+|||+++...
T Consensus        90 ~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           90 GGELFDRILER------GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             SCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CccHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999765      458999999999999999999999   999999999999999   788999999999987654


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...    .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......        .....+.... . 
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~-~-  224 (304)
T 2jam_A          161 NGI----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIKEGY-Y-  224 (304)
T ss_dssp             CBT----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHCC-C-
T ss_pred             CCc----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCC-C-
Confidence            322    1234589999999999764  7889999999999999999999998643210        1111111110 0 


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        .........++.++.+++.+||+.||++|||++++++
T Consensus       225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          225 --EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             --CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0111122234567899999999999999999999996

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-39  Score=329.62  Aligned_cols=243  Identities=23%  Similarity=0.327  Sum_probs=195.1

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.+.||+|+||+||+|+.. +++.||||++....   .....+.+|+..+.++ +||||+++++++.+.+..++||||
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~   92 (289)
T 1x8b_A           13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY   92 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence            445789999999999999965 68999999987542   2345788999999999 899999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC----------------
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED----------------  463 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~----------------  463 (638)
                      +++++|.+++....  .....+++..++.++.|+++||+|||+   ++|+||||||+||+++.+                
T Consensus        93 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           93 CNGGSLADAISENY--RIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             CTTCBHHHHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred             cCCCcHHHHHHhhc--ccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            99999999998642  112468999999999999999999999   999999999999999844                


Q ss_pred             ---CceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc
Q 006620          464 ---FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE  540 (638)
Q Consensus       464 ---~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~  540 (638)
                         ..+||+|||.+.......      ...||+.|+|||++.+. ..++.++||||||+++|+|++|.+++.....    
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ----  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred             CCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence               479999999998765433      23479999999998754 3567899999999999999999887542210    


Q ss_pred             cchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          541 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                             ........   .    ...+..++.++.+++.+||+.||++|||+.++++
T Consensus       237 -------~~~~~~~~---~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -------WHEIRQGR---L----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -------HHHHHTTC---C----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHcCC---C----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                   01111110   1    1111234567889999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.7e-40  Score=331.89  Aligned_cols=248  Identities=26%  Similarity=0.456  Sum_probs=194.4

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeC-ceEEEEEEeccCCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEG-HRRALIYEFVSNGS  404 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gs  404 (638)
                      .+.+.||+|+||+||++.. +++.||||+++... ..+.+.+|++++++++||||+++++++... ...++||||+++++
T Consensus        24 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~  101 (278)
T 1byg_A           24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  101 (278)
T ss_dssp             EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             eEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence            4578999999999999987 48899999997543 456789999999999999999999987654 47899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++.......   
T Consensus       102 L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  171 (278)
T 1byg_A          102 LVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  171 (278)
T ss_dssp             HHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             HHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence            999998642    1237899999999999999999999   999999999999999999999999999988654332   


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                        ....+++.|+|||++.+.  .++.++||||||+++|+|++ |+.||......       ... .....       ...
T Consensus       172 --~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~-~~~~~-------~~~  232 (278)
T 1byg_A          172 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVV-PRVEK-------GYK  232 (278)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHH-HHHTT-------TCC
T ss_pred             --cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHH-HHHhc-------CCC
Confidence              223468899999999764  68899999999999999998 99998643221       111 11111       111


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ......++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            11222345678999999999999999999999999998643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=334.37  Aligned_cols=268  Identities=24%  Similarity=0.394  Sum_probs=205.4

Q ss_pred             hhhhcccCcCcceeEEEEEE-----cCCCEEEEEEecccCC-chhhHHHHHHHHhhcCCcceEEEEeEEEeCc--eEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-----LDGQNVAIKVLNETKG-NGEDFINEVASISRTSHVNIVTLLGFCFEGH--RRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  396 (638)
                      +.+.+.||+|+||.||+++.     .+++.||||++..... ..+.+.+|++++++++||||+++++++....  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            34578999999999999984     3578999999976433 3467899999999999999999999987644  67999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++..
T Consensus       123 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ECCCTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EECCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            99999999999998753     468999999999999999999999   9999999999999999999999999999988


Q ss_pred             ccCCCceee-ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCC----cccchhHHHHHHh
Q 006620          477 CEGRESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS----SEIYFPHWVYKRL  551 (638)
Q Consensus       477 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~  551 (638)
                      ......... .....++..|+|||++.+.  .++.++||||||+++|||++|+.|+.......    ............+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            765443222 2234578889999999764  67899999999999999999998876321100    0000000000000


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      .  ..+ ........+..++.++.+++.+||+.||++|||+.+|++.|+++.++
T Consensus       273 ~--~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          273 I--ELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             H--HHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H--HHh-hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            0  000 01111111233456789999999999999999999999999987654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-39  Score=354.25  Aligned_cols=247  Identities=28%  Similarity=0.355  Sum_probs=202.7

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .|.+.+.||+|+||+||+|+.. +++.||||++...    ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  106 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE  106 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            4556789999999999999964 6899999998643    2345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE---CCCCceEEcccccce
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAK  475 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFg~~~  475 (638)
                      |+.+++|.+++...      ..+++..++.++.|+++||+|||+   ++|+||||||+|||+   +.++.+||+|||+++
T Consensus       107 ~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          107 VYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             CCCSCBHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             cCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999764      468999999999999999999999   999999999999999   567899999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      .......   .....||+.|+|||++.+   .++.++|||||||++|+|++|++||......        .....+....
T Consensus       178 ~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~  243 (484)
T 3nyv_A          178 HFEASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEKGK  243 (484)
T ss_dssp             HBCCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC
T ss_pred             Ecccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCC
Confidence            7654432   234568999999999865   5788999999999999999999999753211        1111111110


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                          ..........++.++.+|+.+||+.||++|||++|+++
T Consensus       244 ----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          244 ----YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ----CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                01112223345678899999999999999999999996

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.6e-40  Score=353.53  Aligned_cols=244  Identities=21%  Similarity=0.311  Sum_probs=190.2

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.++||+|+||.||+|+. .+++.||||++...    ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus       151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  230 (446)
T 4ejn_A          151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA  230 (446)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred             EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence            4578999999999999985 45889999999753    233456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|+|.+++...      ..+++..+..++.||++||+|||+  .++|+||||||+|||++.++.+||+|||+++.....
T Consensus       231 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          231 NGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             SSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            999999999875      468999999999999999999995  168999999999999999999999999999864332


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       .. ...+.. ....  
T Consensus       303 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~-~~~i~~-~~~~--  367 (446)
T 4ejn_A          303 GA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KL-FELILM-EEIR--  367 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH-HHHHHH-CCCC--
T ss_pred             Cc--ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HH-HHHHHh-CCCC--
Confidence            22  23456789999999999764  7899999999999999999999999643211       11 111111 0111  


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  597 (638)
                           .+..++.++.+|+.+||+.||++||     +++|+++
T Consensus       368 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 -----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                 1122456788999999999999999     9999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-39  Score=348.44  Aligned_cols=196  Identities=26%  Similarity=0.372  Sum_probs=162.4

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeC-----ceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEG-----HRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  396 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++.....   ..+.+.+|+.++++++||||+++++++...     ...++|
T Consensus        29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  108 (432)
T 3n9x_A           29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV  108 (432)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence            35789999999999999864 578899999975432   235788999999999999999999998776     578999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+. ++|.+++...      ..+++..++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          109 LEIAD-SDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EECCS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EecCC-cCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            99986 5999999764      469999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCce--------------------eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCC
Q 006620          477 CEGRESI--------------------VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNAN  532 (638)
Q Consensus       477 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~  532 (638)
                      .......                    .......||+.|+|||++... ..++.++|||||||++|||++|..|+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence            6543211                    123456789999999987543 368999999999999999998655553

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.3e-39  Score=333.22  Aligned_cols=255  Identities=20%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEe--CceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFE--GHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~  400 (638)
                      +.+.++||+|+||+||+|+. .+++.||||+++..  ..+.+.+|+.++++++ ||||+++++++.+  ....++||||+
T Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             eEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            34578999999999999985 56889999998743  3567889999999997 9999999999987  66789999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-ceEEcccccceeccC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKICEG  479 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFg~~~~~~~  479 (638)
                      ++++|.+++..         +++..++.++.|+++||+|||+   .+|+||||||+|||++.++ .+||+|||+++....
T Consensus       116 ~~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          116 NNTDFKQLYQT---------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCCCHHHHGGG---------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             CchhHHHHHHh---------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999998853         7889999999999999999999   9999999999999998766 899999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh------HHHHHHhhh
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP------HWVYKRLEL  553 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~------~~~~~~~~~  553 (638)
                      ...   .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.............      .........
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            432   2345689999999998653 368899999999999999999999986433211110000      000000000


Q ss_pred             hh--------hc-------c-ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 EE--------DL-------G-LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ~~--------~~-------~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..        ..       . ...........++.++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00        00       0 000111112235678999999999999999999999996

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.6e-39  Score=334.68  Aligned_cols=256  Identities=25%  Similarity=0.348  Sum_probs=189.3

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.+.++||+|+||+||+|+. .+++.||||+++....   ..+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  115 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA  115 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence            34578999999999999985 4688999999975432   2356789999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE-----CCCCceEEcccccce
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL-----DEDFCPKISDFGLAK  475 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll-----~~~~~~kl~DFg~~~  475 (638)
                      ++ +|.+++...      ..+++..++.++.||++||+|||+   .+|+||||||+|||+     +.++.+||+|||+++
T Consensus       116 ~~-~L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          116 EN-DLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             SE-EHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             CC-CHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            75 999999875      358999999999999999999999   999999999999999     455669999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      .......  ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......   .... .........
T Consensus       186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~-~~~~~~~~~  258 (329)
T 3gbz_A          186 AFGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFK-IFEVLGLPD  258 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-HHHHHCCCC
T ss_pred             ccCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHH-HHHHhCCCc
Confidence            7643322  12345679999999998764 357899999999999999999999997543210   0000 000000000


Q ss_pred             hc-------------cccCCCCc-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DL-------------GLQGIENE-----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~-------------~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..             ........     ....++.++.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00             00000000     01114567889999999999999999999995

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.2e-39  Score=334.92  Aligned_cols=243  Identities=25%  Similarity=0.339  Sum_probs=199.1

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.||+|+||.||+++.. +++.||+|++....    ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  124 (335)
T 2owb_A           45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR  124 (335)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence            4688999999999999964 47899999987542    234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..++.++.|+++||+|||+   ++|+||||||+||+++.++.+||+|||++.......
T Consensus       125 ~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          125 RRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             TCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999998865      468999999999999999999999   999999999999999999999999999998765332


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ..  .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.....       .... ...... ....  
T Consensus       196 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~-~~~~~~-~~~~--  260 (335)
T 2owb_A          196 ER--KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETY-LRIKKN-EYSI--  260 (335)
T ss_dssp             CC--BCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHH-HHHHHT-CCCC--
T ss_pred             cc--ccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHH-HHHhcC-CCCC--
Confidence            21  2345689999999999764  678899999999999999999999864321       1111 111110 0111  


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                           +..+..++.+++.+||+.||++|||+++++++
T Consensus       261 -----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          261 -----PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 11234568899999999999999999999973

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.2e-39  Score=343.66  Aligned_cols=195  Identities=25%  Similarity=0.303  Sum_probs=168.8

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhc------CCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRT------SHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.++||+|+||+||+|+.. +++.||||++.......+.+.+|+.+++.+      +|+||+++++++......++|||
T Consensus       100 ~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e  179 (429)
T 3kvw_A          100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE  179 (429)
T ss_dssp             EEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred             EEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence            45789999999999999864 588999999987655556778888888877      57799999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc--eEEccccccee
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC--PKISDFGLAKI  476 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DFg~~~~  476 (638)
                      |+. ++|.+++....    ...+++..++.++.||++||+|||+   .+|+||||||+|||++.++.  +||+|||++..
T Consensus       180 ~~~-~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          180 LLS-MNLYELIKKNK----FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             CCC-CBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             ccC-CCHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            995 69999998753    2458999999999999999999999   89999999999999999887  99999999976


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCccc
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAV  535 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~  535 (638)
                      .....     ....||+.|+|||++.+.  .++.++|||||||++|||++|++||....
T Consensus       252 ~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          252 EHQRV-----YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             TTCCC-----CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCcc-----cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            54332     345689999999999765  68999999999999999999999997543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.4e-39  Score=328.35  Aligned_cols=244  Identities=25%  Similarity=0.333  Sum_probs=199.4

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||+++.. +++.||+|++....    ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   97 (294)
T 2rku_A           18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC   97 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence            35789999999999999965 47899999986542    23456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           98 RRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             TTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999998765      468999999999999999999999   99999999999999999999999999999876533


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ...  .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       ... ...... ..   
T Consensus       169 ~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~-~~~~~~-~~---  232 (294)
T 2rku_A          169 GER--KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETY-LRIKKN-EY---  232 (294)
T ss_dssp             TCC--BCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHH-HHHHTT-CC---
T ss_pred             ccc--cccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH-HHHhhc-cC---
Confidence            221  2335689999999998764  6788999999999999999999998643211       111 111110 00   


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                          ..+...+..+.+++.+||+.||++|||+++++++
T Consensus       233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                0111234578899999999999999999999974

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.4e-39  Score=347.34  Aligned_cols=259  Identities=20%  Similarity=0.271  Sum_probs=204.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCC-cceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSH-VNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      .+.++||+|+||.||+|++ .+++.||||++..... ...+.+|+++++.++| +++..+..++......++||||+ ++
T Consensus        10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~   87 (483)
T 3sv0_A           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP   87 (483)
T ss_dssp             ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence            4578999999999999985 5689999998875433 3468899999999986 56667777778888999999999 99


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE---CCCCceEEcccccceeccCC
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL---DEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +|.+++....     ..+++..++.|+.||+.||+|||+   ++|+||||||+||||   +.++.+||+|||+++.....
T Consensus        88 sL~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           88 SLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            9999998643     569999999999999999999999   999999999999999   68899999999999877654


Q ss_pred             Ccee-----eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          481 ESIV-----SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       481 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ....     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||...........+..........  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~--  235 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT--  235 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS--
T ss_pred             ccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc--
Confidence            3211     12245689999999999765  68999999999999999999999998654432221111111111100  


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                            ........++.++.+++.+||+.+|++||++++|++.|++++.
T Consensus       236 ------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          236 ------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             ------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                  0011112345688999999999999999999999999988744

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-39  Score=330.84  Aligned_cols=255  Identities=24%  Similarity=0.390  Sum_probs=193.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc--CCC--EEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL--DGQ--NVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|+||+||+|++.  +++  .||||+++...    ...+.+.+|++++++++||||+++++++..+. .++|
T Consensus        20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v   98 (291)
T 1u46_A           20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV   98 (291)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred             eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence            345789999999999999853  233  68999987542    23467889999999999999999999988755 8899


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||++..
T Consensus        99 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           99 TELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            99999999999998753     458999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCcee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          477 CEGRESIV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       477 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ........ ......+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||.....       .... ..... 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~-~~~~~-  239 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQIL-HKIDK-  239 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHH-HHHHT-
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHH-HHHHc-
Confidence            75543322 22334578899999999764  67899999999999999999 9999864321       1111 11110 


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                           ..........++.++.+++.+||+.||++|||+.++++.|+++..
T Consensus       240 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          240 -----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -----cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                 111111222346778999999999999999999999999998654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=328.05  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=197.6

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++......++||||++++
T Consensus        31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  109 (314)
T 3com_A           31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG  109 (314)
T ss_dssp             EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence            345789999999999999865 48899999997643 4467899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....     ..+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||++........ 
T Consensus       110 ~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          110 SVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             EHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence            9999997542     568999999999999999999999   9999999999999999999999999999987654322 


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                       ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       .... .....     ....
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~-~~~~~-----~~~~  244 (314)
T 3com_A          181 -KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIF-MIPTN-----PPPT  244 (314)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH-HHHHS-----CCCC
T ss_pred             -ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHH-HHhcC-----CCcc
Confidence             12345689999999998764  6889999999999999999999998643210       0000 00000     0001


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......++.++.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1112234567899999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.9e-39  Score=348.23  Aligned_cols=257  Identities=25%  Similarity=0.255  Sum_probs=189.9

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  394 (638)
                      |.+.++||+|+||+||+|+. .+++.||||++....   ...+.+.+|+.++++++||||+++++++...      ...+
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            34578999999999999985 458899999997542   2345788999999999999999999999654      4579


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccc
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      +||||+++ +|.+.+..        .+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       144 lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          144 LVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             EEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            99999976 57776642        38899999999999999999999   99999999999999999999999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchhHH
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFPHW  546 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~  546 (638)
                      +.......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||........-        ...+.+
T Consensus       212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          212 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             -----CCC---C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eecCCCcc---cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            87654322   2445789999999999875  7899999999999999999999999754311000        000000


Q ss_pred             H-------HHHhhhhh---hcc--------ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          547 V-------YKRLELEE---DLG--------LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       547 ~-------~~~~~~~~---~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .       ........   ...        ............+.++.+|+.+||+.||++|||++|++++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0       00000000   000        0001111223346789999999999999999999999974

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.5e-39  Score=329.73  Aligned_cols=244  Identities=24%  Similarity=0.373  Sum_probs=200.2

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ...+.||+|+||+||+|+. .+++.||||++....  ...+.+.+|+.++++++||||+++++++......++||||+++
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  104 (303)
T 3a7i_A           25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG  104 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence            3468899999999999985 458899999997543  3456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++..       ..+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       105 ~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          105 GSALDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            999999875       358999999999999999999999   9999999999999999999999999999987654332


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                        ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       . .........       
T Consensus       175 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~~-------  235 (303)
T 3a7i_A          175 --KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPM-------K-VLFLIPKNN-------  235 (303)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------H-HHHHHHHSC-------
T ss_pred             --ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------H-HHHHhhcCC-------
Confidence              12345689999999999764  6788999999999999999999998643210       0 111111110       


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .......++..+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            011112235678899999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=326.23  Aligned_cols=249  Identities=19%  Similarity=0.276  Sum_probs=196.7

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc-----CCchhhHHHHHHHHhhcCCcceEEEEeEEE--eCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET-----KGNGEDFINEVASISRTSHVNIVTLLGFCF--EGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~  397 (638)
                      .+.+.||+|+||.||++.. .+++.||+|+++..     ....+.+.+|++++++++||||+++++++.  +....++||
T Consensus         8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (305)
T 2wtk_C            8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM   87 (305)
T ss_dssp             CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred             eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence            4578999999999999996 45889999998753     234467899999999999999999999984  455789999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||++++ |.+++....    ...+++..++.++.|+++||+|||+   ++++||||||+||+++.++.+||+|||++...
T Consensus        88 e~~~~~-l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           88 EYCVCG-MQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             ECCSEE-HHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             hhccCC-HHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            999875 888887643    2568999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .............||+.|+|||++.+.....+.++||||||+++|||++|+.||.....       .. ....+... ..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~-~~~~i~~~-~~  230 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YK-LFENIGKG-SY  230 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HH-HHHHHHHC-CC
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HH-HHHHHhcC-CC
Confidence            54333333445668999999999875433457799999999999999999999874321       11 11111111 00


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .       .+..++..+.+++.+||+.||++|||+++++++
T Consensus       231 ~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 A-------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             C-------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             C-------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0       111235578899999999999999999999974

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-39  Score=336.04  Aligned_cols=258  Identities=24%  Similarity=0.309  Sum_probs=196.4

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      |.+.+.||+|+||+||+|+.. +++.||||++.....      ..+.+.+|++++++++||||+++++++......++||
T Consensus        12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (346)
T 1ua2_A           12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF   91 (346)
T ss_dssp             -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred             cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence            345789999999999999964 588999999875321      1346789999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++ +|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        92 e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           92 DFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             ECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            99976 8999987643     468889999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh-
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED-  556 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  556 (638)
                      .....  ......||+.|+|||++.+. ..++.++||||||+++|||++|.+||.......   .+.. .......... 
T Consensus       163 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~-i~~~~~~~~~~  235 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTR-IFETLGTPTEE  235 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-HHHHHCCCCTT
T ss_pred             cCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHH-HHHHcCCCChh
Confidence            43322  12345689999999998653 357889999999999999999999986543210   0000 0010000000 


Q ss_pred             -----------ccccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          557 -----------LGLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       557 -----------~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                                 .........    .....+.++.+|+.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                       000000000    012345678999999999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-39  Score=335.70  Aligned_cols=253  Identities=24%  Similarity=0.285  Sum_probs=189.7

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCc------eEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGH------RRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  395 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++.....   ..+.+.+|++++++++||||+++++++....      ..++
T Consensus        28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l  107 (367)
T 1cm8_A           28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL  107 (367)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence            3468899999999999986 4689999999865432   2356789999999999999999999998653      4599


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+ +++|.+++..       ..+++..+..++.|+++||+|||+   .||+||||||+|||++.++.+||+|||+++
T Consensus       108 v~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          108 VMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             EEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            99999 8899999976       358999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHH--------
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWV--------  547 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~--------  547 (638)
                      .....     .....+|+.|+|||++.+. ..++.++||||+||++|||++|+.||.......   .+....        
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPA  247 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence            76432     2345689999999998763 368899999999999999999999997543210   000000        


Q ss_pred             --HHHhhh------hhhcc-ccC-CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 --YKRLEL------EEDLG-LQG-IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 --~~~~~~------~~~~~-~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                        ...+..      ...+. ... .........+.++.+|+.+||+.||++|||+++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence              000000      00000 000 0000112235678899999999999999999999983

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.7e-40  Score=343.63  Aligned_cols=258  Identities=22%  Similarity=0.338  Sum_probs=198.6

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      +.+.+.||+|+||+||+|+.. +++.||+|++.....  ..+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus        35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  114 (360)
T 3eqc_A           35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD  114 (360)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence            345789999999999999964 588999999976532  24578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   + +|+||||||+||+++.++.+||+|||++......
T Consensus       115 ~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          115 GGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             TCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999875      358999999999999999999998   6 8999999999999999999999999998755322


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhH---------------
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH---------------  545 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~---------------  545 (638)
                      .    .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||..............               
T Consensus       186 ~----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          186 M----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             C--------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             c----ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            2    1334689999999999764  788999999999999999999999975432110000000               


Q ss_pred             -------HHHHH------hhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          546 -------WVYKR------LELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       546 -------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                             +....      ......+............++.++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                   00000      00000000000111111224567899999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.4e-39  Score=326.29  Aligned_cols=249  Identities=27%  Similarity=0.364  Sum_probs=196.5

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ...||+|+||+||+|+. .+++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  106 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL  106 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence            35899999999999985 457899999987653 3356788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-CCceEEcccccceeccCCCcee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      .+++....   ....+++..++.++.|+++||+|||+   .+++|+||||+||+++. ++.+||+|||++........  
T Consensus       107 ~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--  178 (295)
T 2clq_A          107 SALLRSKW---GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--  178 (295)
T ss_dssp             HHHHHHTT---CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred             HHHHHhhc---cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--
Confidence            99998752   12456789999999999999999999   99999999999999987 89999999999987654322  


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      ......||+.|+|||++.+....++.++||||||+++|+|++|+.||.......      .........       ....
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-------~~~~  245 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMF-------KVHP  245 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHH-------CCCC
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhccc-------cccc
Confidence            123456899999999997643347889999999999999999999986432210      000000000       0111


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..+..++.++.+++.+||+.||++|||++++++
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            112234567889999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.1e-40  Score=336.90  Aligned_cols=267  Identities=22%  Similarity=0.362  Sum_probs=195.8

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.||+|+||+||+|+..+  .+|+|+++...   ...+.+.+|+.++++++||||+++++++......++||||+++
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~  113 (319)
T 2y4i_B           36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG  113 (319)
T ss_dssp             ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCS
T ss_pred             EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccC
Confidence            357899999999999998743  59999987543   2345678899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++ ++.+||+|||++........
T Consensus       114 ~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          114 RTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             EEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            99999997643     468999999999999999999999   9999999999999998 67999999999876532111


Q ss_pred             ---eeeecccccccceecCceeccc-------cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          483 ---IVSMTGARGTIGYIAPEVFCRN-------FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       483 ---~~~~~~~~gt~~y~aPE~~~~~-------~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                         ........||+.|+|||++.+.       ...++.++||||||+++|||++|+.||......       . ......
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~-~~~~~~  256 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------A-IIWQMG  256 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------H-HHHHHH
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHhc
Confidence               1112334589999999998642       124788999999999999999999998743211       1 111111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCcccCC
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPFLLSS  617 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~~  617 (638)
                      ....   ...   ....++.++.+++.+||+.||++|||++++++.|+++.+.....+.|...+.
T Consensus       257 ~~~~---~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~  315 (319)
T 2y4i_B          257 TGMK---PNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK  315 (319)
T ss_dssp             TTCC---CCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred             cCCC---CCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence            1110   000   1112345688999999999999999999999999999888777666655544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=336.65  Aligned_cols=264  Identities=22%  Similarity=0.282  Sum_probs=188.1

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcC-CcceEEEEeEEE--------eCceE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTS-HVNIVTLLGFCF--------EGHRR  393 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~~~  393 (638)
                      +.+.++||+|+||+||+|++ .+++.||||++.... ...+.+.+|+.+++++. ||||+++++++.        .....
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~  109 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF  109 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence            34578999999999999996 468899999885543 33457889999999996 999999999984        34457


Q ss_pred             EEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCceEECCCCceEEccc
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLDEDFCPKISDF  471 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--iiH~Dikp~NIll~~~~~~kl~DF  471 (638)
                      ++||||+. |+|.+++....   ....+++..++.++.|+++||+|||+   .+  |+||||||+|||++.++.+||+||
T Consensus       110 ~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          110 LLLTELCK-GQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEECCS-EEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             EEEEEecC-CCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence            89999995 69999987632   12469999999999999999999999   88  999999999999999999999999


Q ss_pred             ccceeccCCCcee----------eecccccccceecCceecc-ccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc
Q 006620          472 GLAKICEGRESIV----------SMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE  540 (638)
Q Consensus       472 g~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~  540 (638)
                      |+++.........          ......||+.|+|||++.. ....++.++||||||+++|+|++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998765432211          1113458999999999832 12367889999999999999999999986432210  


Q ss_pred             cchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCc
Q 006620          541 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRPF  613 (638)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~  613 (638)
                           ....      ...     ..........+.+++.+||+.||++|||++|++++|+.+.......+...
T Consensus       261 -----~~~~------~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~  317 (337)
T 3ll6_A          261 -----IVNG------KYS-----IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP  317 (337)
T ss_dssp             ----------------CC-----CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             -----hhcC------ccc-----CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCcc
Confidence                 0000      000     01111123457789999999999999999999999999877655544443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.8e-40  Score=344.50  Aligned_cols=251  Identities=11%  Similarity=0.029  Sum_probs=178.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC----chhhHHHHHHHHhhc--CCcceEEEE-------eEEEeC-
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG----NGEDFINEVASISRT--SHVNIVTLL-------GFCFEG-  390 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~~-  390 (638)
                      .+.+.||+|+||+||+|++. +++.||||++.....    ..+.+.+|+.+++.+  +||||++++       +++... 
T Consensus        65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~  144 (371)
T 3q60_A           65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS  144 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred             eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence            35689999999999999964 688999999987542    234566775544444  699988865       444332 


Q ss_pred             ----------------ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCe
Q 006620          391 ----------------HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL------YKIAVGIARGLEYLHRGCNTRI  448 (638)
Q Consensus       391 ----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~qi~~aL~yLH~~~~~~i  448 (638)
                                      ...++||||++ ++|.+++....     ..+.+..+      ..++.||++||+|||+   ++|
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~i  215 (371)
T 3q60_A          145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQS---KGL  215 (371)
T ss_dssp             SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCC
Confidence                            34799999998 89999998753     23445555      7888999999999999   999


Q ss_pred             EecccCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCC
Q 006620          449 LHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK  528 (638)
Q Consensus       449 iH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~  528 (638)
                      +||||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+....++.++|||||||++|||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999998764321     134567999999999753236899999999999999999999


Q ss_pred             CCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          529 NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       529 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .||.............      .... ..............++.++.+|+.+||+.||++|||+.++++
T Consensus       291 ~Pf~~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKR------PSLR-VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTCCCB------CCTT-SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccchhh------hhhh-hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9998654322111000      0000 000001111111244678899999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6e-39  Score=361.58  Aligned_cols=244  Identities=21%  Similarity=0.287  Sum_probs=199.7

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +.+.+.||+|+||+||+|+.. +++.||||+++..    ....+.+..|..++..+ +||+|+++++++.+.+..++|||
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E  422 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  422 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred             eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence            445789999999999999864 5788999999753    33456778899999887 69999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++...
T Consensus       423 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          423 YVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             CcCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999875      458999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+... .. 
T Consensus       494 ~~~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~-~~-  559 (674)
T 3pfq_A          494 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH-NV-  559 (674)
T ss_dssp             CTTC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSS-CC-
T ss_pred             cCCc--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC-CC-
Confidence            3222  13456799999999999764  789999999999999999999999975321        1111111110 11 


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM-----NRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  597 (638)
                            ..+..++.++.+||.+||+.||++||++     +||++
T Consensus       560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                  1122356788999999999999999997     66664

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.9e-39  Score=323.96  Aligned_cols=244  Identities=24%  Similarity=0.391  Sum_probs=191.6

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||.||+|+.. +++.||||++...    ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (276)
T 2h6d_A           14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV   93 (276)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence            35789999999999999965 6899999998643    233467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++++|.+++...      ..+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        94 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           94 SGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             CSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             CCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999875      358999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ..   .....||+.|+|||++.+. ...+.++||||||+++|+|++|+.||.....       .. ....+.... .   
T Consensus       165 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~~-~---  228 (276)
T 2h6d_A          165 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PT-LFKKIRGGV-F---  228 (276)
T ss_dssp             ---------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHCC-C---
T ss_pred             cc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HH-HHHHhhcCc-c---
Confidence            32   2334579999999998764 2346899999999999999999999864321       11 111111100 0   


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ..    +...+.++.+++.+||+.||++|||+++++++
T Consensus       229 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 YI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            01    11234578899999999999999999999973

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-38  Score=324.96  Aligned_cols=248  Identities=22%  Similarity=0.300  Sum_probs=199.8

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----------CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----------GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRR  393 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  393 (638)
                      .+.+.||+|+||.||+|... +++.||||++....          ...+.+.+|+++++++. ||||+++++++......
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   99 (298)
T 1phk_A           20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   99 (298)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence            34789999999999999964 58899999997543          12346789999999996 99999999999999999


Q ss_pred             EEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      ++||||+++++|.+++...      ..+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus       100 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A          100 FLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999875      468999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccc----cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRN----FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      +........   .....||+.|+|||++.+.    ...++.++||||||+++|+|++|+.||.....       .. ...
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~  239 (298)
T 1phk_A          171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------ML-MLR  239 (298)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHH
T ss_pred             hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HH-HHH
Confidence            987654432   2345689999999998531    23578899999999999999999999864321       00 111


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .+... ..   .........++.++.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~-~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIMSG-NY---QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHT-CC---CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhcC-Cc---ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11110 00   1111222345678999999999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.9e-39  Score=332.40  Aligned_cols=260  Identities=25%  Similarity=0.342  Sum_probs=194.8

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++......   .+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  107 (331)
T 4aaa_A           28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD  107 (331)
T ss_dssp             EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence            45789999999999999964 4889999998655432   3457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus       108 ~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          108 HTILDDLELFP------NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEHHHHHHHST------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cchHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99998887653      458999999999999999999999   999999999999999999999999999998664432


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh-------HHHHHHhhh-
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP-------HWVYKRLEL-  553 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~-  553 (638)
                      .  ......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.............       ......... 
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  12345689999999998754 357889999999999999999999997543211000000       000000000 


Q ss_pred             --hhhccccCCCCc-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 --EEDLGLQGIENE-----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 --~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ............     ....++.++.+|+.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              000111111110     11134678999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.8e-40  Score=330.33  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=198.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEEEEe
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEF  399 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  399 (638)
                      .+.+.||+|+||+||+++.. +++.||+|++....   ...+.+.+|+.++++++||||+++++++..  ....++||||
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   88 (279)
T 2w5a_A            9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY   88 (279)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred             eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence            45789999999999999864 68899999997543   234578899999999999999999998854  5688999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecccCCCceEECCCCceEEcccccc
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR-----ILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~-----iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      +++++|.+++....  .....+++..++.++.|+++||+|||+   .+     ++||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           89 CEGGDLASVITKGT--KERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             CTTEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             CCCCCHHHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            99999999998643  122458999999999999999999999   77     999999999999999999999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      +........  .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.....        ......+...
T Consensus       164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~  231 (279)
T 2w5a_A          164 RILNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREG  231 (279)
T ss_dssp             HHC---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT
T ss_pred             eeecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHhhc
Confidence            866433211  1234579999999999764  688999999999999999999999875421        1111111111


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      .   .    ...+..++.++.+++.+||+.||++|||++||++++..
T Consensus       232 ~---~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          232 K---F----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             C---C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             c---c----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            1   1    11112345678999999999999999999999975543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6e-39  Score=331.02  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=194.3

Q ss_pred             HhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---------CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---------GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRR  393 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  393 (638)
                      .|.+.+.||+|+||.||+|+.. +++.||||++....         .....+.+|++++++++||||+++++++..+. .
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~   89 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y   89 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence            4556789999999999999864 57899999986432         12245789999999999999999999987655 8


Q ss_pred             EEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc---eEEcc
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISD  470 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~D  470 (638)
                      ++||||+++++|.+++...      ..+++..++.++.|+++||+|||+   ++|+||||||+||+++.++.   +||+|
T Consensus        90 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             EEEEECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             EEEEecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            9999999999999998764      468999999999999999999999   99999999999999987654   99999


Q ss_pred             cccceeccCCCceeeecccccccceecCceecc-ccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH
Q 006620          471 FGLAKICEGRESIVSMTGARGTIGYIAPEVFCR-NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       471 Fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      ||+++.......   .....||+.|+|||++.+ ....++.++||||||+++|+|++|+.||.......   ......  
T Consensus       161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~--  232 (322)
T 2ycf_A          161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQI--  232 (322)
T ss_dssp             CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHH--
T ss_pred             Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHH--
Confidence            999987654321   123458999999999742 12367889999999999999999999997543221   111111  


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ....    ..........++.++.+++.+||+.||++|||+.++++
T Consensus       233 --~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 --TSGK----YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             --HHTC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --HhCc----cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence              1000    00011112234677899999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-38  Score=330.94  Aligned_cols=258  Identities=20%  Similarity=0.281  Sum_probs=198.5

Q ss_pred             hhhhcccCcCcceeEEEEEE--cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcc------eEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL--LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN------IVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|+||+||+|..  .+++.||||+++......+.+.+|++++++++|++      ++++++++...+..++|
T Consensus        16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv   95 (339)
T 1z57_A           16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV   95 (339)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEE
Confidence            34678999999999999986  35789999999766555577889999999987665      99999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC--------------
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--------------  462 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~--------------  462 (638)
                      |||+ +++|.+++....    ...+++..++.++.|+++||+|||+   ++|+||||||+|||++.              
T Consensus        96 ~e~~-~~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           96 FELL-GLSTYDFIKENG----FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EcCC-CCCHHHHHHhcC----CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            9999 889999998753    2468999999999999999999999   99999999999999987              


Q ss_pred             -----CCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCC
Q 006620          463 -----DFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDR  537 (638)
Q Consensus       463 -----~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~  537 (638)
                           ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||......
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                 6789999999998754332     345689999999999764  6899999999999999999999999754321


Q ss_pred             Ccccc-------hhHHHHHHhhhhhh-----ccccC----------------CCCchhHHHHHHHHHHHHHcccCCCCCC
Q 006620          538 SSEIY-------FPHWVYKRLELEED-----LGLQG----------------IENEEDKEYARKMILVSLWCIQTNPSDR  589 (638)
Q Consensus       538 ~~~~~-------~~~~~~~~~~~~~~-----~~~~~----------------~~~~~~~~~~~~l~~li~~cl~~dP~~R  589 (638)
                      .....       .+............     .....                .........+.++.+|+.+||+.||++|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            10000       00000000000000     00000                0001122346788999999999999999


Q ss_pred             CCHHHHHH
Q 006620          590 PSMNRVVE  597 (638)
Q Consensus       590 Ps~~evl~  597 (638)
                      ||++|+++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.9e-40  Score=347.51  Aligned_cols=241  Identities=14%  Similarity=0.157  Sum_probs=184.6

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHH---HHHhhcCCcceEEEE-------eEEEeCc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEV---ASISRTSHVNIVTLL-------GFCFEGH  391 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~~~~  391 (638)
                      +.+.||+|+||+||+|+. .+++.||||++...    ....+.+.+|+   +.+++++||||++++       +++.+.+
T Consensus        77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~  156 (377)
T 3byv_A           77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  156 (377)
T ss_dssp             EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred             EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence            468999999999999995 56899999999743    23346788999   455556799999998       6655543


Q ss_pred             -----------------eEEEEEEeccCCCHHHHhhhcCCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 006620          392 -----------------RRALIYEFVSNGSLEKFIHEKHPLET-NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDI  453 (638)
Q Consensus       392 -----------------~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Di  453 (638)
                                       ..++||||+ +|+|.+++........ ...+++..++.|+.||++||+|||+   ++|+||||
T Consensus       157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDi  232 (377)
T 3byv_A          157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL  232 (377)
T ss_dssp             SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred             CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence                             278999999 6799999987532211 2235568899999999999999999   99999999


Q ss_pred             CCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccc---------cCCccccCCeeeHHHHHHHH
Q 006620          454 KPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN---------FGEVSYKSDVYSYGMMVFEM  524 (638)
Q Consensus       454 kp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwslGvil~el  524 (638)
                      ||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.         ...++.++|||||||++|||
T Consensus       233 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          233 RPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            99999999999999999999986432     1234457 999999999753         01578999999999999999


Q ss_pred             hcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          525 TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       525 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ++|+.||.........              ..+ ....     ..++.++.+|+.+||+.||++|||+.++++
T Consensus       307 ltg~~Pf~~~~~~~~~--------------~~~-~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          307 WCADLPITKDAALGGS--------------EWI-FRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHSSCCC------CCS--------------GGG-GSSC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHCCCCCcccccccch--------------hhh-hhhc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999998654321110              000 0000     123467889999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-39  Score=332.26  Aligned_cols=261  Identities=24%  Similarity=0.350  Sum_probs=182.4

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++....  ...+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   97 (303)
T 2vwi_A           18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG   97 (303)
T ss_dssp             EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred             hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence            4578999999999999984 468899999986542  3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          403 GSLEKFIHEKHP--LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       403 gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      ++|.+++.....  ......+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            999999975211  1123568999999999999999999999   99999999999999999999999999998765432


Q ss_pred             Cce---eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh-h
Q 006620          481 ESI---VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE-D  556 (638)
Q Consensus       481 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~  556 (638)
                      ...   .......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.......       .......... .
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~  246 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQNDPPS  246 (303)
T ss_dssp             -------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHTSSCCC
T ss_pred             CCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------HHHHHhccCCCc
Confidence            211   112334689999999998652 257889999999999999999999987543211       0001111000 0


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .............++.++.+++.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000000111223567889999999999999999999996

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=331.65  Aligned_cols=249  Identities=28%  Similarity=0.413  Sum_probs=193.5

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEe------CceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFE------GHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~  397 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++.......+.+.+|+.+++++ +||||+++++++..      ....++||
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~  106 (326)
T 2x7f_A           27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM  106 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence            3478999999999999996 4688999999987766678899999999999 79999999999987      46789999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++++|.+++....    ...+++..++.++.||++||+|||+   .+++|+||||+||+++.++.+||+|||++...
T Consensus       107 e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          107 EFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             ECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            9999999999998642    2468999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCCceeeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      .....  ......||+.|+|||++...   ...++.++||||||+++|+|++|+.||......       ... ......
T Consensus       180 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~-~~~~~~  249 (326)
T 2x7f_A          180 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RAL-FLIPRN  249 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHH-HHHHHS
T ss_pred             CcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHH-HHhhcC
Confidence            43221  12334689999999998631   236788999999999999999999998643210       000 000000


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .   ..   ......++..+.+++.+||+.||++|||++++++
T Consensus       250 ~---~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          250 P---AP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             C---CC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c---cc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0   00   1111223567889999999999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8e-39  Score=326.57  Aligned_cols=250  Identities=28%  Similarity=0.393  Sum_probs=190.6

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEe-------------C
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE-------------G  390 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------------~  390 (638)
                      +.+.+.||+|+||+||+|+. .+++.||||++.......+.+.+|+.++++++||||+++++++.+             .
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK   87 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred             chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence            34578999999999999996 468999999997655556788999999999999999999998865             4


Q ss_pred             ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcc
Q 006620          391 HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD  470 (638)
Q Consensus       391 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  470 (638)
                      ...++||||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           88 STLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence            57889999999999999998643     457889999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCCc------------eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCC
Q 006620          471 FGLAKICEGRES------------IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRS  538 (638)
Q Consensus       471 Fg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~  538 (638)
                      ||++........            ........||+.|+|||++.+. +.++.++||||||+++|||++   ||.....  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~--  233 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME--  233 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence            999986643211            1112345689999999998753 367899999999999999998   4332110  


Q ss_pred             cccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                           ...........    ............+..+.+++.+||+.||++|||++++++
T Consensus       234 -----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 -----RVNILKKLRSV----SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -----HHHHHHHHHST----TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----HHHHHHhcccc----ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                 00011111110    011112222334566889999999999999999999997

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.2e-38  Score=335.83  Aligned_cols=258  Identities=22%  Similarity=0.269  Sum_probs=191.6

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCce------EEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHR------RALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e  398 (638)
                      |.+.+.||+|+||+||+|+..++..||+|++......   ..+|++++++++||||+++++++.....      .++|||
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            3457899999999999999877777999988654322   2379999999999999999999965433      789999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-CCCceEEcccccceec
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKIC  477 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFg~~~~~  477 (638)
                      |+++ ++.+.+....  .....+++..++.++.||++||+|||+   .+|+||||||+|||++ .++.+||+|||+++..
T Consensus       119 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          119 YVPE-TVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             CCSE-EHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ccCc-cHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9976 4444443211  112569999999999999999999999   9999999999999998 7999999999999876


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH-------H
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK-------R  550 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------~  550 (638)
                      ......   ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......   .+......       .
T Consensus       193 ~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          193 IAGEPN---VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             CTTCCC---CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHH
T ss_pred             cCCCCC---cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence            544332   345679999999998654 358999999999999999999999997543211   00000000       0


Q ss_pred             hhh-hh---hccccCCCCch-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          551 LEL-EE---DLGLQGIENEE-----DKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       551 ~~~-~~---~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      +.. ..   ...........     ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            000 00   00011111111     11245688999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.1e-38  Score=332.68  Aligned_cols=256  Identities=22%  Similarity=0.271  Sum_probs=195.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeC-----ceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEG-----HRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~  397 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++.....  ..+.+.+|++++++++||||+++++++...     ...++||
T Consensus        30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  109 (364)
T 3qyz_A           30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ  109 (364)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence            35789999999999999864 578899999975432  236788999999999999999999998764     4689999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+. ++|.+++..       ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       110 e~~~-~~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          110 DLME-TDLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             ECCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccC-cCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            9996 599999976       358999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCcee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh----
Q 006620          478 EGRESIV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE----  552 (638)
Q Consensus       478 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  552 (638)
                      ....... ......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||........   ..... ....    
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~-~~~~~~~~  253 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHIL-GILGSPSQ  253 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHH-HHHCSCCH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHH-HHhCCCCH
Confidence            5332211 12345689999999987654 3578999999999999999999999975432110   00000 0000    


Q ss_pred             -------------hhhhccccCCCC--chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 -------------LEEDLGLQGIEN--EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 -------------~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                                   ............  ......+.++.+|+.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                         000000000000  001123567889999999999999999999997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.9e-39  Score=340.46  Aligned_cols=265  Identities=21%  Similarity=0.293  Sum_probs=181.7

Q ss_pred             hcccCcCcceeEEEEEEc---CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEEEEeccC
Q 006620          328 KNKLGQGGYGGVYKGKLL---DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYEFVSN  402 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  402 (638)
                      .++||+|+||+||+|+..   +++.||||++.... ....+.+|+.++++++||||+++++++..  ....++||||+. 
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            568999999999999865   47899999997543 33578899999999999999999999964  678999999996 


Q ss_pred             CCHHHHhhhcCC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE----CCCCceEEcccccce
Q 006620          403 GSLEKFIHEKHP---LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----DEDFCPKISDFGLAK  475 (638)
Q Consensus       403 gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFg~~~  475 (638)
                      ++|.+++.....   ......+++..++.|+.||++||+|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            588888864321   1122359999999999999999999999   999999999999999    778999999999998


Q ss_pred             eccCCCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--cchhHHHHHHhh
Q 006620          476 ICEGRES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--IYFPHWVYKRLE  552 (638)
Q Consensus       476 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~  552 (638)
                      ....... ........||+.|+|||++.+. ..++.++|||||||++|||++|++||.........  ............
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            7653321 1223445689999999998764 35889999999999999999999999654331100  000011100000


Q ss_pred             hhh---------------------hccccCCCCchhH--------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          553 LEE---------------------DLGLQGIENEEDK--------EYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       553 ~~~---------------------~~~~~~~~~~~~~--------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ...                     .............        ....++.+|+.+||+.||++|||++|++++
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000                     0000000000000        014567899999999999999999999973

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.4e-39  Score=328.64  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=183.1

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.+.+.||+|+||+||+|+. .+++.||||++......   .+.+.++...++.++||||+++++++.+++..++||||+
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~   88 (290)
T 3fme_A            9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM   88 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred             hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence            34578999999999999996 56889999999764322   223344555578889999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      + ++|.+++....  .....+++..++.++.|+++||+|||+   + +++||||||+||+++.++.+||+|||+++....
T Consensus        89 ~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           89 D-TSLDKFYKQVI--DKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             S-EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             c-cchHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            7 49988876531  123579999999999999999999999   7 999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceecc--ccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCR--NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ...   .....||+.|+|||++..  ....++.++||||||+++|+|++|+.||......     ... ......     
T Consensus       163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~-----  228 (290)
T 3fme_A          163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQ-LKQVVE-----  228 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHH-HHHHHH-----
T ss_pred             ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHH-HHHHhc-----
Confidence            332   223458999999999732  1236788999999999999999999999643211     010 111111     


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ..........++.++.+++.+||+.||++|||++|+++
T Consensus       229 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          229 --EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence              01111112234567899999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-38  Score=335.60  Aligned_cols=257  Identities=20%  Similarity=0.244  Sum_probs=192.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeC-------------
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEG-------------  390 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------------  390 (638)
                      +.+.+.||+|+||+||+|+. .+++.||||++......   ..+|++++++++||||+++++++...             
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            34578999999999999985 56899999998755332   34799999999999999999998543             


Q ss_pred             -------------------------ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 006620          391 -------------------------HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN  445 (638)
Q Consensus       391 -------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~  445 (638)
                                               ...++||||++ ++|.+.+....  .....+++..++.++.||++||+|||+   
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~---  159 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIHS---  159 (383)
T ss_dssp             ------------------------CCEEEEEECCCS-EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT---
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---
Confidence                                     34789999997 58888876521  123579999999999999999999999   


Q ss_pred             CCeEecccCCCceEEC-CCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHH
Q 006620          446 TRILHFDIKPHNILLD-EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM  524 (638)
Q Consensus       446 ~~iiH~Dikp~NIll~-~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~el  524 (638)
                      .||+||||||+|||++ .++.+||+|||+++........   ....||+.|+|||++.+. ..++.++||||+||++|||
T Consensus       160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHH
T ss_pred             CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHH
Confidence            9999999999999997 6889999999999976544432   344679999999998764 3589999999999999999


Q ss_pred             hcCCCCCCcccCCCcccchhHHHHHH-------h-hhh---hhccccCCCCc-----hhHHHHHHHHHHHHHcccCCCCC
Q 006620          525 TGEKNNANVAVDRSSEIYFPHWVYKR-------L-ELE---EDLGLQGIENE-----EDKEYARKMILVSLWCIQTNPSD  588 (638)
Q Consensus       525 ltg~~p~~~~~~~~~~~~~~~~~~~~-------~-~~~---~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~  588 (638)
                      ++|+.||.......   .+.......       . ...   ...........     .+...+.++.+|+.+||+.||++
T Consensus       236 l~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          236 ILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            99999997543211   000000000       0 000   00001111111     11124567899999999999999


Q ss_pred             CCCHHHHHH
Q 006620          589 RPSMNRVVE  597 (638)
Q Consensus       589 RPs~~evl~  597 (638)
                      |||+.|+++
T Consensus       313 R~t~~e~l~  321 (383)
T 3eb0_A          313 RINPYEAMA  321 (383)
T ss_dssp             SCCHHHHHT
T ss_pred             CCCHHHHhc
Confidence            999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.6e-38  Score=319.60  Aligned_cols=248  Identities=25%  Similarity=0.340  Sum_probs=199.9

Q ss_pred             HHhhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          323 MTNSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       323 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      ..+.+.+.||+|+||+||+|+.. +++.||||++....   ...+.+.+|++++++++||||+++++++......++|+|
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            34556789999999999999965 68899999986532   345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC---CceEEcccccce
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED---FCPKISDFGLAK  475 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFg~~~  475 (638)
                      |+++++|.+++...      ..+++..++.++.|+++||+|||+   .+++||||||+||+++.+   +.+||+|||++.
T Consensus       102 ~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          102 LYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             ccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999998765      358999999999999999999999   999999999999999754   469999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      .......   .....||+.|+|||++.+   .++.++||||||+++|+|++|+.||......       .. ...+....
T Consensus       173 ~~~~~~~---~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~-~~~~~~~~  238 (287)
T 2wei_A          173 CFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DI-LKRVETGK  238 (287)
T ss_dssp             TBCCCSS---CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH-HHHHHHCC
T ss_pred             eecCCCc---cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------HH-HHHHHcCC
Confidence            6654332   123457999999999865   4788999999999999999999998653211       11 11111110


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                          ..........++.++.+++.+||+.||++|||++++++
T Consensus       239 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          239 ----YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ----CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                00111122334667899999999999999999999997

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.4e-39  Score=327.05  Aligned_cols=250  Identities=24%  Similarity=0.355  Sum_probs=195.1

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG  100 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred             eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence            345789999999999999975 48899999987543 4457889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      ++|.+++....     ..+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus       101 ~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A          101 GAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             CcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            99999987643     568999999999999999999999   9999999999999999999999999998764321110


Q ss_pred             eeeecccccccceecCceecc---ccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          483 IVSMTGARGTIGYIAPEVFCR---NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                        ......||+.|+|||++..   ....++.++||||||+++|+|++|+.||......       ..... ....     
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~-~~~~-----  237 (302)
T 2j7t_A          173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLK-IAKS-----  237 (302)
T ss_dssp             --C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHH-HHHS-----
T ss_pred             --ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHH-Hhcc-----
Confidence              1123458999999999842   1236788999999999999999999998743211       11111 1100     


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..........++.++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00111122344667899999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-38  Score=327.32  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=190.1

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC---chhhHHHHHHHHhhcC--CcceEEEEeEEEeCceEEEEEEec
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---NGEDFINEVASISRTS--HVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.||+|+||+||++...+++.||||++.....   ..+.+.+|++++++++  ||||+++++++......++||| +
T Consensus        31 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~  109 (313)
T 3cek_A           31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C  109 (313)
T ss_dssp             EEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred             EEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-c
Confidence            35789999999999999988899999999975432   3457889999999997  5999999999999999999999 5


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      .+++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+||+++ ++.+||+|||+++.....
T Consensus       110 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          110 GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             CSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence            588999999875      468999999999999999999999   9999999999999996 489999999999876544


Q ss_pred             CceeeecccccccceecCceeccc---------cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRN---------FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      ..........||+.|+|||++.+.         ...++.++||||||+++|||++|+.||......      ........
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~~  253 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  253 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHH
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------HHHHHHHH
Confidence            333223345689999999998641         125788999999999999999999998643221      01111111


Q ss_pred             hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......       ..+...+.++.+++.+||+.||++|||++++++
T Consensus       254 ~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          254 DPNHEI-------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CTTSCC-------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccccc-------CCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            111111       111112457889999999999999999999996

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.7e-38  Score=332.96  Aligned_cols=258  Identities=22%  Similarity=0.297  Sum_probs=196.1

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcC-----------CcceEEEEeEEEeCc
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTS-----------HVNIVTLLGFCFEGH  391 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~~  391 (638)
                      .+.+.+.||+|+||+||+|+. .+++.||||++.......+.+.+|+.++++++           ||||+++++++....
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~   99 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   99 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence            345678999999999999986 56889999999865555567889999998886           889999999988654


Q ss_pred             ----eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecccCCCceEEC-----
Q 006620          392 ----RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLD-----  461 (638)
Q Consensus       392 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiH~Dikp~NIll~-----  461 (638)
                          ..++|||++ +++|.+++....    ...+++..++.++.||++||+|||+   + +|+||||||+|||++     
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A          100 PNGVHVVMVFEVL-GENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             TTEEEEEEEECCC-CEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred             CCCceEEEEEecC-CCCHHHHHHHhh----ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence                789999999 889999998743    2458999999999999999999999   8 999999999999994     


Q ss_pred             -CCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc
Q 006620          462 -EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE  540 (638)
Q Consensus       462 -~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~  540 (638)
                       ..+.+||+|||++.......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.........
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence             44589999999998765332     334689999999999765  6889999999999999999999999755432111


Q ss_pred             cchhHHHHHHhhhhhh---------------c----cccC--------------CCCchhHHHHHHHHHHHHHcccCCCC
Q 006620          541 IYFPHWVYKRLELEED---------------L----GLQG--------------IENEEDKEYARKMILVSLWCIQTNPS  587 (638)
Q Consensus       541 ~~~~~~~~~~~~~~~~---------------~----~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~  587 (638)
                      .... ...........               .    ....              .........+.++.+|+.+||+.||+
T Consensus       245 ~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          245 KDDD-HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             CHHH-HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             ChHH-HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence            0000 00000000000               0    0000              00112346678899999999999999


Q ss_pred             CCCCHHHHHH
Q 006620          588 DRPSMNRVVE  597 (638)
Q Consensus       588 ~RPs~~evl~  597 (638)
                      +|||++|+++
T Consensus       324 ~Rpt~~ell~  333 (373)
T 1q8y_A          324 KRADAGGLVN  333 (373)
T ss_dssp             TCBCHHHHHT
T ss_pred             ccCCHHHHhh
Confidence            9999999997

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.2e-39  Score=336.02  Aligned_cols=254  Identities=22%  Similarity=0.261  Sum_probs=187.7

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCCc------------hhhHHHHHHHHhhcCCcceEEEEeEEEe-----
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN------------GEDFINEVASISRTSHVNIVTLLGFCFE-----  389 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  389 (638)
                      +.+.||+|+||.||+|...+++.||||++......            .+.+.+|++++++++||||+++++++..     
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (362)
T 3pg1_A           26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA  105 (362)
T ss_dssp             EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred             EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence            46899999999999999888999999998653221            2578899999999999999999999854     


Q ss_pred             CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEc
Q 006620          390 GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKIS  469 (638)
Q Consensus       390 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  469 (638)
                      ....++||||+. |+|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+
T Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A          106 MHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             CCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEE
Confidence            346899999997 58998887543     569999999999999999999999   999999999999999999999999


Q ss_pred             ccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH
Q 006620          470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       470 DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      |||+++.......   .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.......   ...... .
T Consensus       177 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~-~  248 (362)
T 3pg1_A          177 DFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---QLNKIV-E  248 (362)
T ss_dssp             CTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH-H
T ss_pred             ecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-H
Confidence            9999985543322   2335689999999998753 368899999999999999999999997533110   000000 0


Q ss_pred             Hhh-------------hhhhc---cccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLE-------------LEEDL---GLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~-------------~~~~~---~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...             .....   ........    .....+..+.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            000             00000   00001110    11123566889999999999999999999996

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-38  Score=338.74  Aligned_cols=257  Identities=23%  Similarity=0.275  Sum_probs=190.9

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  398 (638)
                      .+.+.||+|+||+||+|++. +++.||||++.....   ...+|++++++++||||+++++++...      ...++|||
T Consensus        57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            34688999999999999974 589999999865432   234799999999999999999998642      23678999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC-CceEEcccccceec
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKIC  477 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFg~~~~~  477 (638)
                      |+++ +|.+.+....  .....+++..++.++.||++||+|||+   .+|+||||||+|||++.+ +.+||+|||+++..
T Consensus       134 ~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          134 YVPE-TVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             CCCE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             cccc-cHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            9975 7777665421  112569999999999999999999999   999999999999999854 67899999999976


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH-------H
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK-------R  550 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------~  550 (638)
                      ......   ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......   .+......       .
T Consensus       208 ~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          208 VRGEPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CTTCCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHH
T ss_pred             ccCCCc---eeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence            544322   335689999999998653 368899999999999999999999997543210   01111100       0


Q ss_pred             hhhh----hhccccCCCCch-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          551 LELE----EDLGLQGIENEE-----DKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       551 ~~~~----~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      +...    ............     ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            0000    001111111111     11235678999999999999999999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.7e-38  Score=332.68  Aligned_cols=256  Identities=24%  Similarity=0.235  Sum_probs=187.3

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCc------eEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGH------RRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  395 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++.....   ..+.+.+|+.++++++||||+++++++....      ..++
T Consensus        28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l  107 (371)
T 2xrw_A           28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI  107 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred             eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence            35688999999999999854 588999999975432   2356789999999999999999999997654      7899


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+++ +|.+++..        .+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       108 v~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          108 VMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             EEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            9999965 88888853        38899999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCc--------ccchhHHH
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSS--------EIYFPHWV  547 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~  547 (638)
                      ......   ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........        ....+.+.
T Consensus       176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          176 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -----------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccccc---ccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            654332   12345689999999999764  688999999999999999999999975432100        00000000


Q ss_pred             -------HHHhhhhhhc-----------cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          548 -------YKRLELEEDL-----------GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       548 -------~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                             ..........           .............+.++.+|+.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                   0000000000           00001112233456789999999999999999999999974

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.8e-38  Score=328.82  Aligned_cols=261  Identities=22%  Similarity=0.253  Sum_probs=186.4

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCce-------EEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHR-------RALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------~~lv  396 (638)
                      +.+.+.||+|+||+||+|+. .+++.||||++.........+.+|++.+..++||||+++++++.....       .++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv  104 (360)
T 3e3p_A           25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV  104 (360)
T ss_dssp             EEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence            34578999999999999996 458899999987766556677889999999999999999999976443       7899


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeEecccCCCceEECC-CCceEEccccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH--RGCNTRILHFDIKPHNILLDE-DFCPKISDFGL  473 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg~  473 (638)
                      |||+++ +|.+.+....  .....+++..++.++.|++.||.|||  +   .+|+||||||+|||++. ++.+||+|||+
T Consensus       105 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~  178 (360)
T 3e3p_A          105 MEYVPD-TLHRCCRNYY--RRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGS  178 (360)
T ss_dssp             EECCSC-BHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             eecccc-cHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence            999976 6665554321  12356899999999999999999999  7   99999999999999986 89999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHH-----
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY-----  548 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----  548 (638)
                      ++.......   .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||.......   .......     
T Consensus       179 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~  251 (360)
T 3e3p_A          179 AKKLSPSEP---NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRVLGCP  251 (360)
T ss_dssp             CBCCCTTSC---CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCC
T ss_pred             ceecCCCCC---cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHHcCCC
Confidence            987654432   2345689999999998654 357899999999999999999999997543211   0111100     


Q ss_pred             -----HHhhh-hhhccccCCC--------CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          549 -----KRLEL-EEDLGLQGIE--------NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       549 -----~~~~~-~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                           ..... ..........        .......+.++.+|+.+||+.||++|||+.|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                 00000 0000000000        00111246789999999999999999999999973

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-38  Score=333.83  Aligned_cols=252  Identities=22%  Similarity=0.278  Sum_probs=177.2

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  395 (638)
                      .+.+.||+|+||.||+|.. .+++.||||++.....   ..+.+.+|+.++++++||||+++++++...      ...++
T Consensus        32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l  111 (367)
T 2fst_X           32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL  111 (367)
T ss_dssp             EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred             EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence            3468899999999999985 4688999999865432   245778999999999999999999998754      56799


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      |+|++ +++|.+++..       ..+++..+..++.||++||+|||+   .||+||||||+|||++.++.+||+|||+++
T Consensus       112 v~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          112 VTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             EEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             Eeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            99999 7899998865       358999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh-
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE-  554 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  554 (638)
                      .....     .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......   .+. ......... 
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~-~i~~~~g~p~  250 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLK-LILRLVGTPG  250 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH-HHHHHHCSCC
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-HHHHHhCCCC
Confidence            65432     2345689999999998763 368899999999999999999999997543210   000 000000000 


Q ss_pred             h------------h--ccccCCCCch----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          555 E------------D--LGLQGIENEE----DKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       555 ~------------~--~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .            .  ..........    ....+.++.+|+.+||+.||++|||+++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0            0  0000000000    01234678899999999999999999999974

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.5e-38  Score=329.93  Aligned_cols=256  Identities=21%  Similarity=0.325  Sum_probs=199.1

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCc----h--------------hhHHHHHHHHhhcCCcceEEEEeEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN----G--------------EDFINEVASISRTSHVNIVTLLGFC  387 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~--------------~~~~~E~~~l~~l~h~niv~l~~~~  387 (638)
                      .+.+.||+|+||+||+|+. +++.||||++......    .              +.+.+|++++++++||||+++++++
T Consensus        34 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~  112 (348)
T 2pml_X           34 RIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII  112 (348)
T ss_dssp             EEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred             EEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            4578999999999999998 8999999998643211    1              7789999999999999999999999


Q ss_pred             EeCceEEEEEEeccCCCHHHHhhhcCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc
Q 006620          388 FEGHRRALIYEFVSNGSLEKFIHEKHPLET--NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC  465 (638)
Q Consensus       388 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~  465 (638)
                      .+.+..++||||+++++|.+++........  ...+++..++.++.|+++||+|||+  ..+++||||||+||+++.++.
T Consensus       113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~~  190 (348)
T 2pml_X          113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGR  190 (348)
T ss_dssp             ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTSC
T ss_pred             eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCCc
Confidence            999999999999999999999432211111  3679999999999999999999996  269999999999999999999


Q ss_pred             eEEcccccceeccCCCceeeecccccccceecCceeccccCCccc-cCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh
Q 006620          466 PKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSY-KSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP  544 (638)
Q Consensus       466 ~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  544 (638)
                      +||+|||++......    ......||+.|+|||++.+. ..++. ++||||||+++|||++|+.||......      .
T Consensus       191 ~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~  259 (348)
T 2pml_X          191 VKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL------V  259 (348)
T ss_dssp             EEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS------H
T ss_pred             EEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH------H
Confidence            999999999876543    23456689999999998754 24445 999999999999999999999754321      0


Q ss_pred             HHHHHHhhhhhhccccC------------CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          545 HWVYKRLELEEDLGLQG------------IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       545 ~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .. ...+.... .....            ........++.++.+++.+||+.||++|||++|+++
T Consensus       260 ~~-~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 EL-FNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HH-HHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH-HHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11 11111100 00000            000011335677899999999999999999999996

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.3e-38  Score=337.81  Aligned_cols=253  Identities=22%  Similarity=0.305  Sum_probs=186.7

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      .+.||+|+||+||.+...+++.||||++....  .+.+.+|+.+++++ +||||+++++++.++...++||||+. |+|.
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            57899999999987766689999999986542  35678899999886 79999999999999999999999995 6999


Q ss_pred             HHhhhcCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC-------------CceEEcccc
Q 006620          407 KFIHEKHPLETN-QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-------------FCPKISDFG  472 (638)
Q Consensus       407 ~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~-------------~~~kl~DFg  472 (638)
                      +++......... ...++..++.++.||++||+|||+   .+|+||||||+|||++.+             +.+||+|||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            999875422111 112344567899999999999999   999999999999999654             489999999


Q ss_pred             cceeccCCCcee--eecccccccceecCceeccc-----cCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchh
Q 006620          473 LAKICEGRESIV--SMTGARGTIGYIAPEVFCRN-----FGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFP  544 (638)
Q Consensus       473 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~  544 (638)
                      +++.........  ......||+.|+|||++.+.     ...++.++|||||||++|||++ |+.||.......     .
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~  248 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-----S  248 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-----H
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-----H
Confidence            999876543221  12345689999999998651     1367899999999999999998 899986432210     0


Q ss_pred             HHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          545 HWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..    ..  ...............++.++.+++.+||+.||++|||+.+|++
T Consensus       249 ~i----~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 NI----IR--GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HH----HH--TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH----hc--CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            00    00  1111122222234466788999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-38  Score=356.43  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=199.6

Q ss_pred             HhhhhcccCcCcceeEEEEEEcC----CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          324 TNSFKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.+.||+|+||+||+|.+..    +..||||+++....  ..+.+.+|+.++++++||||+++++++. ++..++||
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~  469 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM  469 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEE
Confidence            34457899999999999998643    45799999875432  2367899999999999999999999885 45689999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++|+|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       470 E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          470 ELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             ECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            9999999999998653     468999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ...... ......+|+.|+|||++.+.  .++.++||||||+++|||++ |..||......       . ....+.....
T Consensus       542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~-~~~~i~~~~~  610 (656)
T 2j0j_A          542 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------D-VIGRIENGER  610 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H-HHHHHHHTCC
T ss_pred             CCCcce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------H-HHHHHHcCCC
Confidence            543322 12334568899999999764  78899999999999999997 89998643211       1 1111111111


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                             ...+..++.++.+++.+||+.||++|||+.+|++.|+++++
T Consensus       611 -------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          611 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                   11122345678899999999999999999999999998754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-38  Score=328.37  Aligned_cols=236  Identities=25%  Similarity=0.354  Sum_probs=194.4

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC-------chhhHHHHHHHHhhcC--CcceEEEEeEEEeCceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG-------NGEDFINEVASISRTS--HVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  395 (638)
                      .+.+.||+|+||+||+|+. .+++.||||++.....       ..+.+.+|+.++++++  |+||+++++++...+..++
T Consensus        46 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~l  125 (320)
T 3a99_A           46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL  125 (320)
T ss_dssp             EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEE
Confidence            4578999999999999985 4688999999975432       2356778999999996  5999999999999999999


Q ss_pred             EEEeccC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-CCCceEEccccc
Q 006620          396 IYEFVSN-GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGL  473 (638)
Q Consensus       396 v~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFg~  473 (638)
                      |+|++.+ ++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++ +++.+||+|||+
T Consensus       126 v~e~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          126 ILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             EEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEcCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            9999976 8999999875      468999999999999999999999   9999999999999998 789999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL  553 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  553 (638)
                      ++......    .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||.....         .     ..
T Consensus       197 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~-----~~  257 (320)
T 3a99_A          197 GALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------I-----IR  257 (320)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H-----HH
T ss_pred             cccccccc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh---------h-----hc
Confidence            98765432    2345689999999998754 2347889999999999999999999864211         0     00


Q ss_pred             hhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       .....       ...++.++.+++.+||+.||++|||+++|++
T Consensus       258 -~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 -GQVFF-------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -CCCCC-------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -ccccc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00001       1123457889999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.5e-38  Score=328.71  Aligned_cols=256  Identities=23%  Similarity=0.291  Sum_probs=193.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeC-----ceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEG-----HRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~  397 (638)
                      .+.+.||+|+||+||+|+.. +++.||||++.....  ....+.+|++++++++||||+++++++...     ...++||
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   93 (353)
T 2b9h_A           14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ   93 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred             EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence            35789999999999999964 588999999965432  235678999999999999999999987754     6789999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+. ++|.+++..       ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        94 e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           94 ELMQ-TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             CCCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eccC-ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            9996 599999876       358999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCcee--------eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH
Q 006620          478 EGRESIV--------SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       478 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      .......        ......||+.|+|||++.+. ..++.++||||||+++|+|++|++||........   . .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~-~~~~~  237 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---L-LLIFG  237 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-HHHHH
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---H-HHHHH
Confidence            5322111        12234689999999987643 3688999999999999999999999975432100   0 00000


Q ss_pred             Hhhhh---------------hhc-cccCCCC----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLELE---------------EDL-GLQGIEN----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~~~---------------~~~-~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .....               ... .......    .....++.++.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000               000 0000000    011234567889999999999999999999997

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.9e-38  Score=324.90  Aligned_cols=245  Identities=24%  Similarity=0.321  Sum_probs=169.2

Q ss_pred             hcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHH-HHHhhcCCcceEEEEeEEEe----CceEEEEEEecc
Q 006620          328 KNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEV-ASISRTSHVNIVTLLGFCFE----GHRRALIYEFVS  401 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~  401 (638)
                      .+.||+|+||+||+|+.. +++.||||++....    ...+|+ ..++.++||||+++++++..    ....++||||++
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            356999999999999965 68999999986542    222333 34566789999999999876    455899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC---CCceEEcccccceecc
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICE  478 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFg~~~~~~  478 (638)
                      +|+|.+++....    ...+++..++.++.|+++||+|||+   ++|+||||||+||+++.   ++.+||+|||+++...
T Consensus       110 gg~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~  182 (336)
T 3fhr_A          110 GGELFSRIQERG----DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT  182 (336)
T ss_dssp             TEEHHHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred             CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence            999999998753    2469999999999999999999999   99999999999999975   4559999999998665


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ...    .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||..........    .........    
T Consensus       183 ~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~----  248 (336)
T 3fhr_A          183 QNA----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRRIRLG----  248 (336)
T ss_dssp             -------------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred             ccc----cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHhhhcc----
Confidence            332    2345679999999998654  68889999999999999999999996543321100    000000000    


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ...........++.++.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            011111112234667899999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-37  Score=320.58  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=195.0

Q ss_pred             hhhcccCcCcceeEEEEEE--cCCCEEEEEEecccC---CchhhHHHHHHHHhhc---CCcceEEEEeEEE-----eCce
Q 006620          326 SFKNKLGQGGYGGVYKGKL--LDGQNVAIKVLNETK---GNGEDFINEVASISRT---SHVNIVTLLGFCF-----EGHR  392 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~~~  392 (638)
                      .+.+.||+|+||+||+|+.  .+++.||||++....   .....+.+|+.+++++   +||||+++++++.     ....
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   93 (326)
T 1blx_A           14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   93 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred             eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence            4578999999999999997  457899999987543   2234677888887776   7999999999987     5667


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      .++||||+. ++|.+++....    ...+++..++.++.|+++||+|||+   .||+||||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           94 LTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EEEEEECCS-CBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             EEEEEecCC-CCHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCc
Confidence            899999997 59999998753    2458999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      +++......   ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.......   .... ......
T Consensus       166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~-i~~~~~  236 (326)
T 1blx_A          166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGK-ILDVIG  236 (326)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHHC
T ss_pred             ccccccCCC---CccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH-HHHHcC
Confidence            998654332   12345689999999999764  68899999999999999999999987543210   0000 000000


Q ss_pred             hh--hhc---------ccc----CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 LE--EDL---------GLQ----GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 ~~--~~~---------~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..  ...         ...    .........++..+.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00  000         000    0000111234567889999999999999999999995

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-37  Score=329.35  Aligned_cols=197  Identities=25%  Similarity=0.285  Sum_probs=166.8

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcC-Cc-----ceEEEEeEEEeCceEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTS-HV-----NIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv~  397 (638)
                      +.+.+.||+|+||+||+|+.. +++.||||+++........+..|+.+++.++ |+     +|+++++++......++||
T Consensus        56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~  135 (382)
T 2vx3_A           56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF  135 (382)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence            345789999999999999864 5789999999865544567778888888875 44     5999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC--CCCceEEcccccce
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDFCPKISDFGLAK  475 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DFg~~~  475 (638)
                      ||+. ++|.+++....    ...+++..++.++.|++.||+|||. +..+|+||||||+|||++  .++.+||+|||+++
T Consensus       136 e~~~-~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          136 EMLS-YNLYDLLRNTN----FRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             ECCC-CBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             ecCC-CCHHHHHhhcC----cCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            9996 59999998753    2458999999999999999999994 127999999999999994  57889999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcc
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVA  534 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~  534 (638)
                      ......     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       210 ~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          210 QLGQRI-----YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             ETTCCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eccccc-----ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            764332     345689999999999765  6899999999999999999999999754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.1e-37  Score=325.69  Aligned_cols=258  Identities=19%  Similarity=0.267  Sum_probs=195.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CC-CEEEEEEecccCCchhhHHHHHHHHhhcCCcc------eEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DG-QNVAIKVLNETKGNGEDFINEVASISRTSHVN------IVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~lv  396 (638)
                      +.+.+.||+|+||+||+|+.. ++ +.||||+++......+.+.+|+.++++++|++      ++.+++++......++|
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv  100 (355)
T 2eu9_A           21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA  100 (355)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEE
Confidence            445789999999999999864 34 68999999765555667888999999998766      99999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEE----------------
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL----------------  460 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll----------------  460 (638)
                      |||+ +++|.+++....    ...+++..++.++.||++||+|||+   ++|+||||||+|||+                
T Consensus       101 ~e~~-~~~l~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A          101 FELL-GKNTFEFLKENN----FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             Eecc-CCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence            9999 668888877642    2468999999999999999999999   999999999999999                


Q ss_pred             ---CCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCC
Q 006620          461 ---DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDR  537 (638)
Q Consensus       461 ---~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~  537 (638)
                         +.++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||......
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence               567899999999998654332     345689999999999764  7889999999999999999999999754321


Q ss_pred             Ccccc-------hhHHHHHHhhhhhhc-----cccC----------------CCCchhHHHHHHHHHHHHHcccCCCCCC
Q 006620          538 SSEIY-------FPHWVYKRLELEEDL-----GLQG----------------IENEEDKEYARKMILVSLWCIQTNPSDR  589 (638)
Q Consensus       538 ~~~~~-------~~~~~~~~~~~~~~~-----~~~~----------------~~~~~~~~~~~~l~~li~~cl~~dP~~R  589 (638)
                      .....       .+.............     ....                ...........++.+|+.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            10000       000000000000000     0000                0001112335678999999999999999


Q ss_pred             CCHHHHHH
Q 006620          590 PSMNRVVE  597 (638)
Q Consensus       590 Ps~~evl~  597 (638)
                      ||+.|+++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9e-38  Score=328.62  Aligned_cols=250  Identities=23%  Similarity=0.281  Sum_probs=189.6

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCceE------EEE
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHRR------ALI  396 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------~lv  396 (638)
                      +.+.||+|+||+||+|+.. +++.||||++......   .+.+.+|+.++++++||||+++++++......      ++|
T Consensus        46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv  125 (371)
T 4exu_A           46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV  125 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred             EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence            4678999999999999864 5889999999764322   35778999999999999999999999877655      999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+. ++|.+++.        ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       126 ~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          126 MPFMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             EECCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             Ecccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence            99996 58888874        348999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh----
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE----  552 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  552 (638)
                      ....     .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.......   ...... ....    
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~-~~~~~~~~  263 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQIL-KVTGVPGT  263 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH-HHHCCCCH
T ss_pred             cccC-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHH-HHhCCCcH
Confidence            5432     2345689999999998763 368899999999999999999999997533110   000000 0000    


Q ss_pred             -------------hhhhccccCCCC--chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          553 -------------LEEDLGLQGIEN--EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       553 -------------~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                                   ....+.......  ......+.++.+|+.+||+.||++|||++|++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                         000000000000  0111235678999999999999999999999963

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=326.14  Aligned_cols=238  Identities=25%  Similarity=0.362  Sum_probs=189.9

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC-------chhhHHHHHHHHhhc----CCcceEEEEeEEEeCc
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG-------NGEDFINEVASISRT----SHVNIVTLLGFCFEGH  391 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~h~niv~l~~~~~~~~  391 (638)
                      .+.+.+.||+|+||.||+|+. .+++.||||++.....       ....+.+|+.++.++    +||||+++++++...+
T Consensus        32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~  111 (312)
T 2iwi_A           32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE  111 (312)
T ss_dssp             -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred             ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence            345678999999999999985 4688999999965432       234566799999998    8999999999999999


Q ss_pred             eEEEEEEe-ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-CCCceEEc
Q 006620          392 RRALIYEF-VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKIS  469 (638)
Q Consensus       392 ~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~  469 (638)
                      ..++|+|+ +.+++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+||+++ .++.+||+
T Consensus       112 ~~~~v~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          112 GFMLVLERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             -CEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             eEEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEE
Confidence            99999999 7899999999875      458999999999999999999999   8999999999999998 88999999


Q ss_pred             ccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHH
Q 006620          470 DFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       470 DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  549 (638)
                      |||++.......    .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||.....         .   
T Consensus       183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~---  245 (312)
T 2iwi_A          183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE---------I---  245 (312)
T ss_dssp             CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H---
T ss_pred             EcchhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH---------H---
Confidence            999998765433    2345689999999998754 2335689999999999999999999863210         0   


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       ..  ....       ....++.++.+++.+||+.||++|||++|+++
T Consensus       246 -~~--~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 -LE--AELH-------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -HH--TCCC-------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -hh--hccC-------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00  0010       11123557889999999999999999999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=319.19  Aligned_cols=257  Identities=24%  Similarity=0.287  Sum_probs=187.1

Q ss_pred             hhhcccCcCcceeEEEEEEcC-CCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEE--------------e
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCF--------------E  389 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------------~  389 (638)
                      .+.+.||+|+||+||+|+... ++.||||++.... ...+.+.+|++++++++||||+++++++.              .
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   93 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE   93 (320)
T ss_dssp             EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred             eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence            356899999999999999754 8899999987543 23467889999999999999999999873              3


Q ss_pred             CceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC-CCCceEE
Q 006620          390 GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD-EDFCPKI  468 (638)
Q Consensus       390 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl  468 (638)
                      ....++||||++ |+|.+++..       ..+++..++.++.|+++||+|||+   .+|+||||||+||+++ +++.+||
T Consensus        94 ~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           94 LNSVYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CSEEEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cCceeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence            467899999997 599999865       358999999999999999999999   9999999999999997 5779999


Q ss_pred             cccccceeccCCCce-eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHH
Q 006620          469 SDFGLAKICEGRESI-VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWV  547 (638)
Q Consensus       469 ~DFg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  547 (638)
                      +|||+++........ .......+|+.|+|||++.+. ..++.++||||||+++|||++|+.||.......   ......
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~  238 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL  238 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            999999876432211 112334578999999988653 368899999999999999999999997543210   000000


Q ss_pred             HH----------H-hhh-----hhhccccCCC-CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          548 YK----------R-LEL-----EEDLGLQGIE-NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       548 ~~----------~-~~~-----~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..          . ...     .......... ......++.++.+++.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00          0 000     0000000000 0011234678899999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=331.45  Aligned_cols=248  Identities=23%  Similarity=0.311  Sum_probs=184.5

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      ...+.||+|+||+||.....+++.||||++....  ...+.+|+++++++ +||||+++++++.+....++||||+. |+
T Consensus        27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~  103 (432)
T 3p23_A           27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT  103 (432)
T ss_dssp             EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred             ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence            3468999999999766556678999999986532  23467899999999 79999999999999999999999996 59


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-----CCceEEcccccceeccC
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICEG  479 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFg~~~~~~~  479 (638)
                      |.+++....     ..+.+..++.++.||++||+|||+   .+|+||||||+|||++.     ...+||+|||+++....
T Consensus       104 L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          104 LQEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             HHHHHHSSS-----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             HHHHHHhcC-----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            999998653     334445577999999999999999   99999999999999943     33688999999987654


Q ss_pred             CCce-eeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          480 RESI-VSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       480 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      .... .......||+.|+|||++.+. ...++.++|||||||++|||++ |..||......        .... .  ...
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------~~~~-~--~~~  244 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------QANI-L--LGA  244 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--------HHHH-H--TTC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--------HHHH-H--hcc
Confidence            3221 223446689999999998642 2356789999999999999999 88888533211        0000 0  000


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......  .........+.+|+.+||+.||++|||+++|++
T Consensus       245 ~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          245 CSLDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCTTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCcccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            001111  112234556789999999999999999999994

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.5e-37  Score=321.33  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=174.9

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccCC--chhhHHHHHH-HHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKG--NGEDFINEVA-SISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.||+|+||.||+|... +++.||||++.....  ....+..|+. +++.++||||+++++++...+..++||||+++
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~  105 (327)
T 3aln_A           26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST  105 (327)
T ss_dssp             C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred             ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence            4678999999999999964 688999999976532  2335556665 67778999999999999999999999999975


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                       +|.+++..... .....+++..+..++.|+++||+|||+   . +++||||||+||+++.++.+||+|||+++......
T Consensus       106 -~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  180 (327)
T 3aln_A          106 -SFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI  180 (327)
T ss_dssp             -EHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred             -ChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence             88888764211 112568999999999999999999999   7 99999999999999999999999999998765432


Q ss_pred             ceeeecccccccceecCceeccc--cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRN--FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      .   .....||+.|+|||++...  ...++.++||||||+++|+|++|+.||.........          .........
T Consensus       181 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------~~~~~~~~~  247 (327)
T 3aln_A          181 A---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ----------LTQVVKGDP  247 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCCCCSCC
T ss_pred             c---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH----------HHHHhcCCC
Confidence            2   2234689999999998421  135788999999999999999999998753221000          000000000


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..........++.++.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            11111111234567899999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=323.67  Aligned_cols=250  Identities=23%  Similarity=0.273  Sum_probs=189.4

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCce------EEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGHR------RALI  396 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv  396 (638)
                      +.+.||+|+||+||+|+.. +++.||||++......   .+.+.+|+.++++++||||+++++++.....      .++|
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv  107 (353)
T 3coi_A           28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV  107 (353)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence            4688999999999999864 5889999999754322   3567899999999999999999999987654      4999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+. ++|.+++.        ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          108 MPFMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             EECCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             ecccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            99997 58888764        248999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh----
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE----  552 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  552 (638)
                      ....     .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.......   .+.... ....    
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~-~~~~~~~~  245 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQIL-KVTGVPGT  245 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHH-HHHCBCCH
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-HHhCCCCH
Confidence            5432     2345679999999998653 367889999999999999999999997543210   000000 0000    


Q ss_pred             -------------hhhhccc--cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          553 -------------LEEDLGL--QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       553 -------------~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                                   ....+..  ...........+.++.+|+.+||+.||++|||+++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                         0000000  000011112346788999999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=315.94  Aligned_cols=247  Identities=22%  Similarity=0.320  Sum_probs=175.4

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCch---hhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      +.+.||+|+||+||+|+.. +++.||||++.......   +.+.++..+++.++||||+++++++..++..++||||+ +
T Consensus        29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~  107 (318)
T 2dyl_A           29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G  107 (318)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred             ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence            4678999999999999964 68899999997654322   23344455678889999999999999999999999999 5


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +.+..+.....     ..+++..++.++.|+++||+|||+   + +++||||||+||+++.++.+||+|||++.......
T Consensus       108 ~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          108 TCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             CcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            56666665432     568999999999999999999998   6 99999999999999999999999999997664432


Q ss_pred             ceeeecccccccceecCceecc---ccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          482 SIVSMTGARGTIGYIAPEVFCR---NFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      .   .....||+.|+|||++.+   ....++.++||||||+++|||++|+.||......      ...... ........
T Consensus       180 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~-~~~~~~~~  249 (318)
T 2dyl_A          180 A---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTK-VLQEEPPL  249 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHH-HHHSCCCC
T ss_pred             c---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHH-HhccCCCC
Confidence            2   233458999999999853   1236788999999999999999999998743211      111111 11110000


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..     ....++.++.+++.+||+.||++|||++++++
T Consensus       250 ~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 LP-----GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CC-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CC-----ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            00     11123567889999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-36  Score=306.48  Aligned_cols=229  Identities=11%  Similarity=0.069  Sum_probs=180.5

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc----hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN----GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      |.+.+.||+|+||.||+|++. +++.||||++......    .+.+.+|+..+.+++||||+++++++.+.+..++||||
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  112 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence            445789999999999999975 4889999999765432    26789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++++|.++++..        .....+.+|+.|+++||+|||+   +||+||||||+|||++.++.+||++++       
T Consensus       113 ~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          113 IRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             CCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             cCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999542        3455788999999999999999   999999999999999999999997443       


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                                     |++         .++.++||||||+++|||++|+.||.............          ... .
T Consensus       175 ---------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----------~~~-~  219 (286)
T 3uqc_A          175 ---------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----------RDT-A  219 (286)
T ss_dssp             ---------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----------BCT-T
T ss_pred             ---------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----------HHh-c
Confidence                           222         35779999999999999999999997654321100000          000 0


Q ss_pred             cCCCC--chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          560 QGIEN--EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       560 ~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      .....  .....++.++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            00000  1112345678999999999999999 99999999998765433

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.2e-36  Score=333.89  Aligned_cols=269  Identities=24%  Similarity=0.285  Sum_probs=198.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEe------CceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFE------GHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l  395 (638)
                      +.+.++||+|+||+||+|.. .+++.||||++....  ...+.+.+|++++++++||||+++++++..      ++..++
T Consensus        16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L   95 (676)
T 3qa8_A           16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL   95 (676)
T ss_dssp             -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence            45688999999999999986 458899999987543  234578899999999999999999998765      677899


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCc---eEEcccc
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFC---PKISDFG  472 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFg  472 (638)
                      ||||+++++|.+++....   ....+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.   +||+|||
T Consensus        96 VmEy~~ggsL~~~L~~~~---~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           96 AMEYCEGGDLRKYLNQFE---NCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             EEECCSSCBHHHHHHSSS---CTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEeCCCCCHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            999999999999998743   12468899999999999999999999   99999999999999987665   9999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc-cchhHHHHHHh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE-IYFPHWVYKRL  551 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~  551 (638)
                      ++........   .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||........- ...........
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          170 YAKELDQGEL---CTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCCBTTSCCC---CCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             cccccccccc---cccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            9987654432   2345689999999999764  7899999999999999999999999643110000 00000000000


Q ss_pred             hh----hhhcccc---CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHhcccC
Q 006620          552 EL----EEDLGLQ---GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNR-----VVEMLEGSLD  604 (638)
Q Consensus       552 ~~----~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~  604 (638)
                      ..    .......   .........++..+.+++.+||+.||++|||+++     +.+.+++++.
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            00    0000010   1111223346788999999999999999999977     4455555443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-35  Score=302.49  Aligned_cols=222  Identities=20%  Similarity=0.285  Sum_probs=175.7

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHH-hhcCCcceEEEEeEEEe----CceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASI-SRTSHVNIVTLLGFCFE----GHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||++.. .+++.||||+++..    ..+.+|++++ +.++||||+++++++..    ....++||||+++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            6799999999999986 56889999998642    4567888887 55689999999999987    6778999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC---CCceEEcccccceeccC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICEG  479 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFg~~~~~~~  479 (638)
                      ++|.+++....    ...+++..++.++.|+++||+|||+   .+|+||||||+||+++.   ++.+||+|||++.....
T Consensus       100 ~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  172 (299)
T 3m2w_A          100 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG  172 (299)
T ss_dssp             CBHHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT
T ss_pred             CcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc
Confidence            99999998753    2469999999999999999999999   99999999999999987   78999999999864321


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                                                ..++.++||||||+++|||++|+.||..........          .....+..
T Consensus       173 --------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~----------~~~~~~~~  216 (299)
T 3m2w_A          173 --------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----------GMKTRIRM  216 (299)
T ss_dssp             --------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C----------CSCCSSCT
T ss_pred             --------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH----------HHHHHHhh
Confidence                                      246779999999999999999999996543211000          00000000


Q ss_pred             c--CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 Q--GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .  .........++.++.+++.+||+.||++|||++|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0  0111111335678999999999999999999999997

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.7e-36  Score=337.88  Aligned_cols=235  Identities=23%  Similarity=0.296  Sum_probs=189.6

Q ss_pred             hhhcccCcCcceeEEEEEEc--CCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCce-----EEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL--DGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHR-----RALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv  396 (638)
                      .+.+.||+|+||+||+|++.  +++.||||++.....  ..+.+.+|++++++++||||+++++++...+.     .++|
T Consensus        83 ~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv  162 (681)
T 2pzi_A           83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV  162 (681)
T ss_dssp             EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEE
Confidence            35789999999999999975  588999999865432  23567899999999999999999999987655     7999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |||+++++|.+++..        .+++..++.|+.||++||+|||+   ++|+||||||+|||++.+ .+||+|||+++.
T Consensus       163 ~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          163 MEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999887643        58999999999999999999999   999999999999999875 999999999987


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ....      ....||+.|+|||++.+.   .+.++||||||+++|+|++|.+|+.........                
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------  285 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------  285 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------------
T ss_pred             cccC------CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCccccccccc----------------
Confidence            6543      334689999999998653   488999999999999999999887643211100                


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhccc
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-SMNRVVEMLEGSL  603 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~  603 (638)
                            ...........+.+++.+||+.||++|| +++++.+.|.+.+
T Consensus       286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                  0112223456788999999999999999 5677777776543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.3e-35  Score=307.86  Aligned_cols=239  Identities=16%  Similarity=0.160  Sum_probs=184.5

Q ss_pred             HHhhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC---------chhhHHHHHHHHhhcC---------CcceEEEE
Q 006620          323 MTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---------NGEDFINEVASISRTS---------HVNIVTLL  384 (638)
Q Consensus       323 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~---------h~niv~l~  384 (638)
                      ..+.+.++||+|+||+||+|+. +++.||||++.....         ..+.+.+|+.++++++         ||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            3456689999999999999998 689999999975431         2267889999998886         77777777


Q ss_pred             eEEE------------------------------eCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHH
Q 006620          385 GFCF------------------------------EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIA  434 (638)
Q Consensus       385 ~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~  434 (638)
                      +.+.                              .....++||||+++|++.+.+.+       ..+++..++.++.||+
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHH
Confidence            7643                              26789999999999987776643       3589999999999999


Q ss_pred             HHHHHHh-cCCCCCeEecccCCCceEECCCC--------------------ceEEcccccceeccCCCceeeeccccccc
Q 006620          435 RGLEYLH-RGCNTRILHFDIKPHNILLDEDF--------------------CPKISDFGLAKICEGRESIVSMTGARGTI  493 (638)
Q Consensus       435 ~aL~yLH-~~~~~~iiH~Dikp~NIll~~~~--------------------~~kl~DFg~~~~~~~~~~~~~~~~~~gt~  493 (638)
                      +||+||| +   .+|+||||||+|||++.++                    .+||+|||+++.....       ...||+
T Consensus       172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~  241 (336)
T 2vuw_A          172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred             HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence            9999999 8   8999999999999999877                    8999999999876532       235899


Q ss_pred             ceecCceeccccCCccccCCeeeHHHH-HHHHhcCCCCCCcccCCCcccchhHHHHHHh-hhhhhccc-cCCCCchhHHH
Q 006620          494 GYIAPEVFCRNFGEVSYKSDVYSYGMM-VFEMTGEKNNANVAVDRSSEIYFPHWVYKRL-ELEEDLGL-QGIENEEDKEY  570 (638)
Q Consensus       494 ~y~aPE~~~~~~~~~s~~~DvwslGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~  570 (638)
                      .|+|||++.+.   .+.++||||+|++ .+++++|..||...          .|..... ........ ..........+
T Consensus       242 ~y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (336)
T 2vuw_A          242 VSMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNV----------LWLHYLTDKMLKQMTFKTKCNTPAMKQI  308 (336)
T ss_dssp             CTTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHHHHHHHHHHHTCCCSSCCCSHHHHHH
T ss_pred             cccChhhhcCC---CccceehhhhhCCCCcccccccCCCcch----------hhhhHHHHhhhhhhccCcccchhhhhhc
Confidence            99999999764   2789999998776 77899998887421          1100000 00001111 12223345678


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHH-H
Q 006620          571 ARKMILVSLWCIQTNPSDRPSMNRVV-E  597 (638)
Q Consensus       571 ~~~l~~li~~cl~~dP~~RPs~~evl-~  597 (638)
                      +.++.+|+.+||+.|     |++|++ +
T Consensus       309 s~~~~dli~~~L~~d-----sa~e~l~~  331 (336)
T 2vuw_A          309 KRKIQEFHRTMLNFS-----SATDLLCQ  331 (336)
T ss_dssp             HHHHHHHHHHGGGSS-----SHHHHHHH
T ss_pred             CHHHHHHHHHHhccC-----CHHHHHhc
Confidence            899999999999976     999998 5

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-35  Score=315.80  Aligned_cols=239  Identities=14%  Similarity=0.152  Sum_probs=173.7

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccC----CchhhHHHHHHHHhhcCC-cc---------------eEE----
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK----GNGEDFINEVASISRTSH-VN---------------IVT----  382 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h-~n---------------iv~----  382 (638)
                      .+.||+|+||+||+|++ .+++.||||++....    ...+.+.+|+.+++.++| +|               ++.    
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            57899999999999995 568999999987332    234678899999999976 21               111    


Q ss_pred             --EEeEEEe-----CceEEEEEEeccCCCHHHHhhhcCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccC
Q 006620          383 --LLGFCFE-----GHRRALIYEFVSNGSLEKFIHEKHP-LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIK  454 (638)
Q Consensus       383 --l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dik  454 (638)
                        +..++..     ....+++|+++ +++|.+++..... ......+++..++.++.|+++||+|||+   ++|+|||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiK  238 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR  238 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcc
Confidence              1111111     22356667765 6799999853210 0112458888999999999999999999   999999999


Q ss_pred             CCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccc--------cCCccccCCeeeHHHHHHHHhc
Q 006620          455 PHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN--------FGEVSYKSDVYSYGMMVFEMTG  526 (638)
Q Consensus       455 p~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~s~~~DvwslGvil~ellt  526 (638)
                      |+|||++.++.+||+|||+++.....     .....| +.|+|||++.+.        ...++.++|||||||++|||++
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999999998865422     244567 999999998321        1257889999999999999999


Q ss_pred             CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006620          527 EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVV  596 (638)
Q Consensus       527 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  596 (638)
                      |+.||..........               .......     .++.++.+|+.+||+.||++||++.+++
T Consensus       313 g~~Pf~~~~~~~~~~---------------~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          313 ADLPNTDDAALGGSE---------------WIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             SSCCCCTTGGGSCSG---------------GGGSSCC-----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             CCCCCCCcchhhhHH---------------HHHhhcc-----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999997543211100               0011111     2246789999999999999999976654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=2.1e-30  Score=285.77  Aligned_cols=186  Identities=18%  Similarity=0.192  Sum_probs=132.5

Q ss_pred             cccCcCcceeEEEEE-EcCCCEEEEEEecccC-----------CchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLNETK-----------GNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      ..++.|+.|.+..++ .--|+.|++|++....           ...+++.+|+++|+++ +|+||++++++++++...||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            456778888777765 4458999999997542           1235689999999999 59999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||++|++|.++|...+      .++..   +|+.||++||+|+|+   +|||||||||+|||++++|.+||+|||+++
T Consensus       320 VMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr  387 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIV  387 (569)
T ss_dssp             EEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred             EEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCe
Confidence            999999999999998753      45543   589999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCC
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNA  531 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~  531 (638)
                      .......  .....+||+.|+|||++.+   .+..++|+||+|++++++.++..++
T Consensus       388 ~~~~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          388 TTPQDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             SCC---C--CSHHHHHHHHHHHHHHC--------------------CCCCTTHHHH
T ss_pred             eCCCCCc--cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccchh
Confidence            7654322  2244679999999999975   4567899999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=2.5e-26  Score=251.80  Aligned_cols=184  Identities=16%  Similarity=0.179  Sum_probs=143.3

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEecccCCc---------hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN---------GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      .+.||+|+||+||++.. .++.+++|+.......         .+.+.+|++++++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999954 5788999986543211         2347899999999999999965555667778899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++++|.+++..              +..++.|+++||+|||+   ++|+||||||+|||++.  .+||+|||+++...
T Consensus       420 ~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          420 YINGKLAKDVIED--------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             CCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             CCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            9999999999875              35799999999999999   99999999999999998  99999999999875


Q ss_pred             CCCcee-----eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCC
Q 006620          479 GRESIV-----SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNA  531 (638)
Q Consensus       479 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~  531 (638)
                      ......     ......||+.|+|||++......|+..+|+|+..+-..+.+.++.++
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            432211     11245689999999999764346788999999988888877666544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=1.2e-22  Score=204.15  Aligned_cols=141  Identities=15%  Similarity=0.097  Sum_probs=114.2

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCC-------------------chhhHHHHHHHHhhcCCcceEEEEeEE
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG-------------------NGEDFINEVASISRTSHVNIVTLLGFC  387 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~~~~  387 (638)
                      +.+.||+|+||.||+|...+++.||||+++....                   ....+.+|++++++++  | +++++++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            3589999999999999987789999999964321                   2346789999999998  4 5666654


Q ss_pred             EeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceE
Q 006620          388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK  467 (638)
Q Consensus       388 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  467 (638)
                      .. +..++||||+++++|.+ +..            .....++.|+++||+|||+   .||+||||||+|||++ ++.+|
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEE
T ss_pred             ec-cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEE
Confidence            33 55699999999999988 422            1245799999999999999   9999999999999999 99999


Q ss_pred             EcccccceeccCCCceeeecccccccceecCceecc
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR  503 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  503 (638)
                      |+|||+++.               +..+.|||++.+
T Consensus       233 l~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          233 IIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             ECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             EEECCCCeE---------------CCCCCHHHHHHH
Confidence            999999873               335678888753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=3e-19  Score=177.13  Aligned_cols=133  Identities=18%  Similarity=0.232  Sum_probs=104.1

Q ss_pred             hhcccCcCcceeEEEEEE-cCCCE--EEEEEecccCCc-------------------------hhhHHHHHHHHhhcCCc
Q 006620          327 FKNKLGQGGYGGVYKGKL-LDGQN--VAIKVLNETKGN-------------------------GEDFINEVASISRTSHV  378 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~  378 (638)
                      +.+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+.++.++.|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            457899999999999997 67888  999997543111                         12578899999999887


Q ss_pred             ce--EEEEeEEEeCceEEEEEEeccC-C----CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEe
Q 006620          379 NI--VTLLGFCFEGHRRALIYEFVSN-G----SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH-RGCNTRILH  450 (638)
Q Consensus       379 ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~~~iiH  450 (638)
                      ++  +.+++.    ...+|||||+.+ |    +|.++...         .++..+..++.|+++||+||| +   .||+|
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~givH  194 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQE---AELVH  194 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHT---SCEEC
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHH---CCEEe
Confidence            53  444442    356899999942 3    67666433         123457889999999999999 8   89999


Q ss_pred             cccCCCceEECCCCceEEcccccceec
Q 006620          451 FDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       451 ~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.67  E-value=1.5e-17  Score=171.43  Aligned_cols=134  Identities=15%  Similarity=0.160  Sum_probs=96.9

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCC---------------chhhH--------HHHHHHHhhcCCcce-
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG---------------NGEDF--------INEVASISRTSHVNI-  380 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~~--------~~E~~~l~~l~h~ni-  380 (638)
                      |.+.+.||+|++|.||+|...+|+.||||+++....               .....        .+|...|.++.+.++ 
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            345789999999999999988899999999763210               00111        245556666644332 


Q ss_pred             -EEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceE
Q 006620          381 -VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL  459 (638)
Q Consensus       381 -v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIl  459 (638)
                       ...++.    ...+|||||++|++|.++...            +....++.|++.+|.+||+   .|||||||||.|||
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAK---HGLIHGDFNEFNIL  237 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEE
Confidence             222221    223799999999888654321            1245788999999999999   89999999999999


Q ss_pred             ECCCC----------ceEEcccccceec
Q 006620          460 LDEDF----------CPKISDFGLAKIC  477 (638)
Q Consensus       460 l~~~~----------~~kl~DFg~~~~~  477 (638)
                      +++++          .+.|+||+.+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98776          3899999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=3.8e-11  Score=118.91  Aligned_cols=137  Identities=15%  Similarity=0.067  Sum_probs=107.6

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccC-CchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK-GNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +...++.|+.+.||++... ++.+++|+..... .....+.+|+++++.+. +..+.+++++....+..++|||+++|.+
T Consensus        18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence            3567788888999999753 6899999986532 23456889999999985 6778899999988889999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG-----------------------------------------  443 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----------------------------------------  443 (638)
                      |.+.+..           ......++.+++++|+.||+.                                         
T Consensus        97 l~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           97 CSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             HHHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             hhhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            9876321           112347888999999999981                                         


Q ss_pred             ---------------CCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          444 ---------------CNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       444 ---------------~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                                     ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                           11459999999999999876566799998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.18  E-value=5.8e-11  Score=117.29  Aligned_cols=131  Identities=16%  Similarity=0.094  Sum_probs=98.1

Q ss_pred             ccC-cCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcc--eEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          330 KLG-QGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN--IVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       330 ~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      .++ .|..+.||++...+++.+++|+....  ....+.+|+++++.+.+.+  +.+++++...++..++||||++|.+|.
T Consensus        26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            454 55569999998767788999997654  3356788999999886544  566888888878899999999998884


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC------------------------------------------  444 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------------------  444 (638)
                        ...         ..   ...++.++++.|+.||+..                                          
T Consensus       104 --~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A          104 --SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             --TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             --cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence              211         11   2356777888888888621                                          


Q ss_pred             -------------CCCeEecccCCCceEECCCCceEEccccccee
Q 006620          445 -------------NTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       445 -------------~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                                   ...++|+|++|.||++++++.+.|+||+.+..
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                         12399999999999998776677999997653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.02  E-value=8.2e-10  Score=114.65  Aligned_cols=141  Identities=18%  Similarity=0.180  Sum_probs=106.6

Q ss_pred             hcccCcCcceeEEEEEEcCCCEEEEEEec--ccC--CchhhHHHHHHHHhhcC--CcceEEEEeEEEeC---ceEEEEEE
Q 006620          328 KNKLGQGGYGGVYKGKLLDGQNVAIKVLN--ETK--GNGEDFINEVASISRTS--HVNIVTLLGFCFEG---HRRALIYE  398 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e  398 (638)
                      .+.|+.|.++.||+.... +..+++|+..  ...  .....+.+|+.+++.+.  +..+.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            357899999999999864 4688899876  332  22357788999999987  45688889888766   44789999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC----------------------------------  444 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------------  444 (638)
                      |++|..+.+...        ..++...+..++.+++++|+.||+..                                  
T Consensus       122 ~v~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          122 FVSGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CCCCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             ecCCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            999987754211        24678888999999999999999720                                  


Q ss_pred             ---------------------CCCeEecccCCCceEECCCCc--eEEcccccceec
Q 006620          445 ---------------------NTRILHFDIKPHNILLDEDFC--PKISDFGLAKIC  477 (638)
Q Consensus       445 ---------------------~~~iiH~Dikp~NIll~~~~~--~kl~DFg~~~~~  477 (638)
                                           ...++|+|++|.||+++.++.  +.|+||+.+..-
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                 257999999999999987653  689999988753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=8.9e-10  Score=111.57  Aligned_cols=186  Identities=18%  Similarity=0.203  Sum_probs=120.5

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcC-Ccc--eEEEEeEEEeCc---eEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVN--IVTLLGFCFEGH---RRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~  402 (638)
                      +.++.|....||+..    +.+++|+.... .....+.+|+++++.+. +..  +.+++.......   ..++|||+++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458899999999863    56899986533 23456788999998874 322  445555433333   34789999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG---------------------------------------  443 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------------------------------------  443 (638)
                      .+|.+....        .++.+.+..++.++++.|+.||+.                                       
T Consensus       101 ~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A          101 VPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             eECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            888754332        366777788888888888888851                                       


Q ss_pred             ----------------CCCCeEecccCCCceEECC--CCceEEcccccceeccCCCceeeeccc---c---------ccc
Q 006620          444 ----------------CNTRILHFDIKPHNILLDE--DFCPKISDFGLAKICEGRESIVSMTGA---R---------GTI  493 (638)
Q Consensus       444 ----------------~~~~iiH~Dikp~NIll~~--~~~~kl~DFg~~~~~~~~~~~~~~~~~---~---------gt~  493 (638)
                                      ....++|+|++|.||++++  +..+.|+||+.+..-............   .         ...
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                            1135899999999999987  566889999988754321110000000   0         000


Q ss_pred             ceec-CceeccccCCccccCCeeeHHHHHHHHhcCCCCC
Q 006620          494 GYIA-PEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNA  531 (638)
Q Consensus       494 ~y~a-PE~~~~~~~~~s~~~DvwslGvil~elltg~~p~  531 (638)
                      +... |+...    ......+.|++|.++|.+.+|..++
T Consensus       253 ~~~~~~~~~~----r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLE----KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHH----HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHH----HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1111 22221    1122357999999999999997654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=1.1e-06  Score=88.78  Aligned_cols=135  Identities=18%  Similarity=0.139  Sum_probs=93.2

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCc---ceEEEEeEEE-eCceEEEEEEeccCCC
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV---NIVTLLGFCF-EGHRRALIYEFVSNGS  404 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gs  404 (638)
                      +.++.|....||+.    ++.+++|+.... .....+.+|+++|+.+.+.   .+.+++.+.. ..+..++|||+++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~-~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKSQ-QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESSH-HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCCc-hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45788888899988    577899985321 2345778999999998742   3566666664 3456789999999988


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG-----------------------------------------  443 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----------------------------------------  443 (638)
                      |.+..-        ..++......++.++++.|+.||+.                                         
T Consensus       100 l~~~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A          100 LGEDGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CHHHHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             Cchhhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            876321        1234444555555555555555541                                         


Q ss_pred             ----------------CCCCeEecccCCCceEECC---CCc-eEEccccccee
Q 006620          444 ----------------CNTRILHFDIKPHNILLDE---DFC-PKISDFGLAKI  476 (638)
Q Consensus       444 ----------------~~~~iiH~Dikp~NIll~~---~~~-~kl~DFg~~~~  476 (638)
                                      ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            1235799999999999987   455 48999997764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.41  E-value=1.4e-06  Score=86.19  Aligned_cols=135  Identities=17%  Similarity=0.151  Sum_probs=97.6

Q ss_pred             ccCcCcce-eEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          330 KLGQGGYG-GVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       330 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      .+..|..| .||+.... ++..+++|+-...  ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            34445544 68988754 4678999986533  3456788999998886 334778888888999999999999998887


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 006620          407 KFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC------------------------------------------  444 (638)
Q Consensus       407 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------------------  444 (638)
                      +......          .....+..++++.|+-||+..                                          
T Consensus       109 ~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          109 QVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            7654321          123456667777777777511                                          


Q ss_pred             -------------CCCeEecccCCCceEECCCCceEEccccccee
Q 006620          445 -------------NTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       445 -------------~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                                   ...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         01379999999999999877778999987653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.27  E-value=2.1e-06  Score=88.73  Aligned_cols=79  Identities=9%  Similarity=-0.013  Sum_probs=56.2

Q ss_pred             ccc-CcCcceeEEEEEEc-------CCCEEEEEEecccC---C-chhhHHHHHHHHhhcC-C--cceEEEEeEEEeC---
Q 006620          329 NKL-GQGGYGGVYKGKLL-------DGQNVAIKVLNETK---G-NGEDFINEVASISRTS-H--VNIVTLLGFCFEG---  390 (638)
Q Consensus       329 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  390 (638)
                      +.| +.|....+|+....       +++.+++|+.....   . ....+.+|+.+++.+. +  -.+.+++.+..+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78888999998754       26789999875432   1 1356778999888885 3  3567788876654   


Q ss_pred             ceEEEEEEeccCCCHHH
Q 006620          391 HRRALIYEFVSNGSLEK  407 (638)
Q Consensus       391 ~~~~lv~e~~~~gsL~~  407 (638)
                      ...++|||+++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999876643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.01  E-value=1.1e-05  Score=82.63  Aligned_cols=143  Identities=15%  Similarity=0.180  Sum_probs=80.3

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCC--cceEEEEe------EEEeCceEEEEEEec
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSH--VNIVTLLG------FCFEGHRRALIYEFV  400 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~~  400 (638)
                      +.|+.|..+.||+....++ .+++|+....   ......|+++++.+..  -.+.+++.      +....+..++++||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            3566677899999987554 5899998753   2334455555555531  12333332      123466788999999


Q ss_pred             cCCCHH-----------H---Hhhhc-CCC--CCC-----CCCCHHH-------------------------------HH
Q 006620          401 SNGSLE-----------K---FIHEK-HPL--ETN-----QKLKWEV-------------------------------LY  427 (638)
Q Consensus       401 ~~gsL~-----------~---~l~~~-~~~--~~~-----~~l~~~~-------------------------------~~  427 (638)
                      +|.++.           +   .++.. ...  ...     ..-.|..                               +.
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542           1   11211 101  000     0112211                               11


Q ss_pred             HHHHHHHHHHHHHhc----------CCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          428 KIAVGIARGLEYLHR----------GCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       428 ~i~~qi~~aL~yLH~----------~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      .+..++..++++|++          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            112223445666652          023789999999999999888899999998765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.98  E-value=3.4e-05  Score=80.81  Aligned_cols=74  Identities=12%  Similarity=0.022  Sum_probs=49.7

Q ss_pred             hcccCcCcceeEEEEEEc-CCCEEEEEEecccC--------CchhhHHHHHHHHhhcCC--c-ceEEEEeEEEeCceEEE
Q 006620          328 KNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--------GNGEDFINEVASISRTSH--V-NIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  395 (638)
                      .+.||.|..+.||++... +++.++||......        ...+.+..|.++++.+..  + .+.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357999999999999753 46789999864321        123456789888887742  3 44566654  3455689


Q ss_pred             EEEeccCC
Q 006620          396 IYEFVSNG  403 (638)
Q Consensus       396 v~e~~~~g  403 (638)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.73  E-value=0.00016  Score=72.70  Aligned_cols=140  Identities=16%  Similarity=0.196  Sum_probs=91.4

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcC---CcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      +.|+.|....+|+... +++.+++|+....  ....+..|.+.|+.+.   ...+.+++++....+..++|||++++..+
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            5688999999999876 4678999987643  3456788999888885   35688888888878889999999998764


Q ss_pred             H--------H---HhhhcCC---CC--CC-----------CCCCHHHHH---HHH----------------HHHHHHH-H
Q 006620          406 E--------K---FIHEKHP---LE--TN-----------QKLKWEVLY---KIA----------------VGIARGL-E  438 (638)
Q Consensus       406 ~--------~---~l~~~~~---~~--~~-----------~~l~~~~~~---~i~----------------~qi~~aL-~  438 (638)
                      .        +   .|+....   +.  ..           -.-+|....   ++.                ..+++.+ .
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            2        1   2232211   00  00           001343221   111                1122222 2


Q ss_pred             HHhc-CCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          439 YLHR-GCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       439 yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      .|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3421 1236899999999999998877 8899973

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.60  E-value=0.00024  Score=74.95  Aligned_cols=31  Identities=13%  Similarity=0.269  Sum_probs=27.8

Q ss_pred             CCeEecccCCCceEECCCCceEEcccccceec
Q 006620          446 TRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       446 ~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ..++|+|++|.|||++.++ ++|+||+.+..-
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            7899999999999998776 999999988753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.54  E-value=0.00017  Score=72.25  Aligned_cols=140  Identities=11%  Similarity=0.116  Sum_probs=75.8

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEEec-cCCCHH
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYEFV-SNGSLE  406 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL~  406 (638)
                      +.|+.|....+|+.     +.+++|+............+|+.+++.+....+ .++++.  +.+.-++++||+ ++.+|.
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~   96 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMS   96 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCC
Confidence            56888999999998     568999886542222233568877777652222 455554  333457899999 665543


Q ss_pred             H---------------HhhhcCCCCC--CCCCC-HHHHHHHHHH--------------HHHHHH----HHhc-CCCCCeE
Q 006620          407 K---------------FIHEKHPLET--NQKLK-WEVLYKIAVG--------------IARGLE----YLHR-GCNTRIL  449 (638)
Q Consensus       407 ~---------------~l~~~~~~~~--~~~l~-~~~~~~i~~q--------------i~~aL~----yLH~-~~~~~ii  449 (638)
                      .               .|.+-+....  ..... +..+..+...              +.+.+.    .+.. .....++
T Consensus        97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~  176 (301)
T 3dxq_A           97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC  176 (301)
T ss_dssp             HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred             HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence            1               1111111000  00011 1111111110              111111    1111 1235689


Q ss_pred             ecccCCCceEECCCCceEEccccccee
Q 006620          450 HFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       450 H~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |+|+.+.||+ ..++.+.|+||..+..
T Consensus       177 HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          177 HCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ccCCCcCCEE-ECCCCEEEEecccccC
Confidence            9999999999 5667889999987764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.48  E-value=0.00032  Score=72.47  Aligned_cols=144  Identities=14%  Similarity=0.164  Sum_probs=84.8

Q ss_pred             cccCcCcceeEEEEEEc--------CCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEe
Q 006620          329 NKLGQGGYGGVYKGKLL--------DGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.|..|-...+|+....        +++.+++|+............+|.++++.+. +.-..++++.+.+    .+|+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            46777888899998864        2478999997543334556678999988876 3223566666543    289999


Q ss_pred             ccCCCHHH--------------HhhhcCCC--CCCCCC--CHHHHHHHHHHHHH-------------------HHHHHhc
Q 006620          400 VSNGSLEK--------------FIHEKHPL--ETNQKL--KWEVLYKIAVGIAR-------------------GLEYLHR  442 (638)
Q Consensus       400 ~~~gsL~~--------------~l~~~~~~--~~~~~l--~~~~~~~i~~qi~~-------------------aL~yLH~  442 (638)
                      ++|.+|..              .|.+.+..  ......  -+.++.++..++..                   .+..|.+
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            98765431              11111111  111112  24555555544422                   2233322


Q ss_pred             -----CCCCCeEecccCCCceEECCC----CceEEccccccee
Q 006620          443 -----GCNTRILHFDIKPHNILLDED----FCPKISDFGLAKI  476 (638)
Q Consensus       443 -----~~~~~iiH~Dikp~NIll~~~----~~~kl~DFg~~~~  476 (638)
                           .....++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                 123579999999999999876    7899999987753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.39  E-value=0.001  Score=67.27  Aligned_cols=144  Identities=15%  Similarity=0.157  Sum_probs=83.0

Q ss_pred             ccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCc--ceEEEEeE-----EEeCceEEEEEEeccC
Q 006620          330 KLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHV--NIVTLLGF-----CFEGHRRALIYEFVSN  402 (638)
Q Consensus       330 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~~  402 (638)
                      .|+ |....||+....+|+.+++|+........+.+..|..+++.+...  .+++++..     ...++..++++|+++|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            456 778899998776777899999875433455677788888777522  23444432     1224566789999987


Q ss_pred             CCHH-----------HH---hhhc-C--CCCCCCCCCHHHH----------------------HHHHHHHHHHHHHHhc-
Q 006620          403 GSLE-----------KF---IHEK-H--PLETNQKLKWEVL----------------------YKIAVGIARGLEYLHR-  442 (638)
Q Consensus       403 gsL~-----------~~---l~~~-~--~~~~~~~l~~~~~----------------------~~i~~qi~~aL~yLH~-  442 (638)
                      .++.           +.   ++.. .  .......+++...                      ...+..++..++-+-. 
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            5432           11   1111 0  0000111222111                      1122222222222211 


Q ss_pred             CCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       443 ~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      .....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1236789999999999998 4 899999987653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.37  E-value=0.00027  Score=74.64  Aligned_cols=72  Identities=14%  Similarity=0.236  Sum_probs=49.3

Q ss_pred             cccCcCcceeEEEEEEcC--------CCEEEEEEecccCCchhhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEEe
Q 006620          329 NKLGQGGYGGVYKGKLLD--------GQNVAIKVLNETKGNGEDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  399 (638)
                      +.|+.|....+|++...+        ++.+++|+.... ...+.+.+|+.+++.+...++ .++++.+..    .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            467788889999998653        478999998432 122566789999888863333 566765532    289999


Q ss_pred             ccCCCH
Q 006620          400 VSNGSL  405 (638)
Q Consensus       400 ~~~gsL  405 (638)
                      ++|.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.35  E-value=0.0006  Score=72.34  Aligned_cols=73  Identities=16%  Similarity=0.063  Sum_probs=47.9

Q ss_pred             cccCcCcceeEEEEEEcC-CCEEEEEEecccCCchhhHHHHHHHHhhcCCcce-EEEEeEEEeCceEEEEEEeccCCCH
Q 006620          329 NKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVASISRTSHVNI-VTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      +.|+.|-...+|+....+ ++.+++|+........-...+|..+++.+...++ .++++.+.  +  .+|+||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            467888889999998754 4789999875432222223589999988874444 56777663  2  259999987544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.31  E-value=0.0014  Score=66.49  Aligned_cols=145  Identities=14%  Similarity=0.091  Sum_probs=75.2

Q ss_pred             cccCcCccee-EEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCC--cceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          329 NKLGQGGYGG-VYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSH--VNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       329 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      +.|+.|+... +|+....+++.+++|......  .+.+..|+.+++.+..  -.+.+++.+.....  +++||++.+.++
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l   99 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF   99 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence            3465555444 667765446778888654432  1344567777766642  23556666533332  689999977677


Q ss_pred             HHHhhhcC------------------CCCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHh---c
Q 006620          406 EKFIHEKH------------------PLET--NQKLKWEVLY-------K-------------IAVGIARGLEYLH---R  442 (638)
Q Consensus       406 ~~~l~~~~------------------~~~~--~~~l~~~~~~-------~-------------i~~qi~~aL~yLH---~  442 (638)
                      .+++....                  ....  -..+......       .             ....+...++.+.   .
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~  179 (333)
T 3csv_A          100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL  179 (333)
T ss_dssp             HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence            65443211                  0000  0111111110       0             0011122222221   1


Q ss_pred             CCCCCeEecccCCCceEECCC----CceEEcccccceec
Q 006620          443 GCNTRILHFDIKPHNILLDED----FCPKISDFGLAKIC  477 (638)
Q Consensus       443 ~~~~~iiH~Dikp~NIll~~~----~~~kl~DFg~~~~~  477 (638)
                      .....++|+|+.+.||+++.+    +.+.|+||+.+..-
T Consensus       180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            123689999999999999874    68999999987753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.25  E-value=0.0016  Score=64.62  Aligned_cols=73  Identities=19%  Similarity=0.286  Sum_probs=53.3

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCC-chhhHHHHHHHHhhcCC---cceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG-NGEDFINEVASISRTSH---VNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+|.|..+.||+....+|+.|++|+...... ....+..|++.|+.+..   --+.+++++  .  ..++|||+++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence            56899999999999999999999998764432 23457789999888852   234555554  2  2478999998764


Q ss_pred             H
Q 006620          405 L  405 (638)
Q Consensus       405 L  405 (638)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.19  E-value=0.0022  Score=64.59  Aligned_cols=145  Identities=17%  Similarity=0.201  Sum_probs=79.8

Q ss_pred             cccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcc--eEEEEeE------EEeCceEEEEEEec
Q 006620          329 NKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN--IVTLLGF------CFEGHRRALIYEFV  400 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~  400 (638)
                      +.|+.|....+|+....++ .+++|+.... ...+.+..|+.+++.+....  +.+++..      ....+..+++++++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            4577788899999987555 6889988753 12345567777777765222  2333321      12345678999999


Q ss_pred             cCCCHHH--------------Hhhhc-CCCCCC--CCCC---HHHHHH------------HHHHHHHHHHHHhc----CC
Q 006620          401 SNGSLEK--------------FIHEK-HPLETN--QKLK---WEVLYK------------IAVGIARGLEYLHR----GC  444 (638)
Q Consensus       401 ~~gsL~~--------------~l~~~-~~~~~~--~~l~---~~~~~~------------i~~qi~~aL~yLH~----~~  444 (638)
                      +|..+..              .++.. ......  ....   |.....            +...+.+.++.+++    ..
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            8865321              12211 011110  0011   211100            00113445555553    12


Q ss_pred             CCCeEecccCCCceEECCCCceEEcccccce
Q 006620          445 NTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       445 ~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3579999999999999877666899998665

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.17  E-value=0.00078  Score=62.60  Aligned_cols=101  Identities=14%  Similarity=0.082  Sum_probs=66.9

Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      -+|.+.|....     .+|+++++|.++.|.+++|.-+-..  +.-..+=+.|..|++..+|.|-+.+ ..+.       
T Consensus        33 vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           33 LSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             ccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------
Confidence            48999999875     7899999999999999998877220  1111333557899999999998764 1111       


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK  528 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~  528 (638)
                             .....+.|||....   ..+.+.=|||||+++|.-+--.
T Consensus        98 -------~~~~~~~~pe~~~~---~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -------AGEPPPVAGKLGYS---QCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ----------------CCSSS---SSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -------ccccCCCChhhccc---cchHHHHHHHHHHHHHHHhhcC
Confidence                   01224668887631   4567778999999999988543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.15  E-value=0.00053  Score=70.80  Aligned_cols=73  Identities=15%  Similarity=0.154  Sum_probs=44.7

Q ss_pred             cccCcCcceeEEEEEEcC---------CCEEEEEEecccCCchhhHHHHHHHHhhcCCcc-eEEEEeEEEeCceEEEEEE
Q 006620          329 NKLGQGGYGGVYKGKLLD---------GQNVAIKVLNETKGNGEDFINEVASISRTSHVN-IVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  398 (638)
                      +.|+.|....+|+....+         ++.+++|+.............|.++++.+...+ ..++++..  .  -.+|+|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            467788888999998643         268999987653322223457888888776333 44666543  2  268999


Q ss_pred             eccCCCH
Q 006620          399 FVSNGSL  405 (638)
Q Consensus       399 ~~~~gsL  405 (638)
                      |++|.++
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.69  E-value=0.0068  Score=61.63  Aligned_cols=68  Identities=13%  Similarity=0.052  Sum_probs=43.8

Q ss_pred             CcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcC---CcceEEEEeE------EEeCceEEEEEEeccC
Q 006620          332 GQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS---HVNIVTLLGF------CFEGHRRALIYEFVSN  402 (638)
Q Consensus       332 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~~  402 (638)
                      |.|....||+....++ .+++|+......     ..|+..++.+.   -|.+++.+..      ....+..++||+|++|
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            4444689999987666 899998765432     34555655553   2224444432      2345678899999998


Q ss_pred             CCH
Q 006620          403 GSL  405 (638)
Q Consensus       403 gsL  405 (638)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.35  E-value=0.0066  Score=63.49  Aligned_cols=143  Identities=13%  Similarity=0.171  Sum_probs=84.7

Q ss_pred             cccCcCcceeEEEEEEcC--------CCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEe
Q 006620          329 NKLGQGGYGGVYKGKLLD--------GQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.|..|-...+|+....+        ++.+++|+........-...+|..+++.+. +.-..++++.+  .  -++|+||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence            457778888999998653        578999997543322223457888888875 32235555533  2  2689999


Q ss_pred             ccCCCHHH--------------HhhhcCC-------CC---CCCCCCHHHHHHHHHHH-------------------HHH
Q 006620          400 VSNGSLEK--------------FIHEKHP-------LE---TNQKLKWEVLYKIAVGI-------------------ARG  436 (638)
Q Consensus       400 ~~~gsL~~--------------~l~~~~~-------~~---~~~~l~~~~~~~i~~qi-------------------~~a  436 (638)
                      ++|.+|..              .|.+.+.       +.   ...+.-+.++.++..++                   ...
T Consensus       152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e  231 (424)
T 3mes_A          152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE  231 (424)
T ss_dssp             CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred             eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence            99865421              1111100       01   11111244444444332                   122


Q ss_pred             HHHHhc---------------------CCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          437 LEYLHR---------------------GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       437 L~yLH~---------------------~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      +.+|.+                     .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            333321                     11256899999999999 7888999999988764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.31  E-value=0.22  Score=51.64  Aligned_cols=30  Identities=30%  Similarity=0.305  Sum_probs=25.3

Q ss_pred             CeEecccCCCceEE------CCCCceEEccccccee
Q 006620          447 RILHFDIKPHNILL------DEDFCPKISDFGLAKI  476 (638)
Q Consensus       447 ~iiH~Dikp~NIll------~~~~~~kl~DFg~~~~  476 (638)
                      .++|+|+.+.|||+      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4567899999987764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.11  E-value=4.7  Score=37.37  Aligned_cols=82  Identities=15%  Similarity=0.171  Sum_probs=58.5

Q ss_pred             CCcceEEEEeEEEeCceEEEEEEeccC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEeccc
Q 006620          376 SHVNIVTLLGFCFEGHRRALIYEFVSN-GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE-YLHRGCNTRILHFDI  453 (638)
Q Consensus       376 ~h~niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~-yLH~~~~~~iiH~Di  453 (638)
                      .||++  -..+-.+++.+.+.++.-++ -++.+ ++         .++...+++++.+|+.... ++++     -+|--|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~---------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l  110 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR---------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIV  110 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH---------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH---------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEE
Confidence            58888  33444666776666665432 23433 22         3677889999999988766 5554     588899


Q ss_pred             CCCceEECCCCceEEcccccc
Q 006620          454 KPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       454 kp~NIll~~~~~~kl~DFg~~  474 (638)
                      +|+||+++.++.+++.-.|+-
T Consensus       111 ~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          111 CPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             CGGGEEECTTCCEEESCCEET
T ss_pred             eCceEEEeCCCcEEEEEcCCc
Confidence            999999999999999877653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.11  E-value=0.18  Score=53.27  Aligned_cols=59  Identities=7%  Similarity=0.055  Sum_probs=18.2

Q ss_pred             hhcccCcCcceeEEEEEEcC-CCEEEE------EEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLLD-GQNVAI------KVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCF  388 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~  388 (638)
                      +.++||   ||.||+|.+.. ..+|||      |..+...   .....+.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            456777   99999998754 467888      6655422   23356788999999999999999988765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	638
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-54
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-44
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-40
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-38
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-36
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 1e-66
 Identities = 79/285 (27%), Positives = 133/285 (46%), Gaps = 27/285 (9%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVTL 383
              ++G G +G VYKGK     +VA+K+LN T       + F NEV  + +T HVNI+  
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
           +G+       A++ ++    SL   +H         K +   L  IA   A+G++YLH  
Sbjct: 70  MGYSTAPQL-AIVTQWCEGSSLYHHLHII-----ETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-C 502
               I+H D+K +NI L ED   KI DFGLA +              G+I ++APEV   
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 503 RNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
           ++    S++SDVY++G++++E+ TG+           +      ++  R  L  DL    
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQL-----PYSNINNRDQIIFMVGRGYLSPDL---- 231

Query: 562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL 606
             ++      + M  +   C++    +RP   +++  +E    SL
Sbjct: 232 --SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 8e-64
 Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 25/279 (8%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
           F  ++G G +G V+ G  L+   VAIK + E   + EDFI E   + + SH  +V L G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
           C E     L++EF+ +G L  ++  +  L        E L  + + +  G+ YL   C  
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFA-----AETLLGMCLDVCEGMAYLEEAC-- 121

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
            ++H D+   N L+ E+   K+SDFG+ +     +   S  G +  + + +PEVF  +F 
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVF--SFS 177

Query: 507 EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 566
             S KSDV+S+G++++E+  E                P+      E+ ED+   G    +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEG-------------KIPYENRSNSEVVEDI-STGFRLYK 223

Query: 567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
            +  +  +  +   C +  P DRP+ +R++  L    +S
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 1e-61
 Identities = 65/274 (23%), Positives = 124/274 (45%), Gaps = 25/274 (9%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
           F  +LG G +G V  GK     +VAIK++ E   + ++FI E   +   SH  +V L G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
           C +     +I E+++NG L  ++ E        + + + L ++   +   +EYL    + 
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SK 119

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
           + LH D+   N L+++    K+SDFGL++     E   S  G++  + +  PEV      
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMY--S 176

Query: 507 EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 566
           + S KSD++++G++++E+              S    P+  +   E  E +  QG+    
Sbjct: 177 KFSSKSDIWAFGVLMWEI-------------YSLGKMPYERFTNSETAEHI-AQGLRLYR 222

Query: 567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
               + K+  +   C      +RP+   ++  + 
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 2e-61
 Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 25/274 (9%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
              +LG G +G V+ G       VA+K L +   + + F+ E   + +  H  +V L   
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
             +     +I E++ NGSL  F+          KL    L  +A  IA G+ ++      
Sbjct: 77  VTQEPIY-IITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEERN-- 129

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
             +H D++  NIL+ +    KI+DFGLA++ E  E   +  GA+  I + APE    N+G
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYG 185

Query: 507 EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 566
             + KSDV+S+G+++ E+                I +P      +        +G     
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHG-----------RIPYPGMTNPEV---IQNLERGYRMVR 231

Query: 567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
                 ++  +   C +  P DRP+ + +  +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 2e-61
 Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 25/286 (8%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            + KLGQG +G V+ G       VAIK L     + E F+ E   + +  H  +V L   
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 387 CFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT 446
             E     ++ E++S GSL  F+  +      + L+   L  +A  IA G+ Y+      
Sbjct: 81  VSEEP-IYIVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVE---RM 132

Query: 447 RILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
             +H D++  NIL+ E+   K++DFGLA++ E  E   +  GA+  I + APE      G
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY--G 189

Query: 507 EVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEE 566
             + KSDV+S+G+++ E+T +             + +P  V + +    D   +G     
Sbjct: 190 RFTIKSDVWSFGILLTELTTKG-----------RVPYPGMVNREV---LDQVERGYRMPC 235

Query: 567 DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPPRP 612
             E    +  +   C +  P +RP+   +   LE    S +   +P
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 6e-61
 Identities = 63/295 (21%), Positives = 118/295 (40%), Gaps = 29/295 (9%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
            +  +G+G +G V++GK   G+ VA+K+ +  +        E+       H NI+  +  
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 387 CFEGHRRA----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
             + +       L+ ++  +GSL  +++          +  E + K+A+  A GL +LH 
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHM 118

Query: 443 GC-----NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS--MTGARGTIGY 495
                     I H D+K  NIL+ ++    I+D GLA   +     +        GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 496 IAPEVFCRNF----GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL 551
           +APEV   +      E   ++D+Y+ G++ +E+    +   +  D     Y        +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 552 E------LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
           E       E+ L        +  E  R M  +   C   N + R +  R+ + L 
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (497), Expect = 3e-58
 Identities = 84/304 (27%), Positives = 142/304 (46%), Gaps = 27/304 (8%)

Query: 309 SLAPKRYRYAD--IKKMTNSFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDF 365
           ++ P    Y    +++   + K+KLG G YG VY+G        VA+K L E     E+F
Sbjct: 1   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60

Query: 366 INEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEV 425
           + E A +    H N+V LLG C       +I EF++ G+L  ++ E +     Q++   V
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVV 116

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           L  +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL+++  G ++  +
Sbjct: 117 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTA 172

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH 545
             GA+  I + APE       + S KSDV+++G++++E+     +    +D         
Sbjct: 173 HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LS 223

Query: 546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
            VY+ LE       +    E  +    K+  +   C Q NPSDRPS   + +  E     
Sbjct: 224 QVYELLE-------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

Query: 606 LQIP 609
             I 
Sbjct: 277 SSIS 280

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (492), Expect = 2e-57
 Identities = 75/306 (24%), Positives = 130/306 (42%), Gaps = 44/306 (14%)

Query: 315 YRYADIKKMTNSF-----------KNKLGQGGYGGVYKGKL-LDGQN---VAIKVLNE-- 357
           + + D  +    F           +  +G G +G V  G L L G+    VAIK L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 358 TKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLET 417
           T+    DF++E + + +  H N++ L G   +     +I EF+ NGSL+ F+ +     T
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 418 NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 477
                   L  +  GIA G++YL        +H D+   NIL++ +   K+SDFGL++  
Sbjct: 127 -----VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 478 EGRES---IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVA 534
           E   S     S  G +  I + APE     + + +  SDV+SYG++++E+          
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYG------ 230

Query: 535 VDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNR 594
                    P+W     ++   +  Q        +    +  + L C Q + + RP   +
Sbjct: 231 -------ERPYWDMTNQDVINAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 595 VVEMLE 600
           +V  L+
Sbjct: 283 IVNTLD 288

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-56
 Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 31/286 (10%)

Query: 328 KNKLGQGGYGGVYKGKLL---DGQNVAIKVLNE--TKGNGEDFINEVASISRTSHVNIVT 382
             +LG G +G V +G         +VAIKVL +   K + E+ + E   + +  +  IV 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           L+G C +     L+ E    G L KF+  K      +++    + ++   ++ G++YL  
Sbjct: 74  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLE- 126

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES-IVSMTGARGTIGYIAPEVF 501
                 +H D+   N+LL      KISDFGL+K     +S   + +  +  + + APE  
Sbjct: 127 --EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 502 CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
             NF + S +SDV+SYG+ ++E               S    P+   K  E+   +  QG
Sbjct: 185 --NFRKFSSRSDVWSYGVTMWEAL-------------SYGQKPYKKMKGPEVMAFI-EQG 228

Query: 562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ 607
              E   E   ++  +   C      DRP    V + +     SL 
Sbjct: 229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 5e-56
 Identities = 75/323 (23%), Positives = 131/323 (40%), Gaps = 42/323 (13%)

Query: 305 RNYGSLAPKRYRYAD---IKKMTNSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVL 355
            NY  + P +  Y       +   SF   LG G +G V +              VA+K+L
Sbjct: 2   NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61

Query: 356 NETKGNG--EDFINEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEK 412
             +      E  ++E+  +S   +H+NIV LLG C  G    +I E+   G L  F+  K
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121

Query: 413 H------------PLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILL 460
                          +    L  E L   +  +A+G+ +L        +H D+   NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178

Query: 461 DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMM 520
                 KI DFGLA+  +   + V    AR  + ++APE         +++SDV+SYG+ 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIF 236

Query: 521 VFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLW 580
           ++E+    ++    +   S+ Y              +  +G      +    +M  +   
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFY-------------KMIKEGFRMLSPEHAPAEMYDIMKT 283

Query: 581 CIQTNPSDRPSMNRVVEMLEGSL 603
           C   +P  RP+  ++V+++E  +
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQI 306

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-55
 Identities = 65/277 (23%), Positives = 119/277 (42%), Gaps = 35/277 (12%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGF 386
               +G+G +G V  G    G  VA+K +       + F+ E + +++  H N+V LLG 
Sbjct: 11  LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGV 68

Query: 387 CFEGHRR-ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
             E      ++ E+++ GSL  ++  +        L  + L K ++ +   +EYL     
Sbjct: 69  IVEEKGGLYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEG--- 121

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
              +H D+   N+L+ ED   K+SDFGL K         +    +  + + APE      
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE-- 174

Query: 506 GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG--LQGIE 563
            + S KSDV+S+G++++E+                  F    Y R+ L++ +    +G +
Sbjct: 175 KKFSTKSDVWSFGILLWEI----------------YSFGRVPYPRIPLKDVVPRVEKGYK 218

Query: 564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
            +        +  V   C   + + RPS  ++ E LE
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (476), Expect = 5e-55
 Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 37/276 (13%)

Query: 329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNG----EDFINEVASISRTSHVNIVTL 383
            ++G G +G VY  + + + + VAIK ++ +        +D I EV  + +  H N +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G     H   L+ E+    + +     K PL+         +  +  G  +GL YLH  
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ------EVEIAAVTHGALQGLAYLHS- 133

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF-C 502
               ++H D+K  NILL E    K+ DFG A I     S V      GT  ++APEV   
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILA 185

Query: 503 RNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
            + G+   K DV+S G+   E+   +                P +    +     +    
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERK---------------PPLFNMNAMSALYHIAQNE 230

Query: 562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
               +   ++         C+Q  P DRP+   +++
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-54
 Identities = 73/303 (24%), Positives = 118/303 (38%), Gaps = 44/303 (14%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN------VAIKVLNETKGNGE--DFINEVASISR-TSH 377
           F   LG G +G V                VA+K+L E   + E    ++E+  +++  SH
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKH-----------------PLETNQK 420
            NIV LLG C       LI+E+   G L  ++  K                    E    
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
           L +E L   A  +A+G+E+L        +H D+   N+L+      KI DFGLA+     
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE 540
            + V    AR  + ++APE      G  + KSDV+SYG++++E+              S 
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEI-------------FSL 262

Query: 541 IYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
              P+           L   G + ++      ++ ++   C   +   RPS   +   L 
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

Query: 601 GSL 603
             L
Sbjct: 323 CQL 325

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-54
 Identities = 82/312 (26%), Positives = 140/312 (44%), Gaps = 40/312 (12%)

Query: 312 PKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDG---QNVAIKVLNE--TKGNGEDFI 366
           P  Y   D   +   F++ +G+G +G V K ++       + AIK + E  +K +  DF 
Sbjct: 1   PTIYPVLDWNDIK--FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58

Query: 367 NEVASISR-TSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN------- 418
            E+  + +   H NI+ LLG C       L  E+  +G+L  F+ +   LET+       
Sbjct: 59  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118

Query: 419 ---QKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK 475
                L  + L   A  +ARG++YL      + +H D+   NIL+ E++  KI+DFGL++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 175

Query: 476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAV 535
                E  V  T  R  + ++A E    N+   +  SDV+SYG++++E+           
Sbjct: 176 GQ---EVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEI----------- 219

Query: 536 DRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRV 595
              S    P+      EL E L  QG   E+      ++  +   C +  P +RPS  ++
Sbjct: 220 --VSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276

Query: 596 VEMLEGSLDSLQ 607
           +  L   L+  +
Sbjct: 277 LVSLNRMLEERK 288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (470), Expect = 2e-54
 Identities = 64/301 (21%), Positives = 119/301 (39%), Gaps = 47/301 (15%)

Query: 327 FKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKGNG--EDFINEVASISRTSHV 378
           +   +G+G +G V++ +            VA+K+L E        DF  E A ++   + 
Sbjct: 17  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEK------------------HPLETNQK 420
           NIV LLG C  G    L++E+++ G L +F+                             
Sbjct: 77  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 421 LKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR 480
           L       IA  +A G+ YL      + +H D+   N L+ E+   KI+DFGL++     
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSS 539
           +   +       I ++ PE    N    + +SDV++YG++++E+ +              
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQ---------- 241

Query: 540 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEML 599
               P++     E+   +   G      +    ++  +   C    P+DRPS   +  +L
Sbjct: 242 ----PYYGMAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

Query: 600 E 600
           +
Sbjct: 297 Q 297

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 1e-53
 Identities = 73/288 (25%), Positives = 132/288 (45%), Gaps = 32/288 (11%)

Query: 326 SFKNKLGQGGYGGVYKGKLLDGQN-----VAIKVLNE--TKGNGEDFINEVASISRTSHV 378
           + +  +G G +G VYKG L          VAIK L    T+    DF+ E   + + SH 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           NI+ L G   +     +I E++ NG+L+KF+ EK       +     L  +  GIA G++
Sbjct: 70  NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMK 124

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE-GRESIVSMTGARGTIGYIA 497
           YL        +H D+   NIL++ +   K+SDFGL+++ E   E+  + +G +  I + A
Sbjct: 125 YLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL 557
           PE    ++ + +  SDV+S+G++++E+                   P+W     E+ + +
Sbjct: 182 PEAI--SYRKFTSASDVWSFGIVMWEVMTYG-------------ERPYWELSNHEVMKAI 226

Query: 558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
              G       +    +  + + C Q   + RP    +V +L+  + +
Sbjct: 227 -NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-53
 Identities = 72/298 (24%), Positives = 127/298 (42%), Gaps = 35/298 (11%)

Query: 319 DIKKMTNSFKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNETKGNGE--DFINEVASI 372
               +   F   +G+G +G VY G LLD        A+K LN     GE   F+ E   +
Sbjct: 23  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82

Query: 373 SRTSHVNIVTLLGFCFEGHRRA-LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAV 431
              SH N+++LLG C        ++  ++ +G L  FI  +           + L    +
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGL 137

Query: 432 GIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE--SIVSMTGA 489
            +A+G+       + + +H D+   N +LDE F  K++DFGLA+    +E  S+ + TGA
Sbjct: 138 QVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 490 RGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVY 548
           +  + ++A E       + + KSDV+S+G++++E+ T                  P+   
Sbjct: 195 KLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAP--------------PYPDV 238

Query: 549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL 606
              ++   L LQG    + +     +  V L C       RPS + +V  +     + 
Sbjct: 239 NTFDITVYL-LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 2e-53
 Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 33/279 (11%)

Query: 329 NKLGQGGYGGVYKGKLLD---GQNVAIKVLNETKGNG---EDFINEVASISRTSHVNIVT 382
            +LG G +G V KG        + VA+K+L     +    ++ + E   + +  +  IV 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
           ++G C E     L+ E    G L K++ +   +      K + + ++   ++ G++YL  
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV------KDKNIIELVHQVSMGMKYLE- 124

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIAPEVF 501
              +  +H D+   N+LL      KISDFGL+K +        + T  +  + + APE  
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 502 CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
                + S KSDV+S+G++++E               S    P+   K  E+   L  +G
Sbjct: 183 NY--YKFSSKSDVWSFGVLMWEAF-------------SYGQKPYRGMKGSEVTAML-EKG 226

Query: 562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
                     R+M  +   C   +  +RP    V   L 
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 4e-53
 Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 29/279 (10%)

Query: 327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVT 382
               +G G YG   K +   DG+ +  K L+    T+   +  ++EV  +    H NIV 
Sbjct: 8   VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67

Query: 383 LLGFCFEGHRRAL--IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
                 +     L  + E+   G L   I      +  Q L  E + ++   +   L+  
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVIT--KGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 441 HR--GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           HR       +LH D+KP N+ LD     K+ DFGLA+I     S        GT  Y++P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSP 183

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 558
           E    N    + KSD++S G +++E+                   P   + + EL   + 
Sbjct: 184 EQM--NRMSYNEKSDIWSLGCLLYELCALM--------------PPFTAFSQKELAGKI- 226

Query: 559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
            +G        Y+ ++  +    +      RPS+  ++E
Sbjct: 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-52
 Identities = 58/303 (19%), Positives = 114/303 (37%), Gaps = 45/303 (14%)

Query: 326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVT 382
              ++LG G  G V+K      G  +A K+++           I E+  +   +   IV 
Sbjct: 9   EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 383 LLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHR 442
             G  +     ++  E +  GSL++ + +   +        ++L K+++ + +GL YL  
Sbjct: 69  FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP------EQILGKVSIAVIKGLTYLRE 122

Query: 443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
               +I+H D+KP NIL++     K+ DFG++       +        GT  Y++PE   
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERL- 175

Query: 503 RNFGEVSYKSDVYSYGMMVFEM-----------------------TGEKNNANVAVDRSS 539
                 S +SD++S G+ + EM                        G+            
Sbjct: 176 -QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 540 EIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSL-----WCIQTNPSDRPSMNR 594
                + +  R  +     L  I NE   +    +  +        C+  NP++R  + +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 595 VVE 597
           ++ 
Sbjct: 295 LMV 297

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 6e-52
 Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 38/281 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNE---TKGNGEDFINEVASISRTSHVNIVT 382
           F  ++G+G +  VYKG   +    VA   L +   TK   + F  E   +    H NIV 
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 383 LLGFCFEGHRR----ALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
                    +      L+ E +++G+L+ ++           +K +VL      I +GL+
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQ 126

Query: 439 YLHRGCNTRILHFDIKPHNILL-DEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIA 497
           +LH      I+H D+K  NI +       KI D GLA +              GT  ++A
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMA 181

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           PE++     +     DVY++GM + EM T E           SE      +Y+R+     
Sbjct: 182 PEMYE---EKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYRRVTSGVK 230

Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                     DK    ++  +   CI+ N  +R S+  ++ 
Sbjct: 231 ------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-51
 Identities = 68/323 (21%), Positives = 123/323 (38%), Gaps = 38/323 (11%)

Query: 326 SFKNKLGQGGYGGVYKGKLLD-----GQNVAIKVLNETKGNG--EDFINEVASISRTSHV 378
                LG G +G VYKG  +         VAIK L E       ++ ++E   ++   + 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           ++  LLG C     + LI + +  G L  ++ E            + L    V IA+G+ 
Sbjct: 72  HVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG-----SQYLLNWCVQIAKGMN 125

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
           YL    + R++H D+   N+L+      KI+DFGLAK+    E      G +  I ++A 
Sbjct: 126 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 558
           E         +++SDV+SYG+ V+E+                   P+      E+   L 
Sbjct: 183 ESILH--RIYTHQSDVWSYGVTVWELMTFG-------------SKPYDGIPASEISSIL- 226

Query: 559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE------GSLDSLQIPPRP 612
            +G    +       + ++ + C   +   RP    ++               +Q   R 
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286

Query: 613 FLLSSGSQPDFSSILVRQTESSM 635
            L S      + +++  +    +
Sbjct: 287 HLPSPTDSNFYRALMDEEDMDDV 309

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 7e-51
 Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 33/283 (11%)

Query: 327 FKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETKGNG----EDFINEVASISRTSHV 378
              KLG G +G V +G+         +VA+K L     +     +DFI EV ++    H 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           N++ L G       + ++ E    GSL   + +              L + AV +A G+ 
Sbjct: 72  NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMG 125

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYIA 497
           YL    + R +H D+   N+LL      KI DFGL + + +  +  V     +    + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL 557
           PE         S+ SD + +G+ ++EM              +    P       ++   +
Sbjct: 183 PESL--KTRTFSHASDTWMFGVTLWEMF-------------TYGQEPWIGLNGSQILHKI 227

Query: 558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
             +G      ++  + +  V + C    P DRP+   + + L 
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 9e-51
 Identities = 67/275 (24%), Positives = 107/275 (38%), Gaps = 28/275 (10%)

Query: 327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTL 383
               LG+G YG V         + VA+K+++  +     E+   E+      +H N+V  
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
            G   EG+ + L  E+ S G L   I     +            +    +  G+ YLH  
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP------EPDAQRFFHQLMAGVVYLHG- 121

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
               I H DIKP N+LLDE    KISDFGLA +         +    GT+ Y+APE+  +
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-K 178

Query: 504 NFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 562
                +   DV+S G+++  M  GE           S   +  W  K+  L     +   
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKID-- 233

Query: 563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                      ++      +  NPS R ++  + +
Sbjct: 234 ------SAPLALL---HKILVENPSARITIPDIKK 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 8e-50
 Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 40/300 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKGNGE--DFINEVASISRTSH- 377
               LG+G +G V +            + VA+K+L E   + E    ++E+  +    H 
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 378 VNIVTLLGFCFE-GHRRALIYEFVSNGSLEKFIHEKHPLETNQK----------LKWEVL 426
           +N+V LLG C + G    +I EF   G+L  ++  K       K          L  E L
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
              +  +A+G+E+L    + + +H D+   NILL E    KI DFGLA+        V  
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPH 545
             AR  + ++APE         + +SDV+S+G++++E+ +   +           +    
Sbjct: 194 GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKIDE 244

Query: 546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS 605
              +RL+       +G           +M    L C    PS RP+ + +VE L   L +
Sbjct: 245 EFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-49
 Identities = 65/277 (23%), Positives = 107/277 (38%), Gaps = 38/277 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGED----FINEVASISRTSHVNIV 381
               LG+G +G VY  +       +A+KVL + +            EV   S   H NI+
Sbjct: 10  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
            L G+  +  R  LI E+   G++ + + +        K   +        +A  L Y H
Sbjct: 70  RLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYITELANALSYCH 123

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
                R++H DIKP N+LL      KI+DFG +            T   GT+ Y+ PE+ 
Sbjct: 124 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMI 176

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ 560
                    K D++S G++ +E   G+          + +  +           + +   
Sbjct: 177 EG--RMHDEKVDLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVT-- 228

Query: 561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                   E AR +I      ++ NPS RP +  V+E
Sbjct: 229 --------EGARDLI---SRLLKHNPSQRPMLREVLE 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-49
 Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 36/286 (12%)

Query: 327 FKNKLGQGGYGGVYKGKLLDGQN----VAIKVLNETKGNG--EDFINEVASISRTSHVNI 380
               +G+G +G V++G  +  +N    VAIK       +   E F+ E  ++ +  H +I
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
           V L+G   E     +I E  + G L  F+  +        L    L   A  ++  L YL
Sbjct: 71  VKLIGVITENPVW-IIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYL 124

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
                 R +H DI   N+L+  + C K+ DFGL++  E      +  G +  I ++APE 
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPES 180

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM--TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 558
              NF   +  SDV+ +G+ ++E+   G          +  +    + V  R+E  E L 
Sbjct: 181 I--NFRRFTSASDVWMFGVCMWEILMHGV---------KPFQGVKNNDVIGRIENGERL- 228

Query: 559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD 604
                          +  +   C   +PS RP    +   L   L+
Sbjct: 229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 3e-49
 Identities = 62/292 (21%), Positives = 115/292 (39%), Gaps = 35/292 (11%)

Query: 317 YADIKKMTN-----SFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNG-EDFINEV 369
           Y  + +  N         +LG G +G VYK +  +     A KV++       ED++ E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 370 ASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKI 429
             ++   H NIV LL   +  +   ++ EF + G+++  + E       + L    +  +
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVV 115

Query: 430 AVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGA 489
                  L YLH     +I+H D+K  NIL   D   K++DFG++       +I      
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSF 170

Query: 490 RGTIGYIAPEVF---CRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPH 545
            GT  ++APEV            YK+DV+S G+ + EM   E  +          +    
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE---LNPMRVLLKI 227

Query: 546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
              +   L +                +  +     C++ N   R + +++++
Sbjct: 228 AKSEPPTLAQPSRW--------SSNFKDFL---KKCLEKNVDARWTTSQLLQ 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 3e-49
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 35/293 (11%)

Query: 326 SFKNKLGQGGYGGVYKGKL------LDGQNVAIKVLNETKGNGE--DFINEVASISRTSH 377
           +   +LGQG +G VY+G             VAIK +NE     E  +F+NE + +   + 
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETN----QKLKWEVLYKIAVGI 433
            ++V LLG   +G    +I E ++ G L+ ++    P   N           + ++A  I
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTI 493
           A G+ YL      + +H D+   N ++ EDF  KI DFG+ +     +           +
Sbjct: 143 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 494 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL 553
            +++PE      G  +  SDV+S+G++++E+                       Y+ L  
Sbjct: 200 RWMSPESL--KDGVFTTYSDVWSFGVVLWEI----------------ATLAEQPYQGLSN 241

Query: 554 EEDLG--LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD 604
           E+ L   ++G   ++       +  +   C Q NP  RPS   ++  ++  ++
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 9e-49
 Identities = 71/295 (24%), Positives = 133/295 (45%), Gaps = 40/295 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLL--------DGQNVAIKVLNE--TKGNGEDFINEVASISR-T 375
               LG+G +G V   + +            VA+K+L    T+ +  D I+E+  +    
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 376 SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHP----------LETNQKLKWEV 425
            H NI+ LLG C +     +I E+ S G+L +++  + P              ++L  + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 426 LYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS 485
           L   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     +    
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPH 545
            T  R  + ++APE         +++SDV+S+G++++E+     +    V          
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VE 244

Query: 546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
            ++K L+       +G   ++      ++ ++   C    PS RP+  ++VE L+
Sbjct: 245 ELFKLLK-------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-46
 Identities = 73/301 (24%), Positives = 119/301 (39%), Gaps = 47/301 (15%)

Query: 304 LRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGN 361
           LR+  S+   + +Y   +K        +GQG  G VY    +  GQ VAI+ +N + +  
Sbjct: 9   LRSIVSVGDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60

Query: 362 GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKL 421
            E  INE+  +    + NIV  L     G    ++ E+++ GSL   + E          
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM------- 113

Query: 422 KWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE 481
               +  +     + LE+LH     +++H DIK  NILL  D   K++DFG        +
Sbjct: 114 DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSE 540
           S    +   GT  ++APEV  R       K D++S G+M  EM  GE             
Sbjct: 171 S--KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGE------------- 213

Query: 541 IYFPHWVYKRLELEEDLGLQGIENEEDKEY----ARKMILVSLWCIQTNPSDRPSMNRVV 596
              P+     L     +   G    ++ E      R  +     C+  +   R S   ++
Sbjct: 214 --PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL---NRCLDMDVEKRGSAKELL 268

Query: 597 E 597
           +
Sbjct: 269 Q 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  158 bits (400), Expect = 9e-44
 Identities = 62/320 (19%), Positives = 124/320 (38%), Gaps = 47/320 (14%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG-EDFINEVASISRTSHVNIVTLL 384
              +LG G +G V++      G N A K +     +  E    E+ ++S   H  +V L 
Sbjct: 30  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
               + +   +IYEF+S G L + + ++H      K+  +   +    + +GL ++H   
Sbjct: 90  DAFEDDNEMVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 445 NTRILHFDIKPHNILLDEDFCP--KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFC 502
               +H D+KP NI+         K+ DFGL    + ++S+   TG      + APEV  
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAE 198

Query: 503 RNFGEVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
                V Y +D++S G++ + +        GE ++  +   +S +       +  +  + 
Sbjct: 199 G--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED- 255

Query: 556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS-LDSLQIPPRPFL 614
                           +  I      +  +P+ R +++   + LE   L     P R   
Sbjct: 256 ---------------GKDFI---RKLLLADPNTRMTIH---QALEHPWLTPGNAPGRDSQ 294

Query: 615 LSSGSQPDFSSILVRQTESS 634
           + S         +  + ++ 
Sbjct: 295 IPSSRYTKIRDSIKTKYDAW 314

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 1e-43
 Identities = 64/298 (21%), Positives = 106/298 (35%), Gaps = 45/298 (15%)

Query: 312 PKRYRYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED----FI 366
           P++ R  D K     F   LG+G +  V   + L   +  AIK+L +     E+      
Sbjct: 2   PRKKRPEDFK-----FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 56

Query: 367 NEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVL 426
            E   +SR  H   V L     +  +      +  NG L K+I +    +          
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD------ETCT 110

Query: 427 YKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSM 486
                 I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+          
Sbjct: 111 RFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167

Query: 487 TGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPH 545
               GT  Y++PE+           SD+++ G +++++  G                 P 
Sbjct: 168 NSFVGTAQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGL---------------PPF 210

Query: 546 WVYKRLELEEDLGLQGIENEE---DKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLE 600
                  +      Q I   E    +++  K   +    +  + + R     +     
Sbjct: 211 RAGNEYLI-----FQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  149 bits (376), Expect = 3e-41
 Identities = 62/290 (21%), Positives = 113/290 (38%), Gaps = 46/290 (15%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG----------EDFINEVASISRT 375
            K  LG+G    V +       +  A+K+++ T G            E  + EV  + + 
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 376 S-HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIA 434
           S H NI+ L           L+++ +  G L  ++ EK  L        +   KI   + 
Sbjct: 67  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL------SEKETRKIMRALL 120

Query: 435 RGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIG 494
             +  LH+     I+H D+KP NILLD+D   K++DFG +   +  E    +    GT  
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174

Query: 495 YIAPEVF----CRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYK 549
           Y+APE+       N      + D++S G++++ +  G                 P W  K
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---------------PPFWHRK 219

Query: 550 RLELEEDL--GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
           ++ +   +  G     + E  +Y+  +  +    +   P  R +    + 
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 2e-40
 Identities = 61/275 (22%), Positives = 108/275 (39%), Gaps = 28/275 (10%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG--EDFINEVASISRTSHVNIVTL 383
           F++ LG G +  V   +     + VAIK + +    G      NE+A + +  H NIV L
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 384 LGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG 443
                 G    LI + VS G L   I EK               ++   +   ++YLH  
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT------ERDASRLIFQVLDAVKYLHDL 126

Query: 444 CNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCR 503
                           LDED    ISDFGL+K+ +       ++ A GT GY+APEV  +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ 183

Query: 504 NFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI 562
                S   D +S G++ + +  G     +   +  ++++          L+ +      
Sbjct: 184 --KPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQI-------LKAEYEFDSP 231

Query: 563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
             ++  + A+  I      ++ +P  R +  + ++
Sbjct: 232 YWDDISDSAKDFI---RHLMEKDPEKRFTCEQALQ 263

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (370), Expect = 3e-40
 Identities = 48/294 (16%), Positives = 92/294 (31%), Gaps = 30/294 (10%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLG 385
              K+G G +G +Y G  +  G+ VAIK+      +      E            +  + 
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIR 69

Query: 386 FCF-EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
           +C  EG    ++ E +     + F               + +  +A  +   +EY+H   
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFS------LKTVLLLADQMISRIEYIHS-- 121

Query: 445 NTRILHFDIKPHNIL---LDEDFCPKISDFGLAKICEGRES-----IVSMTGARGTIGYI 496
               +H D+KP N L     +     I DFGLAK      +             GT  Y 
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED 556
           +         E S + D+ S G ++                +    +     K++    +
Sbjct: 181 SINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238

Query: 557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
           +  +G  +E         +    +C      D+P  + + ++            
Sbjct: 239 VLCKGYPSE-----FATYL---NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 4e-40
 Identities = 52/278 (18%), Positives = 100/278 (35%), Gaps = 42/278 (15%)

Query: 330 KLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCF 388
            LG+G +G V++       +    K +     +      E++ ++   H NI+ L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 389 EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 448
                 +I+EF+S   + + I+         +L    +      +   L++LH      I
Sbjct: 72  SMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHS---HNI 123

Query: 449 LHFDIKPHNILLDEDFCP--KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFG 506
            HFDI+P NI+         KI +FG A+  +  +   +         Y APEV      
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQH--D 178

Query: 507 EVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL 559
            VS  +D++S G +V+ +         E N   +    ++E  F    +K + +E     
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE----- 233

Query: 560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                      A   +      +      R + +  ++
Sbjct: 234 -----------AMDFV---DRLLVKERKSRMTASEALQ 257

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  147 bits (372), Expect = 6e-40
 Identities = 59/279 (21%), Positives = 110/279 (39%), Gaps = 43/279 (15%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN-ETKGNGEDFINEVASISRTSHVNIVTLLGFC 387
           +LG G +G V++      G+    K +N     +     NE++ +++  H  ++ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR 447
            + +   LI EF+S G L   I  +     + K+    +         GL+++H      
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---HS 147

Query: 448 ILHFDIKPHNILLDEDFCP--KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
           I+H DIKP NI+ +       KI DFGLA      E +   T    T  + APE+  R  
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDR-- 202

Query: 506 GEVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG 558
             V + +D+++ G++ + +        GE +   +   +  +  F    +  +  E    
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE---- 258

Query: 559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                       A+  I      +Q  P  R +++  +E
Sbjct: 259 ------------AKDFI---KNLLQKEPRKRLTVHDALE 282

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (372), Expect = 8e-40
 Identities = 58/275 (21%), Positives = 107/275 (38%), Gaps = 35/275 (12%)

Query: 326 SFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGED-------FINEVASISRTSH 377
           S    +G+GG+G VY  +  D G+  A+K L++ +   +            ++ +S    
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 378 VNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
             IV +        + + I + ++ G L   + +              +   A  I  GL
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF------SEADMRFYAAEIILGL 120

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIA 497
           E++H      +++ D+KP NILLDE    +ISD GLA     ++   S+    GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL 557
           PEV  +        +D +S G M+F++    +       +         +   +EL +  
Sbjct: 174 PEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232

Query: 558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM 592
                         R ++      +Q + + R   
Sbjct: 233 S----------PELRSLL---EGLLQRDVNRRLGC 254

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (360), Expect = 6e-39
 Identities = 44/293 (15%), Positives = 101/293 (34%), Gaps = 32/293 (10%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCF 388
           ++G+G +G +++G  LL+ Q VAIK     + +     +E  +    +    +  + +  
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 389 EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRI 448
           +     ++   +   SLE  +         +K   + +   A  +   ++ +H      +
Sbjct: 71  QEGLHNVLVIDLLGPSLEDLLDLC-----GRKFSVKTVAMAAKQMLARVQSIHE---KSL 122

Query: 449 LHFDIKPHNILLDEDFCP-----KISDFGLAKICEGRES-----IVSMTGARGTIGYIAP 498
           ++ DIKP N L+            + DFG+ K      +             GT  Y++ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL 557
                   E S + D+ + G +      G      +    + + Y      +  E ++  
Sbjct: 183 NTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-----RIGEKKQST 235

Query: 558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIPP 610
            L+ +     +E+ + M     +         P  + +  +    L+ L    
Sbjct: 236 PLRELCAGFPEEFYKYM----HYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 8e-39
 Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 49/279 (17%)

Query: 327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGED----FINEVASISRT-SHVNI 380
               LG+G +G V+  +     Q  AIK L +     +D     + E   +S    H  +
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
             +            + E+++ G L   I   H  +             A  I  GL++L
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD------LSRATFYAAEIILGLQFL 119

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
           H      I++ D+K  NILLD+D   KI+DFG+ K     ++        GT  YIAPE+
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEI 174

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDRSSEIYFPHWVYKRLEL 553
                 + ++  D +S+G++++EM        G+         R    ++P W+      
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL------ 226

Query: 554 EEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSM 592
                         ++ A+ ++   +      P  R  +
Sbjct: 227 --------------EKEAKDLL---VKLFVREPEKRLGV 248

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-38
 Identities = 56/288 (19%), Positives = 109/288 (37%), Gaps = 26/288 (9%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLN--ETKGNGEDFINEVASISRTSHVNIVTLLG 385
           + +G+G YG V      ++   VAIK ++  E +   +  + E+  + R  H NI+ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                    +   ++    +   +++   L   Q L  + +      I RGL+Y+H    
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYK---LLKTQHLSNDHICYFLYQILRGLKYIHSA-- 128

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKIC-EGRESIVSMTGARGTIGYIAPEVFCRN 504
             +LH D+KP N+LL+     KI DFGLA++     +    +T    T  Y APE+   +
Sbjct: 129 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187

Query: 505 FGEVSYKSDVYSYGMMVFEM-TGE-----KNNANVAVDRSSEIYFPHWVYKRLELEEDLG 558
            G  +   D++S G ++ EM +       K+  +        +  P        +     
Sbjct: 188 KG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 559 LQGIENEEDKEYARKMILVSL---------WCIQTNPSDRPSMNRVVE 597
              +      +     +  +            +  NP  R  + + + 
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  141 bits (355), Expect = 2e-38
 Identities = 64/286 (22%), Positives = 112/286 (39%), Gaps = 36/286 (12%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED----FINEVASISRTSHVNIV 381
               LG GG   V+  + L   ++VA+KVL             F  E  + +  +H  IV
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 382 TLLGFCFE----GHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGL 437
            +          G    ++ E+V   +L   +H + P+        +   ++     + L
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT------PKRAIEVIADACQAL 124

Query: 438 EYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICEGRESIVSMTGARGTIGYI 496
            + H+     I+H D+KP NI++      K+ DFG+A+ I +   S+       GT  Y+
Sbjct: 125 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           +PE        V  +SDVYS G +++E+ TGE        D    + + H       + E
Sbjct: 182 SPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTG---DSPVSVAYQH-------VRE 229

Query: 556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-SMNRVVEMLE 600
           D       +E        ++   L  +  NP +R  +   +   L 
Sbjct: 230 DPIPPSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-37
 Identities = 63/293 (21%), Positives = 109/293 (37%), Gaps = 39/293 (13%)

Query: 329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGED------FINEVASISRTSHVNIV 381
           + LG+G +  VYK +     Q VAIK +     +          + E+  +   SH NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
            LL         +L+++F+              L          +    +   +GLEYLH
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL------TPSHIKAYMLMTLQGLEYLH 117

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
           +     ILH D+KP+N+LLDE+   K++DFGLAK         + T    T  Y APE+ 
Sbjct: 118 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELL 172

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM-TGE-----KNNANVAVDRSSEIYFP----------H 545
                      D+++ G ++ E+          ++ +        +  P           
Sbjct: 173 FGARM-YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 546 WVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM 598
             Y   +    + L  I +    +    +I         NP  R +  + ++M
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDD-LLDLI---QGLFLFNPCARITATQALKM 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 6e-37
 Identities = 80/345 (23%), Positives = 130/345 (37%), Gaps = 47/345 (13%)

Query: 312 PKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLD-GQNVAIKVLNETKGNGEDFINEVA 370
           P+   Y D K         +G G +G VY+ KL D G+ VAIK + + K        E+ 
Sbjct: 17  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65

Query: 371 SISRTSHVNIVTLLGFCFEGHRR------ALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
            + +  H NIV L  F +    +       L+ ++V           +H     Q L   
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA---RHYSRAKQTLPVI 122

Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICEGRESI 483
            +      + R L Y+H      I H DIKP N+LLD D    K+ DFG AK     E  
Sbjct: 123 YVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179

Query: 484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-TGE-----KNNANVAVDR 537
           VS   +R    Y APE+        +   DV+S G ++ E+  G+      +  +  V+ 
Sbjct: 180 VSYICSR---YYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

Query: 538 SSEIYFP--HWVYKRLELEEDLGLQGIENEEDKEYARKMI---LVSL--WCIQTNPSDRP 590
              +  P    + +      +     I+     +  R       ++L    ++  P+ R 
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

Query: 591 SMNRVVEMLEGS-LDSLQIPPRPFLLSSGSQPDFSSILVRQTESS 634
           +     E    S  D L+  P   L +    P   +   ++  S+
Sbjct: 296 TPL---EACAHSFFDELR-DPNVKLPNGRDTPALFNFTTQELSSN 336

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 6e-37
 Identities = 61/307 (19%), Positives = 110/307 (35%), Gaps = 38/307 (12%)

Query: 331 LGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCF 388
           LG G  G V +       +  A+K+L +          EV    R S   +IV ++    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYE 75

Query: 389 EGHRRA----LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
             +       ++ E +  G L   I ++     +Q        +I   I   ++YLH   
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHS-- 129

Query: 445 NTRILHFDIKPHNILLDEDFCP---KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
              I H D+KP N+L          K++DFG AK      S+ +      T  Y+APEV 
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVL 185

Query: 502 CRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
                +     D++S G++++ +             +  +     +  R+          
Sbjct: 186 GP--EKYDKSCDMWSLGVIMYILLCGY----PPFYSNHGLAISPGMKTRI-RMGQYEFPN 238

Query: 562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS--LDSLQIPPRPFLLSSGS 619
            E  E  E  + +I      ++T P+ R ++    E +     + S ++P  P   S   
Sbjct: 239 PEWSEVSEEVKMLI---RNLLKTEPTQRMTIT---EFMNHPWIMQSTKVPQTPLHTSRVL 292

Query: 620 QPDFSSI 626
           + D    
Sbjct: 293 KEDKERW 299

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  136 bits (343), Expect = 1e-36
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 28/285 (9%)

Query: 329 NKLGQGGYGGVYKGKLLDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLG 385
            K+G+G YG VYK +   G+  A+K +    E +G     I E++ +    H NIV L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 386 FCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCN 445
                 R  L++E +     +     +  LE              + +  G+ Y H    
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE------SVTAKSFLLQLLNGIAYCHD--- 118

Query: 446 TRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNF 505
            R+LH D+KP N+L++ +   KI+DFGLA+       +   T    T+ Y AP+V     
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVL-MGS 175

Query: 506 GEVSYKSDVYSYGMMVFEM-TGE-----KNNANVAVDRSSEIYFPH---WVYKRLELEED 556
            + S   D++S G +  EM  G       + A+  +     +  P+   W       + D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 557 LGLQGIENEEDKEYARKM--ILVSL--WCIQTNPSDRPSMNRVVE 597
                 E    + + + +    + L    ++ +P+ R +  + +E
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-36
 Identities = 64/288 (22%), Positives = 115/288 (39%), Gaps = 27/288 (9%)

Query: 329 NKLGQGGYGGVYKGKLL--DGQNVAIKVLN---ETKGNGEDFINEVA---SISRTSHVNI 380
            ++G+G YG V+K + L   G+ VA+K +      +G     I EVA    +    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 381 VTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYL 440
           V L   C            +    +++ +           +  E +  +   + RGL++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 441 HRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEV 500
           H      ++H D+KP NIL+      K++DFGLA+I   + ++ S+     T+ Y APEV
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEV 186

Query: 501 FCRNFGEVSYKSDVYSYGMMVFEMTGEKN--NANVAVDRSSEIYFPHWVYKRLELEEDLG 558
             +     +   D++S G +  EM   K     +  VD+  +I     +    +   D+ 
Sbjct: 187 LLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 559 LQGIENEEDKEYARKMILVSL---------WCIQTNPSDRPSMNRVVE 597
           L             +  +  +          C+  NP+ R S    + 
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-36
 Identities = 64/286 (22%), Positives = 117/286 (40%), Gaps = 28/286 (9%)

Query: 329 NKLGQGGYGGVYKGK-LLDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLL 384
            K+G+G YG VYK +  L G+ VA+K +    ET+G     I E++ +   +H NIV LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
                 ++  L++EF+ +  L+KF+           +   ++      + +GL + H   
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
              +LH D+KP N+L++ +   K++DFGLA+           T    T+ Y APE+    
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGC 177

Query: 505 FGEVSYKSDVYSYGMMVFEM-TGE-----KNNANVAVDRSSEIYFPHWVYKRLELEEDLG 558
               S   D++S G +  EM T        +  +        +  P  V           
Sbjct: 178 -KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 559 LQGIENEEDKEYARKMILVS-------LWCIQTNPSDRPSMNRVVE 597
                    +++++ +  +           +  +P+ R S    + 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-35
 Identities = 61/280 (21%), Positives = 100/280 (35%), Gaps = 48/280 (17%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETK-------GNGEDFINEVASISRTS--HVN 379
            LG GG+G VY G  + D   VAIK + + +        NG     EV  + + S     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 380 IVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
           ++ LL +        LI E             +        L+ E+       +   + +
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRH 125

Query: 440 LHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAP 498
                N  +LH DIK  NIL+D +    K+ DFG   + +        T   GT  Y  P
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP 178

Query: 499 EVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL 557
           E   R        + V+S G+++++M  G+    +       +++F   V          
Sbjct: 179 EWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------- 227

Query: 558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                         + +I    WC+   PSDRP+   +  
Sbjct: 228 ----------SSECQHLI---RWCLALRPSDRPTFEEIQN 254

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-34
 Identities = 64/283 (22%), Positives = 104/283 (36%), Gaps = 38/283 (13%)

Query: 327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNG-------EDFINEVASISRTSHV 378
              +LG G +  V K +    G   A K + + +          ED   EV+ +    H 
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73

Query: 379 NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLE 438
           N++TL           LI E V+ G L  F+ EK        L  E   +    I  G+ 
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVY 127

Query: 439 YLHRGCNTRILHFDIKPHNILLDEDFCP----KISDFGLAKICEGRESIVSMTGARGTIG 494
           YLH      I HFD+KP NI+L +   P    KI DFGLA   +            GT  
Sbjct: 128 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPE 181

Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE 554
           ++APE+   N+  +  ++D++S G++ + +             S    F     +     
Sbjct: 182 FVAPEIV--NYEPLGLEADMWSIGVITYILL------------SGASPFLGDTKQETLAN 227

Query: 555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE 597
                   E+E     +          +  +P  R ++   ++
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  129 bits (325), Expect = 7e-34
 Identities = 64/280 (22%), Positives = 107/280 (38%), Gaps = 51/280 (18%)

Query: 327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNG----EDFINEVASISRTSHVNIV 381
               LG G +G V+  +   +G+  A+KVL +         E   +E   +S  +H  I+
Sbjct: 8   ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
            + G   +  +  +I +++  G L   + +             V    A  +   LEYLH
Sbjct: 68  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP------NPVAKFYAAEVCLALEYLH 121

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
                 I++ D+KP NILLD++   KI+DFG AK               GT  YIAPEV 
Sbjct: 122 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVV 173

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDRSSEIYFPHWVYKRLELE 554
                  +   D +S+G++++EM                    ++E+ FP +        
Sbjct: 174 ST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF------- 224

Query: 555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNR 594
                    NE+ K+   +        I  + S R    +
Sbjct: 225 ---------NEDVKDLLSR-------LITRDLSQRLGNLQ 248

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 1e-33
 Identities = 66/308 (21%), Positives = 115/308 (37%), Gaps = 36/308 (11%)

Query: 315 YRYADIKKMTNSFKN------KLGQGGYGGVYKGK-LLDGQNVAIKVLN---ETKGNGED 364
           +   ++ K     +        +G G YG V        G  VAIK L    +++   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 365 FINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWE 424
              E+  +    H N++ LL             +F            K  L  ++KL  +
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK--LMKHEKLGED 121

Query: 425 VLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV 484
            +  +   + +GL Y+H        H D+KP N+ ++ED   KI DFGLA+  +      
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE---- 174

Query: 485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDR 537
            MTG   T  Y APEV   N+   +   D++S G ++ EM        G  +   +    
Sbjct: 175 -MTGYVVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232

Query: 538 SSEIYFPHWVYKRLELEEDLG-LQGIENEEDKEYARKMILVS-------LWCIQTNPSDR 589
                 P    +RL+ +E    ++G+   E K++A  +   S          +  +   R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292

Query: 590 PSMNRVVE 597
            +    + 
Sbjct: 293 VTAGEALA 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 4e-33
 Identities = 64/299 (21%), Positives = 115/299 (38%), Gaps = 40/299 (13%)

Query: 329 NKLGQGGYGGVYKGKLL-DGQNVAIKVL---NETKGNGEDFINEVASISRTSHVNIVTLL 384
            K+GQG +G V+K +    GQ VA+K +   NE +G     + E+  +    H N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 385 GFCFEGHRRA--------LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
             C               L+++F  +       +         K     + ++   +  G
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNG 129

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES--IVSMTGARGTIG 494
           L Y+HR    +ILH D+K  N+L+  D   K++DFGLA+     ++      T    T+ 
Sbjct: 130 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 495 YIAPEVFCRNFGEVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDRSSEIYFPHWV 547
           Y  PE+      +     D++  G ++ EM        G      +A+           V
Sbjct: 187 YRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 548 YKRL-------ELEEDLGLQGIENEEDKEYARKMILVSL--WCIQTNPSDRPSMNRVVE 597
           +  +       +LE   G +    +  K Y R    + L    +  +P+ R   +  + 
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-32
 Identities = 53/280 (18%), Positives = 100/280 (35%), Gaps = 48/280 (17%)

Query: 327 FKNKLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGED----FINEVASISRTSHVNIV 381
           +   LG+G +G V   +    G+  A+K+L +     +D     + E   +  T H  + 
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 382 TLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLH 441
            L        R   + E+ + G L   +  +      +   +          A  +  L 
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY---------GAEIVSALE 119

Query: 442 RGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVF 501
              +  +++ DIK  N++LD+D   KI+DFGL K      +  +M    GT  Y+APEV 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVL 177

Query: 502 CRNFGEVSYKSDVYSYGMMVFEM-------TGEKNNANVAVDRSSEIYFPHWVYKRLELE 554
                +     D +  G++++EM         + +     +    EI FP  +       
Sbjct: 178 ED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE---- 231

Query: 555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNR 594
                           A+ ++      ++ +P  R     
Sbjct: 232 ----------------AKSLL---AGLLKKDPKQRLGGGP 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-31
 Identities = 59/287 (20%), Positives = 107/287 (37%), Gaps = 30/287 (10%)

Query: 329 NKLGQGGYGGVYKGKLL-DGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLL 384
            K+G+G YG V+K K     + VA+K +    + +G     + E+  +    H NIV L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
                  +  L++EF      + F         N  L  E++      + +GL + H   
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDS------CNGDLDPEIVKSFLFQLLKGLGFCH--- 118

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
           +  +LH D+KP N+L++ +   K+++FGLA+         S      T+ Y  P+V    
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV--VTLWYRPPDVLFGA 176

Query: 505 FGEVSYKSDVYSYGMMVFEM-TGEK--NNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG 561
               S   D++S G +  E+    +     N   D+   I+         +      L  
Sbjct: 177 -KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 562 IENEEDKEYARKMILVS-----------LWCIQTNPSDRPSMNRVVE 597
            +          ++ V               ++ NP  R S    ++
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (301), Expect = 1e-30
 Identities = 58/333 (17%), Positives = 120/333 (36%), Gaps = 57/333 (17%)

Query: 292 KKTYNYRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGK-LLDGQNV 350
            +   Y + E+ +  +G+     Y+             KLG+G Y  V++   + + + V
Sbjct: 16  HRPREYWDYESHVVEWGN--QDDYQ----------LVRKLGRGKYSEVFEAINITNNEKV 63

Query: 351 AIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRR--ALIYEFVSNGSLEK 407
            +K+L   K   +    E+  +       NI+TL     +   R  AL++E V+N   ++
Sbjct: 64  VVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121

Query: 408 FIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCP- 466
                      Q L    +      I + L+Y H      I+H D+KPHN+++D +    
Sbjct: 122 LY---------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKL 169

Query: 467 KISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT- 525
           ++ D+GLA+     +          +  +  PE+   ++    Y  D++S G M+  M  
Sbjct: 170 RLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL-LVDYQMYDYSLDMWSLGCMLASMIF 225

Query: 526 ------GEKNNANVAVDRSSEIYFPHWV--YKRLELEEDLGLQGIENEEDKEYARKMILV 577
                    +N +  V  +  +          +  +E D     I     ++   + +  
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285

Query: 578 SLW-------------CIQTNPSDRPSMNRVVE 597
                            ++ +   R +    +E
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (302), Expect = 1e-30
 Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 21/200 (10%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNG----EDFINEVASISRTSHVNIVTLL 384
            LG G +G V   K    G + A+K+L++ K       E  +NE   +   +   +V L 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 385 GFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC 444
               +     ++ E+V+ G +   +                    A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS------EPHARFYAAQIVLTFEYLHS-- 159

Query: 445 NTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRN 504
              +++ D+KP N+L+D+    +++DFG AK  +GR          GT   +APE+    
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS- 212

Query: 505 FGEVSYKSDVYSYGMMVFEM 524
               +   D ++ G++++EM
Sbjct: 213 -KGYNKAVDWWALGVLIYEM 231

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 55/279 (19%), Positives = 100/279 (35%), Gaps = 34/279 (12%)

Query: 327 FKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETKGNG-----EDFINEVASISRTSH 377
               LG G YG V+  + +     G+  A+KVL +          E    E   +     
Sbjct: 28  LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87

Query: 378 V-NIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARG 436
              +VTL        +  LI ++++ G L   + ++     ++   +         +   
Sbjct: 88  SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY---------VGEI 138

Query: 437 LEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYI 496
           +  L       I++ DIK  NILLD +    ++DFGL+K     E+  +     GTI Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGTIEYM 197

Query: 497 APEVFCRNFGEVSYKSDVYSYGMMVFEM-TGEKNNANVAVDRSSEIYFPHWVYKRLELEE 555
           AP++            D +S G++++E+ TG                F     K  + E 
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS-------------PFTVDGEKNSQAEI 244

Query: 556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNR 594
              +   E    +E +     +    +  +P  R     
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (282), Expect = 7e-28
 Identities = 61/347 (17%), Positives = 119/347 (34%), Gaps = 58/347 (16%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCF 388
           KLG G +  V+  K +++  +VA+K++   K   E   +E+  + R +  +         
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 389 EGHRRALIY--EFVSNGSLEKFIHEKHPLETNQKLK--------WEVLYKIAVGIARGLE 438
               + L +      NG     + E         +K           + +I+  +  GL+
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 439 YLHRGCNTRILHFDIKPHNILLD-EDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIA 497
           Y+HR C   I+H DIKP N+L++  D    +    +A +          T +  T  Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 498 PEVFCRNFGEVSYKSDVYSYGMMVFEM-TG-------EKNNANVAVDRSSEIY------- 542
           PEV           +D++S   ++FE+ TG       E ++     D  ++I        
Sbjct: 198 PEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255

Query: 543 ---FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLW--------------CIQTN 585
                +  Y R        L+ I   +       +     +               +Q +
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315

Query: 586 PSDRPSMNRVVEMLE-------GSLDSLQIPPRPFLLSSGSQPDFSS 625
           P  R        ++          ++ +++P R    S    P +  
Sbjct: 316 PRKRADAG---GLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFE 359

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-25
 Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 45/310 (14%)

Query: 312 PKRYRYA---DIKKMTNSFK--NKLGQGGYGGVYKGK-LLDGQNVAIKVLN---ETKGNG 362
           P  YR      I ++   ++  + +G G YG V        G  VA+K L+   ++  + 
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 363 EDFINEVASISRTSHVNIVTLLGFCFEGHRRA-----LIYEFVSNGSLEKFIHEKHPLET 417
           +    E+  +    H N++ LL                +   +    L   +        
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK------- 114

Query: 418 NQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 477
            QKL  + +  +   I RGL+Y+H        H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT 171

Query: 478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMT-------GEKNN 530
           +       MTG   T  Y APE+   N+   +   D++S G ++ E+        G  + 
Sbjct: 172 DDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225

Query: 531 ANVAVDRSSEIYFPHWVYKRLELEEDLG-LQGIENEEDKEYARKMILVS-------LWCI 582
             + +           + K++  E     +Q +       +A   I  +          +
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285

Query: 583 QTNPSDRPSM 592
             +   R + 
Sbjct: 286 VLDSDKRITA 295

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 2e-25
 Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 27/205 (13%)

Query: 330 KLGQGGYGGVYKGK-LLDGQNVAIKVLN---ETKGNGEDFINEVASISRTSHVNIVTLLG 385
            +G G  G V      +  +NVAIK L+   + + + +    E+  +   +H NI++LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 386 FCF------EGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEY 439
                    E     L+ E +     +    E            E +  +   +  G+++
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---------DHERMSYLLYQMLCGIKH 134

Query: 440 LHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPE 499
           LH        H D+KP NI++  D   KI DFGLA+          MT    T  Y APE
Sbjct: 135 LHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 188

Query: 500 VFCRNFGEVSYKSDVYSYGMMVFEM 524
           V            D++S G ++ EM
Sbjct: 189 VILGM--GYKENVDIWSVGCIMGEM 211

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.8 bits (222), Expect = 2e-21
 Identities = 26/210 (12%), Positives = 58/210 (27%), Gaps = 31/210 (14%)

Query: 325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGN-----------GEDFINEVASIS 373
           ++    +G+G    V+           +K       +              F       +
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 374 RTSHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGI 433
           R     +  L G           Y +  N      + E    +   +++ E   ++   I
Sbjct: 62  RNEFRALQKLQGLAVPKV-----YAWEGNA----VLMELIDAKELYRVRVENPDEVLDMI 112

Query: 434 ARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTI 493
              +   +      I+H D+  +N+L+  +    I DF  +           +      I
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNI 168

Query: 494 GYIAPEVFCRNFGEVSYKSDVYSYGMMVFE 523
                  F R +     + D+ S    + +
Sbjct: 169 ----ITYFSRTYR---TEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	638
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.57
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.29
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.88
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.6

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=408.12  Aligned_cols=249  Identities=26%  Similarity=0.336  Sum_probs=202.1

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||+|+||+||+|+. .+++.||||+++...  ...+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g   87 (271)
T d1nvra_           8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   87 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence            4578999999999999996 468999999987543  2345789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++...      ..+++..++.++.||++||+|||+   ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus        88 g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          88 GELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CcHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999754      469999999999999999999999   9999999999999999999999999999998765443


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .......+||+.|+|||++.+. ..++.++||||+||++|||++|+.||.........     .  .....      ...
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~--~~~~~------~~~  224 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----Y--SDWKE------KKT  224 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----H--HHHHT------TCT
T ss_pred             cccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-----H--HHHhc------CCC
Confidence            3334556799999999999764 23467899999999999999999999754322110     0  00000      111


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .......++.++.+|+.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11122334667889999999999999999999974

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=410.30  Aligned_cols=254  Identities=27%  Similarity=0.481  Sum_probs=199.7

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      ++.++||+|+||+||+|++.+++.||||+++......+++.+|++++++++|||||+++|++..++..++||||+++|+|
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L   87 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   87 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence            35789999999999999998888999999988777778899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....     ..+++..++.|+.|+++||+|||+   ++|+||||||+|||+++++.+||+|||+++........ .
T Consensus        88 ~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~  158 (263)
T d1sm2a_          88 SDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S  158 (263)
T ss_dssp             HHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             HHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence            99987653     568999999999999999999999   99999999999999999999999999999876544322 2


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCc
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENE  565 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (638)
                      .....||+.|+|||++.+.  .++.++|||||||++|||+|++.|+.....      ... ....+....       ...
T Consensus       159 ~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~-~~~~i~~~~-------~~~  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSE-VVEDISTGF-------RLY  222 (263)
T ss_dssp             ------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHH-HHHHHHHTC-------CCC
T ss_pred             ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHH-HHHHHHhcC-------CCC
Confidence            2345689999999999765  789999999999999999996544432211      111 111111111       111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          566 EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       566 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      .+...+.++.+++.+||+.||++|||++||+++|+++.+
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            122335678899999999999999999999999998654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=411.57  Aligned_cols=261  Identities=29%  Similarity=0.459  Sum_probs=202.3

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      .+.++||+|+||+||+|++.  ..||||+++...   ...+.+.+|++++++++|||||++++++.+ ...++||||+++
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~   87 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG   87 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred             EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence            35789999999999999864  469999987542   334678899999999999999999998754 568999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++....     ..+++..+..|+.||++||+|||+   ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        88 g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          88 SSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999997653     569999999999999999999999   9999999999999999999999999999987765444


Q ss_pred             eeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ........||+.|+|||++.+. .+.++.++|||||||++|||+||+.||......       ...........   ...
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~---~~p  229 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGY---LSP  229 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTS---CCC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCC---CCC
Confidence            3344556799999999998653 235789999999999999999999999754321       11111111110   000


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      ........+++++.+|+.+||+.||++|||++||+++|+.+..+++
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            0111222345688999999999999999999999999998776543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-51  Score=409.89  Aligned_cols=257  Identities=32%  Similarity=0.513  Sum_probs=213.8

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      +.+.++||+|+||+||+|++. +++.||||+++.+....+++.+|++++++++|||||++++++.+++..++||||+++|
T Consensus        19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g   98 (287)
T d1opja_          19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   98 (287)
T ss_dssp             EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence            445789999999999999965 5889999999887777788999999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++....    ...+++..++.|+.|+++||+|||+   ++|+||||||+|||+++++.+||+|||+++........
T Consensus        99 ~l~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          99 NLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             BHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred             chHHHhhhcc----ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence            9999998643    2578999999999999999999999   99999999999999999999999999999876554332


Q ss_pred             eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          484 VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|+.|+......       ......+..       +..
T Consensus       172 -~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~~~~~~i~~-------~~~  234 (287)
T d1opja_         172 -AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEK-------DYR  234 (287)
T ss_dssp             -EETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHT-------TCC
T ss_pred             -eeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------HHHHHHHhc-------CCC
Confidence             33455689999999999765  7899999999999999999987766432211       111111111       111


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                      ...+..++.++.+|+.+||+.||++|||++||++.|+.++.+
T Consensus       235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            222234566889999999999999999999999999987655

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-51  Score=406.96  Aligned_cols=254  Identities=26%  Similarity=0.449  Sum_probs=208.0

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.++||+|+||+||+|++++++.||||+++......+.+.+|++++++++|||||+++|++.+ +..++||||+++|+
T Consensus        15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~   93 (272)
T d1qpca_          15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS   93 (272)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred             eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence            34578999999999999999888899999998777777889999999999999999999998754 56799999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..++.|+.||++||+|||+   ++|+||||||+||||++++.+||+|||+|+....... .
T Consensus        94 L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~  165 (272)
T d1qpca_          94 LVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (272)
T ss_dssp             HHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             HHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence            999886542    2458999999999999999999999   9999999999999999999999999999998765432 2


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      ......||+.|+|||++.+.  .++.++|||||||++|||+||+.|+......       ......+..       +...
T Consensus       166 ~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~-------~~~~  229 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLER-------GYRM  229 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHT-------TCCC
T ss_pred             cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHh-------cCCC
Confidence            33456789999999999764  7899999999999999999976655432210       111111111       1111


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                      ..+..+++++.+|+.+||+.||++|||+++|++.|+..+
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            222345667899999999999999999999999998754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=404.68  Aligned_cols=246  Identities=26%  Similarity=0.344  Sum_probs=203.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      |.+.++||+|+||+||+|+. .+++.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            34578999999999999985 568999999987543 3456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++.+       ..+++..++.++.||++||+|||+   +||+||||||+|||++.++.+||+|||+++.......
T Consensus       102 g~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            999998876       358999999999999999999999   9999999999999999999999999999997754432


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCC
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGI  562 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (638)
                      .  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....       .......... .     ..
T Consensus       172 ~--~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~~~~~-~-----~~  234 (293)
T d1yhwa1         172 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATN-G-----TP  234 (293)
T ss_dssp             C--BCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHH-C-----SC
T ss_pred             c--ccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCH-------HHHHHHHHhC-C-----CC
Confidence            2  2456799999999999764  789999999999999999999999964321       0111111111 0     01


Q ss_pred             CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          563 ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       563 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ....+..++.++.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11223345678899999999999999999999975

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=397.92  Aligned_cols=250  Identities=24%  Similarity=0.433  Sum_probs=211.3

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCCH
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGSL  405 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  405 (638)
                      .+.++||+|+||+||+|++++++.||||+++......+++.+|+.++++++||||++++|++.+++..++||||+++|+|
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l   86 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL   86 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence            36789999999999999998888999999988777778999999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceee
Q 006620          406 EKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVS  485 (638)
Q Consensus       406 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~  485 (638)
                      .+++....     ..+++..+++++.|+++||+|||+   ++|+||||||+|||+++++.+||+|||+++........ .
T Consensus        87 ~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~  157 (258)
T d1k2pa_          87 LNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S  157 (258)
T ss_dssp             HHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred             HHhhhccc-----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence            99987653     568999999999999999999999   99999999999999999999999999999876554332 2


Q ss_pred             ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          486 MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       486 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      .....||+.|+|||++.+.  .++.++||||||+++|||+| |+.||......        .+...+...       ...
T Consensus       158 ~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~-------~~~  220 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQG-------LRL  220 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTT-------CCC
T ss_pred             ecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhC-------CCC
Confidence            3456789999999999765  78999999999999999998 78888644321        111222111       111


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                      ..+...+.++.+|+.+||+.||++|||+++|+++|.+
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            2222345678999999999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-50  Score=409.43  Aligned_cols=253  Identities=27%  Similarity=0.449  Sum_probs=194.9

Q ss_pred             hcccCcCcceeEEEEEEcC-C---CEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          328 KNKLGQGGYGGVYKGKLLD-G---QNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .++||+|+||+||+|++.. +   ..||||.+.....  ..+.|.+|+++|++++|||||+++|++.+++..++||||++
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~  110 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME  110 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence            4689999999999998643 2   2588998865432  34579999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|.+++....     ..+++..++.|+.||++||+|||+   ++|+||||||+||||+.++.+||+|||+++......
T Consensus       111 ~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         111 NGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             TEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999988653     569999999999999999999999   999999999999999999999999999998775443


Q ss_pred             cee---eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          482 SIV---SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       482 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ...   ...+..||+.|+|||.+.+.  .++.++|||||||++|||+| |+.||.....       .. +...+..    
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-------~~-~~~~i~~----  248 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTN-------QD-VINAIEQ----  248 (299)
T ss_dssp             -------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHHHT----
T ss_pred             CcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHc----
Confidence            221   12234579999999998764  78999999999999999998 8999864321       11 1111111    


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                         +.....+...+.++.+|+.+||+.||++|||++||++.|++++++
T Consensus       249 ---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         249 ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence               111122234567789999999999999999999999999987654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=399.87  Aligned_cols=242  Identities=27%  Similarity=0.382  Sum_probs=202.4

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.+.||+|+||+||+|+.. +++.||||++...    ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            346789999999999999964 5889999998643    23456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          88 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             cCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999875      468999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...    ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+... ..  
T Consensus       159 ~~~----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~-~~--  221 (263)
T d2j4za1         159 SRR----TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRV-EF--  221 (263)
T ss_dssp             CCC----EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTT-CC--
T ss_pred             Ccc----cccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcC-CC--
Confidence            432    345689999999999875  688999999999999999999999964321        1111111111 11  


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                           ..+..++.++.+|+.+||+.||++|||++|+++
T Consensus       222 -----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                 111234567889999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=392.48  Aligned_cols=242  Identities=26%  Similarity=0.391  Sum_probs=195.4

Q ss_pred             hhcccCcCcceeEEEEEEc-CCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe----CceEEEEEE
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE----GHRRALIYE  398 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e  398 (638)
                      +.++||+|+||+||+|++. +++.||+|++....   ...+.+.+|++++++++|||||++++++.+    +...++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            5678999999999999864 57899999987543   234578899999999999999999999875    356799999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCceEEC-CCCceEEcccccce
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTR--ILHFDIKPHNILLD-EDFCPKISDFGLAK  475 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--iiH~Dikp~NIll~-~~~~~kl~DFg~~~  475 (638)
                      |+++|+|.+++.+.      ..+++..++.++.||++||+|||+   ++  |+||||||+|||++ +++.+||+|||+++
T Consensus        93 ~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          93 LMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CCCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            99999999999875      468999999999999999999998   77  99999999999996 58899999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      .......    ....||+.|+|||++.+   .++.++|||||||++|||++|+.||......       ......+... 
T Consensus       164 ~~~~~~~----~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~i~~~-  228 (270)
T d1t4ha_         164 LKRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSG-  228 (270)
T ss_dssp             GCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTT-
T ss_pred             eccCCcc----CCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHHHHcC-
Confidence            6544332    34568999999999864   5889999999999999999999999643211       1111111111 


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                           ..........+.++.+|+.+||+.||++|||++|+++
T Consensus       229 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 -----VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 0111122234557889999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=411.76  Aligned_cols=259  Identities=22%  Similarity=0.329  Sum_probs=201.0

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .+.+.++||+|+||+||+|+. .+++.||||+++...  ...+.+.+|+.+|++++|||||++++++.++...++||||+
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~   86 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   86 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            344578999999999999996 468899999997543  33467899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNT-RILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++|+|.+++.+.      ..+++..++.++.|+++||.|||+   + +|+||||||+|||+++++.+||+|||+|+....
T Consensus        87 ~gg~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          87 DGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             TTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999875      468999999999999999999997   5 899999999999999999999999999987643


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh--------
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL--------  551 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  551 (638)
                      ..    ....+||+.|+|||++.+.  .++.++||||+||++|||++|+.||....................        
T Consensus       158 ~~----~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         158 SM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HT----C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             Cc----cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            32    1345799999999999875  789999999999999999999999976433211000000000000        


Q ss_pred             --------------------hhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 --------------------ELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 --------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                                          ...................+.++.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                0000000000000011123567889999999999999999999997

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=399.02  Aligned_cols=258  Identities=28%  Similarity=0.447  Sum_probs=205.0

Q ss_pred             hhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNGS  404 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  404 (638)
                      +.+.+.||+|+||+||+|++++++.||||+++......+.|.+|+.++++++|||||+++|++.+ +..++||||+++|+
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~   97 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS   97 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred             EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCc
Confidence            44678999999999999999888899999998777777889999999999999999999999854 56789999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.+++....    ...+++..++.|+.||+.||+|||+   .+|+||||||+||||++++.+||+|||+++........ 
T Consensus        98 l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-  169 (285)
T d1fmka3          98 LLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  169 (285)
T ss_dssp             HHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             hhhhhhhcc----cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence            999987642    2469999999999999999999999   89999999999999999999999999999876543322 


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIEN  564 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (638)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.|+......      .... ..+..       +...
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~-~~i~~-------~~~~  233 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVL-DQVER-------GYRM  233 (285)
T ss_dssp             ------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHH-HHHHT-------TCCC
T ss_pred             eeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHH-HHHHh-------cCCC
Confidence            22445689999999999764  7899999999999999999977665433211      1111 11111       1111


Q ss_pred             chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          565 EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       565 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      ..+..+++++.+++.+||+.||++|||+++|+++|+..+.+..
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            2223456678999999999999999999999999999876643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=400.10  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=189.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEe--CceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFE--GHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  398 (638)
                      +++.+.||+|+||+||+|+. .+++.||||++.....   ..+.+.+|++++++++|||||++++++.+  +...++|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            34578999999999999986 4688999999875432   24568899999999999999999999865  456899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecccCCCceEECCCCceEEccccccee
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC--NTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      |+++|+|.+++....  .....+++..++.++.||++||+|||+..  ..+|+||||||+|||+++++.+||+|||+++.
T Consensus        86 y~~~g~L~~~i~~~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          86 YCEGGDLASVITKGT--KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             CCTTEEHHHHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             cCCCCcHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999997542  12357999999999999999999999821  12499999999999999999999999999987


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      .......  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+.... 
T Consensus       164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~-  230 (269)
T d2java1         164 LNHDTSF--AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGK-  230 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC-
T ss_pred             cccCCCc--cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCC-
Confidence            6543322  2346789999999999764  789999999999999999999999964321        11111111111 


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                        ..    ..+..+++++.+|+.+||+.||++|||++|+++
T Consensus       231 --~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         231 --FR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              11    112235668899999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=397.85  Aligned_cols=249  Identities=23%  Similarity=0.337  Sum_probs=202.8

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      ++.+.||+|+||+||+|++ .+++.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||+++|
T Consensus        15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g   94 (288)
T d2jfla1          15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence            4568899999999999996 468899999997543 44578899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCce
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESI  483 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~  483 (638)
                      +|.+++.+..     ..+++..+..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+|+....... 
T Consensus        95 ~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          95 AVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            9999987653     569999999999999999999999   9999999999999999999999999999986543211 


Q ss_pred             eeecccccccceecCceeccc---cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          484 VSMTGARGTIGYIAPEVFCRN---FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       484 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                       ......||+.|+|||++...   ...++.++|||||||++|||++|+.||......  +     .... +...     .
T Consensus       166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~-----~~~~-i~~~-----~  231 (288)
T d2jfla1         166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--R-----VLLK-IAKS-----E  231 (288)
T ss_dssp             -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--G-----HHHH-HHHS-----C
T ss_pred             -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--H-----HHHH-HHcC-----C
Confidence             12346789999999998532   235789999999999999999999999754321  1     1111 1111     0


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......+..++.++.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0111223345678899999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=399.49  Aligned_cols=246  Identities=22%  Similarity=0.323  Sum_probs=200.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      |.+.+.||+|+||+||+|+. .+++.||||+++..    ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            45678999999999999996 46899999998643    23456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++.+..
T Consensus        90 ~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          90 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCCHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999875      469999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...........||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+... ... 
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~-~~~-  228 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKL-EYD-  228 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTT-CCC-
T ss_pred             CCcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcC-CCC-
Confidence            4433334456799999999999775  789999999999999999999999974321        1111111111 111 


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            .+..++.++.+||.+||+.||++|||++|+++
T Consensus       229 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 ------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                  11234567889999999999999999999754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=393.34  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=198.8

Q ss_pred             cccCcCcceeEEEEEEcC---CCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKLLD---GQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ++||+|+||+||+|.+.+   ++.||||+++....   ..+++.+|++++++++|||||+++|++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   45799999965432   24578999999999999999999999865 457899999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      |+|.+++...      ..+++..+..|+.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        92 g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          92 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CcHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            9999999875      469999999999999999999999   9999999999999999999999999999998765443


Q ss_pred             ee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          483 IV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       483 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      .. ......||+.|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+...+...      
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~------  226 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKG------  226 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTT------
T ss_pred             ccccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHcC------
Confidence            32 22345689999999999764  78999999999999999997 8999874321        1111111111      


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSL  603 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  603 (638)
                       .....+..++.++.+|+.+||+.||++|||+++|++.|+..+
T Consensus       227 -~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         227 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence             112222345678899999999999999999999999888743

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=404.74  Aligned_cols=258  Identities=27%  Similarity=0.419  Sum_probs=205.5

Q ss_pred             hhhhcccCcCcceeEEEEEEcC-C-----CEEEEEEeccc--CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD-G-----QNVAIKVLNET--KGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  395 (638)
                      +.+.++||+|+||+||+|++.. +     ..||+|++...  ......+.+|+.++.++ +|||||++++++.+.+..++
T Consensus        39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l  118 (325)
T d1rjba_          39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  118 (325)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence            3467899999999999998643 2     26899998653  23446789999999998 79999999999999999999


Q ss_pred             EEEeccCCCHHHHhhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCce
Q 006620          396 IYEFVSNGSLEKFIHEKHPL-----------------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNI  458 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NI  458 (638)
                      ||||+++|+|.++|+..+..                 .....+++..++.|+.|+++||+|||+   ++|+||||||+||
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Ni  195 (325)
T d1rjba_         119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV  195 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGE
T ss_pred             EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhcc
Confidence            99999999999999865321                 112458999999999999999999999   9999999999999


Q ss_pred             EECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCC
Q 006620          459 LLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDR  537 (638)
Q Consensus       459 ll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~  537 (638)
                      |++.++.+||+|||+|+...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||......
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999877665554445566789999999999764  78999999999999999998 89998643321


Q ss_pred             CcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 006620          538 SSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEG  601 (638)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  601 (638)
                             ..........       .....+...+.++.+|+.+||+.||++|||++||+++|.-
T Consensus       274 -------~~~~~~~~~~-------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         274 -------ANFYKLIQNG-------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             -------HHHHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------HHHHHHHhcC-------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence                   1111111111       1112223345688999999999999999999999999963

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=392.84  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=203.4

Q ss_pred             hc-ccCcCcceeEEEEEEc---CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          328 KN-KLGQGGYGGVYKGKLL---DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       328 ~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      .+ +||+|+||+||+|.+.   ++..||||+++...  ...+++.+|++++++++|||||+++|++.+ +..++||||++
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~   91 (285)
T d1u59a_          13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG   91 (285)
T ss_dssp             EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCC
Confidence            44 5999999999999753   34579999997543  234678999999999999999999999865 56899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|+|.+++...+     ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        92 ~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          92 GGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             TEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             CCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999986543     569999999999999999999999   999999999999999999999999999999876544


Q ss_pred             cee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          482 SIV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       482 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ... ......||+.|+|||++.+.  .++.++|||||||++|||+| |+.||......       . +...+..      
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~-~~~~i~~------  227 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------E-VMAFIEQ------  227 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------H-HHHHHHT------
T ss_pred             cccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHc------
Confidence            332 22345689999999999764  78999999999999999998 89998754321       1 1111111      


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                       +...+.+..++.++.+|+.+||+.||++|||+.+|++.|+....
T Consensus       228 -~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         228 -GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             11122233456788999999999999999999999999987543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-49  Score=397.46  Aligned_cols=248  Identities=26%  Similarity=0.352  Sum_probs=188.0

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      |.+.+.||+|+||+||+|+.. +++.||||++....  .....+.+|+.++++++|||||++++++.+++..++||||++
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            456789999999999999964 58899999987543  233567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC---CCCceEEcccccceecc
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICE  478 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFg~~~~~~  478 (638)
                      ||+|.+++...      ..+++..+..++.||++||+|||+   ++|+||||||+|||+.   +++.+||+|||+++...
T Consensus        91 gg~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          91 GGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             SCBHHHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             CCcHHHhhhcc------cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999764      469999999999999999999999   9999999999999994   57899999999998765


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ....   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       . ....+....   
T Consensus       162 ~~~~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~-~~~~i~~~~---  225 (307)
T d1a06a_         162 PGSV---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------K-LFEQILKAE---  225 (307)
T ss_dssp             --------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------H-HHHHHHTTC---
T ss_pred             CCCe---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------H-HHHHHhccC---
Confidence            4432   2345699999999999775  7899999999999999999999999743211       1 111111110   


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       ..........++.++.+|+.+||+.||++|||++|++++
T Consensus       226 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 -YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence             111112223456788999999999999999999999973

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=391.70  Aligned_cols=255  Identities=28%  Similarity=0.473  Sum_probs=198.0

Q ss_pred             hhcccCcCcceeEEEEEEcCC-----CEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          327 FKNKLGQGGYGGVYKGKLLDG-----QNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      ..+.||+|+||+||+|.+.+.     ..||||+++....  ...++.+|++++++++|||||+++|++.+.+..++||||
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence            467899999999999986542     3699999875433  235788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +.+++|.+++....     ..+++..+..++.|++.||+|||+   ++|+||||||+||||+.++.+||+|||+++....
T Consensus        91 ~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          91 MENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             CTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             cccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999887653     579999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      ... ........||+.|+|||++.+.  .++.++|||||||++|||++|+.|+......       ..+...+..     
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~-----  228 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAIND-----  228 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHT-----
T ss_pred             CCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhc-----
Confidence            322 2223345689999999999764  7899999999999999999976665432211       111111111     


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDS  605 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  605 (638)
                        +.....+...+.++.+|+.+||+.||++|||++||++.|+++++.
T Consensus       229 --~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         229 --GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             --TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence              112222234566789999999999999999999999999987653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-49  Score=396.93  Aligned_cols=244  Identities=26%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +...++||+|+||+||+|+. .+++.||||++.....    ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            34568899999999999985 4688999999875432    234688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|..++...      ..+++..++.++.||++||+|||+   +||+||||||+|||+++++.+||+|||+++....
T Consensus        97 ~~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          97 CLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             CSEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             cCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999997776653      569999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCceeeecccccccceecCceeccc-cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRN-FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      .      ....||+.|+|||++.+. .+.++.++|||||||++|||++|+.||.....       ........ ...   
T Consensus       168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~-~~~---  230 (309)
T d1u5ra_         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIA-QNE---  230 (309)
T ss_dssp             B------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHH-HSC---
T ss_pred             C------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHH-hCC---
Confidence            3      235689999999998653 24688999999999999999999999864321       11111111 111   


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                         ........++.++.+|+.+||+.||++|||++|+++
T Consensus       231 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence               111112234668899999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.3e-48  Score=396.10  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=204.6

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      |.+.+.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+++..++||||+++
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  107 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  107 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            45678999999999999986 468899999997543 2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC--CCCceEEcccccceeccCC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DFg~~~~~~~~  480 (638)
                      |+|.+++....     ..+++..++.|+.||++||+|||+   ++|+||||||+|||++  .++.+||+|||+++.+...
T Consensus       108 g~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         108 GELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999996543     569999999999999999999999   9999999999999995  4688999999999987655


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ...   ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....       .... ..+...    ..
T Consensus       180 ~~~---~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~-~~i~~~----~~  242 (350)
T d1koaa2         180 QSV---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETL-RNVKSC----DW  242 (350)
T ss_dssp             SCE---EEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH-HHHHHT----CC
T ss_pred             ccc---ceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHH-HHHHhC----CC
Confidence            433   335689999999999775  688999999999999999999999964321       1111 111110    01


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      .........+++++.+||.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11122233456788999999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-47  Score=395.57  Aligned_cols=253  Identities=22%  Similarity=0.309  Sum_probs=206.4

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      |++.+.||+|+||+||+|+. .+++.||||+++... ...+.+.+|++++++++|||||++++++.++...++||||+++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            45678999999999999986 568999999987653 2345678999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC--CCCceEEcccccceeccCC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD--EDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DFg~~~~~~~~  480 (638)
                      |+|.+++....     ..+++..++.|+.||++||+|||+   +||+||||||+|||++  .++.+||+|||+|+.....
T Consensus       111 g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         111 GELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             ChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99999886543     569999999999999999999999   9999999999999997  6789999999999987665


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcccc
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQ  560 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  560 (638)
                      ...   ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       .. ...+... ..   
T Consensus       183 ~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~-~~~i~~~-~~---  245 (352)
T d1koba_         183 EIV---KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ET-LQNVKRC-DW---  245 (352)
T ss_dssp             SCE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HH-HHHHHHC-CC---
T ss_pred             Cce---eeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HH-HHHHHhC-CC---
Confidence            433   334579999999999765  7899999999999999999999999643211       11 1111110 01   


Q ss_pred             CCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 006620          561 GIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM--LEGS  602 (638)
Q Consensus       561 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  602 (638)
                      .........++.++.+||.+||+.||++|||++|++++  +++.
T Consensus       246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            11112223456788999999999999999999999885  5443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=386.25  Aligned_cols=247  Identities=24%  Similarity=0.323  Sum_probs=202.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC-------CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK-------GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  396 (638)
                      |.+.+.||+|+||+||+|+. .+|+.||||+++...       ...+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus        12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (293)
T d1jksa_          12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   91 (293)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45678999999999999996 568999999986432       1246789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC----ceEEcccc
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF----CPKISDFG  472 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFg  472 (638)
                      |||+++|+|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++    .+||+|||
T Consensus        92 ~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          92 LELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEcCCCccccchhccc------cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999875      469999999999999999999999   9999999999999998766    59999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      +++.......   .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||......       . ....+.
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~-~~~~i~  229 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLANVS  229 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHH
T ss_pred             hhhhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------H-HHHHHH
Confidence            9988755432   2345689999999999764  7899999999999999999999999743211       1 111111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..    ............+.++.+||.+||+.||++|||++|+++
T Consensus       230 ~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         230 AV----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TT----CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hc----CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10    001111222345678899999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.3e-48  Score=389.99  Aligned_cols=259  Identities=24%  Similarity=0.399  Sum_probs=206.2

Q ss_pred             hhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.||+|+||+||+|+..      +++.||||+++.....  .+++.+|++++++++||||+++++++......+++|
T Consensus        16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~   95 (301)
T d1lufa_          16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF   95 (301)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence            45789999999999999864      3468999999754432  457899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCC------------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceE
Q 006620          398 EFVSNGSLEKFIHEKHP------------------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNIL  459 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~------------------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIl  459 (638)
                      ||+++|+|.+++.....                  ......+++..++.|+.|++.||+|||+   ++++||||||+|||
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NIL  172 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCL  172 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceE
Confidence            99999999999976431                  1122458999999999999999999999   99999999999999


Q ss_pred             ECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCC-CCCCcccCCC
Q 006620          460 LDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK-NNANVAVDRS  538 (638)
Q Consensus       460 l~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~-~p~~~~~~~~  538 (638)
                      ++.++.+||+|||+++...............||+.|+|||.+.+.  .++.++|||||||++|||++|. +||.....  
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~--  248 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--  248 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH--
Confidence            999999999999999876554433334456689999999999765  7899999999999999999986 56653321  


Q ss_pred             cccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          539 SEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                           .. ....+...       .....+..++.++.+|+.+||+.||++||||.||+++|+++.+
T Consensus       249 -----~e-~~~~v~~~-------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         249 -----EE-VIYYVRDG-------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             -----HH-HHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -----HH-HHHHHHcC-------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                 11 11111111       1112223345678999999999999999999999999998753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-47  Score=388.76  Aligned_cols=245  Identities=23%  Similarity=0.316  Sum_probs=203.6

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.+.+.||+|+||+||+|+. .+++.||||++++.    ....+.+.+|+.+|++++||||+++++++.+.+.+++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            34578999999999999996 56899999999753    33456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++++|.+||+|||+|+....
T Consensus        87 ~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          87 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             cCCCchhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999999876      468999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...  .....+||+.|+|||++.+.  .++.++|||||||++|||++|++||.....        .......... .+. 
T Consensus       158 ~~~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~-~~~-  223 (337)
T d1o6la_         158 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME-EIR-  223 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCC-
T ss_pred             CCc--ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcC-CCC-
Confidence            332  23456799999999999875  789999999999999999999999975431        1111111111 111 


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  598 (638)
                            .+..++.++.+||.+||+.||++|++     ++|++++
T Consensus       224 ------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         224 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                  12234567889999999999999995     8888764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=385.62  Aligned_cols=253  Identities=24%  Similarity=0.384  Sum_probs=193.6

Q ss_pred             hhhhcccCcCcceeEEEEEEcC----CCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD----GQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      +++.+.||+|+||+||+|++..    +..||||+++....  ..+.+.+|++++++++||||++++|++. .+..++|||
T Consensus         9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E   87 (273)
T d1mp8a_           9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME   87 (273)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEE
Confidence            4567899999999999998643    34688998865433  2467899999999999999999999985 467899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++....     ..+++..++.++.||++||+|||+   ++|+||||||+||++++++.+||+|||+++...
T Consensus        88 ~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          88 LCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             CCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             eccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999987653     568999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ..... ......||+.|+|||++.+.  .++.++|||||||++|||++ |.+||......  +      +...+...   
T Consensus       160 ~~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~------~~~~i~~~---  225 (273)
T d1mp8a_         160 DSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--D------VIGRIENG---  225 (273)
T ss_dssp             ------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--G------HHHHHHTT---
T ss_pred             CCcce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHH--H------HHHHHHcC---
Confidence            43322 22345689999999999764  78999999999999999997 88888754321  1      11111111   


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                          .....+..++.++.+|+.+||+.||++|||++||+++|+.+++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         226 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                1112223456789999999999999999999999999988654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=389.46  Aligned_cols=253  Identities=25%  Similarity=0.429  Sum_probs=199.0

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCC----EEEEEEeccc--CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQ----NVAIKVLNET--KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      ++.++||+|+||+||+|++. +++    .||+|.++..  ....+++.+|++++++++|||||+++|++.++ ..++++|
T Consensus        12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e   90 (317)
T d1xkka_          12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ   90 (317)
T ss_dssp             EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred             EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEE
Confidence            45789999999999999854 343    5888888643  23456899999999999999999999999865 5678889


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      ++.+++|.+++....     ..+++..+++++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          91 LMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             CCTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eccCCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            999999999988753     679999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      ............||+.|+|||++.+.  .++.++|||||||++|||+| |++||......  +  .    ...+...   
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~--~----~~~i~~~---  229 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E--I----SSILEKG---  229 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--G--H----HHHHHHT---
T ss_pred             cccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--H--H----HHHHHcC---
Confidence            55544444556789999999999764  78999999999999999998 78887643321  1  1    1111111   


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                          .....+..++.++.+|+.+||+.||++|||++||+++|+.+..
T Consensus       230 ----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         230 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                1111222345678899999999999999999999999987643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=379.62  Aligned_cols=246  Identities=26%  Similarity=0.461  Sum_probs=193.9

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEe-CceEEEEEEeccCCC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFE-GHRRALIYEFVSNGS  404 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~gs  404 (638)
                      ++.++||+|+||+||+|++ .++.||||+++.+. ..+.+.+|++++++++||||++++|++.+ .+..++||||+++|+
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~   87 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   87 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence            3578899999999999998 57889999997653 45789999999999999999999999865 456899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCcee
Q 006620          405 LEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIV  484 (638)
Q Consensus       405 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~  484 (638)
                      |.++|....    ...+++..+++|+.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++......   
T Consensus        88 L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          88 LVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             HHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence            999997642    1358999999999999999999999   999999999999999999999999999998654432   


Q ss_pred             eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCC
Q 006620          485 SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIE  563 (638)
Q Consensus       485 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (638)
                        ....+|+.|+|||++.+.  .++.++||||||+++|||+| |++|+......       .. ...+.       .+..
T Consensus       158 --~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-------~~-~~~i~-------~~~~  218 (262)
T d1byga_         158 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DV-VPRVE-------KGYK  218 (262)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GH-HHHHT-------TTCC
T ss_pred             --ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-------HH-HHHHH-------cCCC
Confidence              233578999999999764  78999999999999999998 67776543211       11 11111       1122


Q ss_pred             CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          564 NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       564 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      .+.+...+.++.+|+.+||+.||++|||+.+|+++|+++
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            222333456788999999999999999999999999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-46  Score=375.53  Aligned_cols=249  Identities=22%  Similarity=0.314  Sum_probs=203.3

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc----------hhhHHHHHHHHhhcC-CcceEEEEeEEEeCce
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN----------GEDFINEVASISRTS-HVNIVTLLGFCFEGHR  392 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  392 (638)
                      |.+.+.||+|+||+||+|+. .+++.||||++......          .+.+.+|+.++++++ ||||+++++++.+++.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence            34578999999999999986 56889999998754321          235789999999997 9999999999999999


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      .++||||+++|+|.++|+..      ..+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        85 ~~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             EEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999875      469999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccc----cCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHH
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRN----FGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVY  548 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  548 (638)
                      +++.......   .....||+.|+|||++.+.    ...++.++||||+||++|||++|+.||.....        ....
T Consensus       156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~  224 (277)
T d1phka_         156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLML  224 (277)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred             heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHH
Confidence            9998765432   2445789999999998642    12468899999999999999999999975321        1111


Q ss_pred             HHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          549 KRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ..+... ..   .........++.++.+|+.+||+.||++|||++||++
T Consensus       225 ~~i~~~-~~---~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         225 RMIMSG-NY---QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHT-CC---CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHhC-CC---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111111 01   1122223346678999999999999999999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=383.67  Aligned_cols=249  Identities=20%  Similarity=0.250  Sum_probs=204.4

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccCC
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSNG  403 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  403 (638)
                      |.+.+.||+|+||+||+|+.. +++.||||+++........+.+|+++|++++|||||++++++.+++..|+||||++||
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg   86 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL   86 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence            346789999999999999864 5889999999876655667889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC--CCceEEcccccceeccCCC
Q 006620          404 SLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE--DFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       404 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFg~~~~~~~~~  481 (638)
                      +|.+++....     ..+++..++.|+.||++||+|||+   +||+||||||+|||++.  ...+||+|||+++......
T Consensus        87 ~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          87 DIFERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             BHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999997643     469999999999999999999999   99999999999999974  4589999999999876544


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccC
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQG  561 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  561 (638)
                      ..   ....+|+.|+|||.+.+.  .++.++||||+||++|+|++|+.||......        .....+....    ..
T Consensus       159 ~~---~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~----~~  221 (321)
T d1tkia_         159 NF---RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAE----YT  221 (321)
T ss_dssp             EE---EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTC----CC
T ss_pred             cc---cccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC----CC
Confidence            32   334579999999998765  7889999999999999999999999754321        1111111100    01


Q ss_pred             CCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          562 IENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       562 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ........++.++.+|+.+||+.||++|||++|++++
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111222456788999999999999999999999983

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=388.28  Aligned_cols=281  Identities=26%  Similarity=0.455  Sum_probs=217.5

Q ss_pred             cCCCCCcccchHH---HHHHHhhhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCC--chhhHHHHHHHHhhc
Q 006620          307 YGSLAPKRYRYAD---IKKMTNSFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKG--NGEDFINEVASISRT  375 (638)
Q Consensus       307 ~~~~~~~~~~~~~---i~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l  375 (638)
                      |+...+..+.++.   +....+.+.++||+|+||.||+|++.      +++.||||+++....  ...++.+|+.+++++
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l   83 (311)
T d1t46a_           4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL   83 (311)
T ss_dssp             TCCCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeeCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhc
Confidence            4444444444322   33334556889999999999999752      356899999976543  345788999999999


Q ss_pred             -CCcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 006620          376 -SHVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHEKHPL------------ETNQKLKWEVLYKIAVGIARGLEYLHR  442 (638)
Q Consensus       376 -~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~  442 (638)
                       +|||||++++++.+....++||||+++|+|.++++.....            .....+++..+..++.||++||+|||+
T Consensus        84 ~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~  163 (311)
T d1t46a_          84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS  163 (311)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence             6999999999999999999999999999999999875421            123468999999999999999999999


Q ss_pred             CCCCCeEecccCCCceEECCCCceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHH
Q 006620          443 GCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVF  522 (638)
Q Consensus       443 ~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~  522 (638)
                         ++++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+.  .++.++|||||||++|
T Consensus       164 ---~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~  238 (311)
T d1t46a_         164 ---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLW  238 (311)
T ss_dssp             ---TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHH
T ss_pred             ---CCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHH
Confidence               99999999999999999999999999999987765555555667899999999999764  7899999999999999


Q ss_pred             HHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          523 EMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       523 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                      ||+|++.|+........      .....+...       .....+...+.++.+|+.+||+.||++|||+++|+++|++.
T Consensus       239 ellt~g~p~~~~~~~~~------~~~~~i~~~-------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         239 ELFSLGSSPYPGMPVDS------KFYKMIKEG-------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHTTTCCSSTTCCSSH------HHHHHHHHT-------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHH------HHHHHHhcC-------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            99985544432222111      111111111       11112223456789999999999999999999999999986


Q ss_pred             cCC
Q 006620          603 LDS  605 (638)
Q Consensus       603 ~~~  605 (638)
                      +.+
T Consensus       306 i~~  308 (311)
T d1t46a_         306 ISE  308 (311)
T ss_dssp             HHH
T ss_pred             hcc
Confidence            654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.6e-47  Score=383.84  Aligned_cols=242  Identities=26%  Similarity=0.334  Sum_probs=201.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +++.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            34578999999999999996 45899999998643    34456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      ++||+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        86 ~~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          86 IEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             cCCcccccccccc------ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            9999999999875      468889999999999999999999   9999999999999999999999999999998754


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ..     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+... ... 
T Consensus       157 ~~-----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~-~~~-  219 (316)
T d1fota_         157 VT-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNA-ELR-  219 (316)
T ss_dssp             CB-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHC-CCC-
T ss_pred             cc-----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcC-CCC-
Confidence            32     345799999999999765  688999999999999999999999974321        1111111111 111 


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  598 (638)
                            .+..++.++.+++.+||+.||++|+     |+++++++
T Consensus       220 ------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         220 ------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                  1122456788999999999999996     89999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=379.07  Aligned_cols=268  Identities=24%  Similarity=0.327  Sum_probs=199.9

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeCc----eEEEEEEeccC
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEGH----RRALIYEFVSN  402 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~  402 (638)
                      +.++||+|+||+||+|+. +|+.||||+++...........|+..+.+++||||+++++++.+..    ..++||||+++
T Consensus         7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence            468899999999999987 6889999999755332222334555566789999999999998654    67899999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRG-----CNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      |+|.++|++.       .+++..+++++.|++.||+|||+.     +.++|+||||||+||||+.++.+||+|||+++..
T Consensus        86 g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          86 GSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            9999999863       489999999999999999999962     2369999999999999999999999999999987


Q ss_pred             cCCCcee--eecccccccceecCceecccc----CCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccc-------hh
Q 006620          478 EGRESIV--SMTGARGTIGYIAPEVFCRNF----GEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY-------FP  544 (638)
Q Consensus       478 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~  544 (638)
                      .......  ......||+.|+|||++.+..    ..++.++|||||||++|||+||..|+...........       ..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            6544322  223467999999999986531    1367799999999999999999988754332211110       00


Q ss_pred             HHHHHHhhhhhhccccCCC-CchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          545 HWVYKRLELEEDLGLQGIE-NEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      ....... ..... .+... .....+....+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus       239 ~~~~~~~-~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         239 EEMRKVV-CEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHH-TTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHH-hcccc-CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            1111111 00000 01111 11233466779999999999999999999999999988653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-47  Score=382.83  Aligned_cols=257  Identities=26%  Similarity=0.474  Sum_probs=204.1

Q ss_pred             hhhcccCcCcceeEEEEEEcCC----CEEEEEEecccC--CchhhHHHHHHHHhhcCCcceEEEEeEEEe-CceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDG----QNVAIKVLNETK--GNGEDFINEVASISRTSHVNIVTLLGFCFE-GHRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  398 (638)
                      +|.++||+|+||+||+|++.++    ..||||+++...  ...+++.+|++++++++||||++++|++.. +...++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4578899999999999986432    258999987533  234679999999999999999999999876 457899999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++....     ..+++..+.+++.|+++||.|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus       110 ~~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         110 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             CCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EeecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            999999999988653     567888999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCcee--eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhh
Q 006620          479 GRESIV--SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEED  556 (638)
Q Consensus       479 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (638)
                      ......  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||....... +  ....    +...  
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~--~~~~----i~~g--  250 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-D--ITVY----LLQG--  250 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHH----HHTT--
T ss_pred             ccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-H--HHHH----HHcC--
Confidence            443221  22345689999999998764  78999999999999999999888776433211 1  1111    1111  


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 006620          557 LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSL  606 (638)
Q Consensus       557 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  606 (638)
                           .....+...+.++.+|+.+||+.||++|||++||+++|++++.+.
T Consensus       251 -----~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         251 -----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -----CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence                 111122234567889999999999999999999999999987653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=379.04  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=193.4

Q ss_pred             hhhcccCcCcceeEEEEEEcC--C--CEEEEEEecccC----CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLLD--G--QNVAIKVLNETK----GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      ++.+.||+|+||+||+|+...  +  ..||||+++...    ...+++.+|+.++++++||||++++|++.+ ...++||
T Consensus        11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~   89 (273)
T d1u46a_          11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT   89 (273)
T ss_dssp             EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence            457899999999999998532  2  368999987542    224578999999999999999999999975 4678999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++|+|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+||+++.++.+||+|||+++..
T Consensus        90 e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          90 ELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             ECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999887653     569999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCceee-ecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccchhHHHHHHhhhhh
Q 006620          478 EGRESIVS-MTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIYFPHWVYKRLELEE  555 (638)
Q Consensus       478 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  555 (638)
                      ........ .....||..|+|||++.+.  .++.++||||||+++|||+| |+.||.....       .........   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~~~~~~i~~---  229 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDK---  229 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHT---
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------HHHHHHHHh---
Confidence            65543322 2334578899999999875  78999999999999999998 8999864321       111111111   


Q ss_pred             hccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 006620          556 DLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGS  602 (638)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  602 (638)
                          .+...+.+..++.++.+|+.+||+.||++|||+++|++.|+++
T Consensus       230 ----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 ----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                1112222234456789999999999999999999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-46  Score=380.82  Aligned_cols=246  Identities=22%  Similarity=0.291  Sum_probs=196.2

Q ss_pred             cccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhc-CCcceEEEEeEEEe----CceEEEEEEeccC
Q 006620          329 NKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRT-SHVNIVTLLGFCFE----GHRRALIYEFVSN  402 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~~  402 (638)
                      +.||+|+||+||+|++ .+++.||||+++..    ..+.+|++++.++ +|||||++++++.+    ....++||||++|
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            5699999999999986 56899999998643    4667899987655 79999999999875    4678999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC---CCceEEcccccceeccC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE---DFCPKISDFGLAKICEG  479 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFg~~~~~~~  479 (638)
                      |+|.++|....    ...+++..++.|+.||++||+|||+   .+|+||||||+|||++.   .+.+||+|||+++....
T Consensus        94 g~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          94 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             EEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccC
Confidence            99999998642    2469999999999999999999999   99999999999999975   56799999999987765


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ...   .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.........    ........    ...
T Consensus       167 ~~~---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~----~~~~~~i~----~~~  233 (335)
T d2ozaa1         167 HNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIR----MGQ  233 (335)
T ss_dssp             CCC---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCC----SCS
T ss_pred             CCc---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH----HHHHHHHh----cCC
Confidence            443   2446799999999999765  7899999999999999999999999754322110    00000000    000


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                      ..........++.++.+|+.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            111223344567889999999999999999999999984

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-47  Score=384.34  Aligned_cols=261  Identities=27%  Similarity=0.403  Sum_probs=195.6

Q ss_pred             hhhhcccCcCcceeEEEEEEcC------CCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeC-ceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD------GQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEG-HRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~~  394 (638)
                      +.+.++||+|+||+||+|++..      ++.||||+++....  ..+.+.+|+..+.++ +|+||+++++++... ...+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~   94 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   94 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence            4567899999999999998532      35799999975432  345678888888777 589999999988764 4689


Q ss_pred             EEEEeccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC
Q 006620          395 LIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF  464 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~  464 (638)
                      +||||+++|+|.++++.....          .....+++..++.++.||++||+|||+   ++|+||||||+|||+++++
T Consensus        95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCC
Confidence            999999999999999764321          112458999999999999999999999   9999999999999999999


Q ss_pred             ceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCC-CCCCcccCCCcccch
Q 006620          465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK-NNANVAVDRSSEIYF  543 (638)
Q Consensus       465 ~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~  543 (638)
                      .+||+|||+|+...............||+.|+|||++.+.  .++.++|||||||++|||++|. +||......      
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~------  243 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------  243 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS------
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCHH------
Confidence            9999999999876655444344556799999999999764  7899999999999999999875 566533211      


Q ss_pred             hHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          544 PHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                       ......+.....       ...+...+.++.+++.+||+.||++|||++||+++|+++++
T Consensus       244 -~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         244 -EEFCRRLKEGTR-------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             -HHHHHHHHHTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHhcCCC-------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             111121211111       11222345678999999999999999999999999998653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-45  Score=380.96  Aligned_cols=241  Identities=21%  Similarity=0.284  Sum_probs=201.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEeccc----CCchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEe
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNET----KGNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +++.++||+|+||+||+|++ .+|+.||||++...    ....+.+.+|+.+|++++||||+++++++.+....++||||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            45578999999999999986 46899999998643    23456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccC
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEG  479 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~  479 (638)
                      +.+|+|.+++...      ..+++..++.++.||+.||.|||+   ++||||||||+|||++.++.+||+|||+++....
T Consensus       123 ~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         123 VAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             CTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccchhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999875      468999999999999999999999   9999999999999999999999999999998754


Q ss_pred             CCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhccc
Q 006620          480 RESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLGL  559 (638)
Q Consensus       480 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  559 (638)
                      ..     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+.... .  
T Consensus       194 ~~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~-~--  255 (350)
T d1rdqe_         194 RT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGK-V--  255 (350)
T ss_dssp             CB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-C--
T ss_pred             cc-----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCC-C--
Confidence            32     345689999999999875  788999999999999999999999964321        11111111110 1  


Q ss_pred             cCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006620          560 QGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVE  597 (638)
Q Consensus       560 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  597 (638)
                           ..+..++.++.+|+.+||+.||++|+     |++++++
T Consensus       256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 11123456788999999999999994     8999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.1e-46  Score=387.06  Aligned_cols=246  Identities=24%  Similarity=0.316  Sum_probs=196.5

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccC----CchhhHHH---HHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETK----GNGEDFIN---EVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.+.||+|+||+||+|+.. +|+.||||++....    .....+.+   |+.+++.++|||||++++++.+.+..++||
T Consensus         7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm   86 (364)
T d1omwa3           7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL   86 (364)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence            45789999999999999964 68999999986432    22233444   466777778999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceec
Q 006620          398 EFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  477 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~  477 (638)
                      ||+++|+|.++|...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+..
T Consensus        87 E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          87 DLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             CCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EecCCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999875      468899999999999999999999   99999999999999999999999999999977


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhc
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDL  557 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (638)
                      .....    ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........     ........     
T Consensus       158 ~~~~~----~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~~-----  222 (364)
T d1omwa3         158 SKKKP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTL-----  222 (364)
T ss_dssp             SSSCC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHHSS-----
T ss_pred             CCCcc----cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcc-----
Confidence            65432    345699999999998643 2578999999999999999999999975432211     11111000     


Q ss_pred             cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006620          558 GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPS-----MNRVVEM  598 (638)
Q Consensus       558 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  598 (638)
                         ......+..++.++.+||.+||+.||++|||     ++|++++
T Consensus       223 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         223 ---TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ---SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ---cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence               0011112234567899999999999999999     6888763

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-46  Score=375.40  Aligned_cols=255  Identities=21%  Similarity=0.292  Sum_probs=197.2

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC----chhhHHHHHHHHhhcCCcceEEEEeEEEeCc----eEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG----NGEDFINEVASISRTSHVNIVTLLGFCFEGH----RRAL  395 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  395 (638)
                      |.+.+.||+|+||+||+|+. .+++.||||+++....    ..+.+.+|++++++++||||+++++++....    ..++
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            34678999999999999985 5689999999975432    2346889999999999999999999987643    4789


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||++|++|.+++...      ..+++..++.++.||++||+|||+   .||+||||||+|||++.++.++|+|||.+.
T Consensus        89 vmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEECCCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhh
Confidence            99999999999999875      468999999999999999999999   999999999999999999999999999987


Q ss_pred             eccCCCc-eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          476 ICEGRES-IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       476 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ....... ........||+.|+|||++.+.  .++.++|||||||++|||+||++||.....       ...........
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~  230 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVRED  230 (277)
T ss_dssp             ECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcC
Confidence            6543322 2223445799999999999764  789999999999999999999999974321       11111111111


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhcc
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-SMNRVVEMLEGS  602 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~  602 (638)
                      .     .........++.++.+++.+||+.||++|| |++++++.|.++
T Consensus       231 ~-----~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         231 P-----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             C-----CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             C-----CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            0     000111223467889999999999999999 899999998875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=379.00  Aligned_cols=260  Identities=26%  Similarity=0.443  Sum_probs=204.5

Q ss_pred             hhhhcccCcCcceeEEEEEEcC--------CCEEEEEEecccCC--chhhHHHHHHHHhhc-CCcceEEEEeEEEeCceE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLLD--------GQNVAIKVLNETKG--NGEDFINEVASISRT-SHVNIVTLLGFCFEGHRR  393 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  393 (638)
                      +.+.+.||+|+||.||+|+...        +..||||+++....  ...++.+|+..+.++ +|||||++++++.++...
T Consensus        15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~   94 (299)
T d1fgka_          15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL   94 (299)
T ss_dssp             EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence            4467899999999999997532        24799999976543  346788899999888 799999999999999999


Q ss_pred             EEEEEeccCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC
Q 006620          394 ALIYEFVSNGSLEKFIHEKHPL----------ETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED  463 (638)
Q Consensus       394 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~  463 (638)
                      ++||||+++|+|.++|......          .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.+
T Consensus        95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED  171 (299)
T ss_dssp             EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTT
T ss_pred             EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCC
Confidence            9999999999999999765321          123569999999999999999999999   999999999999999999


Q ss_pred             CceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhc-CCCCCCcccCCCcccc
Q 006620          464 FCPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTG-EKNNANVAVDRSSEIY  542 (638)
Q Consensus       464 ~~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  542 (638)
                      +.+||+|||+++...............||+.|+|||.+.+.  .++.++||||||+++|||++ |.+||.....      
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------  243 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  243 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence            99999999999977655444444556789999999999764  78999999999999999998 6777753221      


Q ss_pred             hhHHHHHHhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          543 FPHWVYKRLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       543 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                        ..+...+....       ....+..++.++.+|+.+||+.||++|||+.||++.|++++.
T Consensus       244 --~~~~~~i~~~~-------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 --EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             --HHHHHHHHTTC-------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHcCC-------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence              11222222211       112222345678999999999999999999999999998643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=378.35  Aligned_cols=258  Identities=28%  Similarity=0.469  Sum_probs=202.6

Q ss_pred             hhcccCcCcceeEEEEEEc-CCC--EEEEEEeccc--CCchhhHHHHHHHHhhc-CCcceEEEEeEEEeCceEEEEEEec
Q 006620          327 FKNKLGQGGYGGVYKGKLL-DGQ--NVAIKVLNET--KGNGEDFINEVASISRT-SHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      +.++||+|+||+||+|++. ++.  .||||+++..  ....+.+.+|+++|+++ +|||||+++|++.+++..++||||+
T Consensus        14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~   93 (309)
T d1fvra_          14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   93 (309)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence            5789999999999999864 344  4778887543  33456799999999998 6999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcc
Q 006620          401 SNGSLEKFIHEKHP----------LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISD  470 (638)
Q Consensus       401 ~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  470 (638)
                      ++|+|.++|+....          ......+++..+..++.||++||.|||+   ++|+||||||+|||++.++.+||+|
T Consensus        94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~D  170 (309)
T d1fvra_          94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD  170 (309)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEcc
Confidence            99999999976421          1234679999999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCC-CCCcccCCCcccchhHHHHH
Q 006620          471 FGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKN-NANVAVDRSSEIYFPHWVYK  549 (638)
Q Consensus       471 Fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~  549 (638)
                      ||+++.......   .....||..|+|||.+.+.  .++.++|||||||++|||++|.. ||....        ......
T Consensus       171 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~~~~~  237 (309)
T d1fvra_         171 FGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYE  237 (309)
T ss_dssp             TTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHH
T ss_pred             cccccccccccc---ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCC--------HHHHHH
Confidence            999986543222   2234589999999999764  78999999999999999999765 554321        111112


Q ss_pred             HhhhhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 006620          550 RLELEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQ  607 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  607 (638)
                      .+..       +.....+..++.++.+||.+||+.||++||||+||+++|++++++..
T Consensus       238 ~i~~-------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         238 KLPQ-------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             HGGG-------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHh-------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            1211       11122223456789999999999999999999999999999876543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-46  Score=376.16  Aligned_cols=254  Identities=24%  Similarity=0.283  Sum_probs=194.0

Q ss_pred             hcccCcCcceeEEEEEE-cCCCEEEEEEecccCC------chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEec
Q 006620          328 KNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG------NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFV  400 (638)
Q Consensus       328 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  400 (638)
                      .++||+|+||+||+|++ .+++.||||+++....      ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            36899999999999995 4689999999865421      1346889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCC
Q 006620          401 SNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGR  480 (638)
Q Consensus       401 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~  480 (638)
                      .++++..++...      ..+++..+..++.||++||+|||+   ++|+||||||+|||+++++.+||+|||+++.....
T Consensus        83 ~~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          83 ETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             SEEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             cchHHhhhhhcc------cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC
Confidence            887777665543      568889999999999999999999   99999999999999999999999999999876543


Q ss_pred             CceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh--h----
Q 006620          481 ESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL--E----  554 (638)
Q Consensus       481 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~----  554 (638)
                      ..  ......||+.|+|||++.+. ..++.++|||||||++|||++|++||.......   .+ ....+....  .    
T Consensus       154 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l-~~i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         154 NR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QL-TRIFETLGTPTEEQWP  226 (299)
T ss_dssp             CC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-HHHHHHHCCCCTTTSS
T ss_pred             cc--cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HH-HHHHHhcCCCChhhcc
Confidence            32  22345789999999998653 357899999999999999999999986433210   00 000000000  0    


Q ss_pred             ------hhccccCCCCchh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          555 ------EDLGLQGIENEED----KEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       555 ------~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                            .............    ...+.++.+|+.+||+.||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                  0000011111111    123567899999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-46  Score=378.25  Aligned_cols=244  Identities=22%  Similarity=0.296  Sum_probs=199.6

Q ss_pred             hhhhcccCcCcceeEEEEEEc-CCCEEEEEEeccc----CCchhhHHHHHHHHh-hcCCcceEEEEeEEEeCceEEEEEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNET----KGNGEDFINEVASIS-RTSHVNIVTLLGFCFEGHRRALIYE  398 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e  398 (638)
                      |.+.+.||+|+||+||+|+.. +++.||||+++..    ....+.+..|..++. .++||||+++++++.+++..|+|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            346789999999999999864 6889999999643    334456777777765 6899999999999999999999999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++...
T Consensus        84 y~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          84 YLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             ecCCCcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999875      458999999999999999999999   999999999999999999999999999998665


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhhhhcc
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELEEDLG  558 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  558 (638)
                      .....  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+...+.... . 
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~-~-  220 (320)
T d1xjda_         155 LGDAK--TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN-P-  220 (320)
T ss_dssp             CTTCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-C-
T ss_pred             ccccc--ccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC-C-
Confidence            43322  2445799999999999875  789999999999999999999999974321        11122221111 1 


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006620          559 LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMN-RVVE  597 (638)
Q Consensus       559 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  597 (638)
                            ..+..++.++.+|+.+||+.||++|||+. ++++
T Consensus       221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                  11123456789999999999999999996 6764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=379.06  Aligned_cols=259  Identities=23%  Similarity=0.393  Sum_probs=207.8

Q ss_pred             hhhcccCcCcceeEEEEEEc------CCCEEEEEEecccCCc--hhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL------DGQNVAIKVLNETKGN--GEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIY  397 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  397 (638)
                      .+.++||+|+||+||+|.+.      +++.||||+++.....  ...+.+|++++++++||||+++++++..+...++||
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence            45789999999999999753      2568999999764433  346889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHhhhcCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccc
Q 006620          398 EFVSNGSLEKFIHEKHP----LETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGL  473 (638)
Q Consensus       398 e~~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~  473 (638)
                      ||+++|+|.+++.....    ......+++..+..++.|+++||.|||+   ++|+||||||+|||+++++.+||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeeccc
Confidence            99999999999875421    1122457899999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCC-CCCCcccCCCcccchhHHHHHHhh
Q 006620          474 AKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEK-NNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       474 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      ++...............||+.|+|||.+.+.  .++.++||||||+++|||+||. +||.....       ... ...+.
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------~~~-~~~i~  249 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQV-LRFVM  249 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHH-HHHHH
T ss_pred             ceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCH-------HHH-HHHHH
Confidence            9877655544444555689999999999765  7889999999999999999985 55543211       111 11111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                      .       +.....+...+..+.+++.+||+.||++|||+++|+++|++.++
T Consensus       250 ~-------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 E-------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             T-------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             h-------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1       11112223345679999999999999999999999999998755

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=372.64  Aligned_cols=237  Identities=25%  Similarity=0.354  Sum_probs=194.0

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC-------chhhHHHHHHHHhhcC--CcceEEEEeEEEeCceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG-------NGEDFINEVASISRTS--HVNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~  394 (638)
                      |.+.+.||+|+||+||+|+. .+++.||||+++....       ....+.+|+.++++++  ||||+++++++.+++..+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            34578999999999999986 5689999999875321       2234678999999997  899999999999999999


Q ss_pred             EEEEeccC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-CCceEEcccc
Q 006620          395 LIYEFVSN-GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-DFCPKISDFG  472 (638)
Q Consensus       395 lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg  472 (638)
                      +||||+.+ +++.+++...      ..+++..++.++.||++||+|||+   ++|+||||||+|||++. ++.+||+|||
T Consensus        86 lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccc
Confidence            99999975 6888888765      468999999999999999999999   99999999999999984 5799999999


Q ss_pred             cceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          473 LAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      +++......    .....||+.|+|||++.+. ..++.++||||+||++|||++|+.||.....              ..
T Consensus       157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~  217 (273)
T d1xwsa_         157 SGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------II  217 (273)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HH
T ss_pred             cceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH--------------Hh
Confidence            998765432    2445799999999999764 2346789999999999999999999864210              00


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      . ......       ..++.++.+|+.+||+.||++|||++|+++
T Consensus       218 ~-~~~~~~-------~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 R-GQVFFR-------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             H-CCCCCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             h-cccCCC-------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0 011111       123567899999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=374.25  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=196.7

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ...++||+|+||+||+|++ .+++.||||+++...   ...+.+.+|++++++++|||||++++++.++...++||||+.
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~   84 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   84 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence            3468999999999999996 568999999996543   234678999999999999999999999999999999999996


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      + ++.+++....    ...+++..++.++.|+++||+|||+   ++||||||||+|||++.++.+||+|||.++......
T Consensus        85 ~-~~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          85 Q-DLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             E-EHHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             C-chhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            5 5555554432    2569999999999999999999999   999999999999999999999999999998765433


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh---------
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE---------  552 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------  552 (638)
                      .  ......||+.|+|||++... ..++.++||||+||++|+|++|+.||.......   .+.........         
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTG
T ss_pred             c--cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhcccc
Confidence            2  23445789999999998664 356889999999999999999999997542110   00000000000         


Q ss_pred             -hhhhc--cccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          553 -LEEDL--GLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       553 -~~~~~--~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       .....  ........    .....+.++.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             00000  00000011    111335678999999999999999999999974

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.1e-45  Score=367.86  Aligned_cols=256  Identities=23%  Similarity=0.293  Sum_probs=196.2

Q ss_pred             hhhcccCcCcceeEEEEEEcCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEeccC
Q 006620          326 SFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      ...++||+|+||+||+|++.+++.||||+++...   ...+.+.+|+.++++++||||+++++++..++..++++|++.+
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~   84 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence            3568899999999999999889999999996543   2346789999999999999999999999999999999999987


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCCc
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRES  482 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~~  482 (638)
                      +.+..+....      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+........
T Consensus        85 ~~~~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          85 DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             hhHHHHHhhc------CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            6666655443      579999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             eeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh----------
Q 006620          483 IVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE----------  552 (638)
Q Consensus       483 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  552 (638)
                        ......+++.|+|||.+.+. ..++.++||||+||++|||++|+.||.......   .+... .....          
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i-~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRI-FRILGTPNSKNWPNV  228 (286)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH-HHHHCCCCTTTSTTG
T ss_pred             --ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHH-HHhhCCCChhhccch
Confidence              22344689999999998764 367899999999999999999999997543210   00000 00000          


Q ss_pred             -hhhhc--ccc---CC-CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          553 -LEEDL--GLQ---GI-ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       553 -~~~~~--~~~---~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                       .....  ...   .. ........+.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00000  000   00 01112234567889999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=365.64  Aligned_cols=256  Identities=26%  Similarity=0.368  Sum_probs=192.1

Q ss_pred             hhhhcccCcCcceeEEEEEE-cC-CCEEEEEEecccC---CchhhHHHHHHHHhhc---CCcceEEEEeEEEe-----Cc
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LD-GQNVAIKVLNETK---GNGEDFINEVASISRT---SHVNIVTLLGFCFE-----GH  391 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  391 (638)
                      |++.++||+|+||+||+|++ .+ ++.||||+++...   .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~   88 (305)
T d1blxa_           9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   88 (305)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence            34578999999999999986 34 5679999986532   2234567888887766   69999999999863     34


Q ss_pred             eEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccc
Q 006620          392 RRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDF  471 (638)
Q Consensus       392 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF  471 (638)
                      ..+++|||+.++.+.......     ...+++..++.++.|+++||+|||+   ++|+||||||+|||+++++.+||+||
T Consensus        89 ~~~~~~e~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          89 KLTLVFEHVDQDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEEEEEECCSCBHHHHHHHSC-----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             eEEEEEEeccCCchhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecch
Confidence            678999999887765554433     2568999999999999999999999   99999999999999999999999999


Q ss_pred             ccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh
Q 006620          472 GLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL  551 (638)
Q Consensus       472 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  551 (638)
                      |+++.......   .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||.......   .+.... ...
T Consensus       161 g~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~-~~~  231 (305)
T d1blxa_         161 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKIL-DVI  231 (305)
T ss_dssp             CSCCCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH-HHH
T ss_pred             hhhhhhccccc---CCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHH-Hhh
Confidence            99886543332   3456789999999999765  78999999999999999999999997543210   000000 000


Q ss_pred             hh-h-hh---------ccccCC----CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          552 EL-E-ED---------LGLQGI----ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       552 ~~-~-~~---------~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .. . ..         ......    ........+.++.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00 0 00         000000    00111234567889999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=364.68  Aligned_cols=260  Identities=24%  Similarity=0.274  Sum_probs=191.6

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeCc------eEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEGH------RRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  395 (638)
                      .+.++||+|+||+||+|++ .+++.||||+++.....   .+.+.+|+++|++++|||||++++++...+      ..++
T Consensus        21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  100 (346)
T d1cm8a_          21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL  100 (346)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence            3467899999999999996 45899999999754322   356889999999999999999999998654      4699


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+ +.+|..+++.       ..+++..++.++.||+.||+|||+   +||+||||||+|||++.++.+||+|||+++
T Consensus       101 v~e~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_         101 VMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             EEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence            99999 6688887765       459999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccc-------hhHHHH
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIY-------FPHWVY  548 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~  548 (638)
                      ......     ....||+.|+|||++.+. ..++.++||||+||++|||++|+.||...........       .+....
T Consensus       170 ~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccCCcc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            765432     445689999999998764 3578999999999999999999999975432110000       000000


Q ss_pred             HHhh------hhhhc-cccCC-CCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 006620          549 KRLE------LEEDL-GLQGI-ENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM--LEGS  602 (638)
Q Consensus       549 ~~~~------~~~~~-~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  602 (638)
                      ....      ....+ ..... ........+.++.+|+.+||+.||++|||++|++++  ++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            0000      00000 00000 001112235578899999999999999999999985  5543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-42  Score=355.38  Aligned_cols=259  Identities=21%  Similarity=0.295  Sum_probs=190.4

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccC---CchhhHHHHHHHHhhcCCcceEEEEeEEEe--------Cce
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETK---GNGEDFINEVASISRTSHVNIVTLLGFCFE--------GHR  392 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~  392 (638)
                      |.+.++||+|+||+||+|++ .+++.||||++....   .....+.+|+++|++++||||+++++++..        ...
T Consensus        12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~   91 (318)
T d3blha1          12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   91 (318)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred             EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence            34578999999999999996 568999999986442   234578899999999999999999998865        345


Q ss_pred             EEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccc
Q 006620          393 RALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFG  472 (638)
Q Consensus       393 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg  472 (638)
                      .++||||+.++.+..+....      ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        92 ~~iv~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          92 IYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             EEEEEECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecc
Confidence            78999999876665444332      568999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCce--eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHH
Q 006620          473 LAKICEGRESI--VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKR  550 (638)
Q Consensus       473 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  550 (638)
                      +++........  .......||+.|+|||++.+. ..++.++||||+||++|||++|+.||.......    ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~i~~~  237 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQL  237 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH----HHHHHHHh
Confidence            99876543221  122335689999999998764 367899999999999999999999997532210    00000000


Q ss_pred             hh-hhhh-------------ccc-cCCCCchh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          551 LE-LEED-------------LGL-QGIENEED-----KEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       551 ~~-~~~~-------------~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      .. ....             ... ........     .....++.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00 0000             000 00000011     112446778999999999999999999996

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-42  Score=349.91  Aligned_cols=265  Identities=17%  Similarity=0.240  Sum_probs=207.5

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCC-cceEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSH-VNIVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      |.+.++||+|+||+||+|++ .+++.||||++.... ..+.+.+|++.++.++| +|++.+++++..+...++||||+ +
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~   84 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G   84 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence            44678999999999999996 468899999986543 33567889999999975 89999999999999999999999 7


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECC-----CCceEEcccccceec
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDE-----DFCPKISDFGLAKIC  477 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFg~~~~~  477 (638)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   +||+||||||+|||++.     ++.+||+|||+|+..
T Consensus        85 ~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          85 PSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             CCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            89999987753     568999999999999999999999   99999999999999964     678999999999976


Q ss_pred             cCCCce-----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhh
Q 006620          478 EGRESI-----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLE  552 (638)
Q Consensus       478 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  552 (638)
                      ......     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||............     ..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-----~~i~  229 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-----ERIG  229 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-----HHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-----HHHH
Confidence            543211     122345799999999999875  7899999999999999999999999754432211111     1111


Q ss_pred             hhhhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 006620          553 LEEDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLDSLQIP  609 (638)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  609 (638)
                      ......   ...+....+++++.+++..|++.+|++||+++.+.+.|++++.+....
T Consensus       230 ~~~~~~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~  283 (293)
T d1csna_         230 EKKQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  283 (293)
T ss_dssp             HHHHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             hccCCC---ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence            110000   000011223567889999999999999999999999998877665543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-43  Score=359.42  Aligned_cols=251  Identities=23%  Similarity=0.285  Sum_probs=199.9

Q ss_pred             hhhhcccCcCcceeEEEEEEc----CCCEEEEEEecccC-----CchhhHHHHHHHHhhcCC-cceEEEEeEEEeCceEE
Q 006620          325 NSFKNKLGQGGYGGVYKGKLL----DGQNVAIKVLNETK-----GNGEDFINEVASISRTSH-VNIVTLLGFCFEGHRRA  394 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~  394 (638)
                      |.+.++||+|+||+||+|+..    +++.||||+++...     ...+.+.+|++++++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            456789999999999999752    37899999986432     334678899999999976 89999999999999999


Q ss_pred             EEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccc
Q 006620          395 LIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLA  474 (638)
Q Consensus       395 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~  474 (638)
                      ++|||+.+|+|.+++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       106 ~v~e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeecccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999876      457889999999999999999999   99999999999999999999999999999


Q ss_pred             eeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          475 KICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       475 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      +.+....... .....|++.|+|||.+.+....++.++|||||||+||||++|+.||........   ........... 
T Consensus       177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~---~~~i~~~~~~~-  251 (322)
T d1vzoa_         177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKS-  251 (322)
T ss_dssp             EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHC-
T ss_pred             hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcccC-
Confidence            8765433222 234568999999999976544578899999999999999999999976543221   11111111110 


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRP-----SMNRVVE  597 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  597 (638)
                              ....+..++.++.+|+.+||+.||++||     |++|+++
T Consensus       252 --------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                    0111223567899999999999999999     4788886

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=364.62  Aligned_cols=264  Identities=23%  Similarity=0.241  Sum_probs=192.6

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCchhhHHHHHHHHhhcCCcceEEEEeEEEeC------ceEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGNGEDFINEVASISRTSHVNIVTLLGFCFEG------HRRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  398 (638)
                      ...++||+|+||+||+|++. +++.||||++......   ..+|+++|++++||||+++++++...      ...++|||
T Consensus        23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            34578999999999999964 5899999999765432   34799999999999999999998643      34789999


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC-ceEEcccccceec
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF-CPKISDFGLAKIC  477 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFg~~~~~  477 (638)
                      |++++.+..+....   .....+++..++.++.||++||+|||+   +||+||||||+|||++.++ .+||+|||+++..
T Consensus       100 y~~~~~~~~l~~~~---~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_         100 YVPETVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             CCSEEHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             ccCCccHHHHHhhh---hccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            99765443333221   112579999999999999999999999   9999999999999999765 8999999999877


Q ss_pred             cCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCccc--------chhHHHHH
Q 006620          478 EGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEI--------YFPHWVYK  549 (638)
Q Consensus       478 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~  549 (638)
                      ......   ....||+.|+|||.+.+. ..++.++||||+||++|||++|++||........-.        ........
T Consensus       174 ~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCccc---ccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            654432   345689999999988654 368999999999999999999999996543211000        00000000


Q ss_pred             HhhhhhhccccCCCC-----chhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 006620          550 RLELEEDLGLQGIEN-----EEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM--LEGS  602 (638)
Q Consensus       550 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  602 (638)
                      ...............     ......+.++.+|+.+||+.||++|||++|++++  ++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            000000000111000     0112345678899999999999999999999974  4443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=363.02  Aligned_cols=262  Identities=21%  Similarity=0.263  Sum_probs=192.1

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC--chhhHHHHHHHHhhcCCcceEEEEeEEEeCc----eEEEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG--NGEDFINEVASISRTSHVNIVTLLGFCFEGH----RRALIYE  398 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e  398 (638)
                      .+.++||+|+||+||+|+. .+++.||||+++....  ..+.+.+|+++|++++||||+++++++....    ..+++++
T Consensus        11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~   90 (345)
T d1pmea_          11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT   90 (345)
T ss_dssp             EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE
Confidence            3568999999999999985 5799999999975432  2457889999999999999999999987643    2345556


Q ss_pred             eccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceecc
Q 006620          399 FVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICE  478 (638)
Q Consensus       399 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~  478 (638)
                      ++.+|+|.+++...       .+++..++.++.|++.||+|||+   +||+||||||+|||+++++.+||+|||+++...
T Consensus        91 ~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          91 HLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             ECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            67799999999763       58999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCcee-eecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccch------hH-HHHHH
Q 006620          479 GRESIV-SMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYF------PH-WVYKR  550 (638)
Q Consensus       479 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~------~~-~~~~~  550 (638)
                      ...... ......||+.|+|||++... ..++.++||||+||++|||++|+.||............      +. .....
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            432221 12445689999999998554 36788999999999999999999999754321100000      00 00000


Q ss_pred             -h--hhhh-hccccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006620          551 -L--ELEE-DLGLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVEM  598 (638)
Q Consensus       551 -~--~~~~-~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  598 (638)
                       .  .... ..........    .....+.++.+|+.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0  0000 0000000000    111234578899999999999999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-42  Score=350.82  Aligned_cols=260  Identities=20%  Similarity=0.255  Sum_probs=198.7

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcc-eEEEEeEEEeCceEEEEEEeccC
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTSHVN-IVTLLGFCFEGHRRALIYEFVSN  402 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~  402 (638)
                      |.+.+.||+|+||+||+|++ .+++.||||++.... ..+++..|++++++++|+| |+.+.++..+++..++||||+ +
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~   86 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   86 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence            44678999999999999986 458899999987643 3356789999999998665 555666667888899999999 5


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEEC---CCCceEEcccccceeccC
Q 006620          403 GSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLD---EDFCPKISDFGLAKICEG  479 (638)
Q Consensus       403 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFg~~~~~~~  479 (638)
                      ++|.+.+....     ..+++..+..++.|+++||+|||+   ++|+||||||+|||++   .+..+||+|||+|+....
T Consensus        87 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          87 PSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             Cchhhhhhhcc-----CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            67877776543     579999999999999999999999   9999999999999985   455799999999998764


Q ss_pred             CCce-----eeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhhh
Q 006620          480 RESI-----VSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLELE  554 (638)
Q Consensus       480 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  554 (638)
                      ....     .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            4322     122345799999999999875  689999999999999999999999976543322221111111111100


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 006620          555 EDLGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVEMLEGSLD  604 (638)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  604 (638)
                              .......++.++.+++.+||+.+|++||+++++.+.|++.+.
T Consensus       237 --------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         237 --------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             --------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             --------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence                    001112345678999999999999999999999998887654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=350.92  Aligned_cols=258  Identities=20%  Similarity=0.241  Sum_probs=199.7

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCC---chhhHHHHHHHHhhcCCcceEEEEeEEEeCceEEEEEEecc
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKG---NGEDFINEVASISRTSHVNIVTLLGFCFEGHRRALIYEFVS  401 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  401 (638)
                      ++.++||+|+||+||+|++ .+++.||||+++....   ....+.+|+.++++++||||+++++++.+....++|+|++.
T Consensus         5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~   84 (292)
T d1unla_           5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence            4568999999999999996 5688999999965432   24678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccceeccCCC
Q 006620          402 NGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKICEGRE  481 (638)
Q Consensus       402 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~~~~~~  481 (638)
                      +++|..++...      ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||.++......
T Consensus        85 ~~~l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          85 QDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ccccccccccc------cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99988887754      568899999999999999999999   999999999999999999999999999999775443


Q ss_pred             ceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHhhh--------
Q 006620          482 SIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRLEL--------  553 (638)
Q Consensus       482 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  553 (638)
                      ..  .....+++.|+|||++.+. ..++.++||||+||++|||++|+.||.........  ...........        
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTG
T ss_pred             cc--ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhh
Confidence            22  2334578899999998764 35789999999999999999999997543321110  00000000000        


Q ss_pred             ---hh--h---ccccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          554 ---EE--D---LGLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       554 ---~~--~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                         ..  .   ..............+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00  0   00000111122234567889999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-42  Score=354.38  Aligned_cols=256  Identities=20%  Similarity=0.301  Sum_probs=195.9

Q ss_pred             HhhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEe--CceEEEEEEe
Q 006620          324 TNSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFE--GHRRALIYEF  399 (638)
Q Consensus       324 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~  399 (638)
                      .+.+.++||+|+||+||+|+. .+++.||||+++..  ..+.+.+|+++|++++ ||||+++++++..  ....++||||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~  113 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  113 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence            345678999999999999996 56889999998653  3567889999999996 9999999999974  4568999999


Q ss_pred             ccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCC-CceEEcccccceecc
Q 006620          400 VSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDED-FCPKISDFGLAKICE  478 (638)
Q Consensus       400 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFg~~~~~~  478 (638)
                      +.+++|.++.         ..+++..++.++.||++||+|||+   +||+||||||+|||++.+ +.+||+|||+++...
T Consensus       114 ~~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         114 VNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             CCSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             cCCCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceecc
Confidence            9999997653         348999999999999999999999   999999999999999865 469999999998776


Q ss_pred             CCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh------HHHH---H
Q 006620          479 GRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP------HWVY---K  549 (638)
Q Consensus       479 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~------~~~~---~  549 (638)
                      ....   .....+|+.|+|||.+.+. ..++.++||||+||++|||++|+.||.............      ....   .
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         182 PGQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             CCCc---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            5443   2445689999999998764 357899999999999999999999987544321110000      0000   0


Q ss_pred             Hhhhhh--h---cc--------ccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          550 RLELEE--D---LG--------LQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       550 ~~~~~~--~---~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                      ......  .   ..        ............+.++.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000  0   00        000111122345677899999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-41  Score=350.18  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=189.9

Q ss_pred             hhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEeC-----ceEEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFEG-----HRRALI  396 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  396 (638)
                      ...++||+|+||+||+|++ .+++.||||+++.....   .+.+.+|+++|++++||||+++++++...     ...+++
T Consensus        21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i  100 (348)
T d2gfsa1          21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL  100 (348)
T ss_dssp             EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence            3568999999999999985 56899999999765332   34678999999999999999999998643     344677


Q ss_pred             EEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEccccccee
Q 006620          397 YEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       397 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      ++++.+|+|.+++..       ..+++..++.++.||+.||+|||+   +||+||||||+|||++.++.+|++|||++..
T Consensus       101 ~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1         101 VTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             EEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             EEeecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence            788889999999965       359999999999999999999999   9999999999999999999999999999976


Q ss_pred             ccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchhHHHHHHh-hhhh
Q 006620          477 CEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFPHWVYKRL-ELEE  555 (638)
Q Consensus       477 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  555 (638)
                      ....     .....||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||.......    ......... ....
T Consensus       171 ~~~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~----~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         171 TDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QLKLILRLVGTPGA  240 (348)
T ss_dssp             CTGG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCH
T ss_pred             cCcc-----cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCh
Confidence            5432     2445689999999987654 356889999999999999999999997543210    000000000 0000


Q ss_pred             --------------hccccCCCCc----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          556 --------------DLGLQGIENE----EDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       556 --------------~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                                    ..........    .....+.++.+||.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                          0000000000    01123567889999999999999999999997

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=351.32  Aligned_cols=255  Identities=25%  Similarity=0.258  Sum_probs=185.1

Q ss_pred             hhhcccCcCcceeEEEEEEc-CCCEEEEEEecccCCc---hhhHHHHHHHHhhcCCcceEEEEeEEEe------CceEEE
Q 006620          326 SFKNKLGQGGYGGVYKGKLL-DGQNVAIKVLNETKGN---GEDFINEVASISRTSHVNIVTLLGFCFE------GHRRAL  395 (638)
Q Consensus       326 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l  395 (638)
                      ++.++||+|+||+||+|++. +|+.||||++......   ...+.+|+.++++++||||+++++++..      ....++
T Consensus        20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i   99 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL   99 (355)
T ss_dssp             EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred             EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence            34689999999999999964 5899999999765322   3467899999999999999999999964      368899


Q ss_pred             EEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          396 IYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       396 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                      ||||+.++ +.+.+.        ..+++..++.++.||+.||+|||+   .||+||||||+|||++.++.+|++|||+++
T Consensus       100 v~Ey~~~~-l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1         100 VMELMDAN-LCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEECCSEE-HHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEeccchH-HHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence            99999764 444443        348999999999999999999999   999999999999999999999999999988


Q ss_pred             eccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcc--------cchhHHH
Q 006620          476 ICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSE--------IYFPHWV  547 (638)
Q Consensus       476 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~  547 (638)
                      .......   .....+|+.|+|||++.+.  .++.++||||+||+++||++|+.||.........        ...+...
T Consensus       168 ~~~~~~~---~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         168 TAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             ----------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccccc---cccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            6654332   2345689999999999775  7899999999999999999999999643211000        0000000


Q ss_pred             -------HHHhhhhh--------hc---cccCCCCchhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006620          548 -------YKRLELEE--------DL---GLQGIENEEDKEYARKMILVSLWCIQTNPSDRPSMNRVVE  597 (638)
Q Consensus       548 -------~~~~~~~~--------~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  597 (638)
                             ........        ..   .............+.++.+|+.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   00000000        00   0011122234556788999999999999999999999995

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-37  Score=322.92  Aligned_cols=282  Identities=21%  Similarity=0.272  Sum_probs=198.3

Q ss_pred             hhhhcccCcCcceeEEEEEE-cCCCEEEEEEecccCCchhhHHHHHHHHhhcC-----------CcceEEEEeEEEe--C
Q 006620          325 NSFKNKLGQGGYGGVYKGKL-LDGQNVAIKVLNETKGNGEDFINEVASISRTS-----------HVNIVTLLGFCFE--G  390 (638)
Q Consensus       325 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~--~  390 (638)
                      |.+.++||+|+||+||+|+. .+++.||||+++......+.+.+|+.++++++           |+||+++++++..  .
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            45689999999999999996 56899999999876555567788999888875           5789999988764  3


Q ss_pred             ceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCC------
Q 006620          391 HRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDF------  464 (638)
Q Consensus       391 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~------  464 (638)
                      ...++++++...+.........   .....+++..++.++.||++||+|||+  ..||+||||||+|||++.++      
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          95 NGVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             TEEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cceeeeeeeccccccccccccc---ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence            5666777776554433333222   123678999999999999999999996  27899999999999997654      


Q ss_pred             ceEEcccccceeccCCCceeeecccccccceecCceeccccCCccccCCeeeHHHHHHHHhcCCCCCCcccCCCcccchh
Q 006620          465 CPKISDFGLAKICEGRESIVSMTGARGTIGYIAPEVFCRNFGEVSYKSDVYSYGMMVFEMTGEKNNANVAVDRSSEIYFP  544 (638)
Q Consensus       465 ~~kl~DFg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  544 (638)
                      .++++|||.+.......     ....||+.|+|||++.+.  .++.++||||+||++++|++|+.||.............
T Consensus       170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             eeeEeeccccccccccc-----ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence            49999999998654332     345689999999998764  68899999999999999999999997543321110000


Q ss_pred             HH-------------HHHHhhh-hhhc-------cccCC-----------CCchhHHHHHHHHHHHHHcccCCCCCCCCH
Q 006620          545 HW-------------VYKRLEL-EEDL-------GLQGI-----------ENEEDKEYARKMILVSLWCIQTNPSDRPSM  592 (638)
Q Consensus       545 ~~-------------~~~~~~~-~~~~-------~~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  592 (638)
                      ..             ....... ....       .....           ........+.++.+|+.+||+.||++|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            00             0000000 0000       00000           111234567889999999999999999999


Q ss_pred             HHHHHH--Hhcc--cCCCCCCCCCcccCCC
Q 006620          593 NRVVEM--LEGS--LDSLQIPPRPFLLSSG  618 (638)
Q Consensus       593 ~evl~~--L~~~--~~~~~~~~~p~~~~~~  618 (638)
                      +|++++  +++.  .++...|+++-..+-.
T Consensus       323 ~e~L~Hp~f~~~~~~~~~~~p~~~~~~~~~  352 (362)
T d1q8ya_         323 GGLVNHPWLKDTLGMEEIRVPDRELYGSGS  352 (362)
T ss_dssp             HHHHTCGGGTTCTTCTTCCCTTSCTTCBST
T ss_pred             HHHhcCcccCCCCCcccCCCCCcccCCCCC
Confidence            999985  6543  4455556666665443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=9.6e-24  Score=197.39  Aligned_cols=161  Identities=14%  Similarity=0.123  Sum_probs=118.6

Q ss_pred             hhcccCcCcceeEEEEEEcCCCEEEEEEecccCC-------------------chhhHHHHHHHHhhcCCcceEEEEeEE
Q 006620          327 FKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKG-------------------NGEDFINEVASISRTSHVNIVTLLGFC  387 (638)
Q Consensus       327 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~~~~  387 (638)
                      +.++||+|+||+||+|+..+|+.||||+++....                   ......+|...+.++.|.++++.+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            5689999999999999988899999998753210                   012235688889999999999887652


Q ss_pred             EeCceEEEEEEeccCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCceEECCCCceE
Q 006620          388 FEGHRRALIYEFVSNGSLEKFIHEKHPLETNQKLKWEVLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDEDFCPK  467 (638)
Q Consensus       388 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  467 (638)
                          ..+++|||+++..+.+             ++......++.|++++|+|||+   .||+||||||+|||++++ .++
T Consensus        84 ----~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred             ----CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence                2379999998755432             3334467899999999999999   999999999999999865 589


Q ss_pred             EcccccceeccCCCceeeecccccccceec------CceeccccCCccccCCeeeHHHHH
Q 006620          468 ISDFGLAKICEGRESIVSMTGARGTIGYIA------PEVFCRNFGEVSYKSDVYSYGMMV  521 (638)
Q Consensus       468 l~DFg~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~s~~~DvwslGvil  521 (638)
                      |+|||+|.........          .|..      .|.+.   ..++.++|+||+.--+
T Consensus       143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEGWR----------EILERDVRNIITYFS---RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred             EEECCCcccCCCCCcH----------HHHHHHHHHHHHHHc---CCCCCcccHHHHHHHH
Confidence            9999999765432211          1111      11222   2577899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=2.2e-06  Score=81.88  Aligned_cols=130  Identities=17%  Similarity=0.123  Sum_probs=90.7

Q ss_pred             CcceeEEEEEEcCCCEEEEEEeccc-CCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEeccCCCHHHHhhh
Q 006620          334 GGYGGVYKGKLLDGQNVAIKVLNET-KGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEFVSNGSLEKFIHE  411 (638)
Q Consensus       334 G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  411 (638)
                      ++.+.||+... +++.++||+.... ......+.+|...++.+. +--+.+++.+...++..++||++++|.++.+....
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            34568998865 5566788887543 334456778988888775 44467788888888899999999999888655432


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 006620          412 KHPLETNQKLKWEVLYKIAVGIARGLEYLHRGC-----------------------------------------------  444 (638)
Q Consensus       412 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------------------------------------------  444 (638)
                      .           .....++.++++.++.||+..                                               
T Consensus       104 ~-----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (263)
T d1j7la_         104 E-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD  172 (263)
T ss_dssp             C-----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred             c-----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence            1           112334555666666666421                                               


Q ss_pred             ---------CCCeEecccCCCceEECCCCceEEcccccce
Q 006620          445 ---------NTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       445 ---------~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                               ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                     0237999999999999877666799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=5.6e-06  Score=78.53  Aligned_cols=75  Identities=17%  Similarity=0.112  Sum_probs=54.4

Q ss_pred             ccCcCc-ceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCC--cceEEEEeEEEeCceEEEEEEeccCCCHH
Q 006620          330 KLGQGG-YGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSH--VNIVTLLGFCFEGHRRALIYEFVSNGSLE  406 (638)
Q Consensus       330 ~lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~  406 (638)
                      .+..|. .+.||+....++..+++|.....  ....+..|...++.+..  -.+.+++++..+++..++||++++|.++.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~--~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc--CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            344555 36899998877888999986543  23456778888877753  33677888888888899999999886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.57  E-value=0.00017  Score=72.75  Aligned_cols=74  Identities=14%  Similarity=0.069  Sum_probs=48.5

Q ss_pred             cccCcCcceeEEEEEEcC-CCEEEEEEeccc--------CCchhhHHHHHHHHhhcC-C--cceEEEEeEEEeCceEEEE
Q 006620          329 NKLGQGGYGGVYKGKLLD-GQNVAIKVLNET--------KGNGEDFINEVASISRTS-H--VNIVTLLGFCFEGHRRALI  396 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  396 (638)
                      +.||.|....||++...+ ++.++||.....        ....+....|.+.|+.+. +  ..+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998544 678999975421        112234556888887664 2  346666654  45566899


Q ss_pred             EEeccCCC
Q 006620          397 YEFVSNGS  404 (638)
Q Consensus       397 ~e~~~~gs  404 (638)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.29  E-value=0.00038  Score=68.08  Aligned_cols=139  Identities=13%  Similarity=0.141  Sum_probs=81.1

Q ss_pred             ceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcCCcce--EEEE-----eEEEeCceEEEEEEeccCCCHH--
Q 006620          336 YGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTSHVNI--VTLL-----GFCFEGHRRALIYEFVSNGSLE--  406 (638)
Q Consensus       336 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL~--  406 (638)
                      --.||++...+|+.|++|+.+......+++..|...+..|....+  +..+     .........+.++++++|..+.  
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            357999999899999999988766666778889888887753222  1111     1233456678899998764321  


Q ss_pred             ---------HH---hhhc---CCCCCCCCCC-------------------HH---HHHHHHHHHHHHHHHHh-cCCCCCe
Q 006620          407 ---------KF---IHEK---HPLETNQKLK-------------------WE---VLYKIAVGIARGLEYLH-RGCNTRI  448 (638)
Q Consensus       407 ---------~~---l~~~---~~~~~~~~l~-------------------~~---~~~~i~~qi~~aL~yLH-~~~~~~i  448 (638)
                               ..   ++..   ........++                   .+   .....+.++...+.-.- +....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                     01   1110   0001111111                   11   12223333333333221 2234679


Q ss_pred             EecccCCCceEECCCCceEEccccccee
Q 006620          449 LHFDIKPHNILLDEDFCPKISDFGLAKI  476 (638)
Q Consensus       449 iH~Dikp~NIll~~~~~~kl~DFg~~~~  476 (638)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899987663

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.88  E-value=0.0012  Score=66.40  Aligned_cols=72  Identities=14%  Similarity=0.176  Sum_probs=49.5

Q ss_pred             cccCcCcceeEEEEEEcCC--------CEEEEEEecccCCchhhHHHHHHHHhhcC-CcceEEEEeEEEeCceEEEEEEe
Q 006620          329 NKLGQGGYGGVYKGKLLDG--------QNVAIKVLNETKGNGEDFINEVASISRTS-HVNIVTLLGFCFEGHRRALIYEF  399 (638)
Q Consensus       329 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  399 (638)
                      +.|+.|-.-.+|++...++        +.|++++.... .......+|..+++.+. +.-..++++++..    .+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            5688788889999986542        46778877633 23345568888888886 4334577777643    578999


Q ss_pred             ccCCCH
Q 006620          400 VSNGSL  405 (638)
Q Consensus       400 ~~~gsL  405 (638)
                      ++|.+|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.60  E-value=0.003  Score=61.00  Aligned_cols=164  Identities=14%  Similarity=0.103  Sum_probs=82.5

Q ss_pred             hhhHHHHHHhcCCCCCcccchHHHHHHHhhhhcccCcCcceeEEEEEEcCCCEEEEEEecccCCchhhHHHHHHHHhhcC
Q 006620          297 YRNIEAFLRNYGSLAPKRYRYADIKKMTNSFKNKLGQGGYGGVYKGKLLDGQNVAIKVLNETKGNGEDFINEVASISRTS  376 (638)
Q Consensus       297 ~~~~~~~l~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~  376 (638)
                      ...++.++++|+-.....+             +.|..|---+.|+....+| .+++|+..... ..+++..|++++..+.
T Consensus         5 ~~el~~~l~~Y~lg~~~~~-------------~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1           5 EDELRNFLTQYDVGSLTSY-------------KGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             HHHHHHHHTTBCCCCEEEE-------------EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCceEe-------------ecCCCCcccCeEEEEECCC-cEEEEEcCCCC-CHHHHHHHHHHHHhhh
Confidence            4556667776643221111             3466677788899987655 58999986532 2344556777777765


Q ss_pred             Ccce--EEEE------eEEEeCceEEEEEEeccCCCHHH--------------HhhhcC---CCCCCCCCC---------
Q 006620          377 HVNI--VTLL------GFCFEGHRRALIYEFVSNGSLEK--------------FIHEKH---PLETNQKLK---------  422 (638)
Q Consensus       377 h~ni--v~l~------~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~---~~~~~~~l~---------  422 (638)
                      ..++  ...+      .+.........++.++.+.....              .++...   .........         
T Consensus        70 ~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (316)
T d2ppqa1          70 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD  149 (316)
T ss_dssp             HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred             hccccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhh
Confidence            3221  1111      01122345556666665532210              111100   000000000         


Q ss_pred             ---------HHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCceEECCCCceEEcccccce
Q 006620          423 ---------WEVLYKIAVGIARGLEYLHR-GCNTRILHFDIKPHNILLDEDFCPKISDFGLAK  475 (638)
Q Consensus       423 ---------~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFg~~~  475 (638)
                               .......+......+.-.+. .-..|+||+|+.++||+++.+...-|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         150 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                     00112222223333333332 234689999999999999988777899998765